PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Eguchi, H; Tsutsumi, A; Inoue, A; Odagiri, Y				Eguchi, Hisashi; Tsutsumi, Akizumi; Inoue, Akiomi; Odagiri, Yuko			Psychometric assessment of a scale to measure bonding workplace social capital	PLOS ONE			English	Article							EFFORT-REWARD IMBALANCE; FINNISH PUBLIC-SECTOR; JAPANESE VERSION; PSYCHOLOGICAL DISTRESS; ORGANIZATIONAL JUSTICE; METHODOLOGICAL QUALITY; SHORT QUESTIONNAIRE; MULTILEVEL ANALYSIS; COSMIN CHECKLIST; WORK ENGAGEMENT	OBJECTIVES: Workplace social capital (WSC) has attracted increasing attention as an organizational and psychosocial factor related to worker health. This study aimed to assess the psychometric properties of a newly developed WSC scale for use in work environments, where bonding social capital is important. METHODS: We assessed the psychometric properties of a newly developed 6-item scale to measure bonding WSC using two data sources. Participants were 1,650 randomly selected workers who completed an online survey. Exploratory factor analyses were conducted. We examined the item-item and item-total correlations, internal consistency, and associations between scale scores and a previous 8-item measure of WSC. We evaluated test-retest reliability by repeating the survey with 900 of the respondents 2 weeks later. The overall scale reliability was quantified by an intraclass coefficient and the standard error of measurement. We evaluated convergent validity by examining the association with several relevant workplace psychosocial factors using a dataset from workers employed by an electrical components company (n = 2,975). RESULTS: The scale was unidimensional. The item-item and item-total correlations ranged from 0.52 to 0.78 (p < 0.01) and from 0.79 to 0.89 (p < 0.01), respectively. Internal consistency was good (Cronbach's alpha coefficient: 0.93). The correlation with the 8-item scale indicated high criterion validity (r = 0.81) and the scale showed high test-retest reliability (r = 0.74, p < 0.01). The intraclass coefficient and standard error of measurement were 0.74 (95% confidence intervals: 0.71-0.77) and 4.04 (95% confidence intervals: 1.86-6.20), respectively. Correlations with relevant workplace psychosocial factors showed convergent validity. CONCLUSIONS: The results confirmed that the newly developed WSC scale has adequate psychometric properties.	[Eguchi, Hisashi; Tsutsumi, Akizumi] Kitasato Univ, Sch Med, Dept Publ Hlth, Sagamihara, Kanagawa, Japan; [Inoue, Akiomi] Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Dept Mental Hlth, Kitakyushu, Fukuoka, Japan; [Odagiri, Yuko] Tokyo Med Univ, Dept Prevent Med & Publ Hlth, Tokyo, Japan	Kitasato University; University of Occupational & Environmental Health - Japan; Tokyo Medical University	Eguchi, H (corresponding author), Kitasato Univ, Sch Med, Dept Publ Hlth, Sagamihara, Kanagawa, Japan.	eguchi-sgy@umin.ac.jp		Eguchi, Hisashi/0000-0002-4153-8574; Odagiri, Yuko/0000-0002-7603-4800	Ministry of Education, Culture, Sports, Science and Technology, Japan [4102-21119001]; KAKENHI from the Japan Society for the Promotion of Science [26253042]; Health and Labour Sciences Research from the Ministry of Health, Labour and Welfare, Japan [H27-RodoIppan-004]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); KAKENHI from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Health and Labour Sciences Research from the Ministry of Health, Labour and Welfare, Japan	The present study was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (Research in a Proposed Research Area) 2009-2013 (No. 4102-21119001) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, a KAKENHI Grant Number 26253042 from the Japan Society for the Promotion of Science, and a Health and Labour Sciences Research Grant 2015-2017 (H27-RodoIppan-004) from the Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The present study was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (Research in a Proposed Research Area) 2009-2013 (No. 4102-21119001) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, a KAKENHI Grant Number 26253042 from the Japan Society for the Promotion of Science, and a Health and Labour Sciences Research Grant 2015-2017 (H27-Rodo-Ippan-004) from the Ministry of Health, Labour and Welfare, Japan.	Bae K, 1997, WORK OCCUPATION, V24, P80, DOI 10.1177/0730888497024001006; Brislin RW, 2005, INT J CROSS CULT MAN, V5, P87, DOI 10.1177/1470595805050829; Choi M, 2014, INT J EPIDEMIOL, V43, P1895, DOI 10.1093/ije/dyu212; de Vet HCW, 2006, J RHEUMATOL, V33, P434; Elovainio M, 2002, AM J PUBLIC HEALTH, V92, P105, DOI 10.2105/AJPH.92.1.105; Fujino Y, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002215; Fujisawa Y, 2009, SOC SCI MED, V69, P500, DOI 10.1016/j.socscimed.2009.05.046; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Gao JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085005; Ichida Y, 2009, SOC SCI MED, V69, P489, DOI 10.1016/j.socscimed.2009.05.006; Inoue A, 2014, IND HEALTH, V52, P175, DOI 10.2486/indhealth.2013-0185; Inoue A, 2009, J OCCUP HEALTH, V51, P74, DOI 10.1539/joh.L8042; Jung J, 2012, J OCCUP ENVIRON MED, V54, P23, DOI 10.1097/JOM.0b013e318237a1b6; Jung J, 2011, J OCCUP ENVIRON MED, V53, P318, DOI 10.1097/JOM.0b013e31820d103f; Karasek R., 1985, JOB CONTENT QUESTION; Kawachi I, 2013, GLOBAL PERSPECTIVES; Kawachi I, 2008, SOCIAL CAPITAL HLTH, DOI [10.1007/978-0-387-71311-3_1, DOI 10.1007/978-0-387-71311-3_1]; Kawachi I., 2014, SOCIAL EPIDEMIOLOGY, P290, DOI DOI 10.1093/MED/9780195377903.003.0008; Kawakami N, 1995, INT J BEHAV MED, V2, P358, DOI 10.1207/s15327558ijbm0204_5; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kobayashi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088084; Kouvonen A, 2008, ADDICTION, V103, P1857, DOI 10.1111/j.1360-0443.2008.02315.x; Kouvonen A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-251; Kouvonen A, 2008, AM J EPIDEMIOL, V167, P1143, DOI 10.1093/aje/kwn067; Kurioka S, 2013, J OCCUP HEALTH, V55, P340, DOI 10.1539/joh.12-0235-OA; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; MOORMAN RH, 1991, J APPL PSYCHOL, V76, P845, DOI 10.1037/0021-9010.76.6.845; Odagiri Y, 2010, SANGYO EISEIGAKU ZAS, V52, P631; Oksanen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065846; Oksanen T, 2012, J HYPERTENS, V30, P1129, DOI 10.1097/HJH.0b013e32835377ed; Oksanen T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024732; Oksanen T, 2011, AM J PUBLIC HEALTH, V101, P1742, DOI 10.2105/AJPH.2011.300166; Oksanen T, 2010, J EPIDEMIOL COMMUN H, V64, P684, DOI 10.1136/jech.2008.086074; Oshio T, 2016, J EPIDEMIOL COMMUN H, V70, P25, DOI 10.1136/jech-2015-205962; Oshio T, 2014, IND HEALTH, V52, P313, DOI 10.2486/indhealth.2014-0032; Oyserman D, 2002, PSYCHOL BULL, V128, P3, DOI 10.1037/0033-2909.128.1.3; Schaubroeck J, 2000, J APPL PSYCHOL, V85, P512, DOI 10.1037//0021-9010.85.4.512; Schaufeli WB, 2006, EDUC PSYCHOL MEAS, V66, P701, DOI 10.1177/0013164405282471; Shimazu A, 2008, APPL PSYCHOL-INT REV, V57, P510, DOI 10.1111/j.1464-0597.2008.00333.x; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Siegrist J, 2009, INT ARCH OCC ENV HEA, V82, P1005, DOI 10.1007/s00420-008-0384-3; Streiner DL, 2014, HLTH MEASUREMENT SCA; Suzuki E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051717; Suzuki E, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-489; Suzuki E, 2010, SOC SCI MED, V70, P1367, DOI 10.1016/j.socscimed.2010.01.014; Szreter S, 2004, INT J EPIDEMIOL, V33, P650, DOI 10.1093/ije/dyh013; Terwee CB, 2012, QUAL LIFE RES, V21, P651, DOI 10.1007/s11136-011-9960-1; Tsuboya T, 2015, OCCUP ENVIRON MED, V72, P188, DOI 10.1136/oemed-2014-102427; Van Bogaert P, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01261; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.3.CO;2-5; Wang YY, 2011, J BUS ETHICS, V101, P111, DOI 10.1007/s10551-010-0712-x	51	8	8	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179461	10.1371/journal.pone.0179461	http://dx.doi.org/10.1371/journal.pone.0179461			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JX	28662058	gold, Green Published, Green Submitted			2022-12-27	WOS:000404608300024
J	Kralik, I; Stefanic, M; Brkic, H; Saric, G; Tezak, S; Ivankovic, SG; Griotto, N; Stimac, D; Rubin, O; Salha, T; Ivanisevic, Z; Jurkovic, S; Faj, D				Kralik, Ivana; Stefanic, Mario; Brkic, Hrvoje; Saric, Gordan; Tezak, Stanko; Ivankovic, Svjetlana Grbac; Griotto, Neva; Stimac, Damir; Rubin, Otmar; Salha, Tamer; Ivanisevic, Zrinka; Jurkovic, Slaven; Faj, Dario			Estimated collective effective dose to the population from nuclear medicine diagnostic procedures in Croatia: A comparison of 2010 and 2015	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; FEBRILE INFANTS; UTI	Objective This study presents national surveys of patient exposure from nuclear medicine (NM) diagnostic procedures in 2010 and 2015 in the Republic of Croatia. Methods The survey was performed according to the European Commission Dose DataMed (DDM) project methodology. 28 most frequent NM diagnostic procedures were identified. Data about frequencies of procedures and average administered activities of radioisotopes used in those procedures were collected. Average administered activities were converted to effective doses according to the dose conversion coefficients. Then the collective effective dose to the population and an effective dose per capita were calculated based on the number of the most frequent NM diagnostic procedures and the average effective dose per procedure. Results In 2010, 41200 NM diagnostic procedures led to 146.7 manSv collective effective dose to the population and in 2015, 42000 NM diagnostic procedures led to 146.8 manSv collective effective dose to the population. The frequencies of NM diagnostic procedures were 9.7 and 9.8 annually per 1000 population with 34.1 pSv and 34.2 pSv effective dose per capita for 2010 and 2015, respectively. The main contributors to the annual collective dose from NM in Croatia are examinations of the bone, heart, thyroid and PET/CT tumour diagnostic. Average administered activities have not changed considerably from 2010 to 2015. Nevertheless, within the frequency of some of the procedures, significant changes were found in fiveyear period. Conclusions Frequencies, average administered activities and collective effective dose to the population from NM diagnostic procedures in Croatia are comparable to the values reported by other European surveys. Changes were found between 2010 and 2015 and we intend to perform this study periodically to identify possible trends, but also to raise awareness about the potential dose optimization.	[Kralik, Ivana] State Off Radiol & Nucl Safety, Zagreb, Croatia; [Stefanic, Mario; Brkic, Hrvoje; Saric, Gordan; Stimac, Damir; Rubin, Otmar; Salha, Tamer; Ivanisevic, Zrinka; Faj, Dario] Josip Juraj Strossmayer Univ Osijek, Fac Med, Osijek, Croatia; [Stefanic, Mario; Saric, Gordan; Stimac, Damir; Rubin, Otmar; Salha, Tamer] Univ Hosp Ctr Osijek, Osijek, Croatia; [Tezak, Stanko] Univ Hosp Ctr Zagreb, Zahreb, Croatia; [Ivankovic, Svjetlana Grbac; Griotto, Neva; Jurkovic, Slaven] Univ Hosp Ctr Rijeka, Rijeka, Croatia; [Ivankovic, Svjetlana Grbac; Griotto, Neva; Jurkovic, Slaven] Univ Rijeka, Fac Med, Rijeka, Croatia	University of JJ Strossmayer Osijek; University of Zagreb; University of Rijeka; University of Rijeka	Faj, D (corresponding author), Josip Juraj Strossmayer Univ Osijek, Fac Med, Osijek, Croatia.	dariofaj@mefos.hr	Stimac, Davor/S-7420-2018; Brkić, Hrvoje/B-8477-2013; Štimac, Davor/ABF-7086-2020	Stimac, Davor/0000-0001-8243-2453; Brkić, Hrvoje/0000-0001-6692-6875; IVANISEVIC, ZRINKA/0000-0002-2952-0574; Kralik, Ivana/0000-0002-2912-3472; Faj, Dario/0000-0002-4111-5459; Stefanic, Mario/0000-0001-8995-6137				Andrea C, PRISTUP DJETETU S PR; Balat D, 2014, WORKSH EUR POP DOS M, P26; Clement C. H., 2008, Annals of the ICRP, V38, P1, DOI 10.1016/j.icrp.2008.08.003; European Commision, 2008, EUR GUID EST POP DOS; European Commision. Medical Radiation Exposure of the European Population, 2014, RAD PROTECTION; ICRP, 1988, ANN ICRP, V18; ICRP International commission for radiation protection (ICRP), 1998, ANN ICRP, V28, P1; Kusic Z, 2005, COLLEGIUM ANTROPOL, V29, P9; Kusie Z, 2008, LIJECNICKI VJESNIK, V131, P328; La Scola C, 2013, PEDIATRICS, V131, pE665, DOI 10.1542/peds.2012-0164; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; Montini G, 2009, PEDIATRICS, V123, pE239, DOI 10.1542/peds.2008-1003; National Council on Radiation Protection and Measurements, 2009, 160 NCRP; Nichols M, 2014, EUROPEAN HEART J; Prlie I, 2010, ARHIV HIGIJENU RADA, V61, P69; Roberts KB, 2011, PEDIATRICS, V128, P595, DOI 10.1542/peds.2011-1330; Shrimpton P, 2008, FREQUENCY COLLECTIVE; Skrk D, 2013, RADIOL ONCOL, V47, P304, DOI 10.2478/raon-2013-0048; Teles P, 2013, RADIAT PROT DOSIM, V154, P446, DOI 10.1093/rpd/ncs258; Tsapaki V, 2009, AM J ROENTGENOL, V193, P559, DOI 10.2214/AJR.08.2115; Yeh DM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165526	21	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180057	10.1371/journal.pone.0180057	http://dx.doi.org/10.1371/journal.pone.0180057			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662092	gold, Green Submitted, Green Published			2022-12-27	WOS:000404608300094
J	Ruis, C; Roy, S; Brown, JR; Allen, DJ; Goldstein, RA; Breuer, J				Ruis, Christopher; Roy, Sunando; Brown, Julianne R.; Allen, David J.; Goldstein, Richard A.; Breuer, Judith			The emerging GII.P16-GII.4 Sydney 2012 norovirus lineage is circulating worldwide, arose by late-2014 and contains polymerase changes that may increase virus transmission	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; TOOL	Noroviruses are a leading cause of human gastroenteritis worldwide. The norovirus genotype GII.4 is the most prevalent genotype in the human population and has caused six pandemics since 1995. A novel norovirus lineage containing the GII.P16 polymerase and pandemic GII.4 Sydney 2012 capsid was recently detected in Asia and Germany. We demonstrate that this lineage is also circulating within the UK and USA and has been circulating since October 2014 or earlier. While the lineage does not contain unique substitutions in the capsid, it does contain polymerase substitutions close to positions known to influence polymerase function and virus transmission. These polymerase substitutions are shared with a GII.P16-GII.2 virus that dominated outbreaks in Germany in Winter 2016. We suggest that the substitutions in the polymerase may have resulted in a more transmissible virus and the combination of this polymerase and the pandemic GII.4 capsid may result in a highly transmissible virus. Further surveillance efforts will be required to determine whether the GII.P16-GII.4 Sydney 2012 lineage increases in frequency over the coming months.	[Ruis, Christopher; Roy, Sunando; Goldstein, Richard A.; Breuer, Judith] UCL, Div Infect & Immun, London, England; [Brown, Julianne R.; Breuer, Judith] Great Ormond St Hosp Sick Children, Dept Microbiol Virol & Infect Control, London, England; [Allen, David J.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Pathogen Mol Biol, London, England; [Allen, David J.] Publ Hlth England, Virus Reference Dept, Natl Infect Serv, London, England; [Allen, David J.] NIHR Hlth Protect Res Unit Gastrointestinal Infec, London, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; Public Health England	Ruis, C (corresponding author), UCL, Div Infect & Immun, London, England.	christopher.ruis.10@ucl.ac.uk		Brown, Julianne/0000-0002-4681-9586; Breuer, Judith/0000-0001-8246-0534; Goldstein, Richard/0000-0001-5148-4672	UCL CoMPLEX; Wellcome Trust [203268/Z/16/Z]; National Institute for Health Research (NIHR) [NIHRHCS-D12-03-15]; Medical Research Council (UK) [MC_U117573805]; UCL/UCLHNIHR Biomedical Resource Centre; Engineering and Physical Sciences Research Council [1206225, 1488410] Funding Source: researchfish; Medical Research Council [MC_PC_13056, 1241875] Funding Source: researchfish; National Institute for Health Research [NIHR-HCS-D12-03-15] Funding Source: researchfish; MRC [MC_PC_13056] Funding Source: UKRI	UCL CoMPLEX; Wellcome Trust(Wellcome Trust); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UCL/UCLHNIHR Biomedical Resource Centre; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CR is funded by a studentship form UCL CoMPLEX. SR is funded by the Wellcome Trust grant 203268/Z/16/Z (websitehttps://wellcome.ac.uk/). JRB is funded by a National Institute for Health Research (NIHR) doctoral fellowship (NIHRHCS-D12-03-15, websitehttp://www.nihr.ac.uk/). DJA is affiliated to the National Institute for Health Research Health Protection Research Unit (NIHRHPRU) in Gastrointestinal Infections at University of Liverpool in partnership with Public Health England (PHE), in collaboration with University of East Anglia, University of Oxford and the Institute of Food Research. DJA is based at London School of Hygiene & Tropical Medicine and Public Health England. RAG is funded by the Medical Research Council (UK) grant MC_U117573805 (websitehttps://www.mrc.ac.uk/) .JB receives funding from the UCL/UCLHNIHR Biomedical Resource Centre (websitehttps://www.uclh.nhs.uk/Research/BRC/Pages/Home.aspx).	Arias A, 2016, MSPHERE, P1; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Brown JR, 2016, J CLIN MICROBIOL, V54, P2530, DOI 10.1128/JCM.01052-16; Bull RA, 2007, J GEN VIROL, V88, P3347, DOI 10.1099/vir.0.83321-0; Bull RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000831; Choi YS, 2017, FOOD ENV VIROL; de Graaf M, 2016, NAT REV MICROBIOL, V14, P421, DOI 10.1038/nrmicro.2016.48; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Matsushima Y, 2016, GENOME ANNOUNC, P4; Niendorf S, 2017, EUROSURVEILLANCE, V22, P2, DOI [10.2807/1560-7917.ES.2017.22.4.30447, 10.2807/1560-7917.ES.2017.22.4.304472]; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Vinje J, 2015, J CLIN MICROBIOL, V53, P373, DOI 10.1128/JCM.01535-14; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	15	53	57	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179572	10.1371/journal.pone.0179572	http://dx.doi.org/10.1371/journal.pone.0179572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662035	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000404608300034
J	Agunos, A; Leger, DF; Carson, CA; Gow, SP; Bosman, A; Irwin, RJ; Reid-Smith, RJ				Agunos, Agnes; Leger, David F.; Carson, Carolee A.; Gow, Sheryl P.; Bosman, Angelina; Irwin, Rebecca J.; Reid-Smith, Richard J.			Antimicrobial use surveillance in broiler chicken flocks in Canada, 2013-2015	PLOS ONE			English	Article							USAGE	There is a paucity of data on the reason for and the quantity of antimicrobials used in broiler chickens in Canada. To address this, the Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) implemented surveillance of antimicrobial use (AMU) and antimicrobial resistance (AMR) in broiler chicken flocks in 2013. Shortly after this (2014), the poultry industry banned the preventive use of ceftiofur in broiler chickens. The objectives of this analysis were to describe antimicrobial use (AMU) in Canadian broiler chickens between 2013 and 2015 (n = 378 flocks), compare these results to other animal species in Canada, to highlight the utility of farm surveillance data to evaluate the impact of a policy change, and to explore how different antimicrobial use metrics might affect data interpretation and communication. The surveillance data indicated that the poultry industry policy resulted in lower antimicrobial use and resistance, and they successfully captured information on when, where, why, and how much antimicrobials were being used. The majority of antimicrobials were administered via the feed (95%). The relative frequency of antimicrobial classes used in broiler chickens differed from those used in swine or in food animal production in general. Coccidiostats were the most frequently used antimicrobial classes (53% of total kg). Excluding coccidiostats, the top three most frequently used antimicrobial classes were bacitracin (53% of flocks), virginiamycin (25%) and avilamycin (21%), mainly used for the prevention of necrotic enteritis. Depending on the AMU metric utilized, the relative rankings of the top antimicrobials changed; hence the choice of the AMU metric is an important consideration for any AMU reporting. When using milligrams/Population Correction Unit (mg/PCU) the top three antimicrobial classes used were bacitracins (76 mg/PCU), trimethoprim-sulfonamides (24 mg/PCU), and penicillins (15 mg/PCU), whereas when using a number of Defined Daily Doses in animals using Canadian standards/1,000 chicken-days at risk (nDDDvetCA/1,000 CD) the ranking was bacitracins (223nDDDvetCA/1,000 CD), streptogramins (118 nDDDvetCA/1,000 CD), and trimethoprim-sulfonamides (87 nDDDvetCA/1,000 CD). The median animal treatment days in feed for one cycle (ATD/cycle) during the three-year study were 34 ATD/cycle; this was equal to the mean age of the flocks at pre-harvest sampling day (days at risk), indicating that the studied flocks except those that were raised without antibiotics and organic, were fed with medicated rations throughout the observation period. Overall, more than half (59%) of antimicrobials used in broiler chickens were in classes not used in human medicine, such as ionophores and chemical coccidiostats aimed to prevent coccidiosis. Compared to grower-finisher pigs and in production animal species (national sales data), the mg/PCU of antimicrobials used in broiler chickens was relatively lower. The findings of this paper highlighted the importance of farm-level AMU surveillance in measuring the impact of interventions to reduce antimicrobials in poultry.	[Agunos, Agnes; Leger, David F.; Carson, Carolee A.; Bosman, Angelina; Irwin, Rebecca J.; Reid-Smith, Richard J.] Publ Hlth Agcy Canada, Ctr Foodborne Environm & Zoonot Infect Dis, Guelph, ON, Canada; [Gow, Sheryl P.] Publ Hlth Agcy Canada, Ctr Foodborne Environm & Zoonot Infect Dis, Saskatoon, SK, Canada	Public Health Agency of Canada; Public Health Agency of Canada	Agunos, A (corresponding author), Publ Hlth Agcy Canada, Ctr Foodborne Environm & Zoonot Infect Dis, Guelph, ON, Canada.	agnes.agunos@phac-aspc.gc.ca		Bosman, Angelina/0000-0003-1815-4537; Agunos, Agnes/0000-0003-2357-3509	Public Health Agency of Canada; Saskatchewan Agriculture; Alberta Agriculture and Forestry	Public Health Agency of Canada; Saskatchewan Agriculture; Alberta Agriculture and Forestry	The CIPARS farm surveillance program is funded by the Public Health Agency of Canada. In 2013-2015, the Saskatchewan Agriculture and Alberta Agriculture and Forestry provided partial funding.There was no additional external funding received during the study period.	AgriMedia Inc, 2013, CAN CHICK FARM PLAN; Apley MD, 2012, FOODBORNE PATHOG DIS, V9, P272, DOI 10.1089/fpd.2011.0983; Bos MEH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077525; Boulianne M, 2016, CAN J VET RES, V80, P49; Canadian Animal Health Institute, 2016, COMP VET PROD; Canadian Food Inspection Agency, 2016, COMP MED INGR BROCH; Carrique-Mas JJ, 2015, ZOONOSES PUBLIC HLTH, V62, P70, DOI 10.1111/zph.12165; Chalmers G, 2008, J CLIN MICROBIOL, V46, P3957, DOI 10.1128/JCM.01548-08; Chauvin C, 2008, J VET PHARMACOL THER, V31, P301, DOI 10.1111/j.1365-2885.2008.00960.x; Chicken Farmers of Canada, 2017, ALL CAL 2016 2017, P1; Chicken Farmers of Canada, 2016, RESP ANT US CAN CHIC; Collignon PC, 2016, CLIN INFECT DIS, V63, P1087, DOI 10.1093/cid/ciw475; Collineau L, 2016, ZOONOSES PUBLIC HLTH; DANMAP, 2016, DANMAP 2015 US ANT A, P144; European Medicines Agency, 2017, GUID PROV D IN PRESS, P36; European Medicines Agency, 2016, 6 ESVAC EUR MED AG, P176; European Medicines Agency, 2015, PRINC ASS DEF DAIL D, P68; European Medicines Agency, 2016, DEF DAIL DOS AN DDDV, P29; Government of Canada, 2017, FOOD DRUGS ACT REG A, V151; Government of Canada, 2015, FED ACT PLAN ANT RES; Health Canada, 2009, VET DRUGS DIR CAT AN; Health Canada, 2014, NOT STAK COLL EFF PR; Lanckriet A, 2010, AVIAN PATHOL, V39, P63, DOI 10.1080/03079450903505771; MARAN, 2015, MON ANT RES ANT US A, P190; McDougald LR, 2013, DIS POULTRY, V13th, P1148; Nilsson O, 2016, VET MICROBIOL, V184, P80, DOI 10.1016/j.vetmic.2016.01.012; Nolan LK., 2020, DIS POULTRY, P770, DOI 10.1002/9781119421481.ch18; OIE, 2018, TERR ANIM HLTH CODE, V1, P1; Ontario Animal Health Network Poultry Network, 2016, ONT AN HLTH NETW Q R; Persoons D, 2012, PREV VET MED; PHAC, 2015, CAN INT PROGR ANT RE, P1; Public Health Agency of Canada, 2016, PUBL HLTH AG CAN SUR; Public Health Agency of Canada, 2016, CAN ANT RES SURV SYS; Slavic D, 2011, CAN J VET RES, V75, P89; VKM, 2015, RISK DEV ANT RES US, V30, P1; World Health Organization (WHO), 2016, WHO GLOB ACT PLAN AN, P28	36	34	35	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179384	10.1371/journal.pone.0179384	http://dx.doi.org/10.1371/journal.pone.0179384			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658278	Green Submitted, gold, Green Published			2022-12-27	WOS:000404607900023
J	Akkermans, DHM				Akkermans, Dirk H. M.			Net profit flow per country from 1980 to 2009: The long-term effects of foreign direct investment	PLOS ONE			English	Article							QUANTILE REGRESSION; POLITICAL REGIMES; ECONOMIC-GROWTH; FDI; FIRMS; MODELS; SYSTEM	Aim of the paper The paper aims at describing and explaining net profit flows per country for the period 1980-2009. Net profit flows result from Foreign Direct Investment (FDI) stock and profit repatriation: inward stock creating a profit outflow and outward FDI stock a profit inflow. Profit flows, especially 'normal' ones are not commonly researched. Theoretical background According to world-system theory, countries are part of a system characterised by a core, semi-periphery and periphery, as shown by network analyses of trade relations. Network analyses based on ownership relations of TransNational Corporations (TNCs) show that the top 50 firms that control about 40% of the world economy are almost exclusively located in core countries. So, we may expect a hierarchy in net profit flows with core countries on top and the periphery at the bottom. FDI outflows from the core countries especially rose in the 1990s, so we may expect that the difference has grown in time. Data and results A dataset on 'net profit flow' per country is developed. There are diverging developments in net profit flows since the 1980s, as expected: ever more positive for core countries, negative and ever lower for semi-peripheral and peripheral countries, in particular from the 1990s onwards. A fixed effects quantile regression using publicly available data confirms the prediction that peripheral countries share a unique characteristic: their outward investments do not have a positive influence on net profit flow as is the case with semi-peripheral and core countries. The most probable explanation is that peripheral outward investments are indirectly owned by firms located in core and semi-peripheral countries, so all peripheral profit inflows end up in those countries.	[Akkermans, Dirk H. M.] Univ Groningen, Fac Econ & Business, Dept Global Econ & Management, Groningen, Netherlands	University of Groningen	Akkermans, DHM (corresponding author), Univ Groningen, Fac Econ & Business, Dept Global Econ & Management, Groningen, Netherlands.	d.h.m.akkermans@rug.nl		Akkermans, Dirk/0000-0003-0266-5682				Acemoglu D., 2012, FOREIGN POLICY, P85; Aidt TS, 2011, J DEV ECON, V94, P192, DOI 10.1016/j.jdeveco.2010.01.016; Airault P., 2013, COTE IVOIRE SIFCA ST; Akinrinade S, 2008, GLOBAL S, V2, P159, DOI DOI 10.2979/GSO.2008.2.2.159; Alfaro L, 2004, J INT ECON, V64, P89, DOI 10.1016/S0022-1996(03)00081-3; Altshuler R, 2000, REPATRIATION TAXES R; Amendolagine V, 2013, FDI LOCAL LINKAGES D; [Anonymous], 2014, CAPTURING GAINS AFRI; [Anonymous], 2014, GGDC RES MEMORANDUM; Arnett G., 2015, 3 QUART DECL EU LOBB; Babones SJ, 2012, J WORLD SYST RES, V18, P266, DOI 10.5195/JWSR.2012.470; Bairoch P., 1993, EC WORLD HIST MYTHS; Baker R., 2005, DIRTY MONEY RENEW FR; Barrios S, 2011, EUR ECON REV, V55, P862, DOI 10.1016/j.euroecorev.2010.10.002; Bashir A., 2011, ANAL EXISTING MECH T; Bechtel, 2016, BECHT REP 2016; Beder Sharon, 2006, SUITING THEMSELVES C; Bellemare M. F., 2015, LAGGED EXPLANATORY V; Bennett W.G., 2016, SAMWOP 5 U FREE STAT; Berne Declaration, 2011, COMM SWITZ MOST DANG; Berne Union, 2010, BERN UN YB 2010; Bertocchi G, 2002, EUR ECON REV, V46, P1851, DOI 10.1016/S0014-2921(01)00195-7; Beugelsdijk S, 2008, INT BUS REV, V17, P452, DOI 10.1016/j.ibusrev.2008.02.004; Beugelsdijk S, 2010, J INT BUS STUD, V41, P1444, DOI 10.1057/jibs.2010.29; Blackmon P, 2014, THIRD WORLD Q, V35, P1423, DOI 10.1080/01436597.2014.946260; Blades D, 2014, UNDERSTANDING NATL A; Blattman C, 2010, J ECON LIT, V48, P3, DOI 10.1257/jel.48.1.3; Blonigen BA, 2004, INAPPROPRIATE POOLIN; Bloom N, 2010, AM ECON REV, V100, P619, DOI 10.1257/aer.100.2.619; Bloom N, 2010, J ECON PERSPECT, V24, P203, DOI 10.1257/jep.24.1.203; Borensztein E, 1998, J INT ECON, V45, P115, DOI 10.1016/S0022-1996(97)00033-0; Borgatti S.P., 2018, ANAL SOCIAL NETWORKS; Borgatti SP, 1999, SOC NETWORKS, V21, P375; Bornschier Volker., 1985, TRANSNATIONAL CORPOR; Brambor T, 2006, POLIT ANAL, V14, P63, DOI 10.1093/pan/mpi014; Bruno R.L., 2013, REEXAMINING CONDITIO; Brynildsen O., 2011, EXPORTING GOODS EXPO; Brzezinski Z., 1997, AM PRIMACY ITS GEOST; Brzezinski Z., 2016, AM INTERES, P11; Calderon C, 2004, GREENFIELD FOREIGN D; Canay IA, 2011, ECONOMET J, V14, P368, DOI 10.1111/j.1368-423X.2011.00349.x; Carkovic M V., 2002, DOES FOREIGN DIRECT; Chang H.-J., 2003, KICKING AWAY LADDER; Charlton A., 2003, INCENTIVE BIDDING MO; Chinn MD., 2008, J COMP POLICY ANAL, V10, P309, DOI [10.1080/13876980802231123, DOI 10.1080/13876980802231123]; Chinn MD, 2006, J DEV ECON, V81, P163, DOI 10.1016/j.jdeveco.2005.05.010; Christensen J, 2012, CRIME LAW SOCIAL CH, V57, P325, DOI 10.1007/s10611-011-9347-9; Clark R, 2009, INT J COMP SOCIOL, V50, P5, DOI 10.1177/0020715208098615; Coen D, 1997, J EUR PUBLIC POLICY, V4, P91, DOI 10.1080/135017697344253; Coen D., 2007, 393 PE, P266; Commission on Intellectual Property Rights, 2002, INT INT PROP RIGHTS; de Faria P, 2010, RES POLICY, V39, P956, DOI 10.1016/j.respol.2010.03.005; Deindustrialisation Tregenna F., 2015, DEINDUSTRIALISATION; Dhar B, 2012, N S S S DIMENSION; Dicken P., 2011, MAPPING CHANGING CON; Donnelly Thomas, 2000, REBUILDING AM DEFENS; Doucouliagos H, 2010, 201014 SWP; Dreher A, 2015, WORLD DEV, V66, P346, DOI 10.1016/j.worlddev.2014.08.007; Farole T, 2011, DIR DEV, P1, DOI 10.1596/978-0-8213-8763-4; Farole T., 2010, PERFORMANCE POLICY P; Feria K, 2013, I FOREIGN DIRECT INV; Gereffi G., 2016, GLOBAL VALUE CHAIN A, V2nd; Gereffi G, 1994, STUD POLIT EC WORLD; Gilens M, 2014, PERSPECT POLIT, V12, P564, DOI 10.1017/S1537592714001595; Gonzalez A, 2015, TRADE POST MAK INT T; Gordon K., 2009, OECD INVEST POLICY P, P91; Grimes PE, 2000, A WORLD SYSTEMS READ; Gruie B, 2014, BIS DEBT SECURITIES, P14; Haberly D, 2014, J EC GEOGR; Hanneman R.A., 2005, INTRO SOCIAL NETWORK; Harms P, 2011, FDI IS FDI IS FDI GR, P10; Harvey D., 2005, BRIEF HIST NEOLIBERA; Hassan E., 2010, INTELLECTUAL PROPERT; Henry JS, 2003, TALES GLOBAL UNDERGR; Hermes N, 2003, J DEV STUD, V40, P142, DOI 10.1080/00220380412331293707; Hudson M., 2003, SUPER IMPERIALISM OR, V2nd ed; Vu H, 2014, APPL ECON LETT, V21, P442, DOI 10.1080/13504851.2013.866197; IMF, 2017, COMM PRIC IND EXT DA; International Monetary Fund IMF, 1993, BAL PAYM MAN, V5, P191; Jacobs LM, 2016, J WORLD SYST RES, V22, P373, DOI 10.5195/JWSR.2016.624; Jude C, 2016, WORLD EC; Kamaly A., 2014, MODERN EC, V5, P391, DOI [DOI 10.4236/ME.2014.54038, 10.4236/ME.2014.54038]; Kaplinsky R., 2005, POVERTY INEQUALITY R; Kar D., 2015, ILLICIT FINANCIAL FL; Kentor J, 2003, AM SOCIOL REV, V68, P301, DOI 10.2307/1519770; Killick T, 2005, IMF WORLD BANK POLIC, P244; Kinzer Stephen, 2006, OVERTHROW AM CENTURY; KPMG, 2017, TAX EFF SUPPL CHAIN; Lanz R, 2011, INTRAFIRM TRADE PATT; Larsson B., 2015, NORD J WORK LIFE STU, P5; Ledyaeva S, ROUND TRIP INVESTMEN; Liberti S., 2013, JOURNEYS NEW COLONIA; Lloyd P, 2009, J WORLD SYST RES, V15, P48, DOI 10.5195/JWSR.2009.335; Mahutga M., 2006, SOC FORCES, V84, P1863; Marangos John, 2009, J SOCIO-ECON, V38, P197, DOI [10.1016/j.socec.2008.07.007, DOI 10.1016/J.SOCEC.2008.07.007]; Marshall MG, 2014, DATASET USERS MANUAL, P86; Milanovic B, 2012, WORLD BANK POLICY RE; Milberg W, 2008, ECON SOC, V37, P420, DOI 10.1080/03085140802172706; Moon S., 2008, DOES TRIPS ART 66 2; MORAVCSIK AM, 1989, INT ORGAN, V43, P173, DOI 10.1017/S0020818300004598; Ndikumana L, 2010, AFR DEV REV, V22, P471, DOI 10.1111/j.1467-8268.2010.00243.x; Neto P., 2008, IMPACT FDI CROSS BOR; Neumayer E, 2005, WORLD DEV, V33, P1567, DOI 10.1016/j.worlddev.2005.07.001; Nolan P., 2002, CONTRIBUTIONS POLITI, V21, P91, DOI [DOI 10.1093/CPE/21.1.91, 10.1093/cpe/21.1.91]; Norris P, 2015, PEI35; Nunnenkamp P., 2003, FOREIGN DIRECT INVES; OECD, 2008, OECD BENCHM DEF FOR, V4, DOI 10.1787/9789264045743-en; Ozawa T., 1992, T CORPORATIONS, V1, P27; Palest G., 2012, STEAL ELECTION 9 EAS; Parente P.M.D.C., 2016, J EC METHODS, V5, P1, DOI DOI 10.1515/JEM-2014-0011; Pearce F., 2013, LAND GRABBERS NEW FI; Perkins John., 2004, CONFESSIONS EC HIT M; Piketty T., 2014, CAPITAL 21 CENTURY; Prebisch R, 1950, ECON BULL LAT AM, V7, P1; PRZEWORSKI A, 1993, J ECON PERSPECT, V7, P51, DOI 10.1257/jep.7.3.51; PWC, 2014, NAV COMPL FIND FIN T; Reinhart CM, 2009, THIS TIME IS DIFFERENT: EIGHT CENTURIES OF FINANCIAL FOLLY, P1; Reuter P, 2012, DRAINING DEVELOPMENT?: CONTROLLING FLOWS OF ILLICIT FUNDS FROM DEVELOPING COUNTRIES, P1; Rodrik D., 2011, DEMOCRACY AND THE FU; Rodrik D, 2016, J ECON GROWTH, V21, P1, DOI 10.1007/s10887-015-9122-3; Sabido P, 2013, A YEAR OF BROKEN PRO; Saggi K, 2002, WORLD BANK RES OBSER, V17, P191, DOI 10.1093/wbro/17.2.191; Seabra F, 2005, EC B, P6; Shaxson N., 2011, UNCOVERING DAMAGE OF; Shoup LH, 1977, COUNCIL FOREIGN RELA; Shoup LH, 2015, COUNCIL FOREIGN RELA; SIFCA, 2014, SIFCA 2014 ANN REP; Singer HW, 1950, AM ECON REV, V40, P473; Sonangol, 2015, SON REL CONT 2015 CO; Sornarajah M, 2010, INT LAW FOREIGN INVE; Staff of the International Monetary Fund, 1997, ESAF 10 YEARS EC ADJ; TERLOUW CP, 1993, INT J COMP SOCIOL, V34, P87, DOI 10.1177/002071529303400106; Terlouw Kees, 2003, CAPITALISM NATURE SO, V14, P71, DOI DOI 10.1080/10455750308565547; U.S. Department of Commerce, 2005, US AFR TRAD PROF, P1; UNCTAD, 2006, WORLD INVESTMENT REP; UNCTAD, 2013, GLOBAL VALUE CHAINS; UNCTAD, 2000, WORLD INV REP 2000 C; UNCTAD, 1992, WORLD INV REP; Unctad W., 2014, REV MAR TRANSP; UNDP, 2011, HUM RES SUST MDG PRO; United Nations Conference on Trade and Development (UNCTAD), 2012, STAT COMM DEP; van der Veer KJM, 2015, J RISK INSUR, V82, P601, DOI 10.1111/jori.12034; Varoufakis Y., 2011, GLOBAL MINOTAUR AM T; Vitali S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104655; Vitali S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025995; Wallerstein I, 2011, MOD WORLD SYST, V1, P1; Wallerstein I., 2006, WORLD SYSTEMS ANAL I; Wang M, 2009, KYKLOS, V62, P316, DOI 10.1111/j.1467-6435.2009.00438.x; Weeks J., 2005, IMF WORLD BANK POLIC, P256; Weyzig F., 2013, INT FINANCE TAX AVOI; Williamson J, 1998, ESSAYS INT FINANC; Working Party of the Trade Committee, 2012, MAPP GLOB VAL CHAINS; World Bank, 2011, ENVIRON DEV, P1, DOI 10.1596/978-0-8213-8488-6; World Bank, 2014, IND FOR DIR INV REG; World Bank, 2017, INT DEBT STAT 2017; WTO, 1995, ANN 1C AGR TRAD REL, P33; Xiao G., 2004, ROUND TRIPPING FOREI; Yang B, 2008, APPL ECON LETT, V15, P105, DOI 10.1080/13504850600749081; ZCCM Investments Holdings PLC, 2015, ANN REP 2015; Zucman G., 2015, MISSING WEALTH NATIO; Zucman G, 2013, Q J ECON, V128, P1321, DOI 10.1093/qje/qjt012	162	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179244	10.1371/journal.pone.0179244	http://dx.doi.org/10.1371/journal.pone.0179244			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ2LT	28654644	Green Published, gold, Green Submitted			2022-12-27	WOS:000404541500007
J	Mitsopoulos, P; Lapohos, O; Weraarpachai, W; Antonicka, H; Chang, YH; Madrenas, J				Mitsopoulos, Panagiotis; Lapohos, Orsolya; Weraarpachai, Woranontee; Antonicka, Hana; Chang, Yu-Han; Madrenas, Joaquin			Stomatin-like protein 2 deficiency results in impaired mitochondrial translation	PLOS ONE			English	Article							DNA; ACTIVATION; RIBOSOMES	Mitochondria translate the RNAs for 13 core polypeptides of respiratory chain and ATP synthase complexes that are essential for the assembly and function of these complexes. This process occurs in close proximity to the mitochondrial inner membrane. However, the mechanisms and molecular machinery involved in mitochondrial translation are not fully understood, and defects in this process can result in severe diseases. Stomatin-like protein (SLP)-2 is a mainly mitochondrial protein that forms cardiolipin- and prohibitin-enriched microdomains in the mitochondrial inner membrane that are important for the formation of respiratory supercomplexes and their function. Given this regulatory role of SLP-2 in processes closely associated with the mitochondrial inner membrane, we hypothesized that the function of SLP-2 would have an impact on mitochondrial translation. 35 S-Methionine/cysteine pulse labeling of resting or activated T cells from T cell-specific Slp-2 knockout mice showed a significant impairment in the production of several mitochondrial DNA-encoded polypeptides following T cell activation, including Cytb, COXI, COXII, COXIII, and ATP6. Measurement of mitochondrial DNA stability and mitochondrial transcription revealed that this impairment was at the post-transcriptional level. Examination of mitochondrial ribosome assembly showed that SLP-2 migrated in sucrose-density gradients similarly to the large ribosomal subunit but that its deletion at the genetic level did not affect mitochondrial ribosome assembly. Functionally, the impairment in mitochondrial translation correlated with decreased interleukin-2 production in activated T cells. Altogether, these data show that SLP-2 acts as a general regulator of mitochondrial translation.	[Mitsopoulos, Panagiotis; Lapohos, Orsolya; Chang, Yu-Han; Madrenas, Joaquin] McGill Univ, Dept Microbiol & Immunol, Microbiome & Dis Tolerance Ctr, Montreal, PQ, Canada; [Mitsopoulos, Panagiotis; Lapohos, Orsolya; Chang, Yu-Han; Madrenas, Joaquin] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Weraarpachai, Woranontee; Antonicka, Hana] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Weraarpachai, Woranontee; Antonicka, Hana] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Weraarpachai, Woranontee] Chiang Mai Univ, Fac Med, Dept Biochem, Chiang Mai, Thailand	McGill University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; McGill University; McGill University; Chiang Mai University	Madrenas, J (corresponding author), McGill Univ, Dept Microbiol & Immunol, Microbiome & Dis Tolerance Ctr, Montreal, PQ, Canada.; Madrenas, J (corresponding author), Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA.	joaquin.madrenas@labiomed.org	Madrenas, Quim/P-5008-2019	Antonicka, Hana/0000-0002-2525-2867	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research.	Antonicka H, 2015, CELL REP, V10, P920, DOI 10.1016/j.celrep.2015.01.030; Bogenhagen DF, 2014, CELL METAB, V19, P618, DOI 10.1016/j.cmet.2014.03.013; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Christie DA, 2012, J IMMUNOL, V189, P4349, DOI 10.4049/jimmunol.1103829; Christie DA, 2011, MOL CELL BIOL, V31, P3845, DOI 10.1128/MCB.05393-11; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Greber BJ, 2016, ANNU REV BIOCHEM, V85, P103, DOI 10.1146/annurev-biochem-060815-014343; He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266; Kirchhof MG, 2008, J IMMUNOL, V181, P1927, DOI 10.4049/jimmunol.181.3.1927; Leary SC, 2009, METHODS MOL BIOL, V554, P143, DOI 10.1007/978-1-59745-521-3_10; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Liu MQ, 2000, J BIOL CHEM, V275, P29400, DOI 10.1074/jbc.M002173200; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Mai N, 2017, CELL TISSUE RES, V367, P5, DOI 10.1007/s00441-016-2456-0; Malik AN, 2016, MITOCHONDRION, V29, P59, DOI 10.1016/j.mito.2016.05.003; Mayr JA, 2015, J INHERIT METAB DIS, V38, P629, DOI 10.1007/s10545-015-9831-y; Mitsopoulos P, 2015, MOL CELL BIOL, V35, P1838, DOI 10.1128/MCB.00047-15; Mitsopoulos P, 2013, METHOD CELL BIOL, V117, P411, DOI 10.1016/B978-0-12-408143-7.00022-0; O'Brien T, 2003, IUBMB LIFE, V55, P505, DOI 10.1080/15216540310001626610; Ott M, 2006, EMBO J, V25, P1603, DOI 10.1038/sj.emboj.7601070; Pfeffer S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7019; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Smits P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/737385; SPITHILL TW, 1978, MOL GEN GENET, V164, P155, DOI 10.1007/BF00267380; VANDERKLEI IJ, 1994, MICROSC RES TECHNIQ, V27, P284, DOI 10.1002/jemt.1070270404; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wessels HJCT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068340	29	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179967	10.1371/journal.pone.0179967	http://dx.doi.org/10.1371/journal.pone.0179967			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654702	Green Published, gold, Green Submitted			2022-12-27	WOS:000404541500042
J	Blazevic, S; Horvaticek, M; Kesic, M; Zill, P; Hranilovic, D; Ivanisevic, M; Desoye, G; Stefulj, J				Blazevic, Sofia; Horvaticek, Marina; Kesic, Maja; Zill, Peter; Hranilovic, Dubravka; Ivanisevic, Marina; Desoye, Gernot; Stefulj, Jasminka			Epigenetic adaptation of the placental serotonin transporter gene (SLC6A4) to gestational diabetes mellitus	PLOS ONE			English	Article							DNA METHYLATION; HOUSEKEEPING GENES; FETAL-GROWTH; EXPRESSION; SYSTEM; ASSOCIATION; PROMOTER; HEALTH; PCR; POLYMORPHISMS	We tested the hypothesis that gestational diabetes mellitus (GDM) alters the DNA methylation pattern of the fetal serotonin transporter gene (SLC6A4), and examined the functional relevance of DNA methylation for regulation of the SLC6A4 expression in the human placenta. The study included 50 mother-infant pairs. Eighteen mothers were diagnosed with GDM and 32 had normal glucose tolerance (NGT). All neonates were of normal birth weight and born at term by planned Cesarean section. DNA and RNA were isolated from samples of tissue collected from the fetal side of the placenta immediately after delivery. DNA methylation was quantified at 7 CpG sites within the SLC6A4 distal promoter region using PCR amplification of bisulfite treated DNA and subsequent DNA sequencing. SLC6A4 mRNA levels were measured by reverse transcription D quantitative PCR (RT-qPCR). Functional SLC6A4 polymorphisms (5HTTLPR, STin2, rs25531) were genotyped using standard PCRbased procedures. Average DNA methylation across the 7 analyzed loci was decreased in the GDM as compared to the NGT group (by 27.1%, p = 0.037) and negatively correlated, before and after adjustment for potential confounder/s, with maternal plasma glucose levels at the 24th to 28th week of gestation (p<0.05). Placental SLC6A4 mRNA levels were inversely correlated with average DNA methylation (p = 0.010) while no statistically significant association was found with the SLC6A4 genotypes (p>0.05). The results suggest that DNA methylation of the fetal SLC6A4 gene is sensitive to the maternal metabolic state in pregnancy. They also indicate a predominant role of epigenetic over genetic mechanisms in the regulation of SLC6A4 expression in the human placenta. Longitudinal studies in larger cohorts are needed to verify these results and determine to which degree placental SLC6A4 changes may contribute to long-term outcomes of infants exposed to GDM.	[Blazevic, Sofia; Hranilovic, Dubravka] Univ Zagreb, Fac Sci, Dept Biol, Zagreb, Croatia; [Horvaticek, Marina; Ivanisevic, Marina] Clin Hosp Ctr Zagreb, Dept Obstet & Gynecol, Zagreb, Croatia; [Kesic, Maja; Stefulj, Jasminka] Rudjer Boskovic Inst, Div Mol Biol, Zagreb, Croatia; [Zill, Peter] Ludwig Maximilian Univ Munich, Dept Psychiat, Munich, Germany; [Desoye, Gernot] Med Univ Graz, Dept Obstet & Gynecol, Graz, Austria; [Stefulj, Jasminka] Catholic Univ Croatia, Dept Psychol, Zagreb, Croatia	University of Zagreb; University of Zagreb; Rudjer Boskovic Institute; University of Munich; Medical University of Graz	Stefulj, J (corresponding author), Rudjer Boskovic Inst, Div Mol Biol, Zagreb, Croatia.; Stefulj, J (corresponding author), Catholic Univ Croatia, Dept Psychol, Zagreb, Croatia.	jasminka.stefulj@irb.hr	Stefulj, Jasminka/A-1267-2011; Blazevic, Sofia A/I-3516-2012	Blazevic, Sofia A/0000-0003-2895-4853; Desoye, Gernot/0000-0002-5715-3230	German Academic Exchange Service and Croatian Ministry of Science, Education and Sport; Catholic University of Croatia	German Academic Exchange Service and Croatian Ministry of Science, Education and Sport; Catholic University of Croatia	The study was supported by the bilateral mobility grant of the German Academic Exchange Service and Croatian Ministry of Science, Education and Sport (to JS and PZ), and by the grant of Catholic University of Croatia (to JS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alasaari JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045813; Allard C, 2015, EPIGENETICS-US, V10, P342, DOI 10.1080/15592294.2015.1029700; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; BALKOVETZ DF, 1989, J BIOL CHEM, V264, P2195; Baumann M, 2013, PLACENTA, V34, P1079, DOI 10.1016/j.placenta.2013.06.309; Bergman Y, 2013, NAT STRUCT MOL BIOL, V20, P274, DOI 10.1038/nsmb.2518; Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972; Booij L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119061; Booij L, 2015, J PSYCHIATR NEUROSCI, V40, P5, DOI 10.1503/jpn.140099; Cleal JK, 2009, PLACENTA, V30, P1002, DOI 10.1016/j.placenta.2009.09.002; Crane JD, 2015, NAT MED, V21, P166, DOI 10.1038/nm.3766; Crume TL, 2011, J PEDIATR-US, V158, P941, DOI 10.1016/j.jpeds.2010.12.007; Desgagne V, 2014, EPIGENOMICS-UK, V6, P193, DOI 10.2217/epi.14.3; Devlin AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012201; Domschke K, 2014, INT J NEUROPSYCHOPH, V17, P1167, DOI 10.1017/S146114571400039X; El Hajj N, 2014, REPRODUCTION, V148, pR111, DOI 10.1530/REP-14-0334; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Gilbert WM, 1999, OBSTET GYNECOL, V93, P536, DOI 10.1016/S0029-7844(98)00484-0; Holbrook JD, 2016, EPIGENOMICS-UK, V8, P1173, DOI 10.2217/epi-2016-0079; Homberg JR, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00212; Houde AA, 2015, EPIGENOMICS-UK, V7, P1111, DOI 10.2217/epi.15.72; Hranilovic D, 2004, BIOL PSYCHIAT, V55, P1090, DOI 10.1016/j.biopsych.2004.01.029; Hranilovic D, 2003, BIOL PSYCHIAT, V54, P884, DOI 10.1016/S0006-3223(03)00179-3; Hranilovic D, 2016, AUTISM RES, V9, P204, DOI 10.1002/aur.1519; Januar V, 2015, AM J OBSTET GYNECOL, V213, pS182, DOI 10.1016/j.ajog.2015.07.011; Jiang MH, 2010, LAB INVEST, V90, P282, DOI 10.1038/labinvest.2009.132; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kang HJ, 2013, PROG NEURO-PSYCHOPH, V44, P23, DOI 10.1016/j.pnpbp.2013.01.006; Kinast K, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00072; Lawlor DA, 2011, CIRCULATION, V123, P258, DOI 10.1161/CIRCULATIONAHA.110.980169; Li YC, 2016, J BIOL CHEM, V291, P9657, DOI 10.1074/jbc.M116.713693; Li YC, 2014, P NATL ACAD SCI USA, V111, pE5697, DOI 10.1073/pnas.1416675112; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovrencic MV, 2013, BIOCHEM MEDICA, V23, P7, DOI 10.11613/BM.2013.002; Meller M, 2005, PLACENTA, V26, P601, DOI 10.1016/j.placenta.2004.09.009; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Montirosso R, 2016, EPIGENOMICS-UK, V8, P895, DOI 10.2217/epi-2016-0010; Muller CL, 2016, NEUROSCIENCE, V321, P24, DOI 10.1016/j.neuroscience.2015.11.010; Murphy DL, 2011, CURR OPIN PHARMACOL, V11, P3, DOI 10.1016/j.coph.2011.02.008; Murthi P, 2008, PLACENTA, V29, P798, DOI 10.1016/j.placenta.2008.06.007; Nikolova YS, 2014, NAT NEUROSCI, V17, P1153, DOI 10.1038/nn.3778; Odgerel Z, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.80; Petropoulos S, 2015, ENDOCRINOLOGY, V156, P2222, DOI 10.1210/en.2014-1643; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Provenzi L, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00099; RAMAMOORTHY S, 1993, P NATL ACAD SCI USA, V90, P2542, DOI 10.1073/pnas.90.6.2542; Retnakaran R, 2003, J CLIN ENDOCR METAB, V88, P3507, DOI 10.1210/jc.2003-030186; Sacks KN, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.03.030; Sandovici I, 2012, REPROD BIOMED ONLINE, V25, P68, DOI 10.1016/j.rbmo.2012.03.017; Tarrade A, 2015, J EXP BIOL, V218, P50, DOI 10.1242/jeb.110320; Torloni MR, 2009, OBES REV, V10, P194, DOI 10.1111/j.1467-789X.2008.00541.x; Tylee DS, 2013, AM J MED GENET B, V162, P595, DOI 10.1002/ajmg.b.32150; Unal R, 2007, J NEUROCHEM, V101, P937, DOI 10.1111/j.1471-4159.2007.04469.x; Van Lelyveld N, 2007, NEUROGASTROENT MOTIL, V19, P342, DOI 10.1111/j.1365-2982.2006.00891.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Velasquez JC, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00047; Viau M, 2009, REPROD BIOMED ONLINE, V19, P207, DOI 10.1016/S1472-6483(10)60074-0; Wang DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039501; Watanabe H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147143; Xiang AH, 2015, JAMA-J AM MED ASSOC, V313, P1425, DOI 10.1001/jama.2015.2707; Ye JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100192; Zill P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040479	63	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179934	10.1371/journal.pone.0179934	http://dx.doi.org/10.1371/journal.pone.0179934			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650965	Green Submitted, Green Published, gold			2022-12-27	WOS:000404537300031
J	Hu, W; Li, WJ; Chen, H; Liu, J; Wang, SY; Chen, JH				Hu, Wei; Li, Wenjian; Chen, Hao; Liu, Jing; Wang, Shuyang; Chen, Jihong			Changes in transcript levels of starch hydrolysis genes and raising citric acid production via carbon ion irradiation mutagenesis of Aspergillus niger	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; BEAM IRRADIATION; MUTANT STRAIN; AMYLASE GENES; AMYR; OPTIMIZATION; ACTIVATOR; RICE; ACCUMULATION; BIOREACTOR	The filamentous ascomycete Aspergillus niger is well known for its ability to accumulate citric acid for the hydrolysis of starchy materials. To improve citric acid productivity, heavy ion beam mutagenesis was utilized to produce mutant A. niger strains with enhanced production of citric acid in this work. It was demonstrated that a mutant HW2 with high concentration of citric acid was isolated after carbon ion irradiation with the energy of 80Mev/mu, which was obvious increase higher than the original strain from liquefied corn starch as a feedstock. More importantly, with the evidence from the expression profiles of key genes and enzyme activity involved in the starch hydrolysis process between original strain and various phenotype mutants, our results confirmed that different transcript levels of key genes involving in starch hydrolysis process between original strain and mutants could be a significant contributor to different citric acid concentration in A. niger, such as, amyR and glaA, which therefore opened a new avenue for constructing genetically engineered A. niger mutants for high-yield citric acid accumulation in the future. As such, this work demonstrated that heavy ion beam mutagenesis presented an efficient alternative strategy to be developed to generate various phenotype microbe species mutants for functional genes research.	[Hu, Wei; Li, Wenjian; Liu, Jing; Wang, Shuyang; Chen, Jihong] Chinese Acad Sci, Inst Modern Phys, Lanzhou, Gansu, Peoples R China; [Chen, Hao] Gansu Agr Univ, Coll Food Sci & Engn, Lanzhou, Gansu, Peoples R China	Chinese Academy of Sciences; Institute of Modern Physics, CAS; Gansu Agricultural University	Hu, W; Chen, JH (corresponding author), Chinese Acad Sci, Inst Modern Phys, Lanzhou, Gansu, Peoples R China.	hudongli007@impcas.ac.cn; chjh@impcas.ac.cn		Hu, Wei/0000-0002-6678-9468	National Natural Science Foundation of China [11605259]; western talents program of the Chinese Academy of Sciences [Y706030XB0]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); western talents program of the Chinese Academy of Sciences	This work was supported financially by National Natural Science Foundation of China (No.11605259) and the western talents program of the Chinese Academy of Sciences (Y706030XB0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTON L L, 1972, Journal of Bacteriology, V111, P771; Betiku E, 2013, BIOMASS BIOENERG, V55, P350, DOI 10.1016/j.biombioe.2013.02.034; Bizukojc M, 2010, WORLD J MICROB BIOT, V26, P41, DOI 10.1007/s11274-009-0140-1; Bohle K, 2007, J BIOTECHNOL, V132, P353, DOI 10.1016/j.jbiotec.2007.08.005; Carlsen M, 2001, APPL MICROBIOL BIOT, V57, P346, DOI 10.1007/s002530100772; Chen QF, 2014, GENET MOL RES, V13, P7029, DOI 10.4238/2014.March.26.9; Chen Y, 2016, CURR OPIN BIOTECH, V37, P165, DOI 10.1016/j.copbio.2015.11.004; Dhillon GS, 2013, IND CROP PROD, V41, P78, DOI 10.1016/j.indcrop.2012.04.001; Du Y, 2014, MUTAT RES-GEN TOX EN, V759, P28, DOI 10.1016/j.mrgentox.2013.07.018; Gomi K, 2000, BIOSCI BIOTECH BIOCH, V64, P816, DOI 10.1271/bbb.64.816; Guo JS, 2016, SCI REP-UK, V6, DOI 10.1038/srep25949; Henriksen ALS, 1999, MICROBIOL-SGM, V145, P729, DOI 10.1099/13500872-145-3-729; Hirano T, 2012, MUTAT RES-FUND MOL M, V735, P19, DOI 10.1016/j.mrfmmm.2012.04.010; Hu GR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060700; Hu W, 2016, J ZHEJIANG UNIV-SC B, V17, P262, DOI 10.1631/jzus.B1500120; Hu W, 2014, J ZHEJIANG UNIV-SC B, V15, P1006, DOI 10.1631/jzus.B1400132; Ishikawa S, 2012, P NATL ACAD SCI USA, V109, P19166, DOI 10.1073/pnas.1211132109; Jiang BL, 2017, NUCL SCI TECH, V28, DOI 10.1007/s41365-016-0157-8; Karaffa L, 2003, APPL MICROBIOL BIOT, V61, P189, DOI 10.1007/s00253-002-1201-7; Kazama Y, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-161; Krull R, 2013, J BIOTECHNOL, V163, P112, DOI 10.1016/j.jbiotec.2012.06.024; Lesniak W, 2002, BIOTECHNOL LETT, V24, P1065, DOI 10.1023/A:1016030513270; Li SW, 2011, APPL BIOCHEM BIOTECH, V165, P913, DOI 10.1007/s12010-011-9308-x; Li ZL, 2016, OXID MED CELL LONGEV, V2016, P12, DOI DOI 10.1007/S10529-016-2066-7; Liu JH, 2016, APPL SPECTROSC, V70, P1639, DOI 10.1177/0003702816645605; Lofty WA, 2007, BIORESOURCE TECHNOL, V98, P3470, DOI 10.1016/j.biortech.2006.11.032; Lotfy WA, 2007, BIORESOURCE TECHNOL, V98, P3464, DOI 10.1016/j.biortech.2006.11.007; Lu D, 2010, PLASMA SCI TECHNOL, V12, P753, DOI 10.1088/1009-0630/12/6/21; Murai K, 2013, NUCL INSTRUM METH B, V314, P59, DOI 10.1016/j.nimb.2013.05.026; PAPAGIANNI M, 1994, BIOTECHNOL LETT, V16, P929, DOI 10.1007/BF00128627; Petersen KL, 1999, MOL GEN GENET, V262, P668, DOI 10.1007/s004380051129; Sarangbin S, 1999, CARBOHYD POLYM, V38, P219, DOI 10.1016/S0144-8617(98)00094-0; Show PL, 2015, FRONT LIFE SCI, V8, P271, DOI 10.1080/21553769.2015.1033653; Soccol CR, 2006, FOOD TECHNOL BIOTECH, V44, P141; Suzuki A, 1996, J FERMENT BIOENG, V81, P320, DOI 10.1016/0922-338X(96)80584-8; Takano N, 2013, J RADIAT RES, V54, P637, DOI 10.1093/jrr/rrt007; Tani S, 2001, CURR GENET, V39, P10, DOI 10.1007/s002940000175; vanKuyk PA, 2012, APPL MICROBIOL BIOT, V93, P285, DOI 10.1007/s00253-011-3550-6; Vendruscolo F, 2008, CRIT REV BIOTECHNOL, V28, P1, DOI [10.1080/07388550801913840, 10.1080/07388550801913840 ]; Wang BS, 2017, BIOPROC BIOSYST ENG, V40, P45, DOI 10.1007/s00449-016-1673-y; Wang L, 2016, APPL MICROBIOL BIOT, V100, P5791, DOI 10.1007/s00253-016-7324-z; Yamada K, 2016, SCI REP-UK, V6, DOI 10.1038/srep26327; Yang L, 2017, FUNGAL BIOL REV, V31, P33, DOI 10.1016/j.fbr.2016.11.001; Yang Y., 2013, CHINA BREWING, V32, P22; Yuan XL, 2008, MOL GENET GENOMICS, V279, P545, DOI 10.1007/s00438-008-0332-7; Zhang H, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0463-1	46	5	6	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0180120	10.1371/journal.pone.0180120	http://dx.doi.org/10.1371/journal.pone.0180120			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650980	Green Submitted, Green Published, gold			2022-12-27	WOS:000404537300040
J	Radli, M; Veprintsev, DB; Rudiger, SGD				Radli, Martina; Veprintsev, Dmitry B.; Rudiger, Stefan G. D.			Production and purification of human Hsp90 beta in Escherichia coli	PLOS ONE			English	Article							MOLECULAR CHAPERONE; ATPASE ACTIVITY; EUKARYOTIC HSP90; PROTEIN; REVEALS; PROTEOSTASIS; HYDROLYSIS; COMPLEX; BINDING; DOMAIN	The molecular chaperone Hsp90 is an essential member of the cellular proteostasis system. It plays an important role in the stabilisation and activation of a large number of client proteins and is involved in fatal disease processes, e.g. Alzheimer disease, cancer and cystic fibrosis. This makes Hsp90 a crucial protein to study. Mechanistic studies require large amounts of protein but the production and purification of recombinant human Hsp90 in Escherichia coli is challenging and laborious. Here we identified conditions that influence Hsp90 production, and optimised a fast and efficient purification protocol. We found that the nutrient value of the culturing medium and the length of induction had significant effect on Hsp90 production in Escherichia coli. Our fast, single-day purification protocol resulted in a stable, well-folded and pure sample that was resistant to degradation in a reproducible manner. We anticipate that our results provide a useful tool to produce higher amount of pure, well-folded and stable recombinant human Hsp90 beta in Escherichia coli in an efficient way.	[Radli, Martina; Rudiger, Stefan G. D.] Univ Utrecht, Bijvoet Ctr Biomol Res, Cellular Prot Chem, Padualaan 8, Utrecht, Netherlands; [Radli, Martina; Rudiger, Stefan G. D.] Univ Utrecht, Sci Life, Utrecht, Netherlands; [Veprintsev, Dmitry B.] Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland; [Veprintsev, Dmitry B.] Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland	Utrecht University; Utrecht University; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Rudiger, SGD (corresponding author), Univ Utrecht, Bijvoet Ctr Biomol Res, Cellular Prot Chem, Padualaan 8, Utrecht, Netherlands.; Rudiger, SGD (corresponding author), Univ Utrecht, Sci Life, Utrecht, Netherlands.	s.g.d.rudiger@uu.nl	Veprintsev, Dmitry B/H-2228-2012; Rüdiger, Stefan GD/G-4906-2012	Veprintsev, Dmitry B/0000-0002-3583-5409; Rüdiger, Stefan GD/0000-0002-1807-2972	Internationale Stichting Alzheimer Onderzoek (ISAO) [14542]; FP7 ITN-IDP "ManiFold" [317371]; FP7 ITN "WntsApp" [608180]; Netherlands Organisation for Health Research and Development (ZonMW) [91215084]	Internationale Stichting Alzheimer Onderzoek (ISAO); FP7 ITN-IDP "ManiFold"; FP7 ITN "WntsApp"; Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	This work was supported by the Internationale Stichting Alzheimer Onderzoek (ISAO), grant No. 14542, (https://www.alzheimernederland.nl), FP7 ITN-IDP "ManiFold", grant No. 317371, Marie Curie Actions, Europeans Commission, (https://ec.europa.eu/research/ mariecurieactions/), FP7 ITN "WntsApp", grant No. 608180, Marie Curie Actions, Europeans Commission, (https://ec.eurona.eu/research/ mariecurieactions/) and The Netherlands Organisation for Health Research and Development (ZonMW), Grant No. 91215084 (https //www zonmw.nl/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Buchner J, 1998, METHOD ENZYMOL, V290, P409, DOI 10.1016/S0076-6879(98)90034-9; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Collins T, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-21; Freeman BC, 2000, GENE DEV, V14, P422; Freeman BC, 1996, EMBO J, V15, P2969, DOI 10.1002/j.1460-2075.1996.tb00660.x; Garnier C, 2002, BIOCHEMISTRY-US, V41, P11770, DOI 10.1021/bi025650p; Gordon E, 2008, PROTEIN EXPRES PURIF, V62, P1, DOI 10.1016/j.pep.2008.07.005; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Hipp M. S., 2014, TRENDS CELL BIOL; JAKOB U, 1995, J BIOL CHEM, V270, P14412, DOI 10.1074/jbc.270.24.14412; Karagoz GE, 2014, CELL, V156, P963, DOI 10.1016/j.cell.2014.01.037; Karagoz GE, 2011, P NATL ACAD SCI USA, V108, P580, DOI 10.1073/pnas.1011867108; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kirschke E, 2014, CELL, V157, P1685, DOI 10.1016/j.cell.2014.04.038; Lepyrier E, 2015, BBA-PROTEINS PROTEOM, V1854, P1412, DOI 10.1016/j.bbapap.2015.07.003; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; McLaughlin SH, 2002, J MOL BIOL, V315, P787, DOI 10.1006/jmbi.2001.5245; Moullintraffort L, 2010, FEBS J, V277, P292; Neckers L, 2007, J BIOSCIENCES, V32, P517, DOI 10.1007/s12038-007-0051-y; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pearl LH, 2016, BIOPOLYMERS, V105, P594, DOI 10.1002/bip.22835; PEDERSEN S, 1978, CELL, V14, P179, DOI 10.1016/0092-8674(78)90312-4; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Richter K, 2001, J BIOL CHEM, V276, P33689, DOI 10.1074/jbc.M103832200; Richter K, 2008, J BIOL CHEM, V283, P17757, DOI 10.1074/jbc.M800540200; Rudiger S, 2002, P NATL ACAD SCI USA, V99, P11085, DOI 10.1073/pnas.132393699; Sivashanmugam A, 2009, PROTEIN SCI, V18, P936, DOI 10.1002/pro.102; Southworth DR, 2011, MOL CELL, V42, P771, DOI 10.1016/j.molcel.2011.04.023; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Verba KA, 2016, SCIENCE, V352, P1542, DOI 10.1126/science.aaf5023; WIECH H, 1992, NATURE, V358, P169, DOI 10.1038/358169a0; Workman P, 2004, CANCER LETT, V206, P149, DOI 10.1016/j.canlet.2003.08.032	37	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0180047	10.1371/journal.pone.0180047	http://dx.doi.org/10.1371/journal.pone.0180047			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651008	Green Published, gold, Green Submitted			2022-12-27	WOS:000404537300038
J	Sheng, C; Xia, MR; Yu, HK; Huang, Y; Lu, Y; Liu, F; He, Y; Han, Y				Sheng, Can; Xia, Mingrui; Yu, Haikuo; Huang, Yue; Lu, Yan; Liu, Fang; He, Yong; Han, Ying			Abnormal global functional network connectivity and its relationship to medial temporal atrophy in patients with amnestic mild cognitive impairment	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; ALZHEIMERS-DISEASE; BRAIN ACTIVITY; LOW-FREQUENCY; LOBE ATROPHY; HEAD MOTION; DEMENTIA; MRI; HUBS; ORGANIZATION	Background Amnestic mild cognitive impairment (aMCI), which is recently considered as a high risk status for developing Alzheimer's disease (AD), manifests with gray matter atrophy and increased focal functional activity in the medial temporal lobe (MTL). However, the abnormalities of whole-brain functional network connectivity in aMCI and its relationship to medial temporal atrophy (MTA) remain unknown. Methods In this study, thirty-six aMCI patients and thirty-five healthy controls (HCs) were recruited. Neuropsychological assessments and MTA visual rating scaling were carried out on all participants. Furthermore, whole brain functional network was constructed at voxel level, and functional connectivity strength (FCS) was computed as the sum of the connections for each node to capture its global integrity. General linear model was used to analyze the FCS values differences between aMCI and HCs. Then, the regions showing significant FCS differences were adopted as the imaging markers for discriminative analysis. Finally, the relationship between FCS values and clinical cognitive scores was correlated in patients with aMCI. Results Comparing to HCs, aMCI exhibited significant atrophy in the MTL, while higher FCS values within the bilateral MTL regions and orbitofrontal cortices. Notably, the right hippocampus had the highest classification power, with the area under receiver operating characteristics (ROC) curve (AUC) of 0.790 (confidence interval: 0.678, 0.901). Moreover, FCS values of the right hippocampus and the left temporal pole were positively correlated with the cognitive performance in aMCI. Conclusion This study demonstrated significantly structural atrophy and raised global functional integrity in the MTL, suggesting simultaneous disruption and compensation in prodromal AD. Increased intrinsic functional connectivity in the MTL may have the potential to discriminate subjects with tendency to develop AD.	[Sheng, Can; Han, Ying] Capital Med Univ, XuanWu Hosp, Dept Neurol, Beijing, Peoples R China; [Sheng, Can; Liu, Fang] Tsinghua Univ, Hosp 1, Dept Neurol, Beijing, Peoples R China; [Sheng, Can; Han, Ying] Beijing Inst Brain Disorders, Ctr Alzheimers Dis, Beijing, Peoples R China; [Xia, Mingrui; He, Yong] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China; [Xia, Mingrui; He, Yong] Beijing Normal Univ, Beijing Key Lab Brain Imaging & Connect, Beijing, Peoples R China; [Xia, Mingrui; He, Yong] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing, Peoples R China; [Yu, Haikuo] Capital Med Univ, XuanWu Hosp, Dept Rehabil, Beijing, Peoples R China; [Huang, Yue] UNSW Australia, Fac Med, Sch Med Sci, Sydney, NSW, Australia; [Lu, Yan] Capital Med Univ, XuanWu Hosp, Dept Ophthalmol, Beijing, Peoples R China; [Han, Ying] Beijing Inst Geriatr, Beijing, Peoples R China; [Han, Ying] Natl Clin Res Ctr Geriatr Disorders, Beijing, Peoples R China; [Han, Ying] PKU Care Rehabil Hosp, Beijing, Peoples R China	Capital Medical University; Tsinghua University; Beijing Normal University; Beijing Normal University; Beijing Normal University; Capital Medical University; University of New South Wales Sydney; Capital Medical University	Han, Y (corresponding author), Capital Med Univ, XuanWu Hosp, Dept Neurol, Beijing, Peoples R China.; Han, Y (corresponding author), Beijing Inst Brain Disorders, Ctr Alzheimers Dis, Beijing, Peoples R China.; Han, Y (corresponding author), Beijing Inst Geriatr, Beijing, Peoples R China.; Han, Y (corresponding author), Natl Clin Res Ctr Geriatr Disorders, Beijing, Peoples R China.; Han, Y (corresponding author), PKU Care Rehabil Hosp, Beijing, Peoples R China.	hanying@xwh.ccmu.edu.cn	He, Yong/Q-5756-2018; Huang, Yue/ABI-7205-2020; Xia, Mingrui/J-3267-2019; Sheng, Can/HHT-0186-2022; He, Yong/C-2161-2009	Huang, Yue/0000-0001-6051-2241; Xia, Mingrui/0000-0003-4615-9132; He, Yong/0000-0002-7039-2850	National Key Research and Development Program of China [2016YFC1306300]; National Natural Science Foundation of China [31371007, 81430037, 61633018, 81401479, 81671767]; Beijing Nature Science Foundation [7161009]; Beijing Municipal Science & Technology Commission [Z131100006813022, Z161100002616020, Z141107002514116]; Capital Medical University [16JL-L08]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nature Science Foundation(Beijing Natural Science Foundation); Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); Capital Medical University	This article was supported by the National Key Research and Development Program of China (2016YFC1306300), National Natural Science Foundation of China (Grant No. 31371007, 81430037, 61633018), Beijing Nature Science Foundation (7161009), Beijing Municipal Science & Technology Commission (Z131100006813022, Z161100002616020), Fundamental and Clinical Cooperative Research Program of Capital Medical University (16JL-L08), which were received by Dr. Ying Han. Dr. Yan Lu is the receiver of Beijing Municipal Science & Technology Commission (Z141107002514116). Dr. Mingrui Xia is the receiver of National Natural Science Foundation of China (Grant No. 81401479, 81671767). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Alegret M, 2014, J ALZHEIMERS DIS, V41, P739, DOI 10.3233/JAD-132516; Alsop DC, 2008, NEUROIMAGE, V42, P1267, DOI 10.1016/j.neuroimage.2008.06.006; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brewer AA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00074; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Cho H, 2009, ARCH GERONTOL GERIAT, V48, P415, DOI 10.1016/j.archger.2008.03.014; Crossley NA, 2014, BRAIN, V137, P2382, DOI 10.1093/brain/awu132; Dai ZJ, 2015, CEREB CORTEX, V25, P3723, DOI 10.1093/cercor/bhu246; Das SR, 2013, HIPPOCAMPUS, V23, P1, DOI 10.1002/hipo.22051; Dickerson BC, 2004, ANN NEUROL, V56, P27, DOI 10.1002/ana.20163; Dickerson BC, 2005, NEUROLOGY, V65, P404, DOI 10.1212/01.wnl.0000171450.97464.49; Du HX, 2015, CNS NEUROSCI THER, V21, P802, DOI 10.1111/cns.12431; Espinosa A, 2013, J ALZHEIMERS DIS, V34, P769, DOI 10.3233/JAD-122002; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Gour N, 2011, NEUROIMAGE, V58, P687, DOI 10.1016/j.neuroimage.2011.05.090; Hamalainen A, 2007, NEUROBIOL AGING, V28, P1889, DOI 10.1016/j.neurobiolaging.2006.08.008; Hampel H, 2011, PROG NEUROBIOL, V95, P718, DOI 10.1016/j.pneurobio.2011.11.008; Han Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028664; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; Harper L, 2016, BRAIN, V139, P1211, DOI 10.1093/brain/aww005; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Jessen F, 2014, ALZHEIMERS DEMENT, V10, P844, DOI 10.1016/j.jalz.2014.01.001; Jessen F, 2014, ALZHEIMERS DEMENT, V10, P76, DOI 10.1016/j.jalz.2012.09.017; Jin MW, 2012, MAGN RESON IMAGING, V30, P48, DOI 10.1016/j.mri.2011.07.007; Korf ESC, 2004, NEUROLOGY, V63, P94, DOI 10.1212/01.WNL.0000133114.92694.93; Li X, 2014, J GERIATR PSYCH NEUR, V27, P188, DOI 10.1177/0891988714524629; Li YX, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4680972; Liang X, 2013, P NATL ACAD SCI USA, V110, P1929, DOI 10.1073/pnas.1214900110; Manning EN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097608; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Pasquini L, 2016, J ALZHEIMERS DIS, V51, P313, DOI 10.3233/JAD-150823; Pasquini L, 2015, ALZHEIMERS DEMENT, V11, P475, DOI 10.1016/j.jalz.2014.02.007; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Shu N, 2012, RADIOLOGY, V265, P518, DOI 10.1148/radiol.12112361; Simic G, 2014, CNS NEUROSCI THER, V20, P692, DOI 10.1111/cns.12260; Sperling RA, 2010, NEUROMOL MED, V12, P27, DOI 10.1007/s12017-009-8109-7; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sun Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096505; Ting WKC, 2015, CURR ALZHEIMER RES, V12, P165, DOI 10.2174/1567205012666150204130456; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Wachinger C, 2016, BRAIN, V139, P3253, DOI 10.1093/brain/aww243; Wang JH, 2013, BIOL PSYCHIAT, V73, P472, DOI 10.1016/j.biopsych.2012.03.026; Wang L, 2015, HUM BRAIN MAPP, V36, P768, DOI 10.1002/hbm.22663; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Whitwell JL, 2007, BRAIN, V130, P1777, DOI 10.1093/brain/awm112; Xi Q, 2012, RADIOL MED, V117, P865, DOI 10.1007/s11547-011-0780-8; Xi Q, 2013, CHINESE MED J-PEKING, V126, P2912, DOI 10.3760/cma.j.issn.0366-6999.20130431; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Yassa MA, 2011, P NATL ACAD SCI USA, V108, P8873, DOI 10.1073/pnas.1101567108; Yassa MA, 2010, NEUROIMAGE, V51, P1242, DOI 10.1016/j.neuroimage.2010.03.040; Zeng LL, 2014, P NATL ACAD SCI USA, V111, P6058, DOI 10.1073/pnas.1317424111; Zhou Y, 2013, SMALL WORLD PROPERTI, V2013	64	10	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179823	10.1371/journal.pone.0179823	http://dx.doi.org/10.1371/journal.pone.0179823			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650994	Green Published, Green Submitted, gold			2022-12-27	WOS:000404537300025
J	Abernethy, AP; Arunachalam, A; Burke, T; McKay, C; Cao, XT; Sorg, R; Carbone, DP				Abernethy, Amy P.; Arunachalam, Ashwini; Burke, Thomas; McKay, Caroline; Cao, Xiting; Sorg, Rachael; Carbone, David P.			Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology setting	PLOS ONE			English	Article							MAINTENANCE THERAPY; TREATMENT PATTERNS; SYSTEMIC THERAPY; METASTATIC NSCLC; CHEMOTHERAPY USE; PREDICTORS; GUIDELINES; ERLOTINIB; PHASE-3	Purpose To establish a baseline for care and overall survival (OS) based upon contemporary first line treatments prescribed in the era before the introduction of immune checkpoint inhibitors, for people with metastatic non-small cell lung cancer (NSCLC) without common actionable mutations. Methods Using a nationally representative electronic health record data from the Flatiron dataset which included 162 practices from different regions in US, we identified patients (>= 18 years old) newly diagnosed with stage IV NSCLC initiating first-line anticancer therapy (November 2012-January 2015, with follow-up through July 2015). Patients with documented epidermal growth factor receptor (EGFR) or anaplastic lymphoma kinase (ALK) translocation were excluded. Anti-cancer drug therapy and overall survival were described overall, and by histology. Results A total of 2,014 patients with stage IV NSCLC without known EGFR or ALKgenomic tumor aberrations initiated systemic anticancer therapy, 22% with squamous and 78% with nonsquamous histology. Their mean (SD) age was 67 (10) years, 55% were male, and 87% had a smoking history. In nonsquamous NSCLC, carboplatin plus pemetrexed either without (25.7%) or with bevacizumab (16%) were the most common regimens; 26.6% of nonsquamous patients receiving induction therapy also received continuation maintenance therapy. In squamous NSCLC, carboplatin plus paclitaxel (37.6%) or nab-paclitaxel (21.1%) were the most commonly used regimens. Overall median OS was 9.7 months (95% CI: 9.1, 10.3), 8.5 months (95% CI: 7.4, 10.0) for squamous, and 10.0 months (95% CI: 9.4, 10.8) for nonsquamous NSCLC. Conclusion The results provide context for evaluating the effect of shifting treatment patterns of NSCLC treatments on patient outcomes, and for community oncology benchmarking initiatives.	[Abernethy, Amy P.; Sorg, Rachael] Flatiron Hlth Inc, New York, NY 10010 USA; [Abernethy, Amy P.] Duke Univ, Sch Med, Durham, NC 27708 USA; [Arunachalam, Ashwini; Burke, Thomas; McKay, Caroline; Cao, Xiting] Merck & Co Inc, Ctr Observat & Real World Evidence CORE, Kenilworth, NJ USA; [Carbone, David P.] Ohio State Univ, James Thorac Oncol Ctr, Med Oncol, Columbus, OH 43210 USA	Duke University; Merck & Company; University System of Ohio; Ohio State University	Abernethy, AP (corresponding author), Flatiron Hlth Inc, New York, NY 10010 USA.; Abernethy, AP (corresponding author), Duke Univ, Sch Med, Durham, NC 27708 USA.	amy@flatiron.com	McKay, Caroline/GYR-0296-2022		Merck Co.; Bristol Myers-Squibb; Merck Co., Inc.; Merck Sharp Dohme Corp.	Merck Co.(Merck & Company); Bristol Myers-Squibb(Bristol-Myers Squibb); Merck Co., Inc.(Merck & Company); Merck Sharp Dohme Corp.(Merck & Company)	The dataset used for this study was aggregated by Flatiron Health based upon funding from Merck & Co. Amy Abernethy and Rachael Sorg are salaried by Flatiron Health. Caroline McKay, Thomas Burke, and Xiting Cao are salaried by Merck & Co. Ashwini Arunachalam is an Oncology Outcomes Research Fellow at Merck. David Carbone reports grant/research support from Bristol Myers-Squibb. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was sponsored by Merck & Co., Inc. Medical writing and editorial assistance was provided by Elizabeth V. Hillyer, DVM. This assistance was funded by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ.	Berger ML, 2016, FUTURE ONCOL, V12, P1261, DOI 10.2217/fon-2015-0043; Besse B, 2014, ANN ONCOL, V25, P1475, DOI 10.1093/annonc/mdu123; Cappuzzo F, 2010, LANCET ONCOL, V11, P521, DOI 10.1016/S1470-2045(10)70112-1; Ciuleanu T, 2009, LANCET, V374, P1432, DOI 10.1016/S0140-6736(09)61497-5; Coudert B, 2012, ANN ONCOL, V23, P388, DOI 10.1093/annonc/mdr125; Davis KL, 2015, LUNG CANCER, V87, P176, DOI 10.1016/j.lungcan.2014.11.002; Ettinger David S, 2006, J Natl Compr Canc Netw, V4, P548; Friends of Cancer Research (FOCR) Alexandria Summit, AL SUMM TITL BLUEPR; Gregory A.M., SYSTEMIC THERAPY STA; Henk HJ, 2013, LUNG CANCER MANAG, V2, P189, DOI 10.2217/LMT.13.20; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Howlader N., 2015, SURVEILLANCE EPIDEMI; Lang K, 2009, LUNG CANCER, V63, P264, DOI 10.1016/j.lungcan.2008.05.003; Masters GA, 2015, J CLIN ONCOL, V33, P3488, DOI 10.1200/JCO.2015.62.1342; Moro-Sibilot D, 2015, LUNG CANCER, V90, P427, DOI 10.1016/j.lungcan.2015.11.011; NCCN, 2015, NCCN GUIDELINES NONS; Paz-Ares L, 2012, LANCET ONCOL, V13, P247, DOI 10.1016/S1470-2045(12)70063-3; Reck M, 2014, ANN ONCOL, V25, P27, DOI 10.1093/annonc/mdu199; Reinmuth N, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-139; Ritzwoller DP, 2012, LUNG CANCER, V78, P245, DOI 10.1016/j.lungcan.2012.09.008; Sacher AG, 2015, CANCER-AM CANCER SOC, V121, P2562, DOI 10.1002/cncr.29386; Scaliotti GV, J CLIN ONCOL, V26, P3543; SEER Cancer Statistics Factsheets, 2015, LUNG BRONCH CANC; Travis WD, 2015, J THORAC ONCOL, V10, P1243, DOI 10.1097/JTO.0000000000000630; Zornosa C, 2012, J NATL COMPR CANC NE, V10, P847, DOI 10.6004/jnccn.2012.0088	25	55	55	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0178420	10.1371/journal.pone.0178420	http://dx.doi.org/10.1371/journal.pone.0178420			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644837	Green Submitted, gold, Green Published			2022-12-27	WOS:000404145100005
J	McCreight, JC; Schneider, SE; Wilburn, DB; Swanson, WJ				McCreight, Jennifer C.; Schneider, Sean E.; Wilburn, Damien B.; Swanson, Willie J.			Evolution of microRNA in primates	PLOS ONE			English	Article							DEEP-SEQUENCING DATA; COMPUTATIONAL IDENTIFICATION; TRANSCRIPTION FACTORS; TARGET INTERACTIONS; GENETIC-VARIATION; RAPID EVOLUTION; NONCODING RNAS; STEM-CELLS; MIRNA; EXPRESSION	MicroRNA play an important role in post-transcriptional regulation of most transcripts in the human genome, but their evolution across the primate lineage is largely uncharacterized. A particular miRNA can have one to thousands of messenger RNA targets, establishing the potential for a small change in sequence or overall miRNA structure to have profound phenotypic effects. However, the majority of non-human primate miRNA is predicted solely by homology to the human genome and lacks experimental validation. In the present study, we sequenced thirteen species representing a wide range of the primate phylogeny. Hundreds of miRNA were validated, and the number of species with experimentally validated miRNA was tripled. These species include a sister taxon to humans (bonobo) and basal primates (aye-aye, mouse lemur, galago). Consistent with previous studies, we found the seed region and mature miRNA to be highly conserved across primates, with overall structural conservation of the pre-miRNA hairpin. However, there were a number of interesting exceptions, including a seed shift due to structural changes in miR-501. We also identified an increase in the number of miR-320 paralogs throughout primate evolution. Many of these non-conserved miRNA appear to regulate neuronal processes, illustrating the importance of investigating miRNA to learn more about human evolution.	[McCreight, Jennifer C.; Schneider, Sean E.; Wilburn, Damien B.; Swanson, Willie J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Schneider, Sean E.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	McCreight, JC (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	jcmccreight@gmail.com		Swanson, Willie/0000-0002-6553-0921	National Institutes of Health/National Human Genome Research Institute Genome Training Grant [HG000035]; National Science Foundation Graduate Research Fellowship; National Institutes of Health [HD076862]; UW Royalty Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD076862] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000035] Funding Source: NIH RePORTER	National Institutes of Health/National Human Genome Research Institute Genome Training Grant; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UW Royalty Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by a National Institutes of Health/National Human Genome Research Institute Genome Training Grant, Grant number HG000035, https://www.genome.gov/ 14514710/training-and-career-development-institutional-training-grants-t32/; National Science Foundation Graduate Research Fellowship awarded to JCM, no grant number, https://www.nsfgrfp.org/; UW Royalty Research Fund Grant, no grant number, https.//www.washington.edu/research/or/?page=rrf; and National Institutes of Health, Grant number HD076862, https://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank past and present members of the Swanson and Thomas labs for their assistance, especially R. George for her preliminary miRNA data. Sequencing was performed in collaboration with the lab of Debbie Nickerson, with special thanks to A. Gordon for programming assistance and comments, C. Frazar for library preparation help, and T. Shaffer for quality control on raw reads. Thanks to C. Cassady for programming assistance. We also thank committee members J. Akey, D. Nickerson, C. Quietsch, and W. L. Ruzzo for their feedback. J.C. McCreight was supported by a National Institutes of Health/National Human Genome Research Institute Genome Training Grant (grant number HG000035) and a National Science Foundation Graduate Research Fellowship. This research was funded by a UW Royalty Research Fund Grant and the National Institutes of Health (grant number HD076862).	Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Baev V, 2009, COMPUT BIOL CHEM, V33, P62, DOI 10.1016/j.compbiolchem.2008.07.024; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Bradley RK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000392; Brameier Markus, 2010, BMC Res Notes, V3, P64, DOI 10.1186/1756-0500-3-64; Chang CB, 1998, J NEUROBIOL, V36, P128, DOI 10.1002/(SICI)1097-4695(199808)36:2<128::AID-NEU3>3.0.CO;2-3; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Creighton CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009637; Dannemann M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-116; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Fang ZD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054215; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gallego A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154194; Gao ZL, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00067; Garbett KA, 2015, BIOL PSYCHIAT, V77, P256, DOI 10.1016/j.biopsych.2014.05.015; George RD, 2011, GENOME RES, V21, P1686, DOI 10.1101/gr.121327.111; Gkirtzou K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011843; Glazov EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006349; Goff LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007192; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Goode DL, 2010, GENOME RES, V20, P301, DOI 10.1101/gr.102210.109; Gruber AR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-122; Gruber AR, 2009, PAC S BIOCOMPUT, P69; Hamam D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.462; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hansen TB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010961; Hausser J, 2014, NAT REV GENET, V15, P599, DOI 10.1038/nrg3765; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hu HY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002327; Hu ZH, 2015, J CELL BIOL, V208, P949, DOI 10.1083/jcb.201404092; Iwagami Y, 2013, BRIT J CANCER, V109, P502, DOI 10.1038/bjc.2013.320; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee CT, 2007, DNA CELL BIOL, V26, P209, DOI 10.1089/dna.2006.0545; LI WH, 1987, NATURE, V326, P93, DOI 10.1038/326093a0; Li Yu, 2012, Genomics Proteomics & Bioinformatics, V10, P246, DOI 10.1016/j.gpb.2012.07.005; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Manier DH, 2000, J AFFECT DISORDERS, V61, P51, DOI 10.1016/S0165-0327(99)00190-1; Marti E, 2010, NUCLEIC ACIDS RES, V38, P7219, DOI 10.1093/nar/gkq575; Maziere P, 2007, DRUG DISCOV TODAY, V12, P452, DOI 10.1016/j.drudis.2007.04.002; Natera-Naranjo O, 2010, RNA, V16, P1516, DOI 10.1261/rna.1833310; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Otto SJ, 2007, J NEUROSCI, V27, P6729, DOI 10.1523/JNEUROSCI.0091-07.2007; Pai AA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001316; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Saba R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003652; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Somel M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001214; Speir ML, 2016, NUCLEIC ACIDS RES, V44, pD717, DOI 10.1093/nar/gkv1275; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sun GH, 2009, RNA, V15, P1640, DOI 10.1261/rna.1560209; The Chimpanzee Sequencing and Analysis Consortium, 2004, NATURE, V437, P69; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Ukai T, 2012, J ORTHOP RES, V30, P1915, DOI 10.1002/jor.22157; Vachev TI, 2016, INT J CURR MICROBIOL, V5, P221, DOI DOI 10.20546/ijcmas.2016.501.020; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang X, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0069-6; Washietl S., 2011, RNAZ 2 1 USER MANUAL; White RE, 2012, NEUROREPORT, V23, P590, DOI 10.1097/WNR.0b013e3283540394; Witten D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-58; Yang S, 2011, BIOINFORMATICS, V27, P2972, DOI 10.1093/bioinformatics/btr503; Zhang R, 2007, GENOME RES, V17, P612, DOI 10.1101/gr.6146507	72	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0176596	10.1371/journal.pone.0176596	http://dx.doi.org/10.1371/journal.pone.0176596			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640911	gold, Green Published, Green Submitted			2022-12-27	WOS:000404135800002
J	Petrov, PI; Mandija, S; Sommer, IEC; van den Berg, CAT; Neggers, SFW				Petrov, Petar I.; Mandija, Stefano; Sommer, Iris E. C.; van den Berg, Cornelis A. T.; Neggers, Sebastiaan F. W.			How much detail is needed in modeling a transcranial magnetic stimulation figure-8 coil: Measurements and brain simulations	PLOS ONE			English	Article							INDUCED ELECTRIC-FIELD; TMS; FMRI	Background Despite TMS wide adoption, its spatial and temporal patterns of neuronal effects are not well understood. Although progress has been made in predicting induced currents in the brain using realistic finite element models (FEM), there is little consensus on how a magnetic field of a typical TMS coil should be modeled. Empirical validation of such models is limited and subject to several limitations. Methods We evaluate and empirically validate models of a figure-of-eight TMS coil that are commonly used in published modeling studies, of increasing complexity: simple circular coil model; coil with in-plane spiral winding turns; and finally one with stacked spiral winding turns. We will assess the electric fields induced by all 3 coil models in the motor cortex using a computer FEM model. Biot-Savart models of discretized wires were used to approximate the 3 coil models of increasing complexity. We use a tailored MR based phase mapping technique to get a full 3D validation of the incident magnetic field induced in a cylindrical phantom by our TMS coil. FEM based simulations on a meshed 3D brain model consisting of five tissues types were performed, using two orthogonal coil orientations. Results Substantial differences in the induced currents are observed, both theoretically and empirically, between highly idealized coils and coils with correctly modeled spiral winding turns. Thickness of the coil winding turns affect minimally the induced electric field, and it does not influence the predicted activation. Conclusion TMS coil models used in FEM simulations should include in-plane coil geometry in order to make reliable predictions of the incident field. Modeling the in-plane coil geometry is important to correctly simulate the induced electric field and to correctly make reliable predictions of neuronal activation.	[Petrov, Petar I.; Sommer, Iris E. C.; Neggers, Sebastiaan F. W.] Univ Med Ctr Utrecht, Dept Psychiat, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Mandija, Stefano; van den Berg, Cornelis A. T.] Univ Med Ctr Utrecht, Ctr Image Sci, Utrecht, Netherlands; [van den Berg, Cornelis A. T.] Univ Med Ctr Utrecht, Dept Radiotherapy, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Petrov, PI (corresponding author), Univ Med Ctr Utrecht, Dept Psychiat, Brain Ctr Rudolf Magnus, Utrecht, Netherlands.	P.I.Petrov-2@umcutrecht.nl	Mandija, Stefano/AAN-4050-2021; sommer, iris/D-1190-2014	sommer, iris/0000-0002-2682-5313; Sommer, Iris/0000-0001-5597-3262; Petrov, Petar/0000-0002-7504-6615; van den Berg, Cornelis/0000-0002-5565-6889	DeNeCor project [ENIAC131003]	DeNeCor project	This work was supported by the DeNeCor project being part of the ENIAC Joint Undertaking, Project number ENIAC131003, http://eniac.eu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the DeNeCor project being part of the ENIAC Joint Undertaking.	Bohning DE, 1997, NEUROREPORT, V8, P2535, DOI 10.1097/00001756-199707280-00023; BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; de Berker AO, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00613; De Geeter N, 2015, PHYS MED BIOL, V60, P453, DOI 10.1088/0031-9155/60/2/453; De Geeter N, 2011, IEEE T BIO-MED ENG, V58, P310, DOI 10.1109/TBME.2010.2087758; de Weijer AD, 2014, J CLIN NEUROPHYSIOL, V31, P474, DOI 10.1097/WNP.0000000000000075; Fox PT, 2004, HUM BRAIN MAPP, V22, P1, DOI 10.1002/hbm.20006; Hernandez-Garcia L, 2007, NEUROIMAGE, V36, P1171, DOI 10.1016/j.neuroimage.2007.03.064; Janssen AM, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0036-2; Kammer T, 2007, NEUROIMAGE, V36, P313, DOI 10.1016/j.neuroimage.2007.03.001; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Krieg TD, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/4/046014; Krieg TD, 2013, BRAIN STIMUL, V6, P898, DOI 10.1016/j.brs.2013.05.007; Laakso I, 2014, PHYS MED BIOL, V59, P203, DOI 10.1088/0031-9155/59/1/203; Lefaucheur JP, 2014, CLIN NEUROPHYSIOL, V125, P2150, DOI 10.1016/j.clinph.2014.05.021; Madsen KH, 2015, BRAIN STIMUL, V8, P1205, DOI 10.1016/j.brs.2015.07.035; Mandija S, 2016, NMR BIOMED, P1; Miranda PC, 2003, IEEE T BIO-MED ENG, V50, P1074, DOI 10.1109/TBME.2003.816079; Neggers SFW, 2004, NEUROIMAGE, V21, P1805, DOI 10.1016/j.neuroimage.2003.12.006; Neggers SFW, 2015, PROG BRAIN RES, P1; Nieminen JO, 2015, BRAIN STIMUL, V8, P582, DOI 10.1016/j.brs.2015.01.004; Nummenmaa A, 2014, BRAIN STIMUL, V7, P80, DOI 10.1016/j.brs.2013.10.001; Nummenmaa A, 2013, CLIN NEUROPHYSIOL, V124, P1995, DOI 10.1016/j.clinph.2013.04.019; Opitz A, 2011, NEUROIMAGE, V58, P849, DOI 10.1016/j.neuroimage.2011.06.069; Peres A. S. C., 2009, World Congress on Medical Physics and Biomedical Engineering. World Congress 2009. Diagnostic and Therapeutic Instrumentation, Clinical Engineering, P571, DOI 10.1007/978-3-642-03885-3_159; Petersen RC, 2003, MILD COGNITIVE IMPAIRMENT: AGING TO ALZHEIMER'S DISEASE, P1; Pu LN, 2010, J X-RAY SCI TECHNOL, V18, P57, DOI 10.3233/XST-2010-0241; Rahman A, 2013, J PHYSIOL-LONDON, V591, P2563, DOI 10.1113/jphysiol.2012.247171; Ravazzani P, 1996, ANN BIOMED ENG, V24, P606, DOI 10.1007/BF02684229; Salinas FS, 2007, PHYS MED BIOL, V52, P2879, DOI 10.1088/0031-9155/52/10/016; Salinas FS, 2009, PHYS MED BIOL, V54, P3631, DOI 10.1088/0031-9155/54/12/002; Schutter DJLG, 2006, J ECT, V22, P176, DOI 10.1097/01.yct.0000235924.60364.27; Thielscher A, 2004, CLIN NEUROPHYSIOL, V115, P1697, DOI 10.1016/j.clinph.2004.02.019; Thielscher A, 2002, NEUROIMAGE, V17, P1117, DOI 10.1006/nimg.2002.1282; Thielscher A, 2011, NEUROIMAGE, V54, P234, DOI 10.1016/j.neuroimage.2010.07.061; Wagner TA, 2004, IEEE T BIO-MED ENG, V51, P1586, DOI 10.1109/TBME.2004.827925; Windhoff M, 2013, HUM BRAIN MAPP, V34, P923, DOI 10.1002/hbm.21479	37	18	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0178952	10.1371/journal.pone.0178952	http://dx.doi.org/10.1371/journal.pone.0178952			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640923	Green Published, Green Submitted, gold			2022-12-27	WOS:000404135800014
J	Robinson, A; Hesketh, H; Lahive, E; Horton, AA; Svendsen, C; Rortais, A; Dorne, JL; Baas, J; Heard, MS; Spurgeon, DJ				Robinson, Alex; Hesketh, Helen; Lahive, Elma; Horton, Alice A.; Svendsen, Claus; Rortais, Agnes; Dorne, Jean Lou; Baas, Jan; Heard, Matthew S.; Spurgeon, David J.			Comparing bee species responses to chemical mixtures: Common response patterns?	PLOS ONE			English	Article							APIS-MELLIFERA; ENVIRONMENTAL CONTAMINANTS; HONEY-BEE; TOXICITY; IMPACTS; PESTICIDES; FUNGICIDES; SYNERGISM; SURVIVAL; NEONICOTINOIDS	Pollinators in agricultural landscapes can be exposed to mixtures of pesticides and environmental pollutants. Existing mixture toxicity modelling approaches, such as the models of concentration addition and independent action and the mechanistic DEBtox framework have been previously shown as valuable tools for understanding and ultimately predicting joint toxicity. Here we apply these mixture models to investigate the potential to interpret the effects of semi-chronic binary mixture exposure for three bee species: Apis mellifera, Bombus terrestris and Osmia bicornis within potentiation and mixture toxicity experiments. In the potentiation studies, the effect of the insecticide dimethoate with added propiconazole fungicide and neonicotinoid insecticide clothianidin with added tau-fluvalinate pyrethroid acaricide showed no difference in toxicity compared to the single chemical alone. Clothianidin toxicity showed a small scale, but temporally conserved increase in exposure conducted in the presence of propiconazole, particularly for B. terrestris and O. bicornis, the latter showing a near three-fold increase in clothianidin toxicity in the presence of propiconazole. In the mixture toxicity studies, the dominant response patterns were of additivity, however, binary mixtures of clothianidin and dimethoate in A. mellifera, B. terrestris and male O. bicornis there was evidence of a predominant antagonistic interaction. Given the ubiquitous nature of exposures to multiple chemicals, there is an urgent need to consider mixture effects in pollinator risk assessments. Our analyses suggest that current models, particularly those that utilise time-series data, such as DEBtox, can be used to identify additivity as the dominant response pattern and also those examples of interactions, even when small-scale, that may need to be taken into account during risk assessment.	[Robinson, Alex; Hesketh, Helen; Lahive, Elma; Horton, Alice A.; Svendsen, Claus; Baas, Jan; Heard, Matthew S.; Spurgeon, David J.] Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Rortais, Agnes; Dorne, Jean Lou] European Food Safety Author, Parma, Italy	UK Centre for Ecology & Hydrology (UKCEH); European Food Safety Authority	Spurgeon, DJ (corresponding author), Ctr Ecol & Hydrol, Wallingford, Oxon, England.	dasp@ceh.ac.uk	Svendsen, Claus/A-1250-2009; Horton, Alice A/C-9919-2017; Hesketh, Helen/E-9124-2010; Spurgeon, David J/E-9466-2010	Svendsen, Claus/0000-0001-7281-647X; Horton, Alice A/0000-0001-6058-6048; Spurgeon, David/0000-0003-3264-8760; Dorne, Jean Lou/0000-0003-3305-063X	European Food Safety Authority to Centre for Ecology and Hydrology, UK on "Toxicity of exposure to multiple chemicals in bees and modelling the effect on bee population dynamics using DEB-TOX models" [OC/EFSA/SCER/2013/02]; EU Marie Curie Actions - Research Fellowship Programme FP7-PEOPLE-IEF, BIOME [328931]; Natural Environment Research Council (NERC) through National Capability funding project [NEC05585]	European Food Safety Authority to Centre for Ecology and Hydrology, UK on "Toxicity of exposure to multiple chemicals in bees and modelling the effect on bee population dynamics using DEB-TOX models"; EU Marie Curie Actions - Research Fellowship Programme FP7-PEOPLE-IEF, BIOME; Natural Environment Research Council (NERC) through National Capability funding project	This work was supported by a research grants awarded by the European Food Safety Authority to Centre for Ecology and Hydrology, UK on "Toxicity of exposure to multiple chemicals in bees and modelling the effect on bee population dynamics using DEB-TOX models". Contract/grant number: OC/EFSA/SCER/2013/02. JB was supported by the EU Marie Curie Actions - Research Fellowship Programme 2012 (FP7-PEOPLE-2012-IEF), BIOME, contract nr 328931. The Natural Environment Research Council (NERC) supported additional bee experimental work through National Capability funding project NEC05585 for apiary maintenance.	Altenburger R, 2013, ENVIRON TOXICOL CHEM, V32, P1685, DOI 10.1002/etc.2294; Baas J, 2009, ECOTOX ENVIRON SAFE, V72, P669, DOI 10.1016/j.ecoenv.2008.09.003; Baas J, 2007, ENVIRON TOXICOL CHEM, V26, P1320, DOI 10.1897/06-437R.1; Baas J, 2010, SCI TOTAL ENVIRON, V408, P3735, DOI 10.1016/j.scitotenv.2009.10.066; Bednarska AJ, 2014, ECOTOX ENVIRON SAFE, V108, P242, DOI 10.1016/j.ecoenv.2014.07.017; Belden JB, 2007, INTEGR ENVIRON ASSES, V3, P364, DOI 10.1002/ieam.5630030307; Biddinger DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072587; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Broerse M, 2012, ECOTOXICOLOGY, V21, P795, DOI 10.1007/s10646-011-0839-2; Cedergreen N, 2006, AQUAT TOXICOL, V78, P243, DOI 10.1016/j.aquatox.2006.03.007; Cedergreen N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096580; Cedergreen N, 2012, SCI TOTAL ENVIRON, V427, P229, DOI 10.1016/j.scitotenv.2012.03.086; Chauzat MP, 2011, ENVIRON TOXICOL CHEM, V30, P103, DOI 10.1002/etc.361; Decourtye A, 2013, NATURE, V497, P188, DOI 10.1038/497188a; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Dondero F, 2011, BMC GENOMICS, P12; EFSA Panel of Plant Protection Products and their Residues (PPR), 2012, EFSA J, V2012; FERA, PEST US SURV; Godfray HCJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0558; Heard MS, 2017, SCI TOTAL ENVIRON, V578, P357, DOI 10.1016/j.scitotenv.2016.10.180; Hesketh H, 2016, SCI REP-UK, V6, DOI 10.1038/srep37655; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Iwasaki Y, 2016, ENVIRON TOXICOL CHEM, V35, P526, DOI 10.1002/etc.3263; Jager T, 2010, ECOTOXICOLOGY, V19, P351, DOI 10.1007/s10646-009-0417-z; Johnson RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054092; Johnson RM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031051, 10.1371/journal.pone.0033479]; Johnston G, 1996, ENVIRON POLLUT, V91, P217, DOI 10.1016/0269-7491(95)00045-3; Jonker MJ, 2005, ENVIRON TOXICOL CHEM, V24, P2701, DOI 10.1897/04-431R.1; Kooijman SALM, 1996, WATER RES, V30, P1711, DOI 10.1016/0043-1354(96)00054-1; Lister LJ, 2011, ENVIRON INT, V37, P663, DOI 10.1016/j.envint.2011.01.006; Mao JS, 2009, ENVIRON POLLUT, V157, P2670, DOI 10.1016/j.envpol.2009.05.003; Mao WF, 2011, P NATL ACAD SCI USA, V108, P12657, DOI 10.1073/pnas.1109535108; PILLING ED, 1993, PESTIC SCI, V39, P293, DOI 10.1002/ps.2780390407; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Ramoutar D, 2010, J ECON ENTOMOL, V103, P1810, DOI 10.1603/EC09374; Roat TC, 2013, ARCH ENVIRON CON TOX, V64, P456, DOI 10.1007/s00244-012-9849-1; Sanchez-Bayo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094482; Thompson HM, 2014, APIDOLOGIE, V45, P545, DOI 10.1007/s13592-014-0273-6; Van Gestel C.A., 2016, MIXTURE TOXICITY LIN; Wheeler MW, 2006, ENVIRON TOXICOL CHEM, V25, P1441, DOI 10.1897/05-320R.1; Wiest L, 2011, J CHROMATOGR A, V1218, P5743, DOI 10.1016/j.chroma.2011.06.079; Woodcock BA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12459	42	35	36	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0176289	10.1371/journal.pone.0176289	http://dx.doi.org/10.1371/journal.pone.0176289			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640811	Green Accepted, Green Published, gold			2022-12-27	WOS:000404135800001
J	Abramson, JZ; Hernandez-Lloreda, MV; Esteban, JA; Colmenares, F; Aboitiz, F; Call, J				Abramson, Jose Z.; Victoria Hernandez-Lloreda, Ma; Esteban, Jose-Antonio; Colmenares, Fernando; Aboitiz, Francisco; Call, Josep			Contextual imitation of intransitive body actions in a Beluga whale (Delphinapterus leucas): A "do as other does" study	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; ANIMALS; MECHANISMS; EVOLUTION; CULTURE; FACULTY; US	Cetaceans are remarkable for exhibiting group-specific behavioral traditions or cultures in several behavioral domains (e.g., calls, behavioral tactics), and the question of whether they can be acquired socially, for example through imitative processes, remains open. Here we used a "Do as other does" paradigm to experimentally study the ability of a beluga to imitate familiar intransitive (body-oriented) actions demonstrated by a conspecific. The participant was first trained to copy three familiar behaviors on command (training phase) and then was tested for her ability to generalize the learned "Do as the other does" command to a different set of three familiar behaviors (testing phase). We found that the beluga (1) was capable of learning the copy command signal "Do what-the-other-does"; (2) exhibited high matching accuracy for trained behaviors (mean = 84% of correct performance) after making the first successful copy on command; (3) copied successfully the new set of three familiar generalization behaviors that were untrained to the copy command (range of first copy = 12 to 35 trials); and (4) deployed a high level of matching accuracy (mean = 83%) after making the first copy of an untrained behavior on command. This is the first evidence of contextual imitation of intransitive (body-oriented) movements in the beluga and adds to the reported findings on production imitation of sounds in this species and production imitation of sounds and motor actions in several cetaceans, especially dolphins and killer whales. Collectively these findings highlight the notion that cetaceans have a natural propensity at skillfully and proficiently matching the sounds and body movements demonstrated by conspecifics, a fitness-enhancing propensity in the context of cooperative hunting and anti-predatory defense tactics, and of alliance formation strategies that have been documented in these species' natural habitats. Future work should determine if the beluga can also imitate novel motor actions.	[Abramson, Jose Z.; Aboitiz, Francisco] Pontificia Univ Catolica Chile, Fac Med, Dept Psiquiatria, Santiago, Chile; [Abramson, Jose Z.; Aboitiz, Francisco] Pontificia Univ Catolica Chile, Ctr Interdisciplinario Neurociencia, Santiago, Chile; [Abramson, Jose Z.] Univ Playa Ancha, Ctr Estudios Avanzados, Valparaiso, Chile; [Abramson, Jose Z.; Victoria Hernandez-Lloreda, Ma; Colmenares, Fernando] Univ Complutense Madrid, Grp UCM Estudio Comportamiento Anim & Humano, Madrid, Spain; [Victoria Hernandez-Lloreda, Ma] Univ Complutense Madrid, Fac Psicol, Dept Metodol Ciencias Comportamiento, Campus Somosaguas, Madrid, Spain; [Esteban, Jose-Antonio] Parques Reunidos Valencia SA Oceanog, Res Dept, Valencia, Spain; [Colmenares, Fernando] Univ Complutense Madrid, Fac Psicol, Dept Psicobiol, Campus Somosaguas, Madrid, Spain; [Call, Josep] Univ St Andrews, Sch Psychol & Neurosci, South St, St Andrews, Fife Ky, Scotland; [Call, Josep] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Deutsch Pl 6, Leipzig, Germany	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Universidad de Playa Ancha; Complutense University of Madrid; Complutense University of Madrid; Complutense University of Madrid; University of St Andrews; Max Planck Society	Abramson, JZ (corresponding author), Pontificia Univ Catolica Chile, Fac Med, Dept Psiquiatria, Santiago, Chile.; Abramson, JZ (corresponding author), Pontificia Univ Catolica Chile, Ctr Interdisciplinario Neurociencia, Santiago, Chile.; Abramson, JZ (corresponding author), Univ Playa Ancha, Ctr Estudios Avanzados, Valparaiso, Chile.; Abramson, JZ (corresponding author), Univ Complutense Madrid, Grp UCM Estudio Comportamiento Anim & Humano, Madrid, Spain.	zabramson@psi.ucm.es	; Zamorano-Abramson, Jose/B-3990-2012	Hernandez-Lloreda, Maria Victoria/0000-0003-0966-7453; Call Balaguer, Josep/0000-0002-8597-8336; Zamorano-Abramson, Jose/0000-0001-7106-6419	Ministerio de Economia y Competitividad, Spain [PSI2011-29016C-02-01, PSI2014-51890-C2-1-P]; Universidad Complutense de Madrid y Banco Santander Central Hispano [GR3/14-940813]; Fondo Nacional de Desarrollo Cientifico y Tecnologico/FONDECYT [3140580]; European Research Council [609819]	Ministerio de Economia y Competitividad, Spain; Universidad Complutense de Madrid y Banco Santander Central Hispano; Fondo Nacional de Desarrollo Cientifico y Tecnologico/FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); European Research Council(European Research Council (ERC)European Commission)	The research reported in this paper was partly funded by project grants PSI2011-29016C-02-01, PSI2014-51890-C2-1-P (Ministerio de Economia y Competitividad, Spain) http://www. mineco.gob.es/ and UCM-BSCH GR3/14-940813 (Universidad Complutense de Madrid y Banco Santander Central Hispano) to F.C.A post-doctoral scholarship from Fondo Nacional de Desarrollo Cientifico y Tecnologico/FONDECYT No 3140580 awarded to J.ZA. funded his salary. http://www. conicyt.cl/fondecyt. European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant SOMICS agreement no 609819. Dr. Josep Call. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson JZ, 2013, ANIM COGN, V16, P11, DOI 10.1007/s10071-012-0546-2; Bates LA, 2010, WIRES COGN SCI, V1, P685, DOI 10.1002/wcs.77; BAUER GB, 1994, PERCEPT MOTOR SKILL, V79, P1307, DOI 10.2466/pms.1994.79.3.1307; Byrne R.W., 1994, P223; Byrne RW, 2009, CURR BIOL, V19, pR111, DOI 10.1016/j.cub.2008.11.027; Byrne RW, 2002, ADV STUD BEHAV, V31, P77, DOI 10.1016/S0065-3454(02)80006-7; Call J, 2002, FROM ANIM ANIMAT, P211; Call J, 2001, CYBERNET SYST, V32, P97, DOI 10.1080/019697201300001821; Connor RC, 1998, TRENDS ECOL EVOL, V13, P228, DOI 10.1016/S0169-5347(98)01326-3; Connor RC, 2007, PHILOS T R SOC B, V362, P587, DOI 10.1098/rstb.2006.1997; CUSTANCE DM, 1995, BEHAVIOUR, V132, P837, DOI 10.1163/156853995X00036; Dean L, 2016, INT ENCY ANTHR; Filatova OA, 2015, BEHAVIOUR, V152, P2001, DOI 10.1163/1568539X-00003317; Fugazza C, 2015, APPL ANIM BEHAV SCI, V171, P146, DOI 10.1016/j.applanim.2015.08.033; Galef BG, 2013, BEHAV PROCESS, V100, P123, DOI 10.1016/j.beproc.2013.07.026; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; HAYES KJ, 1952, J COMP PHYSIOL PSYCH, V45, P450, DOI 10.1037/h0053609; Herman LM, 2002, FROM ANIM ANIMAT, P63; Herman Louis M., 2006, P439; Heyes C, 2001, TRENDS COGN SCI, V5, P253, DOI 10.1016/S1364-6613(00)01661-2; Heyes C, 2013, LIFE MIND-PHILOS ISS, P313; Heyes CM, 2000, ADV STUD BEHAV, V29, P215, DOI 10.1016/S0065-3454(08)60106-0; HEYES CM, 1994, BIOL REV, V69, P207, DOI 10.1111/j.1469-185X.1994.tb01506.x; Hoppitt W, 2008, ADV STUD BEHAV, V38, P105, DOI 10.1016/S0065-3454(08)00003-X; Huber L, 2009, PHILOS T R SOC B, V364, P2299, DOI 10.1098/rstb.2009.0060; Jaakkola K., 2010, INT J COMP PSYCHOL, V234, P671, DOI DOI 10.1016/J.JEBDP.20; Jaakkola K, 2013, ANIM COGN, V16, P701, DOI 10.1007/s10071-013-0605-3; Janik VM, 2014, CURR OPIN NEUROBIOL, V28, P60, DOI 10.1016/j.conb.2014.06.010; Janik VM, 2000, ANIM BEHAV, V60, P1, DOI 10.1006/anbe.2000.1410; Marino L, 2007, PLOS BIOL, V5, P966, DOI 10.1371/journal.pbio.0050139; Miles H. Lyn, 1996, P278; MITCHELL RW, 1993, PRIMATES, V34, P301, DOI 10.1007/BF02382625; Range F, 2007, CURR BIOL, V17, P868, DOI 10.1016/j.cub.2007.04.026; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; Ridgway S, 2012, CURR BIOL, V22, pR860, DOI 10.1016/j.cub.2012.08.044; Subiaul F, 2010, BEHAV PROCESS, V83, P222, DOI 10.1016/j.beproc.2009.12.002; Tennie C, 2009, ANIM BEHAV, V77, P1491, DOI 10.1016/j.anbehav.2009.03.008; TOMASELLO M, 1993, BEHAV BRAIN SCI, V16, P495, DOI 10.1017/S0140525X0003123X; Topal J, 2006, ANIM COGN, V9, P355, DOI 10.1007/s10071-006-0051-6; Tsukasa M., 2012, INT J COMP PSYCHOL, V25, P195; van Schaik CP, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P623; Vonk J., 2012, OXFORD HDB COMP EVOL, P144; Whitehead H., 2014, CULTURAL LIVES WHALE; Whiten A, 2000, COGNITIVE SCI, V24, P477; Xitco M. J., 1988, THESIS; Yeater D. B., 2010, INT J COMP PSYCHOL, V23, P379; Zentall T.R., 2013, SOCIAL LEARNING PSYC; Zentall TR, 2011, INTERACT STUD, V12, P233, DOI 10.1075/is.12.2.03zen; Zentall TR, 2001, CYBERNET SYST, V32, P53, DOI 10.1080/019697201300001812	49	3	3	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0178906	10.1371/journal.pone.0178906	http://dx.doi.org/10.1371/journal.pone.0178906			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY6UH	28636677	Green Published, Green Submitted, gold			2022-12-27	WOS:000404118300020
J	Kowalik, A; Kowalska, A; Walczyk, A; Chodurska, R; Kopczynski, J; Chrapek, M; Wypiorkiewicz, E; Chlopek, M; Pieciak, L; Gasior-Perczak, D; Palyga, I; Gruszczynski, K; Nowak, E; Gozdz, S				Kowalik, Artur; Kowalska, Aldona; Walczyk, Agnieszka; Chodurska, Renata; Kopczynski, Janusz; Chrapek, Magdalena; Wypiorkiewicz, Elzbieta; Chlopek, Malgorzata; Pieciak, Liliana; Gasior-Perczak, Danuta; Palyga, Iwona; Gruszczynski, Krzysztof; Nowak, Ewelina; Gozdz, Stanislaw			Evaluation of molecular diagnostic approaches for the detection of BRAF p. V600E mutations in papillary thyroid cancer: Clinical implications	PLOS ONE			English	Article							REAL-TIME PCR; BRAF(V600E) MUTATION; IMMUNOHISTOCHEMICAL DETECTION; UNITED-STATES; CARCINOMA; ASSOCIATION; PROGRESSION; POPULATION; RECURRENCE; PERCENTAGE	Differentiated papillary thyroid cancer (PTC) is the most common cancer of the endocrine system. PTC has a very good prognosis and a high 5 year survival rate; however, some patients are unresponsive to treatment, and their diagnosis eventually results in death. Recent efforts have focused on searching for prognostic and predictive factors that may enable treatment personalization and monitoring across the course of the disease. The presence of the BRAF mutation is considered to contribute to the risk of poor clinical course, according to American Thyroid Association (ATA) recommendations. The method used for genotyping can impact the predicted mutation frequency; however, ATA recommendations do not address this issue. We evaluated the molecular diagnostic (BRAF p. V600E mutation) results of 410 patients treated for PTC. We thoroughly analyzed the impact of three different BRAF mutation detection methods, Sanger Sequencing (Seq), allele-specific amplification PCR (ASA-PCR), and quantitative PCR (qPCR), on the frequency of mutation detection in 399 patients. Using Seq, we detected the BRAF mutation in 37% of patients; however, we were able to detect BRAF mutations in 57% and 60% of patients using the more sensitive ASA-PCR and qPCR technologies, respectively. Differences between methods were particularly marked in the thyroid papillary microcarcinoma group; BRAF p. V600E mutations were found in 37% of patients using Seq and 63% and 66% of patients using ASA-PCR and qPCR, respectively. We also evaluated how these different diagnostic methods were impacted by DNA quality. Applying methods with different sensitivities to the detection of BRAF p. V600E mutations may result in different results for the same patient; such data can influence stratification of patients into different risk groups, leading to alteration of treatment and follow-up schemes.	[Kowalik, Artur; Chodurska, Renata; Wypiorkiewicz, Elzbieta; Chlopek, Malgorzata; Gruszczynski, Krzysztof; Nowak, Ewelina] Holycross Canc Ctr, Dept Mol Diagnost, Kielce, Poland; [Kowalska, Aldona; Walczyk, Agnieszka; Gasior-Perczak, Danuta; Palyga, Iwona] Holycross Canc Ctr, Endocrinol Clin, Kielce, Poland; [Kopczynski, Janusz] Holycross Canc Ctr, Dept Surg Pathol, Kielce, Poland; [Chrapek, Magdalena] Jan Kochanowski Univ Humanities & Sci, Fac Math & Nat Sci, Inst Math, Dept Probabil Theory & Stat, Kielce, Poland; [Gozdz, Stanislaw] Holycross Canc Ctr, Oncol Clin, Kielce, Poland; [Gozdz, Stanislaw] Jan Kochanowski Univ Humanities & Sci, Fac Hlth Sci, Kielce, Poland	Jan Kochanowski University; Jan Kochanowski University	Kowalik, A (corresponding author), Holycross Canc Ctr, Dept Mol Diagnost, Kielce, Poland.	arturko@onkol.kielce.pl	Gąsior-Perczak, Danuta/AAM-2668-2020; KOWALSKA, ALDONA/AAE-9040-2021; Walczyk, Agnieszka/ABC-3334-2020; Kowalik, Artur/K-2111-2017; Kowalik, Artur/AAB-5690-2020; Gozdz, Stanislaw/D-3300-2013	Gąsior-Perczak, Danuta/0000-0003-0936-4890; KOWALSKA, ALDONA/0000-0001-5647-5898; Kowalik, Artur/0000-0002-3718-999X; Kowalik, Artur/0000-0002-3718-999X; Gozdz, Stanislaw/0000-0001-6902-3807; Walczyk, Agnieszka/0000-0002-5083-659X; Chrapek, Magdalena/0000-0003-2480-6124	Holycross Cancer Centre	Holycross Cancer Centre	The study was supported by the Holycross Cancer Centre.	Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; [Anonymous], 2014, R LANG ENV STAT COMP; Barollo S, 2014, THYROID, V24, P809, DOI 10.1089/thy.2013.0403; Brzezianska E, 2007, NEUROENDOCRINOL LETT, V28, P351; Chen AY, 2009, CANCER-AM CANCER SOC, V115, P3801, DOI 10.1002/cncr.24416; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Czarniecka A, 2010, ENDOKRYNOL POL, V61, P462; de Biase D, 2014, J CLIN ENDOCR METAB, V99, pE1530, DOI 10.1210/jc.2013-4389; Gandolfi G, 2013, J CLIN ENDOCR METAB, V98, pE934, DOI 10.1210/jc.2012-3930; Ghossein RA, 2013, J CLIN ENDOCR METAB, V98, pE1414, DOI 10.1210/jc.2013-1408; Gouveia C, 2013, JAMA OTOLARYNGOL, V139, P1164, DOI 10.1001/jamaoto.2013.4501; Guan HX, 2009, J CLIN ENDOCR METAB, V94, P1612, DOI 10.1210/jc.2008-2390; Guerra A, 2012, J CLIN ENDOCR METAB, V97, P2333, DOI 10.1210/jc.2011-3106; Guerra A, 2012, J CLIN ENDOCR METAB, V97, P517, DOI 10.1210/jc.2011-0618; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Huang TG, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-3; Ilie MI, 2014, THYROID, V24, P858, DOI 10.1089/thy.2013.0302; Ito Y, 2014, WORLD J SURG, V38, P679, DOI 10.1007/s00268-013-2223-2; Jeong D, 2013, ANN SURG ONCOL, V20, P759, DOI 10.1245/s10434-012-2494-0; Kang SH, 2013, AM J CLIN PATHOL, V139, P759, DOI 10.1309/AJCPN3ULH6YWBHPH; Kim KH, 2004, YONSEI MED J, V45, P818, DOI 10.3349/ymj.2004.45.5.818; Kim SJ, 2012, WORLD J SURG, V36, P310, DOI 10.1007/s00268-011-1383-1; Koperek O, 2012, AM J SURG PATHOL, V36, P844, DOI 10.1097/PAS.0b013e318246b527; Lasota J, 2014, AM J SURG PATHOL, V38, P1235, DOI 10.1097/PAS.0000000000000229; Lee WS, 2014, SURGERY, V156, P1569, DOI 10.1016/j.surg.2014.08.051; Li C, 2013, J CLIN ENDOCR METAB, V98, P3702, DOI 10.1210/jc.2013-1584; Li N, 2013, THYROID, V23, P103, DOI 10.1089/thy.2012.0392; Nam JK, 2012, AM J SURG, V203, P436, DOI 10.1016/j.amjsurg.2011.02.013; Nikiforov YE, 2011, NAT REV ENDOCRINOL, V7, P569, DOI 10.1038/nrendo.2011.142; Nikiforova MN, 2013, J CLIN ENDOCR METAB, V98, pE1852, DOI 10.1210/jc.2013-2292; Rowe LR, 2007, J CLIN PATHOL, V60, P1211, DOI 10.1136/jcp.2006.040105; Russo M, 2014, THYROID, V24, P1267, DOI 10.1089/thy.2013.0675; Sapio MR, 2006, EUR J ENDOCRINOL, V154, P341, DOI 10.1530/eje.1.02072; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; TOKUDA Y, 1990, J CLIN PATHOL, V43, P748, DOI 10.1136/jcp.43.9.748; Walczyk A, 2014, CLIN ENDOCRINOL, V80, P899, DOI 10.1111/cen.12386; Xing MZ, 2015, J CLIN ONCOL, V33, P42, DOI 10.1200/JCO.2014.56.8253; Xing MZ, 2014, J CLIN ONCOL, V32, P2718, DOI 10.1200/JCO.2014.55.5094; Zagzag J, 2013, SURGERY, V154, P1199, DOI 10.1016/j.surg.2013.06.020	39	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179691	10.1371/journal.pone.0179691	http://dx.doi.org/10.1371/journal.pone.0179691			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636673	gold, Green Published, Green Submitted			2022-12-27	WOS:000404118300050
J	Reinke, LM; Spiegel, M; Plegge, T; Hartleib, A; Nehlmeier, I; Gierer, S; Hoffmann, M; Hofmann-Winkler, H; Winkler, M; Pohlmann, S				Reinke, Lennart Michel; Spiegel, Martin; Plegge, Teresa; Hartleib, Anika; Nehlmeier, Inga; Gierer, Stefanie; Hoffmann, Markus; Hofmann-Winkler, Heike; Winkler, Michael; Poehlmann, Stefan			Different residues in the SARS-CoV spike protein determine cleavage and activation by the host cell protease TMPRSS2	PLOS ONE			English	Article							CORONAVIRUS; ENTRY; VIRUS; GLYCOPROTEIN; INHIBITORS; RECEPTOR; FUSION; H7N9	The spike (S) protein of severe acute respiratory syndrome coronavirus (SARS-CoV) mediates viral entry into target cells. Cleavage and activation of SARS S by a host cell protease is essential for infectious viral entry and the responsible enzymes are potential targets for antiviral intervention. The type II transmembrane serine protease TMPRSS2 cleaves and activates SARS S in cell culture and potentially also in the infected host. Here, we investigated which determinants in SARS S control cleavage and activation by TMPRSS2. We found that SARS S residue R667, a previously identified trypsin cleavage site, is also required for S protein cleavage by TMPRSS2. The cleavage fragments produced by trypsin and TMPRSS2 differed in their decoration with N-glycans, suggesting that these proteases cleave different SARS S glycoforms. Although R667 was required for SARS S cleavage by TMPRSS2, this residue was dispensable for TMPRSS2-mediated S protein activation. Conversely, residue R797, previously reported to be required for SARS S activation by trypsin, was dispensable for S protein cleavage but required for S protein activation by TMPRSS2. Collectively, these results show that different residues in SARS S control cleavage and activation by TMPRSS2, suggesting that these processes are more complex than initially appreciated.	[Reinke, Lennart Michel; Spiegel, Martin; Plegge, Teresa; Hartleib, Anika; Nehlmeier, Inga; Gierer, Stefanie; Hoffmann, Markus; Hofmann-Winkler, Heike; Winkler, Michael; Poehlmann, Stefan] Deutsch Primatenzentrum GmbH, Abt Infekt Biol, Gottingen, Germany; [Spiegel, Martin] Med Hsch Brandenburg Theodor Fontane, Inst Mikrobiol & Virol, Senftenberg, Germany	Deutsches Primatenzentrum (DPZ)	Pohlmann, S (corresponding author), Deutsch Primatenzentrum GmbH, Abt Infekt Biol, Gottingen, Germany.	spoehlmann@dpz.eu	Hoffmann, Markus/J-7836-2018; Pöhlmann, Stefan/H-2395-2011; Spiegel, Martin/H-7843-2019	Hoffmann, Markus/0000-0003-4603-7696; Pöhlmann, Stefan/0000-0001-6086-9136; Winkler, Michael/0000-0002-6198-554X	Leibniz Association (Graduate School for Emerging Infec tious Diseases)	Leibniz Association (Graduate School for Emerging Infec tious Diseases)	The study was supported by the Leibniz Association (Graduate School for Emerging Infec tious Diseases). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belouzard S, 2012, VIRUSES-BASEL, V4, P1011, DOI 10.3390/v4061011; Belouzard S, 2009, P NATL ACAD SCI USA, V106, P5871, DOI 10.1073/pnas.0809524106; Bertram S, 2011, J VIROL, V85, P13363, DOI 10.1128/JVI.05300-11; Bottcher-Friebertshauser E, 2010, J VIROL, V84, P5605, DOI 10.1128/JVI.00140-10; Bosch BJ, 2008, J VIROL, V82, P8887, DOI 10.1128/JVI.00415-08; Cheng Z, 2015, J INFECT DIS; De Jong AS, 2006, J BIOL CHEM, V281, P14144, DOI 10.1074/jbc.M511766200; Follis KE, 2006, VIROLOGY, V350, P358, DOI 10.1016/j.virol.2006.02.003; Glowacka I, 2011, J VIROL, V85, P4122, DOI 10.1128/JVI.02232-10; Hatesuer B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003774; Hilgenfeld R, 2013, ANTIVIR RES, V100, P286, DOI 10.1016/j.antiviral.2013.08.015; Hofmann H, 2004, TRENDS MICROBIOL, V12, P466, DOI 10.1016/j.tim.2004.08.008; Kam YW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007870; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Li WH, 2006, ADV EXP MED BIOL, V581, P209; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10; Millet JK, 2015, VIRUS RES, V202, P120, DOI 10.1016/j.virusres.2014.11.021; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Peitsch C, 2014, J VIROL, V88, P282, DOI 10.1128/JVI.01635-13; Plegge T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166013; Poon LLM, 2004, LANCET INFECT DIS, V4, P663, DOI 10.1016/S1473-3099(04)01172-7; Sakai K, 2014, J VIROL, V88, P5608, DOI 10.1128/JVI.03677-13; Shulla A, 2011, J VIROL, V85, P873, DOI 10.1128/JVI.02062-10; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Simmons G, 2003, VIROLOGY, V305, P115, DOI 10.1006/viro.2002.1730; Simmons G, 2013, ANTIVIR RES, V100, P605, DOI 10.1016/j.antiviral.2013.09.028; Simmons G, 2011, VIROLOGY, V413, P265, DOI 10.1016/j.virol.2011.02.020; Tarnow C, 2014, J VIROL, V88, P4744, DOI 10.1128/JVI.03799-13; Wrensch F, 2014, VIRUSES-BASEL, V6, P3683, DOI 10.3390/v6093683; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhou Y, 2015, ANTIVIR RES, V116, P76, DOI 10.1016/j.antiviral.2015.01.011; Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8	33	52	56	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179177	10.1371/journal.pone.0179177	http://dx.doi.org/10.1371/journal.pone.0179177			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636671	gold, Green Published			2022-12-27	WOS:000404118300029
J	Trattner, C; Parra, D; Elsweiler, D				Trattner, Christoph; Parra, Denis; Elsweiler, David			Monitoring obesity prevalence in the United States through bookmarking activities in online food portals	PLOS ONE			English	Article							DIET QUALITY; CONSUMPTION; ADOLESCENTS; EPIDEMIC; CHILDREN; IMPACT	Studying the impact of food consumption on people's health is a serious matter for its implications on public policy, but it has traditionally been a slow process since it requires information gathered through expensive collection processes such as surveys, census and systematic reviews of research articles. We argue that this process could be supported and hastened using data collected via online social networks. In this work we investigate the relationships between the online traces left behind by users of a large US online food community and the prevalence of obesity in 47 states and 311 counties in the US. Using data associated with the recipes bookmarked over an 9-year period by 144,839 users of the Allrecipes. com food website residing throughout the US, several hierarchical regression models are created to (i) shed light on these relations and (ii) establish their magnitude. The results of our analysis provide strong evidence that bookmarking activities on recipes in online food communities can provide a signal allowing food and health related issues, such as obesity to be better understood and monitored. We discover that higher fat and sugar content in bookmarked recipes is associated with higher rates of obesity. The dataset is complicated, but strong temporal and geographical trends are identifiable. We show the importance of accounting for these trends in the modeling process.	[Trattner, Christoph] MODUL Univ Vienna, Dept New Media Technol, Vienna, Austria; [Parra, Denis] Pontificia Univ Catolica Chile, Dept Ciencia Computac, Santiago, Chile; [Elsweiler, David] Univ Regensburg, Chair Informat Sci I IMSK, Regensburg, Germany	Pontificia Universidad Catolica de Chile; University of Regensburg	Elsweiler, D (corresponding author), Univ Regensburg, Chair Informat Sci I IMSK, Regensburg, Germany.	david.elsweiler@sprachlit.uni-regensburg.de	Parra, Denis/M-2967-2019; Parra, Denis/D-1388-2014	Parra, Denis/0000-0001-9878-8761; Trattner, Christoph/0000-0002-1193-0508; Elsweiler, David/0000-0002-5791-0641	German Research Foundation (DFG) within the funding programme Open Access Publishing; CONICYT [FONDECYT 11150783]	German Research Foundation (DFG) within the funding programme Open Access Publishing(German Research Foundation (DFG)); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by the German Research Foundation (DFG) within the funding programme Open Access Publishing. The author Denis Parra was supported by CONICYT, project FONDECYT 11150783.	Abbar S, 2015, CHI 2015: PROCEEDINGS OF THE 33RD ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P3197, DOI 10.1145/2702123.2702153; Alaimo K, 1994, Adv Data, P1; [Anonymous], 2007, FSA NUTR FOOD BASED; [Anonymous], 2016, ALLRECIPES FOOD FRIE; [Anonymous], 2009, NATURE, DOI DOI 10.1038/nature07634; [Anonymous], 2016, HEALTHY EATING INDEX; [Anonymous], 2013, UNCONDITIONAL MULTIL; [Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; Bates D. M., 2010, IME4 MIXED EFFECTS M; Beaglehole R, 2016, MISUNDERSTANING REAL; Bellisle F., 2005, EUFIC REV, V17, P1; Bowman SA, 2004, PEDIATRICS, V113, P112, DOI 10.1542/peds.113.1.112; BRADBURN NM, 1987, SCIENCE, V236, P157, DOI 10.1126/science.3563494; Bray GA, 1998, AM J CLIN NUTR, V68, P1157, DOI 10.1093/ajcn/68.6.1157; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Buntain C, 2015, WWW'15 COMPANION: PROCEEDINGS OF THE 24TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P777, DOI 10.1145/2740908.2742469; Centers for Disease Control and Prevention, 2016, CDC 247 SAV LIV PROT; De Choudhury M., 2013, 7 INT AAAI C WEBL SO, P2, DOI DOI 10.1145/1810617.1810626; De Choudhury M., 2016, CHARACTERIZING DIETA; Drewnowski A, 2007, EPIDEMIOL REV, V29, P160, DOI 10.1093/epirev/mxm011; EHSA, 2016, NUTR LAB SOFTW NUTR; Elsweiler D, 2017, P SIGIR 2017; Field A., 2012, DISCOVERING STAT USI; Fried D, 2014, IEEE INT CONF BIG DA, P778, DOI 10.1109/BigData.2014.7004305; Ge M., 2015, P 9 ACM C REC SYST, P333, DOI DOI 10.1145/2792838.2796554; Gillum RF, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-27; Giltinan DM, 1995, NONLINEAR MODELS REP, V62; Grace-Martin K., 2016, INTRACLASS CORRELATI; Gross LS, 2004, AM J CLIN NUTR, V79, P774; Hagan P., 2016, WHY FAT NOT SUGAR IS; Holbrook AL, 2003, PUBLIC OPIN QUART, V67, P79, DOI 10.1086/346010; Howard S, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7607; Jacka FN, 2010, AUST NZ J PSYCHIAT, V44, P435, DOI 10.3109/00048670903571598; Kallehave O, 2011, P PINC 2011 WORKSH C; Kuczmarski MF, 2001, J AM DIET ASSOC, V101, P28, DOI 10.1016/S0002-8223(01)00008-6; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Leslie I., 2016, SUGAR CONSPIRACY; Mejova Y., 2015, P 5 INT C DIG HLTH 2, P51, DOI [10.1145/2750511.2750524, DOI 10.1145/2750511.2750524]; Meyer KA, 2000, AM J CLIN NUTR, V71, P921; Newman C., 2013, FAT VS SUGAR WHICH D; Paparrizos J, 2016, P ACM SIGKDD C KNOWL; Paul MJ, 2016, BIOCOMPUT-PAC SYM, P468; Polgreen PM, 2007, CLIN INFECT DIS, V44, P272, DOI 10.1086/510427; Prier KW, 2011, LECT NOTES COMPUT SC, V6589, P18; ROZIN P, 1985, ANN NY ACAD SCI, V443, P189, DOI 10.1111/j.1749-6632.1985.tb27073.x; Sacks G, 2009, HEALTH PROMOT INT, V24, P344, DOI 10.1093/heapro/dap032; Said A, 2014, RSWEB RECSYS; Said A, 2014, P RSWEB 14; Scheibehenne B, 2007, APPETITE, V49, P578, DOI 10.1016/j.appet.2007.03.224; Schoen H, 2013, INTERNET RES, V23, P528, DOI 10.1108/IntR-06-2013-0115; Schwartz H. A., 2013, ICWSM; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Strohmaier M, 2014, IEEE INTELL SYST, V29, P84, DOI 10.1109/MIS.2014.80; Trattner C, 2017, PROCEEDINGS OF THE 26TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'17), P489, DOI 10.1145/3038912.3052573; Trattner C, 2016, ERCIM NEWS, P50; TROIANO RP, 1995, ARCH PEDIAT ADOL MED, V149, P1085, DOI 10.1001/archpedi.1995.02170230039005; Tu YK, 2005, BRIT DENT J, V199, P457, DOI 10.1038/sj.bdj.4812743; Tumasjan A., 2010, P 4 INT AAAI C WEBLO, V4, P178, DOI DOI 10.1074/JBC.M501708200; van Dam R, 2007, EUR J CLIN NUTR, V61, pS75, DOI 10.1038/sj.ejcn.1602939; Wagner C, 2014, EPJ DATA SCI, V3, DOI 10.1140/epjds/s13688-014-0036-7; West J.H., 2012, TEMPORAL VARIABILITY; West R., 2013, WWW, P1399; Who J, 2003, WHO TECH REP SER, V916; Williams G, 2009, OBESITY SCI PRACTICE; Yang C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150881	65	22	22	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179144	10.1371/journal.pone.0179144	http://dx.doi.org/10.1371/journal.pone.0179144			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636665	Green Published, Green Submitted, gold			2022-12-27	WOS:000404118300026
J	Chun, N; Haddadin, AS; Liu, JY; Hou, YF; Wong, KA; Lee, D; Rushbrook, JI; Gulaya, K; Hines, R; Hollis, T; Nuno, BN; Mangi, AA; Hashim, S; Pekna, M; Catalfamo, A; Chin, HY; Patel, F; Rayala, S; Shevde, K; Heeger, PS; Zhang, M				Chun, Nicholas; Haddadin, Ala S.; Liu, Junying; Hou, Yunfang; Wong, Karen A.; Lee, Daniel; Rushbrook, Julie I.; Gulaya, Karan; Hines, Roberta; Hollis, Tamika; Nuno, Beatriz Nistal; Mangi, Abeel A.; Hashim, Sabet; Pekna, Marcela; Catalfamo, Amy; Chin, Hsiao-ying; Patel, Foramben; Rayala, Sravani; Shevde, Ketan; Heeger, Peter S.; Zhang, Ming			Activation of complement factor B contributes to murine and human myocardial ischemia/reperfusion injury	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; MANNOSE-BINDING LECTIN; BYPASS GRAFT-SURGERY; OPEN-HEART-SURGERY; PERCUTANEOUS CORONARY INTERVENTION; ALTERNATIVE PATHWAY COMPLEMENT; CARDIAC TROPONIN-I; C-REACTIVE PROTEIN; NF-KAPPA-B; CARDIOPULMONARY BYPASS	The pathophysiology of myocardial injury that results from cardiac ischemia and reperfusion (I/R) is incompletely understood. Experimental evidence from murine models indicates that innate immune mechanisms including complement activation via the classical and lectin pathways are crucial. Whether factor B (f B), a component of the alternative complement pathway required for amplification of complement cascade activation, participates in the pathophysiology of myocardial I/R injury has not been addressed. We induced regional myocardial I/R injury by transient coronary ligation in WT C57BL/6 mice, a manipulation that resulted in marked myocardial necrosis associated with activation of fB protein and myocardial deposition of C3 activation products. In contrast, in f13(-/-) mice, the same procedure resulted in significantly reduced myocardial necrosis (% ventricular tissue necrotic; fB(-/-) mice, 20 4%; WT mice, 45 3%; P< 0.05) and diminished deposition of C3 activation products in the myocardial tissue (fB(-/-) mice, 0 0%; WT mice, 31 6%; P<0.05). Reconstitution of fB(-/-) mice with WT serum followed by cardiac I/R restored the myocardial necrosis and activated C3 deposition in the myocardium. In translational human studies we measured levels of activated fB (Bb) in intracoronary blood samples obtained during cardio-pulmonary bypass surgery before and after aortic cross clamping (AXCL), during which global heart ischemia was induced. Intracoronary Bb increased immediately after AXCL, and the levels were directly correlated with peripheral blood levels of cardiac troponin I, an established biomarker of myocardial necrosis (Spearman coefficient = 0.465, P < 0.01). Taken together, our results support the conclusion that circulating fB is a crucial pathophysiological	[Chun, Nicholas; Heeger, Peter S.] Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, New York, NY 10029 USA; [Chun, Nicholas; Heeger, Peter S.] Icahn Sch Med Mt Sinai, Translat Transplant Res Ctr, New York, NY 10029 USA; [Haddadin, Ala S.; Hines, Roberta; Hollis, Tamika; Nuno, Beatriz Nistal] Yale Univ, Sch Med, Dept Anesthesiol, New Haven, CT 06510 USA; [Liu, Junying; Hou, Yunfang; Wong, Karen A.; Rushbrook, Julie I.; Gulaya, Karan; Catalfamo, Amy; Chin, Hsiao-ying; Shevde, Ketan; Zhang, Ming] Suny Downstate Med Ctr, Coll Med, Dept Anesthesiol, Brooklyn, NY 11203 USA; [Lee, Daniel] Suny Downstate Med Ctr, Coll Med, Dept Surg, Brooklyn, NY 11203 USA; [Mangi, Abeel A.; Hashim, Sabet] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA; [Pekna, Marcela] Gothenburg Univ, Dept Med Chem & Cell Biol, Gothenburg, Sweden; [Patel, Foramben; Rayala, Sravani] Long Isl Univ, Dept Biomed Sci, Brookville, NY USA; [Zhang, Ming] Suny Downstate Med Ctr, Coll Med, Dept Cell Biol, Brooklyn, NY 11203 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Yale University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Yale University; University of Gothenburg; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Zhang, M (corresponding author), Suny Downstate Med Ctr, Coll Med, Dept Anesthesiol, Brooklyn, NY 11203 USA.; Zhang, M (corresponding author), Suny Downstate Med Ctr, Coll Med, Dept Cell Biol, Brooklyn, NY 11203 USA.	ming.zhang@downstate.edu	Pekna, Marcela/AAM-3261-2021; Pekna, Marcela/AAM-3249-2021; Nistal-Nuno, Beatriz/AFS-7236-2022	Pekna, Marcela/0000-0003-2734-8237; Pekna, Marcela/0000-0003-2734-8237; Nistal-Nuno, Beatriz/0000-0003-2210-0726	NIH [1R21HL088527, 1 R21A1117695-01]; ECRIP Award from New York State Department of Health;  [T32 (5T32DK007757)]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL088527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI117695, T32AI078892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007757] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ECRIP Award from New York State Department of Health; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The research was funded in part by NIH grant 1R21HL088527 (MZ) and 1 R21A1117695-01 (PSH and MZ) and an ECRIP Award from New York State Department of Health (KS and MZ). Dr. Yunfang Hou is an ECRIP fellow. NC is supported by T32 (5T32DK007757).; The authors would like to thank Dr. James Cottrell for his continued support, Drs. Anita Mehrotra, Jeremy Weedon and Feng Dai for helpful advice on biostatistical analyses, and the CT ICU staff members of University Hospital SUNY Downstate and Yale-New Haven Hospital for their valuable assistance. The research was funded in part by NIH grant 1R21HL088527 (MZ) and 1R21AI117695-01 (PSH and MZ) and an ECRIP Award from New York State Department of Health (KS and MZ). Dr. Yunfang Hou is an ECRIP fellow. NC is supported by T32 (5T32DK007757).	Ago T, 2011, CIRC J, V75, P1791, DOI 10.1253/circj.CJ-11-0388; Alam MR, 2014, J MOL CELLULAR CARDI; Alcock RF, 2012, HEART, V98, P792, DOI 10.1136/heartjnl-2011-301577; Arcasoy SM, 2005, J HEART LUNG TRANSPL, V24, P1483, DOI 10.1016/j.healun.2004.11.314; Armstrong PW, 2007, JAMA-J AM MED ASSOC, V297, P43; Arslan F, 2011, NAT REV CARDIOL, V8, P292, DOI 10.1038/nrcardio.2011.38; Atkinson C, 2010, J IMMUNOL, V185, P7007, DOI 10.4049/jimmunol.1001504; Banda NK, 2008, ARTHRITIS RHEUM-US, V58, P3081, DOI 10.1002/art.23865; Barratt-Due A, 2012, IMMUNOBIOLOGY, V217, P1047, DOI 10.1016/j.imbio.2012.07.019; Bay JT, 2013, KIDNEY INT, V83, P264, DOI 10.1038/ki.2012.373; Bell JR, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00096; Berger SP, 2005, AM J TRANSPLANT, V5, P1361, DOI 10.1111/j.1600-6143.2005.00841.x; Berger SP, 2007, J AM SOC NEPHROL, V18, P2416, DOI 10.1681/ASN.2007030262; Bernink FJP, 2014, INT J CARDIOL, V170, P261, DOI 10.1016/j.ijcard.2013.11.007; Braunersreuther V, 2012, CURR PHARM BIOTECHNO, V13, P97, DOI 10.2174/138920112798868782; Brown DI, 2015, CIRC RES, V116, P531, DOI 10.1161/CIRCRESAHA.116.303584; Bruins P, 1997, CIRCULATION, V96, P3542; Busche MN, 2009, AM J PHYSIOL-HEART C, V297, pH1853, DOI 10.1152/ajpheart.00049.2009; Cabrera-Fuentes HA, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0586-x; Calo L, 2013, CURR PHARM DESIGN, V19, P6848, DOI 10.2174/138161281939131127110701; Charlagorla P, 2013, MOL IMMUNOL, V56, P507, DOI 10.1016/j.molimm.2013.05.001; Chen J, 2011, J SURG RES, V167, pE131, DOI 10.1016/j.jss.2009.05.041; Cravedi P, 2014, J CLIN INVEST, V124, P2348, DOI 10.1172/JCI72273; Crespo M, 2013, TRANSPL IMMUNOL, V29, P28, DOI 10.1016/j.trim.2013.07.002; Csencsits K, 2008, AM J TRANSPLANT, V8, P1622, DOI 10.1111/j.1600-6143.2008.02295.x; Cung TT, 2015, NEW ENGL J MED, V373, P1021, DOI 10.1056/NEJMoa1505489; Damman J, 2013, KIDNEY INT, V83, P191, DOI 10.1038/ki.2012.397; Das S, 2012, BBA-BIOMEMBRANES, V1818, P1451, DOI 10.1016/j.bbamem.2011.11.008; Deng YM, 2010, J MOL CELL CARDIOL, V48, P331, DOI 10.1016/j.yjmcc.2009.10.022; Domanski MJ, 2011, JAMA-J AM MED ASSOC, V305, P585, DOI 10.1001/jama.2011.99; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Erbel R, 2014, EUR HEART J, V35, P313, DOI 10.1093/eurheartj/eht550; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fiane AE, 2005, EUR HEART J, V26, P1660, DOI 10.1093/eurheartj/ehi198; Fildes JE, 2008, J HEART LUNG TRANSPL, V27, P1353, DOI 10.1016/j.healun.2008.08.011; Fitch JCK, 1999, CIRCULATION, V100, P2499, DOI 10.1161/01.CIR.100.25.2499; Fleming SD, 2006, AUTOIMMUN REV, V5, P89, DOI 10.1016/j.autrev.2005.09.006; Frohlich GM, 2013, EUR HEART J, V34, P1714, DOI 10.1093/eurheartj/eht090; Gollop ND, 2013, INTERACT CARDIOV TH, V17, P867, DOI 10.1093/icvts/ivt303; Gordon JW, 2011, CIRC RES, V108, P1122, DOI 10.1161/CIRCRESAHA.110.226928; Gottlieb RA, 2011, J CARDIOVASC PHARM T, V16, P233, DOI 10.1177/1074248411409581; Greenson N, 2001, AM HEART J, V141, P447, DOI 10.1067/mhj.2001.113071; Ha TZ, 2011, ANTIOXID REDOX SIGN, V15, P1875, DOI 10.1089/ars.2010.3723; Haas MS, 2010, CARDIOVASC RES, V87, P618, DOI 10.1093/cvr/cvq141; Halestrap AP, 2014, J MOL CELLULAR CARDI; Harboe M, 2008, J CELL MOL MED, V12, P1074, DOI 10.1111/j.1582-4934.2008.00350.x; Hart ML, 2005, J IMMUNOL, V174, P6373, DOI 10.4049/jimmunol.174.10.6373; Hausenloy DJ, 2015, NEW ENGL J MED, V373, P1408, DOI 10.1056/NEJMoa1413534; Hausenloy DJ, 2013, CARDIOVASC RES, V98, P7, DOI 10.1093/cvr/cvt004; Heusch G, 2015, J AM COLL CARDIOL, V65, P177, DOI 10.1016/j.jacc.2014.10.031; Heusch G, 2013, LANCET, V381, P166, DOI 10.1016/S0140-6736(12)60916-7; Hoedemaekers C, 2010, ANN THORAC SURG, V89, P710, DOI 10.1016/j.athoracsur.2009.11.049; Hofmann U, 2015, CIRC RES, V116, P354, DOI 10.1161/CIRCRESAHA.116.304072; HOLT GD, 1990, J BIOL CHEM, V265, P2852; Hourcade DE, 2006, J BIOL CHEM, V281, P2128, DOI 10.1074/jbc.M508928200; Huttemann M, 2012, BBA-BIOENERGETICS, V1817, P598, DOI 10.1016/j.bbabio.2011.07.001; Ibanez B, 2015, J AM COLL CARDIOL, V65, P1455, DOI 10.1016/j.jacc.2015.02.032; Ibernon M, 2014, TRANSPLANT REV-ORLAN, V28, P21, DOI 10.1016/j.trre.2013.10.006; Inserte J, 2012, CARDIOVASC RES, V96, P23, DOI 10.1093/cvr/cvs232; Ito WD, 1997, J MOL CELL CARDIOL, V29, P2169, DOI 10.1006/jmcc.1997.0456; Jane-wit D, 2015, P NATL ACAD SCI USA, V112, P9686, DOI 10.1073/pnas.1503535112; Januzzi JL, 2011, MINERVA ANESTESIOL, V77, P334; Kain V, 2015, J MOL CELL CARDIOL, V84, P24, DOI 10.1016/j.yjmcc.2015.04.003; Kain V, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0444-7; Kimura Y, 2008, BLOOD, V111, P732, DOI 10.1182/blood-2007-05-089821; Koolen BB, 2013, INTERACT CARDIOV TH, V17, P608, DOI 10.1093/icvts/ivt259; Kruger B, 2009, P NATL ACAD SCI USA, V106, P3390, DOI 10.1073/pnas.0810169106; Kuhn-Regnier F, 1999, EUR J CARDIO-THORAC, V15, P67, DOI 10.1016/S1010-7940(98)00289-9; Lachmann PJ, 2009, ADV IMMUNOL, V104, P115, DOI 10.1016/S0065-2776(08)04004-2; Landesberg G, 2003, J AM COLL CARDIOL, V42, P1547, DOI 10.1016/j.jacc.2003.05.001; Lee H, 2010, MOL IMMUNOL, V47, P972, DOI 10.1016/j.molimm.2009.11.022; Lee JC, 2011, CLIN CHEST MED, V32, P279, DOI 10.1016/j.ccm.2011.02.007; Linkermann A, 2013, AM J TRANSPLANT, V13, P2797, DOI 10.1111/ajt.12448; Loupy A, 2013, NEW ENGL J MED, V369, P1215, DOI 10.1056/NEJMoa1302506; Magro CM, 2003, AM J TRANSPLANT, V3, P1143, DOI 10.1034/j.1600-6143.2003.00152.x; Mann DL, 2011, CIRC RES, V108, P1133, DOI 10.1161/CIRCRESAHA.110.226936; Marcheix B, 2008, ANN THORAC SURG, V85, P530, DOI 10.1016/j.athoracsur.2007.08.050; MERI S, 1985, CLIN EXP IMMUNOL, V60, P597; Meybohm P, 2015, NEW ENGL J MED, V373, P1397, DOI 10.1056/NEJMoa1413579; Millington TM, 2010, KIDNEY INT, V78, pS18, DOI 10.1038/ki.2010.417; Mitchell Rita G, 2002, Am Heart J, V144, pE9, DOI 10.1067/mhj.2002.126114; Miura T, 2010, CARDIOVASC DRUG THER, V24, P255, DOI 10.1007/s10557-010-6234-z; Miwa T, 2013, J IMMUNOL, V190, P3552, DOI 10.4049/jimmunol.1202275; Moller-Kristensen M, 2005, SCAND J IMMUNOL, V61, P426, DOI 10.1111/j.1365-3083.2005.01591.x; Morciano G, 2014, J MOL CELLULAR CARDI; Muller AL, 2013, INT J CARDIOL, V164, P39, DOI 10.1016/j.ijcard.2012.01.103; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Neuhof C, 2014, WORLD J CARDIOL, V6, P638, DOI 10.4330/wjc.v6.i7.638; Ong SB, 2015, J MOL CELL CARDIOL, V78, P23, DOI 10.1016/j.yjmcc.2014.11.005; Ovize M, 2010, CARDIOVASC RES, V87, P406, DOI 10.1093/cvr/cvq129; Pavlov VI, 2015, AM J PATHOL, V185, P347, DOI 10.1016/j.ajpath.2014.10.015; PEKNA M, 1993, CLIN EXP IMMUNOL, V91, P404; Pekna M, 1998, SCAND J IMMUNOL, V47, P375; Pickard JMJ, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-014-0453-6; Przyklenk K, 2012, CARDIOVASC RES, V94, P197, DOI 10.1093/cvr/cvr358; Raedler H, 2011, AM J TRANSPLANT, V11, P1397, DOI 10.1111/j.1600-6143.2011.03561.x; Rao JH, 2014, CURR OPIN ORGAN TRAN, V19, P115, DOI 10.1097/MOT.0000000000000064; Rassaf T, 2014, CARDIOVASC RES, V102, P321, DOI 10.1093/cvr/cvu071; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Riedemann NC, 2003, AM J PATHOL, V162, P363, DOI 10.1016/S0002-9440(10)63830-8; Roberts BW, 2013, SHOCK, V39, P229, DOI 10.1097/SHK.0b013e31827f565b; Robinson E, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0476-7; Rodriguez ER, 2005, AM J TRANSPLANT, V5, P2778, DOI 10.1111/j.1600-6143.2005.01074.x; RUBIN B, 1989, MICROCIRC ENDOTH LYM, V5, P207; Sacks SH, 2012, NAT REV IMMUNOL, V12, P431, DOI 10.1038/nri3225; Schmauss D, 2008, CIRCULATION, V117, P2131, DOI 10.1161/CIRCULATIONAHA.107.711911; Schofield ZV, 2013, SHOCK, V40, P463, DOI 10.1097/SHK.0000000000000044; Schoos MM, 2013, MOL IMMUNOL, V54, P408, DOI 10.1016/j.molimm.2013.01.008; Schouten O, 2006, CORONARY ARTERY DIS, V17, P173, DOI 10.1097/00019501-200603000-00012; Schwaeble WJ, 2011, P NATL ACAD SCI USA, V108, P7523, DOI 10.1073/pnas.1101748108; Schwartz Longacre L, 2011, CIRCULATION, V124, P1172, DOI 10.1161/CIRCULATIONAHA.111.032698; SEGHAYE MC, 1993, J THORAC CARDIOV SUR, V106, P978, DOI 10.1016/S0022-5223(19)33968-6; Singh MV, 2009, J CLIN INVEST, V119, P986, DOI 10.1172/JCI35814; Smith PK, 2011, J THORAC CARDIOV SUR, V142, P89, DOI 10.1016/j.jtcvs.2010.08.035; Spitzer D, 2007, J IMMUNOL, V179, P2600, DOI 10.4049/jimmunol.179.4.2600; Stahl GL, 2003, AM J PATHOL, V162, P449, DOI 10.1016/S0002-9440(10)63839-4; Stahl GL, 2012, ANESTH ANALG, V115, P759, DOI 10.1213/ANE.0b013e3182652b7d; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; Thurman JM, 2006, J CLIN INVEST, V116, P357, DOI 10.1172/JCI24521; Thurman JM, 2006, J IMMUNOL, V176, P1305, DOI 10.4049/jimmunol.176.3.1305; Thurman JM, 2003, J IMMUNOL, V170, P1517, DOI 10.4049/jimmunol.170.3.1517; Thurman JM, 2006, J AM SOC NEPHROL, V17, P707, DOI 10.1681/ASN.2005070698; Tsokos GC, 2015, CIRCULATION, V131, P1153, DOI 10.1161/CIRCULATIONAHA.115.015613; Vermes E, 2000, ANN THORAC SURG, V70, P2087, DOI 10.1016/S0003-4975(00)02152-4; Verrier ED, 2004, JAMA-J AM MED ASSOC, V291, P2319, DOI 10.1001/jama.291.19.2319; Walsh MC, 2005, J IMMUNOL, V175, P541, DOI 10.4049/jimmunol.175.1.541; Wang E, 2011, ANESTHESIOLOGY, V114, P603, DOI 10.1097/ALN.0b013e31820a4d5b; Wang Y, 2010, SHOCK, V34, P548, DOI 10.1097/SHK.0b013e3181e686f5; Wolff RA, 2000, J MOL CELL CARDIOL, V32, P225, DOI 10.1006/jmcc.1999.1074; Xiao H, 2007, AM J PATHOL, V170, P52, DOI 10.2353/ajpath.2007.060573; Xu W, 2008, J IMMUNOL, V180, P7613, DOI 10.4049/jimmunol.180.11.7613; Zhai Y, 2004, J IMMUNOL, V173, P7115, DOI 10.4049/jimmunol.173.12.7115; Zhang M, 2007, EXPERT OPIN BIOL TH, V7, P1575, DOI 10.1517/14712598.7.10.1575; Zhang M, 2006, J IMMUNOL, V177, P4727, DOI 10.4049/jimmunol.177.7.4727; Zhang M, 2006, J MOL CELL CARDIOL, V41, P62, DOI 10.1016/j.yjmcc.2006.02.006; Zhang M, 2013, INT J CARDIOL, V166, P499, DOI 10.1016/j.ijcard.2011.11.032; Zhong CY, 2004, ANESTHESIOLOGY, V100, P540, DOI 10.1097/00000542-200403000-00012	138	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179450	10.1371/journal.pone.0179450	http://dx.doi.org/10.1371/journal.pone.0179450			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662037	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300022
J	Spangler, GL; Rosen, BD; Ilori, MB; Hanotte, O; Kim, ES; Sonstegard, TS; Burke, JM; Morgan, JLM; Notter, DR; Van Tassell, CP				Spangler, Gordon L.; Rosen, Benjamin D.; Ilori, Moses Babatunde; Hanotte, Olivier; Kim, Eui-Soo; Sonstegard, Tad S.; Burke, Joan M.; Morgan, James L. M.; Notter, David R.; Van Tassell, Curtis P.			Whole genome structural analysis of Caribbean hair sheep reveals quantitative link to West African ancestry	PLOS ONE			English	Article							WIDE ASSOCIATION REVEALS; HAEMONCHUS-CONTORTUS; RESISTANCE; QTL; HISTORY; ORIGIN; GROWTH; BREEDS	Hair sheep of Caribbean origin have become an important part of the U.S. sheep industry. Their lack of wool eliminates a number of health concerns and drastically reduces the cost of production. More importantly, Caribbean hair sheep demonstrate robust production performance even in the presence of drug-resistant gastrointestinal nematodes, a rising concern to the industry. Despite the growing importance of hair sheep in the Americas their genetic origins have remained speculative. Prior to this report no genetic studies were able to identify a unique geographical origin of hair sheep in the New World. Our study clarifies the African and European ancestry of Caribbean hair sheep. Whole-genome structural analysis was conducted on four established breeds of hair sheep from the Caribbean region. Using breeds representing Africa and Europe we establish an objective measure indicating Caribbean hair sheep are derived from Iberian and West African origins. Caribbean hair sheep result from West African introgression into established ecotypes of Iberian descent. Genotypes from 47,750 autosomal single nucleotide polymorphism markers scored in 290 animals were used to characterize the population structure of the St. Croix, Barbados Black-belly, Morada Nova, and Santa Ines. Principal components, admixture, and phylogenetic analyses results correlate with historical patterns of colonization and trade. These patterns support co-migration of these sheep with humans.	[Spangler, Gordon L.; Rosen, Benjamin D.; Van Tassell, Curtis P.] ARS, Anim Genom & Improvement Lab, USDA, Beltsville, MD 20705 USA; [Ilori, Moses Babatunde; Hanotte, Olivier] Univ Nottingham, Sch Life Sci, Nottingham, England; [Kim, Eui-Soo; Sonstegard, Tad S.] Acceligen Recombinetics Inc, St Paul, MN USA; [Burke, Joan M.] ARS, Dale Bumpers Small Farms Res Stn, USDA, Booneville, AR USA; [Morgan, James L. M.] Katahdin Hair Sheep Int, Fayetteville, AR USA; [Notter, David R.] Virginia Tech, Dept Anim & Poultry Sci, Blacksburg, VA USA	United States Department of Agriculture (USDA); University of Nottingham; United States Department of Agriculture (USDA); Virginia Polytechnic Institute & State University	Rosen, BD (corresponding author), ARS, Anim Genom & Improvement Lab, USDA, Beltsville, MD 20705 USA.	ben.rosen@ars.usda.gov	Burke, Joan M/GLU-6395-2022; Van Tassell, Curtis P./O-4247-2019	Van Tassell, Curtis P./0000-0002-8416-2087; Hanotte, Olivier/0000-0002-2877-4767; Ilori, Babatunde/0000-0002-5316-1495				Alvarez I, 2013, ANIM GENET, V44, P344, DOI 10.1111/j.1365-2052.2012.02398.x; Alvarez I, 2012, SMALL RUMINANT RES, V104, P89, DOI 10.1016/j.smallrumres.2011.10.025; Amarante AFT, 2004, VET PARASITOL, V120, P91, DOI 10.1016/j.vetpar.2003.12.004; Aumont G, 2003, VET PARASITOL, V116, P139, DOI 10.1016/S0304-4017(03)00259-0; Benavides MV, 2016, TRENDS PARASITOL, V32, P470, DOI 10.1016/j.pt.2016.03.007; Blackburn HD, GENETIC STRUCTURE DI; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Bryc, GEN WID PATT POP STR; Burke JM, 2002, VET PARASITOL, V109, P265, DOI 10.1016/S0304-4017(02)00272-8; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chessa B, 2009, SCIENCE, V324, P532, DOI 10.1126/science.1170587; Ciani E, 2014, ANIM GENET, V45, P256, DOI 10.1111/age.12106; Ciani E, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0139-z; Delgado J.V., 2000, ANIM GENET RESOUR IN, V28, P27, DOI [10.1017/S1014233900001334, DOI 10.1017/S1014233900001334]; Fariello MI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103813; Galloway J. H., 2005, SUGAR CANE IND HIST; Gifford-Gonzalez D, 2011, J WORLD PREHIST, V24, P1, DOI DOI 10.1007/s10963-010-9042-2; Henzell T, 2007, AUSTRALIAN AGRICULTURE: ITS HISTORY AND CHALLENGES, P1; Herraez DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007888; Jiang Y, 2014, SCIENCE, V344, P1168, DOI 10.1126/science.1252806; Jones K., MARKETING COULD BOOS; Kijas J, 2017, ANIM GENET, V48, P237, DOI [10.1111/age.12513, 10.1111/age.12409]; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Kijas JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004668; Laloe D., 2010, Diversity, V2, P932, DOI 10.3390/d2060932; Lee T-H, 2014, BMC GENOMICS, P15; Legarra A, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0087-7; Lv F-H, 2014, MOL BIOL EVOL; Lv FH, 2015, MOL BIOL EVOL, V32, P2515, DOI 10.1093/molbev/msv139; Major RH, 1870, SELECT LETT CHRISTOP; Malhado CHM, 2009, SMALL RUMINANT RES, V84, P16, DOI 10.1016/j.smallrumres.2009.04.006; Mariante A. da S., 1999, Animal Genetic Resources Information, P107; Matika O, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0191-3; McManus Concepta, 2010, R. Bras. Zootec., V39, P236, DOI 10.1590/S1516-35982010001300026; Milne C, 2000, SMALL RUMINANT RES, V36, P99, DOI 10.1016/S0921-4488(99)00154-6; Morris ST, 2009, SMALL RUMINANT RES, V86, P59, DOI 10.1016/j.smallrumres.2009.09.019; Muigai AWT, 2013, AFR ARCHAEOL REV, V30, P39, DOI 10.1007/s10437-013-9129-0; Muigai AWT, GENETIC DIVERSITY RE; Notter DR, 2003, SMALL RUMINANT RES, V47, P221, DOI 10.1016/S0921-4488(02)00279-1; Paiva SR, 2011, J HERED, V102, P697, DOI 10.1093/jhered/esr101; Paiva SR, 2005, PESQUI AGROPECU BRAS, V40, P887, DOI 10.1590/S0100-204X2005000900008; Pereira F, 2006, MOL BIOL EVOL, V23, P1420, DOI 10.1093/molbev/msl007; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Raj A, 2014, GENETICS, V197, P573, DOI 10.1534/genetics.114.164350; Salle G, 2012, J ANIM SCI, V90, P4690, DOI 10.2527/jas.2012-5121; Tapio M, 2006, MOL BIOL EVOL, V23, P1776, DOI 10.1093/molbev/msl043; WATSON AM, 1974, J ECON HIST, V34, P8, DOI 10.1017/S0022050700079602; Yang J, 2016, MOL BIOL EVOL, V33, P2576, DOI 10.1093/molbev/msw129; Zygoyiannis D, 2006, SMALL RUMINANT RES, V62, P143, DOI 10.1016/j.smallrumres.2005.07.043	50	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179021	10.1371/journal.pone.0179021	http://dx.doi.org/10.1371/journal.pone.0179021			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662044	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300013
J	Croft, S; Chauvenet, ALM; Smith, GC				Croft, Simon; Chauvenet, Alienor L. M.; Smith, Graham C.			A systematic approach to estimate the distribution and total abundance of British mammals	PLOS ONE			English	Article							DEER	Robust policy decisions regarding the protection and management of terrestrial mammals require knowledge of where species are and in what numbers. The last comprehensive review, presenting absolute estimates at a national scale, was published nearly 20 years ago and was largely based on expert opinion. We investigated and propose a systematic data driven approach combing publically available occurrence data with published density estimates to predict species distribution maps and derive total abundance figures for all terrestrial mammals inhabiting Britain. Our findings suggest that the methodology has potential; generally producing plausible predictions consistent with existing information. However, inconsistencies in the availability and recording of data impact the certainty of this output limiting its current application for policy. Restrictions on access and use of occurrence data at a local level produces "data deserts" for which models cannot compensate. This leads to gaps in spatial distribution of species and consequently underestimates abundance. For many species the limited number of geo-referenced densities hampered the extrapolation from habitat suitability to absolute abundance. Even for well-studied species, further density estimates are required. Many density estimates used were pre-1995 and therefore the derived abundance should not be considered a current estimate. To maximise a systematic approach in the future we make the following recommendations: 1. To mitigate the attitudes of a minority of local data providers occurrence records must be submitted to national surveys such as the Mammal Society's Mammal Tracker. 2. Studies are required to estimate density for common species and in areas of low or no abundance. 3. To ensure such studies can be collated and used efficiently we propose a standardised approach reporting density estimates based on the 1km resolution British National Grid, or habitat representative of the 1km square, with digital maps to accompany publications.	[Croft, Simon; Chauvenet, Alienor L. M.; Smith, Graham C.] Anim & Plant Hlth Agcy, Natl Wildlife Management Ctr, York, N Yorkshire, England; [Chauvenet, Alienor L. M.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia	Animal & Plant Health Agency UK; University of Queensland	Smith, GC (corresponding author), Anim & Plant Hlth Agcy, Natl Wildlife Management Ctr, York, N Yorkshire, England.	graham.smith@apha.gsi.gov.uk	Chauvenet, Alienor/L-9135-2015; Smith, Graham C/J-2593-2013	Chauvenet, Alienor/0000-0002-3743-7375; Smith, Graham C/0000-0002-9897-6794	Department for Environment, Food Rural Affairs [SE0430]	Department for Environment, Food Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA))	This work was funded by the Department for Environment, Food & Rural Affairs (https://www.gov.uk/government/organisations/department-for-environment-food-rural-afairs) under project SE0430. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2010, DIVERS DISTRIB, V16, P515, DOI 10.1111/j.1472-4642.2010.00662.x; Aebischer NJ., 2011, NATL GAMEBAG CENSUS; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Association of Local Environmental Records Centres, LRC ACCR GUID HDB LR; Bates D, IME4 LINEAR MIXED EF; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burham KP, 2002, MODEL SLECTION MULTI; Calcagno V, GLMULTI MODEL SELECT; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Harris S. J., 2015, 673 BTO; Harris SJ, 1995, JOINT NATURE CONSERV; Hijmans R.J., DISMO SPECIES DISTRI; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2015, R CRAN PROJ INTERNET; Hijmans RJ, 2012, ECOLOGY, V93, P679, DOI 10.1890/11-0826.1; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Massei G, 2014, WILDLIFE RES, V41, P1, DOI 10.1071/WR13141; Mazerolle MJ, ALCCMODAVG MODEL SEL; Moore NP, 2003, NEW ZEAL J ZOOL, V30, P443, DOI 10.1080/03014223.2003.9518351; Morton D., 2011, 1107 COUNTR SURV CTR; Naimi B, 2016, ECOGRAPHY; National Biodiversity Network, 2015, STRAT 2015 2020 1 DR; National Records of Scotland, 2011, CENS AGG DAT SCOTLAN; Norbury G, 2015, MAMMAL REV, V45, P79, DOI 10.1111/mam.12034; Office for National Statistics, 2015, 2011 CENS AGGR DAT E; Putman RJ, 1998, MAMMAL REV, V28, P141, DOI 10.1046/j.1365-2907.1998.00031.x; Robertson PA, 2015, MAMMAL REV, V45, P128, DOI 10.1111/mam.12038; ROYSTON P, 1995, APPL STAT-J ROY ST C, V44, P547, DOI 10.2307/2986146; Sandfort R, 2015, MAMMAL REV, V45, P191, DOI 10.1111/mam.12039; Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x; Smith GC, 2007, VET J, V173, P302, DOI 10.1016/j.tvjl.2005.11.017; Smith G. C., 2009, MANAGEMENT DIS WILD; Uhrin M, 2016, MAMMAL REV, V46, P1, DOI 10.1111/mam.12050; Venables WN., 2002, MODERN APPL STAT S 4; Webbon CC, 2004, J APPL ECOL, V41, P768, DOI 10.1111/j.0021-8901.2004.00930.x; Yarnell RW, 2014, MAMMAL REV, V44, P234, DOI 10.1111/mam.12026; Zeileis A., 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i10, DOI 10.18637/JSS.V011.I10]	39	28	29	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0176339	10.1371/journal.pone.0176339	http://dx.doi.org/10.1371/journal.pone.0176339			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658248	Green Published, gold, Green Submitted			2022-12-27	WOS:000404607900002
J	Jerszurki, D; Souza, JLM; Silva, LCR				Jerszurki, Daniela; Souza, Jorge L. M.; Silva, Lucas C. R.			Expanding the geography of evapotranspiration: An improved method to quantify land-to-air water fluxes in tropical and subtropical regions	PLOS ONE			English	Article							LIMITED WEATHER DATA; PENMAN-MONTEITH; TRANSPIRATION RATE; MODELS; HARGREAVES; EVAPORATION; EQUATION; FORMULA; STATE	The development of new reference evapotranspiration (ETo) methods hold significant promise for improving our quantitative understanding of climatic impacts on water loss from the land to the atmosphere. To address the challenge of estimating ETo in tropical and subtropical regions where direct measurements are scarce we tested a new method based on geographical patterns of extraterrestrial radiation (Ra) and atmospheric water potential (psi(air)). Our approach consisted of generating daily estimates of ETo across several climate zones in Brazil as a model system which we compared with standard ETOPM (Penman-Monteith) estimates. In contrast with ETOPM, the simplified method (ETMJS) relies solely on (psi(air) calculated from widely available air temperature (degrees C) and relative humidity (%) data, which combined with Ra data resulted in reliable estimates of equivalent evaporation (Ee) and ETo. We used regression analyses of psi(air) vs ETOPM and Ee vs ETo(PM) to calibrate the ETMJS (psi(air)) and ETows estimates from 2004 to 2014 and between seasons and climatic zone. Finally, we evaluated the performance of the new method based on the coefficient of determination (Fe) and correlation (R), index of agreement "d', mean absolute error (MAE) and mean reason (MR). This evaluation confirmed the suitability of the ETMJS method for application in tropical and subtropical regions, where the climatic information needed for the standard ETOPM calculation is absent.	[Jerszurki, Daniela] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, French Associates Inst Agr & Biotechnol Drylands, Wyler Dept Dryland Agr, Sede Boqer, Israel; [Souza, Jorge L. M.] Univ Fed Parana, Soil & Environm Studies Program, Curitiba, Parana, Brazil; [Silva, Lucas C. R.] Univ Oregon, Environm Studies Program, Eugene, OR 97403 USA; [Silva, Lucas C. R.] Univ Oregon, Dept Geog, Eugene, OR 97403 USA	Ben Gurion University; Universidade Federal do Parana; University of Oregon; University of Oregon	Jerszurki, D (corresponding author), Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, French Associates Inst Agr & Biotechnol Drylands, Wyler Dept Dryland Agr, Sede Boqer, Israel.	danijerszurki@gmail.com	Silva, Lucas/AAA-2476-2022; Silva, Lucas C R/E-1202-2016; Silva, Lucas/GQH-8201-2022	Silva, Lucas/0000-0002-4838-327X; Silva, Lucas C R/0000-0002-4838-327X; 	Coordination for the Improvement of Higher Education Personnel (CAPES/PDSE, Brazil); Araucaria Foundation	Coordination for the Improvement of Higher Education Personnel (CAPES/PDSE, Brazil); Araucaria Foundation(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA)	DJ was supported by Coordination for the Improvement of Higher Education Personnel (CAPES/PDSE, Brazil) (https://www.capes.gov.br) and Araucaria Foundation (http://www.fappr.pr.gov.br).	Alexandris S, 2006, AGR WATER MANAGE, V82, P371, DOI 10.1016/j.agwat.2005.08.001; Alexandris S, 2003, AGR WATER MANAGE, V60, P157, DOI 10.1016/S0378-3774(02)00172-5; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Allen RG, 2005, 078440805X ENV WAT R; Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; [Anonymous], 1963, J IRR DRAIN DIV-ASCE, DOI [10.1061/JRCEA4.0000287, DOI 10.1061/JRCEA4.0000287]; Benevides JG, 1970, AGRONOMIA TROPICAL, V20, P335; Berti A, 2014, AGR WATER MANAGE, V140, P20, DOI 10.1016/j.agwat.2014.03.015; Blaney H., 1950, DETERMINING WATER RE; Borges Alisson C., 2007, Rev. bras. eng. agríc. ambient., V11, P293, DOI 10.1590/S1415-43662007000300008; Borges JCF, 2012, REV BRAS ENG AGR AMB, V16, P380, DOI 10.1590/S1415-43662012000400008; Borges VP, 2010, REV BRAS ENG AGR AMB, V14, P74, DOI 10.1590/S1415-43662010000100010; Budiko M. I., 1974, CLIMATE LIFE; CAMARGO A. P., 1997, REV BRASILEIRA AGROM, V5, P89, DOI DOI 10.13083/1414-3984.V20N02A08; Campbell S., 1977, INTRO ENV BIOPHYSICS; Chagas RM, 2013, IRRIGA; Couvreur V, 2016, AGR FOREST METEOROL, V221, P71, DOI 10.1016/j.agrformet.2016.02.008; da Cunha FF, 2017, ENG AGR-JABOTICABAL, V37, P173, DOI [10.1590/1809-4430-eng.agric.v37n1p173-184/2017, 10.1590/1809-4430-Eng.Agric.v37n1p173-184/2017]; de Araraquara SP, 2005, ENGENHARIA AGRICOLA, V25, P713; Carvalho Luiz Gonsaga de, 2011, Pesqui. Agropecu. Trop., V41, P456, DOI 10.5216/pat.v41i3.12760; de Lacerda ZC, 2015, ENG AGR-JABOTICABAL, V35, P27, DOI 10.1590/1809-4430-Eng.Agric.v35n1p27-38/2015; de Melo GL, 2012, ENG AGR-JABOTICABAL, V32, P874, DOI 10.1590/S0100-69162012000500007; Djaman K, 2015, J HYDROL-REG STUD, V3, P139, DOI 10.1016/j.ejrh.2015.02.002; Duursma RA, 2008, TREE PHYSIOL, V28, P265, DOI 10.1093/treephys/28.2.265; George B.A., 2012, J INDIAN WATER RESOU, V32, P15; Gharun M, 2015, AGR FOREST METEOROL, V200, P249, DOI 10.1016/j.agrformet.2014.09.027; Gocic M, 2010, COMPUT ELECTRON AGR, V71, P158, DOI 10.1016/j.compag.2010.01.003; Gong L, 2006, J HYDROL, V329, P3; Hamon W. R., 1961, J HYDRAUL DIV, V87, P107, DOI [10.1061/JYCEAJ.0000599, DOI 10.1061/JYCEAJ.0000599]; Hargreaves G. H., 1985, Applied Engineering in Agriculture, V1, P96; Hargreaves GH, 2003, J IRRIG DRAIN ENG, V129, P53, DOI 10.1061/(ASCE)0733-9437(2003)129:1(53); Hillel D., 1971, SOIL WATER PHYS PRIN; Hupet F, 2001, J HYDROL, V243, P192, DOI 10.1016/S0022-1694(00)00413-3; Irmak S, 2006, J IRRIG DRAIN ENG, V132, P564, DOI 10.1061/(ASCE)0733-9437(2006)132:6(564); Jensen M.E., 1990, EVAPOTRANSPIRATION I; Kampfer N., 2013, MONITORING ATMOSPHER; Lemos LCD, 2010, REV BRAS ENG AGR AMB, V14, P165, DOI 10.1590/S1415-43662010000200007; LINACRE ET, 1977, AGR METEOROL, V18, P409, DOI 10.1016/0002-1571(77)90007-3; Makkink G.F., 1957, J I WATER ENG, V11, P277; Martinez CJ, 2010, J IRRIG DRAIN ENG, V136, P494, DOI 10.1061/(ASCE)IR.1943-4774.0000214; MEDEIROS A. T., 2002, THESIS, P103; Mendonça José C., 2003, Rev. bras. eng. agríc. ambient., V7, P275, DOI 10.1590/S1415-43662003000200015; Mohawesh OE, 2011, PLANT SOIL ENVIRON, V57, P145, DOI 10.17221/240/2010-PSE; Murray F., 1967, J APPL METEOROL CLIM, V6, P203, DOI [10.1175/1520-0450(1967)0062.0.CO;2, DOI 10.1175/1520-0450(1967)0062.0.CO;2]; Novak V, 2013, EVAPOTRANSPIRATION S; Oliveira Rubens A., 2008, Rev. bras. eng. agríc. ambient., V12, P166, DOI 10.1590/S1415-43662008000200009; Pandey PK, 2016, INT SOIL WATER CONSE, V4, P52, DOI 10.1016/j.iswcr.2016.02.003; PENMAN H. L., 1963, VEGETATION HYDROLOGY; PENMAN HL, 1948, PROC R SOC LON SER-A, V193, P120, DOI 10.1098/rspa.1948.0037; Philip JR, 1964, J APPL METEOROL, V3, P390; Pilau FG, 2012, CIENC RURAL, V42, P283, DOI 10.1590/S0103-84782012000200016; PRIESTLEY CHB, 1972, MON WEATHER REV, V100, P81, DOI 10.1175/1520-0493(1972)100<0081:OTAOSH>2.3.CO;2; Rana G, 1998, THEOR APPL CLIMATOL, V60, P141, DOI 10.1007/s007040050039; Ravazzani G, 2012, J IRRIG DRAIN ENG, V138, P592, DOI 10.1061/(ASCE)IR.1943-4774.0000453; REICHARDT K., 2012, SOLO PLANTA ATMOSFER; Cunha Paulo César Ribeiro da, 2013, Pesqui. Agropecu. Trop., V43, P114, DOI 10.1590/S1983-40632013000200005; Rojas JP, 2013, J IRRIG DRAIN ENG, V139, P285, DOI 10.1061/(ASCE)IR.1943-4774.0000523; Romanenko V.A., 1961, P UKR HYDR RES I KIE; Sabziparvar AA, 2010, J IRRIG DRAIN ENG, V136, P724, DOI 10.1061/(ASCE)IR.1943-4774.0000242; Schendel U, 1967, VEGETATIONS WASSERVE; Schlesinger WH, 2014, AGR FOREST METEOROL, V189, P115, DOI 10.1016/j.agrformet.2014.01.011; Silva AO, 2011, REV CAATINGA; Silva KO, REV BRASILEIRA ENGEN; Silva LCR, 2015, GEOCHEM PERSPECT LET, V1, P33, DOI 10.7185/geochemlet.1504; Silva LCR, 2015, TRENDS PLANT SCI, V20, P399, DOI 10.1016/j.tplants.2015.05.007; Slayter RO, 1967, PLANT WATER RELATION; Syperreck VLG, ACTA SCI AGRONOMY; Tanaka AA, 2016, PESQUI AGROPECU BRAS, V51, P91, DOI 10.1590/S0100-204X2016000200001; Thornthwaite C, 1944, T AM GEOPHYS UNION, V25, P686; Todorovic M, 2013, J HYDROL, V481, P166, DOI 10.1016/j.jhydrol.2012.12.034; Trabert W., 1896, METEOROL Z, V13, P261; Trajkovic S, 2007, J IRRIG DRAIN ENG, V133, P38, DOI 10.1061/(ASCE)0733-9437(2007)133:1(38); Trajkovic S, 2009, WATER RESOUR MANAG, V23, P3057, DOI 10.1007/s11269-009-9423-4; TURC L., 1961, Annales Agronomiques, V12, P13; Valiantzas JD, 2013, J HYDROL, V505, P13, DOI 10.1016/j.jhydrol.2013.09.005; Vescove Humberto V., 2005, Eng. Agríc., V25, P713, DOI 10.1590/S0100-69162005000300017; Weiss A, 2001, AGRON J, V93, P1321, DOI 10.2134/agronj2001.1321; Wilks D.S., 2011, STAT METHODS ATMOSPH; WILLMOTT CJ, 1985, J GEOPHYS RES-OCEANS, V90, P8995, DOI 10.1029/JC090iC05p08995; Wright J.L., 1972, J IRRIGATION DRAINAG, V98, P193, DOI DOI 10.1061/JRCEA4.0013020; Xavier AC, 2016, INT J CLIMATOL, V36, P2644, DOI 10.1002/joc.4518; Xu CY, 2005, J HYDROL, V308, P105, DOI 10.1016/j.jhydrol.2004.10.024; Yan H, 2012, REMOTE SENS ENVIRON, V124, P581, DOI 10.1016/j.rse.2012.06.004; Yoder RE, 2005, APPL ENG AGRIC, V21, P197	84	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180055	10.1371/journal.pone.0180055	http://dx.doi.org/10.1371/journal.pone.0180055			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658324	Green Submitted, gold, Green Published			2022-12-27	WOS:000404607900054
J	Albers-Wolthers, CHJ; de Gier, J; Walen, M; van Kooten, PJS; Lambalk, CB; Leegwater, PAJ; Roelen, BAJ; Schaefers-Okkens, AC; Rutten, VPMG; Millar, RPM; Kooistra, HS				Albers-Wolthers, C. H. J.; de Gier, J.; Walen, M.; van Kooten, P. J. S.; Lambalk, C. B.; Leegwater, P. A. J.; Roelen, B. A. J.; Schaefers-Okkens, A. C.; Rutten, V. P. M. G.; Millar, R. P. M.; Kooistra, H. S.			In vitro and in vivo effects of kisspeptin antagonists p234, p271, p354, and p356 on GPR54 activation	PLOS ONE			English	Article							CENTRAL PRECOCIOUS PUBERTY; GONADOTROPIN-SECRETION; ESTROUS-CYCLE; LUTEINIZING-HORMONE; SEXUAL-BEHAVIOR; RECEPTOR GPR54; CORPUS-LUTEUM; LIFE-SPAN; BITCH; GENE	Kisspeptins (KPs) and their receptor (GPR54 or KiSS1R) play a key-role in regulation of the hypothalamic-pituitary-gonadal axis and are therefore interesting targets for therapeutic interventions in the field of reproductive endocrinology. As dogs show a rapid and robust LH response after the administration of KP10, they can serve as a good animal model for research concerning KP signaling. The aims of the present study were to test the antagonistic properties of KP analogs p234, p271, p354, and p356 in vitro, by determining the intracellular Ca2+ response of CHEM1 cells that stably express human GPR54, and to study the in vivo effects of these peptides on basal plasma LH concentration and the KP10-induced LH response in female dogs. Exposure of the CHEM1 cells to KP-10 resulted in a clear Ca2+ response. P234, p271, p354, and p356 did not prevent or lower the KP10-induced Ca2+ response. Moreover, the in vivo studies in the dogs showed that none of these supposed antagonists lowered the basal plasma LH concentration and none of the peptides lowered the KP10-induced LH response. In conclusion, p234, p271, p354, and p356 had no antagonistic effects in vitro nor any effect on basal and kisspeptin- stimulated plasma LH concentration in female dogs.	[Albers-Wolthers, C. H. J.; de Gier, J.; Walen, M.; Leegwater, P. A. J.; Schaefers-Okkens, A. C.; Kooistra, H. S.] Univ Utrecht, Dept Clin Sci Compan Anim, Fac Vet Med, Utrecht, Netherlands; [van Kooten, P. J. S.; Rutten, V. P. M. G.] Univ Utrecht, Div Immunol, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Lambalk, C. B.] Vrije Univ Amsterdam, Med Ctr, Dept Obstet Gynecol & Reprod Med, Amsterdam, Netherlands; [Roelen, B. A. J.] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands; [Rutten, V. P. M. G.] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, Pretoria, South Africa; [Millar, R. P. M.] Univ Pretoria, Ctr Neuroendocrinol, Pretoria, South Africa; [Millar, R. P. M.] Univ Pretoria, Mammal Res Inst, Pretoria, South Africa; [Millar, R. P. M.] Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Millar, R. P. M.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland	Utrecht University; Utrecht University; Vrije Universiteit Amsterdam; Utrecht University; University of Pretoria; University of Pretoria; University of Pretoria; University of Cape Town; University of Edinburgh	Albers-Wolthers, CHJ (corresponding author), Univ Utrecht, Dept Clin Sci Compan Anim, Fac Vet Med, Utrecht, Netherlands.	c.h.j.albers-wolthers@uu.nl	Rutten, Victor PMG/AAB-6833-2022	Rutten, Victor PMG/0000-0002-6171-1805; Leegwater, Peter/0000-0002-4100-015X; Lambalk, Cornelis/0000-0003-3947-5129				Albers-Wolthers CHJ, 2016, THERIOGENOLOGY, V86, P589, DOI 10.1016/j.theriogenology.2016.02.009; Albers-Wolthers KHJ, 2014, NEUROENDOCRINOLOGY, V99, P178, DOI 10.1159/000364877; Clarke IJ, 2011, FRONT NEUROENDOCRIN, V32, P367, DOI 10.1016/j.yfrne.2011.01.001; Colledge W. H., 2008, V46, P117, DOI 10.1007/400_2007_050; CONCANNON P, 1977, BIOL REPROD, V17, P604, DOI 10.1095/biolreprod17.4.604; d'Anglemont de Tassigny X, 2010, J NEUROSCI, V30, P8581, DOI DOI 10.1523/JNEUR; De Bond JAP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057972; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Dedes I, 2012, SYST BIOL REPROD MED, V58, P121, DOI 10.3109/19396368.2011.651555; Dhillo WS, 2007, J CLIN ENDOCR METAB, V92, P3958, DOI 10.1210/jc.2007-1116; George JT, 2012, HUM REPROD, V27, P3552, DOI 10.1093/humrep/des326; Goodman RL, 2012, ENDOCRINOLOGY, V153, P5918, DOI 10.1210/en.2012-1611; Grachev P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044344; Guerriero KA, 2012, ENDOCRINOLOGY, V153, P825, DOI 10.1210/en.2011-1565; Hashizume T, 2010, ANIM REPROD SCI, V118, P37, DOI 10.1016/j.anireprosci.2009.05.017; Kirby HR, 2010, PHARMACOL REV, V62, P565, DOI 10.1124/pr.110.002774; Kooistra HS, 1999, BIOL REPROD, V60, P65, DOI 10.1095/biolreprod60.1.65; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Lapatto R, 2007, ENDOCRINOLOGY, V148, P4927, DOI 10.1210/en.2007-0078; Li XF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008334; Liu XH, 2011, J NEUROSCI, V31, P2421, DOI 10.1523/JNEUROSCI.5759-10.2011; Mazaheri A, 2015, INT J PREVENTIVE MED, V6, DOI 10.4103/2008-7802.156839; Mikkelsen JD, 2009, REGUL PEPTIDES, V152, P95, DOI 10.1016/j.regpep.2008.10.001; Millar RP, 2010, BRAIN RES, V1364, P81, DOI 10.1016/j.brainres.2010.09.044; NETT TM, 1975, P SOC EXP BIOL MED, V148, P134, DOI 10.3181/00379727-148-38491; Oakley AE, 2009, ENDOCR REV, V30, P713, DOI 10.1210/er.2009-0005; OKKENS AC, 1986, J REPROD FERTIL, V77, P187, DOI 10.1530/jrf.0.0770187; OKKENS AC, 1985, VET QUART, V7, P173, DOI 10.1080/01652176.1985.9693979; Pineda R, 2010, ENDOCRINOLOGY, V151, P722, DOI 10.1210/en.2009-0803; Reece JF, 2006, VET REC, V159, P379, DOI 10.1136/vr.159.12.379; Rhie YJ, 2014, J KOREAN MED SCI, V29, P1120, DOI 10.3346/jkms.2014.29.8.1120; Rhodes L, 2013, E BOOK CONTRACEPTION; Richardson CC, 2006, DIABETOLOGIA, V49, P2131; Roa J, 2006, ENDOCRINOLOGY, V147, P2864, DOI 10.1210/en.2005-1463; Roseweir AK, 2009, HUM REPROD UPDATE, V15, P203, DOI 10.1093/humupd/dmn058; Roseweir AK, 2009, J NEUROSCI, V29, P3920, DOI 10.1523/JNEUROSCI.5740-08.2009; Roseweir AK, 2013, ADV EXP MED BIOL, V784, P159, DOI 10.1007/978-1-4614-6199-9_8; Schaefers-Okkens A. C., 2010, Clinical endocrinology of dogs and cats: an illustrated text, P203; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Smith JT, 2007, ENDOCRINOLOGY, V148, P1150, DOI 10.1210/en.2006-1435; Smith JT, 2011, ENDOCRINOLOGY, V152, P1001, DOI 10.1210/en.2010-1225; Smith JT, 2009, NEUROENDOCRINOLOGY, V90, P283, DOI 10.1159/000227806; Teles MG, 2008, NEW ENGL J MED, V358, P709, DOI 10.1056/NEJMoa073443; Verma S, 2014, NEUROENDOCRINOLOGY, V99, P190, DOI 10.1159/000365419; WILDT DE, 1979, BIOL REPROD, V20, P648, DOI 10.1095/biolreprod20.3.648; Wintermantel TM, 2006, NEURON, V52, P271, DOI 10.1016/j.neuron.2006.07.023; Zmora N, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.131870	47	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179156	10.1371/journal.pone.0179156	http://dx.doi.org/10.1371/journal.pone.0179156			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650956	Green Published, Green Submitted, gold			2022-12-27	WOS:000404537300049
J	Francis, S; Saavedra-Rodriguez, K; Perera, R; Paine, M; Black, WC; Delgoda, R				Francis, Sheena; Saavedra-Rodriguez, Karla; Perera, Rushika; Paine, Mark; Black, William C.; Delgoda, Rupika			Insecticide resistance to permethrin and malathion and associated mechanisms in Aedes aegypti mosquitoes from St. Andrew Jamaica	PLOS ONE			English	Article							SODIUM-CHANNEL GENE; FRENCH-WEST-INDIES; PYRETHROID RESISTANCE; POPULATIONS; MUTATION; MEXICO	The emergence of novel diseases spread by the Aedes aegypti mosquito in Jamaica and the Caribbean, has prompted studies on insecticide resistance towards effective management of the vector. Though Jamaica has been using the organophosphate insecticide malathion in its vector control program for more than 30 years, resistance to the pesticide has not been tested in over a decade. We analyzed resistance to malathion and the pyrethroid insecticide, permethrin on mosquitoes collected across St. Andrew, Jamaica, and analyzed the molecular basis of resistance. The Center for Disease Control (CDC) bioassay revealed that Ae. aegypti mosquitoes from St. Andrew, Jamaica were resistant to permethrin (15 mu g/bottle) with mortalities at 0-8% at 30 minute exposure time, while contact with malathion (50 mu g/bottle) revealed <= 50% mortality at 15 minutes, which increased to 100% at 45 minutes. The standard susceptible New Orleans (NO) strain exhibited 100% mortality within15 minutes. The activities of multifunction oxidases and p-nitro phenyl-acetate esterases were significantly greater in most Jamaican populations in comparison to the NO strain, while activities of glutathione-S-transferase, acetylcholinesterase, a-esterase and beta-esterase activity were relatively equal, or lower than that of the control strain. The frequency of knockdown resistance mutations in the voltage dependent sodium channel gene were measured. All collections were fixed for Cys1,534 while 56% of mosquitoes were Ile1,016/Val1,016 heterozygotes, and 33% were Ile1,016 homozygotes. Aedes aegypti from St. Andrew Jamaica are resistant to permethrin with variations in the mode of mechanism, and possibly developing resistance to malathion. Continued monitoring of resistance is critically important to manage the spread of the vector in the country.	[Francis, Sheena; Delgoda, Rupika] Univ West Indies, Fac Sci & Technol, Nat Prod Inst, Mona, Jamaica; [Saavedra-Rodriguez, Karla; Perera, Rushika; Black, William C.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA; [Paine, Mark] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England	University West Indies Mona Jamaica; Colorado State University; Liverpool School of Tropical Medicine	Delgoda, R (corresponding author), Univ West Indies, Fac Sci & Technol, Nat Prod Inst, Mona, Jamaica.; Black, WC (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA.	William.Black@ColoState.edu; thejani.delgoda@uwimona.edu.jm	Paine, Mark John Ingraham/O-7450-2019; Francis, Sheena/AAA-9461-2019	Paine, Mark John Ingraham/0000-0003-2061-7713; Saavedra-Rodriguez, Karla/0000-0001-8511-3327; Delgoda, Rupika/0000-0002-6100-481X; Francis, Sheena/0000-0002-2240-8627	University of the West Indies, Mona; New Initiative Grant	University of the West Indies, Mona; New Initiative Grant	This work was supported by the University of the West Indies, Mona, Principal's New Initiative Grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Alvarez LC, 2013, J MED ENTOMOL, V50, P1031, DOI 10.1603/ME12254; Barrett JR, 2006, ENVIRON HEALTH PERSP, V114, pA544, DOI 10.1289/ehp.114-a544a; BENDER W, 1983, J MOL BIOL, V168, P17, DOI 10.1016/S0022-2836(83)80320-9; BIGLEY WS, 1962, J INSECT PHYSIOL, V8, P545, DOI 10.1016/0022-1910(62)90065-3; Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25; BLACK WC, 1985, THEOR APPL GENET, V70, P491, DOI 10.1007/BF00305981; Brogdon W, 2010, GUIDELINE EVALUATING; Brogdon WG, 1998, J AM MOSQUITO CONTR, V14, P159; Castle T, 1999, JAMAICA REV PANAM SA, V5, P100; Darriet F, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-88; Flores AE, 2006, J AM MOSQUITO CONTR, V22, P672, DOI 10.2987/8756-971X(2006)22[672:MOIRIF]2.0.CO;2; Fonseca-Gonzalez I, 2011, PEST MANAG SCI, V67, P430, DOI 10.1002/ps.2081; Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989; Marcombe S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-494; MOH, 2016, ZIK VIR OUTBR CONT S; PAHO, 2014, EP AL; Pan American Health Organization (PAHO), 2014, NUMB REP CAS DENG SE; Garcia GP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000531; RAWLINS SC, 1995, J AM MOSQUITO CONTR, V11, P59; Rawlins SC., 1998, REV PANAMERICANA SAL, V4; Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x; Saavedra-Rodriguez K, 2014, INSECT MOL BIOL, V23, P199, DOI 10.1111/imb.12073; The Gleaner, 2014, THE GLEANER; Tiwari S, 2011, ANN ENTOMOL SOC AM, V104, P297, DOI 10.1603/AN10128; Valle D, 2006, QUANTIFICATION METHO; Vera-Maloof FZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004263; WHO, 2017, SIT REP ZIK VIR MICR; WHO, 2013, TEST PROC INS RES MA; Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x; Zhu YC, 2004, INSECT BIOCHEM MOLEC, V34, P1175, DOI 10.1016/j.ibmb.2004.07.008; ZWICK R. W., 1964, MOSQUITO NEWS, V24, P202	34	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179673	10.1371/journal.pone.0179673	http://dx.doi.org/10.1371/journal.pone.0179673			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650966	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000404537300013
J	Iino, C; Shimoyama, T; Igarashi, T; Aihara, T; Ishii, K; Sakamoto, J; Tono, H; Fukuda, S				Iino, Chikara; Shimoyama, Tadashi; Igarashi, Takasato; Aihara, Tomoyuki; Ishii, Kentaro; Sakamoto, Juichi; Tono, Hiroshi; Fukuda, Shinsaku			Biliary drainage improves the predictive value of modified Glasgow Prognostic Scores in inoperable pancreatic cancer	PLOS ONE			English	Article							CHEMOTHERAPY; GEMCITABINE; SURVIVAL; SITE; S-1	Objective To assess the influence of biliary drainage to cholangitis on modified Glasgow Prognostic Score (mGPS) in patients with pancreatic cancer. Methods mGPS was calculated before and after biliary drainage in 47 consecutive patients with inoperable pancreatic cancer who were receiving chemotherapy. Biliary drainage was indicated for malignant obstructive jaundice that prevented the administration of chemotherapy. To elucidate mGPS values, serum levels of CRP and albumin were measured at the time of diagnosis (before biliary drainage). Overall survival was evaluated and risk factors, which contribute to overall survival, were examined. Results Biliary drainage was performed in 15 patients. Using values obtained before biliary drainage, there were no significant differences in median survival time between patients with a mGPS of 0 and those with a mGPS of 1 or 2 (10.7 vs. 9.4 months; p = 0.757). However, using values obtained after biliary drainage, median survival time was significantly higher in patients with a mGPS of 0 than in those with a mGPS of 1 or 2 (11.4 vs. 4.7 months; p = 0.002). Multivariate analysis revealed that a mGPS of 1 or 2 (HR: 3.38; 95% CI: 1.35-8.46, p = 0.009), a carbohydrate antigen 19-9 >1000 U/mL (2.52; 1.22-5.23, p = 0.013), a performance status of 2 (7.68; 2.72-21.28, p = 0.001), carcinoembryonic antigen level >10 ng/mL (2.29; 1.134.61, p = 0.021) were independently associated with overall survival. Conclusion mGPS values obtained after biliary drainage appear to be a more reliable indicator of overall survival in patients with inoperable pancreatic cancer.	[Iino, Chikara; Igarashi, Takasato; Aihara, Tomoyuki; Ishii, Kentaro; Sakamoto, Juichi; Tono, Hiroshi] Hirosaki Municipal Hosp, Dept Internal Med, Hirosaki, Aomori, Japan; [Iino, Chikara; Shimoyama, Tadashi; Igarashi, Takasato; Fukuda, Shinsaku] Hirosaki Univ, Dept Gastroenterol, Grad Sch Med, Hirosaki, Aomori, Japan	Hirosaki University	Iino, C (corresponding author), Hirosaki Municipal Hosp, Dept Internal Med, Hirosaki, Aomori, Japan.; Iino, C (corresponding author), Hirosaki Univ, Dept Gastroenterol, Grad Sch Med, Hirosaki, Aomori, Japan.	chikaran0601@yahoo.co.jp	Iino, Chikara/I-8730-2019	Iino, Chikara/0000-0001-6844-4415				Crumley ABC, 2006, BRIT J CANCER, V94, P637, DOI 10.1038/sj.bjc.6602998; Forrest LM, 2004, BRIT J CANCER, V90, P1704, DOI 10.1038/sj.bjc.6601789; Glen P, 2006, PANCREATOLOGY, V6, P450, DOI 10.1159/000094562; Ishizuka M, 2009, ANN SURG, V250, P268, DOI 10.1097/SLA.0b013e3181b16e24; Kasuga A, 2015, CANCER CHEMOTH PHARM, V75, P457, DOI 10.1007/s00280-014-2665-8; Martin HL, 2014, INTERN MED J, V44, P676, DOI 10.1111/imj.12453; Proctor MJ, 2011, BRIT J CANCER, V104, P726, DOI 10.1038/sj.bjc.6606087; Proctor MJ, 2010, BRIT J CANCER, V103, P870, DOI 10.1038/sj.bjc.6605855; Shimoda M, 2010, CHEMOTHERAPY, V56, P501, DOI 10.1159/000321014; Ueno H, 2013, J CLIN ONCOL, V31, P1640, DOI 10.1200/JCO.2012.43.3680	10	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0178777	10.1371/journal.pone.0178777	http://dx.doi.org/10.1371/journal.pone.0178777			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644836	gold, Green Published, Green Submitted			2022-12-27	WOS:000404145100008
J	Sorensen, ML; Dahl, P; Sams, T				Sorensen, Mikkel Lindstrom; Dahl, Peter; Sams, Thomas			How fast is a collective bacterial state established?	PLOS ONE			English	Article							LUXR-LUXI FAMILY; PSEUDOMONAS-AERUGINOSA; AEROMONAS-HYDROPHILA; AUTOINDUCER-BINDING; ASSOCIATION RATES; DNA-BINDING; QUORUM; PROTEIN; SPECIFICITY; EXPRESSION	Bacteria in a biofilm colony have the capacity to monitor the size and growth conditions for the colony and modify their phenotypical behaviour to optimise attacks, defence, migration, etc. The quorum sensing systems controlling this involve production and sensing of diffusive signal molecules. Frequently, quorum sensing systems carry a positive feedback loop which produces a switch at a threshold size of the colony. This all-or-none switch can be beneficial to create a sudden attack, leaving a host little time to establish a defence. The reaction-diffusion system describing a basal quorum sensing loop involves production of signal molecules, diffusion of signal molecules, and detection of signal molecules. We study the ignition process in a numerical solution for a basal quorum sensor and demonstrate that even in a large colony the ignition travels through the whole colony in a less than a minute. The ignition of the positive feedback loop was examined in different approximations. As expected, in the exact calculation the ignition was found to be delayed compared to a calculation where the binding of signal molecules was quasistatic. The buffering of signal molecules is found to have little effect on the ignition process. Contrary to expectation, we find that the ignition does not start when the threshold is reached at the center-instead it allows for the threshold to be approached in the whole colony followed by an almost simultaneous ignition of the whole biofilm aggregate.	[Sorensen, Mikkel Lindstrom; Dahl, Peter; Sams, Thomas] Tech Univ Denmark, Dept Elect Engn, Biomed Engn, DK-2800 Lyngby, Denmark; [Sorensen, Mikkel Lindstrom; Dahl, Peter] Tech Univ Denmark, Dept Appl Math & Comp Sci, DK-2800 Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark	Sams, T (corresponding author), Tech Univ Denmark, Dept Elect Engn, Biomed Engn, DK-2800 Lyngby, Denmark.	tsams@dtu.dk	Sams, Thomas/A-9781-2014	Sams, Thomas/0000-0002-6316-2539				Abeliovich H, 2005, BIOPHYS J, V89, P76, DOI 10.1529/biophysj.105.060194; Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; [Anonymous], 2016, MATLAB VERS 9 1 0 44; Bjarnsholt T, 2013, TRENDS MICROBIOL, V21, P466, DOI 10.1016/j.tim.2013.06.002; Bottomley MJ, 2007, J BIOL CHEM, V282, P13592, DOI 10.1074/jbc.M700556200; Boyer M, 2009, FEMS MICROBIOL ECOL, V70, P1, DOI 10.1111/j.1574-6941.2009.00745.x; CHOI SH, 1992, J BACTERIOL, V174, P4064, DOI 10.1128/jb.174.12.4064-4069.1992; Claussen A, 2013, INT J MOL SCI, V14, P13360, DOI 10.3390/ijms140713360; EBERHARD A, 1972, J BACTERIOL, V109, P1101, DOI 10.1128/JB.109.3.1101-1105.1972; Fagerlind MG, 2005, BIOSYSTEMS, V80, P201, DOI 10.1016/j.biosystems.2004.11.008; Fagerlind MG, 2003, J MOL MICROB BIOTECH, V6, P88, DOI 10.1159/000076739; Ferkinghoff-Borg J, 2014, MOL BIOSYST, V10, P103, DOI 10.1039/c3mb70230h; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Garde C, 2015, SENSORS-BASEL, V15, P4229, DOI 10.3390/s150204229; Garde C, 2010, J MOL BIOL, V396, P849, DOI 10.1016/j.jmb.2010.01.002; Gonzalez JE, 2006, MICROBIOL MOL BIOL R, V70, P859, DOI 10.1128/MMBR.00002-06; HANZELKA BL, 1995, J BACTERIOL, V177, P815, DOI 10.1128/jb.177.3.815-817.1995; Jefferson KK, 2005, ANTIMICROB AGENTS CH, V49, P2467, DOI 10.1128/AAC.49.6.2467-2473.2005; Kirke DF, 2004, FEMS MICROBIOL LETT, V241, P109, DOI 10.1016/j.femsle.2004.10.011; Lynch MJ, 2002, ENVIRON MICROBIOL, V4, P18, DOI 10.1046/j.1462-2920.2002.00264.x; More MI, 1996, SCIENCE, V272, P1655, DOI 10.1126/science.272.5268.1655; NEALSON KH, 1970, J BACTERIOL, V104, P313, DOI 10.1128/JB.104.1.313-322.1970; Pai A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.43; Pearson JP, 1999, J BACTERIOL, V181, P1203, DOI 10.1128/JB.181.4.1203-1210.1999; Pinto UM, 2009, MOL MICROBIOL, V73, P32, DOI 10.1111/j.1365-2958.2009.06730.x; Sams T., 2017, UNPUB; Sappington KJ, 2011, MBIO, V2, DOI 10.1128/mBio.00011-11; Schlosshauer M, 2004, PROTEIN SCI, V13, P1660, DOI 10.1110/ps.03517304; Schlosshauer M, 2002, J PHYS CHEM B, V106, P12079, DOI 10.1021/jp025894j; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Schuster M, 2004, P NATL ACAD SCI USA, V101, P15833, DOI 10.1073/pnas.0407229101; SKEEL RD, 1990, SIAM J SCI STAT COMP, V11, P1, DOI 10.1137/0911001; Smith KM, 2003, CHEM BIOL, V10, P81, DOI 10.1016/s1074-5521(03)00002-4; STEWART PS, 1993, APPL ENVIRON MICROB, V59, P327, DOI 10.1128/AEM.59.1.327-329.1993; Stoodley P, 1999, BIOTECHNOL BIOENG, V65, P83, DOI 10.1002/(SICI)1097-0290(19991005)65:1<83::AID-BIT10>3.0.CO;2-B; Swift S, 1997, J BACTERIOL, V179, P5271, DOI 10.1128/jb.179.17.5271-5281.1997; Trovato A, 2014, FEMS MICROBIOL LETT, V352, P198, DOI 10.1111/1574-6968.12394; Ventre I, 2003, MOL MICROBIOL, V48, P187, DOI 10.1046/j.1365-2958.2003.03422.x; Welch M, 2000, EMBO J, V19, P631, DOI 10.1093/emboj/19.4.631; Welch M, 2013, BIOCHEMISTRY-US, V52, P4433, DOI 10.1021/bi400315s; Zhu J, 1999, P NATL ACAD SCI USA, V96, P4832, DOI 10.1073/pnas.96.9.4832; Zhu J, 2001, P NATL ACAD SCI USA, V98, P1507, DOI 10.1073/pnas.98.4.1507	43	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0180199	10.1371/journal.pone.0180199	http://dx.doi.org/10.1371/journal.pone.0180199			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644896	gold, Green Submitted, Green Published			2022-12-27	WOS:000404145100065
J	Hindriksen, S; Bramer, AJ; Truong, MA; Vromans, MJM; Post, JB; Verlaan-Klink, I; Snippert, HJ; Lens, SMA; Hadders, MA				Hindriksen, Sanne; Bramer, Arne J.; My Anh Truong; Vromans, Martijn J. M.; Post, Jasmin B.; Verlaan-Klink, Ingrid; Snippert, Hugo J.; Lens, Susanne M. A.; Hadders, Michael A.			Baculoviral delivery of CRISPR/Cas9 facilitates efficient genome editing in human cells	PLOS ONE			English	Article							CHROMOSOMAL PASSENGER COMPLEX; AURORA-B; MAMMALIAN-CELLS; GENE-EXPRESSION; HISTONE H3; HOMOLOGOUS RECOMBINATION; MULTIPROTEIN COMPLEXES; SPINDLE CHECKPOINT; VERTEBRATE CELLS; STEM-CELLS	The CRISPR/Cas9 system is a highly effective tool for genome editing. Key to robust genome editing is the efficient delivery of the CRISPR/Cas9 machinery. Viral delivery systems are efficient vehicles for the transduction of foreign genes but commonly used viral vectors suffer from a limited capacity in the genetic information they can carry. Baculovirus however is capable of carrying large exogenous DNA fragments. Here we investigate the use of baculoviral vectors as a delivery vehicle for CRISPR/Cas9 based genome-editing tools. We demonstrate transduction of a panel of cell lines with Cas9 and an sgRNA sequence, which results in efficient knockout of all four targeted subunits of the chromosomal passenger complex (CPC). We further show that introduction of a homology directed repair template into the same CRISPR/Cas9 baculovirus facilitates introduction of specific point mutations and endogenous gene tags. Tagging of the CPC recruitment factor Haspin with the fluorescent reporter YFP allowed us to study its native localization as well as recruitment to the cohesin subunit Pds5B.	[Hindriksen, Sanne; Bramer, Arne J.; My Anh Truong; Vromans, Martijn J. M.; Post, Jasmin B.; Verlaan-Klink, Ingrid; Snippert, Hugo J.; Lens, Susanne M. A.; Hadders, Michael A.] Univ Med Ctr Utrecht, Sect Mol Canc Res, Ctr Mol Med, Univ Weg 100, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Lens, SMA; Hadders, MA (corresponding author), Univ Med Ctr Utrecht, Sect Mol Canc Res, Ctr Mol Med, Univ Weg 100, Utrecht, Netherlands.	S.M.A.Lens@umcutrecht.nl; M.A.Hadders@umcutrecht.nl		Truong, My Anh/0000-0002-9450-1978	Dutch Cancer Society, KWF Kankerbestrijding [UU2011-5134]; Netherlands Organization for Scientific Research [NWO-Vici 918.12.610, NWO-Veni 722.013.003]	Dutch Cancer Society, KWF Kankerbestrijding(KWF Kankerbestrijding); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was financially supported by The Dutch Cancer Society, KWF Kankerbestrijding (UU2011-5134 to S.M.A.L.) and The Netherlands Organization for Scientific Research (NWO-Vici 918.12.610 to S.M.A.L. and NWO-Veni 722.013.003 to M.A.H.).	Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Airenne KJ, 2013, MOL THER, V21, P739, DOI 10.1038/mt.2012.286; Airenne KJ, 2011, METHODS MOL BIOL, V737, P279, DOI 10.1007/978-1-61779-095-9_12; Barsoum J, 1997, HUM GENE THER, V8, P2011, DOI 10.1089/hum.1997.8.17-2011; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Bieniossek C, 2012, TRENDS BIOCHEM SCI, V37, P49, DOI 10.1016/j.tibs.2011.10.005; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Boyce FM, 1996, P NATL ACAD SCI USA, V93, P2348, DOI 10.1073/pnas.93.6.2348; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Carretero M, 2013, EMBO J, V32, P2938, DOI 10.1038/emboj.2013.230; Carvalho A, 2003, J CELL SCI, V116, P2987, DOI 10.1242/jcs.00612; Cheng RR, 2014, FEBS LETT, V588, P3954, DOI 10.1016/j.febslet.2014.09.008; Cheshenko N, 2001, GENE THER, V8, P846, DOI 10.1038/sj.gt.3301459; Condreay JP, 1999, P NATL ACAD SCI USA, V96, P127, DOI 10.1073/pnas.96.1.127; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Couturier AM, 2016, NUCLEIC ACIDS RES, V44, P10879, DOI 10.1093/nar/gkw921; Cuylen S, 2016, NATURE, V535, P308, DOI 10.1038/nature18610; Cyranoski D, 2016, NATURE, V535, P476, DOI 10.1038/nature.2016.20302; Dai J, 2006, DEV CELL, V11, P741, DOI 10.1016/j.devcel.2006.09.018; Dai J, 2009, J CELL SCI, V122, P4168, DOI 10.1242/jcs.054122; Deyle DR, 2009, CURR OPIN MOL THER, V11, P442; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Edgerton H, 2016, J CELL BIOL, V213, P651, DOI 10.1083/jcb.201511080; Elkins JM, 2012, J MED CHEM, V55, P7841, DOI 10.1021/jm3008954; Fine EJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10777; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Girdler F, 2008, CHEM BIOL, V15, P552, DOI 10.1016/j.chembiol.2008.04.013; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; HOFMANN C, 1995, P NATL ACAD SCI USA, V92, P10099, DOI 10.1073/pnas.92.22.10099; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kallio MJ, 2002, CURR BIOL, V12, P900, DOI 10.1016/S0960-9822(02)00887-4; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Klein UR, 2006, MOL BIOL CELL, V17, P2547, DOI 10.1091/mbc.E05-12-1133; Kost TA, 1999, CURR OPIN BIOTECH, V10, P428, DOI 10.1016/S0958-1669(99)00005-1; Kost TA, 2002, TRENDS BIOTECHNOL, V20, P173, DOI 10.1016/S0167-7799(01)01911-4; Lei YN, 2011, MOL THER, V19, P942, DOI 10.1038/mt.2011.12; Lens SMA, 2003, EMBO J, V22, P2934, DOI 10.1093/emboj/cdg307; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Maggio I, 2014, SCI REP-UK, V4, DOI 10.1038/srep05105; Mahonen AJ, 2007, J BIOTECHNOL, V131, P1, DOI 10.1016/j.jbiotec.2007.05.022; Mahonen AJ, 2010, J BIOTECHNOL, V145, P111, DOI 10.1016/j.jbiotec.2009.11.003; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mansouri M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11529; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; O'Flynn NMJ, 2013, BIOSCIENCE REP, V33, P23, DOI 10.1042/BSR20120093; Ohta S, 2016, MOL CELL PROTEOMICS, V15, P2802, DOI 10.1074/mcp.M116.057885; Pan YF, 2009, J GENE MED, V11, P1030, DOI 10.1002/jgm.1390; Pinder J, 2015, NUCLEIC ACIDS RES, V43, P9379, DOI 10.1093/nar/gkv993; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shoji I, 1997, J GEN VIROL, V78, P2657, DOI 10.1099/0022-1317-78-10-2657; Song J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10548; Song SU, 2003, J GEN VIROL, V84, P697, DOI 10.1099/vir.0.18772-0; SOULE HD, 1990, CANCER RES, V50, P6075; Stewart S, 2005, CANCER RES, V65, P8730, DOI 10.1158/0008-5472.CAN-05-1500; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; TJIA ST, 1983, VIROLOGY, V125, P107; Vader G, 2006, EMBO REP, V7, P85, DOI 10.1038/sj.embor.7400562; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Weiss MB, 2010, ONCOGENE, V29, P4715, DOI 10.1038/onc.2010.220; Wheatley SP, 2001, CURR BIOL, V11, P886, DOI 10.1016/S0960-9822(01)00238-X; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498; Yoshida MM, 2016, J CELL BIOL, V213, P665, DOI 10.1083/jcb.201511079; Zhu HB, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt721	76	23	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179514	10.1371/journal.pone.0179514	http://dx.doi.org/10.1371/journal.pone.0179514			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640891	Green Submitted, Green Published, gold			2022-12-27	WOS:000404135800036
J	Lin, SF; Chien, JY; Kapupara, K; Huang, CYF; Huang, SP				Lin, Shu-Fang; Chien, Jia-Ying; Kapupara, Kishan; Huang, Chi-Ying F.; Huang, Shun-Ping			Oroxylin A promotes retinal ganglion cell survival in a rat optic nerve crush model	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; FACTOR G-CSF; MICROGLIAL ACTIVATION; AXONAL DEGENERATION; MEMORY IMPAIRMENT; ADULT-RAT; INJURY; EXPRESSION; DEATH; INHIBITION	Purpose To investigate the effect of oroxylin A on the survival of retinal ganglion cells (RGC) and the activation of microglial cells in a rat optic nerve (ON) crush model. Methods Oroxylin A (15mg/Kg in 0.2ml phosphate-buffered saline) or phosphate-buffered saline (PBS control) was immediately administered after ON crush once by subcutaneous injection. Rats were euthanized at 2 weeks after the crush injury. The density of RGC was counted by retrograde labeling with FluoroGold and immunostaining of retina flat mounts for Brn3a. Electrophysiological visual function was assessed by flash visual evoked potentials (FVEP). TUNEL assay, immunoblotting analysis of glial fibrillary acidic protein (GFAP), inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in the retinas, and immunohistochemistry of GFAP in the retinas and ED1 in the ON were evaluated. Results Two weeks after the insult, the oroxylin A-treated group had significantly higher FG labeled cells and Brn3a+ cells suggesting preserved RGC density in the central and mid-peripheral retinas compared with those of the PBS-treated group. FVEP measurements showed a significantly better preserved latency of the P1 wave in the ON-crushed, oroxylin A-treated rats than the ON-crushed, PBS treated rats. TUNEL assays showed fewer TUNEL positive cells in the ON-crushed, oroxylin A-treated rats. The number of ED1 positive cells was reduced at the lesion site of the optic nerve in the ON-crushed, oroxylin A-treated group. Increased GFAP expression in the retina was reduced greatly in ON-crushed, oroxylin A-treated group. Furthermore, administration of oroxylin A significantly attenuated ON crush insult-induced iNOS and COX-2 expression in the retinas. Conclusions These results demonstrated that oroxylin A hasss neuroprotective effects on RGC survival with preserved visual function and a decrease in microglial infiltration in the ONs after ON crush injury.	[Lin, Shu-Fang; Huang, Chi-Ying F.] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Chien, Jia-Ying; Kapupara, Kishan; Huang, Shun-Ping] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Chien, Jia-Ying] Natl Tsing Hua Univ, Inst Syst Neurosci, Hsinchu, Taiwan; [Huang, Chi-Ying F.] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei, Taiwan	National Yang Ming Chiao Tung University; Tzu Chi University; National Tsing Hua University; National Yang Ming Chiao Tung University	Huang, CYF (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan.; Huang, SP (corresponding author), Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan.; Huang, CYF (corresponding author), Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei, Taiwan.	cyhuang5@ym.edu.tw; sphophdoc1688@gms.tcu.edu.tw	Huang, Chi-Ying/AFL-7729-2022; Huang, Chi-Ying/AAG-7672-2022	Huang, Chi-Ying/0000-0003-4898-4937; Huang, Chi-Ying/0000-0003-4898-4937; Kapupara, Kishan/0000-0002-0463-9050; Chien, Jia-Ying/0000-0002-3438-9435	Ministry of Science and Technology, R.O.C [MOST 105-2628-B-320-002-MY3]; Yang Ming University collaboration project [YM106C024]	Ministry of Science and Technology, R.O.C; Yang Ming University collaboration project	This work was supported by The Ministry of Science and Technology, R.O.C (grant nos. MOST 105-2628-B-320-002-MY3) and the Yang Ming University collaboration project (YM106C024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by The Ministry of Science and Technology, R.O.C (grant nos. MOST 105-2628-B-320-002-MY3) and the Yang-Ming University collaboration project (YM106C024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors sincerely thank Miss Su Zen Chen for her excellent assistance with figures.	BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Bien A, 1999, J NEUROTRAUM, V16, P153, DOI 10.1089/neu.1999.16.153; Block ML, 2007, BIOCHEM SOC T, V35, P1127, DOI 10.1042/BST0351127; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Bringmann A, 2009, NEUROCHEM INT, V54, P143, DOI 10.1016/j.neuint.2008.10.014; Brown GC, 2010, NITRIC OXIDE-BIOL CH, V23, P153, DOI 10.1016/j.niox.2010.06.001; Brust AK, 2008, BIOMARK INSIGHTS, V3, P387; Chang CH, 2014, EXP EYE RES, V118, P109, DOI 10.1016/j.exer.2013.11.012; Chen YC, 2000, BIOCHEM PHARMACOL, V59, P1445, DOI 10.1016/S0006-2952(00)00255-0; Chien JY, 2016, EXP EYE RES, V143, P148, DOI 10.1016/j.exer.2015.10.004; Dietz GPH, 2005, MOL BRAIN RES, V136, P118, DOI 10.1016/j.molbrainres.2005.01.011; Frank M, 1996, GLIA, V16, P227, DOI 10.1002/(SICI)1098-1136(199603)16:3<227::AID-GLIA5>3.0.CO;2-Z; Hanke J, 2004, ACT NEUR S, V89, P75; Heiduschka P, 2008, GRAEF ARCH CLIN EXP, V246, P1559, DOI 10.1007/s00417-008-0895-3; Huang TL, 2014, OPHTHALMIC RES, V51, P173, DOI 10.1159/000357736; Karim MD, 2006, CURR EYE RES, V31, P273, DOI 10.1080/02713680500536647; Kaufman PL, 1999, P NATL ACAD SCI USA, V96, P9455, DOI 10.1073/pnas.96.17.9455; Kim DH, 2008, NEUROPHARMACOLOGY, V55, P639, DOI 10.1016/j.neuropharm.2008.05.019; Kim DH, 2006, PHARMACOL BIOCHEM BE, V85, P658, DOI 10.1016/j.pbb.2006.10.025; Koeberle PD, 2004, NEUROSCIENCE, V125, P903, DOI 10.1016/S0306-4522(03)00398-1; Koeberle PD, 1999, EXP NEUROL, V158, P366, DOI 10.1006/exnr.1999.7113; Lee S, 2010, NEUROCHEM RES, V35, P1725, DOI 10.1007/s11064-010-0235-y; Leibinger M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.126; Levin LA, 1996, ARCH OPHTHALMOL-CHIC, V114, P488, DOI 10.1001/archopht.1996.01100130484027; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; Lye-Barthel M, 2013, INVEST OPHTH VIS SCI, V54, P909, DOI 10.1167/iovs.12-10109; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Morishita S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084387; Ohlsson M, 2004, RESTOR NEUROL NEUROS, V22, P1; Palin K, 2008, NEUROBIOL DIS, V30, P19, DOI 10.1016/j.nbd.2007.11.012; PELLEGRINO RG, 1984, PROC R SOC SER B-BIO, V222, P155, DOI 10.1098/rspb.1984.0056; Pham TAN, 2012, BIOORG MED CHEM LETT, V22, P2534, DOI 10.1016/j.bmcl.2012.01.135; QUIGLEY HA, 1995, AUST NZ J OPHTHALMOL, V23, P85, DOI 10.1111/j.1442-9071.1995.tb00135.x; Rohatgi T, 2003, J NEUROSCI RES, V73, P246, DOI 10.1002/jnr.10643; Solomon AS, 1996, J NEUROSCI METH, V70, P21, DOI 10.1016/S0165-0270(96)00098-2; Steinsapir K D, 1999, Curr Opin Ophthalmol, V10, P340, DOI 10.1097/00055735-199910000-00011; Strauss KI, 2002, J NEUROTRAUM, V19, P627, DOI 10.1089/089771502753754091; Tonari M, 2012, INVEST OPHTH VIS SCI, V53, P3490, DOI 10.1167/iovs.11-9415; Tsai RK, 2008, EXP EYE RES, V87, P242, DOI 10.1016/j.exer.2008.06.004; Tual-Chalot S, 2013, VIVO; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Wu N, 2014, LIFE SCI, V94, P17, DOI 10.1016/j.lfs.2013.10.034; Wu N, 2009, OPHTHALMIC RES, V42, P21, DOI 10.1159/000219681; Yoles E, 1999, INVEST OPHTH VIS SCI, V40, P65	44	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0178584	10.1371/journal.pone.0178584	http://dx.doi.org/10.1371/journal.pone.0178584			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640893	Green Published, Green Submitted, gold			2022-12-27	WOS:000404135800007
J	Mitsui, N; Nakai, Y; Inoue, T; Udo, N; Kitagawa, K; Wakatsuki, Y; Kameyama, R; Toyomaki, A; Ito, YM; Kitaichi, Y; Nakagawa, S; Kusumi, I				Mitsui, Nobuyuki; Nakai, Yukiei; Inoue, Takeshi; Udo, Niki; Kitagawa, Kan; Wakatsuki, Yumi; Kameyama, Rie; Toyomaki, Atsuhito; Ito, Yoichi M.; Kitaichi, Yuji; Nakagawa, Shin; Kusumi, Ichiro			Association between suicide-related ideations and affective temperaments in the Japanese general adult population	PLOS ONE			English	Article							PATIENT HEALTH QUESTIONNAIRE; STRESSFUL LIFE EVENTS; SELF-HARM; TEMPS-A; CYCLOTHYMIC TEMPERAMENT; DEPRESSIVE SYMPTOMS; CHARACTER PROFILES; BIPOLAR DISORDERS; CHILDHOOD ABUSE; RISK-FACTORS	Background Suicide rates are vastly higher in Japan than in many other countries, although the associations between affective temperaments and suicide-related ideations in the general adult population remain unclear. Therefore, we aimed to elucidate these associations in the present study. Methods We analyzed data from 638 Japanese volunteers who completed both the Patient Health Questionnaire (PHQ-9) and the Temperament Evaluation of the Memphis, Pisa, Paris, and San Diego Auto-questionnaire (TEMPS-A). Participants were then divided into three groups based on PHQ-9 summary scores and responses to the suicide-related ideation item: non-depressive control group (NC; N = 469), depressive symptoms without suicide-related ideations group (non-SI; N = 135), and depressive symptoms with suicide-related ideations group (SI; N = 34). The depressive symptoms were defined for PHQ-9 summary scores >= 5, and the suicide-related ideations were defined for PHQ-9 #9 score >= 1. We then compared TEMPS-A scores among the groups using Kruskal-Wallis tests. Then the 95% confidence intervals of differences in TEMPS-A subscale scores between the NC and non-SI groups, or between NC and SI groups, were calculated. Results Participants of the SI group exhibited significantly higher scores on the depressive, irritable, and anxious temperament subscales than those of the non-SI group. Similarly, women of the SI group exhibited significantly higher scores of the depressive and irritable temperament subscales than women of the non-SI group, while men of the SI group exhibited significantly higher depressive temperament scores than those of the non-SI group. Among all participants and only men, cyclothymic subscale scores were higher in those of the SI group than the non-SI group (not significant), although the 95% confidence intervals did not overlap. Limitations The cross-sectional study design was the main limitation. Conclusions Depressive, irritable, and anxious temperaments are significant risk factors for suicide-related ideations in the Japanese general adult population. Furthermore, irritable temperament in women and depressive temperament in men are associated with suicide-related ideations.	[Mitsui, Nobuyuki; Nakai, Yukiei; Udo, Niki; Kitagawa, Kan; Wakatsuki, Yumi; Kameyama, Rie; Toyomaki, Atsuhito; Kitaichi, Yuji; Nakagawa, Shin; Kusumi, Ichiro] Hokkaido Univ, Grad Sch Med, Dept Psychiat, Sapporo, Hokkaido, Japan; [Inoue, Takeshi] Tokyo Med Univ, Dept Psychiat, Tokyo, Japan; [Ito, Yoichi M.] Hokkaido Univ, Grad Sch Med, Dept Biostat, Sapporo, Hokkaido, Japan	Hokkaido University; Tokyo Medical University; Hokkaido University	Mitsui, N (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Psychiat, Sapporo, Hokkaido, Japan.	nmitsui@med.hokudai.ac.jp	Inoue, Takeshi/X-8057-2019	Mitsui, Nobuyuki/0000-0002-0788-7690; Inoue, Takeshi/0000-0001-5248-1289; Ito, Yoichi M./0000-0001-5073-0827	"Integrated research on neuropsychiatric disorders" conducted under the Strategic Research Program for Brain Sciences of the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Nervous and Mental Disorders from the Ministry of Health, Labor and Welfare [24-2]; Interdisciplinary Project for Psychosomatological Research at Hokkaido University; Grants-in-Aid for Scientific Research [16K10194] Funding Source: KAKEN	"Integrated research on neuropsychiatric disorders" conducted under the Strategic Research Program for Brain Sciences of the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Nervous and Mental Disorders from the Ministry of Health, Labor and Welfare; Interdisciplinary Project for Psychosomatological Research at Hokkaido University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partly supported by the program "Integrated research on neuropsychiatric disorders" conducted under the Strategic Research Program for Brain Sciences of the Ministry of Education, Culture, Sports, Science, and Technology of Japan (http://www.nips.ac.jp/srpbs/); Research Grant 24-2 for Nervous and Mental Disorders from the Ministry of Health, Labor and Welfare; and a grant from the Interdisciplinary Project for Psychosomatological Research at Hokkaido University. TI has received these fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiskal HS, 2005, J AFFECT DISORDERS, V85, P3, DOI 10.1016/j.jad.2004.12.001; Akiskal HS, 2005, J AFFECT DISORDERS, V85, P245, DOI 10.1016/j.jad.2004.12.004; Akiskal HS, 1998, ACTA PSYCHIAT SCAND, V98, P66, DOI 10.1111/j.1600-0447.1998.tb05969.x; Akiskal HS, 2003, J AFFECT DISORDERS, V73, P49, DOI 10.1016/S0165-0327(02)00320-8; Azorin JM, 2009, COMPR PSYCHIAT, V50, P115, DOI 10.1016/j.comppsych.2008.07.004; Balazs J, 2006, J AFFECT DISORDERS, V91, P133, DOI 10.1016/j.jad.2005.12.049; Baldessarini RJ, 2016, J AFFECT DISORDERS, V198, P78, DOI 10.1016/j.jad.2016.03.002; Beevers CG, 2004, SUICIDE LIFE-THREAT, V34, P126, DOI 10.1521/suli.34.2.126.32791; Brezo J, 2006, ACTA PSYCHIAT SCAND, V113, P180, DOI 10.1111/j.1600-0447.2005.00702.x; Calati R, 2008, J PSYCHIATR RES, V42, P938, DOI 10.1016/j.jpsychires.2007.10.006; Cavanagh JTO, 2003, PSYCHOL MED, V33, P395, DOI 10.1017/S0033291702006943; Chatard A, 2009, EUR J PERSONALITY, V23, P19, DOI 10.1002/per.701; Conrad R, 2009, PSYCHIAT RES, V170, P212, DOI 10.1016/j.psychres.2008.09.008; Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y; Guerreiro DF, 2013, J AFFECT DISORDERS, V151, P891, DOI 10.1016/j.jad.2013.07.034; Hawton K, 2009, LANCET, V373, P99, DOI 10.1016/S0140-6736(08)61871-1; Innamorati M, 2015, J AFFECT DISORDERS, V170, P161, DOI 10.1016/j.jad.2014.08.042; Inoue T, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-73; Isometsa ET, 1998, BRIT J PSYCHIAT, V173, P531, DOI 10.1192/bjp.173.6.531; Karam EG, 2015, J AFFECT DISORDERS, V184, P123, DOI 10.1016/j.jad.2015.05.047; Kochman FJ, 2005, J AFFECT DISORDERS, V85, P181, DOI 10.1016/j.jad.2003.09.009; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Matsumoto S, 2005, J AFFECT DISORDERS, V85, P85, DOI 10.1016/j.jad.2003.10.001; Mitsui N, 2014, NEUROPSYCH DIS TREAT, V10, P811, DOI 10.2147/NDT.S59349; Mitsui N, 2013, COMPR PSYCHIAT, V54, P1215, DOI 10.1016/j.comppsych.2013.05.014; Mitsui N, 2013, COMPR PSYCHIAT, V54, P556, DOI 10.1016/j.comppsych.2012.11.002; Muramatsu K, 2007, PSYCHOL REP, V101, P952, DOI 10.2466/pr0.101.3.952-960; Nakai Y, 2015, J AFFECT DISORDERS, V187, P203, DOI 10.1016/j.jad.2015.08.011; Nakai Y, 2014, J AFFECT DISORDERS, V158, P101, DOI 10.1016/j.jad.2014.02.004; Oquendo MA, 2006, ACTA PSYCHIAT SCAND, V114, P151, DOI 10.1111/j.1600-0447.2006.00829.x; Owens D, 2002, BRIT J PSYCHIAT, V181, P193, DOI 10.1192/bjp.181.3.193; Paris J, 2006, HARVARD REV PSYCHIAT, V14, P233, DOI 10.1080/10673220600968662; Perugi G, 2003, J AFFECT DISORDERS, V73, P87, DOI 10.1016/S0165-0327(02)00329-4; Pompili M, 2008, PSYCHOPATHOLOGY, V41, P313, DOI 10.1159/000146069; Pompili Maurizio, 2008, Neuropsychiatr Dis Treat, V4, P247; Pompili M, 2009, EXPERT REV NEUROTHER, V9, P109, DOI 10.1586/14737175.9.1.109; Rihmer A, 2009, J AFFECT DISORDERS, V116, P18, DOI 10.1016/j.jad.2008.10.024; Rihmer Z, 2013, J AFFECT DISORDERS, V149, P350, DOI 10.1016/j.jad.2013.02.010; Rihmer Z, 2010, CURR OPIN PSYCHIATR, V23, P12, DOI 10.1097/YCO.0b013e32833299d4; Skala K, 2012, J AFFECT DISORDERS, V141, P399, DOI 10.1016/j.jad.2012.03.010; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Statham DJ, 1998, PSYCHOL MED, V28, P839, DOI 10.1017/S0033291798006916; Svirko E, 2007, SUICIDE LIFE-THREAT, V37, P409, DOI 10.1521/suli.2007.37.4.409; Vazquez GH, 2012, J AFFECT DISORDERS, V139, P18, DOI 10.1016/j.jad.2011.06.032; Wittkampf KA, 2007, GEN HOSP PSYCHIAT, V29, P388, DOI 10.1016/j.genhosppsych.2007.06.004	45	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179952	10.1371/journal.pone.0179952	http://dx.doi.org/10.1371/journal.pone.0179952			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY6ZV	28640865	Green Published, gold, Green Submitted			2022-12-27	WOS:000404135800086
J	Piening, BC; Geffers, C; Gastmeier, P; Schwab, F				Piening, Brar C.; Geffers, Christine; Gastmeier, Petra; Schwab, Frank			Pathogen-specific mortality in very low birth weight infants with primary bloodstream infection	PLOS ONE			English	Article							LATE-ONSET SEPSIS; OUTCOMES	Objective Mortality in very low birth weight infants following microbiology confirmed primary bloodstream infections varies with the type of causative pathogen. Given evidence from other studies that infections with gram negative bacteria and fungi cause a higher case fatality risk. We tried to confirm this in a nation-wide multi-center trial. Methods A cohort of 55,465 very low birth weight infants from 242 neonatal departments participating in the German national neonatal infection surveillance system NEO-KISS was used to investigate differences in the case fatality risk of microbiology confirmed primary blood-stream infections according to individual pathogens. Cox proportional hazard regression analyses were performed with the outcomes death and time from microbiology confirmed primary bloodstream infections. The results were adjusted to the recorded risk factors and hospital and department characteristics. Results A total of 4 094 very low birth weight infants with microbiology confirmed primary bloodstream infections were included in the analysis. The crude case fatality risk was 5.7%. The Cox proportional hazard regression analysis with adjustment for available risk factors revealed that microbiology confirmed primary bloodstream infections caused by Klebsiella spp. (HR 3.17 CI95 1.69-5.95), Enterobacter spp. (HR 3.42 CI95 1.86-6.27), Escherichia coli (HR 3.32 CI95 1.84-6.00) and Serratia spp. (HR 3.30 CI95 1.44-7.57) were associated with significantly higher case fatality risk compared to Staphylococcus aureus. After adjusting, case fatality risk of Candida albicans causing microbiology confirmed primary bloodstream infections was not higher than that of S. aureus. Conclusion In very low birth weight infants, bloodstream infections caused by gram negative pathogens have an increased case fatality risk compared to bloodstream infections caused by gram positive pathogens. This should be considered for prevention and therapy. Further research should address the specific risk factors for case fatality of C. albicans bloodstream infections.	[Piening, Brar C.; Geffers, Christine; Gastmeier, Petra; Schwab, Frank] Charite Univ Med Ctr, Inst Hyg & Environm Med, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Piening, BC (corresponding author), Charite Univ Med Ctr, Inst Hyg & Environm Med, Berlin, Germany.	brar.piening@charite.de	Piening, Brar/E-2622-2014	Piening, Brar/0000-0002-4478-5597; Gastmeier, Petra/0000-0001-5520-4287; Geffers, Christine/0000-0003-3047-6416	governmental Robert-Koch-Institut	governmental Robert-Koch-Institut	The authors are members of the German national reference center for surveillance of nosocomial infections which is funded by the governmental Robert-Koch-Institut (http://www.rki. de/DE/Content/Infekt/NRZ/nrz_node.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However besides the general funding of the national reference center which enables it to serve its mission of promoting surveillance of nosocomial infections in German hospitals the authors received no specific funding for this work.	Benzouina Soukayna, 2016, Pan Afr Med J, V23, P197, DOI 10.11604/pamj.2016.23.197.7401; Cleminson J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003850.pub5; Francis JH, 2014, AUST NZ J OBSTET GYN, V54, P354, DOI 10.1111/ajo.12205; Gastmeier P, 2004, J HOSP INFECT, V57, P126, DOI 10.1016/j.jhin.2003.12.038; Geffers C, 2008, J HOSP INFECT; Hohlagschwandtner M., 2001, Archives of Gynecology and Obstetrics, V265, P113, DOI 10.1007/s004040100197; Hornik CP, 2012, EARLY HUM DEV, V88, pS69, DOI 10.1016/S0378-3782(12)70019-1; Kaneko M, 2015, J OBSTET GYNAECOL RE, V41, P1056, DOI 10.1111/jog.12686; Leister R, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-11; Levit O, 2014, PEDIATR INFECT DIS J, V33, P143, DOI 10.1097/INF.0000000000000024; Prieto CL, 2013, AM J PERINAT, V30, P353, DOI 10.1055/s-0032-1324701; Makhoul IR, 2005, CLIN INFECT DIS, V40, P218, DOI 10.1086/426444; MODANLOU HD, 1980, AM J OBSTET GYNECOL, V138, P1157, DOI 10.1016/S0002-9378(16)32784-3; Roy P, 2014, J TROP PEDIATRICS, V60, P480, DOI 10.1093/tropej/fmu042; Schwab F, 2015, PEDIATR INFECT DIS J, V34, P235, DOI 10.1097/INF.0000000000000532; Sharma R, 2007, J PEDIATR SURG, V42, P454, DOI 10.1016/j.jpedsurg.2006.10.038; Stoll BJ, 2003, SEMIN PERINATOL, V27, P293, DOI 10.1016/S0146-0005(03)00046-6; Suwal A, 2013, J NEPAL MED ASSOC, V52, P563; Townsel CD, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00006; Tsai MH, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.06.024; Tsai MH, 2016, AM J INFECT CONTROL, V44, P146, DOI 10.1016/j.ajic.2015.09.009; Tsai MH, 2014, PEDIATRICS, V133, pE322, DOI 10.1542/peds.2013-1248; Tsai MH, 2014, PEDIATR INFECT DIS J, V33, pE7, DOI 10.1097/INF.0b013e3182a72ee0; Voigt M, 1996, GEBURTSH FRAUENHEILK, V56, P550, DOI 10.1055/s-2007-1023283	24	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0180134	10.1371/journal.pone.0180134	http://dx.doi.org/10.1371/journal.pone.0180134			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640920	Green Published, Green Submitted, gold			2022-12-27	WOS:000404135800092
J	Prats-Sanchez, L; Martinez-Domeno, A; Camps-Renom, P; Delgado-Mederos, R; Guisado-Alonso, D; Marin, R; Dorado, L; Rudilosso, S; Gomez-Gonzalez, A; Purroy, F; Gomez-Choco, M; Canovas, D; Cocho, D; Garces, M; Abilleira, S; Martin-Fabregas, J				Prats-Sanchez, Luis; Martinez-Domeno, Alejandro; Camps-Renom, Pol; Delgado-Mederos, Raquel; Guisado-Alonso, Daniel; Marin, Rebeca; Dorado, Laura; Rudilosso, Salvatore; Gomez-Gonzalez, Alejandra; Purroy, Francisco; Gomez-Choco, Manuel; Canovas, David; Cocho, Dolores; Garces, Moises; Abilleira, Sonia; Martin-Fabregas, Joan			Risk factors are different for deep and lobar remote hemorrhages after intravenous thrombolysis	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; WHITE-MATTER LESIONS; INTRACEREBRAL HEMORRHAGE; CEREBRAL MICROBLEEDS; SAFE IMPLEMENTATION; THERAPY; CLASSIFICATION; PATHOGENESIS	Background and purpose Remote parenchymal haemorrhage (rPH) after intravenous thrombolysis is defined as hemorrhages that appear in brain regions without visible ischemic damage, remote from the area of ischemia causing the initial stroke symptom. The pathophysiology of rPH is not clear and may be explained by different underlying mechanisms. We hypothesized that rPH may have different risk factors according to the bleeding location. We report the variables that we found associated with deep and lobar rPH after intravenous thrombolysis. Methods This is a descriptive study of patients with ischemic stroke who were treated with intravenous thrombolysis. These patients were included in a multicenter prospective registry. We collected demographic, clinical and radiological data. We evaluated the number and distribution of cerebral microbleeds (CMB) from Magnetic Resonance Imaging. We excluded patients treated endovascularly, patients with parenchymal hemorrhage without concomitant rPH and stroke mimics. We compared the variables from patients with deep or lobar rPH with those with no intracranial hemorrhage. Results We studied 934 patients (mean age 73.9 +/- 12.6 years) and 52.8% were men. We observed rPH in 34 patients (3.6%); 9 (0.9%) were deep and 25 (2.7%) lobar. No hemorrhage was observed in 900 (96.6%) patients. Deep rPH were associated with hypertensive episodes within first 24 hours after intravenous thrombolysis (77.7% vs 23.3%, p<0.001). Lobar rPH were associated with the presence of CMB (53.8% vs 7.9%, p<0.001), multiple (>1) CMB (30.7% vs 4.4%, p = 0.003), lobar CMB (53.8% vs 3.0%, p<0.001) and severe leukoaraiosis (76.9% vs 42%, p = 0.02). Conclusions A high blood pressure within the first 24 hours after intravenous thrombolysis is associated with deep rPH, whereas lobar rPH are associated with imaging markers of amyloid deposition. Thus, our results suggest that deep and lobar rPH after intravenous thrombolysis may have different mechanisms.	[Prats-Sanchez, Luis; Martinez-Domeno, Alejandro; Camps-Renom, Pol; Delgado-Mederos, Raquel; Guisado-Alonso, Daniel; Marin, Rebeca; Martin-Fabregas, Joan] Hosp Santa Creu & Sant Pau, Serv Neurol, Biomed Res Inst, IIB St Pau, Barcelona, Spain; [Dorado, Laura] Hosp Badalona Germans Trias & Pujol, Dept Neurol, Badalona, Spain; [Rudilosso, Salvatore] Hosp Clin Barcelona, Dept Neurol, Barcelona, Spain; [Gomez-Gonzalez, Alejandra] Hosp del Mar, Dept Neurol, Barcelona, Spain; [Purroy, Francisco] Hosp Arnau Vilanova, Dept Neurol, Lleida, Spain; [Gomez-Choco, Manuel] Hosp Moises Broggi, Dept Neurol, St Joan Desp, Spain; [Canovas, David] Hosp Univ Sabadell Corp Sanitaria Parc Taul, Dept Neurol, Sabadell, Spain; [Cocho, Dolores] Univ Granollers, Hosp Gen, Dept Neurol, Granollers, Spain; [Garces, Moises] Hosp Verge de la Cinta, Dept Neurol, Tortosa, Spain; [Abilleira, Sonia] Stroke Programme Agcy Hlth Qual & Assessment Cata, Barcelona, Spain; [Martin-Fabregas, Joan] Univ Autonoma Barcelona, Med Dept, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Hospital of Santa Creu i Sant Pau; Hospital Germans Trias i Pujol; University of Barcelona; Hospital Clinic de Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University Hospital Arnau de Vilanova; Autonomous University of Barcelona	Prats-Sanchez, L (corresponding author), Hosp Santa Creu & Sant Pau, Serv Neurol, Biomed Res Inst, IIB St Pau, Barcelona, Spain.	lpratss@santpau.cat	Purroy, Francisco/D-4538-2009; Gomez-Choco, Manuel/AAA-1958-2021; Rudilosso, Salvatore/B-9265-2018; Guisado-Alonso, Daniel/F-3399-2018	Purroy, Francisco/0000-0002-1808-5968; Gomez-Choco, Manuel/0000-0002-4191-7574; Rudilosso, Salvatore/0000-0002-8775-6884; Martinez-Domeno, Alejandro/0000-0002-9933-3192; Marti-Fabregas, Joan/0000-0001-9229-8649; Cocho, Dolores/0000-0003-2151-6068; Prats Sanchez, Luis Antonio/0000-0002-3192-4631; Abilleira, Sonia/0000-0002-5587-128X; Guisado-Alonso, Daniel/0000-0002-5799-3184; CAMPS-RENOM, POL/0000-0001-6587-6271; GARCES REDONDO, MOISES/0000-0002-1756-5492	Ministery of Health-Institute de Salud Carlos III: RETICS (Redes tematicas de Investigacion Cooperativa) INVICTUS [RD012/0014]; FEDER (Fondo Europeo de Desarrollo Regional)	Ministery of Health-Institute de Salud Carlos III: RETICS (Redes tematicas de Investigacion Cooperativa) INVICTUS; FEDER (Fondo Europeo de Desarrollo Regional)(European Commission)	This work was supported by Ministery of Health-Institute de Salud Carlos III: RETICS (Redes tematicas de Investigacion Cooperativa) INVICTUS RD012/0014, FEDER (Fondo Europeo de Desarrollo Regional). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2009, STROKE, V40, P2442, DOI 10.1161/STROKEAHA.109.548602; Charidimou A, 2015, NEUROLOGY, V85, P927, DOI 10.1212/WNL.0000000000001923; Charidimou A, 2015, BRAIN, V138, P2126, DOI 10.1093/brain/awv162; Chen YW, 2006, NEUROLOGY, V67, P83, DOI 10.1212/01.wnl.0000223613.57229.24; Craig SAA, ENHANCED CONTROL HYP; Curtze S, 2016, ANN NEUROL, V80, P593, DOI 10.1002/ana.24760; Derex L, 2008, J NEUROL NEUROSUR PS, V79, P1093, DOI 10.1136/jnnp.2007.133371; Greenberg SM, 2014, LANCET NEUROL, V13, P419, DOI 10.1016/S1474-4422(14)70003-1; Jeon SB, 2009, NEUROLOGY, V73, P1638, DOI 10.1212/WNL.0b013e3181bd110f; Kapeller P, 2003, STROKE, V34, P441, DOI 10.1161/01.STR.0000049766.26453.E9; Kidwell CS, 2002, STROKE, V33, P95, DOI 10.1161/hs0102.101792; Kimura K, 2013, STROKE, V44, P2776, DOI 10.1161/STROKEAHA.113.001778; Ly JV, 2010, ANN NEUROL, V68, P959, DOI 10.1002/ana.22072; Marti-Fabregas J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156992; Matosevic B, 2013, NEUROLOGY, V80, P1216, DOI 10.1212/WNL.0b013e3182897015; Mazya MV, 2014, STROKE, V45, P1657, DOI 10.1161/STROKEAHA.114.004923; Meretoja A, 2012, STROKE, V43, P2592, DOI 10.1161/STROKEAHA.112.661603; Pantoni L, 2014, CEREBROVASC DIS, V37, P5, DOI 10.1159/000356796; Prats-Sanchez L, 2016, STROKE, V47, P2003, DOI 10.1161/STROKEAHA.116.013952; Ruecker M, 2012, NEUROLOGY, V79, P31, DOI 10.1212/WNL.0b013e31825dcdf0; Shoamanesh A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00203; SLOAN MA, 1995, NEUROLOGY, V45, P649, DOI 10.1212/WNL.45.4.649; Trouillas P, 2006, STROKE, V37, P556, DOI 10.1161/01.STR.0000196942.84707.71; Tsivgoulis G, 2016, JAMA NEUROL, V73, P675, DOI 10.1001/jamaneurol.2016.0292	24	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0178284	10.1371/journal.pone.0178284	http://dx.doi.org/10.1371/journal.pone.0178284			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640874	gold, Green Published, Green Submitted			2022-12-27	WOS:000404135800004
J	Yagi, S; Koh, Y; Akamatsu, H; Kanai, K; Hayata, A; Tokudome, N; Akamatsu, K; Endo, K; Nakamura, S; Higuchi, M; Kanbara, H; Nakanishi, M; Ueda, H; Yamamoto, N				Yagi, Satomi; Koh, Yasuhiro; Akamatsu, Hiroaki; Kanai, Kuninobu; Hayata, Atsushi; Tokudome, Nahomi; Akamatsu, Keiichiro; Endo, Katsuya; Nakamura, Seita; Higuchi, Masayuki; Kanbara, Hisashige; Nakanishi, Masanori; Ueda, Hiroki; Yamamoto, Nobuyuki			Development of an automated size-based filtration system for isolation of circulating tumor cells in lung cancer patients	PLOS ONE			English	Article							BREAST-CANCER; MICROCAVITY ARRAY; BLOOD; EXPRESSION; SURVIVAL	Circulating tumor cells (CTCs), defined as tumor cells circulating in the peripheral blood of patients with solid tumors, are relatively rare. Diagnosis using CTCs is expected to help in the decision-making for precision cancer medicine. We have developed an automated microcavity array (MCA) system to detect CTCs based on the differences in size and deformability between tumor cells and normal blood cells. Herein, we evaluated the system using blood samples from non-small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC) patients. To evaluate the recovery of CTCs, preclinical experiments were performed by spiking NSCLC cell lines (NCI-H820, A549, NCI-H23 and NCI-H441) into peripheral whole blood samples from healthy volunteers. The recovery rates were 70% or more in all cell lines. For clinical evaluation, 6 mL of peripheral blood was collected from 50 patients with advanced lung cancer and from 10 healthy donors. Cells recovered on the filter were stained. We defined CTCs as DAPI-positive, cytokeratin-positive, and CD45-negative cells under the fluorescence microscope. The 50 lung cancer patients had a median age of 72 years (range, 48-85 years); 76% had NSCLC and 20% had SCLC, and 14% were at stage III disease whereas 86% were at stage IV. One or more CTCs were detected in 80% of the lung cancer patients (median 2.5). A comparison of the CellSearch system with our MCA system, using the samples from NSCLC patients, confirmed the superiority of our system (median CTC count, 0 versus 11 for CellSearch versus MCA; p = 0.0001, n = 17). The study results suggest that our MCA system has good clinical potential for diagnosing CTCs in lung cancer.	[Yagi, Satomi; Endo, Katsuya; Nakamura, Seita; Higuchi, Masayuki; Kanbara, Hisashige] Hitachi Chem Co Ltd, Med Business Unit, Ibaraki, Japan; [Yagi, Satomi; Koh, Yasuhiro; Akamatsu, Hiroaki; Kanai, Kuninobu; Hayata, Atsushi; Tokudome, Nahomi; Akamatsu, Keiichiro; Nakanishi, Masanori; Ueda, Hiroki; Yamamoto, Nobuyuki] Wakayama Med Univ, Dept Internal Med 3, Wakayama, Japan	Hitachi Limited; Wakayama Medical University	Koh, Y (corresponding author), Wakayama Med Univ, Dept Internal Med 3, Wakayama, Japan.	ykoh@wakayama-med.ac.jp			Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT); Project for Cancer Research and Therapeutic Evolution (P-CREATE) from the Japan Agency for Medical Research and Development, AMED; Hitachi Chemical Co., Ltd.	Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT); Project for Cancer Research and Therapeutic Evolution (P-CREATE) from the Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Hitachi Chemical Co., Ltd.	This clinical study was supported by the Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT) and the Project for Cancer Research and Therapeutic Evolution (P-CREATE) from the Japan Agency for Medical Research and Development, AMED. Hitachi Chemical Co., Ltd. provided support in the form of salaries for authors [SY, KE, SN, MH and HK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DL, 2016, SCI REP-UK, V6, DOI 10.1038/srep33488; Adams DL, 2016, CANCER EPIDEM BIOMAR, V25, P1037, DOI 10.1158/1055-9965.EPI-15-1221; Bednarz-Knoll N, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2940; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Farace F, 2011, BRIT J CANCER, V105, P847, DOI 10.1038/bjc.2011.294; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Hofman V, 2012, CYTOPATHOLOGY, V23, P30, DOI 10.1111/j.1365-2303.2010.00835.x; Hofman V, 2011, CLIN CANCER RES, V17, P827, DOI 10.1158/1078-0432.CCR-10-0445; Hofman VJ, 2011, AM J CLIN PATHOL, V135, P146, DOI 10.1309/AJCP9X8OZBEIQVVI; Hosokawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067466; Hosokawa M, 2013, ANAL CHEM, V85, P5692, DOI 10.1021/ac400167x; Hosokawa M, 2010, ANAL CHEM, V82, P6629, DOI 10.1021/ac101222x; Hou JM, 2012, J CLIN ONCOL, V30, P525, DOI 10.1200/JCO.2010.33.3716; Koh Y, 2016, EUR J CANCER, V69, pS14, DOI 10.1016/S0959-8049(16)32629-6; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Mazel M, 2015, MOL ONCOL, V9, P1773, DOI 10.1016/j.molonc.2015.05.009; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Naito T, 2012, J THORAC ONCOL, V7, P512, DOI 10.1097/JTO.0b013e31823f125d; Oxnard GR, 2016, J CLIN ONCOL, V34, P3375, DOI 10.1200/JCO.2016.66.7162; Ring AE, 2005, BRIT J CANCER, V92, P906, DOI 10.1038/sj.bjc.6602418; Souza E, 2016, ONCOTARGETS THER, V9, P7503; Stebbing J, 2009, LANCET ONCOL, V10, P1138, DOI 10.1016/S1470-2045(09)70260-8; Vona G, 2000, AM J PATHOL, V156, P57, DOI 10.1016/S0002-9440(10)64706-2; Watanabe M, 2014, CYTOM PART A, V85, P206, DOI 10.1002/cyto.a.22422; Went PT, 2004, HUM PATHOL, V35, P122, DOI 10.1016/j.humpath.2003.08.026; WHO, 2015, CANCER	28	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179744	10.1371/journal.pone.0179744	http://dx.doi.org/10.1371/journal.pone.0179744			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640869	Green Submitted, Green Published, gold			2022-12-27	WOS:000404135800059
J	Chirivi, J; Danies, G; Sierra, R; Schauer, N; Trenkamp, S; Restrepo, S; Sanjuan, T				Chirivi, Juan; Danies, Giovanna; Sierra, Rocio; Schauer, Nicolas; Trenkamp, Sandra; Restrepo, Silvia; Sanjuan, Tatiana			Metabolomic profile and nucleoside composition of Cordyceps nidus sp nov (Cordycipitaceae): A new source of active compounds	PLOS ONE			English	Article							PHYLOGENETIC CLASSIFICATION; ANTIOXIDANT PROPERTIES; BACTERIAL-INFECTIONS; LIGHT WAVELENGTHS; CELL-DEATH; MILITARIS; EVOLUTION; EXTRACT; PHYTOSPHINGOSINE; BIOSYNTHESIS	Cordyceps sensu lato is a genus of arthropod-pathogenic fungi, which have been used traditionally as medicinal in Asia. Within the genus, Ophiocordyceps sinensis is the most coveted and expensive species in China. Nevertheless, harvesting wild specimens has become a challenge given that natural populations of the fungus are decreasing and because large-scale culture of it has not yet been achieved. The worldwide demand for products derived from cultivable fungal species with medicinal properties has increased recently. In this study, we propose a new species, Cordyceps nidus, which parasitizes underground nests of trapdoor spiders. This species is phylogenetically related to Cordyceps militaris, Cordyceps pruinosa, and a sibling species of Cordyceps caloceroides. It is found in tropical rainforests from Bolivia, Brazil, Colombia and Ecuador. We also investigated the medicinal potential of this fungus based on its biochemical properties when grown on four different culture media. The metabolic profile particularly that of nucleosides, in polar and non-polar extracts was determined by UPLC, and then correlated to their antimicrobial activity and total phenolic content. The metabolome showed a high and significant dependency on the substrate used for fungal growth. The mass intensities of nucleosides and derivative compounds were higher in natural culture media in comparison to artificial culture media. Among these compounds, cordycepin was the predominant, showing the potential use of this species as an alternative to O. sinensis. Furthermore, methanol fractions showed antimicrobial activity against gram-positive bacteria, and less than 3.00 mg of gallic acid equivalents per g of dried extract were obtained when assessing its total phenolic content by modified Folin-Ciocalteu method. The presence of polyphenols opens the possibility of further exploring the antioxidant capacity and the conditions that may enhance this characteristic. The metabolic composition and biochemical activity indicate potential use of C. nidus in pharmaceutical applications.	[Chirivi, Juan; Danies, Giovanna; Restrepo, Silvia] Univ Los Andes, Lab Mycol & Plant Dis, Bogota, Colombia; [Chirivi, Juan; Sierra, Rocio; Sanjuan, Tatiana] Univ Los Andes, Prod & Proc Design Grp, Bogota, Colombia; [Schauer, Nicolas; Trenkamp, Sandra] Metabol Discoveries GmbH, Postdam Golm, Germany; [Sanjuan, Tatiana] Univ Antioquia, Lab Taxon & Ecol Hongos, Medellin, Colombia	Universidad de los Andes (Colombia); Universidad de los Andes (Colombia); Universidad de Antioquia	Restrepo, S (corresponding author), Univ Los Andes, Lab Mycol & Plant Dis, Bogota, Colombia.; Sanjuan, T (corresponding author), Univ Los Andes, Prod & Proc Design Grp, Bogota, Colombia.; Sanjuan, T (corresponding author), Univ Antioquia, Lab Taxon & Ecol Hongos, Medellin, Colombia.	srestrep@uniancles.edu.co; t_sanjuan@hotmail.com	Sanjuan, Tatiana/U-9807-2019	Sanjuan, Tatiana/0000-0003-1836-4542; Chirivi-Salomon, Juan/0000-0003-2072-7955; Sierra, Rocio/0000-0002-2074-7772	"The phylogenetic relationship of Cordyceps in the Insecta Class in the Amazon of Colombia" [489-2009]; Metabolomics de Cordyceps nidus and Cordyceps takaomontana: a bioprospective analysis [1204-669-46686]; Metabolomic Discoveries GmbH	"The phylogenetic relationship of Cordyceps in the Insecta Class in the Amazon of Colombia"; Metabolomics de Cordyceps nidus and Cordyceps takaomontana: a bioprospective analysis; Metabolomic Discoveries GmbH	This work was supported in part from the project "The phylogenetic relationship of Cordyceps in the Insecta Class in the Amazon of Colombia" Code 489-2009 (COLCIENCIAS, Department of Science and Technology of Colombia), and the project Metabolomics de Cordyceps nidus and Cordyceps takaomontana: a bioprospective analysis, code 1204-669-46686 (COLCIENCIAS) to metabolomics analysis and to prepare and publish the manuscript. Metabolomic Discoveries GmbH provides support in the form of salaries for authors NS and ST but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contrubutions" section.	[Anonymous], 2014, ENTEROCOCCI COMMENSA; Buckley LF, 2016, HEART LUNG, V45, P232, DOI 10.1016/j.hrtlng.2016.01.011; Chiechio S, 2006, CURR NEUROPHARMACOL, V4, P233, DOI 10.2174/157015906778019509; Chioza A, 2014, J MYCOL; Chirivi-Salomon JS, 2015, PHYTOTAXA, V234, P63; Clinical and Laboratory Standards Institute (CLSI), 2009, M44A NCCLS, V29; Clinical and Laboratory Standards Institute (CLSI), 2010, M51A NCCLS, V30; CLSI, 2012, PERF STAND ANT DISK, V32; Dong JZ, 2012, APPL BIOCHEM BIOTECH, V166, P2030, DOI 10.1007/s12010-012-9628-5; Dong JZ, 2013, J FOOD BIOCHEM, V37, P578, DOI 10.1111/jfbc.12009; Dong JZ, 2012, APPL BIOCHEM BIOTECH, V166, P1215, DOI 10.1007/s12010-011-9506-6; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Elias BC, 2006, MICROBIOL RES, V161, P273, DOI 10.1016/j.micres.2005.10.003; Estcourt LJ, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009733.pub3; Fischer CL, 2012, ANTIMICROB AGENTS CH, V56, P1157, DOI 10.1128/AAC.05151-11; Fong Y. K., 2000, Mycologist, V14, P127, DOI 10.1016/S0269-915X(00)80090-7; Golembiewski J, 2015, J PERIANESTH NURS, V30, P560, DOI 10.1016/j.jopan.2015.09.005; Grant SS, 2013, VIRULENCE, V4, P273, DOI 10.4161/viru.23987; Guo LX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126095; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Harvey-Clark C, 2011, ILAR J, V52, P213, DOI 10.1093/ilar.52.2.213; Holliday J, 2008, INT J MED MUSHROOMS, V10, P219, DOI 10.1615/IntJMedMushr.v10.i3.30; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Hwang IK, 2008, PLANTA MED, V74, P114, DOI 10.1055/s-2008-1034277; Hyun SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073065; Hyun SH, 2013, J MICROBIOL BIOTECHN, V23, P47, DOI 10.4014/jmb.1208.08058; Jin DQ, 2004, BIOL PHARM BULL, V27, P1126, DOI 10.1248/bpb.27.1126; John VU, 2011, [Frontiers in Biology, 生物学前沿], V6, P357; Johnson D, 2009, MYCOL RES, V113, P279, DOI 10.1016/j.mycres.2008.09.008; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keerti, 2014, ISRN Biochem, V2014, P178498, DOI 10.1155/2014/178498; Kepler RM, 2012, MYCOLOGIA, V104, P182, DOI 10.3852/11-070; Kim Soo-Young, 2010, Mycobiology, V38, P133, DOI 10.4489/MYCO.2010.38.2.133; King AE, 2006, TRENDS PHARMACOL SCI, V27, P416, DOI 10.1016/j.tips.2006.06.004; Kornerup A, 1984, METHUEN HDB COLOUR; KUPPERS H, 1979, ATLAS COLORES; Li C, 2006, J FOOD COMPOS ANAL, V19, P800, DOI 10.1016/j.jfca.2006.04.007; Li SP, 2006, J PHARMACEUT BIOMED, V41, P1571, DOI 10.1016/j.jpba.2006.01.046; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Liu ZQ, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-61; MAINS E. B., 1954, BULL TORREY BOT CLUB, V81, P492, DOI 10.2307/2481945; Miller MA, 2015, XSEDE 15 P 2015 XSED, V39, P1, DOI [DOI 10.1145/2792745.2792784, 10.1145/2792745.2792784]; Muller Thomas, 2007, Neuropsychiatr Dis Treat, V3, P211, DOI 10.2147/nedt.2007.3.2.211; Nasca C, 2013, P NATL ACAD SCI USA, V110, P4804, DOI 10.1073/pnas.1216100110; Nemeth J, 2015, J ANTIMICROB CHEMOTH, V70, P382, DOI 10.1093/jac/dku379; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Nicholson WL, 2002, CELL MOL LIFE SCI, V59, P410, DOI 10.1007/s00018-002-8433-7; Oh TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090823; Osborn M., 2009, THERAPEUTICS CLIN RI; Palacios I, 2011, FOOD CHEM, V128, P674, DOI 10.1016/j.foodchem.2011.03.085; Park MT, 2005, BLOOD, V105, P1724, DOI 10.1182/blood-2004-07-2938; Park SJ, 2013, METABOLOMICS, V9, P236, DOI 10.1007/s11306-012-0442-4; Pavicic T., 2007, International Journal of Cosmetic Science, V29, P181, DOI 10.1111/j.1467-2494.2007.00378.x; Peng L, 2002, EUR J PHARMACOL, V446, P53, DOI 10.1016/S0014-2999(02)01794-6; Petch, 1924, ANN ROYAL BOT GARDEN, V8, P119; PETCH T., 1933, Transactions of the British Mycological Society, V18, P48; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rehner SA, 2005, MYCOLOGIA, V97, P84, DOI 10.3852/mycologia.97.1.84; Sanjuan T, 2014, MYCOLOGIA, V106, P260, DOI 10.3852/106.2.260; Sanjuan TI, 2015, FUNGAL BIOL-UK, V119, P901, DOI 10.1016/j.funbio.2015.06.010; Shcherba VV, 2000, APPL BIOCHEM MICRO+, V36, P491, DOI 10.1007/BF02731896; Shrestha B, 2012, MYCOL PROG, V11, P599, DOI 10.1007/s11557-012-0825-y; Shrivastava T.P., 2013, J PHARM TECH, V6, P44; Sims KA, 2006, PHARMACOTHERAPY, V26, P1745, DOI 10.1592/phco.26.12.1745; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stensrud O, 2005, MYCOL RES, V109, P41, DOI 10.1017/S095375620400139X; Sung GH, 2007, STUD MYCOL, P5, DOI 10.3114/sim.2007.57.01; Taylor CP, 2007, EPILEPSY RES, V73, P137, DOI 10.1016/j.eplepsyres.2006.09.008; Tong SS, 2011, J PHARM PHARMACOL, V63, P238, DOI 10.1111/j.2042-7158.2010.01210.x; Tzortzopoulou A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006883.pub2; VanderMolen KM, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-71; WAXMAN DJ, 1983, ANNU REV BIOCHEM, V52, P825, DOI 10.1146/annurev.bi.52.070183.004141; WISSEMAN CL, 1954, J BACTERIOL, V67, P662, DOI 10.1128/JB.67.6.662-673.1954; Yang FQ, 2008, J PHARMACEUT BIOMED, V48, P231, DOI 10.1016/j.jpba.2008.05.012; Yu Y, 2015, ACTA PHARM SIN B, V5, P210, DOI 10.1016/j.apsb.2015.01.012; Yuen GJ, 2008, CLIN PHARMACOKINET, V47, P351, DOI 10.2165/00003088-200847060-00001; Zeilinger S., 2015, BIOSYNTHESIS MOL GEN; Zhang YJ, 2014, MOL ECOL, V23, P5337, DOI 10.1111/mec.12940; Zhao J, 2014, J PHARMACEUT BIOMED, V87, P271, DOI 10.1016/j.jpba.2013.04.025	79	15	17	5	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179428	10.1371/journal.pone.0179428	http://dx.doi.org/10.1371/journal.pone.0179428			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636672	Green Published, gold, Green Submitted			2022-12-27	WOS:000404118300036
J	Goyen, KA; Wright, JD; Cunneen, A; Henning, J				Goyen, Kailiea Arianna; Wright, John David; Cunneen, Alexandra; Henning, Joerg			Playing with fire - What is influencing horse owners' decisions to not vaccinate their horses against deadly Hendra virus infection?	PLOS ONE			English	Article							TRANSMISSION; OUTBREAKS; DEVELOP; BATS	Hendra virus is a zoonotic paramyxovirus, which causes severe respiratory and neurological disease in horses and humans. Since 2012, the Hendra virus sub-unit G vaccine has been available for horse vaccination in Australia. Uptake of the vaccine has been limited and spillover events of Hendra virus infection in horses continue to occur. We conducted an online, questionnaire-based cross-sectional study of 376 horse owners belonging to a variety of different equestrian clubs in Queensland, Australia, to identify risk factors for non-vaccination against Hendra virus. A total of 43.1% (N = 162) of horse owners indicated that they currently did not vaccinate against Hendra virus infection, while 56.9% (N = 214) currently vaccinated against Hendra virus infection. A total of 52 risk factors were evaluated relating to equestrian activities, horse management, perceived risk and severity of horse and human infection with Hendra virus, side effects of Hendra vaccination, other vaccinations conducted by horse owners and horse owners' attitudes towards veterinarians. The final multivariable logistics regression model identified the following risk factors associated with increased odds of non-vaccination against Hendra virus: 1) perceived low risk (compared to high) of Hendra virus infection to horses (considering the horse owners' location and management practices) or horse owners were unsure about the risk of infection, 2) perceived moderate severity (compared to very severe or severe) of Hendra virus infection in humans, 3) horse owners non-vaccination of their pets, 4) horse owners non-vaccination against strangles disease in horses, 5) handling of more than three horses per week (compared to one horse only) and 6) perceived attitude that veterinarians had a high motivation of making money from Hendra virus vaccination (compared to veterinarians having a low motivation of making money from Hendra virus vaccination). Horse owners were more likely to vaccinate against Hendra virus if horses were used for dressage, show jumping or eventing. The study also identified horse owners' concerns about side-effects and about the lack of evidence on vaccine efficacy.	[Goyen, Kailiea Arianna; Wright, John David; Cunneen, Alexandra; Henning, Joerg] Univ Queensland, Fac Sci, Sch Vet Sci, Gatton, Qld, Australia	University of Queensland	Henning, J (corresponding author), Univ Queensland, Fac Sci, Sch Vet Sci, Gatton, Qld, Australia.	j.henning@uq.edu.au	Wright, John/D-7974-2013; Henning, Joerg/G-8662-2017	Henning, Joerg/0000-0002-0282-1318	University of Queensland, School of Veterinary Science, Bequest [2015000168]	University of Queensland, School of Veterinary Science, Bequest	The project was supported by The University of Queensland, School of Veterinary Science, Bequest (2015000168) and Donation Funds to JH and JDW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Broacasting Cooperation, 2015, CONC ALL RISKS HENDR; Australian Pesticides and Veterinary Medicine Authority, 2017, HENDR VIR VACC; Australian Veterinary Association, 2015, VETS CRIT HAT CAMP H; Australian Veterinary Association Ltd, 2017, SUMM ADV EXP REP MAD; Australian Veterinary Association Ltd, 2016, EQ VETS WELC NEW ANN; Australian Veterinary Association Ltd, 2016, HENDR VIR VACC ITS V; Bard AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171380; Broder CC, 2013, ANTIVIR RES, V100, P8, DOI 10.1016/j.antiviral.2013.06.012; Broder CC, 2012, CURR OPIN VIROL, V2, P176, DOI 10.1016/j.coviro.2012.02.016; Field H, 2001, MICROBES INFECT, V3, P307, DOI 10.1016/S1286-4579(01)01384-3; Field H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028678; Halpin K, 2011, AM J TROP MED HYG, V85, P946, DOI 10.4269/ajtmh.2011.10-0567; Kung N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080897; LIEFMAN CE, 1981, AUST VET J, V57, P57, DOI 10.1111/j.1751-0813.1981.tb00444.x; Manyweathers J, 2017, TRANSBOUND EMERG DIS, V64, P1898, DOI 10.1111/tbed.12588; Martin G, 2015, J GEN VIROL, V96, P1229, DOI 10.1099/vir.0.000073; Mendez DH, 2012, EMERG INFECT DIS, V18, P83, DOI 10.3201/eid1801.111006; Middleton D, 2014, VET CLIN N AM-EQUINE, V30, P579, DOI 10.1016/j.cveq.2014.08.004; Middleton D, 2014, EMERG INFECT DIS, V20, P372, DOI 10.3201/eid2003.131159; Murray PK, 1996, AUST VET J, V74, P214, DOI 10.1111/j.1751-0813.1996.tb15406.x; Peel Alison J, 2016, Infect Ecol Epidemiol, V6, P31658, DOI 10.3402/iee.v6.31658; Playford EG, 2010, EMERG INFECT DIS, V16, P219, DOI 10.3201/eid1602.090552; Richens IF, 2015, VET REC, V177, P465, DOI 10.1136/vr.103415; Smith I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025275; Taylor M, 2016, RIRDC PUBLICATION, V16/002; Velkov T, 2014, CURR DRUG TARGETS, V15, P103, DOI 10.2174/1389450114888131204163210; Waller AS, 2014, VET CLIN N AM-EQUINE, V30, P591, DOI 10.1016/j.cveq.2014.08.007; Williamson MM, 1998, AUST VET J, V76, P813, DOI 10.1111/j.1751-0813.1998.tb12335.x; Zahoor Bilal, 2016, Infect Ecol Epidemiol, V6, P31659, DOI 10.3402/iee.v6.31659; Zahoor Bilal A., 2015, Infection Ecology & Epidemiology, V5, P29619, DOI 10.3402/iee.v5.29619	30	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0180062	10.1371/journal.pone.0180062	http://dx.doi.org/10.1371/journal.pone.0180062			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636633	Green Published, gold, Green Submitted			2022-12-27	WOS:000404118300065
J	Chen, QS; Zhang, QL; Xiao, CC; Chen, X				Chen, Qiusong; Zhang, Qinli; Xiao, Chongchun; Chen, Xin			Backfilling behavior of a mixed aggregate based on construction waste and ultrafine tailings	PLOS ONE			English	Article							RECYCLED CONSTRUCTION; DEMOLITION WASTE; MINE	To study the possibility of utilizing mixed construction waste and ultrafine tailings (CW&UT) as a backfilling aggregate that can be placed underground in a mine, physicochemical evaluation, proportioning strength tests, and pumpability experiments were conducted. It was revealed that mixed CW&UT can be used as a backfilling aggregate due to the complementarities of their physicochemical properties. In addition, as the results of the proportioning strength tests show, the compressive strength of a cemented CW&UT backfilling specimen cured for 28 days, with a mass fraction of 72-74%, a cement-sand ratio of 1:12, and a CW proportion of 30%, is higher than 1.0 MPa, which meets the safety requirements and economic consideration of backfilling technology in many underground metal mines, and can also be enhanced with an increase in the cement-sand ratio. The results of the pumpability experiments show that cemented backfilling slurry based on CW&UT can be transported to the stope underground with a common filling pump, with a 16.6 MPa maximum pressure, with the condition that the time of emergency shut-down is less than approximately 20 min. All in all, the research to utilize mixed CW&UT as a backfilling aggregate can not only provide a way to dispose of CW&UT but also will bring large economic benefits and can provide constructive guidance for environmental protection.	[Chen, Qiusong; Zhang, Qinli; Xiao, Chongchun; Chen, Xin] Cent S Univ, Sch Resources & Safety Engn, Changsha, Hunan, Peoples R China; [Chen, Qiusong] Univ Western Australia, Sch Civil & Resource Engn, Crawley, WA, Australia; [Zhang, Qinli] Key Lab Mineral Resources Exploitat & Hazard Cont, Changsha, Hunan, Peoples R China	Central South University; University of Western Australia	Chen, QS (corresponding author), Cent S Univ, Sch Resources & Safety Engn, Changsha, Hunan, Peoples R China.; Chen, QS (corresponding author), Univ Western Australia, Sch Civil & Resource Engn, Crawley, WA, Australia.	qiusong.chen@csu.edu.cn	Chen, Qiusong/AAJ-1106-2020; Chen, Xin/M-4983-2019	Chen, Xin/0000-0002-9293-8105; Chen, Qiusong/0000-0002-7588-8097	12th Five Years Key Programs for Science and Technology Development of China [2015BAB14601]; Fundamental Research Funds for the Central Universities of Central South University [2016zzts092]	12th Five Years Key Programs for Science and Technology Development of China(Chinese Academy of Sciences); Fundamental Research Funds for the Central Universities of Central South University	This work was supported by the 12th Five Years Key Programs for Science and Technology Development of China (NO. 2015BAB14601), http//www.most.gov.cn/ and the Fundamental Research Funds for the Central Universities of Central South University (No. 2016zzts092).	Belem T, 2008, GEOTECH GEOL ENG, V26, P175, DOI 10.1007/s10706-007-9167-y; Benzaazoua M, 2004, MINER ENG, V17, P141, DOI 10.1016/j.mineng.2003.10.022; BOUYOUCOS GJ, 1962, AGRON J, V54, P464, DOI 10.2134/agronj1962.00021962005400050028x; Cardoso R, 2016, WASTE MANAGE, V49, P131, DOI 10.1016/j.wasman.2015.12.021; Carpio M, 2016, CONSTR BUILD MATER, V113, P561, DOI 10.1016/j.conbuildmat.2016.03.061; Certucha-Barragan MT, 2011, MINER PROCESS EXTR M, V32, P60, DOI 10.1080/08827508.2010.530719; Chen QS, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-016-5895-8; Etim RK, 2017, TRANSP GEOTECH, V10, P85, DOI 10.1016/j.trgeo.2017.01.002; Fall M, 2007, J MATER SCI, V42, P3914, DOI 10.1007/s10853-006-0403-2; Guo W, 2002, INT J PRES VES PIP, V79, P403, DOI 10.1016/S0308-0161(02)00039-X; Kiventera J, 2016, INT J MINER PROCESS, V149, P104, DOI 10.1016/j.minpro.2016.02.012; Larson KW, 2000, RELIAB ENG SYST SAFE, V69, P59, DOI 10.1016/S0951-8320(00)00025-9; Li S, 2016, T NONFERR METAL SOC, V26, P1975, DOI 10.1016/S1003-6326(16)64308-X; 김노동, 2015, [journal of the regional association of architectural institute of korea, 대한건축학회연합논문집], V17, P169; Liu Y, 2013, APPL MECH MATER, V268-270, P656, DOI 10.4028/www.scientific.net/AMM.268-270.656; Monteiro ACS, 2010, INT J REFRIG, V33, P1523, DOI 10.1016/j.ijrefrig.2010.09.009; Moretti JP, 2016, CONSTR BUILD MATER, V113, P317, DOI 10.1016/j.conbuildmat.2016.03.062; Ossa A, 2016, J CLEAN PROD, V135, P379, DOI 10.1016/j.jclepro.2016.06.088; Ozalp F, 2016, CONSTR BUILD MATER, V110, P17, DOI 10.1016/j.conbuildmat.2016.01.030; Rungchet A, 2016, J CLEAN PROD, V115, P273, DOI 10.1016/j.jclepro.2015.12.068; Singh CB, 2013, INT J MIN SCI TECHNO, V23, P893, DOI 10.1016/j.ijmst.2013.11.003; Sun W, 2016, CONSTR BUILD MATER, V113, P153, DOI 10.1016/j.conbuildmat.2016.03.050; Vieira CS, 2016, J CLEAN PROD, V124, P299, DOI 10.1016/j.jclepro.2016.02.115; Wang C, 2014, MINER ENG, V58, P113, DOI 10.1016/j.mineng.2014.01.018; Wang X, 2009, MINING SCI TECHNOLOG, P137; Wang XM, 2008, J CENT SOUTH UNIV T, V15, P801, DOI 10.1007/s11771-008-0148-y; Wang XM, 2010, THEORY TECHNOLOGY DE; Wu AX, 2015, INT J MINER PROCESS, V143, P65, DOI 10.1016/j.minpro.2015.09.004; Wu AX, 2009, BIORESOURCE TECHNOL, V100, P1931, DOI 10.1016/j.biortech.2008.10.021; Yang KH, 2015, CONSTR BUILD MATER, V74, P109, DOI 10.1016/j.conbuildmat.2014.10.030; Yin SH, 2013, HYDROMETALLURGY, V133, P1, DOI 10.1016/j.hydromet.2012.11.009; Zhang Q, 2016, MINERALS, V6; Zhang Qiliang, 2011, MODERN ED TECHNOLOGY, V21, P2011; Zhang Qinli, 2014, Science & Technology Review, V32, P51, DOI 10.3981/j.issn.1000-7857.2014.24.007	34	7	7	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179872	10.1371/journal.pone.0179872	http://dx.doi.org/10.1371/journal.pone.0179872			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662072	gold, Green Published, Green Submitted			2022-12-27	WOS:000404608300062
J	Hartmann, AM; Pisella, LI; Medina, I; Nothwang, HG				Hartmann, Anna-Maria; Pisella, Lucie I.; Medina, Igor; Nothwang, Hans Gerd			Molecular cloning and biochemical characterization of two cation chloride cotransporter subfamily members of Hydra vulgaris	PLOS ONE			English	Article							K-CL COTRANSPORTER; FUNCTIONAL EXPRESSION; INTRACELLULAR CHLORIDE; SEQUENCE ALIGNMENT; TRANSPORT ACTIVITY; KCC2; IDENTIFICATION; MUTATIONS; TOPOLOGY; BINDING	Cation Chloride Cotransporters (CCCs) comprise secondary active membrane proteins mainly mediating the symport of cations (Na+, K+) coupled with chloride (CI-). They are divided into K+-CI- outward transporters (KCCs), the Natr-Cl- (NKCCs) and Na+Cl-(NCCs) inward transporters, the cation chloride cotransporter interacting protein CIP1, and the polyamine transporter CCC9. KCCs and N(K)CCs are established in the genome since eukaryotes and metazoans, respectively. Most of the physiological and functional data were obtained from vertebrate species. To get insights into the basal functional properties of KCCs and N(K)CCs in the metazoan lineage, we cloned and characterized KCC and N(K) CC from the cnidarian Hydra vulgaris. HvKCC is composed of 1,032 amino-acid residues. Functional analyses revealed that hvKCC mediates a Natindependent, Cl- and K+ (TI+) dependent cotransport. The classification of hvKCC as a functional K-CI cotransporter is furthermore supported by phylogenetic analyses and a similar structural organization. Interestingly, recently obtained physiological analyses indicate a role of cnidarian KCCs in hyposmotic volume regulation of nematocytes. HvN(K)CC is composed of 965 amino-acid residues. Phylogenetic analyses and structural organization suggest that hvN(K)CC is a member of the N(K)CC subfamily. However, no inorganic ion cotransport function could be detected using different buffer conditions. Thus, hvN(K)CC is a N(K)CC subfamily member without a detectable inorganic ion cotransporter function. Taken together, the data identify two non-bilaterian solute carrier 12 (SLC12) gene family members, thereby paving the way for a better understanding of the evolutionary paths of this important cotransporter family.	[Hartmann, Anna-Maria; Nothwang, Hans Gerd] Carl von Ossietzky Univ Oldenburg, Sch Med & Hlth Sci, Neurogenet Grp, Oldenburg, Germany; [Hartmann, Anna-Maria; Nothwang, Hans Gerd] Carl von Ossietzky Univ Oldenburg, Ctr Neurosci, Oldenburg, Germany; [Pisella, Lucie I.; Medina, Igor] INSERM, Unite 901, INMED, Marseille, France; [Nothwang, Hans Gerd] Carl von Ossietzky Univ Oldenburg, Cluster Excellence Hearing4All, Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Carl von Ossietzky Universitat Oldenburg	Hartmann, AM (corresponding author), Carl von Ossietzky Univ Oldenburg, Sch Med & Hlth Sci, Neurogenet Grp, Oldenburg, Germany.; Hartmann, AM (corresponding author), Carl von Ossietzky Univ Oldenburg, Ctr Neurosci, Oldenburg, Germany.	anna.maria.hartmann@uol.de	; Medina, Igor/O-5532-2016	Nothwang, Hans Gerd/0000-0001-7695-6437; Medina, Igor/0000-0001-6839-5414	Deutsche Forschungsgemeinschaft [HA 6338/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We acknowledge the excellent technical support by M. Reents. We thank Daniel Drees for his help in initial experiments. This work was supported by the Deutsche Forschungsgemeinschaft (grant HA 6338/2-1 to AMH), httpligepris.dfg.deigeprisiprotekt/222358325.	Antrobus SP, 2012, AM J PHYSIOL-CELL PH, V303, pC1180, DOI 10.1152/ajpcell.00274.2012; Aronica E, 2007, NEUROSCIENCE, V145, P185, DOI 10.1016/j.neuroscience.2006.11.041; Arosio D, 2010, NAT METHODS, V7, P516, DOI [10.1038/nmeth.1471, 10.1038/NMETH.1471]; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Boettger T, 2003, EMBO J, V22, P5422, DOI 10.1093/emboj/cdg519; Boettger T, 2002, NATURE, V416, P874, DOI 10.1038/416874a; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Carmosino M, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-16; Casula S, 2001, J BIOL CHEM, V276, P41870, DOI 10.1074/jbc.M107155200; Chen M, 2017, ELIFE, V6, DOI 10.7554/eLife.20142; Colmenero-Flores JM, 2007, PLANT J, V50, P278, DOI 10.1111/j.1365-313X.2007.03048.x; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Culliford SJ, 2003, CELL PHYSIOL BIOCHEM, V13, P181, DOI 10.1159/000072420; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; De Jong JC, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017904.77985.03; Dehaye JP, 2003, J BIOL CHEM, V278, P11811, DOI 10.1074/jbc.M213148200; Di Fulvio M, 2009, PHYSIOLOGY AND PATHOLOGY OF CHLORIDE TRANSPORTERS AND CHANNELS IN THE NERVOUS SYSTEM: FROM MOLECULES TO DISEASES, P169; Doding A, 2012, BIOCHEM BIOPH RES CO, V420, P492, DOI 10.1016/j.bbrc.2012.02.147; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Friedel P, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00007; Gagnon E, 2005, AM J PHYSIOL-CELL PH, V290, P134; Gagnon KBE, 2006, MOL CELL BIOL, V26, P689, DOI 10.1128/MCB.26.2.689-698.2006; Gagnon KB, 2013, AM J PHYSIOL-CELL PH, V304, pC693, DOI 10.1152/ajpcell.00350.2012; GAMBA G, 1993, P NATL ACAD SCI USA, V90, P2749, DOI 10.1073/pnas.90.7.2749; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; GAMBA G, 1994, J BIOL CHEM, V269, P17713; Gerelsaikhan T, 2000, J BIOL CHEM, V275, P40471, DOI 10.1074/jbc.M007751200; Gerelsaikhan T, 2006, BIOCHEMISTRY-US, V45, P12060, DOI 10.1021/bi061126x; Gillen CM, 1996, J BIOL CHEM, V271, P16237, DOI 10.1074/jbc.271.27.16237; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hartmann A-M, 2014, MOL BIOL EVOLUTION; Hartmann A-M, 2014, FRONTIERS CELLULAR N, V8; Hartmann AM, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00470; Hartmann AM, 2010, J BIOL CHEM, V285, P23994, DOI 10.1074/jbc.M110.144063; Hartmann AM, 2009, J NEUROCHEM, V111, P321, DOI 10.1111/j.1471-4159.2009.06343.x; Hekmat-Scafe DS, 2006, J NEUROSCI, V26, P8943, DOI 10.1523/JNEUROSCI.4998-05.2006; Holtzman EJ, 1998, AM J PHYSIOL-RENAL, V275, pF550, DOI 10.1152/ajprenal.1998.275.4.F550; Hoover RS, 2003, J AM SOC NEPHROL, V14, P271, DOI 10.1097/01.ASN.0000043903.93452.D0; Howard HC, 2002, NAT GENET, V32, P384, DOI 10.1038/ng1002; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Hubner CA, 2014, EMBO REPORTS; Isenring P, 2001, COMP BIOCHEM PHYS A, V130, P487, DOI 10.1016/S1095-6433(01)00420-2; Kahle KT, 2014, EMBO REP, V15, P766, DOI 10.15252/embr.201438840; Kahle KT, 2014, EMBO REPORTS; Kaila K, 2014, NAT REV NEUROSCI, V15, P637, DOI 10.1038/nrn3819; Lauf PK, 2006, EXP EYE RES, V82, P55, DOI 10.1016/j.exer.2005.05.002; Lee HHC, 2010, MOL CELL NEUROSCI, V45, P173, DOI 10.1016/j.mcn.2010.06.008; Lemonnier E, 2010, ACTA PAEDIATR, V99, P1885, DOI 10.1111/j.1651-2227.2010.01933.x; Lichtarge O, 2002, CURR OPIN STRUC BIOL, V12, P21, DOI 10.1016/S0959-440X(02)00284-1; Lichtarge O, 2010, CURR OPIN STRUC BIOL, V20, P351, DOI 10.1016/j.sbi.2010.04.002; Marino A, 2010, CELL PHYSIOL BIOCHEM, V26, P209, DOI 10.1159/000320529; Mercado A, 2000, J BIOL CHEM, V275, P30326, DOI 10.1074/jbc.M003112200; Merner ND, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00386; Monette Michelle Y, 2012, J Biol Chem, V287, P2210, DOI 10.1074/jbc.M111.309211; Mount DB, 1999, J BIOL CHEM, V274, P16355, DOI 10.1074/jbc.274.23.16355; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Arroyo JP, 2013, MOL ASPECTS MED, V34, P288, DOI 10.1016/j.mam.2012.05.002; Pacheco-Alvarez D, 2006, J BIOL CHEM, V281, P28755, DOI 10.1074/jbc.M603773200; PAYNE JA, 1995, J BIOL CHEM, V270, P17977, DOI 10.1074/jbc.270.30.17977; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Payne JA, 1997, AJP CELL PHYSL, V273; Pellegrino C, 2011, J PHYSIOL-LONDON, V589, P2475, DOI 10.1113/jphysiol.2010.203703; Puskarjov M, 2014, NEUROPHARMACOLOGY; Race JE, 1999, AM J PHYSIOL-CELL PH, V277, pC1210, DOI 10.1152/ajpcell.1999.277.6.C1210; Raimondo JV, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00202; Rambaut A, 2009, FIGTREE V1 3 1 COMPU; Randall J, 1997, AM J PHYSIOL-CELL PH, V273, pC1267, DOI 10.1152/ajpcell.1997.273.4.C1267; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; Shulga A, 2008, J NEUROSCI, V28, P6996, DOI 10.1523/JNEUROSCI.5268-07.2008; Somasekharan S, 2012, J BIOL CHEM, V287, P17308, DOI 10.1074/jbc.M112.356014; Song LY, 2002, MOL BRAIN RES, V103, P91, DOI 10.1016/S0169-328X(02)00190-0; Stodberg T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9038; Strange K, 2000, AM J PHYSIOL-CELL PH, V279, pC860, DOI 10.1152/ajpcell.2000.279.3.C860; Sun QF, 2010, AM J PHYSIOL-CELL PH, V298, pC26, DOI 10.1152/ajpcell.00376.2009; Tanis JE, 2009, J NEUROSCI, V29, P9943, DOI 10.1523/JNEUROSCI.1989-09.2009; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Tyzio R, 2014, SCIENCE, V343, P675, DOI 10.1126/science.1247190; Uvarov P, 2007, J BIOL CHEM, V282, P30570, DOI 10.1074/jbc.M705095200; Warmuth S, 2009, STRUCTURE, V17, P538, DOI 10.1016/j.str.2009.02.009; Weber M, 2014, J BIOL CHEM; Whisstock JC, 2003, Q REV BIOPHYS, V36, P307, DOI 10.1017/S0033583503003901; XU JC, 1994, P NATL ACAD SCI USA, V91, P2201, DOI 10.1073/pnas.91.6.2201; Zhao BB, 2008, CELL SIGNAL, V20, P1769, DOI 10.1016/j.cellsig.2008.06.011	86	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179968	10.1371/journal.pone.0179968	http://dx.doi.org/10.1371/journal.pone.0179968			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662098	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000404608300081
J	Jin, LQ; Ling, MZ; Yue, WQ				Jin, Li-Qiang; Ling, Mingze; Yue, Weiqiang			Tire-road friction estimation and traction control strategy for motorized electric vehicle	PLOS ONE			English	Review							LITHIUM-ION BATTERY; ULTRACAPACITOR; SYSTEM	In this paper, an optimal longitudinal slip ratio system for real-time identification of electric vehicle (EV) with motored wheels is proposed based on the adhesion between tire and road surface. First and foremost, the optimal longitudinal slip rate torque control can be identified in real time by calculating the derivative and slip rate of the adhesion coefficient. Secondly, the vehicle speed estimation method is also brought. Thirdly, an ideal vehicle simulation model is proposed to verify the algorithm with simulation, and we find that the slip ratio corresponds to the detection of the adhesion limit in real time. Finally, the proposed strategy is applied to traction control system (TCS). The results showed that the method can effectively identify the state of wheel and calculate the optimal slip ratio without wheel speed sensor; in the meantime, it can improve the accelerated stability of electric vehicle with traction control system (TCS).	[Jin, Li-Qiang; Ling, Mingze; Yue, Weiqiang] Jilin Univ, State Key Lab Automot Simulat & Control, Changchun, Peoples R China	Jilin University	Jin, LQ (corresponding author), Jilin Univ, State Key Lab Automot Simulat & Control, Changchun, Peoples R China.	jinlq@jlu.edu.cn			China Postdoctoral Science Foundation [2013M540248]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	Professor Li-Qiang Jin received support from China Postdoctoral Science Foundation (2013M540248). The funder had a role in study design, analysis and decision to publish the manuscript.	Astrom KJ, 2001, CONTROL ENG PRACT, V9, P1163, DOI 10.1016/S0967-0661(01)00062-4; Boyraz P, 2013, IEEE INT VEH SYM, P1330; Cirovic V, 2013, MECHATRONICS, V23, P135, DOI 10.1016/j.mechatronics.2012.11.007; Gustafsson F, 1998, IEEE CONTR SYST MAG, V18, P42, DOI 10.1109/37.710877; Hu X., 2015, IEEE T IND ELECTRON, V62, P1; Hu XS, 2016, ENERGY, V111, P971, DOI 10.1016/j.energy.2016.06.037; Hu XS, 2016, IEEE T CONTR SYST T, V24, P1036, DOI 10.1109/TCST.2015.2476799; Hu XS, 2011, P AMER CONTR CONF, P935; Kataoka H, 2001, ELECTR ENG JPN, V135, P56, DOI 10.1002/eej.1033; Khatun P, 2003, IEEE T VEH TECHNOL, V52, P1356, DOI 10.1109/TVT.2003.815922; Li HZ, 2012, CHIN J MECH ENG-EN, V25, P1130, DOI 10.3901/CJME.2012.06.1130; Li L, 2015, MECH SYST SIGNAL PR, V56-57, P259, DOI 10.1016/j.ymssp.2014.10.006; Li Lianbing, 2004, ANTISLIP CONTROL EV; Okano Takahiro, 2002, P PCC OSAKA 2002 OSA, V4, P2; Ono Eiichi, DENSO TECHNICAL REV, V9; Sawada Mamoru, DENSO TECHNICAL REV, V9; Student C. L., VEHICLE SYSTEM DY S1, V25, P413; Sun FC, 2011, ENERGY, V36, P3531, DOI 10.1016/j.energy.2011.03.059; Svendenius Jacob, 2003, REV WHEEL MODELING F, P16; Umeno T., SAE 2002 WORLD C EXH; Umeno T., ESTIMATION TIRE ROAD; Umeno Takaji, R D REV TOYOTA CRDL, V37; VanZanten Anton T., 1996, 3 INT S ADV VEH CONT, P573; Zhang L, 2015, J POWER SOURCES, V287, P129, DOI 10.1016/j.jpowsour.2015.04.043; Zhang L, 2014, ENERGIES, V7, P3204, DOI 10.3390/en7053204	25	7	8	14	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179526	10.1371/journal.pone.0179526	http://dx.doi.org/10.1371/journal.pone.0179526			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662053	gold, Green Published, Green Submitted			2022-12-27	WOS:000404608300029
J	Nygaard, UC; Li, ZG; Palys, T; Jackson, B; Subbiah, M; Malipatlolla, M; Sampath, V; Maecker, H; Karagas, MR; Nadeau, KC				Nygaard, Unni C.; Li, Zhigang; Palys, Thomas; Jackson, Brian; Subbiah, Melanie; Malipatlolla, Meena; Sampath, Vanitha; Maecker, Holden; Karagas, Margaret R.; Nadeau, Kari C.			Cord blood T cell subpopulations and associations with maternal cadmium and arsenic exposures	PLOS ONE			English	Article							OXIDATIVE STRESS; IMMUNE; POPULATION; EXPRESSION; INFECTION	Background Arsenic and cadmium are environmental pollutants, and although the evidence for adverse immune effects after prenatal arsenic and cadmium exposures is increasing, little is known about the underlying immunological mechanisms. Methods We investigated the relationship between prenatal arsenic and cadmium exposures and a variety of T cell subpopulations measured in cord blood for 63 participants in the New Hampshire Birth Cohort Study. Post-partum toenail concentrations of arsenic and cadmium were used as an estimate of maternal exposure during pregnancy. The characteristics of cord blood proportions of T lymphocytes and subpopulations (expression of markers for Th1, Th2, Th17, Th1Th17, induced and natural regulatory T cells and NKTs) are presented. Results In regression analyses, maternal arsenic exposure levels were inversely associated with cord blood T helper memory cells (-21%, 95% CI: -36%, -3%) and the association was found to be stronger in females. They were also inversely associated with activated T helper memory cells, particularly in males (-26%, 95% CI: -43%, -3%). Similarly, inverse associations were observed between cadmium exposure levels and activated T helper memory cells (-16%, 95% CI: -30%, -1%) and also for T helper memory cells in females (-20%, 95% CI: -35%, -3%). Conclusion The results suggest that prenatal exposures to relatively low levels of arsenic and cadmium may contribute to altered distribution of T cell populations at birth. These changes in theory, could have contributed to the previously reported immunosuppressive effects observed later in infancy/childhood.	[Nygaard, Unni C.; Sampath, Vanitha; Nadeau, Kari C.] Stanford Univ, Dept Med, Sean N Parker Ctr Allergy & Asthma Res,Sch Med, Div Pulm & Crit Care,Div Immunol Allergy & Rheuma, Stanford, CA 94305 USA; [Nygaard, Unni C.; Sampath, Vanitha; Nadeau, Kari C.] Stanford Univ, Dept Pediat, Sean N Parker Ctr Allergy & Asthma Res,Sch Med, Div Pulm & Crit Care,Div Immunol Allergy & Rheuma, Stanford, CA 94305 USA; [Nygaard, Unni C.] Norwegian Inst Publ Hlth, Dept Toxicol & Risk Assessment, Oslo, Norway; [Li, Zhigang; Palys, Thomas; Jackson, Brian; Subbiah, Melanie; Karagas, Margaret R.] Childrens Environm Hlth & Dis Prevent Res Ctr Dar, Lebanon, NH USA; [Malipatlolla, Meena; Maecker, Holden] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA	Stanford University; Stanford University; Norwegian Institute of Public Health (NIPH); Stanford University	Nadeau, KC (corresponding author), Stanford Univ, Dept Med, Sean N Parker Ctr Allergy & Asthma Res,Sch Med, Div Pulm & Crit Care,Div Immunol Allergy & Rheuma, Stanford, CA 94305 USA.; Nadeau, KC (corresponding author), Stanford Univ, Dept Pediat, Sean N Parker Ctr Allergy & Asthma Res,Sch Med, Div Pulm & Crit Care,Div Immunol Allergy & Rheuma, Stanford, CA 94305 USA.	knadeau@stanford.edu			National Institute of Environmental Health Sciences (NIEHS) [P01ES022832, R21ES020936]; US National Institutes of Health (NIH); US Environmental Protection Agency (EPA) [RD83544201]; National Center for Research Resources (NCRR) [P20GM104416]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Environmental Protection Agency (EPA)(United States Environmental Protection Agency); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants P01ES022832 and R21ES020936 by the National Institute of Environmental Health Sciences (NIEHS), US National Institutes of Health (NIH) and RD83544201 from the US Environmental Protection Agency (EPA). Additional laboratory support was provided by the Center of Molecular Epidemiology through grant P20GM104416 from National Center for Research Resources (NCRR), Centers of Biomedical Research Excellence (COBRE) program	Abdul KSM, 2015, ENVIRON TOXICOL PHAR, V40, P828, DOI 10.1016/j.etap.2015.09.016; Agency for Toxic Substances and Disease Registry, 2016, PRIOR LIST HAX SUBST; Ahmed S, 2012, TOXICOL SCI, V129, P305, DOI 10.1093/toxsci/kfs202; Ahmed S, 2011, ENVIRON HEALTH PERSP, V119, P258, DOI 10.1289/ehp.1002086; Bisset LR, 2004, EUR J HAEMATOL, V72, P203, DOI 10.1046/j.0902-4441.2003.00199.x; Cottingham KL, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-149; Dangleben NL, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-73; Davis MA, 2014, J EXPO SCI ENV EPID, V24, P467, DOI 10.1038/jes.2014.38; Duan XX, 2015, INT IMMUNOPHARMACOL, V28, P1059, DOI 10.1016/j.intimp.2015.08.025; Fabrigar L. R., 2012, EXPLORATORY FACTOR A; Farzan SF, 2016, ENVIRON HEALTH PERSP, V124, P840, DOI 10.1289/ehp.1409282; Farzan SF, 2013, ENVIRON RES, V126, P24, DOI 10.1016/j.envres.2013.05.001; Ferrario Daniele, 2016, Curr Environ Health Rep, V3, P1, DOI 10.1007/s40572-016-0082-3; Ferrario D, 2009, TOXICOLOGY, V260, P132, DOI 10.1016/j.tox.2009.03.019; Fragiadakis GK, 2016, J IMMUNOL, V197, P4482, DOI 10.4049/jimmunol.1601195; Fry RC, 2007, PLOS GENET, V3, P2180, DOI 10.1371/journal.pgen.0030207; Hall BM, 2015, CLIN J AM SOC NEPHRO, V10, P2050, DOI 10.2215/CJN.06620714; Hanson ML, 2010, TOXICOL APPL PHARM, V242, P136, DOI 10.1016/j.taap.2009.09.023; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Karagas MR, 2000, AM J EPIDEMIOL, V152, P84, DOI 10.1093/aje/152.1.84; Lappalainen M, 2009, PEDIAT ALLERG IMM-UK, V20, P714, DOI 10.1111/j.1399-3038.2009.00865.x; Morzadec C, 2012, TOXICOLOGY, V300, P46, DOI 10.1016/j.tox.2012.05.025; Nadeau KC, 2014, CLIN IMMUNOL, V155, P188, DOI 10.1016/j.clim.2014.09.004; Okoye AA, 2013, IMMUNOL REV, V254, P54, DOI 10.1111/imr.12066; Pillet S, 2005, TOXICOLOGY, V209, P289, DOI 10.1016/j.tox.2004.12.007; Pillet S, 2006, TOXICOL SCI, V92, P423, DOI 10.1093/toxsci/kfl005; Rager JE, 2014, ENVIRON MOL MUTAGEN, V55, P196, DOI 10.1002/em.21842; Raqib R, 2009, TOXICOL LETT, V185, P197, DOI 10.1016/j.toxlet.2009.01.001; Ritz B, 1998, ARCH ENVIRON HEALTH, V53, P272, DOI 10.1080/00039899809605708; Rosenblum MD, 2016, NAT REV IMMUNOL, V16, P90, DOI 10.1038/nri.2015.1; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sanders AP, 2014, EPIGENETICS-US, V9, P212, DOI 10.4161/epi.26798; SIMONET M, 1984, IMMUNOLOGY, V53, P155; Syed A, 2014, J ALLERGY CLIN IMMUN, V133, P500, DOI 10.1016/j.jaci.2013.12.1037; Thome JJC, 2016, NAT MED, V22, P72, DOI 10.1038/nm.4008; WHO, 2011, GUID DRINK WAT QUAL; Wienecke J, 2012, PLACENTA, V33, P39, DOI 10.1016/j.placenta.2011.10.014	38	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179606	10.1371/journal.pone.0179606	http://dx.doi.org/10.1371/journal.pone.0179606			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662050	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000404608300037
J	Zhang, T; Bai, YX; Hong, XL; Sun, LW; Liu, YJ				Zhang, Tong; Bai, Yuxuan; Hong, Xiuling; Sun, Liwei; Liu, Yujun			Particulate matter and heavy metal deposition on the leaves of Euonymus japonicus during the East Asian monsoon in Beijing, China	PLOS ONE			English	Article							ATMOSPHERIC PARTICLES; TRACE-ELEMENTS; POLLUTION; AREA; VEGETATION; TREES; PM10; SOIL; ACCUMULATION; INDICATORS	Plants can be effectively used as bio-monitors of environmental pollution. However, how the particulate matter (PM) and heavy metal retention ability of plants changes in different areas with human disturbance along with monsoon has not yet been investigated in urban ecosystems. In this study, we measured the amount of PM and heavy metals such as Ni, Cr, Cu, Pb, and Zn accumulated by the leaves of Euonymus japonicus during the East Asian monsoon from different functional units in Beijing, China. A rinse-and-weigh method developed in our laboratory was used to determine the mass of the PM, and electro-thermal atomic absorption spectrometry was used for heavy metal analysis. We found that the types of functional units had little influence, whereas the monsoon had a significant effect on the deposition of PM: northwest areas during the monsoon had the lowest effect (with 0.005, 0.453, 0.643, and 1.569 g/m(2) fine, coarse, large, and total PM, respectively), and the southeast areas during the monsoon had the highest effect (0.015, 2.687, 1.941, and 4.228 g/m(2) for fine, coarse, large, and total PM, respectively). Notable, we found considerable variations in heavy metal accumulation across the functional units analyzed, that is, the accumulation level was higher in communities than in parks (P < 0.0001 for all heavy metals). Moreover, a positive relationship was found between PM retention and heavy metal accumulation by the leaves of E. japonicus. Taken together, our results suggested that the PM and heavy metal retention ability of E. japonicus was sensitive to human disturbance and monsoon in Beijing. Since E. japonicus is a widely distributed tree and has the ability of to purify the atmosphere, it is an ideal plant for mitigating urban environmental pollution.	[Zhang, Tong; Hong, Xiuling; Sun, Liwei; Liu, Yujun] Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Beijing, Peoples R China; [Bai, Yuxuan] Beijing Forestry Univ, Sch Soil & Water Conservat, Yanchi Res Stn, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	Sun, LW; Liu, YJ (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Beijing, Peoples R China.	lsun2013@bjfu.edu.cn; yjliubio@bjfu.edu.cn	Liu, Yujun/H-3661-2015; Bai, Yuxuan/ABB-6460-2020	Liu, Yujun/0000-0001-6588-3359; 	China Special Fund for Forestry Research [201304301]	China Special Fund for Forestry Research	This research was supported by the China Special Fund for Forestry Research in the Public Interest (Grant No. 201304301).	BAIDOURELA A, 2015, NAT ENVIRON POLLUT T, V14, P53; Chang Y, 2015, CHINESE LANDSCAPE AR, V1; [程念亮 Cheng Nianliang], 2015, [环境科学研究, Research of Environmental Sciences], V28, P163; [戴斯迪 Dai Sidi], 2013, [环境科学学报, Acta Scientiae Circumstantiae], V33, P154; Dao Xu, 2015, Huanjing Huaxue-Environmental Chemistry, V34, P60, DOI 10.7524/j.issn.0254-6108.2015.01.2014032603; DMUCHOWSKI W, 1995, ENVIRON POLLUT, V87, P87, DOI 10.1016/S0269-7491(99)80012-8; Dreher KL, 1997, J TOXICOL ENV HEALTH, V50, P285, DOI 10.1080/009841097160492; Espinosa AJF, 2006, CHEMOSPHERE, V62, P1665, DOI 10.1016/j.chemosphere.2005.06.038; Gratani L, 2008, ATMOS ENVIRON, V42, P8273, DOI 10.1016/j.atmosenv.2008.07.032; Hong XiuLing, 2015, Journal of Beijing Forestry University, V37, P147; Jamil S, 2009, LANDSCAPE URBAN PLAN, V92, P136, DOI 10.1016/j.landurbplan.2009.04.002; Ji DS, 2012, ATMOS ENVIRON, V50, P338, DOI 10.1016/j.atmosenv.2011.11.053; Kabata-Pendias A., 2011, TRACE ELEMENTS SOILS, DOI [10.1201/9781420039900, 10.1201/b10158-25, DOI 10.1201/B10158-25]; KIM ND, 1994, ENVIRON POLLUT, V86, P89, DOI 10.1016/0269-7491(94)90010-8; Kozlov MV, 2000, ENVIRON POLLUT, V107, P413, DOI 10.1016/S0269-7491(99)00159-1; Kulizhskiy S, 2014, PROCED EARTH PLAN SC, V10, P399, DOI 10.1016/j.proeps.2014.08.071; Li Q, 2015, INT J CLIMATOL; Li Q, 2016, INT J CLIMATOL, V36, P346, DOI 10.1002/joc.4350; [李永杰 LI Yong-jie], 2009, [水土保持学报, Journal of Soil and Water Conservation], V23, P257; Liang S, 2011, J NW FORESTRY U, V3; Liu DM, 2005, GEOSCIENCE, V4; Liu Ling, 2013, Huanjing Kexue, V34, P2361; Lorenzini G, 2006, ATMOS ENVIRON, V40, P4025, DOI 10.1016/j.atmosenv.2006.03.032; Maisto G, 2004, GEODERMA, V122, P269, DOI 10.1016/j.geoderma.2004.01.013; Martinez-Lopez S, 2014, J SOIL SEDIMENT, V14, P794, DOI 10.1007/s11368-013-0836-6; Monaci F, 2000, ENVIRON POLLUT, V107, P321, DOI 10.1016/S0269-7491(99)00175-X; Nowak David J., 2006, Urban Forestry & Urban Greening, V5, P93, DOI [10.1016/j.ufug.2006.04.002, 10.1016/j.ufug.2006.01.007]; Nowak DJ, 2013, ENVIRON POLLUT, V178, P395, DOI 10.1016/j.envpol.2013.03.050; Pacyna JM., 2001, ENV REV, V9, P269, DOI [10.1139/er-9-4-269, DOI 10.1139/ER-9-4-269, 10.1139/a01-012]; Pope CA, 2009, NEW ENGL J MED, V360, P376, DOI 10.1056/NEJMsa0805646; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Przybysz A, 2014, SCI TOTAL ENVIRON, V481, P360, DOI 10.1016/j.scitotenv.2014.02.072; Qiu Y, 2009, CHEMOSPHERE, V75, P447, DOI 10.1016/j.chemosphere.2008.12.061; Rossini Oliva S, 2004, COMMUN SOIL SCI PLAN, V35, P1543, DOI 10.1081/CSS-120038553; Samara C, 2003, ATMOS ENVIRON, V37, P41, DOI 10.1016/S1352-2310(02)00772-0; Samecka-Cymerman A, 2009, TREES-STRUCT FUNCT, V23, P923, DOI 10.1007/s00468-009-0334-z; Sawidis T, 2011, ENVIRON POLLUT, V159, P3560, DOI 10.1016/j.envpol.2011.08.008; Serbula SM, 2012, ECOTOX ENVIRON SAFE, V76, P209, DOI 10.1016/j.ecoenv.2011.10.009; Shi HW, 2010, NO HORTICULTURE; Simon E, 2006, ENVIRON POLLUT, V159, P1229; Song YS, 2015, ATMOS ENVIRON, V105, P53, DOI 10.1016/j.atmosenv.2015.01.032; Speak AF, 2012, ATMOS ENVIRON, V61, P283, DOI 10.1016/j.atmosenv.2012.07.043; Tomasevic M, 2005, CHEMOSPHERE, V61, P753, DOI 10.1016/j.chemosphere.2005.03.077; Tomasevic M., 2010, FU PHYS CHEM TECH, V8, P1, DOI [DOI 10.2298/FUPCT1001001T, 10.2298/FUPCT1001001T]; Vesper DJ, 2003, J HYDROL, V276, P20, DOI 10.1016/S0022-1694(03)00023-4; Voutsa D, 1996, ENVIRON POLLUT, V94, P325, DOI 10.1016/S0269-7491(96)00088-7; Wang LL, 2014, ADV METEOROL, V2014, DOI 10.1155/2014/685971; Wang L, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008054; [王晓磊 Wang Xiaolei], 2014, [生态学报, Acta Ecologica Sinica], V34, P1910; Wang Y, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-014-4126-6; [王赞红 Wang Zanhong], 2006, [生态环境, Ecology and Environment], V15, P327; Wannaz ED, 2006, SCI TOTAL ENVIRON, V361, P267, DOI 10.1016/j.scitotenv.2005.11.005; Wei Wang, 2008, J LIAONING NORMAL U, V31, p1~4; Wu GX, 2016, SCI CHINA EARTH SCI, V59, P1, DOI 10.1007/s11430-015-5198-z; Wu Z, 2009, J GEOPHYS RES-ATMOS, V114, P85; Xiong Y, 2004, J CHINESE LANDSCAPE, V4; Zhang L., 2010, J GEOPHYS RES, V115, P2232; Zhang XX, 1997, J BEIJING FORESTRY U, V19, P12; Zhang Y. Y., 2009, TROP GEOGRAPHY, V29, P324; Zhao ST, 2016, J NW FORESTRY U; Zhao XJ, 2013, ATMOS CHEM PHYS, V13, P5685, DOI 10.5194/acp-13-5685-2013; Zhong C, 2008, J AGR U HEBEI, V5; Zhou Z., 2001, ACTA ECOL SIN, V22, P2036	63	17	18	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179840	10.1371/journal.pone.0179840	http://dx.doi.org/10.1371/journal.pone.0179840			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662081	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300056
J	Amara, S; Majors, C; Roy, B; Hill, S; Rose, KL; Myles, EL; Tiriveedhi, V				Amara, Suneetha; Majors, Ciera; Roy, Bipradas; Hill, Salisha; Rose, Kristie L.; Myles, Elbert L.; Tiriveedhi, Venkataswarup			Critical role of SIK3 in mediating high salt and IL-17 synergy leading to breast cancer cell proliferation	PLOS ONE			English	Article							INDUCIBLE KINASE 3; CARDIOVASCULAR-DISEASE; COLLAGEN-V; INFLAMMATION; IDENTIFICATION; ACTIVATION; INHIBITION; EXPRESSION; INDUCTION; PATHWAY	Chronic inflammation is a well-known precursor for cancer development and proliferation. We have recently demonstrated that high salt (NaCI) synergizes with sub-effective interleukin (IL)-17 to induce breast cancer cell proliferation. However, the exact molecular mechanisms mediating this effect are unclear. In our current study, we adopted a phosphoproteomic-based approach to identify salt modulated kinase-proteome specific molecular targets. The phosphoprotemics based binary comparison between heavy labelled MCF-7 cells treated with high salt (Delta 0.05 M NaCI) and light labelled MCF-7 cells cultured under basal conditions demonstrated an enhanced phosphorylation of Serine-493 of SIK3 protein. The mRNA transcript and protein expression analysis of SIK3 in MCF-7 cells demonstrated a synergistic enhancement following co-treatment with high salt and sub-effective IL-17 (0.1 ng/mL), as compared to either treatments alone. A similar increase in SIK3 expression was observed in other breast cancer cell lines, MDA-MB-231, BT20, and AU565, while nonmalignant breast epithelial cell line, MCF10A, did not induce SIK3 expression under similar conditions. Biochemical studies revealed mTORC2 acted as upstream mediator of SIK3 phosphorylation. Importantly, cell cycle analysis by flow cytometry demonstrated SIK3 induced GO/G1-phase release mediated cell proliferation, while SIK3 silencing abolished this effect. Also, SIK3 induced pro-inflammatory arginine metabolism, as evidenced by upregulation of the enzymes iNOS and ASS-1, along with downregulation of anti-inflammatory enzymes, arginase-1 and ornithine decarboxylase. Furthermore, gelatin zymography analysis has demonstrated that SIK3 induced expression of tumor metastatic CXCR4 through MMP-9 activation. Taken together, our data suggests a critical role of SIK3 in mediating three important hallmarks of cancer namely, cell proliferation, inflammation and metastasis. These studies provide a mechanistic basis for the future utilization of SIK3 as a key drug discovery target to improve breast cancer therapy.	[Amara, Suneetha] St Thomas Midtown, Dept Med, Nashville, TN USA; [Majors, Ciera; Roy, Bipradas; Myles, Elbert L.; Tiriveedhi, Venkataswarup] Tennessee State Univ, Dept Biol Sci, Nashville, TN 37203 USA; [Hill, Salisha; Rose, Kristie L.] Vanderbilt Univ, Mass Spectrometry Res Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA; [Rose, Kristie L.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Tiriveedhi, Venkataswarup] Vanderbilt Univ, Dept Canc Biol, 221 Kirkland Hall, Nashville, TN 37235 USA	Tennessee State University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Tiriveedhi, V (corresponding author), Tennessee State Univ, Dept Biol Sci, Nashville, TN 37203 USA.; Tiriveedhi, V (corresponding author), Vanderbilt Univ, Dept Canc Biol, 221 Kirkland Hall, Nashville, TN 37235 USA.	vtirivee@tnstate.edu	Roy, Bipradas/AAY-7908-2020	Roy, Bipradas/0000-0001-6472-951X; Tiriveedhi, Venkataswarup/0000-0003-4708-5905	NIH [2U54-CA163066-06-6611]; NATIONAL CANCER INSTITUTE [U54CA163066] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant 2U54-CA163066-06-6611 (VT). The funding organization has no role in the study design, data collection and analysis, decision to publish or preparation of manuscript.	Amara S, 2016, CELL BIOCHEM BIOPHYS, V74, P427, DOI 10.1007/s12013-016-0736-7; Amara S, 2016, ONCOL LETT, V12, P933, DOI 10.3892/ol.2016.4713; Amara S, 2016, CELL IMMUNOL, V302, P1, DOI 10.1016/j.cellimm.2015.12.007; Amara S, 2015, MOL IMMUNOL, V64, P26, DOI 10.1016/j.molimm.2014.10.021; Arif A, 2017, NATURE, V542, P357, DOI 10.1038/nature21380; Bailey SR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00276; Baldo MP, 2015, HEART FAIL REV, V20, P461, DOI 10.1007/s10741-015-9478-7; Berggreen C, 2012, CELL SIGNAL, V24, P1863, DOI 10.1016/j.cellsig.2012.05.001; BEYAERT R, 1989, P NATL ACAD SCI USA, V86, P9494, DOI 10.1073/pnas.86.23.9494; Brocker Chad, 2012, Biomol Concepts, V3, P345; Charoenfuprasert S, 2011, ONCOGENE, V30, P3570, DOI 10.1038/onc.2011.77; Chaturvedi R, 2014, GASTROENTEROLOGY, V146, P1739, DOI 10.1053/j.gastro.2014.02.005; Chen H, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.154; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crusz SM, 2015, NAT REV CLIN ONCOL, V12, P584, DOI 10.1038/nrclinonc.2015.105; D'Elia L, 2014, CANCER TREAT RES, V159, P83, DOI 10.1007/978-3-642-38007-5_6; Dietze EC, 2015, NAT REV CANCER, V15, P248, DOI 10.1038/nrc3896; Dirajlal-Fargo S, 2017, AIDS, V31, P533, DOI 10.1097/QAD.0000000000001363; Du WQ, 2016, EXPERT OPIN THER TAR, V20, P477, DOI 10.1517/14728222.2016.1101452; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Itoh Y, 2015, J BIOL CHEM, V290, P17879, DOI 10.1074/jbc.M115.640821; Kim SY, 2013, MOL ENDOCRINOL, V27, P1958, DOI 10.1210/me.2013-1240; Landskron G, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/149185; Liu Y, 2015, CELL MOL IMMUNOL, V12, DOI 10.1038/cmi.2014.83; Lombardi MS, 2016, J LEUKOCYTE BIOL, V99, P711, DOI 10.1189/jlb.2A0715-307R; Lunn JA, 2007, J BIOL CHEM, V282, P10370, DOI 10.1074/jbc.M607780200; Masui K, 2014, CELL CYCLE, V13, P1053, DOI 10.4161/cc.28377; Nagai S, 2013, ANN NY ACAD SCI, V1280, P30, DOI 10.1111/nyas.12059; Ouwerkerk R, 2007, BREAST CANCER RES TR, V106, P151, DOI 10.1007/s10549-006-9485-4; Platt D, 2014, BIOCHEM BIOPH RES CO, V455, P107, DOI 10.1016/j.bbrc.2014.10.124; Populo H, 2012, INT J MOL SCI, V13, P1886, DOI 10.3390/ijms13021886; Sarma NJ, 2014, J VIROL, V88, P3733, DOI 10.1128/JVI.03060-13; Schorl C, 2007, METHODS, V41, P143, DOI 10.1016/j.ymeth.2006.07.022; Shalapour S, 2015, J CLIN INVEST, V125, P3347, DOI 10.1172/JCI80007; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Sun YN, 2014, TUMOR BIOL, V35, P7765, DOI 10.1007/s13277-014-1816-1; Tiriveedhi V, 2012, AM J TRANSPLANT, V12, P2663, DOI 10.1111/j.1600-6143.2012.04191.x; Tiriveedhi V, 2012, CLIN EXP IMMUNOL, V167, P158, DOI 10.1111/j.1365-2249.2011.04486.x; Tiriveedhi V, 2014, CLIN CANCER RES, V20, P5964, DOI 10.1158/1078-0432.CCR-14-0059; Tiriveedhi V, 2014, TRANSPL IMMUNOL, V30, P93, DOI 10.1016/j.trim.2013.12.003; Tiriveedhi V, 2013, J HEART LUNG TRANSPL, V32, P807, DOI 10.1016/j.healun.2013.06.003; Tiriveedhi V, 2013, J HEART LUNG TRANSPL, V32, P714, DOI 10.1016/j.healun.2013.04.006; Tiriveedhi V, 2012, CELL IMMUNOL, V273, P59, DOI 10.1016/j.cellimm.2011.11.006; Walkinshaw DR, 2013, J BIOL CHEM, V288, P9345, DOI 10.1074/jbc.M113.456996; Weng CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep38894; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Yang G, 2015, CELL REP, V12, P937, DOI 10.1016/j.celrep.2015.07.016; Zaric O, 2016, RADIOLOGY, V280, P39, DOI 10.1148/radiol.2016151304	49	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180097	10.1371/journal.pone.0180097	http://dx.doi.org/10.1371/journal.pone.0180097			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658303	Green Submitted, Green Published, gold			2022-12-27	WOS:000404607900058
J	Heiskanen, K; Ahonen, R; Kanerva, R; Karttunen, P; Timonen, J				Heiskanen, Kati; Ahonen, Riitta; Kanerva, Risto; Karttunen, Pekka; Timonen, Johanna			The reasons behind medicine shortages from the perspective of pharmaceutical companies and pharmaceutical wholesalers in Finland	PLOS ONE			English	Article							DRUG SHORTAGES; IMPACT	The aim of this study was to explore the reasons behind medicine shortages from the perspective of pharmaceutical companies and pharmaceutical wholesalers in Finland. The study took the form of semi-structured interviews. Forty-one pharmaceutical companies and pharmaceutical wholesalers were invited to participate in the study. The pharmaceutical companies were the member organizations of Pharma Industry Finland (PIF) (N = 30) and the Finnish Generic Pharmaceutical Association (FGPA) (N = 7). One company which is a central player in the pharmaceutical market in Finland but does not belong to PIF or FGPA was also invited. The pharmaceutical wholesalers were those with a nationwide distribution network (N = 3). A total of 30 interviews were conducted between March and June 2016. The data were subjected to qualitative thematic analysis. The most common reasons behind medicine shortages in Finland were the small size of the pharmaceutical market (29/30), sudden or fluctuating demand (28/30), small stock sizes (25/30), long delivery time (23/30) and a long or complex production chain (23/30). The reasons for the medicine shortages were supply-related more often than demand-related. However, the reasons were often complex and there was more than one reason behind a shortage. Supply-related reasons behind shortages commonly interfaced with the country-specific characteristics of Finland, whereas demand-related reasons were commonly associated with the predictability and attractiveness of the market. Some reasons, such as raw material shortages, were considered global and thus had similar effects on other countries.	[Heiskanen, Kati; Ahonen, Riitta; Timonen, Johanna] Univ Eastern Finland, Fac Hlth Sci, Sch Pharm Social Pharm, Kuopio Campus, Kuopio, Finland; [Kanerva, Risto] Espoo I Tapiola Pharm, Espoo, Finland; [Karttunen, Pekka] Siilinjarvi I Pharm, Siilinjarvi, Finland	University of Eastern Finland	Heiskanen, K (corresponding author), Univ Eastern Finland, Fac Hlth Sci, Sch Pharm Social Pharm, Kuopio Campus, Kuopio, Finland.	kati.heiskanen@uef.fi	Sarnola, Kati/AAR-5493-2021	Sarnola, Kati/0000-0003-1300-7482	Association of Finnish Pharmacies	Association of Finnish Pharmacies	Association of Finnish Pharmacies : The funder provided support in the form of research grant for author[KH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of the author is articulated in the 'author contributions' section.	[Anonymous], 2008, TENDERING PHARM EU M; Association of Finnish Pharmacies, 2015, ANN REV; Baumer AM, 2004, AM J HEALTH-SYST PH, V61, P2015, DOI 10.1093/ajhp/61.19.2015; Becker DJ, 2013, J ONCOL PRACT, V9, pE122, DOI 10.1200/JOP.2012.000799; Besancon L, 2013, INT PHARM FEDERATION; Bogaert P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125691; Canadian Pharmacists Association, 2010, CAN DRUG SHORT SURV; Claus B., 2015, J PHARM BELG, V1, P24; Creese A, WHOEDMPAR20045; De Weerdt E, 2015, REGUL TOXICOL PHARM, V71, P251, DOI 10.1016/j.yrtph.2015.01.005; Dylst P, 2011, HEALTH POLICY, V101, P146, DOI 10.1016/j.healthpol.2011.03.004; EAHP, EAHP POL BRIEF MED S; EFPIA, 2016, PHARM IND FIG; Erginel E, 2014, EUROPEAN COMMISSION; European Federation of Pharmaceutical Industries and Associations, 2014, EFPIA GOOD PRACT REV; European Healthcare Distribution Association (GIRP), MED SHORT EUR THEIR; European Medicines Agency, EUR MED REG NETW; European Medicines Agency, SHORT CAT; Finnish Medicines Agency, SAAT; Finnish Medicines Agency, REP QUANT BE STOCK M; Finnish Medicines Agency and Social Insurance Institution, 2015, FINN STAT MED STAT P, P56; Gloor C, EVALUATION MED SHORT; Guest G., 2012, APPL THEMATIC ANAL, P11; Hawley KL, 2016, ACAD EMERG MED, V23, P63, DOI 10.1111/acem.12838; Heiskanen K, 2015, HEALTH POLICY, V119, P232, DOI 10.1016/j.healthpol.2014.11.001; Hennink M, 2016, QUAL HEALTH RES, V27, P1; Hunnisett-Dritz D, 2012, AM J HEALTH-SYST PH, V69, P1416, DOI 10.2146/ajhp120113; Institute for Safe Medication Practices [ISMP], 2010, ISMP MED SAFETY ALER, V15, P4; Kaakeh R, 2011, AM J HEALTH-SYST PH, V68, P1811, DOI 10.2146/ajhp110210; McLaughlin M, 2013, J MANAGE CARE PHARM, V19, P783, DOI 10.18553/jmcp.2013.19.9.783; Ministry of Social Affairs and Health, REF PRIC SYST; Ministry social Affairs and Health, SOC WELF HLTH CAR SY; Morrison A, 2011, DRUG SUPPLY DISRUPTI, P17; Pauwels K, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-438; Pelkonen E., 2010, LAAKKEISTA TERVEYTTA, P28; Pharma Industry Finland, OUR ACT; Pharma Industry Finland, MED CAR HOSP MED; Pharma Industry Finland, PHARM MAN FINL; Pharma Industry Finland, 2015, PHARM SAL FINL 2015; Rinnakkaislaaketeollisuusry, RINN TIET SIV; Silverman D, 2013, DOING QUALITATIVE RE, P297; Smith F, COMMUNICATION, V1; Tan YX, 2016, INT J CLIN PHARM-NET, V38, P1133, DOI 10.1007/s11096-016-0342-1; Timonen J, 2013, J PHARM HEALTH SERV, V4, P165, DOI 10.1111/jphs.12021; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; Wiedenmayer K., 2004, ACCESS MED MED SUPPL	46	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179479	10.1371/journal.pone.0179479	http://dx.doi.org/10.1371/journal.pone.0179479			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658307	Green Submitted, gold, Green Published			2022-12-27	WOS:000404607900027
J	Nayyar, S; Sharma, BK; Kaur, A; Kalia, A; Sanghera, GS; Thind, KS; Yadav, IS; Sandhu, JS				Nayyar, Shivani; Sharma, Bipen Kumar; Kaur, Ajinder; Kalia, Anu; Sanghera, Gulzar Singh; Thind, Karanjit Singh; Yadav, Inderjit Singh; Sandhu, Jagdeep Singh			Red rot resistant transgenic sugarcane developed through expression of beta-1,3-glucanase gene	PLOS ONE			English	Article							COLLETOTRICHUM-FALCATUM; TRICHODERMA-HARZIANUM; SUCROSE ACCUMULATION; PATHOGEN; BGN13.1; ENZYMES	Sugarcane (Saccharum spp.) is a commercially important crop, vulnerable to fungal disease red rot caused by Colletotrichum falcatum Went. The pathogen attacks sucrose accumulating parenchyma cells of cane stalk leading to severe losses in cane yield and sugar recovery. We report development of red rot resistant transgenic sugarcane through expression of beta-1,3-glucanase gene from Trichoderma spp. The transgene integration and its expression were confirmed by quantitative reverse transcription-PCR in first clonal generation raised from T0 plants revealing up to 4.4-fold higher expression, in comparison to non-transgenic sugarcane. Bioassay of transgenic plants with two virulent C. falcatum pathotypes, Cf 08 and Cf 09 causing red rot disease demonstrated that some plants were resistant to Cf 08 and moderately resistant to Cf 09. The electron micrographs of sucrose storing stalk parenchyma cells from these plants displayed characteristic sucrose-filled cells inhibiting Cf 08 hyphae and lysis of Cf 09 hyphae; in contrast, the cells of susceptible plants were sucrose depleted and prone to both the pathotypes. The transgene expression was up-regulated (up to 2.0-fold in leaves and 5.0-fold in roots) after infection, as compared to before infection in resistant plants. The transgene was successfully transmitted to second clonal generation raised from resistant transgenic plants. beta-1,3-glucanase protein structural model revealed that active sites Glutamate 628 and Aspartate 569 of the catalytic domain acted as proton donor and nucleophile having role in cleaving beta-1,3-glycosidic bonds and pathogen hyphal lysis.	[Nayyar, Shivani; Kaur, Ajinder; Yadav, Inderjit Singh; Sandhu, Jagdeep Singh] Punjab Agr Univ, Sch Agr Biotechnol, Ludhiana, Punjab, India; [Sharma, Bipen Kumar; Sanghera, Gulzar Singh] Punjab Agr Univ, Reg Res Stn, Kapurthala, India; [Kalia, Anu] Punjab Agr Univ, Electron Microscopy & Nanosci Lab, Ludhiana, Punjab, India; [Thind, Karanjit Singh] Punjab Agr Univ, Dept Plant Breeding & Genet, Ludhiana, Punjab, India	Punjab Agricultural University; Punjab Agricultural University; Punjab Agricultural University; Punjab Agricultural University	Sandhu, JS (corresponding author), Punjab Agr Univ, Sch Agr Biotechnol, Ludhiana, Punjab, India.	js_sandhu@pau.edu	Sanghera, Gulzar S/J-7301-2019; Yadav, Inderjit/AAG-6336-2020; Kalia, Anu/M-5833-2019	yadav, inderjit/0000-0001-9988-945X; Kalia, Anu/0000-0001-8367-1923	School of Agricultural Biotechnology, Punjab Agricultural University, Ludhiana	School of Agricultural Biotechnology, Punjab Agricultural University, Ludhiana	This research was supported by in-house financial support provided by School of Agricultural Biotechnology, Punjab Agricultural University, Ludhiana. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri VP., 1990, DIS SUGARCANE SUGAR; ALBERSHEIM P, 1974, PLANT PHYSIOL, V53, P684, DOI 10.1104/pp.53.5.684; BOZZOLA J, 1999, ELECT MICROSCOPY; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; DELACRUZ J, 1995, J BACTERIOL, V177, P6937, DOI 10.1128/jb.177.23.6937-6945.1995; Donzelli BGG, 2001, GENE, V277, P199, DOI 10.1016/S0378-1119(01)00681-3; El-Katatny Momein H. A., 2008, Archives of Phytopathology and Plant Protection, V41, P175, DOI 10.1080/03235400600679818; Goidin D, 2001, ANAL BIOCHEM, V295, P17, DOI 10.1006/abio.2001.5171; Gupta V, 2010, FUNCT INTEGR GENOMIC, V10, P207, DOI 10.1007/s10142-009-0144-9; Kheiri H-R., 2014, J CROP PROT, V3, P31; Kumar A, 2002, SUGARCANE CROP MANAG, P109; Kumar N, 2011, J PHYTOPATHOL, V159, P260, DOI 10.1111/j.1439-0434.2010.01759.x; Lam E, 2009, GCB BIOENERGY, V1, P251, DOI 10.1111/j.1757-1707.2009.01016.x; Ling H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097469; Liu Mei, 2004, J Zhejiang Univ Sci, V5, P133, DOI 10.1631/jzus.2004.0133; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mercado JA, 2015, TRANSGENIC RES, V24, P979, DOI 10.1007/s11248-015-9895-3; Ming R, 2006, PL BRED RE, V27, P15; MOORE PH, 1995, AUST J PLANT PHYSIOL, V22, P661, DOI 10.1071/PP9950661; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; O'Kennedy MM, 2011, S AFR J BOT, V77, P335, DOI 10.1016/j.sajb.2010.09.016; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prapagdee B, 2008, INT J BIOL SCI, V4, P330; Prathima PT, 2013, APPL BIOCHEM BIOTECH, V171, P488, DOI 10.1007/s12010-013-0346-4; Rott P., 2000, GUIDE SUGARCANE DIS; Saksena P, 2013, J PLANT PROT RES, P53; Satyavir, 2003, INDIAN PHYTOPATHOL, V56, P245; Sharma R, 2015, J PLANT PATHOL MIC S, V1, P3; Singh D., 2012, 10 PATH WORKSH NANN, P9; Singh K, 2004, ANAL BIOCHEM, V335, P330, DOI 10.1016/j.ab.2004.08.030; Singh PP, 1999, PHYTOPATHOLOGY, V89, P92, DOI 10.1094/PHYTO.1999.89.1.92; Singh RK, 2016, MOL GENET GENOMICS, V291, P1363, DOI 10.1007/s00438-016-1190-3; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; SRINIVASAN K. V., 1961, J INDIAN BOT SOC, V40, P566; Sun H, 2006, BIOTECHNOL LETT, V28, P131, DOI 10.1007/s10529-005-5132-0; Sundar AR., 2012, FUNCTIONAL PLANT SCI, P51; Uys L, 2007, PHYTOCHEMISTRY, V68, P2375, DOI 10.1016/j.phytochem.2007.04.023; Vijai Singh, 2008, Sugar Tech, V10, P158, DOI 10.1007/s12355-008-0028-7; Vijai Singh, 2008, Indian Phytopathology, V61, P486; Viswanathan R, 2003, WORLD J MICROB BIOT, V19, P953, DOI 10.1023/B:WIBI.0000007329.68910.e5; Viswanathan R., 1999, Sugar Cane, P9; Viswanathan R., 2013, RECENT ACHIEVEMENTS; Viswanathan R., 2010, PLANT DIS RED ROT SU; Wang JP, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00201; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]	46	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179723	10.1371/journal.pone.0179723	http://dx.doi.org/10.1371/journal.pone.0179723			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658312	gold, Green Submitted, Green Published			2022-12-27	WOS:000404607900041
J	Squarcina, L; Bellani, M; Rossetti, MG; Perlini, C; Delvecchio, G; Dusi, N; Barillari, M; Ruggeri, M; Altamura, CA; Bertoldo, A; Brambilla, P				Squarcina, Letizia; Bellani, Marcella; Rossetti, Maria Gloria; Perlini, Cinzia; Delvecchio, Giuseppe; Dusi, Nicola; Barillari, Marco; Ruggeri, Mirella; Altamura, Carlo A.; Bertoldo, Alessandra; Brambilla, Paolo			Similar white matter changes in schizophrenia and bipolar disorder: A tract-based spatial statistics study	PLOS ONE			English	Article							DIFFUSION-TENSOR; CORPUS-CALLOSUM; RADIAL DIFFUSIVITY; INTERMEDIATE PHENOTYPES; FRACTIONAL ANISOTROPY; I DISORDER; ABNORMALITIES; INTEGRITY; DYSCONNECTIVITY; MICROSTRUCTURE	Several strands of evidence reported a significant overlapping, in terms of clinical symptoms, epidemiology and treatment response, between the two major psychotic disorders-Schizophrenia (SCZ) and Bipolar Disorder (BD). Nevertheless, the shared neurobiological correlates of these two disorders are far from conclusive. This study aims toward a better understanding of possible common microstructural brain alterations in SCZ and BD. Magnetic Resonance Diffusion data of 33 patients with BD, 19 with SCZ and 35 healthy controls were acquired. Diffusion indexes were calculated, then analyzed using Tract-Based Spatial Statistics (TBSS). We tested correlations with clinical and psychological variables. In both patient groups mean diffusion (MD), volume ratio (VR) and radial diffusivity (RD) showed a significant increase, while fractional anisotropy (FA) and mode (MO) decreased compared to the healthy group. Changes in diffusion were located, for both diseases, in the fronto-temporal and callosal networks. Finally, no significant differences were identified between patient groups, and a significant correlations between length of disease and FA and VR within the corpus callosum, corona radiata and thalamic radiation were observed in bipolar disorder. To our knowledge, this is the first study applying TBSS on all the DTI indexes at the same time in both patient groups showing that they share similar impairments in microstructural connectivity, with particular regards to fronto-temporal and callosal communication, which are likely to worsen over time. Such features may represent neural common underpinnings characterizing major psychoses and confirm the central role of white matter pathology in schizophrenia and bipolar disorder.	[Squarcina, Letizia] IRCCS E Medea Sci Inst, Bosisio Parini, Lecco, Italy; [Bellani, Marcella; Dusi, Nicola; Ruggeri, Mirella] AOUI Verona, Sect Psychiat, Verona, Italy; [Rossetti, Maria Gloria] Univ Verona, Sect Psychiat, Dept Neurosci Biomed & Movement Sci, Verona, Italy; [Perlini, Cinzia] Dept Neurosci Biomed & Movement Sci, Sect Clin Psychol, Verona, Italy; [Delvecchio, Giuseppe; Barillari, Marco] Univ Verona, Dept Radiol, Verona, Italy; [Altamura, Carlo A.; Brambilla, Paolo] Univ Milan, Dept Neurosci & Mental Hlth, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy; [Bertoldo, Alessandra] Univ Padua, Dept Informat Engn, Padua, Italy; [Brambilla, Paolo] UTHouston Med Sch, Dept Psychiat & Behav Sci, Houston, TX 77030 USA	IRCCS Eugenio Medea; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; University of Verona; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Padua; Baylor College of Medicine	Brambilla, P (corresponding author), Univ Milan, Dept Neurosci & Mental Hlth, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy.; Brambilla, P (corresponding author), UTHouston Med Sch, Dept Psychiat & Behav Sci, Houston, TX 77030 USA.	paolo.brambilla1@unimi.it	rossetti, maria gloria/AFF-6265-2022; Dusi, Nicola/J-9431-2016; Perlini, Cinzia/F-8492-2010; Delvecchio, Giuseppe/J-7721-2016; Squarcina, Letizia/J-9869-2016; brambilla, paolo/B-4184-2010; Rossetti, Maria Gloria/AAB-9797-2019; Bellani, Marcella/F-3929-2010	Dusi, Nicola/0000-0003-2204-0030; Perlini, Cinzia/0000-0002-4281-0920; Delvecchio, Giuseppe/0000-0003-4750-1980; Squarcina, Letizia/0000-0001-6209-4629; brambilla, paolo/0000-0002-4021-8456; Bellani, Marcella/0000-0003-1727-5396; Barillari, Marco/0000-0002-2820-0229; Rossetti, Maria Gloria/0000-0001-7843-8721	Ministry of Health [GR-20102 316745, GR-2010-2316745, GR-2010-2319022]	Ministry of Health	This study was partly supported by grants from the Ministry of Health (GR-20102 316745) to Paolo Brambilla (GR-2010-2316745) and to Marcella Bellani (GR-2010-2319022).	Altinbas K, 2014, PSYCHIAT DANUB, V26, P200; Anderson D, 2013, BIPOLAR DISORD, V15, P680, DOI 10.1111/bdi.12096; Andersson J. L., 2008, ORG HUM BRAIN MAPP; Ashtari M, 2007, ARCH GEN PSYCHIAT, V64, P1270, DOI 10.1001/archpsyc.64.11.1270; Barnea-Goraly N, 2009, BIOL PSYCHIAT, V66, P238, DOI 10.1016/j.biopsych.2009.02.025; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bauer IE, 2015, J PSYCHIATR RES, V62, P115, DOI 10.1016/j.jpsychires.2015.01.008; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bellani M, 2012, FUNCT NEUROL, V27, P29; Bellani M, 2010, EXP BRAIN RES, V201, P339, DOI 10.1007/s00221-009-2021-0; Bellani M, 2009, BIOCHEM SOC T, V37, P1096, DOI 10.1042/BST0371096; Benedetti F, 2011, BIOL PSYCHIAT, V69, P309, DOI 10.1016/j.biopsych.2010.07.028; Beyer JL, 2005, NEUROPSYCHOPHARMACOL, V30, P2225, DOI 10.1038/sj.npp.1300802; Brambilla P, 2004, J NEUROL NEUROSUR PS, V75, P221; Brambilla P, 2003, BIOL PSYCHIAT, V54, P1294, DOI 10.1016/S0006-3223(03)00070-2; Brambilla P, 2007, INT REV PSYCHIATR, V19, P459, DOI 10.1080/09540260701500975; Brambilla P, 2011, PROG NEURO-PSYCHOPH, V35, P1093, DOI 10.1016/j.pnpbp.2011.03.007; Brambilla P, 2009, INT REV PSYCHIATR, V21, P380, DOI 10.1080/09540260902962172; Camchong J, 2011, SCHIZOPHRENIA BULL, V37, P640, DOI 10.1093/schbul/sbp131; Carter CJ, 2007, SCHIZOPHRENIA BULL, V33, P1343, DOI 10.1093/schbul/sbm007; Cosgrove VE, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-127; Cui LQ, 2011, PSYCHIAT RES-NEUROIM, V194, P347, DOI 10.1016/j.pscychresns.2011.03.010; Cui LQ, 2011, NEUROSCI LETT, V489, P94, DOI 10.1016/j.neulet.2010.11.073; Domen PAE, 2013, SCHIZOPHR RES, V146, P291, DOI 10.1016/j.schres.2013.03.002; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Ellison-Wright I, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-99; Ellison-Wright I, 2010, SCHIZOPHR RES, V117, P1, DOI 10.1016/j.schres.2009.12.022; Emsell L, 2013, BIOL PSYCHIAT, V73, P194, DOI 10.1016/j.biopsych.2012.09.023; Ennis DB, 2006, MAGN RESON MED, V55, P136, DOI 10.1002/mrm.20741; Fitzsimmons J, 2013, CURR OPIN PSYCHIATR, V26, P172, DOI 10.1097/YCO.0b013e32835d9e6a; Florio V, 2013, EXP BRAIN RES, V230, P175, DOI 10.1007/s00221-013-3642-x; Friston KJ, 1999, ACTA PSYCHIAT SCAND, V99, P68, DOI 10.1111/j.1600-0447.1999.tb05985.x; Gupta CN, 2015, SCHIZOPHRENIA BULL, V41, P1133, DOI 10.1093/schbul/sbu177; Haller S, 2011, J PSYCHIATR NEUROSCI, V36, P391, DOI 10.1503/jpn.100140; Heckers S, 2008, SCHIZOPHRENIA BULL, V34, P591, DOI 10.1093/schbul/sbn046; Ivleva EI, 2010, NEUROSCI BIOBEHAV R, V34, P897, DOI 10.1016/j.neubiorev.2009.11.022; Karbasforoushan H, 2015, PSYCHOL MED, V45, P109, DOI 10.1017/S0033291714001111; Knoche C, 2012, NEUROIMAGE, V59, P926, DOI 10.1016/j.neuroimage.2011.07.088; Knochel C, 2016, SCHIZOPHR RES, V172, P78, DOI 10.1016/j.schres.2016.02.007; Koch K, 2011, BRIT J PSYCHIAT, V198, P223, DOI 10.1192/bjp.bp.110.081836; Kubicki M, 2002, AM J PSYCHIAT, V159, P813, DOI 10.1176/appi.ajp.159.5.813; Kumar J, 2015, PSYCHOL MED, V45, P759, DOI 10.1017/S0033291714001810; Kuswanto C. N., 2015, NEUROPSYCHOPHARMACOL, V17; Lee SH, 2013, SCHIZOPHR RES, V143, P231, DOI 10.1016/j.schres.2012.11.029; Levitt JJ, 2012, SCHIZOPHR RES, V136, P55, DOI 10.1016/j.schres.2011.09.009; Li J, 2014, PSYCHIAT RES-NEUROIM, V221, P58, DOI 10.1016/j.pscychresns.2013.10.007; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Liu XY, 2013, BEHAV BRAIN RES, V252, P157, DOI 10.1016/j.bbr.2013.05.061; Lu LH, 2011, BIPOLAR DISORD, V13, P604, DOI 10.1111/j.1399-5618.2011.00958.x; Macritchie KAN, 2013, J AFFECT DISORDERS, V148, P249, DOI 10.1016/j.jad.2012.12.002; Maggioni E, 2017, EPIDEMIOLOG IN PRESS; Maggioni E., 2016, EPIDEMIOL PSYCH SCI, P1; Magioncalda P, 2016, J AFFECT DISORDERS, V193, P39, DOI 10.1016/j.jad.2015.12.050; Maller JJ, 2014, J AFFECT DISORDERS, V169, P118, DOI 10.1016/j.jad.2014.08.016; Mamah D, 2010, PSYCHIAT RES-NEUROIM, V183, P144, DOI 10.1016/j.pscychresns.2010.04.013; McIntosh AM, 2008, BIOL PSYCHIAT, V64, P1088, DOI 10.1016/j.biopsych.2008.07.026; Molina V, 2011, EUR ARCH PSY CLIN N, V261, P313, DOI 10.1007/s00406-010-0183-1; Nakamura K, 2012, PSYCHIAT RES-NEUROIM, V202, P233, DOI 10.1016/j.pscychresns.2011.09.006; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nortje G, 2013, J AFFECT DISORDERS, V150, P192, DOI 10.1016/j.jad.2013.05.034; Oertel-Knochel V, 2014, J AFFECT DISORDERS, V155, P223, DOI 10.1016/j.jad.2013.11.004; Perlini C, 2012, ACTA PSYCHIAT SCAND, V126, P363, DOI 10.1111/j.1600-0447.2012.01864.x; Pettersson-Yeo W, 2011, NEUROSCI BIOBEHAV R, V35, P1110, DOI 10.1016/j.neubiorev.2010.11.004; Reid MA, 2016, SCHIZOPHR RES, V170, P341, DOI 10.1016/j.schres.2015.12.003; Roalf DR, 2013, SCHIZOPHR RES, V143, P172, DOI 10.1016/j.schres.2012.10.014; Roybal DJ, 2015, PSYCHIAT RES-NEUROIM, V232, P184, DOI 10.1016/j.pscychresns.2015.02.007; Scheel M, 2013, BRAIN STRUCT FUNCT, V218, P151, DOI 10.1007/s00429-012-0389-2; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Skudlarski P, 2013, AM J PSYCHIAT, V170, P886, DOI 10.1176/appi.ajp.2013.12111448; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Spoletini I, 2011, SCHIZOPHRENIA BULL, V37, P118, DOI 10.1093/schbul/sbp058; Sussmann JE, 2009, BIPOLAR DISORD, V11, P11, DOI 10.1111/j.1399-5618.2008.00646.x; Tamminga CA, 2013, AM J PSYCHIAT, V170, P1263, DOI 10.1176/appi.ajp.2013.12101339; Tansella M, 2003, BRIT J PSYCHIAT, V183, P167, DOI 10.1192/bjp.183.2.167; Tomasino B, 2011, PSYCHOL MED, V41, P301, DOI 10.1017/S0033291710000875; Torgerson CM, 2013, BRAIN IMAGING BEHAV, V7, P129, DOI 10.1007/s11682-012-9202-3; Vai B, 2014, EXPERT REV NEUROTHER, V14, P631, DOI 10.1586/14737175.2014.915744; Versace A, 2014, MOL PSYCHIATR, V19, P200, DOI 10.1038/mp.2012.188; Wagner G, 2015, CORTEX, V66, P35, DOI 10.1016/j.cortex.2015.02.004; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yu K, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00189; Zhou Y, 2015, NEUROSCI BULL, V31, P207, DOI 10.1007/s12264-014-1502-8	88	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0178089	10.1371/journal.pone.0178089	http://dx.doi.org/10.1371/journal.pone.0178089			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JT	28658249	Green Published, Green Submitted, gold			2022-12-27	WOS:000404607900003
J	Nakamura, R; Okura, T; Fujioka, Y; Sumi, K; Matsuzawa, K; Izawa, S; Ueta, E; Kato, M; Taniguchi, S; Yamamoto, K				Nakamura, Risa; Okura, Tsuyoshi; Fujioka, Yohei; Sumi, Keisuke; Matsuzawa, Kazuhiko; Izawa, Shoichiro; Ueta, Etsuko; Kato, Masahiko; Taniguchi, Shin-ichi; Yamamoto, Kazuhiro			Serum fatty acid-binding protein 4 (FABP4) concentration is associated with insulin resistance in peripheral tissues, A clinical study	PLOS ONE			English	Article							GLUCOSE-UPTAKE; IN-VIVO; SENSITIVITY; OBESITY; ADIPONECTIN; SECRETION; OXIDATION; BIOMARKER; HUMANS; IRISIN	Type 2 diabetes mellitus (T2DM) is caused by insulin resistance and beta cell dysfunction. In recent studies reported that several markers associated with insulin sensitivity in skeletal muscle, Adiponectin and other parameters, such as fatty acid-binding protein (FABP4), have been reported to regulate insulin resistance, but it remains unclear which factor mostly affects insulin resistance in T2DM. In this cross-sectional study, we evaluated the relationships between several kinds of biomarkers and insulin resistance, and insulin secretion in T2DM and healthy controls. We recruited 30 participants (12 T2DM and 18 non-diabetic healthy controls). Participants underwent a meal tolerance test during which plasma glucose, insulin and serum C-peptide immunoreactivity were measured. We performed a hyperinsulinemic-euglycemic clamp and measured the glucose-disposal rate (GDR). The fasting serum levels of adiponectin, insulin-like growth factor-1, irisin, autotaxin, FABP4 and interleukin-6 were measured by ELISA. We found a strong negative correlation between FABP4 concentration and GDR in T2DM (r = -0.657, p = 0.020). FABP4 also was positively correlated with insulin secretion during the meal tolerance test in T2DM (IRI (120): r = 0.604, p = 0.038) and was positively related to the insulinogenic index in non-DM subjects (r = 0.536, p = 0.022). Autotaxin was also related to GDR. However, there was no relationship with insulin secretion. We found that serum FABP4 concentration were associated with insulin resistance and secretion in T2DM. This suggests that FABP4 may play an important role in glucose homeostasis.	[Nakamura, Risa; Okura, Tsuyoshi; Fujioka, Yohei; Sumi, Keisuke; Izawa, Shoichiro; Kato, Masahiko; Yamamoto, Kazuhiro] Tottori Univ, Fac Med, Dept Mol Med & Therapeut, Div Cardiovasc Med Endocrinol & Metab, Yonago, Tottori, Japan; [Matsuzawa, Kazuhiko; Taniguchi, Shin-ichi] Tottori Univ, Dept Reg Med, Fac Med, Yonago, Tottori, Japan; [Ueta, Etsuko] Tottori Univ, Sch Hlth Sci, Fac Med, Yonago, Tottori, Japan	Tottori University; Tottori University; Tottori University	Okura, T (corresponding author), Tottori Univ, Fac Med, Dept Mol Med & Therapeut, Div Cardiovasc Med Endocrinol & Metab, Yonago, Tottori, Japan.	ohkura@med.tottori-u.ac.jp			JSPS KAKENHI [26870373, 16K08935]; Japan Diabetes Foundation; Japan Association for Diabetes Education and Care; MSD	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Diabetes Foundation; Japan Association for Diabetes Education and Care; MSD	This work was supported by a JSPS KAKENHI Grant-in-Aid for Young Scientists (B) grant number 26870373 (2014-2015), JSPS KAKENHI Grant-in-Aid for Scientific Research (C) grant number 16K08935 (2016-), the Japan Diabetes Foundation (2013), grants for young researchers from the Japan Association for Diabetes Education and Care (2013, 2014). This work also supported by the MSD research grant (2013, 2015).	Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Boucher J, 2005, DIABETOLOGIA, V48, P569, DOI 10.1007/s00125-004-1660-8; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DeFronzo RA, 2013, DIABETES CARE, V36, pS127, DOI 10.2337/dcS13-2011; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Furuhashi M, 2015, HYPERTENS RES, V38, P252, DOI 10.1038/hr.2015.2; Greco EA, 2013, WORLD J DIABETES, V4, P31, DOI 10.4239/wjd.v4.i2.31; Hamrick Mark W, 2017, J Bone Metab, V24, P1, DOI 10.11005/jbm.2017.24.1.1; Hideki Ota, 2012, AM J HYPERTENTION; Hoelzel W, 2004, CLIN CHEM, V50, P166, DOI 10.1373/clinchem.2003.024802; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Hsu WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028311; Ishimura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081318; Kawamori R, 1998, DIABETES RES CLIN PR, V41, P35, DOI 10.1016/S0168-8227(98)00056-4; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; Morioka T, 2007, J CLIN INVEST, V117, P2860, DOI 10.1172/JCI30910; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Ohkura T, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-21; Parkes DG, 2001, METABOLISM, V50, P583, DOI 10.1053/meta.2001.22519; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Perakakis N, 2017, NAT REV ENDOCRINOL; Reeves VL, 2015, OBESITY, V23, P2371, DOI 10.1002/oby.21232; Sesti G, 2005, DIABETES CARE, V28, P120, DOI 10.2337/diacare.28.1.120; Sirbu A, 2013, GROWTH HORM IGF RES, V23, P2, DOI 10.1016/j.ghir.2012.10.001; Tamura Y, 2005, J CLIN ENDOCR METAB, V90, P3191, DOI 10.1210/jc.2004-1959; Tomoaki Morioka, 2017, J DIABETES INVESTIG; Tso AWK, 2007, DIABETES CARE, V30, P2667, DOI 10.2337/dc07-0413; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Wu LE, 2014, MOL METAB, V3, P465, DOI 10.1016/j.molmet.2014.02.005; Xu AM, 2006, CLIN CHEM, V52, P405, DOI 10.1373/clinchem.2005.062463; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yang ZG, 2015, INT J CLIN EXP PATHO, V8, P6490; Yeung DCY, 2007, ARTERIOSCL THROM VAS, V27, P1796, DOI 10.1161/ATVBAHA.107.146274; Yoshino Gen, 2006, Journal of the Japan Diabetes Society, V49, P361; Zhang S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146605	39	42	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179737	10.1371/journal.pone.0179737	http://dx.doi.org/10.1371/journal.pone.0179737			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654680	Green Submitted, Green Published, gold			2022-12-27	WOS:000404541500029
J	Fischer, MA; McKinlay, JB; Katz, JN; Gerstenberger, E; Trachtenberg, F; Marceau, LD; Welch, LC				Fischer, Michael A.; McKinlay, John B.; Katz, Jeffrey N.; Gerstenberger, Eric; Trachtenberg, Felicia; Marceau, Lisa D.; Welch, Lisa C.			Physician assessments of drug seeking behavior: A mixed methods study	PLOS ONE			English	Article							CHRONIC OPIOID THERAPY; CHRONIC NONCANCER PAIN; CLINICAL GUIDELINES; PERSISTENT PAIN; UNITED-STATES; CARE; RACE; MANAGEMENT; ETHNICITY; PATTERNS	Background Pain complaints are common, but clinicians are increasingly concerned about overuse of opioid pain medications. This may lead patients with actual pain to be stigmatized as "drug seeking," or attempting to obtain medications they do not require medically. We assessed whether patient requests for specific opioid pain medication would lead physicians to classify them as drug-seeking and change management decisions. Methods and findings Mixed-methods analysis of interviews with 192 office-based primary care physicians after viewing video vignettes depicting patients presenting with back pain. For each presentation physicians were randomly assigned to see either an active request for a specific medication or a more general request for help with pain. The main outcome was assignment by the physician of "drug-seeking" as a potential diagnosis among patients presenting with back pain. Additional outcomes included other actions the physician would take and whether the physician would prescribe the medication requested. A potential diagnosis of drug-seeking behavior was included by 21% of physicians seeing a specific request for oxycodone vs. 3% for a general request for help with back pain (p<0.001). In multivariable models an active request was most strongly associated with a physician-assigned diagnosis of drug-seeking behavior(OR 8.10; 95% CI 2.11-31.15;p = 0.002); other major patient and physician characteristics, including gender and race, did not have strong associations with drug-seeking diagnosis. Physicians described short courses of opioid medications as a strategy for managing patients with pain while avoiding opioid overuse. Conclusions When patients make a specific request for opioid pain medication, physicians are far more likely to suspect that they are drug-seeking. Physician suspicion of drug-seeking behavior did not vary by patient characteristics, including gender and race. The strategies used to assess patients further varied widely. These findings indicate a need for the development of better clinical tools to support the evaluation and management of patients presenting with pain.	[Fischer, Michael A.] Harvard Med Sch, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA USA; [McKinlay, John B.; Gerstenberger, Eric; Trachtenberg, Felicia; Marceau, Lisa D.; Welch, Lisa C.] New England Res Inst, 9 Galen St, Watertown, MA 02172 USA; [McKinlay, John B.; Gerstenberger, Eric; Trachtenberg, Felicia; Marceau, Lisa D.; Welch, Lisa C.] Div Med, Watertown, MA USA; [McKinlay, John B.] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA USA; [Katz, Jeffrey N.] Harvard Med Sch, Brigham & Womens Hosp, Orthoped & Arthrit Ctr Outcomes Res, Dept Orthoped Surg, Boston, MA USA; [Katz, Jeffrey N.] Harvard Med Sch, Brigham & Womens Hosp, Div Rheumatol, Boston, MA USA; [Katz, Jeffrey N.] Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; HealthCore, Inc; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Fischer, MA (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA USA.	mfischer@partners.org	Welch, Lisa Christine/GZK-6246-2022	Welch, Lisa/0000-0001-6269-9310	National Institute of Arthritis and Musculoskeletal and Skin Disorders (NIAMS) (NIH) [AR056992]	National Institute of Arthritis and Musculoskeletal and Skin Disorders (NIAMS) (NIH)	This paper was supported by award number AR056992 from the National Institute of Arthritis and Musculoskeletal and Skin Disorders (NIAMS) (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beletsky L, 2012, JAMA-J AM MED ASSOC, V308, P1863, DOI 10.1001/jama.2012.14205; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Bonham VL, 2001, J LAW MED ETHICS, V29, P52, DOI 10.1111/j.1748-720X.2001.tb00039.x; Burgess DJ, 2008, SOC SCI MED, V67, P1852, DOI 10.1016/j.socscimed.2008.09.009; Chou R, 2009, POL ARCH MED WEWN, V119, P469, DOI 10.20452/pamw.741; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care Board on Health Sciences Policy & Institute of Medicine, 2009, UNEQUAL TREATMENT CO; Department of Veterans Affairs National Pain Management Coordinating Committee, 2000, PAIN 5 VIT SIGN TOOL; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Fetters MD, 2013, HEALTH SERV RES, V48, P2134, DOI 10.1111/1475-6773.12117; Fishbain DA, 2008, PAIN MED, V9, P444, DOI 10.1111/j.1526-4637.2007.00370.x; Green J, 2009, QUALITATIVE METHODS; Grover CA, 2012, J EMERG MED, V42, P15, DOI 10.1016/j.jemermed.2011.05.065; Gureje O, 1998, JAMA-J AM MED ASSOC, V280, P147, DOI 10.1001/jama.280.2.147; Gureje O, 2001, PAIN, V92, P195, DOI 10.1016/S0304-3959(00)00483-8; Hall AJ, 2008, JAMA-J AM MED ASSOC, V300, P2613, DOI 10.1001/jama.2008.802; Jones CM, 2013, JAMA-J AM MED ASSOC, V309, P657, DOI 10.1001/jama.2013.272; Kirsch B, 2000, VHSJ, P49; Konrad TR, 2010, MED CARE, V48, P95, DOI 10.1097/MLR.0b013e3181c12e6a; Kravitz RL, 2005, JAMA-J AM MED ASSOC, V293, P1995, DOI 10.1001/jama.293.16.1995; Krebs EE, 2014, J PAIN, V15, P1148, DOI 10.1016/j.jpain.2014.08.006; Lofland John, 2006, ANAL SOCIAL SETTINGS, V4; Logan J, 2013, MED CARE, V51, P646, DOI 10.1097/MLR.0b013e318293c2c0; Mantyselka P, 2001, PAIN, V89, P175, DOI 10.1016/S0304-3959(00)00361-4; Marceau L., 2012, CLIN VIGNETTES HLTH; Maserejian NN, 2014, ARTHRIT CARE RES, V66, P147, DOI 10.1002/acr.22143; MAX MB, 1995, JAMA-J AM MED ASSOC, V274, P1874, DOI 10.1001/jama.1995.03530230060032; McCarberg BH, 2011, POSTGRAD MED, V123, P119, DOI 10.3810/pgm.2011.03.2270; McKinlay JB, 2014, MED CARE IN PRESS; Mossey JM, 2011, CLIN ORTHOP RELAT R, V469, P1859, DOI 10.1007/s11999-011-1770-9; Pletcher MJ, 2008, JAMA-J AM MED ASSOC, V299, P70, DOI 10.1001/jama.2007.64; Prevention CfDCa, 2013, POL IMP PRESCR PAINK; Prevention CfDCa, 2012, MORBIDITY MORTALITY; Reid MC, 2002, J GEN INTERN MED, V17, P173, DOI 10.1046/j.1525-1497.2002.10435.x; Shavers VL, 2010, J HEALTH CARE POOR U, V21, P177, DOI 10.1353/hpu.0.0255; Streltzer J, 2009, AM J ADDICTION, V18, P1, DOI 10.1080/10550490802544508	36	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0178690	10.1371/journal.pone.0178690	http://dx.doi.org/10.1371/journal.pone.0178690			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY7CO	28644835	Green Submitted, Green Published, gold			2022-12-27	WOS:000404145100007
J	Wu, Q; Sun, RY; Ni, M; Yu, J; Li, YQ; Yu, CJ; Dou, K; Ren, JH; Chen, J				Wu, Qiong; Sun, Ruiyan; Ni, Mi; Yu, Jia; Li, Yaqian; Yu, Chuanjin; Dou, Kai; Ren, Jianhong; Chen, Jie			Identification of a novel fungus, Trichoderma asperellum GDFS1009, and comprehensive evaluation of its biocontrol efficacy	PLOS ONE			English	Article							SYSTEMIC RESISTANCE; ANTIFUNGAL ACTIVITY; PLANT; MYCOPARASITISM; PEPTAIBOLS; DIVERSITY; VIRENS; ACID; BIODIVERSITY; INDUCTION	Due to its efficient broad-spectrum antimicrobial activity, Trichoderma has been established as an internationally recognized biocontrol fungus. In this study, we found and identified a novel strain of Trichoderma asperellum, named GDFS1009. The mycelium of T. asperellum GDFS1009 exhibits a high growth rate, high sporulation capacity, and strong inhibitory effects against pathogens that cause cucumber fusarium wilt and corn stalk rot. T. asperellum GDFS1009 secretes chitinase, glucanase, and protease, which can degrade the cell walls of fungi and contribute to mycoparasitism. The secreted xylanases are good candidates for inducing plant resistance and enhancing plant immunity against pathogens. RNA sequencing (RNA-seq) and gas chromatography-mass spectrometry (GC-MS) showed that T. asperellum GDFS1009 produces primary metabolites that are precursors of antimicrobial compounds; it also produces a variety of antimicrobial secondary metabolites, including polyketides and alkanes. In addition, this study speculated the presence of six antimicrobial peptides via ultra-performance liquid chromatography quadrupole time of flight mass spectrometry (UPLC-QTOF-MS/ MS). Future studies should focus on these antimicrobial metabolites for facilitating widespread application in the field of agricultural bio-control.	[Wu, Qiong; Sun, Ruiyan; Yu, Jia; Li, Yaqian; Yu, Chuanjin; Dou, Kai; Chen, Jie] Shanghai Jiao Tong Univ, Sch Agr & Biol, Dept Environm & Resource, Shanghai, Peoples R China; [Wu, Qiong; Sun, Ruiyan; Yu, Jia; Li, Yaqian; Yu, Chuanjin; Dou, Kai; Chen, Jie] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai, Peoples R China; [Wu, Qiong; Sun, Ruiyan; Yu, Jia; Li, Yaqian; Yu, Chuanjin; Dou, Kai; Chen, Jie] Minist Agr, Key Lab Urban South Agr, Shanghai, Peoples R China; [Ni, Mi] Chinese Acad Sci, State Key Lab Plant Genom, Beijing, Peoples R China; [Ni, Mi] Chinese Acad Sci, Natl Ctr Plant Gene Res Beijing, Inst Genet & Dev Biol, Beijing, Peoples R China; [Ren, Jianhong] Suzhou BioNovoGene Metabol Platform, Suzhou, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Chen, J (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Dept Environm & Resource, Shanghai, Peoples R China.; Chen, J (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai, Peoples R China.; Chen, J (corresponding author), Minist Agr, Key Lab Urban South Agr, Shanghai, Peoples R China.	jiechen59@sjtu.edu.cn		Ni, Mi/0000-0002-8930-6887; Dou, Kai/0000-0003-2665-0231	National Special Project of Basic Work Project for Science and Technology [2014FY120900]; National Natural Science Foundation of China [31270155]; Key Project for Basic Science Research, Science and Technology Commission of Shanghai Municipality [12JC1404600]; China Agriculture Research System [CARS-02]	National Special Project of Basic Work Project for Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project for Basic Science Research, Science and Technology Commission of Shanghai Municipality; China Agriculture Research System	This work was supported by National Special Project of Basic Work Project for Science and Technology (2014FY120900), National Natural Science Foundation of China (31270155), Key Project for Basic Science Research, Science and Technology Commission of Shanghai Municipality (12JC1404600) and China Agriculture Research System (no. CARS-02).	Bailey BA, 2008, BIOL CONTROL, V46, P24, DOI 10.1016/j.biocontrol.2008.01.003; Blaszczyk L, 2011, J APPL GENET, V52, P233, DOI 10.1007/s13353-011-0039-z; Chen LL, 2009, FEMS MICROBIOL LETT, V299, P135, DOI 10.1111/j.1574-6968.2009.01746.x; CLAYDON N, 1987, T BRIT MYCOL SOC, V88, P503, DOI 10.1016/S0007-1536(87)80034-7; DEAN JFD, 1991, PLANT PHYSIOL, V95, P316, DOI 10.1104/pp.95.1.316; Degenkolb T, 2008, CHEM BIODIVERS, V5, P671, DOI 10.1002/cbdv.200890064; DELACRUZ J, 1995, J BACTERIOL, V177, P6937, DOI 10.1128/jb.177.23.6937-6945.1995; Devi G. I., 2013, International Research Journal of Biological Sciences, V2, P16; Djonovic S, 2007, PLANT PHYSIOL, V145, P875, DOI 10.1104/pp.107.103689; Djonovic S, 2006, MOL PLANT MICROBE IN, V19, P838, DOI 10.1094/MPMI-19-0838.02006; GEREMIA RA, 1993, MOL MICROBIOL, V8, P603, DOI 10.1111/j.1365-2958.1993.tb01604.x; GRAHAM AF, 1986, J APPL BACTERIOL, V61, P39, DOI 10.1111/j.1365-2672.1986.tb03756.x; Harman GE, 2006, PHYTOPATHOLOGY, V96, P190, DOI 10.1094/PHYTO-96-0190; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; Hollink E, 2005, TETRAHEDRON LETT, V46, P2005, DOI 10.1016/j.tetlet.2005.01.150; Horace GC, 1986, AGR BIOL CHEM TOKYO, V50, P2943, DOI DOI 10.1080/00021369.1986.10867860; Howell CR, 2003, PLANT DIS, V87, P4, DOI 10.1094/PDIS.2003.87.1.4; Hoyos-Carvajal L, 2009, FUNGAL GENET BIOL, V46, P615, DOI 10.1016/j.fgb.2009.04.006; Jayaraj J, 2010, J PLANT INTERACT, V5, P147, DOI 10.1080/17429140903291012; Kadu S, 2016, WORLD J PHARM LIFE S, V2, P222; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kerroum F, 2015, INT J SCI NAT, V6, P141; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; Krause C, 2006, AMINO ACIDS, V30, P435, DOI 10.1007/s00726-005-0275-9; Kubicek CP, 2003, FUNGAL GENET BIOL, V38, P310, DOI 10.1016/S1087-1845(02)00583-2; Kulkarni A, 2009, EUR J MED CHEM, V44, P2904, DOI 10.1016/j.ejmech.2008.12.012; Leelavathi M. S., 2014, International Journal of Current Microbiology and Applied Sciences, V3, P96; Limon MC, 1999, PHYTOPATHOLOGY, V89, P254, DOI 10.1094/PHYTO.1999.89.3.254; Lin J, 2006, ENVIRON SCI TECHNOL, V29, P82; Liu Y, 2013, J MOL MICROB BIOTECH, V23, P431, DOI 10.1159/000346830; Manter DK, 2007, J MICROBIOL METH, V71, P7, DOI 10.1016/j.mimet.2007.06.016; Metcalf DA, 2004, PLANT DIS, V88, P287, DOI 10.1094/PDIS.2004.88.3.287; Mohamed-Benkada M, 2006, RAPID COMMUN MASS SP, V20, P1176, DOI 10.1002/rcm.2430; Nawrocka J, 2013, BIOL CONTROL, V67, P149, DOI 10.1016/j.biocontrol.2013.07.005; Nielsen KF, 2005, J AGR FOOD CHEM, V53, P8190, DOI 10.1021/jf051279b; NORMAN BH, 1992, TETRAHEDRON LETT, V33, P6803, DOI 10.1016/S0040-4039(00)61780-X; R Core Team, 2021, R LANGUAGE ENV STAT; Ruiz N, 2007, PEPTIDES, V28, P1351, DOI 10.1016/j.peptides.2007.05.012; Sadfi-Zouaoui N, 2009, CAN J MICROBIOL, V55, P154, DOI [10.1139/W08-101, 10.1139/w08-101]; Selvaraj K., 2011, INT J APPL BIOL PHAR, V2, P179; Sharon E, 2007, EUR J PLANT PATHOL, V118, P247, DOI 10.1007/s10658-007-9140-x; Shoresh M, 2004, J ZHEJIANG U AGR LIF, V30, P385; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; STEWART CN, 1993, BIOTECHNIQUES, V14, P748; Sumayo M, 2013, PLANT PATHOLOGY J, V29, P174, DOI 10.5423/PPJ.SI.09.2012.0143; Sun HY, 2006, BIOTECHNOL LETT, V28, P1719, DOI [10.1007/s10529-006-9151-2, 10.1007/s10529-005-5132-0]; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vanholme R, 2012, PLANT CELL, V24, P3506, DOI 10.1105/tpc.112.102574; Vazquez-Garciduenas S, 1998, APPL ENVIRON MICROB, V64, P1442; Vinale F, 2008, PHYSIOL MOL PLANT P, V72, P80, DOI 10.1016/j.pmpp.2008.05.005; Vinale F, 2008, SOIL BIOL BIOCHEM, V40, P1, DOI 10.1016/j.soilbio.2007.07.002; Viterbo A, 2001, FEMS MICROBIOL LETT, V200, P169, DOI 10.1111/j.1574-6968.2001.tb10710.x; Viterbo A, 2007, MOL PLANT PATHOL, V8, P737, DOI 10.1111/J.1364-3703.2007.00430.X; Weindling R, 1932, PHYTOPATHOLOGY, V22, P837; Wolf GA, 1996, J MICROBIOL METH, V25, P337, DOI 10.1016/0167-7012(96)00005-X; Wu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073729; Yang HJ, 2002, J LIQ CHROMATOGR R T, V25, P2709, DOI 10.1081/JLC-120014387; Yedidia I, 2003, APPL ENVIRON MICROB, V69, P7343, DOI 10.1128/AEM.69.12.7343-7353.2003; Yedidia I, 1999, APPL ENVIRON MICROB, V65, P1061; Yedidia I, 2000, PLANT PHYSIOL BIOCH, V38, P863, DOI 10.1016/S0981-9428(00)01198-0; Yuan J, 2012, APPL ENVIRON MICROB, V78, P5942, DOI 10.1128/AEM.01357-12; Yue HR, 2012, CHEM SOC REV, V41, P4218, DOI 10.1039/c2cs15359a; Zakrzewski J, 2011, BIOORG MED CHEM LETT, V21, P514, DOI 10.1016/j.bmcl.2010.10.092	66	55	63	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179957	10.1371/journal.pone.0179957	http://dx.doi.org/10.1371/journal.pone.0179957			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644879	Green Submitted, gold, Green Published			2022-12-27	WOS:000404145100053
J	Babatunde, OO; Jordan, JL; van der Windt, DA; Hill, JC; Foster, NE; Protheroe, J				Babatunde, Opeyemi O.; Jordan, Joanne L.; van der Windt, Danielle A.; Hill, Jonathan C.; Foster, Nadine E.; Protheroe, Joanne			Effective treatment options for musculoskeletal pain in primary care: A systematic overview of current evidence	PLOS ONE			English	Article							LOW-BACK-PAIN; SUBACROMIAL IMPINGEMENT SYNDROME; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; THERAPEUTIC EXERCISE; ADHESIVE CAPSULITIS; SPINAL MANIPULATION; COST-EFFECTIVENESS; MANUAL THERAPY; SHOULDER PAIN; PSYCHOLOGICAL INTERVENTIONS	Background & aims Musculoskeletal pain, the most common cause of disability globally, is most frequently managed in primary care. People with musculoskeletal pain in different body regions share similar characteristics, prognosis, and may respond to similar treatments. This overview aims to summarise current best evidence on currently available treatment options for the five most common musculoskeletal pain presentations (back, neck, shoulder, knee and multi-site pain) in primary care. Methods A systematic search was conducted. Initial searches identified clinical guidelines, clinical pathways and systematic reviews. Additional searches found recently published trials and those addressing gaps in the evidence base. Data on study populations, interventions, and outcomes of intervention on pain and function were extracted. Quality of systematic reviews was assessed using AMSTAR, and strength of evidence rated using a modified GRADE approach. Results Moderate to strong evidence suggests that exercise therapy and psychosocial interventions are effective for relieving pain and improving function for musculoskeletal pain. NSAIDs and opioids reduce pain in the short-term, but the effect size is modest and the potential for adverse effects need careful consideration. Corticosteroid injections were found to be beneficial for short-term pain relief among patients with knee and shoulder pain. However, current evidence remains equivocal on optimal dose, intensity and frequency, or mode of application for most treatment options. Conclusion This review presents a comprehensive summary and critical assessment of current evidence for the treatment of pain presentations in primary care. The evidence synthesis of interventions for common musculoskeletal pain presentations shows moderate-strong evidence for exercise therapy and psychosocial interventions, with short-term benefits only from pharmacological treatments. Future research into optimal dose and application of the most promising treatments is needed.	[Babatunde, Opeyemi O.; Jordan, Joanne L.; van der Windt, Danielle A.; Hill, Jonathan C.; Foster, Nadine E.; Protheroe, Joanne] Keele Univ, Res Inst Primary Care & Hlth Sci, Arthrit Res UK Primary Care Ctr, Keele, Staffs, England	Keele University	Babatunde, OO (corresponding author), Keele Univ, Res Inst Primary Care & Hlth Sci, Arthrit Res UK Primary Care Ctr, Keele, Staffs, England.	o.babatunde@keele.ac.uk	Hill, Jonathan/AAT-2744-2020; Babatunde, Opeyemi/I-1112-2019; Jordan, Joanne/E-8186-2014	Babatunde, Opeyemi/0000-0002-5064-6446; Foster, Nadine/0000-0003-4429-9756; Jordan, Joanne/0000-0002-7191-2977	NIHR [RP-PG-1211-20010]; Centre of Excellence grant from the Arthritis Research UK [20202]; NIHR Research Professorship [NIHR-RP-011-015]; National Institute for Health Research [RP-PG-1211-20010, NF-SI-0515-10095] Funding Source: researchfish	NIHR(National Institute for Health Research (NIHR)); Centre of Excellence grant from the Arthritis Research UK; NIHR Research Professorship; National Institute for Health Research(National Institute for Health Research (NIHR))	This manuscript presents independent research funded by the NIHR under its Programme Grants for Applied Research scheme (grant number: RP-PG-1211-20010) and a Centre of Excellence grant from the Arthritis Research UK (grant number: 20202). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. NF, an NIHR Senior Investigator, and JH are supported through an NIHR Research Professorship awarded to NF (NIHR-RP-011-015).	Aladro-Gonzalvo AR, 2013, J BODYW MOV THER, V17, P125, DOI 10.1016/j.jbmt.2012.08.003; American Academy of Orthopaedic Surgeons (AAOS), 2013, TREATM OST KNEE EV B; [Anonymous], 2013, ARTHRITIS OSTEOPOROS; Arroll B, 2005, BRIT J GEN PRACT, V55, P224; Assendelft WJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000447.pub3; Bartels EM, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005523.pub3; Bellamy N, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005328; Bennell KL, 2011, J SCI MED SPORT, V14, P4, DOI 10.1016/j.jsams.2010.08.002; Benyamin RM, 2012, PAIN PHYSICIAN, V15, pE363; Bidonde J, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011336; Bidonde J, 2014, CURR RHEUMATOL REV, V10, P45, DOI 10.2174/1573403X10666140914155304; Blanchard V, 2010, PHYSIOTHERAPY, V96, P95, DOI 10.1016/j.physio.2009.09.003; Bokarius AV, 2010, PAIN PRACT, V10, P451, DOI 10.1111/j.1533-2500.2010.00377.x; Bono CM, 2011, SPINE J, V11, P64, DOI 10.1016/j.spinee.2010.10.023; Brantingham JW, 2011, J MANIP PHYSIOL THER, V34, P314, DOI 10.1016/j.jmpt.2011.04.002; British Pain Society (BPS), 2013, GUID PAIN MAN PROGR; Bronfort Gert, 2010, Chiropr Osteopat, V18, P3, DOI 10.1186/1746-1340-18-3; Brosseau L, 2003, COCHRANE DB SYST REV; Brosseau L, 2003, COCHRANE DB SYST REV, V2003, DOI DOI 10.1002/14651858.CD004522; Brosseau L, 2012, J BODYW MOV THER, V16, P424, DOI 10.1016/j.jbmt.2012.04.002; Brudvig TJ, 2011, J ORTHOP SPORT PHYS, V41, P734, DOI 10.2519/jospt.2011.3440; Buchbinder R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006189; Buchbinder R, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007005; Buchbinder R., 2003, COCHRANE DB SYST REV, V2003, pCD004016, DOI [DOI 10.1002/14651858.CD004016, 10.1002/14651858.CD004016]; Bunzli S, 2011, PHYSIOTHER RES INT, V16, P4, DOI 10.1002/pri.465; Busch A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003786.pub2; Busch AJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010884; Camarinos J, 2009, J MAN MANIP THER, V17, P206, DOI 10.1179/106698109791352076; Cameron M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010538; Carnes D, 2010, MANUAL THER, V15, P355, DOI 10.1016/j.math.2009.12.006; Carroll LJ, 2009, J MANIP PHYSIOL THER, V32, pS39; Cepeda MS, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005522.pub2; Choi BKL, 2010, OCCUP ENVIRON MED, V67, P795, DOI 10.1136/oem.2010.059873; Cleland J, 2002, J BACK MUSCULOSKELET, V16, P105, DOI 10.3233/BMR-2002-162-309; Coghlan JA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005619.pub2; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cohen SP, 2013, REGION ANESTH PAIN M, V38, P175, DOI 10.1097/AAP.0b013e31828ea086; Cording M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008244.pub3; D'hondt NE, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002267.pub2; da Costa BR, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007323.pub3; Dahm KT, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007612.pub2; Davies RA, 2008, EUR SPINE J, V17, P1423, DOI 10.1007/s00586-008-0783-x; De Bruijn C, 2007, INT J TECHNOL ASSESS, V23, P80, DOI 10.1017/S0266462307051604; Derry S, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007402.pub3; Derry S, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007403.pub3; Deshpande A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004959.pub3; Desmeules F, 2003, CLIN J SPORT MED, V13, P176, DOI 10.1097/00042752-200305000-00009; Diwan SA, 2012, PAIN PHYSICIAN, V15, pE405; Dixon KE, 2007, HEALTH PSYCHOL, V26, P241, DOI 10.1037/0278-6133.26.3.241; Dorrestijn O, 2009, J SHOULDER ELB SURG, V18, P652, DOI 10.1016/j.jse.2009.01.010; Dubinsky RM, 2010, NEUROLOGY, V74, P173, DOI 10.1212/WNL.0b013e3181c918fc; Duivenvoorden T, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004020.pub3; Engers A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004057.pub3; Chaparro LE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004959.pub4; Enthoven WTM, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012087; Ernst E, 2001, J PAIN SYMPTOM MANAG, V22, P879, DOI 10.1016/S0885-3924(01)00337-2; Faber E, 2006, J OCCUP REHABIL, V16, P7, DOI 10.1007/s10926-005-9003-2; Foster NE, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-3; French SD, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004750.pub2; Furlan AD, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001351.pub2; Gebremariam L, 2014, BRIT J SPORT MED, V48, P1202, DOI 10.1136/bjsports-2012-091802; Gebremariam L, 2011, ARCH PHYS MED REHAB, V92, P1900, DOI 10.1016/j.apmr.2011.06.006; Geraets JJXR, 2005, AUST J PHYSIOTHER, V51, P87, DOI 10.1016/S0004-9514(05)70037-4; Gibson JNA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001352.pub3; Gibson JNA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001350.pub4; Goertz CM, 2012, J ELECTROMYOGR KINES, V22, P670, DOI 10.1016/j.jelekin.2012.03.006; Grant Heather J, 2004, J Hand Ther, V17, P274, DOI 10.1197/j.jht.2004.02.013; Grant JA, 2013, J SHOULDER ELB SURG, V22, P1135, DOI 10.1016/j.jse.2013.01.010; Green S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005319; Green S, 2003, Cochrane Database Syst Rev, pCD004258; Guzman J, 2001, BMJ-BRIT MED J, V322, P1511, DOI 10.1136/bmj.322.7301.1511; Hauser W, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3002; Hagen KB, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001254.PUB2; Hanratty CE, 2012, SEMIN ARTHRITIS RHEU, V42, P297, DOI 10.1016/j.semarthrit.2012.03.015; Hartvigsen J, 2013, EUR J PAIN, V17, P452, DOI 10.1002/j.1532-2149.2012.00225.x; Hayden J A, 2005, Cochrane Database Syst Rev, pCD000335; Hayden JA, 2005, ANN INTERN MED, V142, P776, DOI 10.7326/0003-4819-142-9-200505030-00014; Heintjes EM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003472.pub2; Henschke Nicholas, 2008, BMJ, V337, pa171, DOI 10.1136/bmj.a171; Henschke N, 2012, ARTHRIT CARE RES, V64, P1217, DOI 10.1002/acr.21665; Henschke N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002014.pub3; Heymans MW, 2005, SPINE, V30, P2153, DOI 10.1097/01.brs.0000182227.33627.15; Ho CYC, 2009, MANUAL THER, V14, P463, DOI 10.1016/j.math.2009.03.008; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Hoffman BM, 2007, HEALTH PSYCHOL, V26, P1, DOI 10.1037/0278-6133.26.1.1; Hossain M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008402.pub2; Huisstede BMA, 2011, MANUAL THER, V16, P217, DOI 10.1016/j.math.2010.10.012; Hurwitz EL, 2008, SPINE, V33, pS123; Hutchinson AJP, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-36; Institute for Clinical Systems Improvement (ICSI), 2011, ASS MAN CHRON PAIN; Jacobs W, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008326.pub2; Johansson K, 2002, BRIT J GEN PRACT, V52, P145; Johnson M, 2007, PAIN, V130, P157, DOI 10.1016/j.pain.2007.02.007; Jordan KP, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-144; Juni P, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005328.pub3; Kadhim-Saleh A, 2013, RHEUMATOL INT, V33, P2493, DOI 10.1007/s00296-013-2742-z; Kamaleri Y, 2008, PAIN, V138, P41, DOI 10.1016/j.pain.2007.11.002; Kamper SJ, 2014, COCHRANE DATABASE SY, V9; Karjalainen K, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002194; Karjalainen K, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002193; Kay TM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004250.pub4; Khadilkar A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003008.pub3; Trinh K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004870.pub4; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Kroeling P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004251.pub5; Kromer TO, 2009, J REHABIL MED, V41, P870, DOI 10.2340/16501977-0453; Kuczynski JJ, 2012, INT J SPORTS PHYS TH, V7, P647; Kuhn JE, 2009, J SHOULDER ELB SURG, V18, P138, DOI 10.1016/j.jse.2008.06.004; Kuijpers T, 2011, EUR SPINE J, V20, P40, DOI 10.1007/s00586-010-1541-4; Lam M, 2013, SPINE, V38, P2124, DOI 10.1097/01.brs.0000435025.65564.b7; Langevin P, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008626.pub2; Laupattarakasem P, 2014, KNEE SURG SPORT TR A, V22, P142, DOI 10.1007/s00167-012-2340-8; Liddle SD, 2007, MANUAL THER, V12, P310, DOI 10.1016/j.math.2006.12.009; Lin CWC, 2010, PHYS THER, V90, P839, DOI 10.2522/ptj.20100084; Littlewood C, 2012, PHYSIOTHERAPY, V98, P101, DOI 10.1016/j.physio.2011.08.002; Macedo LG, 2009, PHYS THER, V89, P9, DOI 10.2522/ptj.20080103; Machado GC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1225; Maffulli N, 2012, STEM CELLS INT, V2012; Malanga G, 2008, SPINE J, V8, P173, DOI 10.1016/j.spinee.2007.10.013; Mallen C, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1352; Mallen CD, 2007, BRIT J GEN PRACT, V57, P655; Manheimer E, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001977.pub2; Mannerkorpi K, 2007, BEST PRACT RES CL RH, V21, P513, DOI 10.1016/j.berh.2007.04.001; Map of Medicine, 2014, CAR PATHW 2014; Marinko LN, 2011, J SHOULDER ELB SURG, V20, P1351, DOI 10.1016/j.jse.2011.05.013; Martell BA, 2007, ANN INTERN MED, V146, P116, DOI 10.7326/0003-4819-146-2-200701160-00006; Mason L, 2004, BMC MUSCULOSKEL DIS, V5, DOI 10.1186/1471-2474-5-28; Mason Lorna, 2004, BMC Fam Pract, V5, P10, DOI 10.1186/1471-2296-5-10; Maund E, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16110; McGough James J, 2009, Psychiatry (Edgmont), V6, P21; Mitchell C, 2005, BMJ-BRIT MED J, V331, P1124, DOI 10.1136/bmj.331.7525.1124; Moore RA, 2015, EUR J PAIN, V19, P1213, DOI 10.1002/ejp.649; Murphy RJ, 2010, BMJ CLIN EVID 2010; National Health and Medical Research Council (NHMRC), 2009, GUID NONS MAN HIP KN; National Institute for Health and Care Excellence (NICE, 2014, OST CAR MAN AD; National Institute for Health and Care Excellence (NICE, 2009, LOW BACK PAIN EARL M; New Zealand Guidelines Group (NZGG), 2003, DIAGN MAN SOFT TISS; Nikolaidis I, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001466.pub3; Nnoaham KE, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003222.pub2; Oliveira VC, 2012, ARTHRIT CARE RES, V64, P1739, DOI 10.1002/acr.21737; Orrock PJ, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-129; Ostelo RWJG, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002014.pub2; Page MJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011275; Page MJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011324; Parkinson L, 2013, CLIN RHEUMATOL, V32, P167, DOI 10.1007/s10067-012-2116-z; Patel KC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004871.pub4; Paxton ES, 2011, ARTHROSCOPY, V27, P1275, DOI 10.1016/j.arthro.2011.03.088; Peloso Paul M, 2013, Open Orthop J, V7, P473, DOI 10.2174/1874325001307010473; Pereira LM, 2012, CLIN REHABIL, V26, P10, DOI 10.1177/0269215511411113; Poquet N, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008325.pub2; Posadzki P, 2011, CLIN RHEUMATOL, V30, P1257, DOI 10.1007/s10067-011-1764-8; Rasmussen-Barr E, 2009, SPINE, V34, P221, DOI 10.1097/BRS.0b013e318191e7cb; Reichenbach S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007320.pub2; Richmond H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134192; Robertson VJ, 2001, PHYS THER, V81, P1339, DOI 10.1093/ptj/81.7.1339; Rubinstein SM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008880.pub2; Rubinstein SM, 2011, SPINE, V36, pE825; Rubinstein SM, 2013, SPINE, V38, pE158; Rutjes AWS, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003132.pub2; Rutjes AW, 2009, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002823; Seco J, 2011, SPINE J, V11, P966, DOI 10.1016/j.spinee.2011.02.002; Shah N, 2007, BRIT J GEN PRACT, V57, P662; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Siler AC, 2011, J PAIN, V12, P407, DOI 10.1016/j.jpain.2010.09.007; Singh JA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008089.pub2; Slater SL, 2012, MANUAL THER, V17, P201, DOI 10.1016/j.math.2012.01.006; Staal JB, 2008, COCHRANE DATABASE SY, V3; Stanos Steven P, 2013, Postgrad Med, V125, P25; Steffens D, 2016, JAMA INTERN MED, V176, P199, DOI 10.1001/jamainternmed.2015.7431; Strunce JB, 2012, PHYS THER REV, V17, P132, DOI 10.1179/1743288X12Y.0000000006; Sveinsdottir Vigdis, 2012, J Pain Res, V5, P371, DOI 10.2147/JPR.S25330; Tamaoki MJS, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007429.pub2; Teasell RW, 2010, PAIN RES MANAG, V15, P287, DOI 10.1155/2010/106593; Towheed TE, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004257.pub2; Uthman OA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5555; Valentino L, 2022, RSF-RUS SAGE J SOC S, V8, P89, DOI [10.18311/ti/2021/v28i1/24809, 10.1097/QAD.0000000000003368, 10.1016/j.vaccine.2022.07.056, 10.7758/RSF.2022.8.7.05]; van der Heijden RA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010387.pub2; van der Sande R, 2013, ARCH PHYS MED REHAB, V94, P961, DOI 10.1016/j.apmr.2012.11.041; van Middelkoop M, 2011, EUR SPINE J, V20, P19, DOI 10.1007/s00586-010-1518-3; Vickers AJ, 2012, ARCH INTERN MED, V172, P1444, DOI 10.1001/archinternmed.2012.3654; Von Korff M, 2005, PAIN, V117, P304, DOI 10.1016/j.pain.2005.06.017; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Walker BF, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005427.pub2; Waller B, 2009, CLIN REHABIL, V23, P3, DOI 10.1177/0269215508097856; Wang XG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051667, 10.1371/journal.pone.0029469, 10.1371/journal.pone.0047703, 10.1371/journal.pone.0036274, 10.1371/journal.pone.0048069, 10.1371/journal.pone.0032405]; Warden SJ, 2008, ARTHRIT RHEUM-ARTHR, V59, P73, DOI 10.1002/art.23242; Waseem Z, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008257.pub2; Wegner I, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003010.pub5; Wells C, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-7; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013	191	145	148	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0178621	10.1371/journal.pone.0178621	http://dx.doi.org/10.1371/journal.pone.0178621			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640822	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000404135800008
J	Shi, PF; Fan, XN; Ni, JJ; Khan, Z; Li, M				Shi, Pengfei; Fan, Xinnan; Ni, Jianjun; Khan, Zubair; Li, Min			A novel underwater dam crack detection and classification approach based on sonar images	PLOS ONE			English	Article							EARTHQUAKE	Underwater dam crack detection and classification based on sonar images is a challenging task because underwater environments are complex and because cracks are quite random and diverse in nature. Furthermore, obtainable sonar images are of low resolution. To address these problems, a novel underwater dam crack detection and classification approach based on sonar imagery is proposed. First, the sonar images are divided into image blocks. Second, a clustering analysis of a 3-D feature space is used to obtain the crack fragments. Third, the crack fragments are connected using an improved tensor voting method. Fourth, a minimum spanning tree is used to obtain the crack curve. Finally, an improved evidence theory combined with fuzzy rule reasoning is proposed to classify the cracks. Experimental results show that the proposed approach is able to detect underwater dam cracks and classify them accurately and effectively under complex underwater environments.	[Shi, Pengfei; Fan, Xinnan; Ni, Jianjun; Khan, Zubair; Li, Min] Hohai Univ, Coll IOT Engn, Changzhou, Jiangsu, Peoples R China	Hohai University	Shi, PF (corresponding author), Hohai Univ, Coll IOT Engn, Changzhou, Jiangsu, Peoples R China.	flyshn@hotmail.com	Khan, Zubair/X-7459-2019; Khan, Zubair/O-8169-2018	Khan, Zubair/0000-0002-9651-5767; Khan, Zubair/0000-0002-9651-5767	National Natural Science Foundation of China [61573128, 61203365]; Fundamental Research Funds for the Central Universities [2017B02914]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was funded by the National Natural Science Foundation of China (grant numbers 61573128, 61203365), and the Fundamental Research Funds for the Central Universities (grant number 2017B02914). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (grant numbers 61573128, 61203365), and the Fundamental Research Funds for the Central Universities (grant number 2017B02914). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akay B, 2015, SIGNAL IMAGE VIDEO P, V9, P967, DOI 10.1007/s11760-015-0758-4; Andalo FA, 2010, PATTERN RECOGN, V43, P26, DOI 10.1016/j.patcog.2009.06.012; Bernstone C, 2009, MEASUREMENT, V42, P878, DOI 10.1016/j.measurement.2009.01.007; Bouchette G, 2014, IEEE T GEOSCI REMOTE, V52, P1407, DOI 10.1109/TGRS.2013.2250982; Chen CP, 2012, APPL MECH MATER, V220-223, P1315, DOI 10.4028/www.scientific.net/AMM.220-223.1315; Cong-ping Chen, 2012, 2012 International Conference on Systems and Informatics (ICSAI 2012), P1825, DOI 10.1109/ICSAI.2012.6223399; Dou J, 2015, REMOTE SENS-BASEL, V7, P4318, DOI 10.3390/rs70404318; Ghamisi P, 2015, IEEE T GEOSCI REMOTE, V53, P2335, DOI 10.1109/TGRS.2014.2358934; Glisic B, 2012, STRUCT HEALTH MONIT, V11, P161, DOI 10.1177/1475921711414233; Grote AB, 2014, CAN J FISH AQUAT SCI, V71, P545, DOI 10.1139/cjfas-2013-0308; Guan HY, 2015, IEEE T INTELL TRANSP, V16, P2457, DOI 10.1109/TITS.2015.2409192; Kabir S, 2009, CONSTR BUILD MATER, V23, P3166, DOI 10.1016/j.conbuildmat.2009.06.013; Koch C, 2015, ADV ENG INFORM, V29, P196, DOI 10.1016/j.aei.2015.01.008; Lai SL, 2014, J CHIN INST ENG, V37, P428, DOI 10.1080/02533839.2013.799949; Martinez J, 2014, INT J MINER PROCESS, V133, P67, DOI 10.1016/j.minpro.2014.09.008; Martinez-Sanchez A, 2014, J STRUCT BIOL, V186, P49, DOI 10.1016/j.jsb.2014.02.015; Murphy RR, 2009, 2009 IEEE INT WORKSH, P1, DOI DOI 10.1109/SSRR.2009.5424144; Oliveira H, 2013, IEEE T INTELL TRANSP, V14, P155, DOI 10.1109/TITS.2012.2208630; Rashwan HA, 2013, IEEE T IMAGE PROCESS, V22, P2589, DOI 10.1109/TIP.2013.2253481; Rezaiee-Pajand M, 2015, P I CIVIL ENG-STR B, V168, P192, DOI 10.1680/stbu.12.00078; SHAFER G, 1981, PHILOS SCI, V48, P337, DOI 10.1086/289004; Stephan T, 2013, SPIE OPTICAL METROLO; Su HZ, 2013, IEEE SENS J, V13, P1403, DOI 10.1109/JSEN.2012.2227468; Wickramarathne TL, 2013, IEEE T CYBERNETICS, V43, P712, DOI 10.1109/TSMCB.2012.2214771; Williams S., 2008, OCEANS, P1; Xu XY, 2011, PATTERN RECOGN LETT, V32, P956, DOI 10.1016/j.patrec.2011.01.021; Xu XJ, 2013, J CENT SOUTH UNIV, V20, P2605, DOI 10.1007/s11771-013-1775-5; Xue XH, 2014, COMPUT CONCRETE, V13, P633, DOI 10.12989/cac.2014.13.5.633; Ye XW, 2016, J SENSORS, V2016, DOI 10.1155/2016/7103039; Zalama E, 2014, COMPUT-AIDED CIV INF, V29, P342, DOI 10.1111/mice.12042; Zou Q, 2012, PATTERN RECOGN LETT, V33, P227, DOI 10.1016/j.patrec.2011.11.004	31	11	11	5	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179627	10.1371/journal.pone.0179627	http://dx.doi.org/10.1371/journal.pone.0179627			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640925	Green Published, gold, Green Submitted			2022-12-27	WOS:000404135800046
J	Andreozzi, F; Mannino, GC; Mancuso, E; Spiga, R; Perticone, F; Sesti, G				Andreozzi, Francesco; Mannino, Gaia Chiara; Mancuso, Elettra; Spiga, Rosangela; Perticone, Francesco; Sesti, Giorgio			Plasma kisspeptin levels are associated with insulin secretion in nondiabetic individuals	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; GLUCOSE-TOLERANCE; KISS-1; GENE; SENSITIVITY; GPR54; METABOLISM; METASTIN; GLUCAGON; PLACENTA	To evaluate if plasma kisspeptin concentrations are associated with insulin secretion, as suggested by recent in vitro studies, independently of confounders. 261 nondiabetic subjects were stratified into tertiles according to kisspeptin values. Insulin secretion was assessed using indexes derived from oral glucose tolerance test (OGTT). After adjusting for age, gender, and BMI, subjects in the highest (tertile 3) kisspeptin group exhibited significantly lower values of insulinogenic index, corrected insulin response (CIR30), and Stumvoll indexes for first-phase and second-phase insulin release as compared with low (tertile 1) or intermediate (tertile 2) kisspeptin groups. Univariate correlations between kisspeptin concentration and metabolic variables showed that kisspeptin concentration was significantly and positively correlated with age, blood pressure, and 2-h post-load glucose, and inversely correlated with BMI, and waist circumference. There was an inverse relationship between kisspeptin levels and OGTT-derived indexes of glucose-stimulated insulin secretion. A multivariable regression analysis in a model including all the variables significantly correlated with kisspeptin concentration showed thar age (I-3 =-0.338, P<0.0001), BMI (I-3 = 0.272, P<0.0001), 2-h post-load glucose ((3 =-0.229, P<0.0001), and kisspeptin ((3 =-0.105, P 0.03) remained associated with insulinogenic index. These factors explained 34.6% of the variance of the insulinogenic index. In conclusion, kisspeptin concentrations are associated with insulin secretion independently of important determinants of glucose homeostasis such as gender, age, adiposity, 2-h post-load glucose, and insulin sensitivity.	[Andreozzi, Francesco; Mannino, Gaia Chiara; Mancuso, Elettra; Spiga, Rosangela; Perticone, Francesco; Sesti, Giorgio] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, CZ, Italy	Magna Graecia University of Catanzaro	Sesti, G (corresponding author), Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, CZ, Italy.	sesti@unicz.it	Perticone, Francesco/I-4260-2017; Mancuso, Elettra/AAD-5180-2020; Mannino, Gaia C/K-1580-2016; Spiga, Rosangela/AAB-4421-2020; Andreozzi, Francesco/J-4073-2018	Mancuso, Elettra/0000-0002-0562-9196; Mannino, Gaia C/0000-0002-6341-4572; Spiga, Rosangela/0000-0002-3331-6568; Andreozzi, Francesco/0000-0001-9375-1513; Sesti, Giorgio/0000-0002-1618-7688	Foundation for Diabetes Research of the Italian Diabetes Society, through the award of "Fondazione Diabete Ricerca FO.DI.RI.-MSD"	Foundation for Diabetes Research of the Italian Diabetes Society, through the award of "Fondazione Diabete Ricerca FO.DI.RI.-MSD"	The authors received no specific funding for this work, which was supported, in part, by the Foundation for Diabetes Research of the Italian Diabetes Society, through the award of "Fondazione Diabete Ricerca FO.DI.RI.-MSD" scholarships in 2014 and 2015 to Gaia Chiara Mannino. FO.DI.RI. and MSD 2014-2015-Dr. Gaia Chiara Mannino. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilban M, 2004, J CELL SCI, V117, P1319, DOI 10.1242/jcs.00971; Cetkovic A, 2012, ENDOCR RES, V37, P78, DOI 10.3109/07435800.2011.639319; d'Anglemont de Tassigny X, 2007, P NATL ACAD SCI USA, V104, P10714, DOI 10.1073/pnas.0704114104; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Fiorentino TV, 2015, NUTR METAB CARDIOVAS, V25, P510, DOI 10.1016/j.numecd.2015.02.007; Gottsch ML, 2009, PEPTIDES, V30, P4, DOI 10.1016/j.peptides.2008.06.016; Hanson RL, 2000, AM J EPIDEMIOL, V151, P190; Hauge-Evans AC, 2006, DIABETOLOGIA, V49, P2131, DOI 10.1007/s00125-006-0343-z; Hiden U, 2007, REV ENDOCR METAB DIS, V8, P31, DOI 10.1007/s11154-007-9030-8; Hiney JK, 2009, ENDOCRINOLOGY, V150, P376, DOI 10.1210/en.2008-0954; Horikoshi Y, 2003, J CLIN ENDOCR METAB, V88, P914, DOI 10.1210/jc.2002-021235; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Lee JH, 1997, INT J CANCER, V71, P1035, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1035::AID-IJC20>3.3.CO;2-T; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Muir AI, 2001, J BIOL CHEM, V276, P28969, DOI 10.1074/jbc.M102743200; Oakley AE, 2009, ENDOCR REV, V30, P713, DOI 10.1210/er.2009-0005; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Panidis D, 2006, FERTIL STERIL, V85, P1778, DOI 10.1016/j.fertnstert.2005.11.044; Schwetz TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113020; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Silveira LG, 2010, J CLIN ENDOCR METAB, V95, P2276, DOI 10.1210/jc.2009-2421; Silvestre RA, 2008, J ENDOCRINOL, V196, P283, DOI 10.1677/JOE-07-0454; Song WJ, 2014, CELL METAB, V19, P667, DOI 10.1016/j.cmet.2014.03.005; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295; Teles MG, 2008, NEW ENGL J MED, V358, P709, DOI 10.1056/NEJMoa073443; Tolson KP, 2016, ENDOCRINOLOGY, V157, P4192, DOI 10.1210/en.2016-1501; Tolson KP, 2014, J CLIN INVEST, V124, P3075, DOI 10.1172/JCI71075; Vikman J, 2009, DIABETES OBES METAB, V11, P197, DOI 10.1111/j.1463-1326.2009.01116.x	28	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179834	10.1371/journal.pone.0179834	http://dx.doi.org/10.1371/journal.pone.0179834			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636637	Green Published, Green Submitted, gold			2022-12-27	WOS:000404118300057
J	Lake, MP; Bouchard, LS				Lake, Michael P.; Bouchard, Louis-S.			Targeted nanodiamonds for identification of subcellular protein assemblies in mammalian cells	PLOS ONE			English	Article							POLY(PROPYLENE IMINE) DENDRIMERS; NUCLEAR-PORE COMPLEX; QUANTUM DOTS; FLUORESCENT NANODIAMONDS; GOLD NANOPARTICLES; IN-VITRO; ELECTRON-MICROSCOPY; SIRNA DELIVERY; TOXICITY; NUP98	Transmission electron microscopy (TEM) can be used to successfully determine the structures of proteins. However, such studies are typically done ex situ after extraction of the protein from the cellular environment. Here we describe an application for nanodiamonds as targeted intensity contrast labels in biological TEM, using the nuclear pore complex (NPC) as a model macroassembly. We demonstrate that delivery of antibody-conjugated nanodiamonds to live mammalian cells using maltotriose-conjugated polypropylenimine dendrimers results in efficient localization of nanodiamonds to the intended cellular target. We further identify signatures of nanodiamonds under TEM that allow for unambiguous identification of individual nanodiamonds from a resin-embedded, OsO4-stained environment. This is the first demonstration of nanodiamonds as labels for nanoscale TEM-based identification of subcellular protein assemblies. These results, combined with the unique fluorescence properties and biocompatibility of nanodiamonds, represent an important step toward the use of nanodiamonds as markers for correlated optical/electron bioimaging.	[Lake, Michael P.; Bouchard, Louis-S.] Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA; [Bouchard, Louis-S.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Bouchard, Louis-S.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA; [Bouchard, Louis-S.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Bouchard, Louis-S.] Univ Calif Los Angeles, Ctr Comprehens Canc, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Bouchard, LS (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.; Bouchard, LS (corresponding author), Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA.; Bouchard, LS (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.; Bouchard, LS (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA.; Bouchard, LS (corresponding author), Univ Calif Los Angeles, Ctr Comprehens Canc, Los Angeles, CA 90095 USA.	bouchard@chem.ucla.edu			AFOSR/DARPA QUASAR; Arnold and Mabel Beckman Foundation	AFOSR/DARPA QUASAR; Arnold and Mabel Beckman Foundation	This work was supported by AFOSR/DARPA QUASAR, Arnold and Mabel Beckman Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbe E., 1881, J ROYAL MICROSCOPICA, V1, P388, DOI DOI 10.1111/J.1365-2818.1881.TB05909.X; Barok M, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3621; Buchser W., 2014, ASSAY GUIDANCE MANUA; Chatel G, 2012, J STRUCT BIOL, V177, P81, DOI 10.1016/j.jsb.2011.11.004; Chen M, 2005, EXP CELL RES, V305, P51, DOI 10.1016/j.yexcr.2004.12.021; Chen M, 2010, J PHYS CHEM LETT, V1, P3167, DOI 10.1021/jz1013278; Chow EK, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001713; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; Deerinck TJ, 2008, TOXICOL PATHOL, V36, P112, DOI 10.1177/0192623307310950; Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334; El-Say K. M., 2011, J APPL PHARM SCI, V01, P29; Faklaris O, 2009, ACS NANO, V3, P3955, DOI 10.1021/nn901014j; Franiak-Pietryga I, 2013, MOL PHARMACEUT, V10, P2490, DOI 10.1021/mp400142p; Franks TM, 2013, TRENDS CELL BIOL, V23, P112, DOI 10.1016/j.tcb.2012.10.013; Frantsuzov P, 2008, NAT PHYS, V4, P519, DOI 10.1038/nphys1001; Griffis ER, 2003, MOL BIOL CELL, V14, P600, DOI 10.1091/mbc.E02-09-0582; Gu YJ, 2009, TOXICOL APPL PHARM, V237, P196, DOI 10.1016/j.taap.2009.03.009; Guo ST, 2011, J NANOMATER, V2011, DOI 10.1155/2011/742895; Hirsch PB, 1977, ELECT MICROSCOPY THI; Huang YA, 2014, SCI REP; Ivask A, 2015, CURR TOP MED CHEM, V15, P1914, DOI 10.2174/1568026615666150506150109; Jelezko F, 2001, SINGLE MOL, V2, P255, DOI 10.1002/1438-5171(200112)2:4<255::AID-SIMO255>3.0.CO;2-D; Klajnert B, 2008, CHEM-EUR J, V14, P7030, DOI 10.1002/chem.200800342; Kreyling WG, 2015, NAT NANOTECHNOL, V10, P619, DOI [10.1038/NNANO.2015.111, 10.1038/nnano.2015.111]; Kucsko G, 2013, NATURE, V500, P54, DOI 10.1038/nature12373; Le Sage D, 2013, NATURE, V496, P486, DOI 10.1038/nature12072; Levy R., 2010, NANO REV; Mahamid J, 2016, SCIENCE, V351, P969, DOI 10.1126/science.aad8857; Mayhew TM, 2011, J ANAT, V219, P647, DOI 10.1111/j.1469-7580.2011.01438.x; Mayhew TM, 2009, ANN ANAT, V191, P153, DOI 10.1016/j.aanat.2008.11.001; Mkandawire M, 2009, J BIOPHOTONICS, V2, P596, DOI 10.1002/jbio.200910002; Moore L, 2013, J DENT RES, V92, P976, DOI 10.1177/0022034513504952; Nagarajan S, 2016, NANOSCALE, V8, P11588, DOI 10.1039/c6nr01908k; Oh E, 2016, NAT NANOTECHNOL, V11, P479, DOI [10.1038/NNANO.2015.338, 10.1038/nnano.2015.338]; Paget V, 2014, NANOTOXICOLOGY, V8, P46, DOI 10.3109/17435390.2013.855828; Rodgers KR, 2016, BIOTECHNOL ADV, V34, P1149, DOI 10.1016/j.biotechadv.2016.07.004; Rothen-Rutishauser B, 2014, NANOMEDICINE-UK, V9, P607, DOI [10.2217/NNM.13.24, 10.2217/nnm.13.24]; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Shimkunas RA, 2009, BIOMATERIALS, V30, P5720, DOI 10.1016/j.biomaterials.2009.07.004; SHIUE WK, 1982, J R STAT SOC C-APPL, V31, P130; Soenen SJ, 2012, ACS NANO, V6, P5767, DOI 10.1021/nn301714n; Souquere S, 2015, NUCLEUS-PHILA, V6, P326, DOI 10.1080/19491034.2015.1082695; Thiberge S, 2004, P NATL ACAD SCI USA, V101, P3346, DOI 10.1073/pnas.0400088101; Thomas M, 2003, P NATL ACAD SCI USA, V100, P9138, DOI 10.1073/pnas.1233634100; Tuchin V. V., 2015, TISSUE OPTICS LIGHT; Tzeng YK, 2011, ANGEW CHEM INT EDIT, V50, P2262, DOI 10.1002/anie.201007215; von Appen A, 2015, NATURE, V526, P140, DOI 10.1038/nature15381; Wingard CJ, 2011, NANOTOXICOLOGY, V5, P531, DOI 10.3109/17435390.2010.530004; Xi GF, 2014, NANOMED-NANOTECHNOL, V10, P381, DOI 10.1016/j.nano.2013.07.013; Yu SJ, 2005, J AM CHEM SOC, V127, P17604, DOI 10.1021/ja0567081; Zhang DM, 2009, NANO LETT, V9, P666, DOI 10.1021/nl803054h; Ziemba B, 2014, INT J PHARMACEUT, V461, P391, DOI 10.1016/j.ijpharm.2013.12.011; Ziemba B, 2011, J BIOMED MATER RES A, V99A, P261, DOI 10.1002/jbm.a.33196; Zurbuchen MA, 2013, SCI REP-UK, V3, DOI 10.1038/srep02668	54	15	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179295	10.1371/journal.pone.0179295	http://dx.doi.org/10.1371/journal.pone.0179295			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636640	Green Published, gold, Green Submitted			2022-12-27	WOS:000404118300031
J	Coutinho, E; Schuller, B				Coutinho, Eduardo; Schuller, Bjorn			Shared acoustic codes underlie emotional communication in music and speech-Evidence from deep transfer learning	PLOS ONE			English	Article							RECOGNITION; EXPRESSION	Music and speech exhibit striking similarities in the communication of emotions in the acoustic domain, in such a way that the communication of specific emotions is achieved, at least to a certain extent, by means of shared acoustic patterns. From an Affective Sciences points of view, determining the degree of overlap between both domains is fundamental to understand the shared mechanisms underlying such phenomenon. From a Machine learning perspective, the overlap between acoustic codes for emotional expression in music and speech opens new possibilities to enlarge the amount of data available to develop music and speech emotion recognition systems. In this article, we investigate time-continuous predictions of emotion (Arousal and Valence) in music and speech, and the Transfer Learning between these domains. We establish a comparative framework including intra- (i.e., models trained and tested on the same modality, either music or speech) and cross-domain experiments (i.e., models trained in one modality and tested on the other). In the cross domain context, we evaluated two strategies the direct transfer between domains, and the contribution of Transfer Learning techniques (feature-representation-transfer based on Denoising Auto Encoders) for reducing the gap in the feature space distributions. Our results demonstrate an excellent cross-domain generalisation performance with and without feature representation transfer in both directions. In the case of music, cross-domain approaches outperformed intra-domain models for Valence estimation, whereas for Speech intra-domain models achieve the best performance. This is the first demonstration of shared acoustic codes for emotional expression in music and speech in the time-continuous domain.	[Coutinho, Eduardo] Univ Liverpool, Dept Mus, Liverpool, Merseyside, England; [Coutinho, Eduardo; Schuller, Bjorn] Imperial Coll London, Dept Comp, London, England	University of Liverpool; Imperial College London	Coutinho, E (corresponding author), Univ Liverpool, Dept Mus, Liverpool, Merseyside, England.; Coutinho, E (corresponding author), Imperial Coll London, Dept Comp, London, England.	e.coutinho@liverpool.ac.uk	Coutinho, Eduardo/K-1391-2019	Coutinho, Eduardo/0000-0001-5234-1497; Schuller, Bjorn/0000-0002-6478-8699	European Union [645378]	European Union(European Commission)	This work was partially funded by European Union's Horizon 2020 (blipe:/ec.europa.eu/programmestorizon2020/) research and innovation programme under grant agreement No. 645378 (ARIA-VALUSPA) awarded to Bjorn Schuller.	Alain G, 2014, J MACH LEARN RES, V15, P3563; Aljanaki A, 2014, WORK NOT P MED 2014, V1263; Aljanaki A, 2015, WORK NOT P MED 2015, V1436; Arnold A., 2007, PROC 7 IEEE INT C DA, P77, DOI DOI 10.1109/ICDMW.2007.109; Balkwill LL, 2004, JPN PSYCHOL RES, V46, P337, DOI 10.1111/j.1468-5584.2004.00265.x; Balkwill LL, 1999, MUSIC PERCEPT, V17, P43, DOI 10.2307/40285811; Bengio, 2011, P ICML, DOI DOI 10.1177/1753193411430810; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; BOURLARD H, 1988, BIOL CYBERN, V59, P291, DOI 10.1007/BF00332918; Brown S, 2000, ORIGINS OF MUSIC, P271; Coutinho E, 2014, MEDIAEVAL WORKSH, V1263, P5; Coutinho E, 2017, MUSIC PERCEPT, V34, P371, DOI 10.1525/MP.2017.34.4.371; Coutinho E, 2014, IEEE IJCNN, P3592, DOI 10.1109/IJCNN.2014.6889814; Coutinho E, 2013, COGNITION EMOTION, V27, P658, DOI 10.1080/02699931.2012.732559; Coutinho E, 2011, EMOTION, V11, P921, DOI 10.1037/a0024700; Coutinho E, 2009, MUSIC PERCEPT, V27, P1, DOI 10.1525/MP.2009.27.1.1; Deng J, 2013, INT CONF AFFECT, P511, DOI 10.1109/ACII.2013.90; Douglas-Cowie E, 2007, LECT NOTES COMPUT SC, V4738, P488; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; Eyben F., 2013, P 21 ACM INT C MULT, P835, DOI 10.1145/2502081.2502224; Feng Y., 2003, P 26 ANN INT ACM SIG, P375, DOI [DOI 10.1145/860500.860508, 10.1145/860435.860508]; Fritz T, 2009, CURR BIOL, V19, P573, DOI 10.1016/j.cub.2009.02.058; Gabrielsson Alf, 2010, HDB MUSIC EMOTION TH, P367, DOI DOI 10.1093/ACPROF:OSO/9780199230143.003.0014; Gers FA, 2000, NEURAL COMPUT, V12, P2451, DOI 10.1162/089976600300015015; Graves A, 2005, NEURAL NETWORKS, V18, P602, DOI 10.1016/j.neunet.2005.06.042; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Grewe O, 2007, EMOTION, V7, P774, DOI 10.1037/1528-3542.7.4.774; Hunter PG, 2008, COGNITION EMOTION, V22, P327, DOI 10.1080/02699930701438145; Ilie G, 2006, MUSIC PERCEPT, V23, P319, DOI 10.1525/mp.2006.23.4.319; Ilie G, 2011, MUSIC PERCEPT, V28, P247, DOI 10.1525/MP.2011.28.3.247; Juslin PN, 2008, BEHAV BRAIN SCI, V31, P559, DOI 10.1017/S0140525X08005293; Juslin PN, 2013, PHYS LIFE REV, V10, P235, DOI 10.1016/j.plrev.2013.05.008; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Kawakami A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00311; KIVY P, 1980, PHILOS STUD, V38, P351, DOI 10.1007/BF00419335; Korhonen M, 2004, MODELING CONTINUOUS; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Lin YC, 2011, ACM T MULTIM COMPUT, V7, DOI 10.1145/2037676.2037683; McKeown G, 2012, IEEE T AFFECT COMPUT, V3, P5, DOI 10.1109/T-AFFC.2011.20; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Peretz I, 2001, ANN NY ACAD SCI, V930, P153, DOI 10.1111/j.1749-6632.2001.tb05731.x; Ranzato M.A., 2007, ADV NEURAL INF PROCE, P1137, DOI DOI 10.7551/mitpress/7503.003.0147; Ringeval F., 2013, AUT FAC GEST REC FG, P1, DOI [DOI 10.1109/FG.2013.6553805, 10.1109/FG.2013.6553805]; Ringeval F, 2015, MM'15: PROCEEDINGS OF THE 2015 ACM MULTIMEDIA CONFERENCE, P1335, DOI 10.1145/2733373.2806408; Ringeval F, 2015, PATTERN RECOGN LETT, V66, P22, DOI 10.1016/j.patrec.2014.11.007; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Scherer K. R., 2001, MUSIC EMOTION THEORY, DOI DOI 10.1016/j.jsams.2011.06.003; Scherer Klaus R, 2013, EMOTIONAL POWER MUSI, V2013, P121, DOI DOI 10.1093/ACPROF:OSO/9780199654888.003.0010; SCHERER KR, 1995, J VOICE, V9, P235, DOI 10.1016/S0892-1997(05)80231-0; Schubert E, 2004, MUSIC PERCEPT, V21, P561, DOI 10.1525/mp.2004.21.4.561; Schuller B, 2011, 2 LECT NOT COMP SCI, V6975; Schuller B, 2013, INTERSPEECH, P148; Schuller B, 2010, IEEE T AFFECT COMPUT, V1, P119, DOI 10.1109/T-AFFC.2010.8; Schuller B, 2014, INTERSPEECH, P427; Thompson WF, 2006, SEMIOTICA, V158, P407, DOI 10.1515/SEM.2006.017; Vincent P., 2008, P 25 INT C MACHINE L, P1096, DOI 10.1145/1390156.1390294; Vincent P, 2010, J MACH LEARN RES, V11, P3371; Weninger F, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00292; Wollmer M, 2010, IEEE J-STSP, V4, P867, DOI 10.1109/JSTSP.2010.2057200; Wollmer M, 2008, INTERSPEECH 2008: 9TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2008, VOLS 1-5, P597; Wollmer M, 2011, ACM T SPEECH LANGUAG, V7, P12; Zentner M, 2008, EMOTION, V8, P494, DOI 10.1037/1528-3542.8.4.494	63	13	13	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179289	10.1371/journal.pone.0179289	http://dx.doi.org/10.1371/journal.pone.0179289			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EZ3JT	28658285	Green Submitted, Green Published, gold			2022-12-27	WOS:000404607900019
J	Duffy-Anderson, JT; Stabeno, PJ; Siddon, EC; Andrews, AG; Cooper, DW; Eisner, LB; Farley, EV; Harpold, CE; Heintz, RA; Kimmel, DG; Sewall, FF; Spear, AH; Yasumishii, EC				Duffy-Anderson, Janet T.; Stabeno, Phyllis J.; Siddon, Elizabeth C.; Andrews, Alex G.; Cooper, Daniel W.; Eisner, Lisa B.; Farley, Edward V.; Harpold, Colleen E.; Heintz, Ron A.; Kimmel, David G.; Sewall, Fletcher F.; Spear, Adam H.; Yasumishii, Ellen C.			Return of warm conditions in the southeastern Bering Sea: Phytoplankton - Fish	PLOS ONE			English	Article							POLLOCK THERAGRA-CHALCOGRAMMA; WALLEYE POLLOCK; SHELF; ZOOPLANKTON; AGE-0; ABUNDANCE; NORTHERN; IMPACTS; BIOMASS; GROWTH	In 2014, the Bering Sea shifted back to warmer ocean temperatures (+2 degrees C above average), bringing concern for the potential for a new warm stanza and broad biological and ecological cascading effects. In 2015 and 2016 dedicated surveys were executed to study the progression of ocean heating and ecosystem response. We describe ecosystem response to multiple, consecutive years of ocean warming and offer perspective on the broader impacts. Ecosystem changes observed include reduced spring phytoplankton biomass over the southeast Bering Sea shelf relative to the north, lower abundances of large-bodied crustacean zooplankton taxa, and degraded feeding and body condition of age-0 walleye pollock. This suggests poor ecosystem conditions for young pollock production and the risk of significant decline in the number of pollock available to the pollock fishery in 2-3 years. However, we also noted that high quality prey, large copepods and euphausiids, and lower temperatures in the north may have provided a refuge from poor conditions over the southern shelf, potentially buffering the impact of a sequential-year warm stanza on the Bering Sea pollock population. We offer the hypothesis that juvenile (age-0, age-1) pollock may buffer deleterious warm stanza effects by either utilizing high productivity waters associated with the strong, northerly Cold Pool, as a refuge from the warm, low production areas of the southern shelf, or by exploiting alternative prey over the southern shelf. We show that in 2015, the ocean waters influenced by spring sea ice (the Cold Pool) supported robust phytoplankton biomass (spring) comprised of centric diatom chains, a crustacean copepod community comprised of large-bodied taxa (spring, summer), and a large aggregation of midwater fishes, potentially young pollock. In this manner, the Cold Pool may have acted as a trophic refuge in that year. The few age-0 pollock occurring over the southeast shelf consumed high numbers of euphausiids which may have provided a high quality alternate prey. In 2016 a retracted Cold Pool precluded significant refuging in the north, though pollock foraging on available euphausiids over the southern shelf may have mitigated the effect of warm waters and reduced large availability of large copepods. This work presents the hypothesis that, in the short term, juvenile pollock can mitigate the drastic impacts of sustained warming. This short-term buffering, combined with recent observations (2017) of renewed sea ice presence over southeast Bering Sea shelf and a potential return to average or at least cooler ecosystem conditions, suggests that recent warm year stanza (2014-2016) effects to the pollock population and fishery may be mitigated.	[Duffy-Anderson, Janet T.; Cooper, Daniel W.; Harpold, Colleen E.; Kimmel, David G.; Spear, Adam H.] NOAA, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA; [Stabeno, Phyllis J.] Pacific Marine Environm Lab, Seattle, WA USA; [Siddon, Elizabeth C.; Andrews, Alex G.; Eisner, Lisa B.; Farley, Edward V.; Heintz, Ron A.; Sewall, Fletcher F.; Yasumishii, Ellen C.] NOAA, Alaska Fisheries Sci Ctr, Auke Bay Labs, Natl Marine Fisheries Serv, Juneau, AK USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA	Duffy-Anderson, JT (corresponding author), NOAA, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA.	Janet.Duffy-Anderson@noaa.gov	Farley, E/HHM-4227-2022; Kimmel, David/AFM-9673-2022; Kimmel, David G./N-1148-2019	Kimmel, David/0000-0001-7232-7801; 	National Oceanic and Atmospheric Administration; National Marine Fisheries Service, Office of Science and Technology; North Pacific Climate Regimes and Ecosystem Productivity Program	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); National Marine Fisheries Service, Office of Science and Technology; North Pacific Climate Regimes and Ecosystem Productivity Program	This work was supported by the National Oceanic and Atmospheric Administration. Support was also provided by the National Marine Fisheries Service, Office of Science and Technology and by the North Pacific Climate Regimes and Ecosystem Productivity Program.	[Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], [No title captured]; Bacheler NM, 2010, FISH OCEANOGR, V19, P107, DOI 10.1111/j.1365-2419.2009.00531.x; Boldt JL, 2012, FISH B-NOAA, V110, P293; Bond NA, 2015, GEOPHYS RES LETT, V42, P3414, DOI 10.1002/2015GL063306; Coyle KO, 2011, FISH OCEANOGR, V20, P139, DOI 10.1111/j.1365-2419.2011.00574.x; Coyle KO, 2008, DEEP-SEA RES PT II, V55, P1775, DOI 10.1016/j.dsr2.2008.04.029; Coyle KO, 2002, PROG OCEANOGR, V55, P177, DOI 10.1016/S0079-6611(02)00077-0; Dalsgaard J, 2013, ADV MAR BIOL, V46, P225; DeRobertis A, 2014, NMFS AFSC 272; Duffy-Anderson JT, 2016, DEEP-SEA RES PT II, V134, P283, DOI 10.1016/j.dsr2.2015.02.001; Eisner LB, 2016, DEEP-SEA RES PT II, V134, P100, DOI 10.1016/j.dsr2.2015.07.012; Eisner LB, 2014, DEEP-SEA RES PT II, V109, P157, DOI 10.1016/j.dsr2.2014.03.004; Farley Edward V. Jr, 2005, Alaska Fishery Research Bulletin, V11, P15; Grebmeier JM, 2006, SCIENCE, V311, P1461, DOI 10.1126/science.1121365; Heintz RA, 2013, DEEP-SEA RES PT II, V94, P150, DOI 10.1016/j.dsr2.2013.04.006; HINCKLEY S, 1987, FISH B-NOAA, V85, P481; Hollowed AB, 2012, DEEP-SEA RES PT II, V65-70, P230, DOI 10.1016/j.dsr2.2012.02.008; Hunsicker ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066025; Hunt GL, 2011, ICES J MAR SCI, V68, P1230, DOI 10.1093/icesjms/fsr036; Hurst TP, 2007, CAN J FISH AQUAT SCI, V64, P449, DOI 10.1139/F07-025; Kotwicki S., 2016, STOCK ASSESSMENT FIS, P55; Ladd C, 2016, ECOSYSTEM CONSIDERAT, P87; Laney SR, 2014, DEEP-SEA RES PT II, V105, P30, DOI 10.1016/j.dsr2.2014.03.012; Lomas MW, 2012, DEEP-SEA RES PT II, V65-70, P126, DOI 10.1016/j.dsr2.2012.02.010; Moss JH, 2009, T AM FISH SOC, V138, P497, DOI 10.1577/T08-126.1; Parsons T. R., 1984, MANUAL CHEM BIOL MET, DOI [10.1016/B978-0-08-030287-4.50004-9, DOI 10.1016/C2009-0-07774-5]; PETERSON W, 2015, WARM BLOB CONTINUES, V23, P44; Peterson W., 2015, WARM BLOB CONTINUES, V23, P36; Petrik CM, 2016, ICES J MAR SCI, V73, P1890, DOI 10.1093/icesjms/fsw004; Siddon EC, 2013, DEEP-SEA RES PT II, V94, P140, DOI 10.1016/j.dsr2.2012.12.007; Siddon EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084526; Sigler MF, 2016, DEEP-SEA RES PT II, V134, P223, DOI 10.1016/j.dsr2.2016.01.003; Sogard SM, 2000, J FISH BIOL, V56, P1; Sogard SM, 1996, MAR ECOL PROG SER, V133, P43, DOI 10.3354/meps133043; Stabeno PJ, 2016, DEEP-SEA RES PT II, V134, P13, DOI 10.1016/j.dsr2.2016.05.010; Stabeno PJ, 2012, DEEP-SEA RES PT II, V65-70, P31, DOI 10.1016/j.dsr2.2012.02.020; Stabeno PJ, 2012, DEEP-SEA RES PT II, V65-70, P14, DOI 10.1016/j.dsr2.2012.02.019; Stabeno PJ, 1999, UASGCP REP, V99, P1; Thorson JT, 2015, ICES J MAR SCI, V72, P1297, DOI 10.1093/icesjms/fsu243; VIDAL J, 1986, DEEP-SEA RES, V33, P523, DOI 10.1016/0198-0149(86)90129-9; Wang SX, 2014, LECT NOTES COMPUT SC, V8388, P175, DOI 10.1007/978-3-319-06826-8_14; Wyllie Echeverria Tina, 1995, Canadian Special Publication of Fisheries and Aquatic Sciences, V121, P131; Wyllie-Echeverria T, 1998, FISH OCEANOGR, V7, P159, DOI 10.1046/j.1365-2419.1998.00058.x	44	50	51	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0178955	10.1371/journal.pone.0178955	http://dx.doi.org/10.1371/journal.pone.0178955			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658253	Green Submitted, Green Published, gold			2022-12-27	WOS:000404607900010
J	Banni, M; Sforzini, S; Arlt, VM; Barranger, A; Dallas, LJ; Oliveri, C; Aminot, Y; Pacchioni, B; Millino, C; Lanfranchi, G; Readman, JW; Moore, MN; Viarengo, A; Jha, AN				Banni, Mohamed; Sforzini, Susanna; Arlt, Volker M.; Barranger, Audrey; Dallas, Lorna J.; Oliveri, Caterina; Aminot, Yann; Pacchioni, Beniamina; Millino, Caterina; Lanfranchi, Gerolamo; Readman, James W.; Moore, Michael N.; Viarengo, Aldo; Jha, Awadhesh N.			Assessing the impact of Benzo[a]pyrene on Marine Mussels: Application of a novel targeted low density microarray complementing classical biomarker responses	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; TISSUE-SPECIFIC EXPRESSION; OXIDATIVE DNA-DAMAGE; HEAT-SHOCK-PROTEIN; MYTILUS-EDULIS-L; IN-VIVO; DIGESTIVE GLAND; METABOLIC-ACTIVATION; ACTIN CYTOSKELETON; GENE-EXPRESSION	Despite the increasing use of mussels in environmental monitoring and ecotoxicological studies, their genomes and gene functions have not been thoroughly explored. Several cDNA microarrays were recently proposed for Mytilus spp., but putatively identified partial transcripts have rendered the generation of robust transcriptional responses difficult in terms of pathway identification. We developed a new low density oligonucleotide microarray with 465 probes covering the same number of genes. Target genes were selected to cover most of the well-known biological processes in the stress response documented over the last decade in bivalve species at the cellular and tissue levels. Our new 'STressREsponse Microarray' (STREM) platform consists of eight sub-arrays with three replicates for each target in each sub-array. To assess the potential use of the new array, we tested the effect of the ubiquitous environmental pollutant benzo[a] pyrene (B[a] P) at 5, 50, and 100 mu g/L on two target tissues, the gills and digestive gland, of Mytilus galloprovincialis exposed invivo for three days. Bioaccumulation of B[a] P was also determined demonstrating exposure in both tissues. In addition to the well-known effects of B[a] P on DNA metabolism and oxidative stress, the new array data provided clues about the implication of other biological processes, such as cytoskeleton, immune response, adhesion to substrate, and mitochondrial activities. Transcriptional data were confirmed using qRT-PCR. We further investigated cellular functions and possible alterations related to biological processes highlighted by the microarray data using oxidative stress biomarkers ( Lipofuscin content) and the assessment of genotoxicity. DNA damage, as measured by the alkaline comet assay, increased as a function of dose. DNA adducts measurements using 32 P-postlabeling method also showed the presence of bulky DNA adducts (i.e. dG-N-2-BPDE). Lipofiscin content increased significantly in B[a] P exposed mussels. Immunohistochemical analysis of tubulin and actin showed changes in cytoskeleton organisation. Our results adopting an integrated approach confirmed that the combination of newly developed transcriptomic approcah, classical biomarkers along with chemical analysis of water and tissue samples should be considered for environmental bioimonitoring and ecotoxicological studies to obtain holistic information to assess the impact of contaminants on the biota.	[Banni, Mohamed; Sforzini, Susanna; Oliveri, Caterina; Viarengo, Aldo] Univ Piemonte Orientale, Dept Sci & Technol Innovat DiSIT, Alessandria, Italy; [Banni, Mohamed] Sousse Univ, ISA Chott Mariem, Lab Biochem & Environm Toxicol, Sousse, Tunisia; [Arlt, Volker M.] Kings Coll London, MRC PHE Ctr Environm & Hlth, Analyt & Environm Sci Div, London, England; [Arlt, Volker M.] Kings Coll London, Publ Hlth England, NIHR Hlth Protect Res Unit Hlth Impact Environm H, London, England; [Barranger, Audrey; Dallas, Lorna J.; Moore, Michael N.; Jha, Awadhesh N.] Univ Plymouth, Sch Biol & Marine Sci, Plymouth, Devon, England; [Aminot, Yann; Readman, James W.] Univ Plymouth, Ctr Chem Sci, Plymouth, Devon, England; [Pacchioni, Beniamina; Millino, Caterina; Lanfranchi, Gerolamo] Univ Padua, Padua, Italy; [Readman, James W.; Moore, Michael N.] Plymouth Marine Lab, Prospect Pl, Plymouth, Devon, England; [Moore, Michael N.] Univ Exeter, Med Sch, Knowledge Spa, ECEHH,Royal Cornwall Hosp, Truro, Cornwall, England	University of Eastern Piedmont Amedeo Avogadro; Universite de Sousse; University of London; King's College London; Public Health England; University of London; King's College London; University of Plymouth; University of Plymouth; University of Padua; Plymouth Marine Laboratory; Royal Cornwall Hospital; University of Exeter	Banni, M (corresponding author), Univ Piemonte Orientale, Dept Sci & Technol Innovat DiSIT, Alessandria, Italy.; Banni, M (corresponding author), Sousse Univ, ISA Chott Mariem, Lab Biochem & Environm Toxicol, Sousse, Tunisia.; Jha, AN (corresponding author), Univ Plymouth, Sch Biol & Marine Sci, Plymouth, Devon, England.	m_banni@yahoo.fr; a.jha@plymouth.ac.uk	Barranger, Audrey/AAJ-8271-2020; Banni, Mohamed/M-2144-2014	Sforzini, Susanna/0000-0002-7310-7605; Banni, Mohamed/0000-0001-9764-0343; Jha, Awadhesh/0000-0001-9660-4308; Aminot, Yann/0000-0002-6507-9261; Arlt, Volker Manfred/0000-0003-4314-9318; Viarengo, Aldo/0000-0002-1557-6526; Barranger, Audrey/0000-0002-2947-6921	Natural Environment Research Council (NERC), UK [NE/L006782/1]; Cancer Research UK [C313/A14329]; Wellcome Trust [101126/Z/13/Z, 101126/B/13/Z]; National Institute for Health Research Health Protection Research Unit (NIHR HPRU); Public Health England (PHE); NERC [NE/L006782/1] Funding Source: UKRI; Natural Environment Research Council [NE/L006782/1] Funding Source: researchfish	Natural Environment Research Council (NERC), UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research Health Protection Research Unit (NIHR HPRU); Public Health England (PHE); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study is supported by Natural Environment Research Council (NERC), UK (Grant No.NE/L006782/1; PI: ANJ). Work at King's College London is further supported by Cancer Research UK (Grant C313/A14329), the Wellcome Trust (Grants 101126/Z/13/Z and 101126/B/13/Z) and in part by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Health Impact of Environmental Hazards at King's College London in partnership with Public Health England (PHE). The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR, the Department of Health or PHE.	Akcha F, 2000, MAR ECOL PROG SER, V205, P195, DOI 10.3354/meps205195; Al Refaii A, 2009, MOL MICROBIOL, V71, P748, DOI 10.1111/j.1365-2958.2008.06561.x; Al-Subiai SN, 2012, MUTAT RES-GEN TOX EN, V745, P92, DOI 10.1016/j.mrgentox.2011.12.019; Altenburger R, 2003, BIOMARKERS PAH PROSP, P147; Altenburger R, 2012, ENVIRON SCI TECHNOL, V46, P2508, DOI 10.1021/es2038036; Arlt VM, 2008, CARCINOGENESIS, V29, P656, DOI 10.1093/carcin/bgn002; Attig H, 2010, ECOTOX ENVIRON SAFE, V73, P1712, DOI 10.1016/j.ecoenv.2010.08.007; Banan A, 2001, AM J PHYSIOL-GASTR L, V280, pG1234, DOI 10.1152/ajpgi.2001.280.6.G1234; Banni M, 2005, BIOMARKERS, V10, P105, DOI 10.1080/13547500500107497; Banni M, 2010, ECOTOX ENVIRON SAFE, V73, P842, DOI 10.1016/j.ecoenv.2009.12.032; Banni M, 2009, CHEMOSPHERE, V77, P902, DOI 10.1016/j.chemosphere.2009.08.041; Banni M, 2016, ENVIRON RES, V145, P135, DOI 10.1016/j.envres.2015.12.003; Banni M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018904; Banni M, 2009, COMP BIOCHEM PHYS C, V149, P414, DOI 10.1016/j.cbpc.2008.09.017; Bayne B.L., 1976, MARINE MUSSELS THEIR; Bignell JP, 2011, MAR ENVIRON RES, V72, P25, DOI 10.1016/j.marenvres.2011.05.004; Canesi L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019803; Canova S, 1998, MUTAT RES-FUND MOL M, V399, P17, DOI 10.1016/S0027-5107(97)00263-7; Carlson EA, 2002, AQUAT TOXICOL, V56, P289, DOI 10.1016/S0166-445X(01)00223-5; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cleveland DW, 1989, CURR OPIN CELL BIOL, V1, P10, DOI 10.1016/S0955-0674(89)80030-4; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Connelly H, 2010, INT J TOXICOL, V29, P532, DOI 10.1177/1091581810377518; Connolly MH, 2008, INT J DEV BIOL, V52, P71, DOI 10.1387/ijdb.062241mc; D'Agata A, 2014, NANOTOXICOLOGY, V8, P549, DOI 10.3109/17435390.2013.807446; Dallas LJ, 2013, MUTAT RES-GEN TOX EN, V754, P22, DOI 10.1016/j.mrgentox.2013.03.009; Dalle-Donne I, 2001, FREE RADICAL BIO MED, V31, P1624, DOI 10.1016/S0891-5849(01)00749-3; Dalziel AC, 2009, MOL ECOL, V18, P4997, DOI 10.1111/j.1365-294X.2009.04427.x; Devier MH, 2005, J ENVIRON MONITOR, V7, P224, DOI 10.1039/b409577d; Di Y, 2017, MUTAGENESIS, V32, P77, DOI 10.1093/mutage/gew049; Di YA, 2011, ENVIRON SCI TECHNOL, V45, P8974, DOI 10.1021/es201547x; Dondero F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-195; Farkas J, 2015, SCI TOTAL ENVIRON, V511, P469, DOI 10.1016/j.scitotenv.2014.12.084; Gomez-Mendikute A, 2003, TOXICOL IN VITRO, V17, P539, DOI 10.1016/S0887-2333(03)00093-6; Gracey AY, 2008, CURR BIOL, V18, P1501, DOI 10.1016/j.cub.2008.08.049; Hess MT, 1997, MOL CELL BIOL, V17, P7069, DOI 10.1128/MCB.17.12.7069; Jerina D M, 1991, Adv Exp Med Biol, V283, P533; Jha AN, 1996, MUTAT RES-ENVIR MUTA, V359, P141, DOI 10.1016/S0165-1161(96)90260-5; Kamel N, 2012, ARCH ENVIRON CON TOX, V63, P534, DOI 10.1007/s00244-012-9790-3; Kelley ML, 2001, ONCOGENE, V20, P748, DOI 10.1038/sj.onc.1204144; Krais AM, 2016, ARCH TOXICOL, V90, P839, DOI 10.1007/s00204-015-1531-8; Kucab JE, 2015, MUTAT RES-FUND MOL M, V773, P48, DOI 10.1016/j.mrfmmm.2015.01.013; Ling H, 2004, P NATL ACAD SCI USA, V101, P2265, DOI 10.1073/pnas.0308332100; Liu T, 2015, GENE, V555, P108, DOI 10.1016/j.gene.2014.10.051; LIVINGSTONE DR, 1984, SCI TOTAL ENVIRON, V39, P209, DOI 10.1016/0048-9697(84)90080-9; Lockwood BL, 2010, J EXP BIOL, V213, P3548, DOI 10.1242/jeb.046094; Long AS, 2016, TOXICOL APPL PHARM, V290, P31, DOI 10.1016/j.taap.2015.11.010; Maria VL, 2013, AQUAT TOXICOL, V144, P284, DOI 10.1016/j.aquatox.2013.10.009; Martin D, 2010, J VIROL, V84, P2522, DOI 10.1128/JVI.01883-09; MARTINEZ PG, 1995, TOXICOL APPL PHARM, V131, P332, DOI 10.1006/taap.1995.1076; Matocq MD, 2009, MOL ECOL, V18, P2310, DOI 10.1111/j.1365-294X.2009.04172.x; McGarry MA, 2002, BIOCHEM BIOPH RES CO, V294, P101, DOI 10.1016/S0006-291X(02)00437-0; MERCK KB, 1993, J BIOL CHEM, V268, P1046; MOORE MN, 1988, MAR ECOL PROG SER, V46, P81, DOI 10.3354/meps046081; Negri A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066802; Pearse A. G. E., 1985, HISTOCHEMISTRY THEOR, V2, P441; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Phillips DH, 2014, METHODS MOL BIOL, V1105, P127, DOI 10.1007/978-1-62703-739-6_10; Riva C, 2011, AQUAT TOXICOL, V104, P14, DOI 10.1016/j.aquatox.2011.03.008; Rizvi SM, 2004, MOL CELL, V15, P913, DOI 10.1016/j.molcel.2004.09.001; Sogbanmu TO, 2016, ENVIRON SCI POLLUT R, V23, P14489, DOI 10.1007/s11356-016-6490-y; Tanguy A, 2008, GENE, V408, P27, DOI 10.1016/j.gene.2007.10.021; Telli-Karakoc F, 2002, MAR ENVIRON RES, V54, P511, DOI 10.1016/S0141-1136(02)00192-7; Tian SM, 2013, AQUAT TOXICOL, V144, P162, DOI 10.1016/j.aquatox.2013.09.031; Venier P, 2006, MUTAT RES-FUND MOL M, V602, P121, DOI 10.1016/j.mrfmmm.2006.08.007; Walker C, 2006, AM J PATHOL, V168, P1526, DOI 10.2353/ajpath.2006.050603; Wessel N, 2007, AQUAT TOXICOL, V85, P133, DOI 10.1016/j.aquatox.2007.08.007; Widdows J, 2002, MAR ENVIRON RES, V53, P327, DOI 10.1016/S0141-1136(01)00120-9; Yakovleva L, 2006, BIOCHEMISTRY-US, V45, P7644, DOI 10.1021/bi060158h	69	41	41	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0178460	10.1371/journal.pone.0178460	http://dx.doi.org/10.1371/journal.pone.0178460			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651000	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000404537300046
J	Alexander, PM; Caudell, DL; Kucera, GL; Pladna, KM; Pardee, TS				Alexander, Peter M.; Caudell, David L.; Kucera, Gregory L.; Pladna, Kristin M.; Pardee, Timothy S.			The novel phospholipid mimetic KPC34 is highly active against preclinical models of Philadelphia chromosome positive acute lymphoblastic leukemia	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; PROTEIN-KINASE-C; ACUTE MYELOID-LEUKEMIA; BCR-ABL; ADULT; CHEMOTHERAPY; IMATINIB; CELLS; RESISTANCE; DASATINIB	Philadelphia chromosome positive B cell acute lymphoblastic leukemia (Ph+ ALL) is an aggressive cancer of the bone marrow. The addition of tyrosine kinase inhibitors (TKIs) has improved outcomes but many patients still suffer relapse and novel therapeutic agents are needed. KPC34 is an orally available, novel phospholipid conjugate of gemcitabine, rationally designed to overcome multiple mechanisms of resistance, inhibit the classical and novel isoforms of protein kinase C, is able to cross the blood brain barrier and is orally bio-available. KPC34 had an IC50 in the nanomolar range against multiple ALL cell lines tested but was lowest for Ph+ lines. In mice bearing either naive or resistant Ph+ ALL, KPC34 treatment resulted in significantly improved survival compared to cytarabine and gemcitabine. Treatment with KPC34 and doxorubicin was more effective than doxorubicin and cytarabine. Mice with recurrence of their ALL after initial treatment with cytarabine and doxorubicin saw dramatic improvements in hind limb paralysis after treatment with KPC34 demonstrating activity against established CNS disease. Consistent with this KPC34 was better than gemcitabine at reducing CNS leukemic burden. These promising pre-clinical results justify the continued development of KPC34 for the treatment of Ph+ALL.	[Alexander, Peter M.; Kucera, Gregory L.; Pladna, Kristin M.; Pardee, Timothy S.] Wake Forest Baptist Hlth, Sect Hematol & Oncol, Internal Med, Winston Salem, NC 27157 USA; [Caudell, David L.] Wake Forest Baptist Hlth, Pathol Comparat Med, Winston Salem, NC USA; [Kucera, Gregory L.; Pardee, Timothy S.] Wake Forest Univ, Ctr Comprehens Canc, Canc Biol, Winston Salem, NC 27109 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University	Pardee, TS (corresponding author), Wake Forest Baptist Hlth, Sect Hematol & Oncol, Internal Med, Winston Salem, NC 27157 USA.; Pardee, TS (corresponding author), Wake Forest Univ, Ctr Comprehens Canc, Canc Biol, Winston Salem, NC 27109 USA.	tspardee@wakehealth.edu		Pardee, Timothy/0000-0002-1186-6948	Doug Coley Foundation for Leukemia Research, Wake Forest Innovations (SPARK award, TSP); National Cancer Institute [T32CA079448-09, 1K08CA169809-01, P30CA012197]; NCI Cancer Center [P30CA012197]; NATIONAL CANCER INSTITUTE [K08CA169809, P30CA012197, T32CA079448] Funding Source: NIH RePORTER	Doug Coley Foundation for Leukemia Research, Wake Forest Innovations (SPARK award, TSP); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Doug Coley Foundation for Leukemia Research, Wake Forest Innovations (SPARK award, TSP), and the National Cancer Institute (T32CA079448-09, PMA, 1K08CA169809-01, TSP, P30CA012197, GLK).The Cell virus and vector laboratory and flow to me try core are supported by NCI Cancer Center Support Grant (CCSG) P30CA012197.	Annino L, 2002, BLOOD, V99, P863, DOI 10.1182/blood.V99.3.863; Boulos N, 2011, BLOOD, V117, P3585, DOI 10.1182/blood-2010-08-301267; Brankatschk M, 2010, J NEUROSCI, V30, P10441, DOI 10.1523/JNEUROSCI.5943-09.2010; Cortes JE, 2012, NEW ENGL J MED, V367, P2075, DOI 10.1056/NEJMoa1205127; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Fielding AK, 2007, BLOOD, V109, P944, DOI 10.1182/blood-2006-05-018192; Fielding Adele K, 2015, Am Soc Clin Oncol Educ Book, pe352, DOI 10.14694/EdBook_AM.2015.35.e352; Fielding AK, 2014, BLOOD, V123, P843, DOI 10.1182/blood-2013-09-529008; Foa R, 2011, BLOOD, V118, P6521, DOI 10.1182/blood-2011-05-351403; Galmarini CM, 2003, BRIT J HAEMATOL, V122, P53, DOI 10.1046/j.1365-2141.2003.04386.x; Galmarini CM, 2002, BRIT J HAEMATOL, V117, P860, DOI 10.1046/j.1365-2141.2002.03538.x; Garg R, 2014, ONCOGENE, V33, P5225, DOI 10.1038/onc.2013.524; Goncalves RP, 2005, LEUKEMIA RES, V29, P955, DOI 10.1016/j.leukres.2005.01.013; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Jabbour E, 2010, CANCER-AM CANCER SOC, V116, P2290, DOI 10.1002/cncr.25008; Jiffar T, 2004, LEUKEMIA, V18, P505, DOI 10.1038/sj.leu.2403275; Kim DY, 2015, BLOOD, V126, P746, DOI 10.1182/blood-2015-03-636548; Kuang P, 2016, LEUKEMIA LYMPHOMA, V57, P2321, DOI 10.3109/10428194.2016.1144882; Li BS, 2015, NAT MED, V21, P563, DOI 10.1038/nm.3840; Lilly MB, 2010, AM J HEMATOL, V85, P164, DOI 10.1002/ajh.21615; Linker C, 2002, J CLIN ONCOL, V20, P2464, DOI 10.1200/JCO.2002.07.116; Markova B, 2010, ONCOGENE, V29, P739, DOI 10.1038/onc.2009.374; Marks DI, 2010, HEMATOL-AM SOC HEMAT, P13, DOI 10.1182/asheducation-2010.1.13; Moschovi M, 2004, J PEDIAT HEMATOL ONC, V26, P289, DOI 10.1097/00043426-200405000-00006; Mullighan CG, 2013, BLOOD, V122, P3899, DOI 10.1182/blood-2013-08-460311; Nowak G, 2003, J PHARMACOL EXP THER, V306, P157, DOI 10.1124/jpet.103.050336; Ottmann OG, 2013, LEUKEMIA, V27, P1411, DOI 10.1038/leu.2012.324; Ottmann Oliver G, 2009, Hematology Am Soc Hematol Educ Program, P371, DOI 10.1182/asheducation-2009.1.371; Pickin KA, 2009, J DRUG DELIV SCI TEC, V19, P31, DOI 10.1016/S1773-2247(09)50004-4; Porkka K, 2008, BLOOD, V112, P1005, DOI 10.1182/blood-2008-02-140665; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Reman O, 2008, LEUKEMIA RES, V32, P1741, DOI 10.1016/j.leukres.2008.04.011; Rickert RC, 2013, NAT REV IMMUNOL, V13, P578, DOI 10.1038/nri3487; Roy M, 2015, CHEM-BIOL INTERACT, V242, P195, DOI 10.1016/j.cbi.2015.10.004; Ruvolo PP, 2011, J CELL BIOCHEM, V112, P1696, DOI 10.1002/jcb.23090; Todd RF, 2015, TUMOR BOARD REV GUID; Tzoneva G, 2013, NAT MED, V19, P368, DOI 10.1038/nm.3078; Zensi A, 2010, J DRUG TARGET, V18, P842, DOI 10.3109/1061186X.2010.513712; Zuber J, 2009, GENE DEV, V23, P877, DOI 10.1101/gad.1771409	39	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179798	10.1371/journal.pone.0179798	http://dx.doi.org/10.1371/journal.pone.0179798			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644853	Green Published, gold, Green Submitted			2022-12-27	WOS:000404145100038
J	Kang, YM; Jung, CH; Cho, YK; Jang, JE; Hwang, JY; Kim, EH; Lee, WJ; Park, JY; Kim, HK				Kang, Yu Mi; Jung, Chang Hee; Cho, Yun Kyung; Jang, Jung Eun; Hwang, Jenie Yoonoo; Kim, Eun Hee; Lee, Woo Je; Park, Joong-Yeol; Kim, Hong-Kyu			Visceral adiposity index predicts the conversion of metabolically healthy obesity to an unhealthy phenotype	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; CARDIOMETABOLIC RISK; INSULIN-RESISTANCE; FAT DISTRIBUTION; INFLAMMATION; MORTALITY; ASSOCIATION; OVERWEIGHT	Objective Some individuals with metabolically healthy obesity (MHO) convert to metabolically unhealthy obesity (MUO) phenotype, and visceral adiposity is one of proposed mechanisms underlying such conversion. Visceral adipose index (VAI) is a novel mathematical model which estimates visceral adiposity based on anthropometric and lipid profiles. We aimed to determine the association of VAI-estimated visceral adiposity with the MHO-to-MUO conversion and the predictive value of VAI in estimating such unfavorable outcomes. Methods A total of 2,204 Korean subjects with the MHO phenotype were enrolled and stratified by body mass index and metabolic health state according to Wildman criteria at baseline and last follow-up examinations. VAI was calculated at baseline. Results Over a median follow-up period of 41.1 months, 46.0% of subjects converted to MUO phenotype. Higher VAI quartiles were associated with a greater proportion of subjects who underwent MHO-to-MUO conversion, and also with increased odds ratios for such conversion even after multivariate analyses. The optimal VAI cut off value was around 1.00, and VAI had a greater power in the prediction of MHO-to MUO conversion than waist circumference in both genders. Conclusion MHO phenotypes with high VAI values are associated with poor future metabolic outcomes. VAI-estimated visceral adiposity is well correlated with the prognosis of MHO subjects, and VAI has a good predictive value in determining the MHO-to-MUO conversion.	[Kang, Yu Mi; Jung, Chang Hee; Cho, Yun Kyung; Jang, Jung Eun; Lee, Woo Je; Park, Joong-Yeol] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea; [Hwang, Jenie Yoonoo; Kim, Eun Hee; Kim, Hong-Kyu] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hlth Screening & Promot Ctr, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Jung, CH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea.; Kim, HK (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hlth Screening & Promot Ctr, Seoul, South Korea.	chjung0204@gmail.com; hkkim0801@amc.seoul.kr	Kang, Yu Mi/AAW-2935-2020; Jung, Chang Hee/AAU-7897-2020	Jung, Chang Hee/0000-0003-4043-2396				Al-Daghri NM, 2014, PEDIATR RES, V75, P459, DOI 10.1038/pr.2013.229; Amato MC, 2010, DIABETES CARE, V33, P920, DOI 10.2337/dc09-1825; Amato MC, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/730827; Appleton SL, 2013, DIABETES CARE, V36, P2388, DOI 10.2337/dc12-1971; Arnlov J, 2010, CIRCULATION, V121, P230, DOI 10.1161/CIRCULATIONAHA.109.887521; Bell JA, 2014, OBES REV, V15, P504, DOI 10.1111/obr.12157; Bluher M, 2010, CURR OPIN LIPIDOL, V21, P38, DOI 10.1097/MOL.0b013e3283346ccc; Demerath EW, 2008, AM J CLIN NUTR, V88, P1263, DOI 10.3945/ajcn.2008.26546; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Hinnouho GM, 2015, EUR HEART J, V36, P551, DOI 10.1093/eurheartj/ehu123; Hinnouho GM, 2013, DIABETES CARE, V36, P2294, DOI 10.2337/dc12-1654; Hwang YC, 2015, INT J OBESITY, V39, P1365, DOI 10.1038/ijo.2015.75; Jung CH, 2014, OBESITY, V22, P2613, DOI 10.1002/oby.20883; Kim TN, 2013, J CLIN ENDOCR METAB, V98, P811, DOI 10.1210/jc.2012-3292; Koster A, 2010, OBESITY, V18, P2354, DOI 10.1038/oby.2010.86; Kuk JL, 2009, DIABETES CARE, V32, P2297, DOI 10.2337/dc09-0574; Mangge H, 2013, OBESITY, V21, pE71, DOI 10.1002/oby.20061; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594; Oh JY, 2013, OBESITY, V21, P1690, DOI 10.1002/oby.20096; Oh SW, 2011, DIABETES METAB J, V35, P561, DOI 10.4093/dmj.2011.35.6.561; Park YW, 2002, INT J OBESITY, V26, P978, DOI 10.1038/sj.ijo.0801982; Peppa M, 2013, EUR J INTERN MED, V24, P824, DOI 10.1016/j.ejim.2013.07.001; Peppa M, 2013, OBESITY, V21, P1807, DOI 10.1002/oby.20227; Phillips CM, 2013, J CLIN ENDOCR METAB, V98, pE1610, DOI 10.1210/jc.2013-2038; Rutter MK, 2004, CIRCULATION, V110, P380, DOI 10.1161/01.CIR.0000136581.59584.0E; Samocha-Bonet D, 2014, OBES REV, V15, P697, DOI 10.1111/obr.12199; Seo MH, 2014, ENDOCRINOL METAB, V29, P427, DOI 10.3803/EnM.2014.29.4.427; Snijder MB, 2005, DIABETOLOGIA, V48, P301, DOI 10.1007/s00125-004-1637-7; van der A DL, 2014, OBESITY, V22, P557, DOI 10.1002/oby.20480; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; WANG QL, 1994, AM J CLIN NUTR, V60, P843, DOI 10.1093/ajcn/60.6.843; Wannamethee SG, 2005, J EPIDEMIOL COMMUN H, V59, P134, DOI 10.1136/jech.2003.015651; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Yeh ETH, 2003, CIRCULATION, V107, P370, DOI 10.1161/01.CIR.0000053731.05365.5A	36	32	34	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179635	10.1371/journal.pone.0179635	http://dx.doi.org/10.1371/journal.pone.0179635			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644850	gold, Green Published, Green Submitted			2022-12-27	WOS:000404145100026
J	Latorre, P; Varona, L; Burgos, C; Carrodeguas, JA; Lopez-Buesa, P				Latorre, Pedro; Varona, Luis; Burgos, Carmen; Carrodeguas, Jose A.; Lopez-Buesa, Pascual			O-GlcNAcylation mediates the control of cytosolic phosphoenolpyruvate carboxykinase activity via Pgc1 alpha	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; ASSOCIATION ANALYSIS; FAT DEPOSITION; MUSCLE; GENE; EXPRESSION; EPISTASIS; QUALITY; TRAITS; MODEL	PGC1 alpha is a coactivator of many transcription factors and cytosolic phosphoenolpyruvate carboxykinase (PCK1) is a key enzyme for gluconeogenesis. PGC1a interacts with the transcription factor PPAR. to stimulate PCK1 expression and thus de novo glucose synthesis. These proteins are not only important for central energy metabolism but also for supplying intermediates for other metabolic pathways, including lipidogenesis and protein synthesis and might therefore be important factors in the ethiopathogenesis of metabolic disorders like diabetes but also in other pathologies like cancer. Since polymorphisms in these proteins have been related to some phenotypic traits in animals like pigs and PGC1a G482S polymorphism increases fat deposition in humans, we have investigated the molecular basis of such effects focusing on a commonly studied polymorphism in pig Pgc1 alpha, which changes a cysteine at position 430 (WT) of the protein to a serine (C430S). Biochemical analyses show that Pgc1a WT stimulates higher expression of human PCK1 in HEK293T and HepG2 cells. Paradoxically, Pgc1a WT is less stable than Pgc1 alpha p. C430S in HEK293T cells. However, the study of different post- translational modifications shows a higher OGlcNAcylation level of Pgc1 alpha p. C430S. This higher O-GlcNAcylation level significantly decreases the interaction between Pgc1 alpha and PPAR. demonstrating the importance of post-translational glycosylation of PGC1 alpha in the regulation of PCK1 activity. This, furthermore, could explain at least in part the observed epistatic effects between PGC1a and PCK1 in pigs.	[Latorre, Pedro; Burgos, Carmen; Lopez-Buesa, Pascual] Univ Zaragoza, Fac Vet, Dept Prod Anim & Ciencia Alimentos, Zaragoza, Spain; [Latorre, Pedro; Burgos, Carmen; Carrodeguas, Jose A.; Lopez-Buesa, Pascual] Univ Zaragoza, BIFIIQFR CSIC Joint Unit, Inst Biocomputac & Fis Sistemas Complejos BIFI, Zaragoza, Spain; [Varona, Luis] Univ Zaragoza, Dept Anat Embriol & Genet, Zaragoza, Spain; [Varona, Luis] IA2, Zaragoza, Spain; [Carrodeguas, Jose A.] Univ Zaragoza, Fac Ciencias, Dept Bioquim & Biol Mol & Celular, Zaragoza, Spain; [Carrodeguas, Jose A.] IIS Aragon, Zaragoza, Spain	University of Zaragoza; University of Zaragoza; University of Zaragoza; University of Zaragoza	Lopez-Buesa, P (corresponding author), Univ Zaragoza, Fac Vet, Dept Prod Anim & Ciencia Alimentos, Zaragoza, Spain.; Carrodeguas, JA; Lopez-Buesa, P (corresponding author), Univ Zaragoza, BIFIIQFR CSIC Joint Unit, Inst Biocomputac & Fis Sistemas Complejos BIFI, Zaragoza, Spain.; Carrodeguas, JA (corresponding author), Univ Zaragoza, Fac Ciencias, Dept Bioquim & Biol Mol & Celular, Zaragoza, Spain.; Carrodeguas, JA (corresponding author), IIS Aragon, Zaragoza, Spain.	carrode@unizar.es; plopezbu@unizar.es	Varona, Luis/C-2744-2012; Román, Pedro Ángel Latorre/K-1052-2019	Varona, Luis/0000-0001-6256-5478; Latorre Muro, Pedro/0000-0002-6794-3535	Ministerio de Economia, Industria y Competitividad [AGL2015-66177]; University of Zaragoza [UZ 2014-CIE-03, UZ-2015-BIO-01]; la Caixa' Foundation	Ministerio de Economia, Industria y Competitividad; University of Zaragoza; la Caixa' Foundation(La Caixa Foundation)	This work has been funded by grants AGL2015-66177 to P.L.B. and J.A.C. from Ministerio de Economia, Industria y Competitividad (http://www.mineco.gob.es/portal/site/mineco/), UZ 2014-CIE-03 to P.L.B. and UZ-2015-BIO-01 to J.A.C. from University of Zaragoza (http://www.unizar.es). Funders' role has been limited to financial support. P.L. is supported by a predoctoral fellowship from la Caixa Foundation (https://www.fundacionbancarialacaixa.org/corporate/home_es.html).	Alvarez-Castro JM, 2007, GENETICS, V176, P1151, DOI 10.1534/genetics.106.067348; Bin Ruan H, 2012, CELL METAB, V16, P226; Chen YM, 2013, NUTR RES, V33, P332, DOI 10.1016/j.nutres.2013.02.003; Dekkers JCM, 2012, CURR GENOMICS, V13, P207, DOI 10.2174/138920212800543057; Erkens T, 2010, CZECH J ANIM SCI, V55, P200, DOI 10.17221/263/2009-CJAS; Erkens T, 2009, CZECH J ANIM SCI, V54, P408, DOI 10.17221/12/2009-CJAS; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Gandolfi G, 2011, MEAT SCI, V89, P478, DOI 10.1016/j.meatsci.2011.05.015; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; Glorian M, 2001, BIOCHIMIE, V83, P933, DOI 10.1016/S0300-9084(01)01343-8; Higashida K, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001603; Housley MP, 2009, J BIOL CHEM, V284, P5148, DOI 10.1074/jbc.M808890200; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kunej T, 2005, J ANIM BREED GENET, V122, P7, DOI 10.1111/j.1439-0388.2004.00498.x; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Latorre P, 2016, SCI REP-UK, V6, DOI 10.1038/srep19617; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu R, 2011, J ANIM VET ADV, V10, P2301, DOI 10.3923/javaa.2011.2301.2304; Mackay TFC, 2014, NAT REV GENET, V15, P22, DOI 10.1038/nrg3627; Plomin R, 2009, GENETICS; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Takikita S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015239; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; Trausch-Azar J, 2010, J BIOL CHEM, V285, P40192, DOI 10.1074/jbc.M110.131615; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wood JD, 2004, MEAT SCI, V67, P651, DOI 10.1016/j.meatsci.2004.01.007; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556	32	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179988	10.1371/journal.pone.0179988	http://dx.doi.org/10.1371/journal.pone.0179988			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644880	Green Submitted, gold, Green Published			2022-12-27	WOS:000404145100056
J	Park, J; Kim, IH; Fong, JJ; Koo, KS; Choi, WJ; Tsai, TS; Park, D				Park, Jaejin; Kim, Il-Hun; Fong, Jonathan J.; Koo, Kyo-Soung; Choi, Woo-Jin; Tsai, Tein-Shun; Park, Daesik			Northward dispersal of sea kraits (Laticauda semifasciata) beyond their typical range	PLOS ONE			English	Article							CLIMATE-CHANGE; ELAPIDAE LATICAUDINAE; SNAKE; SERPENTES; SHIFTS; PHYLOGEOGRAPHY; ABUNDANCE; FISHES	Marine reptiles are declining globally, and recent climate change may be a contributing factor. The study of sea snakes collected beyond their typical distribution range provides valuable insight on how climate change affects marine reptile populations. Recently, we collected 12 Laticauda semifasciata (11 females, 1 male) from the waters around southern South Korea-an area located outside its typical distribution range (Japan, China including Taiwan, Philippines and Indonesia). We investigated the genetic origin of Korean specimens by analyzing mitochondrial cytochrome b gene (Cytb) sequences. Six individuals shared haplotypes with a group found in Taiwan-southern Ryukyu Islands, while the remaining six individuals shared haplotypes with a group encompassing the entire Ryukyu Archipelago. These results suggest L. semifasciata moved into Korean waters from the Taiwan-Ryukyu region via the Taiwan Warm Current and/or the Kuroshio Current, with extended survival facilitated by ocean warming. We highlight several contributing factors that increase the chances that L. semifasciata establishes new northern populations beyond the original distribution range.	[Park, Jaejin; Kim, Il-Hun; Koo, Kyo-Soung; Choi, Woo-Jin] Kangwon Natl Univ, Dept Biol, Chunchon, Kangwon, South Korea; [Fong, Jonathan J.] Lingnan Univ, Sci Unit, Tuen Mun, Hong Kong, Peoples R China; [Tsai, Tein-Shun] Natl Pingtung Univ Sci & Technol, Dept Biol Sci & Technol, Neipu Township, Pingtung County, Taiwan; [Park, Daesik] Kangwon Natl Univ, Div Sci Educ, Chunchon, Kangwon, South Korea; [Kim, Il-Hun] Natl Marine Biodivers Inst Korea, Chungnam, South Korea	Kangwon National University; Lingnan University; National Pingtung University Science & Technology; Kangwon National University; Marine Biodiversity Institute of Korea (MABIK)	Park, D (corresponding author), Kangwon Natl Univ, Div Sci Educ, Chunchon, Kangwon, South Korea.	parkda@kangwon.ac.kr	Tsai, Tein-Shun/P-8928-2019	FONG, Jonathan/0000-0002-3648-6730; Park, Jaejin/0000-0001-8794-5776; Park, Daesik/0000-0001-9209-0493; Tsai, Tein-Shun/0000-0002-7245-1826	National Research Foundation of Korea-Ministry of Education [2014R1A1A4A01005302]	National Research Foundation of Korea-Ministry of Education(Ministry of Education (MOE), Republic of KoreaNational Research Foundation of Korea)	Research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2014R1A1A4A01005302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKLEY RA, 1970, SCI J, V6, P54; Brischoux F, 2007, P 11 ANN M HLTH SCI; Brischoux F, 2007, MAR ECOL PROG SER, V350, P145, DOI 10.3354/meps07133; Brischoux F, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0436; Brischoux F, 2013, J SEA RES, V76, P1, DOI 10.1016/j.seares.2012.10.010; Burbrink FT, 2000, EVOLUTION, V54, P2107, DOI 10.1554/0014-3820(2000)054[2107:MDPOTP]2.0.CO;2; 장승민, 2006, 한국해양환경•에너지학회지, V9, P55; Chapman JW, 2011, CURR BIOL, V21, pR861, DOI 10.1016/j.cub.2011.08.014; Choi Youn, 2013, Hangug Hwangyeong Saengmul Haghoeji, V31, P45; Dunson WA, 1975, BIOL SEA SNAKES; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Goiran C, 2013, CORAL REEFS, V32, P281, DOI 10.1007/s00338-012-0977-x; Gordon Larry, 2015, LOS ANGELES TIMES; Great Barrier Reef Marine Park Authority, 2012, VULNERABILITY ASSESS; Hamann M, 2007, VULNERABILITY MARINE; Hawkes LA, 2007, GLOBAL CHANGE BIOL, V13, P923, DOI 10.1111/j.1365-2486.2007.01320.x; Heatwole H, 2005, HERPETOL MONOGR, V19, P1, DOI 10.1655/0733-1347(2005)019[0001:GVISKO]2.0.CO;2; Heatwole H, 1999, SEA SNAKES; Heatwole H, 2016, J SEA RES, V115, P18, DOI 10.1016/j.seares.2016.05.003; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ineich I, 2007, MAR BIOL, V151, P793, DOI 10.1007/s00227-006-0527-6; Jung S, 2014, REV FISH BIOL FISHER, V24, P443, DOI 10.1007/s11160-013-9310-1; Kang Y. S., 1975, ILLUSTRATED ENCY FAU, V17; Kharin VE, 2009, RUSS J MAR BIOL +, V35, P8, DOI 10.1134/S1063074009010027; Kim Il-Hun, 2016, Journal of Ecology and Environment, V40, P1, DOI 10.1186/s41610-016-0002-3; Kim LT, 2009, FAUNA CHOSUN AMPHIBI; Ko JC, 2015, JFMSE, V27, P319, DOI DOI 10.13000/JFMSE.2015.27.2.319; Kobayashi DR, 2011, ICES J MAR SCI; Last PR, 2011, GLOBAL ECOL BIOGEOGR, V20, P58, DOI 10.1111/j.1466-8238.2010.00575.x; Lee HJ, 2013, KOREAN J HERPETOLOGY, V5, P45; Lee JN, 2003, B BASIC SCI RES CTR, V15, P153; Liu YL, 2010, MAR BIOL, V157, P2369, DOI 10.1007/s00227-010-1501-x; Lukoschek V, 2013, BIOL CONSERV, V166, P191, DOI 10.1016/j.biocon.2013.07.004; Mao S. H., 1980, SEA SNAKES TAIWAN NA; Cao NV, 2014, CONSERV BIOL, V28, P1677, DOI 10.1111/cobi.12387; Park J, 2016, KOREAN J HERPETOL, V7, P6; Park Jaejin, 2016, Animal Systematics Evolution and Diversity, V32, P148, DOI 10.5635/ASED.2016.32.2.148; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Rasmussen AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027373; Reading CJ, 2010, BIOL LETTERS, V6, P777, DOI 10.1098/rsbl.2010.0373; SHANNON FREDERICK A., 1956, HERPETOLOGICA, V12, P22; Sheehy CM, 2012, INTEGR COMP BIOL, V52, P321, DOI 10.1093/icb/ics088; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stejneger LH, 1907, HERPETOLOGY JAPAN AD; Su Y, 2005, ZOOL STUD, V44, P403; Tandavanitj Nontivich, 2013, Current Herpetology, V32, P135, DOI 10.5358/hsj.32.135; Tandavanitj N, 2013, ZOOL SCI, V30, P633, DOI 10.2108/zsj.30.633; Toriba M., 1994, P206; TU MC, 1990, J HERPETOL, V24, P119, DOI 10.2307/1564218; Wallace BP, 2016, MARINE REPTILES; Wang SA, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-43; Zhao E, 1993, HERPETOLOGY CHINA, V10	52	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179871	10.1371/journal.pone.0179871	http://dx.doi.org/10.1371/journal.pone.0179871			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644894	Green Published, Green Submitted, gold			2022-12-27	WOS:000404145100045
J	Bethge, P; Carta, S; Lorenzo, DA; Egolf, L; Goniotaki, D; Madisen, L; Voigt, FF; Chen, JL; Schneider, B; Ohkura, M; Nakai, J; Zeng, HK; Aguzzi, A; Helmchen, F				Bethge, Philipp; Carta, Stefano; Lorenzo, Dayra A.; Egolf, Ladan; Goniotaki, Despoina; Madisen, Linda; Voigt, Fabian F.; Chen, Jerry L.; Schneider, Bernard; Ohkura, Masamichi; Nakai, Junichi; Zeng, Hongkui; Aguzzi, Adriano; Helmchen, Fritjof			An R-CaMP1.07 reporter mouse for cell-typespecific expression of a sensitive red fluorescent calcium indicator	PLOS ONE			English	Article							IMAGING NEURAL ACTIVITY; TRANSGENIC MICE; PROJECTION NEURONS; CA2+ INDICATORS; GENE-EXPRESSION; CRE-RECOMBINASE; DRIVER LINES; PROTEINS; CORTEX; REORGANIZATION	Genetically encoded calcium indicators (GECIs) enable imaging of in vivo brain cell activity with high sensitivity and specificity. In contrast to viral infection or in utero electroporation, indicator expression in transgenic reporter lines is induced noninvasively, reliably, and homogenously. Recently, Cre/tTA-dependent reporter mice were introduced, which provide high-level expression of green fluorescent GECIs in a cell-type-specific and inducible manner when crossed with Cre and tTA driver mice. Here, we generated and characterized the first red-shifted GECI reporter line of this type using R-CaMP1.07, a red fluorescent indicator that is efficiently two-photon excited above 1000 nm. By crossing the new R-CaMP1.07 reporter line to Cre lines driving layer-specific expression in neocortex we demonstrate its high fidelity for reporting action potential firing in vivo, long-term stability over months, and versatile use for functional imaging of excitatory neurons across all cortical layers, especially in the previously difficult to access layers 4 and 6.	[Bethge, Philipp; Carta, Stefano; Lorenzo, Dayra A.; Egolf, Ladan; Voigt, Fabian F.; Chen, Jerry L.; Helmchen, Fritjof] Univ Zurich, Brain Res Inst, Zurich, Switzerland; [Carta, Stefano; Lorenzo, Dayra A.; Goniotaki, Despoina; Voigt, Fabian F.; Aguzzi, Adriano; Helmchen, Fritjof] Univ Zurich, Neurosci Ctr Zurich ZNZ, Zurich, Switzerland; [Carta, Stefano; Lorenzo, Dayra A.; Goniotaki, Despoina; Voigt, Fabian F.; Aguzzi, Adriano; Helmchen, Fritjof] ETH, Zurich, Switzerland; [Goniotaki, Despoina; Aguzzi, Adriano] Univ Hosp Zurich, Inst Neuropathol, Zurich, Switzerland; [Madisen, Linda; Zeng, Hongkui] Allen Inst Brain Sci, Seattle, WA USA; [Schneider, Bernard] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lausanne, Switzerland; [Ohkura, Masamichi; Nakai, Junichi] Saitama Univ, Brain Sci Inst, Saitama, Japan; [Chen, Jerry L.] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital; Allen Institute for Brain Science; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Saitama University; Boston University	Helmchen, F (corresponding author), Univ Zurich, Brain Res Inst, Zurich, Switzerland.; Helmchen, F (corresponding author), Univ Zurich, Neurosci Ctr Zurich ZNZ, Zurich, Switzerland.; Helmchen, F (corresponding author), ETH, Zurich, Switzerland.	helmchen@hifo.uzh.ch	Ohkura, Masamichi/J-6976-2012; Nakai, Junichi/GQZ-6415-2022; Goniotaki, Despoina/AAP-5931-2021; Schneider, Bernard/H-6168-2011; Helmchen, Fritjof/A-6255-2008	Aguzzi, Adriano/0000-0002-0344-6708; Ohkura, Masamichi/0000-0002-3659-7780; Schneider, Bernard/0000-0001-5485-8748; Voigt, Fabian/0000-0002-7108-2176; Chen, Jerry/0000-0002-7409-7859; Helmchen, Fritjof/0000-0002-8867-9569; Goniotaki, Despoina/0000-0003-2120-8858	Swiss National Science Foundation [31003A-149858]; Sinergia [CRSII3_147660]; U.S. BRAIN Initiative (NIH) [1U01NS090475-01]; Human Frontier Science Program (HFSP); CandDoc Forschungskredit of the University of Zurich; Regional Innovation Cluster Program; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science (JSPS); Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from MEXT; Japan Agency for Medical Research and Development (AMED); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS090475] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26282217] Funding Source: KAKEN	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Sinergia; U.S. BRAIN Initiative (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program (HFSP)(Human Frontier Science Program); CandDoc Forschungskredit of the University of Zurich; Regional Innovation Cluster Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from MEXT; Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Swiss National Science Foundation (31003A-149858; F.H.; and Sinergia grant CRSII3_147660; A.A., F.H., and B.S.; www.snf.ch), the U.S. BRAIN Initiative (NIH grant 1U01NS090475-01; F.H.; VAPAV.braininitiative.nih.gov), an Human Frontier Science Program (HFSP; www.hfsp.org) postdoctoral fellowship (P.B.), and a CandDoc Forschungskredit of the University of Zurich (D.A. L.; wvivi.uzh.ch). This work was also partially supported by the Regional Innovation Cluster Program (City Area Type, Central Saitama Area) (J. N.), Grants-in-Aid KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology (MEXT; www.mext.go.dp) and the Japan Society for the Promotion of Science (JSPS; www.isps.go.ip) (M.O., J.N.) and the program for Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from MEXT and the Japan Agency for Medical Research and Development (AMED; www.amed.go.jp) (J.N.). H. Z. and L.M. thank the founders of the Allen Institute (www.alleninstitute.org), Paul G. Allen and Jody Allen, for their vision, encouragement, and support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackman JB, 2012, NATURE, V490, P219, DOI 10.1038/nature11529; Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; Atkin SD, 2009, J NEUROSCI METH, V181, P212, DOI 10.1016/j.jneumeth.2009.05.006; Briggs F, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/neuro.04.003.2010; Brunk UT, 2002, FREE RADICAL BIO MED, V33, P611, DOI 10.1016/S0891-5849(02)00959-0; Carandini M, 2015, J NEUROSCI, V35, P53, DOI 10.1523/JNEUROSCI.0594-14.2015; Chen JL, 2016, ELIFE, V5, DOI 10.7554/eLife.14679; Chen JL, 2015, NAT NEUROSCI, V18, P1101, DOI 10.1038/nn.4046; Chen JL, 2013, NATURE, V499, P336, DOI 10.1038/nature12236; Chen Q, 2012, NEURON, V76, P297, DOI 10.1016/j.neuron.2012.07.011; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Collot M, 2015, ELIFE, V4, DOI 10.7554/eLife.05808; Dana H, 2016, ELIFE, V5, DOI 10.7554/eLife.12727; Dana H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108697; Direnberger S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2035; Eichhoff G, 2008, EUR J NUCL MED MOL I, V35, pS99, DOI 10.1007/s00259-007-0709-6; Empson RM, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12468; Garner AR, 2012, SCIENCE, V335, P1513, DOI 10.1126/science.1214985; Gerfen CR, 2013, NEURON, V80, P1368, DOI 10.1016/j.neuron.2013.10.016; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Gschwend O, 2015, NAT NEUROSCI, V18, P1474, DOI 10.1038/nn.4089; Harris JA, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00076; Hasan MT, 2004, PLOS BIOL, V2, P763, DOI 10.1371/journal.pbio.0020163; Heim N, 2007, NAT METHODS, V4, P127, DOI 10.1038/nmeth1009; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Horikawa K, 2010, NAT METHODS, V7, P729, DOI 10.1038/nmeth.1488; Horton NG, 2013, NAT PHOTONICS, V7, P205, DOI [10.1038/nphoton.2012.336, 10.1038/NPHOTON.2012.336]; Huang ZJ, 2013, ANNU REV NEUROSCI, V36, P183, DOI 10.1146/annurev-neuro-062012-170307; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Inoue M, 2015, NAT METHODS, V12, P893, DOI 10.1038/nmeth0915-893b; Issa JB, 2014, NEURON, V83, P944, DOI 10.1016/j.neuron.2014.07.009; Kim TH, 2016, CELL REP, V17, P3385, DOI 10.1016/j.celrep.2016.12.004; Lecoq J, 2014, NAT NEUROSCI, V17, P1825, DOI 10.1038/nn.3867; Lin MZ, 2016, NAT NEUROSCI, V19, P1142, DOI 10.1038/nn.4359; Lutcke H, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00009; Ma Y, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0360; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mank M, 2008, CHEM REV, V108, P1550, DOI 10.1021/cr078213v; Margolis DJ, 2012, NAT NEUROSCI, V15, P1539, DOI 10.1038/nn.3240; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Murakami T, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00020; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Ohkura M, 2012, PLOS ONE, V7, pe3993; Pilz GA, 2016, J NEUROSCI, V36, P7407, DOI 10.1523/JNEUROSCI.3065-15.2016; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Safaiyan S, 2016, NAT NEUROSCI, V19, P995, DOI 10.1038/nn.4325; Sato M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125354; Shen Y, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.3.031203; Sofroniew NJ, 2016, ELIFE, V5, DOI 10.7554/eLife.14472; Stirman JN, 2016, NAT BIOTECHNOL, V34, P857, DOI 10.1038/nbt.3594; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Thestrup T, 2014, NAT METHODS, V11, P175, DOI [10.1038/NMETH.2773, 10.1038/nmeth.2773]; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tischbirek C, 2015, P NATL ACAD SCI USA, V112, P11377, DOI 10.1073/pnas.1514209112; Vanni MP, 2014, J NEUROSCI, V34, P15931, DOI 10.1523/JNEUROSCI.1818-14.2014; Walker AS, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00034; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; Wu J., 2014, NAT COMMUN, V5; Wu JH, 2013, ACS CHEM NEUROSCI, V4, P963, DOI 10.1021/cn400012b; Xie YC, 2016, J NEUROSCI, V36, P1261, DOI 10.1523/JNEUROSCI.2744-15.2016; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	69	24	24	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179460	10.1371/journal.pone.0179460	http://dx.doi.org/10.1371/journal.pone.0179460			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640817	Green Published, gold, Green Submitted			2022-12-27	WOS:000404135800033
J	Constant, D; Harries, J; Daskilewicz, K; Myer, L; Gemzell-Danielsson, K				Constant, Deborah; Harries, Jane; Daskilewicz, Kristen; Myer, Landon; Gemzell-Danielsson, Kristina			Is self-assessment of medical abortion using a low-sensitivity pregnancy test combined with a checklist and phone text messages feasible in South African primary healthcare settings? A randomized trial	PLOS ONE			English	Article							FOLLOW-UP; MOBILE PHONES; FEASIBILITY; WOMEN; ACCEPTABILITY; MIFEPRISTONE	Objective To evaluate feasibility of self-assessment of medical abortion outcome using a low-sensitivity urine pregnancy test, checklist and text messages. The study assessed whether accurate self-assessment required a demonstration of the low-sensitivity urine pregnancy test or if verbal instructions suffice. Methods This non-inferiority trial enrolled 525 adult women from six public sector abortion clinics. Eligible women were undergoing medical abortion at gestations within 63 days. Consenting women completed a baseline interview, received standard care with mifepristone and home-administration of misoprostol. All were given a low-sensitivity urine pregnancy test and checklist for use 14 days later, sent text reminders, and asked to attend in-clinic follow-up after two weeks. Women were randomly assigned 1: 1 to an instruction-only group (n = 262; issued with pre-scripted instructions on the low-sensitivity pregnancy test), or a demonstration group (n = 263; performed practice tests guided by lay health workers). The primary outcome was accurate self-assessment of incomplete abortion, defined as needing additional misoprostol or vacuum aspiration. Analysis was by intention to treat and a noninferiority margin was set to six percentage points. Women's acceptability of their abortion procedure and preferences for follow-up were also assessed. Results Follow-up was 81% for abortion outcome, confirmed in-clinic at two weeks or self-reported within six months. Non-inferiority of instruction-only to a demonstration was inconclusive for accurate self-assessment (risk difference for instruction-only-demonstration: -2.5%; 95% CI: -9% to 4%). Comparing instruction-only to demonstration groups, 99% and 100% found the pregnancy test easy to do; and 91% and 93% respectively chose the pregnancy test, checklist and text messages for abortion outcome assessment in the future. Conclusion Routine self-assessment using a low-sensitivity pregnancy test, checklist and text messages is feasible and preferred by women attending South African primary care abortion clinics. Counselling with additional emphasis on prompt recognition of ongoing pregnancies is recommended.	[Constant, Deborah; Harries, Jane; Daskilewicz, Kristen] Univ Cape Town, Sch Publ Hlth & Family Med, Womens Hlth Res Unit, Cape Town, South Africa; [Constant, Deborah; Myer, Landon] Univ Cape Town, Sch Publ Hlth & Family Med, Div Epidemiol & Biostat, Cape Town, South Africa; [Gemzell-Danielsson, Kristina] Karolinska Inst, Dept Obstet & Gynecol, Stockholm, Sweden	University of Cape Town; University of Cape Town; Karolinska Institutet	Constant, D (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, Womens Hlth Res Unit, Cape Town, South Africa.; Constant, D (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, Div Epidemiol & Biostat, Cape Town, South Africa.	Deborah.constant@uct.ac.za	Harries, Jane/R-6504-2019	Harries, Jane/0000-0001-7359-8419; Constant, Deborah/0000-0002-7176-9963	Safe Abortion Action Fund; University of Cape Town Research Office; Harry Crossley Clinical Research Fellowship; South African National Research Foundation	Safe Abortion Action Fund; University of Cape Town Research Office; Harry Crossley Clinical Research Fellowship; South African National Research Foundation(National Research Foundation - South Africa)	Safe Abortion Action Fund. http://www.saafund.org<https://protect-za.mimecastcom/s/61NqBMsgLxKJCo> University of Cape Town Research Office. http://www.researchoffice.uct.ac.za<https://protect-za.mimecast.com/s/NIewBgf2g81JiN> The Harry Crossley Clinical Research Fellowship. http.//www.educationinnovations.org/funder/harry-crossley-foundation<https://protect-za.mimecast.com/s/bJp1BnhWOD1vtG> The South African National Research Foundation. http://www.nrf.ac.za<https://protect-za. mimecast.com/s/JReKB3f2oY10iJ>. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Exelgyn provided and shipped the pregnancy tests free of charge.	Blum J, 2016, CONTRACEPTION, V94, P115, DOI 10.1016/j.contraception.2016.04.001; Blum J, 2012, CONTRACEPTION, V86, P757, DOI 10.1016/j.contraception.2012.06.005; Bracken H, 2014, CONTRACEPTION, V90, P29, DOI 10.1016/j.contraception.2014.03.016; Cameron ST, 2015, CONTRACEPTION, V91, P6, DOI 10.1016/j.contraception.2014.09.009; Cameron ST, 2012, CONTRACEPTION, V86, P67, DOI 10.1016/j.contraception.2011.11.010; Cargo Mojca, 2013, S AFRICA MHEALTH LAN; Clark W, 2010, OBSTET GYNECOL, V115, P264, DOI 10.1097/AOG.0b013e3181c996f3; Constant D, 2015, REPROD HEALTH MATTER, V22, P83, DOI 10.1016/S0968-8080(14)43791-1; Constant D, 2014, CONTRACEPTION, V90, P226, DOI 10.1016/j.contraception.2014.04.009; de Tolly KM, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.3165; Hassoun D, 2016, EUR J OBSTET GYN R B, V197, P174, DOI 10.1016/j.ejogrb.2015.11.013; Iyengar K, 2015, LANCET GLOB HEALTH, V3, pE537, DOI 10.1016/S2214-109X(15)00150-3; Jackson AV, 2012, CONTRACEPTION, V85, P192, DOI 10.1016/j.contraception.2011.05.019; Lynd K, 2013, INT J GYNECOL OBSTET, V121, P144, DOI 10.1016/j.ijgo.2012.11.022; Michie L, 2014, CONTRACEPTION, V89, P440, DOI 10.1016/j.contraception.2014.01.010; Ngoc NTN, 2014, OBSTET GYNECOL, V123, P88, DOI 10.1097/AOG.0000000000000050; Oppegaard KS, 2015, LANCET, V385, P698, DOI 10.1016/S0140-6736(14)61054-0; Platais I, 2015, CONTRACEPTION, V91, P178, DOI 10.1016/j.contraception.2014.11.004; Raymond EG, 2013, CONTRACEPTION, V87, P26, DOI 10.1016/j.contraception.2012.06.011; WCDOH, 2010, PROV POL STAND GUID; World Health Organization, 2012, SAF AB TECHN POL GUI, V2nd ed.; World Health Organization, 2015, HLTH WORK ROL PROV S	22	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179600	10.1371/journal.pone.0179600	http://dx.doi.org/10.1371/journal.pone.0179600			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640845	Green Published, gold, Green Submitted			2022-12-27	WOS:000404135800043
J	Reuscher, MG; Baguley, JG; Conrad-Forrest, N; Cooksey, C; Hyland, JL; Lewis, C; Montagna, PA; Ricker, RW; Rohal, M; Washburn, T				Reuscher, Michael G.; Baguley, Jeffrey G.; Conrad-Forrest, Nathan; Cooksey, Cynthia; Hyland, Jeffrey L.; Lewis, Christopher; Montagna, Paul A.; Ricker, Robert W.; Rohal, Melissa; Washburn, Travis			Temporal patterns of Deepwater Horizon impacts on the benthic infauna of the northern Gulf of Mexico continental slope	PLOS ONE			English	Article							SEA SEDIMENT; COMMUNITY; CONSEQUENCES; TOXICITY; MARINE; MODEL	The Deepwater Horizon oil spill occurred in spring and summer 2010 in the northern Gulf of Mexico. Research cruises in 2010 (approximately 2-3 months after the well had been capped), 2011, and 2014 were conducted to determine the initial and subsequent effects of the oil spill on deep-sea soft-bottom infauna. A total of 34 stations were sampled from two zones: 20 stations in the "impact" zone versus 14 stations in the "non-impact" zone. Chemical contaminants were significantly different between the two zones. Polycyclic aromatic hydrocarbons averaged 218 ppb in the impact zone compared to 14 ppb in the non-impact zone. Total petroleum hydrocarbons averaged 1166 ppm in the impact zone compared to 102 ppm in the non-impact zone. While there was no difference between zones for meiofauna and macrofauna abundance, community diversity was significantly lower in the impact zone. Meiofauna taxa richness over the three sampling periods averaged 8 taxa/sample in the impact zone, compared to 10 taxa/sample in the non-impact zone; and macrofauna richness averaged 25 taxa/sample in the impact zone compared to 30 taxa/sample in the non-impact zone. Oil originating from the Deepwater Horizon oil spill reached the seafloor and had a persistent negative impact on diversity of soft-bottom, deep-sea benthic communities. While there are signs of recovery for some benthic community variables, full recovery has not yet occurred four years after the spill.	[Reuscher, Michael G.; Montagna, Paul A.; Rohal, Melissa; Washburn, Travis] Texas A&M Univ Corpus Christi, Harte Res Inst Gulf Mexico Studies, Corpus Christi, TX 78412 USA; [Baguley, Jeffrey G.; Conrad-Forrest, Nathan] Univ Nevada, Dept Biol, Reno, NV 89557 USA; [Cooksey, Cynthia] NOAA, Natl Marine Fisheries Serv, Charleston, SC USA; [Hyland, Jeffrey L.] NOAA, Natl Ctr Coastal Ocean Sci, Charleston, SC USA; [Lewis, Christopher] Ind Econ Inc, Cambridge, MA USA; [Ricker, Robert W.] NOAA, Off Response & Restorat, Assessment & Restorat Div, Santa Rosa, CA USA	Texas A&M University System; Texas A&M University Corpus Christi; Nevada System of Higher Education (NSHE); University of Nevada Reno; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS); National Oceanic Atmospheric Admin (NOAA) - USA	Reuscher, MG (corresponding author), Texas A&M Univ Corpus Christi, Harte Res Inst Gulf Mexico Studies, Corpus Christi, TX 78412 USA.	michael.reuscher@tamucc.edu	Montagna, Paul A./J-8208-2017; Washburn, Travis/C-2200-2019; Reuscher, Michael/O-5498-2015	Montagna, Paul A./0000-0003-4199-3312; Washburn, Travis/0000-0001-7316-6237; Reuscher, Michael/0000-0001-5150-9876	British Petroleum (BP); National Oceanic and Atmospheric Administration (NOAA); NOAA's Office of Response and Restoration (ORR) [DG133C06NC1729]; Industrial Economics (IE) [1050-TAMUCC, 1050-UNR]; NOAA's Office of Response and Restoration (ORR)	British Petroleum (BP); National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA's Office of Response and Restoration (ORR); Industrial Economics (IE); NOAA's Office of Response and Restoration (ORR)	Sample collection on R/V Gyre and R/V Ocean Veritas during the Deepwater Horizon (DWH) oil spill response phase was funded by British Petroleum (BP) and the National Oceanic and Atmospheric Administration (NOAA). Sample collection on the 2011M/V Sarah Bordelon and 2014 M/V Irish cruises, follow-up sample processing and data analysis, and production of this paper were funded in part under contract DG133C06NC1729 from NOAA's Office of Response and Restoration (ORR) via subcontract 1050-TAMUCC and 1050-UNR from Industrial Economics (IE), and through an internal transfer of funds from NOAA's Office of Response and Restoration (OR&R) to NOAA's National Centers for Coastal Ocean Science (NCCOS), as part of the DWH Natural Resource Damage Assessment. The views expressed herein are those of the authors and do not necessarily reflect the views of NOAA or any of its personnel. The study design and scope of work for the present deep-water/soft-bottom benthic study was approved jointly by representatives of the DWH NRDA Trustees and BP; neither party had a role in the corresponding sample processing, data analysis, decision to publish, or preparation of the manuscript. Christopher Lewis is employed by Industrial Economics, Incorporated. Industrial Economics, Incorporated provided support in the form of salary for author CL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this authors is articulated in the 'author contributions' section.; Sample collection on R/V Gyre and R/V Ocean Veritas during the Deepwater Horizon (DWH) oil spill response phase was funded by British Petroleum (BP) and the National Oceanic and Atmospheric Administration (NOAA). Sample collection on the 2011M/V Sarah Bordelon and 2014 M/V Irish cruises, follow-up sample processing and data analysis, and production of this paper were funded in part under contract DG133C06NC1729 from NOAA's Office of Response and Restoration (ORR) via subcontract 1050-TAMUCC and 1050-UNR from Industrial Economics (IE), and through an internal transfer of funds from NOAA's Office of Response and Restoration (OR&R) to NOAA's National Centers for Coastal Ocean Science (NCCOS), as part of the DWH Natural Resource Damage Assessment.	Aulenbach B T, 2007, 20071080 US GEOL SUR, DOI [10.3133/ofr20071080, DOI 10.3133/OFR20071080]; Balthis WL, 2017, INTEG ENVIRON ASSESS; BILLETT DSM, 1983, NATURE, V302, P520, DOI 10.1038/302520a0; Carman KR, 2000, MAR ENVIRON RES, V49, P255, DOI 10.1016/S0141-1136(99)00072-0; Clarke K.R., 2014, CHANGE MARINE COMMUN, V3; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR, 2015, PRIMER V7 USER MANUA; Deepwater Horizon Natural Resource Damage Assessment Trustees, 2016, DEEPWATER HORIZON OI; GRAF G, 1989, NATURE, V341, P437, DOI 10.1038/341437a0; GRASSLE JF, 1977, NATURE, V265, P618, DOI 10.1038/265618a0; HAAKE B, 1993, DEEP-SEA RES PT I, V40, P1323, DOI 10.1016/0967-0637(93)90114-I; Halfar J, 2007, SCIENCE, V316, P987, DOI 10.1126/science.1138289; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; KERR RA, 1980, SCIENCE, V208, P484, DOI 10.1126/science.208.4443.484; Kujawinski EB, 2013, ENVIRON SCI TECHNOL, V45, P1298; KUKERT H, 1992, DEEP-SEA RES, V39, P1349, DOI 10.1016/0198-0149(92)90073-3; LAMPITT RS, 1985, DEEP-SEA RES, V32, P885, DOI 10.1016/0198-0149(85)90034-2; LONG ER, 1995, ENVIRON MANAGE, V19, P81, DOI 10.1007/BF02472006; Long ER, 1998, ENVIRON TOXICOL CHEM, V17, P714, DOI 10.1002/etc.5620170428; MacDonald IR, 2015, J GEOPHYS RES-OCEANS, V120, P8364, DOI 10.1002/2015JC011062; Masson D. G., 1996, OCEANOGRAPHY ILLUSTR, P136; Montagna PA, 2017, INTEGR ENVIRON ASSES, V13, P342, DOI 10.1002/ieam.1791; Montagna PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070540; Peterson CH, 1996, CAN J FISH AQUAT SCI, V53, P2637, DOI 10.1139/cjfas-53-11-2637; Reuscher MG, 2017, HYDROBIOLOGIA, V790, P233, DOI 10.1007/s10750-016-3034-x; Roberts CM, 2002, TRENDS ECOL EVOL, V17, P242, DOI 10.1016/S0169-5347(02)02492-8; SMITH CR, 1989, NATURE, V341, P27, DOI 10.1038/341027a0; SWARTZ RC, 1995, ENVIRON TOXICOL CHEM, V14, P1977, DOI 10.1002/etc.5620141120; Timmermann A, 1999, NATURE, V398, P694, DOI 10.1038/19505	29	14	14	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179923	10.1371/journal.pone.0179923	http://dx.doi.org/10.1371/journal.pone.0179923			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640913	Green Submitted, Green Published, gold			2022-12-27	WOS:000404135800083
J	Viljakainen, HT; Koistinen, HA; Tervahartiala, T; Sorsa, T; Andersson, S; Makitie, O				Viljakainen, Heli T.; Koistinen, Heikki A.; Tervahartiala, Taina; Sorsa, Timo; Andersson, Sture; Makitie, Outi			Metabolic milieu associates with impaired skeletal characteristics in obesity	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BONE-MINERAL DENSITY; INSULIN-RESISTANCE; ADIPOSE-TISSUE; FRACTURE RISK; LEPTIN; INFLAMMATION; TURNOVER; WOMEN; SENSITIVITY	High leptin concentration, low-grade inflammation, and insulin resistance often coexist in obese subjects; this adverse metabolic milieu may be the main culprit for increased fracture risk and impaired bone quality seen in patients with type 2 diabetes. We examined the associations of leptin, hs (high sensitivity)-CRP and insulin resistance with bone turnover markers (BTMs) and bone characteristics in 55 young obese adults (median BMI 40 kg/m(2)) and 65 non-obese controls. Mean age of the subjects was 19.5 +/- 2.5 years (mean +/- SD). Concentrations of leptin, adiponectin, hs-CRP, MMP-8 and TIMP-1, fasting plasma glucose and insulin (to calculate HOMA), BTMs (BAP, P1NP, CTX-1, and TRAC5b) were measured. Bone characteristics were determined with pQCT at radius and tibia, and with DXA for central sites. Leptin, hs-CRP and HOMA correlated inversely with BTMs: the partial coefficients were 1.5-1.9 fold higher in males than in females. After adjusting for age, BMI, and other endocrine factors, leptin displayed an independent effect in males on radial bone mass (p = 0.019), tibial trabecular density (p = 0.025) and total hip BMD (p = 0.043), with lower densities in males with high leptin. In females, the model adjusting for age, BMI, and other endocrine factors, revealed that hs-CRP had independent effects on radial bone mass (p = 0.034) and lumbar spine BMD (p = 0.016), women with high hs-CRP having lower values. Partial correlations of adiponectin and TIMP-1 with bone characteristics were discrepant; MMP-8 showed no associations. In conclusion, in young obese adults and their controls, leptin, hs-CRP and HOMA associate inversely with BTMs and bone characteristics. Leptin appears to be the key independent effector in males, whereas hs-CRP displayed a predominant role in females.	[Viljakainen, Heli T.; Andersson, Sture; Makitie, Outi] Univ Helsinki, Childrens Hosp, Helsinki, Finland; [Viljakainen, Heli T.; Koistinen, Heikki A.; Tervahartiala, Taina; Sorsa, Timo; Andersson, Sture; Makitie, Outi] Helsinki Univ Hosp, Helsinki, Finland; [Viljakainen, Heli T.; Makitie, Outi] Folkhalsan Res Ctr, Helsinki, Finland; [Koistinen, Heikki A.] Univ Helsinki, Dept Med, Helsinki, Finland; [Koistinen, Heikki A.] Univ Helsinki, Abdominal Ctr Endocrinol, Helsinki, Finland; [Koistinen, Heikki A.] Minerva Fdn, Helsinki, Finland; [Tervahartiala, Taina; Sorsa, Timo] Univ Helsinki, Dept Oral & Maxillofacial Dis, Helsinki, Finland; [Sorsa, Timo] Karolinska Inst, Div Periodontol, Dept Dent Med, Huddinge, Sweden; [Makitie, Outi] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Makitie, Outi] Karolinska Univ Hosp, Clin Genet, Stockholm, Sweden	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; University of Helsinki; University of Helsinki; University of Helsinki; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Viljakainen, HT (corresponding author), Univ Helsinki, Childrens Hosp, Helsinki, Finland.; Viljakainen, HT (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.; Viljakainen, HT (corresponding author), Folkhalsan Res Ctr, Helsinki, Finland.	heli.viljakainen@helsinki.fi	Koistinen, Heikki/J-7313-2016	Koistinen, Heikki/0000-0001-7870-070X	Academy of Finland [277843, 258753]; Sigrid Juselius Foundation; Foundation for Pediatric Research; Folkhalsan Research Foundation; Novo Nordisk Foundation; Swedish Research Council; Swedish Childhood Cancer Foundation; Ahokas Foundation; Finska Lakaresallskapet; Liv och Halsa Foundation; Helsinki University Hospital research funds; Novo Nordisk Fonden [NNF16OC0021322] Funding Source: researchfish	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Foundation for Pediatric Research; Folkhalsan Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Childhood Cancer Foundation(European Commission); Ahokas Foundation; Finska Lakaresallskapet; Liv och Halsa Foundation; Helsinki University Hospital research funds; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by funds from the Academy of Finland (grant number 277843, 258753), Sigrid Juselius Foundation, Foundation for Pediatric Research, Folkhalsan Research Foundation, Novo Nordisk Foundation, Swedish Research Council, Swedish Childhood Cancer Foundation, Ahokas Foundation, Finska Lakaresallskapet, and Liv och Halsa Foundation, and Helsinki University Hospital research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi-Abhari S, 2013, BONE, V56, P67, DOI 10.1016/j.bone.2013.05.009; Aroor AR, 2013, METABOLISM, V62, P1543, DOI 10.1016/j.metabol.2013.07.001; Berglundh S, 2015, OSTEOPOROSIS INT, V26, P727, DOI 10.1007/s00198-014-2951-7; Cohen A, 2013, J CLIN ENDOCR METAB, V98, P2562, DOI 10.1210/jc.2013-1047; Dahl K, 2015, BONE, V72, P65, DOI 10.1016/j.bone.2014.11.012; Dimitri P, 2015, J CLIN ENDOCR METAB, V100, P594, DOI 10.1210/jc.2014-3199; Dimitri P, 2011, BONE, V48, P189, DOI 10.1016/j.bone.2010.09.034; Gaudio A, 2014, DIABETES VASC DIS RE, V11, P48, DOI 10.1177/1479164113510923; Gaudio A, 2012, J CLIN ENDOCR METAB, V97, P3744, DOI 10.1210/jc.2012-1901; Gursoy UK, 2010, J CLIN PERIODONTOL, V37, P487, DOI 10.1111/j.1600-051X.2010.01563.x; Hanemaaijer R, 1997, J BIOL CHEM, V272, P31504, DOI 10.1074/jbc.272.50.31504; Harford KA, 2011, P NUTR SOC, V70, P408, DOI 10.1017/S0029665111000565; Hind K, 2010, J CLIN DENSITOM, V13, P413, DOI 10.1016/j.jocd.2010.06.002; Hribal ML, 2014, CURR PHARM DESIGN, V20, P609, DOI 10.2174/13816128113199990016; Kindler JM, 2016, J CLIN ENDOCR METAB, V101, P198, DOI 10.1210/jc.2015-3451; Kotake S, 2014, BBA-GEN SUBJECTS, V1840, P1209, DOI 10.1016/j.bbagen.2013.12.013; Laurent MR, 2016, OSTEOPOROSIS INT, V27, P3227, DOI 10.1007/s00198-016-3656-x; Lee BC, 2014, BBA-MOL BASIS DIS, V1842, P446, DOI 10.1016/j.bbadis.2013.05.017; Lee HS, 2015, EXP CLIN ENDOCR DIAB, V123, P604, DOI 10.1055/s-0035-1559795; Legiran S, 2012, CLIN CASES MINER BON, V9, P145; Lorentzon M, 2006, J BONE MINER RES, V21, P1871, DOI 10.1359/JBMR.060814; Lucas R, 2012, CLIN ENDOCRINOL, V77, P665, DOI 10.1111/j.1365-2265.2012.04430.x; Nagase H, 2003, BIOCHEM SOC SYMP, V70, P201, DOI 10.1042/bss0700201; Oei L, 2014, OSTEOPOROSIS INT, V25, P1247, DOI 10.1007/s00198-013-2578-0; Paganelli M, 2007, INFLAMM BOWEL DIS, V13, P416, DOI 10.1002/ibd.20039; Parajuli A, 2015, BONE, V81, P152, DOI 10.1016/j.bone.2015.07.012; Pollock NK, 2015, MOL CELL ENDOCRINOL, V410, P52, DOI 10.1016/j.mce.2015.03.016; Potikanond S, 2016, J ENDOCRINOL, V228, P85, DOI 10.1530/JOE-15-0333; Romagnoli E, 2016, ENDOCRINE, V54, P342, DOI 10.1007/s12020-016-0857-1; Sayers A, 2012, J BONE MINER RES, V27, P610, DOI 10.1002/jbmr.1467; Shanbhogue VV, 2016, LANCET DIABETES ENDO, V4, P159, DOI 10.1016/S2213-8587(15)00283-1; Sherk VD, 2011, J CLIN DENSITOM, V14, P321, DOI 10.1016/j.jocd.2011.03.010; Viljakainen HT, 2015, CALCIFIED TISSUE INT, V97, P364, DOI 10.1007/s00223-015-0031-4; Viljakainen H, 2014, J CLIN ENDOCR METAB, V99, P2155, DOI 10.1210/jc.2013-3097; Viljakainen HT, 2011, BONE, V48, P212, DOI 10.1016/j.bone.2010.09.022; Weinhold B, 1997, BIOCHEM J, V327, P425, DOI 10.1042/bj3270425	36	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179660	10.1371/journal.pone.0179660	http://dx.doi.org/10.1371/journal.pone.0179660			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640843	Green Published, Green Submitted, gold			2022-12-27	WOS:000404135800048
J	Park, SH; Won, HJ; Kim, SY; Shin, YM; Kim, PN; Yoon, SM; Park, JH; Kim, JH				Park, So Hyun; Won, Hyung Jin; Kim, So Yeon; Shin, Yong Moon; Kim, Pyo Nyun; Yoon, Sang Min; Park, Jin-hong; Kim, Jong Hoon			Efficacy and safety of ultrasound-guided implantation of fiducial markers in the liver for stereotactic body radiation therapy	PLOS ONE			English	Article							FOCAL HEPATIC-LESIONS; HEPATOCELLULAR-CARCINOMA; PERCUTANEOUS BIOPSY; RADIOTHERAPY; DISEASE; RADIOSURGERY; SONOGRAPHY; CYBERKNIFE; ABLATION	Objective Stereotactic body radiation therapy (SBRT) for the treatment of a malignancy in the liver requires the perilesional implantation of fiducial markers for lesion detection. The purpose of this study is to evaluate the efficacy and safety of ultrasound (US)-guided marker implantation for SBRT. Methods We retrospectively reviewed 299, US-guided, intrahepatic fiducial markers implanted in 101 patients between November 2013 and September 2014. SBRT-planning CT images were analyzed to determine the technical success of the implantation, the mean distance between the tumor margin and the marker, with the ideal location of fiducials defined as the distance between a marker and a tumor less than 3 cm and the distance between markers greater than 2 cm according to the tumor conspicuity seen on gray-scale US and the artifact obscuring tumor margins. We also evaluated procedure-related major and minor complications. Results Technical success was achieved in 291 (97.3%) fiducial marker implantations. The mean distance between the tumor and the marker was 3.1 cm (S. D., 2.1 cm; range, 0-9.5 cm). Of 101 patients, 72 lesions (71.3%, 2.2 +/- 1.0 cm; range, 0-3.0 cm) had fiducial markers located in an ideal location. The ideal location of fiducials was more common in visible lesions than in poorly conspicuous lesions (90.2% vs. 52.0%, P < 0.001). Seventeen markers (5.8%) developed beam-hardening artifacts obscuring the tumor margins. There were no major complications, although 12 patients (11.9%) developed minor complications. Conclusions US-guided implantation of fiducial markers in the liver is an effective and safe procedure with only rare complications.	[Park, So Hyun; Won, Hyung Jin; Kim, So Yeon; Shin, Yong Moon; Kim, Pyo Nyun] Univ Ulsan, Coll Med, Div Abdominal Radiol, Asan Med Ctr,Dept Radiol, Seoul, South Korea; [Park, So Hyun; Won, Hyung Jin; Kim, So Yeon; Shin, Yong Moon; Kim, Pyo Nyun] Univ Ulsan, Coll Med, Res Inst Radiol, Asan Med Ctr, Seoul, South Korea; [Park, So Hyun] Gachon Univ, Gil Med Ctr, Dept Radiol, Incheon, South Korea; [Yoon, Sang Min; Park, Jin-hong; Kim, Jong Hoon] Univ Ulsan, Coll Med, Dept Radiat Oncol, Asan Med Ctr, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Gachon University; University of Ulsan	Won, HJ (corresponding author), Univ Ulsan, Coll Med, Div Abdominal Radiol, Asan Med Ctr,Dept Radiol, Seoul, South Korea.; Won, HJ (corresponding author), Univ Ulsan, Coll Med, Res Inst Radiol, Asan Med Ctr, Seoul, South Korea.	hjwon@amc.seoul.kr		Park, So Hyun/0000-0001-9935-2863; Park, Jin-hong/0000-0002-1088-0174				Bujold A, 2013, J CLIN ONCOL, V31, P1631, DOI 10.1200/JCO.2012.44.1659; Chang SD, 2001, STEREOT FUNCT NEUROS, V76, P204, DOI 10.1159/000066719; Cheng JCH, 2002, INT J RADIAT ONCOL, V54, P156, DOI 10.1016/S0360-3016(02)02915-2; Das IJ, 1996, RADIOTHER ONCOL, V38, P61, DOI 10.1016/0167-8140(95)01674-0; Dawson LA, 2000, J CLIN ONCOL, V18, P2210, DOI 10.1200/JCO.2000.18.11.2210; Facciuto ME, 2012, J SURG ONCOL, V105, P692, DOI 10.1002/jso.22104; Kim JH, 2012, KOREAN J RADIOL, V13, P307, DOI 10.3348/kjr.2012.13.3.307; Kothary N, 2009, AM J ROENTGENOL, V192, P1090, DOI 10.2214/AJR.08.1399; Kothary N, 2009, J VASC INTERV RADIOL, V20, P235, DOI 10.1016/j.jvir.2008.09.026; Lee MT, 2009, J CLIN ONCOL, V27, P1585, DOI 10.1200/JCO.2008.20.0600; Lee MW, 2014, ULTRASONOGRAPHY, V33, P227, DOI 10.14366/usg.14021; Liang SX, 2006, INT J RADIAT ONCOL, V65, P426, DOI 10.1016/j.ijrobp.2005.12.031; Liu C-H, 2015, J MED SCI, V35, P92; Masuzaki R, 2011, J GASTROEN HEPATOL, V26, P759, DOI 10.1111/j.1440-1746.2010.06559.x; Minami Y, 2011, WORLD J GASTROENTERO, V17, P4952, DOI 10.3748/wjg.v17.i45.4952; Oldrini G, 2015, DIAGN INTERV IMAG, V96, P589, DOI 10.1016/j.diii.2014.01.010; Park HJ, 2013, J ULTRAS MED, V32, P1557, DOI 10.7863/ultra.32.9.1557; Sacks David, 2003, J Vasc Interv Radiol, V14, pS199; Wu W, 2006, AM J ROENTGENOL, V187, P752, DOI 10.2214/AJR.05.0535; Xu ZY, 2006, INT J RADIAT ONCOL, V65, P189, DOI 10.1016/j.ijrobp.2005.11.034; Yoon SH, 2010, EUR RADIOL, V20, P2047, DOI 10.1007/s00330-010-1757-z	21	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179676	10.1371/journal.pone.0179676	http://dx.doi.org/10.1371/journal.pone.0179676			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636658	Green Published, Green Submitted, gold			2022-12-27	WOS:000404118300048
J	Duong, TM; Gomez, AB; Sherratt, TN				Duong, Tammy M.; Gomez, Ann B.; Sherratt, Thomas N.			Response of adult dragonflies to artificial prey of different size and colour	PLOS ONE			English	Article							PRAYING-MANTIS; APOSEMATIC COLORATION; PREDATORS; SELECTION; MIMICRY; ODONATA; WASPS	Aposematism is an evolved, cross-species association between a preys' unprofitability and the presence of conspicuous signals. Avian predators have been widely employed to understand the evolution of these warning signals However, insect predators are abundant, diverse, and highly visual foragers that have been shown to be capable of learned aversion. Therefore, it is likely that their behaviour also shapes the nature of anti-predator traits. In this study, we evaluated the rates of attack of a community (13 species) of mature adult dragonflies (Odonata) on artificial prey of varying size (2.5-31 mm lengthwise) and colour pattern (black, black/yellow striped). The relative attack rates of dragonflies on prey increased as prey size decreased, but there was no evidence that the attack rates by dragonflies were affected by prey colour pattern and no evidence for an interaction between colour pattern and size. To investigate prey selection by specific predator species under field conditions, we compared the time to attack distributions of black-painted prey presented to two common dragonflies: Leucorrhinia intacta and the larger, Libellula pulchella. We found that the two dragonfly species, as well as the two sexes, had different foraging responses. L. pulchella was more likely to attack larger prey, and females of both species more likely to attack prey than males. Collectively, our results indicate that dragonflies are highly size selective. However, while the nature of this selectivity varies among dragonfly species, there is little evidence that classic black/yellow warning signals deter attack by these aerial invertebrate predators.	[Duong, Tammy M.; Gomez, Ann B.; Sherratt, Thomas N.] Carleton Univ, Ottawa Carleton Inst Biol, Dept Biol, Ottawa, ON, Canada	Carleton University; University of Ottawa	Sherratt, TN (corresponding author), Carleton Univ, Ottawa Carleton Inst Biol, Dept Biol, Ottawa, ON, Canada.	Tom.Sherratt@Carleton.ca			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by The Natural Sciences and Engineering Research Council of Canada.; We thank members of the Sherratt Lab for their input, edits, and feedback, notably Changku Kang and Sophie Potter. We also thank the staff of Queens University Biological Station for their care and assistance. Prof. Robert Olberg and an anonymous referee provided helpful feedback on an earlier version of this paper. This project was funded by Natural Sciences and Engineering Research Council of Canada grants to T.N.S.	ANHOLT BR, 1991, EVOLUTION, V45, P1091, DOI 10.1111/j.1558-5646.1991.tb04377.x; Baird JM, 1997, J INSECT BEHAV, V10, P655, DOI 10.1007/BF02765385; Bates H, 1862, BIOL J LINN SOC, V23, P495; Baum T, 2014, J INSECT BEHAV, V27, P333, DOI 10.1007/s10905-013-9422-4; BEATTY GEORGE H., 1951, BULL BROOKLYN ENT SOC, V46, P29; BERENBAUM MR, 1984, AM MIDL NAT, V111, P64, DOI 10.2307/2425543; BOWDISH TI, 1993, AM MIDL NAT, V129, P215, DOI 10.2307/2426501; Bybee SM, 2012, ORG DIVERS EVOL, V12, P241, DOI 10.1007/s13127-012-0090-6; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; Cott H.B., 1940, ADAPTIVE COLORATION; Dunham MJ, 1992, DETERMINANTS TERRITO, V9, P112; Edmunds M., 1974, DEFENCE ANIMALS; GELPERIN A, 1968, NATURE, V219, P399, DOI 10.1038/219399a0; GUILFORD T, 1994, J THEOR BIOL, V170, P311, DOI 10.1006/jtbi.1994.1192; Guillermo-Ferreira R, 2015, J INSECT PHYSIOL, V81, P129, DOI 10.1016/j.jinsphys.2015.07.010; HANSEN B, 1994, LIMNOL OCEANOGR, V39, P395, DOI 10.4319/lo.1994.39.2.0395; Hisada M., 1965, Journal of the Faculty of Science Hokkaido University Zoology, V15, P568; Hossie TJ, 2012, ANIM BEHAV, V84, P167, DOI 10.1016/j.anbehav.2012.04.027; IWASAKI T, 1990, J ETHOL, V8, P75, DOI 10.1007/BF02350277; Jones CD, 2008, FIELD GUIDE DRAGONFL; Kauppinen J, 2003, ANIM BEHAV, V66, P505, DOI 10.1006/anbe.2003.2225; Mappes J, 2005, TRENDS ECOL EVOL, V20, P598, DOI 10.1016/j.tree.2005.07.011; MARDEN JH, 1995, J EXP BIOL, V198, P2095; Morris RL, 2016, BEHAV ECOL, V27, P920, DOI 10.1093/beheco/arv233; ODonnell S, 1996, J INSECT BEHAV, V9, P159, DOI 10.1007/BF02213730; Olberg RM, 2005, J COMP PHYSIOL A, V191, P791, DOI 10.1007/s00359-005-0002-8; Penney HD, 2012, NATURE, V483, P461, DOI 10.1038/nature10961; Poulton EB, 1890, COLOURS ANIMALS THEI; Prudic KL, 2007, BEHAV ECOL, V18, P41, DOI 10.1093/beheco/arl046; R Core Team, 2013, R LANG ENV STAT COMP; Rashed A, 2005, ANIM BEHAV, V70, P1195, DOI 10.1016/j.anbehav.2005.03.009; Ruxton GD, 2004, AVOIDING ATTACK EVOL; SHELLY TE, 1978, ENVIRON ENTOMOL, V7, P790, DOI 10.1093/ee/7.6.790; Skelhorn J, 2016, BEHAV ECOL; Symondson WOC, 2002, ANNU REV ENTOMOL, V47, P561, DOI 10.1146/annurev.ento.47.091201.145240; Taylor LA, 2014, ANIM BEHAV, V90, P149, DOI 10.1016/j.anbehav.2014.01.025; Wallace AR, 1889, DARWINISM; Yang EC, 1996, J COMP PHYSIOL A, V178, P543, DOI 10.1007/BF00190184	38	11	11	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179483	10.1371/journal.pone.0179483	http://dx.doi.org/10.1371/journal.pone.0179483			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662042	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300026
J	Weir, GM; Karkada, M; Hoskin, D; Stanford, MM; MacDonald, L; Mansour, M; Liwski, RS				Weir, Genevieve M.; Karkada, Mohan; Hoskin, David; Stanford, Marianne M.; MacDonald, Lisa; Mansour, Marc; Liwski, Robert S.			Combination of poly I:C and Pam3CSK4 enhances activation of B cells in vitro and boosts antibody responses to protein vaccines in vivo	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ANTIGEN-PRESENTING CELLS; EXPRESSION; STIMULATION; VACCINATION; INHIBITION; INDUCTION; PLATFORM; LIGANDS; SYNERGY	Vaccines that can rapidly induce strong and robust antibody-mediated immunity could improve protection from certain infectious diseases for which current vaccine formulations are inefficient. For indications such as anthrax and influenza, antibody production in vivo is a correlate of efficacy. Toll-like receptor (TLR) agonists are frequently studied for their role as vaccine adjuvants, largely because of their ability to enhance initiation of immune responses to antigens by activating dendritic cells. However, TLRs are also expressed on B cells and may contribute to effective B cell activation and promote differentiation into antigen-specific antibody producing plasma cells in vivo. We sought to discover an adjuvant system that could be used to augment antibody responses to influenza and anthrax vaccines. We first characterized an adjuvant system in vitro which consisted of two TLR ligands, poly I:C (TLR3) and Pam3CSK4 (TLR2), by evaluating its effects on B cell activation. Each agonist enhanced B cell activation through increased expression of surface receptors, cytokine secretion and proliferation. However, when B cells were stimulated with poly I:C and Pam3CSK4 in combination, further enhancement to cell activation was observed. Using B cells isolated from knockout mice we confirmed that poly I:C and Pam3CSK4 were signaling through TLR3 and TLR2, respectively. B cells activated with Poly I:C and Pam3CSK4 displayed enhanced capacity to stimulate allogeneic CD4(+) T cell activation and differentiate into antibody-producingplasma cells in vitro. Mice vaccinated with influenza or anthrax antigens formulated with poly I:C and Pam3CSK4 in DepoVax (TM) vaccine platform developed a rapid and strong antigen-specific serum antibody titer that persisted for at least 12 weeks after a single immunization. These results demonstrate that combinations of TLR adjuvants promote more effective B cell activation in vitro and can be used to augment antibody responses to vaccines in vivo.	[Weir, Genevieve M.; Karkada, Mohan; Stanford, Marianne M.; MacDonald, Lisa; Mansour, Marc] Immunovaccine Inc, Res & Dev, Halifax, NS, Canada; [Weir, Genevieve M.; Karkada, Mohan; Hoskin, David; Stanford, Marianne M.; Liwski, Robert S.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Hoskin, David; Liwski, Robert S.] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Liwski, Robert S.] Queen Elizabeth 2 Hlth Sci Ctr, Div Hematopathol, Dept Pathol & Lab Med, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Queen Elizabeth II Health Sciences Centre	Weir, GM (corresponding author), Immunovaccine Inc, Res & Dev, Halifax, NS, Canada.; Weir, GM (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada.	gweir@imvaccine.com		Stanford, Marianne/0000-0003-0432-3707; Weir, Genevieve/0000-0002-6285-7187	Immunovaccine Inc., Canada Foundation for Innovation Award; Dalhousie University Clinical Research Scholar Award; NSERC Discovery Grant	Immunovaccine Inc., Canada Foundation for Innovation Award; Dalhousie University Clinical Research Scholar Award; NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by Immunovaccine Inc., Canada Foundation for Innovation Award, Dalhousie University Clinical Research Scholar Award and an NSERC Discovery Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amu S, 2010, SCAND J IMMUNOL, V71, P275, DOI 10.1111/j.1365-3083.2010.02380.x; Archambault AS, 2013, J IMMUNOL, V191, P545, DOI 10.4049/jimmunol.1201598; Bagchi A, 2007, J IMMUNOL, V178, P1164, DOI 10.4049/jimmunol.178.2.1164; Barr TA, 2007, EUR J IMMUNOL, V37, P3040, DOI 10.1002/eji.200636483; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Bekeredjian-Ding I, 2009, IMMUNOLOGY, V128, P311, DOI 10.1111/j.1365-2567.2009.03173.x; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Berinstein NL, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1026529; Berinstein NL, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-156; Boeglin E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025542; Brewer KD, 2014, VACCINE, V32, P6956, DOI 10.1016/j.vaccine.2014.10.058; Buchta CM, 2014, IMMUNOL RES, V59, P12, DOI 10.1007/s12026-014-8523-2; Caproni E, 2012, J IMMUNOL, V188, P3088, DOI 10.4049/jimmunol.1101764; Chang ZL, 2010, INFLAMM RES, V59, P791, DOI 10.1007/s00011-010-0208-2; Chiu C, 2014, CURR TOP MICROBIOL; Duthie MS, 2011, IMMUNOL REV, V239, P178, DOI 10.1111/j.1600-065X.2010.00978.x; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; Garg R, 2014, J GEN VIROL, V95, P1043, DOI 10.1099/vir.0.062570-0; Garman L, 2014, TOXINS, V6, P2424, DOI 10.3390/toxins6082424; Good DW, 2012, J BIOL CHEM, V287, P20208, DOI 10.1074/jbc.M111.336255; Gururajan M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000863; He B, 2010, NAT IMMUNOL, V11, P836, DOI 10.1038/ni.1914; Heer AK, 2007, J IMMUNOL, V178, P2182, DOI 10.4049/jimmunol.178.4.2182; Hou BD, 2011, IMMUNITY, V34, P375, DOI 10.1016/j.immuni.2011.01.011; Jain S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020651; Karkada M, 2010, VACCINE, V28, P6176, DOI 10.1016/j.vaccine.2010.07.025; Karkada M, 2010, J IMMUNOTHER, V33, P250, DOI 10.1097/CJI.0b013e3181c1f1e9; Katsenelson N, 2007, EUR J IMMUNOL, V37, P1785, DOI 10.1002/eji.200636800; Kaur M, 2013, EXPERT REV VACCINES, V12, P955, DOI 10.1586/14760584.2013.814860; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; LENSCHOW DJ, 1994, J IMMUNOL, V153, P1990; Matthews K, 2012, J IMMUNOL, V189, P5729, DOI 10.4049/jimmunol.1200601; Mifsud EJ, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00079; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Perez-Giron JV, 2014, J IMMUNOL, V193, P1324, DOI 10.4049/jimmunol.1400222; Pone EJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1769; Reperant Leslie A, 2014, F1000Prime Rep, V6, P47, DOI 10.12703/P6-47; Rieckmann P, 1997, METHODS, V11, P128, DOI 10.1006/meth.1996.0396; Rivera A, 2001, INT IMMUNOL, V13, P1583, DOI 10.1093/intimm/13.12.1583; Rivino L, 2004, J EXP MED, V200, P725, DOI 10.1084/jem.20040774; Rodriguez-Pinto D, 2005, EUR J IMMUNOL, V35, P1097, DOI 10.1002/eji.200425732; Treml LS, 2007, J IMMUNOL, V178, P7531, DOI 10.4049/jimmunol.178.12.7531; Vanhoutte F, 2008, IMMUNOL LETT, V116, P86, DOI 10.1016/j.imlet.2007.11.014; Vollmer J, 2004, J ENDOTOXIN RES, V10, P431, DOI 10.1179/096805104225006534; Wells JW, 2008, J IMMUNOL, V181, P3422, DOI 10.4049/jimmunol.181.5.3422; WU CQ, 1994, J INTERFERON RES, V14, P357, DOI 10.1089/jir.1994.14.357	47	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180073	10.1371/journal.pone.0180073	http://dx.doi.org/10.1371/journal.pone.0180073			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662082	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300098
J	Wilson, G; Ye, ZP; Xie, H; Vahl, S; Dawson, E; Rowlen, K				Wilson, Garrett; Ye, Zhiping; Xie, Hang; Vahl, Steven; Dawson, Erica; Rowlen, Kathy			Automated interpretation of influenza hemagglutination inhibition (HAI) assays: Is plate tilting necessary?	PLOS ONE			English	Article							REPRODUCIBILITY; PROTECTION	The hemagglutination inhibition assay (HAI) is widely used to evaluate vaccine-induced antibody responses as well as to antigenically characterize influenza viruses. The results of an HAI assay are based on an endpoint titration where the titers are generally manually interpreted and recorded by a well-trained expert. For serological applications, the lack of standardization in endpoint interpretation and interference from non-specific inhibitors in clinical samples can translate into a high degree of variability in the results. For example, tilting HAI plates at 45-60 degrees to look for a "tear drop pattern" with avian red blood cells is a common practice by many, but not all, research laboratories. In this work, we tested the hypothesis that an automated image analysis algorithm can be used to achieve an accurate and non-subjective interpretation of HAI assays specifically without the need to tilt plates. In a side-by-side comparison study performed during FDA's biannual serological screening process for influenza viruses, titer calls for more than 2200 serum samples were made by the Cypher One automated hemagglutination analyzer without tilting and by an expert human with tilting. The comparison yielded 95.6% agreement between the expert reader and automated interpretation method (within +/- 1 dilution) for the complete dataset. Performance was also evaluated relative to the type of red blood cell (turkey and guinea pig) and influenza strain (12 different viruses). For the subset that utilized guinea pig red blood cells (similar to 44% of the samples), for which no plate tilting was required, the agreement with an expert reader was 97.2%. For the subset that utilized turkey red blood cells (similar to 56% of the samples), for which plate tilting was necessary by the expert reader, the agreement was 94.3%. Overall these results support the postulate that algorithm-based interpretation of a digital record with no plate tilting could replace manual reading for greater consistency in HAI assays.	[Wilson, Garrett; Vahl, Steven; Dawson, Erica; Rowlen, Kathy] InDevR Inc, Boulder, CO 80301 USA; [Ye, Zhiping; Xie, Hang] US FDA, Div Viral Prod, Off Vaccines Res & Review, Ctr Biol Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Dawson, E (corresponding author), InDevR Inc, Boulder, CO 80301 USA.	dawson@indevr.com	Xie, Hang/AAC-9092-2019	Xie, Hang/0000-0001-8318-5554	National Institute of Allergy and Infectious Diseases [R43A1106054]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases (https//www.niaid.nihgov/), Grant number: R43A1106054 to KR GW ED SV. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. InDevR Inc provided support in the form of salaries for authors GW, ED, SV, and KR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ewing ML, 1996, AVIAN DIS, V40, P13, DOI 10.2307/1592366; Nguyen M, 2016, JALA-J LAB AUTOM, V21, P287, DOI 10.1177/2211068215610061; Oie, 2016, MANUAL DIAGNOSTIC TE, Vseventh.; Reber A, 2013, EXPERT REV VACCINES, V12, P519, DOI [10.1586/erv.13.35, 10.1586/ERV.13.35]; WHO Global Influenza Surveillance Network, 2011, MAN LAB DIAGN VIR SU, P43; Wood J M, 2011, Pharmeur Bio Sci Notes, V2011, P36; WOOD JM, 1994, VACCINE, V12, P167, DOI 10.1016/0264-410X(94)90056-6; Wood JM, 2012, VACCINE, V30, P210, DOI 10.1016/j.vaccine.2011.11.019; Xie H, 2017, CLIN INFECT DIS; Xie H, 2011, CLIN INFECT DIS, V53, P1179, DOI 10.1093/cid/cir693; Xie H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016650; Zacour M, 2016, CLIN VACCINE IMMUNOL, V23, P236, DOI 10.1128/CVI.00613-15	12	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179939	10.1371/journal.pone.0179939	http://dx.doi.org/10.1371/journal.pone.0179939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662088	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300075
J	Banuet-Martinez, M; Espinosa-de Aquino, W; Elorriaga-Verplancken, FR; Flores-Moran, A; Garcia, OP; Camacho, M; Acevedo-Whitehouse, K				Banuet-Martinez, Marina; Espinosa-de Aquino, Wendy; Elorriaga-Verplancken, Fernando R.; Flores-Moran, Adriana; Garcia, Olga P.; Camacho, Mariela; Acevedo-Whitehouse, Karina			Climatic anomaly affects the immune competence of California sea lions	PLOS ONE			English	Article							PRENATAL STRESS; LIFE-HISTORY; FUR SEALS; MILK; METABOLISM; NUTRITION; IMPACTS; ENERGY; COUNT	The past decades have been characterized by a growing number of climatic anomalies. As these anomalies tend to occur suddenly and unexpectedly, it is often difficult to procure empirical evidence of their effects on natural populations. We analysed how the recent sea surface temperature (SST) anomaly in the northeastern Pacific Ocean affects body condition, nutritional status, and immune competence of California sea lion pups. We found that pup body condition and blood glucose levels of the pups were lower during high SST events, although other biomarkers of malnutrition remained unchanged, suggesting that pups were experiencing early stages of starvation. Glucose-dependent immune responses were affected by the SST anomaly; specifically, pups born during high SST events had lower serum concentrations of IgG and IgA, and were unable to respond to an immune challenge. This means that not only were pups that were born during the SST anomaly less able to synthesize protective antibodies; they were also limited in their ability to respond rapidly to nonspecific immune challenges. Our study provides empirical evidence that atypical climatic conditions can limit energetic reserves and compromise physiological responses that are essential for the survival of a marine top predator.	[Banuet-Martinez, Marina; Espinosa-de Aquino, Wendy; Flores-Moran, Adriana; Acevedo-Whitehouse, Karina] Autonomous Univ Queretaro, Sch Nat Sci, Unit Basic & Appl Microbiol, Queretaro, Mexico; [Elorriaga-Verplancken, Fernando R.] IPN, Dept Fisheries & Marine Biol, Ctr Interdisciplinario Ciencias Marinas, CICIMAR, La Paz, Mexico; [Garcia, Olga P.; Camacho, Mariela] Autonomous Univ Queretaro, Sch Nat Sci, Dept Human Nutr, Queretaro, Mexico; [Acevedo-Whitehouse, Karina] Marine Mammal Ctr, Sausalito, CA 94965 USA	Universidad Autonoma de Queretaro; Instituto Politecnico Nacional - Mexico; Universidad Autonoma de Queretaro	Acevedo-Whitehouse, K (corresponding author), Autonomous Univ Queretaro, Sch Nat Sci, Unit Basic & Appl Microbiol, Queretaro, Mexico.; Acevedo-Whitehouse, K (corresponding author), Marine Mammal Ctr, Sausalito, CA 94965 USA.	karina.acevedo.whitehouse@uaq.mx		Garcia, Olga P/0000-0003-4040-8345; Acevedo-Whitehouse, Karina/0000-0001-8954-8782	Autonomous University of Queretaro [142908]; Mexican Consejo Nacional de Cienciay Tecnologia (CONACYT) [CB-181876, CB-153530, 287579, 369084, 778607]; Programa de Fortalecimiento a la Calidad Educativa, PFCE (Mexico)	Autonomous University of Queretaro; Mexican Consejo Nacional de Cienciay Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Fortalecimiento a la Calidad Educativa, PFCE (Mexico)	This work was funded by a grant from the Autonomous University of Queretaro (Fund for the Advancement of Scientific Research, 142908; http://www.uaq.mx/dip/index.php/fofi-uaq) and partly funded by the Mexican Consejo Nacional de Cienciay Tecnologia (CONACYT; http://www.conacyt.gob.mx), grant numbers: CB-181876 and CB-153530. Data from the 2012 cohort was collected during a study funded by CONACYT grant number CB-153530. AFM, WEA and MBM are funded by CONACYT graduate scholarships 287579, 369084, and 778607, respectively. Publication fees were covered by support from the Programa de Fortalecimiento a la Calidad Educativa, PFCE 2016 (Mexico).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alestra T, 2015, J EXP MAR BIOL ECOL, V468, P29, DOI 10.1016/j.jembe.2015.03.017; BARBER RT, 1983, SCIENCE, V222, P1203, DOI 10.1126/science.222.4629.1203; Bond NA, 2015, GEOPHYS RES LETT, V42, P3414, DOI 10.1002/2015GL063306; Bossart GD, 2001, CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION, P383, DOI 10.1201/9781420041637.sec4; Chust G, 2014, GLOBAL CHANGE BIOL, V20, P2124, DOI 10.1111/gcb.12562; Cook P, 2011, BIOL LETTERS, V7, P536, DOI 10.1098/rsbl.2011.0127; Demas GE, 2011, J ANIM ECOL, V80, P710, DOI 10.1111/j.1365-2656.2011.01813.x; Devney CA, SENS TROP SEAB, V90, P1175; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Elorriaga-Verplancken FR, 2016, PLOS ONE, V11; Garcia-Rodriguez FJ, 2004, FISH B-NOAA, V102, P47; Georges JY, 2001, PHYSIOL BIOCHEM ZOOL, V74, P548, DOI 10.1086/322164; Gulland FMD, 2012, JAVMA-J AM VET MED A, V241, P943, DOI 10.2460/javma.241.7.943; Hall AJ, 2002, FUNCT ECOL, V16, P462, DOI 10.1046/j.1365-2435.2002.00649.x; Honda T, 2016, CLIN CHIM ACTA, V457, P46, DOI 10.1016/j.cca.2016.03.017; Inelmen EM, 2006, CACHEXIA WASTING MOD, P59; Jeklova E, 2008, VET IMMUNOL IMMUNOP, V122, P231, DOI 10.1016/j.vetimm.2007.11.011; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; KERR DS, 1978, METABOLISM, V27, P411, DOI 10.1016/0026-0495(78)90097-5; Kintisch E, 2015, SCIENCE, V348, P17, DOI 10.1126/science.348.6230.17; Kuhn CE, 2014, MAR MAMMAL SCI, V30, P1297, DOI 10.1111/mms.12110; Lawler DF, 2014, PMMC CASE REP MAR MA, V1, P1; Leising AW, 2015, CAL COOP OCEAN FISH, V56, P31; Leung ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062728; LOWRY MS, 1991, FISH B-NOAA, V89, P331; Marques AH, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00120; Martin LB, 2006, FUNCT ECOL, V20, P290, DOI 10.1111/j.1365-2435.2006.01094.x; Martin LB, 2003, P ROY SOC B-BIOL SCI, V270, P153, DOI 10.1098/rspb.2002.2185; Maucher JM, 2005, ENVIRON HEALTH PERSP, V113, P461, DOI 10.1289/ehp.7649; McCabe RM, 2016, GEOPHYS RES LETT, V43, P10366, DOI 10.1002/2016GL070023; McClatchie S, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150628; McDade TW, 2005, AM J HUM BIOL, V17, P81, DOI 10.1002/ajhb.20095; Merlot E, 2008, BRAIN BEHAV IMMUN, V22, P42, DOI 10.1016/j.bbi.2007.05.007; MONGINI PKA, 1981, J EXP MED, V153, P1, DOI 10.1084/jem.153.1.1; National Oceanic and Atmospheric Administration, EL DISC; National Oceanic and Atmospheric Administration, 2014, FAQS 2013 CALIF SEA; Norberg SE, 2011, J WILDLIFE DIS, V47, P217, DOI 10.7589/0090-3558-47.1.217; Ono KA, 1991, PINNIPEDS EL NINO RE, P185; Palmer CS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00001; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; PRENTICE AM, 1983, HUM NUTR-CLIN NUTR, V37, P53; R Development Core Team, 2016, R LANG ENV STAT COMP; Ramsdell JS, 2008, MAR DRUGS, V6, P262, DOI [10.3390/md20080013, 10.3390/md6020262]; Rauw WM, 2014, FRONT GENET, V3, P267; Riet-Sapriza FG, 2012, J MAMMAL, V93, P1006, DOI 10.1644/11-MAMM-A-220.2; Robinson CJ, 2016, GEOPHYS RES LETT, V43, P7066, DOI 10.1002/2016GL069356; ROE CF, 1965, ANN SURG, V161, P140, DOI 10.1097/00000658-196501000-00022; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; TRILLMICH F, 1985, OECOLOGIA, V67, P19, DOI 10.1007/BF00378445; Vera-Massieu C, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150108; Weise MJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027113; Westerman DA, 1999, BRIT J HAEMATOL, V107, P512; WHITEHEAD RG, 1979, POSTGRAD MED J, V55, P303, DOI 10.1136/pgmj.55.643.303; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131	54	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179359	10.1371/journal.pone.0179359	http://dx.doi.org/10.1371/journal.pone.0179359			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658317	Green Published, gold, Green Submitted			2022-12-27	WOS:000404607900022
J	Gil-Arias, A; Harvey, S; Carceles, A; Praxedes, A; Del Villar, F				Gil-Arias, Alexander; Harvey, Stephen; Carceles, Adrian; Praxedes, Alba; Del Villar, Fernando			Impact of a hybrid TGfU-Sport Education unit on student motivation in physical education	PLOS ONE			English	Article							GAME PERFORMANCE; DECISION-MAKING; DIRECT INSTRUCTION; SELF-DETERMINATION; SKILL EXECUTION; PERCEIVED LOCUS; TACTICAL GAMES; COMPETENCE; KNOWLEDGE; MODELS	The Teaching Games for Understanding (TGfU) and Sport Education (SE) pedagogical models share several objectives and pedagogical processes. Despite this seemingly uncanny relationship, few studies have examined the efficacy of a hybrid TGfU/SE pedagogical model, particularly how a teacher's utilization of such a model impacts on student motivation. The purpose of the current study was to investigate the effect a hybrid TGfU/SE unit, in comparison to direct instruction, on students' perceptions of various aspects of their motivation to engage in physical education (autonomous motivation, basic psychological needs, enjoyment and intention to be physically active). A crossover design was utilized, using the technique of counterbalancing. One group experienced a hybrid SE/TGfU unit first, followed by a unit of direct instruction. A second group experienced the units in the opposite order. Participants were 55 students. The intervention was conducted over a total of 16 lessons. The hybrid unit was designed according to the characteristics of SE by using seasons, roles, persistent teams, etc. Learning tasks set by the teacher during individual lessons, however, were designed according to the pedagogical principles of TGfU. Student motivation data was generated using validated questionnaires. Results showed that regardless of the order of intervention, the two groups showed significant improvements in autonomy, competence and enjoyment when they were taught using the hybrid model. Instead, in the variables autonomous motivation, relatedness and intention to be physically active there were no significant improvements in one group. These results demonstrate that it is possible to design varied learning situations in which affiliation, leadership and trust are fostered, while tasks are adapted to the characteristics of the students. All this can cause greater autonomous motivation, and consequently, perceived competence in the student, a positive image of the sport to practice, and therefore greater enjoyment and to be physically active.	[Gil-Arias, Alexander; Carceles, Adrian] Catholic Univ San Antonio Murcia UCAM, Fac Sport, Murcia, Spain; [Harvey, Stephen] Ohio Univ, Athens, OH 45701 USA; [Praxedes, Alba] Univ Extremadura, Fac Sport Sci, Caceres, Spain; [Del Villar, Fernando] Rey Juan Carlos Univ, Area Phys Educ & Sport, Madrid, Spain	Universidad Catolica de Murcia; University System of Ohio; Ohio University; Universidad de Extremadura; Universidad Rey Juan Carlos	Gil-Arias, A (corresponding author), Catholic Univ San Antonio Murcia UCAM, Fac Sport, Murcia, Spain.	agilarias@ucam.edu		Harvey, Stephen/0000-0002-1854-4108; PRAXEDES PIZARRO, ALBA/0000-0001-8959-480X				Amado D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085275; Murcia JAM, 2009, SPAN J PSYCHOL, V12, P327, DOI 10.1017/S1138741600001724; Araujo R, 2016, EUR PHYS EDUC REV, V22, P185, DOI 10.1177/1356336X15597927; Arias-Estero JL, 2013, REV EDUC-MADRID, P485, DOI 10.4438/1988-592X-RE-2013-362-239; Baena-Extremera A, 2012, REV PSICODIDACT, V17, P377, DOI 10.1387/RevPsicodidact.4037; Borges F, 2014, REV PSICODIDACT, V19, P173; Carlson TB, 1997, J TEACH PHYS EDUC, V16, P176, DOI 10.1123/jtpe.16.2.176; Casey A, 2014, PHYS EDUC SPORT PEDA, V19, P18, DOI 10.1080/17408989.2012.726977; DAVIDS K, 1988, QUEST, V40, P126, DOI 10.1080/00336297.1988.10483894; De Meyer J, 2014, J EDUC PSYCHOL, V106, P541, DOI 10.1037/a0034399; Deci E.L., 2002, HDB SELF DETERMINATI; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Diaz-Del-Cueto M, 2012, CULT EDUC, V24, P273, DOI 10.1174/113564012802845677; DUDA JL, 1992, J EDUC PSYCHOL, V84, P290, DOI 10.1037/0022-0663.84.3.290; Dyson B, 2004, QUEST, V56, P226, DOI 10.1080/00336297.2004.10491823; Farias CF, 2015, J TEACH PHYS EDUC, V34, P363, DOI 10.1123/jtpe.2013-0149; Ferriz R, 2015, REV PSICOL DEPORTE, V24, P329; GOUDAS M, 1994, BRIT J EDUC PSYCHOL, V64, P453, DOI 10.1111/j.2044-8279.1994.tb01116.x; Grasten A, 2012, J SPORT SCI MED, V11, P260; Grube D., 2005, TEACHING ELEMENTARY, V16, P32; Gucciardi DF, 2015, J SCI MED SPORT, V18, P31, DOI 10.1016/j.jsams.2013.11.011; Harvey S., 2015, Asia-Pacific Journal of Health, Sport and Physical Education, V6, P175, DOI 10.1080/18377122.2015.1051268; Harvey S, 2014, PHYS EDUC SPORT PEDA, V19, P278, DOI 10.1080/17408989.2012.754005; Hastie P., 2006, PHYS EDUC SPORT PEDA, V11, P1, DOI DOI 10.1080/17408980500466813; Hastie P, 2014, EUR PHYS EDUC REV, V20, P215, DOI 10.1177/1356336X14524858; Hastie PA, 2014, J TEACH PHYS EDUC, V33, P422, DOI 10.1123/jtpe.2013-0141; Hastie PA, 2013, RES Q EXERCISE SPORT, V84, P336, DOI 10.1080/02701367.2013.812001; Kirk D, 2013, EDUC PHILOS THEORY, V45, P973, DOI 10.1080/00131857.2013.785352; Kline P., 1998, NEW PSYCHOMETRICS SC; Light R, 2003, QUEST, V55, P161, DOI 10.1080/00336297.2003.10491797; Light R, 2006, EUR PHYS EDUC REV, V12, P99, DOI 10.1177/1356336X06060659; Light RL, 2014, SPORT EDUC SOC, V19, P258, DOI 10.1080/13573322.2012.665803; Mahedero P, 2015, J TEACH PHYS EDUC, V34, P626, DOI 10.1123/jtpe.2014-0061; Mandigo J, 2008, EUR PHYS EDUC REV, V14, P407, DOI 10.1177/1356336X08095673; Mesquita I, 2012, EUR PHYS EDUC REV, V18, P205, DOI 10.1177/1356336X12440027; Metzler M., 2011, INSTRUCTIONAL MODELS; Mitchell SA, 2006, TEACHING SPORTS CONC; Murcia JAM, 2008, REV MEX PSICOL, V25, P295; Morgan K., 2005, European Physical Education Review, V11, P257, DOI 10.1177/1356336X05056651; Moy B, 2016, PHYS EDUC SPORT PEDA, V21, P517, DOI 10.1080/17408989.2015.1072506; Ntoumanis N, 2009, THEORY RES EDUC, V7, P194, DOI 10.1177/1477878509104324; Pallant J., 2007, SPSS SURVIVAL MANUAL, VVolume 15, DOI DOI 10.1111/1753-6405.12166; Pereira J, 2015, J SPORT SCI MED, V14, P118; Perlman D, 2010, J TEACH PHYS EDUC, V29, P433, DOI 10.1123/jtpe.29.4.433; Peters D., 2010, EUROPEAN J PHYS HLTH, V4 (2), P57; Rutten C, 2012, J TEACH PHYS EDUC, V31, P216, DOI 10.1123/jtpe.31.3.216; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Sanchez-Oliva D, 2014, J TEACH PHYS EDUC, V33, P232, DOI 10.1123/jtpe.2013-0043; Siedentop D., 1994, SPORT ED QUALITY PE; Siedentop DL, 2011, COMPLETE GUIDE SPORT; Slavin R.E., 2002, EDUC RES-UK, V31, P15, DOI [10.3102/0013189X031007015, DOI 10.3102/0013189X031007015]; Smith L, 2015, EUR PHYS EDUC REV, V21, P93, DOI 10.1177/1356336X14555293; Spittle M., 2009, Physical Education and Sport Pedagogy, V14, P253, DOI 10.1080/17408980801995239; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; Tan CWK, 2012, PHYS EDUC SPORT PEDA, V17, P331, DOI 10.1080/17408989.2011.582486; Tessier D, 2010, CONTEMP EDUC PSYCHOL, V35, P242, DOI 10.1016/j.cedpsych.2010.05.005; Thomas JR., 2015, RES METHODS PHYS ACT, V7; Thorpe, 1982, B PHYS ED, V18 (1), P5, DOI DOI 10.1177/1356336X13496001; Vallerand RJ, 2001, ADV MOTIVATION SPORT, P163; Vlachopoulos SP, 2006, MEAS PHYS EDUC EXERC, V10, P179, DOI 10.1207/s15327841mpee1003_4; Wallhead TL, 2004, RES Q EXERCISE SPORT, V75, pA83; Wallhead TL, 2014, RES Q EXERCISE SPORT, V85, P478, DOI 10.1080/02701367.2014.961051; Wallhead TL, 2013, PHYS EDUC SPORT PEDA, V18, P427, DOI 10.1080/17408989.2012.690377; Ward P, 2015, RES Q EXERCISE SPORT, V86, P130, DOI 10.1080/02701367.2014.987908; Werner P. H., 1996, Journal of Physical Education, Recreation & Dance, V67, P28	65	42	44	5	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179876	10.1371/journal.pone.0179876	http://dx.doi.org/10.1371/journal.pone.0179876			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JT	28658267	Green Submitted, Green Published, gold			2022-12-27	WOS:000404607900044
J	McNamara, JW; Li, A; Lal, S; Bos, JM; Harris, SP; van der Velden, J; Ackerman, MJ; Cooke, R; dos Remedios, CG				McNamara, James W.; Li, Amy; Lal, Sean; Bos, J. Martijn; Harris, Samantha P.; van der Velden, Jolanda; Ackerman, Michael J.; Cooke, Roger; dos Remedios, Cristobal G.			MYBPC3 mutations are associated with a reduced super-relaxed state in patients with hypertrophic cardiomyopathy	PLOS ONE			English	Article							BINDING-PROTEIN-C; REGULATORY LIGHT-CHAIN; MYOSIN ATP TURNOVER; CARDIAC MYOSIN; MUSCLE MYOSIN; EXPRESSION PATTERNS; HEAVY-MEROMYOSIN; ATOMIC MODEL; HEART-MUSCLE; PHOSPHORYLATION	The "super-relaxed state" (SRX) of myosin represents a 'reserve' of motors in the heart. Myosin heads in the SRX are bound to the thick filament and have a very low ATPase rate. Changes in the SRX are likely to modulate cardiac contractility. We previously demonstrated that the SRX is significantly reduced in mouse cardiomyocytes lacking cardiac myosin binding protein C (cMyBP-C). Here, we report the effect of mutations in the cMyBP-C gene (MYBPC3) using samples from human patients with hypertrophic cardiomyopathy (HCM). Left ventricular (LV) samples from 11 HCM patients were obtained following myectomy surgery to relieve LV outflow tract obstruction. HCM samples were genotyped as either MYBPC3 mutation positive (MYBPC3(mut)) or negative (HCMsmn) and were compared to eight non-failing donor hearts. Compared to donors, only MYBPC3mut samples display a significantly diminished SRX, characterised by a decrease in both the number of myosin heads in the SRX and the lifetime of ATP turnover. These changes were not observed in HCMsmn samples. There was a positive correlation (p < 0.01) between the expression of cMyBP-C and the proportion of myosin heads in the SRX state, suggesting cMyBP-C modulates and maintains the SRX. Phosphorylation of the myosin regulatory light chain in MYBPC3mut samples was significantly decreased compared to the other groups, suggesting a potential mechanism to compensate for the diminished SRX. We conclude that by altering both contractility and sarcomeric energy requirements, a reduced SRX may be an important disease mechanism in patients with MYBPC3 mutations.	[McNamara, James W.; Lal, Sean; dos Remedios, Cristobal G.] Univ Sydney, Bosch Inst, Discipline Anat & Histol, Sydney, NSW, Australia; [McNamara, James W.] Univ Cincinnati, Coll Med, Div Cardiovasc Hlth & Dis, Cincinnati, OH USA; [Li, Amy] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT USA; [Bos, J. Martijn; Ackerman, Michael J.] Mayo Clin, Dept Pediat & Adolescent Med, Div Pediat Cardiol, Rochester, MN USA; [Bos, J. Martijn; Ackerman, Michael J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Windland Smith Rice Sudden Death Genom Lab, Rochester, MN USA; [Harris, Samantha P.] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ USA; [van der Velden, Jolanda] Vrije Univ Amsterdam, Med Ctr, Inst Cardiovasc Res, Dept Physiol, De Boelelaan 1117, Amsterdam, Netherlands; [Ackerman, Michael J.] Mayo Clin, Dept Cardiovasc Dis, Div Heart Rhythm Serv, Rochester, MN USA; [Cooke, Roger] Univ Calif San Francisco, Dept Biochem & Biophys, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of Sydney; University System of Ohio; University of Cincinnati; University of Vermont; Mayo Clinic; Mayo Clinic; University of Arizona; Vrije Universiteit Amsterdam; Mayo Clinic; University of California System; University of California San Francisco	McNamara, JW (corresponding author), Univ Sydney, Bosch Inst, Discipline Anat & Histol, Sydney, NSW, Australia.; McNamara, JW (corresponding author), Univ Cincinnati, Coll Med, Div Cardiovasc Hlth & Dis, Cincinnati, OH USA.	mcnamajw@ucmail.uc.edu	McNamara, James/T-6660-2019	van der Velden, Jolanda/0000-0001-5224-5788; McNamara, James/0000-0003-3754-6405	NG Macintosh Memorial Fund (Discipline of Anatomy and Histology, The University of Sydney); National Heart Foundation [GNT1093852, PB 12S 6939]; Netherlands	NG Macintosh Memorial Fund (Discipline of Anatomy and Histology, The University of Sydney); National Heart Foundation(National Heart Foundation of Australia); Netherlands(Netherlands Government)	JWM, AL and SL were supported by the NG Macintosh Memorial Fund (Discipline of Anatomy and Histology, The University of Sydney). The National Heart Foundation supports SL (GNT1093852) and AL (PB 12S 6939). We thank Medical Advances Without Animals for funding the Sydney Heart Bank equipment. The study was supported in part by a grant from The Netherlands	AL-Khayat HA, 2013, P NATL ACAD SCI USA, V110, P318, DOI 10.1073/pnas.1212708110; Alamo L, 2008, J MOL BIOL, V384, P780, DOI 10.1016/j.jmb.2008.10.013; Ashrafian H, 2003, TRENDS GENET, V19, P263, DOI 10.1016/S0168-9525(03)00081-7; BONNE G, 1995, NAT GENET, V11, P438, DOI 10.1038/ng1295-438; Colson BA, 2014, BIOCH BIOPHYS RES CO; Colson BA, 2008, CIRC RES, V103, P244, DOI 10.1161/CIRCRESAHA.108.178996; Colson BA, 2012, J MOL CELL CARDIOL, V53, P609, DOI 10.1016/j.yjmcc.2012.07.012; Colson BA, 2010, J PHYSIOL-LONDON, V588, P981, DOI 10.1113/jphysiol.2009.183897; COOKE R, 1985, BIOPHYS J, V48, P789, DOI 10.1016/S0006-3495(85)83837-6; Cooke Roger, 2011, Biophys Rev, V3, P33; Craig R, 2006, CURR OPIN STRUC BIOL, V16, P204, DOI 10.1016/j.sbi.2006.03.006; CRAIG R, 1976, PROC R SOC SER B-BIO, V192, P451, DOI 10.1098/rspb.1976.0023; Crilley JG, 2003, J AM COLL CARDIOL, V41, P1776, DOI 10.1016/S0735-1097(02)03009-7; FERENCZI MA, 1978, BIOCHEM J, V171, P165, DOI 10.1042/bj1710165; Freiburg A, 1996, EUR J BIOCHEM, V235, P317, DOI 10.1111/j.1432-1033.1996.00317.x; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; Green EM, 2016, SCIENCE, V351, P617, DOI 10.1126/science.aad3456; Harris SP, 2002, CIRC RES, V90, P594, DOI 10.1161/01.RES.0000012222.70819.64; Helms AS, 2014, CIRC-CARDIOVASC GENE, V7, P434, DOI 10.1161/CIRCGENETICS.113.000448; Herron TJ, 2006, CIRC RES, V98, P1290, DOI 10.1161/01.RES.0000222059.54917.ef; Hooijman P, 2011, BIOPHYS J, V100, P1969, DOI 10.1016/j.bpj.2011.02.061; Houston BA, 2014, CLIN MED INSIGHTS-CA, V8, P53, DOI 10.4137/CMC.S15717; Husberg C, 2012, PROTEOMICS, V12, P973, DOI 10.1002/pmic.201100116; Kampourakis T, 2016, P NATL ACAD SCI USA, V113, pE3039, DOI 10.1073/pnas.1602776113; Kampourakis T, 2015, J MOL CELL CARDIOL, V85, P199, DOI 10.1016/j.yjmcc.2015.06.002; Kampourakis T, 2014, P NATL ACAD SCI USA, V111, P18763, DOI 10.1073/pnas.1413922112; Kobayashi T, 2008, PFLUG ARCH EUR J PHY, V457, P37, DOI 10.1007/s00424-008-0511-8; Kong SW, 2010, CIRC-CARDIOVASC GENE, V3, P138, DOI 10.1161/CIRCGENETICS.109.904698; Lin B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069671; Lin ZQ, 2016, DEV CELL, V39, P466, DOI 10.1016/j.devcel.2016.09.005; Lynch TL, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/424751; Marston S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138568; Marston S, 2012, J MUSCLE RES CELL M, V33, P75, DOI 10.1007/s10974-011-9268-3; Marston S, 2009, CIRC RES, V105, P219, DOI 10.1161/CIRCRESAHA.109.202440; McNamara JW, 2016, J MOL CELL CARDIOL, V94, P65, DOI 10.1016/j.yjmcc.2016.03.009; McNamara James W, 2015, Biophys Rev, V7, P5, DOI 10.1007/s12551-014-0151-5; Mollova M, 2013, P NATL ACAD SCI USA, V110, P1446, DOI 10.1073/pnas.1214608110; Moore JR, 2012, CIRC RES, V111, P375, DOI 10.1161/CIRCRESAHA.110.223842; MYBURGH KH, 1995, J GEN PHYSIOL, V106, P957, DOI 10.1085/jgp.106.5.957; Naber N, 2011, J MOL BIOL, V411, P943, DOI 10.1016/j.jmb.2011.06.051; Oakley CE, 2007, INT J BIOCHEM CELL B, V39, P2161, DOI 10.1016/j.biocel.2006.12.008; Polizzotti BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5171; Radke MB, 2014, ELIFE, V3, DOI 10.7554/eLife.01603; Ratti J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.156646; Razumova MV, 2008, J GEN PHYSIOL, V132, P575, DOI 10.1085/jgp.200810013; Reconditi M, 2017, P NATL ACAD SCI USA, V114, P3240, DOI 10.1073/pnas.1619484114; RosalieWitjas-Paalberends E, 2014, CARDIOVASC RES, V103, P248, DOI 10.1093/cvr/cvu127; Santos S, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-17; Semsarian C, 2015, J AM COLL CARDIOL, V65, P1249, DOI 10.1016/j.jacc.2015.01.019; Sequeira V, 2013, CIRC RES, V112, P1491, DOI 10.1161/CIRCRESAHA.111.300436; Shaffer JF, 2009, J BIOL CHEM, V284, P12318, DOI 10.1074/jbc.M808850200; Spudich JA, 2015, BIOCHEM SOC T, V43, P64, DOI 10.1042/BST20140324; Spudich JA, 2014, BIOPHYS J, V106, P1236, DOI 10.1016/j.bpj.2014.02.011; STARR R, 1978, BIOCHEM J, V171, P813, DOI 10.1042/bj1710813; STARR R, 1971, FEBS LETT, V15, P40, DOI 10.1016/0014-5793(71)80075-3; Stewart MA, 2010, P NATL ACAD SCI USA, V107, P430, DOI 10.1073/pnas.0909468107; Theis JL, 2009, CIRC-HEART FAIL, V2, P325, DOI 10.1161/CIRCHEARTFAILURE.108.789735; Towbin JA, 2009, PACE, V32, pS23, DOI 10.1111/j.1540-8159.2009.02381.x; van Dijk SJ, 2015, J MOL CELL CARDIOL, V88, P124, DOI 10.1016/j.yjmcc.2015.09.006; van Dijk SJ, 2009, CIRCULATION, V119, P1473, DOI 10.1161/CIRCULATIONAHA.108.838672; WATKINS H, 1995, NAT GENET, V11, P434, DOI 10.1038/ng1295-434; Wendt T, 2001, P NATL ACAD SCI USA, V98, P4361, DOI 10.1073/pnas.071051098; Wijnker PJM, 2016, J MOL CELL CARDIOL; Woodhead JL, 2005, NATURE, V436, P1195, DOI 10.1038/nature03920; Zaremba R, 2007, PROTEOM CLIN APPL, V1, P1285, DOI 10.1002/prca.200600891; Zhao FQ, 2009, J MOL BIOL, V385, P423, DOI 10.1016/j.jmb.2008.10.038; Zoghbi ME, 2008, P NATL ACAD SCI USA, V105, P2386, DOI 10.1073/pnas.0708912105	67	57	58	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180064	10.1371/journal.pone.0180064	http://dx.doi.org/10.1371/journal.pone.0180064			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658286	Green Published, Green Submitted, gold			2022-12-27	WOS:000404607900055
J	Cortesi, PA; D'Angiolella, LS; Vellucci, R; Allegri, M; Casale, G; Favaretti, C; Kheiraoui, F; Cesana, G; Mantovani, LG				Cortesi, Paolo Angelo; D'Angiolella, Lucia Sara; Vellucci, Renato; Allegri, Massimo; Casale, Giuseppe; Favaretti, Carlo; Kheiraoui, Flavia; Cesana, Giancarlo; Mantovani, Lorenzo Giovanni			Cost-effectiveness analysis of oral fentanyl formulations for breakthrough cancer pain treatment	PLOS ONE			English	Article							OPIOID ANALGESICS; CLINICAL-PRACTICE; PREVALENCE; MANAGEMENT; RECOMMENDATIONS; MULTICENTER; THERAPY; HOSPICE; CARE; BTCP	Breakthrough cancer Pain (BTcP) has a high prevalence in cancer population. Patients with BTcP reported relevant health care costs and poor quality of life. The study assessed the cost-effectiveness of the available Oral Fentanyl Formulations (OFFs) for BTcP in Italy. A decision-analytical model was developed to estimate costs and benefits associated with treatments, from the Italian NHS perspective. Expected reductions in pain intensity per BTcP episodes were translated into, percentage of BTcP reduction, resource use and Quality-Adjusted-Life-Years (QALYs). Relative efficacy, resources used and unit costs data were derived from the literature and validated by clinical experts. Probabilistic and deterministic sensitivity analyses were performed. At base-case analysis, Sublingual Fentanyl Citrate (FCSL) compared to other oral formulations reported a lower patient's cost ((sic) 1,960.8) and a higher efficacy (18.7% of BTcP avoided and 0.0507 QALYs gained). The sensitivity analyses confirmed the main results in all tested scenarios, with the highest impact reported by BTcP duration and health care resources consumption parameters. Between OFFs, FCSL is the cost-effective option due to faster reduction of pain intensity. However, new research is needed to better understand the economic and epidemiologic impact of BTcP, and to collect more robust data on economic and quality of life impact of the different fentanyl formulations. Different fentanyl formulations are available to manage BTcP in cancer population. The study is the first that assesses the different impact in terms of cost and effectiveness of OFFs, providing new information to better allocate the resources available to treat BTcP and highlighting the need of better data.	[Cortesi, Paolo Angelo; D'Angiolella, Lucia Sara; Cesana, Giancarlo; Mantovani, Lorenzo Giovanni] Univ Milano Bicocca, Res Ctr Publ Hlth CESP, Monza, Italy; [Vellucci, Renato] Univ Hosp Careggi, Palliat Care & Pain Therapy Unit, Florence, Italy; [Allegri, Massimo] Univ Parma, Azienda Osped, Dept Surg Sci, Anesthesia Intens Care & Pain Therapy Serv, Parma, Italy; [Casale, Giuseppe] ANTEA Ctr, Antea Formad Educ, Rome, Italy; [Favaretti, Carlo; Kheiraoui, Flavia] Univ Cattolica Sacro Cuore, Inst Publ Hlth, Rome, Italy	University of Milano-Bicocca; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Parma; University Hospital of Parma; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	D'Angiolella, LS (corresponding author), Univ Milano Bicocca, Res Ctr Publ Hlth CESP, Monza, Italy.	l.dangiolella@campus.unimib.it	Allegri, Massimo/W-1090-2019; Cortesi, Paolo Angelo/AAD-7926-2020; Mantovani, Lorenzo Giovanni/AAC-4263-2021	Allegri, Massimo/0000-0002-8201-980X; vellucci, renato/0000-0002-5462-7920; Cortesi, Paolo Angelo/0000-0001-5241-4473				Abernethy Amy P, 2008, Am J Manag Care, V14, pS129; Agenzia Italiana del Farmaco (AIFA), CONS SPES FARM; Bennet D., 2005, PHARMACOL THERAPEUT, V30, P296; Brennan F, 2007, ANESTH ANALG, V105, P205, DOI 10.1213/01.ane.0000268145.52345.55; Caraceni A, 1999, PAIN, V82, P263, DOI 10.1016/S0304-3959(99)00073-1; Caraceni A, 2012, LANCET ONCOL, V13, pE58, DOI 10.1016/S1470-2045(12)70040-2; Chang Andrew, 2015, J Pain Palliat Care Pharmacother, V29, P247, DOI 10.3109/15360288.2015.1063560; Coluzzi PH, 2001, PAIN, V91, P123, DOI 10.1016/S0304-3959(00)00427-9; Cortesi PA, 2015, QIJPH, V4, P1; Darba J, 2014, CLINICOECONOMIC OUTC, V6, P1, DOI 10.2147/CEOR.S52273; Davis MP, 2012, J PAIN SYMPTOM MANAG, V44, pE1, DOI 10.1016/j.jpainsymman.2012.06.002; Deandrea S, 2014, J PAIN SYMPTOM MANAG, V47, P57, DOI 10.1016/j.jpainsymman.2013.02.015; Di Palma M, 2004, B CANCER, V91, P95; Fortner BV, 2002, J PAIN, V3, P38, DOI 10.1054/jpai.2002.27136; Fortner BV, 2003, J PAIN SYMPTOM MANAG, V25, P334, DOI 10.1016/S0885-3924(02)00679-6; Fortner BV, 2003, J PAIN SYMPTOM MANAG, V25, P9, DOI 10.1016/S0885-3924(02)00597-3; Furneri G, 2016, FARMECONOMIA, V17, P67, DOI 10.7175/fe.v17i2.1251; GRANT M, 1995, NURS CLIN N AM, V30, P673; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Mercadante S, 2016, SUPPORT CARE CANCER, V24, P961, DOI 10.1007/s00520-015-2951-y; Mercadante S, 2015, CLIN J PAIN, V31, P214, DOI 10.1097/AJP.0000000000000161; Mercadante S, 2012, DRUGS, V72, P181, DOI 10.2165/11597260-000000000-00000; National Institute for Health and Care Excellence (NICE), GUID METH TECHN APPR; National Institute for Health and Clinical Excellence (NICE), OP PALL CAR SAF EFF; Novotna S, 2014, CLIN THER, V36, P357, DOI 10.1016/j.clinthera.2014.01.006; Olivieri I, 2008, RHEUMATOLOGY, V47, P1664, DOI 10.1093/rheumatology/ken320; PORTENOY RK, 1990, PAIN, V41, P273, DOI 10.1016/0304-3959(90)90004-W; Portenoy RK, 1999, PAIN, V81, P129, DOI 10.1016/S0304-3959(99)00006-8; Portenoy RK, 2010, PAIN, V151, P617, DOI 10.1016/j.pain.2010.07.028; Ripamonti CI, 2012, ANN ONCOL, V23, P139, DOI 10.1093/annonc/mds233; Scalone L, 2013, VALUE HEALTH, V16, P814, DOI 10.1016/j.jval.2013.04.008; Taylor DR, 2013, CLIN PHARMACOL-ADV A, V5, P131, DOI 10.2147/CPAA.S26649; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; Vellucci R, 2016, DRUGS, V76, P315, DOI 10.1007/s40265-015-0519-2; Vissers DCJ, 2011, VALUE HEALTH, V14, P274, DOI 10.1016/j.jval.2010.09.007; Walker G, 2003, PALLIATIVE MED, V17, P219, DOI 10.1191/0269216303pm755oa; Zeppetella G, 2001, PALLIATIVE MED, V15, P243, DOI 10.1191/026921601678576220; Zeppetella G, 2000, J PAIN SYMPTOM MANAG, V20, P87, DOI 10.1016/S0885-3924(00)00161-5; Zeppetella G, 2013, COCHRANE DB SYST REV, V21; Zeppetella G, 2014, J PAIN SYMPTOM MANAG, V47, P772, DOI 10.1016/j.jpainsymman.2013.05.020; Zucco F, 2014, ADV THER, V31, P657, DOI 10.1007/s12325-014-0130-z	41	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179523	10.1371/journal.pone.0179523	http://dx.doi.org/10.1371/journal.pone.0179523			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654672	Green Submitted, Green Published, gold			2022-12-27	WOS:000404541500017
J	Wang, DJ; Amoozgar, B; Porco, T; Wang, Z; Lin, SC				Wang, Dajiang; Amoozgar, Behzad; Porco, Travis; Wang, Zhen; Lin, Shan C.			Ethnic differences in lens parameters measured by ocular biometry in a cataract surgery population	PLOS ONE			English	Article							ANGLE-CLOSURE GLAUCOMA; INTRAOCULAR-PRESSURE REDUCTION; ANTERIOR-CHAMBER DEPTH; NARROW ANGLES; UNEVENTFUL PHACOEMULSIFICATION; NONGLAUCOMATOUS EYES; POSITION PARAMETERS; PREVALENCE; EPIDEMIOLOGY; IMPLANTATION	Purpose To investigate whether differences exist in lens position and other lens parameters among major ethnic groups with cataractous eyes, which may help explain racial differences in angle closure risk. Methods This retrospective, cross-sectional study included 807 adult patients who had cataract surgery between years 2014 and 2016 at the University of California, San Francisco (UCSF). Adult patients of white, Asian, Hispanic and African-American ethnicity were included. Lens position (LP), defined as anterior chamber depth (ACD) + 1/2 lens thickness (LT), was assessed using measurements from optical biometry. Other assessed biometric parameters included axial length (AL), relative lens position (RLP) (defined as LP/AL), and anterior chamber depth (ACD). Results A total of 807 patients and 1361 eyes were included in this study from a database of patients having cataract surgery. Mean age was 69.2 years (age range from 18 to 101 years old), and 60.3% of patients were women. The mean LP measurements were 5.54 +/- 0.32 mmfor white, 5.38 +/- 0.32 mmfor Asian, 5.32 +/- 0.30 mm for Hispanic, and 5.40 +/- 0.28 mm for African-American participants. After adjusting for age, sex, and AL, significant differences were found when comparing LP in paired comparisons among White cohort with Asians (P<0.001), Hispanics (P<0.001) and African- Americans (P = 0.003). Additionally, when comparing RLP, similar significant results were found when comparing Whites with Asians (P< 0.001), Hispanics (P< 0.001) and African-Americans (P = 0.002). Lastly, pair-wise comparison of LT between ethnic groups showed significantdifferences while comparing Asians with Whites (P = 0.001) and Asians with African-Americans (P<0.001). Conclusion The results of this study suggest that the LP of Hispanic, Asian, and African-American patients are significantly smaller than that of White patients, and among all ethnic groups, Hispanics and after Asians have the smallest LP (P<0.001) and RLP (P< 0.001). These findings may have implications for the relative risk of angle closure and the potential IOP response after cataract surgery among different ethnic groups.	[Wang, Dajiang; Amoozgar, Behzad; Lin, Shan C.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Wang, Dajiang] Gen Hosp Peoples Liberat Army, Dept Ophthalmol, Beijing, Peoples R China; [Porco, Travis] Univ Calif San Francisco, Proctor Fdn, San Francisco, CA USA; [Wang, Zhen] Mayo Clin, Evidence Based Practice Ctr, Rochester, MN USA; [Wang, Zhen] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN USA; [Wang, Zhen] Mayo Clin, Dept Hlth Sci Res, Div Hlth Care Policy & Res, Rochester, MN USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Mayo Clinic; Mayo Clinic; Mayo Clinic	Lin, SC (corresponding author), Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA.	Shan.Lin@ucsf.edu		Wang, Dajiang/0000-0002-8726-1996	NIH-NEI (BETHESDA, Maryland, USA) [EY002162]; Research to Prevent Blindness (New York, New York, USA); That Man May See, Inc (San Francisco, California, USA); Beijing Natural Science Foundation [7162180]; Chinese National Natural Science Fund [81260147]	NIH-NEI (BETHESDA, Maryland, USA); Research to Prevent Blindness (New York, New York, USA)(Research to Prevent Blindness (RPB)); That Man May See, Inc (San Francisco, California, USA); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Chinese National Natural Science Fund(National Natural Science Foundation of China (NSFC))	This study was supported by NIH-NEI EY002162-CORE GRANT FOR VISION RESEARCH (BETHESDA, Maryland, USA), Research to Prevent Blindness (New York, New York, USA), and That Man May See, Inc (San Francisco, California, USA). This study was also supported by the Beijing Natural Science Foundation (7162180) and Chinese National Natural Science Fund (81260147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulrazik M, 2007, J GLAUCOMA, V16, P129, DOI 10.1097/01.ijg.0000212280.80724.e3; ALSBIRK PH, 1975, ACTA OPHTHALMOL, V53, P436; [Anonymous], 2002, SEMINARS OPHTHALMOLO; Chen RI, 2015, JAMA OPHTHALMOL, V133, P437, DOI 10.1001/jamaophthalmol.2014.5864; Coh P, 2016, INVEST OPHTH VIS SCI, V57, P2593, DOI 10.1167/iovs.16-19384; CONGDON N, 1992, SURV OPHTHALMOL, V36, P411, DOI 10.1016/S0039-6257(05)80022-0; Congdon NG, 1996, ACTA OPHTHALMOL SCAN, V74, P113; Cruysberg LPJ, 2010, BRIT J OPHTHALMOL, V94, P106, DOI 10.1136/bjo.2009.161729; Devereux JG, 2000, ARCH OPHTHALMOL-CHIC, V118, P257; Dooley I, 2010, EYE, V24, P520, DOI 10.1038/eye.2009.339; FISHER RF, 1972, J ANAT, V112, P207; Foster PJ, 1996, ARCH OPHTHALMOL-CHIC, V114, P1235, DOI 10.1001/archopht.1996.01100140435011; George R, 2003, BRIT J OPHTHALMOL, V87, P399, DOI 10.1136/bjo.87.4.399; Hayashi K, 2001, J CATARACT REFR SURG, V27, P1779, DOI 10.1016/S0886-3350(01)01036-7; He MG, 2006, INVEST OPHTH VIS SCI, V47, P2782, DOI 10.1167/iovs.06-0051; Hsu CH, 2015, INVEST OPHTH VIS SCI, V56, P7807, DOI 10.1167/iovs.15-17926; Huang GF, 2012, J CATARACT REFR SURG, V38, P108, DOI 10.1016/j.jcrs.2011.06.037; Huang GF, 2011, ARCH OPHTHALMOL-CHIC, V129, P1283, DOI 10.1001/archophthalmol.2011.272; Jonas JB, 2015, INVEST OPHTH VIS SCI, V56, P5309, DOI 10.1167/iovs.15-16796; Kingman S, 2004, B WORLD HEALTH ORGAN, V82, P887; Lavanya R, 2008, OPHTHALMOLOGY, V115, P1720, DOI 10.1016/j.ophtha.2008.03.015; Lavanya R, 2008, ARCH OPHTHALMOL-CHIC, V126, P686, DOI 10.1001/archopht.126.5.686; Lee RY, 2012, CURR EYE RES, V37, P486, DOI 10.3109/02713683.2012.669006; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Leung CK, 2010, BRIT J OPHTHALMOLOGY; Leydolt C, 2008, EYE, V22, P657, DOI 10.1038/sj.eye.6702709; Lim MCC, 2006, J GLAUCOMA, V15, P260, DOI 10.1097/01.ijg.0000212212.10395.76; LOWE RF, 1970, BRIT J OPHTHALMOL, V54, P161, DOI 10.1136/bjo.54.3.161; Mierzejewski Andrzej, 2008, Klin Oczna, V110, P11; Nongpiur ME, 2011, OPHTHALMOLOGY, V118, P474, DOI 10.1016/j.ophtha.2010.07.025; Otori Y, 2011, JPN J OPHTHALMOL, V55, P103, DOI 10.1007/s10384-010-0918-6; Pereira FAS, 2003, OPHTHALMOLOGY, V110, P1799, DOI 10.1016/S0161-6420(03)00623-7; Poley BJ, 2009, J CATARACT REFR SURG, V35, P1946, DOI 10.1016/j.jcrs.2009.05.061; Prum Bruce E Jr, 2016, Ophthalmology, V123, pP1, DOI 10.1016/j.ophtha.2015.10.049; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 2001, ARCH OPHTHALMOL-CHIC, V119, P1819, DOI 10.1001/archopht.119.12.1819; Sakata K, 2007, INVEST OPHTH VIS SCI, V48, P4974, DOI 10.1167/iovs.07-0342; Salmon J F, 1994, J Glaucoma, V3, P237; Salmon JF, 1999, PROG RETIN EYE RES, V18, P121, DOI 10.1016/S1350-9462(98)00007-X; SAXENA S, 1993, ANN OPHTHALMOL, V25, P453; Seah SKL, 1997, ARCH OPHTHALMOL-CHIC, V115, P1436, DOI 10.1001/archopht.1997.01100160606014; Shammas HJ, 2012, AM J OPHTHALMOL, V153, P55, DOI 10.1016/j.ajo.2011.06.012; Shrivastava A, 2010, CURR OPIN OPHTHALMOL, V21, P118, DOI 10.1097/ICU.0b013e3283360ac3; Slabaugh MA, 2014, CURR OPIN OPHTHALMOL, V25, P122, DOI 10.1097/ICU.0000000000000033; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Vizzeri G, 2010, CURR OPIN OPHTHALMOL, V21, P20, DOI 10.1097/ICU.0b013e328332f562; Wang DD, 2012, CLIN EXP OPHTHALMOL, V40, P162, DOI 10.1111/j.1442-9071.2011.02658.x; Wong TY, 2006, BRIT J OPHTHALMOL, V90, P506, DOI 10.1136/bjo.2005.083733	48	21	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179836	10.1371/journal.pone.0179836	http://dx.doi.org/10.1371/journal.pone.0179836			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654694	gold, Green Submitted, Green Published			2022-12-27	WOS:000404541500035
J	Mackiewicz, P; Moska, M; Wierzbicki, H; Gagat, P; Mackiewicz, D				Mackiewicz, Pawel; Moska, Magdalena; Wierzbicki, Heliodor; Gagat, Przemyslaw; Mackiewicz, Dorota			Evolutionary history and phylogeographic relationships of shrews from Sorex araneus group	PLOS ONE			English	Article							DETECTING TEMPORAL SHIFTS; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENETICS; HYBRID ZONE; CHROMOSOMAL REARRANGEMENTS; MARITIMENSIS INSECTIVORA; GROUP MAMMALIA; S-ARANEUS; SORICIDAE; DIVERSIFICATION	Shrews of the Sorex genus are an evolutionarily successful group that includes more than 77 species widely distributed in Eurasia and North America. The genus is one of the rare cases where karyotypic changes reflect well the evolutionary relationships among its species. The taxa showing the greatest variation in karyotype are usually classified into the Sorex araneus group. Its evolution was associated with chromosomal rearrangements, which could have promoted fast diversification of this group into many chromosomal races and species. These processes were additionally complicated by introgressions of mitochondrial DNA, which made the evolutionary history of this group quite complex and difficult to infer. To tackle the problem, we performed multi-method phylogenetic analyses based on mitochondrial cytochrome b that is considered a good molecular marker available for many representatives of Sorex. The results were compared with phylogenies based on chromosomal rearrangement data and put into temporal and spatial context using molecular dating and historical biogeography methods. We complemented the study with the estimation of diversification rates within the S. araneus group as well as comparing the results with paleontological records and climatic oscillations within the last 4 million years. Based on the gathered data, we proposed a hypothetical scenario for the evolution and geographic dispersion of species belonging to the S. araneus group. The shrews began to diversify about 2.7 million years ago in Eurasia and then migrated at least twice to North America. The evolution of shrews was driven by Pleistocene glacial and interglacial cycles, which increased their speciation rate and the emergence of new lineages. The migrations of populations were accompanied by introgressions of mitochondrial DNA into native shrews and occurred at least twice.	[Mackiewicz, Pawel; Gagat, Przemyslaw; Mackiewicz, Dorota] Univ Wroclaw, Fac Biotechnol, Dept Genom, Wroclaw, Poland; [Moska, Magdalena; Wierzbicki, Heliodor] Wroclaw Univ Environm & Life Sci, Dept Genet, Wroclaw, Poland	University of Wroclaw; Wroclaw University of Environmental & Life Sciences	Mackiewicz, P (corresponding author), Univ Wroclaw, Fac Biotechnol, Dept Genom, Wroclaw, Poland.	pamac@smorfland.uni.wroc.pl	Wierzbicki, Heliodor/AAX-3691-2021; Gagat, Przemysław/ABC-2296-2020; Mackiewicz, Dorota/AAJ-8963-2020	Wierzbicki, Heliodor/0000-0003-4937-556X; Gagat, Przemysław/0000-0001-9077-439X; Mackiewicz, Dorota/0000-0001-8922-8615; Moska, Magdalena/0000-0001-9866-9906; Mackiewicz, Pawel/0000-0003-4855-497X	Wroclaw Center of Biotechnology program "The Leading National Research Center (KNOW)"	Wroclaw Center of Biotechnology program "The Leading National Research Center (KNOW)"	Publication costs were supported by Wroclaw Center of Biotechnology program "The Leading National Research Center (KNOW) for years 2014-2018".; We would like to thank three anonymous Reviewers for their valuable comments and insightful remarks that significantly improved the paper. We are very grateful to prof. Jacques Hausser, prof. Larisa Biltueva and prof. Barbara Rzebik-Kowalska for helpful discussion about karyotypes and chromosomal rearrangements in shrews. Publication costs were supported by Wroclaw Center of Biotechnology program "The Leading National Research Center (KNOW) for years 2014-2018".	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Antoine P, 2016, QUATERNARY SCI REV, V149, P338, DOI 10.1016/j.quascirev.2016.07.035; Bannikova AA, 2010, MOL BIOL+, V44, P658, DOI 10.1134/S0026893310040230; Bannikova AA, 2010, BIOL J LINN SOC, V101, P721, DOI 10.1111/j.1095-8312.2010.01510.x; Basset P, 2008, J EVOLUTION BIOL, V21, P842, DOI 10.1111/j.1420-9101.2008.01506.x; Basset P, 2007, CYTOGENET GENOME RES, V116, P282, DOI 10.1159/000100412; Basset P, 2006, MOL ECOL, V15, P1577, DOI 10.1111/j.1365-294X.2006.02891.x; Biltueva L, 2011, CYTOGENET GENOME RES, V135, P51, DOI 10.1159/000330577; Borisov YM, 2012, COMP CYTOGENET, V6, P267, DOI 10.3897/CompCytogen.v6i3.3019; BRUNET-LECOMITE P, 1988, Bulletin Mensuel de la Societe Linneenne de Lyon, V57, P201; Brunner H, 2002, ACTA THERIOL, V47, P245, DOI 10.1007/BF03194146; Brunner H, 2002, CYTOGENET GENOME RES, V96, P85, DOI 10.1159/000063039; DANNELID E, 1991, MAMMAL REV, V21, P1, DOI 10.1111/j.1365-2907.1991.tb00284.x; DANNELID E, 1994, FOLIA ZOOL, V43, P71; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dubey S, 2007, MOL PHYLOGENET EVOL, V44, P126, DOI 10.1016/j.ympev.2006.12.002; Ezard T, 2009, SPECIES LIMITS THRES; Fumagalli L, 1999, MOL PHYLOGENET EVOL, V11, P222, DOI 10.1006/mpev.1998.0568; Fumagalli L, 1996, HEREDITAS, V125, P191, DOI 10.1111/j.1601-5223.1996.00191.x; Garcia-Perea Rosa, 1997, Mammalian Species, V554, P1; George SB, 1994, SPECIAL PUBLICATION, V18, P289; GRAF J-D, 1979, Bonner Zoologische Beitraege, V30, P14; Grigoryeva OO, 2011, RUSS J GENET+, V47, P1132, DOI 10.1134/S1022795411090067; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hansen J, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0294; HAUSSER J, 1991, Memoires de la Societe Vaudoise des Sciences Naturelles, V19, P79; HAUSSER J, 1994, FOLIA ZOOL, V43, P1; Hausser J., 1985, Acta Zoologica Fennica, P125; Hausser Jacques, 1994, Carnegie Museum of Natural History Special Publication, V18, P295; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; HOFFMANN R S, 1987, Acta Theriologica Sinica, V7, P100; Hofreiter M, 2009, CURR BIOL, V19, pR584, DOI 10.1016/j.cub.2009.06.030; Hope AG, 2011, MOL ECOL, V20, P4346, DOI 10.1111/j.1365-294X.2011.05226.x; Hope AG, 2010, J MAMMAL, V91, P1041, DOI 10.1644/09-MAMM-A-402.1; Hutterer R, 2005, MAMMAL SPECIES WORLD, P220; Ivanitskaya E.Yu., 1994, Carnegie Museum of Natural History Special Publication, V18, P313; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Jobb G, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0513-z; Kirkland Gordon L. Jr, 1996, Mammalian Species, V524, P1; Kotsakis Tassos, 2003, Deinsea (Rotterdam), V10, P313; Lapini L, 2001, ACTA THERIOL, V46, P337, DOI 10.1007/BF03192441; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Lopez-Fuster MJ, 1999, ACTA THERIOL, V44, P113; Lugon-Moulin N, 1999, MOL ECOL, V8, P419, DOI 10.1046/j.1365-294X.1999.00595.x; Lukacova L, 1996, HEREDITAS, V125, P233, DOI 10.1111/j.1601-5223.1996.00233.x; MEYLAN A, 1973, Zeitschrift fuer Saeugetierkunde, V38, P143; Meylan A, 1991, CYTOGENETICS SOREX A, V19.1, P125; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Nee S, 2001, EVOLUTION, V55, P661, DOI 10.1554/0014-3820(2001)055[0661:ISRFP]2.0.CO;2; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ohdachi SD, 2006, J ZOOL, V270, P177, DOI 10.1111/j.1469-7998.2006.00125.x; OKHOTINA MV, 1983, ZOOL ZH, V62, P409; Orlov V.N., 2010, Povolzhskii Ekologicheskii Zhurnal, V1, P111; Orlov VN, 2011, RUSS J GENET+, V47, P711, DOI 10.1134/S1022795411060159; Osipova VA, 2006, ACTA THERIOL, V51, P129, DOI 10.1007/BF03192664; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Popov Vasil V., 2003, Acta Zoologica Cracoviensia, V46, P43; Prost S, 2013, GLOBAL CHANGE BIOL, V19, P1865, DOI 10.1111/gcb.12153; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; R Core Team, 2013, R LANG ENV STAT COMP; Rabosky DL, 2008, EVOLUTION, V62, P1866, DOI 10.1111/j.1558-5646.2008.00409.x; Rabosky DL, 2006, EVOLUTION, V60, P1152; Rabosky DL, 2006, EVOL BIOINFORM, V2, P247; Rambaut A., 2014, TRACER V1 6; Rambaut A., 2012, FIGTREE V1 4 0; RAUSCH VR, 1993, P BIOL SOC WASH, V106, P410; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Rofes J, 2016, PALAEOGEOGR PALAEOCL, V459, P508, DOI 10.1016/j.palaeo.2016.07.021; ROGERS KL, 1985, NATL GEOGR RES, V1, P535; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rzebik-Kowalska Barbara, 2015, Acta Zoologica Cracoviensia, V58, P137, DOI 10.3409/azc.58_2.137; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; SEARLE J B, 1991, Memoires de la Societe Vaudoise des Sciences Naturelles, V19, P13; SHARMAN GB, 1956, NATURE, V177, P941, DOI 10.1038/177941a0; Shchipanov NA, 2016, BIOL BULL+, V43, P876, DOI 10.1134/S106235901608015X; Sher A.V., 1974, INT GEOL REV, V16, P1; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Stewart DT, 2002, CAN J ZOOL, V80, P94, DOI 10.1139/Z01-207; Swofford DL, 1998, PHYLOGENETIC ANAL US; TABERLET P, 1994, EVOLUTION, V48, P623, DOI 10.1111/j.1558-5646.1994.tb01349.x; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Virina E.I., 1984, IZVESTIA RUSSIAN ACA, V11, P61; VOLOBOUEV V, 1989, Z ZOOL SYST EVOL, V27, P252; VOLOBOUEV V, 1991, Memoires de la Societe Vaudoise des Sciences Naturelles, V19, P131; VOLOBOUEV VT, 1988, CAN J ZOOL, V66, P1968, DOI 10.1139/z88-288; VOLOBOUEV VT, 1989, J HERED, V80, P284, DOI 10.1093/oxfordjournals.jhered.a110855; White TA, 2010, SYST BIOL, V59, P262, DOI 10.1093/sysbio/syq004; WOJCIK JM, 1988, HEREDITY, V61, P225, DOI 10.1038/hdy.1988.109; Yannic G, 2008, MOL PHYLOGENET EVOL, V47, P237, DOI 10.1016/j.ympev.2008.01.029; Yannic G, 2008, J EVOLUTION BIOL, V21, P658, DOI 10.1111/j.1420-9101.2008.01526.x; Yannic G, 2010, MOL PHYLOGENET EVOL, V57, P1062, DOI 10.1016/j.ympev.2010.09.015; Yannic G, 2009, HEREDITY, V102, P616, DOI 10.1038/hdy.2009.19; Yannic G, 2012, BIOL J LINN SOC, V105, P864, DOI 10.1111/j.1095-8312.2011.01824.x; Yu Y, 2015, MOL PHYLOGENET EVOL, V87, P46, DOI 10.1016/j.ympev.2015.03.008; Zaitsev Mikhail V., 2002, Acta Zoologica Cracoviensia, V45, P283; Zaitsev MV, 2005, ADV BIOL SHREWS II S, V1, P49; Zima J., 1998, EVOLUTION SHREWS, P175	100	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179760	10.1371/journal.pone.0179760	http://dx.doi.org/10.1371/journal.pone.0179760			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650986	Green Published, Green Submitted, gold			2022-12-27	WOS:000404537300019
J	Godany, M; Khatri, BS; Goldstein, RA				Godany, Martin; Khatri, Bhavin S.; Goldstein, Richard A.			Optimal chemotactic responses in stochastic environments	PLOS ONE			English	Article							MICROSCALE NUTRIENT PATCHES; BACTERIAL CHEMOTAXIS; BEHAVIORAL-RESPONSES; ESCHERICHIA-COLI; RHODOBACTER-SPHAEROIDES; INTERMITTENT ROTATION; MARINE-BACTERIA; STRATEGIES		[Godany, Martin; Khatri, Bhavin S.; Goldstein, Richard A.] UCL, Div Infect & Immun, London, England; [Godany, Martin; Khatri, Bhavin S.] Francis Crick Inst, London, England	University of London; University College London; Francis Crick Institute	Goldstein, RA (corresponding author), UCL, Div Infect & Immun, London, England.	r.goldstein@ucl.ac.uk		Goldstein, Richard/0000-0001-5148-4672; Khatri, Bhavin/0000-0002-0312-336X	Biotechnology and Biological Sciences Research Council [BB/P007562/1] Funding Source: Medline; Medical Research Council [MC_PC_13056, MC_U117573805] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahmed T, 2010, INTEGR BIOL-UK, V2, P604, DOI 10.1039/c0ib00049c; ARMITAGE JP, 1987, J BACTERIOL, V169, P514, DOI 10.1128/jb.169.2.514-518.1987; Armitage JP, 1997, ARCH MICROBIOL, V168, P249, DOI 10.1007/s002030050496; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Bespalov VA, 1996, P NATL ACAD SCI USA, V93, P10084, DOI 10.1073/pnas.93.19.10084; Blackburn N, 1998, SCIENCE, V282, P2254, DOI 10.1126/science.282.5397.2254; Blackburn N, 1999, MAR ECOL PROG SER, V189, P1, DOI 10.3354/meps189001; Bray D, 2007, CURR BIOL, V17, P12, DOI 10.1016/j.cub.2006.11.027; Celani A, 2010, P NATL ACAD SCI USA, V107, P1391, DOI 10.1073/pnas.0909673107; Clark DA, 2005, P NATL ACAD SCI USA, V102, P9150, DOI 10.1073/pnas.0407659102; DANG CV, 1986, J BACTERIOL, V166, P275, DOI 10.1128/jb.166.1.275-280.1986; de Gennes PG, 2004, EUR BIOPHYS J BIOPHY, V33, P691, DOI 10.1007/s00249-004-0426-z; Dufour YS, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003694; Egbert MD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001004; Frankel NW, 2014, ELIFE, V3, DOI 10.7554/eLife.03526; Goldstein RA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000084; GOTZ R, 1987, J BACTERIOL, V169, P3146; Hamer R, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-3; Hoff WD, 1997, ANNU REV BIOPH BIOM, V26, P223, DOI 10.1146/annurev.biophys.26.1.223; Johansen JE, 2002, AQUAT MICROB ECOL, V28, P229, DOI 10.3354/ame028229; Kafri Y, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.238101; MathWorks, 2013, MATLAB IM PROC TOOLB; Mitchell JG, 2002, AM NAT, V160, P727, DOI 10.1086/343874; Packer HL, 2000, FEMS MICROBIOL LETT, V189, P299, DOI 10.1111/j.1574-6968.2000.tb09247.x; POOLE PS, 1988, J BACTERIOL, V170, P5673, DOI 10.1128/jb.170.12.5673-5679.1988; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; SCHNITZER MJ, 1993, PHYS REV E, V48, P2553, DOI 10.1103/PhysRevE.48.2553; SEGALL JE, 1986, P NATL ACAD SCI USA, V83, P8987, DOI 10.1073/pnas.83.23.8987; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Soyer OS, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-240; Stocker R, 2008, P NATL ACAD SCI USA, V105, P4209, DOI 10.1073/pnas.0709765105; Stocker R, 2012, MICROBIOL MOL BIOL R, V76, P792, DOI 10.1128/MMBR.00029-12; Vladimirov N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000242; Wuichet K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000724	34	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6												14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644830	Green Published, gold, Green Submitted			2022-12-27	WOS:000404145100011
J	Park, CH; Li, XR; Zhao, Y; Jia, RL; Hur, JS				Park, Chan-Ho; Li, Xin Rong; Zhao, Yang; Jia, Rong Liang; Hur, Jae-Seoun			Rapid development of cyanobacterial crust in the field for combating desertification	PLOS ONE			English	Article							BIOLOGICAL SOIL CRUSTS; MOJAVE DESERT; HEATED SOILS; DISTURBANCE; INOCULATION; RECOVERY; EROSION; MICROSTRUCTURE; COMMUNITIES; SYSTEMS	Desertification is currently a major concern, and vast regions have already been devastated in the arid zones of many countries. Combined application of cyanobacteria with soil fixing chemicals is a novel method of restoring desertified areas. Three cyanobacteria, Nostoc sp. Vaucher ex Bornet & Flahault, Phormidium sp. Kutzing ex Gomont and Scytonema arcan-geli Bornet ex Flahault were isolated and tested in this study. Tacki-Spray (TM) (TKS7), which consists of bio-polysaccharides and tackifiers, was used as a soil fixing agent. In addition, superabsorbent polymer (SAP) was applied to the soil as a water-holding material and nutrient supplement. Application of cyanobacteria with superabsorbent polymer and TKS7 (CST) remarkably improved macro-aggregate stability against water and erodibility against wind after 12 months of inoculation when compared to the control soil. The mean weight diameter and threshold friction velocity of the CST treated soil were found to be 75% and 88% of those of the approximately 20-year-old natural cyanobacterial crust (N-BSC), respectively, while these values were 68% and 73% of those of the N-BSC soil after a single treatment of cyanobacteria alone (CY). Interestingly, biological activities of CST were similar to those of CY. Total carbohydrate contents, cyanobacterial biomass, microbial biomass, soil respiration, carbon fixation and effective quantum yield of CST treated soil were enhanced by 50-100% of the N-BSC, while those of control soil were negligible. Our results suggest that combined application of cyanobacteria with soil fixing chemicals can rapidly develop cyanobacterial crust formation in the field within 12 months. The physical properties and biological activities of the inoculated cyanobacterial crust were stable during the study period. The novel method presented herein serves as another approach for combating desertification in arid regions.	[Park, Chan-Ho; Hur, Jae-Seoun] Sunchon Natl Univ, Korean Lichen Res Inst, 255 Jungang Ro, Sunchon, South Korea; [Li, Xin Rong; Zhao, Yang; Jia, Rong Liang] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Peoples R China	Sunchon National University; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS	Hur, JS (corresponding author), Sunchon Natl Univ, Korean Lichen Res Inst, 255 Jungang Ro, Sunchon, South Korea.	jshur1@sunchon.ac.kr	Li, Xinrong/GNW-6025-2022		Forest Science & Technology Projects [5111212L030100]; Korea Forest Service; Chinese Academy of Sciences [2013T2Z0007]	Forest Science & Technology Projects; Korea Forest Service(Korea Forest Service); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by a grant from the Forest Science & Technology Projects (Project No. 5111212L030100) provided by the Korea Forest Service and the Chinese Academy of Sciences visiting professorship for senior international scientists (Grant No. 2013T2Z0007). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acea MJ, 2003, SOIL BIOL BIOCHEM, V35, P513, DOI 10.1016/S0038-0717(03)00005-1; Acea MJ, 2001, BIOL FERT SOILS, V33, P118, DOI 10.1007/s003740000298; Barger NN, 2006, BIOGEOCHEMISTRY, V77, P247, DOI 10.1007/s10533-005-1424-7; BELNAP J, 1993, GREAT BASIN NAT, V53, P40; Belnap J, 2007, EARTH SURF PROC LAND, V32, P75, DOI 10.1002/esp.1372; BELNAP J, 1993, GREAT BASIN NAT, V53, P89; Belnap J, 2001, ECOL STU AN, V150, P363; Belnap J, 2001, BIOL SOIL CRUST ECOL; Buttars SM, 1998, ARID SOIL RES REHAB, V12, P165, DOI 10.1080/15324989809381506; Concostrina-Zubiri L, 2014, ECOL APPL, V24, P1863, DOI 10.1890/13-1416.1; Corti A, 2002, MACROMOL CHEM PHYS, V203, P1526, DOI 10.1002/1521-3935(200207)203:10/11<1526::AID-MACP1526>3.0.CO;2-R; de Caire GZ, 2000, SOIL BIOL BIOCHEM, V32, P1985, DOI 10.1016/S0038-0717(00)00174-7; Dorey G., 1991, POLYM INT, V24, P255, DOI [10.1002/pi.4990240409, DOI 10.1002/PI.4990240409]; Felde VJMNL, 2014, BIODIVERS CONSERV, V23, P1687, DOI 10.1007/s10531-014-0693-7; Gog L, 2005, CHEMOECOLOGY, V15, P115, DOI 10.1007/s00049-005-0294-8; Hamza MA, 2005, SOIL TILL RES, V82, P121, DOI 10.1016/j.still.2004.08.009; Harper K. T., 1988, Vegetation science applications for rangeland analysis and management.., P135; HOBBIE SE, 1998, CHLOROFORM FUMIGATIO; Jia RL, 2012, SOIL BIOL BIOCHEM, V45, P31, DOI 10.1016/j.soilbio.2011.09.021; Kuske CR, 2012, ISME J, V6, P886, DOI 10.1038/ismej.2011.153; Lan SB, 2014, ENVIRON SCI TECHNOL, V48, P307, DOI 10.1021/es403785j; Lee SS, 2011, J SOIL WATER CONSERV, V66, P172, DOI 10.2489/jswc.66.3.172; Li JR, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043245; Li XR, 2006, ECOL ENG, V28, P149, DOI 10.1016/j.ecoleng.2006.05.020; Li Y, 2011, PROCEDIA ENVIRON SCI, V11, P763, DOI 10.1016/j.proenv.2011.12.118; Liu J, 2012, ENVIRON EARTH SCI, V65, P589, DOI 10.1007/s12665-011-1106-9; Liu LC, 2007, AUST J SOIL RES, V45, P422, DOI 10.1071/SR06175; Lundquist EJ, 1999, SOIL BIOL BIOCHEM, V31, P1661, DOI 10.1016/S0038-0717(99)00080-2; Maestre FT, 2006, MICROB ECOL, V52, P365, DOI 10.1007/s00248-006-9017-0; Mager DM, 2011, J ARID ENVIRON, V75, P91, DOI 10.1016/j.jaridenv.2010.10.001; Malam Issa O, 2001, GEODERMA, V101, P15, DOI 10.1016/S0016-7061(00)00093-8; Malam Issa O, 2007, PLANT SOIL, V290, P209, DOI 10.1007/s11104-006-9153-9; Maqubela M. P., 2012, African Journal of Biotechnology, V11, P10726; Millennium Ecosystem Assessment, 2005, MILLENNIUM ECOSYSTEM; Nisha R, 2007, GEODERMA, V138, P49, DOI 10.1016/j.geoderma.2006.10.007; Park CH, 2017, ARID LAND RES MANAG, V31, P81, DOI 10.1080/15324982.2016.1198842; Park CH, 2015, ARID LAND RES MANAG, V29, P55, DOI 10.1080/15324982.2014.928835; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Ritchie RJ, 2008, PHOTOSYNTH RES, V96, P201, DOI 10.1007/s11120-008-9300-7; Ritchie RJ, 2006, PHOTOSYNTH RES, V89, P27, DOI 10.1007/s11120-006-9065-9; Rodriguez AR, 2006, CATENA, V66, P228, DOI 10.1016/j.catena.2006.02.001; Rossi F, 2012, SOIL BIOL BIOCHEM, V46, P33, DOI 10.1016/j.soilbio.2011.10.016; SAFARIK I, 1992, PLANT SOIL, V143, P109, DOI 10.1007/BF00009135; Schreiber U., 1998, P320; TIEDEMANN AR, 1980, SOIL BIOL BIOCHEM, V12, P471, DOI 10.1016/0038-0717(80)90082-6; TISDALL JM, 1982, J SOIL SCI, V33, P141, DOI 10.1111/j.1365-2389.1982.tb01755.x; UNCCD, 2001, GLOB AL DUST SANDST; Wang QR, 2011, ENVIRON MONIT ASSESS, V174, P241, DOI 10.1007/s10661-010-1454-z; Wang WB, 2009, SOIL BIOL BIOCHEM, V41, P926, DOI 10.1016/j.soilbio.2008.07.001; Warren S.D., 2003, BIOL SOIL CRUST STRU, P327, DOI [10.1007/978-3-642-56475-8_24, DOI 10.1007/978-3-642-56475-8_24]; West N. E., 1990, Advances in Ecological Research, V20, P179, DOI 10.1016/S0065-2504(08)60055-0; Williams AJ, 2012, SOIL SCI SOC AM J, V76, P1685, DOI 10.2136/sssaj2012.0021; Williams WJ, 2008, J ARID ENVIRON, V72, P1064, DOI 10.1016/j.jaridenv.2007.11.017; Wu YW, 2013, PLANT SOIL, V370, P115, DOI 10.1007/s11104-013-1611-6; Yan-Gui S, 2013, LAND DEGRAD DEV, V24, P342, DOI 10.1002/ldr.1131; Yang J, 2007, ENVIRON POLLUT, V149, P125, DOI 10.1016/j.envpol.2006.12.021; Yonter G, 2010, EKOLOJI, V19, P35, DOI 10.5053/ekoloji.2010.776; Yu J, 2003, SOIL SCI SOC AM J, V67, P630, DOI 10.2136/sssaj2003.0630; Zaady E, 2014, AEOLIAN RES, V13, P81, DOI 10.1016/j.aeolia.2014.04.002; Zohuriaan-Mehr MJ, 2008, IRAN POLYM J, V17, P451	61	57	62	6	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179903	10.1371/journal.pone.0179903	http://dx.doi.org/10.1371/journal.pone.0179903			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644849	Green Published, Green Submitted, gold			2022-12-27	WOS:000404145100048
J	Gao, J; Shen, B; Xiong, JJ; Lu, YH; Jiang, QW				Gao, Jie; Shen, Bing; Xiong, JianJing; Lu, Yihan; Jiang, Qingwu			The measles epidemic trend over the past 30 years in a central district in Shanghai, China	PLOS ONE			English	Article							OUTBREAK	Background Measles vaccination over the past 50 years has greatly reduced the incidence of measles. However, measles among migrants and the resulting changes in epidemiological characteristics have brought new challenges to the elimination of measles. We aim to describe the measles epidemic trend over the past 30 years in a central district in Shanghai, China. Methods The present study was conducted in the Jing'an District, which is located in the center of Shanghai. Based on historical surveillance data of measles, we calculated the incidence of measles among local residents and migrants separately. Next, we classified all of the cases of the measles among local residents between 1984 and 2015 into 8 age groups and 5 birth cohorts. Finally, we calculated the measles incidence in each time period by the different age groups and birth cohorts, to understand the measles epidemic trend over past 30 years in the Jing'an District. Results A total of 103 cases of measles were reported from the Jing'an District, Shanghai, from 1984 to 2015. For infants less than 1 year of age and adults over 30 years of age, the incidence of measles continued to rise over the past 30 years. For a specific birth cohort, the incidence of measles after measles vaccination declined initially, and was then followed by a rebound. Conclusions The incidence of measles in older adults and infants increased in some developed regions, which slows the process of measles elimination. This suggested that the population immunity against measles after measles vaccination would gradually reduce with time. We recommend supplemental immunization against measles in adults in order to reduce the immunity decline, especially for migrants.	[Gao, Jie; Lu, Yihan; Jiang, Qingwu] Fudan Univ, Sch Publ Hlth, Minister Educ, Key Lab Publ Hlth Safety, Shanghai, Peoples R China; [Gao, Jie; Shen, Bing; Xiong, JianJing] Jingan Dist Ctr Dis Control & Prevent, Shanghai, Peoples R China	Fudan University; Shanghai Center for Disease Control & Prevention	Lu, YH; Jiang, QW (corresponding author), Fudan Univ, Sch Publ Hlth, Minister Educ, Key Lab Publ Hlth Safety, Shanghai, Peoples R China.	luyihan@fudan.edu.cn; jiangqw@shmu.edu.cn		Jiang, Qingwu/0000-0001-8921-3317				Abram L. H., 2016, INT J INFECT DIS, V45, P103; [Anonymous], WKLY EPIDEMIOL REC; Cao L., 2012, CHIN J VACCINES IMMU, V18, P419; Cho HK, 2016, J KOREAN MED SCI, V31, P1957, DOI 10.3346/jkms.2016.31.12.1957; David ND, 2014, VACCINE, V32, P6880; Gao Jie, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P1163; Han K, 2016, HUM VACC IMMUNOTHER, V12, P2181, DOI 10.1080/21645515.2016.1159364; Jordan SM, 2015, BIOMED RES INT; Li J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-986; Ma C, 2014, B WORLD HEALTH ORGAN, V92, P340, DOI 10.2471/BLT.13.130195; Ma C, 2011, J INFECT DIS, V204, pS447, DOI 10.1093/infdis/jir103; McCarthy M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h436; Ogbuanu I U, 2016, SAMJ, S. Afr. med. j., V106, P715, DOI [10.7196/samj.2016.v106i7.10651, 10.7196/SAMJ.2016.v106i7.10651]; Shi Y, 2006, CHINESE J VACCINES I, V12, P32; Tang ZZ, 2016, AM J INFECT CONTROL, V44, pE51, DOI 10.1016/j.ajic.2015.11.005; Wang XX, 2015, VACCINE, V33, P6186, DOI 10.1016/j.vaccine.2015.10.008; WHO position papers Measles vaccines, WER 2004, P14130; Williams GA, 2016, SCAND J PUBLIC HEALT, V44, P6, DOI 10.1177/1403494815610182; World Health Organization, 2010, 63 WORLD HLTH ASS PR, V11; Xu TQ, 1997, CHINESE J VACCINES I, V3, P24; Zhang MX, 2016, EMERG INFECT DIS, V22, P144, DOI 10.3201/eid2201.151293	21	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179470	10.1371/journal.pone.0179470	http://dx.doi.org/10.1371/journal.pone.0179470			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640919	Green Published, gold, Green Submitted			2022-12-27	WOS:000404135800034
J	Qiu, J; Wang, JH; Xu, ZQ; Liu, HQ; Ren, J				Qiu, Jun; Wang, Jinhao; Xu, Zhongqi; Liu, Huiqing; Ren, Jie			Quantitation of underivatized branched-chain amino acids in sport nutritional supplements by capillary electrophoresis with direct or indirect UV absorbance detection	PLOS ONE			English	Article							ZONE-ELECTROPHORESIS; GAS-CHROMATOGRAPHY; PROTEIN-SYNTHESIS; SEPARATION; MASS; ENANTIOMERS; PERFORMANCE; DERIVATIVES; PLASMA; HPLC	The branched-chain amino acids (BCAAs) including leucine (Leu), isoleucine (Ile) and valine (Val) play a pivotal role in the human body. Herein, we developed capillary electrophoresis (CE) coupled with conventional UV detector to quantify underivatized BCAAs in two kinds of sport nutritional supplements. For direct UV detection at 195 nm, the BCAAs (Leu, two enantiomers of Ile and Val) were separated in a background electrolyte (BGE) consisting of 40.0 mmol/L sodium tetraborate, and 40.0 mmol/L beta-cyclodextrin (beta-CD) at pH 10.2. In addition, the indirect UV detection at 264 nm was achieved in a BGE of 2.0 mmol/L Na2HPO4, 10.0 mmol/L p-aminosalicylic acid (PAS) as UV absorbing probe, and 40.0 mmol/L beta-CD at pH 12.2. The beta-CD significantly benefited the isomeric separation of Leu, L- and D-Ile. The optimal conditions allowed the LODs (limit of detections) of direct and indirect UV absorption detection to be tens mu mol/L level, which was comparable to the reported CE inline derivatization method. The RSDs (relative standard deviations) of migration time and peak area were less than 0.91% and 3.66% (n = 6). Finally, CE with indirect UV detection method was applied for the quantitation of BCAAs in two commercial sport nutritional supplements, and good recovery and precision were obtained. Such simple CE method without tedious derivatization process is feasible of quality control and efficacy evaluation of the supplemental proteins.	[Qiu, Jun; Wang, Jinhao] Shanghai Res Inst Sports Sci, Shanghai, Peoples R China; [Xu, Zhongqi; Liu, Huiqing] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai, Peoples R China; [Ren, Jie] Shanghai Univ Sport, China Table Tennis Coll, Shanghai, Peoples R China	Donghua University; Shanghai University of Sport	Xu, ZQ (corresponding author), Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai, Peoples R China.; Ren, J (corresponding author), Shanghai Univ Sport, China Table Tennis Coll, Shanghai, Peoples R China.	chemxzq@dhu.edu.cn; renjiemail2008@163.com	, 徐中其@东华/AHB-5022-2022; Xu, Zhongqi/D-1023-2010	, 徐中其@东华/0000-0003-4786-6234; Xu, Zhongqi/0000-0003-4786-6234	Shanghai Municipal Natural Science Foundation [16ZR1401400]; Shanghai Sports Bureau [14ZH024]	Shanghai Municipal Natural Science Foundation; Shanghai Sports Bureau	This work was financed by Shanghai Municipal Natural Science Foundation (16ZR1401400), and partly supported by the General Plan of Science & Technology in 2014 from Shanghai Sports Bureau (Project No. 14ZH024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blomstrand E, 2006, J NUTR, V136, p544S, DOI 10.1093/jn/136.2.544S; Boniglia C, 2002, J FOOD SCI, V67, P1352, DOI 10.1111/j.1365-2621.2002.tb10287.x; Cavazza A, 2000, J AGR FOOD CHEM, V48, P3324, DOI 10.1021/jf991368m; Chang PL, 2011, ELECTROPHORESIS, V32, P1080, DOI 10.1002/elps.201000445; Coufal P, 2003, ELECTROPHORESIS, V24, P671, DOI 10.1002/elps.200390079; Cruzat VF, 2014, J INT SOC SPORT NUTR, V11, DOI 10.1186/s12970-014-0061-8; Dai ZL, 2014, J CHROMATOGR B, V964, P116, DOI 10.1016/j.jchromb.2014.03.025; Crespo ICD, 2015, ELECTROPHORESIS, V36, P1179, DOI 10.1002/elps.201400534; Devries MC, 2015, J FOOD SCI, V80, pA8, DOI 10.1111/1750-3841.12802; Falavigna G, 2012, NUTRIENTS, V4, P1767, DOI 10.3390/nu4111767; Friedman M, 2012, AMINO ACIDS, V42, P1553, DOI 10.1007/s00726-011-0915-1; Gioia MG, 2007, J PHARMACEUT BIOMED, V45, P456, DOI 10.1016/j.jpba.2007.07.016; Hands SL, 2009, AGING-US, V1, P586, DOI 10.18632/aging.100070; How ZT, 2014, J CHROMATOGR A, V1370, P135, DOI 10.1016/j.chroma.2014.10.040; Kanda A, 2013, BRIT J NUTR, V110, P981, DOI 10.1017/S0007114512006174; Leao P, 2010, J SEP SCI, V33, P2394; Lin EP, 2013, TALANTA, V114, P297, DOI 10.1016/j.talanta.2013.05.039; Mitsuhashi S, 2014, CURR OPIN BIOTECH, V26, P38, DOI 10.1016/j.copbio.2013.08.020; Moreno-Gonzalez D, 2013, ELECTROPHORESIS, V34, P2615, DOI 10.1002/elps.201300247; Poinsot V, 2010, ELECTROPHORESIS, V31, P105, DOI 10.1002/elps.200900399; Rodriguez NR, 2009, MED SCI SPORT EXER, V41, P709, DOI 10.1249/MSS.0b013e31890eb86; Stalikas CD, 2000, J CHROMATOGR A, V872, P215, DOI 10.1016/S0021-9673(99)01300-X; TAKEUCHI T, 1986, J CHROMATOGR, V370, P83, DOI 10.1016/S0021-9673(00)94676-4; Tian MM, 2014, ELECTROPHORESIS, V35, P577, DOI 10.1002/elps.201300416; Tuma P, 2015, ELECTROPHORESIS, V36, P1969, DOI 10.1002/elps.201400585; Wang T, 2015, J PHARMACEUT BIOMED, V114, P426, DOI 10.1016/j.jpba.2015.06.015; WANG TS, 1992, J CHROMATOGR, V607, P119, DOI 10.1016/0021-9673(92)87061-C; Zampolli MG, 2007, J CHROMATOGR A, V1150, P162, DOI 10.1016/j.chroma.2006.12.033	28	9	9	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179892	10.1371/journal.pone.0179892	http://dx.doi.org/10.1371/journal.pone.0179892			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640882	Green Published, Green Submitted, gold			2022-12-27	WOS:000404135800079
J	Rizal, G; Karki, S; Thakur, V; Wanchana, S; Alonso-Cantabrana, H; Dionora, J; Sheehy, JE; Furbank, R; von Caemmerer, S; Quick, WP				Rizal, Govinda; Karki, Shanta; Thakur, Vivek; Wanchana, Samart; Alonso-Cantabrana, Hugo; Dionora, Jacque; Sheehy, John E.; Furbank, Robert; von Caemmerer, Susanne; Quick, William Paul			A sorghum (Sorghum bicolor) mutant with altered carbon isotope ratio	PLOS ONE			English	Article							PROTEIN FAMILIES; DISCRIMINATION; GENE; PANTHER; KINASE; TOOL; RECOGNITION; GROWTH	Recent efforts to engineer C-4 photosynthetic traits into C-3 plants such as rice demand an understanding of the genetic elements that enable C-4 plants to outperform C-3 plants. As a part of the C-4 Rice Consortium's efforts to identify genes needed to support C-4 photosynthesis, EMS mutagenized sorghum populations were generated and screened to identify genes that cause a loss of C-4 function. Stable carbon isotope ratio (delta C-13) of leaf dry matter has been used to distinguishspecies with C-3 and C-4 photosynthetic pathways. Here, we report the identification of a sorghum (Sorghum bicolor) mutant with a low delta C-13 characteristic. A mutant (named Mut33) with a pale phenotype and stunted growth was identified from an EMS treated sorghum M-2 population. The stable carbon isotope analysis of the mutants showed a decrease of C-13 uptake capacity. The noise of random mutation was reduced by crossing the mutant and its wildtype (WT). The back-cross (BC1F1) progenies were like the WT parent in terms of C-13 values and plant phenotypes. All the BC1F2 plants with low delta C-13 died before they produced their 6 th leaf. Gas exchange measurements of the low delta C-13 sorghum mutants showed a higher CO2 compensation point (25.24 mu mol CO2. mol(-1) air) and the maximum rate of photosynthesis was less than 5 mu mol.m(-2). s(-1). To identify the genetic determinant of this trait, four DNA pools were isolated; two each from normal and low delta C-13 BC1F2 mutant plants. These were sequenced using an Illumina platform. Comparison of allele frequency of the single nucleotide polymorphisms (SNPs) between the pools with contrasting phenotype showed that a locus in Chromosome 10 between 57,941,104 and 59,985,708 bps had an allele frequency of 1. There were 211 mutations and 37 genes in the locus, out of which mutations in 9 genes showed non-synonymous changes. This finding is expected to contribute to future research on the identification of the causal factor differentiating C-4 from C-3 species that can be used in the transformation of C-3 to C-4 plants.	[Rizal, Govinda; Karki, Shanta; Thakur, Vivek; Wanchana, Samart; Dionora, Jacque; Sheehy, John E.; Quick, William Paul] IRRI, Rice Ctr C4, Los Banos, Laguna, Philippines; [Karki, Shanta] Govt Nepal, Minist Agr Dev, Kathmandu, Nepal; [Thakur, Vivek] Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India; [Alonso-Cantabrana, Hugo; Furbank, Robert; von Caemmerer, Susanne] Australian Natl Univ, Res Sch Biol, Div Plant Sci, Australian Res Council Ctr Excellence Translat Ph, Acton, ACT, Australia; [Sheehy, John E.; Quick, William Paul] Univ Sheffield, Sheffield, S Yorkshire, England; [Rizal, Govinda] Beldangi 2,Extension E3-25, Jhapa, Nepal	CGIAR; International Rice Research Institute (IRRI); CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); Australian National University; University of Sheffield	Quick, WP (corresponding author), IRRI, Rice Ctr C4, Los Banos, Laguna, Philippines.; Quick, WP (corresponding author), Univ Sheffield, Sheffield, S Yorkshire, England.	w.p.quick@irri.org	Furbank, Robert T/A-1884-2010; von Caemmerer, Susanne/C-9317-2009; Wanchana, Samart/AAF-5773-2020; Karki, Shanta/AAO-2373-2021	Furbank, Robert T/0000-0001-8700-6613; Alonso-Cantabrana, Hugo/0000-0002-5462-5861; Wanchana, Samart/0000-0002-5459-3425; Rizal, Govinda/0000-0002-6245-1996	Bill and Melinda Gates Foundation; UKAID (UK); IRRI; International Rice Research Institute (IRRI); Australian National University (ANU)	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); UKAID (UK); IRRI; International Rice Research Institute (IRRI)(CGIAR); Australian National University (ANU)(Australian National University)	The research on C4 rice is funded by Bill and Melinda Gates Foundation, UKAID (UK) and IRRI to Dr William Paul Quick, International Rice Research Institute (IRRI) and Dr Robert Furbank, Dr Susanne von Caemmerer, Australian National University (ANU).	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Alonso-Cantabrana H, 2016, J EXP BOT, V67, P3109, DOI 10.1093/jxb/erv555; Contreras-Cornejo HA, 2015, MOL PLANT MICROBE IN, V28, P701, DOI 10.1094/MPMI-01-15-0005-R; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Burdiak P, 2015, J EXP BOT, V66, P3325, DOI 10.1093/jxb/erv143; CERLING TE, 1993, NATURE, V361, P344, DOI 10.1038/361344a0; Chen ZX, 2001, PLANT PHYSIOL, V126, P473, DOI 10.1104/pp.126.2.473; Collins NC, 1998, MOL PLANT MICROBE IN, V11, P968, DOI 10.1094/MPMI.1998.11.10.968; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dievart A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-367; Downs GS, 2013, PLANT PHYSIOL, V161, P1830, DOI 10.1104/pp.112.213231; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; FARQUHAR GD, 1984, AUST J PLANT PHYSIOL, V11, P539, DOI 10.1071/PP9840539; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gresset S, 2014, PLANT PHYSIOL, V164, P131, DOI 10.1104/pp.113.224816; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; HENDERSON SA, 1992, AUST J PLANT PHYSIOL, V19, P263, DOI 10.1071/PP9920263; HUBICK KT, 1990, PLANT PHYSIOL, V92, P534, DOI 10.1104/pp.92.2.534; Klug A, 1999, J MOL BIOL, V293, P215, DOI 10.1006/jmbi.1999.3007; KU SB, 1980, PLANTA, V147, P277, DOI 10.1007/BF00379833; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ling QH, 2011, PHOTOSYNTH RES, V107, P209, DOI 10.1007/s11120-010-9606-0; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mitchell AJ, 2016, BIOCHEM, V56, P441; Mochida K, 2011, PLANT CELL PHYSIOL, V52, P2017, DOI 10.1093/pcp/pcr153; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; OLEARY MH, 1981, PHYTOCHEMISTRY, V20, P553, DOI 10.1016/0031-9422(81)85134-5; Pengelly JJL, 2010, J EXP BOT, V61, P4109, DOI 10.1093/jxb/erq226; Rizal G, 2015, PLANT J, V84, P257, DOI 10.1111/tpj.13007; Rizal G, 2014, CROP SCI, V54, P520, DOI 10.2135/cropsci2013.07.0471; Roux M, 2011, PLANT CELL, V23, P2440, DOI 10.1105/tpc.111.084301; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schultz HR, 1996, VITIS, V35, P169; Sun CW, 2009, PLANT PHYSIOL, V150, P879, DOI 10.1104/pp.109.137240; Sun CW, 2001, PLANT CELL, V13, P2053, DOI 10.1105/tpc.13.9.2053; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; von Caemmerer S, 2014, J EXP BOT, V65, P3459, DOI 10.1093/jxb/eru127; VONCAEMMERER S, 1992, PLANT CELL ENVIRON, V15, P1063; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Wang P, 2013, PLANT J, V75, P656, DOI 10.1111/tpj.12229; Zeinalov Yuzeir, 1999, Bulgarian Journal of Plant Physiology, V25, P26	48	3	3	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179567	10.1371/journal.pone.0179567	http://dx.doi.org/10.1371/journal.pone.0179567			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640841	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000404135800040
J	Amdahl, J; Diaz, J; Sharma, A; Park, J; Chandiwana, D; Delea, TE				Amdahl, Jordan; Diaz, Jose; Sharma, Arati; Park, Jinhee; Chandiwana, David; Delea, Thomas E.			Cost-effectiveness of pazopanib versus sunitinib for metastatic renal cell carcinoma in the United Kingdom	PLOS ONE			English	Article							CANCER; TRIAL; UNCERTAINTY; THERAPY; CANADA	Background Sunitinib and pazopanib are the only two targeted therapies for the first-line treatment of locally advanced or metastatic renal cell carcinoma (mRCC) recommended by the United Kingdom's National Institute for Health and Care Excellence. Pazopanib demonstrated non-inferior efficacy and a differentiated safety profile versus sunitinib in the phase III COMPARZ trial. The current analysis provides a direct comparison of the cost-effectiveness of pazopanib versus sunitinib from the perspective of the United Kingdom's National Health Service based on data from COMPARZ and other sources. Methods A partitioned-survival analysis model with three health states (alive with no progression, alive with progression, or dead) was used to estimate the incremental cost per qualityadjusted life-year (QALY) gained for pazopanib versus sunitinib over five years (duration of follow-up for final survival analysis in COMPARZ). The proportion of patients in each health state over time was based on Kaplan-Meier distributions for progression-free and overall survival from COMPARZ. Utility values were based on EQ-5D data from the pivotal study of pazopanib versus placebo. Costs were based on medical resource utilisation data from COMPARZ and unit costs from secondary sources. Probabilistic and deterministic sensitivity analyses were conducted to assess uncertainty of model results. Results In the base case, pazopanib was estimated to provide more QALYs (0.0565, 95% credible interval [CrI]: -0.0920 to 0.2126) at a lower cost (-1,061 pound, 95% CrI: -4,328 pound to 2,067) pound versus sunitinib. The probability that pazopanib yields more QALYs than sunitinib was estimated to be 76%. For a threshold value of 30,000 pound per QALY gained, the probability that pazopanib is cost-effective versus sunitinib was estimated to be 95%. Pazopanib was dominant in most scenarios examined in deterministic sensitivity analyses. Conclusions Pazopanib is likely to be a cost-effective treatment option compared with sunitinib as firstline treatment of mRCC in the United Kingdom.	[Amdahl, Jordan; Sharma, Arati; Delea, Thomas E.] Policy Anal Inc, Res, Brookline, MA 02445 USA; [Diaz, Jose] GlaxoSmithKline, Global Hlth Outcomes Oncol, Stockley Pk West, Uxbridge, Middx, England; [Park, Jinhee] Novartis Pharmaceut, Worldwide Hlth Outcomes Value & Access, E Hanover, NJ USA; [Chandiwana, David] Novartis Pharmaceut UK Ltd, Worldwide Hlth Outcomes Value & Access, Camberley, Surrey, England; [Diaz, Jose] Bristol Myers Squibb, Worldwide Hlth Econ & Outcomes Res Markets, Twickenham, Greater London, England	Policy Analysis Inc; GlaxoSmithKline; Novartis; Novartis; Bristol-Myers Squibb	Delea, TE (corresponding author), Policy Anal Inc, Res, Brookline, MA 02445 USA.	tdelea@pai2.com		Sharma, Arati/0000-0002-2831-2941	Glaxo Smith Kline; Novartis Pharmaceuticals Corporation; GSK; Novartis	Glaxo Smith Kline(GlaxoSmithKline); Novartis Pharmaceuticals Corporation(Novartis); GSK(GlaxoSmithKline); Novartis(Novartis)	Funding for this study was provided to PAI by Glaxo Smith Kline and Novartis Pharmaceuticals Corporation. Pazopanib is an asset of Novartis AG as of March 2,2015. The funders provided support in the form of salaries for authors; JD receiveda salary from both GSK and Novartis, and JP and DC received a salary from Novartis. The funders were involved in the concept and design of the study, as well as the interpretation of the data, writing and approval of the manuscript and the decision to submit.	Amdahl J, 2016, CURR ONCOL, V23, pE340, DOI 10.3747/co.23.2244; [Anonymous], 2016, VOTRIENT PACKAGE INS; Auguste P, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15180; Briggs AH, 2000, PHARMACOECONOMICS, V17, P479, DOI 10.2165/00019053-200017050-00006; Chabot I, 2010, VALUE HEALTH, V13, P837, DOI 10.1111/j.1524-4733.2010.00738.x; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Coppin C, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001425.pub2; Coppin C, 2011, BJU INT, V108, P1556, DOI 10.1111/j.1464-410X.2011.10629.x; Curtis L., 2012, UNIT COSTS HLTH SOCI; Delea TE, 2015, J MANAG CARE SPEC PH, V21, P46, DOI 10.18553/jmcp.2015.21.1.46; Dodd LE, 2008, J CLIN ONCOL, V26, P3791, DOI 10.1200/JCO.2008.16.1711; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; Egton Medical Information Systems Limited, 2016, REN CANC; Escudier B, 2014, J CLIN ONCOL, V32, P1412, DOI 10.1200/JCO.2013.50.8267; GlaxoSmithKline, 2013, RAND DOUBL BLIND CRO; Hansen RN, 2015, J MANAG CARE SPEC PH, V21, P37, DOI 10.18553/jmcp.2015.21.1.37; Keisner SV, 2011, DRUGS, V71, P443, DOI 10.2165/11588960-000000000-00000; Lothgren M, 2000, HEALTH ECON, V9, P623, DOI 10.1002/1099-1050(200010)9:7<623::AID-HEC539>3.0.CO;2-V; Mitchell AP, 2015, J ONCOL PRACT, V11, P491, DOI 10.1200/JOP.2015.004929; Motzer R, 2012, ANN ONCOL, V23; Motzer RJ, 2000, J UROLOGY, V163, P408, DOI 10.1016/S0022-5347(05)67889-5; National Institute for Health and Care Excellence (NICE), 2013, GUID METH TECHN APPR; National Institute for Health and Clinical Excellence (NICE), 2009, SUN 1 LIN TREATM ADV; NHS Department of Health, 2012, REF COSTS 2011 12; NHS National Institute for Health and Care Excellence (NICE), 2011, PAZ 1 LIN TREAT ADV; Sonpavde Guru, 2007, Curr Oncol Rep, V9, P115, DOI 10.1007/s11912-007-0007-2; Spiegelhalter D, 2004, BAYESIAN APPROACHES, P65; Sternberg CN, 2010, J CLIN ONCOL, V28, P1061, DOI 10.1200/JCO.2009.23.9764; Stinnett AA, 1998, MED DECIS MAKING, V18, pS68, DOI 10.1177/0272989X98018002S09; Thompson R, 2010, 10030 CEP	30	20	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0175920	10.1371/journal.pone.0175920	http://dx.doi.org/10.1371/journal.pone.0175920			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636648	gold, Green Published, Green Submitted			2022-12-27	WOS:000404118300002
J	Guo, L; Zhou, LL; Gao, Q; Zhang, AJ; Wei, J; Hong, DT; Chu, YK; Duan, XG; Zhang, Y; Xu, GX				Guo, Le; Zhou, Linlin; Gao, Qian; Zhang, Aijun; Wei, Jun; Hong, Dantong; Chu, Yuankui; Duan, Xiangguo; Zhang, Ying; Xu, Guangxian			MicroRNA-144-3p inhibits autophagy activation and enhances Bacillus Calmette-Guerin infection by targeting ATG4a in RAW264.7 macrophage cells	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSES; INNATE; DIFFERENTIATION; PROLIFERATION; DEGRADATION; MIR-144-3P; PATHWAYS; ROLES; BCG	MicroRNAs (miRNAs) are small noncoding nucleotides that play major roles in the response of host immune cells. Autophagy plays a key role in activating the antimicrobial host defense against Mycobacterium tuberculosis (M. tuberculosis). Whether miRNAs specifically influence the activation of macrophage autophagy during M. tuberculosis infection is largely unknown. In the present study, we demonstrate that Mycobacterium bovis Bacillus Calmette-Guerin (BCG) infection of macrophages leads to increased expression of miR-144-3p, which targets autophagy-related gene 4a (ATG4a), to inhibit autophagy activation and antimicrobial responses to BCG. Overexpression of miR-144-3p significantly decreased both mRNA and protein levels of ATG4a, inhibited the formation of autophagosomes in RAW264.7 cells and increased intracellular survival of BCG. However, transfection with miR-144-3p inhibitor led to an increase in ATG4a levels, accelerated the autophagic response in macrophages, and decreased BCG survival in macrophages. The experimental results of this study reveal a novel role of miR-144-3p in inhibiting autophagy activation by targeting ATG4a and enhancing BCG infection, and provide potential targets for developing improved treatment.	[Guo, Le; Wei, Jun; Xu, Guangxian] Ningxia Med Univ, Gen Hosp, Ningxia Key Lab Clin & Pathogen Microbiol, Yinchuan, Peoples R China; [Guo, Le; Zhou, Linlin; Gao, Qian; Zhang, Aijun; Wei, Jun; Hong, Dantong; Chu, Yuankui; Duan, Xiangguo; Xu, Guangxian] Ningxia Med Univ, Sch Clin Med, Dept Med Lab, Yinchuan, Peoples R China; [Zhou, Linlin] North China Univ Sci & Technol, Clin Lab, Affiliated Hosp, Tangshan, Peoples R China; [Zhang, Ying] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Ningxia Medical University; Ningxia Medical University; North China University of Science & Technology; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Xu, GX (corresponding author), Ningxia Med Univ, Sch Clin Med, Dept Med Lab, Yinchuan, Peoples R China.	xuguangxian@nxmu.edu.cn			National Natural Science Foundation of China [31472168, 31160494]; Clinical Laboratory Diagnosis Creative Group Open Project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Clinical Laboratory Diagnosis Creative Group Open Project	This work was funded by the National Natural Science Foundation of China (No. 31472168; No. 31160494) and the 2013 Clinical Laboratory Diagnosis Creative Group Open Project.	Araya J, 2013, INTERNAL MED, V52, P2295, DOI 10.2169/internalmedicine.52.1118; Baena A, 2009, TISSUE ANTIGENS, V74, P189, DOI 10.1111/j.1399-0039.2009.01301.x; Betin VMS, 2013, AUTOPHAGY, V9, P881, DOI 10.4161/auto.24172; Bhatt K, 2007, J CLIN IMMUNOL, V27, P347, DOI 10.1007/s10875-007-9084-0; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Cemma M, 2012, CURR BIOL, V22, pR540, DOI 10.1016/j.cub.2012.06.001; Chatterjee A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095716; Chen CZ, 2013, IMMUNOL REV, V253, P112, DOI 10.1111/imr.12060; Chen SS, 2015, CELL PHYSIOL BIOCHEM, V35, P997, DOI 10.1159/000369755; Felekkis K, 2010, HIPPOKRATIA, V14, P236; Fenton M J, 1998, Curr Opin Hematol, V5, P72, DOI 10.1097/00062752-199801000-00012; Frankel LB, 2012, CARCINOGENESIS, V33, P2018, DOI 10.1093/carcin/bgs266; Frankel LB, 2011, EMBO J, V30, P4628, DOI 10.1038/emboj.2011.331; Gozuacik D, 2008, CELL DEATH DIFFER, V15, P1875, DOI 10.1038/cdd.2008.121; Guo L, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00134; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Gwak HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047449; Ha Tai-You, 2011, Immune Netw, V11, P11, DOI [10.4110/in.2011.11.3.135, 10.4110/in.2011.11.1.11]; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hernandez-Pando R, 2009, ARCH IMMUNOL THER EX, V57, P355, DOI 10.1007/s00005-009-0042-9; Hossain MM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/179174; Hu YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094997; Huang C, 2016, FEBS LETT, V590, P795, DOI 10.1002/1873-3468.12112; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Jo EK, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00097; Juenemann Katrin, 2012, Int J Cell Biol, V2012, P189794, DOI 10.1155/2012/189794; Kanayama M, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00047; Kim JK, 2015, J IMMUNOL, V194, P5355, DOI 10.4049/jimmunol.1402557; Korbel DS, 2008, MICROBES INFECT, V10, P995, DOI 10.1016/j.micinf.2008.07.039; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Li K, 2016, MOL CELLS; Li M, 2011, J BIOL CHEM, V286, P7327, DOI 10.1074/jbc.M110.199059; Liu F, 2015, TUMOUR BIOL; Liu HY, 2016, CELL MOL BIOL, V62, P87; Lv Y, 2016, INT J INFECT DIS, V43, P68, DOI 10.1016/j.ijid.2015.12.014; Marino G, 2003, J BIOL CHEM, V278, P3671, DOI 10.1074/jbc.M208247200; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Ohsumi Y, 2004, SEMIN CELL DEV BIOL, V15, P231, DOI 10.1016/j.semcdb.2003.12.004; Pelayo MCG, 2009, INFECT IMMUN, V77, P2230, DOI 10.1128/IAI.01099-08; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; Quesniaux V, 2004, MICROBES INFECT, V6, P946, DOI 10.1016/j.micinf.2004.04.016; Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x; Rosenberger CM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006305; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Singh Y, 2013, J BIOL CHEM, V288, P5056, DOI 10.1074/jbc.C112.439778; Song L, 2014, J CELL MOL MED, V18, P2266, DOI 10.1111/jcmm.12380; Tanida I, 2004, J BIOL CHEM, V279, P47704, DOI 10.1074/jbc.M407016200; Tekirdag KA, 2013, AUTOPHAGY, V9, P374, DOI 10.4161/auto.23117; Wang JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003697; Zhang SY, 2016, ONCOTARGET, V7, P11637, DOI 10.18632/oncotarget.7025	51	38	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179772	10.1371/journal.pone.0179772	http://dx.doi.org/10.1371/journal.pone.0179772			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636635	Green Published, gold, Green Submitted			2022-12-27	WOS:000404118300054
J	Jourdan, M; Robert, N; Cren, M; Thibaut, C; Duperray, C; Kassambara, A; Cogne, M; Tarte, K; Klein, B; Moreaux, J				Jourdan, Michel; Robert, Nicolas; Cren, Mailys; Thibaut, Coraline; Duperray, Christophe; Kassambara, Alboukadel; Cogne, Michel; Tarte, Karin; Klein, Bernard; Moreaux, Jerome			Characterization of human FCRL4-positive B cells	PLOS ONE			English	Article							EXPRESSION; FCRL4; RECEPTORS; TISSUE; POPULATION; GENERATION; MECHANISM; PROMOTES; IRTA1; TAIL	FCRL4 is an immunoregulatory receptor that belongs to the Fc receptor-like (FCRL) family. In healthy individuals, FCRL4 is specifically expressed by memory B cells (MBCs) localized in sub-epithelial regions of lymphoid tissues. Expansion of FCRL4+ B cells has been observed in blood and other tissues in various infectious and autoimmune disorders. Currently, the mechanisms involved in pathological FCRL4+ B cell generation are actively studied, but they remain elusive. As in vivo FCRL4+ cells are difficult to access and to isolate, here we developed a culture system to generate in vitro FCRL4+ B cells from purified MBCs upon stimulation with soluble CD40 ligand and/or CpG DNA to mimic T-cell dependent and/or T cell independent activation, respectively. After 4 days of stimulation, FCRL4+ B cells represented 17% of all generated cells. Transcriptomic and phenotypic analyses of in vitro generated FCRL4+ cells demonstrated that they were closely related to FCRL4+ tonsillar MBCs. They strongly expressed inhibitory receptor genes, as observed in exhausted FCRL4+ MBCs from blood samples of HIV-infected individuals with high viremia. In agreement, cell cycle genes were significantly downregulated and the number of cell divisions was two-fold lower in in vitro generated FCRL4+ than FCRL4- cells. Finally, due to their reduced proliferation and differentiation potential, FCRL4+ cells were less prone to differentiate into plasma cells, differently from FCRL4- cells. Our in vitro model could be of major interest for studying the biology of normal and pathological FCRL4+ cells.	[Jourdan, Michel; Thibaut, Coraline; Kassambara, Alboukadel; Klein, Bernard; Moreaux, Jerome] UM, CNRS, UMR 9002, Inst Human Genet, Montpellier, France; [Robert, Nicolas; Kassambara, Alboukadel; Klein, Bernard; Moreaux, Jerome] CHU Montpellier, Dept Biol Hematol, Lab Monitoring Innovat Therapies, Montpellier, France; [Cren, Mailys] INSERM, U1040, Montpellier, France; [Duperray, Christophe] Montpellier Rio Imaging, Cytometry IRB, Montpellier, France; [Cogne, Michel] Univ Limoges, CNRS UMR 7276, Limoges, France; [Tarte, Karin] CHU Rennes, Pole Cellules & Tissus, Rennes, France; [Tarte, Karin] INSERM, U917, Rennes, France; [Klein, Bernard; Moreaux, Jerome] Univ Montpellier I, UFR Med, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Limoges; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Moreaux, J (corresponding author), UM, CNRS, UMR 9002, Inst Human Genet, Montpellier, France.; Moreaux, J (corresponding author), CHU Montpellier, Dept Biol Hematol, Lab Monitoring Innovat Therapies, Montpellier, France.; Moreaux, J (corresponding author), Univ Montpellier I, UFR Med, Montpellier, France.	jerome.moreaux@igh.cnrs.fr	tarte, karin/GXV-1815-2022; Duperray, Christophe/P-6922-2017; cogné, michel/D-7370-2015; J, Moreaux/ABA-2974-2021; moreaux, jerome/HGA-5649-2022	tarte, karin/0000-0002-6809-917X; cogné, michel/0000-0002-8519-4427; J, Moreaux/0000-0002-5717-3207; 	Institut National du Cancer [2012-109/087437, PLBIO15-256]; Conseil Regional Languedoc Roussillon [R14026FF]; Fondation de France [201400047510]; Institut Thematigue Multi-organismes Cancer (MMTT); SIRIC Montpellier [INCa-DGOS-Inserm 6045]	Institut National du Cancer(Institut National du Cancer (INCA) France); Conseil Regional Languedoc Roussillon(Region Occitanie); Fondation de France(Fondation de France); Institut Thematigue Multi-organismes Cancer (MMTT); SIRIC Montpellier	This work was supported by Institut National du Cancer (2012-109/087437 and PLBIO15-256), Conseil Regional Languedoc Roussillon (R14026FF), Fondation de France (201400047510), Institut Thematigue Multi-organismes Cancer (MM&TT) and SIRIC Montpellier (INCa-DGOS-Inserm 6045).	Amara K, 2017, J AUTOIMMUN; Bernard NJ, 2014, NAT REV RHEUMATOL, V10, DOI [10.1038/nrrheum.2014.170, 10.1038/nrrheum.2014.60, 10.1038/nrrheum.2014.166, 10.1038/nrrheum.2014.72, 10.1038/nrrheum.2014.180, 10.1038/nrrheum.2014.141, 10.1038/nrrheum.2014.25, 10.1038/nrrheum.2014.88, 10.1038/nrrheum.2013.187, 10.1038/nrrheum.2013.207, 10.1038/nrrheum.2014.96]; Charles ED, 2011, BLOOD, V117, P5425, DOI 10.1182/blood-2010-10-312942; Daeron M, 2008, IMMUNOL REV, V224, P11, DOI 10.1111/j.1600-065X.2008.00666.x; Davis RS, 2007, ANNU REV IMMUNOL, V25, P525, DOI 10.1146/annurev.immunol.25.022106.141541; Duchez S, 2010, P NATL ACAD SCI USA, V107, P3064, DOI 10.1073/pnas.0912393107; Ehrhardt GRA, 2008, J EXP MED, V205, P1807, DOI 10.1084/jem.20072682; Ehrhardt GRA, 2005, J EXP MED, V202, P783, DOI 10.1084/jem.20050879; Ehrhardt GRA, 2003, P NATL ACAD SCI USA, V100, P13489, DOI 10.1073/pnas.1935944100; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Falini B, 2003, BLOOD, V102, P3684, DOI 10.1182/blood-2003-03-0750; Hartmann G, 2000, J IMMUNOL, V164, P944, DOI 10.4049/jimmunol.164.2.944; Hatzivassiliou G, 2001, IMMUNITY, V14, P277, DOI 10.1016/S1074-7613(01)00109-1; Jelicic K, 2013, NAT IMMUNOL, V14, P1256, DOI 10.1038/ni.2746; Johrens K, 2005, HAEMATOLOGICA, V90, P1070; Jourdan M, 2014, LEUKEMIA, V28, P1647, DOI 10.1038/leu.2014.61; Jourdan M, 2016, ONCOTARGET, V7, P28096, DOI 10.18632/oncotarget.8581; Jourdan M, 2011, J IMMUNOL, V187, P3931, DOI 10.4049/jimmunol.1101230; Jourdan M, 2009, BLOOD, V114, P5173, DOI 10.1182/blood-2009-07-235960; Kardava L, 2011, J CLIN INVEST, V121, P2614, DOI 10.1172/JCI45685; Kassambara A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004077; Laffleur B, 2014, ONCOTARGET, V5, P1118, DOI 10.18632/oncotarget.1546; Maecker HT, 2004, CYTOM PART A, V62A, P169, DOI 10.1002/cyto.a.20092; Martin SW, 2002, NAT IMMUNOL, V3, P182, DOI 10.1038/ni752; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Pogue SL, 2000, J EXP MED, V191, P1031, DOI 10.1084/jem.191.6.1031; Polson AG, 2006, INT IMMUNOL, V18, P1363, DOI 10.1093/intimm/dxl069; Sanz I, 2008, SEMIN IMMUNOL, V20, P67, DOI 10.1016/j.smim.2007.12.006; Sohn HW, 2011, BLOOD, V118, P6332, DOI 10.1182/blood-2011-05-353102; Tangye SG, 2003, J IMMUNOL, V170, P261, DOI 10.4049/jimmunol.170.1.261; Tangye SG, 2009, EUR J IMMUNOL, V39, P2065, DOI 10.1002/eji.200939531; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Waisman A, 2007, J EXP MED, V204, P747, DOI 10.1084/jem.20062024; Wilson TJ, 2012, J IMMUNOL, V188, P4741, DOI 10.4049/jimmunol.1102651; Yeo L, 2015, ANN RHEUM DIS, V74, P928, DOI 10.1136/annrheumdis-2013-204116; Zeng Z, 2012, CLIN RHEUMATOL, V31, P1449, DOI 10.1007/s10067-012-2028-y	37	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179793	10.1371/journal.pone.0179793	http://dx.doi.org/10.1371/journal.pone.0179793			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636654	Green Published, gold, Green Submitted			2022-12-27	WOS:000404118300055
J	Walker, F; Bucker, B; Anderson, NC; Schreij, D; Theeuwes, J				Walker, Francesco; Bucker, Berno; Anderson, Nicola C.; Schreij, Daniel; Theeuwes, Jan			Looking at paintings in the Vincent Van Gogh Museum: Eye movement patterns of children and adults	PLOS ONE			English	Article							ATTENTION; SALIENCY; CAPTURE; OVERT	In the present study, we examined the eye movement behaviour of children and adults looking at five Van Gogh paintings in the Van Gogh Museum, Amsterdam. The goal of the study was to determine the role of top-down and bottom-up attentional processes in the first stages of participants' aesthetic experience. Bottom-up processes were quantified by determining a salience map for each painting. Top-down processing was manipulated by first allowing participants to view the paintings freely, then providing background information about each painting, and then allowing them to view the paintings a second time. The salience analysis showed differences between the eye movement behaviour of children and adults, and differences between the two phases. In the children, the first five fixations during the free viewing phase were strongly related to visually salient features of the paintings- indicating a strong role for bottom-up factors. In the second phase, after children had received background information, top-down factors played a more prominent role. By contrast, adults' observed patterns were similar in both phases, indicating that bottom-up processes did not play a major role when they viewed the paintings. In the second phase, children and adults both spent more time looking at regions that were mentioned in the background information. This effect was greater for adults than for children, confirming the notion that adults, when viewing paintings, rely much more on top-down processing than children.	[Walker, Francesco; Bucker, Berno; Anderson, Nicola C.; Schreij, Daniel; Theeuwes, Jan] Vrije Univ Amsterdam, Dept Expt & Appl Psychol, Amsterdam, Netherlands; [Walker, Francesco] Univ Twente, Ctr Transport Studies, Enschede, Netherlands; [Anderson, Nicola C.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	Vrije Universiteit Amsterdam; University of Twente; University of British Columbia	Walker, F (corresponding author), Vrije Univ Amsterdam, Dept Expt & Appl Psychol, Amsterdam, Netherlands.; Walker, F (corresponding author), Univ Twente, Ctr Transport Studies, Enschede, Netherlands.	francesco.walker89@gmail.com	Theeuwes, Jan/ABF-3771-2020	Theeuwes, Jan/0000-0002-5849-7721	European Research Council (ERC) advancedgrant [ERC-2012-AdG 323413]	European Research Council (ERC) advancedgrant(European Research Council (ERC))	This research was supported by a European Research Council (ERC) advancedgrant [ERC-2012-AdG 323413] to Jan Theeuwes.	Acik A, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00207; Anderson NC, 2015, J VISION, V15, DOI 10.1167/15.5.9; Awh E, 2012, TRENDS COGN SCI, V16, P437, DOI 10.1016/j.tics.2012.06.010; Belke B., 2006, PSYCHOL SCI, V48, P115; Brieber D, 2015, ACTA PSYCHOL, V154, P36, DOI 10.1016/j.actpsy.2014.11.004; Brieber D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099019; Carbon CC, 2017, I-PERCEPTION, V8, DOI 10.1177/2041669517694184; Chua HF, 2005, P NATL ACAD SCI USA, V102, P12629, DOI 10.1073/pnas.0506162102; Devue C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034598; Findlay J. M., 2003, ACTIVE VISION PSYCHO; Foulsham T, 2008, J VISION, V8, DOI 10.1167/8.2.6; Fuchs I, 2011, COGN COMPUT, V3, P25, DOI 10.1007/s12559-010-9062-3; Hayhoe M, 2005, TRENDS COGN SCI, V9, P188, DOI 10.1016/j.tics.2005.02.009; Heidenreich SM, 2011, EMPIR STUD ARTS, V29, P51, DOI 10.2190/EM.29.1.d; Henry C. K., 1992, VISUAL ARTS RES, P82; Ho-Phuoc T, 2010, COGN COMPUT, V2, P344, DOI 10.1007/s12559-010-9078-8; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Kassner M, 2014, PROCEEDINGS OF THE 2014 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING (UBICOMP'14 ADJUNCT), P1151, DOI 10.1145/2638728.2641695; Land M. F., 1994, NATURE; Land MF, 2001, VISION RES, V41, P3559, DOI 10.1016/S0042-6989(01)00102-X; Locher P., 1999, EMPIR STUD ARTS, V17, P121, DOI DOI 10.2190/R1WN-TAF2-376D-EFUH; Locher P. J., 2006, PSYCHOL SCI, V48, P106, DOI DOI 10.1198/016214504000000683; Locher PJ, 2001, PERCEPTION, V30, P449, DOI 10.1068/p3008; Madden DJ, 2007, NEUROBIOL AGING, V28, P459, DOI 10.1016/j.neurobiolaging.2006.01.005; Madden DJ, 2004, ADV CELL AGING GERON, V15, P41; Massaro D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037285; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; Pihko E, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00094; Quian Quiroga R., 2011, ADV CLIN NEUROSCIENC, V11, P15; Quiroga RQ, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00098; Raz N., 2000, HDB AGING COGNITION, V2nd, P1; Risko EF, 2012, COGNITION, V122, P86, DOI 10.1016/j.cognition.2011.08.014; Silvia PJ, 2013, EMPIR STUD ARTS, V31, P107, DOI 10.2190/EM.31.1.f; Smith J., 2001, EMPIRICAL STUDIES AR, V19, P229, DOI [10.2190/5MQM-59JH-X21R-JN5J, DOI 10.2190/5MQM-59JH-X21R-JN5J]; Smith JK, 1993, ISSUES MEASUREMENT E; Smith LF, 2017, PSYCHOL AESTHET CREA, V11, P77, DOI 10.1037/aca0000049; Swami V, 2013, PSYCHOL AESTHET CREA, V7, P285, DOI 10.1037/a0030965; Tatler BW, 2007, J VISION, V7, DOI 10.1167/7.14.4; Theeuwes J, 2006, VIS COGN, V13, P657, DOI 10.1080/13506280500410949; Theeuwes J, 1998, PSYCHOL SCI, V9, P379, DOI 10.1111/1467-9280.00071; Theeuwes J, 1999, J EXP PSYCHOL HUMAN, V25, P1595, DOI 10.1037/0096-1523.25.6.1595; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; Underwood G, 2006, Q J EXP PSYCHOL, V59, P1931, DOI 10.1080/17470210500416342; Walther D, 2006, NEURAL NETWORKS, V19, P1395, DOI 10.1016/j.neunet.2006.10.001; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; ZANGEMEISTER WH, 1995, NEUROPSYCHOLOGIA, V33, P1009, DOI 10.1016/0028-3932(95)00014-T	46	35	35	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0178912	10.1371/journal.pone.0178912	http://dx.doi.org/10.1371/journal.pone.0178912			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY6UH	28636664	Green Submitted, gold, Green Published			2022-12-27	WOS:000404118300021
J	Song, Y; Li, JH; Shin, HD; Liu, L; Du, GC; Chen, J				Song, Yang; Li, Jianghua; Shin, Hyun-dong; Liu, Long; Du, Guocheng; Chen, Jian			Tuning the transcription and translation of L-amino acid deaminase in Escherichia coli improves alpha-ketoisocaproate production from L-leucine	PLOS ONE			English	Article							MUSCLE PROTEIN-SYNTHESIS; CORYNEBACTERIUM-GLUTAMICUM; SECONDARY STRUCTURE; BIOSYNTHESIS; EFFICIENCY; DESIGN; REGION; CODON	alpha-Ketoisocaproate (KIC) is used widely in the pharmaceutical and nutraceutical industries. In previous studies, we achieved a one-step biosynthesis of KIC from L-leucine, using an Escherichia coli whole-cell biocatalyst expressing an L-amino acid deaminase (L-AAD) from Proteus vulgaris. Herein, we report the fine-tuning of L-AAD gene expression in E. coli BL21 (DE3) at the transcriptional and translational levels to improve the KIC titer. By optimizing the plasmid origin with different copy numbers, modulating messenger RNA structure downstream of the initiation codon, and designing the sequences at the ribosome binding site, we increased biocatalyst activity to 31.77%, 24.89%, and 30.20%, respectively, above that achieved with BL21/pet28a-lad. The highest KIC titers reached 76.47 g.L-1, 80.29 g.L-1, and 81.41 g.L-1, respectively. Additionally, the integration of these three engineering strategies achieved an even higher KIC production of 86.55 g.L-1 and a higher L-leucine conversion rate of 94.25%. The enzyme-engineering strategies proposed herein may be generally applicable to the construction of other biocatalysts.	[Song, Yang; Li, Jianghua; Liu, Long; Du, Guocheng; Chen, Jian] Jiangnan Univ, Minist Educ, Key Lab Carbohydrate Chem & Biotechnol, Wuxi, Peoples R China; [Song, Yang; Li, Jianghua; Liu, Long; Du, Guocheng; Chen, Jian] Jiangnan Univ, Synerget Innovat Ctr Food Safety & Nutr, Wuxi, Peoples R China; [Shin, Hyun-dong] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA	Jiangnan University; Jiangnan University; University System of Georgia; Georgia Institute of Technology	Liu, L; Du, GC (corresponding author), Jiangnan Univ, Minist Educ, Key Lab Carbohydrate Chem & Biotechnol, Wuxi, Peoples R China.; Liu, L; Du, GC (corresponding author), Jiangnan Univ, Synerget Innovat Ctr Food Safety & Nutr, Wuxi, Peoples R China.	longliu@jiangnan.edu.cn; gcdu@jiangnan.edu.cn	li, jianghua/GXG-4735-2022	Qu, Shan/0000-0003-0016-5422	Enterprise-University-Research Prospective Program Jiangsu Province [BY2013015-37]; Fundamental Research Funds for the Central Universities [JUSRP51307]; 863 Program [2014AA021200, 2015AA021004]	Enterprise-University-Research Prospective Program Jiangsu Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); 863 Program(National High Technology Research and Development Program of China)	This work was financially supported by the Enterprise-University-Research Prospective Program Jiangsu Province (BY2013015-37), the Fundamental Research Funds for the Central Universities (JUSRP51307) and the 863 Program (2014AA021200, 2015AA021004).	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Aparicio M, 2012, J RENAL NUTR, V22, pS22, DOI 10.1053/j.jrn.2011.09.006; Borujeni AE, 2013, NUCLEIC ACIDS RES; Buckle-Vallant V, 2014, APPL MICROBIOL BIOT, V98, P297, DOI 10.1007/s00253-013-5310-2; Choi JH, 2004, APPL MICROBIOL BIOT, V64, P625, DOI 10.1007/s00253-004-1559-9; CHUA B, 1979, J BIOL CHEM, V254, P8358; COOPER AJ, 1983, CHEM REV, V83, P321, DOI 10.1021/cr00055a004; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; Escobar J, 2010, J NUTR, V140, P1418, DOI 10.3945/jn.110.123042; Goodman DB, 2013, SCIENCE, V342, P475, DOI 10.1126/science.1241934; Guan NZ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06951; Hossain GS, 2014, J BIOTECHNOL, V169, P112, DOI 10.1016/j.jbiotec.2013.10.026; Jin YS, 2007, METAB ENG, V9, P337, DOI 10.1016/j.ymben.2007.03.003; Ju YC, 2016, J STRUCT BIOL, V195, P306, DOI 10.1016/j.jsb.2016.07.008; Mutalik VK, 2013, NAT METHODS, V10, P354, DOI [10.1038/NMETH.2404, 10.1038/nmeth.2404]; Nielsen DR, 2009, METAB ENG, V11, P262, DOI 10.1016/j.ymben.2009.05.003; Norton LE, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-67; Ricci JCD, 2000, CRIT REV BIOTECHNOL, V20, P79, DOI 10.1080/07388550008984167; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Seo SW, 2013, METAB ENG, V15, P67, DOI 10.1016/j.ymben.2012.10.006; Seo SW, 2009, BIOTECHNOL BIOENG, V104, P611, DOI 10.1002/bit.22431; Song Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep12614; Vogt M, 2014, METAB ENG, V22, P40, DOI 10.1016/j.ymben.2013.12.001; Yu ZL, 2012, APPL BIOCHEM BIOTECH, V167, P1, DOI 10.1007/s12010-012-9611-1; Zhou YS, 2010, J BIOL CHEM, V285, P33718, DOI 10.1074/jbc.M110.136846; Zhu YH, 2011, ENZYME MICROB TECH, V49, P321, DOI 10.1016/j.enzmictec.2011.06.008; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	28	7	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179229	10.1371/journal.pone.0179229	http://dx.doi.org/10.1371/journal.pone.0179229			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662040	Green Submitted, Green Published, gold			2022-12-27	WOS:000404608300018
J	Yang, H; Su, T; Yang, W; Yang, CP; Lu, L; Chen, ZM				Yang, Hua; Su, Ting; Yang, Wei; Yang, Chunping; Lu, Lin; Chen, Zhangming			The developmental transcriptome of the bamboo snout beetle Cyrtotrachelus buqueti and insights into candidate pheromonebinding proteins	PLOS ONE			English	Article							MENEVILLE COLEOPTERA-CURCULIONIDAE; ODORANT-BINDING-PROTEINS; MOLECULAR CHARACTERIZATION; ANTHERAEA-POLYPHEMUS; EXPRESSION ANALYSIS; CRYSTAL-STRUCTURE; LIGAND-BINDING; IDENTIFICATION; GENES; MOTH	Cyrtotrachelus buqueti is an extremely harmful bamboo borer, and the larvae of this pest attack clumping bamboo shoots. Pheromone-binding proteins (PBPs) play an important role in identifying insect sex pheromones, but the C. buqueti genome is not readily available for PBP analysis. Developmental transcriptomes of eggs, larvae from the first instar to the prepupal stage, pupae, and adults (females and males) from emergence to mating were built by RNA sequencing (RNA-Seq) in the present study to establish a sequence background of C. buqueti to help understand PBPs. Approximately 164.8 million clean reads were obtained and annotated into 108,854 transcripts. These were assembled into 24,338, 21,597, 24,798, 21,886, 24,642, and 83,115 unigenes for eggs, larvae, pupae, females, males, and the combined datasets, respectively. Unigenes were annotated against NCBI non-redundant protein sequences, NCBI non-redundant nucleotide sequences, Gene Ontology (GO), Protein family, Clusters of Orthologous Groups of Proteins/Clusters of Eukaryotic Orthologous Groups (KOG), Swiss-Prot, and KEGG Orthology databases. A total of 17,213 unigenes were annotated into 55 sub-categories belonging to three main GO categories; 10,672 unigenes were classified into 26 functional categories by KOG classification, and 8,063 unigenes were classified into five functional KEGG categories. RSEM software for RNA sequencing showed that 4,816, 3,176, 3,661, 2,898, 4,316, 8,019, 7,273, 5,922, 5,844, and 4,570 genes were differentially expressed between larvae and males, larvae and eggs, larvae and pupae, larvae and females, males and females, males and eggs, males and pupae, females and eggs, females and pupae, and eggs and pupae, respectively. Of these, three were confirmed to be significantly differentially expressed between larvae, females, and males. Furthermore, PBP Cbuq7577_g1 was highly expressed in the antenna of males. A comprehensive sequence resource of a desirable quality was constructed from developmental transcriptomes of C. buqueti eggs, larvae, pupae, and adults. This work enriches the genomic data of C. buqueti, and facilitates our understanding of its metamorphosis, development, and response to environmental change. The identified candidate PBP Cbuq7577_g1 might play a crucial role in identifying sex pheromones, and could be used as a targeted gene to control C. buqueti numbers by disrupting sex pheromone communication.	[Yang, Hua; Su, Ting; Yang, Wei; Yang, Chunping; Lu, Lin; Chen, Zhangming] Sichuan Agr Univ, Coll Forestry, Key Lab Ecol Forestry Engn Sichuan Prov, Chengdu, Peoples R China	Sichuan Agricultural University	Yang, W (corresponding author), Sichuan Agr Univ, Coll Forestry, Key Lab Ecol Forestry Engn Sichuan Prov, Chengdu, Peoples R China.	ywei0218@aliyun.com			National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work received support from the National Natural Science Foundation of China, http://www.nsfc.gov.cn/.	Abraham D, 2005, INSECT BIOCHEM MOLEC, V35, P1100, DOI 10.1016/j.ibmb.2005.05.002; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bette S, 2002, INSECT BIOCHEM MOLEC, V32, P241, DOI 10.1016/S0965-1748(01)00171-0; Biedler JK, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-206; Callahan FE, 2000, INSECT BIOCHEM MOLEC, V30, P507, DOI 10.1016/S0965-1748(00)00027-8; Calvello M, 2005, INSECT BIOCHEM MOLEC, V35, P297, DOI 10.1016/j.ibmb.2005.01.002; [陈封政 Chen Fengzheng], 2005, [植物保护, Plant Protection], V31, P89; de Santis F, 2006, J CHEM ECOL, V32, P1703, DOI 10.1007/s10886-006-9103-2; DU GH, 1995, BIOCHEMISTRY-US, V34, P8726, DOI 10.1021/bi00027a023; Etebari K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-446; Forstner Maike, 2006, Invertebrate Neuroscience, V6, P177, DOI 10.1007/s10158-006-0032-0; Glusman G, 2000, MAMM GENOME, V11, P1016, DOI 10.1007/s003350010196; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; HANSSON BS, 1995, EXPERIENTIA, V51, P1003, DOI 10.1007/BF01946910; He Hua-Liang, 2012, Acta Entomologica Sinica, V55, P1; Ju Rui-ting, 2005, Zhongguo Senlin Bingchong, V24, P7; KAISSLING KE, 1986, ANNU REV NEUROSCI, V9, P121, DOI 10.1146/annurev.ne.09.030186.001005; Klusak V, 2003, CHEM BIOL, V10, P331, DOI 10.1016/S1074-5521(03)00074-7; KRIEGER J, 1993, INSECT BIOCHEM MOLEC, V23, P449, DOI 10.1016/0965-1748(93)90052-T; Krieger J, 1996, INSECT BIOCHEM MOLEC, V26, P297, DOI 10.1016/0965-1748(95)00096-8; Kruse SW, 2003, NAT STRUCT BIOL, V10, P694, DOI 10.1038/nsb960; Lartigue A, 2004, J BIOL CHEM, V279, P4459, DOI 10.1074/jbc.M311212200; Lartigue A, 2003, J BIOL CHEM, V278, P30213, DOI 10.1074/jbc.M304688200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mang Ding-Ze, 2012, Acta Entomologica Sinica, V55, P291; Mohanty S, 2004, J MOL BIOL, V337, P443, DOI 10.1016/j.jmb.2004.01.009; Pei MS, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2470-3; Picimbon JF, 2002, INSECT BIOCHEM MOLEC, V32, P839, DOI 10.1016/S0965-1748(01)00172-2; PRESTWICH GD, 1995, CHEM SENSES, V20, P461, DOI 10.1093/chemse/20.4.461; Robertson HM, 1999, INSECT MOL BIOL, V8, P501, DOI 10.1046/j.1365-2583.1999.00146.x; STEINBRECHT RA, 1995, CELL TISSUE RES, V282, P203, DOI 10.1007/BF00319112; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van't Hof AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010889; Wang Wei-de, 2005, Sichuan Journal of Zoology, V24, P540; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang XY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1200-y; Wu C-S, 2016, PLOS ONE, V11; Xiao SQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011377; Xiu WM, 2008, J CHEM ECOL, V34, P487, DOI 10.1007/s10886-008-9452-0; Xiu WM, 2007, J CHEM ECOL, V33, P947, DOI 10.1007/s10886-007-9277-2; Yang Hua, 2015, Acta Entomologica Sinica, V58, P60; Yang Hua, 2010, Acta Entomologica Sinica, V53, P286; Yang Yao-Jun, 2010, Acta Entomologica Sinica, V53, P1087; Yang Yao-jun, 2009, Yingyong Shengtai Xuebao, V20, P1980; Zhang LW, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2256-z; Zhang Shuai, 2009, Scientia Agricultura Sinica, V42, P2359	48	13	15	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179807	10.1371/journal.pone.0179807	http://dx.doi.org/10.1371/journal.pone.0179807			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662071	Green Submitted, gold, Green Published			2022-12-27	WOS:000404608300050
J	Ahn, SJ; Kim, JH; Lee, BR				Ahn, Seong Joon; Kim, Ji Hong; Lee, Byung Ro			Choroidal change in acute anterior uveitis associated with human leukocyte antigen-B27	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; THICKNESS; DISEASE	Purpose To evaluate choroidal changes in eyes with acute anterior uveitis associated with human leukocyte antigen (HLA)-B27 Methods In 44 patients with first-onset, unilateral, acute-onset (<1 week) anterior uveitis for which diagnostic work-ups revealed positivity only for HLA-B27, wide-field three-dimensional volumetric raster scan using swept-source optical coherence tomography was performed for both eyes. Choroidal thickness was measured by automated segmentation and thickness mapping and compared between eyes with uveitis and the fellow eyes at baseline. Choroidal thickness was compared before and after topical and/or systemic corticosteroid therapy. Relative choroidal thickening was defined as the choroidal thickness of the uveitic eye minus that of the corresponding eye and correlated with the degree of intraocular inflammation. Results Compared to the fellow eyes, eyes with acute anterior uveitis showed significant choroidal thickening on the subfoveal and parafoveal areas at baseline (all P < 0.05). En face choroidal imaging showed dilation of large choroidal vessels on the macula. Relative choroidal thickening significantly correlated with the degree of anterior chamber inflammation at baseline (correlation coefficient = 0.341, P = 0.023). After treating inflammation, the choroid on the macula thinned significantly (from 262.1 +/- 66.5 to 239.5 +/- 61.0 pm in the subfoveal choroid, P<0.001). Conclusions Eyes with HLA-B27-associated anterior uveitis showed significant choroidal thickening at acute phase that subsequently decreased after treatment, indicating subclinical choroidal inflammation in the eyes. Choroidal thickness might indicate disease activity in acute anterior uveitis associated with HLA-B27.	[Ahn, Seong Joon; Kim, Ji Hong; Lee, Byung Ro] Hanyang Univ Hosp, Dept Ophthalmol, Seoul, South Korea	Hanyang University; Hanyang University Hospital	Lee, BR (corresponding author), Hanyang Univ Hosp, Dept Ophthalmol, Seoul, South Korea.	brlee@hanyang.ac.kr						Chang JH, 2005, SURV OPHTHALMOL, V50, P364, DOI 10.1016/j.survophthal.2005.04.003; Fleischman D, 2012, OCUL IMMUNOL INFLAMM, V20, P300, DOI 10.3109/09273948.2012.682637; Gehl Z, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-103; Goldenberg D, 2013, GRAEF ARCH CLIN EXP, V251, P2037, DOI 10.1007/s00417-013-2334-3; Heinz C, 2016, GRAEF ARCH CLIN EXP, V254, P361, DOI 10.1007/s00417-015-3218-5; Ishikawa S, 2014, BRIT J OPHTHALMOL, V98, P1508, DOI 10.1136/bjophthalmol-2014-305333; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; Johnson RN, 2013, FLUORESCEIN ANGIOGRA; Kim M, 2013, INVEST OPHTH VIS SCI, V54, P6033, DOI 10.1167/iovs.13-12231; Kola M, 2014, OCUL IMMUNOL INFLAMM, V22, P434, DOI 10.3109/09273948.2014.928734; Li XQ, 2011, INVEST OPHTH VIS SCI, V52, P8438, DOI 10.1167/iovs.11-8108; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; Maruko I, 2011, RETINA-J RET VIT DIS, V31, P510, DOI 10.1097/IAE.0b013e3181eef053; McCannel CA, 1996, AM J OPHTHALMOL, V121, P35, DOI 10.1016/S0002-9394(14)70532-X; Nakai K, 2012, GRAEF ARCH CLIN EXP, V250, P1089, DOI 10.1007/s00417-011-1910-7; RODRIGUEZ A, 1994, OPHTHALMOLOGY, V101, P1267; ROTHOVA A, 1992, BRIT J OPHTHALMOL, V76, P137, DOI 10.1136/bjo.76.3.137; Tan CS, 2012, INVEST OPHTH VIS SCI, V53, P261, DOI 10.1167/iovs.11-8782; Wei WB, 2013, OPHTHALMOLOGY, V120, P175, DOI 10.1016/j.ophtha.2012.07.048; Yan H, 2015, OCUL IMMUNOL INFLAMM, P1	20	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180109	10.1371/journal.pone.0180109	http://dx.doi.org/10.1371/journal.pone.0180109			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658315	Green Submitted, gold, Green Published			2022-12-27	WOS:000404607900059
J	Malato, G; Shervette, VR; Amaya, RN; Rivera, JV; Salazar, FN; Delgado, PC; Karpan, KC; Aguirre, WE				Malato, Grace; Shervette, Virginia R.; Navarrete Amaya, Ronald; Valdiviezo Rivera, Jonathan; Nugra Salazar, Fredy; Calle Delgado, Paola; Karpan, Kirby C.; Aguirre, Windsor E.			Parallel body shape divergence in the Neotropical fish genus Rhoadsia (Teleostei: Characidae) along elevational gradients of the western slopes of the Ecuadorian Andes	PLOS ONE			English	Article							ECOLOGICAL OPPORTUNITY; GENETIC ASSIMILATION; ADAPTIVE DIVERGENCE; EVOLUTION; SPECIATION; LAKE; CHARACIFORMES; STICKLEBACKS; ASSEMBLAGES; MECHANISMS	Neotropical mountain streams are important contributors of biological diversity. Two species of the characid genus Rhoadsia differing for an ecologically important morphological trait, body depth, have been described from mountain streams of the western slopes of the Andes in Ecuador. Rhoadsia altipinna is a deeper-bodied species reported from low elevations in southwestern Ecuador and northern Peru, and Rhoadsia minor is a more streamlined species that was described from high elevations (>1200 m) in the Esmeraldas drainage in northwestern Ecuador. Little is known about these species and their validity as distinct species has been questioned. In this study, we examine how their body shape varies along replicated elevational gradients in different drainages of western Ecuador using geometric morphometrics and the fineness ratio. We also use sequences of the mitochondrial cytochrome oxidase c I gene and the second intron of the S7 nuclear gene to examine whether genetic data are consistent with the existence of two species. We found that body depth varies continuously among populations within drainages as a function of elevation, and that body shape overlaps among drainages, such that low elevation populations of R. minor in the Esmeraldas drainage have similar body depths to higher elevation R. altipinna in southern drainages. Although a common general trend of declining body depth with elevation is clear, the pattern and magnitude of body shape divergence differed among drainages. Sequencing of mitochondrial and nuclear genes failed to meet strict criteria for the recognition of two species (e.g., reciprocal monophyly and deep genetic structure). However, there was a large component of genetic variation for the COI gene that segregated among drainages, indicating significant genetic divergence associated with geographic isolation. Continued research on Rhoadsia in western Ecuador may yield significant insight into adaptation and speciation in Neotropical mountain streams.	[Malato, Grace; Karpan, Kirby C.; Aguirre, Windsor E.] Depaul Univ, Dept Biol Sci, Chicago, IL 60604 USA; [Shervette, Virginia R.] Univ South Carolina, Dept Biol Geol, Aiken, SC USA; [Navarrete Amaya, Ronald] Urbanizac Paraiso Rio 1, Guayaquil, Ecuador; [Valdiviezo Rivera, Jonathan] Museo Ciencias Nat, Inst Nacl Biodiversidad, Quito, Ecuador; [Nugra Salazar, Fredy] Univ Azuay, Lab Zool Vertebrados, Cuenca, Ecuador; [Calle Delgado, Paola] Escuela Super Politecn Litoral, Fac Ciencias Vida, Guayaquil, Ecuador	DePaul University; Universidad del Azuay; Escuela Superior Politecnica del Litoral	Aguirre, WE (corresponding author), Depaul Univ, Dept Biol Sci, Chicago, IL 60604 USA.	waguirre@depaul.edu	Salazar, Fredy/GYU-3693-2022	Aguirre, Windsor/0000-0003-3641-5120	Sigma Xi; University Research Council; Department of Biological Sciences; College of Science and Health at DePaul University; USCA Department of Biology/Geology	Sigma Xi; University Research Council; Department of Biological Sciences; College of Science and Health at DePaul University; USCA Department of Biology/Geology	Internal Funding and Student funding through Sigma Xi: Financial support was provided by the University Research Council, the Department of Biological Sciences, and the College of Science and Health at DePaul University, Sigma Xi, and the USCA Department of Biology/Geology.	Aguirre Windsor, 2014, Check List, V10, P382; Aguirre WE, 2016, COPEIA, V104, P554, DOI 10.1643/CG-15-289; Aguirre WE, 2016, EVOL ECOL RES, V17, P373; Aguirre WE, 2014, BIOL J LINN SOC, V113, P204, DOI 10.1111/bij.12316; Aguirre WE, 2013, COPEIA, P312, DOI 10.1643/CI-12-083; Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; Barriga R. S., 2012, REV POLITECNICA, V30, P83, DOI DOI 10.5962/BHL.TITLE.67474; Bartels P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043641; Bass MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008767; BELL MA, 1976, SYST ZOOL, V25, P211, DOI 10.2307/2412489; Bell MA, 2013, EVOL ECOL RES, V15, P377; BOHLKE JAMES, 1958, PROC ACAD NAT SCI PHILADELPHIA, V110, P1; Brawand D, 2014, NATURE, V513, P375, DOI 10.1038/nature13726; Bussing WA, 1987, PECES AGUAS CONTINEN; Campbell P, 2010, EVOLUTION, V64, P1955, DOI 10.1111/j.1558-5646.2010.00962.x; Cardoso A., 2003, CHECKLIST FRESHWATER, P213; Carvajal-Quintero JD, 2015, ECOL EVOL, V5, P2608, DOI 10.1002/ece3.1539; Chambers EA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154363; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Chow S, 1998, MOL ECOL, V7, P1255; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Cooke GM, 2009, FRESHWATER BIOL, V54, P1216, DOI 10.1111/j.1365-2427.2009.02172.x; Crispo E, 2007, EVOLUTION, V61, P2469, DOI 10.1111/j.1558-5646.2007.00203.x; De La Barra E, 2016, REV BIOL TROP, V64, P173; de Queiroz K, 1998, ENDLESS FORMS, P57; Diaz J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157419; Drevecky CJ, 2013, J FISH BIOL, V83, P111, DOI 10.1111/jfb.12154; Eigenmann C. H., 1914, Indiana University Studies Bloomington, V24; Elmer KR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6168; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Funk WC, 2016, MOL ECOL, V25, P2176, DOI 10.1111/mec.13605; Gagnaire PA, 2013, EVOLUTION, V67, P2483, DOI 10.1111/evo.12075; Gavrilets S., 2004, MONOGRAPHS POPULATIO; Georgakopoulou E, 2007, J FISH BIOL, V70, P278, DOI 10.1111/j.1095-8649.2007.01305.x; Gery J., 1977, CHARACOIDS WORLD; Glodek GS, 1978, FRESHWATER FISHES W; Gomez N., 2001, NUEVO ATLAS ECUADOR; Gomez N., 1989, ELEMENTOS GEOGRAFIA; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; He SP, 2008, MOL PHYLOGENET EVOL, V46, P818, DOI 10.1016/j.ympev.2007.06.001; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hendry AP, 2009, CAN J FISH AQUAT SCI, V66, P1383, DOI 10.1139/F09-074; Hendry AP, 2002, EVOLUTION, V56, P1199; Hey Jody, 2009, P15; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Jimenez Prado P, 2015, GU PECES AGUAS CONTI; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Kolbe JJ, 2012, SCIENCE, V335, P1086, DOI 10.1126/science.1209566; Langerhans R. Brian, 2010, P200, DOI 10.1201/b10190-8; Langerhans RB, 2004, AM NAT, V164, P335, DOI 10.1086/422857; Lavinia PD, 2016, J AVIAN BIOL, V47, P84, DOI 10.1111/jav.00766; Licona-Vera Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101870; Loh M, 2014, CONSERV GENET RESOUR, V6, P229, DOI 10.1007/s12686-013-0062-y; LOSOS JB, 1992, SYST BIOL, V41, P403, DOI 10.2307/2992583; Lu GQ, 1999, EVOLUTION, V53, P1491, DOI 10.1111/j.1558-5646.1999.tb05413.x; Lujan NK, 2013, J BIOGEOGR, V40, P1715, DOI 10.1111/jbi.12131; Maldonado-Ocampo JA, 2012, PECES DULCEACU COLAS; Malinsky M, 2015, SCIENCE, V350, P1493, DOI 10.1126/science.aac9927; Mayden RL, 2009, MOL PHYLOGENET EVOL, V51, P500, DOI 10.1016/j.ympev.2008.12.015; Mayr E., 1963, ANIMAL SPECIES EVOLU; Morrison CL, 2006, CONSERV GENET, V7, P129, DOI 10.1007/s10592-005-5681-8; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nei M., 1987, MOL EVOLUTIONARY GEN; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Nosil P, 2009, TRENDS ECOL EVOL, V24, P145, DOI 10.1016/j.tree.2008.10.011; Peres-Neto PR, 2004, OECOLOGIA, V140, P352, DOI 10.1007/s00442-004-1578-3; Pigliucci M., 2001, SYN ECO EVO; Pigliucci M, 2006, J EXP BIOL, V209, P2362, DOI 10.1242/jeb.02070; RAHEL FJ, 1991, T AM FISH SOC, V120, P319, DOI 10.1577/1548-8659(1991)120<0319:FAAHGI>2.3.CO;2; REIST JD, 1985, CAN J ZOOL, V63, P1429, DOI 10.1139/z85-213; Reyes WD, 2015, THESIS; Rohit FJ, 2013, TPSDIG VERSION 2 17; Rohit FJ, 2013, RELATIVE WARPS VERSI; Rohit FJ, 2004, THIN PLATE SPLINE VE; Rohit FJ, 2011, TPSREGR VERSION 1 40; ROSS ST, 1986, COPEIA, P352, DOI 10.2307/1444996; Ruber L, 1999, P NATL ACAD SCI USA, V96, P10230, DOI 10.1073/pnas.96.18.10230; Sanchez-Romero O, 2015, COMP CYTOGENET, V9, P271, DOI 10.3897/CompCytogen.v9i2.4504; Schluter D, 1996, PHILOS T R SOC B, V351, P807, DOI 10.1098/rstb.1996.0075; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schluter D, 2009, P NATL ACAD SCI USA, V106, P9955, DOI 10.1073/pnas.0901264106; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; TERBORGH J, 1977, ECOLOGY, V58, P1007, DOI 10.2307/1936921; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747; Ward AB, 2010, INTEGR COMP BIOL, V50, P1106, DOI 10.1093/icb/icq029; Wellborn GA, 2015, ECOL EVOL, V5, P176, DOI 10.1002/ece3.1347; West-Eberhard Mary Jane, 2003, pi; Willis SC, 2005, OECOLOGIA, V142, P284, DOI 10.1007/s00442-004-1723-z; Wund MA, 2008, AM NAT, V172, P449, DOI 10.1086/590966; Yoder JB, 2010, J EVOLUTION BIOL, V23, P1581, DOI 10.1111/j.1420-9101.2010.02029.x; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1	94	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179432	10.1371/journal.pone.0179432	http://dx.doi.org/10.1371/journal.pone.0179432			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658255	Green Published, gold, Green Submitted			2022-12-27	WOS:000404607900024
J	Testa, L; Latib, A; Bollati, M; Montone, RA; Colombo, A; Crea, F; Bedogni, F				Testa, Luca; Latib, Azeem; Bollati, Mario; Montone, Rocco Antonio; Colombo, Antonio; Crea, Filippo; Bedogni, Francesco			Unprotected left main revascularization: Percutaneous coronary intervention versus coronary artery bypass. An updated systematic review and meta-analysis of randomised controlled trials	PLOS ONE			English	Review							5-YEAR OUTCOMES; ELUTING STENTS; GRAFT-SURGERY; DISEASE; SYNERGY; TAXUS	Background The optimal treatment of unprotected left main (UPLM) with either PCI or CABG remains uncertain. Aim The purpose of this study was to determine the comparative safety and efficacy of PCI versus CABG in patients with UPLM disease. Methods Search of BioMedCentral, CENTRAL, mRCT, PubMed, major cardiological congresses proceedings and references cross-check (updated November 2016). Outcomes were the rate of MACE [all cause death, MI, stroke], the rates of the individual components of MACE and the rate of target vessel revascularisation (TVR). Results We identified 6 Randomised Controlled Trials totalling 4717 patients allocated to PCI or CABG. At 1 year follow up, PCI and CABG were substantially equivalent with respect to the rates of MACE [PCI 8.5% vs CABG 8.9%, OR 1.02,(0.76-1.36), p = 0.9], death [PCI 5.4% vs CABG 6.6%, OR 0.81,(0.63-1.03),p = 0.08] and MI [PCI 3.4% vs CABG 4.3%, OR 0.80 (0.59-1.07), p = 0.14]. Notably, PCI was associated with a significantly lower rate of stroke [PCI 0.6% vs CABG 1.8%, OR 0.36,(0.17-0.79), p = 0.01] and with a significantly higher rate of TVR [PCI 8.7% vs CABG 4.5%, OR 2.00(1.46-2.75), p<0.01]. At a median follow up of 5years, the rates of MACE were similar between the two strategies: PCI 14.6% vs CABG 13.8%, OR 1.02(0.76-1.38), p = 0.89. Likewise, the rates of death [PCI 8% and CABG 7.7%, OR 1(0.77-1.31), P = 0.9], MI [PCI 6.1% vs CABG 5%, OR 1.41(0.85-2.34), P = 0.19,12 59%], and stroke [PCI 2% vs CABG 2.2%, OR 0.85(0.42-1.81), p = 0.65,] were similar while PCI was associated with a significantly higher rate of TVR [14.5% vs CABG 8.9%, OR 1.73(1.41-2.13), p<0.01]. Conclusion In patients with UPLM disease, PCI and CABG are associated with similar rates of MACE and mortality at 1 year as well as after 5 years. Differences can be detected for individual end points at both short and long term FU.	[Testa, Luca; Bollati, Mario; Montone, Rocco Antonio; Bedogni, Francesco] IRCCS Pol S Donato, Dept Cardiol, Milan, Italy; [Latib, Azeem; Colombo, Antonio] EMO GVM Ctr Cuore Columbus Milan, Intervent Cardiol Unit, San Raffaele Sci Inst, Milan, Italy; [Crea, Filippo] Univ Cattolica Sacro Cuore, Dept Cardiol, Rome, Italy	IRCCS Policlinico San Donato; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Testa, L (corresponding author), IRCCS Pol S Donato, Dept Cardiol, Milan, Italy.	luctes@gmail.com	Bedogni, Francesco/ABE-1509-2020; Montone, Rocco Antonio/J-7352-2016; Testa, Luca/J-8226-2018; Latib, Azeem/B-4165-2008; Colombo, Antonio/N-2960-2015	Bedogni, Francesco/0000-0002-4975-6605; Montone, Rocco Antonio/0000-0002-6439-1018; Latib, Azeem/0000-0001-9035-343X; Colombo, Antonio/0000-0002-2940-2455; Bollati, Mario/0000-0001-8805-7439; testa, luca/0000-0003-4687-3686				Ahn JM, 2015, J AM COLL CARDIOL, V65, P2198, DOI 10.1016/j.jacc.2015.03.033; Biondi-Zoccai GGL, 2005, INT J EPIDEMIOL, V34, P224, DOI 10.1093/ije/dyh311; Biondi-Zoccai Giuseppe G L, 2004, Ital Heart J, V5, P486; Boudriot E, 2011, J AM COLL CARDIOL, V57, P538, DOI 10.1016/j.jacc.2010.09.038; Buszman PE, 2016, JACC-CARDIOVASC INTE, V9, P318, DOI 10.1016/j.jcin.2015.10.044; Buszman PE, 2009, J AM COLL CARDIOL, V54, P1500, DOI 10.1016/j.jacc.2009.07.007; Capodanno D, 2011, J AM COLL CARDIOL, V58, P1426, DOI 10.1016/j.jacc.2011.07.005; Clarke M, 2001, COCHRANE REVIEWERS H; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fihn SD, 2014, J AM COLL CARDIOL, V64, P1929, DOI 10.1016/j.jacc.2014.07.017; Makikallio T, 2016, LANCET, V388, P2742; Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; Morice MC, 2014, CIRCULATION, V129, P2388, DOI 10.1161/CIRCULATIONAHA.113.006689; Morice MC, 2010, CIRCULATION, V121, P2645, DOI 10.1161/CIRCULATIONAHA.109.899211; Nerlekar N, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.116.004729; Park SJ, 2011, NEW ENGL J MED, V364, P1718, DOI 10.1056/NEJMoa1100452; Sheiban I, 2016, AM J CARDIOL, V118, P32, DOI 10.1016/j.amjcard.2016.04.007; Stone GW, 2016, NEW ENGL J MED, V375, P2223, DOI 10.1056/NEJMoa1610227; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/ejcts/ezu366, 10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224]	19	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179060	10.1371/journal.pone.0179060	http://dx.doi.org/10.1371/journal.pone.0179060			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658308	Green Published, gold, Green Submitted			2022-12-27	WOS:000404607900013
J	Lopes, TM; Bailly, D; Almeida, BA; Santos, NCL; Gimenez, BCG; Landgraf, GO; Sales, PCL; Lima-Ribeiro, MS; Cassemiro, FAS; Rangel, TF; Diniz, JAF; Agostinho, AA; Gomes, LC				Lopes, Taise M.; Bailly, Dayani; Almeida, Bia A.; Santos, Natalia C. L.; Gimenez, Barbara C. G.; Landgraf, Guilherme O.; Sales, Paulo C. L.; Lima-Ribeiro, Matheus S.; Cassemiro, Fernanda A. S.; Rangel, Thiago F.; Diniz-Filho, Jose A. F.; Agostinho, Angelo A.; Gomes, Luiz C.			Two sides of a coin: Effects of climate change on the native and non-native distribution of Colossoma macropomum in South America	PLOS ONE			English	Article							FRESH-WATER BIODIVERSITY; SPECIES DISTRIBUTION MODELS; PROPAGULE PRESSURE; FISH ASSEMBLAGES; RANGE SHIFTS; INVASION; NICHE; AQUACULTURE; ECOSYSTEMS; MANAGEMENT	Climate change and species invasions interact in nature, disrupting biological communities. Based on this knowledge, we simultaneously assessed the effects of climate change on the native distribution of the Amazonian fish Colossoma macropomum as well as on its invasiveness across river basins of South America, using ecological niche modeling. We used six niche models within the ensemble forecast context to predict the geographical distribution of C. macropomum for the present time, 2050 and 2080. Given that this species has been continuously introduced into non-native South American basins by fish farming activities, we added the locations of C. macropomum farms into the modeling process to obtain a more realistic scenario of its invasive potential. Based on modelling outputs we mapped climate refuge areas at different times. Our results showed that a plenty of climatically suitable areas for the occurrence of C. macropomum occurrence are located outside the original basins at the present time and that its invasive potential is greatly amplified by fish farms. Simulations of future geographic ranges revealed drastic range contraction in the native region, implying concerns not only with respect to the species conservation but also from a socio-economic perspective since the species is a cornerstone of artisanal and commercial fisheries in the Amazon. Although the invasive potential is projected to decrease in the face of climate change, climate refugia will concentrate in Parana A River, Southeast Atlantic and East Atlantic basins, putting intense, negative pressures on the native fish fauna these regions. Our findings show that short and long-term management actions are required for: i) the conservation of natural stocks of C. macropomum in the Amazon, and ii) protecting native fish fauna in the climate refuges of the invaded regions.	[Lopes, Taise M.; Bailly, Dayani; Almeida, Bia A.; Santos, Natalia C. L.; Gimenez, Barbara C. G.; Landgraf, Guilherme O.; Sales, Paulo C. L.; Cassemiro, Fernanda A. S.; Agostinho, Angelo A.; Gomes, Luiz C.] Univ Estadual Maringa, Programa Posgrad Ecol Ambientes Aquat Continentai, Maringa, Parana, Brazil; [Gimenez, Barbara C. G.] Univ Fed Parana, CEM, Programa Posgrad Sistemas Costeiros & Ocean, Pontal Do Parana, PR, Brazil; [Sales, Paulo C. L.] Univ Fed Piaui, Dept Biol, Picos, PI, Brazil; [Lima-Ribeiro, Matheus S.] Univ Fed Goias, Lab Macroecol, Jatai, Go, Brazil; [Rangel, Thiago F.; Diniz-Filho, Jose A. F.] Univ Fed Goias, ICB, Dept Ecol, Goiania, Go, Brazil; [Agostinho, Angelo A.; Gomes, Luiz C.] Univ Estadual Maringa, Nucleo Pesquisas Limnol Ictiol & Aquicultura NUPE, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Federal do Parana; Universidade Federal do Piaui; Universidade Federal de Goias; Universidade Federal de Goias; Universidade Estadual de Maringa	Lopes, TM (corresponding author), Univ Estadual Maringa, Programa Posgrad Ecol Ambientes Aquat Continentai, Maringa, Parana, Brazil.	taisemlopes@gmail.com	Agostinho, Angelo Antonio/S-1538-2019; Gomes, Luiz/D-5886-2013; Almeida, Bia/M-7569-2019; LIMA-RIBEIRO, MATHEUS S./H-9503-2014; Rangel, Thiago F/H-8708-2012; Agostini, Angelo/D-5888-2013; Santos, Natália/AAA-1859-2021; Diniz-Filho, José Alexandre Felizola/D-9405-2013	Agostinho, Angelo Antonio/0000-0002-4707-9444; Almeida, Bia/0000-0001-9738-0270; LIMA-RIBEIRO, MATHEUS S./0000-0002-3322-1702; Rangel, Thiago F/0000-0002-2001-7382; Agostini, Angelo/0000-0002-4707-9444; Diniz-Filho, José Alexandre Felizola/0000-0002-0967-9684; gomes, Luiz/0000-0001-7295-723X				Agostinho AA, 2007, ECOLOGIA MANEJO RECU; Agostinho AA, 2010, NAT CONSERVACAO, V8, P103, DOI 10.4322/natcon.00802001; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Barcante B., 2015, PUBVET, V9, P287; Beaumont LJ, 2009, ECOGRAPHY, V32, P757, DOI 10.1111/j.1600-0587.2009.05705.x; Bertelsmeier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075438; Bond N, 2011, MAR FRESHWATER RES, V62, P1043, DOI 10.1071/MF10286; Booth DJ, 2011, MAR FRESHWATER RES, V62, P1027, DOI 10.1071/MF10270; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Buckley LB, 2010, ECOL LETT, V13, P1041, DOI 10.1111/j.1461-0248.2010.01479.x; Busby JR, 1991, NATURE CONSERVATION, P64, DOI DOI 10.1046/J.1365-294X.2001.01244.X; Carey MP, 2012, FRONT ECOL ENVIRON, V10, P373, DOI 10.1890/110060; CARPENTER G, 1993, BIODIVERS CONSERV, V2, P667, DOI 10.1007/BF00051966; Claro-Jr Luiz, 2004, Acta Amaz., V34, P133, DOI 10.1590/S0044-59672004000100018; Comte L, 2013, FRESHWATER BIOL, V58, P625, DOI 10.1111/fwb.12081; Copp GH, 2005, J APPL ICHTHYOL, V21, P242, DOI 10.1111/j.1439-0426.2005.00690.x; da Costa OTF, 2004, AQUACULTURE, V232, P627, DOI [10.1016/s0044-8486(03)00524-6, 10.1016/S0044-8486(03)00524-6]; de Azevedo-Santos VM, 2011, NEOTROP ICHTHYOL, V9, P915, DOI 10.1590/S1679-62252011000400024; Diniz JAF, 2010, INSECT CONSERV DIVER, V3, P213, DOI 10.1111/j.1752-4598.2010.00090.x; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Eby LA, 2006, TRENDS ECOL EVOL, V21, P576, DOI 10.1016/j.tree.2006.06.016; Farber O, 2003, ECOL MODEL, V160, P115, DOI 10.1016/S0304-3800(02)00327-7; Diniz JAF, 2010, REV BRAS ENTOMOL, V54, P339, DOI 10.1590/S0085-56262010000300001; Gaston KJ, 2009, AM NAT, V174, P595, DOI 10.1086/605982; Gois KS, 2015, HYDROBIOLOGIA, V746, P401, DOI 10.1007/s10750-014-2061-8; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Heino J, 2009, BIOL REV, V84, P39, DOI 10.1111/j.1469-185X.2008.00060.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Hortal J, 2008, OIKOS, V117, P847, DOI 10.1111/j.0030-1299.2008.16434.x; Isaac V. J., 1996, Fisheries Management and Ecology, V3, P315, DOI 10.1046/j.1365-2400.1996.d01-154.x; Kroupova H, 2005, VET MED-CZECH, V50, P461, DOI 10.17221/5650-VETMED; Leprieur F, 2009, FISH FISH, V10, P88, DOI 10.1111/j.1467-2979.2008.00314.x; Leprieur F, 2008, PLOS BIOL, V6, P404, DOI 10.1371/journal.pbio.0060028; Lima DP, 2012, NAT CONSERVACAO, V10, P88, DOI 10.4322/natcon.2012.015; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lockwood JL, 2009, DIVERS DISTRIB, V15, P904, DOI 10.1111/j.1472-4642.2009.00594.x; Mata C, 2009, TOXICOL LETT, V189, pS191, DOI 10.1016/j.toxlet.2009.06.577; Meek MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046373; Moran EV, 2014, ECOL LETT, V17, P637, DOI 10.1111/ele.12262; Moyle PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063883; Naylor RL, 2001, SCIENCE, V294, P1655, DOI 10.1126/science.1064875; O'Donnell J, 2012, GLOBAL CHANGE BIOL, V18, P617, DOI 10.1111/j.1365-2486.2011.02537.x; Ortega JCG, 2015, HYDROBIOLOGIA, V745, P31, DOI 10.1007/s10750-014-2089-9; Parker-Allie F, 2009, CLIMATIC CHANGE, V94, P87, DOI 10.1007/s10584-009-9549-7; Pelicice FM, 2014, CONSERV LETT, V7, P55, DOI 10.1111/conl.12029; Pelicice FM, 2009, BIOL INVASIONS, V11, P1789, DOI 10.1007/s10530-008-9358-3; Peterson AT, 2012, NAT CONSERVACAO, V10, P102, DOI 10.4322/natcon.2012.019; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Poff NL, 2002, PHILOS T R SOC A, V360, P1497, DOI 10.1098/rsta.2002.1012; Rahel FJ, 2008, CONSERV BIOL, V22, P521, DOI 10.1111/j.1523-1739.2008.00950.x; Rahel FJ, 2007, FRESHWATER BIOL, V52, P696, DOI 10.1111/j.1365-2427.2006.01708.x; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Ricciardi A, 2007, CONSERV BIOL, V21, P329, DOI 10.1111/j.1523-1739.2006.00615.x; Ruffino M.L., 1994, ACTA BIOL VENEZUELIC, V15, P37; Saint-Paul U., 1985, ANIM RES DEV, V22, P7; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schindler DE, 2001, ECOSYSTEMS, V4, P308, DOI 10.1007/s10021-001-0013-4; Sipaúba-Tavares LH., 2007, Braz. J. Biol., V67, P459, DOI 10.1590/S1519-69842007000300010; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Strayer DL, 2010, J N AM BENTHOL SOC, V29, P344, DOI 10.1899/08-171.1; Taylor S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035565; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tomala D, 2014, LAT AM J AQUAT RES, V42, P971, DOI 10.3856/vol42-issue5-fulltext-4; Val A.L., 1995, FISHES AMAZON THEIR, V1st; Valery L, 2008, BIOL INVASIONS, V10, P1345, DOI 10.1007/s10530-007-9209-7; van Vliet MTH, 2013, CLIMATIC CHANGE, V121, P739, DOI 10.1007/s10584-013-0976-0; Wilson JRU, 2007, FRONT ECOL ENVIRON, V5, P409, DOI 10.1890/060077.01; Winemiller KO, 2016, SCIENCE, V351, P128, DOI 10.1126/science.aac7082; Winemiller KO, 2008, J BIOGEOGR, V35, P1551, DOI 10.1111/j.1365-2699.2008.01917.x; Woodward G, 2010, PHILOS T R SOC B, V365, P2093, DOI 10.1098/rstb.2010.0055	74	17	19	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179684	10.1371/journal.pone.0179684	http://dx.doi.org/10.1371/journal.pone.0179684			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654663	Green Published, Green Submitted, gold			2022-12-27	WOS:000404541500024
J	Nangia, N; Bale, R; Chen, N; Hanna, Y; Patankar, NA				Nangia, Nishant; Bale, Rahul; Chen, Nelson; Hanna, Yohanna; Patankar, Neelesh A.			Optimal specific wavelength for maximum thrust production in undulatory propulsion	PLOS ONE			English	Article							SWIMMING PERFORMANCE; FISH; KINEMATICS; STEADY; HYDRODYNAMICS; FLOW; STIFFNESS; LOCOMOTION; MOTION; DRAG	What wavelengths do undulatory swimmers use during propulsion? In this work we find that a wide range of body/caudal fin (BCF) swimmers, from larval zebrafish and herring to fully-grown eels, use specific wavelength (ratio of wavelength to tail amplitude of undulation) values that fall within a relatively narrow range. The possible emergence of this constraint is interrogated using numerical simulations of fluid-structure interaction. Based on these, it was found that there is an optimal specific wavelength (OSW) that maximizes the swimming speed and thrust generated by an undulatory swimmer. The observed values of specific wavelength for BCF animals are relatively close to this OSW. The mechanisms underlying the maximum propulsive thrust for BCF swimmers are quantified and are found to be consistent with the mechanisms hypothesized in prior work. The adherence to an optimal value of specific wavelength in most natural hydrodynamic propulsors gives rise to empirical design criteria for man-made propulsors.	[Nangia, Nishant; Patankar, Neelesh A.] Northwestern Univ, Engn Sci & Appl Math, Evanston, IL 60208 USA; [Bale, Rahul; Chen, Nelson; Hanna, Yohanna; Patankar, Neelesh A.] Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA; [Bale, Rahul] RIKEN, AICS, Kobe, Hyogo, Japan; [Chen, Nelson] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA; [Hanna, Yohanna] Univ Southern Calif, Dept Aerosp & Mech Engn, Los Angeles, CA USA	Northwestern University; Northwestern University; RIKEN; University of California System; University of California Berkeley; University of Southern California	Patankar, NA (corresponding author), Northwestern Univ, Engn Sci & Appl Math, Evanston, IL 60208 USA.; Patankar, NA (corresponding author), Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA.	n-patankar@northwestern.edu	Bale, Rahul/D-2469-2016; Patankar, Neelesh A/B-7603-2009	Bale, Rahul/0000-0003-4586-2782; 	National Science Foundation [CBET-0828749, CMMI-0941674, CBET-1066575, ACI-1053575, DGE-1324585]; Directorate For Engineering [1066575] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by National Science Foundation grants CBET-0828749, CMMI-0941674 and CBET-1066575 to NAP. Computational resources were provided by Northwestern University High Performance Computing System-Quest. This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant number ACI-1053575. This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. DGE-1324585 to NN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 1998, J FLUID MECH, V360, P41, DOI 10.1017/S0022112097008392; BATTY RS, 1984, J EXP BIOL, V110, P217; Bhalla APS, 2014, J COMPUT PHYS, V256, P88, DOI 10.1016/j.jcp.2013.08.043; Bhalla APS, 2013, J COMPUT PHYS, V250, P446, DOI 10.1016/j.jcp.2013.04.033; Blake R.W., 1983, FISH LOCOMOTION; Borazjani I, 2010, J EXP BIOL, V213, P89, DOI 10.1242/jeb.030932; Borazjani I, 2008, J EXP BIOL, V211, P1541, DOI 10.1242/jeb.015644; Borazjani I, 2009, J EXP BIOL, V212, P576, DOI 10.1242/jeb.025007; D'Aout K, 1999, BELG J ZOOL, V129, P305; D'Aout K, 1999, J EXP BIOL, V202, P1511; DAout K, 1997, J EXP BIOL, V200, P1863; Donley JM, 2000, J EXP BIOL, V203, P3103; Dowis HJ, 2003, J EXP BIOL, V206, P2749, DOI 10.1242/jeb.00496; Fuiman LA, 1997, J EXP BIOL, V200, P1745; Gazzola M, 2014, NAT PHYS, V10, P758, DOI 10.1038/NPHYS3078; Gillis GB, 1996, AM ZOOL, V36, P656; GRAHAM JB, 1987, J EXP BIOL, V127, P27; IBAMR, 2016, IBAMR AD DISTR MEM P; JAYNE BC, 1995, J EXP BIOL, V198, P585; Kancharala AK, 2016, BIOINSPIR BIOMIM, V11, DOI 10.1088/1748-3190/11/5/056016; Langerhans RB, 2009, J EVOLUTION BIOL, V22, P1057, DOI 10.1111/j.1420-9101.2009.01716.x; Lauder GV, 2006, FISH PHYSIOL, V23, P425, DOI 10.1016/S1546-5098(05)23011-X; Lauder GV, 2012, INTEGR COMP BIOL; Liao JC, 2002, J EXP BIOL, V205, P2875; Long JH, 1996, J EXP BIOL, V199, P2139; Low KH, 2006, J VIB CONTROL, V12, P1337, DOI 10.1177/1077546306070597; Low KH, 2006, INT J AUTOM COMPUT, V3, P348, DOI 10.1007/s11633-006-0348-6; Lucas KN, 2015, BIOINSPIR BIOMIM, V10, DOI 10.1088/1748-3190/10/5/056019; Lucas KN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4293; Muller UK, 2008, J EXP BIOL, V211, P196, DOI 10.1242/jeb.005629; Muller UK, 2004, J EXP BIOL, V207, P853, DOI 10.1242/jeb.00821; Muller UK, 1997, J EXP BIOL, V200, P2893; Sfakiotakis M, 1999, IEEE J OCEANIC ENG, V24, P237, DOI 10.1109/48.757275; Shen L, 2003, J FLUID MECH, V484, P197, DOI 10.1017/S0022112003004294; Taylor GK, 2003, NATURE, V425, P707, DOI 10.1038/nature02000; Triantafyllou MS, 2000, ANNU REV FLUID MECH, V32, P33, DOI 10.1146/annurev.fluid.32.1.33; Tytell ED, 2004, J EXP BIOL, V207, P1825, DOI 10.1242/jeb.00968; van Weerden JF, 2014, FISH FISH, V15, P397, DOI 10.1111/faf.12022; VIDELER JJ, 1984, J EXP BIOL, V109, P209; Webb PW, 2002, J EXP BIOL, V205, P2125; WEBB PW, 1992, J EXP BIOL, V162, P157	41	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179727	10.1371/journal.pone.0179727	http://dx.doi.org/10.1371/journal.pone.0179727			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654649	Green Published, Green Submitted, gold			2022-12-27	WOS:000404541500027
J	Linde, K; Treml, J; Steinig, J; Nagl, M; Kersting, A				Linde, Katja; Treml, Julia; Steinig, Jana; Nagl, Michaela; Kersting, Anette			Grief interventions for people bereaved by suicide: A systematic review	PLOS ONE			English	Review							PREVENT COMPLICATED GRIEF; QUALITY-OF-LIFE; PROLONGED GRIEF; TRAUMATIC GRIEF; MENTAL-HEALTH; SURVIVORS; DISORDER; FAMILY; RISK; EFFICACY	Background Adaption to the loss of a loved one due to suicide can be complicated by feelings of guilt, shame, responsibility, rejection, and stigmatization. Therefore people bereaved by suicide have an increased risk for developing complicated grief which is related to negative physical and mental disorders and an increased risk for suicidal behavior. Grief interventions are needed for this vulnerable population. The aim of this systematic review was to provide an overview of the current state of evidence concerning the effectiveness of interventions that focus on grief for people bereaved by suicide. Methods We conducted a systematic literature search using PubMed, Web of Science, and Psycl NFO for articles published up until November 2016. Relevant papers were identified and methodological quality was assessed by independent raters. A narrative synthesis was conducted. Results Seven intervention studies met the inclusion criteria. Two interventions were based on cognitive -behavioral approaches, four consisted of bereavement groups, and one utilized writing therapy. As five of the seven interventions were effective in reducing grief intensity on at least one outcome measure, there is some evidence that they are beneficial. Bereavement groups tend to be effective in lowering the intensity of uncomplicated grief, as are writing interventions in lowering suicide -specific aspects of grief. Cognitive -behavioral programs were helpful for a subpopulation of people who had high levels of suicidal ideation. Limitation On average, methodological quality was low so the evidence for benefits is not robust. The stability of treatment effects could not be determined as follow-up assessments are rare. Generalizability is limited due to homogeneous enrollments of mainly female, white, middleaged individuals. Conclusions People bereaved by suicide are especially vulnerable to developing complicated grief. Therefore, grief therapies should be adapted to and evaluated in this population. Prevention of complicated grief may be successful in populations of high risk individuals.	[Linde, Katja; Treml, Julia; Steinig, Jana; Nagl, Michaela; Kersting, Anette] Univ Leipzig, Dept Psychosomat Med & Psychotherapy, Leipzig, Germany	Leipzig University	Kersting, A (corresponding author), Univ Leipzig, Dept Psychosomat Med & Psychotherapy, Leipzig, Germany.	Anette.Kersting@medizin.uni-leipzig.de			German Research Foundation (DFG); Universitat Leipzig within the program of Open Access Publishing	German Research Foundation (DFG)(German Research Foundation (DFG)); Universitat Leipzig within the program of Open Access Publishing	We acknowledge support from the German Research Foundation (DFG) and Universitat Leipzig within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerbo E, 2005, J EPIDEMIOL COMMUN H, V59, P407, DOI 10.1136/jech.2004.024950; Allumbaugh DL, 1999, J COUNS PSYCHOL, V46, P370, DOI 10.1037/0022-0167.46.3.370; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Barlow CA, 2010, DEATH STUD, V34, P915, DOI 10.1080/07481181003761435; BARRETT TW, 1989, SUICIDE LIFE-THREAT, V19, P201; Boelen PA, 2005, J PSYCHOPATHOL BEHAV, V27, P291, DOI 10.1007/s10862-005-2409-5; Boelen PA, 2003, DEATH STUD, V27, P227, DOI 10.1080/07481180302889; Boelen PA, 2007, EUR ARCH PSY CLIN N, V257, P444, DOI 10.1007/s00406-007-0744-0; Boelen PA, 2006, CLIN PSYCHOL-SCI PR, V13, P109, DOI 10.1111/j.1468-2850.2006.00013.x; Bonanno GA, 2001, CLIN PSYCHOL REV, V21, P705, DOI 10.1016/S0272-7358(00)00062-3; Bonanno GA, 2002, J PERS SOC PSYCHOL, V83, P1150, DOI 10.1037//0022-3514.83.5.1150; Bonanno GA, 2004, PSYCHOL AGING, V19, P260, DOI 10.1037/0882-7974.19.2.260; Cavanagh JTO, 2003, PSYCHOL MED, V33, P395, DOI 10.1017/S0033291702006943; Centers for Disease Control and Prevention, 2013, INJ PREV CONTR DIV V; Centre for Reviews and Dissemination, 2009, CRDS GUID UND REV HE; Cerel J, 2000, J AM ACAD CHILD PSY, V39, P437, DOI 10.1097/00004583-200004000-00012; Clark Sheila E., 2000, INT HDB SUICIDE ATTE, P467, DOI DOI 10.1002/9780470698976.CH26; Constantino R E, 1996, Issues Ment Health Nurs, V17, P131, DOI 10.3109/01612849609035002; Constantino RE, 2001, SUICIDE LIFE-THREAT, V31, P428, DOI 10.1521/suli.31.4.428.22044; Currier JM, 2008, PSYCHOL BULL, V134, P648, DOI 10.1037/0033-2909.134.5.648; De Groot MH, 2006, SUICIDE LIFE-THREAT, V36, P418, DOI 10.1521/suli.2006.36.4.418; de Groot M, 2007, BMJ-BRIT MED J, V334, P994, DOI 10.1136/bmj.39161.457431.55; de Groot M, 2010, SUICIDE LIFE-THREAT, V40, P425, DOI 10.1521/suli.2010.40.5.425; Dyregrov K, 2003, DEATH STUD, V27, P143, DOI 10.1080/07481180302892; Ellenbogen S, 2001, SUICIDE LIFE-THREAT, V31, P83, DOI 10.1521/suli.31.1.83.21315; Farberow N L, 1992, Crisis, V13, P23; Germain A, 2005, J TRAUMA STRESS, V18, P343, DOI 10.1002/jts.20035; Hawton K, 2003, BRIT MED J, V327, P177, DOI 10.1136/bmj.327.7408.177; Heritier SR, 2003, MED J AUSTRALIA, V179, P438, DOI 10.5694/j.1326-5377.2003.tb05627.x; Hogan NS, 2001, DEATH STUD, V25, P1, DOI 10.1080/074811801750058609; Horowitz M. J, 2003, FOCUS, V1, P290, DOI DOI 10.1176/FOC.1.3.290; Jackson D, 2015, J CHILD HEALTH CARE, V19, P495, DOI 10.1177/1367493513519297; Jordan JR, 2008, PSYCHIAT ANN, V38, P679, DOI 10.3928/00485713-20081001-05; Jordan JR, 2001, SUICIDE LIFE-THREAT, V31, P91, DOI 10.1521/suli.31.1.91.21310; Kersting A, 2013, PSYCHOTHER PSYCHOSOM, V82, P372, DOI 10.1159/000348713; Kersting A, 2011, J AFFECT DISORDERS, V131, P339, DOI 10.1016/j.jad.2010.11.032; Kovac SH, 2000, SUICIDE LIFE-THREAT, V30, P50; Latham AE, 2004, SUICIDE LIFE-THREAT, V34, P350, DOI 10.1521/suli.34.4.350.53737; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Maercker A, 2013, WORLD PSYCHIATRY, V12, P198, DOI 10.1002/wps.20057; McDaid C, 2008, BRIT J PSYCHIAT, V193, P438, DOI 10.1192/bjp.bp.107.040824; Mitchell AM, 2005, SUICIDE LIFE-THREAT, V35, P498, DOI 10.1521/suli.2005.35.5.498; Nam I, 2016, J LOSS TRAUMA, V21, P325, DOI 10.1080/15325024.2015.1067099; National Collaborating Centre for Methods and Tools, 2020, COVID 19 RAP EV REV; Neimeyer RA, 2009, CURR DIR PSYCHOL SCI, V18, P352, DOI 10.1111/j.1467-8721.2009.01666.x; Newson RS, 2011, J AFFECT DISORDERS, V132, P231, DOI 10.1016/j.jad.2011.02.021; PENNEBAKER JW, 1986, J ABNORM PSYCHOL, V95, P274, DOI 10.1037/0021-843X.95.3.274; Pitman A, 2014, LANCET PSYCHIAT, V1, P86, DOI 10.1016/S2215-0366(14)70224-X; Pompili M, 2013, INDIAN J PSYCHIAT, V55, P256, DOI 10.4103/0019-5545.117145; Prigerson HG, 1997, AM J PSYCHIAT, V154, P616, DOI 10.1176/ajp.154.5.616; Prigerson HG, 1995, PSYCHIAT RES, V59, P65, DOI 10.1016/0165-1781(95)02757-2; Prigerson HG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000121; Qin P, 2003, ARCH GEN PSYCHIAT, V60, P797, DOI 10.1001/archpsyc.60.8.797; Rosner R, 2015, J AFFECT DISORDERS, V183, P106, DOI 10.1016/j.jad.2015.04.051; Rosner R, 2014, J AFFECT DISORDERS, V167, P56, DOI 10.1016/j.jad.2014.05.035; Sanders CM, 1985, MANUAL GRIEF EXPERIE; Schut Henk, 2005, J Palliat Med, V8 Suppl 1, pS140; Shear K, 2005, JAMA-J AM MED ASSOC, V293, P2601, DOI 10.1001/jama.293.21.2601; Shear MK, 2014, JAMA PSYCHIAT, V71, P1287, DOI 10.1001/jamapsychiatry.2014.1242; Shear MK, 2011, DEPRESS ANXIETY, V28, P103, DOI 10.1002/da.20780; Silverman GK, 2000, PSYCHOL MED, V30, P857, DOI 10.1017/S0033291799002524; Simon NM, 2007, COMPR PSYCHIAT, V48, P395, DOI 10.1016/j.comppsych.2007.05.002; Simon NM, 2013, JAMA-J AM MED ASSOC, V310, P416, DOI 10.1001/jama.2013.8614; Stroebe M, 2010, OMEGA-J DEATH DYING, V61, P273, DOI 10.2190/OM.61.4.b; Sveen CA, 2008, SUICIDE LIFE-THREAT, V38, P13, DOI 10.1521/suli.2008.38.1.13; Szanto K, 1997, SUICIDE LIFE-THREAT, V27, P194; Szanto K, 2006, J CLIN PSYCHIAT, V67, P233, DOI 10.4088/JCP.v67n0209; Szumilas M, 2011, CAN J PUBLIC HEALTH, V102, P18, DOI 10.1007/BF03404872; Tal Young Ilanit, 2012, Dialogues Clin Neurosci, V14, P177; Wagner B, 2006, DEATH STUD, V30, P429, DOI 10.1080/07481180600614385; Wilson A, 2010, DEATH STUD, V34, P625, DOI 10.1080/07481181003761567; Wittouck C, 2014, CRISIS, V35, P193, DOI 10.1027/0227-5910/a000252; Wittouck C, 2011, CLIN PSYCHOL REV, V31, P69, DOI 10.1016/j.cpr.2010.09.005; World Health Organization, 2014, PREV SUIC GLOB IMP; Zisook S, 2009, WORLD PSYCHIATRY, V8, P67	75	43	44	6	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179496	10.1371/journal.pone.0179496	http://dx.doi.org/10.1371/journal.pone.0179496			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY7CO	28644859	Green Submitted, Green Published, gold			2022-12-27	WOS:000404145100019
J	Okun, E; Marton, D; Cohen, D; Griffioen, K; Kanfi, Y; Illouz, T; Madar, R; Cohen, HY				Okun, Eitan; Marton, Daniel; Cohen, Daniel; Griffioen, Kathleen; Kanfi, Yariv; Illouz, Tomer; Madar, Ravit; Cohen, Haim Y.			Sirt6 alters adult hippocampal neurogenesis	PLOS ONE			English	Article							STEM-CELL FATE; DENTATE GYRUS; NEURONAL DIFFERENTIATION; CALORIE RESTRICTION; PROLIFERATION; DEACETYLASE; GROWTH; MECHANISMS; EXPRESSION; EXERCISE	Sirtuins are pleiotropic NAD(+) dependent histone deacetylases involved in metabolism, DNA damage repair, inflammation and stress resistance. SIRT6, a member of the sirtuin family, regulates the process of normal aging and increases the lifespan of male mice over-expressing Sirt6 by 15%. Neurogenesis, the formation of new neurons within the hippocampus of adult mammals, involves several complex stages including stem cell proliferation, differentiation, migration and network integration. During aging, the number of newly generated neurons continuously declines, and this is correlated with a decline in neuronal plasticity and cognitive behavior. In this study we investigated the involvement of SIRT6 in adult hippocampal neurogenesis. Mice over-expressing Sirt6 exhibit increased numbers of young neurons and decreased numbers of mature neurons, without affecting glial differentiation. This implies of an involvement of SIRT6 in neuronal differentiation and maturation within the hippocampus. This work adds to the expanding body of knowledge on the regulatory mechanisms underlying adult hippocampal neurogenesis, and describes novel roles for SIRT6 as a regulator of cell fate during adult hippocampal neurogenesis.	[Okun, Eitan; Marton, Daniel; Cohen, Daniel; Kanfi, Yariv; Illouz, Tomer; Madar, Ravit; Cohen, Haim Y.] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Okun, Eitan; Marton, Daniel; Cohen, Daniel; Illouz, Tomer; Madar, Ravit] Bar Ilan Univ, Leslie & Susan Gonda Multidisciplinary Brain Res, Ramat Gan, Israel; [Okun, Eitan] Bar Ilan Univ, Paul Feder Lab Alzheimers Dis Res, Ramat Gan, Israel; [Griffioen, Kathleen] Liberty Univ, Dept Biol & Chem, Lynchburg, VA USA	Bar Ilan University; Bar Ilan University; Bar Ilan University; Liberty University	Okun, E (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.; Okun, E (corresponding author), Bar Ilan Univ, Leslie & Susan Gonda Multidisciplinary Brain Res, Ramat Gan, Israel.; Okun, E (corresponding author), Bar Ilan Univ, Paul Feder Lab Alzheimers Dis Res, Ramat Gan, Israel.	eitan.okun@biu.ac.il	okun, eitan/AAC-9571-2019; Kornweitz, Haya/L-6469-2018	okun, eitan/0000-0001-8474-1487; Kornweitz, Haya/0000-0002-3562-0141; Cohen, Haim Y./0000-0002-6613-8710; Madar, Ravit/0000-0002-2025-8178	Paul Feder Laboratory on Alzheimer's disease research; European Foundation for the Study of Diabetes [MSD 2014_1] Funding Source: researchfish	Paul Feder Laboratory on Alzheimer's disease research; European Foundation for the Study of Diabetes	This work was funded and carried out in the Paul Feder Laboratory on Alzheimer's disease research.	Bondolfi L, 2004, NEUROBIOL AGING, V25, P333, DOI 10.1016/S0197-4580(03)00083-6; Brandt MD, 2012, STEM CELLS, V30, P2843, DOI 10.1002/stem.1244; Calvanese V, 2010, P NATL ACAD SCI USA, V107, P13736, DOI 10.1073/pnas.1001399107; Canto C, 2011, PHYSIOLOGY, V26, P214, DOI 10.1152/physiol.00010.2011; Carro E, 2001, J NEUROSCI, V21, P5678, DOI 10.1523/JNEUROSCI.21-15-05678.2001; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Denis-Donini S, 2008, J NEUROSCI, V28, P3911, DOI 10.1523/JNEUROSCI.0148-08.2008; Donoghue JF, 2011, JOVE-J VIS EXP, DOI 10.3791/3157; Elhanati S, 2013, CELL REP, V4, P905, DOI 10.1016/j.celrep.2013.08.006; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; Etchegaray JP, 2015, NAT CELL BIOL, V17, P545, DOI 10.1038/ncb3147; Faigle R, 2013, BBA-GEN SUBJECTS, V1830, P2435, DOI 10.1016/j.bbagen.2012.09.002; Franklin K. B. J., 2008, COMPACT; Gage G. J., 2012, J VIS EXP; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Guo HF, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-56; Hayes NL, 2002, DEV BRAIN RES, V134, P77, DOI 10.1016/S0165-3806(01)00324-8; Hisahara S, 2008, P NATL ACAD SCI USA, V105, P15599, DOI 10.1073/pnas.0800612105; HYNES M, 1995, NEURON, V15, P35, DOI 10.1016/0896-6273(95)90062-4; Imai S, 2009, CELL BIOCHEM BIOPHYS, V53, P65, DOI 10.1007/s12013-008-9041-4; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Klempin F, 2012, STEM CELLS, V30, P500, DOI 10.1002/stem.1005; Kumar V, 2016, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00308; Lee KE, 2014, P NATL ACAD SCI USA, V111, P2794, DOI 10.1073/pnas.1308758111; Ma CY, 2014, DEVELOPMENT, V141, P4697, DOI 10.1242/dev.117937; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; Matsumata M, 2012, STEM CELLS, V30, P1532, DOI 10.1002/stem.1124; McNally JG, 1999, METHODS, V19, P373, DOI 10.1006/meth.1999.0873; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Piao J, 2013, SCI REP-UK, V3, DOI 10.1038/srep03022; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Schwer B, 2010, P NATL ACAD SCI USA, V107, P21790, DOI 10.1073/pnas.1016306107; Simeoni F, 2013, SCI REP-UK, V3, DOI 10.1038/srep03085; Simic P, 2013, EMBO MOL MED, V5, P430, DOI 10.1002/emmm.201201606; Steele AD, 2006, P NATL ACAD SCI USA, V103, P3416, DOI 10.1073/pnas.0511290103; Sun Wu, 2014, STEM CELLS; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Yang SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017057; Yao QP, 2014, INT J BIOCH CELL BIO; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao Y, 2015, STROKE, V46, P1966, DOI 10.1161/STROKEAHA.115.009216	56	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179681	10.1371/journal.pone.0179681	http://dx.doi.org/10.1371/journal.pone.0179681			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644902	gold, Green Published, Green Submitted			2022-12-27	WOS:000404145100032
J	Rosbach, M; Andersen, JS				Rosbach, Michael; Andersen, John Sahl			Patient-experienced burden of treatment in patients with multimorbidity - A systematic review of qualitative data	PLOS ONE			English	Review							PRIMARY-CARE; META-ETHNOGRAPHY; COMPLEX PATIENTS; HEART-FAILURE; HEALTH-CARE; MORTALITY; EPIDEMIOLOGY; CHALLENGES; DISEASE	Objective To synthesize existing qualitative literature on patient-experienced burden of treatment in multimorbid patients. Methods A literature search identified available qualitative studies on the topic of burden of treatment in multimorbidity and meta-ethnography was applied as method. The authors' original findings were preserved, but also synthesized to new interpretations to investigate the concept of the burden of treatment using the Cumulative Complexity Model. Results Nine qualitative studies were identified. The majority of the 1367 participants from 34 different countries were multimorbid. The treatment burden components, experienced by patients, were identified for each study. The components financial burden, lack of knowledge, diet and exercise, medication burden and frequent healthcare reminding patients of their health problem were found to attract additional attention from the multimorbid patients. In studies conducted in the US and Australia the financial burden and the time and travel burden were found most straining to patients with deprived socioeconomic status. The burden of treatment was found to be a complex concept consisting of many different components and factors interacting with each other. The size of the burden was associated to the workload of demands (number of conditions, number of medications and health status), the capacity (cognitive, physical and financial resources, educational level, cultural background, age, gender and employment conditions) and the context (structure of healthcare and social support). Patients seem to use strategies such as prioritizing between treatments to diminish the workload and mobilizing and coordinating resources to improve their ability to manage the burden of treatment. They try to routinize and integrate the treatment into their daily lives, which might be a way to maintain the balance between workload and capacity. Conclusions Healthcare providers need to increase the focus on minimizing multimorbid patients' burden of treatment. Findings in this review suggest that the weight of the burden needs to be established in the individual patient and components of the burden must be identified.	[Rosbach, Michael] Univ Copenhagen, Dept Publ Hlth, Res Unit Gen Practice, Copenhagen, Denmark; Univ Copenhagen, Dept Publ Hlth, Sect Gen Practice, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Rosbach, M (corresponding author), Univ Copenhagen, Dept Publ Hlth, Res Unit Gen Practice, Copenhagen, Denmark.	Rosbach@hotmail.com						[Anonymous], 2010, SOCIAL RES METHODS Q; Atkins S, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-21; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bayliss Elizabeth A, 2003, Ann Fam Med, V1, P15, DOI 10.1370/afm.4; Boehmer KR, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0525-9; Bohlen K, 2012, DIABETES CARE, V35, P47, DOI 10.2337/dc11-1082; Campbell R, 2003, SOC SCI MED, V56, P671, DOI 10.1016/S0277-9536(02)00064-3; De Geest S, 2003, EUR J CARDIOVASC NUR, V2, P323, DOI [DOI 10.1016/S1474-5151(03)00091-4, 10.1016/S1474-5151(03)00091-4]; Demain S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125457; Eton DT, 2017, QUAL LIFE RES, V26, P489, DOI 10.1007/s11136-016-1397-0; Eton DT, 2015, PATIENT-RELAT OUTCOM, V6, P117, DOI 10.2147/PROM.S78955; Fortin M, 2004, HEALTH QUAL LIFE OUT, V2, P51, DOI [10.1186/1477-7525-2-51, DOI 10.1186/1477-7525-2-51]; Gallacher K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001473; Gallacher K, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-10; Gallacher K, 2011, ANN FAM MED, V9, P235, DOI 10.1370/afm.1249; Glynn LG, 2011, FAM PRACT, V28, P516, DOI 10.1093/fampra/cmr013; Haynes RB, 2002, JAMA-J AM MED ASSOC, V288, P2880, DOI 10.1001/jama.288.22.2880; Ho PM, 2006, ARCH INTERN MED, V166, P1836, DOI 10.1001/archinte.166.17.1836; Kahn LS, 2015, CHRONIC ILLN, V11, P171, DOI 10.1177/1742395314559751; Lee TA, 2007, J GEN INTERN MED, V22, P403, DOI 10.1007/s11606-007-0277-2; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; MAY C, 2009, BMJ-BRIT MED J, V339, DOI DOI 10.1136/BMJ.B2803; May CR, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-281; May CR, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-29; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Noblit G. W., 1988, METAETHNOGRAPHY SYNT; Noel P, 2005, HEALTH EXPECT, V8, P54, DOI 10.1111/j.1369-7625.2004.00312.x; Pound P, 2005, SOC SCI MED, V61, P133, DOI 10.1016/j.socscimed.2004.11.063; Rasmussen JN, 2007, JAMA-J AM MED ASSOC, V297, P177, DOI 10.1001/jama.297.2.177; Ridgeway JL, 2014, PATIENT PREFER ADHER, V8, P339, DOI 10.2147/PPA.S58014; Ring N R K, 2011, NHS QUALITY IMPROVEM; Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929; Sav A, 2013, HEALTH SOC CARE COMM, V21, P665, DOI 10.1111/hsc.12052; Sawatzky R, 2016, ANS ADV NURSING SCI; Shippee ND, 2012, J CLIN EPIDEMIOL, V65, P1041, DOI 10.1016/j.jclinepi.2012.05.005; Tran VT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0356-x; Tran VT, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-109; Tran VT, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-68; Violan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102149; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; Ward BW, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120203; WHO USDoHaNSa, 2011, GLOBAL HLTH AGING; Willadsen TG, 2016, SCAND J PRIM HEALTH, V34, P112, DOI 10.3109/02813432.2016.1153242	43	98	97	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179916	10.1371/journal.pone.0179916	http://dx.doi.org/10.1371/journal.pone.0179916			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY7CO	28644877	Green Published, gold, Green Submitted			2022-12-27	WOS:000404145100050
J	van Cleef, EHCB; D'Aaurea, AAP; Favaro, VR; van Cleef, FOS; Barducci, RS; Almeida, MTC; Neto, ORM; Ezequiel, JMB				van Cleef, Eric H. C. B.; D'Aaurea, Andre A. P.; Favaro, Vanessa R.; van Cleef, Flavia O. S.; Barducci, Robson S.; Almeida, Marco T. C.; Machado Neto, Otavio R.; Ezequiel, Jane M. B.			Effects of dietary inclusion of high concentrations of crude glycerin on meat quality and fatty acid profile of feedlot fed Nellore bulls	PLOS ONE			English	Article							CARCASS CHARACTERISTICS; YOUNG BULLS; CHOLESTEROL CONCENTRATION; LONGISSIMUS MUSCLE; OLEIC-ACID; BEEF; TRAITS; PERFORMANCE; SUPPLEMENTATION; LIMOUSIN	Crude glycerin, the main by-product of biodiesel production, can replace dietary energy sources, such as corn. The objective of this study was to evaluate the inclusion of up to 30% of crude glycerin in dry matter (DM) of the total diets, and its effects on meat quality parameters of feedlot Nellore bulls. Thirty animals (227.7 +/- 23.8 kg body weight; 18 months old) were housed in individual pens and fed 5 experimental diets, containing 0, 7.5, 15, 22.5 or 30% crude glycerin (DM basis). After 103 d (21 d adaptation) animals were slaughtered and the Longissimus muscle was collected. The characteristics assessed were chemical composition, fatty acid profile, cholesterol, shear force, pH, color, water-holding capacity, cooking loss and sensory properties. The increasing inclusion of crude glycerin in the diets did not affect the chemical composition of the Longissimus muscle (P > 0.10). A quadratic effect was observed when levels of crude glycerin were increased, on the concentration of pentadecanoic, palmitoleic and eicosenoic fatty acids in meat (P < 0.05), and on the activity of the delta-9 desaturase 16 and delta-9 desaturase 18 enzymes (P < 0.05). The addition of crude glycerin increased the gamma linolenic fatty acid concentration (P < 0.01), and altered the monounsaturated fatty acids in Longissimus muscle of animals (P-quad. < 0.05). Crude glycerin decreased cholesterol content in meat (P < 0.05), and promoted higher flavor score and greasy intensity perception of the meat (P < 0.01). The inclusion of up to 30% crude glycerin in Nellore cattle bulls'diets (DM basis) improves meat cholesterol and sensory attributes, such as flavor, without affecting significantly the physical traits, the main fatty acid concentrations and the chemical composition.	[van Cleef, Eric H. C. B.; D'Aaurea, Andre A. P.; Favaro, Vanessa R.; van Cleef, Flavia O. S.; Barducci, Robson S.; Almeida, Marco T. C.; Ezequiel, Jane M. B.] Sao Paulo State Univ Unesp, Sch Agr & Vet Sci, Sao Paulo, Brazil; [Machado Neto, Otavio R.] Sao Paulo State Univ Unesp, Sch Vet Med & Anim Sci, Sao Paulo, Brazil; [van Cleef, Eric H. C. B.] Univ Fed Triangulo Mineiro, Iturama, MG, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Federal do Triangulo Mineiro	van Cleef, EHCB (corresponding author), Sao Paulo State Univ Unesp, Sch Agr & Vet Sci, Sao Paulo, Brazil.; van Cleef, EHCB (corresponding author), Univ Fed Triangulo Mineiro, Iturama, MG, Brazil.	ericvancleef@gmail.com	Neto, Otávio Machado/AAY-2091-2021; Neto, Otávio R Machado/K-2516-2013; Neto, Otávio R. Machado/AAZ-7544-2020; Almeida, Marco Túlio Costa/AAP-1684-2020; van Cleef, Eric H C B/H-5590-2012; Almeida, Marco Túlio Costa/D-5025-2012; Ezequiel, Jane M. B./L-2154-2019; Ezequiel, Jane M. B./C-3443-2019	Neto, Otávio Machado/0000-0002-4449-7771; Neto, Otávio R Machado/0000-0002-4449-7771; Almeida, Marco Túlio Costa/0000-0001-8730-0425; Almeida, Marco Túlio Costa/0000-0001-8730-0425; Ezequiel, Jane M. B./0000-0002-2503-371X; Ezequiel, Jane M. B./0000-0002-2503-371X; van Cleef, Eric/0000-0003-1656-2502	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [09/51857-3, 08/53712-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP grant numbers 09/51857-3,08/53712-0), http://www.fapesp.br/.	ALHASANI SM, 1993, J AOAC INT, V76, P902; Almeida MTC, ANIM PROD SCI; AMSA, 2015, RES GUID COOK SENS E, V2nd ed; AOAC, 1990, OFFICIAL METHODS ANA; AOAC (Association of Official Analytical Chemists), 1999, OFFICIAL METHODS ANA, V16; Bass PD, 2008, J ANIM SCI, V86, P1658, DOI 10.2527/jas.2007-0688; Bermingham EN, 2008, AUST J EXP AGR, V48, P726, DOI 10.1071/EA08010; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Carvalho JRR, 2014, MEAT SCI, V96, P977, DOI 10.1016/j.meatsci.2013.10.020; Carvalho VB, 2015, MEAT SCI, V110, P285, DOI 10.1016/j.meatsci.2015.08.001; van Cleef EHCB, 2014, REV BRAS ZOOTECN, V43, P86, DOI 10.1590/S1516-35982014000200006; CIE, 2004, COL TECHN REP; Daniel ZCTR, 2004, J ANIM SCI, V82, P747; Duckett SK, 2014, DIABET METAB SYND OB, V7, P553, DOI 10.2147/DMSO.S72695; Egea M, 2014, MEAT SCI, V98, P673, DOI 10.1016/j.meatsci.2014.06.034; Eiras CE, 2014, MEAT SCI, V96, P930, DOI 10.1016/j.meatsci.2013.10.002; Elam NA, 2008, P SW NUTR C AZ US, P21; Faria PB, 2012, MEAT SCI, V90, P733, DOI 10.1016/j.meatsci.2011.11.004; Francozo MC, 2013, BRAZ ARCH BIOL TECHN, V56, P327, DOI 10.1590/S1516-89132013000200019; Geppert J, 2008, BRIT J NUTR, V99, P360, DOI 10.1017/S0007114507801577; Gervois P, 2000, CLIN CHEM LAB MED, V38, P3, DOI 10.1515/CCLM.2000.002; Gilmore LA, 2011, J NUTR, V141, P1188, DOI 10.3945/jn.110.136085; GRUNDY SM, 1994, AM J CLIN NUTR, V60, p986S, DOI 10.1093/ajcn/60.6.986S; Gunn PJ, 2010, J ANIM SCI, V88, P1771, DOI 10.2527/jas.2009-2325; Hamm R., 1986, MUSCLE AS FOOD, P135, DOI DOI 10.1016/B978-0-12-084190-5.50009-6; Houben JH, 2000, MEAT SCI, V55, P331, DOI 10.1016/S0309-1740(99)00161-8; Immonen K, 2000, MEAT SCI, V54, P163, DOI 10.1016/S0309-1740(99)00090-X; Joo ST, 2013, MEAT SCI, V95, P828, DOI 10.1016/j.meatsci.2013.04.044; Lage JF, 2014, MEAT SCI, V96, P1158, DOI 10.1016/j.meatsci.2013.10.027; Mach N, 2008, MEAT SCI, V78, P232, DOI 10.1016/j.meatsci.2007.06.021; Mach N, 2009, J ANIM SCI, V87, P632, DOI 10.2527/jas.2008-0987; MalauAduli AEO, 1997, AUST J AGR RES, V48, P715, DOI 10.1071/A96083; Maw SJ, 2003, MEAT SCI, V63, P185, DOI 10.1016/S0309-1740(02)00069-4; Meilgaard M.C., 2007, SENSORY EVALUATION T, V4th ed., DOI 10.1201/b16452; Fernandes ARM, 2009, REV BRAS ZOOTECN, V38, P705, DOI 10.1590/S1516-35982009000400017; Muchenje V, 2009, FOOD CHEM, V112, P279, DOI 10.1016/j.foodchem.2008.05.103; NRC, 2000, NAT RES COUNC NUTR R, V7th; *NRC, 1989, DIET HLTH IMPL RED C; Oliveira EA, 2012, MEAT SCI, V90, P28, DOI 10.1016/j.meatsci.2011.05.024; Prado IN, 2008, J ANIM FEED SCI, V17, P307, DOI 10.22358/jafs/66610/2008; Pratiwi NMW, 2006, SMALL RUMINANT RES, V64, P77, DOI 10.1016/j.smallrumres.2005.04.016; Scollan N, 2006, MEAT SCI, V74, P17, DOI 10.1016/j.meatsci.2006.05.002; Shackelford S. D., 1991, Journal of Muscle Foods, V2, P289, DOI 10.1111/j.1745-4573.1991.tb00461.x; Thornton KJ, 2012, J ANIM SCI, V90, P1617, DOI 10.2527/jas.2011-4678; Torres E.A.F.S., 2000, CIENCIA TECNOL ALIME, V20, P145, DOI DOI 10.1590/S0101-20612000000200003; ULBRICHT TLV, 1991, LANCET, V338, P985, DOI 10.1016/0140-6736(91)91846-M; Vahmani P, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0026-z; van Cleef EHCB, 2016, CAN J ANIM SCI, V96, P461, DOI 10.1139/cjas-2015-0170; Vito ES, 2015, MEAT SCI, V100, P17, DOI 10.1016/j.meatsci.2014.09.008; Viturro E, 2009, J STEROID BIOCHEM, V115, P62, DOI 10.1016/j.jsbmb.2009.02.011; WHEELER TL, 1987, J ANIM SCI, V65, P1531, DOI 10.2527/jas1987.6561531x; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0	53	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179830	10.1371/journal.pone.0179830	http://dx.doi.org/10.1371/journal.pone.0179830			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644883	Green Published, gold, Green Submitted			2022-12-27	WOS:000404145100042
J	Cresswell, JA; Ganaba, R; Sarrassat, S; Cousens, S; Some, H; Diallo, AH; Filippi, V				Cresswell, Jenny A.; Ganaba, Rasmane; Sarrassat, Sophie; Cousens, Simon; Some, Henri; Diallo, Abdoulaye Hama; Filippi, Veronique			Predictors of exclusive breastfeeding and consumption of soft, semi- solid or solid food among infants in Boucle du Mouhoun, Burkina Faso: A cross- sectional survey	PLOS ONE			English	Article							EARLY INITIATION; PROMISE-EBF; DETERMINANTS; MORTALITY; PROMOTION; COMMUNITY; BARRIERS; CARE	Introduction Exclusive breastfeeding is among the most effective interventions for preventing child mortality. The objectives of this paper are to describe infant feeding knowledge and practices in Boucle du Mouhoun, Burkina Faso; to identify predictors of exclusive breastfeeding among infants <6 months, and consumption of soft, semi-solid or solid food among infants 6-11 months; to describe mothers' sources of information regarding breastfeeding. Methods A cross-sectional survey (n = 2288) of a representative sample of women aged 15-49 years with at least one live birth in past year took place during June and July 2015. Crude and multivariable random-effects logistic regressions were used to identify factors predictive of exclusive breastfeeding and consumption of soft, semi-solid or solid food. Results 30% of infants <6 months were exclusively breastfed; 67% of infants age 6-11 months consumed soft, semi-solid or solid food the day and night before the interview. 2% of infants age 6-11 months had a minimum acceptable diet. There was strong evidence of a positive association between knowledge and practice of exclusive breastfeeding, nonetheless 60% of mothers who correctly identified that an infant should be exclusively breastfed for 6 months did not breastfeed their infant exclusively. Only 42% of mothers reported receiving advice on breastfeeding from a health worker, despite all mothers having contact with a health worker at least once during pregnancy or postpartum. Conclusion Given poor practices and low levels of knowledge, targeted interventions are needed to improve infant nutrition in Boucle du Mouhoun during antenatal, delivery and postnatal care. Most women now deliver in a facility in Burkina Faso; increased attention should be paid to ensuring that existing guidelines relating to support and counselling for infant feeding are adhered to. Factors such as social norms are also important and these should be investigated in more detail using qualitative methods.	[Cresswell, Jenny A.; Sarrassat, Sophie; Cousens, Simon; Filippi, Veronique] London Sch Hyg & Trop Med, London, England; [Ganaba, Rasmane; Some, Henri] AFRICSante, Bobo Dioulasso, Burkina Faso; [Diallo, Abdoulaye Hama] Ctr MURAZ, Bobo Dioulasso, Burkina Faso	University of London; London School of Hygiene & Tropical Medicine; Centre Muraz	Cresswell, JA (corresponding author), London Sch Hyg & Trop Med, London, England.	Jenny.Cresswell@lshtm.ac.uk		Cresswell, Jenny/0000-0002-9553-1132; Cherif, ISSIFOU/0000-0002-1590-3312; Sarrassat, Sophie/0000-0001-6872-6455	Bill & Melinda Gates Foundation [OPP50838]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	The research was supported by funding from the Bill & Melinda Gates Foundation, Grant Number OPP50838.	Agho KE, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-2; Blanchet K, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0476-5; Chola L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142718; de Onis M, 2013, MATERN CHILD NUTR, V9, P6, DOI 10.1111/mcn.12075; Diallo AH, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-45; Duysburgh E, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0562-8; Engebretsen IMS, 2014, INT BREASTFEED J, V9, DOI 10.1186/1746-4358-9-19; Fjeld E, 2008, INT BREASTFEED J, V3, DOI 10.1186/1746-4358-3-26; Ganaba R, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0875-2; GUNNLAUGSSON G, 1992, INT J EPIDEMIOL, V21, P935, DOI 10.1093/ije/21.5.935; Issaka AI, 2015, MATERN CHILD NUTR, V11, P31, DOI 10.1111/mcn.12193; Issaka AI, 2015, NUTRIENTS, V7, P948, DOI 10.3390/nu7020948; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Moore SE, 2007, AM J CLIN NUTR, V85, P1075, DOI 10.1093/ajcn/85.4.1075; Quyen Thi Tu Bui, 2016, Global Health Action, V9, P29433; Rollins NC, 2016, LANCET, V387, P491, DOI 10.1016/S0140-6736(15)01044-2; Sankar MJ, 2015, ACTA PAEDIATR, V104, P3, DOI 10.1111/apa.13147; Tawiah-Agyemang C, 2008, J PERINATOL, V28, pS46, DOI 10.1038/jp.2008.173; Tylleskar T, 2011, LANCET, V378, P420, DOI 10.1016/S0140-6736(11)60738-1; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; WHO, 2003, GLOB STRAT INF YOUNG; WHO UNICEF USAID AED UCDAVIS IFPRI, 2007, IND ASS INF YOUNG CH	23	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179593	10.1371/journal.pone.0179593	http://dx.doi.org/10.1371/journal.pone.0179593			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640900	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000404135800041
J	Patel, PG; Selvarajah, S; Guerard, KP; Bartlett, JMS; Lapointe, J; Berman, DM; Okello, JBA; Park, PC				Patel, Palak G.; Selvarajah, Shamini; Guerard, Karl-Philippe; Bartlett, John M. S.; Lapointe, Jacques; Berman, David M.; Okello, John B. A.; Park, Paul C.			Reliability and performance of commercial RNA and DNA extraction kits for FFPE tissue cores	PLOS ONE			English	Article							METHYLATION-SPECIFIC PCR; PROSTATE-CANCER; SAMPLES; QUANTIFICATION; EXPRESSION; BIOMARKERS; QUALITY	Cancer biomarker studies often require nucleic acid extraction from limited amounts of for-malin- fixed, paraffin-embedded (FFPE) tissues, such as histologic sections or needle cores. A major challenge is low quantity and quality of extracted nucleic acids, which can limit our ability to perform genetic analyses, and have a significant influence on overall study design. This study was aimed at identifying the most reliable and reproducible method of obtaining sufficient high-quality nucleic acids from FFPE tissues. We compared the yield and quality of nucleic acids from 0.6-mm FFPE prostate tissue cores across 16 DNA and RNA extraction protocols, using 14 commercially available kits. Nucleic acid yield was determined by fluorometry, and quality was determined by spectrophotometry. All protocols yielded nucleic acids in quantities that are compatible with downstream molecular applications. However, the protocols varied widely in the quality of the extracted RNA and DNA. Four RNA and five DNA extraction protocols, including protocols from two kits for dual-extraction of RNA and DNA from the same tissue source, were prioritized for further quality assessment based on the yield and purity of their products. Specifically, their compatibility with downstream reactions was assessed using both NanoString nCounter gene expression assays and reverse-transcriptase real-time PCR for RNA, and methylation-specific PCR assays for DNA. The kit deemed most suitable for FFPE tissue was the AllPrep kit by Qiagen because of its yield, quality, and ability to purify both RNA and DNA from the same sample, which would be advantageous in biomarker studies.	[Patel, Palak G.; Selvarajah, Shamini; Berman, David M.; Okello, John B. A.; Park, Paul C.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada; [Patel, Palak G.; Berman, David M.; Okello, John B. A.] Queens Univ, Queens Canc Res Inst, Div Canc Biol & Genet, Kingston, ON, Canada; [Guerard, Karl-Philippe; Lapointe, Jacques] McGill Univ, Div Urol, Dept Surg, Montreal, PQ, Canada; [Guerard, Karl-Philippe; Lapointe, Jacques] McGill Univ, Res Inst, Hlth Ctr, Montreal, PQ, Canada; [Bartlett, John M. S.] Ontario Inst Canc Res, Diagnost Dev Program, Toronto, ON, Canada	McMaster University; Queens University - Canada; Queens University - Canada; McGill University; McGill University; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Park, PC (corresponding author), Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada.	pcp1@queensu.ca	Okello, John B A/B-5157-2018; berman, david/HIR-4177-2022	Okello, John B A/0000-0002-5889-1905; Selvarajah, Shamini/0000-0002-9894-4864; berman, david/0000-0001-5985-3698; Guerard, Karl-Philippe/0000-0002-7229-3952	Movember Foundation Grant through Prostate Cancer Canada [T2014.01]; Movember Foundation [T2014.01]	Movember Foundation Grant through Prostate Cancer Canada; Movember Foundation	Funding for this work was provided by the Movember Foundation Grant #T2014.01 through Prostate Cancer Canada to JMSB, JL, DMB, PCP and others: http://www.prostatecancer.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was awarded by Prostate Cancer Canada and is proudly funded by the Movember Foundation-Grant #T2014.01.	Bonin S, 2003, J CLIN PATHOL-MOL PA, V56, P184, DOI 10.1136/mp.56.3.184; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Chen B, 2001, CURRENT PROTOCOLS HU; Daniunaite K, 2014, J UROLOGY, V192, P1849, DOI 10.1016/j.juro.2014.06.075; Demidenko R, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1689-8; Dietrich D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077771; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Groelz D, 2013, EXP MOL PATHOL, V94, P188, DOI 10.1016/j.yexmp.2012.07.002; He JT, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0418-z; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Kalia M, 2015, METABOLISM, V64, pS16, DOI 10.1016/j.metabol.2014.10.027; Kalman LV, 2013, ARCH PATHOL LAB MED, V137, P983, DOI 10.5858/arpa.2012-0311-RA; King CE, 2009, BIOTECHNIQUES, V47, P941, DOI 10.2144/000113244; Kotorashvili A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034683; Ku JL, 2011, METHODS MOL BIOL, V791, P23, DOI 10.1007/978-1-61779-316-5_3; Ludyga N, 2012, VIRCHOWS ARCH, V460, P131, DOI 10.1007/s00428-011-1184-9; Mattocks CJ, 2010, EUR J HUM GENET, V18, P1276, DOI 10.1038/ejhg.2010.101; Okello JBA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013931; Okello JBA, 2010, ANAL BIOCHEM, V400, P110, DOI 10.1016/j.ab.2010.01.014; Patel PG, 2016, JOVE-J VIS EXP, DOI 10.3791/54299; Radstrom P, 2004, MOL BIOTECHNOL, V26, P133, DOI 10.1385/MB:26:2:133; Reis PP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-46; Ross JS, 2011, BIOMARK MED, V5, P277, DOI [10.2217/BMM.11.29, 10.2217/bmm.11.29]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x; Sheffield J, MICROSC MICROANAL, V13, P200; Tam S, 2014, LAB INVEST, V94, P350, DOI 10.1038/labinvest.2013.157; van Beers EH, 2006, BRIT J CANCER, V94, P333, DOI 10.1038/sj.bjc.6602889; Wang FF, 2007, J MOL DIAGN, V9, P441, DOI 10.2353/jmoldx.2007.070004; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Wilfinger WW, 1997, BIOTECHNIQUES, V22, P474, DOI 10.2144/97223st01	31	35	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179732	10.1371/journal.pone.0179732	http://dx.doi.org/10.1371/journal.pone.0179732			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640876	Green Submitted, gold, Green Published			2022-12-27	WOS:000404135800058
J	Ye, YC; Yang, M; Zhang, SY; Zeng, Y				Ye, Yicong; Yang, Ming; Zhang, Shuyang; Zeng, Yong			Percutaneous coronary intervention in left main coronary artery disease with or without intravascular ultrasound: A meta-analysis	PLOS ONE			English	Article							ELUTING STENT IMPLANTATION; 5-YEAR OUTCOMES; BYPASS-SURGERY; IMPACT; GUIDANCE; LESIONS	This meta-analysis compared IVUS-guided with angiography-guided PCI to determine the effect of IVUS on the mortality in patients with LM CAD. Current guidelines recommend intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI)) in patients with left main coronary artery disease (LM CAD; Class IIa, level of evidence B). A systematic search of the MEDLINE, Embase, and Cochrane Central Register of Controlled Trials databases was conducted to identify randomized or non-randomized studies comparing IVUS-guided PCI with angiography-guided PCI in LM CAD. Ten studies (9 non-randomized and 1 randomized) with 6,480 patients were included. The primary outcome was mortality including all-cause death and cardiac death. Compared with angiography-guide PCI, IVUS-guided PCI was associated with significantly lower risks of all-cause death (risk ratio [RR] 0.60, 95% confidence interval [CI] 0.47-0.75, p<0.001), cardiac death (RR 0.47, 95% CI 0.33-0.66, p<0.001), target lesion revascularization (RR 0.43, 95% CI 0.25-0.73, p = 0.002), and in-stent thrombosis (RR 0.28, 95% CI 0.12-0.67, p = 0.004). Subgroup analyses indicated the beneficial effect of IVUS-guide PCI was consistent across different types of studies (unadjusted non-randomized studies, propensity score-matched non-randomized studies, or randomized trial), study populations (Asian versus non-Asian), and lengths of follow-up (<3 years versus >= 3 years). IVUS-guided PCI in LM CAD significantly reduced the risks of all-cause death by similar to 40% compared with conventional angiography-guided PCI.	[Zhang, Shuyang; Zeng, Yong] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Cardiol, Beijing, Peoples R China; Chinese Acad Med Sci, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College	Zhang, SY; Zeng, Y (corresponding author), Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Cardiol, Beijing, Peoples R China.	pumchzhangsy@163.com; pumchzy@163.com	Ye, Yicong/AFV-8932-2022	YANG, ming/0000-0001-9843-3848; Zhang, Shuyang/0000-0002-1532-0029; Ye, Yicong/0000-0002-9433-6140	CAMS Major Collaborative Innovation Project [2016-I2M-1-011]	CAMS Major Collaborative Innovation Project	This work was supported by CAMS Major Collaborative Innovation Project (No. 2016-I2M-1-011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by CAMS Major Collaborative Innovation Project (No. 2016-I2M-1-011).	Agostoni P, 2005, AM J CARDIOL, V95, P644, DOI 10.1016/j.amjcard.2004.10.042; Ahn JM, 2015, J AM COLL CARDIOL, V65, P2198, DOI 10.1016/j.jacc.2015.03.033; Andell P, 2017, CIRC-CARDIOVASC INTE, V10, DOI 10.1161/CIRCINTERVENTIONS.116.004813; Bavishi C, 2017, AM HEART J, V185, P26, DOI 10.1016/j.ahj.2016.10.008; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Capodanno D, 2011, J AM COLL CARDIOL, V58, P1426, DOI 10.1016/j.jacc.2011.07.005; Chen SL, 2013, CATHETER CARDIO INTE, V81, P456, DOI 10.1002/ccd.24601; Hernandez JM, 2014, JACC-CARDIOVASC INTE, V7, P244, DOI 10.1016/j.jcin.2013.09.014; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DETRE KM, 1975, CIRCULATION, V52, P979, DOI 10.1161/01.CIR.52.6.979; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FISHER LD, 1982, CATHETER CARDIO DIAG, V8, P565, DOI 10.1002/ccd.1810080605; Furuichi S, 2007, CATHETER CARDIO INTE, V70, P856, DOI 10.1002/ccd.21219; Gao XF, 2014, PATIENT PREFER ADHER, V8, P1299, DOI 10.2147/PPA.S65768; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jama A, 2011, J AM COLL CARDIOL, V58, pB167; Kang SJ, 2014, CATHETER CARDIO INTE, V83, P545, DOI 10.1002/ccd.25057; Kang SJ, 2011, CIRC-CARDIOVASC INTE, V4, P562, DOI 10.1161/CIRCINTERVENTIONS.111.964643; Kim BK, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.115.002592; Kinoshita N, 2010, AM J CARDIOL, V105, p59B; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Morice MC, 2014, CIRCULATION, V129, P2388, DOI 10.1161/CIRCULATIONAHA.113.006689; Narbute I, 2012, EURO INTERVENTION J, V8, pN101; Nerlekar N, 2016, EUROINTERVENTION J E, Patent No. 27840327; Oviedo C, 2010, CIRC-CARDIOVASC INTE, V3, P105, DOI 10.1161/CIRCINTERVENTIONS.109.906016; Park SH, 2012, AM J CARDIOL, V109, p123S, DOI 10.1016/j.amjcard.2012.01.433; Park Seung-Jung, 2015, EuroIntervention, V11 Suppl V, pV120, DOI 10.4244/EIJV11SVA27; Park SJ, 2009, CIRC-CARDIOVASC INTE, V2, P167, DOI 10.1161/CIRCINTERVENTIONS.108.799494; Park SJ, 2001, J AM COLL CARDIOL, V38, P1054, DOI 10.1016/S0735-1097(01)01491-7; Park Y, 2011, INT J CARDIOL, V148, P174, DOI 10.1016/j.ijcard.2009.10.052; Roh Jae-Hyung, 2015, EuroIntervention, V11 Suppl V, pV125, DOI 10.4244/EIJV11SVA28; Shah BR, 2005, J CLIN EPIDEMIOL, V58, P550, DOI 10.1016/j.jclinepi.2004.10.016; Shin DH, 2016, JACC-CARDIOVASC INTE, V9, P2232, DOI 10.1016/j.jcin.2016.07.021; Stone GW, 2016, NEW ENGL J MED, V375, P2223, DOI 10.1056/NEJMoa1610227; Tan Q, 2015, SAUDI MED J, V36, P549, DOI 10.15537/smj.2015.5.11251; Tang YD, 2016, J AM COLL CARDIOL, V68, pB224, DOI 10.1016/j.jacc.2016.09.693; Trac MH, 2016, CAN MED ASSOC J, V188, pE120, DOI 10.1503/cmaj.150901; Valentine Jeffrey C, 2013, Res Synth Methods, V4, P26, DOI 10.1002/jrsm.1064; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/ejcts/ezu366, 10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224]; ZIR LM, 1976, CIRCULATION, V53, P627, DOI 10.1161/01.CIR.53.4.627	41	48	51	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179756	10.1371/journal.pone.0179756	http://dx.doi.org/10.1371/journal.pone.0179756			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640875	Green Submitted, Green Published, gold			2022-12-27	WOS:000404135800060
J	Chow, LQ; Santana-Davila, R; Pantel, A; Roth, M; Anderson, LN; Failor, A; Doot, R; Mankoff, D				Chow, Laura Q.; Santana-Davila, Rafael; Pantel, Austin; Roth, Mara; Anderson, Leslie N.; Failor, Alan; Doot, Robert; Mankoff, David			A phase I study of pazopanib in combination with escalating doses of 131 I in patients with well-differentiated thyroid carcinoma borderline refractory to radioiodine	PLOS ONE			English	Article							DOUBLE-BLIND; CANCER; THERAPY; TRIAL	Objective This trial was conducted to evaluate the ability of pazopanib to overcome therapeutic 131 I resistance. Materials, methods and patients This phase 1 trial assesses the combination of pazopanib and escalating doses of radioiodine (131 I) in patients with recurrent or metastatic thyroid cancer that are borderline or relatively iodine refractory. Radioiodine uptake scans were assessed post therapy and compared to historical pre-treatment scans. Patients underwent FDG PET/CT before and after the initial pazopanib treatment to identify the impact of pazopanib on the cancer prior to (131) I therapy. Results A dose limiting toxicity (cardiac arrhythmia and grade 3 fatigue) in the first patient in the first cohort prompted expansion to a total of 6 patients. Additional grade 3-4 hematologic toxicity and low accrual in the expanded cohort led to the decision not to pursue further study of the regimen. In patients with measurable disease 4/5 (80%) achieved stable disease. Median progression free survival was 6.7 months. At 3 years of follow up, one patient died due to progressive disease, two are being treated with systemic therapy and 3 continue without requiring subsequent therapy at 15, 27 and 35 months from the last dose of pazopanib. There was no convincing impact of pazopanib on iodine uptake in scans performed pre- and post- therapy compared to scans from historical 131 I treatments without pazopanib. Conclusion Despite a suggestion of therapeutic efficacy, combined pazopanib and 131 I resulted in increased toxicity. There was no convincing evidence that the administration of pazopanib improved iodine uptake or retention. Trial registration ClinicalTrials. gov NCT01413113	[Chow, Laura Q.; Santana-Davila, Rafael; Anderson, Leslie N.] Univ Washington, Dept Med, Div Med Oncol, Fred Hutchison Canc Res Ctr, Seattle, WA 98105 USA; [Pantel, Austin; Doot, Robert; Mankoff, David] Univ Penn, Dept Nucl Med, Philadelphia, PA 19104 USA; [Roth, Mara; Failor, Alan] Univ Washington, Dept Med, Div Endocrinol, Seattle, WA USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Pennsylvania; University of Washington; University of Washington Seattle	Chow, LQ (corresponding author), Univ Washington, Dept Med, Div Med Oncol, Fred Hutchison Canc Res Ctr, Seattle, WA 98105 USA.	lqchow@u.washington.edu	Doot, Robert/AAS-7848-2021	Doot, Robert/0000-0003-1747-239X	National Comprehensive Cancer Network (NCCN) Oncology Research Program - Novartis Pharmaceuticals Corporation (formerly GlaxoSmithKline, LLC)	National Comprehensive Cancer Network (NCCN) Oncology Research Program - Novartis Pharmaceuticals Corporation (formerly GlaxoSmithKline, LLC)	This study was approved and funded by the National Comprehensive Cancer Network (NCCN) Oncology Research Program from general research support provided by Novartis Pharmaceuticals Corporation (formerly GlaxoSmithKline, LLC). Study drug was provided by Novartis Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENUA RS, 1962, AMER J ROENTGENOL RA, V87, P171; Bible KC, 2010, LANCET ONCOL, V11, P962, DOI 10.1016/S1470-2045(10)70203-5; Brose MS, 2014, LANCET, V384, P319, DOI 10.1016/S0140-6736(14)60421-9; Burns WR, 2010, SEMIN ONCOL, V37, P557, DOI 10.1053/j.seminoncol.2010.10.008; Carr LL, 2010, CLIN CANCER RES, V16, P5260, DOI 10.1158/1078-0432.CCR-10-0994; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Davies L, 2014, JAMA OTOLARYNGOL, V140, P317, DOI 10.1001/jamaoto.2014.1; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Elisei R, 2013, J CLIN ONCOL, V31, P3639, DOI 10.1200/JCO.2012.48.4659; Ho AL, 2013, NEW ENGL J MED, V368, P623, DOI 10.1056/NEJMoa1209288; Kohandel M, 2007, PHYS MED BIOL, V52, P3665, DOI 10.1088/0031-9155/52/13/001; MAXON HR, 1983, NEW ENGL J MED, V309, P937, DOI 10.1056/NEJM198310203091601; Pietras K, 2005, J CLIN ONCOL, V23, P939, DOI 10.1200/JCO.2005.07.093; Rutherford GC, 2008, CLIN RADIOL, V63, P453, DOI 10.1016/j.crad.2007.08.002; Schlumberger M, 2015, NEW ENGL J MED, V372, P621, DOI 10.1056/NEJMoa1406470; Senan S, 2007, ONCOLOGIST, V12, P465, DOI 10.1634/theoncologist.12-4-465; Storer B. E., 1989, CONTROLLED CLIN TRIA, V45, P925, DOI DOI 10.2307/2531693; Wells SA, 2012, J CLIN ONCOL, V30, P134, DOI 10.1200/JCO.2011.35.5040; Xing MZ, 2013, NAT REV CANCER, V13, P184, DOI 10.1038/nrc3431; Zhang XC, 2010, ARCH PATHOL LAB MED, V134, P786, DOI 10.1043/1543-2165-134.5.786	20	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0178325	10.1371/journal.pone.0178325	http://dx.doi.org/10.1371/journal.pone.0178325			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662033	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300005
J	Raval, SB; Britton, CA; Zhao, TJ; Krishnamurthy, N; Santini, T; Gorantla, VS; Ibrahim, TS				Raval, Shailesh B.; Britton, Cynthia A.; Zhao, Tiejun; Krishnamurthy, Narayanan; Santini, Tales; Gorantla, Vijay S.; Ibrahim, Tamer S.			Ultra-high field upper extremity peripheral nerve and non-contrast enhanced vascular imaging	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; 7 T; HIGH-RESOLUTION; MR-ANGIOGRAPHY; CT ANGIOGRAPHY; INTRACRANIAL ANEURYSMS; FIBER TRACTOGRAPHY; OCCLUSIVE DISEASE; TRANSCEIVER ARRAY; BRACHIAL-PLEXUS	Objective The purpose of this study was to explore the efficacy of Ultra-high field [UHF] 7 Tesla [T] MRI as compared to 3T MRI in non-contrast enhanced [nCE] imaging of structural anatomy in the elbow, forearm, and hand [upper extremity]. Materials and method A wide range of sequences including T1 weighted [T1] volumetric interpolate breath-hold exam [VIBE], T2 weighted [T2] double-echo steady state [DESS], susceptibility weighted imaging [SWI], time-of-flight [TOF], diffusion tensor imaging [DTI], and diffusion spectrum imaging [DSI] were optimized and incorporated with a radiofrequency [RF] coil system composed of a transverse electromagnetic [TEM] transmit coil combined with an 8-channel receive-only array for 7T upper extremity [UE] imaging. In addition, Siemens optimized protocol/ sequences were used on a 3T scanner and the resulting images from T1 VIBE and T2 DESS were compared to that obtained at 7T qualitatively and quantitatively [SWI was only qualitatively compared]. DSI studio was utilized to identify nerves based on analysis of diffusion weighted derived fractional anisotropy images. Images of forearm vasculature were extracted using a paint grow manual segmentation method based on MIPAV [Medical Image Processing, Analysis, and Visualization]. Results High resolution and high quality signal-to-noise ratio [SNR] and contrast-to-noise ratio [CNR] D images of the hand, forearm, and elbow were acquired with nearly homogeneous 7T excitation. Measured [performed on the T1 VIBE and T2 DESS sequences] SNR and CNR values were almost doubled at 7T vs. 3T. Cartilage, synovial fluid and tendon structures could be seen with higher clarity in the 7T T1 and T2 weighted images. SWI allowed high resolution and better quality imaging of large and medium sized arteries and veins,capillary networks and arteriovenous anastomoses at 7T when compared to 3T. 7T diffusion weighted sequence [not performed at 3T] demonstrates that the forearm nerves are clearly delineated by fiber tractography. The proper digital palmar arteries and superficial palmar arch could also be clearly visualized using TOF nCE 7T MRI. Conclusion Ultra-high resolution neurovascular imaging in upper extremities is possible at 7T without use of renal toxic intravenous contrast. 7T MRI can provide superior peripheral nerve [based on fiber anisotropy and diffusion coefficient parameters derived from diffusion tensor/spectrum imaging] and vascular [nCE MRA and vessel segmentation] imaging.	[Raval, Shailesh B.; Krishnamurthy, Narayanan; Santini, Tales; Ibrahim, Tamer S.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Raval, Shailesh B.; Britton, Cynthia A.; Ibrahim, Tamer S.] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA; [Zhao, Tiejun] Siemens Med Solut, New York, NY USA; [Gorantla, Vijay S.] Dept Plast Surg, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Siemens AG	Ibrahim, TS (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.; Ibrahim, TS (corresponding author), Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA.; Gorantla, VS (corresponding author), Dept Plast Surg, Pittsburgh, PA 15213 USA.	gorantlavs@upmc.edu; tibrahim@pitt.edu	Raval, Shailesh/O-5176-2019	Raval, Shailesh/0000-0001-9202-236X; Santini, Tales/0000-0003-4533-9190	National Institutes of Health [5R01EB009848]; U.S. Army Medical Research and Materiel Command (DOD) [W81XWH-10-1-0618]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009848] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Army Medical Research and Materiel Command (DOD)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institutes of Health (5R01EB009848) to TSI and the U.S. Army Medical Research and Materiel Command (DOD W81XWH-10-1-0618) to VSG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard BD, 2003, NEUROSURGERY, V53, P199, DOI 10.1227/01.NEU.0000069534.43067.28; [Anonymous], 2014, MED IM PROC AN VIS M; Anzidei M, 2012, RADIOL MED, V117, P54, DOI 10.1007/s11547-011-0651-3; Aussenhofer SA, 2012, MAGN RESON MED, V68, P1325, DOI 10.1002/mrm.24451; Bae KT, 2010, J MAGN RESON IMAGING, V31, P255, DOI 10.1002/jmri.22019; Barberi EA, 2000, MAGNET RESON MED, V43, P284, DOI 10.1002/(SICI)1522-2594(200002)43:2<284::AID-MRM16>3.0.CO;2-C; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Behr B, 2009, SKELETAL RADIOL, V38, P911, DOI 10.1007/s00256-009-0673-2; Bencardino Jenny T, 2004, Magn Reson Imaging Clin N Am, V12, P333, DOI 10.1016/j.mric.2004.02.010; Biomedical R, 2015, 16 CHANNEL WRIST ARR; Bode AS, 2012, EUR J VASC ENDOVASC, V43, P88, DOI 10.1016/j.ejvs.2011.09.012; BOSKAMP EB, 1985, RADIOLOGY, V157, P449, DOI 10.1148/radiology.157.2.4048454; Bottomley PA, 1978, PHYS MED BIOL, V23; Braidy C, 2012, AM J ROENTGENOL, V199, pW629, DOI 10.2214/AJR.12.8513; Chang G, 2010, J MAGN RESON IMAGING, V31, P740, DOI 10.1002/jmri.22072; Chen CN, 1989, BIOMEDICAL MAGNETIC; Chhabra A, 2010, AM J NEURORADIOL, V31, P1363, DOI 10.3174/ajnr.A2002; Chhabra A, 2012, SKELETAL RADIOL, V41, P257, DOI 10.1007/s00256-011-1146-y; Du R, 2010, J NEUROSURG, V112, P362, DOI 10.3171/2009.7.JNS09414; EDELSTEIN WA, 1986, J MAGN RESON, V67, P156, DOI 10.1016/0022-2364(86)90421-X; Fernandez-Miranda JC, 2012, NEUROSURGERY, V71, P430, DOI 10.1227/NEU.0b013e3182592faa; Fischer A, 2014, INVEST RADIOL, V49, P331, DOI 10.1097/RLI.0000000000000044; Forster A, 2014, CLIN NEURORADIOL, V24, P347, DOI 10.1007/s00062-013-0261-7; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haider CR, 2011, J MAGN RESON IMAGING, V34, P2, DOI 10.1002/jmri.22469; Haims AH, 2004, AM J ROENTGENOL, V182, P1267, DOI 10.2214/ajr.182.5.1821267; Hamdan A, 2011, JACC-CARDIOVASC IMAG, V4, P50, DOI 10.1016/j.jcmg.2010.10.007; Hoh BL, 2004, NEUROSURGERY, V54, P1329, DOI 10.1227/01.NEU.0000125325.22576.83; Ibrahim TS, 2009, NMR BIOMED, V22, P927, DOI 10.1002/nbm.1406; Ibrahim TS, 2001, MAGN RESON IMAGING, V19, P1339, DOI 10.1016/S0730-725X(01)00404-0; Itagaki MW, 2009, RADIOLOGY, V252, P468, DOI 10.1148/radiol.2523081241; Jambawalikar S, 2010, SKELETAL RADIOL, V39, P1073, DOI 10.1007/s00256-010-0974-5; Jazi MH, 2011, ARYA ATHEROSCLER, V7, P58; Juras V, 2012, EUR J RADIOL, V81, P1846, DOI 10.1016/j.ejrad.2011.05.023; Kang CK, 2016, MAGN RESON MED, V75, P1640, DOI 10.1002/mrm.25600; Karamessini MT, 2004, EUR J RADIOL, V49, P212, DOI 10.1016/S0720-048X(03)00173-6; Kleinerman RA, 2006, PEDIATR RADIOL, V36, P121, DOI 10.1007/s00247-006-0191-5; Koopmans PJ, 2008, MAGN RESON MATER PHY, V21, P149, DOI 10.1007/s10334-007-0101-3; Kraff O, 2010, MED PHYS, V37, P6368, DOI 10.1118/1.3517176; Kramer CM, 2009, JACC-CARDIOVASC IMAG, V2, P916, DOI 10.1016/j.jcmg.2009.05.002; Lee WN, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/16/5075; Liu X, 2007, AM J ROENTGENOL, V189, P1326, DOI 10.2214/AJR.07.2805; Masi JN, 2005, RADIOLOGY, V236, P140, DOI 10.1148/radiol.2361040747; Moore KR, 2001, AM J NEURORADIOL, V22, P786; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Nezafat R, 2009, NAT REV CARDIOL, V6, P676, DOI 10.1038/nrcardio.2009.184; Obusez EC, 2014, AM J NEURORADIOL, V35, P1527, DOI 10.3174/ajnr.A3909; Pomper MG, 1999, AM J NEURORADIOL, V20, P75; Raghuraman S, 2013, J MAGN RESON IMAGING, V38, P238, DOI 10.1002/jmri.23883; Raval SB, 2015, PLAST RECONSTR SURG; Raval SB, 2016, NMR BIOMED; Raval SB, 2015, ULTRAHIGH FIELD 7T M; Raval SB, 2015, UPPER EXTREMITY NEUR; Regatte RR, 2007, J MAGN RESON IMAGING, V25, P262, DOI 10.1002/jmri.20814; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; ROEMER PB, 1990, MAGNET RESON MED, V16, P192, DOI 10.1002/mrm.1910160203; Sadikin C, 2007, J FORMOS MED ASSOC, V106, P691, DOI 10.1016/S0929-6646(08)60030-3; Sakuma H, 2011, RADIOLOGY, V258, P340, DOI 10.1148/radiol.10100116; Sampath SC, 2013, SPORTS HEALTH, V5, P34, DOI 10.1177/1941738112467941; Schmitter S, 2014, MAGN RESON MED, V71, P966, DOI 10.1002/mrm.24749; Sibley CT, 2009, J AM COLL CARDIOL, V54, P77, DOI 10.1016/j.jacc.2009.04.022; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Takagi T, 2009, NEUROIMAGE, V44, P884, DOI 10.1016/j.neuroimage.2008.09.022; Thakkar R, 2012, AM J ROENTGENOL, V198; Thawait SK, 2012, AM J NEURORADIOL, V33, P203, DOI 10.3174/ajnr.A2465; Tipper G, 2005, CLIN RADIOL, V60, P565, DOI 10.1016/j.crad.2004.09.012; Todua FI, 2013, GEORGIAN MED NEW DEC; Truwit CL, 2007, RADIOLOGY, V245, P362, DOI 10.1148/radiol.2452061670; Van De Moortele PF, 2005, MAGN RESON MED, V54, P1503, DOI 10.1002/mrm.20708; van der Kolk AG, 2013, EUR J RADIOL, V82, P708, DOI 10.1016/j.ejrad.2011.07.007; Vargas MI, 2010, EUR J RADIOL, V74, P403, DOI 10.1016/j.ejrad.2010.01.024; VAUGHAN JT, 1994, MAGNET RESON MED, V32, P206, DOI 10.1002/mrm.1910320209; Vaughan JT, 2001, MAGN RESON MED, V46, P24, DOI 10.1002/mrm.1156; Vaughan TT, 2009, MAGN RESON MED, V61, P244, DOI 10.1002/mrm.21751; Vertinsky AT, 2008, AM J NEURORADIOL, V29, P1753, DOI 10.3174/ajnr.A1189; Viallon M, 2008, EUR RADIOL, V18, P1018, DOI 10.1007/s00330-007-0834-4; Vogelius ES, 2011, MAGN RESON IMAGING C, V19, P567, DOI 10.1016/j.mric.2011.05.004; Wrede K. H., 2016, EUR RADIOL; Yamada H, 2014, PLOS ONE, V9; Yang Q, 2009, J AM COLL CARDIOL, V54, P69, DOI 10.1016/j.jacc.2009.03.016; Yeh F, 2010, DEP PSYCHOL; Zhang CC, 2014, CANCER MED-US, V3, P462, DOI 10.1002/cam4.215; Zhang N., 2015, PLOS ONE, V10; Zhang W, 2011, RHEUMATOLOGY, V50, P1712, DOI 10.1093/rheumatology/keq453	85	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0175629	10.1371/journal.pone.0175629	http://dx.doi.org/10.1371/journal.pone.0175629			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662061	gold, Green Published, Green Submitted			2022-12-27	WOS:000404608300001
J	Tanaka, M; Endo, S; Kotake, F; Al-Saari, N; Amin, AKMR; Feng, G; Mino, S; Doi, H; Ogura, Y; Hayashi, T; Suda, W; Hattori, M; Yumoto, I; Sawabe, T; Sawabe, T; Araki, T				Tanaka, Mami; Endo, Shoko; Kotake, Fumihito; Al-Saari, Nurhidayu; Amin, A. K. M. Rohul; Feng, Gao; Mino, Sayaka; Doi, Hidetaka; Ogura, Yoshitoshi; Hayashi, Tetsuya; Suda, Wataru; Hattori, Masahira; Yumoto, Isao; Sawabe, Toko; Sawabe, Tomoo; Araki, Toshiyoshi			Vibrio aphrogenes sp. nov., in the Rumoiensis clade isolated from a seaweed	PLOS ONE			English	Article							RHIZOBIUM-LEGUMINOSARUM-HUPE; TRITONIUS STRAIN AM2; MARINE BACTERIUM	A novel strain Vibrio aphrogenes sp. nov. strain CA-1004(T) isolated from the surface of seaweed collected on the coast of Mie Prefecture in 1994 [1] was characterized using poly phasic taxonomy including multilocus sequence analysis (MLSA) and a genome based comparison. Both phylogenetic analyses on the basis of 16S rRNA gene sequences and MLSA based on eight protein-coding genes (gapA, gyrB, ftsZ, mreB, pyrH, recA, rpoA, and topA) showed the strain could be placed in the Rumoiensis Glade in the genus Vibrio. Sequence similarities of the 16S rRNA gene and the multilocus genes against the Rumoiensis Glade members, V. rumoiensis, V. algivorus, V. casei, and V. litoralis, were low enough to propose V. aphrogenes sp. nov. strain CA-1004(T) as a separate species. The experimental DNA-DNA hybridization data also revealed that the strain CA-1004(T) was separate from four known Rumoiensis Glade species. The G+C content of the V. aphrogenes strain was determined as 42.1% based on the genome sequence. Major traits of the strain were non motile, halophilic, fermentative, alginolytic, and gas production. A total of 27 traits (motility, growth temperature range, amylase, alginase and lipase productions, and assimilation of 19 carbon compounds) distinguished the strain from the other species in the Rumoiensis Glade. The name V. aphrogenes sp. nov. is proposed for this species in the Rumoiensis Glade, with CA-1004(T) as the type strain (JCM 31643(T) = DSM 103759(T)).	[Tanaka, Mami; Endo, Shoko; Kotake, Fumihito; Al-Saari, Nurhidayu; Amin, A. K. M. Rohul; Feng, Gao; Mino, Sayaka; Sawabe, Tomoo] Hokkaido Univ, Fac Fisheries, Microbiol Lab, Hakodate, Hokkaido, Japan; [Doi, Hidetaka] Ajinomoto Co Inc, Proc Dev Labs, Res Inst Biosci Prod & Fine Chem, Kawasaki, Kanagawa, Japan; [Ogura, Yoshitoshi; Hayashi, Tetsuya] Kyushu Univ, Fac Med Sci, Dept Bacteriol, Fukuoka, Japan; [Suda, Wataru; Hattori, Masahira] Univ Tokyo, Grad Sch Frontier Sci, Lab Metagen, Kashiwa, Chiba, Japan; [Suda, Wataru] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan; [Hattori, Masahira] Waseda Univ, Grad Sch Adv Sci & Engn, Tokyo, Japan; [Yumoto, Isao] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido, Japan; [Sawabe, Toko] Hakodate Jr Coll, Dept Food & Nutr, Hakodate, Hokkaido, Japan; [Araki, Toshiyoshi] Mie Univ, Iga Res Inst, Iga, Japan	Hokkaido University; Ajinomoto Co Inc; Kyushu University; University of Tokyo; Keio University; Waseda University; National Institute of Advanced Industrial Science & Technology (AIST); Mie University	Sawabe, T (corresponding author), Hokkaido Univ, Fac Fisheries, Microbiol Lab, Hakodate, Hokkaido, Japan.	sawabe@fish.hokudai.ac.jp	Hattori, Masahira/AAD-3785-2019; Suda, Wataru/AAF-4469-2019; Al-saari, Nurhidayu/V-3466-2019; Hayashi, Tetsuya/ABA-1074-2020; Yumoto, Isao/N-2053-2018	Yumoto, Isao/0000-0001-9525-3155; Al-saari, Nurhidayu/0000-0002-2952-7039	Kaken [16H0497606]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [221S0002]	Kaken(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Kaken (16H0497606) (TS). This work was also supported by Grant in Aid for Scientific Research on Innovative Area "Genome Science" from Ministry of Education, Culture, Sports, Science, and Technology of Japan (No.221S0002).	Al-Saari N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136279; Albareda M, 2015, METALLOMICS, V7, P691, DOI [10.1039/c4mt00298a, 10.1039/C4MT00298A]; Araki T, 1999, FISHERIES SCI, V65, P937, DOI 10.2331/fishsci.65.937; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bandelt HJ, 1992, MOL PHYLOGENET EVOL, V1, P242, DOI 10.1016/1055-7903(92)90021-8; Bleicher A, 2010, INT J SYST EVOL MICR, V60, P1745, DOI 10.1099/ijs.0.016493-0; Brito B, 2010, J BACTERIOL, V192, P925, DOI 10.1128/JB.01045-09; Doi H, 2016, INT J SYST EVOL MICR, V66, P3164, DOI 10.1099/ijsem.0.001165; Gomez-Gil B., 2014, FAMILY VIBRIONACEAE, V9, P659; Gomez-Gil B, 2016, ANTON LEEUW INT J G, V109, P817, DOI 10.1007/s10482-016-0681-x; Gonzales AD, 2016, SPRINGER HDB MARINE; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kajitani R, 2014, GENOME RES, V24, P1384, DOI 10.1101/gr.170720.113; Kim M, 2014, INT J SYST EVOL MICR, V64, P346, DOI 10.1099/ijs.0.059774-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee I, 2016, INT J SYST EVOL MICR, V66, P1100, DOI 10.1099/ijsem.0.000760; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; Matsumura Y, 2015, INT J HYDROGEN ENERG, V40, P9137, DOI 10.1016/j.ijhydene.2015.05.137; Matsumura Y, 2014, INT J HYDROGEN ENERG, V39, P7270, DOI 10.1016/j.ijhydene.2014.02.164; Meier-Kolthoff JP, 2013, ARCH MICROBIOL, V195, P413, DOI 10.1007/s00203-013-0888-4; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Nam YD, 2007, INT J SYST EVOL MICR, V57, P562, DOI 10.1099/ijs.0.64653-0; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Rossello-Mora R, 2015, SYST APPL MICROBIOL, V38, P1; Sawabe T, 2007, J BACTERIOL, V189, P7932, DOI 10.1128/JB.00693-07; Sawabe T, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00414; Stackebrandt E., 2006, MICROBIOL TODAY, V33, P152; Takeda H, 2011, ENERG ENVIRON SCI, V4, P2575, DOI 10.1039/c1ee01236c; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson CC, 2015, ARCH MICROBIOL, V197, P359, DOI 10.1007/s00203-014-1071-2; Tindall BJ, 2010, INT J SYST EVOL MICR, V60, P249, DOI 10.1099/ijs.0.016949-0; Yumoto I, 1999, APPL ENVIRON MICROB, V65, P67	32	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180053	10.1371/journal.pone.0180053	http://dx.doi.org/10.1371/journal.pone.0180053			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662104	Green Submitted, Green Published, gold			2022-12-27	WOS:000404608300093
J	Xing, HY; Li, B; Peng, D; Wang, CY; Wang, GY; Li, P; Le, YY; Wang, JM; Ye, G; Chen, JH				Xing, Hai-Yan; Li, Bin; Peng, Dan; Wang, Chun-Yan; Wang, Guan-Ying; Li, Pan; Le, Ying-Ying; Wang, Ji-Ming; Ye, George; Chen, Jian-Hong			A novel monoclonal antibody against the N terminus of A beta(1-42) reduces plaques and improves cognition in a mouse model of Alzheimer's disease	PLOS ONE			English	Article							AMYLOID-BETA; A-BETA; PHASE-3 TRIALS; BAPINEUZUMAB; THERAPIES; PEPTIDES; BINDING; BURDEN; TARGET; BRAIN	Senile plaques consisting of Amyloid-beta (4) peptides, in particular A beta(1-42), are the hallmark of Alzheimer's disease (AD) and have been the primary therapeutic targets. Passive immunotherapy with monoclonal antibodies (mAbs) has shown initial success in mouse models of AD. However, the existing A beta-directed mAbs mostly were tested on animal models or patients with advanced disease. The effects and mechanisms of mAbs on animals or human trial participants in the prodromal phase of AD are not fully clarified. In the current study, a novel mAb (3F5) directed against the 1-11 amino acids of A beta(1-42) was generated by immunizing mice with an emulsion of full length human A beta(1-42). The mAb (3F5) showed the ability to disrupt A beta(1-42) aggregation and prevent A beta-mediated neurotoxicity in vitro. In a mouse model of AD, administration with 3F5 for 3 months in 6 months-old mice demonstrated that the mAb specifically bound with A beta(1-42) to promote the depolymerization of A beta fibrils, facilitated endocytosis of A beta(1-42) by microglia, and attenuated the death and apoptosis of neuronal cells, accompanied by neurite outgrowth. APP/PS1 double-transgenic mice treated with 3F5 mAb showed reduced memory loss, cognitive decline, and decreased levels of amyloid deposits in the brain. A beta(1-42) levels in cerebral tissues were also significantly reduced, whereas serum A beta(1-42) was markedly increased. Interestingly, the concentration of 3F5 in peripheral circulation is much higher than that in the brain. These results indicate that 3F5 is able to cross the blood-brain barrier (BBB) to bind A beta and initiates the phagocytosis of antibody/A beta complexes by microglia in the amyloid depositing mice. 3F5 also promotes 4 efflux from the brain. As a consequence, the antibody reduces plaques in the AD mouse brain, in association with reduction in the pathology of AD.	[Xing, Hai-Yan; Li, Bin; Peng, Dan; Wang, Guan-Ying; Li, Pan; Chen, Jian-Hong] Third Mil Med Univ, Dept Pharm, Daping Hosp, Chongqing, Peoples R China; [Xing, Hai-Yan; Li, Bin; Peng, Dan; Wang, Guan-Ying; Li, Pan; Chen, Jian-Hong] Third Mil Med Univ, Inst Surg Res, Chongqing, Peoples R China; [Wang, Chun-Yan; Ye, George] Anogen Yes Biotech, Mississauga, ON, Canada; [Le, Ying-Ying] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China; [Wang, Ji-Ming] Natl Canc Inst Frederick, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD USA	Army Medical University; Army Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chen, JH (corresponding author), Third Mil Med Univ, Dept Pharm, Daping Hosp, Chongqing, Peoples R China.; Chen, JH (corresponding author), Third Mil Med Univ, Inst Surg Res, Chongqing, Peoples R China.	chenjh-110@263.net	Le, Yingying/L-9785-2017	Le, Yingying/0000-0002-7990-3899	National Natural Science Foundation of China [81302867, 81273608]; Chongqing Programs for Science and Technology Development [CSTC2015jcyjBX0018]; National Cancer Institute, National Institutes of Health [HHSN 26/200800001E]; Intramural Research Program of NCI, NIH, USA	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Programs for Science and Technology Development; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of NCI, NIH, USA	This project was supported by the grants from the National Natural Science Foundation of China (Grant No. 81302867 and 81273608). We also gratefully acknowledge the financial support from the Chongqing Programs for Science and Technology Development (CSTC2015jcyjBX0018). Ji Ming Wang was funded by Federal funds from the National Cancer Institute, National Institutes of Health, under contract No. HHSN 26/200800001E and supported in part by the Intramural Research Program of NCI, NIH, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson O, 2012, J NEUROSCI, V32, P9677, DOI 10.1523/JNEUROSCI.4742-11.2012; Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Amanatkar HR, 2017, EXPERT REV NEUROTHER, V17, P7, DOI 10.1080/14737175.2016.1194203; Arai H, 2016, GERIATR GERONTOL INT, V16, P644, DOI 10.1111/ggi.12516; Bachmeier CJ, 2011, MICROCIRCULATION, V18, P373, DOI 10.1111/j.1549-8719.2011.00096.x; Bohrmann B, 2012, J ALZHEIMERS DIS, V28, P49, DOI 10.3233/JAD-2011-110977; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; Dodel R, 2011, J NEUROSCI, V31, P5847, DOI 10.1523/JNEUROSCI.4401-10.2011; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Enache TA, 2016, ANAL CHIM ACTA, V926, P36, DOI 10.1016/j.aca.2016.04.015; Freeman GB, 2012, CURR ALZHEIMER RES, V9, P1059; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Houacine J, 2012, NEUROBIOL AGING, V33, P2704, DOI 10.1016/j.neurobiolaging.2011.12.033; Jiao SS, 2016, NEUROTOX RES, V29, P256, DOI 10.1007/s12640-015-9589-x; Laskowitz DT, 2010, NEUROLOGY, V74, P2026, DOI 10.1212/WNL.0b013e3181e03844; Ma LN, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0517-y; McLaurin J, 2002, NAT MED, V8, P1263, DOI 10.1038/nm790; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; Selkoe DJ, 2004, ANN INTERN MED, V140, P627, DOI 10.7326/0003-4819-140-8-200404200-00047; Underwood E, 2015, SCIENCE, V349, P464, DOI 10.1126/science.349.6247.464; Vandenberghe R, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0189-7; Wang JP, 2016, BRAIN RES, V1635, P169, DOI 10.1016/j.brainres.2016.01.028; Watt AD, 2014, ACTA NEUROPATHOL, V127, P803, DOI 10.1007/s00401-014-1290-2; Webster SJ, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt182; Yi Keonwoo, 2014, Psychiatr Danub, V26 Suppl 1, P256; Zhang Y, 2011, NEUROSCIENTIST, V17, P163, DOI 10.1177/1073858410381532	27	12	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180076	10.1371/journal.pone.0180076	http://dx.doi.org/10.1371/journal.pone.0180076			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662102	Green Submitted, Green Published, gold			2022-12-27	WOS:000404608300099
J	Jones, AK; Cross, P; Burton, M; Millman, C; O'Brien, SJ; Rigby, D				Jones, Anna K.; Cross, Paul; Burton, Michael; Millman, Caroline; O'Brien, Sarah J.; Rigby, Dan			Estimating the prevalence of food risk increasing behaviours in UK kitchens	PLOS ONE			English	Article							RANDOMIZED-RESPONSE; CAMPYLOBACTER INFECTION; SENSITIVE QUESTIONS; FOODBORNE ILLNESS; UNITED-STATES; OUTBREAK; BELIEFS; WORKING; ENGLAND	Foodborne disease poses a serious threat to public health. In the UK, half a million cases are linked to known pathogens and more than half of all outbreaks are associated with catering establishments. The UK Food Standards Agency (FSA) has initiated the UK Food Hygiene Rating Scheme in which commercial food establishments are inspected and scored with the results made public. In this study we investigate the prevalence of food risk increasing behaviours among chefs, catering students and the public. Given the incentive for respondents to misreport when asked about illegal or illicit behaviours we employed a Randomised Response Technique designed to elicit more accurate prevalence rates of such behaviours. We found 14% of the public not always hand-washing immediately after handling raw meat, poultry or fish; 32% of chefs and catering students had worked within 48 hours of suffering from diarrhoea or vomiting. 22% of the public admitted having served meat "on the turn" and 33% of chefs and catering students admitted working in kitchens where such meat was served; 12% of the public and 16% of chefs and catering students admitted having served chicken at a barbeque when not totally sure it was fully cooked. Chefs in fine-dining establishment were less likely to wash their hands after handling meat and fish and those who worked in award winning restaurants were more likely to have returned to work within 48 hours of suffering from diarrhoea and vomiting. We found no correlation between the price of a meal in an establishment, nor its Food Hygiene Rating Score, and the likelihood of any of the food malpractices occurring.	[Jones, Anna K.] Nat Resources Wales, Bangor, Gwynedd, Wales; [Cross, Paul] Bangor Univ, Bangor, Gwynedd, Wales; [Burton, Michael] Univ Western Australia, Perth, WA, Australia; [Millman, Caroline; Rigby, Dan] Univ Manchester, Manchester, Lancs, England; [O'Brien, Sarah J.] Univ Liverpool, Liverpool, Merseyside, England	Bangor University; University of Western Australia; University of Manchester; University of Liverpool	Rigby, D (corresponding author), Univ Manchester, Manchester, Lancs, England.	dan.rigby@manchester.ac.uk	Rigby, Dan/A-9606-2009	Rigby, Dan/0000-0003-0820-5740; O'Brien, Sarah Jane/0000-0003-2896-8999; burton, michael/0000-0003-4213-4093	Medical Research Council (MRC); Natural Environment Research Council (NERC); Economic and Social Research Council (ESRC); Biotechnology and Biosciences Research Council (BBSRC); Food Standards Agency (FSA) through Environmental & Social Ecology of Human Infectious Diseases (ESEI) Initiative [G11007991]; MRC [G1100799] Funding Source: UKRI; Medical Research Council [G1100799] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Biotechnology and Biosciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Food Standards Agency (FSA) through Environmental & Social Ecology of Human Infectious Diseases (ESEI) Initiative; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council (MRC), Natural Environment Research Council (NERC), Economic and Social Research Council (ESRC), Biotechnology and Biosciences Research Council (BBSRC) and Food Standards Agency (FSA) through the Environmental & Social Ecology of Human Infectious Diseases (ESEI) Initiative. [Grant Reference: G11007991]	Allerberger F, 2003, INFECTION, V31, P19, DOI 10.1007/s15010-002-3088-8; Andreoletti O, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1437; [Anonymous], 2014, COSTED EXTENSION 2 S; Bolton DJ, 2008, FOOD CONTROL, V19, P291, DOI 10.1016/j.foodcont.2007.04.006; BORUCH RF, 1971, AM SOCIOL, V6, P308; Brown LG, 2013, J FOOD PROTECT, V76, P2141, DOI 10.4315/0362-028X.JFP-13-129; BUCHMAN TA, 1982, J ACCOUNTING RES, V20, P263, DOI 10.2307/2490775; Carpenter LR, 2013, J FOOD PROTECT, V76, P2146, DOI 10.4315/0362-028X.JFP-13-128; Channel 4, 2015, NIGHTM KITCH REST C; Clayton DA, 2002, INT J ENVIRON HEAL R, V12, P25, DOI 10.1080/09603120120110031; Contzen N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136445; Cross P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053681; Donovan JJ, 2003, HUM PERFORM, V16, P81, DOI 10.1207/S15327043HUP1601_4; European Food Safety Authority, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4329; Evans H S, 1998, Commun Dis Public Health, V1, P165; Food Standards Agency, FIND OUT MOR FOOD HY; Food Standards Agency, FOOD HANDL FITN WORK; Food Standards Agency, 2015, MICR SURV CAMP CONT; Food Standards Agency, 2011, FOODB DIS STRAT 2010; Food Standards Agency, 2013, ANN REP CHIEF SCI 20; Gras LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042599; Green L, 2005, INT J HYG ENVIR HEAL, V208, P27, DOI 10.1016/j.ijheh.2005.01.005; Green L. R., 2005, Food Protection Trends, V25, P981; Griffith C, 1998, FOOD CONTROL, V9, P225, DOI 10.1016/S0956-7135(98)00003-6; Health Protection Agency, 2009, REP INV FOODB OUTB N; Health Protection Agency DfE Food and Rural Affairs Department of Agriculture and Rural Development (Northern Ireland) Scottish Government Welsh Government Food Standards Agency Animal Health and Veterinary Laboratories Agency Public Health Agency Health Protection Scotland Public Health Wales, 2011, ZOON REP UK 2010; Hoffmann S, 2012, J FOOD PROTECT, V75, P1292, DOI 10.4315/0362-028X.JFP-11-417; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/j.ijfoodmicro.2007.01.006; IKRAM R, 1994, NEW ZEAL MED J, V107, P430; Jann B., 2011, RRLOGIT STATA MODULE; Jay LS, 1999, J FOOD PROTECT, V62, P1285, DOI 10.4315/0362-028X-62.11.1285; John FAVS, 2010, BIOL CONSERV, V143, P1025, DOI 10.1016/j.biocon.2010.01.018; Kapperud G, 2003, AM J EPIDEMIOL, V158, P234, DOI 10.1093/aje/kwg139; Lasky T, 2002, EPIDEMIOLOGY, V13, P593, DOI 10.1097/00001648-200209000-00017; Lensvelt-Mulders GJLM, 2007, COMPUT HUM BEHAV, V23, P591, DOI 10.1016/j.chb.2004.11.001; Lensvelt-Mulders GJLM, 2005, SOCIOL METHOD RES, V33, P319, DOI 10.1177/0049124104268664; Lensvelt-Mulders GJLM, 2005, QUAL QUANT, V39, P253, DOI 10.1007/s11135-004-0432-3; Little CL, 2010, EPIDEMIOL INFECT, V138, P1691, DOI 10.1017/S0950268810001974; Louis VR, 2005, APPL ENVIRON MICROB, V71, P85, DOI 10.1128/AEM.71.1.85-92.2005; Maddala G. S., 1983, LTD DEPENDENT QUALIT; Mintel Group, 2010, BARB FOODS UK; Nichols GL, 2005, EMERG INFECT DIS, V11, P361, DOI 10.3201/eid1103.040460; Petroczi A, 2011, SUBST ABUSE TREAT PR, V6, DOI 10.1186/1747-597X-6-20; Prior G, 2014, FOOD YOU 2014 UK B 3; Redmond E. C., 2004, British Food Journal, V106, P581, DOI 10.1108/00070700410553585; Redmond E. C., 2003, INT J CONSUM STUD, V27, P17, DOI DOI 10.1046/J.1470-6431.2003.00283.X; Rocourt J., 2003, PRESENT STATE FOODBO; Rosenfeld B, AM J POLITI IN PRESS; Rossvoll EH, 2013, J FOOD PROTECT, V76, P1939, DOI 10.4315/0362-028X.JFP-12-269; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Scott Elizabeth, 2003, Can J Infect Dis, V14, P277; Severi E, 2012, EPIDEMIOL INFECT, V140, P1748, DOI 10.1017/S0950268811002615; Sumner S, 2011, J FOOD PROTECT, V74, P215, DOI 10.4315/0362-028X.JFP-10-108; Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859; van der Heijden PGM, 2000, SOCIOL METHOD RES, V28, P505, DOI 10.1177/0049124100028004005; Wimbush JC, 1997, J APPL PSYCHOL, V82, P756; Yapp C, 2006, FOOD CONTROL, V17, P42, DOI 10.1016/j.foodcont.2004.08.007	57	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0175816	10.1371/journal.pone.0175816	http://dx.doi.org/10.1371/journal.pone.0175816			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JT	28658250	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000404607900001
J	Sullivan, C; Lage, CR; Yoder, JA; Postlethwait, JH; Kim, CH				Sullivan, Con; Lage, Christopher R.; Yoder, Jeffrey A.; Postlethwait, John H.; Kim, Carol H.			Evolutionary divergence of the vertebrate TNFAIP8 gene family: Applying the spotted gar orthology bridge to understand ohnolog loss in teleosts	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA INFECTION; WHOLE GENOME DUPLICATION; CONSERVED SYNTENY; ZEBRAFISH MODEL; POOR-PROGNOSIS; TIPE2; METASTASIS; REVEALS; PROTEIN; EXPRESSION	Comparative functional genomic studies require the proper identification of gene orthologs to properly exploit animal biomedical research models. To identify gene orthologs, comprehensive, conserved gene synteny analyses are necessary to unwind gene histories that are convoluted by two rounds of early vertebrate genome duplication, and in the case of the teleosts, a third round, the teleost genome duplication (TGD). Recently, the genome of the spotted gar, a holostean outgroup to the teleosts that did not undergo this third genome duplication, was sequenced and applied as an orthology bridge to facilitate the identification of teleost orthologs to human genes and to enhance the power of teleosts as biomedical models. In this study, we apply the spotted gar orthology bridge to help describe the gene history of the vertebrate TNFAIP8 family. Members of the TNFAIP8 gene family have been linked to regulation of immune function and homeostasis and the development of multiple cancer types. Through a conserved gene synteny analysis, we identified zebrafish orthologs to human TNFAIP8L1 and TNFAIP8L3 genes and two co-orthologs to human TNFAIP8L2, but failed to identify an ortholog to human TNFAIP8. Through the application of the orthology bridge, we determined that teleost orthologs to human TNFAIP8 genes were likely lost in a genome inversion event after their divergence from their common ancestor with spotted gar. These findings demonstrate the value of this enhanced approach to gene history analysis and support the development of teleost models to study complex questions related to an array of biomedical issues, including immunity and cancer.	[Sullivan, Con; Kim, Carol H.] Univ Maine, Dept Mol & Biomed Sci, Orono, ME 04469 USA; [Sullivan, Con; Kim, Carol H.] Univ Maine, Grad Sch Biomed Sci & Engn, Orono, ME 04469 USA; [Lage, Christopher R.] Univ Maine, Program Biol, Augusta, ME USA; [Yoder, Jeffrey A.] North Carolina State Univ, Dept Mol Biomed Sci, Raleigh, NC 27695 USA; [Postlethwait, John H.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Augusta; University of Maine Orono; University of North Carolina; North Carolina State University; University of Oregon	Sullivan, C; Kim, CH (corresponding author), Univ Maine, Dept Mol & Biomed Sci, Orono, ME 04469 USA.; Sullivan, C; Kim, CH (corresponding author), Univ Maine, Grad Sch Biomed Sci & Engn, Orono, ME 04469 USA.	con.sullivan@maine.edu; carolkim@maine.edu		Kim, Carol/0000-0002-0465-4496; Yoder, Jeffrey/0000-0002-6083-1311	National Institutes of Health; National Institute of General Medical Sciences of the National Institutes of Health [P20GM103423]; J.H.P [R01RR020833, R01OD011116, PO1HD22486]; C.H.K [R01GM087308, P20GM103534]; U.S. Department of Agriculture National Institute of Food and Agriculture Hatch project [ME021610]; Triangle Center for Evolutionary Medicine (TriCEM); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR020833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103534, P20GM103423, R01GM087308] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); J.H.P; C.H.K; U.S. Department of Agriculture National Institute of Food and Agriculture Hatch project; Triangle Center for Evolutionary Medicine (TriCEM); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (www.nih.gov) grants to C.S. (Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103423), J.H.P. (R01RR020833, R01OD011116 and PO1HD22486), and C.H.K. (R01GM087308 and P20GM103534), by the U.S. Department of Agriculture National Institute of Food and Agriculture Hatch project number ME021610, and by a grant from the Triangle Center for Evolutionary Medicine (TriCEM) (http://tricem.dreamhosters.com/) to J.A.Y. The funders had no role in study design, data collection and analysis, decision to publish, orpreparation of the manuscript.	Ahn SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001088; Amores A, 2011, GENETICS, V188, P799, DOI 10.1534/genetics.111.127324; Bentley VL, 2015, HAEMATOLOGICA, V100, P70, DOI 10.3324/haematol.2014.110742; Bernut A, 2015, JOVE-J VIS EXP, DOI 10.3791/53130; Braasch I, 2016, NAT GENET, V48, P427, DOI 10.1038/ng.3526; Brannon MK, 2009, CELL MICROBIOL, V11, P755, DOI 10.1111/j.1462-5822.2009.01288.x; Brothers KM, 2012, JOVE-J VIS EXP, DOI 10.3791/4051; Brothers KM, 2011, EUKARYOT CELL, V10, P932, DOI 10.1128/EC.05005-11; Burgos JS, 2008, ZEBRAFISH, V5, P323, DOI 10.1089/zeb.2008.0552; Canestro C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000496; Cao XL, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-149; Catchen JM, 2011, METHOD CELL BIOL, V104, P259, DOI 10.1016/B978-0-12-374814-0.00015-X; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Chen L, 2016, EXP THER MED, V12, P238, DOI 10.3892/etm.2016.3327; Clatworthy AE, 2009, INFECT IMMUN, V77, P1293, DOI 10.1128/IAI.01181-08; Corkery DP, 2011, BRIT J HAEMATOL, V153, P786, DOI 10.1111/j.1365-2141.2011.08661.x; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Ding C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028151; Ding CB, 2015, INT J MOL MED, V35, P791, DOI 10.3892/ijmm.2015.2063; Fayngerts SA, 2014, CANCER CELL, V26, P465, DOI 10.1016/j.ccr.2014.07.025; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Force A, 1999, GENETICS, V151, P1531; Freundt EC, 2008, CELL, V133, P401, DOI 10.1016/j.cell.2008.04.017; Gabor KA, 2014, DIS MODEL MECH, V7, P1227, DOI 10.1242/dmm.014746; Gao XM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0050247, 10.1371/journal.pone.0061801]; Ghotra VPS, 2015, CANCER RES, V75, P230, DOI 10.1158/0008-5472.CAN-14-0629; Ghotra VPS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031281; Goldsmith JR, 2017, CELL MOL IMMUNOL, V14, P482, DOI 10.1038/cmi.2017.4; Gus-Brautbar Y, 2012, MOL CELL, V45, P610, DOI 10.1016/j.molcel.2012.01.006; Haldi Maryann, 2006, Angiogenesis, V9, P139, DOI 10.1007/s10456-006-9040-2; Harfouche R, 2009, ANGIOGENESIS, V12, P325, DOI 10.1007/s10456-009-9154-4; Horrevoets AJG, 1999, BLOOD, V93, P3418, DOI 10.1182/blood.V93.10.3418.410k23_3418_3431; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Hu RY, 2016, ONCOTARGETS THER, V9, P4473, DOI 10.2147/OTT.S100593; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Knox BP, 2014, EUKARYOT CELL, V13, P1266, DOI 10.1128/EC.00080-14; Kumar D, J BIOL CHEM; Lee SLC, 2009, P NATL ACAD SCI USA, V106, P19485, DOI 10.1073/pnas.0909228106; Li Y K, 2015, J APPL MATH, V2015, DOI DOI 10.1145/2801040.2801062; Li YX, 2015, BIOCHEM BIOPH RES CO, V457, P43, DOI 10.1016/j.bbrc.2014.12.080; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Liu QQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126176; Lou YW, 2011, MOL IMMUNOL, V49, P4, DOI 10.1016/j.molimm.2011.08.006; MARGUSH T, 1981, B MATH BIOL, V43, P239, DOI 10.1007/BF02459446; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; Neely MN, 2002, INFECT IMMUN, V70, P3904, DOI 10.1128/IAI.70.7.3904-3914.2002; Nicoli S, 2007, CANCER RES, V67, P2927, DOI 10.1158/0008-5472.CAN-06-4268; Ohno S., 1970, P1; Palha N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003619; Parichy DM, 2016, NAT GENET, V48, P344, DOI 10.1038/ng.3532; Pasquier J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2709-z; Patel S, 1997, ORAL ONCOL, V33, P197, DOI 10.1016/S0964-1955(96)00065-6; Phennicie RT, 2010, INFECT IMMUN, V78, P4542, DOI 10.1128/IAI.00302-10; Porturas TP, 2015, J IMMUNOL, V194, P5743, DOI 10.4049/jimmunol.1401987; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Prajsnar TK, 2008, CELL MICROBIOL, V10, P2312, DOI 10.1111/j.1462-5822.2008.01213.x; Pruvot B, 2011, HAEMATOL-HEMATOL J, V96, P612, DOI 10.3324/haematol.2010.031401; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shen P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134114; Shi TY, 2013, CARCINOGENESIS, V34, P770, DOI 10.1093/carcin/bgt001; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sullivan C, 2008, FISH SHELLFISH IMMUN, V25, P341, DOI 10.1016/j.fsi.2008.05.005; Sullivan C, 2007, J IMMUNOL, V178, P4517, DOI 10.4049/jimmunol.178.7.4517; Sun HH, 2008, CELL, V133, P415, DOI 10.1016/j.cell.2008.03.026; Sun HH, 2012, J IMMUNOL, V189, P2768, DOI 10.4049/jimmunol.1103477; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Tobin DM, 2008, CELL MICROBIOL, V10, P1027, DOI 10.1111/j.1462-5822.2008.01133.x; Voelz K, 2015, DIS MODEL MECH, V8, P1375, DOI 10.1242/dmm.019992; Wagner DS, 2010, BIOMATERIALS, V31, P7567, DOI 10.1016/j.biomaterials.2010.06.031; Wu J, 2015, BIOMED RES INT, V2015, P1, DOI DOI 10.1371/J0URNAL.P0NE.0128280; Yang M, 2014, HISTOPATHOLOGY, V65, P517, DOI 10.1111/his.12413; Zhang BB, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0102917, 10.1371/journal.pone.0085439]; Zhang CB, 2013, INT J CANCER, V133, P31, DOI 10.1002/ijc.27996; Zhang YH, 2015, INT J ONCOL, V46, P254, DOI 10.3892/ijo.2014.2725; [张志镇 Zhang Zhizhen], 2015, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V34, P1; Zhu Y, 2016, CANCER GENE THER, V23, P98, DOI 10.1038/cgt.2016.6	78	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179517	10.1371/journal.pone.0179517	http://dx.doi.org/10.1371/journal.pone.0179517			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658311	gold, Green Published, Green Submitted			2022-12-27	WOS:000404607900030
J	Chen, YZ; Jiang, BJ; Zhuang, YG; Peng, H; Chen, WG				Chen, Yuanzhuo; Jiang, Bojie; Zhuang, Yugang; Peng, Hu; Chen, Weiguo			Differential effects of heat shock protein 90 and serine 1179 phosphorylation on endothelial nitric oxide synthase activity and on its cofactors	PLOS ONE			English	Article							AKT-DEPENDENT PHOSPHORYLATION; ENOS ACTIVATION; CELLS; HEAT-SHOCK-PROTEIN-90; MODULATION; HSP90; HSP90-ALPHA; RELEASE; PATHWAY; DOMAIN	Endothelial nitric oxide synthase (eNOS) is responsible for maintaining systemic blood pressure, vascular remodeling and angiogenesis. Previous studies showed that bovine eNOS serine 1179 (Serine 1177 for human eNOS) phosphorylation enhanced NO synthesis. Meanwhile, heat shock protein 90 (Hsp90) plays a critical role in maintenance of eNOS structure and function. However, the regulatory difference and importance between Serine 1179 phosphorylation and Hsp90 on eNOS activity have not been evaluated. In current studies, S1179D eNOS was employed to mimic phospho-eNOS and exhibited markedly increased enzyme activity than wild type eNOS (WT eNOS). Hsp90 showed a dose-dependent increase for both WT eNOS and S1179D eNOS activity at the presence of all eNOS cofactors, such as Calcium/Calmodulin (Ca2+/CaM), BH4, and NADPH etc. The enhancement effects were abolished by dominant-negative mutant Hsp 90 protein. ENOS-cofactors dynamic assay showed that Hsp90 enhanced WT eNOS affinity to NADPH, L-arginine, and CaM but not to Ca2+ and BH4. The impact of eNOS Serine 1179 phosphorylation and Hsp90 on eNOS affinity to cofactors has also been compared. Different from the effect of Hsp90 on eNOS affinity to specific cofactors, Serine 1179 phosphorylation significantly increased eNOS affinity to all cofactors. Moreover, VEGF-induced eNOS phosphorylation in bovine aortic endothelial cells (BAECs) and more NO generation from eNOS compared to control. Inhibition of Hsp90 by geldanamycin decreased eNOS activity and decreased endothelial viability. In conclusion, by changing eNOS structure, Hsp90 profoundly affected eNOS functions, including change of affinity of eNOS to cofactors like Ca2+, L-arginine, BH4 and further affecting NO generation capability. These specific cofactors regulated by Hsp 90 could become potential therapeutic targets of the eNOS-related diseases in future.	[Chen, Yuanzhuo; Jiang, Bojie; Zhuang, Yugang; Peng, Hu; Chen, Weiguo] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Emergency Med, Shanghai, Peoples R China	Tongji University	Chen, WG (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Emergency Med, Shanghai, Peoples R China.	1966chenweiguo@tongji.edn.cn		chen, weiguo/0000-0001-9395-0053	National Scientific Foundation of China [81671938, 81501696]	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Scientific Foundation of China 81671938, Dr. Hu Peng; and the National Scientific Foundation of China 81501696 Dr. Yuanzhuo Chen.	Balligand JL, 2009, PHYSIOL REV, V89, P481, DOI 10.1152/physrev.00042.2007; Balligand JL, 2002, CIRC RES, V90, P838, DOI 10.1161/01.RES.0000018173.10175.FF; Barauna VG, 2013, BIOCHEM BIOPH RES CO, V441, P713, DOI 10.1016/j.bbrc.2013.10.108; Chen WG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105479; Cortes-Gonzalez C, 2010, CELL PHYSIOL BIOCHEM, V26, P657, DOI 10.1159/000322333; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Fleming I, 2010, PFLUG ARCH EUR J PHY, V459, P793, DOI 10.1007/s00424-009-0767-7; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Fontana J, 2002, CIRC RES, V90, P866, DOI 10.1161/01.RES.0000016837.26733.BE; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Grafton JP, 2000, J BIOL CHEM, V275, P22268; Heiss EH, 2014, CURR PHARM DESIGN, V20, P3503, DOI 10.2174/13816128113196660745; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; McCabe TJ, 2000, J BIOL CHEM, V275, P6123, DOI 10.1074/jbc.275.9.6123; Miao RQ, 2008, ARTERIOSCL THROM VAS, V28, P105, DOI 10.1161/ATVBAHA.107.155499; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Natarajan M, 2015, AM J PHYSIOL-CELL PH, V308, pC673, DOI 10.1152/ajpcell.00367.2014; Ou J, 2003, FREE RADICAL BIO MED, V34, P269, DOI 10.1016/S0891-5849(02)01299-6; Ou JS, 2003, TOXICOL SCI, V73, P90, DOI 10.1093/toxsci/kfg062; Peng H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142854; Peng H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140365; Scotland RS, 2002, CIRC RES, V90, P904, DOI 10.1161/01.RES.0000016506.04193.96; Siragusa M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa2819; Tanaka M, 2015, ENVIRON TOXICOL, V30, P223, DOI 10.1002/tox.21888; Vellecco V, 2016, DIABETES OBES METAB, V18, P1236, DOI 10.1111/dom.12750; Xu H, 2007, J BIOL CHEM, V282, P37567, DOI 10.1074/jbc.M706464200; Zou MH, 2002, J BIOL CHEM, V277, P32552, DOI 10.1074/jbc.M204512200	27	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179978	10.1371/journal.pone.0179978	http://dx.doi.org/10.1371/journal.pone.0179978			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654706	Green Submitted, Green Published, gold			2022-12-27	WOS:000404541500044
J	Chua, MJ; Hart, AJ; Mittal, R; Harris, IA; Xuan, W; Naylor, JM				Chua, Matthew J.; Hart, Andrew J.; Mittal, Rajat; Harris, Ian A.; Xuan, Wei; Naylor, Justine M.			Early mobilisation after total hip or knee arthroplasty: A multicentre prospective observational study	PLOS ONE			English	Article							DIRECT ANTERIOR APPROACH; LENGTH-OF-STAY; LOCAL INFILTRATION; PAIN-CONTROL; REPLACEMENT; REHABILITATION; RECOVERY; SURGERY; COMPLICATIONS; AMBULATION	Objective Early mobilisation is recommended following total hip arthroplasty (THA) or total knee arthroplasty (TKA) to prevent venous thromboembolism (VTE). We sought to determine the proportions of patients that first mobilised on post-operative day 0 (POD 0) and factors associated with earlier time to mobilisation. Methods A prospective cohort study was conducted involving patients with hip or knee osteoarthritis who had undergone primary unilateral THA (n = 818) and TKA (n = 989) at 19 Australian hospitals. Patient-related (e.g. age, gender, body mass index), treatment-related (e.g. hospital site, presence of indwelling catheter) and mobilisation-related variables were collected on standardised forms. Time was measured by post-operative days, where POD 0 was defined as the day of surgery ending at midnight. Multivariate Poisson regression analysis identified associations between patient-and treatment-related covariates and time to mobilisation. Results Inter-hospital variation was evident, but overall, only 9.4% of THA and 5.6% of TKA patients mobilised on POD 0. For THA patients, earlier time to mobilisation was associated with hospital site and absences of an indwelling catheter and acute complications. For TKA patients, earlier time to mobilisation was associated with hospital site and absence of donor blood transfusion. Conclusions Few THA and TKA patients mobilise POD 0, although some hospitals appear more aggressive with their mobilisation attempts than others. Treatment-related factors, not patientrelated, are associated with post-operative day of mobilisation, indicating the potentially pivotal role of service providers in promoting early mobilisation to improve health outcomes and reduce rates of VTE.	[Chua, Matthew J.; Hart, Andrew J.; Mittal, Rajat; Harris, Ian A.; Naylor, Justine M.] Univ New South Wales, Sydney, NSW, Australia; [Mittal, Rajat; Harris, Ian A.; Naylor, Justine M.] Liverpool Hosp, Whitlam Orthopaed Res Ctr, Sydney, NSW, Australia; [Harris, Ian A.; Xuan, Wei; Naylor, Justine M.] Ingham Inst Appl Med Res, Sydney, NSW, Australia	University of New South Wales Sydney; Liverpool Hospital; Ingham Institute for Applied Medical Research	Chua, MJ (corresponding author), Univ New South Wales, Sydney, NSW, Australia.	matthewchua93@gmail.com	Naylor, Justine/R-8459-2019	Naylor, Justine/0000-0002-9147-1312	Hospitals Contribution Fund of Australia (HCF) Research Foundation [IHIIAMR2012073043]	Hospitals Contribution Fund of Australia (HCF) Research Foundation	This work was partially supported by the Hospitals Contribution Fund of Australia (HCF) Research Foundation (grant number IHIIAMR2012073043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In kind support was provided by the University of New South Wales. There was no additional external funding received for this study.	American Academy of Orthopaedic Surgeons, 2011, AM AC ORTH SURG CLIN; Australian Orthopaedic Association National Joint Replacement Registry, 2016, ANN REPORT; Bergin PF, 2011, J BONE JOINT SURG AM, V93A, P1392, DOI 10.2106/JBJS.J.00557; Chen AF, 2012, J ARTHROPLASTY, V27, P851, DOI 10.1016/j.arth.2012.01.011; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Epstein Nancy E, 2014, Surg Neurol Int, V5, pS66, DOI 10.4103/2152-7806.130674; Glassou EN, 2014, ACTA ORTHOP, V85, P493, DOI 10.3109/17453674.2014.942586; Hallert O, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-17; Holm B, 2010, DISABIL REHABIL, V32, P300, DOI 10.3109/09638280903095965; Husted H, 2008, ACTA ORTHOP, V79, P168, DOI 10.1080/17453670710014941; Husted H, 2010, ACTA ORTHOP, V81, P599, DOI 10.3109/17453674.2010.525196; Jorgensen CC, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003965; Kerr DR, 2008, ACTA ORTHOP, V79, P174, DOI 10.1080/17453670710014950; Larsen K, 2008, ACTA ORTHOP, V79, P149, DOI 10.1080/17453670710014923; Malviya A, 2011, ACTA ORTHOP, V82, P577, DOI 10.3109/17453674.2011.618911; Marques EMR, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-220; Murray DW, 2007, J BONE JOINT SURG BR, V89B, P1010, DOI 10.1302/0301-620X.89B8; National Health and Medical Research Council, 2009, CLIN PRACT GUID PREV; National Institute for Health and Clinical Excellence, 2010, VEN THROMB RED RISK; New South Wales Department of Health, 2014, PREV VEN THROMB 2014; Oldmeadow LB, 2006, ANZ J SURG, V76, P607, DOI 10.1111/j.1445-2197.2006.03786.x; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Renkawitz T, 2010, CLIN REHABIL, V24, P230, DOI 10.1177/0269215509353267; Rodriguez JA, 2014, CLIN ORTHOP RELAT R, V472, P455, DOI 10.1007/s11999-013-3231-0; Schneider M, 2009, ARCH ORTHOP TRAUM SU, V129, P1585, DOI 10.1007/s00402-009-0825-9; Shah NA, 2014, J ARTHROPLASTY, V29, P2224, DOI 10.1016/j.arth.2014.06.010; Stewart SP, 2012, ORTHOP NURS, V31, P224, DOI 10.1097/NOR.0b013e31825dfd5d; Tayrose G, 2013, BULL HOSP JT DIS, V71, P222; Wellman SS, 2011, CURR REV MUSCULOSKE, V4, P84, DOI 10.1007/s12178-011-9091-x; Xu CP, 2014, KNEE, V21, P636, DOI 10.1016/j.knee.2014.02.024	30	41	45	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179820	10.1371/journal.pone.0179820	http://dx.doi.org/10.1371/journal.pone.0179820			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654699	Green Published, Green Submitted, gold			2022-12-27	WOS:000404541500034
J	Yun, JS; Bae, JM; Kim, KJ; Jung, YS; Kim, GM; Kim, HR; Lee, JS; Ko, SH; Cha, SA; Ahn, YB				Yun, Jae-Seung; Bae, Jung Min; Kim, Ki-Jo; Jung, Yu Seok; Kim, Gyong Moon; Kim, Hyung-Rae; Lee, Jun-Seok; Ko, Seung-Hyun; Cha, Seon-Ah; Ahn, Yu-Bae			Increased risk of thyroid diseases in patients with systemic lupus erythematosus: A nationwide population-based Study in Korea	PLOS ONE			English	Article							AUTOIMMUNE-DISEASES; SOUTH-KOREA; ASSOCIATION; PREVALENCE; CANCER; SLE; HYPOTHYROIDISM; MALIGNANCIES; MECHANISMS; DATABASE	We investigated the association between autoimmune thyroid disease and systemic lupus erythematosus (SLE) using nationwide insurance claims data for the entire Korean population. Claims data for the period 2009-2013 were retrieved from the National Health Insurance System database. SLE and thyroid disease were identified using the International Classification of Diseases codes and medication information. Logistic regression analyses were used to evaluate the association between SLE and thyroid disease. The study used records from 17,495 patients with SLE and 52,485 age- and sex-matched control subjects. A greater prevalence of Graves' disease (0.94% vs. 0.46%, P < 0.001), Hashimoto's thyroiditis (2.68% vs. 0.80%, P < 0.001), and thyroid cancer (1.81% vs. 1.30%, P < 0.001) was observed in SLE patients than in control subjects. Multivariate regression analyses demonstrated that SLE was significantly associated with an increased risk of both autoimmune thyroid disease and thyroid cancer (Graves' disease: odds ratio [OR] 2.07, 95% confidence interval [CI] 1.70-2.53; Hashimoto's thyroiditis: OR 3.42, 95% CI 3.00-3.91; thyroid cancer: OR 1.40, 95% CI 1.22-1.60). Age- and sex-stratified analyses revealed that the risk of autoimmune thyroid disease in SLE patients was increased for all age groups and the female group. An association between thyroid cancer and SLE was identified only in the 20- to 59-year-old age group and in the female group. Using a large population-based study, we demonstrated that patients with SLE are at a greater risk of developing thyroid disease than matched control individuals.	[Yun, Jae-Seung; Kim, Hyung-Rae; Lee, Jun-Seok; Ko, Seung-Hyun; Cha, Seon-Ah; Ahn, Yu-Bae] Catholic Univ Korea, Div Endocrinol & Metab, Dept Internal Med, St Vincents Hosp,Coll Med, Suwon, South Korea; [Bae, Jung Min; Jung, Yu Seok; Kim, Gyong Moon] Catholic Univ Korea, Dept Dermatol, St Vincents Hosp, Coll Med, Suwon, South Korea; [Kim, Ki-Jo] Catholic Univ Korea, Div Rheumatol, Dept Internal Med, St Vincents Hosp,Coll Med, Suwon, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Ahn, YB (corresponding author), Catholic Univ Korea, Div Endocrinol & Metab, Dept Internal Med, St Vincents Hosp,Coll Med, Suwon, South Korea.	vincentendo@catholic.ac.kr		Ahn, YuBae/0000-0001-8658-2731				Anaya JM, 2012, AUTOIMMUN REV, V11, P781, DOI 10.1016/j.autrev.2012.02.002; Antonelli A, 2015, RHEUMATOLOGY; Antonelli A, 2010, METABOLISM, V59, P896, DOI 10.1016/j.metabol.2009.10.010; Antonelli A, 2010, J CLIN ENDOCR METAB, V95, P314, DOI 10.1210/jc.2009-0677; Aranow C, 2002, J RHEUMATOL, V29, P1674; Azizi G, 2011, ENDOCR PRACT, V17, P201, DOI 10.4158/EP10123.OR; Bakr A, 2014, LUPUS, V23, P825, DOI 10.1177/0961203314525866; Ballotti S, 2006, HORM RES, V66, P132, DOI 10.1159/000094251; BOEY ML, 1993, LUPUS, V2, P51, DOI 10.1177/096120339300200109; Boi F, 2005, EUR J ENDOCRINOL, V153, P637, DOI 10.1530/eje.1.02020; Cao LH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122964; Cen H, 2013, AUTOIMMUNITY, V46, P455, DOI 10.3109/08916934.2013.796937; Chang DM, 1998, LUPUS, V7, P462, DOI 10.1191/096120398678920479; Chen YJ, 2010, AM J MED, V123, DOI 10.1016/j.amjmed.2010.08.006; Danchenko N, 2006, LUPUS, V15, P308, DOI 10.1191/0961203306lu2305xx; Flanagan SE, 2014, NAT GENET, V46, P812, DOI 10.1038/ng.3040; Franco JS, 2015, CLIN ENDOCRINOL, V83, P943, DOI 10.1111/cen.12662; Garber JR, 2012, THYROID, V22, P1200, DOI 10.1089/thy.2012.0205; Garcia MA, 2005, LUPUS, V14, P938, DOI 10.1191/0961203305lu2245oa; Gayed M, 2009, LUPUS, V18, P479, DOI 10.1177/0961203309102556; Goobie GC, 2015, CURR OPIN RHEUMATOL, V27, P454, DOI 10.1097/BOR.0000000000000202; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hong JS, 2014, ACTA CARDIOL, V69, P513, DOI 10.1080/AC.69.5.3044878; Jenkins RC, 2002, THYROID, V12, P977, DOI 10.1089/105072502320908312; Ju JH, 2014, J EPIDEMIOL, V24, P295, DOI 10.2188/jea.JE20120204; KAUSMAN D, 1995, BRIT J RHEUMATOL, V34, P361; KINLEN LJ, 1992, J AUTOIMMUN, V5, P363, DOI 10.1016/0896-8411(92)90055-U; Kumar K, 2012, RHEUMATOL INT, V32, P73, DOI 10.1007/s00296-010-1556-5; Lin WY, 2015, J MICROBIOL IMMUNOL, V48, P676, DOI 10.1016/j.jmii.2014.03.004; Mader R, 2007, CLIN RHEUMATOL, V26, P1891, DOI 10.1007/s10067-007-0602-5; MAGARO M, 1992, CLIN EXP RHEUMATOL, V10, P67; Mao S, 2016, J CANCER RES CLIN, V142, P253, DOI 10.1007/s00432-015-2032-0; Robazzi TCMV, 2012, REV BRAS REUMATOL, V52, P417; MILLER FW, 1987, ARTHRITIS RHEUM-US, V30, P1124, DOI 10.1002/art.1780301006; Moon JH, 2013, ENDOCRINOL METAB, V28, P275, DOI 10.3803/EnM.2013.28.4.275; Namjou B, 2005, ARTHRITIS RHEUM-US, V52, P3646, DOI 10.1002/art.21413; Pan XF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123291; Parikh-Patel A, 2008, CANCER CAUSE CONTROL, V19, P887, DOI 10.1007/s10552-008-9151-8; Park S, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5745; Pyne D, 2002, ANN RHEUM DIS, V61, P70, DOI 10.1136/ard.61.1.70; Song SO, 2014, DIABETES METAB J, V38, P395, DOI 10.4093/dmj.2014.38.5.395; Soto ME, 2004, CLIN EXP RHEUMATOL, V22, P713; Stathatos N, 2012, CURR OPIN RHEUMATOL, V24, P70, DOI 10.1097/BOR.0b013e32834ddb27; Trager J, 2001, CURR OPIN RHEUMATOL, V13, P345, DOI 10.1097/00002281-200109000-00002; VIANNA JL, 1991, J RHEUMATOL, V18, P1193; Watad A, 2015, AUTOIMMUNITY, P1; Watad A, 2016, AUTOIMMUN REV, V15, P484, DOI 10.1016/j.autrev.2016.01.019; WHITE RG, 1961, LANCET, V1, P368; Wu H, 2005, ARTHRITIS RHEUM-US, V52, P2396, DOI 10.1002/art.21223; Yurkovich M, 2014, ARTHRIT CARE RES, V66, P608, DOI 10.1002/acr.22173; Zonana-Nacach A, 2000, ARTHRITIS RHEUM, V43, P1801, DOI 10.1002/1529-0131(200008)43:8<1801::AID-ANR16>3.0.CO;2-O	51	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179088	10.1371/journal.pone.0179088	http://dx.doi.org/10.1371/journal.pone.0179088			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654679	gold, Green Submitted, Green Published			2022-12-27	WOS:000404541500005
J	O'Connor, K; Carroll, GR; Kovacs, B				O'Connor, Kieran; Carroll, Glenn R.; Kovacs, Balazs			Disambiguating authenticity: Interpretations of value and appeal	PLOS ONE			English	Article							CONSUMER PERCEPTIONS; CONJOINT-ANALYSIS; MECHANICAL TURK; DECEPTION; REGRET; MODEL	While shaping aesthetic judgment and choice, socially constructed authenticity takes on some very different meanings among observers, consumers, producers and critics. Using a theoretical framework positing four distinct meanings of socially constructed authenticity-type, moral, craft, and idiosyncratic-we aim to document empirically the unique appeal of each type. We develop predictions about the relationships between attributed authenticity and corresponding increases in the value ascribed to it through: (1) consumer value ratings, (2) willingness to pay, and (3) behavioral choice. We report empirical analyses from a research program of three multi-method studies using (1) archival data from voluntary consumer evaluations of restaurants in an online review system, (2) a university-based behavioral lab experiment, and (3) an online survey-based experiment. Evidence is consistent across the studies and suggests that perceptions of four distinct subtypes of socially constructed authenticity generate increased appeal and value even after controlling for option quality. Findings suggest additional directions for research on authenticity.	[O'Connor, Kieran] Univ Virginia, McIntire Sch Commerce, Charlottesville, VA 22903 USA; [Carroll, Glenn R.] Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA; [Kovacs, Balazs] Yale Univ, Yale Sch Management, Management Grp, New Haven, CT USA	University of Virginia; Stanford University; Yale University	O'Connor, K (corresponding author), Univ Virginia, McIntire Sch Commerce, Charlottesville, VA 22903 USA.	oconnor@virginia.edu	Carroll, Glenn R/L-3378-2016		McIntire School of Commerce; Stanford Graduate School of Business; Yale School of Management	McIntire School of Commerce; Stanford Graduate School of Business; Yale School of Management	The authors received no specific funding for this work. They would like to thank the McIntire School of Commerce, Stanford Graduate School of Business, and Yale School of Management for support.	Aronson E., 1990, METHODS RES SOCIAL P; BABIN BJ, 1994, J CONSUM RES, V20, P644, DOI 10.1086/209376; Baron JN, 2004, IND CORP CHANGE, V13, P3, DOI 10.1093/icc/13.1.3; Barrera D, 2012, SOCIOL METHOD RES, V41, P383, DOI 10.1177/0049124112452526; BAUGH B, 1988, J AESTHET ART CRITIC, V46, P477, DOI 10.2307/431285; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Beverland M. B., 2009, BUILDING BRAND AUTHE; Beverland MB, 2005, J MANAGE STUD, V42, P1003, DOI 10.1111/j.1467-6486.2005.00530.x; Bonetti S., 1998, J EC PSYCHOL; BREHM JW, 1956, J ABNORM SOC PSYCH, V52, P384, DOI 10.1037/h0041006; BREHM JW, 1970, J PERS SOC PSYCHOL, V14, P1, DOI 10.1037/h0028616; Cable DM, 2013, ADMIN SCI QUART, V58, P1, DOI 10.1177/0001839213477098; Camus S., 2004, RECHERCHE APPL MARKE, V19, P39, DOI DOI 10.1177/076737010401900407; Carroll GR, 2009, RES ORGAN BEHAV, V29, P255, DOI 10.1016/j.riob.2009.06.003; Carroll GR, 2000, AM J SOCIOL, V106, P715, DOI 10.1086/318962; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Colson G, 2016, AM J AGR ECON, V98, P610, DOI 10.1093/ajae/aav067; Cook KS, 2008, SOC PSYCHOL Q; Cooper DJ, 2014, J WINE ECON, V9, P111, DOI 10.1017/jwe.2014.18; Davies Stephen, 2001, MUSICAL WORKS PERFOR; Derbaix M, 2010, RECH APPL MARKET-ENG, V25, P57, DOI 10.1177/205157071002500303; Dutton D., 2003, AESTHETICS EVOLUTION, P693; Elsbach KD, 2003, ADMIN SCI QUART, V48, P622, DOI 10.2307/3556639; Elsbach KD, 2001, PSYCHOLOGY OF LEGITIMACY, P391; ELSBACH KD, 1992, ACAD MANAGE J, V35, P699, DOI 10.2307/256313; Festinger L., 1957, THEORY COGNITIVE DIS, V2; Field LW, 2009, AM ETHNOL, V36, P507, DOI 10.1111/j.1548-1425.2009.01176.x; Fine GaryAlan., 2004, EVERYDAY GENIUS SELF; Frazier BN, 2009, J COGN CULT, V9, P1, DOI 10.1163/156853709X414601; Galperin I, 2014, PLOS ONE, V9; Grayson K, 2004, J CONSUM RES, V31, P296, DOI 10.1086/422109; Grazian D., 2010, HDB CULTURAL SOCIOLO, P191; Grazian David, 2003, BLUE CHICAGO SEARCH; GREEN PE, 1990, J MARKETING, V54, P3, DOI 10.2307/1251756; GREEN PE, 1978, J CONSUM RES, V5, P103, DOI 10.1086/208721; Gupta S, 2006, MARKET SCI, V25, P718, DOI 10.1287/mksc.1060.0221; Hannan M.T., 2007, LOGICS ORG THEORY AU; Hersch G, 2015, STUD HIST PHILOS S A; Hertwig R, 2008, ETHICS BEHAV, V18, P59, DOI 10.1080/10508420701712990; Holt D., 2010, CULTURAL STRATEGY US; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Kolar T, 2010, TOURISM MANAGE, V31, P652, DOI 10.1016/j.tourman.2009.07.010; Koontz A, 2010, SOCIOL COMPASS, V4, P977, DOI 10.1111/j.1751-9020.2010.00334.x; Kovacs B, 2016, SOCIOL SCI IN PRESS, V3; Kovacs B, 2014, ORGAN SCI, V25, P458, DOI 10.1287/orsc.2013.0843; Kutner M. H., 2004, APPL LINEAR REGRESSI; Lehman DW, 2014, MANAGE SCI, V60, P2602, DOI 10.1287/mnsc.2014.1903; Lindholm C., 2008, CULTURE AUTHENTICITY; Luca M, 2016, MANAGE SCI, V62, P3412, DOI 10.1287/mnsc.2015.2304; MERTON RK, 1987, ANNU REV SOCIOL, V13, P1, DOI 10.1146/annurev.so.13.080187.000245; NEMEROFF C, 1994, ETHOS, V22, P158, DOI 10.1525/eth.1994.22.2.02a00020; Newman GE, 2014, J MARKETING RES, V51, P371, DOI 10.1509/jmr.11.0022; Newman GE, 2012, J EXP PSYCHOL GEN, V141, P558, DOI 10.1037/a0026035; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Peterson R., 1997, CREATING COUNTRY MUS; Podolny JM, 2004, IND CORP CHANGE, V13, P91, DOI 10.1093/icc/13.1.91; Potter A., 2010, AUTHENTICITY HOAX; Qirko H, 2014, POP MUSIC SOC, V37, P291, DOI 10.1080/03007766.2013.798552; Sidali KL, 2014, BRIT FOOD J, V116, P1692, DOI 10.1108/BFJ-02-2014-0056; SIMONSON I, 1992, J CONSUM RES, V19, P105, DOI 10.1086/209290; Sweeney JC, 2001, J RETAILING, V77, P203, DOI 10.1016/S0022-4359(01)00041-0; Trillin C., 2011, TRILLIN ON TEXAS; Trilling Lionel, 1972, SINCERITY AUTHENTICI; Weber Max, 1968, EC SOC; Weber R. P., 1990, BASIC CONTENT ANAL, V2nd; Wherry F. F., 2006, Journal of Consumer Culture, V6, P5, DOI 10.1177/1469540506060867; ZEITHAML VA, 1988, J MARKETING, V52, P2, DOI 10.2307/1251446	67	24	24	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179187	10.1371/journal.pone.0179187	http://dx.doi.org/10.1371/journal.pone.0179187			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ2KD	28650997	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000404537300002
J	Villacampa, P; Menger, KE; Abelleira, L; Ribeiro, J; Duran, Y; Smith, AJ; Ali, RR; Luhmann, UF; Bainbridge, JWB				Villacampa, Pilar; Menger, Katja E.; Abelleira, Laura; Ribeiro, Joana; Duran, Yanai; Smith, Alexander J.; Ali, Robin R.; Luhmann, Ulrich F.; Bainbridge, James W. B.			Accelerated oxygen-induced retinopathy is a reliable model of ischemia-induced retinal neovascularization	PLOS ONE			English	Article							PATHOLOGICAL ANGIOGENESIS; MOUSE	Retinal ischemia and pathological angiogenesis cause severe impairment of sight. Oxygen-induced retinopathy (OIR) in young mice is widely used as a model to investigate the underlying pathological mechanisms and develop therapeutic interventions. We compared directly the conventional OIR model (exposure to 75% O-2 from postnatal day (P) 7 to P12) with an alternative, accelerated version (85% O-2 from P8 to P11). We found that accelerated OIR induces similar pre-retinal neovascularization but greater retinal vascular regression that recovers more rapidly. The extent of retinal gliosis is similar but neuroretinal function, as measured by electroretinography, is better maintained in the accelerated model. We found no systemic or maternal morbidity in either model. Accelerated OIR offers a safe, reliable and more rapid alternative model in which pre-retinal neovascularization is similar but retinal vascular regression is greater.	[Villacampa, Pilar; Menger, Katja E.; Abelleira, Laura; Ribeiro, Joana; Duran, Yanai; Smith, Alexander J.; Ali, Robin R.; Luhmann, Ulrich F.; Bainbridge, James W. B.] UCL, UCL Inst Ophthalmol, Div Genet, London, England; [Villacampa, Pilar] Duran i Reynals Hosp, Bellvitge Biomed Res Inst IDIBELL, Gran Via Hosp 199-203, Barcelona, Spain; [Luhmann, Ulrich F.] F Hoffmann La Roche Ltd, Roche Innovat Ctr Basel, Basel, Switzerland	University of London; University College London; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; Roche Holding	Bainbridge, JWB (corresponding author), UCL, UCL Inst Ophthalmol, Div Genet, London, England.	j.bainbridge@ucl.ac.uk	Villacampa, Pilar/B-1801-2019	Villacampa, Pilar/0000-0002-2860-7475; Bainbridge, James/0000-0003-1318-8201; Claudio RIbeiro, Joana Filipa/0000-0002-9290-6023; Luhmann, Ulrich F.O./0000-0002-1993-1951; Menger, Katja/0000-0002-6972-7326; Abelleira Hervas, Laura Esther/0000-0003-2423-8307; Ali, Robin/0000-0003-3126-6517	People Programme (Marie Curie Actions); European Union's Seventh Framework Programme under Research Executive Agency [629556]; Special Trustees of Moorfields Eye Hospital [ST1503B]; National Institute for Health Research [NF-SI-0513-10074, NF-SI-0508-10130, NIHR-RP-011-003] Funding Source: researchfish	People Programme (Marie Curie Actions); European Union's Seventh Framework Programme under Research Executive Agency; Special Trustees of Moorfields Eye Hospital; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by the People Programme (Marie Curie Actions, https://ec.europa.eu/programmes/horizon2020/en/h2020-section/marie-sklodowska-curie-actions) and the European Union's Seventh Framework Programme (FP7/2007-2013) under Research Executive Agency grant agreement 629556 to PV and the Special Trustees of Moorfields Eye Hospital (https.//www.mooteldseyecharity.org.uk/) (Grant ST1503B) to JWBB; JWBB is a National Institute of Health Research (NIHR, http://www.nihr.ac.uk/) Research Professor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauchamp MH, 2004, FREE RADICAL BIO MED, V37, P1885, DOI 10.1016/j.freeradbiomed.2004.09.008; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Claxton S, 2003, EXP EYE RES, V77, P305, DOI 10.1016/S0014-4835(03)00153-2; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Gu XL, 2003, AM J PHYSIOL-CELL PH, V285, pC546, DOI 10.1152/ajpcell.00424.2002; Hippert C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120415; Kubota Y, 2009, J EXP MED, V206, P1089, DOI 10.1084/jem.20081605; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Mowat FM, 2012, AM J PATHOL, V180, P1726, DOI 10.1016/j.ajpath.2011.12.033; Okuno Y, 2012, NAT MED, V18, P1208, DOI 10.1038/nm.2846; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101	13	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179759	10.1371/journal.pone.0179759	http://dx.doi.org/10.1371/journal.pone.0179759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650964	Green Submitted, Green Published, gold			2022-12-27	WOS:000404537300018
J	Watanabe, T; Nishimoto, T; Mlakar, L; Heywood, J; Malaab, M; Hoffman, S; Feghali-Bostwick, C				Watanabe, Tomoya; Nishimoto, Tetsuya; Mlakar, Logan; Heywood, Jonathan; Malaab, Maya; Hoffman, Stanley; Feghali-Bostwick, Carol			Optimization of a murine and human tissue model to recapitulate dermal and pulmonary features of systemic sclerosis	PLOS ONE			English	Article							ANIMAL-MODEL; BLEOMYCIN; SKIN; FIBROSIS; MICE; SCLERODERMA; INFUSION	The murine bleomycin (BLM)-induced fibrosis model is the most widely used in systemic sclerosis (SSc) studies. It has been reported that systemic delivery of BLM via continuous diffusion from subcutaneously implanted osmotic minipumps can cause fibrosis of the skin, lungs, and other internal organs. However, the mouse strain, dosage of BLM, administration period, and additional important features differ from one report to the next. In this study, by employing the pump model in C57BL/6J mice, we show a dose-dependent increase in lung fibrosis by day 28 and a transient increase in dermal thickness. Dermal thickness and the level of collagen in skin treated with high-dose BLM was significantly higher than in skin treated with low dose BLM or vehicle. A reduction in the thickness of the adipose layer was noted in both high and low dose groups at earlier time points suggesting that the loss of the fat layer precedes the onset of fibrosis. High-dose BLM also induced dermal fibrosis and increased expression of fibrosis-associated genes ex vivo in human skin, thus confirming and extending the in vivo findings, and demonstrating that a human organ culture model can be used to assess the effect of BLM on skin. In summary, our findings suggest that the BLM pump model is an attractive model to analyze the underlying mechanisms of fibrosis and test the efficacy of potential therapies. However, the choice of mouse strain, duration of BLM administration and dose must be carefully considered when using this model.	[Watanabe, Tomoya; Nishimoto, Tetsuya; Mlakar, Logan; Heywood, Jonathan; Malaab, Maya; Hoffman, Stanley; Feghali-Bostwick, Carol] Med Univ South Carolina, Dept Med, Div Rheumatol & Immunol, Charleston, SC 29425 USA	Medical University of South Carolina	Feghali-Bostwick, C (corresponding author), Med Univ South Carolina, Dept Med, Div Rheumatol & Immunol, Charleston, SC 29425 USA.	feghalib@musc.edu			NIH [K24 AR060297, R42 HL127802, R01 HL121262]; iBio Inc.; Kitty Trask Holt Endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R42HL127802, R01HL121262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR060297] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); iBio Inc.; Kitty Trask Holt Endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by funding to CF-B from NIH (K24 AR060297, R42 HL127802, and R01 HL121262), iBio Inc, and the Kitty Trask Holt Endowment. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida I, 2011, AUTOIMMUN REV, V10, P693, DOI 10.1016/j.autrev.2011.04.025; FLEISCHMAJER R, 1972, ARCH DERMATOL, V105, P59, DOI 10.1001/archderm.105.1.59; HARRISON JH, 1987, J PHARMACOL EXP THER, V243, P1185; Kalluri R, 2000, CURR OPIN NEPHROL HY, V9, P413, DOI 10.1097/00041552-200007000-00013; Lee R, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00140; Lee R, 2014, AM J PHYSIOL-LUNG C, V306, pL736, DOI 10.1152/ajplung.00210.2013; Lemaire R, 2016, ARTHRITIS RHEUMATOL, V68, P473, DOI 10.1002/art.39443; Liang MR, 2015, LAB INVEST, V95, P342, DOI 10.1038/labinvest.2014.145; Mahajan VS, 2016, CELL REP, V15, P1901, DOI 10.1016/j.celrep.2016.04.080; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Mouratis MA, 2011, CURR OPIN PULM MED, V17, P355, DOI 10.1097/MCP.0b013e328349ac2b; Santos AM, 2009, J CLIN INVEST, V119, P3613, DOI 10.1172/JCI38988; Scotton CJ, 2010, AM J PHYSIOL-LUNG C, V299, pL439, DOI 10.1152/ajplung.00258.2010; Steen VD, 2007, ANN RHEUM DIS, V66, P940, DOI 10.1136/ard.2006.066068; Walkin L, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-18; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yamaguchi Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003421; Yamamoto T, 1999, J INVEST DERMATOL, V112, P456, DOI 10.1046/j.1523-1747.1999.00528.x; Yamamoto T, 2000, ARCH DERMATOL RES, V292, P535, DOI 10.1007/s004030000183; Yang IV, 2015, TRANSL RES, V165, P48, DOI 10.1016/j.trsl.2014.03.011; Yasuoka H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087754	21	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179917	10.1371/journal.pone.0179917	http://dx.doi.org/10.1371/journal.pone.0179917			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651005	Green Published, gold, Green Submitted			2022-12-27	WOS:000404537300029
J	Advani, M; Weile, DS				Advani, Madhu; Weile, Daniel S.			Position and orientation inference via on-board triangulation	PLOS ONE			English	Article							SMART ANTENNAS; LOCALIZATION	This work proposes a new approach to determine the spatial location and orientation of an object using measurements performed on the object itself. The on-board triangulation algorithm we outline could be implemented in lieu of, or in addition to, well-known alternatives such as Global Positioning System (GPS) or standard triangulation, since both of these correspond to significantly different geometric pictures and necessitate different hardware and algorithms. We motivate the theory by describing situations in which on-board triangulation would be useful and even preferable to standard methods. The on-board triangulation algorithm we outline involves utilizing dumb beacons which broadcast omnidirectional single frequency radio waves, and smart antenna arrays on the object itself to infer the direction of the beacon signals, which may be used for onboard calculation of the position and orientation of the object. Numerical examples demonstrate the utility of the method and its noise tolerance.	[Advani, Madhu] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Weile, Daniel S.] Univ Delaware, Dept Elect & Comp Engn, Newark, DE USA	Harvard University; University of Delaware	Weile, DS (corresponding author), Univ Delaware, Dept Elect & Comp Engn, Newark, DE USA.	weile@udel.edu						Appel M., 2015, P 28 INT TECHN M SAT; Bulusu N, 2000, IEEE PERS COMMUN, V7, P28, DOI 10.1109/98.878533; Cuntz M., 2010, P ION GNSS 2010, P21; Hofmann-Wellenhof B., 2012, GLOBAL POSITIONING S; Konovaltsev A, 2014, I NAVIG SAT DIV INT, P2853; Liberti J.C., 1999, PR H COMMUN ENGN EM; Lim CH, 2007, IEEE T CONSUM ELECTR, V53, P618, DOI 10.1109/TCE.2007.381737; Moshtagh N, 2009, IEEE T ROBOT, V25, P851, DOI 10.1109/TRO.2009.2022439; Rife J., 2015, TECHN PRACT ROB APPL, P1; Rife J, 2016, IEEE T ROBOT, V32, P1280, DOI 10.1109/TRO.2016.2593026; Shi J, 2005, IEEE C INT TRANSP SY; Tron R, 2016, IEEE DECIS CONTR P, P1806, DOI 10.1109/CDC.2016.7798527; Weisstein E., INSCRIBED ANGLE; Weisstein E.W., CIRCLE	14	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0180089	10.1371/journal.pone.0180089	http://dx.doi.org/10.1371/journal.pone.0180089			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644874	Green Submitted, gold, Green Published			2022-12-27	WOS:000404145100062
J	Kronborg, TM; Hansen, JF; Rasmussen, AK; Vorkamp, K; Nielsen, CH; Frederiksen, M; Hofman-Bang, J; Hahn, CH; Ramhoj, L; Feldt-Rasmussen, U				Kronborg, Thit Mynster; Hansen, Juliana Frohnert; Rasmussen, Ase Krogh; Vorkamp, Katrin; Nielsen, Claus Henrik; Frederiksen, Marie; Hofman-Bang, Jacob; Hahn, Christoffer Holst; Ramhoj, Louise; Feldt-Rasmussen, Ulla			The flame retardant DE-71 (a mixture of polybrominated diphenyl ethers) inhibits human differentiated thyroid cell function in vitro	PLOS ONE			English	Article							POLYCHLORINATED-BIPHENYLS; EPITHELIAL-CELLS; ENVIRONMENTAL CHEMICALS; DEVELOPMENTAL EXPOSURE; PBDE MIXTURE; HORMONES; SERUM; DUST; HYPOTHYROIDISM; THYROGLOBULIN	Background Normal thyroid function is essential for general growth and metabolism, but can be affected by endocrine disrupting chemicals (EDCs). Polybrominated diphenyl ethers (PBDEs) have been used worldwide to reduce flammability in different materials and are suspected to be EDCs. The production of the commercial Penta- and OctaBDE mixtures is banned, but DecaBDEs and existing products may leak PBDEs into the environment. Our aim was to investigate the effect of the PentaBDE mixture DE-71 on human thyroid cells in vitro. Materials and methods Primary human thyroid cells were obtained as paraadenomatous tissue and cultured in monolayers. The influence of DE-71 on cyclic adenosine monophosphate (cAMP) and thyroglobulin (Tg) production was examined in the culture medium by competitive radioimmunoassay and enzyme-linked immunosorbent assay, respectively. Real-time quantitative PCR analysis of thyroid-specific genes was performed on the exposed cell cultures. PBDE concentrations were determined in cellular and supernatant fractions of the cultures. Results DE-71 inhibited Tg-release from TSH-stimulated thyrocytes. At 50 mg/L DE-71, mean Tg production was reduced by 71.9% ( range: 8.5-98.7%), and cAMP by 95.1% ( range: 91.5-98.8%) compared to controls). Expression of mRNA encoding Tg, TPO and TSHr were significantly inhibited (p<0.0001, p = 0.0079, and p = 0.0002, respectively). The majority of DE-71 added was found in the cell fraction. No cytotoxicity was found. Conclusions DE-71 inhibited differentiated thyroid cell functions in a two phase response manner and a concentration-dependent inhibition of Tg and cAMP production, respectively, as well as expression of mRNA encoding Tg, TPO and TSHr. Our findings suggest an inhibiting effect of PBDEs on thyroid cells.	[Kronborg, Thit Mynster; Hansen, Juliana Frohnert; Rasmussen, Ase Krogh; Feldt-Rasmussen, Ulla] Univ Copenhagen, Rigshosp, Dept Med Endocrinol, Copenhagen O, Denmark; [Vorkamp, Katrin] Aarhus Univ, Dept Environm Sci, Roskilde, Denmark; [Nielsen, Claus Henrik] Univ Copenhagen, Rigshosp, Inst Inflammat Res, Copenhagen N, Denmark; [Frederiksen, Marie] Natl Res Ctr Working Environm, Copenhagen O, Denmark; [Hofman-Bang, Jacob] Univ Copenhagen, Rigshosp, Dept Nephrol, Copenhagen O, Denmark; [Hahn, Christoffer Holst] Rigshosp, Dept Ear Nose Throat Head & Neck Surg, Copenhagen O, Denmark; [Ramhoj, Louise] Tech Univ Denmark, Natl Food Inst, Lyngby, Denmark	Rigshospitalet; University of Copenhagen; Aarhus University; Rigshospitalet; University of Copenhagen; National Research Centre for the Working Environment; Rigshospitalet; University of Copenhagen; Rigshospitalet; Technical University of Denmark	Feldt-Rasmussen, U (corresponding author), Univ Copenhagen, Rigshosp, Dept Med Endocrinol, Copenhagen O, Denmark.	ufeldt@rh.dk	Ramhøj, Louise/HGC-4949-2022; Frederiksen, Marie/AAW-9783-2021; Feldt-Rasmussen, Ulla/AAB-9218-2021	Ramhøj, Louise/0000-0002-0298-8003; Frederiksen, Marie/0000-0003-1553-5414; Feldt-Rasmussen, Ulla/0000-0002-5903-3355; Nielsen, Claus Henrik/0000-0001-7543-9016; Vorkamp, Katrin/0000-0002-1131-5687	Novo Nordisk foundation [13495, 8005, 14266]; Arvid Nilsson's Fund [R129-A4222]; Danish Council for Independent Research [0602-01959B, 35108-001]; Novo Nordisk Fonden [NNF14OC0013495] Funding Source: researchfish	Novo Nordisk foundation(Novo Nordisk FoundationNovocure Limited); Arvid Nilsson's Fund; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Novo Nordisk Fonden(Novo Nordisk Foundation)	Ulla Feldt-Rasmussen received funding as main supervisor on the scholarship project "Interaction between thyroid autoimmunity and endocrine disrupting chemicals" by the Novo Nordisk foundation (application number: 13495), for Thit Mynster Kronborg's salary. Ulla Feldt-Rasmussen further received funding for research salary, equipment and material from the local region's (RegionH, R129-A4222) research fund, from Arvid Nilsson's Fund, Novo Nordisk Foundation (application number 8005 and 14266) and Danish Council for Independent Research (0602-01959B). Thit Mynster Kronborg received funding from the Danish Foundation "Musikforlaeggernes Agnes og Knut Morks fond" (35108-001), which sponsored equipment and materials. None of the funding agencies had any role or influence on this study, and none of the authors had any conflicts of interest.	Bellanger M, 2015, J CLIN ENDOCR METAB, V100, P1256, DOI 10.1210/jc.2014-4323; Birnbaum LS, 2004, ENVIRON HEALTH PERSP, V112, P9, DOI 10.1289/ehp.6559; Boas M, 2006, EUR J ENDOCRINOL, V154, P599, DOI 10.1530/eje.1.02128; Boas M, 2012, MOL CELL ENDOCRINOL, V355, P240, DOI 10.1016/j.mce.2011.09.005; Bondy GS, 2013, ENVIRON TOXICOL, V28, P215, DOI 10.1002/tox.20713; Chevrier J, 2010, ENVIRON HEALTH PERSP, V118, P1444, DOI 10.1289/ehp.1001905; Christiansson A, 2009, ENVIRON SCI POLLUT R, V16, P312, DOI 10.1007/s11356-009-0150-4; Darnerud PO, 2008, INT J ANDROL, V31, P152, DOI 10.1111/j.1365-2605.2008.00869.x; Darnerud PO, 2001, ENVIRON HEALTH PERSP, V109, P49, DOI 10.2307/3434846; de Wit CA, 2002, CHEMOSPHERE, V46, P583, DOI 10.1016/S0045-6535(01)00225-9; de Wit CA, 2010, SCI TOTAL ENVIRON, V408, P2885, DOI 10.1016/j.scitotenv.2009.08.037; de-Miranda AS, 2016, REPROD TOXICOL, V63, P114, DOI 10.1016/j.reprotox.2016.05.017; DIAMANT M, 1991, AUTOIMMUNITY, V11, P21, DOI 10.3109/08916939108994704; Dodson RE, 2012, ENVIRON SCI TECHNOL, V46, P13056, DOI 10.1021/es303879n; ERICSON LE, 1992, TOXICOL LETT, V64-5, P365, DOI 10.1016/0378-4274(92)90209-3; FOWLES JR, 1994, TOXICOLOGY, V86, P49, DOI 10.1016/0300-483X(94)90052-3; Frederiksen M, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-32; Frederiksen M, 2010, INT J HYG ENVIR HEAL, V213, P233, DOI 10.1016/j.ijheh.2010.04.008; Frederiksen M, 2009, INT J HYG ENVIR HEAL, V212, P109, DOI 10.1016/j.ijheh.2008.04.005; Fromme H, 2016, INT J HYG ENVIR HEAL, V219, P1, DOI 10.1016/j.ijheh.2015.08.004; Geyer H.J., 2004, ORGANOHALOGEN COMP, V66, P3820; Groothuis FA, 2015, TOXICOLOGY, V332, P30, DOI 10.1016/j.tox.2013.08.012; Han GG, 2011, BIOMED ENVIRON SCI, V24, P112, DOI 10.3967/0895-3988.2011.02.004; Hansen JF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151192; Hansen JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131168; Harrad S, 2006, ENVIRON SCI TECHNOL, V40, P4633, DOI 10.1021/es0609147; Jacobson MH, 2016, ENVIRON RES, V149, P222, DOI 10.1016/j.envres.2016.05.022; Julander A, 2005, INT ARCH OCC ENV HEA, V78, P584, DOI 10.1007/s00420-005-0627-5; Kim UJ, 2014, ENVIRON POLLUT, V184, P193, DOI 10.1016/j.envpol.2013.08.034; Kim UJ, 2012, ENVIRON SCI TECHNOL, V46, P6261, DOI 10.1021/es2038678; Kim UJ, 2011, CHEMOSPHERE, V85, P487, DOI 10.1016/j.chemosphere.2011.08.008; Kim YR, 2014, CHEMOSPHERE, V106, P1, DOI 10.1016/j.chemosphere.2013.12.064; Kingsley Ibhazeheibo, 2012, Niger J Physiol Sci, V27, P123; Kodavanti PRS, 2010, TOXICOL SCI, V116, P297, DOI 10.1093/toxsci/kfq105; Koike E, 2013, J APPL TOXICOL, V33, P1451, DOI 10.1002/jat.2809; La Guardia MJ, 2006, ENVIRON SCI TECHNOL, V40, P6247, DOI 10.1021/es060630m; Lagalante AF, 2011, ENVIRON INT, V37, P899, DOI 10.1016/j.envint.2011.03.007; Legler J, 2003, ENVIRON INT, V29, P879, DOI 10.1016/S0160-4120(03)00104-1; Lv QY, 2015, CHEMOSPHERE, V120, P621, DOI 10.1016/j.chemosphere.2014.08.029; MADSEN SN, 1976, ACTA ENDOCRINOL-COP, V81, P208, DOI 10.1530/acta.0.0810208; Martin PA, 2007, ENVIRON TOXICOL CHEM, V26, P988, DOI 10.1897/06-246R.1; Mynster KT, 2016, PLOS ONE, V11; Oulhote Y, 2016, J CLIN ENDOCR METAB, V101, P590, DOI 10.1210/jc.2015-2659; Patel J, 2011, J ENDOCRINOL, V209, P1, DOI 10.1530/JOE-10-0444; Peltier MR, 2012, PLACENTA, V33, P745, DOI 10.1016/j.placenta.2012.06.005; RASMUSSEN AK, 1988, ALLERGY, V43, P435, DOI 10.1111/j.1398-9995.1988.tb00915.x; Rasmussen AK, 2000, EXP CLIN ENDOCR DIAB, V108, P67, DOI 10.1055/s-2000-5797; Rasmussen AK, 1997, ENDOCRINOLOGY, V138, P2043, DOI 10.1210/en.138.5.2043; Rasmussen AK, 1996, MOL CELL ENDOCRINOL, V116, P173, DOI 10.1016/0303-7207(95)03712-8; Rasmussen AK, 2000, DAN MED BULL, V47, P94; Rasmussen AK, 1996, MOL CELL ENDOCRINOL, V116, P165, DOI 10.1016/0303-7207(95)03711-X; Sanders JM, 2006, XENOBIOTICA, V36, P103, DOI 10.1080/00498250500485107; Stapleton HM, 2011, ENVIRON HEALTH PERSP, V119, P1454, DOI 10.1289/ehp.1003235; Stoker TE, 2004, TOXICOL SCI, V78, P144, DOI 10.1093/toxsci/kfh029; Streets SS, 2006, ENVIRON SCI TECHNOL, V40, P7263, DOI 10.1021/es061337p; Vorkamp K, 2014, ARCH ENVIRON CON TOX, V67, P9, DOI 10.1007/s00244-013-9988-z; Vorkamp K, 2011, ENVIRON INT, V37, P1, DOI 10.1016/j.envint.2010.06.001; Wei RG, 2010, TOXICOL IN VITRO, V24, P1078, DOI 10.1016/j.tiv.2010.03.015; Wirth JR, 2014, J APPL TOXICOL; Wu JP, 2008, ENVIRON INT, V34, P1109, DOI 10.1016/j.envint.2008.04.001; Zhang ZL, 2014, SCI TOTAL ENVIRON, V468, P158, DOI 10.1016/j.scitotenv.2013.08.029; Zhou T, 2002, TOXICOL SCI, V66, P105, DOI 10.1093/toxsci/66.1.105; Zhou T, 2001, TOXICOL SCI, V61, P76, DOI 10.1093/toxsci/61.1.76; Zoeller RT, 2007, THYROID, V17, P811, DOI 10.1089/thy.2007.0107	64	14	17	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179858	10.1371/journal.pone.0179858	http://dx.doi.org/10.1371/journal.pone.0179858			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644858	gold, Green Published, Green Submitted			2022-12-27	WOS:000404145100044
J	Aberdam, E; Petit, I; Sangari, L; Aberdam, D				Aberdam, Edith; Petit, Isabelle; Sangari, Linda; Aberdam, Daniel			Induced pluripotent stem cell-derived limbal epithelial cells (LiPSC) as a cellular alternative for in vitro ocular toxicity testing	PLOS ONE			English	Article							DIFFERENTIATION; IRRITATION; MODEL; EXPRESSION; CHEMICALS	Induced pluripotent stem cells hold great potential to produce unlimited amount of differentiated cells as cellular source for regenerative medicine but also for in vitro drug screening and cytotoxicity tests. Ocular toxicity testing is mandatory to evaluate the risks of drugs and cosmetic products before their application to human patients by preventing eye irritation or insult. Since the global ban to use animals, many human-derived alternatives have been proposed, from ex-vivo enucleated postmortem cornea, primary corneal cell culture and immortalized corneal epithelial cell lines. All of them share limitations for their routine use. Using an improved protocol, we derived limbal epithelial cells from human induced pluripotent stem cells, named LiPSC, that are able to be passaged and differentiate further into corneal epithelial cells. Comparative RT-qPCR, immunofluorescence staining, flow cytometry analysis and zymography assays demonstrate that LiPSC are morphologically and molecularly similar to the adult stem cells. Moreover, contrary to HCE, LiPSC and primary limbal cells display similarly sensitive to cytotoxicity treatment among passages. Our data strongly suggest that LiPSC could become a powerful alternative cellular model for cosmetic and drug tests.	[Aberdam, Daniel] INSERM, U976, Paris, France; Univ Paris Diderot, Hop St Louis, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Aberdam, D (corresponding author), INSERM, U976, Paris, France.	daniel.aberdam@inserm.fr	Petit, isabelle/AAF-5620-2020; Aberdam, Daniel/G-3299-2013	Petit, isabelle/0000-0002-9782-0683; Aberdam, Daniel/0000-0002-4019-5418	Agence Nationale pour la Recherche [ANR-Emergence 11-EMMA-023, ANR-13-PRTS-0001]; The competitiveness cluster MEDICEN; INSERM; Universite Paris-Diderot	Agence Nationale pour la Recherche(French National Research Agency (ANR)); The competitiveness cluster MEDICEN; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris-Diderot	This study was supported by the Agence Nationale pour la Recherche (ANR-Emergence 11-EMMA-023 and ANR-13-PRTS-0001); The competitiveness cluster MEDICEN; INSERM; and Universite Paris-Diderot.	Aberdam E, 2008, STEM CELLS, V26, P440, DOI 10.1634/stemcells.2007-0588; Ahmad S, 2007, STEM CELLS, V25, P1145, DOI 10.1634/stemcells.2006-0516; Alepee N, 2016, TOXICOL IN VITRO, V31, P43, DOI 10.1016/j.tiv.2015.11.012; Araki-Sasaki K., 1995, INVEST OPHTH VIS SCI, V6, P614; Cheng CC, 2009, J CELL SCI, V122, P4473, DOI 10.1242/jcs.054791; Draize JH, 1944, J PHARMACOL EXP THER, V82, P377; Erbani J, 2016, STEM CELL REV; Kaluzhny Y, 2011, ATLA-ALTERN LAB ANIM, V39, P339, DOI 10.1177/026119291103900409; Katoh M, 2013, TOXICOL IN VITRO, V27, P2184, DOI 10.1016/j.tiv.2013.08.008; KURPAKUS MA, 1990, INVEST OPHTH VIS SCI, V31, P448; Li DQ, 2001, EXP EYE RES, V73, P449, DOI 10.1006/exer.2001.1054; Mikhailova A, 2015, SCI REP-UK, V5, DOI 10.1038/srep14684; Mikhailova A, 2014, STEM CELL REP, V2, P219, DOI 10.1016/j.stemcr.2013.12.014; Miyashita H, 2013, STEM CELL TRANSL MED, V2, P758, DOI 10.5966/sctm.2012-0156; Petit I, 2012, STEM CELL RES, V8, P134, DOI 10.1016/j.scr.2011.09.003; Ronkko S, 2016, DRUG DELIV TRANSL RE, V6, P660, DOI 10.1007/s13346-016-0330-y; Sareen D, 2014, STEM CELL TRANSL MED, V3, P1002, DOI 10.5966/sctm.2014-0076; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Shalom-Feuerstein R, 2013, P NATL ACAD SCI USA, V110, P2152, DOI 10.1073/pnas.1201753109; Shalom-Feuerstein R, 2012, STEM CELLS, V30, P898, DOI 10.1002/stem.1068; Wilson SL, 2015, TOXICOLOGY, V327, P32, DOI 10.1016/j.tox.2014.11.003	21	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179913	10.1371/journal.pone.0179913	http://dx.doi.org/10.1371/journal.pone.0179913			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640863	gold, Green Published, Green Submitted			2022-12-27	WOS:000404135800082
J	Ambrosius, W; Michalak, S; Kazmierski, R; Andrzejewska, N; Kozubski, W				Ambrosius, Wojciech; Michalak, Slawomir; Kazmierski, Radoslaw; Andrzejewska, Natalia; Kozubski, Wojciech			Predictive value of serum transthyretin for outcome in acute ischemic stroke	PLOS ONE			English	Article							NUTRITIONAL-STATUS; CEREBRAL-ISCHEMIA; LOW PREALBUMIN; BRAIN; MECHANISMS; MORTALITY; SEVERITY; PROTEINS; DISEASE	Introduction The impact of choroid plexus with its blood cerebrospinal fluid barrier in the ischemic stroke pathology is poorly explored. Transthyretin (TTR) is a protein synthesized in liver and just in choroid plexus. Objectives The current study was designed to assess the prognostic value of serum TTR for functional outcome (at the time of hospital discharge) and long-term (one-year) overall mortality in ischemic stroke patients. Patients and methods We conducted a prospective observational study. Patients (n = 81) with acute (< 24 hours of symptoms onset) ischemic stroke consecutively admitted to Stroke Unit were included. An unfavorable outcome was defined as a modified Rankin Scale (mRS) score > 3. The relationships between serum TTR levels and clinical outcome were analyzed using multivariate analysis. One-year mortality was analyzed by Kaplan Meier survival curves stratified by mean value of TTR. Results Compared with patients with mRS <3, patients with an unfavorable outcome at hospital discharge had significantly lower TTR levels on admission (P< 0.0001). In non -survivals serum TTR levels were significantly lower compared with patients who survive one year of observation (P 0.009). Using multivariate analysis, transthyretin emerged as an independent predictor for unfavorable outcome at the day of hospital discharge (adjusted odds ratio = 0.96; 95% CI: 0.9-0.99, P <0.05). A one-year mortality of patients with the lower TTR levels was significantly higher than in patients with TTR levels above mean value (P= 0.02). Conclusions Serum level of TTR at admission was a predictor of functional outcome after ischemic stroke and was also associated with one-year mortality in stroke survivals.	[Ambrosius, Wojciech; Kozubski, Wojciech] Poznan Univ Med Sci, Dept Neurol, Poznan, Poland; [Michalak, Slawomir] Poznan Univ Med Sci, Dept Neurochem & Neuropathol, Poznan, Poland; [Kazmierski, Radoslaw; Andrzejewska, Natalia] Poznan Univ Med Sci, Ludwik Bierkowski Hosp, Dept Neurol & Cerebrovasc Disorders, Poznan, Poland	Poznan University of Medical Sciences; Poznan University of Medical Sciences; Poznan University of Medical Sciences	Ambrosius, W (corresponding author), Poznan Univ Med Sci, Dept Neurol, Poznan, Poland.	wambrosius@ump.edu.pl	Ambrosius, Wojciech/AGL-7764-2022	Kozubski, Wojciech/0000-0003-2777-261X; Ambrosius, Wojciech/0000-0002-8018-9776				Adams HP, 2015, STROKE, V46, pE114, DOI 10.1161/STROKEAHA.114.007773; AHO K, 1980, B WORLD HEALTH ORGAN, V58, P113; Ambrosius W, 2011, EXP CLIN ENDOCR DIAB, V119, P139, DOI 10.1055/s-0030-1267918; Audebert HJ, 2004, STROKE, V35, P2128, DOI 10.1161/01.STR.0000137607.61697.77; Chertow GM, 2005, KIDNEY INT, V68, P2794, DOI 10.1111/j.1523-1755.2005.00751.x; Delpont B, 2016, EUR NEUROL, V76, P125, DOI 10.1159/000449055; Dennis M, 2003, STROKE, V34, P1450, DOI 10.1161/01.STR.0000074037.49197.8C; Devoto G, 2006, CLIN CHEM, V52, P2281, DOI 10.1373/clinchem.2006.080366; DICKSON PW, 1987, J BIOL CHEM, V262, P13907; Elkind MSV, 2010, STROKE, V41, pS3, DOI 10.1161/STROKEAHA.110.594945; Ennis SR, 2006, J CEREBR BLOOD F MET, V26, P675, DOI 10.1038/sj.jcbfm.9600224; Fleming CE, 2009, PROG NEUROBIOL, V89, P266, DOI 10.1016/j.pneurobio.2009.07.007; Furlan JC, 2014, EUR J NEUROL, V21, P215, DOI 10.1111/ene.12233; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gao C, 2011, CLIN EXP MED, V11, P49, DOI 10.1007/s10238-010-0103-8; Gidday JM, 2005, AM J PHYSIOL-HEART C, V289, pH558, DOI 10.1152/ajpheart.01275.2004; Groger M, 2005, J CEREBR BLOOD F MET, V25, P978, DOI 10.1038/sj.jcbfm.9600096; Hamilton JA, 2001, CELL MOL LIFE SCI, V58, P1491, DOI 10.1007/PL00000791; Kassem NA, 2006, AM J PHYSIOL-REG I, V291, pR1310, DOI 10.1152/ajpregu.00789.2005; Kazmierski R, 2012, NEUROLOGY, V79, P1677, DOI 10.1212/WNL.0b013e31826e9a83; Keep RF, 2005, BLOOD-CEREBROSPINAL FLUID BARRIER, P345; Lee KH, 2016, KIDNEY RES CLIN PRAC, V35, P169, DOI 10.1016/j.krcp.2016.06.002; Lourenco P, 2014, HEART, V100, P1780, DOI 10.1136/heartjnl-2014-305747; Ma LL, 2016, CLIN CHIM ACTA, V458, P63, DOI 10.1016/j.cca.2016.04.023; Ma YH, 2012, J NEUROSCI RES, V90, P1873, DOI 10.1002/jnr.23088; Prapunpoj P, 2009, FEBS J, V276, P5330, DOI 10.1111/j.1742-4658.2009.07243.x; Richardson SJ, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00066; Santos SD, 2010, J NEUROCHEM, V115, P1434, DOI 10.1111/j.1471-4159.2010.07047.x; Shen HC, 2011, ARCH GERONTOL GERIAT, V53, pE149, DOI 10.1016/j.archger.2010.08.001; Ye S, 2017, INT J NEUROSCI, V127, P601, DOI 10.1080/00207454.2016.1218874	30	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179806	10.1371/journal.pone.0179806	http://dx.doi.org/10.1371/journal.pone.0179806			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636639	Green Published, gold, Green Submitted			2022-12-27	WOS:000404118300056
J	Baughman, BM; Wang, HC; An, Y; Kireev, D; Stashko, MA; Jessen, HJ; Pearce, KH; Frye, SV; Shears, SB				Baughman, Brandi M.; Wang, Huanchen; An, Yi; Kireev, Dmitri; Stashko, Michael A.; Jessen, Henning J.; Pearce, Kenneth H.; Frye, Stephen V.; Shears, Stephen B.			RETRACTION: A High-Throughput ScreeningCompatible Strategy for the Identification of Inositol Pyrophosphate Kinase Inhibitors (vol 10, e0164378, 2016) (Retraction of Vol 10, art no E0164378, 2016)	PLOS ONE			English	Retraction													Jessen, Henning/O-1157-2019; Jessen, Henning/F-5108-2014	Jessen, Henning/0000-0002-1025-9484; Jessen, Henning/0000-0002-1025-9484				Baughman BM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164378	1	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0180272	10.1371/journal.pone.0180272	http://dx.doi.org/10.1371/journal.pone.0180272			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636659	gold, Green Published, Green Submitted			2022-12-27	WOS:000404118300066
J	Decker, S; Rempis, E; Schnack, A; Braun, V; Rubaihayo, J; Busingye, P; Tumwesigye, NM; Harms, G; Theuring, S				Decker, Sarah; Rempis, Eva; Schnack, Alexandra; Braun, Vera; Rubaihayo, John; Busingye, Priscilla; Tumwesigye, Nazarius Mbona; Harms, Gundel; Theuring, Stefanie			Prevention of mother-to-child transmission of HIV: Postpartum adherence to Option B+ until 18 months in Western Uganda	PLOS ONE			English	Article							FOLLOW-UP; ANTIRETROVIRAL PROPHYLAXIS; UNINFECTED CHILDREN; WOMEN; CARE; PMTCT; RETENTION; PREGNANCY; THERAPY; PROGRAM	Since 2012, the WHO recommends Option B+ for the prevention of mother-to-child transmission of HIV. This approach entails the initiation of lifelong antiretroviral therapy in all HIV positive pregnant women, also implying protection during breastfeeding for 12 months or longer. Research on long-term adherence to Option B+ throughout breastfeeding is scarce to date. Therefore, we conducted a prospective observational cohort study in Fort Portal, Western Uganda, to assess adherence to Option B+ until 18 months postpartum. In 2013, we recruited 67 HIV-positive, Option B+ enrolled women six weeks after giving birth and scheduled them for follow-up study visits after six, twelve and 18 months. Two adherence measures, self-reported drug intake and amount of drug refill visits, were combined to define adherence, and were assessed together with feeding information at all study visits. At six months postpartum, 51% of the enrolled women were considered to be adherent. Until twelve and 18 months postpartum, adherence for the respective follow-up interval decreased to 19% and 20.5% respectively. No woman was completely adherent until 18 months. At the same time, 76.5% of the women breastfed for >= 12 months. Drug adherence was associated with younger age (p<0.01), lower travel costs (p = 0.02), and lower number of previous deliveries (p = 0.04). Long-term adherence to Option B+ seems to be challenging. Considering that in our cohort, prolonged breastfeeding until >= 12 months was widely applied while postpartum adherence until the end of breastfeeding was poor, a potential risk of postpartum vertical transmission needs to be taken seriously into account for Option B+ implementation.	[Decker, Sarah; Rempis, Eva; Schnack, Alexandra; Braun, Vera; Harms, Gundel; Theuring, Stefanie] Charite, Inst Trop Med & Int Hlth, Berlin, Germany; [Rubaihayo, John] Mt Moon Univ, Dept Publ Hlth, Ft Portal, Uganda; [Busingye, Priscilla] Holy Family Virika Hosp, Ft Portal, Uganda; [Tumwesigye, Nazarius Mbona] Makerere Univ, Sch Publ Hlth, Coll Hlth Sci, Kampala, Uganda	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Makerere University	Theuring, S (corresponding author), Charite, Inst Trop Med & Int Hlth, Berlin, Germany.	stefanie.theuring@charite.de	Rubaihayo, John/HDO-2747-2022	Tumwesigye, Nazarius Mbona/0000-0001-7085-8780; Rubaihayo, Prof. John/0000-0002-3421-2242	German Federal Ministry for Economic Cooperation and Development via the ESTHER programme; HW&J Hector Foundation Germany	German Federal Ministry for Economic Cooperation and Development via the ESTHER programme; HW&J Hector Foundation Germany	The study was funded by the German Federal Ministry for Economic Cooperation and Development via the ESTHER programme (Ensemble pour une Solidarite Therapeutique Hospitaliere En Reseau, http://health.bmz.de/what_we_do/Partnersriips-for-global-health/Hospital_partnerships_ESFHER_/index.htm), and by the HW&J Hector Foundation Germany (hilps://www.hector-stiflung.de/startseite/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BREASTFEEDING; [Anonymous], 2016, THAIL IS 1 COUNTR AS; Chinkonde JR, 2009, REPROD HEALTH MATTER, V17, P143, DOI 10.1016/S0968-8080(09)33440-0; Clouse K, 2014, JAIDS-J ACQ IMM DEF, V67, pE12, DOI 10.1097/QAI.0000000000000263; Clouse K, 2013, TROP MED INT HEALTH, V18, P451, DOI 10.1111/tmi.12072; Colvin CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108150; Ebuy H, 2015, INT J INFECT DIS, V33, P123, DOI 10.1016/j.ijid.2014.12.026; Fawzy A, 2011, J INFECT DIS, V203, P1222, DOI 10.1093/infdis/jir019; Finocchario-Kessler S, 2014, AIDS, V28, pS313, DOI 10.1097/QAD.0000000000000332; Geldsetzer P, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20679; Hodgson I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111421; Jamieson DJ, 2012, LANCET, V379, P2449, DOI 10.1016/S0140-6736(12)60321-3; Joint United Nations Programme for HIV/ AIDS (UNAIDS), 2014, THE GAP REP 2014; Jones SA, 2005, AIDS CARE, V17, P466, DOI 10.1080/09540120412331319723; Kieffer MP, 2011, JAIDS-J ACQ IMM DEF, V57, pE85, DOI 10.1097/QAI.0b013e31821acc6e; Kim MH, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.4.17389; Kirsten I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021020; Kuhn L, 2008, NEW ENGL J MED, V359, P130, DOI 10.1056/NEJMoa073788; Kurewa E N, 2011, Open AIDS J, V5, P51, DOI 10.2174/1874613601105010051; le Roux IM, 2013, AIDS, V27, P1461, DOI 10.1097/QAD.0b013e3283601b53; Levy JM, 2009, REPROD HEALTH MATTER, V17, P152, DOI 10.1016/S0968-8080(09)33436-9; Llenas-Garcia J, 2016, TROP MED INT HEALTH, V21, P1003, DOI 10.1111/tmi.12728; Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f; Nassali M, 2009, AIDS CARE, V21, P1124, DOI 10.1080/09540120802707467; Ngoma MS, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19352; Odeny TA, 2014, AIDS, V28, P2307, DOI 10.1097/QAD.0000000000000409; Okawa S, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0697-7; Okonji JA, 2012, JAIDS-J ACQ IMM DEF, V61, P249, DOI 10.1097/QAI.0b013e318262514f; Peltzer K, 2011, ACTA PAEDIATR, V100, P1253, DOI 10.1111/j.1651-2227.2011.02253.x; Psaros C, 2015, CURR HIV-AIDS REP, V12, P1, DOI 10.1007/s11904-014-0252-6; Schnack A, 2016, AIDS PATIENT CARE ST, V30, P110, DOI 10.1089/apc.2015.0318; Taha TE, 2011, CLIN INFECT DIS, V53, P388, DOI 10.1093/cid/cir413; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; The Republic of Uganda, 2014, HIV AIDS UG COUNTR P; UNAIDS, 2016, FAST TRACK UPD INV N; UNICEF, 2014, EXECUTIVE SUMMARY; World Health Organisation, 2010, PREV MOTH TO CHILD T; World Health Organization, 2013, CONGUID UANT DRU; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2010, GUID HIV INT FEED 20	40	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179448	10.1371/journal.pone.0179448	http://dx.doi.org/10.1371/journal.pone.0179448			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662036	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300021
J	Knopfel, T; Atanassoff, A; Hernando, N; Biber, J; Wagner, CA				Knoepfel, Thomas; Atanassoff, Alexander; Hernando, Nati; Biber, Juerg; Wagner, Carsten A.			Renal localization and regulation by dietary phosphate of the MCT14 orphan transporter	PLOS ONE			English	Article							THYROID-HORMONE TRANSPORTER; AMINO-ACID TRANSPORTER; VITAMIN-D METABOLISM; MONOCARBOXYLATE TRANSPORTER; P-I; MOUSE MODEL; FUNCTIONAL-CHARACTERIZATION; PROXIMAL TUBULE; GENE-EXPRESSION; RAT-KIDNEY	MCT14 is an orphan transporter belonging to the SLC16 transporter family mediating the transport of monocarboxylates, aromatic amino acids, creatine, and thyroid hormones. The expression, tissue localization, regulation, and function of MCT14 are unknown. In mouse MCT14 mRNA abundance is highest in kidney. Using a newly developed and validated antibody, MCT14 was localized to the luminal membrane of the thick ascending limb of the loop of Henle colocalizing in the same cells with uromodulin and NKCC2. MCT14 mRNA and protein was found to be highly regulated by dietary phosphate intake in mice being increased by high dietary phosphate intake at both mRNA and protein level. In order to identify the transport substrate(s), we expressed MCT14 in Xenopus laevis oocytes where MCT14 was integrated into the plasma membrane. However, no transport was discovered for the classic substrates of the SLC16 family nor for phosphate. In summary, MCT14 is an orphan transporter regulated by phosphate and highly enriched in kidney localizing to the luminal membrane of one specific nephron segment.	[Knoepfel, Thomas; Atanassoff, Alexander; Hernando, Nati; Biber, Juerg; Wagner, Carsten A.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Knoepfel, Thomas; Atanassoff, Alexander; Hernando, Nati; Biber, Juerg; Wagner, Carsten A.] NCCR Kidney CH, Zurich, Switzerland	University of Zurich	Wagner, CA (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.; Wagner, CA (corresponding author), NCCR Kidney CH, Zurich, Switzerland.	Wagnerca@access.uzh.ch		Knopfel, Thomas/0000-0002-8274-0736	National Center for Excellence in Research NCCR Kidney; Swiss National Science Foundation	National Center for Excellence in Research NCCR Kidney; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by the National Center for Excellence in Research NCCR Kidney. CH was financed by the Swiss National Science Foundation to JB and CAW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abplanalp J, 2013, HUM MOL GENET, V22, P3218, DOI 10.1093/hmg/ddt175; Ansermet C, 2016, J AM SOC NEPHROL; Becker HM, 2010, AM J PHYSIOL-RENAL, V299, pF141, DOI 10.1152/ajprenal.00488.2009; Bernascone I, 2010, HUM MOL GENET, V19, P2998, DOI 10.1093/hmg/ddq205; Biber J, 2004, AM J PHYSIOL-RENAL, V287, pF871, DOI 10.1152/ajprenal.00244.2004; Bourgeois S, 2013, PFLUG ARCH EUR J PHY, V465, P1557, DOI 10.1007/s00424-013-1298-9; Castorino JJ, 2011, TRAFFIC, V12, P483, DOI 10.1111/j.1600-0854.2010.01155.x; CUSTER M, 1994, AM J PHYSIOL, V266, pF767, DOI 10.1152/ajprenal.1994.266.5.F767; Dhayat N, 2016, J AM SOC NEPHROL, V27, P1426, DOI 10.1681/ASN.2015040411; Eladari D, 1999, J BIOL CHEM, V274, P28420, DOI 10.1074/jbc.274.40.28420; Friesema ECH, 2004, LANCET, V364, P1435, DOI 10.1016/S0140-6736(04)17226-7; Friesema ECH, 2003, J BIOL CHEM, V278, P40128, DOI 10.1074/jbc.M300909200; Giovannini D, 2013, CELL REP, V3, P1866, DOI 10.1016/j.celrep.2013.05.035; GREGER R, 1985, PHYSIOL REV, V65, P760, DOI 10.1152/physrev.1985.65.3.760; Halestrap AP, 2012, IUBMB LIFE, V64, P1, DOI 10.1002/iub.573; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Hattenhauer O, 1999, AM J PHYSIOL-GASTR L, V277, pG756, DOI 10.1152/ajpgi.1999.277.4.G756; Hu MC, 2013, ANNU REV PHYSIOL, V75, P503, DOI 10.1146/annurev-physiol-030212-183727; Kim DK, 2001, J BIOL CHEM, V276, P17221, DOI 10.1074/jbc.M009462200; Kirat D, 2013, CELL TISSUE RES, V352, P585, DOI 10.1007/s00441-013-1570-5; Kirat D, 2009, HISTOCHEM CELL BIOL, V132, P447, DOI 10.1007/s00418-009-0621-1; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; Loffing J, 2004, J AM SOC NEPHROL, V15, P2276, DOI 10.1097/01.ASN.0000138234.18569.63; Murakami Y, 2005, DRUG METAB DISPOS, V33, P1845, DOI 10.1124/dmd.105.005264; Murer H, 1999, AM J PHYSIOL-RENAL, V277, pF676, DOI 10.1152/ajprenal.1999.277.5.F676; Nowik M, 2008, PHYSIOL GENOMICS, V32, P322, DOI 10.1152/physiolgenomics.00160.2007; Park SY, 2005, ARCH PHARM RES, V28, P421, DOI 10.1007/BF02977671; Plotkin MD, 1996, KIDNEY INT, V50, P174, DOI 10.1038/ki.1996.300; Poole RC, 1996, BIOCHEM J, V320, P817, DOI 10.1042/bj3200817; Rampoldi L, 2011, KIDNEY INT, V80, P338, DOI 10.1038/ki.2011.134; Roshanbin S, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0274-7; Scanni R, 2014, J AM SOC NEPHROL, V25, P2730, DOI 10.1681/ASN.2013101076; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Suh PG, 2001, BIOCHEM BIOPH RES CO, V288, P1, DOI 10.1006/bbrc.2001.5710; Thomas L, 2016, J AM SOC NEPHROLOGY; Wagner CA, 2008, AM J PHYSIOL-RENAL, V294, pF1373, DOI 10.1152/ajprenal.00613.2007; Xie WS, 2000, BIOCHEM J, V352, P227, DOI 10.1042/0264-6021:3520227; Zhang MYH, 2002, ENDOCRINOLOGY, V143, P587, DOI 10.1210/en.143.2.587	39	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0177942	10.1371/journal.pone.0177942	http://dx.doi.org/10.1371/journal.pone.0177942			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662032	gold, Green Accepted, Green Published			2022-12-27	WOS:000404608300003
J	Bijleveld, E; Baalbergen, J				Bijleveld, Erik; Baalbergen, Joost			Prenatal exposure to testosterone (2D:4D) and social hierarchy together predict voice behavior in bankers	PLOS ONE			English	Article							DIGIT RATIO 2D4D; EMPLOYEE SILENCE; FINGER LENGTHS; 2ND; RESPONSES; 2D/4D; ASSOCIATIONS; METAANALYSIS; ANTECEDENTS; PERFORMANCE	Prohibitive voice behaviors are employees' expressions of concern about practices, incidents, or behaviors that may potentially harm the organization. In this study, we examined a potential biological correlate of prohibitive voice: prenatal exposure to testosterone. In a sample of bankers, we used 2D:4D (i.e., the ratio of the length of the index finger to the length of the ring finger) as a marker for prenatal exposure to testosterone (lower 2D:4D suggests higher prenatal exposure to testosterone). We used a self-report scale to measure prohibitive voice. For low-ranked employees, lower 2D:4D was related to using less voice. No such relation was found for high-ranked employees. Conclusions should be drawn with caution, because the findings only applied to voice regarding the organization as a whole (and not to voice regarding the own team), and because of methodological limitations. However, the findings are consistent with the ideas that (a) people low in 2D:4D tend to strive to attain and maintain social status and that (b) remaining silent about perceived problems in the organization is at least for low-ranked employees a means to achieve this goal.	[Bijleveld, Erik] Radboud Univ Nijmegen, Inst Behav Sci, Nijmegen, Netherlands; [Baalbergen, Joost] Univ Utrecht, Dept Psychol, Utrecht, Netherlands	Radboud University Nijmegen; Utrecht University	Bijleveld, E (corresponding author), Radboud Univ Nijmegen, Inst Behav Sci, Nijmegen, Netherlands.	e.bijleveld@psych.ru.nl			Netherlands Organisation for Scientific Research [016-165-100]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	During the analysis and writing stages of this paper, EB was supported by grant 016-165-100 from the Netherlands Organisation for Scientific Research (pmw.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; Anderson C, 2010, RES ORGAN BEHAV, V30, P55, DOI 10.1016/j.riob.2010.08.002; [Anonymous], 2013, THESIS COLUMBIA U NE; Apicella CL, 2008, EVOL HUM BEHAV, V29, P384, DOI 10.1016/j.evolhumbehav.2008.07.001; Apicella CL, 2015, ADAPT HUM BEHAV PHYS, V1, P358, DOI 10.1007/s40750-014-0020-2; Bang AK, 2005, HUM REPROD, V20, P3109, DOI 10.1093/humrep/dei170; Berenbaum SA, 2009, ENDOCRINOLOGY, V150, P5119, DOI 10.1210/en.2009-0774; Boksem MAS, 2013, PSYCHOL SCI, V24, P2306, DOI 10.1177/0956797613495063; BOOTH A, 1989, HORM BEHAV, V23, P556, DOI 10.1016/0018-506X(89)90042-1; Breedlove SM, 2010, ENDOCRINOLOGY, V151, P4116, DOI 10.1210/en.2010-0041; Brosnan M, 2011, PERS INDIV DIFFER, V51, P371, DOI 10.1016/j.paid.2010.07.009; Brown WM, 2002, HORM BEHAV, V42, P380, DOI 10.1006/hbeh.2002.1830; Buck JJ, 2003, HUM REPROD, V18, P976, DOI 10.1093/humrep/deg198; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Coates JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008036; Coates JM, 2009, P NATL ACAD SCI USA, V106, P623, DOI 10.1073/pnas.0810907106; Detert JR, 2007, ACAD MANAGE J, V50, P869; Fleming AS, 2002, HORM BEHAV, V42, P399, DOI 10.1006/hbeh.2002.1840; Galinsky AD, 2003, J PERS SOC PSYCHOL, V85, P453, DOI 10.1037/0022-3514.85.3.453; Garza P, 2011, PLOS ONE, V6; Hermans EJ, 2008, BIOL PSYCHIAT, V63, P263, DOI 10.1016/j.biopsych.2007.05.013; Honekopp J, 2010, AM J HUM BIOL, V22, P619, DOI 10.1002/ajhb.21054; Honekopp J, 2010, PERS INDIV DIFFER, V48, P4, DOI 10.1016/j.paid.2009.08.009; Howlett C, 2015, BEHAV ECOL SOCIOBIOL, V69, P61, DOI 10.1007/s00265-014-1817-5; LePine JA, 2001, J APPL PSYCHOL, V86, P326, DOI 10.1037//0021-9010.86.2.326; LePine JA, 1998, J APPL PSYCHOL, V83, P853, DOI 10.1037/0021-9010.83.6.853; Liang J, 2012, ACAD MANAGE J, V55, P71, DOI 10.5465/amj.2010.0176; Loi R, 2014, INT J HOSP MANAG, V36, P23, DOI 10.1016/j.ijhm.2013.08.001; Lutchmaya S, 2004, EARLY HUM DEV, V77, P23, DOI 10.1016/j.earlhumdev.2003.12.002; Manning JT, 2013, ANDROLOGY-US, V1, P94, DOI 10.1111/j.2047-2927.2012.00013.x; Millet K, 2006, BIOL PSYCHOL, V71, P111, DOI 10.1016/j.biopsycho.2005.06.001; Millet K, 2008, AM J HUM BIOL, V20, P110, DOI 10.1002/ajhb.20689; Millet K, 2007, PERS INDIV DIFFER, V43, P289, DOI 10.1016/j.paid.2006.11.024; Millet K, 2011, PERS INDIV DIFFER, V51, P397, DOI 10.1016/j.paid.2010.04.005; Milliken FJ, 2003, J MANAGE STUD, V40, P1453, DOI 10.1111/1467-6486.00387; Milliken FJ, 2003, J MANAGE STUD, V40, P1563, DOI 10.1111/1467-6486.00391; Morrison EW, 2011, ACAD MANAG ANN, V5, P373, DOI 10.1080/19416520.2011.574506; Munafo MR, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0021; Neyse L, 2016, SCI REP-UK, V6, DOI 10.1038/srep23294; Puts DA, 2015, HORM BEHAV, V70, P14, DOI 10.1016/j.yhbeh.2015.01.006; Ronay R, 2010, J BEHAV DECIS MAKING, V23, P473, DOI 10.1002/bdm.671; RUSBULT CE, 1988, ACAD MANAGE J, V31, P599, DOI 10.2307/256461; Ryan KD, 1998, DRIVING FEAR OUT WOR, V2nd; Ryckmans J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143307; Schonbrodt FD, 2013, J RES PERS, V47, P609, DOI 10.1016/j.jrp.2013.05.009; Simmons J. P., 2013, M SOC PERS SOC PSYCH; Stamper CL, 2001, J ORGAN BEHAV, V22, P517, DOI 10.1002/job.100; Stenstrom E, 2011, PERS INDIV DIFFER, V51, P412, DOI 10.1016/j.paid.2010.07.003; Tangirala S, 2008, PERS PSYCHOL, V61, P37, DOI 10.1111/j.1744-6570.2008.00105.x; Van den Bergh B, 2006, P ROY SOC LOND B BIO, P273; Van den Broeck A, 2010, J OCCUP ORGAN PSYCH, V83, P981, DOI 10.1348/096317909X481382; Van Dyne L, 2003, J MANAGE STUD, V40, P1359, DOI 10.1111/1467-6486.00384; Ventura T, 2013, EARLY HUM DEV, V89, P107, DOI 10.1016/j.earlhumdev.2012.08.009; Voracek M, 2009, PSICOTHEMA, V21, P382; Weber EU, 2002, J BEHAV DECIS MAKING, V15, P263, DOI 10.1002/bdm.414; Weis SE, 2007, PERS INDIV DIFFER, V43, P485, DOI 10.1016/j.paid.2006.12.017; WITHEY MJ, 1989, ADMIN SCI QUART, V34, P521, DOI 10.2307/2393565; Zethraeus N, 2009, P NATL ACAD SCI USA, V106, P6535, DOI 10.1073/pnas.0812757106; Zheng ZG, 2011, P NATL ACAD SCI USA, V108, P16289, DOI 10.1073/pnas.1108312108	59	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180008	10.1371/journal.pone.0180008	http://dx.doi.org/10.1371/journal.pone.0180008			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JT	28658299	Green Published, gold, Green Submitted			2022-12-27	WOS:000404607900052
J	Castellanos, N; Martinez, LC; Silva, EH; Teodoro, AV; Serrao, JE; Oliveira, EE				Castellanos, Nathaly; Martinez, Luis C.; Silva, Eder H.; Teodoro, Adenir V.; Serrao, Jose Eduardo; Oliveira, Eugenio E.			Ultrastructural analysis of salivary glands in a phytophagous stink bug revealed the presence of unexpected muscles	PLOS ONE			English	Article							DIGESTIVE ENZYMES; GROSS MORPHOLOGY; PREDATORY BUG; SOYBEAN SEED; HEMIPTERA; HETEROPTERA; PENTATOMIDAE; COCKROACH; AMYLASE; DAMAGE	The exceptional abilities of stink bugs (Hemiptera: Pentatomidae) to colonize a diverse group of plants have been attributed to the feeding behaviors and the functions of the salivary complex of these insects. Here, we describe the ultrastructure of the salivary glands of the Neotropical brown stink bug, Euschistus heros, which is a major component of the pentatomid pest complex on soybeans, Glycine max, in the neotropics. Our results revealed a salivary gland complex consisting of two lobes (i.e., anterior and posterior), with a constriction between them (i.e., the hilum), in which the salivary and accessory gland ducts are inserted. The principal gland epithelium has a single layer of cells lining an enlarged lumen filled with saliva, and these cells are cuboidal, rich in rough endoplasmic reticulum and secretory vesicles, with well-developed nuclei, all of which are typical features of protein-secreting cells. We report, for the first time in insects, the presence of a layer of muscle cells surrounding the columnar hilum epithelium. The accessory salivary gland cells are cuboidal with nuclei containing condensed chromatin and cytoplasm rich in vacuoles and rough endoplasmic reticulum, indicating the potential involvement of these glands in water transport/secretion. The lumen content of each lobe of the principal gland suggests that the lobes produce different compounds. Thus, our results suggest that the E. heros salivary complex might have unconventional mechanisms to mix/release saliva, which might help explain the polyphagous abilities of these insects.	[Castellanos, Nathaly; Silva, Eder H.; Oliveira, Eugenio E.] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil; [Martinez, Luis C.; Serrao, Jose Eduardo] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil; [Teodoro, Adenir V.] Embrapa Tabuleiros Costeiros, Av Beira Mar 3250, Aracaju, SE, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Oliveira, EE (corresponding author), Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil.	eugenio@ufv.br	de Oliveira, Eugenio Eduardo/ABE-8935-2021; Teodoro, Adenir/AAY-1190-2021; Martínez, Luis Carlos/H-4495-2013; de Oliveira, Eugênio Eduardo/F-4045-2016	de Oliveira, Eugenio Eduardo/0000-0003-1174-6564; Martínez, Luis Carlos/0000-0001-7741-2984; Castellanos, Nathaly/0000-0001-8713-5183	Coordenacao a de Aperfeicaoamento de Pessoal de Nivel Superior (CAPES Foundation); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Fundacao Arthur Bernardes (FUNARBE)	Coordenacao a de Aperfeicaoamento de Pessoal de Nivel Superior (CAPES Foundation); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao Arthur Bernardes (FUNARBE)	This work was supported by awards from the Coordenacao a de Aperfeicaoamento de Pessoal de Nivel Superior (CAPES Foundation), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) and Fundacao Arthur Bernardes (FUNARBE). The funders had no role in study design, data collection	AMMAR E, 1986, INT J INSECT MORPHOL, V15, P417, DOI 10.1016/0020-7322(86)90034-6; Azambuja R, 2013, NEOTROP ENTOMOL, V42, P359, DOI 10.1007/s13744-013-0132-6; Azevedo DD, 2007, BRAZ ARCH BIOL TECHN, V50, P469, DOI 10.1590/S1516-89132007000300013; Baptist BA, 1941, Q J MICROSC SCI, V83, P91; Baumann O., 2002, BMC PHYSIOL, V2, P1, DOI [10.1186/1472-6793-2-9, DOI 10.1186/1472-6793-2-9]; Borges M., 2006, METODOLOGIAS CRIACAO; Boyd DW, 2003, ANN ENTOMOL SOC AM, V96, P667, DOI 10.1603/0013-8746(2003)096[0667:DEASMO]2.0.CO;2; COHEN AC, 1995, ANNU REV ENTOMOL, V40, P85, DOI 10.1146/annurev.en.40.010195.000505; Cohen Allen Carson, 1998, American Entomologist, V44, P103; Cooper WR, 2010, ENVIRON ENTOMOL, V39, P223, DOI 10.1603/EN09079; Costa Lima A, 1942, ESCOLA NACL AGRONOMI, V2; De Castro AA, 2013, ANN ENTOMOL SOC AM, V106, P273, DOI 10.1603/AN12070; Depieri RA, 2011, NEOTROP ENTOMOL, V40, P197, DOI 10.1590/S1519-566X2011000200007; Kumar SM, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.1901; Martinez LC, 2015, MICROSC MICROANAL, V21, P1514, DOI 10.1017/S1431927615015469; Martinez LC, 2014, PROTOPLASMA, V251, P535, DOI 10.1007/s00709-013-0549-0; Miles P.W., 1972, Advances Insect Physiol, V9, P183, DOI 10.1016/S0065-2806(08)60277-5; MILES PW, 1976, EXPERIENTIA, V32, P1011, DOI 10.1007/BF01933942; MILES PW, 1964, J INSECT PHYSIOL, V10, P147, DOI 10.1016/0022-1910(64)90103-9; Moreno A, 2011, ENTOMOL EXP APPL, V139, P145, DOI 10.1111/j.1570-7458.2011.01117.x; Nodari EF, 2011, EXP PARASITOL, V128, P151, DOI 10.1016/j.exppara.2011.02.003; Nunes PH, 2006, MICRON, V37, P57, DOI 10.1016/j.micron.2005.06.005; Oliveira JA, 2006, B ENTOMOL RES, V96, P251, DOI 10.1079/BER2006420; Panizzi A.R., 2012, SOJA MANEJO INTEGRAD, P335; Peiffer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088483; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Roma Gislaine Cristina, 2003, Cytologia (Tokyo), V68, P101, DOI 10.1508/cytologia.68.101; Santos CA, 2005, SOCIOBIOLOGY, V46, P579; Serrao JE, 2008, J MED ENTOMOL, V45, P991, DOI 10.1603/0022-2585(2008)45[991:UOTSGI]2.0.CO;2; Silva CC, 2008, PESQUI AGROPECU BRAS, V43, P575, DOI 10.1590/S0100-204X2008000500004; Silva FAC, 2012, NEOTROP ENTOMOL, V41, P386, DOI 10.1007/s13744-012-0061-9; Silva FAC, 2011, NEOTROP ENTOMOL, V40, P35, DOI 10.1590/S1519-566X2011000100005; Smaniotto LF, 2015, FLA ENTOMOL, V98, P7, DOI 10.1653/024.098.0103; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; SUTHERLA.DJ, 1968, J INSECT PHYSIOL, V14, P21, DOI 10.1016/0022-1910(68)90130-3; TERRA WR, 1994, COMP BIOCHEM PHYS B, V109, P1, DOI 10.1016/0305-0491(94)90141-4; Torres JB, 2009, BRAZ ARCH BIOL TECHN, V52, P1199, DOI 10.1590/S1516-89132009000500018; Tuelher ES, 2016, COMPETITION PHYTOPHA; Vinokurov K, 2014, J INSECT PHYSIOL, V60, P58, DOI 10.1016/j.jinsphys.2013.11.005; WHITEHEAD AT, 1971, J MORPHOL, V135, P483, DOI 10.1002/jmor.1051350405; Zeng F, 2000, COMP BIOCHEM PHYS A, V126, P101, DOI 10.1016/S1095-6433(00)00193-8; Zhong HY, 2013, MICRON, V45, P83, DOI 10.1016/j.micron.2012.10.019	42	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179478	10.1371/journal.pone.0179478	http://dx.doi.org/10.1371/journal.pone.0179478			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658296	gold, Green Published, Green Submitted			2022-12-27	WOS:000404607900026
J	Chatterjee, S; Talaat, KR; van Seventer, EE; Feng, CG; Scott, AL; Jedlicka, A; Dziedzic, A; Nutman, TB				Chatterjee, Soumya; Talaat, Kawsar R.; van Seventer, Emily E.; Feng, Carl G.; Scott, Alan L.; Jedlicka, Anne; Dziedzic, Amanda; Nutman, Thomas B.			Mycobacteria induce TPL-2 mediated IL-10 in IL-4-generated alternatively activated macrophages	PLOS ONE			English	Article							IMMUNE-RESPONSE; TUBERCULOSIS INFECTION; WUCHERERIA-BANCROFTI; LYMPHATIC FILARIASIS; EFFECTOR FUNCTION; GENE-EXPRESSION; DENDRITIC CELLS; HUMAN MONOCYTES; PATHOGENS; LUNG	IL-4 drives expansion of Th2 cells that cause generation of alternatively activated macrophages (AAMs). Filarial infections are established early in life, induce increased IL-4 production are co-endemic with tuberculosis (TB). We sought to understand, therefore, how mycobacteria are handled in the context of IL-4-induced AAM. Comparing IL-4 generated in vitro monocyte derived human AAMs to LPS and IFN-gamma generated classically macrophages (CAMs), both infected with mycobacteria (BCG), we demonstrated increased early BCG uptake and increased IL-10 production in AAMs compared to CAMs. We further demonstrated that increased IL-10 production is mediated by upregulation of tumor progression locus 2 (TPL-2), an upstream activator of extracellular signal related kinases (ERKs) in AAMs but not in CAMs, both at the transcript as well as the protein level. Pharmacologic inhibition of TPL-2 significantly diminished IL-10 production only in BCG-infected AAMs. Finally, we validated our findings in an in vivo C57Bl/6 model of filarial infection, where an exaggerated Th2 induced lung-specific alternative activation led to TPL-2 and IL-10 upregulation on subsequent TB infection. These data show that in response to mycobacterial infection, IL-4 generated AAMs in chronic filarial infections have impaired immune responses to TB infection by increasing IL-10 production in a TPL-2 mediated manner.	[Chatterjee, Soumya; Talaat, Kawsar R.; van Seventer, Emily E.; Feng, Carl G.; Nutman, Thomas B.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Scott, Alan L.; Jedlicka, Anne; Dziedzic, Amanda] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Chatterjee, Soumya] St Louis Univ, Doisy Res Ctr, Div Infect Dis Allergy & Immunol, Dept Internal Med, St Louis, MO 63103 USA; [Talaat, Kawsar R.] Johns Hopkins Univ, Dept Int Hlth, Div Global Epidemiol & Control, Baltimore, MD USA; [Feng, Carl G.] Univ Sydney, Cent Clin Sch, Div Infect Dis & Immunol, Dept Med, Sydney, NSW, Australia	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Saint Louis University; Johns Hopkins University; University of Sydney	Chatterjee, S (corresponding author), NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.; Chatterjee, S (corresponding author), St Louis Univ, Doisy Res Ctr, Div Infect Dis Allergy & Immunol, Dept Internal Med, St Louis, MO 63103 USA.	chatterjees@slu.edu		Chatterjee, Soumya/0000-0003-3628-3738; feng, carl/0000-0003-4301-4640	Division of Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000197] Funding Source: NIH RePORTER	Division of Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported [in part] by the Division of Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AS, 2009, J IMMUNOL, V183, P718, DOI 10.4049/jimmunol.0801212; Antonelli LRV, 2010, J CLIN INVEST, V120, P1674, DOI 10.1172/JCI40817; Anuradha R, 2013, J IMMUNOL, V191, P2466, DOI 10.4049/jimmunol.1300911; Babu S, 2009, J INFECT DIS, V199, P1827, DOI 10.1086/599090; BARNES PF, 1993, INFECT IMMUN, V61, P3482, DOI 10.1128/IAI.61.8.3482-3489.1993; BLOOM BR, 1994, IMMUNOBIOLOGY, V191, P526, DOI 10.1016/S0171-2985(11)80459-6; Bonecini-Almeida MG, 1998, MEM I OSWALDO CRUZ, V93, P399, DOI 10.1590/S0074-02761998000300023; Boyd A, 2013, INFECT IMMUN, V81, P1420, DOI 10.1128/IAI.01301-12; Feng CG, 2005, J IMMUNOL, V174, P4185, DOI 10.4049/jimmunol.174.7.4185; Gavrin LK, 2005, BIOORG MED CHEM LETT, V15, P5288, DOI 10.1016/j.bmcl.2005.08.029; GAZZINELLI RT, 1992, J IMMUNOL, V148, P1792; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hamlin KL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001941; Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Kaiser F, 2009, J EXP MED, V206, P1863, DOI 10.1084/jem.20091059; Kang PB, 2005, J EXP MED, V202, P987, DOI 10.1084/jem.20051239; Katz MS, 2013, J PEDIATR SURG, V48, P345, DOI 10.1016/j.jpedsurg.2012.11.013; Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; McNab FW, 2013, J IMMUNOL, V191, P1732, DOI 10.4049/jimmunol.1300146; MIYOSHI J, 1991, MOL CELL BIOL, V11, P4088, DOI 10.1128/MCB.11.8.4088; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Nutman TB, 2001, PARASITE IMMUNOL, V23, P389, DOI 10.1046/j.1365-3024.2001.00399.x; O'Leary S., 2011, CELL MOL BIOL, V45, P172, DOI [10.1165/rcmb.2010-0319OC, DOI 10.1165/RCMB.2010-03190C]; Pesce J, 2006, J CLIN INVEST, V116, P2044, DOI 10.1172/JCI27727; Porthouse KH, 2006, INFECT IMMUN, V74, P2366, DOI 10.1128/IAI.74.4.2366-2372.2006; Potian JA, 2011, J EXP MED, V208, P1863, DOI 10.1084/jem.20091473; Rajaram MVS, 2010, J IMMUNOL, V185, P929, DOI 10.4049/jimmunol.1000866; Redford PS, 2010, EUR J IMMUNOL, V40, P2200, DOI 10.1002/eji.201040433; Redpath S, 2001, TRENDS MICROBIOL, V9, P86, DOI 10.1016/S0966-842X(00)01919-3; Reece JJ, 2006, INFECT IMMUN, V74, P4970, DOI 10.1128/IAI.00687-06; Rothfuchs AG, 2009, J IMMUNOL, V182, P6915, DOI 10.4049/jimmunol.0900074; Salgame P, 2013, NAT IMMUNOL, V14, P1118, DOI 10.1038/ni.2736; Schlesinger LS, 1996, J INVEST MED, V44, P312; SCHLESINGER LS, 1993, J IMMUNOL, V150, P2920; Semnani RT, 2006, INFECT IMMUN, V74, P4409, DOI 10.1128/IAI.01106-05; Semnani RT, 2011, INFECT IMMUN, V79, P3957, DOI 10.1128/IAI.05191-11; Semnani RT, 2011, INFECT IMMUN; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Staples KJ, 2007, J IMMUNOL, V178, P4779, DOI 10.4049/jimmunol.178.8.4779; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Stewart GR, 1999, CLIN EXP IMMUNOL, V117, P517; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; WHO, 2014, GLOB TUB REP 2014; Yoneda T, 1998, AM J RESP CRIT CARE, V158, P395, DOI 10.1164/ajrccm.158.2.9707102	51	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179701	10.1371/journal.pone.0179701	http://dx.doi.org/10.1371/journal.pone.0179701			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658262	Green Published, Green Submitted, gold			2022-12-27	WOS:000404607900038
J	Langbein, J				Langbein, Joerg			Firewood, smoke and respiratory diseases in developing countries-The neglected role of outdoor cooking	PLOS ONE			English	Article							INDOOR AIR-POLLUTION; SOLID-FUEL USE; PARTICULATE MATTER; BIOMASS FUELS; PNEUMONIA; BEHAVIOR; HEALTH; RISK; COMBUSTION; HOUSEHOLDS	Smoke from cooking in the kitchen is one of the world's leading causes of premature child death, claiming the lives of 500,000 children under five annually. This study analyses the role of outdoor cooking and the prevalence of respiratory diseases among children under five years by means of probit regressions using information from 41 surveys conducted in 30 developing countries from Asia, Africa and Latin America. I find that outdoor cooking reduces respiratory diseases among young children aged 0-4 by around 9 percent, an effect that reaches 13 percent among children aged 0-1. The results suggest that simple behavioral interventions, such as promoting outdoor cooking, can have a substantial impact on health hazards.	[Langbein, Joerg] RWI Leibniz Inst Econ Res, Hohenzollernstr 1-3, D-45128 Essen, Germany; [Langbein, Joerg] Ruhr Univ Bochum, Univ Str 150, D-44801 Bochum, Germany	RWI - Leibniz Institut fur Wirtschaftsforschung; Ruhr University Bochum	Langbein, J (corresponding author), RWI Leibniz Inst Econ Res, Hohenzollernstr 1-3, D-45128 Essen, Germany.; Langbein, J (corresponding author), Ruhr Univ Bochum, Univ Str 150, D-44801 Bochum, Germany.	joerg.langbein@rwi-essen.de			Ministerium fur Innovation,Wissenschaft und Forschung des landes Nordrhein-Westfalen; DFG Open Access Publication Funds of the Ruhr-Universitat Bochum	Ministerium fur Innovation,Wissenschaft und Forschung des landes Nordrhein-Westfalen; DFG Open Access Publication Funds of the Ruhr-Universitat Bochum	This research was under taken while I was part of the junior research group at RWI led by Prof. Dr. Jorg Peters.The group itself is parly financed by the Ministerium fur Innovation,Wissenschaft und Forschung des landes Nordrhein-Westfalen under the following programme : http://www.wissenschaft.nrw.de/forschung/foerderung/sonstigefoerderprogramme/foerderprogrammnachwuchsforschungsgruppennrw-2015-2021/. Further funding by the DFG Open Access Publication Funds of the Ruhr-Universitat Bochum is acknowledged.The funders had no role in study design,data collection and analysis, decision to publish,orpreparation of the manuscript.	Albalak R, 1999, THORAX, V54, P1004, DOI 10.1136/thx.54.11.1004; Amegah AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113920; Anenberg SC, 2013, ENVIRON SCI TECHNOL, V47, P3944, DOI 10.1021/es304942e; [Anonymous], 2014, BURD DIS JOINT EFF H; Balakrishnan K, 2002, ENVIRON HEALTH PERSP, V110, P1069, DOI 10.1289/ehp.021101069; Balakrishnan K, 2014, IND QUAL GUID HOUS F; Barnes B, 2015, J HEALTH COMMUN, V20, P3, DOI 10.1080/10810730.2014.996305; Barnes BR, 2014, INT J ENV RES PUB HE, V11, P4607, DOI 10.3390/ijerph110504607; Bensch G, 2015, J HEALTH ECON, V42, P44, DOI 10.1016/j.jhealeco.2015.03.006; Boadi KO, 2006, J BIOSOC SCI, V38, P403, DOI 10.1017/S0021932005026635; Brauer M, 2012, ENVIRON SCI TECHNOL, V46, P652, DOI 10.1021/es2025752; Bruce NG, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S8; Buchner H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128933; Dasgupta S, 2009, INDOOR AIR, V19, P22, DOI 10.1111/j.1600-0668.2008.00558.x; Dasgupta S, 2006, HEALTH POLICY PLANN, V21, P444, DOI 10.1093/heapol/czl027; Dasgupta S, 2015, J ENVIRON DEV, V24, P345, DOI 10.1177/1070496515588590; Dherani M, 2008, B WORLD HEALTH ORGAN, V86, P390, DOI 10.2471/BLT.07.044529; DHS Demographic and Health Survey, 2006, GUIDE DHS STAT DEMOG; ESMAP Energy Sector Management Assistance Program, 2015, STAT GLOB CLEAN IMPR; Ezzati M, 2002, ENVIRON HEALTH PERSP, V110, P1057, DOI 10.1289/ehp.021101057; Goodwin NJ, 2015, J HEALTH COMMUN, V20, P43, DOI 10.1080/10810730.2014.1002958; Haspil-Corgan TA, 2004, ANN EMERG MED, V44, pS37, DOI 10.1016/j.annemergmed.2004.07.121; Hosgood HD, 2010, ENVIRON HEALTH PERSP, V118, P1743, DOI 10.1289/ehp.1002217; Jin Y, 1982, SOC SCI MED, V62, p3161 ; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Martin WJ, 2011, SCIENCE, V334, P180, DOI 10.1126/science.1213088; McCracken JP, 2012, GLOB HEART, V7, P223, DOI 10.1016/j.gheart.2012.06.010; Moya J, 2004, PEDIATRICS, V113, P996; Nasir ZA, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024002; Pande JN, 1998, RESP MED TROPICS; Paynter S, 2013, EPIDEMIOL INFECT, V141, P1328, DOI 10.1017/S0950268812001379; Po JYT, 2011, THORAX, V66, P232, DOI 10.1136/thx.2010.147884; Rao S, 2012, ENVIRON MODEL ASSESS, V17, P613, DOI 10.1007/s10666-012-9317-3; Rehfuess EA, 2009, J EPIDEMIOL COMMUN H, V63, P887, DOI 10.1136/jech.2008.082685; Rosa G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091011; Ruth M, 2013, INT J SERVICE LEARNI, P151; SA Sy., 2022, ENERGY RES SOC SCI, V89; Smith KR, 2014, ANNU REV PUBL HEALTH, V35, P185, DOI 10.1146/annurev-publhealth-032013-182356; Smith KR, 2011, LANCET, V378, P1717, DOI 10.1016/S0140-6736(11)60921-5; Smith KR, 2000, THORAX, V55, P518, DOI 10.1136/thorax.55.6.518; Van Vliet EDS, 2013, ENVIRON RES, V127, P40, DOI 10.1016/j.envres.2013.08.009; WHO, 2014, IND AIR QUAL GUID HO; Yu F, 2011, ENVIRON RESOUR ECON, V50, P495, DOI 10.1007/s10640-011-9479-5	43	29	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0178631	10.1371/journal.pone.0178631	http://dx.doi.org/10.1371/journal.pone.0178631			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JT	28658290	gold, Green Published, Green Submitted			2022-12-27	WOS:000404607900007
J	Liu, HY; Han, Y; Chen, XS; Bai, L; Guo, SP; Li, L; Wu, P; Yin, YP				Liu, Hong-ye; Han, Yan; Chen, Xiang-sheng; Bai, Li; Guo, Shu-ping; Li, Li; Wu, Peng; Yin, Yue-ping			Comparison of efficacy of treatments for early syphilis: A systematic review and network meta-analysis of randomized controlled trials and observational studies	PLOS ONE			English	Review								Background Parenteral penicillin is the first-line regimen for treating syphilis, but unsuitable for some patients due to penicillin allergy and lacking health resources. Unfortunately, the efficacy of penicillin alternatives remains poorly understood. This study aimed to assess the efficacy of ceftriaxone and doxycycline/tetracycline in treating early syphilis relative to that of penicillin, and thereby to determine which antibiotic is a better replacement for penicillin. Method By searching literature from PubMed, Cochrane Central Register of Controlled Trials, Embase, the Web of Science, and ClinicalTrials. gov and systematically screening relevant studies, eligible randomized controlled trials (RCTs) and observational studies on treatments with penicillin, doxycycline/tetracycline, and ceftriaxone for early syphilis were identified and combined in this systematic review. Estimated risk ratios (RRs) and 95% confidence intervals (CIs) were utilized to compare their serological response and treatment failure rates. At 12-month follow up, serological response rates were compared by a direct meta-analysis and network meta-analysis (NMA), while treatment failure rates were compared with a direct meta-analysis. Result Three RCTs and seven cohort studies were included in this research. The results of NMA demonstrated that no significant differences existed in serological response rate at 12month follow-up between any two of the three treatments (doxycycline/tetracycline vs. penicillin RR = 1.01, 95% CI 0.89-1.14; ceftriaxone vs. penicillin RR = 1.00, 95% CI 0.89-1.13; ceftriaxone vs. doxycycline/tetracycline RR = 0.99, 95% CI 0.96-1.03), which was consistent with the outcomes of the direct meta-analysis. In addition, the direct meta-analysis indicated that, at 12-month follow-up, penicillin and ceftriaxone treatment groups had similar treatment failure rates (RR = 0.92, 95% CI 0.12-6.93), while treatment failure rate was significantly lower among penicillin recipients than among doxycycline/tetracycline recipients (RR = 0.58, 95% CI 0.38-0.89). Conclusion Ceftriaxone is as effective as penicillin in treating early syphilis with regard to serological response and treatment failure rate. Compared with doxycycline/tetracycline, ceftriaxone appears to be a better choice as the substitution of penicillin.	[Liu, Hong-ye; Han, Yan; Chen, Xiang-sheng; Yin, Yue-ping] Chinese Acad Med Sci, Peking Union Med Coll, Inst Dermatol,Chinese CDC, Reference STD Lab,Natl Ctr STD Control,Jiangsu Ke, Nanjing, Jiangsu, Peoples R China; [Liu, Hong-ye; Bai, Li; Guo, Shu-ping; Li, Li] Shanxi Med Univ, Affiliated Hosp 1, Dept Dermatol & Venereol, Taiyuan, Peoples R China; [Wu, Peng] Shanxi Med Univ, Sch Publ Hlth, Hlth Stat Teaching & Res Sect, Taiyuan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS; Peking Union Medical College; Shanxi Medical University; Shanxi Medical University	Yin, YP (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Dermatol,Chinese CDC, Reference STD Lab,Natl Ctr STD Control,Jiangsu Ke, Nanjing, Jiangsu, Peoples R China.	yinyp@ncstdlc.org			Scientific and technological innovation projects of medicine and health of Chinese Academy of Medical Sciences [2016-I2M-3-021]	Scientific and technological innovation projects of medicine and health of Chinese Academy of Medical Sciences	This work was supported by Scientific and technological innovation projects of medicine and health of Chinese Academy of Medical Sciences (2016-I2M-3-021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PLOS ONE; [Anonymous], COCHRANE DATABASE SY; [Anonymous], HIV MED; [Anonymous], BMJ; [Anonymous], N ENGL J MED; ARCILLA JD, 1974, CURR THER RES CLIN E, V16, P1126; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Chen XS, 2013, CLIN MICROBIOL INFEC, V19, P975, DOI 10.1111/1469-0691.12098; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Clement ME, 2014, JAMA-J AM MED ASSOC, V312, P1905, DOI 10.1001/jama.2014.13259; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Eaton Molly, 2009, Curr Infect Dis Rep, V11, P157, DOI 10.1007/s11908-009-0023-5; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ghanem KG, 2006, CLIN INFECT DIS, V42, pE45, DOI 10.1086/500406; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hook EW, 2010, J INFECT DIS, V201, P1729, DOI 10.1086/652239; Janier M, 2014, J EUR ACAD DERMATOL, V28, P1581, DOI 10.1111/jdv.12734; Karp G, 2009, EUR J INTERN MED, V20, P9, DOI 10.1016/j.ejim.2008.04.002; Kingston M, 2016, INT J STD AIDS, V27, P421, DOI 10.1177/0956462415624059; Li J, 2014, J INFECT DEV COUNTR, V8, P228, DOI 10.3855/jidc.3013; Liang Z, 2016, INT J ANTIMICROB AG, V47, P6, DOI 10.1016/j.ijantimicag.2015.10.020; Lukehart SA, 2004, NEW ENGL J MED, V351, P154, DOI 10.1056/NEJMoa040216; Merins V, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0175-8; MOORTHY TT, 1987, SEX TRANSM DIS, V14, P116, DOI 10.1097/00007435-198704000-00013; Psomas KC, 2012, MED MALADIES INFECT, V42, P15, DOI 10.1016/j.medmal.2011.10.003; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Riedner G, 2005, NEW ENGL J MED, V353, P1236, DOI 10.1056/NEJMoa044284; Robertson C, 2013, BJU INT, V112, P798, DOI 10.1111/bju.12247; SCHROETER AL, 1972, J AMER MED ASSOC, V221, P471, DOI 10.1001/jama.221.5.471; SCOFER H, 1989, CHEMOTHERAPY, V35, P140, DOI 10.1159/000238661; Spornraft-Ragaller P, 2011, EUR J MED RES, V16, P47, DOI 10.1186/2047-783X-16-2-47; Stamm LV, 2010, ANTIMICROB AGENTS CH, V54, P583, DOI 10.1128/AAC.01095-09; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stegeman BH, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5298; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Verde PE, 2015, RES SYNTH METHODS, V6, P45, DOI 10.1002/jrsm.1122; Whitehead A., 2002, METAANALYSIS CONTROL; Wong T, 2008, AM J MED, V121, P903, DOI 10.1016/j.amjmed.2008.04.042; Yates AB, 2008, AM J MED, V121, P572, DOI 10.1016/j.amjmed.2007.12.005; Zetola NM, 2007, MAYO CLIN PROC, V82, P1091, DOI 10.4065/82.9.1091	42	12	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180001	10.1371/journal.pone.0180001	http://dx.doi.org/10.1371/journal.pone.0180001			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658325	gold, Green Published, Green Submitted			2022-12-27	WOS:000404607900050
J	Myers, NM; Leung, IC; Mcgee, SW; Eggleson, K; Lieberman, M				Myers, Nicholas M.; Leung, Ivan C.; McGee, Sean W.; Eggleson, Kathleen; Lieberman, Marya			Green design of a paper test card for urinary iodine analysis	PLOS ONE			English	Article							SANDELL-KOLTHOFF REACTION; DEFICIENCY; CHILDREN; PHONES; IRON; IONS	When young children do not receive adequate amounts of the micronutrient iodine in their diet, their growth and cognitive development can be impaired. Nearly every country in the world has programs in place to track iodine intake and provide supplemental iodine if needed, usually in the form of fortified salt. The iodine nutrition status of a population can be tracked by monitoring iodine levels in urine samples to see if the median value falls in the range of 100-300 micrograms of iodine per liter of urine (mu g I/L), which indicates adequate or more than adequate iodine nutrition. Many low and middle-income countries (LMIC) do not have a laboratory capable of carrying out this challenging assay, so samples must be sent out for assay in external labs, which is expensive and time-consuming. In most LMIC, population iodine surveys are carried out every 5-10 years, which limits the utility of the data for program monitoring and evaluation. To solve this problem, we developed a field-friendly paper test card that uses the Sandell-Kolthoff reaction to measure urinary iodine levels. A blind internal validation study showed that 93% of samples (n = 60) of iodide in an artificial urine matrix were categorized correctly by visual analysis as deficient, adequate, or excessive for levels set forth by the World Health Organization. Quantitative measurements based on computer image analysis had an error of 40 +/- 20 mu g I/L (n = 35 for samples in the calibration range) and these results categorized 88% of the samples (n = 60) correctly. We employed lifecycle analysis principles to address the known toxicity of arsenic, which is an obligatory reagent in the Sandell-Kolthoff reaction. Disposal of the cards in a landfill (their most likely destination after use) could let arsenic leach into groundwater; toxicity characteristic leaching procedure (TCLP) tests showed that the level of arsenic leached from the cards was 28.78 ppm, which is above the United States Environmental Protection Agency's limit of 5 parts per million for solid waste. We integrated a remediation module into the card. This module contains oxone, to oxidize As(III) to As(V) oxyacids, and the iron oxide goethite. TCLP testing showed that the leachable amount of arsenic was reduced by at least 97.6% - from 28.8 ppm to lower than 0.7 +/- 0.7 ppm (n = 20). This upstream intervention rendered the test card suitable for landfilling while retaining its functionality to perform a critical public health evaluation.	[Myers, Nicholas M.; Leung, Ivan C.; Lieberman, Marya] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [McGee, Sean W.; Eggleson, Kathleen] Univ Notre Dame, Dept Elect Engn, Notre Dame, IN 46556 USA; [Leung, Ivan C.] Georgetown Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20007 USA; [Eggleson, Kathleen] Indiana Univ Sch Med, Dept Med, South Bend, IN 46615 USA; [Eggleson, Kathleen] Indiana Univ Sch Med, Dept Med & Mol Genet, South Bend, IN 46615 USA	University of Notre Dame; University of Notre Dame; Georgetown University; Indiana University System; Indiana University South Bend; Indiana University System; Indiana University South Bend	Lieberman, M (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.; Eggleson, K (corresponding author), Univ Notre Dame, Dept Elect Engn, Notre Dame, IN 46556 USA.; Eggleson, K (corresponding author), Indiana Univ Sch Med, Dept Med, South Bend, IN 46615 USA.; Eggleson, K (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, South Bend, IN 46615 USA.	keggleso@nd.edu; mlieberm@nd.edu	Lieberman, Marya/AAG-9542-2021	Myers, Nicholas/0000-0003-0270-2930; Lieberman, Marya/0000-0003-3968-8044	Global Alliance for Improved Nutrition; Notre Dame College of Science Undergraduate Research Fellowship; Serim Research Corporation; Center for Nano Science and Technology	Global Alliance for Improved Nutrition; Notre Dame College of Science Undergraduate Research Fellowship; Serim Research Corporation; Center for Nano Science and Technology	This work was supported by Global Alliance for Improved Nutrition (http://www.gainhealth.org/) (NMM); Notre Dame College of Science Undergraduate Research Fellowship (http://science.nd.edu/research/undergraduate-research/) (ICL); Serim Research Corporation (http://www.serim.com/) (ICL); and The Center for Nano Science and Technology (http://nano.nd.edu/) (SWM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aker JC, 2010, J ECON PERSPECT, V24, P207, DOI 10.1257/jep.24.3.207; Anastas P. T., 1998, GREEN CHEM THEORY PR; [Anonymous], 2007, ASS IOD DEF DIS MON; [Anonymous], 2015, GLOBAL IODINE NUTR S; [Anonymous], 2004, TOXICITY CHARACTERIS, P1; [Anonymous], 2016, EQUIP ROUND 43; Bourdoux P, 1988, IDD NEWSLETTER, V4, P8; Caulfield LE, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P551; Chaplan CA, 2014, ANAL METHODS-UK, V6, P1296, DOI 10.1039/c4ay00205a; Dixit S, 2003, ENVIRON SCI TECHNOL, V37, P4182, DOI 10.1021/es030309t; DUNN JT, 1993, THYROID, V3, P119, DOI 10.1089/thy.1993.3.119; Ferreira T., IMAGEJ USER GUIDE IJ; Giles DE, 2011, J ENVIRON MANAGE, V92, P3011, DOI 10.1016/j.jenvman.2011.07.018; Gnat D, 2003, CLIN CHEM, V49, P186, DOI 10.1373/49.1.186; Lee DK, 2011, PHYS CHEM CHEM PHYS, V13, P1239, DOI 10.1039/c003991h; Makhmudov AA., 2011, CHALLENGE IODINE DEF; Markou KB, 2002, THYROID, V12, P407, DOI 10.1089/105072502760043495; Martinez AW, 2008, ANAL CHEM, V80, P3699, DOI 10.1021/ac800112r; Martinez AW, 2007, ANGEW CHEM INT EDIT, V46, P1318, DOI 10.1002/anie.200603817; Martinez AW, 2010, ANAL CHEM, V82, P3, DOI 10.1021/ac9013989; Ohashi T, 2000, CLIN CHEM, V46, P529; Pino S, 1998, EXP CLIN ENDOCR DIAB, V106, pS22, DOI 10.1055/s-0029-1212041; Putman DF, 1971, COMPOSITION CONCENTR; Qian M, 2005, ASIA PAC J CLIN NUTR, V14, P32; Rendl J, 1998, J CLIN ENDOCR METAB, V83, P1007, DOI 10.1210/jc.83.3.1007; Sandell EB, 1934, J AM CHEM SOC, V56, P1426, DOI 10.1021/ja01321a510; Shen L, 2012, LAB CHIP, V12, P4240, DOI [10.1039/c2lc40741h, 10.1039/c2lc40741]; STOLC V, 1961, FRESEN Z ANAL CHEM, V183, P262, DOI 10.1007/BF00474698; Viera AJ, 2005, FAM MED, V37, P360; Yagoda H., 1937, IND ENG CHEM ANAL ED, V9, P79; Zimmermann MB, 2008, LANCET, V372, P1251, DOI 10.1016/S0140-6736(08)61005-3; Zimmermann MB, 2013, J CLIN ENDOCR METAB, V98, P1271, DOI 10.1210/jc.2012-3952	32	3	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179716	10.1371/journal.pone.0179716	http://dx.doi.org/10.1371/journal.pone.0179716			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658293	Green Submitted, gold, Green Published			2022-12-27	WOS:000404607900040
J	Fu, J; Liu, ZH; Li, ZT; Wang, YF; Yang, KJ				Fu, Jian; Liu, Zhihua; Li, Zuotong; Wang, Yufeng; Yang, Kejun			Alleviation of the effects of saline-alkaline stress on maize seedlings by regulation of active oxygen metabolism by Trichoderma asperellum	PLOS ONE			English	Article							IMPROVES SALT TOLERANCE; ANTIOXIDANT DEFENSE; LIPID-PEROXIDATION; HYDROGEN-PEROXIDE; CUCUMBER GROWTH; ZEA-MAYS; HARZIANUM; ACID; RESPONSES; ENZYMES	This study investigated the influence of Trichoderma asperellum on active oxygen production in maize seedlings under saline-alkaline stress conditions. Two maize cultivars were tested: 'Jiangyu 417' ('JY417'), which can tolerate saline-alkaline stress; and, 'Xianyu 335' ('XY335'), which is sensitive to saline-alkaline stress. The seedlings were grown on natural saline-alkaline soil (pH 9.30) in plastic pots. To each liter of saline-alkaline soil, 200 mL of T. asperellum spore suspension was applied; three fungal suspensions were used, namely, 1 x 10(3), 1 x 10(6), and 1 x 10(9) spores/L. A control with only the vehicle applied was also established, along with a second control in which untreated meadow soil (pH 8.23) was used. Root and leaf samples were collected when the seedlings had three heart-shaped leaves and the fourth was in the developmental phase. Physical and biochemical parameters related to oxidation resistance were assessed. The results indicated that the 'JY417' and 'XY335' seedlings showed different degrees of oxidative damage and differences in their antioxidant defense systems under saline-alkaline stress. As the spore density of the fungal suspension increased, the K+ and Ca2+ contents in the seedlings increased, but Na+ content decreased. Moreover, fungal treatment promoted the synthesis or accumulation of osmolytes, which enhanced the water absorbing capacity of the cells, increased antioxidant enzyme activities, enhanced the content of non-enzyme antioxidants, and reduced the accumulation of reactive oxygen species. Fungal treatment alleviated oxidative damage caused by the saline-alkaline stress in roots and leaves of the seedlings. The application of T. asperellum overcame the inhibitory effect of saline-alkaline soil stress on the growth of maize seedlings. In the present experiment, application with 1 x 10 9 spores/L gave the optimal results.	[Fu, Jian; Li, Zuotong; Wang, Yufeng; Yang, Kejun] Heilongjiang Bayi Agr Univ, Key Lab Crop Germplasm Improvement & Cultivat Col, Educ Dept, Coll Agron, Daqing, Peoples R China; [Liu, Zhihua] Northeast Forestry Univ, Sch Forestry, Harbin, Heilongjiang, Peoples R China	Heilongjiang Bayi Agricultural University; Northeast Forestry University - China	Yang, KJ (corresponding author), Heilongjiang Bayi Agr Univ, Key Lab Crop Germplasm Improvement & Cultivat Col, Educ Dept, Coll Agron, Daqing, Peoples R China.	byndykj@163.com			National science and technology support plan of China [2013BAD07B01]; Chinese National science and technology support plan [2015BAD23B05-04]; Heilongjiang Bayi Agricultural university graduate student innovation fund projects [YJSCX2016-Z01]	National science and technology support plan of China; Chinese National science and technology support plan; Heilongjiang Bayi Agricultural university graduate student innovation fund projects	This work was supported by grants from National science and technology support plan of China (2013BAD07B01); Chinese National science and technology support plan (2015BAD23B05-04); Heilongjiang Bayi Agricultural university graduate student innovation fund projects (YJSCX2016-Z01).; Our thanks go to the Forestry College of Northeast Forestry University "Trichoderma research team" for providing the "Dedicated trichoderma of maize. This work was supported by grants from the National Science and Technology Support Plan of China (2013BAD07B01); Chinese National Science and Technology Support Plan (2015BAD23B05-04); Heilongjiang Bayi Agricultural University graduate student innovation fund projects (YJSCX2016-Z01).	Abogadallah GM, 2010, PLANT SIGNAL BEHAV, V5, P369, DOI 10.4161/psb.5.4.10873; Aebi H, 1984, Methods Enzymol, V105, P121; Ahmad P, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00868; Akcin A, 2016, BRAZ J BOT, V39, P101, DOI 10.1007/s40415-015-0218-y; Contreras-Cornejo HA, 2009, PLANT PHYSIOL, V149, P1579, DOI 10.1104/pp.108.130369; Arora A, 2002, CURR SCI INDIA, V82, P1227; Azarmi R, 2011, AFR J BIOTECHNOL, V10, P5850; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brotman Y, 2013, PLOS PATHOG, V9, P14; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Ci DW, 2009, CHEMOSPHERE, V77, P1620, DOI 10.1016/j.chemosphere.2009.08.062; EGLEY GH, 1983, PLANTA, V157, P224, DOI 10.1007/BF00405186; ELSTNER EF, 1976, ANAL BIOCHEM, V70, P616, DOI 10.1016/0003-2697(76)90488-7; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Guler NS, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-016-2153-3; Hashem A, 2014, J PLANT INTERACT, V9, P857, DOI 10.1080/17429145.2014.983568; Hermosa R, 2011, J PLANT PHYSIOL, V168, P1295, DOI 10.1016/j.jplph.2011.01.027; Hernandez JA, 2000, PLANT CELL ENVIRON, V23, P853, DOI 10.1046/j.1365-3040.2000.00602.x; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; KAMPFENKEL K, 1995, ANAL BIOCHEM, V225, P165, DOI 10.1006/abio.1995.1127; Kim SY, 2005, J BIOCHEM MOL BIOL, V38, P218; Kim Y, 2004, PLANT GROWTH REGUL, V44, P87, DOI 10.1007/s10725-004-2746-5; Kumar K, 2017, J BASIC MICROB, V57, P141, DOI 10.1002/jobm.201600369; Li J, 2012, PLANT PHYSIOL, V159, P1771, DOI 10.1104/pp.112.195370; Mastouri F, 2012, MOL PLANT MICROBE IN, V25, P1264, DOI 10.1094/MPMI-09-11-0240; Mastouri F, 2010, PHYTOPATHOLOGY, V100, P1213, DOI 10.1094/PHYTO-03-10-0091; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Neto ADD, 2006, ENVIRON EXP BOT, V56, P87, DOI 10.1016/j.envexpbot.2005.01.008; Pandey V, 2016, PLANTA, V243, P1251, DOI 10.1007/s00425-016-2482-x; Petrov VD, 2012, AOB PLANTS, V10, P4; Qi WZ, 2013, J BASIC MICROB, V53, P355, DOI 10.1002/jobm.201200031; Rawat L, 2011, PLANT SOIL, V347, P387, DOI 10.1007/s11104-011-0858-z; SCHAEDLE M, 1977, PLANT PHYSIOL, V59, P1011, DOI 10.1104/pp.59.5.1011; Sekmen AH, 2012, ENVIRON EXP BOT, V77, P63, DOI 10.1016/j.envexpbot.2011.10.012; Shoresh M, 2008, PLANT PHYSIOL, V147, P2147, DOI 10.1104/pp.108.123810; Singh HB, 2010, BIORESOURCE TECHNOL, V101, P6444, DOI 10.1016/j.biortech.2010.03.057; Singh PK, 2013, PHYSIOL MOL BIOL PLA, V19, P53, DOI 10.1007/s12298-012-0126-6; Sohrabi Y, 2012, SYMBIOSIS, V56, P5, DOI 10.1007/s13199-012-0152-8; Stepien P, 2005, PHYSIOL PLANTARUM, V125, P31, DOI 10.1111/j.1399-3054.2005.00534.x; Suzuki N, 2012, PLANT CELL ENVIRON, V35, P259, DOI 10.1111/j.1365-3040.2011.02336.x; Velikova V, 2000, PLANT SCI, V151, P59, DOI 10.1016/S0168-9452(99)00197-1; Viterbo A, 2010, FEMS MICROBIOL LETT, V305, P42, DOI 10.1111/j.1574-6968.2010.01910.x; Wang WB, 2009, PLANT PHYSIOL BIOCH, V47, P570, DOI 10.1016/j.plaphy.2009.02.009; Wang XP, 2011, SCI HORTIC-AMSTERDAM, V130, P248, DOI 10.1016/j.scienta.2011.07.006; Willekens H, 1997, EMBO J, V16, P4806, DOI 10.1093/emboj/16.16.4806; Xu LH, 2014, BIOL PLANTARUM, V58, P751, DOI 10.1007/s10535-014-0442-5; Yin LN, 2013, ACTA PHYSIOL PLANT, V35, P3099, DOI 10.1007/s11738-013-1343-5; ZARCINAS BA, 1987, COMMUN SOIL SCI PLAN, V18, P131, DOI 10.1080/00103628709367806; Zhang FG, 2013, PLANT SOIL, V368, P433, DOI 10.1007/s11104-012-1519-6; Zhang S, 2016, FRONTIERS PLANT SCI, V7; Zhang X, 2011, PLANT MOL BIOL, V75, P365, DOI 10.1007/s11103-011-9732-x	54	34	35	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179617	10.1371/journal.pone.0179617	http://dx.doi.org/10.1371/journal.pone.0179617			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654652	Green Submitted, gold, Green Published			2022-12-27	WOS:000404541500021
J	Zhao, MZ; Wang, TL; Wu, P; Guo, WY; Su, LT; Wang, Y; Liu, YJ; Yan, F; Wang, QY				Zhao, Mingzhu; Wang, Tianliang; Wu, Ping; Guo, Wenyun; Su, Liantai; Wang, Ying; Liu, Yajing; Yan, Fan; Wang, Qingyu			Isolation and characterization of GmMYBJ3, an R2R3-MYB transcription factor that affects isoflavonoids biosynthesis in soybean	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; GENE-EXPRESSION; SYNTHASE; DROUGHT; FAMILY; PLANTS	Isoflavonoids are secondary metabolites that play a variety of roles in plant-microbe interactions and plant defenses against abiotic stresses. Here we report a new MYB transcription factor (TF) gene, GmMYBJ3, that is involved in the isoflavonoids biosynthesis. The GmMYBJ3 gene is 1,002 bp long and encodes a protein of 333 amino acids. Amino acid sequence analysis showed that GmMYBJ3 is a typical R2R3 MYB TF. Yeast expression experiment demonstrated that GmMYBJ3 has its transcription activity in the nucleus and is transiently expressed in onion epidermal cells. The GmMYBJ3 gene was transformed into soybean and the expression activity of the GmMYBJ3 gene was significantly positively correlated with total isoflavonoid accumulation in soybean. Transient expression assays indicated that GmMYBJ3 can activate CHS8 expression. Furthermore, we analyzed the expressions of several genes known involved in the isoflavonoid biosynthesis, including CHS8, CHI1A, PAL1, IFS2 and F3H, in the GmMYBJ3 transgenic plants. The results showed that the expression levels of CHS8 and CHI1A were significantly increased in the transgenic plants compared to wild-type plants, but those of PAL1, IFS2 and F3H remained similar between the transgenic and wild-type plants. These results suggest that GmMYBJ3 participates in the isoflavonoid biosynthesis through regulation of CHS8 and CHI1A in soybean.	[Zhao, Mingzhu; Wang, Tianliang; Wu, Ping; Guo, Wenyun; Su, Liantai; Wang, Ying; Liu, Yajing; Yan, Fan; Wang, Qingyu] Jilin Univ, Coll Plant Sci, Jilin Key Lab Crop Genet Engn, Changchun, Jilin, Peoples R China	Jilin University	Wang, QY (corresponding author), Jilin Univ, Coll Plant Sci, Jilin Key Lab Crop Genet Engn, Changchun, Jilin, Peoples R China.	qywang@jlu.edu.cn			National Natural Science Foundation of China [31671714]; Major Science and Technology Sponsored Program for Transgenic Biological Breeding [2014ZX08004-003, 016ZX08004-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science and Technology Sponsored Program for Transgenic Biological Breeding	This work was supported by the National Natural Science Foundation of China (No.31671714) and the Major Science and Technology Sponsored Program for Transgenic Biological Breeding (No. 2014ZX08004-003, No. (016ZX08004-003).	Aoki T, 2000, J PLANT RES, V113, P475, DOI 10.1007/PL00013958; Bommert P, 2013, NAT GENET, V45, P334, DOI 10.1038/ng.2534; Caldwell CR, 2005, J AGR FOOD CHEM, V53, P1125, DOI 10.1021/jf0355351; Cominelli E, 2005, CURR BIOL, V15, P1196, DOI 10.1016/j.cub.2005.05.048; Dastmalchi M, 2015, PLANTA, V241, P507, DOI 10.1007/s00425-014-2200-5; Dhaubhadel S, 2007, PLANT PHYSIOL, V143, P326, DOI 10.1104/pp.106.086306; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Endt DV, 2002, PHYTOCHEMISTRY, V61, P107, DOI 10.1016/S0031-9422(02)00185-1; Ferguson BJ, 2003, J PLANT GROWTH REGUL, V22, P47, DOI 10.1007/s00344-003-0032-9; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gomez-Maldonado J, 2004, PLANT J, V39, P513, DOI 10.1111/j.1365-313X.2004.02153.x; Grotewold E, 1998, PLANT CELL, V10, P721, DOI 10.1105/tpc.10.5.721; Gutierrez-Gonzalez JJ, 2011, THEOR APPL GENET, V123, P1375, DOI 10.1007/s00122-011-1673-x; Gutierrez-Gonzalez JJ, 2010, PLANT CELL PHYSIOL, V51, P936, DOI 10.1093/pcp/pcq065; HAHLBROCK K, 1989, ANNU REV PLANT PHYS, V40, P347, DOI 10.1146/annurev.pp.40.060189.002023; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Jung W, 2000, NAT BIOTECHNOL, V18, P208, DOI 10.1038/72671; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kassem MA, 2004, J BIOMED BIOTECHNOL, P52, DOI 10.1155/S1110724304304018; KOES RE, 1989, GENE, V81, P245, DOI 10.1016/0378-1119(89)90185-6; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Li XW, 2013, GENE, V532, P72, DOI 10.1016/j.gene.2013.09.015; Liu XQ, 2013, PLANT BIOTECHNOL REP, V7, P445, DOI 10.1007/s11816-013-0283-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marles MAS, 2003, PHYTOCHEMISTRY, V64, P367, DOI 10.1016/S0031-9422(03)00377-7; Mehrtens F, 2005, PLANT PHYSIOL, V138, P1083, DOI 10.1104/pp.104.058032; Mellway RD, 2009, PLANT PHYSIOL, V150, P924, DOI 10.1104/pp.109.139071; Messina MJ, 1999, AM J CLIN NUTR, V70, p439S, DOI 10.1093/ajcn/70.3.439s; Park JS, 2008, PLANT CELL REP, V27, P985, DOI 10.1007/s00299-008-0521-1; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108; Primomo VS, 2005, CROP SCI, V45, P2454, DOI 10.2135/cropsci2004.0672; Pueppke SG, 1996, CRIT REV BIOTECHNOL, V16, P1, DOI 10.3109/07388559609146599; Rochfort S, 2007, J AGR FOOD CHEM, V55, P7981, DOI 10.1021/jf071704w; Shelton D, 2012, PLANT PHYSIOL, V159, P531, DOI 10.1104/pp.112.194753; SHIRLEY BW, 1995, PLANT J, V8, P659, DOI 10.1046/j.1365-313X.1995.08050659.x; Smallwood C.J, 2012, DETECTION QUANTITATI; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Stracke R, 2007, PLANT J, V50, P660, DOI 10.1111/j.1365-313X.2007.03078.x; Su LT, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1889-5; Todd JJ, 1996, PLANT CELL, V8, P687, DOI 10.1105/tpc.8.4.687; Tuteja JH, 2008, CROP SCI, V48, pS49, DOI 10.2135/cropsci2007.10.0542tpg; Vadivel AKA, 2016, PHYTOCHEM REV, V15, P391, DOI 10.1007/s11101-015-9431-3; Weisshaar B, 1998, CURR OPIN PLANT BIOL, V1, P251, DOI 10.1016/S1369-5266(98)80113-1; Weston K, 1998, CURR OPIN GENET DEV, V8, P76, DOI 10.1016/S0959-437X(98)80065-8; Yang YN, 2000, PLANT J, V22, P543, DOI 10.1046/j.1365-313x.2000.00760.x; Yi JX, 2010, PLANT J, V62, P1019, DOI 10.1111/j.1365-313X.2010.04214.x; Yi JX, 2010, PLANTA, V231, P741, DOI 10.1007/s00425-009-1079-z; Yu O, 2003, PHYTOCHEMISTRY, V63, P753, DOI 10.1016/S0031-9422(03)00345-5; Zeng GL, 2009, THEOR APPL GENET, V118, P1455, DOI 10.1007/s00122-009-0994-5	51	14	16	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179990	10.1371/journal.pone.0179990	http://dx.doi.org/10.1371/journal.pone.0179990			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654660	Green Published, gold, Green Submitted			2022-12-27	WOS:000404541500047
J	Fernandez-Tendero, E; Day, A; Legros, S; Habrant, A; Hawkins, S; Chabbert, B				Fernandez-Tendero, Eva; Day, Arnaud; Legros, Sandrine; Habrant, Anouck; Hawkins, Simon; Chabbert, Brigitte			Changes in hemp secondary fiber production related to technical fiber variability revealed by light microscopy and attenuated total reflectance Fourier transform infrared spectroscopy	PLOS ONE			English	Article							CANNABIS-SATIVA L.; FT-IR SPECTROSCOPY; MECHANICAL-PROPERTIES; CHEMICAL-COMPOSITION; INDUSTRIAL HEMP; HARVEST TIME; BAST FIBERS; CELL-WALL; QUALITY; YIELD	Interest in hemp (Cannabis sativa L.) is increasing due to the development of a new range of industrial applications based on bast fibers. However the variability of bast fiber yield and quality represents an important barrier to further exploitation. Primary and secondary fiber content was examined in two commercial hemp varieties (Fedora 17, Santhica 27) grown under contrasted sowing density and irrigation conditions. Both growing conditions and hemp varieties impact stem tissue architecture with a large effect on the proportion of secondary fibers but not primary fibers. Attenuated total reflectance infrared spectroscopy allowed the discrimination of manually-isolated native primary fibers and secondary fibers but did not reveal any clustering according to growing conditions and variety. Infrared data were confirmed by wet chemistry analyses that revealed slight but significant differences between primary and secondary fiber cell wall composition. Infrared spectroscopy of technical fibers obtained after mechanical defibering revealed differences with native primary, but not secondary fibers and also discriminated samples obtained from plants grown under different conditions. Altogether the results suggested that the observed variability of hemp technical fibers could be partially explained by i) differences in secondary fiber production and ii) differential behavior during mechanical defibering resulting in unequal separation of primary and secondary fibers.	[Fernandez-Tendero, Eva; Habrant, Anouck; Chabbert, Brigitte] Univ Reims, INRA, FARE Lab, Reims, France; [Fernandez-Tendero, Eva; Day, Arnaud; Hawkins, Simon] Univ Lille, CNRS, UGSF, UMR 8576, Lille, France; [Fernandez-Tendero, Eva; Day, Arnaud] Fibres Rech Dev, Troyes, France; [Legros, Sandrine] Terres Inovia, Troyes, France	INRAE; Universite de Reims Champagne-Ardenne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Chabbert, B (corresponding author), Univ Reims, INRA, FARE Lab, Reims, France.	brigitte.chabbert@inra.fr	Chabbert, Brigitte/Q-8746-2019; chabbert, brigitte/A-3438-2009	Chabbert, Brigitte/0000-0001-9887-3122; chabbert, brigitte/0000-0001-9887-3122	Champagne-Ardenne Region; Nord - Pas de Calais Region; European Union (FEDER funds); French Association for Research and Technology; Troyes Champagne Metropole	Champagne-Ardenne Region(Region Grand-Est); Nord - Pas de Calais Region(Region Hauts-de-FranceEuropean Commission); European Union (FEDER funds)(European Commission); French Association for Research and Technology; Troyes Champagne Metropole	This work was performed in the frame of the project MAPROFI (MAitrise des PROprietes des fibres de chanvre (fibre / chenevotte), dans le cadre de valorisations en agro-composites base polymere) funded by the Champagne-Ardenne and Nord - Pas de Calais Regions, the European Union (FEDER funds), the French Association for Research and Technology, and Troyes Champagne Metropole.	Abidi N, 2014, CARBOHYD POLYM, V100, P9, DOI 10.1016/j.carbpol.2013.01.074; Abot A, 2013, J COMPOS MATER, V47, P1067, DOI 10.1177/0021998313477669; Akerholm M, 2001, POLYMER, V42, P963, DOI 10.1016/S0032-3861(00)00434-1; Amaducci S, 2000, IND CROP PROD, V11, P179, DOI 10.1016/S0926-6690(99)00063-1; Amaducci S, 2008, FIELD CROP RES, V107, P161, DOI 10.1016/j.fcr.2008.02.002; Arend M, 2007, TREE PHYSIOL, V27, P985, DOI 10.1093/treephys/27.7.985; Beaugrand J, 2004, CARBOHYD RES, V339, P2529, DOI 10.1016/j.carres.2004.08.012; Berta M, 2009, J PLANT PHYSIOL, V166, P521, DOI 10.1016/j.jplph.2008.08.005; Blake AW, 2008, PLANTA, V228, P1, DOI 10.1007/s00425-008-0713-5; Bonatti PM, 2004, EUPHYTICA, V140, P55, DOI 10.1007/s10681-004-4755-x; Cronier D, 2005, J AGR FOOD CHEM, V53, P8279, DOI 10.1021/jf051253k; Dai DS, 2011, VIB SPECTROSC, V55, P300, DOI 10.1016/j.vibspec.2010.12.009; FAIX O, 1991, HOLZFORSCHUNG, V45, P21, DOI 10.1515/hfsg.1991.45.s1.21; Faruk O, 2012, PROG POLYM SCI, V37, P1552, DOI 10.1016/j.progpolymsci.2012.04.003; Gorshkova T, 2012, CRIT REV PLANT SCI, V31, P201, DOI 10.1080/07352689.2011.616096; Hanninen T, 2012, IND CROP PROD, V39, P7, DOI 10.1016/j.indcrop.2012.01.025; Hoppner F., 1995, Journal of the International Hemp Association, V2, P18; IIYAMA K, 1990, J SCI FOOD AGR, V51, P145, DOI 10.1002/jsfa.2740510202; Islam MS, 2010, J POLYM ENVIRON, V18, P696, DOI 10.1007/s10924-010-0225-9; Joshi CP, 2004, NEW PHYTOL, V164, P53, DOI 10.1111/j.1469-8137.2004.01155.x; Kabir MM, 2012, COMPOS PART B-ENG, V43, P159, DOI 10.1016/j.compositesb.2011.06.003; Kostic MM, 2010, IND CROP PROD, V32, P169, DOI 10.1016/j.indcrop.2010.04.014; Le Troedec M, 2008, COMPOS PART A-APPL S, V39, P514, DOI 10.1016/j.compositesa.2007.12.001; Liu M, 2015, IND CROP PROD, V76, P880, DOI 10.1016/j.indcrop.2015.07.046; Liu M, 2015, IND CROP PROD, V69, P29, DOI 10.1016/j.indcrop.2015.02.010; Lupoi JS, 2014, BIOENERG RES, V7, P1, DOI 10.1007/s12155-013-9352-1; Mediavilla V., 1999, Agrarforschung, V6, P393; Mediavilla V, 2001, IND CROP PROD, V13, P49, DOI 10.1016/S0926-6690(00)00052-2; Ouajai S, 2005, MACROMOL BIOSCI, V5, P124, DOI 10.1002/mabi.200400151; Pickering KL, 2007, J BIOBASED MATER BIO, V1, P109, DOI 10.1166/jbmb.2007.012; Placet V, 2014, J MATER SCI, V49, P8317, DOI 10.1007/s10853-014-8540-5; Ranalli P, 2004, EUPHYTICA, V140, P121, DOI 10.1007/s10681-004-4760-0; Sankari HS, 2000, IND CROP PROD, V11, P73, DOI 10.1016/S0926-6690(99)00038-2; Santos JDG, 2013, CARBOHYD POLYM, V92, P1997, DOI 10.1016/j.carbpol.2012.11.089; Schafer TA, 2006, IND CROP PROD, V23, P88, DOI 10.1016/j.indcrop.2005.04.003; Schwanninger M, 2004, VIB SPECTROSC, V36, P23, DOI 10.1016/j.vibspec.2004.02.003; Thygesen LG, 2011, J MATER SCI, V46, P2135, DOI 10.1007/s10853-010-5049-4; Westerhuis W, 2009, ANN APPL BIOL, V155, P225, DOI 10.1111/j.1744-7348.2009.00334.x	38	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179794	10.1371/journal.pone.0179794	http://dx.doi.org/10.1371/journal.pone.0179794			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640922	Green Published, gold, Green Submitted			2022-12-27	WOS:000404135800066
J	Furui, A; Hayashi, H; Nakamura, G; Chin, T; Tsuji, T				Furui, Akira; Hayashi, Hideaki; Nakamura, Go; Chin, Takaaki; Tsuji, Toshio			An artificial EMG generation model based on signal-dependent noise and related application to motion classification	PLOS ONE			English	Article							MYOELECTRIC SIGNAL; OPTIMAL MYOPROCESSOR; VOLUME CONDUCTOR; ELECTROMYOGRAPHY; CONTRACTIONS; MUSCLES	This paper proposes an artificial electromyogram (EMG) signal generation model based on signal-dependent noise, which has been ignored in existing methods, by introducing the stochastic construction of the EMG signals. In the proposed model, an EMG signal variance value is first generated from a probability distribution with a shape determined by a commanded muscle force and signal-dependent noise. Artificial EMG signals are then generated from the associated Gaussian distribution with a zero mean and the generated variance. This facilitates representation of artificial EMG signals with signal-dependent noise superimposed according to the muscle activation levels. The frequency characteristics of the EMG signals are also simulated via a shaping filter with parameters determined by an autoregressive model. An estimation method to determine EMG variance distribution using rectified and smoothed EMG signals, thereby allowing model parameter estimation with a small number of samples, is also incorporated in the proposed model. Moreover, the prediction of variance distribution with strong muscle contraction from EMG signals with low muscle contraction and related artificial EMG generation are also described. The results of experiments conducted, in which the reproduction capability of the proposed model was evaluated through comparison with measured EMG signals in terms of amplitude, frequency content, and EMG distribution demonstrate that the proposed model can reproduce the features of measured EMG signals. Further, utilizing the generated EMG signals as training data for a neural network resulted in the classification of upper limb motion with a higher precision than by learning from only measured EMG signals. This indicates that the proposed model is also applicable to motion classification.	[Furui, Akira] Hiroshima Univ, Grad Sch Engn, Dept Syst Cybernet, Higashihiroshima, Japan; [Hayashi, Hideaki; Tsuji, Toshio] Hiroshima Univ, Inst Engn, Dept Syst Cybernet, Higashihiroshima, Japan; [Nakamura, Go] Hyogo Rehabil Ctr, Robot Rehabil Ctr, Kobe, Hyogo, Japan; [Chin, Takaaki] Hyogo Rehabil Ctr Hosp, Dept Orthoped Surgeon, Kobe, Hyogo, Japan	Hiroshima University; Hiroshima University	Furui, A (corresponding author), Hiroshima Univ, Grad Sch Engn, Dept Syst Cybernet, Higashihiroshima, Japan.; Tsuji, T (corresponding author), Hiroshima Univ, Inst Engn, Dept Syst Cybernet, Higashihiroshima, Japan.	furui@bsys.hiroshima-u.ac.jp; tsuji@bsys.hiroshima-u.ac.jp	Furui, Akira/AAA-1127-2019; Tsuji, Toshio/D-6210-2011	Furui, Akira/0000-0003-1554-6607; Tsuji, Toshio/0000-0002-7689-3963; Hayashi, Hideaki/0000-0002-4800-1761				Bilodeau M, 1997, J ELECTROMYOGR KINES, V7, P87, DOI 10.1016/S1050-6411(96)00024-7; Blok JH, 2002, ANN BIOMED ENG, V30, P566, DOI 10.1114/1.1475345; BOX GEP, 1958, ANN MATH STAT, V29, P610, DOI 10.1214/aoms/1177706645; Burg J., 1967, 37 ANN INT MEET; Clancy EA, 2001, IEEE ENG MED BIOL, V20, P47, DOI 10.1109/51.982275; DE LUCA CJ, 1979, IEEE T BIO-MED ENG, V26, P313, DOI 10.1109/TBME.1979.326534; Farina D, 2004, IEEE T BIO-MED ENG, V51, P415, DOI 10.1109/TBME.2003.820998; Fukuda O, 2003, IEEE T ROBOTIC AUTOM, V19, P210, DOI 10.1109/TRA.2003.808873; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hayashi H, 2017, IEEE TRANS BIOMED EN; HOGAN N, 1980, IEEE T BIO-MED ENG, V27, P396, DOI 10.1109/TBME.1980.326653; HOGAN N, 1980, IEEE T BIO-MED ENG, V27, P382, DOI 10.1109/TBME.1980.326652; Huang H, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056005; HUDGINS B, 1993, IEEE T BIO-MED ENG, V40, P82, DOI 10.1109/10.204774; HUNTER IW, 1987, MED BIOL ENG COMPUT, V25, P121, DOI 10.1007/BF02442838; Jones KE, 2002, J NEUROPHYSIOL, V88, P1533, DOI 10.1152/jn.2002.88.3.1533; Ju ZJ, 2014, IEEE-ASME T MECH, V19, P456, DOI 10.1109/TMECH.2013.2240312; Khezri M, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-45; Lowery MM, 2002, IEEE T BIO-MED ENG, V49, P446, DOI 10.1109/10.995683; Lucas MF, 2008, BIOMED SIGNAL PROCES, V3, P169, DOI 10.1016/j.bspc.2007.09.002; Nazarpour K, 2013, BRAIN RES BULL, V90, P88, DOI 10.1016/j.brainresbull.2012.09.012; PARKER PA, 1986, CRIT REV BIOMED ENG, V13, P283; PERSON RS, 1970, ELECTROEN CLIN NEURO, V28, P625, DOI 10.1016/0013-4694(70)90205-1; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SHWEDYK E, 1977, IEEE T BIO-MED ENG, V24, P417, DOI 10.1109/TBME.1977.326175; Song R, 2008, IEEE T NEUR SYS REH, V16, P371, DOI 10.1109/TNSRE.2008.926707; Tanizaki H., 2008, EC B, V3, P1; Tsuji T, 1999, IEEE T SYST MAN CY C, V29, P60, DOI 10.1109/5326.740670; Vredenbregt J., 1973, CLIN BIOMECH, V24, P607, DOI [10.1159/000394062, DOI 10.1159/000394062]; Witkovsky V, 2001, KYBERNETIKA, V37, P79; WOODS JJ, 1983, AM J PHYS MED REHAB, V62, P287	31	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0180112	10.1371/journal.pone.0180112	http://dx.doi.org/10.1371/journal.pone.0180112			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640883	Green Published, gold, Green Submitted			2022-12-27	WOS:000404135800091
J	Bocanegra-Ibarias, P; Garza-Gonzalez, E; Morfin-Otero, R; Barrios, H; Villarreal-Trevino, L; Rodriguez-Noriega, E; Garza-Ramos, U; Petersen-Morfin, S; Silva-Sanchez, J				Bocanegra-Ibarias, Paola; Garza-Gonzalez, Elvira; Morfin-Otero, Rayo; Barrios, Humberto; Villarreal-Trevino, Licet; Rodriguez-Noriega, Eduardo; Garza-Ramos, Ulises; Petersen-Morfin, Santiago; Silva-Sanchez, Jesus			Molecular and microbiological report of a hospital outbreak of NDM-1-carrying Enterobacteriaceae in Mexico	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE; PROVIDENCIA-RETTGERI; ESCHERICHIA-COLI; RESISTANCE; BACTERIA; PLASMID; GENES; PCR; IDENTIFICATION; SURVEILLANCE	Objectives To characterize the microbiological, molecular and epidemiological data of an outbreak of carbapenem-resistant Enterobacteriaceae (CRE) in a tertiary-care hospital in Mexico. Methods From September 2014 to July 2015, all CRE clinical isolates recovered during an outbreak in the Hospital Civil " Fray Antonio Alcalde" in Jalisco, Mexico were screened for antimicrobial susceptibility, carbapenemase production, carbapenemase-encoding genes, and plasmid profiles. Horizontal transfer of imipenem resistance; and clonal diversity by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST); as well as biofilm production and the presence of 14 virulence genes were analyzed in selected isolates. Results Fifty-two carbapenem-resistant isolates corresponding to 5 species were detected, i. e., Klebsiella pneumoniae (n = 46), Enterobacter cloacae (n = 3), Escherichia coli (n = 1), Providencia rettgeri (n = 1) and Citrobacter freundii (n = 1) with carbapenemase encoding genes blaNDM-1 (n = 48), blaVIM (n = 3), blaIMP (n = 1) and blaKPC (n = 1) detected in these isolates. The blaNDM-1 gene was detected in plasmids from 130-to 170-kb in K. pneumoniae (n = 46); E. cloacae (n = 3), E. coli (n = 1) and P. rettgeri (n = 1). The transfer of plasmids harboring the blaNDM-1 gene was obtained in eight transconjugants. One plasmid restriction pattern was detected, with the blaNDM-1 identified in different restriction fragments. Predominant clone A of K. pneumoniae isolates archived 28/ 46 (60%) isolates and belongs to ST392. Besides, ST307, ST309, ST846, ST2399, and ST2400 were detected for K. pneumoniae; as well as E. cloacae ST182 and E. coli ST10. The fimA and uge genes were more likely to be identified in K. pneumoniae carbapenem-susceptible isolates (p = < 0.001) and biofilm production was more liable to be observed in carbapenem-resistant isolates (p = < 0.05). Conclusions Four Enterobacteriaceae species harboring the bla(NDM-1) gene were detected in a nosocomial outbreak in Mexico; horizontal transfer and strain transmission were demonstrated for the bla(NDM-1) gene. Given the variation in the size of the plasmid harboring bla(NDM-1), complex rearrangements must also be occurring.	[Bocanegra-Ibarias, Paola; Villarreal-Trevino, Licet] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, San Nicolas De Los Garza, Nuevo Leon, Mexico; [Garza-Gonzalez, Elvira] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Serv Gastroenterol, Monterrey, Nuevo Leon, Mexico; [Morfin-Otero, Rayo; Rodriguez-Noriega, Eduardo; Petersen-Morfin, Santiago] Univ Guadalajara, Hosp Civil Guadalajara Fray Antonio Alcalde, Ctr Univ Ciencias Salud, Inst Patol Infecciosa & Expt, Guadalajara, Jalisco, Mexico; [Barrios, Humberto; Garza-Ramos, Ulises; Silva-Sanchez, Jesus] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico	Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad de Guadalajara; Instituto Nacional de Salud Publica	Silva-Sanchez, J (corresponding author), Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico.	jsilva@insp.mx	Morfín-Otero, Rayo/AAR-8027-2021	Morfín-Otero, Rayo/0000-0001-9576-1950; Garza Ramos, Ulises/0000-0002-5013-3050; Bocanegra-Ibarias, Paola/0000-0003-4602-3817; Rodriguez-Noriega, Eduardo/0000-0002-1386-4815	Mexican Council for Science and Technology [136339, 130224]	Mexican Council for Science and Technology	This work was supported by grants 136339 and 130224 from Mexican Council for Science and Technology (http://conacyt.gob.mx/) to JSS.	[Anonymous], 2016, M100S CLSI; Aschbacher R, 2008, J ANTIMICROB CHEMOTH, V61, P515, DOI 10.1093/jac/dkm508; Bado I, 2016, J GLOB ANTIMICROB RE, V6, P5, DOI 10.1016/j.jgar.2016.02.001; Bandeira M, 2014, PATHOGENS, V3, P720, DOI 10.3390/pathogens3030720; Baroud M, 2013, INT J ANTIMICROB AG, V41, P75, DOI 10.1016/j.ijantimicag.2012.08.010; Barrios H, 2014, PEDIATR INFECT DIS J, V33, P335, DOI 10.1097/INF.0000000000000173; Barrios H, 2013, J ANTIMICROB CHEMOTH, V68, P1934, DOI 10.1093/jac/dkt124; BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Bontron S, 2016, J ANTIMICROB CHEMOTH, V71, P2318, DOI 10.1093/jac/dkw139; Burmolle M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041259; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Chang FY, 2001, ANTIMICROB AGENTS CH, V45, P2407, DOI 10.1128/AAC.45.9.2407-2413.2001; Carvalho-Assef APD, 2013, J ANTIMICROB CHEMOTH, V68, P2956, DOI 10.1093/jac/dkt298; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Dortet L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/249856; Ellington MJ, 2007, J ANTIMICROB CHEMOTH, V59, P321, DOI 10.1093/jac/dkl481; Fuursted K, 2012, MICROBES INFECT, V14, P155, DOI 10.1016/j.micinf.2011.08.015; Garza-Ramos U, 2016, MICROB DRUG RESIST, V22, P179, DOI 10.1089/mdr.2015.0181; Garza-Ramos U, 2014, DIAGN MICR INFEC DIS, V79, P483, DOI 10.1016/j.diagmicrobio.2014.05.010; Hamprecht A, 2013, J ANTIMICROB CHEMOTH, V68, P558, DOI 10.1093/jac/dks447; Jamal WY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152638; Jean SS, 2015, FUTURE MICROBIOL, V10, P407, DOI [10.2217/FMB.14.135, 10.2217/fmb.14.135]; Kaufmann Mary Elizabeth, 1998, V15, P33; KIESER T, 1984, PLASMID, V12, P19, DOI 10.1016/0147-619X(84)90063-5; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Levesque S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144878; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Miller J.H, 1972, EXPT MOL GENETICS, pxvi; Miyoshi-Akiyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066358; Nishio H, 2004, J CLIN MICROBIOL, V42, P5256, DOI 10.1128/JCM.42.11.5256-5263.2004; Nordmann P, 2002, CLIN MICROBIOL INFEC, V8, P321, DOI 10.1046/j.1469-0691.2002.00401.x; Osterblad M, 2012, J ANTIMICROB CHEMOTH, V67, P2860, DOI 10.1093/jac/dks299; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P5403, DOI 10.1128/AAC.00585-11; Rojas LJ, 2016, ANTIMICROB AGENTS CH, V60, P4346, DOI 10.1128/AAC.03072-15; Rozales FP, 2014, INT J INFECT DIS, V25, P79, DOI 10.1016/j.ijid.2014.01.005; Sader HS, 2016, INT J ANTIMICROB AG, V48, P144, DOI 10.1016/j.ijantimicag.2016.04.021; Shiroto K, 2005, J MED MICROBIOL, V54, P1065, DOI 10.1099/jmm.0.46194-0; Stepanovic S, 2007, APMIS, V115, P891, DOI 10.1111/j.1600-0463.2007.apm_630.x; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; The European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2016, CLIN BREAKP BACT V 6; Torres-Gonzalez P, 2015, ANTIMICROB AGENTS CH, V59, P7080, DOI 10.1128/AAC.00055-15; Wang Q, 2016, EUR J CLIN MICROBIOL; Wei WJ, 2015, CHINESE MED J-PEKING, V128, P1969, DOI 10.4103/0366-6999.160566; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Xie LY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00133; Zhu J, 2016, EUR J CLIN MICROBIOL, V35, P611, DOI 10.1007/s10096-016-2578-z	47	55	59	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179651	10.1371/journal.pone.0179651	http://dx.doi.org/10.1371/journal.pone.0179651			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636666	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000404118300046
J	Miyazawa, K; Masujin, K; Okada, H; Ushiki-Kaku, Y; Matsuura, Y; Yokoyama, T				Miyazawa, Kohtaro; Masujin, Kentaro; Okada, Hiroyuki; Ushiki-Kaku, Yuko; Matsuura, Yuichi; Yokoyama, Takashi			Selective propagation of mouse-passaged scrapie prions with long incubation period from a mixed prion population using GT1-7 cells	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; STRAIN VARIATION; MURINE BIOASSAY; SHEEP; TRANSMISSION; INACTIVATION; ANTIBODIES; COFACTOR; AGENT	In our previous study, we demonstrated the propagation of mouse-passaged scrapie isolates with long incubation periods (L-type) derived from natural Japanese sheep scrapie cases in murine hypothalamic GT1-7 cells, along with disease-associated prion protein (PrPSc) accumulation. We here analyzed the susceptibility of GT1-7 cells to scrapie prions by exposure to infected mouse brains at different passages, following interspecies transmission. Wild-type mice challenged with a natural sheep scrapie case (Kanagawa) exhibited heterogeneity of transmitted scrapie prions in early passages, and this mixed population converged upon one with a short incubation period (S-type) following subsequent passages. However, when GT1-7 cells were challenged with these heterologous samples, L-type prions became dominant. This study demonstrated that the susceptibility of GT1-7 cells to L-type prions was at least 10(5) times higher than that to S-type prions and that L-type prion-specific biological characteristics remained unchanged after serial passages in GT1-7 cells. This suggests that a GT1-7 cell culture model would be more useful for the economical and stable amplification of L-type prions at the laboratory level. Furthermore, this cell culture model might be used to selectively propagate L-type scrapie prions from a mixed prion population.	[Miyazawa, Kohtaro; Masujin, Kentaro; Okada, Hiroyuki; Matsuura, Yuichi] Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Div Transboundary Anim Dis, Prion Dis Unit, Tsukuba, Ibaraki, Japan; [Ushiki-Kaku, Yuko] Nippi Res Inst Biomatrix, Toride, Ibaraki, Japan; [Yokoyama, Takashi] NARO, Natl Inst Anim Hlth, Dept Planning & Gen Adm, Tsukuba, Ibaraki, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan	Miyazawa, K (corresponding author), Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Div Transboundary Anim Dis, Prion Dis Unit, Tsukuba, Ibaraki, Japan.	miyazawak@affrc.go.jp	Matsuura, Yuichi/AAF-3170-2021; Miyazawa, Kohtaro/ABB-1464-2021	Matsuura, Yuichi/0000-0003-3383-7918; 	Ministry of Health, Labor, and Welfare of Japan; National Agriculture and Food Research Organization (NARO)	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Agriculture and Food Research Organization (NARO)	K. Miyazawa received the Grants-in-Aid from the Ministry of Health, Labor, and Welfare of Japan. K. Miyazawa, K. Masujin, HO, YM and TY received the basic research fund of National Agriculture and Food Research Organization (NARO).	Beck KE, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-77; Beck KE, 2012, BRAIN PATHOL, V22, P265, DOI 10.1111/j.1750-3639.2011.00526.x; Beringue V, 2008, VET RES, V39, DOI 10.1051/vetres:2008024; Bruce ME, 2003, BRIT MED BULL, V66, P99, DOI 10.1093/bmb/66.1.99; BRUCE ME, 1993, BRIT MED BULL, V49, P822, DOI 10.1093/oxfordjournals.bmb.a072649; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; CARP RI, 1991, J GEN VIROL, V72, P293, DOI 10.1099/0022-1317-72-2-293; Cassard H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6821; Comoy EE, 2015, SCI REP-UK, V5, DOI 10.1038/srep11573; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Grassmann A, 2013, VIRUSES-BASEL, V5, P374, DOI 10.3390/v5010374; Hirogari Y, 2003, MICROBIOL IMMUNOL, V47, P871, DOI 10.1111/j.1348-0421.2003.tb03453.x; Horiuchi M, 2002, J CLIN MICROBIOL, V40, P3421, DOI 10.1128/JCM.40.9.3421-3426.2002; Ma JY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002589; Masujin K, 2009, ARCH VIROL, V154, P1929, DOI 10.1007/s00705-009-0534-2; Matsuura Y, 2013, BIOCHEM BIOPH RES CO, V432, P86, DOI 10.1016/j.bbrc.2013.01.081; Miyazawa K, 2014, PRION, V8, P306, DOI 10.4161/pri.32232; Oelschlegel AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117154; Okada H, 2011, J COMP PATHOL, V144, P251, DOI 10.1016/j.jcpa.2010.10.001; Ryou C, 2007, J MICROBIOL BIOTECHN, V17, P1059; Shimizu Y, 2010, MICROBIOL IMMUNOL, V54, P112, DOI 10.1111/j.1348-0421.2009.00190.x; Supattapone S, 2014, J BIOL CHEM, V289, P19850, DOI 10.1074/jbc.R113.511329; Takatsuki H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126930; Thackray AM, 2011, J GEN VIROL, V92, P1482, DOI 10.1099/vir.0.028886-0; Ushiki-Kaku Y, 2014, J VET MED SCI, V76, P285, DOI 10.1292/jvms.13-0409; Ushiki-Kaku Y, 2010, J BIOL CHEM, V285, P11931, DOI 10.1074/jbc.M109.058859; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Yokoyama T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015450; Yoshioka M, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-134; Zurawel AA, 2014, BIOCHEMISTRY-US, V53, P68, DOI 10.1021/bi4014825	30	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179317	10.1371/journal.pone.0179317	http://dx.doi.org/10.1371/journal.pone.0179317			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636656	Green Published, gold, Green Submitted			2022-12-27	WOS:000404118300032
J	van Amsterdam, MA; van Assen, S; Sprenger, HG; Wilting, KR; Stienstra, Y; Bierman, WFW				van Amsterdam, Marleen A.; van Assen, Sander; Sprenger, Herman G.; Wilting, Kasper R.; Stienstra, Ymkje; Bierman, Wouter F. W.			Yield of yearly routine physical examination in HIV-1 infected patients is limited: A retrospective cohort study in the Netherlands	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; INVASIVE ANAL CANCER; MEN; MALIGNANCIES; SEX	Background Routine physical examinations might be of value in HIV-infected patients, but the yield is unknown. We determined the diagnoses that would have been missed without performing annual routine physical examinations in HIV-infected patients with stable disease. Methods Data were collected from the medical records of 299 HIV-1-infected patients with CD4 count >350 cells/mm(3) if not using combination antiretroviral therapy (cART), or CD4 count >100 cells/mm3 and undetectable viral load if using cART. We defined the diagnoses that would have been missed without performing routine physical examinations on annual check-ups in 2010. Exclusion criteria were hepatitis B/C co-infection, start/switch of cART <24 weeks, pregnancy, and transgenderism. Results 215 patients (72%) had positive findings: lipodystrophy (30%), lymphadenopathy (16%) and hypertension (8.4%) were the most common. Two-thirds of all findings were not new or were based on complaints indicating a physical examination even if not routinely scheduled. For 24 patients (8.0%) the routine physical examination led to the finding of a new diagnosis: six-all men who have sex with men (MSM)-had a concurrent sexually transmitted infection, eight had hypertension, and ten others had a large variety of diagnoses. A total atrioventricular block with bradycardia was the most clinically relevant finding. Conclusions Annual physical examinations of HIV-infected patients with stable disease brought few new diagnoses that would have been missed without performing a routine examination. Our results suggest that standard assessments could be restricted to six-monthly measuring blood pressure in all patients and annually performing anogenital and digital rectal examination on MSM.	[van Amsterdam, Marleen A.; Sprenger, Herman G.; Stienstra, Ymkje; Bierman, Wouter F. W.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Infect Dis Serv, Groningen, Netherlands; [van Assen, Sander] Treant Zorggroep, Dept Internal Med, Emmen, Netherlands; [Wilting, Kasper R.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol & Infect Control, Groningen, Netherlands	University of Groningen; University of Groningen	Bierman, WFW (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Infect Dis Serv, Groningen, Netherlands.	w.f.w.bierman@umcg.nl						Aberg JA, 2014, CLIN INFECT DIS, V58, pE1, DOI [10.1093/cid/cit665, 10.1093/cid/cit757]; Anuurad E, 2009, METAB SYNDR RELAT D, V7, P401, DOI 10.1089/met.2008.0096; Barber T, 2011, HIV MED, V12, P73; Berry JM, 2014, INT J CANCER, V134, P1147, DOI 10.1002/ijc.28431; Boulware LE, 2007, ANN INTERN MED, V146, P289, DOI 10.7326/0003-4819-146-4-200702200-00008; Boyd, MONITORING REPORT 20; Buchacz K, 2004, AIDS, V18, P2075, DOI 10.1097/00002030-200410210-00012; Chin-Hong PV, 2002, CLIN INFECT DIS, V35, P1127, DOI 10.1086/344057; Crum-Cianflone N, 2009, ARCH INTERN MED, V169, P1130, DOI 10.1001/archinternmed.2009.104; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; European AIDS Clinical Society, 2016, EACS GUID VERS 8 1; European AIDS Clinical Society, 2014, EACS GUID VERS 7 1; GAINES H, 1988, BRIT MED J, V297, P1363, DOI 10.1136/bmj.297.6660.1363; Heiligenberg M, 2012, AIDS, V26, P646, DOI 10.1097/QAD.0b013e3283504bbf; Heiligenberg M, 2012, SEX TRANSM DIS, V39, P8, DOI 10.1097/OLQ.0b013e3182354e81; Helfand M, 2001, AM J PREV MED, V20, P47, DOI 10.1016/S0749-3797(01)00258-6; Henley SJ, 2014, MMWR-MORBID MORTAL W, V63, P1; Kalichman SC, 2011, SEX TRANSM INFECT, V87, P183, DOI 10.1136/sti.2010.047514; Krogsboll LT, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7191; Lee PK, 2006, J ANTIMICROB CHEMOTH, V57, P803, DOI 10.1093/jac/dkl092; Mocroft A, 2010, JAIDS-J ACQ IMM DEF, V55, P262, DOI 10.1097/QAI.0b013e3181e9be6b; Nag D, 2016, J CYTOL, V33, P66, DOI 10.4103/0970-9371.182518; Ong JJ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-557; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Piketty C, 2008, AIDS, V22, P1203, DOI 10.1097/QAD.0b013e3283023f78; Seaberg EC, 2005, AIDS, V19, P953, DOI 10.1097/01.aids.0000171410.76607.f8; Sungkanuparph S, 2005, CLIN INFECT DIS, V41, P1326, DOI 10.1086/496985; Thiebaut R, 2005, ANTIVIR THER, V10, P811; Tuddenham S, 2013, SEX TRANSM DIS, V40, P886, DOI 10.1097/OLQ.0000000000000041; van Sighem A, 2010, AIDS, V24, P1527, DOI 10.1097/QAD.0b013e32833a3946; Wang CCJ, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0406-0; Wolff T, 2009, ANN INTERN MED, V150, P194, DOI 10.7326/0003-4819-150-3-200902030-00009; Zetola NM, 2007, CLIN INFECT DIS, V44, P1222, DOI 10.1086/513427	33	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179539	10.1371/journal.pone.0179539	http://dx.doi.org/10.1371/journal.pone.0179539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636651	Green Published, gold, Green Submitted			2022-12-27	WOS:000404118300040
J	Cai, GT; Chen, BH; Li, Z; Wei, W; Wang, P; Dong, WQ				Cai, Gaotai; Chen, Bohong; Li, Zhen; Wei, Wei; Wang, Ping; Dong, Wenqi			The different expressed serum proteins in rhCygb treated rat model of liver fibrosis by the optimized two-dimensional gel electrophoresis	PLOS ONE			English	Article							BIOMARKER CANDIDATES; HEPATIC-FIBROSIS; CYTOGLOBIN; ACTIVATION; CELLS	Liver fibrosis, a common pathological process of chronic liver diseases, is the final stage of liver dysfunction that has severely deleterious impact on human health. Cytoglobin was first discovered in 2001 by proteomic analysis in rat stellate cells and was reported to play an important role in controlling tissue fibrosis. However, the mechanism by which cytoglobin inhibits or reverses the progression of fibrosis remains unclear. The present study examines the effect of recombinant human cytoblobin (rhCygb) in a rat model of liver fibrosis. Proteomic approaches were employed to identify differentially expressed proteins in the fibrosis model. Optimized conditions for two-dimensional gel electrophoresis were developed to provide improved protein detection and separation. A total of 43 spots were obtained and, through the use of matrix-assisted laser desorption ionization time-of-flight mass spectrometry, 30 differentially expressed proteins were identified. Gene ontology term annotation and KEGG pathway analysis allowed us to explore the function of the represented proteins. Based on these results, we provide a theory of the molecular mechanism related to rhCygb reversion of fibrosis and which will assist in the identification of biomarkers in patient serum to improve early diagnosis of liver fibrosis.	[Cai, Gaotai; Chen, Bohong; Li, Zhen; Wei, Wei; Wang, Ping; Dong, Wenqi] Southern Med Univ, Dept Lab Med & Biotechnol, Guangzhou, Guangdong, Peoples R China; [Chen, Bohong] Sun Yat Sen Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Sun Yat Sen University	Dong, WQ (corresponding author), Southern Med Univ, Dept Lab Med & Biotechnol, Guangzhou, Guangdong, Peoples R China.	dongwq63@263.net		Bohong, Chen/0000-0003-2745-1015	Guangdong Province Science and Technology Plan Project [20106031500012, 2013A022100027]; Guangzhou Science and Technology Project [201510010104]	Guangdong Province Science and Technology Plan Project; Guangzhou Science and Technology Project	This study was supported by the Guangdong Province Science and Technology Plan Project (No. 20106031500012, No. 2013A022100027) and the Guangzhou Science and Technology Project (No. 201510010104).	Chen S, 2015, EVID BASED COMPL ALT; Cheng HT, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5185317; Cowan ML, 2010, TRENDS MOL MED, V16, P171, DOI 10.1016/j.molmed.2010.01.006; Cugno G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151599; Gafencu AV, 2007, J BIOL CHEM, V282, P21776, DOI 10.1074/jbc.M611422200; Gangadharan B, 2007, CLIN CHEM, V53, P1792, DOI 10.1373/clinchem.2007.089144; Han YH, 2012, BIOCHEM BIOPH RES CO, V426, P427, DOI 10.1016/j.bbrc.2012.08.113; Jimi Eijiro, 2016, Clin Calcium, V26, P298, DOI CliCa1602298304; Kataoka T, 2012, RENAL FAILURE, V34, P1181, DOI 10.3109/0886022X.2012.717496; Kawada N, 2001, J BIOL CHEM, V276, P25318, DOI 10.1074/jbc.M102630200; Latina A, 2016, ONCOGENE, V35, P1493, DOI 10.1038/onc.2015.222; Thuy LTT, 2015, AM J PATHOL, V185, P1045, DOI 10.1016/j.ajpath.2014.12.017; Lee JE, 2015, ASIAN AUSTRAL J ANIM, V28, P788, DOI 10.5713/ajas.14.0790; Li L., 2009, J PROTEOM BIOINFORM, V2, P485, DOI DOI 10.4172/JPB.1000110; Li Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep23508; Motoyama H, 2014, LAB INVEST, V94, P192, DOI 10.1038/labinvest.2013.135; Nakatani K, 2004, LAB INVEST, V84, P91, DOI 10.1038/labinvest.3700013; Oleksiewicz U, 2011, CELL MOL LIFE SCI, V68, P3869, DOI 10.1007/s00018-011-0764-9; Raatschen N, 2012, CURR PROTOC MICROBIO; Ratib S, 2014, J HEPATOL, V60, P282, DOI 10.1016/j.jhep.2013.09.027; Roche S, 2009, J PROTEOMICS, V72, P945, DOI 10.1016/j.jprot.2009.03.008; Shi CC, 2016, AM J TRANSL RES, V8, P125; Sopena B, 1996, LIVER, V16, P303; Tejero J, 2016, BBA-MOL CELL BIOL L, V1861, P391, DOI 10.1016/j.bbalip.2016.02.022; Toosi AEK, 2015, ROM J INTERN MED, V53, P304, DOI 10.1515/rjim-2015-0039; Trebicka J, 2010, J HEPATOL, V53, P702, DOI 10.1016/j.jhep.2010.04.025; Wang JY, 1998, LIVER, V18, P180; Westermeier Reiner, 2011, Methods Biochem Anal, V54, P411; Yang LB, 2011, DIGEST DIS SCI, V56, P3305, DOI 10.1007/s10620-011-1745-4	29	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0177968	10.1371/journal.pone.0177968	http://dx.doi.org/10.1371/journal.pone.0177968			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662027	gold, Green Submitted, Green Published			2022-12-27	WOS:000404608300004
J	Tung, CH; Chen, CW; Sun, HH; Chu, YW				Tung, Chi-Hua; Chen, Chi-Wei; Sun, Han-Hao; Chu, Yen-Wei			Predicting human protein subcellular localization by heterogeneous and comprehensive approaches	PLOS ONE			English	Article							GENE ONTOLOGY TERMS; SINGLE; SITES; MODES	Drug development and investigation of protein function both require an understanding of protein subcellular localization. We developed a system, REALoc, that can predict the subcellular localization of singleplex and multiplex proteins in humans. This system, based on comprehensive strategy, consists of two heterogeneous systematic frameworks that integrate one-to-one and many-to-many machine learning methods and use sequence-based features, including amino acid composition, surface accessibility, weighted sign aa index, and sequence similarity profile, as well as gene ontology function-based features. REALoc can be used to predict localization to six subcellular compartments (cell membrane, cytoplasm, endoplasmic reticulum/Golgi, mitochondrion, nucleus, and extracellular). REALoc yielded a 75.3% absolute true success rate during five-fold cross-validation and a 57.1% absolute true success rate in an independent database test, which was >10% higher than six other prediction systems. Lastly, we analyzed the effects of Vote and GANN models on singleplex and multiplex localization prediction efficacy. REALoc is freely available at http://predictor.nchu.edu.tw/REALoc.	[Tung, Chi-Hua] Chung Hua Univ, Dept Bioinformat, Hsinchu, Taiwan; [Chen, Chi-Wei; Sun, Han-Hao; Chu, Yen-Wei] Natl Chung Hsing Univ 250, Inst Genom & Bioinformat, Taichung 402, Taiwan; [Chu, Yen-Wei] Natl Chung Hsing Univ 250, Ctr Biotechnol, Agr Biotechnol Ctr, Inst Mol Biol,Grad Inst Biotechnol, Taichung 402, Taiwan	Chung Hua University; National Chung Hsing University; National Chung Hsing University	Chu, YW (corresponding author), Natl Chung Hsing Univ 250, Inst Genom & Bioinformat, Taichung 402, Taiwan.; Chu, YW (corresponding author), Natl Chung Hsing Univ 250, Ctr Biotechnol, Agr Biotechnol Ctr, Inst Mol Biol,Grad Inst Biotechnol, Taichung 402, Taiwan.	ywchu@nchu.edu.tw	Chu, Yen-Wei/AAJ-4508-2020	Chu, Yen-Wei/0000-0002-5525-4011; Chen, Chi-Wei/0000-0002-5799-9017	Ministry of Science and Technology,Taiwan, R.O.C [105-2221-E-216-021]	Ministry of Science and Technology,Taiwan, R.O.C(Ministry of Science and Technology, Taiwan)	This research was supported by Ministry of Science and Technology,Taiwan, R.O.C. under grant number 105-2221-E-216-021.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Blum T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-274; Briesemeister S, 2010, BIOINFORMATICS, V26, P1232, DOI 10.1093/bioinformatics/btq115; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen J, 2016, BRIEF BIOINFORM; Cherian BS, 2010, BIOCHEM BIOPH RES CO, V391, P1670, DOI 10.1016/j.bbrc.2009.12.118; Chi SM, 2012, BIOINFORMATICS, V28, P1028, DOI 10.1093/bioinformatics/bts062; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2012, MOL BIOSYST, V8, P629, DOI 10.1039/c1mb05420a; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Goldberg T, 2012, BIOINFORMATICS, V28, pI458, DOI 10.1093/bioinformatics/bts390; Guo XT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28087; He JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037155; Huang WL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-80; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Lin H, 2009, ACTA BIOTHEOR, V57, P321, DOI 10.1007/s10441-008-9067-4; Liu B, 2016, NEUROCOMPUTING, V217, P46, DOI 10.1016/j.neucom.2015.12.138; Liu B, 2016, BIOINFORMATICS, V32, P2411, DOI 10.1093/bioinformatics/btw186; Liu B, 2017, BIOINFORMATICS, V33, P35, DOI [10.1093/bioinformatics/btv604, 10.1093/bioinformatics/btw539]; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu J, 2015, J BIOMOL STRUCT DYN, V33, P7, DOI [10.1080/07391102.2015.1032552, 10.1080/07391102.2015.1014422]; Lu Z, 2005, PAC S BIOC PAC S BIO; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Mei SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037716; Nair R, 2005, J MOL BIOL, V348, P85, DOI 10.1016/j.jmb.2005.02.025; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Shen HB, 2009, ANAL BIOCHEM, V394, P269, DOI 10.1016/j.ab.2009.07.046; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WALTER P, 1981, J CELL BIOL, V91, P545, DOI 10.1083/jcb.91.2.545; Wan S, 2012, 2012 IEEE INT C; Wan SB, 2011, IEEE INT WORKS MACH; Wang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091160; Wei LY, 2016, NEUROCOMPUTING, V217, P73, DOI 10.1016/j.neucom.2015.09.137; Yoon Y, 2012, IEEE ACM T COMPUT BI, V9, P609, DOI 10.1109/TCBB.2011.131; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018	44	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0178832	10.1371/journal.pone.0178832	http://dx.doi.org/10.1371/journal.pone.0178832			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658305	Green Published, gold			2022-12-27	WOS:000404607900009
J	Wang, YY; Chi, JW; Che, K; Chen, Y; Sun, XL; Wang, YG; Wang, ZC				Wang, Yunyang; Chi, Jingwei; Che, Kui; Chen, Ying; Sun, Xiaolin; Wang, Yangang; Wang, Zhongchao			Fasting plasma glucose and serum uric acid levels in a general Chinese population with normal glucose tolerance: A U-shaped curve	PLOS ONE			English	Article							DOUBLE-BLIND; URATE; SODIUM; INSULIN; IDENTIFICATION; ASSOCIATION; RESISTANCE; EXCRETION; TRANSPORT; METFORMIN	Objective Although several epidemiological studies assessed the relationship between fasting plasma glucose (FPG) and serum uric acid (SUA) levels, the results were inconsistent. A cross-sectional study was conducted to investigate this relationship in Chinese individuals with normal glucose tolerance. Research design and methods A total of 5,726 women and 5,457 men with normal glucose tolerance were enrolled in the study. All subjects underwent a 75-g oral glucose tolerance test. Generalized additive models and two-piecewise linear regression models were applied to assess the relationship. Results A U-shaped relationship between FPG and SUA was observed. After adjusting for potential confounders, the inflection points of FPG levels in the curves were 4.6 mmol/L in women and 4.7 mmol/L in men respectively. SUA levels decreased with increasing fasting plasma glucose concentrations before the inflection points (regression coefficient [beta] = -36.4, P < 0.001 for women; beta = -33.5, P < 0.001 for men), then SUA levels increased = 17.8, P < 0.001 for women; beta = 13.9, P < 0.001 for men). Additionally, serum insulin levels were positively associated with FPG and SUA (P < 0.05). Conclusions A U-shaped relationship between FPG and SUA levels existed in Chinese individuals with normal glucose tolerance. The association is partly mediated through serum insulin levels.	[Wang, Yunyang; Chen, Ying; Sun, Xiaolin; Wang, Yangang; Wang, Zhongchao] Qingdao Univ, Affiliated Hosp, Dept Endocrinol & Metab, Qingdao, Shandong, Peoples R China; [Chi, Jingwei; Che, Kui] Qingdao Univ, Affiliated Hosp, Lab Thyroid Dis, Qingdao, Shandong, Peoples R China	Qingdao University; Qingdao University	Wang, YG; Wang, ZC (corresponding author), Qingdao Univ, Affiliated Hosp, Dept Endocrinol & Metab, Qingdao, Shandong, Peoples R China.	nlwang@yeah.net; tony_qdu@126.com			National Natural Science Foundation of China [81571625, 81600601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (No. 81571625 and No. 81600601, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON RG, 1976, AM J PHYSIOL, V230, P1276, DOI 10.1152/ajplegacy.1976.230.5.1276; [Anonymous], 2007, J AM STAT ASSOC, DOI DOI 10.1198/JASA.2007.S188; Aswani R, 2011, CLIN PEDIATR, V50, P1057, DOI 10.1177/0009922811414288; Augustin R, 2004, J BIOL CHEM, V279, P16229, DOI 10.1074/jbc.M312226200; Bailey CJ, 2011, TRENDS PHARMACOL SCI, V32, P63, DOI 10.1016/j.tips.2010.11.011; Bailey CJ, 2010, LANCET, V375, P2223, DOI 10.1016/S0140-6736(10)60407-2; Caulfield MJ, 2008, PLOS MED, V5, P1509, DOI 10.1371/journal.pmed.0050197; Cefalu WT, 2013, LANCET, V382, P941, DOI 10.1016/S0140-6736(13)60683-2; Chaudhary K, 2013, CARDIORENAL MED, V3, P208, DOI 10.1159/000355405; Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; CHOW GC, 1960, ECONOMETRICA, V28, P591, DOI 10.2307/1910133; Cicero AFG, 2014, DIABETES RES CLIN PR, V104, P183, DOI 10.1016/j.diabres.2014.02.005; Cicero AFG, 2017, ANN MED, V49, P275, DOI 10.1080/07853890.2016.1222451; Clemencon B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108852; COOK DG, 1986, POSTGRAD MED J, V62, P1001, DOI 10.1136/pgmj.62.733.1001; Doshi M, 2011, NUCLEOS NUCLEOT NUCL, V30, P1290, DOI 10.1080/15257770.2011.603711; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; Ferrannini E, 2013, DIABETES OBES METAB, V15, P721, DOI 10.1111/dom.12081; GALVAN AQ, 1995, AM J PHYSIOL-ENDOC M, V268, pE1, DOI 10.1152/ajpendo.1995.268.1.E1; HERMAN JB, 1982, LANCET, V2, P240; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; LEVINSON DJ, 1980, ANN RHEUM DIS, V39, P173, DOI 10.1136/ard.39.2.173; Li HB, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003456; Lipkowitz MS, 2012, CURR RHEUMATOL REP, V14, DOI 10.1007/s11926-012-0240-z; Liu YH, 2013, EURASIP J BIOINFORM, DOI 10.1186/1687-4153-2013-8; Maesaka JK, 1998, AM J KIDNEY DIS, V32, P917, DOI 10.1016/S0272-6386(98)70067-8; Maiuolo J, 2016, INT J CARDIOL, V213, P8, DOI 10.1016/j.ijcard.2015.08.109; Mandal AK, 2015, ANNU REV PHYSIOL, V77, P323, DOI 10.1146/annurev-physiol-021113-170343; Mather A, 2011, KIDNEY INT, V79, pS1, DOI 10.1038/ki.2010.509; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meisinger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037180; Mount DB, 2006, RHEUM DIS CLIN N AM, V32, P313, DOI 10.1016/j.rdc.2006.02.006; Muscelli E, 1996, AM J HYPERTENS, V9, P746, DOI 10.1016/0895-7061(96)00098-2; Nair S, 2010, J CLIN ENDOCR METAB, V95, P34, DOI 10.1210/jc.2009-0473; Nan HR, 2007, DIABETES RES CLIN PR, V76, P68, DOI 10.1016/j.diabres.2006.07.022; Nan HR, 2010, DIABETES VASC DIS RE, V7, P40, DOI 10.1177/1479164109347408; Oda E, 2009, INTERNAL MED, V48, P1785, DOI 10.2169/internalmedicine.48.2426; OLEFSKY J, 1973, DIABETES, V22, P507, DOI 10.2337/diab.22.7.507; PODEVIN R, 1968, NEPHRON, V5, P134, DOI 10.1159/000179623; So A, 2010, J CLIN INVEST, V120, P1791, DOI 10.1172/JCI42344; Su JX, 2014, ARCH PHARM RES, V37, P1336, DOI 10.1007/s12272-014-0413-6; terMaaten JC, 1997, CLIN SCI, V92, P51; TUOMILEHTO J, 1988, AM J EPIDEMIOL, V127, P321, DOI 10.1093/oxfordjournals.aje.a114807; Vrhovac I, 2015, PFLUG ARCH EUR J PHY, V467, P1881, DOI 10.1007/s00424-014-1619-7; WHITEHEAD TP, 1992, ANN CLIN BIOCHEM, V29, P159, DOI 10.1177/000456329202900206; Wilding JPH, 2013, DIABETES OBES METAB, V15, P403, DOI 10.1111/dom.12038; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; WU JM, 1977, ENZYME, V22, P60, DOI 10.1159/000458509	49	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180111	10.1371/journal.pone.0180111	http://dx.doi.org/10.1371/journal.pone.0180111			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658284	Green Submitted, Green Published, gold			2022-12-27	WOS:000404607900060
J	Belaunzaran-Zamudio, PF; Mosqueda-Gomez, JL; Macias-Hernandez, A; Sierra-Madero, JG; Ahmed, S; Beyrer, C				Belaunzaran-Zamudio, Pablo F.; Mosqueda-Gomez, Juan L.; Macias-Hernandez, Alejando; Sierra-Madero, Juan G.; Ahmed, Saifuddin; Beyrer, Chris			Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico	PLOS ONE			English	Article							HIV-INFECTION; DRUG-USERS; INCARCERATION; TRANSMISSION; EPIDEMIOLOGY; THAILAND; BANGKOK; IMPACT; AIDS	Objectives To estimate the prevalence of HCV-infection and identify associated factors among inmates in the State Prison System of Guanajuato in Mexico (Sep-2011 to Feb-2012). Methods Cross-sectional, observational study in 10 prisons in the State of Guanajuato in Mexico (2011-2012). We offered HCV-testing and applied audio computer-assisted self-interviews to all adults imprisoned in the State Prison System. We used a complex survey analysis to estimate the distribution of variables and its corresponding 95% confidence intervals, taking into consideration the expected cluster effect by common characteristics within prisons. Inverse probability weights were applied to correct potential biased estimates arising from non-participation in accrual activities and non-response rates. We fitted multivariate logistic regression models to identify risk-behaviors associated to HCV-infection. Results We included data of 2,519 participating inmates. Prevalence of HCV-infection was 4.9 (95% CI = 3.6-5.9). Most HCV-infected inmates were male (99%). Before being incarcerated, inmates with HCV-infection were more frequently tattooed, used and injected drugs more frequently, and were more likely to share materials for injecting, when compared with those non-infected. During incarceration, HCV-infected inmates got tattoos and used drugs more often than non-infected, including injecting-drugs and sharing materials. Injecting-drug use (OR = 7.6, 95% CI, 2.5-23.4), sharing materials for injecting-drugs (OR = 19.6, 95% CI, 4.7-81.7) and being tattooed at least once before incarceration (OR = 2.1, 95% CI, 1.1-3.9), but not during incarceration, were independently associated to HCV-infection. Conclusions The prevalence of HCV-infection among inmates in the State of Guanajuato in Mexico is considerably higher than in the general population. The most important risk factors for HCV in this inmate population were injecting-drugs and sharing materials for injections before incarceration. High-risk behaviors during imprisonment are very high particularly among those already infected. HCV diagnostic and treatment services, and harm-reduction programs for incarcerated injecting-drug users in Mexico should be integrated to control the HCV epidemic in Mexico.	[Belaunzaran-Zamudio, Pablo F.; Ahmed, Saifuddin; Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Belaunzaran-Zamudio, Pablo F.; Macias-Hernandez, Alejando; Sierra-Madero, Juan G.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Infectol, Mexico City, DF, Mexico; [Belaunzaran-Zamudio, Pablo F.] Univ Nacl Autonoma Mexico, Fac Med, Div Invest, Mexico City, DF, Mexico; [Mosqueda-Gomez, Juan L.; Macias-Hernandez, Alejando] Univ Guanajuato, Dept Microbiol, Guanajuato, Mexico; [Mosqueda-Gomez, Juan L.] CAPASITS, Guanajuato, Mexico; [Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Johns Hopkins Ctr Publ Hlth & Human Rights, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Nacional Autonoma de Mexico; Universidad de Guanajuato; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Belaunzaran-Zamudio, PF (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.; Belaunzaran-Zamudio, PF (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Infectol, Mexico City, DF, Mexico.; Belaunzaran-Zamudio, PF (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Div Invest, Mexico City, DF, Mexico.	p.belaunz@infecto.mx	Belaunzaran-Zamudio, Pablo F./T-4218-2019; Macías, Alejandro Molina/HHS-2363-2022; Belaunzarán-Zamudio, Pablo Francisco/T-4085-2019; Sierra Madero, Juan/AAW-8825-2021	Belaunzaran-Zamudio, Pablo F./0000-0003-4775-4734; Mosqueda, Juan Luis/0000-0003-1356-684X; Macias, Alejandro/0000-0002-6573-4350	Mexican Government through the National Council for Science and Technology (Consejo Nacional para la Ciencia y Tecnologia, CONACYT); NIH	Mexican Government through the National Council for Science and Technology (Consejo Nacional para la Ciencia y Tecnologia, CONACYT); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Mexican Government through the National Council for Science and Technology (Consejo Nacional para la Ciencia y Tecnologia, CONACYT). The Ministry of Health of the State of Guanajuato provided logistic support and transportation. Pablo F Belaunzaran received support for traveling, housing and living expenses from the Universidad de Guanajuato and the Johns Hopkins University Center for Global Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We also declare, again, that none of the authors have competing interests to disclose beyond standard NIH grant funding.	Alvarado-Esquivel C, 2005, EPIDEMIOL INFECT, V133, P679, DOI 10.1017/S0950268805003961; Awofeso Niyi, 2002, Aust Health Rev, V25, P162; Bautista-Arredondo S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131718; Belaunzaran-Zamudio PF, 2017, AIDS RES HUM RETROV, V33, P524, DOI [10.1089/AID.2016.0271, 10.1089/aid.2016.0271]; BREWER TF, 1992, AIDS, V6, P623, DOI 10.1097/00002030-199207000-00002; Buavirat A, 2003, BRIT MED J, V326, P308, DOI 10.1136/bmj.326.7384.308; Coelho HC, 2009, REV SOC BRAS MED TRO, V42, P369, DOI 10.1590/S0037-86822009000400002; Curtis SL, 2004, SEX TRANSM INFECT S2, V80, pii22; DESJARLAIS DC, 1992, AIDS, V6, P1053, DOI 10.1097/00002030-199210000-00001; Dolan K, 2007, LANCET INFECT DIS, V7, P32, DOI 10.1016/S1473-3099(06)70685-5; Fox RK, 2005, CLIN INFECT DIS, V41, P177, DOI 10.1086/430913; Freudenberg N, 2001, J URBAN HEALTH, V78, P214, DOI 10.1093/jurban/78.2.214; Hellard ME, 2007, AM J INFECT CONTROL, V35, P477, DOI 10.1016/j.ajic.2006.08.002; Hellard ME, 2004, EPIDEMIOL INFECT, V132, P409, DOI 10.1017/S0950268803001882; *I NAC SAL PUBL, 2008, ENC NAC AD; International Centre for Prison Studies, 2014, WORLD PRIS BRIEF; Jafari S, 2010, INT J INFECT DIS, V14, pE928, DOI 10.1016/j.ijid.2010.03.019; Kondro W, 2007, CAN MED ASSOC J, V176, P433, DOI 10.1503/cmaj.070095; Langhaug LF, 2011, SEX TRANSM INFECT, V87, P165, DOI 10.1136/sti.2009.037374; Macalino G. E., 2004, International Journal of Drug Policy, V15, P103, DOI 10.1016/j.drugpo.2003.10.006; Pluhar E, 2007, J ASSOC NURSE AIDS C, V18, P51, DOI 10.1016/j.jana.2007.05.002; Reichmann WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008728; Rhodes T, 2005, SOC SCI MED, V61, P1026, DOI 10.1016/j.socscimed.2004.12.024; Royston P, 2009, STATA J, V9, P252, DOI 10.1177/1536867X0900900205; Samuel MC, 2005, EPIDEMIOL INFECT, V133, P1146, DOI 10.1017/S0950268805225517; Sarang A, 2006, ADDICTION, V101, P1787, DOI 10.1111/j.1360-0443.2006.01617.x; Small W, 2005, SUBST USE MISUSE, V40, P831, DOI 10.1081/JA-200030795; Szklo M., 2007, EPIDEMIOLOGY BASICS; Thaisri H, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-25; Tohme RA, 2012, CLIN INFECT DIS, V54, P1167, DOI 10.1093/cid/cir991; United Nations Office on Drugs and Crime, 2012, POL BRIEF HIV PREV T; Urbanus AT, 2009, AIDS, V23, pF1, DOI 10.1097/QAD.0b013e32832e5631; Vanable PA, 2009, J ADOLESCENT HEALTH, V44, P214, DOI 10.1016/j.jadohealth.2008.09.002; Vescio MF, 2008, J EPIDEMIOL COMMUN H, V62, P305, DOI 10.1136/jech.2006.051599	34	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179931	10.1371/journal.pone.0179931	http://dx.doi.org/10.1371/journal.pone.0179931			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ2LT	28654650	Green Submitted, Green Published, gold			2022-12-27	WOS:000404541500039
J	Matignon, M; Pilon, C; Commereuc, M; Grondin, C; Leibler, C; Kofman, T; Audard, V; Cohen, JA; Canoui-Poitrine, F; Grimbert, P				Matignon, Marie; Pilon, Caroline; Commereuc, Morgane; Grondin, Cynthia; Leibler, Claire; Kofman, Tomek; Audard, Vincent; Cohen, Jose; Canoui-Poitrine, Florence; Grimbert, Philippe			Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an observational study	PLOS ONE			English	Article							DONOR-SPECIFIC ANTIBODIES; GLOBAL OUTCOMES KDIGO; B-CELLS; RENAL-TRANSPLANTATION; SUBCLINICAL REJECTION; POSITION STATEMENT; IMMUNE GLOBULIN; RISK-FACTOR; GRAFT LOSS; DESENSITIZATION	Background Approximately 25% of kidney transplant recipients develop de novo anti-HLA donor-specific antibodies (dnDSA) leading to acute antibody-mediated rejection (ABMR) in 30% of patients. Preemptive therapeutic strategies are not available. Methods We conducted a prospective observational study including 11 kidney transplant recipients. Inclusion criteria were dnDSA occurring within the first year after transplant and normal allograft biopsy. All patients were treated with high-dose IVIG (2 g/kg 0, 1 and 2 months post-dnDSA). The primary efficacy outcome was incidence of clinical and subclinical acute ABMR within 12 months after dnDSA detection as compared to a historical control group (IVIG-). Results Acute ABMR occurred in 2 or 11 patients in the IVIG+ group and in 1 of 9 patients in the IVIG-group. IVIG treatment did not affect either class I or class II DSA, as observed at the end of the follow-up. IVIG treatment significantly decreased Fc gamma RIIA mRNA expression in circulating leukocytes, but did not affect the expression of any other markers of B cell activation. Conclusions In this first pilot study including kidney allograft recipients with early dnDSA, preemptive treatment with high-dose IVIG alone did not prevent acute ABMR and had minimal effects on DSA outcome and B cell phenotype.	[Matignon, Marie; Commereuc, Morgane; Leibler, Claire; Kofman, Tomek; Audard, Vincent; Grimbert, Philippe] Henri Mondor Hosp, AP HP, Nephrol & Transplantat Dept, Creteil, France; [Matignon, Marie; Grimbert, Philippe] CIC Biotherapies 504, Creteil, France; [Matignon, Marie; Pilon, Caroline; Grondin, Cynthia; Leibler, Claire; Audard, Vincent; Cohen, Jose; Grimbert, Philippe] INSERM, U955, Team 21, Creteil, France; [Matignon, Marie; Pilon, Caroline; Leibler, Claire; Audard, Vincent; Cohen, Jose; Grimbert, Philippe] Paris Est Univ UPEC, Creteil, France; [Pilon, Caroline; Grondin, Cynthia; Cohen, Jose] Henri Mondor Hosp, AP HP, CIC Biotherapies 504, Creteil, France; [Canoui-Poitrine, Florence] Henri Mondor Hosp, AP HP, Publ Hlth Dept, Creteil, France; [Canoui-Poitrine, Florence] Paris Est Univ, UPEC, IMRB EA CEpiA Unit Clin Epidemiol & Ageing 7376, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Matignon, M (corresponding author), Henri Mondor Hosp, AP HP, Nephrol & Transplantat Dept, Creteil, France.; Matignon, M (corresponding author), CIC Biotherapies 504, Creteil, France.; Matignon, M (corresponding author), INSERM, U955, Team 21, Creteil, France.; Matignon, M (corresponding author), Paris Est Univ UPEC, Creteil, France.	marie.matignon@aphp.fr	Leibler, Claire/Q-6678-2018; Cohen, José/Q-4816-2018; Matignon, Marie B/Q-8091-2018; grimbert, philippe/Q-5337-2018; Canoui-Poitrine, Florence/R-4474-2018	Cohen, José/0000-0002-5077-6726; Canoui-Poitrine, Florence/0000-0001-9970-6051; AUDARD, Vincent/0000-0001-5343-2550; Leibler, Claire/0000-0001-7787-2817				Archdeacon P, 2011, AM J TRANSPLANT, V11, P896, DOI 10.1111/j.1600-6143.2011.03525.x; Casey MJ, 2014, TRANSPLANTATION, V98, P306, DOI 10.1097/TP.0000000000000057; Chesneau M, 2014, AM J TRANSPLANT, V14, P144, DOI 10.1111/ajt.12508; Cooper JE, 2011, TRANSPLANTATION, V91, P1103, DOI 10.1097/TP.0b013e3182139da1; Devos JM, 2014, TRANSPLANTATION, V97, P534, DOI 10.1097/01.TP.0000438196.30790.66; Djamali A, 2014, AM J TRANSPLANT, V14, P255, DOI 10.1111/ajt.12589; Einecke G, 2009, AM J TRANSPLANT, V9, P2520, DOI 10.1111/j.1600-6143.2009.02799.x; Galeotti C, 2015, TRENDS MOL MED, V21, P145, DOI 10.1016/j.molmed.2015.01.005; Gaston RS, 2010, TRANSPLANTATION, V90, P68, DOI 10.1097/TP.0b013e3181e065de; Haas M, 2014, AM J TRANSPLANT, V14, P272, DOI 10.1111/ajt.12590; Heemann U, 2011, NEPHROL DIAL TRANSPL, V26, P2099, DOI 10.1093/ndt/gfr169; Heilman RL, 2014, TRANSPLANTATION; Jordan S, 2003, AM J TRANSPLANT, V3, P653, DOI 10.1034/j.1600-6143.2003.00121.x; Jordan SC, 2004, J AM SOC NEPHROL, V15, P3256, DOI 10.1097/01.ASN.0000145878.92906.9F; Jordan SC, 2015, IMMUNOTHERAPY-UK, V7, P377, DOI [10.2217/IMT.15.10, 10.2217/imt.15.10]; Jordan SC, 2014, CURR OPIN ORGAN TRAN, V19, P591, DOI 10.1097/MOT.0000000000000128; Lachmann N, 2009, TRANSPLANTATION, V87, P1505, DOI 10.1097/TP.0b013e3181a44206; Lefaucheur C, 2016, J AM SOC NEPHROL, V27, P293, DOI 10.1681/ASN.2014111120; Lefaucheur C, 2010, J AM SOC NEPHROL, V21, P1398, DOI 10.1681/ASN.2009101065; Leibler C, 2014, AM J TRANSPLANT, V14, P1173, DOI 10.1111/ajt.12721; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Loupy A, 2010, TRANSPLANTATION, V89, P1403, DOI 10.1097/TP.0b013e3181da1cc3; Mitrevski M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00004; Montgomery RA, 2011, NEW ENGL J MED, V365, P318, DOI 10.1056/NEJMoa1012376; Moreso F, 2006, AM J TRANSPLANT, V6, P747, DOI 10.1111/j.1600-6143.2005.01230.x; Moreso F, 2012, TRANSPLANTATION, V93, P41, DOI 10.1097/TP.0b013e31823bb647; Stolp J, 2014, NAT REV NEPHROL, V10, P389, DOI 10.1038/nrneph.2014.80; Terasaki PI, 2007, AM J TRANSPLANT, V7, P408, DOI 10.1111/j.1600-6143.2006.01644.x; Toyoda M, 2003, AM J TRANSPLANT, V3, P156, DOI 10.1034/j.1600-6143.2003.00011.x; Vo AA, 2008, NEW ENGL J MED, V359, P242, DOI 10.1056/NEJMoa0707894; Vo AA, 2014, TRANSPLANTATION, V98, P312, DOI 10.1097/TP.0000000000000064	31	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0178572	10.1371/journal.pone.0178572	http://dx.doi.org/10.1371/journal.pone.0178572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654684	gold, Green Submitted, Green Published			2022-12-27	WOS:000404541500002
J	Kim, JW; Lim, CW; Kim, B				Kim, Jong Won; Lim, Chae Woong; Kim, Bumseok			Effects of nicotine on corneal wound healing following acute alkali burn	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CIGARETTE-SMOKE; FIBROSIS; PROLIFERATION; NEOVASCULARIZATION; PROTEIN; ALPHA; CELLS; PROGRESSION; KERATOCYTES	Epidemiological studies have indicated that smoking is a pivotal risk factor for the progression of several chronic diseases. Nicotine, the addictive component of cigarettes, has powerful pathophysiological properties in the body. Although the effects of cigarette smoking on corneal re-epithelialization have been studied, the effects of nicotine on corneal wound healing-related neovascularization and fibrosis have not been fully demonstrated. The aim of this study was to evaluate the effects of chronic administration of nicotine on corneal wound healing following acute insult induced by an alkali burn. BALB/C female mice randomly received either vehicle (2% saccharin) or nicotine 100 or 200 mu g/ml in 2% saccharin) in drinking water ad libitum. After 1 week, animals were re-randomized and the experimental group was subjected to a corneal alkali burn, and then nicotine was administered until day 14 after the alkali burn. A corneal alkali burn model was generated by placing a piece of 2 mm-diameter filter paper soaked in 1N NaOH on the right eye. Histopathological analysis and the expression level of the pro-angiogenic genes vascular endothelial growth factor VEGF) and matrix metalloproteinase-9 MMP9) revealed that chronic nicotine administration enhanced alkali burn-induced corneal neovascularization. Furthermore, the mRNA expression of the pro-fibrogenic factors alpha-smooth muscle actin alpha SMA), transforming growth factor-beta TGF-beta), and collagen alpha 1 Col1) was enhanced in the high-concentration nicotine-treated group compared with the vehicle group after corneal injury. Immunohistochemical analysis also showed that the alpha SMA-positive area was increased in chronic nicotine-treated mice after corneal alkali burn. An in vitro assay found that expression of the alpha 3, alpha 7, and beta 1 nicotinic acetylcholine receptor nAChR) subunits was significantly increased by chemical injury in human corneal fibroblast cells. Moreover, alkali-induced fibrogenic gene expression and proliferation of fibroblast cells were further increased by treatment with nicotine and cotinine. The proliferation of such cells induced by treatment of nicotine and cotinine was reduced by inhibition of the PI3K and PKC pathways using specific inhibitors. In conclusion, chronic administration of nicotine accelerated the angiogenic and fibrogenic healing processes in alkali-burned corneal tissue.	[Kim, Bumseok] Chonbuk Natl Univ, Coll Vet Med, Biosafety Res Inst, Iksan, South Korea; Chonbuk Natl Univ, Coll Vet Med, Pathol Lab, Plus Program BK21, Iksan, South Korea	Jeonbuk National University; Jeonbuk National University	Kim, B (corresponding author), Chonbuk Natl Univ, Coll Vet Med, Biosafety Res Inst, Iksan, South Korea.	bskims@jbnu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science, and Technology [2011-0009309]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), which is funded by the Ministry of Education, Science, and Technology (2011-0009309)	Arany I, 2012, AM J PHYSIOL-RENAL, V302, pF722, DOI 10.1152/ajprenal.00338.2011; Ari S, 2013, CUTAN OCUL TOXICOL, V32, P9, DOI 10.3109/15569527.2012.686078; Azzalini L, 2010, HEPATOLOGY, V51, P1567, DOI 10.1002/hep.23516; Balansky R, 2007, CARCINOGENESIS, V28, P2236, DOI 10.1093/carcin/bgm122; Boor P, 2009, J CELL MOL MED, V13, P4484, DOI 10.1111/j.1582-4934.2008.00518.x; Boretsky A, 2015, CURR EYE RES, V40, P368, DOI 10.3109/02713683.2014.924147; Cao L, 2011, INVEST OPHTH VIS SCI, V52, P2272, DOI 10.1167/iovs.10-5972; Cardinale A, 2012, CRIT REV TOXICOL, V42, P68, DOI 10.3109/10408444.2011.623150; Chung EJ, 2014, BIOTECHNOL LETT, V36, P1217, DOI 10.1007/s10529-014-1487-4; Condon ET, 2007, J SURG RES, V140, P135, DOI 10.1016/j.jss.2007.01.008; Darby IA, 2014, CLIN COSMET INV DERM, V7, P301, DOI 10.2147/CCID.S50046; Ebihara N, 2007, INVEST OPHTH VIS SCI, V48, P3069, DOI 10.1167/iovs.06-0968; Ejaz S, 2009, FOOD CHEM TOXICOL, V47, P601, DOI 10.1016/j.fct.2008.12.018; Finnson KW, 2013, ADV WOUND CARE, V2, P195, DOI 10.1089/wound.2013.0429; Goette A, 2007, HEART, V93, P1056, DOI 10.1136/hrt.2005.087171; Gu Y, 2014, PPAR RES, V2014, DOI 10.1155/2014/464935; Hou HY, 2008, EXP EYE RES, V86, P983, DOI 10.1016/j.exer.2008.03.018; ISHIZAKI M, 1993, INVEST OPHTH VIS SCI, V34, P3320; Jaimes EA, 2007, AM J PHYSIOL-HEART C, V292, pH76, DOI 10.1152/ajpheart.00693.2006; Jensen K, 2013, DIGEST LIVER DIS, V45, P754, DOI 10.1016/j.dld.2013.02.023; Jeon HS, 2012, CYTOKINE, V59, P280, DOI 10.1016/j.cyto.2012.04.006; Jester JV, 1997, CORNEA, V16, P177; Jester JV, 2003, INVEST OPHTH VIS SCI, V44, P1850, DOI 10.1167/iovs.02-0973; Jetton JA, 2014, CORNEA, V33, P453, DOI 10.1097/ICO.0000000000000100; John G, 2014, CLIN SCI, V126, P207, DOI 10.1042/CS20130117; Kara S, 2015, SEMIN OPHTHALMOL, P1; Kiuchi K, 2008, INVEST OPHTH VIS SCI, V49, P1705, DOI 10.1167/iovs.07-0089; Lee HS, 2014, GRAEF ARCH CLIN EXP, V252, P951, DOI 10.1007/s00417-014-2633-3; Li T, 2011, MOL VIS, V17, P797; LIN NG, 1992, CURR EYE RES, V11, P899, DOI 10.3109/02713689209033487; Lu PR, 2007, CORNEA, V26, P199, DOI 10.1097/01.ico.0000248385.16896.34; Lu Q, 2011, AM J PHYSIOL-LUNG C, V301, pL847, DOI 10.1152/ajplung.00178.2011; Ma CZ, 2009, WOUND REPAIR REGEN, V17, P387, DOI 10.1111/j.1524-475X.2009.00478.x; Mabley J, 2011, INFLAMMATION, V34, P231, DOI 10.1007/s10753-010-9228-x; Nakao S, 2007, AM J PATHOL, V171, P1058, DOI 10.2353/ajpath.2007.070172; Okada Y, 2014, LAB INVEST, V94, P1030, DOI 10.1038/labinvest.2014.85; Okada Y, 2011, AM J PATHOL, V178, P2654, DOI 10.1016/j.ajpath.2011.02.043; Pakyari M, 2013, ADV WOUND CARE, V2, P215, DOI 10.1089/wound.2012.0406; Pan HW, 2011, MOL BIOL REP, V38, P4501, DOI 10.1007/s11033-010-0581-5; Park GJ, 2013, J PERIODONTAL RES, V48, P483, DOI 10.1111/jre.12030; Park YJ, 2008, VASC PHARMACOL, V49, P32, DOI 10.1016/j.vph.2008.05.001; Pons M, 2011, INVEST OPHTH VIS SCI, V52, P3842, DOI 10.1167/iovs.10-6254; Rehan VK, 2005, AM J PHYSIOL-LUNG C, V289, pL667, DOI 10.1152/ajplung.00358.2004; Schaal C, 2014, MOL CANCER RES, V12, P14, DOI 10.1158/1541-7786.MCR-13-0541; Shan HL, 2009, CARDIOVASC RES, V83, P465, DOI 10.1093/cvr/cvp130; Sharma GD, 2007, EXP EYE RES, V85, P289, DOI 10.1016/j.exer.2007.05.004; Sloniecka M, 2015, INT IMMUNOPHARMACOL, V29, P57, DOI 10.1016/j.intimp.2015.05.039; Snoek SA, 2010, BRIT J PHARMACOL, V160, P322, DOI 10.1111/j.1476-5381.2010.00699.x; Soeda J, 2012, BIOCHEM BIOPH RES CO, V417, P17, DOI 10.1016/j.bbrc.2011.10.151; Suner IJ, 2004, INVEST OPHTH VIS SCI, V45, P311, DOI 10.1167/iovs.03-0733; Ueno M, 2005, INVEST OPHTH VIS SCI, V46, P4097, DOI 10.1167/iovs.05-0548; White LA, 2000, BBA-GENE STRUCT EXPR, V1490, P259, DOI 10.1016/S0167-4781(00)00002-6; Wilson SE, 2007, EXP EYE RES, V85, P305, DOI 10.1016/j.exer.2007.06.009; Yang LL, 2010, TOXICOL PATHOL, V38, P560, DOI 10.1177/0192623310368983; Zengin MO, 2014, BRIT J OPHTHALMOL, V98, P233, DOI 10.1136/bjophthalmol-2013-304044; Zhou WJ, 2012, INT J OPHTHALMOL-CHI, V5, P251, DOI 10.3980/j.issn.2222-3959.2012.03.01	56	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179982	10.1371/journal.pone.0179982	http://dx.doi.org/10.1371/journal.pone.0179982			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644870	Green Published, gold, Green Submitted			2022-12-27	WOS:000404145100055
J	Lan, CC; Peng, CK; Tang, SE; Huang, KL; Wu, CP				Lan, Chou-Chin; Peng, Chung-Kan; Tang, Shih-En; Huang, Kun-Lun; Wu, Chin-Pyng			Carbonic anhydrase inhibitor attenuates ischemia-reperfusion induced acute lung injury	PLOS ONE			English	Article							THERAPEUTIC APPLICATIONS; ACETAZOLAMIDE; TRANSPLANTATION; HYPERCAPNIA; ACTIVATORS; CYTOKINES; PATHWAYS; RATS	Ischemia-reperfusion (IR)-induced acute lung injury (ALI) is implicated in several clinical conditions including lung transplantation, cardiopulmonary bypass surgery, re-expansion of collapsed lung from pneumothorax or pleural effusion and etc. IR-induced ALI remains a challenge in the current treatment. Carbonic anhydrase has important physiological function and influences on transport of CO2. Some investigators suggest that CO2 influences lung injury. Therefore, carbonic anhydrase should have the role in ALI. This study was undertaken to define the effect of a carbonic anhydrase inhibitor, acetazolamide (AZA), in IR-induced ALI, that was conducted in a rat model of isolated-perfused lung with 30 minutes of ischemia and 90 minutes of reperfusion. The animals were divided into six groups (n = 6 per group): sham, sham + AZA 200 mg/kg body weight (BW), IR, IR + AZA 100 mg/kg BW, IR + AZA 200 mg/kg BW and IR+ AZA 400 mg/kg BW. IR caused significant pulmonary microvascular hyper-permeability, pulmonary edema, pulmonary hypertension, neutrophilic sequestration, and an increase in the expression of pro-inflammatory cytokines. Increases in carbonic anhydrase expression and perfusate pCO(2) levels were noted, while decreased Na-K-ATPase expression was noted after IR. Administration of 200mg/kg BW and 400mg/kg BW AZA significantly suppressed the expression of pro-inflammatory cytokines (TNF-alpha, IL-1, IL-6 and IL-17) and attenuated IR-induced lung injury, represented by decreases in pulmonary hyper-permeability, pulmonary edema, pulmonary hypertension and neutrophilic sequestration. AZA attenuated IR-induced lung injury, associated with decreases in carbonic anhydrase expression and pCO2 levels, as well as restoration of Na-K-ATPase expression.	[Lan, Chou-Chin] Taipei Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Internal Med, Div Pulm Med, New Taipei, Taiwan; [Lan, Chou-Chin] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Peng, Chung-Kan; Tang, Shih-En; Huang, Kun-Lun] Triserv Gen Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan; [Peng, Chung-Kan; Tang, Shih-En; Huang, Kun-Lun] Natl Def Med Ctr, Inst Undersea & Hyperbar Med, Taipei, Taiwan; [Wu, Chin-Pyng] Li Shin Hosp, Dept Crit Care Med, Taichung, Tao Yuan County, Taiwan	Buddhist Tzu Chi General Hospital; Taipei Tzu Chi Hospital; Tzu Chi University; Tri-Service General Hospital; National Defense Medical Center	Huang, KL (corresponding author), Triserv Gen Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan.; Huang, KL (corresponding author), Natl Def Med Ctr, Inst Undersea & Hyperbar Med, Taipei, Taiwan.; Wu, CP (corresponding author), Li Shin Hosp, Dept Crit Care Med, Taichung, Tao Yuan County, Taiwan.	kun@ndmctsgh.edu.tw; chinpyng@mail.ndmctsgh.edu.tw	Wu, Chin-Pyng/W-8447-2019		Taipei Tzu Chi Hospital; Buddhist Tzu Chi Medical Foundation [TCRD-TPE-103-38, TCRD TPE-104-33]; Li-Shin Hospital [LS-2013-02, LS2014-02]	Taipei Tzu Chi Hospital; Buddhist Tzu Chi Medical Foundation; Li-Shin Hospital	This study was supported by grants from the Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation (TCRD-TPE-103-38 and TCRD TPE-104-33), and the Li-Shin Hospital (LS-2013-02 and LS2014-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrip.	An Y, 2013, CELL PHYSIOL BIOCHEM, V32, P1151, DOI 10.1159/000354515; Bejaoui M, 2015, J PHARMACOL EXP THER, V355, P191, DOI 10.1124/jpet.115.225177; Briva A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001238; BROMBERG BB, 1993, INVEST OPHTH VIS SCI, V34, P339; Chen J, 2008, AM J RESP CELL MOL, V38, P32, DOI 10.1165/rcmb.2007-0121OC; CRANDALL ED, 1978, J CLIN INVEST, V62, P618, DOI 10.1172/JCI109168; Effros RM, 2008, AM J RESP CELL MOL, V39, P124, DOI 10.1165/ajrcmb.39.1.124; Esbaugh AJ, 2006, RESP PHYSIOL NEUROBI, V154, P185, DOI 10.1016/j.resp.2006.03.007; Ferrari RS, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/590987; Guo FY, 2012, TRANSL STROKE RES, V3, P130, DOI 10.1007/s12975-011-0106-0; Kvarstein Gunnvald, 1997, Tidsskrift for den Norske Laegeforening, V117, P4251; Lan CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159922; Lehmann S, 2012, ANN THORAC SURG, V93, P913, DOI 10.1016/j.athoracsur.2011.11.033; Liang GY, 2011, ACTA CARDIOL, V66, P323, DOI 10.1080/AC.66.3.2114132; Lin PT, 2015, INT J CLIN EXP MED, V8, P12736; Lindskog S, 1997, PHARMACOL THERAPEUT, V74, P1, DOI 10.1016/S0163-7258(96)00198-2; Matalon S, 2015, AM J PHYSIOL-LUNG C, V309, pL1229, DOI 10.1152/ajplung.00319.2015; Sharma AK, 2011, AM J RESP CRIT CARE, V183, P1539, DOI 10.1164/rccm.201007-1173OC; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Supuran CT, 2011, FUTURE MED CHEM, V3, P1165, DOI [10.4155/fmc.11.69, 10.4155/FMC.11.69]; Thys F, 2001, RESUSCITATION, V49, P105, DOI 10.1016/S0300-9572(00)00339-7; Tsuang WM, 2013, ANN INTERN MED, V158, P650, DOI 10.7326/0003-4819-158-9-201305070-00004; Vadasz I, 2008, J CLIN INVEST, V118, P752, DOI 10.1172/JCI29723; Vadasz I, 2012, AM J RESP CELL MOL, V46, P417, DOI 10.1165/rcmb.2011-0395PS; Veldhuizen RAW, 2001, EUR RESPIR J, V17, P488, DOI 10.1183/09031936.01.17304880; Wang C, 2016, CYTOKINE, V83, P110, DOI 10.1016/j.cyto.2016.04.003; Wang JZ, 2014, LECT NOTES COMPUT SC, V8673, P73, DOI 10.1007/978-3-319-10404-1_10; Xu B, 2011, J SURG RES, V166, pE157, DOI 10.1016/j.jss.2010.11.902; Yu X, 2016, BIOMED PHARMACOTHER, V82, P489, DOI 10.1016/j.biopha.2016.05.025; Yumoto Masato, 2005, J Anesth, V19, P287, DOI 10.1007/s00540-005-0338-9	30	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179822	10.1371/journal.pone.0179822	http://dx.doi.org/10.1371/journal.pone.0179822			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644844	Green Published, Green Submitted, gold			2022-12-27	WOS:000404145100041
J	Lek, MT; Cruz, S; Ibe, NU; Beck, WHJ; Bielicki, JK; Weers, PMM; Narayanaswami, V				Lek, Mark T.; Cruz, Siobanth; Ibe, Nnejiuwa U.; Beck, Wendy H. J.; Bielicki, John K.; Weers, Paul M. M.; Narayanaswami, Vasanthy			Swapping the N- and C-terminal domains of human apolipoprotein E3 and Al reveals insights into their structure/activity relationship	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; RECEPTOR-BINDING DOMAIN; AMPHIPATHIC ALPHA-HELIX; CHOLESTEROL EFFLUX; MASS-SPECTROMETRY; APOA-I; CRYSTAL-STRUCTURE; LIPID ASSOCIATION; SELF-ASSOCIATION; AQUEOUS-SOLUTION	Apolipoprotein (apo) E3 and apoAl are exchangeable apolipoproteins that play a dominant role in regulating plasma lipoprotein metabolism. ApoE3 (299 residues) is composed of an N-terminal (NT) domain bearing a 4-helix bundle and a C-terminal (CT) domain bearing a series of amphipathic a-helices. ApoAl (243 residues) also comprises a highly helical NT domain and a less structured CT tail. The objective of this study was to understand their structural and functional role by generating domain swapped chimeras: apoE3-NT/apoAlCT and apoAl-NT/apoE-CT. The bacterially overexpressed chimeras were purified by affinity chromatography and their identity confirmed by immunoblotting and mass spectrometry. Their a-helical content was comparable to that of the parent proteins. ApoE3-NT/apoAl-CT retained the denaturation profile of apoE3 NT domain, with apoAl CT tail eliciting a relatively unstructured state; its lipid binding ability improved dramatically compared to apoE3 indicative of a significant role of apoAl CT tail in lipid binding interaction. The LDL receptor interaction and ability to promote ABCA1-mediated cholesterol efflux of apoE3-NT/apoAl-CT was comparable to that of apoE3. In contrast, apoAl-NT/apoE-CT elicited an unfolding pattern and lipid binding ability that were similar to that of apoAl. As expected, DMPC/apoAl-NT/ apoE-CT discoidal particles did not elicit LDLr binding ability, and promoted SR-B1 mediated cellular uptake of lipids to a limited extent. However, apoAl-NT/apoE-CT displayed an enhanced ability to promote cholesterol efflux compared to apoAl, indicative of a significant role for apoE CT domain in mediating this function. Together, these results indicate that the functional attributes of apoAl and apoE3 can be conferred on each other and that NT-CT domain interactions significantly modulate their structure and function.	[Lek, Mark T.; Cruz, Siobanth; Ibe, Nnejiuwa U.; Beck, Wendy H. J.; Weers, Paul M. M.; Narayanaswami, Vasanthy] Calif State Univ Long Beach, Dept Chem & Biochem, Long Beach, CA 90840 USA; [Bielicki, John K.] Lawrence Berkeley Natl Lab, Donner Lab, Berkeley, CA USA	California State University System; California State University Long Beach; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Narayanaswami, V (corresponding author), Calif State Univ Long Beach, Dept Chem & Biochem, Long Beach, CA 90840 USA.	vas.narayanaswami@csulb.edu		Narayanaswami, Vasanthy/0000-0001-7088-4057	National Institutes of Health/ National Institute of General Medical Sciences [GM105561, GM008074, GM089564]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM105561, T34GM008074, SC3GM089564] Funding Source: NIH RePORTER	National Institutes of Health/ National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by VN: National Institutes of Health/ National Institute of General Medical Sciences (GM105561) https//www.nigms.nih.gov/ Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript VN & NUI: National Institutes of Health/ National Institute of General Medical Sciences (GM008074) littps://www.nigms.nih.gov/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript PM MW: National Institutes of Health/ National Institute of General Medical Sciences (GM089564) https://www.nigms.nih.gov/ Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGERBECK LP, 1988, J BIOL CHEM, V263, P6249; Alexander ET, 2011, ARTERIOSCL THROM VAS, V31, P320, DOI 10.1161/ATVBAHA.110.216226; Beckstead JA, 2005, BIOCHEMISTRY-US, V44, P4591, DOI 10.1021/bi0477135; Bielicki JK, 2016, CURR OPIN LIPIDOL, V27, P40, DOI 10.1097/MOL.0000000000000258; Bielicki JK, 2010, J LIPID RES, V51, P1496, DOI 10.1194/jlr.M003665; Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291; Castellani LW, 2001, ARTERIOSCL THROM VAS, V21, P1870, DOI 10.1161/atvb.21.12.1870; Chen JL, 2011, P NATL ACAD SCI USA, V108, P14813, DOI 10.1073/pnas.1106420108; Chetty PS, 2013, J LIPID RES, V54, P1589, DOI 10.1194/jlr.M034785; Chetty PS, 2009, P NATL ACAD SCI USA, V106, P19005, DOI 10.1073/pnas.0909708106; Choy N, 2003, J MOL BIOL, V334, P527, DOI 10.1016/j.jmb.2003.09.059; DONOVAN JM, 1987, BIOCHEMISTRY-US, V26, P8116, DOI 10.1021/bi00399a015; Eichner JE, 2002, AM J EPIDEMIOL, V155, P487, DOI 10.1093/aje/155.6.487; Fabilane CS, 2016, PROTEIN PEPTIDE LETT, V23, P404, DOI 10.2174/0929866523666160223122257; Fan DP, 2004, BIOCHEMISTRY-US, V43, P5055, DOI 10.1021/bi035958w; Fisher C, 2004, BIOCHEMISTRY-US, V43, P1037, DOI 10.1021/bi035529y; Frank PG, 2000, J LIPID RES, V41, P853; Garai K, 2010, BIOCHEMISTRY-US, V49, P9533, DOI 10.1021/bi101407m; Getz GS, 2009, J LIPID RES, V50, pS156, DOI 10.1194/jlr.R800058-JLR200; Gursky O, 2013, J MOL BIOL, V425, P1, DOI 10.1016/j.jmb.2012.09.027; Hafiane A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131997; Hafiane A, 2014, BBA-MOL CELL BIOL L, V1841, P1498, DOI 10.1016/j.bbalip.2014.07.018; Holvoet P, 1998, J CLIN INVEST, V102, P379, DOI 10.1172/JCI3038; Huang RYC, 2011, BIOCHEMISTRY-US, V50, P9273, DOI 10.1021/bi2010027; JOHNSON JD, 1979, BIOCHEMISTRY-US, V18, P1292, DOI 10.1021/bi00574a027; Khumsupan P, 2011, BBA-BIOMEMBRANES, V1808, P352, DOI 10.1016/j.bbamem.2010.09.007; Kim SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135130; Krimbou L, 2004, J LIPID RES, V45, P839, DOI 10.1194/jlr.M300418-JLR200; Leman LJ, 2014, J MED CHEM, V57, P2169, DOI 10.1021/jm4005847; LI WH, 1988, J LIPID RES, V29, P245; Li XP, 2002, J BIOL CHEM, V277, P21149, DOI 10.1074/jbc.M200658200; Liadaki KN, 2000, J BIOL CHEM, V275, P21262, DOI 10.1074/jbc.M002310200; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Maletinska L, 2000, CANCER RES, V60, P2300; Mei XH, 2011, J BIOL CHEM, V286, P38570, DOI 10.1074/jbc.M111.260422; Narayanaswami V, 2001, J BIOL CHEM, V276, P37853; NG DS, 1995, ARTERIOSCL THROM VAS, V15, P2157, DOI 10.1161/01.ATV.15.12.2157; Nguyen D, 2014, BIOCHEMISTRY-US, V53, P4025, DOI 10.1021/bi500340z; Palgunachari MN, 1996, ARTERIOSCL THROM VAS, V16, P328, DOI 10.1161/01.ATV.16.2.328; Panagotopulos SE, 2002, J BIOL CHEM, V277, P39477, DOI 10.1074/jbc.M207005200; Patel AB, 2010, BIOCHEMISTRY-US, V49, P1766, DOI 10.1021/bi901902e; Perez K, 2006, J VIROL METHODS, V135, P254, DOI 10.1016/j.jviromet.2006.03.020; Phillips MC, 2014, J BIOL CHEM, V289, P24020, DOI 10.1074/jbc.R114.583658; Phillips MC, 2013, J LIPID RES, V54, P2034, DOI 10.1194/jlr.R034025; RUBIN EM, 1991, NATURE, V353, P265, DOI 10.1038/353265a0; SEGREST JP, 1994, ADV PROTEIN CHEM, V45, P303; SEGREST JP, 1992, J LIPID RES, V33, P141; SHIMANO H, 1995, J CLIN INVEST, V95, P469, DOI 10.1172/JCI117687; Sivashanmugam A, 2009, J BIOL CHEM, V284, P14657, DOI 10.1074/jbc.M901012200; SWANEY JB, 1978, J BIOL CHEM, V253, P7069; Thomas MJ, 2008, J LIPID RES, V49, P1875, DOI 10.1194/jlr.R800010-JLR200; Thuahnai ST, 2003, J LIPID RES, V44, P1132, DOI 10.1194/jlr.M200429-JLR200; Tran TN, 2014, BIOCHEMISTRY-US, V53, P361, DOI 10.1021/bi401404u; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Vedhachalam C, 2007, BIOCHEMISTRY-US, V46, P2583, DOI 10.1021/bi602407r; Vitali C, 2014, CARDIOVASC RES, V103, P405, DOI 10.1093/cvr/cvu148; von Eckardstein A, 2001, ARTERIOSCL THROM VAS, V21, P13, DOI 10.1161/01.ATV.21.1.13; Weers PMM, 2003, BIOPHYS CHEM, V100, P481, DOI 10.1016/S0301-4622(02)00300-9; Wei DS, 2004, ANAL BIOCHEM, V331, P401, DOI 10.1016/j.ab.2004.04.019; WESTERLUND JA, 1993, J BIOL CHEM, V268, P15745; WETTERAU JR, 1988, J BIOL CHEM, V263, P6240; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhang YH, 2007, BIOCHEMISTRY-US, V46, P10722, DOI 10.1021/bi700672v; Zheng Y, 2012, BIOCHEMISTRY-US, V51, P6400, DOI 10.1021/bi300626g; Zheng Y, 2011, BIOCHEMISTRY-US, V50, P4068, DOI 10.1021/bi2002955	67	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0178346	10.1371/journal.pone.0178346	http://dx.doi.org/10.1371/journal.pone.0178346			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644829	Green Submitted, Green Published, gold			2022-12-27	WOS:000404145100003
J	Zhou, L; Zeng, QY; Jin, SS; Cheng, GY				Zhou, Lin; Zeng, Qiyan; Jin, Shaosheng; Cheng, Guangyan			The impact of changes in dietary knowledge on adult overweight and obesity in China	PLOS ONE			English	Article							NUTRITION KNOWLEDGE; SOCIOECONOMIC-STATUS; TRENDS; ASSOCIATION; PREVALENCE	Overweight and obesity are rapidly growing threats in China. Improvement in dietary knowledge can potentially prevent overweight and obesity, conditions which are receiving substantial attention from international organizations and governments. The purpose of this study was to investigate the impact of changes in dietary knowledge on adult overweight and obesity, using a balanced panel data consisting of 10,401 samples from the 2006, 2009, and 2011 iterations of the China Health and Nutrition Survey. Results indicate that overweight and obesity are becoming increasingly problematic in China, and the level of dietary knowledge among Chinese adults needs improvement. Moreover, the empirical results indicate that changes in dietary knowledge among adults has no significant influence on adult overweight and obesity, a likely result of lacking systematic dietary knowledge and having inadequate guidance on overweight/obesity-related behaviors.	[Zhou, Lin; Cheng, Guangyan] Minist Agr, Inst Food & Nutr Dev, Beijing, Peoples R China; [Zeng, Qiyan] Renmin Univ China, Sch Agr Econ & Rural Dev, Beijing, Peoples R China; [Jin, Shaosheng] Zhejiang Univ, Sch Publ Affairs, CARD, Hangzhou, Zhejiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Renmin University of China; Zhejiang University	Jin, SS (corresponding author), Zhejiang Univ, Sch Publ Affairs, CARD, Hangzhou, Zhejiang, Peoples R China.	ssjin@zju.edu.cn		Zeng, Qiyan/0000-0002-8598-447X	National Natural Science Foundation of China [NNSFC-71273233]; Major Program of the Key Research Institute of Chinese Ministry of Education [15JJD790032]; Chinese Academic of Agricultural Science [ASTIPI FND-2016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Program of the Key Research Institute of Chinese Ministry of Education; Chinese Academic of Agricultural Science	Jin acknowledges funding support from the National Natural Science Foundation of China (NNSFC-71273233) and the Major Program of the Key Research Institute of Chinese Ministry of Education (No.15JJD790032). Zhou and Cheng acknowledge funding support from the Agricultural Science and Technology Innovation Program from Chinese Academic of Agricultural Science (ASTIPI FND-2016).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonaccio M, 2013, APPETITE, V68, P139, DOI 10.1016/j.appet.2013.04.026; Chou SY, 2004, J HEALTH ECON, V23, P565, DOI 10.1016/j.jhealeco.2003.10.003; Dallongeville J, 2001, PUBLIC HEALTH NUTR, V4, P27, DOI 10.1079/PHN200052; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Gomez CG, 2011, ARCH LATINOAM NUTR, V61, P396; International Food Policy Research Institute (IFPRI), 2016, GLOB NUTR REP 2016 P, DOI 10.2499/9780896295841; Jin SS, 2014, FOOD QUAL PREFER, V36, P144, DOI 10.1016/j.foodqual.2014.04.005; Lakdawalla D, 2009, ECON HUM BIOL, V7, P283, DOI 10.1016/j.ehb.2009.08.001; Laz TH, 2015, J COMMUN HEALTH, V40, P542, DOI 10.1007/s10900-014-9969-9; Liu RD, 2015, FOOD QUAL PREFER, V41, P103, DOI 10.1016/j.foodqual.2014.11.007; Misra A, 2011, INT J OBESITY, V35, P167, DOI 10.1038/ijo.2010.135; O'Brien G, 2007, HEALTH EDUC RES, V22, P571, DOI 10.1093/her/cyl119; Popkin B. M., 2003, Development Policy Review, V21, P581, DOI 10.1111/j.1467-8659.2003.00225.x; Qin XZ, 2016, HEALTH ECON, V25, P1291, DOI 10.1002/hec.3217; Reinehr T, 2003, NUTR RES, V23, P645, DOI 10.1016/S0271-5317(03)00025-3; Roemling C, 2012, APPETITE, V58, P1005, DOI 10.1016/j.appet.2012.02.053; Shimokawa S, 2013, FOOD POLICY, V38, P35, DOI 10.1016/j.foodpol.2012.09.001; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Sobal J., 1984, MARRIAGE FAM REV, V7, P115, DOI DOI 10.1300/J002V07N01_10; Thakur N, 1999, Fam Med, V31, P122; Tineke DV, 2009, APPETITE, V52, P788; Verweij LM, 2011, J OCCUP ENVIRON MED, V53, P722, DOI 10.1097/JOM.0b013e318222af9b; Villareal DT, 2005, OBES RES, V13, P1849, DOI 10.1038/oby.2005.228; Wagner MG, 2016, APPETITE, V100, P94, DOI 10.1016/j.appet.2016.02.002; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Zhang Q, 2004, OBES RES, V12, P1622, DOI 10.1038/oby.2004.202	28	26	27	10	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179551	10.1371/journal.pone.0179551	http://dx.doi.org/10.1371/journal.pone.0179551			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY7CO	28644891	gold, Green Published, Green Submitted			2022-12-27	WOS:000404145100022
J	Akerele, D; Ljolje, D; Talundzic, E; Udhayakumar, V; Lucchi, NW				Akerele, David; Ljolje, Dragan; Talundzic, Eldin; Udhayakumar, Venkatachalam; Lucchi, Naomi W.			Molecular diagnosis of Plasmodium ovale by photo-induced electron transfer fluorogenic primers: PET-PCR	PLOS ONE			English	Article							REAL-TIME PCR; WALLIKERI INFECTION; MALARIA; MICROSCOPY; FALCIPARUM; PARASITE; IDENTIFICATION; MALAYSIA; CURTISI; ASSAY	Accurate diagnosis of malaria infections continues to be challenging and elusive, especially in the detection of submicroscopic infections. Developing new malaria diagnostic tools that are sensitive enough to detect low-level infections, user friendly, cost effective and capable of performing large scale diagnosis, remains critical. We have designed novel self-quenching photo-induced electron transfer (PET) fluorogenic primers for the detection of P. ovale by real-time PCR. In our study, a total of 173 clinical samples, consisting of different malaria species, were utilized to test this novel PET-PCR primer. The sensitivity and specificity were calculated using nested-PCR as the reference test. The novel primer set demonstrated a sensitivity of 97.5% and a specificity of 99.2% (95% CI 85.2-99.8% and 95.2-99.9% respectively). Furthermore, the limit of detection for P. ovale was found to be 1 parasite/mu l. The PET-PCR assay is a new molecular diagnostic tool with comparable performance to other commonly used PCR methods. It is relatively easy to perform, and amiable to large scale malaria surveillance studies and malaria control and elimination programs. Further field validation of this novel primer will be helpful to ascertain the utility for large scale malaria screening programs.	[Akerele, David] Emory Med Ctr, Div Pediat Infect Dis, Atlanta, GA USA; [Ljolje, Dragan; Talundzic, Eldin] Atlanta Res & Educ Fdn, Decatur, GA USA; [Udhayakumar, Venkatachalam; Lucchi, Naomi W.] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Lucchi, NW (corresponding author), Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA.	Nlucchi@cdc.gov		Lucchi, Naomi/0000-0001-8789-8041	Malaria Branch; CDC; Atlanta Research and Education Foundation (AREF)	Malaria Branch; CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Atlanta Research and Education Foundation (AREF)	We would like to thank the Malaria Branch, CDC, and the Atlanta Research and Education Foundation (AREF) for supporting this project and Dr. John W. Barnwell for proving critical samples used in this study. We would also like to thank Dr. Colin Sutherland and his lab team at London School of Hygiene and Tropical Medicine for providing us with our P. ovale curtisi and P. ovale wallikeri clinical samples.	Calderaro A, 2007, J CLIN MICROBIOL, V45, P1624, DOI 10.1128/JCM.02316-06; Calderaro A, 2008, DIAGN MICR INFEC DIS, V61, P434, DOI 10.1016/j.diagmicrobio.2008.03.016; Chaturvedi N, 2015, T ROY SOC TROP MED H, V109, P352, DOI 10.1093/trstmh/trv015; Chavatte JM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0985-8; Cinquetti G, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-288; Cohen R, 2013, AM J TROP MED HYG, V89, P501, DOI 10.4269/ajtmh.12-0724; Collins WE, 2005, CLIN MICROBIOL REV, V18, P570, DOI 10.1128/CMR.18.3.570-581.2005; Diallo MA, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1485-1; Erdman Laura K, 2008, Travel Med Infect Dis, V6, P82, DOI 10.1016/j.tmaid.2007.10.001; Fuehrer HP, 2012, J CLIN MICROBIOL, V50, P4100, DOI 10.1128/JCM.02180-12; Nguyen HV, 2012, AM J TROP MED HYG, V87, P989, DOI 10.4269/ajtmh.2012.12-0047; Houze S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-284; Johnston SP, 2006, J CLIN MICROBIOL, V44, P1087, DOI 10.1128/JCM.44.3.1087-1089.2006; Lau YL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-389; Lee EY, 1999, CLIN INFECT DIS, V29, P697, DOI 10.1086/598667; Liew JWK, 2016, MALARIA J, V15, DOI 10.1186/s12936-015-1070-z; Lucchi NW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056677; Luo W, 2005, J CLIN MICROBIOL, V43, P1851, DOI 10.1128/JCM.43.4.1851-1857.2005; LYSENKO AJ, 1969, B WORLD HEALTH ORGAN, V40, P383; Maltha J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-171; Miller RH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003469; Mueller I, 2007, TRENDS PARASITOL, V23, P278, DOI 10.1016/j.pt.2007.04.009; O'Meara WP, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-118; Oguike MC, 2011, INT J PARASITOL, V41, P677, DOI 10.1016/j.ijpara.2011.01.004; Rojo-Marcos G, 2014, EMERG INFECT DIS, V20, P409, DOI 10.3201/eid2003.130745; Snounou G, 1996, Methods Mol Biol, V50, P263; Talundzic E, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-31; William T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002026; Win TT, 2004, EMERG INFECT DIS, V10, P1235, DOI 10.3201/eid1007.030411; Win TT, 2002, TROP MED INT HEALTH, V7, P231, DOI 10.1046/j.1365-3156.2002.00857.x; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; World Health Organization, 2015, WORLD MAL REP 2015	32	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179178	10.1371/journal.pone.0179178	http://dx.doi.org/10.1371/journal.pone.0179178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640824	Green Submitted, Green Published, gold			2022-12-27	WOS:000404135800020
J	Chen, J; Guo, W; Dang, XQ; Huang, YK; Liu, FY; Meng, XZ; An, YY; Long, MX; Bao, JL; Zhou, ZY; Xiang, ZH; Pan, GQ				Chen, Jie; Guo, Wei; Dang, Xiaoqun; Huang, Yukang; Liu, Fangyan; Meng, Xianzhi; An, Yaoyao; Long, Mengxian; Bao, Jialing; Zhou, Zeyang; Xiang, Zhonghuai; Pan, Guoqing			Easy labeling of proliferative phase and sporogonic phase of microsporidia Nosema bombycis in host cells	PLOS ONE			English	Article							POLAR TUBE PROTEINS; SPORE WALL PROTEIN; EMERGENT PATHOGENS; IDENTIFICATION; LOCALIZATION; ADHERENCE; SAMPLES	Microsporidia are eukaryotic, unicellular parasites that have been studied for more than 150 years. These organisms are extraordinary in their ability to invade a wide range of hosts including vertebrates and invertebrates, such as human and commercially important animals. A lack of appropriate labeling methods has limited the research of the cell cycle and protein locations in intracellular stages. In this report, an easy fluorescent labeling method has been developed to mark the proliferative and sporogonic phases of microsporidia Nosema bombycis in host cells. Based on the presence of chitin, Calcofluor White M2R was used to label the sporogonic phase, while beta-tubulin antibody coupled with fluorescence secondary antibody were used to label the proliferative phase by immunofluorescence. This method is simple, efficient and can be used on both infected cells and tissue slices, providing a great potential application in microsporidia research.	[Chen, Jie; Guo, Wei; Huang, Yukang; Liu, Fangyan; Meng, Xianzhi; An, Yaoyao; Long, Mengxian; Bao, Jialing; Zhou, Zeyang; Xiang, Zhonghuai; Pan, Guoqing] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Chen, Jie; Huang, Yukang; Liu, Fangyan; Meng, Xianzhi; An, Yaoyao; Long, Mengxian; Bao, Jialing; Zhou, Zeyang; Xiang, Zhonghuai; Pan, Guoqing] Minist Agr, Key Lab Sericultural Biol & Genet Breeding, Chongqing, Peoples R China; [Guo, Wei] Shandong Univ, State Key Lab Microbial Technol, Sch Life Sci, Jinan, Peoples R China; [Dang, Xiaoqun; Zhou, Zeyang] Chongqing Normal Univ, Coll Life Sci, Chongqing, Peoples R China	Southwest University - China; Ministry of Agriculture & Rural Affairs; Shandong University; Chongqing Normal University	Pan, GQ (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.; Pan, GQ (corresponding author), Minist Agr, Key Lab Sericultural Biol & Genet Breeding, Chongqing, Peoples R China.	gqpan@swu.edu.cn		Huang, Yukang/0000-0002-7108-8340	National Natural Science Foundation of China [31602012, 31470250, 31402138]; China Postdoctoral Science Foundation [2015M570763]; Fundamental Research Funds for the Central Universities [XDJK2015C004, XDJK2015A010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is supported by the grants from National Natural Science Foundation of China (No. 31602012, 31470250, 31402138); Project funded by China Postdoctoral Science Foundation (No. 2015M570763), and Fundamental Research Funds for the Central Universities (No. XDJK2015C004, XDJK2015A010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becnel JJ, 2014, MICROSPORIDIA: PATHOGENS OF OPPORTUNITY, 1ST EDITION, P521; Bouzahzah B, 2010, INFECT IMMUN, V78, P2745, DOI 10.1128/IAI.01205-09; Cali A, 2014, MICROSPORIDIA: PATHOGENS OF OPPORTUNITY, 1ST EDITION, P71; Campbell SE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003676; Chen J, 2013, PARASITOLOGY, V140, P1394, DOI 10.1017/S0031182013000875; Dang XQ, 2013, J INVERTEBR PATHOL, V112, P166, DOI 10.1016/j.jip.2012.10.009; Dubuffet A, 2013, APPL ENVIRON MICROB, V79, P385, DOI 10.1128/AEM.02699-12; Franzen C., 2008, OPEN PARASITOL J, V2, P1, DOI [10.2174/1874421400802010001, DOI 10.2174/1874421400802010001]; Graczyk TK, 2007, J CLIN MICROBIOL, V45, P1255, DOI 10.1128/JCM.01975-06; Green LC, 2000, J CLIN MICROBIOL, V38, P3811, DOI 10.1128/JCM.38.10.3811-3814.2000; Hazard EI, 1976, AGR TECHNICAL B, P104; Heinz E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004547; Kent ML, 2014, MICROSPORIDIA: PATHOGENS OF OPPORTUNITY, 1ST EDITION, P493; Lee SC, 2014, MICROSPORIDIA: PATHOGENS OF OPPORTUNITY, 1ST EDITION, P231; Li W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108279; Li Z, 2012, EUKARYOT CELL, V11, P229, DOI 10.1128/EC.05127-11; Liu H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01459; Liu H, 2016, ACTA BIOCH BIOPH SIN, V48, P246, DOI 10.1093/abbs/gmv140; Liu R, 2012, HUBEI AGR SCI, V51, P1797; [刘仁华 LIU Renhua], 2010, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V19, P53; LOM JII, 1963, ACTA PROTOZOOLOGICA, V1, P81; Luallen RJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005724; Moura H, 1997, ARCH PATHOL LAB MED, V121, P888; [潘国庆 Pan Guoqing], 2013, [蚕业科学, Acta Sericologica Sinica], V39, P310; Pan MH, 2007, IN VITRO CELL DEV-AN, V43, P101, DOI 10.1007/s11626-006-9009-x; Peterson TS, 2011, DIS AQUAT ORGAN, V95, P175, DOI 10.3354/dao02346; Polonais V, 2013, FEMS MICROBIOL LETT, V346, P36, DOI 10.1111/1574-6968.12198; Qiu HaiHong, 2014, African Journal of Biotechnology, V13, P2459; Reinke AW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14023; Santiana M, 2016, J EUKARYOT MICROBIOL, V63, P318, DOI 10.1111/jeu.12281; Stentiford GD, 2016, TRENDS PARASITOL, V32, P336, DOI 10.1016/j.pt.2015.12.004; Stentiford GD, 2013, TRENDS PARASITOL, V29, P567, DOI 10.1016/j.pt.2013.08.005; Troemel ER, 2008, PLOS BIOL, V6, P2736, DOI 10.1371/journal.pbio.0060309; Tsaousis AD, 2008, NATURE, V453, P553, DOI 10.1038/nature06903; VANGOOL T, 1993, J CLIN PATHOL, V46, P694, DOI 10.1136/jcp.46.8.694; Vavra J, 2014, MICROSPORIDIA: PATHOGENS OF OPPORTUNITY, 1ST EDITION, P1; Wang Y, 2015, PARASITOLOGY, V142, P534, DOI 10.1017/S0031182014001565; Wu ZL, 2008, PROTEOMICS, V8, P2447, DOI 10.1002/pmic.200700584; Yang DL, 2015, INFECT IMMUN, V83, P1715, DOI 10.1128/IAI.03155-14; Yang DL, 2014, J PARASITOL, V100, P623, DOI 10.1645/13-286.1; Zhang X, 2009, AGR SCI TECHNOLOGY, V10, P164; Zhao WX, 2015, PARASITOLOGY, V142, P865, DOI 10.1017/S0031182015000190	42	15	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179618	10.1371/journal.pone.0179618	http://dx.doi.org/10.1371/journal.pone.0179618			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640848	Green Submitted, gold, Green Published			2022-12-27	WOS:000404135800044
J	Wang, J; Wang, Q; Lu, DF; Zhou, FF; Wang, D; Feng, RL; Wang, K; Molday, R; Xie, J; Wen, TQ				Wang, Jiao; Wang, Qian; Lu, Dongfang; Zhou, Fangfang; Wang, Dong; Feng, Ruili; Wang, Kai; Molday, Robert; Xie, Jiang; Wen, Tieqiao			A biosystems approach to identify the molecular signaling mechanisms of TMEM30A during tumor migration	PLOS ONE			English	Article							CANCER-CELL INVASION; COLORECTAL-CANCER; DOWN-REGULATION; BREAST-CANCER; LUNG-CANCER; GTPASE AXIS; METASTASIS; ADHESION; NETWORK; CDC50A	Understanding the molecular mechanisms underlying cell migration, which plays an important role in tumor growth and progression, is critical for the development of novel tumor therapeutics. Overexpression of transmembrane protein 30A (TMEM30A) has been shown to initiate tumor cell migration, however, the molecular mechanisms through which this takes place have not yet been reported. Thus, we propose the integration of computational and experimental approaches by first predicting potential signaling networks regulated by TMEM30A using a) computational biology methods, b) our previous mass spectrometry results of the TMEM30A complex in mouse tissue, and c) a number of migration-related genes manually collected from the literature, and subsequently performing molecular biology experiments including the in vitro scratch assay and real-time quantitative polymerase chain reaction (qPCR) to validate the reliability of the predicted network. The results verify that the genes identified in the computational signaling network are indeed regulated by TMEM30A during cell migration, indicating the effectiveness of our proposed method and shedding light on the regulatory mechanisms underlying tumor migration, which facilitates the understanding of the molecular basis of tumor invasion.	[Wang, Jiao; Wang, Qian; Zhou, Fangfang; Wang, Dong; Feng, Ruili; Wen, Tieqiao] Shanghai Univ, Sch Life Sci, Lab Mol Neural Biol, Shanghai, Peoples R China; [Lu, Dongfang; Xie, Jiang] Shanghai Univ, Sch Comp Engn & Sci, Shanghai, Peoples R China; [Wang, Kai] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai Key Lab Mol Androl, Shanghai, Peoples R China; [Molday, Robert] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada	Shanghai University; Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of British Columbia	Wen, TQ (corresponding author), Shanghai Univ, Sch Life Sci, Lab Mol Neural Biol, Shanghai, Peoples R China.; Xie, J (corresponding author), Shanghai Univ, Sch Comp Engn & Sci, Shanghai, Peoples R China.	jiangx@shu.edu.cn; wtq@shu.edu.cn		WANG, kai/0000-0002-6194-0480	National Natural Science Foundation of China [31500827]; Natural Science Foundation of Shanghai [14ZR1414400]; Young Eastern Scholar [QD2015033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Young Eastern Scholar	This work was sponsored by the National Natural Science Foundation of China (Grant Number 31500827), the Natural Science Foundation of Shanghai (Grant Number 14ZR1414400), and Young Eastern Scholar (Grant Number QD2015033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoli G, 2017, BREAST, V31, P57, DOI 10.1016/j.breast.2016.10.004; Ahronian LG, 2016, ONCOGENE, V35, P4653, DOI 10.1038/onc.2016.2; Becker MS, 2016, ONCOTARGET, V7, P51908, DOI 10.18632/oncotarget.10188; Chikara S, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-016-1512-3; Clark AG, 2015, CURR OPIN CELL BIOL, V36, P13, DOI 10.1016/j.ceb.2015.06.004; Devis L, 2017, J PATHOL, V241, P475, DOI 10.1002/path.4851; Fan JA, 2010, CANCER BIOTHER RADIO, V25, P521, DOI 10.1089/cbr.2010.0784; Folmer DE, 2012, J HISTOCHEM CYTOCHEM, V60, P205, DOI 10.1369/0022155411435705; Fujino Y, 2017, CANCER SCI, V108, P390, DOI 10.1111/cas.13152; He XQ, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0633-8; Indovina P, 2017, J CELL PHYSIOL, V232, P129, DOI 10.1002/jcp.25397; Jacquemet G, 2015, CURR OPIN CELL BIOL, V36, P23, DOI 10.1016/j.ceb.2015.06.007; Ji ZW, 2015, SCI REP-UK, V5, DOI 10.1038/srep13291; Ji ZW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102798; Kato U, 2013, J BIOL CHEM, V288, P4922, DOI 10.1074/jbc.M112.402701; Khajah MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041847; Kikkawa Y, 2016, EXP CELL RES, V344, P76, DOI 10.1016/j.yexcr.2016.04.002; Kpetemey M, 2016, ONCOTARGET, V7, P54913, DOI 10.18632/oncotarget.10798; Krakhmal NV, 2015, ACTA NATURAE, V7, P17, DOI 10.32607/20758251-2015-7-2-17-28; Li CL, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2628-z; Li JJ, 2017, J BIOL CHEM, V292, P1112, DOI 10.1074/jbc.M116.750349; Li ZW, 2017, CELL DEATH DIFFER, V24, P59, DOI 10.1038/cdd.2016.95; Liang WC, 2015, ONCOTARGET, V6, P22513, DOI 10.18632/oncotarget.4154; Miyoshi N, 2010, ONCOL REP, V23, P505, DOI 10.3892/or_00000662; Poulter NS, 2015, INT J BIOCHEM CELL B, V66, P69, DOI 10.1016/j.biocel.2015.07.008; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Schmid SL, 2010, MOL BIOL CELL, V21, P3818, DOI 10.1091/mbc.E10-05-0386; Schwickert A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143993; Segal E, 2003, BIOINFORMATICS, V19, pi264, DOI 10.1093/bioinformatics/btg1037; Sun HW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168907; te Boekhorst V, 2016, ADV CANCER RES, V132, P209, DOI 10.1016/bs.acr.2016.07.005; Tung KH, 2013, CANCER LETT, V331, P58, DOI 10.1016/j.canlet.2012.12.001; Vestergaard AL, 2015, FEBS LETT, V589, P3908, DOI 10.1016/j.febslet.2015.11.031; Wang J, 2013, J NEUROSCI RES, V91, P1394, DOI 10.1002/jnr.23261; Wang J, 2012, MOL BIOSYST, V8, P2916, DOI 10.1039/c2mb25147g; Wang K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-164; Wang KF, 2017, CANCER LETT, V394, P1, DOI 10.1016/j.canlet.2016.12.036; Wang WS, 2010, DIS ESOPHAGUS, V23, P512, DOI 10.1111/j.1442-2050.2009.01035.x; Zegers Mirjam M, 2014, Small GTPases, V5, pe28997, DOI 10.4161/sgtp.28997; Zhang DJ, 2017, INT J CANCER, V140, P2298, DOI 10.1002/ijc.30656; Zhang X, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0181-x; Zhao Xing-Ming, 2009, Journal of Bioinformatics and Computational Biology, V7, P309, DOI 10.1142/S0219720009004138; Zimmermann Miriam, 2013, Methods Mol Biol, V986, P227, DOI 10.1007/978-1-62703-311-4_15	43	1	1	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179900	10.1371/journal.pone.0179900	http://dx.doi.org/10.1371/journal.pone.0179900			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640862	Green Published, Green Submitted, gold			2022-12-27	WOS:000404135800080
J	Fairhurst, MT; Scott, M; Deroy, O				Fairhurst, Merle T.; Scott, Minnie; Deroy, Ophelia			Voice over: Audio-visual congruency and content recall in the gallery setting	PLOS ONE			English	Article							TRIAL MULTISENSORY MEMORIES; SEMANTIC CONGRUENCY; SENSORY MODALITY; TERM-MEMORY; GENDER; FACES; INFORMATION; RECOGNITION; PERCEPTION; KNOWLEDGE	Experimental research has shown that pairs of stimuli which are congruent and assumed to 'go together' are recalled more effectively than an item presented in isolation. Will this multisensory memory benefit occur when stimuli are richer and longer, in an ecological setting? In the present study, we focused on an everyday situation of audio-visual learning and manipulated the relationship between audio guide tracks and viewed portraits in the galleries of the Tate Britain. By varying the gender and narrative style of the voice-over, we examined how the perceived congruency and assumed unity of the audio guide track with painted portraits affected subsequent recall. We show that tracks perceived as best matching the viewed portraits led to greater recall of both sensory and linguistic content. We provide the first evidence that manipulating crossmodal congruence and unity assumptions can effectively impact memory in a multisensory ecological setting, even in the absence of precise temporal alignment between sensory cues.	[Fairhurst, Merle T.; Deroy, Ophelia] Univ London, Sch Adv Study, Ctr Study Senses, London, England; [Fairhurst, Merle T.; Deroy, Ophelia] Ludwig Maximilians Univ Munchen, Munich Ctr Neurosci, Munich, Germany; [Scott, Minnie] Tate Leaning, London, England	University of London; University of London School of Advanced Study; University of Munich	Fairhurst, MT (corresponding author), Univ London, Sch Adv Study, Ctr Study Senses, London, England.; Fairhurst, MT (corresponding author), Ludwig Maximilians Univ Munchen, Munich Ctr Neurosci, Munich, Germany.	merle.fairhurst@gmail.com		Deroy, Ophelia/0000-0001-9431-3136	RTS-AHRC, within the Arts and Humanities Research Council 'Science in Culture' scheme [AH-L007053/1]; AHRC [AH/L007053/1] Funding Source: UKRI	RTS-AHRC, within the Arts and Humanities Research Council 'Science in Culture' scheme; AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	MerleT. Fairhurst and Ophelia Derory are funded by the RTS-AHRC grant (AH-L007053/1), within the Arts and Humanities Research Council 'Science in Culture' scheme.	Altieri N, 2015, BRAIN TOPOGR, V28, P479, DOI 10.1007/s10548-013-0333-7; Blank H, 2011, J NEUROSCI, P31; Blank H, 2015, HUM BRAIN MAPP, V36, P324, DOI 10.1002/hbm.22631; Brieber D, 2015, ACTA PSYCHOL, V154, P36, DOI 10.1016/j.actpsy.2014.11.004; Bulthoff I, 2015, COGNITION, V137, P9, DOI 10.1016/j.cognition.2014.12.006; Campanella S, 2007, TRENDS COGN SCI, V11, P535, DOI 10.1016/j.tics.2007.10.001; Chan JS, 2013, MULTISENS RES BRILL, V26, P184; de Boisferon AH, 2015, INFANCY, V20, P661, DOI 10.1111/infa.12088; Deroy O., 2013, CONSCIOUS COGN, V22; Deroy O, 2016, MULTISENS RES, V29, P29, DOI 10.1163/22134808-00002488; Fernald GM, 1921, J EDUC RES, V4, P355, DOI 10.1080/00220671.1921.10879216; Flom R., 2013, INTEGRATING FACE AND, P71, DOI [https://doi.org/10.1007/978-1-4614-3585-3_4, DOI 10.1007/978-1-4614-3585-3_4]; Goolkasian P, 2005, AM J PSYCHOL, V118, P61; GREEN KP, 1991, PERCEPT PSYCHOPHYS, V50, P524, DOI 10.3758/BF03207536; Heikkila J, 2016, EXP BRAIN RES, V234, P1199, DOI 10.1007/s00221-015-4341-6; Hyde DC, 2011, DEV PSYCHOBIOL, V53, P359, DOI 10.1002/dev.20525; Imai M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116494; Joassin F, 2011, NEUROIMAGE, V54, P1654, DOI 10.1016/j.neuroimage.2010.08.073; Kim RS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001532; Lachs L, 2004, ECOL PSYCHOL, V16, P159, DOI 10.1207/s15326969eco1603_1; Lee SG, 2016, IEEE T BIOMED ENG, V7486, P1, DOI DOI 10.1109/IEDM.2016.7838026; Lehmann S, 2005, COGNITIVE BRAIN RES, V24, P326, DOI 10.1016/j.cogbrainres.2005.02.005; Liu TT, 2012, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2012-4; Maria Montessori, 1912, MONTESSORI METHOD; Matusz PJ, 2015, EUR J NEUROSCI, V41, P699, DOI 10.1111/ejn.12804; Mavica LW, 2013, J EXP PSYCHOL HUMAN, V39, P307, DOI 10.1037/a0030945; McGettigan C, 2011, J COGNITIVE NEUROSCI, V23, P961, DOI 10.1162/jocn.2010.21491; Meyerhoff HS, 2016, MEM COGNITION, V44, P390, DOI 10.3758/s13421-015-0575-6; Moran ZD, 2013, MULTISENS RES, V26, P581, DOI 10.1163/22134808-00002436; Murray MM, 2004, NEUROIMAGE, V21, P125, DOI 10.1016/j.neuroimage.2003.09.035; Murray MM, 2005, NEUROIMAGE, V27, P473, DOI 10.1016/j.neuroimage.2005.04.016; Pa J, 2008, J COGNITIVE NEUROSCI, V20, P2198, DOI 10.1162/jocn.2008.20154; Papeo L, 2015, BRAIN LANG, V141, P135, DOI 10.1016/j.bandl.2014.11.011; Patterson ML, 2002, J EXP CHILD PSYCHOL, V81, P93, DOI 10.1006/jecp.2001.2644; Perrodin C, 2015, TRENDS COGN SCI, V19, P783, DOI 10.1016/j.tics.2015.09.002; POULINDUBOIS D, 1994, DEV PSYCHOL, V30, P436, DOI 10.1037/0012-1649.30.3.436; Quak M, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00197; Seitz AR, 2006, CURR BIOL, V16, P1422, DOI 10.1016/j.cub.2006.05.048; Shams L, 2008, TRENDS COGN SCI, V12, P411, DOI 10.1016/j.tics.2008.07.006; SPELKE ES, 1979, INFANT BEHAV DEV, V2, P13, DOI 10.1016/S0163-6383(79)80004-1; Spence C, 2011, ATTEN PERCEPT PSYCHO, V73, P971, DOI 10.3758/s13414-010-0073-7; Thelen A, 2015, COGNITION, V138, P148, DOI 10.1016/j.cognition.2015.02.003; Thelen A, 2013, MULTISENS RES, V26, P483, DOI 10.1163/22134808-00002426; THOMPSON VA, 1994, CAN J EXP PSYCHOL, V48, P380, DOI 10.1037/1196-1961.48.3.380; Vatakis A, 2007, PERCEPT PSYCHOPHYS, V69, P744, DOI 10.3758/BF03193776; von Kriegstein K, 2006, PLOS BIOL, V4, P1809, DOI 10.1371/journal.pbio.0040326; WALKER S, 1995, PERCEPT PSYCHOPHYS, V57, P1124, DOI 10.3758/BF03208369; WALKER-ANDREWS A S, 1991, Ecological Psychology, V3, P55, DOI 10.1207/s15326969eco0302_1; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; Yovel G, 2013, TRENDS COGN SCI, V17, P263, DOI 10.1016/j.tics.2013.04.004	50	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0177622	10.1371/journal.pone.0177622	http://dx.doi.org/10.1371/journal.pone.0177622			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY6UH	28636667	gold, Green Published, Green Submitted			2022-12-27	WOS:000404118300004
J	Kundu, AK; Iyer, SV; Chandra, S; Adhikari, AS; Iwakuma, T; Mandal, TK				Kundu, Anup K.; Iyer, Swathi V.; Chandra, Sruti; Adhikari, Amit S.; Iwakuma, Tomoo; Mandal, Tarun K.			Novel siRNA formulation to effectively knockdown mutant p53 in osteosarcoma	PLOS ONE			English	Article							GENE-THERAPY; PANCREATIC-CANCER; IN-VITRO; DELIVERY; NANOPARTICLES; TUMORS; CELLS; EXPRESSION; ADENOVIRUS; MUTATIONS	Objectives The tumor suppressor p53 plays a crucial role in the development of osteosarcoma. The primary objective of this study is to develop and optimize lipid based nanoparticle formulations that can carry siRNA and effectively silence mutant p53 in 318-1, a murine osteosarcoma cell line. Methods The nanoparticles were composed of a mixture of two lipids (cholesterol and DOTAP) and either PLGA or PLGA-PEG and prepared by using an EmulsiFlex-B3 high pressure homogenizer. A series of studies that include using different nanoparticles, different amount of siRNAs, cell numbers, incubation time, transfection media volume, and storage temperature was performed to optimize the gene silencing efficiency. Key findings Replacement of lipids by PLGA or PLGA-PEG decreased the particle size and overall cytotoxicity. Among all lipid-polymer nanoformulations, nanoparticles with 10% PLGA showed highest mutant p53 knockdown efficiency while maintaining higher cell viability when a nanoparticle to siRNA ratio equal to 6.8: 0.66 and 75 nM siRNA was used. With long term storage the mutant p53 knockdown efficiency decreased to a greater extent. Conclusions This study warrants a future evaluation of this formulation for gene silencing efficiency of mutant p53 in tissue culture and animal models for the treatment of osteosarcoma.	[Kundu, Anup K.; Mandal, Tarun K.] Xavier Univ, Ctr Nanomed & Drug Delivery, Coll Pharm, New Orleans, LA 70125 USA; [Kundu, Anup K.; Chandra, Sruti] Xavier Univ Louisiana, Dept Biol, New Orleans, LA 70125 USA; [Iyer, Swathi V.; Adhikari, Amit S.; Iwakuma, Tomoo] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA USA; [Iyer, Swathi V.; Adhikari, Amit S.; Iwakuma, Tomoo] Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA USA	Xavier University of Louisiana; Xavier University of Louisiana; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Kundu, AK (corresponding author), Xavier Univ, Ctr Nanomed & Drug Delivery, Coll Pharm, New Orleans, LA 70125 USA.; Kundu, AK (corresponding author), Xavier Univ Louisiana, Dept Biol, New Orleans, LA 70125 USA.	akundu@xula.edu		Iyer, Swathi/0000-0001-5686-2978	Louisiana Cancer Research Consortium, NIMHD [TL4GM118968, 5G12MD007595]; NIGMS [8UL1GM118967, R25GM060926]; NIH [1R01CA127481, R21CA129776, 1G12RR02626001]; Loui siana Board of Regents RC/EEP; LEQSF [(2007-12)-ENH-PKSFI-PRS-02]; Xavier University of Louisiana and LBRN Pilot; NATIONAL CANCER INSTITUTE [R01CA174735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [UL1GM118967] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007595] Funding Source: NIH RePORTER	Louisiana Cancer Research Consortium, NIMHD; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Loui siana Board of Regents RC/EEP; LEQSF; Xavier University of Louisiana and LBRN Pilot; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work is funded in part by the Louisiana Cancer Research Consortium, NIMHD grant number TL4GM118968 and 5G12MD007595, NIGMS grant number 8UL1GM118967 and R25GM060926, NIH grants1R01CA127481, R21CA129776, 1G12RR02626001, Loui siana Board of Regents RC/EEP (2007-11), and LEQSF (2007-12)-ENH-PKSFI-PRS-02, CUR from Xavier University of Louisiana and LBRN Pilot. The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	Adhikari AS, 2010, CANCER RES, V70, P4602, DOI 10.1158/0008-5472.CAN-09-3463; Apaolaza PS, 2016, BIOMATERIALS, V90, P40, DOI 10.1016/j.biomaterials.2016.03.004; Benjamin R, 2001, Hum Gene Ther, V12, P1591; Berman SD, 2008, P NATL ACAD SCI USA, V105, P11851, DOI 10.1073/pnas.0805462105; Chandra PK, 2012, MOL THER, V20, P1724, DOI 10.1038/mt.2012.107; Chen X, 2014, CELL REP, V7, P104, DOI 10.1016/j.celrep.2014.03.003; Davis ME, 2002, CURR OPIN BIOTECH, V13, P128, DOI 10.1016/S0958-1669(02)00294-X; De Paula D, 2007, RNA, V13, P431, DOI 10.1261/rna.459807; Denduluri Sahitya K, 2015, J Biomed Res, V30, DOI 10.7555/JBR.29.20150075; DiGiusto DL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000931; Du J, 2012, INT J MOL SCI, V13, P516, DOI 10.3390/ijms13010516; Eastham JA, 2000, J UROLOGY, V164, P814, DOI 10.1016/S0022-5347(05)67320-X; Gary DJ, 2007, J CONTROL RELEASE, V121, P64, DOI 10.1016/j.jconrel.2007.05.021; Gopalakrishnan AM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01534; Grayson ACR, 2006, PHARM RES-DORDR, V23, P1868, DOI 10.1007/s11095-006-9009-2; Hattori Y, 2015, BIOL PHARM BULL, V38, P30, DOI 10.1248/bpb.b14-00526; Heare T, 2009, CURR OPIN PEDIATR, V21, P365, DOI 10.1097/MOP.0b013e32832b1111; Hecker JG, 2016, METHODS MOL BIOL, V1382, P307, DOI 10.1007/978-1-4939-3271-9_23; Iyer SV, 2016, ONCOTARGET, V7, P5401, DOI 10.18632/oncotarget.6634; Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0; Kafri T, 1998, P NATL ACAD SCI USA, V95, P11377, DOI 10.1073/pnas.95.19.11377; Khan A, 2004, J DRUG TARGET, V12, P393, DOI 10.1080/10611860400003858; Kundu AK, 2012, INT J PHARMACEUT, V423, P525, DOI 10.1016/j.ijpharm.2011.11.040; Kundu AK, 2012, EUR J PHARM BIOPHARM, V80, P257, DOI 10.1016/j.ejpb.2011.10.023; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; LESOONWOOD LA, 1995, HUM GENE THER, V6, P395, DOI 10.1089/hum.1995.6.4-395; Lim YH, 2016, WILEY INTERDISCIP RE, V10, P1401; Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377; Mercade E, 2001, ANN ONCOL, V12, P379, DOI 10.1023/A:1011177223129; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; Nemunaitis J, 2000, J CLIN ONCOL, V18, P609, DOI 10.1200/JCO.2000.18.3.609; Ottaviani G, 2009, CANCER TREAT RES, V152, P3, DOI 10.1007/978-1-4419-0284-9_1; Overholtzer M, 2003, P NATL ACAD SCI USA, V100, P11547, DOI 10.1073/pnas.1934852100; Ren YA, 2016, CANCER RES, V76, P2206, DOI 10.1158/0008-5472.CAN-15-1046; Schiffelers RM, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh140; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Takahashi Shunji, 2006, Breast Cancer, V13, P8, DOI 10.2325/jbcs.13.8; Thomas CE, 2001, MOL THER, V3, P36, DOI 10.1006/mthe.2000.0224; Wunder JS, 2005, J CLIN ONCOL, V23, P1483, DOI 10.1200/JCO.2005.04.074; Zhao X, 2015, BIOMATERIALS, V46, P13, DOI 10.1016/j.biomaterials.2014.12.028; Zhdanov RI, 2002, BIOELECTROCHEMISTRY, V58, P53, DOI 10.1016/S1567-5394(02)00132-9	41	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179168	10.1371/journal.pone.0179168	http://dx.doi.org/10.1371/journal.pone.0179168			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636657	Green Submitted, Green Published, gold			2022-12-27	WOS:000404118300027
J	De Marco, C; Laudanna, C; Rinaldo, N; Oliveira, DM; Ravo, M; Weisz, A; Ceccarelli, M; Caira, E; Rizzuto, A; Zoppoli, P; Malanga, D; Viglietto, G				De Marco, Carmela; Laudanna, Carmelo; Rinaldo, Nicola; Oliveira, Duarte Mendes; Ravo, Maria; Weisz, Alessandro; Ceccarelli, Michele; Caira, Elvira; Rizzuto, Antonia; Zoppoli, Pietro; Malanga, Donatella; Viglietto, Giuseppe			Specific gene expression signatures induced by the multiple oncogenic alterations that occur within the PTEN/PI3K/AKT pathway in lung cancer	PLOS ONE			English	Article							MACROPHAGE INHIBITORY CYTOKINE-1; ACTIVATING TRANSCRIPTION FACTOR-3; CYCLIN-DEPENDENT KINASE; LIPOCALIN 2; INDUCED APOPTOSIS; AKT ACTIVATION; PHOSPHORYLATION; GROWTH; PTEN; P53	Hyperactivation of the phosphatydil-inositol-3' phosphate kinase (PI3K)/AKT pathway is observed in most NSCLCs, promoting proliferation, migration, invasion and resistance to therapy. AKT can be activated through several mechanisms that include loss of the negative regulator PTEN, activating mutations of the catalytic subunit of PI3K (PIK3CA) and/or mutations of AKT1 itself. However, number and identity of downstream targets of activated PI3K/AKT pathway are poorly defined. To identify the genes that are targets of constitutive PI3K/AKT signalling in lung cancer cells, we performed a comparative transcriptomic analysis of human lung epithelial cells (BEAS-2B) expressing active mutant AKT1 (AKT1-E17K), active mutant PIK3CA (PIK3CA-E545K) or that are silenced for PTEN. We found that, altogether, aberrant PI3K/AKT signalling in lung epithelial cells regulated the expression of 1,960/20,436 genes (9%), though only 30 differentially expressed genes (DEGs) (15 up-regulated, 12 down-regulated and 3 discordant) out of 20,436 that were common among BEAS-AKT1E17K, BEAS-PIK3CA-E545K and BEAS-shPTEN cells (0.1%). Conversely, DEGs specific for mutant AKT1 were 133 (85 up-regulated; 48 down-regulated), DEGs specific for mutant PIK3CA were 502 (280 up-regulated; 222 down-regulated) and DEGs specific for PTEN loss were 1549 (799 up-regulated, 750 down-regulated). The results obtained from array analysis were confirmed by quantitative RT-PCR on selected up-and down-regulated genes (n = 10). Treatment of BEAS-C cells and the corresponding derivatives with pharmacological inhibitors of AKT (MK2206) or PI3K (LY294002) further validated the significance of our findings. Moreover, mRNA expression of selected DEGs (SGK1, IGFBP3, PEG10, GDF15, PTGES, S100P, respectively) correlated with the activation status of the PI3K/AKT pathway assessed by S473 phosphorylation in NSCLC cell lines (n = 6). Finally, we made use of Ingenuity Pathway Analysis (IPA) to investigate the relevant BioFunctions enriched by the costitutive activation of AKT1-, PI3K-or PTEN-dependent signalling in lung epithelial cells. Expectedly, the analysis of the DEGs common to all three alterations highlighted a group of BioFunctions that included Cell Proliferation of tumor cell lines (14 DEGs), Invasion of cells (10 DEGs) and Migration of tumour cell lines (10 DEGs), with a common core of 5 genes (ATF3, CDKN1A, GDF15, HBEGF and LCN2) that likely represent downstream effectors of the pro-oncogenic activities of PI3K/AKT signalling. Conversely, IPA analysis of exclusive DEGs led to the identification of different downstream effectors that are modulated by mutant AKT1 (TGFBR2, CTSZ, EMP1), mutant PIK3CA (CCND2, CDK2, IGFBP2, TRIB1) and PTEN loss (ASNS, FHL2). These findings not only shed light on the molecular mechanisms that are activated by aberrant signalling through the PI3K/AKT pathway in lung epithelial cells, but also contribute to the identification of previously unrecognised molecules whose regulation takes part in the development of lung cancer.	[De Marco, Carmela; Laudanna, Carmelo; Oliveira, Duarte Mendes; Caira, Elvira; Zoppoli, Pietro; Malanga, Donatella; Viglietto, Giuseppe] Magna Graecia Univ Catanzaro, Dipartimento Med Sperimentale & Clin, Catanzaro, Italy; [Rinaldo, Nicola; Viglietto, Giuseppe] Biogem Scarl, Inst Rihe Genet Gaetano Salvatore, Ariano Irpino, Italy; [Ravo, Maria; Weisz, Alessandro] Univ Salerno, Lab Med Mol & Genom, Fac Med & Chirurg, Baronissi, Italy; [Ceccarelli, Michele] Univ Sannio, Dipartimento Biol & Ambientali, Benevento, Italy; [Rizzuto, Antonia] Magna Graecia Univ Catanzaro, Dipartimento Sci Med & Chirurg, Catanzaro, Italy	Magna Graecia University of Catanzaro; University of Salerno; University of Sannio; Magna Graecia University of Catanzaro	Zoppoli, P (corresponding author), Magna Graecia Univ Catanzaro, Dipartimento Med Sperimentale & Clin, Catanzaro, Italy.	zoppoli.pietro@gmail.com; viglietto@unicz.it	ravegnini, gloria/K-1330-2016; Viglietto, Giuseppe/AAC-2852-2019; rizzuto, antonia/GVT-4842-2022; De Marco, Carmela/J-6797-2015; Zoppoli, Pietro/J-9954-2018; Ceccarelli, Michele/AGP-1739-2022; Malanga, Donatella/J-4877-2018; Weisz, Alessandro/A-1317-2014	ravegnini, gloria/0000-0002-7774-402X; Viglietto, Giuseppe/0000-0003-2327-7515; rizzuto, antonia/0000-0003-4359-4702; De Marco, Carmela/0000-0002-4893-4246; Zoppoli, Pietro/0000-0002-7860-9655; Malanga, Donatella/0000-0002-0491-7698; Weisz, Alessandro/0000-0003-0455-2083; Mendes Oliveira, Duarte/0000-0003-3922-3060; LAUDANNA, Carmelo/0000-0002-0397-6020; Ravo, Maria/0000-0003-1003-2922	Associazione Italiana Ricerca sul Cancro (Al RC) [IG-12969, IG-17426]; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) [2010W4J4RM_001, PON01_27082]; Ministero Italiano per la Salute (Young Researcher Grants) [GR- 2011-02350476]	Associazione Italiana Ricerca sul Cancro (Al RC)(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Ministero Italiano per la Salute (Young Researcher Grants)	This work was supported by grants from the Associazione Italiana Ricerca sul Cancro (Al RC) to GV (IG-12969) and to AW (IG-17426), from Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) (2010W4J4RM_001 and PON01_27082) to GV and from Ministero Italiano per la Salute to MR (Young Researcher Grants, GR- 2011-02350476). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio N, 2010, AM J PATHOL, V177, P2622, DOI 10.2353/ajpath.2010.091075; [Anonymous], INT J PHOTOENERGY, DOI DOI 10.1186/1476-511X-13-189; Anttila MA, 1999, BRIT J CANCER, V79, P1870, DOI 10.1038/sj.bjc.6690298; Balsara BR, 2004, CARCINOGENESIS, V25, P2053, DOI 10.1093/carcin/bgh226; Basil CF, 2006, CANCER RES, V66, P2953, DOI 10.1158/0008-5472.CAN-05-3433; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Boespflug ND, 2014, BLOOD, V123, P2084, DOI 10.1182/blood-2013-06-510909; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Brown DA, 2006, CLIN CANCER RES, V12, P89, DOI 10.1158/1078-0432.CCR-05-1331; Brown DA, 2003, CLIN CANCER RES, V9, P2642; Brown DA, 2009, CLIN CANCER RES, V15, P6658, DOI 10.1158/1078-0432.CCR-08-3126; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Bukholm IK, 2000, VIRCHOWS ARCH, V436, P224, DOI 10.1007/s004280050034; Caffo O, 1996, CLIN CANCER RES, V2, P1591; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Chen YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106812; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cicatiello L, 2010, AM J PATHOL, V176, P2113, DOI 10.2353/ajpath.2010.090837; Datta S.R., 1999, CELLULAR SURVIVAL PL; De Marco C, 2015, ONCOTARGET, V6, P39634, DOI 10.18632/oncotarget.4022; Ding GX, 2015, PROSTATE, V75, P957, DOI 10.1002/pros.22978; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Gartel AL, 2006, MOL CANCER THER, V5, P1385, DOI 10.1158/1535-7163.MCT-06-0163; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Hettmer S, 2015, ELIFE, V4, DOI 10.7554/eLife.09436; Hirsch FR, 2004, THYMUS HEART, V7, P16; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Jackson RJ, 2002, ONCOGENE, V21, P8486, DOI 10.1038/sj.onc.1205946; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jiang XJ, 2016, ANTICANCER RES, V36, P509; Karan D, 2003, BIOCHEM BIOPH RES CO, V305, P598, DOI 10.1016/S0006-291X(03)00823-4; Kawauchi J, 2002, J BIOL CHEM, V277, P39025, DOI 10.1074/jbc.M202974200; Kim KW, 2008, ASIAN SPINE J, V2, P1, DOI 10.4184/asj.2008.2.1.1; Koh SA, 2015, ONCOL REP, V34, P2179, DOI 10.3892/or.2015.4189; Koopmann J, 2004, CLIN CANCER RES, V10, P2386, DOI 10.1158/1078-0432.CCR-03-0165; Lee DH, 2003, CANCER RES, V63, P4648; Leng XH, 2009, CANCER RES, V69, P8579, DOI 10.1158/0008-5472.CAN-09-1934; Leung L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046677; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Lim WT, 2007, ONCOL REP, V17, P853; Lin CW, 2012, ORAL DIS, V18, P734, DOI 10.1111/j.1601-0825.2012.01938.x; Liu YF, 2016, FEBS LETT, V590, P2594, DOI 10.1002/1873-3468.12304; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu S, 2006, INT J ONCOL, V28, P245; Malanga D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147334; Malanga D, 2015, ONCOTARGET, V6, P42667, DOI 10.18632/oncotarget.5626; Mandal M, 1998, ONCOGENE, V16, P217, DOI 10.1038/sj.onc.1201529; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Memmott RM, 2010, CLIN CANCER RES, V16, P4, DOI 10.1158/1078-0432.CCR-09-0234; Mimeault M, 2010, J CELL PHYSIOL, V224, P626, DOI 10.1002/jcp.22196; Minna JD, 2002, CANCER CELL, V1, P49, DOI 10.1016/S1535-6108(02)00027-2; Mongre R, 2016, INT J ONCOL, V48, P84, DOI 10.3892/ijo.2015.3245; Nakagomi S, 2003, J NEUROSCI, V23, P5187; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Nobori K, 2002, J MOL CELL CARDIOL, V34, P1387, DOI 10.1006/jmcc.2002.2091; Ogawa M, 2001, INT J MOL MED, V7, P479; Okano J, 2000, J BIOL CHEM, V275, P30934, DOI 10.1074/jbc.M004112200; Papadimitrakopoulou V, 2006, J THORAC ONCOL, V1, P749, DOI 10.1016/S1556-0864(15)30399-3; Reddel RR, 1998, ANN NY ACAD SCI, V854, P8, DOI 10.1111/j.1749-6632.1998.tb09887.x; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; Rossig L, 2001, MOL CELL BIOL, V21, P5644, DOI 10.1128/MCB.21.16.5644-5657.2001; Roth P, 2010, CLIN CANCER RES, V16, P3851, DOI 10.1158/1078-0432.CCR-10-0705; SAMBROOK J, 1992, MOL CLONING LAB MANU; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scrima M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030427; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; St Germain C, 2010, NEOPLASIA, V12, P527, DOI 10.1593/neo.92048; Tang JM, 2006, LUNG CANCER, V51, P181, DOI 10.1016/j.lungcan.2005.10.003; Thompson MR, 2009, J MOL MED, V87, P1053, DOI 10.1007/s00109-009-0520-x; Tran Hien, 2003, Sci STKE, V2003, pRE5, DOI 10.1126/stke.2003.172.re5; Tsao AS, 2003, CANCER EPIDEM BIOMAR, V12, P660; Tsui KH, 2012, J MOL ENDOCRINOL, V49, P153, DOI 10.1530/JME-11-0149; Tsurutani J, 2006, J CLIN ONCOL, V24, P306, DOI 10.1200/JCO.2005.02.4133; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Wang A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-268; Wang J, 2011, PLOS ONE, V6; Wang Z, 2015, ONCOGENE, V34, P4975, DOI 10.1038/onc.2014.426; Wilhelm F, 2015, GROWTH HORM IGF RES, V25, P115, DOI 10.1016/j.ghir.2015.03.003; Wu M, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.68; Xu Cheng-Xiong, 2010, Front Biosci (Elite Ed), V2, P1472; Xu JB, 2007, LUNG CANCER, V58, P36, DOI 10.1016/j.lungcan.2007.04.019; Yamaguchi K, 2004, J BIOL CHEM, V279, P49617, DOI 10.1074/jbc.M408796200; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Zareen N, 2013, CELL DEATH DIFFER, V20, P1719, DOI 10.1038/cdd.2013.128; Zhang L, 2017, EFFECTS IGF 1 INF AL; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032; Zhou GL, 2003, MOL CELL BIOL, V23, P8058, DOI 10.1128/MCB.23.22.8058-8069.2003	94	40	41	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0178865	10.1371/journal.pone.0178865	http://dx.doi.org/10.1371/journal.pone.0178865			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662101	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300010
J	Garza, DA; Riley, SP; Martinez, JJ				Garza, Daniel A.; Riley, Sean P.; Martinez, Juan J.			Expression of Rickettsia Adr2 protein in E-coli is sufficient to promote resistance to complement- mediated killing, but not adherence to mammalian cells	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; MEDITERRANEAN SPOTTED-FEVER; CRYSTAL-STRUCTURE; CONORII; INVASION; INFECTION; VITRONECTIN; ROMPB	Bacteria exposed to host serum are subject to the antibacterial effects to the complement system. However, pathogenic microorganisms have evolved mechanisms of evading this immune attack. We have previously demonstrated that at least two R. conorii antigens, RC1281/Adr1 and OmpB beta-peptide, contribute to the evasion of complement-mediated killing by binding the complement regulatory proteins vitronectin and factor H. RC1282/Adr2, a protein related to Adr1, is predicted to share similar structural features, suggesting that this protein may also contribute to evasion of complement-mediated killing. Interestingly, the R. prowazekii Adr1 and Adr2(RP828) proteins were originally found to interact with host cell surface proteins, suggesting their putative roles as adhesins in this pathogenic rickettsial species. In this study, we expressed both R. conorii and R. prowazekii Adr2 on the surface of a non-adherent, serum-sensitive strain of E. coli to examine the potential role of this protein to mediate evasion of complement-mediated killing and adherence to host cells. We demonstrate that, similar to R. conorii Adr1, R. conorii and R. prowazekii Adr2 are sufficient to mediate serum resistance and to promote interaction with the host complement regulator vitronectin. Furthermore, we demonstrate that expression of Adr2 in a non-adherent strain of E. coli is insufficient to mediate adherence to cultured mammalian endothelial cells. Together, our data demonstrate that the R. conorii and R. prowazekii Adr2 protein does not participate in the interactions with mammalian cells, but rather, participates in the evasion of killing by complement.	[Garza, Daniel A.; Riley, Sean P.; Martinez, Juan J.] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Vector Borne Dis Labs, Baton Rouge, LA 70803 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Martinez, JJ (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Vector Borne Dis Labs, Baton Rouge, LA 70803 USA.	jmartinez@lsu.edu	Martinez, Juan/GXM-4393-2022	Riley, Sean P/0000-0002-4384-4540	The National Institues of Health, National Institute of Allergy and Infectious Diseases [AI072606, AI10392]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI103912, R01AI072606] Funding Source: NIH RePORTER	The National Institues of Health, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in part by awards from The National Institues of Health, National Institute of Allergy and Infectious Diseases (AI072606 and AI10392) to JJM. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Balraj P, 2009, ANN NY ACAD SCI, V1166, P94, DOI 10.1111/j.1749-6632.2009.04517.x; Cardwell MM, 2009, INFECT IMMUN, V77, P5272, DOI 10.1128/IAI.00201-09; Chan YGY, 2009, CELL MICROBIOL, V11, P629, DOI 10.1111/j.1462-5822.2008.01279.x; Chan YGY, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00139; Chan YGY, 2011, INFECT IMMUN, V79, P2303, DOI 10.1128/IAI.01324-10; Crespo P, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1042-3; Espejo E, 2016, EPIDEMIOLOGY INFECT, P1; Fish AI, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00061; Garcia-Magallon B, 2015, REV ESP SALUD PUBLIC, V89, P321, DOI 10.4321/S1135-57272015000300009; Gong W, 2014, VACCINE, V32, P2027; Gong WP, 2015, VACCINE, V33, P985, DOI 10.1016/j.vaccine.2015.01.017; Gong WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100253; Hillman RD, 2013, CELL MICROBIOL, V15, P727, DOI 10.1111/cmi.12068; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Lee JH, 2013, PROTEIN SCI, V22, P1425, DOI 10.1002/pro.2322; Lewis LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001027; Li M, 2015, ACTA CRYSTALLOGR D, V71, P2109, DOI 10.1107/S1399004715013905; Madasu Y, 2013, P NATL ACAD SCI USA, V110, pE2677, DOI 10.1073/pnas.1307235110; Martinez JJ, 2004, J CELL SCI, V117, P5097, DOI 10.1242/jcs.01382; Otterdal K, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.05.010; Renesto P, 2006, RES MICROBIOL, V157, P605, DOI 10.1016/j.resmic.2006.02.002; Riley SP, 2014, CELL MICROBIOL, V16, P849, DOI 10.1111/cmi.12243; Riley SP, 2012, INFECT IMMUN, V80, P2735, DOI 10.1128/IAI.00349-12; Riley SP, 2010, INFECT IMMUN, V78, P1895, DOI 10.1128/IAI.01165-09; Rovery C, 2008, EMERG INFECT DIS, V14, P1360, DOI 10.3201/eid1409.071133; Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9; Singh B, 2010, MOL MICROBIOL, V78, P545, DOI 10.1111/j.1365-2958.2010.07373.x; Thanassi DG, 1998, P NATL ACAD SCI USA, V95, P3146, DOI 10.1073/pnas.95.6.3146; Uchiyama T, 2006, MICROBES INFECT, V8, P801, DOI 10.1016/j.micinf.2005.10.003; Vandeputte-Rutten L, 2003, J BIOL CHEM, V278, P24825, DOI 10.1074/jbc.M302803200; Vellaiswamy M, 2011, MICROB PATHOGENESIS, V50, P233, DOI 10.1016/j.micpath.2011.01.009; Walker DH, 2008, NAT REV MICROBIOL, V6, P375, DOI 10.1038/nrmicro1866	32	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179544	10.1371/journal.pone.0179544	http://dx.doi.org/10.1371/journal.pone.0179544			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662039	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300032
J	Pfeiffer, D; Rossmanith, E; Lang, I; Falkenhagen, D				Pfeiffer, Dagmar; Rossmanith, Eva; Lang, Ingrid; Falkenhagen, Dieter			miR-146a, miR-146b, and miR-155 increase expression of IL-6 and IL-8 and support HSP10 in an In vitro sepsis model	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; ENDOTHELIAL-CELL; ADHESION MOLECULES; ACTIVATION; LIPOPOLYSACCHARIDE; INFLAMMATION; MODULATION; MICRORNAS; SHOCK	microRNAs (miRNAs) play an essential role in inflammation processes including sepsis. This study aimed to identify miRNAs as candidates for therapies that are involved in the innate immune response and to assess their potential functions in the activation of the endothelium. We stimulated THP-1 monocytes with 10 ng/ml LPS for 4 h and used the supernatant for the stimulation of human umbilical vein endothelial cells (HUVEC) or human pulmonary microvascular endothelial cells (HPMEC) for 16 h. miRNA array analysis (of 1,891 miRNAs) identified a 1.5-fold upregulation of miR-146a, miR-146b, and miR-155 in stimulated endothelial cells. HUVEC were transfected with miRNA inhibitors for miR-146a, miR-146b, and miR-155 to investigate the function of these miRNAs in endothelial inflammatory pathways. Inhibition of miR-146a resulted in a diminished release of interleukin (IL)-6 and IL-8 by respective 68% and 55% (P<0.001). Inhibition of miR-146b reduced the expression of IL-6 by 49% (P<0.001). Inhibition of miR-155 reduced the expression of IL-6 and IL-8 by respective 31% (P<0.001) and 14%. The inhibition of miR-146a, miR-146b, and miR-155 reduced the release of HSP10 by 50%, 35%, and 69% (P<0.05), respectively, but did not influence the expression of HSP27 or TXA2. In conclusion, miR-146a, miR-146b, and miR-155 are exerting anti-inflammatory properties by down-regulating IL-6 and IL-8, and influencing the expression of HSP10 in the activated endothelium. We provide evidence for the central role of selected miRNAs in sepsis and their use in the development of small interfering RNA therapeutics to target immune cells and sepsis pathways.	[Pfeiffer, Dagmar; Lang, Ingrid] Med Univ Graz, Inst Cell Biol Histol & Embryol, Graz, Austria; [Pfeiffer, Dagmar; Rossmanith, Eva; Falkenhagen, Dieter] Danube Univ Krems, Ctr Biomed Technol, Krems, Austria	Medical University of Graz; Danube University Krems	Pfeiffer, D (corresponding author), Med Univ Graz, Inst Cell Biol Histol & Embryol, Graz, Austria.; Pfeiffer, D (corresponding author), Danube Univ Krems, Ctr Biomed Technol, Krems, Austria.	Dagmar.Pfeiffer@medunigraz.at		Brislinger, Dagmar/0000-0002-7319-5377; Lang-Olip, Ingrid/0000-0003-0403-4884	Niederosterreichische Forschungs-und Bildungsges	Niederosterreichische Forschungs-und Bildungsges	This work was supported by the Niederosterreichische Forschungs-und Bildungsges. m.b.H (NFB). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexy T, 2014, PHYSIOL GENOMICS, V46, P833, DOI 10.1152/physiolgenomics.00079.2014; Athanasas-Platsis S, 2004, IMMUNOL CELL BIOL, V82, P361, DOI 10.1111/j.0818-9641.2004.01260.x; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Cheng HS, 2013, EMBO MOL MED, V5, P1017, DOI 10.1002/emmm.201202318; Cheng Y, 2012, INFLAMMATION, V35, P1308, DOI 10.1007/s10753-012-9443-8; DAMAS P, 1989, CRIT CARE MED, V17, P975, DOI 10.1097/00003246-198910000-00001; Diestel A, 2008, CRYOBIOLOGY, V57, P216, DOI 10.1016/j.cryobiol.2008.08.005; Fish JE, 2012, J CLIN INVEST, V122, P1967, DOI 10.1172/JCI63818; Giuliano John S Jr, 2011, Open Inflamm J, V4, P49; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Henderson B, 2010, CELL BIOCHEM FUNCT, V28, P1, DOI 10.1002/cbf.1609; Ince C, 2016, J APPL PHYSIOL, V120, P226, DOI 10.1152/japplphysiol.00298.2015; Jersmann HPA, 2001, INFECT IMMUN, V69, P1273, DOI 10.1128/IAI.69.3.1273-1279.2001; Jia Haibo, 2011, Int J Biochem Mol Biol, V2, P47; Johnson BJ, 2005, J BIOL CHEM, V280, P4037, DOI 10.1074/jbc.M411569200; Kjaergaard AG, 2013, BASIC CLIN PHARMACOL, V113, P273, DOI 10.1111/bcpt.12091; Kumar S, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.39; MA G, 1978, TISSUE CULTURE ASS M, V4, P5; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; McCall MN, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-78; Nooteboom A, 2006, CLIN EXP IMMUNOL, V144, P362, DOI 10.1111/j.1365-2249.2006.03074.x; Quinn SR, 2011, INT IMMUNOL, V23, P421, DOI 10.1093/intimm/dxr034; Schildberger A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/697972; Schildberger A, 2010, INNATE IMMUN-LONDON, V16, P278, DOI 10.1177/1753425909341885; Schwanzer-Pfeiffer D, 2010, CELL IMMUNOL, V263, P65, DOI 10.1016/j.cellimm.2010.02.017; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P50, DOI 10.1136/ard.2008.100289; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Suarez Y, 2010, J IMMUNOL, V184, P21, DOI 10.4049/jimmunol.0902369; Sun XH, 2012, J CLIN INVEST, V122, P1973, DOI 10.1172/JCI61495; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Vasa-Nicotera M, 2011, ATHEROSCLEROSIS, V217, P326, DOI 10.1016/j.atherosclerosis.2011.03.034; Wu XY, 2014, J CELL BIOCHEM, V115, P1928, DOI 10.1002/jcb.24864; Zhu K, 2013, CARCINOGENESIS, V34, P2071, DOI 10.1093/carcin/bgt160	35	56	62	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179850	10.1371/journal.pone.0179850	http://dx.doi.org/10.1371/journal.pone.0179850			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662100	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300059
J	Wettenschwiler, PD; Annaheim, S; Lorenzetti, S; Ferguson, SJ; Stampfli, R; Psikuta, A; Rossi, RM				Wettenschwiler, Patrick D.; Annaheim, Simon; Lorenzetti, Silvio; Ferguson, Stephen J.; Stampfli, Rolf; Psikuta, Agnes; Rossi, Rene M.			Validation of an instrumented dummy to assess mechanical aspects of discomfort during load carriage	PLOS ONE			English	Article							PRESSURE MEASUREMENTS; SUBJECTIVE RESPONSES; SHOULDER INTERFACE; HUMAN LOCOMOTION; MEDICAL ASPECTS; BACK-PAIN; SYSTEMS; GAIT; MASS; PERCEPTIONS	Due to the increasing load in backpacks and other load carriage systems over the last decades, load carriage system designs have to be adapted accordingly to minimize discomfort and to reduce the risk of injury. As subject studies are labor-intensive and include further challenges such as intra-subject and inter-subject variability, we aimed to validate an instrumented dummy as an objective laboratory tool to assess the mechanical aspects of discomfort. The validation of the instrumented dummy was conducted by comparison with a recent subject study. The mechanical parameters that characterize the static and dynamic interaction between backpack and body during different backpack settings were compared. The second aim was to investigate whether high predictive power (coefficient of determination R-2>0.5) in assessing the discomfort of load carriage systems could be reached using the instrumented dummy. Measurements were conducted under static conditions, simulating upright standing, and dynamic conditions, simulating level walking. Twelve different configurations of a typical load carriage system, a commercially available backpack with a hip belt, were assessed. The mechanical parameters were measured in the shoulder and the hip region of the dummy and consisted of average pressure, peak pressure, strap force and relative motion between the system and the body. The twelve configurations consisted of three different weights (15kg, 20kg, and 25kg), combined with four different hip belt tensions (30N, 60N, 90N, and 120N). Through the significant (p<0.05) correlation of the mechanical parameters measured on the dummy with the corresponding values of the subject study, the dummy was validated for all static measurements and for dynamic measurements in the hip region to accurately simulate the interaction between the human body and the load carriage system. Multiple linear regressions with the mechanical parameters measured on the dummy as independent variables and the corresponding subjective discomfort scores from the subject study as the dependent variable revealed a high predictive power of the instrumented dummy. The dummy can explain 75% or more of the variance in discomfort using average pressures as predictors and even 79% or more of the variance in discomfort using strap forces as predictors. Use of the dummy enables objective, fast, and iterative assessments of load carriage systems and therefore reduces the need for labor-intensive subject studies in order to decrease the mechanical aspects of discomfort during load carriage.	[Wettenschwiler, Patrick D.; Annaheim, Simon; Stampfli, Rolf; Psikuta, Agnes; Rossi, Rene M.] Empa, Swiss Fed Labs Mat Sci & Technol, St Gallen, Switzerland; [Wettenschwiler, Patrick D.; Lorenzetti, Silvio; Ferguson, Stephen J.] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Swiss Federal Institutes of Technology Domain; ETH Zurich	Wettenschwiler, PD (corresponding author), Empa, Swiss Fed Labs Mat Sci & Technol, St Gallen, Switzerland.; Wettenschwiler, PD (corresponding author), Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland.	patrick.wettenschwiler@empa.ch	Lorenzetti, Silvio Rene/B-1188-2009; Ferguson, Stephen J./A-4118-2012; Rossi, Rene Michel/A-1507-2012; Annaheim, Simon/B-1389-2017	Lorenzetti, Silvio Rene/0000-0002-8339-8960; Ferguson, Stephen J./0000-0003-0650-5889; Rossi, Rene Michel/0000-0003-0946-682X; Annaheim, Simon/0000-0002-8192-1391; Psikuta, Agnes/0000-0003-0385-3140	armasuisse	armasuisse	This study was funded by armasuisse (www.ar.admin.ch/internet/armasuisse/en/home.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong HG, 1988, ANTHROPOMETRY MASS D, VI; Attwells RL, 2006, ERGONOMICS, V49, P1527, DOI 10.1080/00140130600757237; Cavallo Carla Maria, 2003, Work, V20, P137; Chow DHK, 2011, INT J IND ERGONOM, V41, P530, DOI 10.1016/j.ergon.2011.04.001; de Looze MP, 2003, ERGONOMICS, V46, P985, DOI 10.1080/0014013031000121977; Dockrell S, 2015, APPL ERGON, V51, P281, DOI 10.1016/j.apergo.2015.05.009; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Grimmer K, 2002, BMC MUSCULOSKEL DIS, P3; Gutierrez J., 2009, THESIS COLEGIO POSTG; Hadid A, 2012, J APPL PHYSIOL, V112, P597, DOI 10.1152/japplphysiol.00990.2011; HOLLOWAY GA, 1976, J APPL PHYSIOL, V40, P597, DOI 10.1152/jappl.1976.40.4.597; INMAN VT, 1966, CAN MED ASSOC J, V94, P1047; Jacobson B, 2000, PERCEPT MOTOR SKILL, V90, P605, DOI 10.2466/PMS.90.2.605-608; Jacobson BH, 2003, ERGONOMICS, V46, P1035, DOI 10.1080/0014013021000045255; Jones GR, 2005, APPL ERGON, V36, P79, DOI 10.1016/j.apergo.2004.07.001; Kim JH, 2011, ERGONOMICS, V54, P626, DOI 10.1080/00140139.2011.583362; Knapik J, 1996, APPL ERGON, V27, P207, DOI 10.1016/0003-6870(96)00013-0; Knapik JJ, 2004, MIL MED, V169, P45, DOI 10.7205/MILMED.169.1.45; Mackie HW, 2005, APPL ERGON, V36, P199, DOI 10.1016/j.apergo.2004.10.007; Martin J, 2000, MILITARY LOAD CARRIA; Morin E, 2007, DEV DYNAMIC BIOMECHA; Morrissey MP, 2013, TEXT PROG, V45, P145, DOI 10.1080/00405167.2013.845540; Negrini S, 2002, SPINE, V27, P187, DOI 10.1097/00007632-200201150-00014; Orendurff MS, 2004, J REHABIL RES DEV, V41, P829, DOI 10.1682/JRRD.2003.10.0150; Piscione J, 2006, EUR J APPL PHYSIOL, V97, P573, DOI 10.1007/s00421-006-0221-x; Psikuta A, 2008, PHYSIOL MEAS, V29, P181, DOI 10.1088/0967-3334/29/2/002; Saibene F, 2003, EUR J APPL PHYSIOL, V88, P297, DOI 10.1007/s00421-002-0654-9; SANGEORZAN BJ, 1989, J ORTHOP RES, V7, P423, DOI 10.1002/jor.1100070315; SAUNDERS JBDM, 1953, J BONE JOINT SURG AM, V35-A, P543, DOI 10.2106/00004623-195335030-00003; Seitz H, 2004, INT CONGR SER, V1268, P567, DOI 10.1016/j.ics.2004.03.139; Sharpe SR, 2008, J BIOMECH, V41, P968, DOI 10.1016/j.jbiomech.2007.12.018; Sheir-Neiss GI, 2003, SPINE, V28, P922, DOI 10.1097/00007632-200305010-00015; Simpson KM, 2012, APPL ERGON, V43, P479, DOI 10.1016/j.apergo.2011.07.005; Simpson KM, 2011, APPL ERGON, V42, P403, DOI 10.1016/j.apergo.2010.08.018; Staszkiewicz R, 2010, ACTA BIOENG BIOMECH, V12, P13; Stevenson JM, 2004, ERGONOMICS, V47, P1160, DOI 10.1080/00140130410001699119; Stevenson JM, 1997, RES DEV ADV PERSONAL; THORSTENSSON A, 1984, ACTA PHYSIOL SCAND, V121, P9, DOI 10.1111/j.1748-1716.1984.tb10452.x; Untaroiu CD, 2015, P ASME DETC CIE 2015; Wettenschwiler PD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142004; Wettenschwiler PD, 2015, INT J IND ERGONOM, V49, P60, DOI 10.1016/j.ergon.2015.06.003; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Zemp R, 2015, APPL ERGON, V48, P273, DOI 10.1016/j.apergo.2014.12.010	43	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180069	10.1371/journal.pone.0180069	http://dx.doi.org/10.1371/journal.pone.0180069			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JX	28662084	Green Published, gold			2022-12-27	WOS:000404608300096
J	Vasu, V; Turner, KJ; George, S; Greenall, J; Slijepcevic, P; Griffin, DK				Vasu, Vimal; Turner, Kara J.; George, Shermi; Greenall, John; Slijepcevic, Predrag; Griffin, Darren K.			Preterm infants have significantly longer telomeres than their term born counterparts	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; OXIDATIVE STRESS; LYMPHOCYTE SUBSETS; HUMAN FIBROBLASTS; GESTATIONAL-AGE; BLOOD-PRESSURE; DNA-DAMAGE; STEM-CELLS; LENGTH; ASSOCIATION	There are well-established morbidities associated with preterm birth including respiratory, neurocognitive and developmental disorders. However several others have recently emerged that characterise an 'aged' phenotype in the preterm infant by term-equivalent age. These include hypertension, insulin resistance and altered body fat distribution. Evidence shows that these morbidities persist into adult life, posing a significant public health concern. In this study, we measured relative telomere length in leukocytes as an indicator of biological ageing in 25 preterm infants at term equivalent age. Comparing our measurements with those from 22 preterm infants sampled at birth and from 31 term-born infants, we tested the hypothesis that by term equivalent age, preterm infants have significantly shorter telomeres (thus suggesting that they are prematurely aged). Our results demonstrate that relative telomere length is highly variable in newborn infants and is significantly negatively correlated with gestational age and birth weight in preterm infants. Further, longitudinal assessment in preterm infants who had telomere length measurements available at both birth and term age (n = 5) suggests that telomere attrition rate is negatively correlated with increasing gestational age. Contrary to our initial hypothesis however, relative telomere length was significantly shortest in the term born control group compared to both preterm groups and longest in the preterm at birth group. In addition, telomere lengths were not significantly different between preterm infants sampled at birth and those sampled at term equivalent age. These results indicate that other, as yet undetermined, factors may influence telomere length in the preterm born infant and raise the intriguing hypothesis that as preterm gestation declines, telomere attrition rate increases.	[Vasu, Vimal; George, Shermi; Greenall, John] East Kent Hosp Univ Fdn NHS Trust, William Harvey Hosp, Dept Child Hlth, Ashford, Kent, England; [Vasu, Vimal; Turner, Kara J.; Griffin, Darren K.] Univ Kent, Sch Biosci, Giles Lane, Canterbury, Kent, England; [Slijepcevic, Predrag] Brunel Univ London, Dept Life Sci, Coll Hlth & Life Sci, Uxbridge, Middx, England	University of Kent; Brunel University	Vasu, V (corresponding author), East Kent Hosp Univ Fdn NHS Trust, William Harvey Hosp, Dept Child Hlth, Ashford, Kent, England.; Vasu, V (corresponding author), Univ Kent, Sch Biosci, Giles Lane, Canterbury, Kent, England.	vimal.vasu@nhs.net		Vasu, Vimal/0000-0003-2606-9797	Medical Research Council (GB) (Digital Scientific UK); East Kent Hospitals University NHS Foundation Trust	Medical Research Council (GB) (Digital Scientific UK); East Kent Hospitals University NHS Foundation Trust	This work was supported from the Medical Research Council (GB) (case studentship sponsored by Digital Scientific UK) and via an East Kent Hospitals University NHS Foundation Trust internal project grant scheme award is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaikalakoteswari A, 2007, ATHEROSCLEROSIS, V195, P83, DOI 10.1016/j.atherosclerosis.2006.12.003; Akkad A, 2006, BJOG-INT J OBSTET GY, V113, P318, DOI 10.1111/j.1471-0528.2005.00839.x; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Asghar M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2263; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Aviv A, 1997, HYPERTENSION, V29, P1067, DOI 10.1161/01.HYP.29.5.1067; Aviv A, 2006, INT J EPIDEMIOL, V35, P1424, DOI 10.1093/ije/dyl169; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Benetos A, 2014, INT J EPIDEMIOL, V43, P1799, DOI 10.1093/ije/dyu146; Berrington JE, 2005, CLIN EXP IMMUNOL, V140, P289, DOI 10.1111/j.1365-2249.2005.02767.x; Bhat R, 2012, PEDIATRICS, V129, pE682, DOI 10.1542/peds.2011-1827; Bijnens E, 2015, ENVIRON INT, V79, P1, DOI 10.1016/j.envint.2015.02.008; Blencowe H, 2016, LANCET GLOB HEALTH, V4, pE98, DOI 10.1016/S2214-109X(15)00275-2; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Cole TJ, 2014, ARCH DIS CHILD-FETAL, V99, pF34, DOI 10.1136/archdischild-2012-303536; Costeloe KL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7976; de Jong F, 2012, HYPERTENSION, V59, P226, DOI 10.1161/HYPERTENSIONAHA.111.181784; Drury SS, 2015, J PEDIATR-US, V166, P1181, DOI 10.1016/j.jpeds.2015.01.003; Ehrenkranz RA, 1999, PEDIATRICS, V104, P280, DOI 10.1542/peds.104.2.280; Entringer S., 2014, J CLIN ENDOCRINOLOGY, V100, P267; Entringer S, 2015, ANN NUTR METAB, V66, P202, DOI 10.1159/000381925; Entringer S, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.11.033; Epel ES, 2009, HORM-INT J ENDOCRINO, V8, P7, DOI 10.14310/horm.2002.1217; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Factor-Litvak P, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3927; Factor-Litvak P, 2015, AM J OBSTET GYNECOL, V212, pS39, DOI 10.1016/j.ajog.2014.10.102; Faragher RGA, 1998, BIOESSAYS, V20, P985, DOI 10.1002/(SICI)1521-1878(199812)20:12<985::AID-BIES4>3.3.CO;2-1; Ferrari F, 2016, J MATERN-FETAL NEO M, V29, P1283, DOI 10.3109/14767058.2015.1046045; Friedrich U, 2001, PEDIATR RES, V49, P252, DOI 10.1203/00006450-200102000-00020; Gielen M, 2014, PLACENTA, V35, P791, DOI 10.1016/j.placenta.2014.05.010; Gingell-Littlejohn M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068133; Grati FR, 2014, J CLIN MED, V3, P809, DOI 10.3390/jcm3030809; Hadchouel A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136123; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Holmes DK, 2009, BIOGERONTOLOGY, V10, P279, DOI 10.1007/s10522-008-9194-y; Hovi P, 2007, NEW ENGL J MED, V356, P2053, DOI 10.1056/NEJMoa067187; Howson CP, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S1; Johansson S, 2005, CIRCULATION, V112, P3430, DOI 10.1161/CIRCULATIONAHA.105.540906; Kawanishi S, 2004, ANN NY ACAD SCI, V1019, P278, DOI 10.1196/annals.1297.047; Koppelstaetter C, 2008, AGING CELL, V7, P491, DOI 10.1111/j.1474-9726.2008.00398.x; Lansdorp PM, 2008, BLOOD, V111, P1759, DOI 10.1182/blood-2007-09-084913; Levy D, 2010, P NATL ACAD SCI USA, V107, P9293, DOI 10.1073/pnas.0911494107; Liang GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023462; LINDSEY J, 1991, MUTAT RES, V256, P45, DOI 10.1016/0921-8734(91)90032-7; Liu JK, 2010, J CLIN ENDOCR METAB, V95, P5419, DOI 10.1210/jc.2010-1378; Mangino M, 2015, J MED GENET, V52, P157, DOI 10.1136/jmedgenet-2014-102681; Mangino M, 2012, HUM MOL GENET, V21, P5385, DOI 10.1093/hmg/dds382; Marchetto NM, 2016, AM J CLIN EXP OBSTET; McLaren E., 2014, LIVE BIRTHS ENGLAND; Menon R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031136; Moore T, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7961; Moreno-Palomo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091753; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Nordfjall K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000375; Oikawa S, 1999, FEBS LETT, V453, P365, DOI 10.1016/S0014-5793(99)00748-6; Okuda K, 2002, PEDIATR RES, V52, P377, DOI 10.1203/01.PDR.0000022341.72856.72; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Parkinson JRC, 2013, PEDIATRICS, V131, pE1240, DOI 10.1542/peds.2012-2177; Pathai S, 2013, MECH AGEING DEV; PRATHER AA, 2011, J AGING RES, V2011; Rufer N, 1999, J EXP MED, V190, P157, DOI 10.1084/jem.190.2.157; Salihu HM, 2015, SLEEP, V38, P559, DOI 10.5665/sleep.4570; Salihu HM, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.08.026; Salpea KD, 2010, ATHEROSCLEROSIS, V209, P42, DOI 10.1016/j.atherosclerosis.2009.09.070; Scheible KM, 2015, CLIN IMMUNOL, V161, P65, DOI 10.1016/j.clim.2015.07.003; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SERIES IM, 1991, EARLY HUM DEV, V26, P143, DOI 10.1016/0378-3782(91)90018-X; Shay JW, 2003, CLIN CANCER RES, V9, P3521; Smeets CCJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143951; Thomas EL, 2008, ARCH DIS CHILD-FETAL, V93, pF382, DOI 10.1136/adc.2007.127431; Thomas EL, 2011, PEDIATR RES, V70, P507, DOI 10.1203/PDR.0b013e31822d7860; Tinnion R, 2013, ARCH DIS CHILD; Unryn BM, 2005, AGING CELL, V4, P97, DOI 10.1111/j.1474-9728.2005.00144.x; Uthaya S, 2005, PEDIATR RES, V57, P211, DOI 10.1203/01.PDR.0000148284.58934.1C; VanDeVoorde RG., 2014, KIDNEY URINARY TRACT, P349, DOI [10.1007/978-3-642-39988-6_20, DOI 10.1007/978-3-642-39988-6_20]; Vassallo PF, 2014, BLOOD, V123, P2116, DOI 10.1182/blood-2013-02-484956; Vasu V TEL, 2009, 50 ANN M EUR SOC PAE, V98, P1; von Zglinicki T, 2005, CURR MOL MED, V5, P197; Weng NP, 1997, P NATL ACAD SCI USA, V94, P10827, DOI 10.1073/pnas.94.20.10827; Wenger SL, 2014, GENE; Xu JP, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-188	87	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180082	10.1371/journal.pone.0180082	http://dx.doi.org/10.1371/journal.pone.0180082			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658264	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000404607900057
J	Vincent, WJB; Harvie, EA; Sauer, JD; Huttenlocher, A				Vincent, William J. B.; Harvie, Elizabeth A.; Sauer, John-Demian; Huttenlocher, Anna			Neutrophil derived LTB4 induces macrophage aggregation in response to encapsulated Streptococcus iniae infection	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSES; LEUKOTRIENE B-4; KLEBSIELLA-PNEUMONIAE; TRANSGENIC ZEBRAFISH; HOST-DEFENSE; T-CELLS; VIRULENCE; INFLAMMATION; ACTIVATION; RELEASE	Immune cells sense and react to a multitude of factors including both host and microbe-derived signals. Understanding how cells translate these cues into particular cellular behaviors is a complex yet critical area of study. We have previously shown that both neutrophils and macrophages are important for controlling the fish pathogen Streptococcus iniae. Here, we report both host and bacterial determinants leading to the formation of organized macrophage aggregates as part of the host inflammatory response in a subset of infected larvae. Streptococcal capsule was a required signal for aggregate formation. Macrophage aggregation coincided with NF kappa B activity, and the formation of these aggregates is mediated by leukotriene B4 (LTB4) produced by neutrophils. Depletion, inhibition, or genetic deletion of leukotriene A4 hydrolase (Lta4h), which catalyzes the last step in LTB4 synthesis, resulted in the absence of macrophage aggregation. Larvae with impaired neutrophil function also had impaired macrophage aggregation; however, aggregate formation was partially rescued with the addition of exogenous LTB4. Neutrophil-specific expression of lta4h was sufficient to rescue macrophage aggregation in Lta4h-deficient larvae and increased host survival following infection. In summary, our findings highlight a novel innate immune response to infection in which specific bacterial products drive neutrophils that modulate macrophage behavior through eicosanoid signaling.	[Vincent, William J. B.; Harvie, Elizabeth A.] Univ Wisconsin, Dept Med Microbiol & Immunol, Microbiol Doctoral Training Program, Madison, WI 53706 USA; [Vincent, William J. B.; Harvie, Elizabeth A.; Sauer, John-Demian; Huttenlocher, Anna] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Huttenlocher, Anna] Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Huttenlocher, A (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA.; Huttenlocher, A (corresponding author), Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA.	huttenlocher@wisc.edu	Sauer, John-Demian/AAV-8538-2020	Sauer, John-Demian/0000-0001-9367-794X	National Institutes of Health, National Research Service [AI55397]; Molecular Biosciences Training Grant [T32-GM07215, R01-CA188034, R35-GM118027]; NATIONAL CANCER INSTITUTE [R01CA188034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118027, T32GM007215] Funding Source: NIH RePORTER	National Institutes of Health, National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Biosciences Training Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health, National Research Service Award AI55397 (EAH), Molecular Biosciences Training Grant T32-GM07215 (WJBV), R01-CA188034 (JDS) and R35-GM118027 (AH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew W, 2007, VET MICROBIOL, V122, P1, DOI 10.1016/j.vetmic.2007.03.002; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Bailie MB, 1996, J IMMUNOL, V157, P5221; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; BRACH MA, 1992, EUR J IMMUNOL, V22, P2705, DOI 10.1002/eji.1830221034; Cieslewicz MJ, 2001, J BIOL CHEM, V276, P139, DOI 10.1074/jbc.M005702200; Davey MS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002040; DEMITSU T, 1989, DERMATOLOGICA, V179, P129, DOI 10.1159/000248472; Deng Q, 2011, DEV CELL, V21, P735, DOI 10.1016/j.devcel.2011.07.013; DEWALD B, 1985, BIOCHEM BIOPH RES CO, V128, P297, DOI 10.1016/0006-291X(85)91678-X; Flamand L, 2004, J INFECT DIS, V189, P2001, DOI 10.1086/386374; Flamand L, 2007, J IMMUNOL, V178, P8036, DOI 10.4049/jimmunol.178.12.8036; Fuller JD, 2001, INFECT IMMUN, V69, P1994, DOI 10.1128/IAI.69.4.1994-2000.2001; GOLDMAN G, 1993, SURGERY, V113, P297; Harvie EA, 2013, INFECT IMMUN, V81, P110, DOI 10.1128/IAI.00642-12; Kalyan S, 2014, CELL MOL LIFE SCI, V71, P2335, DOI 10.1007/s00018-013-1495-x; Kanther M, 2011, GASTROENTEROLOGY, V141, P197, DOI 10.1053/j.gastro.2011.03.042; Kuhns DB, 2001, J IMMUNOL, V167, P2869, DOI 10.4049/jimmunol.167.5.2869; LeBert DC, 2014, SEMIN IMMUNOL, V26, P315, DOI 10.1016/j.smim.2014.04.007; Li L, 2011, BLOOD, V117, P1359, DOI 10.1182/blood-2010-06-290700; Locke JB, 2007, J BACTERIOL, V189, P1279, DOI 10.1128/JB.01175-06; Lowe BA, 2007, INFECT IMMUN, V75, P1255, DOI 10.1128/IAI.01484-06; Mancuso P, 1998, INFECT IMMUN, V66, P5140, DOI 10.1128/IAI.66.11.5140-5146.1998; Mancuso P, 2010, INFECT IMMUN, V78, P2264, DOI 10.1128/IAI.01323-09; Mathias JR, 2007, J CELL SCI, V120, P3372, DOI 10.1242/jcs.009159; Mathias JR, 2006, J LEUKOCYTE BIOL, V80, P1281, DOI 10.1189/jlb.0506346; Medeiros AI, 2008, J IMMUNOL, V181, P8544, DOI 10.4049/jimmunol.181.12.8544; Morona JK, 2004, J INFECT DIS, V189, P1905, DOI 10.1086/383352; Oehlers SH, 2016, J INFECT DIS, V137, P1; Oehlers SH, 2015, NATURE, V517, P612, DOI 10.1038/nature13967; Peres CM, 2007, MICROBES INFECT, V9, P483, DOI 10.1016/j.micinf.2007.01.006; Peters-Golden M, 2005, J IMMUNOL, V174, P589, DOI 10.4049/jimmunol.174.2.589; Provost E, 2007, GENESIS, V45, P625, DOI 10.1002/dvg.20338; Sabbione F, 2014, EUR J IMMUNOL, V44, P819, DOI 10.1002/eji.201343664; Seiler P, 2003, EUR J IMMUNOL, V33, P2676, DOI 10.1002/eji.200323956; Serezani CH, 2006, J IMMUNOL, V177, P3201, DOI 10.4049/jimmunol.177.5.3201; Serezani CH, 2011, J CLIN INVEST, V121, P671, DOI 10.1172/JCI43302; Sionov RV, 2015, CANCER MICROENVIRON, V8, P125, DOI 10.1007/s12307-014-0147-5; Talvani A, 2002, INFECT IMMUN, V70, P4247, DOI 10.1128/IAI.70.8.4247-4253.2002; Tauzin S, 2014, J CELL BIOL, V207, P589, DOI 10.1083/jcb.201408090; Tobin DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067828; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Vincent WJB, 2016, CELL MICROBIOL, V18, P591, DOI 10.1111/cmi.12536; Wan M, 2007, FASEB J, V21, P2897, DOI 10.1096/fj.06-7974com; Xiong HZ, 2016, CELL, V165, P679, DOI 10.1016/j.cell.2016.03.017; Yang CT, 2012, CELL HOST MICROBE, V12, P301, DOI 10.1016/j.chom.2012.07.009	46	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179574	10.1371/journal.pone.0179574	http://dx.doi.org/10.1371/journal.pone.0179574			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658259	gold, Green Published, Green Submitted			2022-12-27	WOS:000404607900033
J	Binhi, VN; Prato, FS				Binhi, Vladimir N.; Prato, Frank S.			Biological effects of the hypomagnetic field: An analytical review of experiments and theories	PLOS ONE			English	Review							ZERO-MAGNETIC-FIELD; CRYPTOCHROME-DEPENDENT RESPONSES; STRESS-INDUCED ANALGESIA; ESCHERICHIA-COLI-CELLS; GEOMAGNETIC-FIELD; ELECTROMAGNETIC-FIELDS; STOCHASTIC DYNAMICS; MAGNETOSTATIC FIELD; CHILDHOOD LEUKEMIA; UPPER BEAK	During interplanetary flights in the near future, a human organism will be exposed to prolonged periods of a hypomagnetic field that is 10,000 times weaker than that of Earth's. Attenuation of the geomagnetic field occurs in buildings with steel walls and in buildings with steel reinforcement. It cannot be ruled out also that a zero magnetic field might be interesting in biomedical studies and therapy. Further research in the area of hypomagnetic field effects, as shown in this article, is capable of shedding light on a fundamental problem in biophysics-the problem of primary magnetoreception. This review contains, currently, the most extensive bibliography on the biological effects of hypomagnetic field. This includes both a review of known experimental results and the putative mechanisms of magnetoreception and their explanatory power with respect to the hypomagnetic field effects. We show that the measured correlations of the HMF effect with HMF magnitude and inhomogeneity and type and duration of exposure are statistically absent. This suggests that there is no general biophysical MF target similar for different organisms. This also suggests that magnetoreception is not necessarily associated with evolutionary developed specific magnetoreceptors in migrating animals and magnetotactic bacteria. Independently, there is nonspecific magnetoreception that is common for all organisms, manifests itself in very different biological observables as mostly random reactions, and is a result of MF interaction with magnetic moments at a physical level-moments that are present everywhere in macromolecules and proteins and can sometimes transfer the magnetic signal at the level of downstream biochemical events. The corresponding universal mechanism of magnetoreception that has been given further theoretical analysis allows one to determine the parameters of magnetic moments involved in magnetoreception-their gyromagnetic ratio and thermal relaxation time-and so to better understand the nature of MF targets in organisms.	[Binhi, Vladimir N.] AM Prokhorov Gen Phys Inst, Moscow, Russia; [Binhi, Vladimir N.] Moscow MV Lomonosov State Univ, Moscow, Russia; [Prato, Frank S.] Lawson Hlth Res Inst, London, ON, Canada; [Prato, Frank S.] Univ Western Ontario, London, ON, Canada	Russian Academy of Sciences; Prokhorov General Physics Institute of the Russian Academy of Sciences; Lomonosov Moscow State University; Western University (University of Western Ontario); Western University (University of Western Ontario)	Prato, FS (corresponding author), Lawson Hlth Res Inst, London, ON, Canada.; Prato, FS (corresponding author), Univ Western Ontario, London, ON, Canada.	prato@lawsonimaging.ca	Binhi, Vladimir N./H-9370-2016; Prato, Frank S/C-9117-2014	Binhi, Vladimir N./0000-0003-1341-9591; Prato, Frank/0000-0002-4592-2522	Natural Sciences and Engineering Research Council of Canada (NSERC) [2014-05589]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grant number 2014-05589 by The Natural Sciences and Engineering Research Council of Canada (NSERC), http://www.nserc-crsna.gc.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A., 2000, INTRO THEORY FERROMA; Ahmad M, 2007, PLANTA, V225, P615, DOI 10.1007/s00425-006-0383-0; ASASHIMA M, 1991, BIOELECTROMAGNETICS, V12, P215, DOI 10.1002/bem.2250120403; Banerjee S. K., 1985, MAGNETITE BIOMINERAL, V5, P17; Barnes F, 2017, BIOELECTROMAGNETICS, V38, P322, DOI 10.1002/bem.22041; Begall S, 2008, P NATL ACAD SCI USA, V105, P13451, DOI 10.1073/pnas.0803650105; BEISCHER DE, 1965, ANN NY ACAD SCI, V134, P454, DOI 10.1111/j.1749-6632.1965.tb56052.x; BEISCHER DE, 1971, ANN NY ACAD SCI, V188, P324, DOI 10.1111/j.1749-6632.1971.tb13107.x; Beischer DE., 1967, EXPOSURE MAN LOW INT, V1018; BELJAVSKAJA NA, 1992, BIOFIZIKA+, V37, P759; Belostotskaya GB, 2011, VESTNIK STPETERSBU 4, P198; Belyaev I, 2011, MUTAT RES-GEN TOX EN, V722, P56, DOI 10.1016/j.mrgentox.2011.03.012; Belyaev IY, 1997, BBA-GEN SUBJECTS, V1336, P465, DOI 10.1016/S0304-4165(97)00059-7; Belyaev IY, 2001, BBA-GEN SUBJECTS, V1526, P269, DOI 10.1016/S0304-4165(01)00138-6; Belyavskaya NA, 2004, ADV SPACE RES-SERIES, V34, P1566, DOI 10.1016/j.asr.2004.01.021; Belyavskaya NA, 2001, ADV SPACE RES, V28, P645, DOI 10.1016/S0273-1177(01)00373-8; Binghy VN, 1997, BIOFIZIKA+, V42, P338; Binhi VN, 2007, ELECTROMAGN BIOL MED, V26, P45, DOI 10.1080/15368370701205677; Binhi V. N., 2016, Biophysics, V61, P170, DOI 10.1134/S000635091601005X; Binhi V. N., 2006, Biophysics, V51, P497, DOI 10.1134/S0006350906030250; Binhi VN, 2009, ELECTROMAGN BIOL MED, V28, P310, DOI [10.1080/15368370903167246, 10.3109/15368370903167246]; Binhi V. N., 1997, ELECTRO MAGNETOBIOL, V16, P203; Binhi V.N., 2011, PRINCIPLES ELECTROMA; Binhi V.N., 2002, MAGNETOBIOLOGY UNDER; Binhi V, 2008, INT J RADIAT BIOL, V84, P569, DOI 10.1080/09553000802195323; Binhi VN, 2017, BIOELECTROMAGNETICS, V38, P41, DOI 10.1002/bem.22011; Binhi VN, 2006, BIOELECTROMAGNETICS, V27, P58, DOI 10.1002/bem.20178; Binhi VN, 2005, EUROPHYS LETT, V70, P850, DOI 10.1209/epl/i2004-10525-6; Binhi VN, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051912; Binhi VN, 2003, PHYS-USP+, V46, P259, DOI 10.1070/PU2003v046n03ABEH001283; Binhi VN, 2001, ELECTRO MAGNETOBIOL, V20, P43, DOI 10.1081/JBC-100103159; Binhi VN, 2001, BIOELECTROMAGNETICS, V22, P79, DOI 10.1002/1521-186X(200102)22:2<79::AID-BEM1009>3.0.CO;2-7; Binhi VN, 2000, BIOELECTROMAGNETICS, V21, P34, DOI 10.1002/(SICI)1521-186X(200001)21:1<34::AID-BEM6>3.0.CO;2-8; BLACKMAN CF, 1993, FASEB J, V7, P801, DOI 10.1096/fasebj.7.9.8330687; BLISS VL, 1976, NATURE, V261, P411, DOI 10.1038/261411a0; BOGATINA N I, 1979, Doklady Akademii Nauk Ukrainskoi SSR Seriya B Geologicheskie Khimicheskie i Biologicheskie Nauki, P460; Bogatina NI, 2006, VISN KHARK NATS U BI, P78; Bogatina NI, 1979, RUSSIAN J PLANT PHYS, V26, P620; Bogomolova EV, 2014, USPEKHI MEDITSINSKOY, V12, P15; Breus TK, 2016, PHYS-USP+, V59, P502, DOI 10.3367/UFNe.2015.12.037693; Brocklehurst B, 1996, INT J RADIAT BIOL, V69, P3, DOI 10.1080/095530096146147; BROWN WF, 1963, PHYS REV, V130, P1677, DOI 10.1103/PhysRev.130.1677; Buchachenko AL, 2014, RUSS CHEM REV+, V83, P1, DOI 10.1070/RC2014v083n01ABEH004335; Buchachenko A.L., 1978, MAGNETIC SPIN EFFECT; Bunkin AF, 2006, PHYS-USP+, V49, P855, DOI 10.1070/PU2006v049n08ABEH006082; Burger T, 2010, J R SOC INTERFACE, V7, P1275, DOI 10.1098/rsif.2009.0551; BUSBY DOUGLAS E., 1968, SPACE LIFE SCI, V1, P23, DOI 10.1007/BF00924230; Bystrova E. Yu, 2009, Mikologiya i Fitopatologiya, V43, P438; Cai JM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.100501; Cao CQ, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006855; Celestino C, 1998, PLANT CELL TISS ORG, V54, P65, DOI 10.1023/A:1006034510170; CHEW GL, 1989, CAN J ZOOL, V67, P641, DOI 10.1139/z89-092; Choleris E, 2002, P ROY SOC B-BIOL SCI, V269, P193, DOI 10.1098/rspb.2001.1866; Ciorba D, 2001, ELECTRO MAGNETOBIOL, V20, P313, DOI 10.1081/JBC-100108572; Ciortea LI, 2001, ELECTRO MAGNETOBIOL, V20, P127, DOI 10.1081/JBC-100104138; Cohen AE, 2009, J PHYS CHEM A, V113, P11084, DOI 10.1021/jp907113p; Conley CC, 1969, BIOL EFFECTS MAGNETI, P29; Creanga DE, 2004, J MAGN MAGN MATER, V272, P2442, DOI 10.1016/j.jmmm.2003.12.853; Creanga DE, 2002, ELECTROMAGN BIOL MED, V21, P31, DOI 10.1081/JBC-120003109; Davila AF, 2003, PHYS CHEM EARTH, V28, P647, DOI 10.1016/S1474-7065(03)00118-9; Del Seppia C, 2000, LIFE SCI, V66, P1299, DOI 10.1016/S0024-3205(00)00437-9; Del Seppia C, 2007, NEUROSCI BIOBEHAV R, V31, P619, DOI 10.1016/j.neubiorev.2007.01.003; Demtsun NA, 2008, PHYS ALIVE, V16, P68; Dhiman SK, 2015, THESIS; [Дмитриев С.П. Dmitriev S.P.], 2012, [Научное приборостроение, Scientific Instrumentation, Nauchnoe priborostroenie], V22, P68; Dobrota C, 2002, ESA SP PUBL, V518, P445; Dorofteiu M., 1995, Cytobios, V84, P179; Dubrov AP, 1978, GEOMAGNETIC FIELD LI; Eldashev I. S., 2010, Biophysics, V55, P765, DOI 10.1134/S0006350910050143; Engels S, 2014, NATURE, V509, P353, DOI 10.1038/nature13290; Eremenko T, 1997, BIOELECTROMAGNETICS, V18, P58, DOI 10.1002/(SICI)1521-186X(1997)18:1<58::AID-BEM9>3.0.CO;2-4; FESENKO EE, 1995, FEBS LETT, V366, P49, DOI 10.1016/0014-5793(95)98629-W; Fesenko EE, 2010, ELECTROMAGN BIOL MED, V29, P1, DOI 10.3109/15368371003627290; Fleissner G, 2007, NATURWISSENSCHAFTEN, V94, P631, DOI 10.1007/s00114-007-0236-0; FOMICHEVA VM, 1992, BIOFIZIKA+, V37, P745; FOMICHEVA VM, 1992, BIOFIZIKA+, V37, P750; Fu JP, 2016, BIOELECTROMAGNETICS, V37, P212, DOI 10.1002/bem.21968; Gauger EM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.040503; Godlevsky LS, 2013, CENT EUR J MED, V8, P517, DOI 10.2478/s11536-012-0147-0; GOVORUN RD, 1992, BIOFIZIKA+, V37, P738; Goychuk I, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.042711; GrassiSchultheiss PP, 1997, BIOMETALS, V10, P351, DOI 10.1023/A:1018340920329; GREENE AE, 1966, AEROSPACE MED, V37, P251; Gurfinkel YI, 2016, LIFE SCI SPACE RES, V8, P1, DOI 10.1016/j.lssr.2015.11.001; Hafemeister D., 2014, PHYS SOCIETAL ISSUES, P331; Halberg F, 2011, WORLD HEART J, V3, P1; Harris SR, 2009, J R SOC INTERFACE, V6, P1193, DOI 10.1098/rsif.2008.0519; Hart V, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-80; Hore PJ, 2016, ANNU REV BIOPHYS, V45, P299, DOI 10.1146/annurev-biophys-032116-094545; IEEE, 2010, C95312010 IEEE; Jeong JH, 2000, J AUTON PHARMACOL, V20, P259, DOI 10.1046/j.1365-2680.2000.00189.x; Jia B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105604; [贾斌 Jia Bin], 2011, [航天医学与医学工程, Space Medicine & Medical Engineering], V24, P318; [贾斌 JIA Bin], 2009, [航天医学与医学工程, Space Medicine & Medical Engineering], V22, P308; Jiang JC, 1998, ACTA SEISMOLOGICA SI, V11, P487; Johnsen S, 2008, PHYS TODAY, V61, P29, DOI 10.1063/1.2897947; [КАНЦЕРОВА Надежда Павловна Kantserova N.P.], 2016, [Геофизические процессы и биосфера, Geofizicheskie protsessy i biosfera], V15, P18, DOI 10.21455/gpb2016.4-2; KATO R, 1990, PLANT CELL PHYSIOL, V31, P565; KATO R, 1989, PLANT CELL PHYSIOL, V30, P605, DOI 10.1093/oxfordjournals.pcp.a077782; Kattnig DR, 2016, NAT CHEM, V8, P384, DOI [10.1038/NCHEM.2447, 10.1038/nchem.2447]; Kavokin K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173887; Kaznacheev VP, 1985, BIOINFORMATIONAL FUN; [Ходанович Марина Юрьевна Khodanovich Marina Yu.], 2013, [Вестник Томского государственного университета. Биология, Tomsk State University Journal of Biology, Vestnik Tomskogo gosudarstvennogo universiteta. Biologiya], P146; Konovalov AI, 2014, RUSS CHEM B+, V63, P1, DOI 10.1007/s11172-014-0388-y; Konovalov AI, 2013, HER RUSS ACAD SCI+, V83, P513, DOI 10.1134/S1019331613060099; Korolyov V.A., 2009, SCI NOTES TAURIDA VE, V22, P68; Kostyuk AS, 2014, SCI NOTES TAURIDA 6, V27, P113; Kostyuk AS, 2013, SCI NOTES TAURIDA 6, V26, P75; Kostyuk AS, 2009, SCI NOTES TAURIDA 6, V22, P75; Kovacs PE, 1997, CRIT REV ENV SCI TEC, V27, P319, DOI 10.1080/10643389709388503; Koziak AM, 2006, BIOELECTROMAGNETICS, V27, P10, DOI 10.1002/bem.20170; Krylov VV, 2013, ELECTROMAGN BIOL MED, V32, P30, DOI 10.3109/15368378.2012.700291; Kulikov VY, 2011, MED ED SIBERIA NETWO; Kulikov VY, 2010, MED ED SIBERIA NETWO; Kulikov VY, 2009, MED ED SIBERIA NETWO; [Куранова Мирья Леонидовна Kuranova M.L.], 2010, [Вестник Санкт-Петербургского университета. Серия 3: Биология, Vestnik Sankt-Peterburgskogo universiteta. Seriya 3: Biologiya], P99; Kuz'mina VV, 2015, BIOL BULL+, V42, P61, DOI 10.1134/S1062359015010070; [Кузьменко Наталия Владимировна Kuzmenko N.V.], 2013, [Вестник Санкт-Петербургского университета. Серия 3: Биология, Vestnik Sankt-Peterburgskogo universiteta. Seriya 3: Biologiya], P64; Landau LD, 1977, THEORETICAL PHYS; Lebedev V. M., 2014, Bulletin of the Russian Academy of Sciences: Physics, V78, P626, DOI 10.3103/S1062873814070181; LEUCHT T, 1987, NATURWISSENSCHAFTEN, V74, P192, DOI 10.1007/BF00372927; Lewis RC, 2016, J TOXICOL ENV HEAL B, V19, P29, DOI 10.1080/10937404.2015.1134370; Li JF, 2001, PROG BIOCHEM BIOPHYS, V28, P358; Lin H, 2001, J CELL BIOCHEM, V81, P143, DOI 10.1002/1097-4644(20010401)81:1<143::AID-JCB1030>3.0.CO;2-4; LINDAUER M, 1968, Z VERGL PHYSIOL, V60, P219, DOI 10.1007/BF00298600; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; Ludwig F, 2014, J MAGN MAGN MATER, V360, P169, DOI 10.1016/j.jmmm.2014.02.020; Marina YK, 2011, TOMSK STATE UNIV J, P155; MARKOV MS, 1993, BIOELECTROCH BIOENER, V30, P119, DOI 10.1016/0302-4598(93)80069-7; Martino CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022753; Martino CF, 2010, BIOELECTROMAGNETICS, V31, P649, DOI 10.1002/bem.20606; Martino CF, 2010, BIOELECTROMAGNETICS, V31, P296, DOI 10.1002/bem.20565; Maxwell KL, 2005, PROTEIN SCI, V14, P602, DOI 10.1110/ps.041205405; McCreary CR, 2002, BIOELECTROMAGNETICS, V23, P315, DOI 10.1002/bem.10019; Melkikh AV, 2015, PROG BIOPHYS MOL BIO, V119, P137, DOI 10.1016/j.pbiomolbio.2015.07.001; Mo WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep22624; Mo WC, 2015, PROG BIOCHEM BIOPHYS, V42, P639; Mo WC, 2012, PROG BIOCHEM BIOPHYS, V39, P835, DOI 10.3724/SP.J.1206.2011.00597; Mo WC, 2012, BIOELECTROMAGNETICS, V33, P238, DOI 10.1002/bem.20699; Mo WC, 2011, ADV SPACE RES, V47, P1616, DOI 10.1016/j.asr.2010.12.024; Mo WC, 2014, SCI CHINA LIFE SCI, V57, P448, DOI 10.1007/s11427-014-4644-z; Mo WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056592; Negishi Y, 1999, ADV SPACE RES, V23, P2029, DOI 10.1016/S0273-1177(99)00342-7; Nemec P, 2001, SCIENCE, V294, P366, DOI 10.1126/science.1063351; Nishimura T, 2010, J EXP BIOL, V213, P1985, DOI 10.1242/jeb.031609; Novikov S. M., 2008, Biophysics, V53, P243, DOI 10.1134/S0006350908030135; Novikov V. V., 2007, Biophysics, V52, P498, DOI 10.1134/S0006350907050077; Novikov VV, 2008, BIOELECTROMAGNETICS, V29, P387, DOI 10.1002/bem.20407; Novikov VV, 2014, ZHIVYE BIOKOSNYE SIS, P1; Osipenko M., 2008, Biophysics, V53, P317, DOI 10.1134/S0006350908040167; Ozheredov VA, 2016, INT J BIOMETEOROL; Panina L. K., 2012, Mikologiya i Fitopatologiya, V46, P81; Pershin S. M., 2013, Biofizika, V58, P910; [Платова Н.Г. Platova N.G.], 2016, [Авиакосмическая и экологическая медицина, Aerospace and Environmental Medicine, Aviakosmicheskaya i ekologicheskaya meditsina], V50, P35; Podkovkin V. G., 1995, Radiatsionnaya Biologiya Radioekologiya, V35, P906; Poiata A, 2003, ELECTROMAGN BIOL MED, V22, P171, DOI 10.1081/JBC-120024626; Polesel D N, 2014, PROG MODERN BIOMED, V49, P70; Politanski P, 2013, BIOELECTROMAGNETICS, V34, P333, DOI 10.1002/bem.21767; Portelli LA, 2012, BIOELECTROMAGNETICS, V33, P706, DOI 10.1002/bem.21720; Prato FS, 2017, BIOELECTROMAGNETICS, V38, P324, DOI 10.1002/bem.22040; Prato FS, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1046; Prato FS, 2009, J R SOC INTERFACE, V6, P17, DOI 10.1098/rsif.2008.0156; Prato FS, 2005, BIOELECTROMAGNETICS, V26, P109, DOI 10.1002/bem.20056; Rakosy-Tican L, 2005, BIOELECTROMAGNETICS, V26, P548, DOI 10.1002/bem.20134; Ritz T, 2009, BIOPHYS J, V96, P3451, DOI 10.1016/j.bpj.2008.11.072; Roman A, 2009, BIOELECTROMAGNETICS, V30, P21, DOI 10.1002/bem.20435; Ryzhkina IS, 2012, DOKL PHYS CHEM, V447, P193, DOI 10.1134/S0012501612110024; Ryzhkina IS, 2012, DOKL PHYS CHEM, V446, P153, DOI 10.1134/S0012501612090047; SAFRONOVA VG, 1992, BIOL MEMBRANY, V9, P1164; Salikhov K.M., 1984, SPIN POLARIZATION MA, VVolume 22, P419, DOI [10.1002/bbpc.198400037, DOI 10.1002/BBPC.198400037]; Salvan A, 2015, INT J ENV RES PUB HE, V12, P2184, DOI 10.3390/ijerph120202184; Sandodze V. Ya., 1995, Radiatsionnaya Biologiya Radioekologiya, V35, P19; SANDWEISS J, 1990, BIOELECTROMAGNETICS, V11, P203, DOI 10.1002/bem.2250110210; Sarimov R. M., 2008, Biophysics, V53, P433, DOI 10.1134/S0006350908050205; SCHULTEN K, 1978, Z PHYS CHEM NEUE FOL, V111, P1, DOI 10.1524/zpch.1978.111.1.001; [Севастьянова Е.В. Sevostyanova E.V.], 2007, [Сибирский научный медицинский журнал, The Siberian Scientific Medical Journal], V27, P93; Shah SA, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.094438; Shaitan K. V., 2015, Biophysics, V60, P692, DOI 10.1134/S0006350915050206; Shcherbakov VP, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031921; Shen G., 2012, INT, V49, P56; Solov'yov IA, 2007, BIOPHYS J, V92, P2711, DOI 10.1529/biophysj.106.097139; Solov'yov IA, 2009, BIOPHYS J, V96, P4804, DOI 10.1016/j.bpj.2009.03.048; Spivak I. M., 2016, Biophysics, V61, P435, DOI 10.1134/S0006350916030180; STEINER UE, 1989, CHEM REV, V89, P51, DOI 10.1021/cr00091a003; Temour'yants NA, 2011, NEUROPHYSIOLOGY+, V42, P276, DOI 10.1007/s11062-011-9160-1; Temuryants N.A., 2008, PHYS ALIVE, V16, P85; Thomas AW, 1997, PEPTIDES, V18, P703, DOI 10.1016/S0196-9781(97)00004-1; Tikhonov VI, 2002, SCIENCE, V296, P2363, DOI 10.1126/science.1069513; Timmel CR, 1998, MOL PHYS, V95, P71, DOI 10.1080/00268979809483134; Tiras KP, 2014, FUNDAMENTALNYE ISSLE, V12, P1442; Tombarkiewicz B, 2008, ENVIRON TOXICOL PHAR, V26, P75, DOI 10.1016/j.etap.2008.02.003; Treiber CD, 2012, NATURE, V484, P367, DOI 10.1038/nature11046; Trofimov AV, 2008, B EXP BIOL MED+, V146, P100, DOI 10.1007/s10517-008-0221-4; Trukhanov K. A., 2014, Radiatsionnaya Biologiya Radioekologiya, V54, P179, DOI 10.7868/S086980311402012X; TrulA Z, 2005, ROMANIAN J BIOPHYS, V15, P73; Truta Z, 2012, ROM BIOTECH LETT, V17, P6928; Tsetlin V V, 2014, Aviakosm Ekolog Med, V48, P36; Tumanyants KN, 2016, INT J APPL FUNDAMENT, V1, P199; VERKIN B I, 1976, Mikrobiologiya, V45, P1067; Vladimirsky BM, 2015, SPACE WEATHER BIOSPH; Volkov AA, 2014, EPL-EUROPHYS LETT, V106, DOI 10.1209/0295-5075/106/46004; Volpe Pietro, 2005, Environmentalist, V25, P83, DOI 10.1007/s10669-005-4270-1; Volpe Pietro, 2005, Environmentalist, V25, P75, DOI 10.1007/s10669-005-4269-7; Voronin AY, 2004, B SIBERIAN BRANCH RU, V1, P73; Walker MM, 1985, MAGNETITE BIOMINERAL, P155; Wan GJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132966; Wan GJ, 2014, J INSECT PHYSIOL, V68, P7, DOI 10.1016/j.jinsphys.2014.06.016; Wang DL, 2008, BIOCHEM BIOPH RES CO, V376, P363, DOI 10.1016/j.bbrc.2008.08.156; Wang XB, 2003, CHINESE SCI BULL, V48, P2454; Wang XK, 2008, GEOMICROBIOL J, V25, P296, DOI 10.1080/01490450802258295; Wiltschko R., 1995, TIEROSYCHOL; Xiao Y, 2009, ADV SPACE RES, V44, P226, DOI 10.1016/j.asr.2009.04.013; Xu CX, 2017, BIOELECTROMAGNETICS, V38, P1, DOI 10.1002/bem.22004; Xu CX, 2015, BIOELECTROMAGNETICS, V36, P476, DOI 10.1002/bem.21927; Xu CX, 2013, BIOELECTROMAGNETICS, V34, P437, DOI 10.1002/bem.21788; Xu CX, 2012, ADV SPACE RES, V49, P834, DOI 10.1016/j.asr.2011.12.004; Yamashita M, 2004, ADV SPACE RES, V34, P1575, DOI 10.1016/j.asr.2004.01.022; Yarmolyuk N. S., 2010, SCI NOTES TAURIDA V, V23, P200; Yarmolyuk NS, 2009, SCI NOTES TAURIDA 6, V22, P302; YORKE ED, 1981, J THEOR BIOL, V89, P533, DOI 10.1016/0022-5193(81)90367-2; YuG Grigoriev, 1995, RAD BIOL RADIOECOLOG, V35, P3; Zamoshchina T A, 2012, Aviakosm Ekolog Med, V46, P17; Zangi R, 2007, J AM CHEM SOC, V129, P4678, DOI 10.1021/ja068305m; Zapka M, 2009, NATURE, V461, P1274, DOI 10.1038/nature08528; Zhang B, 2004, NEUROSCI LETT, V371, P190, DOI 10.1016/j.neulet.2004.08.072; Zhang X, 2007, BIOELECTROMAGNETICS, V28, P155, DOI 10.1002/bem.20290	226	58	68	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179340	10.1371/journal.pone.0179340	http://dx.doi.org/10.1371/journal.pone.0179340			51	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654641	Green Published, gold			2022-12-27	WOS:000404541500010
J	Nam, HY; Raghavendran, HRB; Pingguan-Murphy, B; Abbas, AA; Merican, AM; Kamarul, T				Nam, Hui Yin; Raghavendran, Hanumantha Rao Balaji; Pingguan-Murphy, Belinda; Abbas, Azlina A.; Merican, Azhar M.; Kamarul, Tunku			Fate of tenogenic differentiation potential of human bone marrow stromal cells by uniaxial stretching affected by stretch-activated calcium channel agonist gadolinium	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ION CHANNELS; SIGNALING PATHWAYS; MECHANICAL-STRESS; TENDON REPAIR; STRAIN; CHONDROCYTES; OSTEOBLASTS; APOPTOSIS; DEATH	The role for mechanical stimulation in the control of cell fate has been previously proposed, suggesting that there may be a role of mechanical conditioning in directing mesenchymal stromal cells (MSCs) towards specific lineage for tissue engineering applications. Although previous studies have reported that calcium signalling is involved in regulating many cellular processes in many cell types, its role in managing cellular responses to tensile loading (mechanotransduction) of MSCs has not been fully elucidated. In order to establish this, we disrupted calcium signalling by blocking stretch-activated calcium channel (SACC) in human MSCs (hMSCs) in vitro. Passaged-2 hMSCs were exposed to cyclic tensile loading (1 Hz + 8% for 6, 24, 48, and 72 hours) in the presence of the SACC blocker, gadolinium. Analyses include image observations of immunochemistry and immunofluorescence staining from extracellular matrix (ECM) production, and measuring related tenogenic and apoptosis gene marker expression. Uniaxial tensile loading increased the expression of tenogenic markers and ECM production. However, exposure to strain in the presence of 20 mu M gadolinium reduced the induction of almost all tenogenic markers and ECM staining, suggesting that SACC acts as a mechanosensor in strain-induced hMSC tenogenic differentiation process. Although cell death was observed in prolonged stretching, it did not appear to be apoptosis mediated. In conclusion, the knowledge gained in this study by elucidating the role of calcium in MSC mechanotransduction processes, and that in prolonged stretching results in non-apoptosis mediated cell death may be potential useful for regenerative medicine applications.	[Nam, Hui Yin; Raghavendran, Hanumantha Rao Balaji; Abbas, Azlina A.; Merican, Azhar M.; Kamarul, Tunku] Univ Malaya, Fac Med, Dept Orthopaed Surg NOCERAL, Tissue Engn Grp, Kuala Lumpur, Malaysia; [Pingguan-Murphy, Belinda] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Nam, HY; Kamarul, T (corresponding author), Univ Malaya, Fac Med, Dept Orthopaed Surg NOCERAL, Tissue Engn Grp, Kuala Lumpur, Malaysia.	huiyin26@yahoo.com; tkzrea@um.edu.my	ABBAS, AZLINA AMIR/B-5405-2010; Merican, Azhar M/S-2982-2019; Tunku Zainol Abidin, Tunku Kamarul Zaman/B-9633-2011; raghavendran, hanumantha rao balaji/B-8507-2012; Nam, Hui Yin/F-5013-2013; Pingguan-Murphy, Belinda/B-8332-2010	ABBAS, AZLINA AMIR/0000-0003-4423-4653; Merican, Azhar M/0000-0001-6442-8776; Tunku Zainol Abidin, Tunku Kamarul Zaman/0000-0002-6028-1313; Pingguan-Murphy, Belinda/0000-0001-5567-1141	High Impact Research Ministry of Education, HIR-MoE [UM.C/625/1/HIR/MOHE/CHAN/03, A000003-50001]; University of Malaya	High Impact Research Ministry of Education, HIR-MoE; University of Malaya(Universiti Malaya)	This work was supported by High Impact Research Ministry of Education, HIR-MoE Grant (Reference number - UM.C/625/1/HIR/MOHE/CHAN/03, account number - A000003-50001). We also thank the University of Malaya for a PhD thesis scholarship for the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by High Impact Research-Ministry of Education, HIR-MoE Grant (Reference number UM.C/625/1/HIR/MOHE/CHAN/03, account number - A000003-50001). We also thank the University of Malaya for a PhD thesis scholarship for the first author.	Banes AJ, 1999, CLIN ORTHOP RELAT R, pS356; Banes AJ., 2001, CURR OPIN ORTHOP, V12, P389; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Blatt NB, 2001, BIOORGAN MED CHEM, V9, P1371, DOI 10.1016/S0968-0896(01)00041-4; Bootman MD, 2001, SEMIN CELL DEV BIOL, V12, P3, DOI 10.1006/scdb.2000.0211; Boudreault F, 2002, AM J PHYSIOL-CELL PH, V282, pC219, DOI 10.1152/ajpcell.00317.2001; Bullough R, 2008, DISABIL REHABIL, V30, P1746, DOI 10.1080/09638280701788258; Cain K, 2003, DRUG METAB REV, V35, P337, DOI 10.1081/DMR-120026497; Caldwell RA, 1998, AM J PHYSIOL-CELL PH, V275, pC619, DOI 10.1152/ajpcell.1998.275.2.C619; Chuen FS, 2004, J HISTOCHEM CYTOCHEM, V52, P1151, DOI 10.1369/jhc.3A6232.2004; Cigognini D, 2013, DRUG DISCOV TODAY, V18, P1099, DOI 10.1016/j.drudis.2013.06.007; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Coirault C, 1999, EUR RESPIR J, V14, P1297, DOI 10.1183/09031936.99.14612979; Costa P, 2012, INT J BIOCHEM CELL B, V44, P2233, DOI 10.1016/j.biocel.2012.09.003; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Docheva D, 2015, ADV DRUG DELIVER REV, V84, P222, DOI 10.1016/j.addr.2014.11.015; Dook JE, 1997, MED SCI SPORT EXER, V29, P291, DOI 10.1097/00005768-199703000-00002; Ge DX, 2009, BIOCHEM BIOPH RES CO, V381, P317, DOI 10.1016/j.bbrc.2009.01.173; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Hamill OP, 1996, PHARMACOL REV, V48, P231; Hung CT, 1996, J BIOMECH, V29, P1411, DOI 10.1016/0021-9290(96)84536-2; Huo B, 2010, PHILOS T R SOC A, V368, P617, DOI 10.1098/rsta.2009.0221; Jang JY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/860652; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; Kawano S, 2002, CELL CALCIUM, V32, P165, DOI 10.1016/S0143416002001240; Kearney EM, 2010, ANN BIOMED ENG, V38, P1767, DOI 10.1007/s10439-010-9979-4; Kearney EM, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2979870; Khatib L, 2004, FASEB J, V18, P1903, DOI 10.1096/fj.04-1814fje; Killian ML, 2012, J SHOULDER ELB SURG, V21, P228, DOI 10.1016/j.jse.2011.11.002; Kim TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109378; Lebart MC, 2006, FEBS J, V273, P3415, DOI 10.1111/j.1742-4658.2006.05350.x; Liu YK, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025004; Maeda T, 2011, CURR BIOL, V21, P933, DOI 10.1016/j.cub.2011.04.007; Massoud EIE, 2013, WORLD J ORTHOP, V4, P229, DOI 10.5312/wjo.v4.i4.229; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; Mayr M, 2002, FASEB J, V16, P1423, DOI 10.1096/fj.02-0042fje; McKayed KK, 2012, STEM CELLS CANC STEM, P199; McMahon LA, 2008, ANN BIOMED ENG, V36, P185, DOI 10.1007/s10439-007-9416-5; Miyauchi A, 2000, J BIOL CHEM, V275, P3335, DOI 10.1074/jbc.275.5.3335; Mobasheri A, 2002, CELL BIOL INT, V26, P1, DOI 10.1006/cbir.2001.0826; Nam HY, 2015, BIOMECH MODEL MECHAN, V14, P649, DOI 10.1007/s10237-014-0628-y; Nam HY, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4309; Nowycky MC, 2002, J CELL SCI, V115, P3715, DOI 10.1242/jcs.00078; Park JS, 2004, BIOTECHNOL BIOENG, V88, P359, DOI 10.1002/bit.20250; Park JY, 2002, BIOCHEM BIOPH RES CO, V290, P1176, DOI 10.1006/bbrc.2001.6323; Pingguan-Murphy B, 2005, ARCH BIOCHEM BIOPHYS, V444, P45, DOI 10.1016/j.abb.2005.09.015; Riddle RC, 2006, AM J PHYSIOL-CELL PH, V290, pC776, DOI 10.1152/ajpcell.00082.2005; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; RUKNUDIN A, 1993, AM J PHYSIOL, V264, pH960, DOI 10.1152/ajpheart.1993.264.3.H960; Salameh A, 2013, BBA-BIOMEMBRANES, V1828, P147, DOI 10.1016/j.bbamem.2011.12.030; Scott A, 2007, ARTHRITIS RHEUM-US, V56, P871, DOI 10.1002/art.22426; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sun XH, 2012, BONE, V51, P860, DOI 10.1016/j.bone.2012.08.116; Sun XH, 2012, BONE, V50, P581, DOI 10.1016/j.bone.2011.12.015; Tan JL, 2015, BONE RES, V3, DOI 10.1038/boneres.2015.3; Thompson WR, 2012, GENE, V503, P179, DOI 10.1016/j.gene.2012.04.076; Tonelli FMP, 2012, ADV EXP MED BIOL, V740, P891, DOI 10.1007/978-94-007-2888-2_40; Upadhyay R. K, 2015, J REGEN MED TISSUE E, V4, P1; Wall M. E., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P70; Wang ECY, 2003, AM J PHYSIOL-RENAL, V285, pF651, DOI 10.1152/ajprenal.00403.2002; Wang JHC, 2006, J BIOMECH, V39, P1563, DOI 10.1016/j.jbiomech.2005.05.011; Wang JHC, 2000, CONNECT TISSUE RES, V41, P29, DOI 10.3109/03008200009005639; Wedhas N, 2005, FASEB J, V19, P1986, DOI 10.1096/fj.05-4198com; Wright MO, 1997, J ORTHOPAED RES, V15, P742, DOI 10.1002/jor.1100150517; YANG XC, 1989, SCIENCE, V243, P1068, DOI 10.1126/science.2466333; Yano S, 2004, J INVEST DERMATOL, V122, P783, DOI 10.1111/j.0022-202X.2004.22328.x; Yao L, 2006, TISSUE ENG, V12, P1843, DOI 10.1089/ten.2006.12.1843	67	8	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0178117	10.1371/journal.pone.0178117	http://dx.doi.org/10.1371/journal.pone.0178117			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654695	Green Published, gold, Green Submitted			2022-12-27	WOS:000404541500012
J	Osugi, T; Sasakura, Y; Satake, H				Osugi, Tomohiro; Sasakura, Yasunori; Satake, Honoo			The nervous system of the adult ascidian Ciona intestinalis Type A (Ciona robusta): Insights from transgenic animal models	PLOS ONE			English	Article							GONADOTROPIN-RELEASING HORMONES; ANCESTRAL CHORDATE BRAIN; EVOLUTIONARY ORIGIN; OOCYTE GROWTH; PROTOCHORDATE; FAMILY; GENES; SUPERFAMILY; TUNICATES; RECEPTOR	The nervous system of ascidians is an excellent model system to provide insights into the evolutionary process of the chordate nervous system due to their phylogenetic positions as the sister group of vertebrates. However, the entire nervous system of adult ascidians has yet to be functionally and anatomically investigated. In this study, we have revealed the whole dorsal and siphon nervous system of the transgenic adult ascidian of Ciona intestinalis Type A (Ciona robusta) in which a Kaede reporter gene is expressed in a pan-neuronal fashion. The fluorescent signal of Kaede revealed the innervation patterns and distribution of neurons in the nervous system of Ciona. Precise microscopic observation demonstrated the clear innervation of the anterior and posterior main nerves to eight and six lobes of the oral and atrial siphons, respectively. Moreover, visceral nerves, previously identified as unpaired nerves, were found to be paired; one nerve was derived from the posterior end of the cerebral ganglion and the other from the right posterior nerve. This study further revealed the full trajectory of the dorsal strand plexus and paired visceral nerves on either side from the cerebral ganglion to the ovary, and precise innervation between the cerebral ganglion and the peripheral organs including the gonoduct, cupular organ, rectum and ovary. The differential innervation patterns of visceral nerves and the dorsal strand plexus indicate that the peripheral organs including the ovary undergo various neural regulations. Collectively, the present anatomical analysis revealed the major innervation of the dorsal and siphon nervous systems of adult Ciona.	[Osugi, Tomohiro; Satake, Honoo] Suntory Fdn Life Sci, Bioorgan Res Inst, Kyoto, Japan; [Sasakura, Yasunori] Univ Tsukuba, Shimoda Marine Res Ctr, Shizuoka, Japan	Suntory Holdings Ltd; University of Tsukuba	Satake, H (corresponding author), Suntory Fdn Life Sci, Bioorgan Res Inst, Kyoto, Japan.	satake@sunbor.or.jp		Osugi, Tomohiro/0000-0001-6987-9576	Japan Society for the promotion of Science [26840108, 25440161]; Grants-in-Aid for Scientific Research [16K07430] Funding Source: KAKEN	Japan Society for the promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the promotion of Science (http://www.isps.go.jp/english/index.html) to TO (26840108) and HS (25440161). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abitua PB, 2012, NATURE, V492, P104, DOI 10.1038/nature11589; Adams BA, 2003, ENDOCRINOLOGY, V144, P1907, DOI 10.1210/en.2002-0216; Aoyama M, 2008, ENDOCRINOLOGY, V149, P4346, DOI 10.1210/en.2008-0323; Aoyama M, 2012, PEPTIDES, V34, P186, DOI 10.1016/j.peptides.2011.07.019; Auger H, 2010, DEV BIOL, V339, P374, DOI 10.1016/j.ydbio.2009.12.040; Bollner T, 1997, P ROY SOC B-BIOL SCI, V264, P1117, DOI 10.1098/rspb.1997.0154; BONE Q, 1978, J ZOOL, V186, P417; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Braun K, 2016, ZOOMORPHOLOGY, V135, P351, DOI 10.1007/s00435-016-0317-8; Brunetti R, 2015, J ZOOL SYST EVOL RES, V53, P186, DOI 10.1111/jzs.12101; Burighel P, 2001, INVERTEBR BIOL, V120, P185, DOI 10.1111/j.1744-7410.2001.tb00123.x; Dahlberg C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004458; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Delsuc F, 2008, GENESIS, V46, P592, DOI 10.1002/dvg.20450; Dufour HD, 2006, P NATL ACAD SCI USA, V103, P8727, DOI 10.1073/pnas.0600805103; Egertova M, 2007, J COMP NEUROL, V502, P660, DOI 10.1002/cne.21331; FEDELE M, 1938, ATTI ACCADEMIA NAZIO, V27, P370; GOODBODY I, 1974, ADV MAR BIOL, V12, P1; Hasunuma I, 2013, ZOOL SCI, V30, P311, DOI 10.2108/zsj.30.311; Horie T, 2011, NATURE, V469, P525, DOI 10.1038/nature09631; Hozumi A, 2015, DEV DYNAM, V244, P1375, DOI 10.1002/dvdy.24317; Imai JH, 2007, J COMP NEUROL, V501, P316, DOI 10.1002/cne.21246; Imai JH, 2007, J COMP NEUROL, V501, P335, DOI 10.1002/cne.21247; Jeffery WR, 2015, GENESIS, V53, P48, DOI 10.1002/dvg.22799; Joly JS, 2007, DEV DYNAM, V236, P1832, DOI 10.1002/dvdy.21124; Kawada T, 2008, PEPTIDES, V29, P1672, DOI 10.1016/j.peptides.2008.05.030; Kawada T, 2011, ENDOCRINOLOGY, V152, P2416, DOI 10.1210/en.2010-1348; Kawada T, 2009, PEPTIDES, V30, P2200, DOI 10.1016/j.peptides.2009.08.014; Lacalli TC, 1998, PHILOS T ROY SOC B, V353, P1943, DOI 10.1098/rstb.1998.0347; Mackie GO, 2006, CAN J ZOOL, V84, P1146, DOI 10.1139/Z06-106; Mackie GO, 2005, CAN J ZOOL, V83, P151, DOI 10.1139/Z04-177; MACKIE GO, 1995, J MAR BIOL ASSOC UK, V75, P141, DOI 10.1017/S0025315400015253; Manni L, 2006, J COMP NEUROL, V495, P363, DOI 10.1002/cne.20867; Manni L, 2015, STRUCTURE EVOLUTION; Markman B, 1958, ACTA ZOOLOGICA, V34, P13; Matsubara S, 2016, GEN COMP ENDOCR, V227, P101, DOI 10.1016/j.ygcen.2015.05.010; Matsuoka T, 2005, GENESIS, V41, P67, DOI 10.1002/gene.20096; NICOL D, 1991, J COMP NEUROL, V309, P415, DOI 10.1002/cne.903090402; Ohta N, 2010, ZOOL SCI, V27, P842, DOI 10.2108/zsj.27.842; Olinski RP, 2006, PEPTIDES, V27, P2535, DOI 10.1016/j.peptides.2006.06.008; Olinski RP, 2006, MOL BIOL EVOL, V23, P10, DOI 10.1093/molbev/msj002; Pennati R, 2012, EUR J HISTOCHEM, V56, P96, DOI [10.4081/ejh.2012.e16, 10.4081/ejh.2012.16]; Richter S, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-29; Rigon F, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-112; Sasakura Y, 2003, P NATL ACAD SCI USA, V100, P7726, DOI 10.1073/pnas.1230736100; Satake H, 2004, J BIOL CHEM, V279, P53798, DOI 10.1074/jbc.M408161200; Satoh N, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1729; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Sekiguchi T, 2007, GEN COMP ENDOCR, V150, P233, DOI 10.1016/j.ygcen.2006.08.010; Sekiguchi T, 2012, J ENDOCRINOL, V213, P99, DOI 10.1530/JOE-11-0410; Sekiguchi T, 2009, FEBS J, V276, P4437, DOI 10.1111/j.1742-4658.2009.07151.x; Takamura K, 2010, ZOOL SCI, V27, P191, DOI 10.2108/zsj.27.191; Terakado K, 2001, GEN COMP ENDOCR, V124, P277, DOI 10.1006/gcen.2001.7728; Terakubo HQ, 2010, DEV DYNAM, V239, P2278, DOI 10.1002/dvdy.22361; Tsutsui H, 1998, GEN COMP ENDOCR, V112, P426, DOI 10.1006/gcen.1998.7160; Wada H, 1998, DEVELOPMENT, V125, P1113; Yamana Y, 2005, NIPPON SUISAN GAKK, V71, P299, DOI 10.2331/suisan.71.299	57	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0180227	10.1371/journal.pone.0180227	http://dx.doi.org/10.1371/journal.pone.0180227			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651020	Green Published, gold, Green Submitted			2022-12-27	WOS:000404537300043
J	Pardo, E; Carcamo, C; Martin, RUS; Ciampi, E; Segovia-Miranda, F; Curkovic-Pena, C; Montecino, F; Holmes, C; Tichauer, JE; Acuna, E; Osorio-Barrios, F; Castro, M; Cortes, P; Oyanadel, C; Valenzuela, DM; Pacheco, R; Naves, R; Soza, A; Gonzalez, A				Pardo, Evelyn; Carcamo, Claudia; Uribe-San Martin, Reinaldo; Ciampi, Ethel; Segovia-Miranda, Fabian; Curkovic-Pena, Cristobal; Montecino, Fabian; Holmes, Christopher; Enrique Tichauer, Juan; Acuna, Eric; Osorio-Barrios, Francisco; Castro, Marjorie; Cortes, Priscilla; Oyanadel, Claudia; Valenzuela, David M.; Pacheco, Rodrigo; Naves, Rodrigo; Soza, Andrea; Gonzalez, Alfonso			Galectin-8 as an immunosuppressor in experimental autoimmune encephalomyelitis and a target of human early prognostic antibodies in multiple sclerosis	PLOS ONE			English	Article							REGULATORY T-CELLS; CENTRAL-NERVOUS-SYSTEM; ALPHA-4 INTEGRIN EXPRESSION; INTRATHECAL IGM SYNTHESIS; B-CELLS; LUPUS-ERYTHEMATOSUS; CEREBROSPINAL-FLUID; POTASSIUM CHANNEL; OLIGOCLONAL IGM; DENDRITIC CELLS	Galectin-8 (Gal-8) is a member of a glycan-binding protein family that regulates the immune system, among other functions, and is a target of antibodies in autoimmune disorders. However, its role in multiple sclerosis (MS), an autoimmune inflammatory disease of the central nervous system (CNS), remains unknown. We study the consequences of Gal-8 silencing on lymphocyte subpopulations and the development of experimental autoimmune encephalitis (EAE), to then assess the presence and clinical meaning of anti-Gal-8 antibodies in MS patients. Lgals8/Lac-Z knock-in mice lacking Gal-8 expression have higher polarization toward Th17 cells accompanied with decreased CCR6(+) and higher CXCR3(+) regulatory T cells (Tregs) frequency. These conditions result in exacerbated MOG(35-55) peptide-induced EAE. Gal-8 eliminates activated Th17 but not Th1 cells by apoptosis and ameliorates EAE in C57BL/6 wild-type mice. beta-gal histochemistry reflecting the activity of the Gal-8 promoter revealed Gal-8 expression in a wide range of CNS regions, including high expression in the choroid-plexus. Accordingly, we detected Gal-8 in human cerebrospinal fluid, suggesting a role in the CNS immune-surveillance circuit. In addition, we show that MS patients generate function-blocking anti-Gal-8 antibodies with pathogenic potential. Such antibodies block cell adhesion and Gal-8-induced Th17 apoptosis. Furthermore, circulating anti-Gal-8 antibodies associate with relapsing-remitting MS (RRMS), and not with progressive MS phenotypes, predicting clinical disability at diagnosis within the first year of follow-up. Our results reveal that Gal-8 has an immunosuppressive protective role against autoimmune CNS inflammation, modulating the balance of Th17 and Th1 polarization and their respective Tregs. Such a role can be counteracted during RRMS by anti-Gal-8 antibodies, worsening disease prognosis. Even though anti-Gal-8 antibodies are not specific for MS, our results suggest that they could be a potential early severity biomarker in RRMS.	[Pardo, Evelyn; Segovia-Miranda, Fabian; Curkovic-Pena, Cristobal; Montecino, Fabian; Holmes, Christopher; Cortes, Priscilla; Oyanadel, Claudia; Soza, Andrea; Gonzalez, Alfonso] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Aging & Regenerat CARE, Santiago, Chile; [Pardo, Evelyn] Univ Chile, Inst Biomed Sci, Anat & Dev Biol Program, Gerosci Ctr Brain Hlth & Metab, Santiago, Chile; [Carcamo, Claudia; Uribe-San Martin, Reinaldo; Ciampi, Ethel] Pontificia Univ Catolica Chile, Fac Med, Dept Neurol, Santiago, Chile; [Enrique Tichauer, Juan; Acuna, Eric; Naves, Rodrigo] Univ Chile, Fac Med, Inst Ciencias Biomed, Santiago, Chile; [Osorio-Barrios, Francisco; Oyanadel, Claudia; Pacheco, Rodrigo] Fdn Ciencia & Vida, Santiago, Chile; [Castro, Marjorie] Univ San Sebastian, Fac Ciencias Salud, Santiago, Chile; [Cortes, Priscilla; Oyanadel, Claudia; Soza, Andrea] Univ San Sebastian, Fac Ciencia, Santiago, Chile; [Valenzuela, David M.] Regeneron Pharmaceut, New York, NY USA; [Pacheco, Rodrigo] Univ Andres Bello, Dept Ciencias Biol, Fac Ciencias Biol, Santiago, Chile; [Gonzalez, Alfonso] Univ San Sebastian, Fac Med, Santiago, Chile	Pontificia Universidad Catolica de Chile; Universidad de Chile; Pontificia Universidad Catolica de Chile; Universidad de Chile; Universidad San Sebastian; Universidad San Sebastian; Regeneron; Universidad Andres Bello; Universidad San Sebastian	Soza, A; Gonzalez, A (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Aging & Regenerat CARE, Santiago, Chile.; Soza, A (corresponding author), Univ San Sebastian, Fac Ciencia, Santiago, Chile.; Gonzalez, A (corresponding author), Univ San Sebastian, Fac Med, Santiago, Chile.	andrea.soza@uss.cl; agonzara@uss.cl	Naves, Rodrigo/H-4829-2014	Naves, Rodrigo/0000-0002-1203-3593; Oyanadel, Claudia/0000-0002-5018-9767; Osorio-Barrios, Francisco/0000-0002-6853-7846; Soza, Andrea/0000-0003-3783-5231; Pacheco, Rodrigo/0000-0001-8057-9806; Pardo, Evelyn/0000-0002-2516-5632	CONICYT [PFB12/2007, PFB-16]; FONDECYT [1131122, 1130271, 1140049]; Programa de Formacion de Capital Human Avanzado Magister Nacional from CONICYT [22140120]	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Programa de Formacion de Capital Human Avanzado Magister Nacional from CONICYT	Financial support: Grants CONICYT PFB12/2007 (A.G), FONDECYT #1131122 (A.S), FONDECYT 1130271(R.P.), FONDECYT 1140049 (R.N.) and PFB-16 from CONICYT (R.P.). F.O.-B holds a scholarship (22140120) of the Programa de Formacion de Capital Human Avanzado Magister Nacional from CONICYT. CAPES CONICYT FB 0002 (Line 3) to FB (P.C.). FONDECYT N 3120061 (E.P.). The funder provided support in the form of salaries for authors EP, CC, CH, CC, CH, PC, CO, RP, RN, AS and AG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arellano G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00492; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Benarroch EE, 2016, NEUROLOGY, V86, P286, DOI 10.1212/WNL.0000000000002298; Brickshawana A, 2014, LANCET NEUROL, V13, P795, DOI 10.1016/S1474-4422(14)70141-3; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Carcamo C, 2006, EXP CELL RES, V312, P374, DOI 10.1016/j.yexcr.2005.10.025; Cedeno-Laurent F, 2012, J IMMUNOL, V188, P3127, DOI 10.4049/jimmunol.1103433; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chen Y, 2006, J CLIN INVEST, V116, P1317, DOI 10.1172/JCI25308; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Dendrou CA, 2015, NAT REV IMMUNOL, V15, P545, DOI 10.1038/nri3871; Derfuss T, 2009, P NATL ACAD SCI USA, V106, P8302, DOI 10.1073/pnas.0901496106; Dhaeze T, 2015, AUTOIMMUN REV, V14, P735, DOI 10.1016/j.autrev.2015.04.006; Dominguez-Villar M, 2011, NAT MED, V17, P673, DOI 10.1038/nm.2389; Elola MT, 2015, BIOCHEM J, V469, P1, DOI 10.1042/BJ20150461; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Fraussen J, 2014, AUTOIMMUN REV, V13, P1126, DOI 10.1016/j.autrev.2014.07.002; Garcia-Barragan N, 2009, EUR J NEUROL, V16, P380, DOI 10.1111/j.1468-1331.2008.02504.x; Glatigny S, 2011, J IMMUNOL, V187, P6176, DOI 10.4049/jimmunol.1102515; Hall AO, 2012, IMMUNITY, V37, P511, DOI 10.1016/j.immuni.2012.06.014; Harrison DM, 2014, ANN INTERN MED, V160, DOI 10.7326/0003-4819-160-7-201404010-01004; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Huber AK, 2014, NEUROLOGY, V83, P1500, DOI 10.1212/WNL.0000000000000908; Ideo H, 2003, GLYCOBIOLOGY, V13, P713, DOI 10.1093/glycob/cwg094; Ideo H, 2011, J BIOL CHEM, V286, P11346, DOI 10.1074/jbc.M110.195925; Ilarregui JM, 2009, NAT IMMUNOL, V10, P981, DOI 10.1038/ni.1772; Jiang HR, 2009, J IMMUNOL, V182, P1167, DOI 10.4049/jimmunol.182.2.1167; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kaltner H, 2012, HISTOL HISTOPATHOL, V27, P397, DOI 10.14670/HH-27.397; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; Kleinewietfeld M, 2014, IMMUNOL REV, V259, P231, DOI 10.1111/imr.12169; Koch MA, 2012, IMMUNITY, V37, P501, DOI 10.1016/j.immuni.2012.05.031; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Krumbholz M, 2012, NAT REV NEUROL, V8, P613, DOI 10.1038/nrneurol.2012.203; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Mandrioli J, 2008, J NEUROL, V255, P1023, DOI 10.1007/s00415-008-0827-5; Massardo L, 2009, LUPUS, V18, P539, DOI 10.1177/0961203308099973; Mathey EK, 2007, J EXP MED, V204, P2363, DOI 10.1084/jem.20071053; Mayer MC, 2012, THER ADV NEUROL DISO, V5, P147, DOI 10.1177/1756285611433772; Metz C, 2016, BIOL RES, V49, DOI 10.1186/s40659-016-0091-6; Muller M, 2007, J IMMUNOL, V179, P2774, DOI 10.4049/jimmunol.179.5.2774; Nabi IR, 2015, J CELL SCI, V128, P2213, DOI 10.1242/jcs.151159; Naves R, 2013, J IMMUNOL, V191, P2967, DOI 10.4049/jimmunol.1300419; Nishi N, 2003, GLYCOBIOLOGY, V13, P755, DOI 10.1093/glycob/cwg102; Norambuena A, 2009, J BIOL CHEM, V284, P12670, DOI 10.1074/jbc.M808949200; Oomizu S, 2012, CLIN IMMUNOL, V143, P51, DOI 10.1016/j.clim.2012.01.004; Ottum PA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00539; Owens GP, 2009, ANN NEUROL, V65, P639, DOI 10.1002/ana.21641; Pal Z, 2012, BBA-GEN SUBJECTS, V1820, P1512, DOI 10.1016/j.bbagen.2012.05.015; Pardo E, 2006, REV MED CHILE, V134, P159; Poueymirou WT, 2007, NAT BIOTECHNOL, V25, P91, DOI 10.1038/nbt1263; Prado C, 2012, J IMMUNOL, V188, P3062, DOI 10.4049/jimmunol.1103096; Probstel AK, 2015, INT J MOL SCI, V16, P16576, DOI 10.3390/ijms160716576; Rabinovich GA, 2012, IMMUNITY, V36, P322, DOI 10.1016/j.immuni.2012.03.004; Ransohoff RM, 2015, NATURE REV NEUROLOGY; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Rieckmann P, 2001, TRENDS NEUROSCI, V24, P548, DOI 10.1016/S0166-2236(00)01860-9; Rothhammer V, 2011, J EXP MED, V208, P2465, DOI 10.1084/jem.20110434; Rowse AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052658; Ruiz FM, 2014, FEBS J, V281, P1446, DOI 10.1111/febs.12716; Sampson JF, 2016, IMMUNOL CELL BIOL, V94, P213, DOI 10.1038/icb.2015.72; Sampson JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130772; Sebban LE, 2007, J IMMUNOL, V179, P1225, DOI 10.4049/jimmunol.179.2.1225; Segovia-Miranda F, 2015, ARTHRITIS RHEUMATOLO; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Shen P, 2015, NAT REV IMMUNOL, V15, P441, DOI 10.1038/nri3857; Sie C, 2014, EXP NEUROL, V262, P18, DOI 10.1016/j.expneurol.2014.03.009; Srivastava R, 2012, NEW ENGL J MED, V367, P115, DOI 10.1056/NEJMoa1110740; Starossom SC, 2012, IMMUNITY, V37, P249, DOI 10.1016/j.immuni.2012.05.023; Steelman AJ, 2013, J BIOL CHEM, V288, P23776, DOI 10.1074/jbc.M113.451658; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Swanton J, 2014, HAND CLINIC, V122, P371, DOI 10.1016/B978-0-444-52001-2.00015-7; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Tribulatti MV, 2007, GLYCOBIOLOGY, V17, P1404, DOI 10.1093/glycob/cwm104; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Vicuna L, 2013, BIOL RES, V46, P275, DOI 10.4067/S0716-97602013000300008; Villar LM, 2012, MULT SCLER J, V18, P250, DOI 10.1177/1352458511415890; Villar LM, 2005, J CLIN INVEST, V115, P187, DOI 10.1172/JCI200522833; Villar LM, 2003, ANN NEUROL, V53, P222, DOI 10.1002/ana.10441; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Zhang SD, 2015, P NATL ACAD SCI USA, V112, P5585, DOI 10.1073/pnas.1506220112; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271; Zhuo Y, 2008, J BIOL CHEM	86	26	26	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0177472	10.1371/journal.pone.0177472	http://dx.doi.org/10.1371/journal.pone.0177472			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650992	Green Submitted, gold, Green Published			2022-12-27	WOS:000404537300045
J	Tu, XJ; Hwang, WJ; Ma, HI; Chang, LH; Hsu, SP				Tu, Xiao-Jing; Hwang, Wen-Juh; Ma, Hui-Ing; Chang, Ling-Hui; Hsu, Shih-Pin			Determinants of generic and specific healthrelated quality of life in patients with Parkinson's disease	PLOS ONE			English	Article							MDS-UPDRS; NONMOTOR SYMPTOMS; CHINESE VERSION; QUESTIONNAIRE PDQ-39; RATING-SCALES; DISORDER; RECOMMENDATIONS; VALIDATION; CRITIQUE; PROGRESSION	Objectives Generic and disease-specific health-related quality of life (HRQoL) instruments may reflect different aspects of lives in patients with Parkinson's disease (PD) and thus be associated with different determinants. We used the same cluster of predictors for the generic and disease- specific HRQoL instruments to examine and compare the determinants of HRQoL. Method HRQoL was measured in 92 patients with PD by the 36-item Short-Form Health Survey (SF-36) and the 39-item Parkinson's Disease Questionnaire (PDQ-39). The predictors included demographic and disease characteristics, and motor and non-motor symptoms. Multiple regression analyses were used to identify HRQoL determinants. Results Depressive symptoms and motor difficulties of daily living were the first two significant determinants for both instruments. The other significant determinant for the SF-36 was fatigue and non-motor difficulties of daily living, and for the PDQ-39 was motor signs of PD. Conclusions The results suggest the importance of the evaluation and intervention focused on depressive symptoms and motor difficulties of daily living in patients with PD. In addition, the SF-36 seems more related to non-motor symptoms, while the PDQ-39 appears more associated with motor symptoms. This information is important for understanding results from these two instruments and for choosing which to use.	[Tu, Xiao-Jing; Ma, Hui-Ing; Chang, Ling-Hui] Natl Cheng Kung Univ, Coll Med, Inst Allied Hlth Sci, Tainan, Taiwan; [Hwang, Wen-Juh] Natl Cheng Kung Univ, Dept Neurol, Coll Med, Tainan, Taiwan; [Ma, Hui-Ing; Chang, Ling-Hui] Natl Cheng Kung Univ, Dept Occupat Therapy, Coll Med, Tainan, Taiwan; [Hsu, Shih-Pin] E Da Hosp, Dept Neurol, Kaohsiung, Taiwan; [Hsu, Shih-Pin] I Shou Univ, Kaohsiung, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; E-Da Hospital; I Shou University	Ma, HI (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Allied Hlth Sci, Tainan, Taiwan.; Ma, HI (corresponding author), Natl Cheng Kung Univ, Dept Occupat Therapy, Coll Med, Tainan, Taiwan.; Hsu, SP (corresponding author), E Da Hosp, Dept Neurol, Kaohsiung, Taiwan.; Hsu, SP (corresponding author), I Shou Univ, Kaohsiung, Taiwan.	huingma@mail.ncku.edu.tw; a.pin.hsu@gmail.com	Chang, Ling-Hui/AAG-2410-2019	Chang, Ling Hui/0000-0003-4129-6947	E-Da Hospital, Kaohsiung, Taiwan [NCKUEDA 10214]	E-Da Hospital, Kaohsiung, Taiwan	The study was supported by grant NCKUEDA 10214 from E-Da Hospital, Kaohsiung, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bushnell DM, 1999, QUAL LIFE RES, V8, P345, DOI 10.1023/A:1008979705027; Caap-Ahlgren M, 2001, ARCH GERONTOL GERIAT, V32, P23, DOI 10.1016/S0167-4943(00)00087-X; Carod-Artal FJ, 2007, MOVEMENT DISORD, V22, P1408, DOI 10.1002/mds.21408; Chan ACM, 1996, J AGING HEALTH, V8, P238, DOI 10.1177/089826439600800205; Cubo E, 2002, EUR J NEUROL, V9, P589, DOI 10.1046/j.1468-1331.2002.00484.x; Den Oudsten BL, 2007, MOVEMENT DISORD, V22, P1528, DOI 10.1002/mds.21567; Den Oudsten BL, 2007, MOVEMENT DISORD, V22, P1390, DOI 10.1002/mds.21539; Dowding CH, 2006, DRUG AGING, V23, P693, DOI 10.2165/00002512-200623090-00001; Duncan GW, 2014, MOVEMENT DISORD, V29, P195, DOI 10.1002/mds.25664; Friedman JH, 2010, MOVEMENT DISORD, V25, P805, DOI 10.1002/mds.22989; Fuh JL, 2000, QUAL LIFE RES, V9, P675, DOI 10.1023/A:1008993821633; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Grosset KA, 2005, MOVEMENT DISORD, V20, P616, DOI 10.1002/mds.20393; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; Hu MH, 2010, J LONG TERM CARE, V14, P267; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jenkinson C, 1999, PHARMACOECONOMICS, V15, P157, DOI 10.2165/00019053-199915020-00004; Lawrence BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102294; Ma HI, 2005, QUAL LIFE RES, V14, P565, DOI 10.1007/s11136-004-0687-0; Maetzler W, 2009, LANCET NEUROL, V8, P1158, DOI 10.1016/S1474-4422(09)70291-1; Martinez-Martin P, 2014, EUR J NEUROL, V21, P519, DOI 10.1111/ene.12349; Martinez-Martin P, 1998, J NEUROL, V245, pS2, DOI 10.1007/PL00007733; Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P2371, DOI 10.1002/mds.23834; Martinez-Martin P, 2011, J NEUROL SCI, V310, P12, DOI 10.1016/j.jns.2011.05.006; Muangpaisan W, 2009, J EPIDEMIOL, V19, P281, DOI 10.2188/jea.JE20081034; Muller B, 2013, PARKINSONISM RELAT D, V19, P1027, DOI 10.1016/j.parkreldis.2013.07.010; PATRICK DL, 1989, MED CARE, V27, pS217, DOI 10.1097/00005650-198903001-00018; Post B, 2007, MOVEMENT DISORD, V22, P1839, DOI 10.1002/mds.21537; Qin ZH, 2009, PARKINSONISM RELAT D, V15, P767, DOI 10.1016/j.parkreldis.2009.05.011; Qin ZH, 2009, CLIN NEUROL NEUROSUR, V111, P733, DOI 10.1016/j.clineuro.2009.07.001; Reuther M, 2007, PARKINSONISM RELAT D, V13, P108, DOI 10.1016/j.parkreldis.2006.07.009; Rodriguez-Blazquez C, 2013, PARKINSONISM RELAT D, V19, P889, DOI 10.1016/j.parkreldis.2013.05.017; Schrag A, 2000, J NEUROL NEUROSUR PS, V69, P308, DOI 10.1136/jnnp.69.3.308; Schrag A, 2007, MOVEMENT DISORD, V22, P1077, DOI 10.1002/mds.21333; Simpson J, 2014, DISABIL REHABIL, V36, P1964, DOI 10.3109/09638288.2014.883442; Skorvanek M, 2015, J NEUROL SCI, V353, P87, DOI 10.1016/j.jns.2015.04.013; Skorvanek M, 2013, J GERIATR PSYCH NEUR, V26, P237, DOI 10.1177/0891988713500587; Soh SE, 2011, PARKINSONISM RELAT D, V17, P1, DOI 10.1016/j.parkreldis.2010.08.012; Tariq SH, 2006, AM J GERIAT PSYCHIAT, V14, P900, DOI 10.1097/01.JGP.0000221510.33817.86; Verbaan D, 2011, PARKINSONISM RELAT D, V17, P632, DOI 10.1016/j.parkreldis.2011.05.022; Wang MY, 2016, QUAL LIFE RES, V25, P89, DOI 10.1007/s11136-015-1056-x; Yu RL, 2017, MOV DISORD CLIN PRAC, V4, P68, DOI 10.1002/mdc3.12349	42	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0178896	10.1371/journal.pone.0178896	http://dx.doi.org/10.1371/journal.pone.0178896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ2KD	28650957	Green Published, gold, Green Submitted			2022-12-27	WOS:000404537300048
J	Seidlin, M; Holzman, R; Knight, P; Korf, B; Miller, VR; Viskochil, D; Bakker, A				Seidlin, Mindell; Holzman, Robert; Knight, Pamela; Korf, Bruce; Miller, Vanessa Rangel; Viskochil, David; Bakker, Annette		Childrens Tumor Fdn	Characterization and utilization of an international neurofibromatosis web-based, patient-entered registry: An observational study	PLOS ONE			English	Article							TYPE-1	The neurofibromatoses (neurofibromatosis type 1, neurofibromatosis type 2 and schwannomatosis) are rare disorders having clinical manifestations that vary greatly from patient to patient. The rarity and variability of these disorders has made it challenging for investigators to identify sufficient numbers of patients with particular clinical characteristics or specific germline mutations for participation in interventional studies. Similarly, because the natural history of all types of neurofibromatosis (NF) is variable and unique for each individual, it is difficult to identify meaningful clinical outcome measures for potential therapeutic interventions. In 2012, the Children's Tumor Foundation created a web-based patient-entered database, the NF Registry, to inform patients of research opportunities for which they fit general eligibility criteria and enable patients to contact investigators who are seeking to enroll patients in approved trials. Registrants were recruited through CTF-affiliated NF clinics and conferences, through its website, and by word-of-mouth and social media. Following online consent, demographic information and details regarding manifestations of NF were solicited on the Registry website. Statistical analyses were performed on data from a cohort of 4680 registrants (the number of registrants as of October 9, 2015) who met diagnostic criteria for one of the 3 NF conditions. The analyses support our hypothesis that patient-reported symptom incidences in the NF Registry are congruent with published clinician-sourced data. Between April 26, 2013 and July 8, 2016, the registry has been useful to investigators in recruitment, particularly for observational trials, especially those for development of patient reported outcomes.	[Seidlin, Mindell; Knight, Pamela; Bakker, Annette] Childrens Tumor Fdn, New York, NY 10005 USA; [Holzman, Robert] NYU, Sch Med, Dept Med, New York, NY USA; [Korf, Bruce] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA; [Miller, Vanessa Rangel] Invitae, San Francisco, CA USA; [Viskochil, David] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA	New York University; University of Alabama System; University of Alabama Birmingham; Utah System of Higher Education; University of Utah	Knight, P (corresponding author), Childrens Tumor Fdn, New York, NY 10005 USA.	pknight@ctf.org		bakker, annette/0000-0001-8420-7831	Children's Tumor Foundation	Children's Tumor Foundation	The funder (Children's Tumor Foundation) provided support in the form of salaries for authors AB and PK and fees for consultants MS and RH. Authors BK and DV received no direct compensation for their work on the manuscript. Author VM is an employee of lnvitae (formerly AltaVoice), a commercial company which collects a fee from the study sponsor for providing Registry hosting services. She has no direct financial interest in the publication of this manuscript. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the "author contributions" section of the journal form.	[Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; Boulanger JM, 2005, CAN J NEUROL SCI, V32, P225, DOI 10.1017/S0317167100004017; Carstensen B., 2016, EPI PACKAGE STAT ANA; Cnossen MH, 1998, ARCH DIS CHILD, V78, P408, DOI 10.1136/adc.78.5.408; Evans DGR, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-16; EVANS DGR, 1992, Q J MED, V84, P603; Friedman JM, 1997, AM J MED GENET, V70, P138, DOI 10.1002/(SICI)1096-8628(19970516)70:2<138::AID-AJMG7>3.0.CO;2-U; HUSON SM, 1989, J MED GENET, V26, P712, DOI 10.1136/jmg.26.11.712; Johnson KJ, 2013, CONTEMP CLIN TRIALS, V34, P305, DOI 10.1016/j.cct.2012.12.002; McKeever Karl, 2008, Ulster Med J, V77, P160; Messiaen L, 2009, JAMA-J AM MED ASSOC, V302, P2111, DOI 10.1001/jama.2009.1663; Nemethova M, 2013, ANN HUM GENET, V77, P364, DOI 10.1111/ahg.12026; Ostrow KL, 2016, AM J MED GENET A, V9999A, P1; Overweg-Plandsoen W C, 1997, Ned Tijdschr Geneeskd, V141, P624; Plotkin SR, 2013, AM J MED GENET A, V161A, P405, DOI 10.1002/ajmg.a.35760; R Development Core Team, 2016, R LANG ENV STAT COMP; Richesson RL, 2009, CONTEMP CLIN TRIALS, V30, P55, DOI 10.1016/j.cct.2008.09.002; Sabbagh A, 2013, HUM MUTAT, V34, P1510, DOI 10.1002/humu.22392; Sharkey EK, 2015, CONTEMP CLIN TRIALS, V40, P212, DOI 10.1016/j.cct.2014.12.006; Steinhagen-Thiessen, 2017, ATHEROSCLEROSIS; Tan MH, 2015, CONTEMP CLIN TRIALS, V41, P31, DOI 10.1016/j.cct.2014.12.012; Workman T.A., 2013, ENGAGING PATIENTS IN	22	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0178639	10.1371/journal.pone.0178639	http://dx.doi.org/10.1371/journal.pone.0178639			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644838	Green Submitted, Green Published, gold			2022-12-27	WOS:000404145100006
J	Waisi, H; Jankovic, B; Jankovic, M; Nikolic, B; Dimkic, I; Lalevic, B; Raicevic, V				Waisi, Hadi; Jankovic, Bojan; Jankovic, Marija; Nikolic, Bogdan; Dimkic, Ivica; Lalevic, Blazo; Raicevic, Vera			New insights in dehydration stress behavior of two maize hybrids using advanced distributed reactivity model (DRM). Responses to the impact of 24-epibrassinolide	PLOS ONE			English	Article							DESICCATION TOLERANCE; WATER RELATIONS; ABIOTIC STRESS; DROUGHT; BRASSINOSTEROIDS; KINETICS; GROWTH; SUGARS; PHOTOSYNTHESIS; TREHALOSE	Proposed distributed reactivity model of dehydration for seedling parts of two various maize hybrids (ZP434, ZP704) was established. Dehydration stresses were induced thermally, which is also accompanied by response of hybrids to heat stress. It was found that an increased value of activation energy counterparts within radicle dehydration of ZP434, with a high concentration of 24-epibrassinolide (24-EBL) at elevated operating temperatures, probably causes activation of diffusion mechanisms in cutin network and may increases likelihood of formation of free volumes, large enough to accommodate diffusing molecule. Many small random effects were detected and can be correlated with micro-disturbing in a space filled with water caused by thermal gradients, increasing capillary phenomena, and which can induce thermo-capillary migration. The influence of seedling content of various sugars and minerals on dehydration was also examined. Estimated distributed reactivity models indicate a dependence of reactivity on structural arrangements, due to present interactions between water molecules and chemical species within the plant.	[Waisi, Hadi] Inst Dev Water Resources Jaroslav Cerni, Dept Sci Res & Informat Technol, Belgrade, Serbia; [Jankovic, Bojan] Univ Belgrade, Fac Phys Chem, Dept Gen & Phys Chem, Belgrade, Serbia; [Jankovic, Marija] Univ Belgrade, Inst Nucl Sci Vinca, Radiat & Environm Protect Dept, Belgrade, Serbia; [Nikolic, Bogdan] Inst Plant Protect & Environm, Dept Phytopharm & Environm Protect, Belgrade, Serbia; [Dimkic, Ivica] Univ Belgrade, Dept Microbiol, Fac Biol, Belgrade, Serbia; [Lalevic, Blazo; Raicevic, Vera] Univ Belgrade, Dept Environm Microbiol, Fac Agr, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Belgrade; University of Belgrade	Waisi, H (corresponding author), Inst Dev Water Resources Jaroslav Cerni, Dept Sci Res & Informat Technol, Belgrade, Serbia.	hadiwaisi@yahoo.com	Dimkić, Ivica/AAE-1508-2019; Dimkic, Ivica/GWR-2445-2022	Dimkic, Ivica/0000-0002-0425-5938; Waisi, Hadi/0000-0001-7654-8329; Jankovic, Bojan/0000-0001-7520-1972	Serbian Ministry of Education, Science and Technological Development [172015, TR31080, III43009]	Serbian Ministry of Education, Science and Technological Development	This research work was partially supported by the Serbian Ministry of Education, Science and Technological Development under the projects number 172015, TR31080 and III43009.	Abreu JM, 2000, INTAKE NUTRITIVE VAL, P1; Aguilera JM, 1999, MICROSTRUCTURAL PRIN; Anjum SA, 2011, AFR J AGR RES, V6, P2026; [Anonymous], 2007, 3051B EPA US; Aquino P, 1999, CIMMYT WORLD MAIZE F, P18; Arnholdt-Schmitt B, 2004, PLANT PHYSIOL, V136, P2579, DOI 10.1104/pp.104.042531; Bajguz A, 2007, PLANT PHYSIOL BIOCH, V45, P95, DOI 10.1016/j.plaphy.2007.01.002; Bajguz A, 2009, PLANT PHYSIOL BIOCH, V47, P1, DOI 10.1016/j.plaphy.2008.10.002; Bartwal A, 2013, J PLANT GROWTH REGUL, V32, P216, DOI 10.1007/s00344-012-9272-x; Benesova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038017; Berg JM, 2002, BIOCHEMISTRY-US, P40; Bertoia LM, 2002, CROP SCI, V42, P365, DOI 10.2135/cropsci2002.0365; Bolan N, 2012, HDB SOIL SCI RESOURC, P11; Brenac P, 1997, J PLANT PHYSIOL, V150, P481, DOI 10.1016/S0176-1617(97)80102-2; Bruce TJA, 2007, PLANT SCI, V173, P603, DOI 10.1016/j.plantsci.2007.09.002; Burke EJ, 2010, J HYDROL, V388, P131, DOI 10.1016/j.jhydrol.2010.04.035; Burnham AK, 1999, ENERG FUEL, V13, P1, DOI 10.1021/ef9800765; CHIRIFE J, 1973, J AGR FOOD CHEM, V21, P936, DOI 10.1021/jf60190a041; de Mendonca JRG, 1998, J STAT PHYS, V92, P651, DOI 10.1023/A:1023044822735; Du HW, 2016, EUPHYTICA, V208, P113, DOI 10.1007/s10681-015-1599-5; Farooq M, 2009, J AGRON CROP SCI, V195, P262, DOI 10.1111/j.1439-037X.2009.00368.x; FRIEDMAN HL, 1964, J POLYM SCI POL SYM, P183; Galagali N, 2015, CHEM ENG SCI, V123, P170, DOI 10.1016/j.ces.2014.10.030; Galmes J, 2007, PLANTA, V226, P671, DOI 10.1007/s00425-007-0515-1; Goubet I, 1998, J AGR FOOD CHEM, V46, P1981, DOI 10.1021/jf970709y; Guichard S, 2005, J PLANT GROWTH REGUL, V24, P201, DOI 10.1007/s00344-005-0040-z; Gururani MA, 2015, INT J MOL SCI, V16, P19055, DOI 10.3390/ijms160819055; Halford NG, 2011, ANN APPL BIOL, V158, P1, DOI 10.1111/j.1744-7348.2010.00443.x; HASHIMOTO K, 1982, AICHE J, V28, P737, DOI 10.1002/aic.690280506; International Seed Testing Association, 1996, SUPPL SEED SCI TECHN, V24, P1; Kim KN, 2013, PLANT BIOTECHNOL REP, V7, P1, DOI 10.1007/s11816-012-0228-1; KOSTER KL, 1988, PLANT PHYSIOL, V88, P829, DOI 10.1104/pp.88.3.829; KUO TM, 1988, J AGR FOOD CHEM, V36, P32, DOI 10.1021/jf00079a008; Levitt J, 1980, CHILLING FREEZING HI; Liu L, 2001, CHEM REV, V101, P673, DOI 10.1021/cr990416z; Lucarini M, 2003, J AM CHEM SOC, V125, P8318, DOI 10.1021/ja034963k; Mader T, FEEDING HIGH MOISTUR; Naseem H, 2014, J PLANT INTERACT, V9, P689, DOI 10.1080/17429145.2014.902125; Nautiyal PC, 2008, EUPHYTICA, V159, P43, DOI 10.1007/s10681-007-9455-x; Pinheiro C, 2011, J EXP BOT, V62, P869, DOI 10.1093/jxb/erq340; Redillas MCFR, 2012, PLANT BIOTECHNOL REP, V6, P89, DOI 10.1007/s11816-011-0210-3; Sasse JM, 2003, J PLANT GROWTH REGUL, V22, P276, DOI 10.1007/s00344-003-0062-3; Simon P, 2004, J THERM ANAL CALORIM, V76, P123, DOI 10.1023/B:JTAN.0000027811.80036.6c; Sola-Penna M, 1998, ARCH BIOCHEM BIOPHYS, V360, P10, DOI 10.1006/abbi.1998.0906; Sootsuwan K, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-180; Stanojevic M, 2015, PLANT FOOD HUM NUTR, V70, P433, DOI 10.1007/s11130-015-0515-4; Sun Wendell Q., 2002, P47, DOI 10.1079/9780851995342.0047; Sun WQ, 1998, BBA-GEN SUBJECTS, V1425, P235, DOI 10.1016/S0304-4165(98)00076-2; Suresh SJ, 2000, J CHEM PHYS, V113, P9727, DOI 10.1063/1.1320822; Talaat NB, 2016, J PLANT GRO IN PRESS; Thussagunpanit J, 2015, J PLANT GROWTH REGUL, V34, P320, DOI 10.1007/s00344-014-9467-4; Ton J, 2007, PLANT J, V49, P16, DOI 10.1111/j.1365-313X.2006.02935.x; Vardharajula S, 2011, J PLANT INTERACT, V6, P1, DOI 10.1080/17429145.2010.535178; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Vyazovkin S, 1997, ANNU REV PHYS CHEM, V48, P125, DOI 10.1146/annurev.physchem.48.1.125; Vyazovkin S, 2011, THERMOCHIM ACTA, V520, P1, DOI 10.1016/j.tca.2011.03.034; Waisi HK, 2016, HEM IND IN PRESS; Walters C, 1997, SEED SCI RES, V7, P125, DOI 10.1017/S0960258500003469; Williams B, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005705; Yu JQ, 2004, J EXP BOT, V55, P1135, DOI 10.1093/jxb/erh124; Zeng HT, 2010, J PLANT GROWTH REGUL, V29, P44, DOI 10.1007/s00344-009-9111-x	61	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179650	10.1371/journal.pone.0179650	http://dx.doi.org/10.1371/journal.pone.0179650			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644899	Green Published, Green Submitted, gold			2022-12-27	WOS:000404145100029
J	Teran, GE; Ferrer, J; Benitez, M; Alonso, F; Aguilera, G; Mirande, JM				Enrique Teran, Guillermo; Ferrer, Juliano; Benitez, Mauricio; Alonso, Felipe; Aguilera, Gaston; Marcos Mirande, Juan			Living in the waterfalls: A new species of Trichomycterus (Siluriformes: Trichomycteridae) from Tabay stream, Misiones, Argentina	PLOS ONE			English	Article							SOUTHEASTERN BRAZIL; CATFISH; GENUS; BASIN; CORDILLERA; COLOMBIA	A new species assigned to the genus Trichomycterus from the area of the waterfalls of Tabay stream, Parana A River basin, Misiones, Argentina, is described. Trichomycterus ytororo sp. nov. is distinguished from all other species in the genus by the presence of 31-35 dorsal procurrent caudal-fin rays and the combination of some external characters such as: coloration, number of pectoral-fin rays and pores of the laterosensory canals. The new taxon belongs to a presumably monophyletic group of species composed of T. crassicaudatus, T. igobi, and T. stawiarski based on the presence of 24 or more thickly ossified and rigid procurrent caudal-fin rays with a slender distal tip extending along the tips of at least ten neural spines.	[Enrique Teran, Guillermo; Aguilera, Gaston; Marcos Mirande, Juan] UEL CONICET, Inst Vertebrados, Fdn Miguel Lillo, San Miguel De Tucuman, Argentina; [Ferrer, Juliano] Univ Fed Rio Grande do Sul, Programa Posgrad Biol Anim, Dept Zool, Porto Alegre, RS, Brazil; [Benitez, Mauricio] UNaM CONICET, Inst Biol Subtrop, Lab Genet Evolut, Posadas, Argentina; [Alonso, Felipe] IBIGEO CONICET, Inst Bio & Geociencias NOA, Rosario De Lerma, Salta, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Miguel Lillo Foundation; Universidade Federal do Rio Grande do Sul	Aguilera, G (corresponding author), UEL CONICET, Inst Vertebrados, Fdn Miguel Lillo, San Miguel De Tucuman, Argentina.	gaguilera@lillo.org.ar	Alonso, Felipe/AAA-5717-2020; Ferrer, Juliano/V-9887-2019	Alonso, Felipe/0000-0001-7227-2732; Ferrer, Juliano/0000-0001-6198-6289; Aguilera, Gaston/0000-0002-5486-2787; Mirande, Juan Marcos/0000-0003-4370-3526; Teran, Guillermo/0000-0002-3795-3345	Fondo para la Investigacion Cientifica y Tecnica [PICT-2011-0992]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP-11420110100301]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [152354/2016-6]; Mercedes Azpelicueta (CONICET)	Fondo para la Investigacion Cientifica y Tecnica; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Mercedes Azpelicueta (CONICET)	This work was supported by Fondo para la Investigacion Cientifica y Tecnica (PICT-2011-0992 to JMM), http://www.agencia.mincyt.gob.ar/frontend/agencia/fondo/foncyt; Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP-11420110100301 to JMM), http://www.conicet. gov.ar/; and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Proc. 152354/2016-6 to JF), http://cnpq.br/web/guest/paging-inicial. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Pablo Pereyra (FML) for figure 3. We thank Celeste Kummer for assistance with the radiograph of the holotype and paratypes. Mercedes Azpelicueta (CONICET) for constant support. This work was possible due to the invaluable help of Diego Baldo and Juan Martin Ferro. We thank Pedro Sanchez for logistical assistance in the field. Ministerio de Ecologia, Misiones for collecting permits. We thank Carlos DoNascimiento (IAvH) and an anonymous reviewer for careful reviews in the manuscript. We are also thankful to Fundacion Miguel Lillo, CONICET (PIP-11420110100301 to JMM) and FONCyT (PICT-2011-0992 to JMM); CNPq (Proc. 152354/2016-6 to JF).	Arratia FG, 1978, STUD NEOTROP FAUNA E, V13, P157; ARRATIA G, 1984, Zoologische Jahrbuecher Abteilung fuer Systematik Oekologie und Geographie der Tiere, V111, P493; Arratia G., 1990, INT S VERT BIOG SYST, P395; Arratia Gloria, 1998, Ichthyological Exploration of Freshwaters, V9, P347; Barbosa M.A., 2008, INT J ICHTHYOLOGY, V14, P175; Barbosa Maria Anais, 2003, Ichthyological Exploration of Freshwaters, V14, P281; Barbosa MA, 2012, VERTEBR ZOOL, V62, P79; Barbosa MA, 2010, ICHTHYOL EXPLOR FRES, V21, P97; Baskin J. N, 1973, STRUCTURE RELATIONSH; Bockmann Flávio A., 2004, Neotrop. ichthyol., V2, P61, DOI 10.1590/S1679-62252004000200003; Costa W.J.E.M., 1992, REV FRANCAISE AQUARI, V18, P101; Costa Wilson J.E.M., 1993, Revue Francaise d'Aquariologie Herpetologie, V20, P43; Datovo A, 2012, ZOOTAXA, P33; Datovo A, 2010, NEOTROP ICHTHYOL, V8, P193, DOI 10.1590/S1679-62252010000200001; de Pinna Mario C.C., 1998, P279; de Pinna MCC, 2003, CHECK LIST FRESHWATE, P270; DEPINNA MCC, 1989, AM MUS NOVIT, P1; DoNascimiento C, 2015, COPEIA, V103, P933, DOI 10.1643/CI-14-132; DoNascimiento C, 2014, NEOTROP ICHTHYOL, V12, P717, DOI 10.1590/1982-0224-20140005; Dutra GM, 2012, NEOTROP ICHTHYOL, V10, P225, DOI 10.1590/S1679-62252012000200001; Eigenmann C. H., 1917, Philadelphia Proceedings of the American Philosophical Society, V56; Eigenmann CH., 1918, MEMOIRS CARNEGIE MUS, V7, P259, DOI DOI 10.5962/BHL.TITLE.43951; Eschmeyer WN, CATALOG FISHES GENER; Fernandez L, 2005, COPEIA, P68; Fernandez L, 2006, ENVIRON BIOL FISH, V75, P385, DOI 10.1007/s10641-005-5065-4; Fernandez L, 2009, COPEIA, P195, DOI 10.1643/CI-08-083; Ferrer J, 2013, NEOTROP ICHTHYOL, V11, P217, DOI 10.1590/S1679-62252013000200001; Garcia-Melo LJ, 2016, ZOOTAXA, V4117, P226, DOI 10.11646/zootaxa.4117.2.6; Lima Sergio M.Q., 2004, Zootaxa, V761, P1; Rizzato PP, 2017, J MORPHOL, V278, P4, DOI 10.1002/jmor.20616; Schaefer SA, 2009, COPEIA, P510, DOI 10.1643/CI-08-186; Schultze H.-P, 2013, MESOZOIC FISHES, P187; TAYLOR W R, 1985, Cybium, V9, P107; Wosiacki WB, 2005, ZOOTAXA, P49; Wosiacki Wolmar B., 2008, Neotropical Ichthyology, V6, P17; Wosiacki WB, 2008, COPEIA, P273, DOI 10.1643/CI-06-237	36	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179594	10.1371/journal.pone.0179594	http://dx.doi.org/10.1371/journal.pone.0179594			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640842	Green Submitted, Green Published, gold			2022-12-27	WOS:000404135800042
J	Hussain, MZ; Abbas, S; Irshad, M				Hussain, Malik Zawwar; Abbas, Samreen; Irshad, Misbah			Quadratic trigonometric B-spline for image interpolation using GA	PLOS ONE			English	Article							CURVE	In this article, a new quadratic trigonometric B-spline with control parameters is constructed to address the problems related to two dimensional digital image interpolation. The newly constructed spline is then used to design an image interpolation scheme together with one of the soft computing techniques named as Genetic Algorithm (GA). The idea of GA has been formed to optimize the control parameters in the description of newly constructed spline. The Feature SIMilarity (FSIM), Structure SIMilarity (SSIM) and Multi-Scale Structure SIMilarity (MS-SSIM) indices along with traditional Peak Signal-to-Noise Ratio (PSNR) are employed as image quality metrics to analyze and compare the outcomes of approach offered in this work, with three of the present digital image interpolation schemes. The upshots show that the proposed scheme is better choice to deal with the problems associated to image interpolation.	[Hussain, Malik Zawwar; Abbas, Samreen] Univ Punjab, Dept Math, Lahore, Pakistan; [Irshad, Misbah] Women Univ, Dept Math, Lahore Coll, Lahore, Pakistan	University of Punjab	Hussain, MZ (corresponding author), Univ Punjab, Dept Math, Lahore, Pakistan.	malikzawwar.math@pu.edu.pk	ABBAS, SAMREEN/AAZ-4993-2020	ABBAS, SAMREEN/0000-0003-3708-0115; Hussain, Malik Zawwar/0000-0002-9335-3117				Bartels R., 1984, CS8340 U WAT; Danielsson PE, LITHISYI11521990 LIN; Fevralev D., 2011, EURASIP J ADV SIG PR, V2011, P1, DOI DOI 10.1186/1687-6180-2011-41; Foley T. A., 1986, Computer-Aided Geometric Design, V3, P281, DOI 10.1016/0167-8396(86)90004-X; Han X., 2002, COMPUT AIDED GEOM D, V19, P479; Han XA, 2009, APPL MATH LETT, V22, P226, DOI 10.1016/j.aml.2008.03.015; Han XL, 2004, COMPUT AIDED GEOM D, V21, P535, DOI 10.1016/j.cagd.2004.03.001; Holland JH., 1975, Q REV BIOL; Hoschek J, 1993, FUNDAMENTALS COMPUTE; HOU HS, 1978, IEEE T ACOUST SPEECH, V26, P508; Hung KW, 2015, SIGNAL PROCESS-IMAGE, V39, P26, DOI 10.1016/j.image.2015.07.003; KEYS RG, 1981, IEEE T ACOUST SPEECH, V29, P1153, DOI 10.1109/TASSP.1981.1163711; Lewis J., 1975, SIAM SIGNUM M SAN FR; Li JC, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/731648; Li X, 2001, IEEE T IMAGE PROCESS, V10, P1521, DOI 10.1109/83.951537; Li XH, 2008, 2008 IEEE PHOTONICSGLOBAL@SINGAPORE (IPGC), VOLS 1 AND 2, P341; Luu L, 2011, OPT LETT, V36, P3070, DOI 10.1364/OL.36.003070; LYCHE T, 1979, J APPROX THEORY, V25, P266, DOI 10.1016/0021-9045(79)90017-0; Parker J, 1983, IEEE Trans Med Imaging, V2, P31, DOI 10.1109/TMI.1983.4307610; Sarfraz M, 2008, INTERACTIVE CURVE MO; Sarfraz M, 2010, INT J COMPUT MATH, V87, P797, DOI 10.1080/00207160802196009; SCHOENBERG IJ, 1964, J MATH MECH, V13, P795; Schoenberg J., 1981, SPLINE FUNCTION BASI; UNSER M, 1993, IEEE T SIGNAL PROCES, V41, P821, DOI 10.1109/78.193220; Walz G, 1997, BIT, V37, P189, DOI 10.1007/BF02510180; Wang GZ, 2004, COMPUT AIDED GEOM D, V21, P193, DOI 10.1016/j.cagd.2003.10.002; Wang Z, 2003, CONF REC ASILOMAR C, P1398; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Zhang L, 2011, IEEE T IMAGE PROCESS, V20, P2378, DOI 10.1109/TIP.2011.2109730	29	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179721	10.1371/journal.pone.0179721	http://dx.doi.org/10.1371/journal.pone.0179721			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640906	Green Published, Green Submitted, gold			2022-12-27	WOS:000404135800056
J	Sauer, AJ; Fritsch, E; Undorf-Spahn, K; Nguyen, P; Marec, F; Heckel, DG; Jehle, JA				Sauer, Annette J.; Fritsch, Eva; Undorf-Spahn, Karin; Nguyen, Petr; Marec, Frantisek; Heckel, David G.; Jehle, Johannes A.			Novel resistance to Cydia pomonella granulovirus (CpGV) in codling moth shows autosomal and dominant inheritance and confers cross-resistance to different CpGV genome groups	PLOS ONE			English	Article							SEX-CHROMOSOMES; BACULOVIRUS RESISTANCE; LEPIDOPTERA; KARYOTYPE; ISOLATE; INSECTICIDE; SEQUENCE; VIRUS	Commercial Cydia pomonella granulovirus (CpGV) products have been successfully applied to control codling moth (CM) in organic and integrated fruit production for more than 30 years. Since 2005, resistance against the widely used isolate CpGV-M has been reported from different countries in Europe. The inheritance of this so-called type I resistance is dominant and linked to the Z chromosome. Recently, a second form (type II) of CpGV resistance in CM was reported from a field population (NRW-WE) in Germany. Type II resistance confers reduced susceptibility not only to CpGV-M but to most known CpGV isolates and it does not follow the previously described Z-linked inheritance of type I resistance. To further analyze type II resistance, two CM strains, termed CpR5M and CpR5S, were generated from parental NRW-WE by repeated mass crosses and selection using the two isolates CpGV-M and CpGV-S, respectively. Both CpR5M and CpR5S were considered to be genetically homogeneous for the presence of the resistance allele(s). By crossing and backcrossing experiments with a susceptible CM strain, followed by resistance testing of the offspring, an autosomal dominant inheritance of resistance was elucidated. In addition, cross-resistance to CpGV-M and CpGV-S was detected in both strains, CpR5M and CpR5S. To test the hypothesis that the autosomal inheritance of type II resistance was caused by a large interchromosomal rearrangement involving the Z chromosome, making type I resistance appear to be autosomal in these strains; fluorescence in situ hybridization with bacterial artificial chromosome probes (BAC-FISH) was used to physically map the Z chromosomes of different CM strains. Conserved synteny of the Z-linked genes in CpR5M and other CM strains rejects this hypothesis and argues for a novel genetic and functional mode of resistance in CM populations with type II resistance.	[Sauer, Annette J.; Fritsch, Eva; Undorf-Spahn, Karin; Jehle, Johannes A.] JKI, Fed Res Ctr Cultivated Plants, Inst Biol Control, Darmstadt, Germany; [Nguyen, Petr; Marec, Frantisek] Czech Acad Sci, Inst Entomol, Biol Ctr, Ceske Budejovice, Czech Republic; [Nguyen, Petr] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Heckel, David G.] Max Planck Inst Chem Ecol, Dept Entomol, Jena, Germany	Julius Kuhn-Institut; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Max Planck Society	Jehle, JA (corresponding author), JKI, Fed Res Ctr Cultivated Plants, Inst Biol Control, Darmstadt, Germany.	Johannes.Jehle@julius-kuehn.de	Marec, Frantisek/G-7943-2014; Nguyen, Petr/G-5826-2010; Nguyen, Petr/AAI-5203-2020; Heckel, David G/K-2138-2013	Marec, Frantisek/0000-0002-6745-5603; Nguyen, Petr/0000-0003-1395-4287; Nguyen, Petr/0000-0003-1395-4287; Heckel, David G/0000-0001-8991-2150; Jehle, Johannes A./0000-0002-8143-7743	Federal Organic Farming Scheme [050EO23/1]; Deutsche Forschungsgemeinschaft [Je245/14-1]; Czech Science Foundation [14-22765S, 14-35819P]; Max-Planck-Gesellschaft	Federal Organic Farming Scheme; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Czech Science Foundation(Grant Agency of the Czech Republic); Max-Planck-Gesellschaft(Max Planck Society)	This work was supported by the Federal Organic Farming Scheme (www.ble.de) (grant 050EO23/1) and by the Deutsche Forschungsgemeinschaft (www.dfg.de) (grant Je245/14-1) to JAJ. Cytogenetic experiments were financed by the Czech Science Foundation (grants 14-22765S and 14-35819P) to FM. DGH was supported by the Max-Planck-Gesellschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The author thanks Dr. Doreen Gabriel for her support in the statistical analyses and Sarah Schilling, Doris El Mazouar and Birgit Weihrauch for excellent technical assistance in insect rearing. We appreciate useful suggestions and corrections of the manuscript by Katharina Saar. This work was supported by the Federal Organic Farming Scheme (www.ble.de) (grant 050EO23/1) and by the Deutsche Forschungsgemeinschaft (www.dfg.de) (grant Je245/14-1) to JAJ. Cytogenetic experiments were financed by the Czech Science Foundation (grants 14-22765S and 14-35819P) to FM. DGH was supported by the Max-Planck-Gesellschaft The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT WS, 1987, J AM MOSQUITO CONTR, V3, P302; Ahola V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5737; Asser-Kaiser S, 2007, SCIENCE, V317, P1916, DOI 10.1126/science.1146542; Asser-Kaiser S, 2011, VIROLOGY, V410, P360, DOI 10.1016/j.virol.2010.11.021; Berling M, 2013, PEST MANAG SCI, V69, P1261, DOI 10.1002/ps.3493; Berling M, 2009, APPL ENVIRON MICROB, V75, P925, DOI 10.1128/AEM.01998-08; Bourguet D, 2000, J ECON ENTOMOL, V93, P1588, DOI 10.1603/0022-0493-93.6.1588; Carpenter JE, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P115, DOI 10.1007/1-4020-4051-2_5; d'Alencon E, 2010, P NATL ACAD SCI USA, V107, P7680, DOI 10.1073/pnas.0910413107; Eberle KE, 2008, J INVERTEBR PATHOL, V98, P293, DOI 10.1016/j.jip.2008.03.003; Eberle KE, 2006, J INVERTEBR PATHOL, V93, P201, DOI 10.1016/j.jip.2006.07.001; Eberle KE, 2009, J GEN VIROL, V90, P662, DOI 10.1099/vir.0.006999-0; Fritsch E., 2005, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes, V57, P29; Fritsch E, EC 2006; Fukova I, 2005, GENOME, V48, P1083, DOI 10.1139/G05-063; Gebhardt MM, 2014, P NATL ACAD SCI USA, V111, P15711, DOI 10.1073/pnas.1411089111; Graillot B, 2014, VIRUSES-BASEL, V6, P5135, DOI 10.3390/v6125135; Herniou EA, 2001, J VIROL, V75, P8117, DOI 10.1128/JVI.75.17.8117-8126.2001; Ivaldi-Sender C, 1974, ECOLOGIE ANIMALE, V6, P337; Jehle JA, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.02330-16, 10.1128/aem.02330-16]; Jehle J. A., 2014, Ecofruit. 16th International Conference on Organic-Fruit Growing: Proceedings, 17-19 February 2014, Hohenheim, Germany, P244; Jehle JA, EC 2006; Kienzle J, EC 2008; KRAPPA R, 1991, J VIROL, V65, P805, DOI 10.1128/JVI.65.2.805-812.1991; Lacey LA, 2008, BIOCONTROL SCI TECHN, V18, P639, DOI 10.1080/09583150802267046; Luque T, 2001, J GEN VIROL, V82, P2531, DOI 10.1099/0022-1317-82-10-2531; Nguyen P, 2013, P NATL ACAD SCI USA, V110, P6931, DOI 10.1073/pnas.1220372110; Sauphanor B., 2006, PHYTOMA DEFENSE VEGE, V590, P24; Schmitt A, 2013, J APPL ENTOMOL, V137, P641, DOI 10.1111/jen.12046; SMITH IRL, 1988, VIROLOGY, V166, P240, DOI 10.1016/0042-6822(88)90165-1; TABASHNIK BE, 1991, J ECON ENTOMOL, V84, P703, DOI 10.1093/jee/84.3.703; TANADA Y, 1964, J INSECT PATHOL, V6, P378; Traut W, 2007, SEX DEV, V1, P332, DOI 10.1159/000111765; Undorf-Spahn K, 2012, J INVERTEBR PATHOL, V111, P136, DOI 10.1016/j.jip.2012.07.005; Van't Hof AE, 2013, HEREDITY, V110, P283, DOI 10.1038/hdy.2012.84; Wolf KW, 1996, INT J INSECT MORPHOL, V25, P37, DOI 10.1016/0020-7322(95)00021-6; Yoshido A, 2005, GENETICS, V170, P675, DOI 10.1534/genetics.104.040352; Zichova T, 2013, BIOCONTROL, V58, P525, DOI 10.1007/s10526-013-9507-1	38	18	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179157	10.1371/journal.pone.0179157	http://dx.doi.org/10.1371/journal.pone.0179157			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640892	Green Submitted, Green Published, gold			2022-12-27	WOS:000404135800019
J	Susek, K; Braszewska-Zalewska, A; Bewick, AJ; Hasterok, R; Schmitz, RJ; Naganowska, B				Susek, Karolina; Braszewska-Zalewska, Agnieszka; Bewick, Adam J.; Hasterok, Robert; Schmitz, Robert J.; Naganowska, Barbara			Epigenomic diversification within the genus Lupinus	PLOS ONE			English	Article							DNA METHYLATION PATTERNS; 5-METHYLCYTOSINE-RICH REGIONS; HISTONE MODIFICATIONS; H3 LYSINE-9; CHROMOSOMES; ANGUSTIFOLIUS; POLYPLOIDY; GENES; MAPS; L.	Deciphering the various chemical modifications of both DNA and the histone compound of chromatin not only leads to a better understanding of the genome-wide organisation of epigenetic landmarks and their impact on gene expression but may also provide some insights into the evolutionary processes. Although both histone modifications and DNA methylation have been widely investigated in various plant genomes, here we present the first study for the genus Lupinus. Lupins, which are members of grain legumes (pulses), are beneficial for food security, nutrition, health and the environment. In order to gain a better understanding of the epigenetic organisation of genomes in lupins we applied the immunostaining of methylated histone H3 and DNA methylation as well as whole-genome bisulfite sequencing. We revealed variations in the patterns of chromatin modifications at the chromosomal level among three crop lupins, i.e. L. angustifolius (2n = 40), L. albus (2n = 50) and L. luteus (2n = 52), and the legume model plant Medicago truncatula (2n = 16). Different chromosomal patterns were found depending on the specific modification, e.g. H3K4me2 was localised in the terminal parts of L. angustifolius and M. truncatula chromosomes, which is in agreement with the results that have been obtained for other species. Interestingly, in L. albus and L. luteus this modification was limited to one arm in the case of all of the chromosomes in the complement. Additionally, H3K9me2 was detected in all of the analysed species except L. luteus. DNA methylation sequencing (CG, CHG and CHH contexts) of aforementioned crop but also wild lupins such as L. cosentinii (2n = 32), L. digitatus (2n = 36), L. micranthus (2n = 52) and L. pilosus (2n = 42) supported the range of interspecific diversity. The examples of epigenetic modifications illustrate the diversity of lupin genomes and could be helpful for elucidating further epigenetic changes in the evolution of the lupin genome.	[Susek, Karolina; Naganowska, Barbara] Polish Acad Sci, Inst Plant Genet, Dept Genom, Poznan, Poland; [Braszewska-Zalewska, Agnieszka; Hasterok, Robert] Univ Silesia Katowice, Dept Plant Anat & Cytol, Katowice, Poland; [Bewick, Adam J.; Schmitz, Robert J.] Univ Georgia, Dept Genet, Athens, GA 30602 USA	Polish Academy of Sciences; Institute of Plant Genetics of the Polish Academy of Sciences; University of Silesia in Katowice; University System of Georgia; University of Georgia	Susek, K (corresponding author), Polish Acad Sci, Inst Plant Genet, Dept Genom, Poznan, Poland.	ksus@igr.poznan.pl	susek, karolina/V-2494-2019; Schmitz, Robert/AAY-7659-2020; Hasterok, Robert/A-1629-2008	susek, karolina/0000-0002-8518-4720; Schmitz, Robert/0000-0001-7538-6663; Hasterok, Robert/0000-0001-6667-2721; Braszewska, Agnieszka/0000-0003-0997-8753	National Science Centre, Poland [2011/03/B/NZ2/01420]	National Science Centre, Poland(National Science Centre, Poland)	This work was supported by the National Science Centre, Poland, grant no. 2011/03/B/NZ2/01420 to KS (https://,www.ncn.gov.pl/?language=en). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bewick AJ, 2016, G3-GENES GENOM GENET, V6, P447, DOI 10.1534/g3.115.025668; Borowska N, 2011, CHROMOSOME RES, V19, P955, DOI 10.1007/s10577-011-9243-2; Braszewska-Zalewska A, 2012, GENOME, V55, P68, DOI [10.1139/G11-076, 10.1139/g11-076]; Braszewska-Zalewska A, 2010, GENOME, V53, P203, DOI [10.1139/g09-088, 10.1139/G09-088]; Braszewska-Zalewska AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069204; Breiling A, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0016-6; Cannon SB, 2015, MOL BIOL EVOL, V32, P193, DOI 10.1093/molbev/msu296; Castiglione MR, 2008, PROTOPLASMA, V233, P107, DOI 10.1007/s00709-008-0296-9; Chen XS, 2013, CURR OPIN PLANT BIOL, V16, P164, DOI 10.1016/j.pbi.2013.03.004; Chen X, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00836; Chen ZJ, 2006, BIOESSAYS, V28, P240, DOI 10.1002/bies.20374; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Diez CM, 2014, CURR OPIN PLANT BIOL, V18, P1, DOI 10.1016/j.pbi.2013.11.017; Drummond CS, 2012, SYST BIOL, V61, P443, DOI 10.1093/sysbio/syr126; Dubin MJ, 2015, ELIFE, V4, DOI 10.7554/eLife.05255; Eichten SR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002372; Feitoza L, 2011, GENETICA, V139, P305, DOI 10.1007/s10709-011-9550-8; Feng SH, 2011, CURR OPIN PLANT BIOL, V14, P179, DOI 10.1016/j.pbi.2010.12.002; Fonseca A, 2014, CYTOGENET GENOME RES, V143, P168, DOI 10.1159/000360572; Frediani M, 1996, CHROMOSOME RES, V4, P141, DOI 10.1007/BF02259707; Fuchs J, 2006, TRENDS PLANT SCI, V11, P199, DOI 10.1016/j.tplants.2006.02.008; Gladstones J. S., 1998, P1; Hane JK, 2016, PLANT BIOTECH J; Houben A, 2003, PLANT J, V33, P967, DOI 10.1046/j.1365-313X.2003.01681.x; Jackson S, 2010, CURR OPIN PLANT BIOL, V13, P153, DOI 10.1016/j.pbi.2009.11.004; Jasencakova Z, 2003, PLANT J, V33, P471, DOI 10.1046/j.1365-313X.2003.01638.x; Jin WW, 2008, CHROMOSOME RES, V16, P1203, DOI 10.1007/s10577-008-1269-8; Jordan WT, 2016, GENOME BIOL, V17, P1; Kim KD, 2015, PLANT PHYSIOL, V168, P1433, DOI 10.1104/pp.15.00408; Kroc M, 2014, THEOR APPL GENET, V127, P1237, DOI 10.1007/s00122-014-2294-y; Kulikova O, 2001, PLANT J, V27, P49, DOI 10.1046/j.1365-313x.2001.01057.x; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lesniewska K, 2011, J HERED, V102, P228, DOI 10.1093/jhered/esq107; Li Q, 2014, PLANT CELL, V26, P4602, DOI 10.1105/tpc.114.133140; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Naganowska B, 2003, ANN BOT-LONDON, V92, P349, DOI 10.1093/aob/mcg145; Nelson MN, 2006, THEOR APPL GENET, V113, P225, DOI 10.1007/s00122-006-0288-0; Nelson MN, 2010, DNA RES, V17, P73, DOI 10.1093/dnares/dsq001; Neumann P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00234; Nevado B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12384; Niederhuth CE, 2016, BIORXIV; Pikaard CS, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019315; de Paula CMP, 2016, PLANT CELL REP, V35, P1359, DOI 10.1007/s00299-016-1969-z; Rigal M, 2016, P NATL ACAD SCI USA, V113, pE2083, DOI 10.1073/pnas.1600672113; Riggs A.D., 1996, COLD SPRING HARBOR M, V32, P29; Schmitz RJ, 2013, GENOME RES, V23, P1663, DOI 10.1101/gr.152538.112; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; Schultz MD, 2015, NATURE, V523, P212, DOI 10.1038/nature14465; Seymour DK, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004785; Shi JH, 2006, GENETICS, V173, P1571, DOI 10.1534/genetics.106.056853; Soppe WJJ, 2002, EMBO J, V21, P6549, DOI 10.1093/emboj/cdf657; Springer NM, 2016, PLANT CELL, V28, P314, DOI 10.1105/tpc.15.00911; Susek K, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01152; Urich MA, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2014.114; Wendel JF, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0908-1; West PT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105267; Wyrwa K, 2016, CHROMOSOME RES; Zilberman D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-249	58	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179821	10.1371/journal.pone.0179821	http://dx.doi.org/10.1371/journal.pone.0179821			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640886	gold, Green Published			2022-12-27	WOS:000404135800070
J	Takahashi, M; Takahashi, M; Komine, K; Yamada, H; Kasahara, Y; Chikamatsu, S; Okita, A; Ito, S; Ouchi, K; Okada, Y; Imai, H; Saijo, K; Shirota, H; Takahashi, S; Mori, T; Shimodaira, H; Ishioka, C				Takahashi, Masahiro; Takahashi, Masanobu; Komine, Keigo; Yamada, Hideharu; Kasahara, Yuki; Chikamatsu, Sonoko; Okita, Akira; Ito, Shukuei; Ouchi, Kota; Okada, Yoshinari; Imai, Hiroo; Saijo, Ken; Shirota, Hidekazu; Takahashi, Shin; Mori, Takahiro; Shimodaira, Hideki; Ishioka, Chikashi			The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study	PLOS ONE			English	Article							COMPREHENSIVE GERIATRIC ASSESSMENT; OLDER PATIENTS; SURVIVAL; ONCOLOGY; TOLERANCE; MORTALITY; CHEMOTHERAPY; ADULTS; RISK	Background Some elderly cancer patients, even with good Eastern Cooperative Oncology Group performance status (ECOG-PS), have poor survival outcomes and cannot tolerate standard therapy. Few studies have detailed the associations between the G8 screening tool, ECOG-PS, and overall survival (OS) in such patients. Methods Cancer patients, aged 70 years or older, were assessed for G8 and classified into three groups according to their G8 score: <11 as the low score group, 11-14 as the intermediate score group, and > 14 as the high score group. We retrospectively analyzed the association between G8 score and OS in all patients and for each ECOG-PS-categorized group. Results Out of 264 enrolled patients, most patients (87%) with solid tumor were categorized as TNM stage IV. ECOG-PS was 0 or 1 in 215 patients and >= 2 in 48; there was missing data for one patient. Among all patients, the low score group with a median OS of 7.7 months survived significantly less than both the high score group with a median OS of 25.6 months [ Hazard ratio (HR) 3.48; 95% confidence interval (CI), 1.96-6.63; p < 0.0001] and the intermediate score group with a median of 15.6 months (HR 1.83; 95% CI, 1.28-2.65; p < 0.001). In the multivariate analysis, TNM stage and G8 score were independent prognostic factors for OS. When patients with an ECOG-PS of 0 or 1 were analyzed, patients with a lower G8 score showed significantly shorter OS than patients with a higher score when any two groups were compared. Conclusion This novel classification of the G8 score contributes to prompt identification of patients with poor prognosis and improved the prognostic value of ECOG-PS. Using G8 with ECOG-PS may be helpful in deciding treatment for elderly patients with advanced cancer.	[Takahashi, Masahiro; Takahashi, Masanobu; Komine, Keigo; Yamada, Hideharu; Kasahara, Yuki; Chikamatsu, Sonoko; Okita, Akira; Ito, Shukuei; Ouchi, Kota; Okada, Yoshinari; Imai, Hiroo; Saijo, Ken; Shirota, Hidekazu; Takahashi, Shin; Mori, Takahiro; Shimodaira, Hideki; Ishioka, Chikashi] Tohoku Univ Hosp, Dept Med Oncol, Aoba Ku, Sendai, Miyagi, Japan; [Takahashi, Masahiro; Takahashi, Masanobu; Komine, Keigo; Yamada, Hideharu; Kasahara, Yuki; Chikamatsu, Sonoko; Okita, Akira; Ito, Shukuei; Ouchi, Kota; Okada, Yoshinari; Imai, Hiroo; Saijo, Ken; Takahashi, Shin; Shimodaira, Hideki; Ishioka, Chikashi] Tohoku Univ, Inst Dev Aging & Canc, Dept Clin Oncol, Aoba Ku, Sendai, Miyagi, Japan	Tohoku University; Tohoku University	Ishioka, C (corresponding author), Tohoku Univ Hosp, Dept Med Oncol, Aoba Ku, Sendai, Miyagi, Japan.; Ishioka, C (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Dept Clin Oncol, Aoba Ku, Sendai, Miyagi, Japan.	chikashi@tohoku.ac.jp		Ishioka, Chikashi/0000-0002-3023-1227; qi wu, xiao feng/0000-0003-2502-3666; Masahiro, Takahashi/0000-0001-6820-6011; Mori, Takahiro/0000-0001-7324-8574; Takahashi, Shin/0000-0001-6695-3099	JSPS KAKENHI [JP16K19304]; Ono Pharmaceutical Company; Taiho Pharma; Taiho; Chugai; Takeda; Byer; Pfeizer; Mochida; Asahikasei; Bristol-Myers Squibb; Daiichi-Sankyo; Merck Serono; Novartis; Yakult; Ono; Grants-in-Aid for Scientific Research [15K08962] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ono Pharmaceutical Company; Taiho Pharma; Taiho; Chugai; Takeda(Takeda Pharmaceutical Company Ltd); Byer; Pfeizer; Mochida; Asahikasei(Asahi Kasei Corporation); Bristol-Myers Squibb(Bristol-Myers Squibb); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Merck Serono(Merck & Company); Novartis(Novartis); Yakult; Ono; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP16K19304, Masahiro Takahashi. Masanobu Takahashi reports receiving research funding from Ono Pharmaceutical Company. K.S. reports receiving research funding from Taiho Pharma. Hideki S. reports receiving research funding from Taiho Pharma. C. I. reports receiving lecture fees from Taiho, Chugai, Takeda, Byer, Pfeizer, Mochida, Asahikasei, Bristol-Myers Squibb, Daiichi-Sankyo, Merck Serono, and Novartis, and research funding from Chugai, Taiho, Bristol-Myers Squibb, Daiichi-Sankyo, Merck Serono, Yakult, Ono, and Novartis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio T, 2016, EUR J CANC, pii; Bellera CA, 2012, ANN ONCOL, V23, P2166, DOI 10.1093/annonc/mdr587; Bourdel-Marchasson I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148523; Braes T, 2009, AGE AGEING, V38, P600, DOI 10.1093/ageing/afp097; Bridgewater J, 2016, ANN ONCOL, V27, P134, DOI 10.1093/annonc/mdv483; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clough-Gorr KM, 2010, J CLIN ONCOL, V28, P380, DOI 10.1200/JCO.2009.23.5440; Decoster L, 2015, ANN ONCOL, V26, P288, DOI 10.1093/annonc/mdu210; Denewet N, 2016, ACTA CLIN BELG, V71, P206, DOI 10.1080/17843286.2016.1153816; Dubruille S, 2015, J GERIATR ONCOL, V6, P362, DOI 10.1016/j.jgo.2015.07.006; Freyer G, 2005, ANN ONCOL, V16, P1795, DOI 10.1093/annonc/mdi368; Hamaker ME, 2012, LANCET ONCOL, V13, pE437, DOI 10.1016/S1470-2045(12)70259-0; Hamaker ME, 2014, ANN HEMATOL, V93, P1031, DOI 10.1007/s00277-013-2001-0; Hamaker ME, 2012, ONCOLOGIST, V17, P1439, DOI 10.1634/theoncologist.2012-0186; Hori M, 2015, JPN J CLIN ONCOL, V45, P884, DOI 10.1093/jjco/hyv088; Iacovelli R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108940; Jonna S, 2016, SUPPORT CARE CANCER, V24, P4807, DOI 10.1007/s00520-016-3334-8; Kanesvaran R, 2011, J CLIN ONCOL, V29, P3620, DOI 10.1200/JCO.2010.32.0796; Kenis C, 2014, J CLIN ONCOL, V32, P19, DOI 10.1200/JCO.2013.51.1345; Kobayashi Y, 2011, J CANCER RES CLIN, V137, P1079, DOI 10.1007/s00432-010-0973-x; Kuzuya M, 2005, NUTRITION, V21, P498, DOI 10.1016/j.nut.2004.08.023; Liuu E, 2014, J GERIATR ONCOL, V5, P11, DOI 10.1016/j.jgo.2013.08.003; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Puts MTE, 2012, JNCI-J NATL CANCER I, V104, P1133, DOI 10.1093/jnci/djs285; Puts MTE, 2011, CRIT REV ONCOL HEMAT, V78, P138, DOI 10.1016/j.critrevonc.2010.04.003; Saliba D, 2001, J AM GERIATR SOC, V49, P1691, DOI 10.1046/j.1532-5415.2001.49281.x; Sargent DJ, 2009, J CLIN ONCOL, V27, P1948, DOI 10.1200/JCO.2008.20.2879; Sattar S, 2014, ONCOLOGIST, V19, P1056, DOI 10.1634/theoncologist.2014-0180; Soubeyran P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115060; Soubeyran P, 2012, J CLIN ONCOL, V30, P1829, DOI 10.1200/JCO.2011.35.7442; Wedding U, 2007, J CANCER RES CLIN, V133, P945, DOI 10.1007/s00432-007-0233-x; Wildiers H, 2014, J CLIN ONCOL, V32, P2595, DOI 10.1200/JCO.2013.54.8347	32	42	43	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179694	10.1371/journal.pone.0179694	http://dx.doi.org/10.1371/journal.pone.0179694			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640844	Green Published, Green Submitted, gold			2022-12-27	WOS:000404135800053
J	Das, A; Rahman, MI; Ferdous, AS; Al-Amin; Rahman, MM; Nahar, N; Uddin, MA; Islam, MR; Khan, H				Das, Avizit; Rahman, Mohammad Imtiazur; Ferdous, Ahlan Sabah; Al-Amin; Rahman, Mohammad Mahbubur; Nahar, Nilufar; Uddin, Md. Aftab; Islam, Mohammad Riazul; Khan, Haseena			An endophytic Basidiomycete, Grammothele lineata, isolated from Corchorus olitorius, produces paclitaxel that shows cytotoxicity	PLOS ONE			English	Article							TAXOL(R) PACLITAXEL; FUNGUS; LEAF	Grammothele lineata, an endophyte isolated in our laboratory from jute (Corchorus olitorius acc. 2015) was found to be a substantial paclitaxel producer. Taxol and its related compounds, produced by this endophyte were extracted by growing the fungus in simple nutrient media (potato dextrose broth, PDB). Taxol was identified and characterized by different analytical techniques (TLC, HPLC, FTIR, LC-ESI-MS/MS) following its extraction by ethyl acetate. In PDB media, this fungus was found to produce 382.2 mu gL(-1) of taxol which is about 7.6 x 10(3) fold higher than the first reported endophytic fungi, Taxomyces andreanae. The extracted taxol exhibited cytotoxic activity in an in vitro culture of HeLa cancer cell line. The fungal extract also exhibited antifungal and antibacterial activities against different pathogenic strains. This is the first report of a jute endophytic fungus harboring the capacity to produce taxol and also the first reported taxol producing species that belongs to the Basidiomycota phylum, so far unknown to be a taxol producer. These findings suggest that the fungal endophyte, Grammothele lineata can be an excellent source of taxol and can also serve as a potential species for chemical and genetic engineering to enhance further the production of taxol.	[Das, Avizit; Rahman, Mohammad Imtiazur; Ferdous, Ahlan Sabah; Al-Amin; Islam, Mohammad Riazul; Khan, Haseena] Univ Dhaka, Dept Biochem & Mol Biol, Dhaka, Bangladesh; [Rahman, Mohammad Mahbubur] BCSIR, Dev Fiber & Polymer Sci Lab, Dhaka, Bangladesh; [Nahar, Nilufar] Univ Dhaka, Dept Chem, Dhaka, Bangladesh; [Uddin, Md. Aftab] Univ Dhaka, Dept Genet Engn & Biotechnol, Dhaka, Bangladesh	University of Dhaka; Bangladesh Council of Scientific & Industrial Research (BCSIR); University of Dhaka; University of Dhaka	Khan, H (corresponding author), Univ Dhaka, Dept Biochem & Mol Biol, Dhaka, Bangladesh.	haseena@du.ac.bd		Uddin, Md. Aftab/0000-0003-1665-2751; Amin, Al-/0000-0002-6641-4404; khan, haseena/0000-0003-4643-4106; Ferdous, Ahlan/0000-0002-3610-304X	Higher Education Quality Enhancement Project (HEQEP) [CP-3250]; Ministry of Education, Government of People's Republic of Bangladesh; The World Bank	Higher Education Quality Enhancement Project (HEQEP); Ministry of Education, Government of People's Republic of Bangladesh; The World Bank	This work was supported by Subproject: CP-3250, window2, academic innovation fund, Under the Higher Education Quality Enhancement Project (HEQEP), Funded by Ministry of Education, Government of People's Republic of Bangladesh with the assistance of The World Bank (funding received by HK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedi Y.S., 1996, SUPPLEMENT CULTIVATI, P443; Bhanot A., 2011, INT J PHYTOMED, V3, P9; Chen L, 2016, CRIT REV MICROBIOL, V42, P454, DOI 10.3109/1040841X.2014.959892; Choi J, 2016, MYCOBIOLOGY, V44, P105, DOI 10.5941/MYCO.2016.44.2.105; Defoirdt N, 2010, COMPOS PART A-APPL S, V41, P588, DOI 10.1016/j.compositesa.2010.01.005; DIDIER E, 1994, TETRAHEDRON LETT, V35, P3063, DOI 10.1016/S0040-4039(00)76828-6; Erkel G, 2008, BIOTECHNOLOGY SET, P489; Gangadevi V., 2008, MYCOL BALC, V5, P1, DOI DOI 10.5281/zenodo.2548403; Goveas SW, 2011, EURASIA J BIOSCI, V5, P48, DOI DOI 10.5053/EJ0BI0S.2011.5.0.6; Gu Y, 2015, APPL BIOCHEM BIOTECH, V175, P155, DOI 10.1007/s12010-014-1254-y; Hao X., 2013, NATURAL PRODUCTS, P2797, DOI DOI 10.1007/978-3-642-22144-6_124; Heinig U, 2013, FUNGAL DIVERS, V60, P161, DOI 10.1007/s13225-013-0228-7; HOLTON RA, 1994, J AM CHEM SOC, V116, P1599, DOI 10.1021/ja00083a067; Hu YM, 2003, ACTA BOT SIN, V45, P373; Ilhan S., 2007, International Journal of Natural and Engineering Sciences, V1, P59; Kathiravan G, 2010, FITOTERAPIA, V81, P557, DOI 10.1016/j.fitote.2010.01.021; Kumaran RS, 2008, ENG LIFE SCI, V8, P438, DOI 10.1002/elsc.200800019; Kumaran RS, 2008, J BIOSCI BIOENG, V106, P103, DOI 10.1263/jbb.106.103; Kumaran RS, 2010, J BIOSCI BIOENG, V110, P541, DOI 10.1016/j.jbiosc.2010.06.007; Kumaran RS, 2009, BIOTECHNOL APPL BIOC, V54, P21, DOI 10.1042/BA20080110; Kusari S, 2014, TRENDS BIOTECHNOL, V32, P304, DOI 10.1016/j.tibtech.2014.03.011; Lee S.B., 1988, FUNGAL GENET REP, V35, P23, DOI [10.4148/1941-4765.1531, DOI 10.4148/1941-4765.1531]; Li CJ, 2012, MOLECULES, V17, P9348, DOI 10.3390/molecules17089348; Merlin JN, 2012, J ACAD IND RES, V1, P281; Mirjalili MH, 2012, FEMS MICROBIOL LETT, V328, P122, DOI 10.1111/j.1574-6968.2011.02488.x; Najnin RA, 2015, ANN MICROBIOL, V65, P1615, DOI 10.1007/s13213-014-1001-1; NICOLAOU KC, 1994, NATURE, V367, P630, DOI 10.1038/367630a0; Noh MJ, 1999, BIOTECHNOL BIOENG, V64, P620, DOI 10.1002/(SICI)1097-0290(19990905)64:5&lt;620::AID-BIT13&gt;3.0.CO;2-W; Pinruan U, 2010, FUNGAL DIVERS, V41, P71, DOI 10.1007/s13225-010-0029-1; Quin MB, 2014, NAT PROD REP, V31, P1449, DOI 10.1039/c4np00075g; Reck MA, 2009, MYCOTAXON, V109, P361, DOI 10.5248/109.361; Schuffler A, 2009, MYCOTA, V15, P209; Somjaipeng S, 2016, ENZYME MICROB TECH, V90, P69, DOI 10.1016/j.enzmictec.2016.05.002; STIERLE A, 1993, SCIENCE, V260, P214, DOI 10.1126/science.8097061; STULL DP, 1995, APPL BIOCHEM BIOTECH, V54, P133, DOI 10.1007/BF02787915; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Walker K, 2001, PHYTOCHEMISTRY, V58, P1, DOI 10.1016/S0031-9422(01)00160-1; Wang X., 2014, PROCEDIA ENV SCI, V16, P125; Wawrzyn GT, 2012, CHEM BIOL, V19, P772, DOI 10.1016/j.chembiol.2012.05.012; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Xiong ZQ, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-71; Yuan JF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-935; Zaidman BZ, 2005, APPL MICROBIOL BIOT, V67, P453, DOI 10.1007/s00253-004-1787-z; Zhang B, 2005, P NATL ACAD SCI USA, V102, P227, DOI 10.1073/pnas.0406361102; Zhang P, 2008, BIOTECHNOL LETT, V30, P2119, DOI 10.1007/s10529-008-9801-7; Zhao J, 2011, MINI-REV MED CHEM, V11, P159, DOI 10.2174/138955711794519492; Zhou X, 2007, APPL BIOCHEM MICRO+, V43, P439, DOI 10.1134/S000368380704014X; Zhou XW, 2010, APPL MICROBIOL BIOT, V86, P1707, DOI 10.1007/s00253-010-2546-y	48	24	26	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0178612	10.1371/journal.pone.0178612	http://dx.doi.org/10.1371/journal.pone.0178612			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636663	Green Submitted, Green Published, gold			2022-12-27	WOS:000404118300014
J	Iki, T; Tanaka, M; Kitajiri, S; Kita, T; Kawasaki, Y; Mizukoshi, A; Fujibuchi, W; Nakagawa, T; Nakahata, T; Ito, J; Omori, K; Saito, MK				Iki, Takehiro; Tanaka, Michihiro; Kitajiri, Shin-ichiro; Kita, Tomoko; Kawasaki, Yuri; Mizukoshi, Akifumi; Fujibuchi, Wataru; Nakagawa, Takayuki; Nakahata, Tatsutoshi; Ito, Juichi; Omori, Koichi; Saito, Megumu K.			Microarray analyses of otospheres derived from the cochlea in the inner ear identify putative transcription factors that regulate the characteristics of otospheres	PLOS ONE			English	Article							HAIR CELL REGENERATION; EMBRYONIC STEM-CELLS; DIFFERENTIAL EXPRESSION; DIRECT CONVERSION; SELF-RENEWAL; SENSORY EPITHELIA; SUPPORTING CELLS; GENE GJB3; MOUSE; PLURIPOTENCY	Various tissues possess tissue-specific stem/progenitor cells, including the inner ears. Stem/progenitor cells of the inner ear can be isolated as so-called otospheres from differentiated cells using a sphere forming assay. Although recent studies have demonstrated the characteristics of otospheres to some extent, most of the features of these cells are unknown. In this report, we describe the findings of transcriptome analyses with a cDNA microarray of otospheres derived from the cochleae of the inner ears of neonatal mice in order to clarify the gene expression profile of otic stem/progenitor cells. There were common transcription factors between otospheres and embryonic stem cells, which were supposed to be due to the stemness of otospheres. In comparison with the cochlear sensory epithelium, the otospheres shared characteristics with the cochlea, although several transcription factors specific for otospheres were identified. These transcription factors are expected to be essential for maintaining the characteristics of otospheres, and appear to be candidate genes that promote the direct conversion of cells into otic stem/progenitor cells.	[Iki, Takehiro; Kawasaki, Yuri; Mizukoshi, Akifumi; Nakagawa, Takayuki; Saito, Megumu K.] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Clin Applicat, Kyoto, Japan; [Iki, Takehiro; Kita, Tomoko; Mizukoshi, Akifumi; Nakagawa, Takayuki; Ito, Juichi; Omori, Koichi] Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kyoto, Japan; [Tanaka, Michihiro] Kyoto Univ, Ctr iPS Cell Res & Applicat, Informat & Secur Off, Kyoto, Japan; [Kitajiri, Shin-ichiro] Shinshu Univ, Sch Med, Dept Hearing Implant Sci, Kyoto, Japan; [Fujibuchi, Wataru] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Cell Growth & Differentiat, Kyoto, Japan; [Ito, Juichi] Shiga Med Ctr Res Inst, Hearing Commun Med Ctr, Shiga, Japan	Kyoto University; Kyoto University; Kyoto University; Shinshu University; Kyoto University	Saito, MK (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Clin Applicat, Kyoto, Japan.	msaito@cira.kyoto-u.ac.jp	Omori, Koichi/AAU-9017-2021	Omori, Koichi/0000-0003-3404-5461	Japan Society for the Promotion of Science (JSPS) [26293369]; KAKENHI [16H05352]; Takeda Science Foundation [16K15719]; Grants-in-Aid for Scientific Research [17H06277] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Grant-in-Aid for Scientific Research (B) from Japan Society for the Promotion of Science (JSPS, 26293369) to [SK], KAKENHI grant number 16H05352 to [MKS], the second step of Visionary Research Grant (a stepwise encouraging program) by Takeda Science Foundation to [SK], and Grant-in-Aid for Challenging Exploratory Research (JSPS, 16K15719) to [TI]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bassiouni M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164579; Cafaro J, 2007, DEV DYNAM, V236, P156, DOI 10.1002/dvdy.21023; Chapman G, 1997, GENOMICS, V46, P223, DOI 10.1006/geno.1997.4969; Chen HW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8095; Chen KHJ, 2016, ASIA PAC EDUC REV, V17, P1, DOI 10.1007/s12564-016-9415-z; Chen P, 1999, DEVELOPMENT, V126, P1581; Coppens AG, 2001, DEV BRAIN RES, V126, P191, DOI 10.1016/S0165-3806(00)00153-X; CORWIN JT, 1988, SCIENCE, V240, P1772, DOI 10.1126/science.3381100; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Diensthuber M, 2009, JARO-J ASSOC RES OTO, V10, P173, DOI 10.1007/s10162-009-0161-3; Doherty JM, 2008, STEM CELLS, V26, P2124, DOI 10.1634/stemcells.2008-0380; Duncan LJ, 2006, J COMP NEUROL, V499, P691, DOI 10.1002/cne.21114; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fekete DM, 1998, J NEUROSCI, V18, P7811; FORGE A, 1993, SCIENCE, V259, P1616, DOI 10.1126/science.8456284; Forge A, 1998, J COMP NEUROL, V397, P69; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Heller S, 2002, JARO, V3, P488, DOI 10.1007/s10162-002-2050-x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jacques BE, 2014, DEV NEUROBIOL, V74, P438, DOI 10.1002/dneu.22134; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Jin SQ, 2003, ONCOGENE, V22, P8536, DOI 10.1038/sj.onc.1206907; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kiernan AE, 2005, SOX2 IS REQUIRED SEN, V426, P423; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kirkegaard M, 2006, NEUROSCIENCE, V142, P425, DOI 10.1016/j.neuroscience.2006.06.037; LATCHMAN DS, 1993, INT J EXP PATHOL, V74, P417; Li HW, 2003, P NATL ACAD SCI USA, V100, P13495, DOI 10.1073/pnas.2334503100; Li HW, 2003, NAT MED, V9, P1293, DOI 10.1038/nm925; Lin JZ, 2007, CURR MED CHEM, V14, P2937, DOI 10.2174/092986707782360051; Lou XX, 2013, CELL REPROGRAM, V15, P514, DOI 10.1089/cell.2013.0020; Lou XX, 2013, NEUROSCI LETT, V534, P18, DOI 10.1016/j.neulet.2012.12.001; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Malgrange B, 2002, MECH DEVELOP, V112, P79, DOI 10.1016/S0925-4773(01)00642-6; Marro S, 2011, CELL STEM CELL, V9, P374, DOI 10.1016/j.stem.2011.09.002; Masui S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-45; Micallef L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101717; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morris KA, 2005, JARO-J ASSOC RES OTO, V6, P75, DOI 10.1007/s10162-004-5046-x; Morrison A, 1999, MECH DEVELOP, V84, P169, DOI 10.1016/S0925-4773(99)00066-0; NADOL JB, 1993, NEW ENGL J MED, V329, P1092, DOI 10.1056/NEJM199310073291507; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Oh SH, 1996, J NEUROSCI, V16, P6463; Oiticica J, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-119; Orkin SH, 2008, COLD SH Q B, V73, P195, DOI 10.1101/sqb.2008.72.001; Oshima K, 2007, JARO-J ASSOC RES OTO, V8, P18, DOI 10.1007/s10162-006-0058-3; Oshima Kazuo, 2009, V493, P141, DOI 10.1007/978-1-59745-523-7_9; Plum A, 2002, GENOMICS, V79, P24, DOI 10.1006/geno.2001.6671; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; RAPHAEL Y, 1992, J NEUROCYTOL, V21, P663, DOI 10.1007/BF01191727; Resendes BL, 2004, JARO-J ASSOC RES OTO, V5, P185, DOI 10.1007/s10162-003-4042-x; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Richard DJ, 2008, NATURE, V453, P677, DOI 10.1038/nature06883; Richard G, 1998, NAT GENET, V20, P366, DOI 10.1038/3840; Roccio M, 2015, NAT PUBL GR NATURE P, V5, P1; Saunders JC, 2010, ILAR J, V51, P326, DOI 10.1093/ilar.51.4.326; Savary E, 2008, MECH DEVELOP, V125, P674, DOI 10.1016/j.mod.2008.05.001; Schepens J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063006; Shang JL, 2010, JARO-J ASSOC RES OTO, V11, P203, DOI 10.1007/s10162-009-0206-7; Shi FX, 2013, P NATL ACAD SCI USA, V110, P13851, DOI 10.1073/pnas.1219952110; Smeti I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088757; Smeti I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042987; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Taniguchi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048544; Tarasov KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002478; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; TSUE TT, 1994, OTOLARYNG HEAD NECK, V111, P281, DOI 10.1016/S0194-5998(94)70603-4; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Waldhaus J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036066; Wang ZX, 2007, STEM CELLS, V25, P2173, DOI 10.1634/stemcells.2007-0085; WARCHOL ME, 1993, SCIENCE, V259, P1619, DOI 10.1126/science.8456285; Waryah AM, 2009, CLIN GENET, V76, P270, DOI 10.1111/j.1399-0004.2009.01209.x; White PM, 2006, NATURE, V441, P984, DOI 10.1038/nature04849; Xia JH, 1998, NAT GENET, V20, P370, DOI 10.1038/3845; Yamaji M, 2013, CELL STEM CELL, V12, P368, DOI 10.1016/j.stem.2012.12.012; Yerukhimovich MV, 2007, DEV NEUROSCI-BASEL, V29, P251, DOI 10.1159/000096415; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882; Zhai SQ, 2005, J NEUROBIOL, V65, P282, DOI 10.1002/neu.20190; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhang Y, 2007, J NEUROSCI METH, V164, P271, DOI 10.1016/j.jneumeth.2007.05.009; Zheng LL, 2000, CELL, V102, P377, DOI 10.1016/S0092-8674(00)00042-8	85	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179901	10.1371/journal.pone.0179901	http://dx.doi.org/10.1371/journal.pone.0179901			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662075	gold, Green Published, Green Submitted			2022-12-27	WOS:000404608300067
J	Bruecker, CH; Mikulich, V				Bruecker, Christoph H.; Mikulich, Vladimir			Sensing of minute airflow motions near walls using pappus-type nature-inspired sensors	PLOS ONE			English	Article							SHEAR-STRESS; JET	This work describes the development and use of pappus-like structures as sensitive sensors to detect minute air-flow motions. We made such sensors from pappi taken from nature grown seed, whose filiform hairs' length-scale is suitable for the study of large-scale turbulent convection flows. The stem with the pappus on top is fixated on an elastic membrane on the wall and tilts under wind-load proportional to the velocity magnitude in direction of the wind, similar as the biological sensory hairs found in spiders, however herein the sensory hair has multiple filiform protrusions at the tip. As the sensor response is proportional to the drag on the tip and a low mass ensures a larger bandwidth, lightweight pappus structures similar as those found in nature with documented large drag are useful to improve the response of artificial sensors. The pappus of a Dandelion represents such a structure which has evolved to maximize wind-driven dispersion, therefore it is used herein as the head of our sensor. Because of its multiple hairs arranged radially around the stem it generates uniform drag for all wind directions. While still being permeable to the flow, the hundreds of individual hairs on the tip of the sensor head maximize the drag and minimize influence of pressure gradients or shear-induced lift forces on the sensor response as they occur in non permeable protrusions. In addition, the flow disturbance by the sensor itself is limited. The optical recording of the head-motion allows continuously remote-distance monitoring of the flow fluctuations in direction and magnitude. Application is shown for the measurement of a reference flow under isothermal conditions to detect the early occurrence of instabilities.	[Bruecker, Christoph H.] City Univ London, Dept Mech Engn & Aeronaut, London, England; [Mikulich, Vladimir] TU Bergakad Freiberg, Inst Mech & Fluid Dynam, Freiburg, Germany	City University London; Technical University Freiberg	Bruecker, CH (corresponding author), City Univ London, Dept Mech Engn & Aeronaut, London, England.	christoph.bruecker@city.ac.uk		Bruecker, Christoph/0000-0001-5834-3020	Royal Academy of Engineering [RCSRF1617\4\11]; BAE SYSTEMS	Royal Academy of Engineering(Royal Academy of Engineering - UK); BAE SYSTEMS	The position of Professor Christoph Bruecker is co-funded by BAE SYSTEMS and the Royal Academy of Engineering (Research Chair no. RCSRF1617\4\11) as the Chair in Aeronautical Engineering at City, University of London. The funders had no role in the study design nor did they have acted as an expert witness in relevant legal proceedings or have sat or currently sit on a committee for an organization that may benefit from publication of the paper.	Albrecht HE, 2007, LASER DOPPLER PHASE; BAJURA RA, 1970, PHYS FLUIDS, V13, P1653, DOI 10.1063/1.1693137; BARTH FG, 2003, SENSORS SENSING BIOL; Battista L, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4798298; Bleckmann H, 2012, FLOW SENSING AIR WAT; Brucker C, 2005, EXP FLUIDS, V39, P464, DOI 10.1007/s00348-005-1003-7; Brucker C, 2007, EXP FLUIDS, V42, P737, DOI 10.1007/s00348-007-0282-6; Bruecker C, 2016, OPT EXPRESS, V24, P21407, DOI 10.1364/OE.24.021407; BRUUN H.H., 1996, HOT WIRE ANEMOMETRY; Casseau V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125040; du Puits R, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.124301; GLAUERT MB, 1956, J FLUID MECH, V1, P625, DOI 10.1017/S002211205600041X; Gogineni S, 1997, EXP FLUIDS, V23, P121, DOI 10.1007/s003480050093; GREENE DF, 1990, FUNCT ECOL, V4, P117, DOI 10.2307/2389661; Lai JCS, 1996, INT J HEAT FLUID FL, V17, P377, DOI 10.1016/0142-727X(95)00017-K; Levin O, 2005, J FLUID MECH, V539, P313, DOI 10.1017/S0022112005005628; Liebe E., 2006, FLOW PHENOMENA NATUR; MONKEWITZ PA, 1982, PHYS FLUIDS, V25, P1137, DOI 10.1063/1.863880; Pandolfi C, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/2/025003; Raffel M, 2007, EXP FLUID MECH, P1, DOI 10.1007/978-3-540-72308-0; Schlichting H., 2006, GRENZSCHICHT THEORIE, V10	21	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179253	10.1371/journal.pone.0179253	http://dx.doi.org/10.1371/journal.pone.0179253			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658272	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000404607900017
J	Chen, ZH; Liu, LG; Tu, JF; Qin, GM; Su, WW; Geng, XG; Chen, XJ; Wu, HG; Pan, WS				Chen, Zhihao; Liu, Lingang; Tu, Jiangfeng; Qin, Guangming; Su, Weiwei; Geng, Xiaoge; Chen, Xiaojun; Wu, Hongguang; Pan, Wensheng			Improvement of atropine on esophagogastric junction observation during sedative esophagogastroduodenoscopy	PLOS ONE			English	Article							LOWER ESOPHAGEAL SPHINCTER; ENDOSCOPIC SEDATION; GASTRIC CARDIA; PROPOFOL; CANCER; TONE; CONTRACTION; PRESSURE	Background and study aims Although sedation esophagogastroduodenoscopy (EGD) is now widely used, previous research has reported that sedation during EGD exhibits a negative effect on esophagogastric junction (EGJ) exposure. Atropine might improve EGJ exposure, as noted in clinical practice. The aim of this study was to examine whether sedation had a negative effect on EGJ observation in the Chinese population, and whether atropine had some ability to act as an antidote to this unexpected secondary effect of sedation. Patients and methods In this cross-sectional study, subjects were divided into the following three groups according to the methods of EGD examination: the non-sedation group, the propofol-fentanyl combined sedation group and the combined sedation with atropine administration group. The EGJ observation was assessed by a key photograph taken with the endoscopic camera 1 cm from the EGJ, which was rated on the following four-degree scale: excellent (score = 4), good (score = 3), fair (score = 2) and poor (score = 1). Results The EGJ exposure was better in the sedation group administered atropine (score = 2.64 +/- 1.05) than in the sedation group (score = 1.99 +/- 1.08, P < 0.05) but not as good as in the non-sedation group (score = 3.24 +/- 1.12, P < 0.05). Reduced detection of EGJ diseases in the sedation group was also found, compared to the non-sedation group (P < 0.05). Only the use of atropine (OR = 2.381, 95%CI: 1.297-4.371, P = 0.005) was independently associated with excellent observation of the EGJ during sedation EGD. Conclusions Combined propofol-fentanyl sedation reduces the extent of exposure of the EGJ during EGD and reduces the detection of EGJ diseases. The application of atropine in the sedation endoscopy examination helped to achieve better EGJ observation, but still cannot achieve an equal extent of exposure compared to non-sedation EGD.	[Chen, Zhihao; Liu, Lingang; Tu, Jiangfeng; Su, Weiwei; Geng, Xiaoge; Chen, Xiaojun; Pan, Wensheng] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China; [Liu, Lingang] Longsai Hosp, Dept Gastroenterol, Ningbo, Zhejiang, Peoples R China; [Tu, Jiangfeng; Pan, Wensheng] Zhejiang Prov Peoples Hosp, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China; [Qin, Guangming] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Lab, Hangzhou, Zhejiang, Peoples R China; [Wu, Hongguang] Quzhou Second Peoples Hosp, Dept Gastroenterol, Quzhou, Peoples R China	Zhejiang University; Zhejiang Provincial People's Hospital; Zhejiang University	Pan, WS (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China.; Pan, WS (corresponding author), Zhejiang Prov Peoples Hosp, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China.	wspan223@163.com	Geng, Xiaoge/GQA-5474-2022; chen, zhihao/GXM-3816-2022; su, wei/GZM-3986-2022		National Natural Science Foundation of China [81372302]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (general project No. 81372302), https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list.	Ajani JA, 2016, J NATL COMPR CANC NE, V14, P1286, DOI 10.6004/jnccn.2016.0137; Bhardwaj Atul, 2012, Patholog Res Int, V2012, P814146, DOI 10.1155/2012/814146; Blaser MJ, 2002, EUR J GASTROEN HEPAT, V14, P107, DOI 10.1097/00042737-200202000-00003; Cohen LB, 2006, AM J GASTROENTEROL, V101, P967, DOI 10.1111/j.1572-0241.2006.00500.x; Cohen LB, 2004, GASTROINTEST ENDOSC, V59, P795, DOI 10.1016/S0016-5107(04)00349-9; COHEN S, 1971, J CLIN INVEST, V50, P449, DOI 10.1172/JCI106512; COTTON BR, 1984, BRIT J ANAESTH, V56, P37, DOI 10.1093/bja/56.1.37; Farre R, 2008, BRIT J PHARMACOL, V153, P858, DOI 10.1038/sj.bjp.0707572; Fitzgerald RC, 2014, GUT, V63, P7, DOI 10.1136/gutjnl-2013-305372; Horiguchi T, 2002, ANESTH ANALG, V95, P389, DOI 10.1097/00000539-200208000-00027; Japan Gastroenterological Endoscopy Society postgraduate education committee, 2006, GUID GASTR END; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kim ES, 2014, WORLD J GASTROENTERO, V20, P5527, DOI 10.3748/wjg.v20.i18.5527; Li ZS., 2014, CHIN J PRACT INTERN, V34, P756; MAZUR JM, 1973, SURGERY, V73, P818; MITTAL RK, 1995, AM J PHYSIOL-GASTR L, V269, pG577, DOI 10.1152/ajpgi.1995.269.4.G577; Muir WW, 1998, AM J VET RES, V59, P157; Physicians' Desk Reference, 1998, PROBL POSS IMPR; Powley TL, 2013, AUTON NEUROSCI-BASIC, V177, P129, DOI 10.1016/j.autneu.2013.03.008; PREIKSAITIS HG, 1994, GASTROENTEROLOGY, V106, P381, DOI 10.1016/0016-5085(94)90596-7; RAMSAY MAE, 1974, BRIT MED J, V2, P656, DOI 10.1136/bmj.2.5920.656; Rantanen T, 2016, ANTICANCER RES, V36, P2323; Riphaus A, 2010, Z GASTROENTEROL, V48, P392, DOI 10.1055/s-0028-1109765; Shaker R, 2004, AM J PHYSIOL-GASTR L, V287, pG815, DOI 10.1152/ajpgi.00120.2004; Sharma P, 2006, GASTROENTEROLOGY, V131, P1392, DOI 10.1053/j.gastro.2006.08.032; Stein HJ, 2000, SURG ONCOL, V9, P35, DOI 10.1016/S0960-7404(00)00021-9; STURDEVANT RA, 1974, GASTROENTEROLOGY, V67, P551; Tournadre JP, 1998, CAN J ANAESTH, V45, P479, DOI 10.1007/BF03012585; Wadhwa V, 2017, CLIN GASTROENTEROL H, V15, P194, DOI 10.1016/j.cgh.2016.07.013; Zhou YN, 2008, CANCER LETT, V269, P18, DOI 10.1016/j.canlet.2008.04.013	30	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179490	10.1371/journal.pone.0179490	http://dx.doi.org/10.1371/journal.pone.0179490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654639	Green Published, Green Submitted, gold			2022-12-27	WOS:000404541500015
J	Jo, JH; Cho, IR; Jung, JH; Lee, HS; Chung, MJ; Bang, S; Park, SW; Chung, JB; Song, SY; Park, JY				Jo, Jung Hyun; Cho, In Rae; Jung, Jang Han; Lee, Hee Seung; Chung, Moon Jae; Bang, Seungmin; Park, Seung Woo; Chung, Jae Bock; Song, Si Young; Park, Jeong Youp			Clinical characteristics of second primary pancreatic cancer	PLOS ONE			English	Article							MALIGNANCIES; PREVALENCE; SURVIVAL; RISK	Purpose Several studies reported the increased risk of second primary pancreatic ductal adenocarcinoma (2nd PDAC) in cancer survivors. However, data on the characteristics of 2nd PDAC are insufficient. Methods This retrospective cohort study included 1759 patients with PDAC. They were classified as having 2nd PDAC or first primary PDAC (1st PDAC) according to a prior diagnosed cancer of different origin, at least 6 months before PDAC diagnosis. Results There were 110 patients (6.4%) with 2nd PDAC and 1606 (93.6%) patients with 1st PDAC. Patients with 2nd PDAC presented with older age (66.5 vs. 62.2 years, p < 0.001) and higher rate of resectability (26.4% vs. 15.9%, p = 0.004) at diagnosis than those with 1st PDAC. Multivariate analysis without considering resectable status showed that 2nd PDAC (hazard ratio [HR] 0.73, 95% confidence interval [CI] 0.56-0.94, p = 0.016) was associated with better overall survival. After adjusting for resectable status, however, 2nd PDAC (HR 0.85, 95% CI 0.66-1.09, p = 0.198) was no longer associated with overall survival. When subgroups were separately analyzed according to initial treatment modality, the effectiveness of surgery and chemotherapy were similar between 2nd and 1st PDAC (33.1 vs. 28.5 months, p = 0.860 and 10.8 vs. 10.7 months, p = 0.952). Conclusions The proportion of resectable cases was significantly higher in 2nd PDAC. When surgery with curative aim was possible, the overall survival was increased even in patients with 2nd PDAC. These results suggest the importance of screening for second primary cancer in cancer survivors.	[Jo, Jung Hyun; Cho, In Rae; Jung, Jang Han; Lee, Hee Seung; Chung, Moon Jae; Bang, Seungmin; Park, Seung Woo; Chung, Jae Bock; Song, Si Young; Park, Jeong Youp] Yonsei Univ, Severance Hosp, Coll Med, Div Gastroenterol,Dept Internal Med, Seoul, South Korea	Yonsei University; Yonsei University Health System	Park, JY (corresponding author), Yonsei Univ, Severance Hosp, Coll Med, Div Gastroenterol,Dept Internal Med, Seoul, South Korea.	SENSASS@yuhs.ac	Jo, Jung Hyun/V-8316-2019; Song, SY/E-2891-2012	Jo, Jung Hyun/0000-0002-2641-8873; Park, Seung Woo/0000-0001-8230-964X; Park, Jeong Youp/0000-0003-0110-8606; Lee, HEE SEUNG/0000-0002-2825-3160; Chung, Moon Jae/0000-0002-5920-8549; Song, Si Young/0000-0002-1417-4314				Amin S, 2012, CANCER-AM CANCER SOC, V118, P1244, DOI 10.1002/cncr.26414; Boice J D Jr, 1985, Natl Cancer Inst Monogr, V68, P3; Canto MI, 2013, GUT, V62, P339, DOI 10.1136/gutjnl-2012-303108; Chong I, 2012, HARRISONS PRINCIPLES; Donin N, 2016, CANCER-AM CANCER SOC, V122, P3075, DOI 10.1002/cncr.30164; Duchateau CSJ, 2005, CHEST, V127, P1152, DOI 10.1378/chest.127.4.1152; Hackert T, 2012, PANCREAS, V41, P212, DOI 10.1097/MPA.0b013e3182240602; Hemminki K, 2003, INT J CANCER, V103, P525, DOI 10.1002/ijc.10863; Howlader N., 2016, SEER CANC STAT REV 1; Kebudi R, 2016, CURR PEDIAT REV; NEUGUT AI, 1995, CANCER, V76, P589, DOI 10.1002/1097-0142(19950815)76:4<589::AID-CNCR2820760408>3.0.CO;2-9; Oh CM, 2016, CANCER RES TREAT, V48, P436, DOI 10.4143/crt.2016.089; Park JE, 2016, ALCOHOL ALCOHOL; Rahimi E, 2016, DIGEST DIS SCI, V61, P1652, DOI 10.1007/s10620-016-4170-x; Ryerson AB, 2016, CANCER-AM CANCER SOC, V122, P1312, DOI 10.1002/cncr.29936; Shen M, 2006, AM J EPIDEMIOL, V163, P502, DOI 10.1093/aje/kwj073; Soliman Hatem, 2008, Cancer Control, V15, P55	17	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179784	10.1371/journal.pone.0179784	http://dx.doi.org/10.1371/journal.pone.0179784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650984	Green Published, Green Submitted, gold			2022-12-27	WOS:000404537300023
J	Li, XH; Wang, BN; Yang, TW; Zhu, DW; Nie, ZN; Xu, JC				Li, Xinghua; Wang, Baona; Yang, Tewu; Zhu, Duanwei; Nie, Zhongnan; Xu, Junchi			Identification of soil P fractions that are associated with P loss from surface runoff under various cropping systems and fertilizer rates on sloped farmland	PLOS ONE			English	Article							PHOSPHORUS FRACTIONS; OVERLAND-FLOW; DETACHMENT RATE; SEDIMENT; FORMS; ERODIBILITY; TRANSPORT; STRENGTH; NITROGEN	Soil phosphorus (P) fractions and runoff P concentration were measured to understand the fate of soil P entering surface runoff water during summer cropping season of different double cropping systems under two fertilizer regimes. The dominant form of runoff P was particulate P (PP). Runoff total P (TP) was higher at the vegetative growth stage and lower at the crop reproductive stage. TP and PP were derived mainly from soil Olsen-P, Al-P and Fe-P and amounts increased with sediment content in runoff water. Runoff P discharge was closely related to the changes in soil P forms. Soil Olsen-P, mainly consisting of some Ca-2-P and Al-P, was increased by elevating fertilizer rate. Along with crop growth, there were active interconversions among Olsen-P, Org-P, Fe-P and O-Al-P in the soil, and some available P converted into Ca-10-P, with O-Fe-P possibly being a transitional form for this conversion. The oilseed rape/corn system had less runoff TP at the early stage, and wheat/sweet potato system had a lower runoff P at the late stage. Intercropping corn with sweet potato in the field with oilseed rape as a previous crop may be helpful for alleviating runoff P load during the summer in this region.	[Li, Xinghua; Wang, Baona; Yang, Tewu; Xu, Junchi] Huazhong Agr Univ, Coll Plant Sci & Technol, MOA Key Lab Crop Ecophysiol & Farming Syst Middle, Wuhan, Peoples R China; [Yang, Tewu; Zhu, Duanwei] Cooperat Innovat Ctr Sustainable Pig Prod, Wuhan, Peoples R China; [Zhu, Duanwei] Huazhong Agr Univ, Lab Plant Nutr & Ecol Environm Res, Wuhan, Peoples R China; [Nie, Zhongnan] Dept Econ Dev Jobs Transport & Resources, Hamilton, Vic, Australia	Huazhong Agricultural University; Huazhong Agricultural University	Yang, TW (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, MOA Key Lab Crop Ecophysiol & Farming Syst Middle, Wuhan, Peoples R China.; Yang, TW (corresponding author), Cooperat Innovat Ctr Sustainable Pig Prod, Wuhan, Peoples R China.	yangtewu@mail.hzau.edu.cn	Xu, Junchi/J-1462-2017	Xu, Junchi/0000-0001-6370-6041	National Key Research and Development Program of China [SQ2017YFNC060063]; Research and Demonstration on Agro-Ecological Restoration Technology in Danjiangkou Reservoir Region for the South-to-North Water Transfer Project [2007BAD87B09]	National Key Research and Development Program of China; Research and Demonstration on Agro-Ecological Restoration Technology in Danjiangkou Reservoir Region for the South-to-North Water Transfer Project	This work was supported by the National Key Research and Development Program of China (grant no. SQ2017YFNC060063) and Research and Demonstration on Agro-Ecological Restoration Technology in Danjiangkou Reservoir Region for the South-to-North Water Transfer Project (grant no. 2007BAD87B09).; This work was supported by the National Key Research and Development Program of China (Grant No. SQ2017YFNC060063) and Research and Demonstration on Agro-Ecological Restoration Technology in Danjiangkou Reservoir Region for the South-to-North Water Transfer Project (Grant No. 2007BAD87B09). The authors thank Mr. Andy Bruere, the Bay of Plenty Regional Council, New Zealand, for his helpful comments on the language/grammar of the manuscript.	Ai Y, 2010, PROGRESSES COMPREHEN, P46; Bao SD, 2000, AGROCHEMICAL SOIL AN, P25; Buehler S, 2002, SOIL SCI SOC AM J, V66, P868, DOI 10.2136/sssaj2002.0868; Casermeiro MA, 2004, CATENA, V57, P91, DOI 10.1016/S0341-8162(03)00160-7; Chen Xin, 2000, China Environmental Science, V20, P284; [成庆利 CHENG Qingli], 2008, [水土保持研究, Research of Soil and Water Conservation], V15, P202; do Nascimento CAC, 2015, SCI REP-UK, V5, DOI 10.1038/srep17967; Doody D, 2006, SCI TOTAL ENVIRON, V372, P247, DOI 10.1016/j.scitotenv.2006.08.029; Dougherty WJ, 2011, SOIL RES, V49, P523, DOI 10.1071/SR11151; Douglas CL, 1998, J ENVIRON QUAL, V27, P1170, DOI 10.2134/jeq1998.00472425002700050023x; Gao YJ, 2009, NUTR CYCL AGROECOSYS, V85, P109, DOI 10.1007/s10705-009-9252-0; Gao Yang, 2008, China Environmental Science, V28, P542; GREENHILL NB, 1983, AUST J SOIL RES, V21, P139, DOI 10.1071/SR9830139; Gu YC., 1990, SOILS, V22, P101; GU YC, 1997, CHIN J SOIL SCI, V29, P13; HEDLEY MJ, 1982, SOIL SCI SOC AM J, V46, P970, DOI 10.2136/sssaj1982.03615995004600050017x; Jackson ML., 1957, SOIL SCI, V84, P1334; Jalali M, 2013, ENVIRON MONIT ASSESS, V185, P8557, DOI 10.1007/s10661-013-3195-2; Kirkby MJ, 1996, J SOIL WATER CONSERV, V51, P391; Kwong KFNK, 2002, AGR ECOSYST ENVIRON, V91, P147, DOI 10.1016/S0167-8809(01)00237-7; Lei HongJun, 2007, Acta Pedologica Sinica, V44, P860; Leytem AB, 2005, SOIL SCI SOC AM J, V69, P1516, DOI 10.2136/sssaj2004.0315; [李承力 LI Chengli], 2011, [水土保持学报, Journal of Soil and Water Conservation], V25, P83; Mamo M, 2001, T ASAE, V44, P1175; Mamo M, 2001, T ASAE, V44, P1167; Marquez CO, 2004, SOIL SCI SOC AM J, V68, P725, DOI 10.2136/sssaj2004.0725; McDowell R, 2002, J ENVIRON QUAL, V31, P217, DOI 10.2134/jeq2002.0217; McDowell RW, 2004, NEW ZEAL J AGR RES, V47, P137, DOI 10.1080/00288233.2004.9513581; McDowell RW, 2003, NEW ZEAL J AGR RES, V46, P239, DOI 10.1080/00288233.2003.9513550; Moody PW, 2011, SOIL RES, V49, P247, DOI 10.1071/SR10140; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Nash David, 2002, P225, DOI 10.1079/9780851995458.0225; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; Pagliari PH, 2013, BIOL FERT SOILS, V49, P987, DOI 10.1007/s00374-013-0798-2; Pan CZ, 2006, J HYDROL, V331, P178, DOI 10.1016/j.jhydrol.2006.05.011; Pikul JL, 2003, SOIL SCI SOC AM J, V67, P859, DOI 10.2136/sssaj2003.0859; Pote DH, 1999, J ENVIRON QUAL, V28, P170, DOI 10.2134/jeq1999.00472425002800010020x; Pote DH, 1996, SOIL SCI SOC AM J, V60, P855, DOI 10.2136/sssaj1996.03615995006000030025x; Reddy KR, 1998, SOIL SCI SOC AM J, V62, P1134, DOI 10.2136/sssaj1998.03615995006200040039x; Robertson FA, 2008, AGR ECOSYST ENVIRON, V126, P195, DOI 10.1016/j.agee.2008.01.023; Samadi A, 1998, AUST J SOIL RES, V36, P585, DOI 10.1071/S97060; SEPA, 2003, TECHN SPEC REQ MON S; SHARPLEY AN, 1994, J ENVIRON QUAL, V23, P437, DOI 10.2134/jeq1994.00472425002300030006x; Sharpley AN, 2001, PLANT SOIL, V237, P287, DOI 10.1023/A:1013335814593; Shen J, 2004, FIELD CROP RES, V86, P225, DOI 10.1016/j.fcr.2003.08.013; [盛海君 Sheng Haijun], 2004, [生态学报, Acta Ecologica Sinica], V24, P2837; Shigaki F, 2006, J ENVIRON QUAL, V35, P2229, DOI 10.2134/jeq2006.0112; Sui YB, 1999, SOIL SCI SOC AM J, V63, P1174, DOI 10.2136/sssaj1999.6351174x; Wang J, 2010, PEDOSPHERE, V20, P304, DOI 10.1016/S1002-0160(10)60018-5; [向万胜 Xiang Wansheng], 2004, [植物营养与肥料学报, Plant nutrition and fertitizer science], V10, P663; Yu S, 2006, SOIL BIOL BIOCHEM, V38, P619, DOI 10.1016/j.soilbio.2005.02.040; Yu SF, 2003, CHIN J SOIL SCI, V34, P422; 刘建玲, 1999, [植物营养与肥料学报, Plant Nutrition and Fertitizer Science], V5, P14	53	6	7	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179275	10.1371/journal.pone.0179275	http://dx.doi.org/10.1371/journal.pone.0179275			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650990	Green Submitted, Green Published, gold			2022-12-27	WOS:000404537300004
J	Logan, JM; Bean, SB; Myers, AE				Logan, John M.; Bean, Sarah B.; Myers, Andrew E.			Author contributions to ecological publications: What does it mean to be an author in modern ecological research?	PLOS ONE			English	Article							BIOMEDICAL JOURNALS; R-PACKAGE; GHOST; HONORARY; DISCLOSURE; CRITERIA; ORDER; FULFILLMENT; PREVALENCE; ARTICLES	Authorship is a central element of scientific research carrying a variety of rewards and responsibilities, and while various guidelines exist, actual author contributions are often ambiguous. Inconsistent or limited contributions threaten to devalue authorship as intellectual currency and diminish authors' responsibility for published content. Researchers have assessed author contributions in the medical literature and other research fields, but similar data for the field of ecological research are lacking. Authorship practices in ecological research are broadly representative of a variety of fields due to the cross-disciplinary nature of collaborations in ecological studies. To better understand author contributions to current research, we distributed a survey regarding co-author contributions to a random selection of 996 lead authors of manuscripts published in ecological journals in 2010. We obtained useable responses from 45% of surveyed authors. Reported lead author contributions in ecological research studies consistently included conception of the project idea, data collection, analysis, and writing. Middle and last author contributions instead showed a high level of individual variability. Lead authorship in ecology is well defined while secondary authorship is more ambiguous. Nearly half (48%) of all studies included in our survey had some level of non-compliance with Ecological Society of America (ESA) authorship guidelines and the majority of studies (78%) contained at least one co-author that did not meet International Committee of Medical Journal Editors (ICMJE) requirements. Incidence of non-compliance varied with lead author occupation and author position. The probability of a study including an author that was non-compliant with ESA guidelines was lowest for professor-led studies and highest for graduate student and post doctoral researcher-led studies. Among studies with > two co-authors, all lead authors met ESA guidelines and only 2% failed to meet ICMJE requirements. Middle (24% ESA, 63% ICMJE) and last (37% ESA, 60% ICMJE) authors had higher rates of non-compliance. The probability of a study containing a coauthor that did not meet ESA or ICMJE requirements increased significantly with the number of co-authors per study although even studies with only two co-authors had a high probability of non-compliance of approximately 60% (ICMJE) and 15 to 40% (ESA). Given the variable and often limited contributions of authors in our survey and past studies of other research disciplines, institutions, journals, and scientific societies need to implement new approaches to instill meaning in authorship status. A byline approach may not alter author contributions but would better define individual contributions and reduce existing ambiguity regarding the meaning of authorship in modern ecological research.	[Logan, John M.] Massachusetts Div Marine Fisheries, New Bedford, MA 02114 USA; [Bean, Sarah B.] Buttonwood Pk Zoo, New Bedford, MA USA; [Myers, Andrew E.] Derryfield Sch, Manchester, NH USA	Massachusetts Division of Marine Fisheries	Logan, JM (corresponding author), Massachusetts Div Marine Fisheries, New Bedford, MA 02114 USA.	john.logan@state.ma.us		Logan, John/0000-0002-0590-7678				Abambres Miguel, 2016, Science & Technology Libraries, V35, P263, DOI 10.1080/0194262X.2016.1242450; Albert T., 2003, HANDLE AUTHORSHIP DI, DOI DOI 10.24318/COPE.2018.1.1; American Physical Society, 2002, ETH VAL 02 2 GUID PR; Bates T, 2004, JAMA-J AM MED ASSOC, V292, P86, DOI 10.1001/jama.292.1.86; Bennett Dianne M, 2003, Emerg Med (Fremantle), V15, P263, DOI 10.1046/j.1442-2026.2003.00432.x; Benos DJ, 2005, ADV PHYSIOL EDUC, V29, P59, DOI 10.1152/advan.00056.2004; Bhopal R, 1997, BRIT MED J, V314, P1009, DOI 10.1136/bmj.314.7086.1009; BMC Ecology, 2017, ED POL; Bosnjak L, 2012, SCIENTOMETRICS, V93, P751, DOI 10.1007/s11192-012-0773-y; British Sociological Association, 2001, AUTH GUID; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Burrows S, 2011, FAC RES PUBL PRESENT; Clement TP, 2014, SCI ENG ETHICS, V20, P345, DOI 10.1007/s11948-013-9454-3; Cohen J.E., 1988, STAT POWER ANAL BEHA; Costas R, 2011, SCIENTOMETRICS, V88, P145, DOI 10.1007/s11192-011-0368-z; CULLITON BJ, 1988, SCIENCE, V242, P658, DOI 10.1126/science.3187511; da Silva JAT, 2016, SCI ENG ETHICS, V22, P1457, DOI 10.1007/s11948-015-9716-3; Dickson JG, 1978, WILDLIFE SOC B, V6, P260; Ecological Society of America, 2013, EC SOC AM ETH; Eisenberg RL, 2011, RADIOLOGY, V259, P479, DOI 10.1148/radiol.11101500; Elliott KC, 2017, ACCOUNT RES, V24, P80, DOI 10.1080/08989621.2016.1251320; Fisheries Management and Ecology, 2017, AUTH GUID; Flanagin A, 1998, JAMA-J AM MED ASSOC, V280, P222, DOI 10.1001/jama.280.3.222; Frandsen TF, 2010, J INFORMETR, V4, P608, DOI 10.1016/j.joi.2010.06.010; Frontiers in Ecology and Evolution, 2017, AUTH GUID; Gollogly L, 2006, REV SAUDE PUBL, V40, P24, DOI 10.1590/S0034-89102006000400004; GOODMAN NW, 1994, BRIT MED J, V309, P1482, DOI 10.1136/bmj.309.6967.1482; Gotzsche PC, 2009, PLOS MED, V6, P122, DOI 10.1371/journal.pmed.1000023; Haeussler C, 2013, RES POLICY, V42, P688, DOI 10.1016/j.respol.2012.09.009; Hoen WP, 1998, JAMA-J AM MED ASSOC, V280, P217, DOI 10.1001/jama.280.3.217; Hothorn T, 2008, J STAT SOFTW, V28, P1; Hsieh TC, 2016, METHODS ECOL EVOL, V7, P1451, DOI 10.1111/2041-210X.12613; Hundley V., 2013, HLTH RENAISSANCE, V11, P98, DOI DOI 10.3126/HREN.V11I2.8214; HUTH EJ, 1986, ANN INTERN MED, V104, P257, DOI 10.7326/0003-4819-104-2-257; Hwang SS, 2003, RADIOLOGY, V226, P16, DOI 10.1148/radiol.2261011255; Ilakovac V, 2007, CAN MED ASSOC J, V176, P41; International Committee of Medical Journal Editors, 2017, J FOLLOWING ICMJE RE; International Committee of Medical Journal Editors, 2006, UN REQ BIOM J UNPUB; Ivanis A, 2011, PLOS ONE, V6; Ivanis A, 2008, J GEN INTERN MED, V23, P1303, DOI 10.1007/s11606-008-0599-8; Ivanis A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020206; Kates RW, 2001, SCIENCE, V292, P641, DOI 10.1126/science.1059386; Kornhaber RA, 2015, INT J NANOMED, V10, DOI 10.2147/IJN.S87585; Kostoff RN, 2002, BIOSCIENCE, V52, P937, DOI 10.1641/0006-3568(2002)052[0937:OS]2.0.CO;2; Kwok LS, 2005, J MED ETHICS, V31, P554, DOI 10.1136/jme.2004.010553; Latour B., 1986, LAB LIFE CONSTRUCTIO; Logan JM, 2016, FRONT ECOL ENVIRON, V14, P297, DOI 10.1002/fee.1301; Marusic A, 2006, CURR MED RES OPIN, V22, P1035, DOI 10.1185/030079906X104885; Mirzazadeh A, 2011, IRAN J PUBLIC HEALTH, V40, P15; Monteiro R, 2004, REV BRASILEIRA CIRUR, V19, P3; Mulligan A, 2014, CHALLENGES DEFINING; Nakazawa M., 2015, FMSB FUNCTIONS MED S; National Institutes of Health Office of the Director, 2016, GUID POL COND RES IN; Oberlander SE, 2006, ETHICS BEHAV, V16, P217, DOI 10.1207/s15327019eb1603_3; ODUM EP, 1977, SCIENCE, V195, P1289, DOI 10.1126/science.195.4284.1289; Osborne J. W, 2009, PRACTICAL ASSESSMENT, V14, P1, DOI DOI 10.7275/25PE-BA85; Pennington DD, 2008, ECOL SOC, V13; R Core Team, 2021, R LANGUAGE ENV STAT; Rennie D, 1997, JAMA-J AM MED ASSOC, V278, P579, DOI 10.1001/jama.278.7.579; Resnik D, 1997, SCI ENG ETHICS, V3, P237, DOI DOI 10.1007/S11948-997-0023-5; Resnik DB, 2016, J MED ETHICS, V42, P199, DOI 10.1136/medethics-2015-103171; Seymour SB, 2006, RICHMOND J LAW TECHN, V12, P1; SHAPIRO DW, 1994, JAMA-J AM MED ASSOC, V271, P438, DOI 10.1001/jama.271.6.438; Sheikh A, 2000, J MED ETHICS, V26, P422, DOI 10.1136/jme.26.6.422; Slone RM, 1996, AM J ROENTGENOL, V167, P571, DOI 10.2214/ajr.167.3.8751654; Smart P, 2013, SCI EDITORS HDB; Smith R, 1997, BRIT MED J, V314, P992, DOI 10.1136/bmj.314.7086.992; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tice PP, 2005, AM MED WRITERS ASS J, V20, P7; Tress G, 2005, LANDSCAPE ECOL, V20, P479, DOI 10.1007/s10980-004-3290-4; Tscharntke T, 2007, PLOS BIOL, V5, P13, DOI 10.1371/journal.pbio.0050018; Venables WN., 2002, MODERN APPL STAT S, V4; Vinther S, 2012, DAN MED J, V59; Wager E, 2007, PLOS MED, V4, P5, DOI 10.1371/journal.pmed.0040034; Wager E, 2006, J ROY SOC MED, V99, P542, DOI 10.1258/jrsm.99.11.542; Wager E, 2009, MATURITAS, V62, P109, DOI 10.1016/j.maturitas.2008.12.001; Weltzin JF, 2006, FRONT ECOL ENVIRON, V4, P435, DOI 10.1890/1540-9295(2006)4[435:AIEAAA]2.0.CO;2; Wislar JS, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6128	79	20	20	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179956	10.1371/journal.pone.0179956	http://dx.doi.org/10.1371/journal.pone.0179956			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ2KD	28650967	Green Submitted, Green Published, gold			2022-12-27	WOS:000404537300032
J	Ward, NP; Poff, AM; Koutnik, AP; D'Agostino, DP				Ward, Nathan P.; Poff, Angela M.; Koutnik, Andrew P.; D'Agostino, Dominic P.			Complex I inhibition augments dichloroacetate cytotoxicity through enhancing oxidative stress in VM-M3 glioblastoma cells	PLOS ONE			English	Article							PYRUVATE-DEHYDROGENASE KINASE; MULTIPLE-MYELOMA CELLS; GLUCOSE-METABOLISM; STEM-CELLS; METFORMIN; CANCER; RESISTANCE; MECHANISMS; APOPTOSIS; SURVIVAL	The robust glycolytic metabolism of glioblastoma multiforme (GBM) has proven them susceptible to increases in oxidative metabolism induced by the pyruvate mimetic dichloroacetate (DCA). Recent reports demonstrate that the anti- diabetic drug metformin enhances the damaging oxidative stress associated with DCA treatment in cancer cells. We sought to elucidate the role of metformin's reported activity as a mitochondrial complex I inhibitor in the enhancement of DCA cytotoxicity in VM-M3 GBM cells. Metformin potentiated DCA- induced superoxide production, which was required for enhanced cytotoxicity towards VM- M3 cells observed with the combination. Similarly, rotenone enhanced oxidative stress resultant from DCA treatment and this too was required for the noted augmentation of cytotoxicity. Adenosine monophosphate kinase (AMPK) activation was not observed with the concentration of metformin required to enhance DCA activity. Moreover, addition of an activator of AMPK did not enhance DCA cytotoxicity, whereas an inhibitor of AMPK heightened the cytotoxicity of the combination. Our data indicate that metformin enhancement of DCA cytotoxicity is dependent on complex I inhibition. Particularly, that complex I inhibition cooperates with DCA- induction of glucose oxidation to enhance cytotoxic oxidative stress in VM-M3 GBM cells.	[Ward, Nathan P.; Poff, Angela M.; Koutnik, Andrew P.; D'Agostino, Dominic P.] Univ S Florida, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	D'Agostino, DP (corresponding author), Univ S Florida, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA.	ddagosti@health.usf.edu	D'Agostino, Dominic/GPJ-9744-2022; Koutnik, Andrew/U-5194-2017	Koutnik, Andrew/0000-0002-5491-3919; Ward, Nathan/0000-0003-4920-0081; Ward, Nathan/0000-0001-7714-2494	Scivation, Inc.	Scivation, Inc.	This study was funded through a charitable donation from Scivation, Inc. to DPD; however, they had no role in the design of the study, collection, analysis and interpretation of the data, or writing of this manuscript	Adamson C, 2009, EXPERT OPIN INV DRUG, V18, P1061, DOI 10.1517/13543780903052764; Bell EL, 2007, MOL CELL BIOL, V27, P5737, DOI 10.1128/MCB.02265-06; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Choi YW, 2014, CANCER LETT, V346, P300, DOI 10.1016/j.canlet.2014.01.015; Chu QSC, 2015, INVEST NEW DRUG, V33, P603, DOI 10.1007/s10637-015-0221-y; Clark PM, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-015-0613-6; Corominas-Faja B, 2012, AGING-US, V4, P480, DOI 10.18632/aging.100472; Dai YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092962; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dunbar EM, 2014, INVEST NEW DRUG, V32, P452, DOI 10.1007/s10637-013-0047-4; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; GRIFFITH OW, 1982, J BIOL CHEM, V257, P13704; Gritti M, 2014, ONCOTARGET, V5, P11252, DOI 10.18632/oncotarget.2617; HALESTRAP AP, 1975, BIOCHEM J, V148, P85, DOI 10.1042/bj1480085; Haugrud AB, 2014, BREAST CANCER RES TR, V147, P539, DOI 10.1007/s10549-014-3128-y; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; Huysentruyt LC, 2008, INT J CANCER, V123, P73, DOI 10.1002/ijc.23492; Jiang W, 2016, ONCOTARGET; Ko EM, 2014, GYNECOL ONCOL, V132, P438, DOI 10.1016/j.ygyno.2013.11.021; Kumar A, 2013, TOXICOL APPL PHARM, V273, P196, DOI 10.1016/j.taap.2013.09.005; Kumar K, 2013, J MOL MED, V91, P749, DOI 10.1007/s00109-013-0996-2; Laskov I, 2014, GYNECOL ONCOL, V134, P607, DOI 10.1016/j.ygyno.2014.06.014; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Martinez-Reyes I, 2016, MOL CELL, V61, P199, DOI 10.1016/j.molcel.2015.12.002; Michelakis ED, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000677; Nair V, 2014, J BIOL CHEM, V289, P27692, DOI 10.1074/jbc.M114.592576; Nevadunsky NS, 2014, GYNECOL ONCOL, V132, P236, DOI 10.1016/j.ygyno.2013.10.026; Orrenius S, 2007, DRUG METAB REV, V39, P443, DOI 10.1080/03602530701468516; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pathak RK, 2014, ACS CHEM BIOL, V9, P1178, DOI 10.1021/cb400944y; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Pernicova I, 2014, NAT REV ENDOCRINOL, V10, P143, DOI 10.1038/nrendo.2013.256; Pfister AS, 2015, J BIOL CHEM, V290, P10905, DOI 10.1074/jbc.M114.634246; Poff AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127407; Poff AM, 2014, INT J CANCER, V135, P1711, DOI 10.1002/ijc.28809; Poff AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065522; Ramanathan B, 2005, CANCER RES, V65, P8455, DOI 10.1158/0008-5472.CAN-05-1162; Roh JL, 2016, CANCER LETT, V371, P20, DOI 10.1016/j.canlet.2015.11.023; Sanchez WY, 2013, BRIT J CANCER, V108, P1624, DOI 10.1038/bjc.2013.120; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Schockel L, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0138-0; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shen H, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0130-0; Shen YC, 2013, BRIT J CANCER, V108, P72, DOI 10.1038/bjc.2012.559; STACPOOLE PW, 1989, METABOLISM, V38, P1124, DOI 10.1016/0026-0495(89)90051-6; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Sun RC, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-142; Sun RC, 2010, BREAST CANCER RES TR, V120, P253, DOI 10.1007/s10549-009-0435-9; Sutendra G, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00038; Ta NL, 2015, LIPIDS, V50, P1167, DOI 10.1007/s11745-015-4075-z; Tebbe C, 2014, ONCOTARGET, V5, P4746, DOI 10.18632/oncotarget.2012; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; Wong JYY, 2008, GYNECOL ONCOL, V109, P394, DOI 10.1016/j.ygyno.2008.01.038; Xuan Y, 2014, EXP CELL RES, V321, P219, DOI 10.1016/j.yexcr.2013.12.009; Yu ZY, 2016, ONCOL LETT, V11, P2792, DOI 10.3892/ol.2016.4315; Yu ZY, 2015, ONCOTARGET, V6, P32930, DOI 10.18632/oncotarget.5405; Zhao Z, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/140913; Zhong F, 2015, ONCOL LETT, V10, P1416, DOI 10.3892/ol.2015.3391; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhou P, 2005, BRIT J HAEMATOL, V128, P636, DOI 10.1111/j.1365-2141.2005.05369.x; Zhuang YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108444	67	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0180061	10.1371/journal.pone.0180061	http://dx.doi.org/10.1371/journal.pone.0180061			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644886	gold, Green Published, Green Submitted			2022-12-27	WOS:000404145100060
J	D'Amico, M; Kinel, E; Roncoletta, P				D'Amico, Moreno; Kinel, Edyta; Roncoletta, Piero			Normative 3D opto-electronic stereophotogrammetric posture and spine morphology data in young healthy adult population	PLOS ONE			English	Article							LOW-BACK-PAIN; LEG LENGTH DISCREPANCY; STANDING LATERAL RADIOGRAPHS; BIOMECHANICAL SKELETON MODEL; SAGITTAL PLANE; RECIPROCAL ANGULATION; IDIOPATHIC SCOLIOSIS; THORACIC KYPHOSIS; MOVEMENT ANALYSIS; VERTEBRAL BODIES	Design: Observational cross-sectional study. The current study aims to yield normative data: i.e., the physiological standard for 30 selected quantitative 3D parameters that accurately capture and describe a full-skeleton, upright-standing attitude. Specific and exclusive consideration was given to three distinct categories: postural, spine morphology and pelvic parameters. To capture such 3D parameters, the authors selected a non-ionising 3D optoelectronic stereo-photogrammetric approach. This required the identification and measurement of 27 body landmarks, each specifically tagged with a skin marker. As subjects for the measurement of these parameters, a cohort of 124 asymptomatic young adult volunteers was recruited. All parameters were identified and measured within this group. Postural and spine morphology data have been compared between genders. In this regard, only five statistically significant differences were found: pelvis width, pelvis torsion, the "lumbar" lordosis angle value, the lumbar curve length, and the T12-L5 anatomically-bound lumbar angle value. The "thoracic" kyphosis mean angle value was the same in both sexes and, even if, derived from skin markers placed on spinous processes it resulted in perfect agreement with the X-ray based literature. As regards lordosis, a direct comparison was more difficult because methods proposed in the literature differ as to the number and position of vertebrae under consideration, and their related angle values. However, when the L1 superior-L5 inferior end plate Cobb angle was considered, these results aligned strongly with the existing literature. Asymmetry was a standard postural-spinal feature for both sexes. Each subject presented some degree of leg length discrepancy (LLD) with mu = 9.37mm. This was associated with four factors: unbalanced posture and/or underfoot loads, spinal curvature in the frontal plane, and pelvis torsion. This led to the additional study of the effect of LLD equalisation influence on upright posture, relying on a sub-sample of 100 subjects (51 males, 49 females). As a result of the equalisation, about 82% of this sub-sample showed improvement in standing posture, mainly in the frontal plane; while in the sagittal plane less than 1/3 of the sub-sample showed evidence of change in spinal angles. A significant variation was found in relation to pelvis torsion: 46% of subjects showed improvement, 49% worsening. The method described in study presents several advantages: non-invasive aspect; relatively short time for a complete postural evaluation with many clinically useful 3D and 2D anatomical/biomechanical/ clinical parameters; analysis of real neutral unconstrained upright standing posture.	[D'Amico, Moreno; Roncoletta, Piero] SMART Lab Skeleton Movement Anal & Adv Rehabil Te, Pescara, Italy; [Kinel, Edyta] Univ Med Sci, Dept Rheumatol & Rehabil, Clin Rehabil, Poznan, Poland		D'Amico, M (corresponding author), SMART Lab Skeleton Movement Anal & Adv Rehabil Te, Pescara, Italy.	damicomoreno@gmail.com	Kinel, Edyta/AAX-9964-2020; Kinel, Edyta/F-5251-2012	Kinel, Edyta/0000-0001-9106-8016; 	Bioengineering & Biomedicine Company Srl	Bioengineering & Biomedicine Company Srl	The Bioengineering & Biomedicine Company Srl provided access to its Posture and Movement Biomechanical laboratory for free, letting the authors to freely use without any limitations this facility to carry out the measurements for the study. Bioengineering & Biomedicine Company Srl also provided funding for the publication fee. The Bioengineering & Biomedicine Company Srl did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Biomedicine Company Srl did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aziz YI, 1971, P S CLOS RANG PHOT G; Amabile C, 2016, EUR SPINE J, P1; [Anonymous], 2008, NEUR DIS PUBL HLTH C, V65, P154, DOI 10.1001/archneurol.2007.19; Beaudoin L, 1999, EUR SPINE J, V8, P40, DOI 10.1007/s005860050125; Been E, 2014, SPINE J, V14, P87, DOI 10.1016/j.spinee.2013.07.464; Blondel B, 2012, ORTHOP TRAUMATOL-SUR, V98, P109, DOI 10.1016/j.otsr.2011.12.001; Borghese NA, 2001, MED BIOL ENG COMPUT, V39, P76, DOI 10.1007/BF02345269; Campos MH, 2015, J BIOMECH, V48, P969, DOI 10.1016/j.jbiomech.2015.02.011; Cerveri P, 1998, J BIOMECH, V31, P935, DOI 10.1016/S0021-9290(98)00104-3; Cheng XG, 1998, SKELETAL RADIOL, V27, P380, DOI 10.1007/s002560050402; Chiari L, 2005, GAIT POSTURE, V21, P197, DOI 10.1016/j.gaitpost.2004.04.004; Chong AK, 2009, PHOTOGRAMM REC, V24, P264, DOI 10.1111/j.1477-9730.2009.00540.x; CLEVELAND RH, 1988, INVEST RADIOL, V23, P301, DOI 10.1097/00004424-198804000-00010; D'Amico M, 2002, STUD HEALTH TECHNOL, V88, P285; D'Amico M, 2002, ST HEAL T, V88, P365; D'Amico M, 2008, STUD HEALTH TECHNOL, V140, P79, DOI 10.3233/978-1-58603-888-5-79; D'Amico M., 1997, KINESIOLOGY, V29, P5; D'Amico M., 2001, P 18 ISB INT SOC BIO; D'Amico M., 2007, EUR MED PHYS, V43, P1; D'Amico M., 1996, INT C SIRER SCOL STA, P279; D'Amico M, 2011, GAIT POSTURE, V33, pS37; D'Amico M, 2011, 2011 IEEE INT WORKSH, P605, DOI [DOI 10.1109/MEMEA.2011.5966711, 10.1109/MeMeA.2011.5966711]; D'Amico M, 2006, ST HEAL T, V123, P409; D'Amico M, 2006, STUD HEALTH TECHNOL, V123, P188; D'Amico Moreno, 2002, Stud Health Technol Inform, V91, P149; D'Amico M, 2012, STUD HEALTH TECHNOL, V176, P108, DOI 10.3233/978-1-61499-067-3-108; D'Amico M, 2012, STUD HEALTH TECHNOL, V176, P146, DOI 10.3233/978-1-61499-067-3-146; D'Amico M, 2010, STUD HEALTH TECHNOL, V158, P118, DOI 10.3233/978-1-60750-573-0-118; Damasceno Luiz Henrique Fonseca, 2006, Acta ortop. bras., V14, P193, DOI 10.1590/S1413-78522006000400003; DAMICO M, 1992, MED BIOL ENG COMPUT, V30, P193, DOI 10.1007/BF02446130; DAMICO M, 1990, MED BIOL ENG COMPUT, V28, P407, DOI 10.1007/BF02441963; DAmico M, 1997, ST HEAL T, V37, P161; DAmico M, 1997, ST HEAL T, V37, P155; DAmico M, 1997, ST HEAL T, V37, P151; DAmico M, 1997, ST HEAL T, V37, P143; DAMICO M, 1995, ST HEAL T, V15, P33; DAPENA J, 1982, J BIOMECH, V15, P11, DOI 10.1016/0021-9290(82)90030-6; De Boor C., 2001, PRACTICAL GUIDE SPLI; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; de Leva P, 1996, J BIOMECH, V29, P1231, DOI 10.1016/0021-9290(96)00021-8; de Oliveira TS, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/186156; Don R, 2012, EUR J PHYS REHAB MED, V48, P255; Engsberg JR, 2008, J APPL BIOMECH, V24, P94, DOI 10.1123/jab.24.1.94; Faugeras O, 1993, 3 DIMENSIONAL COMPUT; Ferreira EA, 2011, J MANIP PHYSIOL THER, V34, P371, DOI 10.1016/j.jmpt.2011.05.018; Ferreira EAG, 2010, CLINICS, V65, P675, DOI 10.1590/S1807-59322010000700005; Ferrigno G, 1992, FREQUENCY DOMAIN IMP, P1093; FON GT, 1980, AM J ROENTGENOL, V134, P979, DOI 10.2214/ajr.134.5.979; Fortin C, 2012, PHYSIOTHERAPY, V98, P64, DOI 10.1016/j.physio.2010.12.006; Furlanetto TS, 2016, WORLD J ORTHOP, V7, P136, DOI 10.5312/wjo.v7.i2.136; Furlanetto TS, 2012, COMPUT METH PROG BIO, V108, P203, DOI 10.1016/j.cmpb.2012.03.012; GELB DE, 1995, SPINE, V20, P1351, DOI 10.1097/00007632-199506000-00005; GRACOVETSKY S, 1995, SPINE, V20, P1036, DOI 10.1097/00007632-199505000-00010; Gracovetsky SA, 1998, SPINE, V23, P568, DOI 10.1097/00007632-199803010-00009; GREIGELMORRIS P, 1992, PHYS THER, V72, P425; GROSS RH, 1983, AM J SPORT MED, V11, P121, DOI 10.1177/036354658301100303; Guigui P, 2003, REV CHIR ORTHOP, V89, P496; Hay O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133685; Jackson RP, 2000, SPINE, V25, P2808, DOI 10.1097/00007632-200011010-00014; Jackson RP, 1998, SPINE, V23, P1750, DOI 10.1097/00007632-199808150-00008; JACKSON RP, 1994, SPINE, V19, P1611, DOI 10.1097/00007632-199407001-00010; Janssen MMA, 2009, SPINE, V34, pE826, DOI 10.1097/BRS.0b013e3181a9fd85; Kandel Eric R, 2012, PRINCIPLES NEURAL SC; Knutson Gary A, 2005, Chiropr Osteopat, V13, P11, DOI 10.1186/1746-1340-13-11; Korovessis PG, 1998, SPINE, V23, P700, DOI 10.1097/00007632-199803150-00010; Kotwicki T, 2007, SCOLIOSIS SPINAL DIS, V2, DOI 10.1186/1748-7161-2-18; Krawczky B, 2014, J MANIP PHYSIOL THER, V37, P269, DOI 10.1016/j.jmpt.2014.01.002; Leroux MA, 2000, SPINE, V25, P1689, DOI 10.1097/00007632-200007010-00012; Liu YK, 1973, PERSPECTIVES BIOMEDI, P203; Manchikanti L, PAIN PHYS, V12, pE35; Marks M, 2009, SPINE, V34, P949, DOI 10.1097/BRS.0b013e318199650a; Mincer AE, 1997, J PHYS THER SCI, P1; NEGRINI A, 1995, ST HEAL T, V15, P101; Negrini A, 2001, EUR MEDICOPHYS, V37, P135; Negrini S, 2012, SCOLIOSIS SPINAL DIS, V7, DOI 10.1186/1748-7161-7-3; Norton BJ, 2004, J ORTHOP SPORT PHYS, V34, P524, DOI 10.2519/jospt.2004.34.9.524; Ranavolo A, 2013, APPL ERGON, V44, P192, DOI 10.1016/j.apergo.2012.07.004; Roussouly P, 2005, SPINE, V30, P346, DOI 10.1097/01.brs.0000152379.54463.65; Roussouly P, 2010, EUR SPINE J, V19, P1824, DOI 10.1007/s00586-010-1476-9; Saad KR, 2012, J BODYW MOV THER, V16, P210, DOI 10.1016/j.jbmt.2011.03.005; Schmid S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135689; SEIDEL GK, 1995, J BIOMECH, V28, P995, DOI 10.1016/0021-9290(94)00149-X; Silvatti AP, 2012, J BIOMECH, V45, P1112, DOI 10.1016/j.jbiomech.2012.01.004; Sokal R.R., 1994, BIOMETRY PRINCIPLES; Soukka A, 1976, ASS MILD INEQUALITY; STAGNARA P, 1982, SPINE, V7, P335, DOI 10.1097/00007632-198207000-00003; STOKES IAF, 1994, SPINE, V19, P236, DOI 10.1097/00007632-199401001-00020; Takacs M, 2015, ANN BIOMED ENG, V43, P348, DOI 10.1007/s10439-014-1160-z; Tsuji T, 2001, J Orthop Sci, V6, P307, DOI 10.1007/s007760100023; Tuzun C, 1999, CLIN RHEUMATOL, V18, P308, DOI 10.1007/s100670050107; van der Jagt-Willems HC, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0018-z; Vialle R, 2005, J BONE JOINT SURG AM, V87A, P260, DOI 10.2106/JBJS.D.02043; VOUTSINAS SA, 1986, CLIN ORTHOP RELAT R, P235; Vygodsky M, 1987, MATH HDB HIGHER MATH; White A.A., 1990, CLIN BIOMECH; World Health Organization, GLOB DAT BOD MASS IN; Zagyapan R, 2012, ANAT RES INT ANAT RE, V2012; Zaiontz C, 2016, REAL STAT USING EXCE; Zatsiorsky V, 1990, VIVO BODY SEGMENT IN, P186; Zemp R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095426; Zhao GR, 2008, J BIONIC ENG, V5, P328, DOI 10.1016/S1672-6529(08)60177-8	101	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179619	10.1371/journal.pone.0179619	http://dx.doi.org/10.1371/journal.pone.0179619			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640899	Green Published, gold, Green Submitted			2022-12-27	WOS:000404135800045
J	Kamimura, E; Tanaka, S; Takaba, M; Tachi, K; Baba, K				Kamimura, Emi; Tanaka, Shinpei; Takaba, Masayuki; Tachi, Keita; Baba, Kazuyoshi			In vivo evaluation of inter-operator reproducibility of digital dental and conventional impression techniques	PLOS ONE			English	Article							ALL-CERAMIC CROWNS; IMPLANT IMPRESSIONS; 3D SURFACE; ACCURACY; CAD/CAM; SCANNERS; MODELS; FIT; RELIABILITY; PRECISION	Purpose The aim of this study was to evaluate and compare the inter-operator reproducibility of three-dimensional (3D) images of teeth captured by a digital impression technique to a conventional impression technique in vivo. Materials and methods Twelve participants with complete natural dentition were included in this study. A digital impression of the mandibular molars of these participants was made by two operators with different levels of clinical experience, 3 or 16 years, using an intra-oral scanner (Lava COS, 3M ESPE). A silicone impression also was made by the same operators using the double mix impression technique (Imprint3, 3M ESPE). Stereolithography (STL) data were directly exported from the Lava COS system, while STL data of a plaster model made from silicone impression were captured by a three-dimensional (3D) laboratory scanner (D810, 3shape). The STL datasets recorded by two different operators were compared using 3D evaluation software and superimposed using the best-fit-algorithm method (least-squares method, PolyWorks, InnovMetric Software) for each impression technique. Inter-operator reproducibility as evaluated by average discrepancies of corresponding 3D data was compared between the two techniques (Wilcoxon signed-rank test). Results The visual inspection of superimposed datasets revealed that discrepancies between repeated digital impression were smaller than observed with silicone impression. Confirmation was forthcoming from statistical analysis revealing significantly smaller average inter-operator reproducibility using a digital impression technique (0.014 +/- 0.02 mm) than when using a conventional impression technique (0.023 +/- 0.01 mm). Conclusion The results of this in vivo study suggest that inter-operator reproducibility with a digital impression technique may be better than that of a conventional impression technique and is independent of the clinical experience of the operator.	[Kamimura, Emi; Tanaka, Shinpei; Takaba, Masayuki; Tachi, Keita; Baba, Kazuyoshi] Showa Univ, Sch Dent, Dept Prosthodont, Tokyo, Japan	Showa University	Baba, K (corresponding author), Showa Univ, Sch Dent, Dept Prosthodont, Tokyo, Japan.	kazuyoshi@dent.showa-u.ac.jp	Baba, Kazuyoshi/AAY-2304-2021	Baba, Kazuyoshi/0000-0001-8025-2168	Japan Society for the Promotion of Science [26462939]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Japan Society for the Promotion of Science Award Number: 26462939 vertical bar Recipient: Shinpei Tanaka.	Abdel-Azim T, 2015, J PROSTHET DENT, V114, P554, DOI 10.1016/j.prosdent.2015.04.001; Ahrberg D, 2016, CLIN ORAL INVEST, V20, P291, DOI 10.1007/s00784-015-1504-6; Arslan Y, 2015, J ADV PROSTHODONT, V7, P431, DOI 10.4047/jap.2015.7.6.431; Asquith JA, 2012, CLEFT PALATE-CRAN J, V49, P530, DOI 10.1597/10-099; Baba K, 2014, J PROSTHODONT RES, V58, P1, DOI 10.1016/j.jpor.2013.12.003; Barreto MS, 2016, ANGLE ORTHOD, V86, P255, DOI 10.2319/120914-890.1; Berrendero S, 2016, CLIN ORAL INVESTIG; Boeddinghaus M, 2015, CLIN ORAL INVEST, V19, P2027, DOI 10.1007/s00784-015-1430-7; Brawek PK, 2013, CLIN ORAL INVEST, V17, P2119, DOI 10.1007/s00784-013-0923-5; Cho SH, 2015, J PROSTHET DENT, V113, P310, DOI 10.1016/j.prosdent.2014.09.027; Ender A, 2011, Int J Comput Dent, V14, P11; Ender A, 2015, CLIN ORAL INVESTIG; Ender A, 2016, J PROSTHET DENT, V115, P313, DOI 10.1016/j.prosdent.2015.09.011; Ender A, 2013, J PROSTHET DENT, V109, P121, DOI 10.1016/S0022-3913(13)60028-1; Gruen A, 2005, ISPRS J PHOTOGRAMM, V59, P151, DOI 10.1016/j.isprsjprs.2005.02.006; Guth JF, 2013, CLIN ORAL INVEST, V17, P1201, DOI 10.1007/s00784-012-0795-0; Hayashi K, 2013, AM J ORTHOD DENTOFAC, V144, P619, DOI 10.1016/j.ajodo.2013.04.021; Karl M, 2012, QUINTESSENCE INT, V43, P555; Kim SY, 2013, INT J PROSTHODONT, V26, P161, DOI 10.11607/ijp.3014; Kollmuss M, 2016, CLIN ORAL INVEST, V20, P791, DOI 10.1007/s00784-015-1554-9; Kwon SW, 2004, AUTOMAT CONSTR, V13, P67, DOI 10.1016/j.autcon.2003.08.007; KWON SW, 2003, 20 INT S; Lee SJ, 2015, CLIN ORAL IMPLAN RES, V26, P715, DOI 10.1111/clr.12375; Lee WS, 2016, J PROSTHODONT RES, V60, P98, DOI 10.1016/j.jpor.2015.10.002; Logozzo S., 2011, INTERNET J MED TECHN, V5, P1, DOI [10.5580/1b90, DOI 10.5580/1B90]; Patzelt SBM, 2014, CLIN ORAL INVEST, V18, P1687, DOI 10.1007/s00784-013-1132-y; Rhee YK, 2015, J ADV PROSTHODONT, V7, P460, DOI 10.4047/jap.2015.7.6.460; Schaefer O, 2014, J DENT, V42, P677, DOI 10.1016/j.jdent.2014.01.016; SCOTTI R., 2011, J DENT; Seelbach P, 2013, CLIN ORAL INVEST, V17, P1759, DOI 10.1007/s00784-012-0864-4; Shah S, 2004, J DENT, V32, P653, DOI 10.1016/j.jdent.2004.07.005; Sousa MVS, 2012, AM J ORTHOD DENTOFAC, V142, P269, DOI 10.1016/j.ajodo.2011.12.028; Su TS, 2015, J PROSTHODONT, V24, P313, DOI 10.1111/jopr.12218; Su TS, 2016, J PROSTHET DENT; Syrek A, 2010, J DENT, V38, P553, DOI 10.1016/j.jdent.2010.03.015; Valero E, 2012, SENSORS-BASEL, V12, P5705, DOI 10.3390/s120505705; van der Meer WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043312; Wismeijer D, 2014, CLIN ORAL IMPLAN RES, V25, P1113, DOI 10.1111/clr.12234; Yang X, 2015, MATERIALS, V8, P3945, DOI 10.3390/ma8073945; Yong-KwonCho, 2003, KSCE Journal of Civil Engineering, V7, P225; Yuzbasioglu E, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-10	41	21	21	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179188	10.1371/journal.pone.0179188	http://dx.doi.org/10.1371/journal.pone.0179188			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636642	Green Submitted, Green Published, gold			2022-12-27	WOS:000404118300030
J	Fontanarosa, C; Pane, F; Sepe, N; Pinto, G; Trifuoggi, M; Squillace, M; Errico, F; Usiello, A; Pucci, P; Amoresano, A				Fontanarosa, Carolina; Pane, Francesca; Sepe, Nunzio; Pinto, Gabriella; Trifuoggi, Marco; Squillace, Marta; Errico, Francesco; Usiello, Alessandro; Pucci, Piero; Amoresano, Angela			Quantitative determination of free D-Asp, L-Asp and N-methyl-D-aspartate in mouse brain tissues by chiral separation and Multiple Reaction Monitoring tandem mass spectrometry	PLOS ONE			English	Article							D-AMINO ACIDS; LIQUID-CHROMATOGRAPHY; CAPILLARY-ELECTROPHORESIS; SYNAPTIC PLASTICITY; D-ALANINE; D-SERINE; MAMMALS; OXIDASE; PLASMA; MICE	Several studies have suggested that free D-Asp has a crucial role in N-methyl D-Asp receptor-mediated neurotransmission playing very important functions in physiological and pathological processes. This paper describes the development of an analytical procedure for the direct and simultaneous determination of free D-Asp, L-Asp and N-methyl D-Asp in specimens of different mouse brain tissues using chiral LC-MS/MS in Multiple Reaction Monitoring scan mode. After comparing three procedures and different buffers and extraction solvents, a simple preparation procedure was selected the analytes of extraction. The method was validated by analyzing L-Asp, D-Asp and N-methyl D-Asp recovery at different spiked concentrations (50, 100 and 200 pg/mu l) yielding satisfactory recoveries (75-110%), and good repeatability. Limits of detection (LOD) resulted to be 0.52 pg/mu l for D-Asp, 0.46 pg/mu l for L-Asp and 0.54 pg/mu l for NMDA, respectively. Limits of quantification (LOQ) were 1.57 pg/mu l for D-Asp, 1.41 pg/mu l for L-Asp and 1.64 pg/mu l for NMDA, respectively. Different concentration levels were used for constructing the calibration curves which showed good linearity. The validated method was then successfully applied to the simultaneous detection of D-Asp, L-Asp and NMDA in mouse brain tissues. The concurrent, sensitive, fast, and reproducible measurement of these metabolites in brain tissues will be useful to correlate the amount of free D-Asp with relevant neurological processes, making the LC-MS/MS MRM method well suited, not only for research work but also for clinical analyses.	[Fontanarosa, Carolina; Pane, Francesca; Sepe, Nunzio; Pinto, Gabriella; Trifuoggi, Marco; Pucci, Piero; Amoresano, Angela] Univ Naples Federico II, Dept Chem Sci, Naples, Italy; [Fontanarosa, Carolina; Pane, Francesca; Amoresano, Angela] Ist Nazl Biostrutture & Biosistemi, Rome, Italy; [Squillace, Marta; Errico, Francesco; Usiello, Alessandro; Pucci, Piero] Univ Naples Federico II, CEINGE Adv Biotechnol, Naples, Italy; [Errico, Francesco] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy	University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Naples Federico II; University of Naples Federico II	Amoresano, A (corresponding author), Univ Naples Federico II, Dept Chem Sci, Naples, Italy.; Amoresano, A (corresponding author), Ist Nazl Biostrutture & Biosistemi, Rome, Italy.	angamor@unina.it		Pinto, Gabriella/0000-0001-9169-3452; PUCCI, Pietro/0000-0002-5885-1495	Italian Ministry of Health [GR-2009-1605759]	Italian Ministry of Health(Ministry of Health, Italy)	The research was supported in part by a grant from the Italian Ministry of Health (Call Giovani Ricercatori 2009, project:GR-2009-1605759,http://www.Salute.gov.it). There was additional external funding received for this study.	Adams CM, 2005, ANAL CHEM, V77, P4571, DOI 10.1021/ac0503963; ARMSTRONG D W, 1991, Amino Acids (Vienna), V1, P97, DOI 10.1007/BF00808096; ARMSTRONG DW, 1993, AMINO ACIDS, V5, P299, DOI 10.1007/BF00805992; ARMSTRONG DW, 1993, J PHARMACEUT BIOMED, V11, P881, DOI 10.1016/0731-7085(93)80044-2; ARMSTRONG DW, 1995, CHIRALITY, V7, P474, DOI 10.1002/chir.530070614; Bai Lu, 2009, Bioanal Rev, V1, P7; Billard JM, 2012, AMINO ACIDS, V43, P1851, DOI 10.1007/s00726-012-1346-3; BROCCARDO M, 1981, BRIT J PHARMACOL, V73, P625, DOI 10.1111/j.1476-5381.1981.tb16797.x; Cava F, 2011, CELL MOL LIFE SCI, V68, P817, DOI 10.1007/s00018-010-0571-8; D'Aniello A, 2000, FASEB J, V14, P699, DOI 10.1096/fasebj.14.5.699; D'Aniello A, 2007, BRAIN RES REV, V53, P215, DOI 10.1016/j.brainresrev.2006.08.005; D'Aniello S, 2011, FASEB J, V25, P1014, DOI 10.1096/fj.10-168492; Desai MJ, 2004, J MASS SPECTROM, V39, P177, DOI 10.1002/jms.571; Nguyen DT, 2012, BIOMED CHROMATOGR, V26, P1353, DOI 10.1002/bmc.2703; Errico F, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.2; Errico F, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.59; Errico F, 2006, GENE, V374, P50, DOI 10.1016/j.gene.2006.01.010; Errico F, 2013, J PSYCHIATR RES, V47, P1432, DOI 10.1016/j.jpsychires.2013.06.013; Errico F, 2012, AMINO ACIDS, V43, P1861, DOI 10.1007/s00726-012-1356-1; Fitznar HP, 1999, J CHROMATOGR A, V832, P123, DOI 10.1016/S0021-9673(98)01000-0; Hamase K, 2002, J CHROMATOGR B, V781, P73, DOI 10.1016/S1570-0232(02)00690-6; Hamase K, 2007, J CHROMATOGR A, V1143, P105, DOI 10.1016/j.chroma.2006.12.078; Han H, 2011, J CHROMATOGR B, V879, P3196, DOI 10.1016/j.jchromb.2011.01.023; Jako T, 2014, ELECTROPHORESIS, V35, P2870, DOI 10.1002/elps.201400224; Jia CX, 2014, ANAL CHEM, V86, P2972, DOI 10.1021/ac4033824; Karakawa S, 2015, J PHARMACEUT BIOMED, V115, P123, DOI 10.1016/j.jpba.2015.05.024; Lapainis T, 2008, J CHROMATOGR A, V1184, P144, DOI 10.1016/j.chroma.2007.10.098; Livnat I, 2016, ANAL CHEM, V88, P11868, DOI 10.1021/acs.analchem.6b03658; Long ZQ, 2002, ARCH BIOCHEM BIOPHYS, V404, P92, DOI 10.1016/S0003-9861(02)00241-2; Maier NM, 2001, J CHROMATOGR A, V906, P3, DOI 10.1016/S0021-9673(00)00532-X; Miao H, 2006, J CHROMATOGR A, V1106, P56, DOI 10.1016/j.chroma.2005.09.037; Moe LA, 2013, AM J BOT, V100, P1692, DOI 10.3732/ajb.1300033; Morikawa A, 2001, J CHROMATOGR B, V757, P119, DOI 10.1016/S0378-4347(01)00131-1; Nimura N, 2003, ANAL BIOCHEM, V315, P262, DOI 10.1016/S0003-2697(02)00705-4; Petritis K, 2000, J CHROMATOGR A, V896, P253, DOI 10.1016/S0021-9673(00)00582-3; PINGPING Z, 1993, BRAIN RES, V609, P253, DOI 10.1016/0006-8993(93)90880-V; Radkov AD, 2014, APPL MICROBIOL BIOT, V98, P5363, DOI 10.1007/s00253-014-5726-3; Rocco A, 2013, TRAC-TREND ANAL CHEM, V52, P206, DOI 10.1016/j.trac.2013.05.022; Sekine M, 2002, ANAL BIOCHEM, V310, P114, DOI 10.1016/S0003-2697(02)00315-9; Teleki A, 2015, ANAL BIOCHEM, V475, P4, DOI 10.1016/j.ab.2015.01.002; Tsesarskaia M, 2009, BIOMED CHROMATOGR, V23, P581, DOI 10.1002/bmc.1156; Visser WF, 2011, J CHROMATOGR A, V1218, P7130, DOI 10.1016/j.chroma.2011.07.087; Wagner Z, 2012, ANAL BIOANAL CHEM, V404, P2363, DOI 10.1007/s00216-012-6384-x; Wei Ru, 2014, Methods Mol Biol, V1198, P171, DOI 10.1007/978-1-4939-1258-2_12; Zapata Agustin, 2009, Curr Protoc Neurosci, VChapter 7, DOI 10.1002/0471142301.ns0704s48	45	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179748	10.1371/journal.pone.0179748	http://dx.doi.org/10.1371/journal.pone.0179748			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662080	gold, Green Published, Green Submitted			2022-12-27	WOS:000404608300046
J	Jia, LP; Zhang, Y; Liu, LY; Dong, HJ; Zhao, LQ; Qian, Y				Jia, Liping; Zhang, You; Liu, Liying; Dong, Huijin; Zhao, Linqing; Qian, Yuan			High prevalence of GII norovirus in hospitalized children with acute diarrhea, in Beijing	PLOS ONE			English	Article							ACUTE GASTROENTERITIS; NORWALK VIRUS; DISEASE; EPIDEMIOLOGY; INFECTIONS; SUSCEPTIBILITY; SURVEILLANCE; TRANSMISSION; GENOTYPES; OUTBREAK	This study was addressed to the relationship between norovirus and acute diarrhea in hospitalized children, including hospital-acquired infection (HAI) and community-acquired infection (CAI) in a children's hospital in Beijing. RT-PCR was used to detect norovirus in stool specimen, followed by sequence analysis for PCR products. From 2010 to 2013, a total of 1248 specimens, including 661 from the HAI group and 587 from the CAI group were tested for norovirus. Norovirus were detected in 380 of 1248 (30.4%) diarrheal specimens. The positive rate for norovirus detection was higher in children within HAI group than CAI group (35.3%, 232/661 vs. 25.6%, 148/587), and the difference was significant (X-2 = 14.35, P<0.05). For age distribution, the highest positivity rates of norovirus were in age of 0-5 months for HAI group and 12-23 months for CAI group. In the study, 262 amplicons of the VP1 region from norovirus-positive specimens were sequenced, which showed GII. 3 and GII. 4 norovirus were the most common genotypes detected in 50.0% (n = 131) and 48.9% (n = 128) of the positive specimens, respectively. Regarding the wards distribution, GII. 3 norovirus was mainly detected in ward for neonatal diseases (36/85 in HAI group; 19/46 in CAI group), GII. 4 norovirus was mainly detected in ward for respiratory and digestive diseases (21/85 in HAI group; 15/33 in CAI group). Conclusion: The data elaborated the importance of norovirus in hospital associated infectious diarrhea. The prevalence of norovirus is higher from HAI group than CAI group, and the norovirus from the patients in CAI group could be the source of infection in HAI group.	[Jia, Liping; Zhang, You; Liu, Liying; Dong, Huijin; Zhao, Linqing; Qian, Yuan] Capital Inst Pediat, Lab Virol, Beijing Key Lab Etiol Viral Dis Children, Beijing, Peoples R China	Capital Institute of Pediatrics (CIP)	Qian, Y (corresponding author), Capital Inst Pediat, Lab Virol, Beijing Key Lab Etiol Viral Dis Children, Beijing, Peoples R China.	yqianbjc@263.net	Jia, li/GPW-8015-2022; li, jia/GVT-7587-2022	Jia, Liping/0000-0003-4528-7693	Beijing Municipal Science and Technology Commission [Z111107056811041]	Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission)	This work was supported by the grant (No. Z111107056811041) from Beijing Municipal Science and Technology Commission, (http://www. bjnsf.org:8081/search/search_simp_p.jsp). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atmar RL, 2008, EMERG INFECT DIS, V14, P1553, DOI 10.3201/eid1410.080117; Beersma MFC, 2009, J HOSP INFECT, V71, P199, DOI 10.1016/j.jhin.2008.11.018; Bernard H, 2014, EPIDEMIOL INFECT, V142, P63, DOI 10.1017/S0950268813000435; Boon D, 2011, J VIROL, V85, P8656, DOI 10.1128/JVI.00472-11; Bucardo F, 2008, J CLIN MICROBIOL, V46, P2573, DOI 10.1128/JCM.00505-08; Cunliffe NA, 2010, EMERG INFECT DIS, V16, P55, DOI 10.3201/eid1601.090401; Donaldson EF, 2008, IMMUNOL REV, V225, P190, DOI 10.1111/j.1600-065X.2008.00680.x; Esposito S, 2014, PEDIATR INFECT DIS J, V33, P314, DOI 10.1097/INF.0000000000000035; Franck KT, 2015, J INFECT DIS, V212, P881, DOI 10.1093/infdis/jiv105; Gonzalez-Galan V, 2011, CLIN MICROBIOL INFEC, V17, P1895, DOI 10.1111/j.1469-0691.2011.03506.x; Green J, 1998, J HOSP INFECT, V39, P39, DOI 10.1016/S0195-6701(98)90241-9; Green K.Y., 2001, FIELDS VIROLOGY, P949; Hall AJ, 2013, EMERG INFECT DIS, V19, P1198, DOI 10.3201/eid1908.130465; Hutson AM, 2004, TRENDS MICROBIOL, V12, P279, DOI 10.1016/j.tim.2004.04.005; Jia LP, 2014, INFECT GENET EVOL, V28, P71, DOI 10.1016/j.meegid.2014.09.006; Kapikian AZ, 2000, J INFECT DIS, V181, pS295, DOI 10.1086/315584; KAPLAN JE, 1982, AM J PUBLIC HEALTH, V72, P1329, DOI 10.2105/AJPH.72.12.1329; Kesson AM, 2010, MED J AUSTRALIA, V192, P108, DOI 10.5694/j.1326-5377.2010.tb03434.x; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Li CSY, 2009, J MED VIROL, V81, P1903, DOI 10.1002/jmv.21611; Liu LY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088791; Lorrot M, 2011, EUR J CLIN MICROBIOL, V30, P361, DOI 10.1007/s10096-010-1094-9; Medici MC, 2006, J MED VIROL, V78, P1486, DOI 10.1002/jmv.20723; Munir N, 2014, J MED VIROL, V86, P1203, DOI 10.1002/jmv.23774; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Rasanen S, 2011, EUR J PEDIATR, V170, P1413, DOI 10.1007/s00431-011-1443-4; Rydell GE, 2011, REV MED VIROL, V21, P370, DOI 10.1002/rmv.704; Solano R, 2014, EUR J GASTROEN HEPAT, V26, P1160, DOI 10.1097/MEG.0000000000000179; Spackova M, 2010, INFECT CONT HOSP EP, V31, P1273, DOI 10.1086/657133; Sukhrie FHA, 2012, CLIN INFECT DIS, V54, P931, DOI 10.1093/cid/cir971; Sukhrie FHA, 2011, J CLIN MICROBIOL, V49, P602, DOI 10.1128/JCM.01443-10; Tran A, 2010, J CLIN MICROBIOL, V48, P1943, DOI 10.1128/JCM.02181-09; Tsai CN, 2014, J MED VIROL, V86, P335, DOI 10.1002/jmv.23728; Zintz Carmelann, 2005, Infection Genetics and Evolution, V5, P281, DOI 10.1016/j.meegid.2004.06.010	35	6	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179839	10.1371/journal.pone.0179839	http://dx.doi.org/10.1371/journal.pone.0179839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662103	Green Submitted, Green Published, gold			2022-12-27	WOS:000404608300055
J	Agersnap, S; Larsen, WB; Knudsen, SW; Strand, D; Thomsen, PF; Hesselsoe, M; Mortensen, PB; Vralstad, T; Moller, PR				Agersnap, Sune; Larsen, William Brenner; Knudsen, Steen Wilhelm; Strand, David; Thomsen, Philip Francis; Hesselsoe, Martin; Mortensen, Peter Bondgaard; Vralstad, Trude; Moller, Peter Rask			Monitoring of noble, signal and narrow-clawed crayfish using environmental DNA from freshwater samples	PLOS ONE			English	Article							APHANOMYCES-ASTACI; ORCONECTES-LIMOSUS; POPULATION-SIZE; EDNA; TOOL; BIODIVERSITY; EUROPE; DETECT; LAKE	For several hundred years freshwater crayfish (Crustacea-Decapoda-Astacidea) have played an important ecological, cultural and culinary role in Scandinavia. However, many native populations of noble crayfish Astacus astacus have faced major declines during the last century, largely resulting from human assisted expansion of non-indigenous signal crayfish Pacifastacus leniusculus that carry and transmit the crayfish plague pathogen. In Denmark, also the non-indigenous narrow-clawed crayfish Astacus leptodactylus has expanded due to anthropogenic activities. Knowledge about crayfish distribution and early detection of non-indigenous and invasive species are crucial elements in successful conservation of indigenous crayfish. The use of environmental DNA (eDNA) extracted from water samples is a promising new tool for early and non-invasive detection of species in aquatic environments. In the present study, we have developed and tested quantitative PCR (qPCR) assays for species-specific detection and quantification of the three above mentioned crayfish species on the basis of mitochondrial cytochrome oxidase 1 (mtDNA-CO1), including separate assays for two clades of A. leptodactylus. The limit of detection (LOD) was experimentally established as 5 copies/PCR with two different approaches, and the limit of quantification (LOQ) were determined to 5 and 10 copies/PCR, respectively, depending on chosen approach. The assays detected crayfish in natural freshwater ecosystems with known populations of all three species, and show promising potentials for future monitoring of A. astacus, P. leniusculus and A. leptodactylus. However, the assays need further validation with data 1) comparing traditional and eDNA based estimates of abundance, and 2) representing a broader geographical range for the involved crayfish species.	[Agersnap, Sune; Larsen, William Brenner; Knudsen, Steen Wilhelm; Moller, Peter Rask] Univ Copenhagen, Sect Evolutionary Genom, Nat Hist Museum Denmark, Univ Pk 15, Copenhagen O, Denmark; [Strand, David; Vralstad, Trude] Norwegian Vet Inst, Oslo, Norway; [Thomsen, Philip Francis] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, Oster Voldgade 5-7, Copenhagen, Denmark; [Hesselsoe, Martin] Amphi Consult ApS, Niels Jernes Vej 10, Aalborg O, Denmark; [Mortensen, Peter Bondgaard] Eurofins Miljo AS, Ladelundsvej 85, Vejen, Denmark	University of Copenhagen; Norwegian Veterinary Institute; University of Copenhagen	Agersnap, S (corresponding author), Univ Copenhagen, Sect Evolutionary Genom, Nat Hist Museum Denmark, Univ Pk 15, Copenhagen O, Denmark.	suneagersnap@gmail.com	Hesselsøe, Martin/AAI-1342-2021; Knudsen, Steen W/C-1072-2015; Knudsen, Steen/X-7948-2019; Thomsen, Philip Francis/AAE-9354-2019	Knudsen, Steen W/0000-0003-0428-9940; Knudsen, Steen/0000-0003-0428-9940; Thomsen, Philip Francis/0000-0002-9867-4366; Hesselsoe, Martin/0000-0001-5323-4108; Vralstad, Trude/0000-0002-5859-8039; Agersnap, Sune/0000-0001-9193-8069	Danish Innovation Foundation [104-2012-1]; University of Copenhagen; Amphi Consult ApS; Eurofins A/S; TARGET project [NFR/243907]	Danish Innovation Foundation; University of Copenhagen; Amphi Consult ApS; Eurofins A/S; TARGET project	This study was partly funded by the Danish Innovation Foundation 104-2012-1 in collaboration with University of Copenhagen, Amphi Consult ApS and Eurofins A/S. The part of this study performed at the Norwegian Veterinary Institute was funded by the TARGET project (NFR/243907). The funder provided support in the form of salaries for author SWK and research materials for authors SA, WBL, SWK, DS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This study was partly funded by the Danish Innovation Foundation 104-2012-1 in collaboration with University of Copenhagen, Amphi Consult ApS and Eurofins Miljo A/S. The part of this study performed at the Norwegian Veterinary Institute was funded by the TARGET project (NFR/243907). Thanks to private lake owners, local municipalities, and the Danish Nature Agency for permission to sample their lakes. Thanks to Marcus A. Krag, Henrik Carl and Tore Hejl-Holm Hansen for assisting with various parts of field work.	Akhan S, 2014, GENETICA, V142, P381, DOI 10.1007/s10709-014-9782-5; [Anonymous], 2016, VERSION RAY BROWNRIG; [Anonymous], 2015, TRANSITION PLAN 9 CO; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Berdal KG, 2008, EUROPEAN FOOD RES TE; Biggs J, 2015, BIOL CONSERV, V183, P19, DOI 10.1016/j.biocon.2014.11.029; Bivand R.S., 2013, APPL SPATIAL DATA AN, DOI 10.1007/978-1-4614-7618-4; Bolat Y, 2011, AFR J BIOTECHNOL, V10, P11778; Burns M, 2008, EUR FOOD RES TECHNOL, V226, P1513, DOI 10.1007/s00217-007-0683-z; Deagle BE, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0562; Deiner K, 2015, BIOL CONSERV, V183, P53, DOI 10.1016/j.biocon.2014.11.018; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Diaz-Ferguson E, 2014, MANAG BIOL INVASION, V5, P121, DOI 10.3391/mbi.2014.5.2.05; Dougherty MM, 2016, J APPL ECOL, V53, P722, DOI 10.1111/1365-2664.12621; Ellison SLR, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-33; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Forsstrom T, 2016, MAR POLLUT BULL, V109, P350, DOI 10.1016/j.marpolbul.2016.05.054; Fricke R, 2016, GUIDE FISH COLLECTIO; Fuereder Leopold, 2002, Berichte des Naturwissenschaftlich-Medizinischen Vereins in Innsbruck, V89, P169; Gherardi F., 1999, CRAYFISH EUROPE ALIE; Goldberg CS, 2016, METHODS ECOL EVOL, V7, P1299, DOI 10.1111/2041-210X.12595; Holdich DM, 2009, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2009025; Ikeda K, 2016, CONSERV GENET RESOUR, V8, P231, DOI 10.1007/s12686-016-0541-z; Jane SF, 2015, MOL ECOL RESOUR, V15, P216, DOI 10.1111/1755-0998.12285; Kahle D, 2013, R J, V5, P144; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kelly RP, 2014, SCIENCE, V344, P1455, DOI 10.1126/science.1251156; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; Kouba A, 2014, KNOWL MANAG AQUAT EC, p05P1, DOI 10.1051/kmae/2014007; Kozubikova E, 2011, DIS AQUAT ORGAN, V97, P113, DOI 10.3354/dao02411; Kozubikova E, 2011, J INVERTEBR PATHOL, V108, P214, DOI 10.1016/j.jip.2011.08.002; Larson ER, 2017, HYDROBIOLOGIA, V800, P173, DOI 10.1007/s10750-017-3210-7; Luciani TJ, 2014, RSVGDEVICE R SVG GRA; Maguire I, 2014, INVERTEBR SYST, V28, P117, DOI 10.1071/IS13030; Maier MA, 2016, APPL ENVIRON MICROB, V82, P3868, DOI 10.1128/AEM.00087-16; Makkonen J, 2012, DIS AQUAT ORGAN, V102, P129, DOI 10.3354/dao02547; Marchesi U, 2015, JRC95544 ENGL EUR CO; Matheson C.D., 2010, OPEN ENZYME INHIB J, V3, P38, DOI [10.2174/1874940201003010038, DOI 10.2174/1874940201003010038]; McKee AM, 2015, BIOL CONSERV, V183, P70, DOI 10.1016/j.biocon.2014.11.031; Nychka D, 2015, U CORPORATION ATMOSP; Parkyn S., 2015, Freshwater crayfish: a global overview, P205; Pebesma E.J., 2005, R NEWS, V5; Pilotto F, 2008, J CRUSTACEAN BIOL, V28, P633, DOI 10.1651/07-2967.1; Port JA, 2016, MOL ECOL, V25, P527, DOI 10.1111/mec.13481; R Core Team, 2013, LANG ENV STAT COMP; Reynolds J., 2011, MANAGEMENT FRESHWATE, DOI [10.1017/CBO9781139031790, DOI 10.1017/CBO9781139031790]; Richard A.B., 2016, MAPS DRAW GEOGRAPHIC; Roussel JM, 2015, J APPL ECOL, V52, P823, DOI 10.1111/1365-2664.12428; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schrimpf A, 2011, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2011065; Sigsgaard EE, 2015, BIOL CONSERV; Sigsgaard EE, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0004; Snow, 2016, TEACHINGDEMOS DEMONS; South A, 2011, R J, V3, P35; Souty-Grosset C, 2006, ATLAS CRAYFISH EUROP; Spens J, 2016, METHODS ECOLOGY EVOL; Strand DA, 2014, J APPL ECOL, V51, P544, DOI 10.1111/1365-2664.12218; Strickler KM, 2015, BIOL CONSERV, V183, P85, DOI 10.1016/j.biocon.2014.11.038; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165252; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Treguier A, 2014, J APPL ECOL, V51, P871, DOI 10.1111/1365-2664.12262; Turner CR, 2015, BIOL CONSERV, V183, P93, DOI 10.1016/j.biocon.2014.11.017; Valentini A, 2016, MOL ECOL, V25, P929, DOI 10.1111/mec.13428; Vralstad T, 2009, VET MICROBIOL, V137, P146, DOI 10.1016/j.vetmic.2008.12.022; Wickham H., 2016, SCALES SCALE FUNCTIO; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520; Ramirez-Castillo FY, 2015, PATHOGENS, V4, P307, DOI 10.3390/pathogens4020307	76	48	49	4	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179261	10.1371/journal.pone.0179261	http://dx.doi.org/10.1371/journal.pone.0179261			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654642	Green Submitted, gold, Green Published			2022-12-27	WOS:000404541500008
J	Graffigna, G; Barello, S; Bonanomi, A				Graffigna, Guendalina; Barello, Serena; Bonanomi, Andrea			The role of Patient Health Engagement Model (PHE-model) in affecting patient activation and medication adherence: A structural equation model	PLOS ONE			English	Article							SELF-MANAGEMENT; FUNCTIONAL RECOVERY; CLINICIAN BELIEFS; EXTERNAL CONTROL; CONTROLLED-TRIAL; MEASURE PAM; OWN HEALTH; CARE; OUTCOMES; SUPPORT	Background Increasing bodies of scientific research today examines the factors and interventions affecting patients' ability to self-manage and adhere to treatment. Patient activation is considered the most reliable indicator of patients' ability to manage health autonomously. Only a few studies have tried to assess the role of psychosocial factors in promoting patient activation. A more systematic modeling of the psychosocial factors explaining the variance of patient activation is needed. Objective To test the hypothesized effect of patient activation on medication adherence; to test the the hypothesized effects of positive emotions and of the quality of the patient/doctor relationship on patient activation; and to test the hypothesized mediating effect of Patient Health Engagement (PHE-model) in this pathway. Material and methods This cross-sectional study involved 352 Italian-speaking adult chronic patients. The survey included measures of i) patient activation (Patient Activation Measure 13-short form); ii) Patient Health Engagement model (Patient Health Engagement Scale); iii) patient adherence (4 item-Morinsky Medication Adherence Scale); iv) the quality of the patients' emotional feelings (Manikin Self Assessment Scale); v) the quality of the patient/doctor relationship (Health Care Climate Questionnaire). Structural equation modeling was used to test the hypotheses proposed. Results According to the theoretical model we hypothesized, research results confirmed that patients' activation significantly affects their reported medication adherence. Moreover, psychosocial factors, such as the patients' quality of the emotional feelings and the quality of the patient/doctor relationship were demonstrated to be factors affecting the level of patient activation. Finally, the mediation effect of the Patient Health Engagement model was confirmed by the analysis. Conclusions Consistently with the results of previous studies, these findings demonstrate that the Patient Health Engagement Model is a critical factor in enhancing the quality of care. The Patient Health Engagement Model might acts as a mechanism to increase patient activation and adherence.	[Graffigna, Guendalina; Barello, Serena] Univ Cattolica Sacro Cuore, Dept Psychol, Milan, Italy; [Bonanomi, Andrea] Univ Cattolica Sacro Cuore, Dept Stat Sci, Milan, Italy	Catholic University of the Sacred Heart; Catholic University of the Sacred Heart	Graffigna, G (corresponding author), Univ Cattolica Sacro Cuore, Dept Psychol, Milan, Italy.	guendalina.graffigna@unicatt.it	Barello, Serena/ABD-6168-2020	Barello, Serena/0000-0002-8514-2563; BONANOMI, Andrea/0000-0003-2857-1430; GRAFFIGNA, GUENDALINA/0000-0003-4378-7467				Alegria M, 2009, J GEN INTERN MED, V24, P534, DOI 10.1007/s11606-009-1074-x; Bandura A., 1977, PSYCHOL REV, V84, P191, DOI [DOI 10.1037/0033-295X.84.2.191, DOI 10.1016/0146-6402(78)90002-4, 10.1016/0146-6402(78)90002-4, 10.1037/0033-295x.84.2.191]; Bandura A., 1994, ENCY HUMAN BEHAV, VVolume 4, P71, DOI DOI 10.1108/13665620810871097; Barello S, 2015, PSICOLOGIA SALUTE, V3, P11; Barello S, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.02013; Barello S, 2017, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.02020; Barello S, 2015, QUAL LIFE RES, V24, P1087, DOI 10.1007/s11136-014-0846-x; Barello S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005582; Batalden M, 2016, BMJ QUAL SAF, V25, P509, DOI 10.1136/bmjqs-2015-004315; Becker ER, 2008, MED CARE, V46, P795, DOI 10.1097/MLR.0b013e31817919c0; Blakemore A, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1843-2; Bos-Touwen I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126400; Bos-Touwen Irene, 2015, Curr Heart Fail Rep, V12, P223, DOI 10.1007/s11897-015-0259-3; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Castellucci LA, 2015, THROMB RES, V136, P727, DOI 10.1016/j.thromres.2015.07.007; Eikelenboom N, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-336; Gary TL, 2003, DIABETES EDUCATOR, V29, P488, DOI 10.1177/014572170302900313; Goodworth MCR, 2016, J HEALTH PSYCHOL, V21, P82, DOI 10.1177/1359105314522085; Graffigna G., 2016, PATIENT ENGAGEMENT C, DOI [10.1515/9783110452440, DOI 10.1515/9783110452440]; Graffigna G, 2016, PROMOTING PATIENT EN, P192, DOI DOI 10.4018/978-1-4666-9992-2.CH010; Graffigna G, 2014, STUDIES HLTH TECHNOL, V203; Graffigna G, 2016, PATIENT ENGAGEMENT C, P1, DOI DOI 10.1515/9783110452440; Graffigna G, 2016, GIVING BACK ROLE PAT; Graffigna G, 2016, INNOVATING HEALTHCAR; Graffigna G., 2016, PATIENT ENGAGEMENT C; Graffigna G., 2017, FACTORS AFFECTING PA; Graffigna G, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00812; Graffigna G, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2974521; Graffigna G, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0232-9; Graffigna G, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00274; Graffigna G, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-648; Greene J, 2015, HEALTH AFFAIR, V34, P431, DOI 10.1377/hlthaff.2014.0452; Greene J, 2012, J GEN INTERN MED, V27, P520, DOI 10.1007/s11606-011-1931-2; Guyatt GH, 2014, J GEN INTERN MED, V29, P562, DOI 10.1007/s11606-013-2727-3; Harvey L, 2012, PATIENT EDUC COUNS, V88, P338, DOI 10.1016/j.pec.2012.02.005; Hendriks M, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-393; Hibbard JH, 2005, HEALTH SERV RES, V40, P1918, DOI 10.1111/j.1475-6773.2005.00438.x; Hibbard JH, 2004, HEALTH SERV RES, V39, P1005, DOI 10.1111/j.1475-6773.2004.00269.x; Hibbard JH, 2003, MED CARE, V41, pI61; Hibbard JH, 2015, MED CARE RES REV, V72, P324, DOI 10.1177/1077558715573871; Hibbard JH, 2013, HEALTH AFFAIR, V32, P207, DOI 10.1377/hlthaff.2012.1061; Hibbard JH, 2010, PATIENT EDUC COUNS, V78, P377, DOI 10.1016/j.pec.2009.12.015; Hibbard JH, 2010, HEALTH EXPECT, V13, P65, DOI 10.1111/j.1369-7625.2009.00571.x; Hibbard JH, 2008, AM J MANAG CARE, V14, P729; Lamiani G, 2009, ASSIST INFERM E RIC, V28; Lamiani G, 2012, PATIENT EDUC COUNS, V87, P307, DOI 10.1016/j.pec.2011.11.012; Lefcourt H.M., 1991, LOCUS OF CONTROL, DOI DOI 10.1016/B978-0-12-590241-0.50013-7; Lozza E, 2013, ECON IND DEMOCRACY, V34, P89, DOI 10.1177/0143831X12436617; Magnezi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113391; Maindal HT, 2011, SCAND J PUBLIC HEALT, V39, P262, DOI 10.1177/1403494811402721; McCusker J, 2016, HEALTH EDUC BEHAV; McCusker J, 2016, ACTIVATION SELF EFFI; Menichetti J, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01405; Mosen DM, 2007, J AMBUL CARE MANAG, V30, P21, DOI 10.1097/00004479-200701000-00005; Nijman J, 2014, J HEALTH COMMUN, V19, P955, DOI 10.1080/10810730.2013.837561; Parchman ML, 2010, ACTIVATION MEDICATIO, P410; Pennarola BW, 2012, MED CARE RES REV, V69, P194, DOI 10.1177/1077558711431460; Prey JE, 2016, PATIENT ED COUNS; Prey JE, 2013, J AM MED INFORM ASSN, P1; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; Provenzi L, 2016, JOGNN J OBSTET GYNEC, V45; Rademakers J, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0799-y; Rask KJ, 2009, DIABETES EDUCATOR, V35, P622, DOI 10.1177/0145721709335004; Remmers C, 2009, J AMBUL CARE MANAG, V32, P320, DOI 10.1097/JAC.0b013e3181ba6e77; ROTTER JB, 1965, J PERS SOC PSYCHOL, V2, P598, DOI 10.1037/h0022473; ROTTER JB, 1966, PSYCHOL MONOGR, V80, P1, DOI 10.1037/h0092976; Schmidt K, 2012, J CLIN EPIDEMIOL, V65, P206, DOI 10.1016/j.jclinepi.2011.06.003; Shively MJ, 2013, J CARDIOVASC NURS, V28, P20, DOI 10.1097/JCN.0b013e318239f9f9; Skolasky RL, 2013, CONTEMP CLIN TRIALS, V36, P207, DOI 10.1016/j.cct.2013.06.018; Skolasky RL, 2011, J BONE JOINT SURG AM, V93A, P1665, DOI [10.2106/JBJSJ.00855, 10.2106/JBJS.J.00855]; Skolasky Richard L, 2008, Spine (Phila Pa 1976), V33, pE784, DOI 10.1097/BRS.0b013e31818027f1; SMITH PB, 1995, INT J PSYCHOL, V30, P377, DOI 10.1080/00207599508246576; Smith SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074373; Solomon M, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1924; Sorrentino M, 2015, ADMIN SOC; Stoilkova-Hartmann A, 2015, HEART LUNG, V44, P347, DOI 10.1016/j.hrtlng.2015.05.003; Szema AM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061449, 10.1371/journal.pone.0074373]; Tajadura-Jimenez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040682; Tan X, 2014, INNOVATIONS PHARM, V5, P165, DOI DOI 10.24926/IIP.V5I3.347; Triberti S, 2016, J BIOMED INFORM, V63, P150, DOI 10.1016/j.jbi.2016.08.010; Williams GC, 1998, DIABETES CARE, V21, P1644, DOI 10.2337/diacare.21.10.1644	81	69	70	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179865	10.1371/journal.pone.0179865	http://dx.doi.org/10.1371/journal.pone.0179865			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ2LT	28654686	Green Published, Green Submitted, gold			2022-12-27	WOS:000404541500038
J	Huang, WP; Chou, LS				Huang, Wan-Ping; Chou, Lien-Siang			Temperature effects on life history traits of two sympatric branchiopods from an ephemeral wetland	PLOS ONE			English	Article							ANDRODIOECIOUS CLAM SHRIMP; EULIMNADIA-TEXANA; INBREEDING DEPRESSION; PHENOTYPIC PLASTICITY; METABOLIC-RATE; DAPHNIA-MAGNA; BRINE SHRIMP; GROWTH-RATE; BODY-SIZE; HYPOXIA	Temperature effects on organisms are of multiple scientific interests, such as for their life history performance and for the study of evolutionary strategies. We have cultured two sympatric branchiopod species from an ephemeral pond in northern Taiwan, Branchinella kugenumaensis and Eulimnadia braueriana, and compared their hatching rate, maturation time, sex ratio, growth of body length, survivorship, clutch size, net reproductive rate R-0, generation time T-G, and intrinsic rate of natural increase r in relation to temperature (15, 20, 25 and 30 degrees C). We found that E. braueriana had a significantly higher temperature-dependent fecundity and intrinsic population growth pattern (R-0 and r). In contrast, B. kugenumaensis reproduced much slower than E. braueriana with much lower R-0 (90-100 folds less) and r (about 10 folds less) at 15, 20 and 25 degrees C and with a double as long T-G at 20 and 25 degrees C. In addition, E. braueriana increased its chance of hermaphroditic sexual reproductive mode at higher temperature because of a significantly delayed maturation of males from hermaphrodites. In contrast, B. kugenumaensis showed no significant change in reproductive mode with temperature. This is the first study indicating a significant differentiation in life history parameters of two sympatric branchiopods mediated by temperature.	[Huang, Wan-Ping; Chou, Lien-Siang] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei, Taiwan	National Taiwan University	Chou, LS (corresponding author), Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei, Taiwan.	chouls@ntu.edu.tw			Yangmingshan National Park [095-301020300G-1008]; National Science Council [NSC101-2311-B002-004, MOST106-2119-M-002-028]	Yangmingshan National Park; National Science Council(Ministry of Science and Technology, Taiwan)	Funding support was received from Yangmingshan National Park (Grant: 095-301020300G-1008), and partial support from National Science Council (NSC101-2311-B002-004 and MOST106-2119-M-002-028).; We appreciate funding support from Yangmingshan National Park (Grant: 095-301020300G-1008), and partial support from National Science Council (NSC101-2311-B002-004 and MOST106-2119-M-002-028). We are grateful to Dr. Siang-Lin Huang, Chun-Chieh Wang, Chew-Yuen Lee and Jer-Yuh Liu for helping in field egg collections and indoor culturing works, and early suggestion in statistic methods by Hui-Wen Yang.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Allan EL, 2006, J EXP MAR BIOL ECOL, V337, P103, DOI 10.1016/j.jembe.2006.06.006; Angilletta MJ, 2004, INTEGR COMP BIOL, V44, P498, DOI 10.1093/icb/44.6.498; Bonato O, 1993, INT J ACAROL, V16, P241; Booth DT, 2007, J INSECT PHYSIOL, V53, P950, DOI 10.1016/j.jinsphys.2007.03.009; Boven L, 2008, MAR FRESHWATER RES, V59, P940, DOI 10.1071/MF08154; CARPENTER JH, 1966, LIMNOL OCEANOGR, V11, P264, DOI 10.4319/lo.1966.11.2.0264; Chapman LJ, 2000, ECOL LETT, V3, P387, DOI 10.1046/j.1461-0248.2000.00160.x; Chi H, 2006, ENVIRON ENTOMOL, V35, P10, DOI 10.1603/0046-225X-35.1.10; Crispo E, 2010, J EVOLUTION BIOL, V23, P2091, DOI 10.1111/j.1420-9101.2010.02069.x; Eder E, 1997, HYDROBIOLOGIA, V359, P13, DOI 10.1023/A:1003146416563; Ekau W, 2010, BIOGEOSCIENCES, V7, P1669, DOI 10.5194/bg-7-1669-2010; Geister TL, 2008, J INSECT PHYSIOL, V54, P1253, DOI 10.1016/j.jinsphys.2008.06.002; Geister TL, 2009, J COMP PHYSIOL B, V179, P87, DOI 10.1007/s00360-008-0293-5; Glatz J, 2017, B ENTOMOL RES, V107, P39, DOI 10.1017/S0007485316000572; Goldmann T, 1999, HISTOCHEM CELL BIOL, V112, P335, DOI 10.1007/PL00007905; Guadagnoli JA, 2005, J EXP BIOL, V208, P3543, DOI 10.1242/jeb.01794; Henry Y, 2017, ECOTOX ENVIRON SAFE, V137, P42, DOI 10.1016/j.ecoenv.2016.11.011; Hollenbeck VG, 2002, BEHAV ECOL, V13, P561, DOI 10.1093/beheco/13.4.561; Huang SL, 2010, J CRUSTACEAN BIOL, V30, P366, DOI 10.1651/09-3235.1; Huang WP, 2015, J CRUSTACEAN BIOL, V35, P330, DOI 10.1163/1937240X-00002336; Isla JA, 2004, J PLANKTON RES, V26, P579, DOI 10.1093/plankt/fbh049; Jager T, 2017, MAR BIOL, V164, DOI 10.1007/s00227-016-3030-8; Lamkemeyer T, 2003, CAN J ZOOL, V81, P237, DOI 10.1139/Z03-001; Landry CL, 2007, NEW PHYTOL, V176, P891, DOI 10.1111/j.1469-8137.2007.02228.x; Mondal RP, 2017, ACTA TROP, V166, P262, DOI 10.1016/j.actatropica.2016.11.034; Nylin S, 1998, ANNU REV ENTOMOL, V43, P63, DOI 10.1146/annurev.ento.43.1.63; Obbard DJ, 2006, AM NAT, V167, P354, DOI 10.1086/499546; Olmstead AW, 2007, INT J BIOL SCI, V3, P77; Panov VE, 1998, CAN J ZOOL, V76, P1107, DOI 10.1139/cjz-76-6-1107; Petersen MF, 2003, J EXP BIOL, V206, P359, DOI 10.1242/jeb.00111; Petrov B, 1997, HYDROBIOLOGIA, V359, P23, DOI 10.1023/A:1003186014746; Pirow R, 2007, FEBS J, V274, P3374, DOI 10.1111/j.1742-4658.2007.05871.x; Rogers DC, 2015, J LIMNOL, V74, P85, DOI 10.4081/jlimnol.2014.1036; Scanabissi F, 2002, HYDROBIOLOGIA, V486, P263, DOI 10.1023/A:1021371306687; Sokolova IM, 2003, J EXP BIOL, V206, P195, DOI 10.1242/jeb.00054; Spicer JI, 1999, J EXP BIOL, V202, P3637; SPICER JI, 1994, J EXP ZOOL, V270, P508, DOI 10.1002/jez.1402700604; Stewart AD, 2002, GENETICS, V160, P975; Theodorou K, 2006, GENET SEL EVOL, V38, P371, DOI 10.1051/gse:2006010; Thomas JA, 2010, MOL BIOL EVOL, V27, P1173, DOI 10.1093/molbev/msq009; Timms BV, 2016, ZOOTAXA, V4066, P351, DOI 10.11646/zootaxa.4066.4.1; Timms BV, 2005, J ROY SOC NEW ZEAL, V35, P409, DOI 10.1080/03014223.2005.9517792; Timms BV, 2002, HYDROBIOLOGIA, V486, P239, DOI 10.1023/A:1021315221708; Wang CC, 2012, J CRUSTACEAN BIOL, V32, P39, DOI 10.1163/193724011X615316; Wang LH, 2017, PESTIC BIOCHEM PHYS, V136, P64, DOI 10.1016/j.pestbp.2016.08.002; Wang YJ, 2011, MAR POLLUT BULL, V63, P201, DOI 10.1016/j.marpolbul.2011.05.035; Weeks SC, 2010, J EVOLUTION BIOL, V23, P1100, DOI 10.1111/j.1420-9101.2010.01963.x; Weeks SC, 2009, J EVOLUTION BIOL, V22, P1781, DOI 10.1111/j.1420-9101.2009.01813.x; Weeks SC, 1999, CAN J ZOOL, V77, P1402, DOI 10.1139/cjz-77-9-1402; Weeks SC, 2004, J EVOLUTION BIOL, V17, P475, DOI 10.1111/j.1420-9101.2004.00712.x; Weeks SC, 2006, INTEGR COMP BIOL, V46, P449, DOI 10.1093/icb/icj048; Zar JH, 1999, BIOSTATISTICAL ANAL; Zhu XX, 2017, BIOTECHNOL LETT, V39, P85, DOI 10.1007/s10529-016-2223-z	54	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179449	10.1371/journal.pone.0179449	http://dx.doi.org/10.1371/journal.pone.0179449			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654929	Green Submitted, gold, Green Published			2022-12-27	WOS:000404541500014
J	Ulfenborg, B; Karlsson, A; Riveiro, M; Ameen, C; Akesson, K; Andersson, CX; Sartipy, P; Synnergren, J				Ulfenborg, Benjamin; Karlsson, Alexander; Riveiro, Maria; Ameen, Caroline; Akesson, Karolina; Andersson, Christian X.; Sartipy, Peter; Synnergren, Jane			A data analysis framework for biomedical big data: Application on mesoderm differentiation of human pluripotent stem cells	PLOS ONE			English	Article							CARDIAC DEVELOPMENT; EXPRESSION ANALYSIS; HEART; INDUCTION; PATHWAY; ALGORITHMS; SYSTEM; GENES; ROLES; VIEW	The development of high-throughput biomolecular technologies has resulted in generation of vast omics data at an unprecedented rate. This is transforming biomedical research into a big data discipline, where the main challenges relate to the analysis and interpretation of data into new biological knowledge. The aim of this study was to develop a framework for biomedical big data analytics, and apply it for analyzing transcriptomics time series data from early differentiation of human pluripotent stem cells towards the mesoderm and cardiac lineages. To this end, transcriptome profiling by microarray was performed on differentiating human pluripotent stem cells sampled at eleven consecutive days. The gene expression data was analyzed using the five-stage analysis framework proposed in this study, including data preparation, exploratory data analysis, confirmatory analysis, biological knowledge discovery, and visualization of the results. Clustering analysis revealed several distinct expression profiles during differentiation. Genes with an early transient response were strongly related to embryonic-and mesendoderm development, for example CER1 and NODAL. Pluripotency genes, such as NANOG and SOX2, exhibited substantial downregulation shortly after onset of differentiation. Rapid induction of genes related to metal ion response, cardiac tissue development, and muscle contraction were observed around day five and six. Several transcription factors were identified as potential regulators of these processes, e.g. POU1F1, TCF4 and TBP for muscle contraction genes. Pathway analysis revealed temporal activity of several signaling pathways, for example the inhibition of WNT signaling on day 2 and its reactivation on day 4. This study provides a comprehensive characterization of biological events and key regulators of the early differentiation of human pluripotent stem cells towards the mesoderm and cardiac lineages. The proposed analysis framework can be used to structure data analysis in future research, both in stem cell differentiation, and more generally, in biomedical big data analytics.	[Ulfenborg, Benjamin; Sartipy, Peter; Synnergren, Jane] Univ Skovde, Sch Biosci, Skovde, Sweden; [Karlsson, Alexander; Riveiro, Maria] Univ Skovde, Sch Informat, Skovde, Sweden; [Ameen, Caroline; Akesson, Karolina; Andersson, Christian X.] Takara Bio Europe AB, Gothenburg, Sweden; [Sartipy, Peter] AstraZeneca, Cardiovasc & Metab Dis Global Med Dev Unit, Gothenburg Molndal, Sweden	University of Skovde; Takara Bio Inc.; AstraZeneca	Ulfenborg, B (corresponding author), Univ Skovde, Sch Biosci, Skovde, Sweden.	benjamin.ulfenborg@his.se	Riveiro, Maria/D-6238-2015; Riveiro, Maria/N-3417-2019; Synnergren, Jane/AAY-3149-2021; Synnergren, Jane/T-4247-2018; Ulfenborg, Benjamin/G-7865-2019	Riveiro, Maria/0000-0003-2900-9335; Synnergren, Jane/0000-0003-4697-0590; Synnergren, Jane/0000-0003-4697-0590; Ulfenborg, Benjamin/0000-0001-9242-4852	Knowledge Foundation [2013/89, 2014/0301, 2014/0294]	Knowledge Foundation	This study was supported by grants to JS from the Knowledge Foundation [2013/89, 2014/0301, 2014/0294]. The Knowledge Foundation provided support in the form of salaries for authors (BU, AK, MR, PS, JS). CXA, KA and CA are employed by Takara Bio Europe AB, and PS is employed by AstraZeneca. The commercial funders did contribute with data collection and analysis, as well as in preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Antoine L., 2014, AMAP ANOTHER MULTIDI; Bacardit J, 2014, BIG DATA, V2, P164, DOI 10.1089/big.2014.0023; Binder H, 2015, DTSCH ARZTEBL INT, V112, P137, DOI 10.3238/arztebl.2015.0137; Bisson JA, 2015, DEV BIOL, V398, P80, DOI 10.1016/j.ydbio.2014.11.015; Burridge PW, 2007, STEM CELLS, V25, P929, DOI 10.1634/stemcells.2006-0598; Calderon D, 2016, DEV DYNAM, V245, P1130, DOI 10.1002/dvdy.24441; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Deb A, 2014, CARDIOVASC RES, V102, P214, DOI 10.1093/cvr/cvu054; Fahad A, 2014, IEEE T EMERG TOP COM, V2, P267, DOI 10.1109/TETC.2014.2330519; Fathi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022856; Foley AC, 2005, GENE DEV, V19, P387, DOI 10.1101/gad.1279405; Gessert S, 2010, CIRC RES, V107, P186, DOI 10.1161/CIRCRESAHA.110.221531; Han D, 2015, J MOL NEUROSCI, V55, P109, DOI 10.1007/s12031-014-0382-8; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Ho PJ, 2012, CELL TRANSPLANT, V21, P801, DOI 10.3727/096368911X627507; Holzinger A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S6-I1; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim DS, 2014, PLOS ONE, V9; Klein D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02178; Li FF, 2016, MOL MED REP, V14, P1459, DOI 10.3892/mmr.2016.5428; Li K, 2016, BIOCHEM BIOPH RES CO, V471, P1, DOI 10.1016/j.bbrc.2016.01.182; Louw JJ, 2015, AM J MED GENET A, V167, P1142, DOI 10.1002/ajmg.a.36989; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Margolis R, 2014, J AM MED INFORM ASSN, V21, P957, DOI 10.1136/amiajnl-2014-002974; Mazzotta S, 2016, STEM CELL REP, V7, P764, DOI 10.1016/j.stemcr.2016.08.008; Moretti A, 2007, CELL MOL LIFE SCI, V64, P674, DOI 10.1007/s00018-007-6520-5; Nair R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042580; Piccini I, 2016, GENOM DATA, V10, P71, DOI 10.1016/j.gdata.2016.09.007; Pirim H, 2012, COMPUT OPER RES, V39, P3046, DOI 10.1016/j.cor.2012.03.008; Rao J, 2016, CELL STEM CELL, V18, P341, DOI 10.1016/j.stem.2015.11.019; Risebro CA, 2006, DEVELOPMENT, V133, P4595, DOI 10.1242/dev.02625; Ruiz-Villalba A, 2016, DEV DYNAM, V245, P294, DOI 10.1002/dvdy.24372; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Satish L, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0119-8; SHNEIDERMAN B, 1992, ACM T GRAPHIC, V11, P92, DOI 10.1145/102377.115768; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Thies RS, 2015, DEVELOPMENT, V142, P3077, DOI [10.1242/dev.126482, 10.1242/dev.131250]; Tukey JW, 1977, EXPLORATORY DATA ANA; van den Berg CW, 2015, DEVELOPMENT, V142, P3231, DOI 10.1242/dev.123810; Van Vliet P, 2012, CARDIOVASC RES, V96, P352, DOI 10.1093/cvr/cvs270; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Xu Rui, 2010, IEEE Rev Biomed Eng, V3, P120, DOI 10.1109/RBME.2010.2083647; Yang Z, 2015, INT J MOL MED, V35, P579, DOI 10.3892/ijmm.2014.2051; Zhang M, 2015, STEM CELLS, V33, P1456, DOI 10.1002/stem.1964; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120	48	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179613	10.1371/journal.pone.0179613	http://dx.doi.org/10.1371/journal.pone.0179613			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654683	Green Published, gold, Green Submitted			2022-12-27	WOS:000404541500020
J	Wszedybyl-Winklewska, M; Wolf, J; Swierblewska, E; Kunicka, K; Mazur, K; Gruszecki, M; Winklewski, PJ; Frydrychowski, AF; Bieniaszewski, L; Narkiewicz, K				Wszedybyl-Winklewska, Magdalena; Wolf, Jacek; Swierblewska, Ewa; Kunicka, Katarzyna; Mazur, Kamila; Gruszecki, Marcin; Winklewski, Pawel J.; Frydrychowski, Andrzej F.; Bieniaszewski, Leszek; Narkiewicz, Krzysztof			Increased inspiratory resistance affects the dynamic relationship between blood pressure changes and subarachnoid space width oscillations	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; CEREBROSPINAL-FLUID PULSATILITY; PIAL ARTERY PULSATION; MUELLER MANEUVER; HEALTHY-ADULTS; HEMODYNAMICS; RESPIRATION; HUMANS; FLOW; INDIVIDUALS	Background and objective Respiration is known to affect cerebrospinal fluid (CSF) movement. We hypothesised that increased inspiratory resistance would affect the dynamic relationship between blood pressure (BP) changes and subarachnoid space width (SAS) oscillations. Methods Experiments were performed in a group of 20 healthy volunteers undergoing controlled intermittent Mueller Manoeuvres (the key characteristic of the procedure is that a studied person is subjected to a controlled, increased inspiratory resistance which results in marked potentiation of the intrathoracic negative pressure). BP and heart rate (HR) were measured using continuous finger-pulse photoplethysmography; oxyhaemoglobin saturation with an ear-clip sensor; end-tidal CO2 with a gas analyser; cerebral blood flow velocity (CBFV), pulsatility and resistive indices with Doppler ultrasound. Changes in SAS were recorded with a new method i.e. near-infrared transillumination/backscattering sounding. Wavelet transform analysis was used to assess the BP and SAS oscillations coupling. Results Initiating Mueller manoeuvres evoked cardiac SAS component decline (-17.8%, P<0.001), systolic BP, diastolic BP and HR increase (+6.3%, P<0.001; 6.7%, P<0.001 and +2.3%, P<0.05, respectively). By the end of Mueller manoeuvres, cardiac SAS component and HR did not change (+2.3% and 0.0%, respectively; both not statistically significant), but systolic and diastolic BP was elevated (+12.6% and +8.9%, respectively; both P<0.001). With reference to baseline values there was an evident decrease in wavelet coherence between BP and SAS oscillations at cardiac frequency in the first half of the Mueller manoeuvres (-32.3%, P<0.05 for left hemisphere and -46.0%, P<0.01 for right hemisphere) which was followed by subsequent normalization at end of the procedure (+3.1% for left hemisphere and +23.1% for right hemisphere; both not statistically significant). Conclusions Increased inspiratory resistance is associated with swings in the cardiac contribution to the dynamic relationship between BP and SAS oscillations. Impaired cardiac performance reported in Mueller manoeuvres may influence the pattern of cerebrospinal fluid pulsatility.	[Wszedybyl-Winklewska, Magdalena; Winklewski, Pawel J.; Frydrychowski, Andrzej F.] Med Univ Gdansk, Inst Human Physiol, Gdansk, Poland; [Wolf, Jacek; Swierblewska, Ewa; Kunicka, Katarzyna; Narkiewicz, Krzysztof] Med Univ Gdansk, Dept Hypertens & Diabetol, Gdansk, Poland; [Wolf, Jacek; Narkiewicz, Krzysztof] St Annes Univ Hosp Brno FNUSA, Int Clin Res Ctr, Dept Cardiovasc Dis, Brno, Czech Republic; [Mazur, Kamila] Gdansk Univ Technol, Fac Elect Telecommun & Informat, Dept Biomed Engn, Gdansk, Poland; [Gruszecki, Marcin] Med Univ Gdansk, Dept Radiol Informat & Stat, Gdansk, Poland; [Winklewski, Pawel J.] Pomeranian Univ Slupsk, Inst Hlth Sci, Slupsk, Poland; [Bieniaszewski, Leszek] Med Univ Gdansk, Ctr Med Simulat, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; St Anne's University Hospital Brno (FNUSA-ICRC); Fahrenheit Universities; Gdansk University of Technology; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Wszedybyl-Winklewska, M (corresponding author), Med Univ Gdansk, Inst Human Physiol, Gdansk, Poland.	magdalenawinklewska@gumed.edu.pl	Bieniaszewski, Leszek/U-9635-2018	Bieniaszewski, Leszek/0000-0001-6237-521X; Wszedybyl-Winklewska, Magdalena/0000-0001-5180-7224; Gruszecki, Marcin/0000-0003-1709-3939; Narkiewicz, Krzysztof/0000-0001-5949-5018; Winklewski, Pawel/0000-0002-1671-2163	European Regional Development Fund - Project FNUSA-ICRC [CZ.1.05/1.1.00/02.0123]; REGPOT ICRC-ERA Human Bridge grant [316345]	European Regional Development Fund - Project FNUSA-ICRC; REGPOT ICRC-ERA Human Bridge grant	Drs. Jacek Wolf, and Krzysztof Narkiewicz are supported by the European Regional Development Fund - Project FNUSA-ICRC (No. CZ.1.05/1.1.00/02.0123) and by the REGPOT ICRC-ERA Human Bridge grant No. 316345 provided by the EU.	Bateman GA, 2002, NEURORADIOLOGY, V44, P740, DOI 10.1007/s00234-002-0812-0; Beggs CB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153960; Beggs CB, 2016, J NEUROIMAGING, V26, P136, DOI 10.1111/jon.12249; Beggs CB, 2014, J MAGN RESON IMAGING, V40, P1215, DOI 10.1002/jmri.24468; Bernjak A, 2012, FLUCT NOISE LETT, V11, DOI 10.1142/S0219477512400135; CARLSON JT, 1993, CHEST, V103, P1763, DOI 10.1378/chest.103.6.1763; Chen LY, 2015, NEUROIMAGE, V122, P281, DOI 10.1016/j.neuroimage.2015.07.073; Clemson PT, 2014, PHYS REP, V542, P297, DOI 10.1016/j.physrep.2014.04.001; CONDOS WR, 1987, CIRCULATION, V76, P1020, DOI 10.1161/01.CIR.76.5.1020; Dreha-Kulaczewski S, 2015, J NEUROSCI, V35, P2485, DOI 10.1523/JNEUROSCI.3246-14.2015; Frydrychowski AE, 2002, IEEE T BIO-MED ENG, V49, P887, DOI 10.1109/TBME.2002.800786; Frydrychowski AF, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2753756; Frydrychowski AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048245; Frydrychowski AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037529; GREITZ D, 1993, ACTA RADIOL, V34, P321; GUNTHEROTH WG, 1967, CIRC RES, V20, P381, DOI 10.1161/01.RES.20.4.381; HANLY PJ, 1989, CHEST, V95, P735, DOI 10.1378/chest.95.4.735; Jolly TAD, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00782; Konecny T, 2014, CATHETER CARDIO INTE, V84, P1138, DOI 10.1002/ccd.25433; Koshino Y, 2010, CIRC-CARDIOVASC IMAG, V3, P282, DOI 10.1161/CIRCIMAGING.109.901561; Linninger AA, 2005, IEEE T BIO-MED ENG, V52, P557, DOI 10.1109/TBME.2005.844021; Magnano C, 2012, J MAGN RESON IMAGING, V36, P825, DOI 10.1002/jmri.23730; Orban M, 2008, AM J CARDIOL, V102, P1557, DOI 10.1016/j.amjcard.2008.07.050; Reinhard M, 2000, CLIN PHYSIOL, V20, P292; ROBOTHAM JL, 1979, J APPL PHYSIOL, V47, P1295, DOI 10.1152/jappl.1979.47.6.1295; SCHRIJEN F, 1975, PFLUG ARCH EUR J PHY, V355, P205, DOI 10.1007/BF00583684; SCHROTH G, 1992, NEURORADIOLOGY, V35, P10, DOI 10.1007/BF00588271; Shamsuzzaman ASM, 2003, JAMA-J AM MED ASSOC, V290, P1906, DOI 10.1001/jama.290.14.1906; Shiogai Y, 2010, PHYS REP, V488, P51, DOI 10.1016/j.physrep.2009.12.003; SOMERS VK, 1993, J AUTONOM NERV SYST, V44, P253, DOI 10.1016/0165-1838(93)90038-V; SOMERS VK, 1995, J CLIN INVEST, V96, P1897, DOI 10.1172/JCI118235; Stefanovska A, 1999, IEEE T BIO-MED ENG, V46, P1230, DOI 10.1109/10.790500; Torrence C, 1999, J CLIMATE, V12, P2679, DOI 10.1175/1520-0442(1999)012<2679:ICITEM>2.0.CO;2; Wagner BP, 2003, INTENS CARE MED, V29, P196, DOI 10.1007/s00134-002-1592-z; Winklewski PJ, 2015, MICROVASC RES, V99, P86, DOI 10.1016/j.mvr.2015.03.003; Winklewski PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135429; Winklewski PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135751; Wszedybyl-Winklewska M, 2017, PLOS ONE UNPUB; Wszedybyl-Winklewska M, 2015, J HYPERTENS, V33, P1811, DOI 10.1097/HJH.0000000000000613; Wszedybyl-Winklewska M, 2011, MICROVASC RES, V82, P369, DOI 10.1016/j.mvr.2011.08.003	41	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179503	10.1371/journal.pone.0179503	http://dx.doi.org/10.1371/journal.pone.0179503			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654638	gold, Green Submitted, Green Published			2022-12-27	WOS:000404541500016
J	Abebe, M; Ali, I; Ayele, S; Overbo, J; Aseffa, A; Mihret, A				Abebe, Meseret; Ali, Ibrahim; Ayele, Samuel; Overbo, Johakim; Aseffa, Abraham; Mihret, Adane			Seroprevalence and risk factors of Hepatitis E Virus infection among pregnant women in Addis Ababa, Ethiopia	PLOS ONE			English	Article							BLOOD-DONORS; HIGHLY PREVALENT; VIRAL-HEPATITIS; CLINICAL-COURSE; HEV INFECTION; ANTIBODIES; FRANCE; EPIDEMIOLOGY; AFRICA	Background Hepatitis E virus (HEV) is highly endemic in several African countries with high mortality rate among pregnant women. The prevalence of antibodies to HEV in Ethiopian pregnant women is not known. The study was conducted to investigate the prevalence of anti-HEV IgG and anti-HEV IgM among pregnant women. Material and methods A total of 386 serum samples were collected from pregnant women between April 2014 to January 2015 in Gandhi Memorial Hospital and four selected Health centers in Addis Ababa, Ethiopia. Data were collected for socio demographic characteristics using a structured questionnaire. Serum samples were examined for anti-HEV IgG and anti-HEV IgM using ELISA. The association of anti-HEV status with risk factors was assessed. Factors demonstrating significant association in bivariate analysis were included in multivariate logistic regression models. Analyses were performed using SPSS version 21. Results Anti-HEV IgG antibody was detected in 122 (31.6%) women and two women (0.5%) were positive for anti-HEV IgM from the total 386 women. Age and educational status had statistically significant association with HEV infection. There was no significant association between anti-HEV antibody seroprevalence rate with trimester, parity, HIV status and other risk factors. Conclusion In this study we found a high seroprevalence rate of anti-HEV IgG among pregnant women in Addis Ababa Ethiopia. Preventive measures like improvement of education and creating awareness may reduce the risk in pregnant women. Moreover nationwide surveillance of HEV especially in rural setting should be conducted to establish a national estimate and validate our findings.	[Abebe, Meseret; Ayele, Samuel; Aseffa, Abraham; Mihret, Adane] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Ali, Ibrahim] Addis Ababa Univ, Coll Hlth Sci, Addis Ababa, Ethiopia; [Overbo, Johakim] Norwegian Inst Publ Hlth, Oslo, Norway	Addis Ababa University; Norwegian Institute of Public Health (NIPH)	Mihret, A (corresponding author), Armauer Hansen Res Inst, Addis Ababa, Ethiopia.	adane_mihret@yahoo.com	Aseffa, Abraham/J-3248-2016	Aseffa, Abraham/0000-0002-8028-1150; Mihret, Adane/0000-0003-3183-4772				Adjei AA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-108; Al-Tayeb ZA, 2004, AM J RECOMMUNICATI, V2; Begum N, 2009, INDIAN J MED RES, V130, P709; Blut Arbeitskreis, 2009, TRANSFUS MED HEMOTH, V36, P40, DOI DOI 10.1159/; Boccia D, 2006, CLIN INFECT DIS, V42, P1679, DOI 10.1086/504322; Caron M, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-158; Hoofnagle JH, 2012, NEW ENGL J MED, V367, P1237, DOI 10.1056/NEJMra1204512; Huang F, 2013, BRAZ J INFECT DIS, V17, P716, DOI 10.1016/j.bjid.2013.02.006; Johargy AK, 2013, J PAK MED ASSOC, V63, P185; Kamar N, 2014, CLIN MICROBIOL REV, V27, P116, DOI 10.1128/CMR.00057-13; Kar P, 2012, MEDICINE, V22, P459; Khuroo MS, 2009, J VIRAL HEPATITIS, V16, P519, DOI 10.1111/j.1365-2893.2009.01101.x; Khuroo MS, 2003, J VIRAL HEPATITIS, V10, P61, DOI 10.1046/j.1365-2893.2003.00398.x; Kim JH, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-308; Klein SL, 2004, PARASITE IMMUNOL, V26, P247, DOI 10.1111/j.0141-9838.2004.00710.x; Mansuy JM, 2008, J MED VIROL, V80, P289, DOI 10.1002/jmv.21056; Mansuy JM, 2011, EMERG INFECT DIS, V17, P2309, DOI 10.3201/eid1712.110371; Lindemann MLM, 2010, J MED VIROL, V82, P1666, DOI 10.1002/jmv.21840; Mousavi SSB, 2014, JUNDISHAPUR J MICROB, V7, DOI 10.5812/jjm.6993; Patra S, 2007, ANN INTERN MED, V147, P28, DOI 10.7326/0003-4819-147-1-200707030-00005; Renou C, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-68; Shukla S, 2011, JBIOSCI TECH, V2, P279; Stoszek SK, 2006, T ROY SOC TROP MED H, V100, P95, DOI 10.1016/j.trstmh.2004.12.005; Tabarraei A, 2011, GORGAN IRAN N E CASP, P162; Teo CG, 2012, EPIDEMIOL INFECT, V140, P767, DOI 10.1017/S0950268811002925; Traore KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048125; TSEGA E, 1992, CLIN INFECT DIS, V14, P961, DOI 10.1093/clinids/14.4.961; Vasickova P, 2007, VET MED-CZECH, V52, P365, DOI 10.17221/1999-VETMED; World Health Organization, 2002, HEP E DEP COMM DIS S	29	20	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0180078	10.1371/journal.pone.0180078	http://dx.doi.org/10.1371/journal.pone.0180078			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650982	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000404537300039
J	Nagano, H; Kishaba, T; Nei, Y; Yamashiro, S; Takara, H				Nagano, Hiroaki; Kishaba, Tomoo; Nei, Yuichirou; Yamashiro, Shin; Takara, Hiroaki			Indications of airway stenting for severe central airway obstruction due to advanced cancer	PLOS ONE			English	Article							QUALITY-OF-LIFE; TRACHEOBRONCHIAL STENOSIS; METAL STENTS; LUNG-CANCER; MANAGEMENT	Background Management of severe central airway obstruction due to advanced cancer is a medical and technical challenge. The impact of airway stenting on the clinical outcome of such patients is unclear. Method This single-center, retrospective study evaluated 21 patients who underwent airway stenting for advanced cancer. We examined predictors of the post-stenting mortality, including age, serum albumin, tracheal diameter, smoking, opioid use, respiratory failure, and performance status (PS). We also compared survival according to the PS. Results The mean survival period after stenting was 85.2 days. On univariate analysis, age, albumin, PS before airway stenting, respiratory failure, admission route, and PS grade were the candidates as possible predictors of prognosis after the procedure. On multivariate analysis, PS before airway stenting was identified as possible predictor of prognosis after stenting (HR 1.6180, 95% CI 0.969 to 2.7015, p = 0.066). The mean survival period after stenting was significantly longer in the good PS group, compared to the poor PS group (147.8 days vs. 38.2 days, p = 0.0346). Conclusion Airway stenting for advanced cancer may be more effective for patients in good general condition than in those with poor performance status.	[Nagano, Hiroaki; Kishaba, Tomoo; Nei, Yuichirou; Yamashiro, Shin] Okinawa Chubu Hosp, Dept Resp Med, Uruma, Okinawa, Japan; [Takara, Hiroaki] Okinawa Chubu Hosp, Dept Radiol, Uruma, Okinawa, Japan; [Nagano, Hiroaki] 281 Miyazato, Uruma City, Okinawa, Japan	Okinawa Chubu Central Hospital; Okinawa Chubu Central Hospital	Nagano, H (corresponding author), Okinawa Chubu Hosp, Dept Resp Med, Uruma, Okinawa, Japan.; Nagano, H (corresponding author), 281 Miyazato, Uruma City, Okinawa, Japan.	hiroakinoko322violin@gmail.com		Nagano, Hiroaki/0000-0001-5587-5662				Agrafiotis M, 2009, RESPIRATION, V78, P69, DOI 10.1159/000213244; Bolliger CT, 2002, EUR RESPIR J, V19, P356, DOI 10.1183/09031936.02.00204602; Conacher ID, 2003, BRIT J ANAESTH, V90, P367, DOI 10.1093/bja/aeg053; Davis N, 2006, BRIT J ANAESTH, V96, P132, DOI 10.1093/bja/aei267; Eon Ji, 2013, KOREAN J THORACIC CA, V46, P80; Ernst A, 2003, CHEST, V123, P1693, DOI 10.1378/chest.123.5.1693; Fabrice Paganin, 2008, PLOS ONE, V3, P1; Gang Ma, 2008, CHIN J CANCER, V27, P153; Hardavella G, 2015, BREATHE, V11, P203, DOI 10.1183/20734735.008415; Herth FJF, 2010, EUR RESPIR J, V36, P1370, DOI 10.1183/09031936.00049809; Hong Y, 2013, J CRIT CARE, V28, P669, DOI 10.1016/j.jcrc.2013.05.020; Jonathan Puchalski, 2012, PAKISTAN J CHEST MED, V18, P38; Jordhoy MS, 2001, BRIT J CANCER, V85, P1478, DOI 10.1054/bjoc.2001.2116; Keisuke Matsuo, 2009, J JAPAN SOC RESP END, V29, P26; Masamichi Takagi, 2006, OURNAL JAPANESE RESP, V44, P997; McGrath EE, 2012, ARCH BRONCONEUMOL, V48, P43, DOI 10.1016/j.arbres.2011.09.008; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Prigerson HG, 2015, JAMA ONCOL, V1, P778, DOI 10.1001/jamaoncol.2015.2378; Puchalski J, 2013, CLIN CHEST MED, V34, P557, DOI 10.1016/j.ccm.2013.05.002; Saji H, 2010, INTERACT CARDIOV TH, V11, P425, DOI 10.1510/icvts.2010.238196; Wallace Akerley, 2015, NATL COMPREHENSIVE C, P32; Wilson GE, 1996, THORAX, V51, P248, DOI 10.1136/thx.51.3.248; Wood DE, 2003, ANN THORAC SURG, V76, P167, DOI 10.1016/S0003-4975(03)00033-X; Zakaluzny SA, 2003, OTOLARYNG HEAD NECK, V128, P478, DOI 10.1016/S0194-5998(03)00002-0	24	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179795	10.1371/journal.pone.0179795	http://dx.doi.org/10.1371/journal.pone.0179795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651011	Green Published, gold, Green Submitted			2022-12-27	WOS:000404537300024
J	Schilgen, B; Nienhaus, A; Handtke, O; Schulz, H; Mosko, M				Schilgen, Benjamin; Nienhaus, Albert; Handtke, Oriana; Schulz, Holger; Moesko, Mike			Health situation of migrant and minority nurses: A systematic review	PLOS ONE			English	Review							JOB CONTENT QUESTIONNAIRE; CULTURAL COMPETENCE; FILIPINO-AMERICAN; WORK-ENVIRONMENT; FEMALE NURSES; IMMIGRANT; EXPERIENCES; DISCRIMINATION; ACCULTURATION; RECRUITMENT	Introduction Globally, life expectancy together with multimorbidity and chronic diseases are increasing. This leads to a growing demand for care and hence for healthcare personnel and nurses. To meet this demand, healthcare workers from abroad are increasingly hired. The nurses' workplace in general is characterized by physically and psychologically demanding tasks, while that of migrant and minority nurses is additionally characterized by discriminatory practices. The present knowledge about the health of migrant and minority nurses and the terminology in this context are diverse. Thus, the purpose of this review is to systematically identify and synthesize international publications that explicitly focus on migrant nurses' health. Materials and methods A systematic review of relevant studies was undertaken using the databases Medline, PsycINFO, CINAHL and Web of Science. The screening process was conducted in several phases. This review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines while the methodological quality assessment of the included papers was performed with the Mixed Method Appraisal Tool (MMAT). Results Out of 11,599 citations initially obtained, 14 empirical studies were included in the final synthesis. The methodological quality of the empirical studies and reviews was diverse. The majority of the studies were conducted in the US and the nurses under study migrated from countries like the Philippines, India, Europe, and Africa. Among migrant nurses of different origins, there are differences in their physiological responses to stress. Migrant nurses and native nurses differ in reporting work-related injuries. Discussion Migrant and minority nurses are at high risk of work-related injuries and discrimination than native or majority nurses. However, mixed results were obtained, namely that the reported health of migrant nurses either improves over time or it decreases. This review revealed that discrimination is the leading cause of impaired health amongst migrant and minority nurses.	[Schilgen, Benjamin; Handtke, Oriana; Schulz, Holger; Moesko, Mike] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany; [Nienhaus, Albert] Univ Med Ctr Hamburg Eppendorf, Inst Hlth Serv Res Dermatol & Nursing, Competence Ctr Epidemiol & Hlth Serv Res Nursing, Hamburg, Germany; [Nienhaus, Albert] German Social Accid Insurance Inst Hlth & Welf Se, Dept Occupat Hlth Res, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Schilgen, B (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany.	b.schilgen@uke.de			Institution for Statutory Accident Insurance and Prevention in the Health and Welfare services	Institution for Statutory Accident Insurance and Prevention in the Health and Welfare services	This work was supported by the Institution for Statutory Accident Insurance and Prevention in the Health and Welfare services Grant recipient is: Dr. Mike MoEsko (BGW). URL: www.bgw-online.de. The fundsare provided by a non-profit organization that is part of the social security system in Germany. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto AM, 2014, EUR J PUBLIC HEALTH, V24, P445, DOI 10.1093/eurpub/cku021; Ahonen EQ, 2007, SCAND J WORK ENV HEA, V33, P96, DOI 10.5271/sjweh.1112; Akresh Ilana Redstone, 2008, Biodemography Soc Biol, V54, P183, DOI 10.1080/19485565.2008.9989141; Allan HT, 2009, J NURS MANAGE, V17, P898, DOI 10.1111/j.1365-2834.2009.00983.x; Amani S, 2014, MIGRATION HLTH WORKE; Amin NA, 2015, INT J OCCUP ENV MED, V6, P232, DOI 10.15171/ijoem.2015.550; [Anonymous], 2015, ILO GLOBAL ESTIMATES; Arksey Hilary., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Assion H-J., 2004, PSYCHIATR REHABIL J, P489; Beechinor LAV, 2008, INT J NURS PRACT, V14, P178, DOI 10.1111/j.1440-172X.2008.00680.x; Bernal D, 2015, INT J NURS STUD, V52, P635, DOI 10.1016/j.ijnurstu.2014.11.003; Bhugra Dinesh, 2005, World Psychiatry, V4, P18; Biering K, 2016, OCCUP ENVIRON MED, P1; BLACK JS, 1991, J INT BUS STUD, V22, P225, DOI 10.1057/palgrave.jibs.8490301; BOLLINI P, 1995, SOC SCI MED, V41, P819, DOI 10.1016/0277-9536(94)00386-8; Brown Daniel E, 2003, Blood Press Monit, V8, P237, DOI 10.1097/00126097-200312000-00003; Brown DE, 2000, PSYCHOSOM MED, V62, P394, DOI 10.1097/00006842-200005000-00013; Campbell J, 2013, FORUM REPORT 3 GLOBA; Carthon JMB, 2014, NURS OUTLOOK, V62, P259, DOI 10.1016/j.outlook.2014.04.006; Castles S, 2000, INT SOC SCI J, V52, P269, DOI 10.1111/1468-2451.00258; Chien TW, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-478; Choobineh A., 2011, Eastern Mediterranean Health Journal, V17, P335; Cohen J, 2009, J NURS CARE QUAL, V24, P308, DOI 10.1097/NCQ.0b013e3181a4699a; Cooper RA, 2002, HEALTH AFFAIR, V21, P140, DOI 10.1377/hlthaff.21.1.140; DeLapp T, 2008, J NURS EDUC, V47, P293, DOI 10.3928/01484834-20080701-06; Delavari M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-458; DEVRIES DH, 2016, HUM RESOUR HEALTH, V14, DOI DOI 10.1186/S12960-016-0136-5; Dunlavy AC, 2016, SOC SCI MED, V154, P36, DOI 10.1016/j.socscimed.2016.02.018; Dunlavy AC, 2013, INT J ENV RES PUB HE, V10, P2871, DOI 10.3390/ijerph10072871; Ea EE, 2008, J NURS SCHOLARSHIP, V40, P46, DOI 10.1111/j.1547-5069.2007.00205.x; Fujishiro K, 2010, AM J IND MED, V53, P194, DOI 10.1002/ajim.20733; Gallagher RW, 2015, NURS EDUC TODAY, V35, P333, DOI 10.1016/j.nedt.2014.10.021; Garner SL, 2015, INT J NURS STUD, V52, P1879, DOI 10.1016/j.ijnurstu.2015.07.003; Ghilan K, 2013, INT J OCCUP MED ENV, V26, P605, DOI 10.2478/s13382-013-0124-0; Han YJ, 2016, PSYCHIAT DANUB, V28, P176; Hayne AN, 2009, J TRANSCULT NURS, V20, P313, DOI 10.1177/1043659609334927; Hener T, 1997, INT J SOC PSYCHIATR, V43, P247, DOI 10.1177/002076409704300402; Henry L, 2007, J CLIN NURS, V16, P2196, DOI 10.1111/j.1365-2702.2007.02094.x; Hogh A, 2011, SCAND J PSYCHOL, V52, P49, DOI 10.1111/j.1467-9450.2010.00840.x; Horrigan JM, 2013, WORKPLACE HEALTH SAF, V61, P173, DOI 10.3928/21650799-20130327-18; Hurtado DA, 2012, INT NURS REV, V59, P237, DOI 10.1111/j.1466-7657.2011.00948.x; Jabali SMT, 2013, INT J OCCUP ENV MED, V4, P96; Janssens H, 2013, J OCCUP HEALTH, V55, P132, DOI 10.1539/joh.12-0164-OA; Kim CW, 2013, ASIAN NURS RES, V7, P128, DOI 10.1016/j.anr.2013.07.003; Kirkcaldy B, 2006, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V49, P873, DOI 10.1007/s00103-006-0021-9; Kline DS, 2003, J NURS SCHOLARSHIP, V35, P107, DOI 10.1111/j.1547-5069.2003.00107.x; Klingler C, 2016, HUM RESOUR HEALTH, V14, DOI 10.1186/s12960-016-0153-4; Lee H, 2016, CLIN PEDIATR, V55, P785, DOI 10.1177/0009922815604599; Lee H, 2016, WORKPLACE HEALTH SAF, V64, P350, DOI 10.1177/2165079916633222; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Li HY, 2014, Int J Nurs Sci, V1, P314, DOI 10.1016/j.ijnss.2014.07.006; Li J., 2014, ELECTRON J DIFFER EQ, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0089893; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Likupe G., 2013, J PSYCHOL ISSUES ORG, V3, P227, DOI [10.1002/jpoc.21071, DOI 10.1002/JPOC.21071]; Likupe G, 2015, J NURS MANAGE, V23, P231, DOI 10.1111/jonm.12119; Liou SR, 2009, NURS RES, V58, P218, DOI 10.1097/NNR.0b013e3181a308cd; Mallender J, 2014, DISCRIMINATION MIGRA; Mathers CD, 2015, LANCET, V385, P540, DOI 10.1016/S0140-6736(14)60569-9; McHugh MD, 2011, HEALTH AFFAIR, V30, P202, DOI 10.1377/hlthaff.2010.0100; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Neiterman E, 2015, HEALTH-LONDON, V19, P615, DOI 10.1177/1363459314567788; Nino A, 2016, J MARITAL FAM THER, V42, P123, DOI 10.1111/jmft.12115; Okechukwu CA, 2014, AM J IND MED, V57, P573, DOI 10.1002/ajim.22221; Olaussen SJ, 2016, AUST J PRIM HEALTH, V22, P100, DOI 10.1071/PY14114; Organisation for Economic and Co-operative Development, 2015, INT MIGR OUTL 2015; Organisation for Economic Cooperation and Development, 2009, INT MIGR OUTL 2009 S; Organisation for Economic Cooperation and Development, 2015, HLTH WORKF MIGR; Pace R., 2010, 38 ANN M N AM PRIM C; Paradies Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138511; Pittman P, 2014, AM J NURS, V114, P26, DOI 10.1097/01.NAJ.0000441792.93279.29; Pluye P., 2011, PROPOSAL MIXED METHO; Prince MJ, 2015, LANCET, V385, P549, DOI 10.1016/S0140-6736(14)61347-7; Pung LX, 2016, INT NURS REV; Renzaho AMN, 2013, INT J QUAL HEALTH C, V25, P261, DOI 10.1093/intqhc/mzt006; Renzaho AMN, 2016, GLOBALISATION MIGRAT, P1; Renzaho AMN, THEORISING SOCIAL EX, P117; Renzaho A, 2008, AUST HEALTH REV, V32, P223, DOI 10.1071/AH080223; Ribeiro RP, 2012, REV ESC ENFERM USP, V46, P495, DOI 10.1590/S0080-62342012000200031; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; Sashidharan T, 2012, CULT DIVERS ETHN MIN, V18, P203, DOI 10.1037/a0027689; Satyen L., 2016, GLOBALISATION MIGRAT, P479, DOI [10.1142/9781783268894_0014, DOI 10.1142/9781783268894_0014]; Schenker MB, 2010, AM J IND MED, V53, P329, DOI 10.1002/ajim.20834; Shen ZW, 2015, J TRANSCULT NURS, V26, P308, DOI 10.1177/1043659614524790; Shields MA, 2002, ECONOMICA, V69, P295, DOI 10.1111/1468-0335.00284; Shutes I, 2012, SOC POLIT, V19, P78, DOI 10.1093/sp/jxr025; SIMOENS S, 2005, OECD HLTH WORKING PA, V19; Simpson CL, 2000, J OCCUP ENVIRON MED, V42, P1035, DOI 10.1097/00043764-200010000-00011; Stevens GWJM, 2003, SOC PSYCH PSYCH EPID, V38, P576, DOI 10.1007/s00127-003-0677-5; Tak S, 2010, AM J IND MED, V53, P951, DOI 10.1002/ajim.20852; Taylor R., 2011, HLTH REF M CHALL AG; Wallace JE, 2009, LANCET, V374, P1714, DOI 10.1016/S0140-6736(09)61424-0; Wang CW, 2008, J TRANSCULT NURS, V19, P140, DOI 10.1177/1043659607312968; World Health Organization, 2006, LIST 57 COUNTR FAC R; World Health Organization (WHO), 2010, WHO GLOB COD PRACT I; Xu Yu, 2008, ANS Adv Nurs Sci, V31, pE33, DOI 10.1097/01.ANS.0000319570.99254.e5	96	23	24	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179183	10.1371/journal.pone.0179183	http://dx.doi.org/10.1371/journal.pone.0179183			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ2KD	28650981	Green Published, Green Submitted, gold			2022-12-27	WOS:000404537300050
J	Vanneste, S; Ost, J; Van Havenbergh, T; De Ridder, D				Vanneste, Sven; Ost, Jan; Van Havenbergh, Tony; De Ridder, Dirk			Resting state electrical brain activity and connectivity in fibromyalgia	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; ELECTROMAGNETIC TOMOGRAPHY; ANTERIOR THALAMUS; CLINICAL PAIN; PHASE SYNCHRONY; INSULAR CORTEX; LOCALIZATION; STIMULATION; EEG; NETWORK	The exact mechanism underlying fibromyalgia is unknown, but increased facilitatory modulation and/or dysfunctional descending inhibitory pathway activity are posited as possible mechanisms contributing to sensitization of the central nervous system. The primary goal of this study is to identify a fibromyalgia neural circuit that can account for these abnormalities in central pain. The second goal is to gain a better understanding of the functional connectivity between the default and the executive attention network (salience network plus dorsal lateral prefrontal cortex) in fibromyalgia. We examine neural activity associated with fibromyalgia (N = 44) and compare these with healthy controls (N = 44) using resting state source localized EEG. Our data support an important role of the pregenual anterior cingulate cortex but also suggest that the degree of activation and the degree of integration between different brain areas is important. The inhibition of the connectivity between the dorsal lateral prefrontal cortex and the posterior cingulate cortex on the pain inhibitory pathway seems to be limited by decreased functional connectivity with the pregenual anterior cingulate cortex. Our data highlight the functional dynamics of brain regions integrated in brain networks in fibromyalgia patients.	[Vanneste, Sven] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA; [Ost, Jan; Van Havenbergh, Tony] Sint Augustinus Hosp Antwerp, BRAI2N, Antwerp, Belgium; [De Ridder, Dirk] Univ Otago, Dunedin Sch Med, Sect Neurosurg, Dept Surg Sci, Dunedin, New Zealand	University of Texas System; University of Texas Dallas; University of Otago	Vanneste, S (corresponding author), Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA.	sven.vanneste@utdallas.edu		Vanneste, Sven/0000-0003-1513-5752				[Anonymous], 1950, PSYCHOSURGERY; Anticevic A, 2012, TRENDS COGN SCI, V16, P584, DOI 10.1016/j.tics.2012.10.008; Babiloni F, 2005, NEUROIMAGE, V24, P118, DOI 10.1016/j.neuroimage.2004.09.036; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Bennett R, 2005, CLIN EXP RHEUMATOL, V23, pS154; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; Chen Andrew C. N., 1994, Brain Topography, V7, P129, DOI 10.1007/BF01186771; Cifre I, 2012, PSYCHOSOM MED, V74, P55, DOI 10.1097/PSY.0b013e3182408f04; Congedo M., 2002, EUREKA VERSION 3 0 C; David O, 2002, IEEE T BIO-MED ENG, V49, P975, DOI 10.1109/TBME.2002.802013; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; Dierks T, 2000, CLIN NEUROPHYSIOL, V111, P1817, DOI 10.1016/S1388-2457(00)00427-2; Domnick Claudia, 2009, J Pain Res, V2, P49; Engel AK, 2013, NEURON, V80, P867, DOI 10.1016/j.neuron.2013.09.038; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Erpelding N, 2012, PAIN, V153, P1602, DOI 10.1016/j.pain.2012.03.012; Fallon N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159198; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Huber MT, 2006, EXP BRAIN RES, V173, P14, DOI 10.1007/s00221-006-0366-1; Iannetti GD, 2010, EXP BRAIN RES, V205, P1, DOI 10.1007/s00221-010-2340-1; Ichesco E, 2014, J PAIN, V15, P815, DOI 10.1016/j.jpain.2014.04.007; Jensen KB, 2013, ARTHRITIS RHEUM-US, V65, P3293, DOI 10.1002/art.38170; Jensen KB, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-32; Jensen KB, 2009, PAIN, V144, P95, DOI 10.1016/j.pain.2009.03.018; Joos K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040544; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Kujala J, 2008, NEUROIMAGE, V39, P1706, DOI 10.1016/j.neuroimage.2007.10.042; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Llinas RR, 2009, PHILOS T R SOC B, V364, P1301, DOI 10.1098/rstb.2008.0309; Loggia ML, 2014, ARTHRITIS RHEUMATOL, V66, P203, DOI [10.1002/art.38396, 10.1002/art.38191]; Martinez-Lavin M, 2009, RHEUM DIS CLIN N AM, V35, P285, DOI 10.1016/j.rdc.2009.05.005; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Meeus M, 2007, CLIN RHEUMATOL, V26, P465, DOI 10.1007/s10067-006-0433-9; Metz AE, 2009, P NATL ACAD SCI USA, V106, P2423, DOI 10.1073/pnas.0809897106; Moriarty O, 2012, J NEUROSCI METH, V204, P1, DOI 10.1016/j.jneumeth.2011.10.024; Mouraux A, 2011, NEUROIMAGE, V54, P2237, DOI 10.1016/j.neuroimage.2010.09.084; Mulert C, 2004, NEUROIMAGE, V22, P83, DOI 10.1016/j.neuroimage.2003.10.051; Napadow V, 2012, ARTHRITIS RHEUM-US, V64, P2398, DOI 10.1002/art.34412; Napadow V, 2010, ARTHRITIS RHEUM-US, V62, P2545, DOI 10.1002/art.27497; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nir RR, 2012, CLIN NEUROPHYSIOL, V123, P605, DOI 10.1016/j.clinph.2011.08.006; Nir RR, 2010, BRAIN RES, V1344, P77, DOI 10.1016/j.brainres.2010.05.004; Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pascual-Marqui RD, 2007, 07103341 ARXIV; Pereira EAC, 2014, BRIT J NEUROSURG, V28, P471, DOI 10.3109/02688697.2013.857006; Pizzagalli D, 2001, AM J PSYCHIAT, V158, P405, DOI 10.1176/appi.ajp.158.3.405; Pizzagalli DA, 2004, MOL PSYCHIATR, V9, P393, DOI 10.1038/sj.mp.4001469; Pujol J, 2014, PAIN, V155, P1492, DOI 10.1016/j.pain.2014.04.028; Pujol J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005224; Rahm B, 2015, COMPR PSYCHIAT, V59, P80, DOI 10.1016/j.comppsych.2015.02.005; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Rengachary J, 2011, FRONT HUM NEUROSCI, V5, DOI [10.3389/fnhum.2011.00029, 10.3389/fnhum.2011.00069]; Richter P, 1998, PSYCHOPATHOLOGY, V31, P160, DOI 10.1159/000066239; Roelofs J, 2003, PAIN, V101, P299, DOI 10.1016/S0304-3959(02)00338-X; Rotge J., 2014, SOC COGN AFFECT NEUR; Sadaghiani S, 2012, J NEUROSCI, V32, P14305, DOI 10.1523/JNEUROSCI.1358-12.2012; Sadaghiani S, 2010, J NEUROSCI, V30, P10243, DOI 10.1523/JNEUROSCI.1004-10.2010; Schacter DL, 2012, AM PSYCHOL, V67, P603, DOI 10.1037/a0029869; Schmidt-Wilcke T, 2014, NEUROIMAGE-CLIN, V6, P252, DOI 10.1016/j.nicl.2014.09.007; Schmidt-Wilcke T, 2014, PAIN MED, V15, P1346, DOI 10.1111/pme.12460; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Sterling P, 2012, PHYSIOL BEHAV, V106, P5, DOI 10.1016/j.physbeh.2011.06.004; Truini A, 2016, CLIN EXP RHEUMATOL, V34, pS129; Vanneste S., 2010, CLIN NEUROPHYSIOL; Vanneste S, 2011, EUR J NEUROSCI, V34, P605, DOI 10.1111/j.1460-9568.2011.07778.x; Vanneste S, 2011, CLIN NEUROPHYSIOL, V122, P578, DOI 10.1016/j.clinph.2010.07.022; Vitacco D, 2002, HUM BRAIN MAPP, V17, P4, DOI 10.1002/hbm.10038; Volpe U, 2007, BRAIN RES BULL, V73, P220, DOI 10.1016/j.brainresbull.2007.03.003; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Wiech K, 2010, J NEUROSCI, V30, P16324, DOI 10.1523/JNEUROSCI.2087-10.2010; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2013, NAT REV RHEUMATOL, V9, P751, DOI 10.1038/nrrheum.2013.96; Worrell GA, 2000, BRAIN TOPOGR, V12, P273, DOI 10.1023/A:1023407521772; Zaehle T, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-63; Zumsteg D, 2006, CLIN NEUROPHYSIOL, V117, P192, DOI 10.1016/j.clinph.2005.09.015; Zumsteg D, 2005, NEUROLOGY, V65, P1657, DOI 10.1212/01.wnl.0000184516.32369.1a; Zumsteg D, 2006, EPILEPSIA, V47, P1958, DOI 10.1111/j.1528-1167.2006.00824.x; Zumsteg D, 2006, CLIN NEUROPHYSIOL, V117, P1602, DOI 10.1016/j.clinph.2006.04.008	82	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0178516	10.1371/journal.pone.0178516	http://dx.doi.org/10.1371/journal.pone.0178516			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ2KD	28650974	Green Published, gold, Green Submitted			2022-12-27	WOS:000404537300047
J	Panzuto, F; Cicchese, N; Partelli, S; Rinzivillo, M; Capurso, G; Merola, E; Manzoni, M; Pucci, E; Iannicelli, E; Pilozzi, E; Rossi, M; Doglioni, C; Falconi, M; Delle Fave, G				Panzuto, Francesco; Cicchese, Noemi; Partelli, Stefano; Rinzivillo, Maria; Capurso, Gabriele; Merola, Elettra; Manzoni, Marco; Pucci, Eugenio; Iannicelli, Elsa; Pilozzi, Emanuela; Rossi, Michele; Doglioni, Claudio; Falconi, Massimo; Delle Fave, Gianfranco			Impact of Ki67 re-assessmentat time of disease progression in patients with pancreatic neuroendocrine neoplasms	PLOS ONE			English	Article							TUMORS; GUIDELINES; METASTASES; MANAGEMENT; INDEX	Background Although re-assessment of proliferative activity by K67 evaluation during the course of neuroendocrine neoplasms (NENs) is recommended in selected patients, its impact on patients' management is not clear due to the lack of data supporting this practice. Aim To investigate Ki67 change at time of progressive disease (PD) in entero-pancreatic NENs (EP-NENs). Patients and methods Retrospective analysis of sporadic EP-NENs which received histological re-assessment after PD once radiologically documented. Results Forty-three patients were evaluated, including 24 pancreatic NENs (PNENs), and 19 small intestine NENs (SI-NENs). At time of initial histological evaluation, 19 patients had grade 1 (G1) NETs (44.2%), and 24 grade 2 (G2) NETs (55.8%), overall median Ki67 being 3% (range 1%-20%). At time of PD, 13 patients had G1 NETs (30.2%), 26 G2 NETs (60.5%), and 4 had grade 3 (G3) NECs (9.3%), thus resulting in a significant median Ki67 increase (8%, range 1%-70%; p = 0.0006), and a G upgrading in 12 patients (27.9%). A statistically significant Ki67 increase and G grading change at time of PD was observed in PNENs (p = 0.0005 and p = 0.028, respectively). Conversely, no statistically significant change occurred in non-PNENs. Conclusions In PNENs with documented PD, Ki67 increase occurs in a significant proportion of patients, providing useful information necessary to choose appropriate therapeutic options.	[Panzuto, Francesco; Cicchese, Noemi; Rinzivillo, Maria; Capurso, Gabriele; Merola, Elettra; Delle Fave, Gianfranco] Sapienza Univ Rome, St Andrea Hosp, Digest & Liver Dis Unit, Rome, Italy; [Partelli, Stefano; Falconi, Massimo] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Pancreas Translat & Clin Res Ctr, Pancreat Surg Unit, Milan, Italy; [Manzoni, Marco] San Raffaele Hosp Sci Inst, Dept Endocrinol & Internal Med, Milan, Italy; [Pucci, Eugenio; Pilozzi, Emanuela] Sapienza Univ Rome, St Andrea Hosp, Dept Expt Med & Pathol, Rome, Italy; [Iannicelli, Elsa; Rossi, Michele] Sapienza Univ Rome, St Andrea Hosp, Dept Radiol, Rome, Italy; [Doglioni, Claudio] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Dept Pathol, Milan, Italy	Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Panzuto, F (corresponding author), Sapienza Univ Rome, St Andrea Hosp, Digest & Liver Dis Unit, Rome, Italy.	francesco.panzuto@ospedalesantandrea.it	Manzoni, Marco Federico/AAB-1738-2021; Panzuto, Francesco/Y-2882-2019; merola, elettra/AAJ-1189-2020; Capurso, Gabriele/AAB-1389-2019; PILOZZI, Emanuela/AAC-1854-2022; Partelli, Stefano/K-3787-2018	Panzuto, Francesco/0000-0003-2789-4289; merola, elettra/0000-0001-9553-7684; Capurso, Gabriele/0000-0002-0019-8753; PILOZZI, Emanuela/0000-0002-7110-9172; Partelli, Stefano/0000-0001-8938-6170; Falconi, Massimo/0000-0001-9654-7243	AIRC [IG 2015, Id 17177]	AIRC(Fondazione AIRC per la ricerca sul cancro)	This work was supported by AIRC grant IG 2015, Id 17177.	Coriat R, 2016, ONCOLOGIST, V21, P1191, DOI 10.1634/theoncologist.2015-0476; Frilling A, 2014, LANCET ONCOL, V15, pE8, DOI 10.1016/S1470-2045(13)70362-0; Grillo F, 2016, NEUROENDOCRINOLOGY, V103, P452, DOI 10.1159/000439434; Miller HC, 2014, WORLD J SURG, V38, P1353, DOI 10.1007/s00268-014-2451-0; Oberg K, 2012, ANN ONCOL, V23, P124, DOI 10.1093/annonc/mds295; Panzuto F, 2005, ENDOCR-RELAT CANCER, V12, P1083, DOI 10.1677/erc.1.01017; Panzuto F, 2012, NEUROENDOCRINOLOGY, V96, P32, DOI 10.1159/000334038; Panzuto F, 2011, J CLIN ONCOL, V29, P2372, DOI 10.1200/JCO.2010.33.0688; Pape UF, 2008, CANCER-AM CANCER SOC, V113, P256, DOI 10.1002/cncr.23549; Pavel M, 2016, NEUROENDOCRINOLOGY, V103, P172, DOI 10.1159/000443167; Rindi G, 2012, JNCI-J NATL CANCER I, V104, P764, DOI 10.1093/jnci/djs208; Rindi G., 2010, WHO CLASSIFICATION T, pS13; Rindi G, 2011, DIGEST LIVER DIS, V43, pS356, DOI 10.1016/S1590-8658(11)60591-4; Simsek DH, 2014, J NUCL MED, V55, P1811, DOI 10.2967/jnumed.114.142224; Singh S, 2014, EJSO-EUR J SURG ONC, V40, P1517, DOI 10.1016/j.ejso.2014.06.016; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205	16	32	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179445	10.1371/journal.pone.0179445	http://dx.doi.org/10.1371/journal.pone.0179445			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644861	Green Published, Green Submitted, gold			2022-12-27	WOS:000404145100015
J	Wang, J; Wang, ZL; Du, XF; Yang, HQ; Han, F; Han, YH; Yuan, F; Zhang, LY; Peng, SZ; Guo, EH				Wang, Jun; Wang, Zhilan; Du, Xiaofen; Yang, Huiqing; Han, Fang; Han, Yuanhuai; Yuan, Feng; Zhang, Linyi; Peng, Shuzhong; Guo, Erhu			A high-density genetic map and QTL analysis of agronomic traits in foxtail millet [Setaria italica (L.) P. Beauv.] using RAD-seq	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MARKERS; CONSTRUCTION; SEQUENCE; DNA; MODEL; RICE; LOCI; DIVERSITY; VIRIDIS	Foxtail millet (Setaria italica), a very important grain crop in China, has become a new model plant for cereal crops and biofuel grasses. Although its reference genome sequence was released recently, quantitative trait loci (QTLs) controlling complex agronomic traits remains limited. The development of massively parallel genotyping methods and next-generation sequencing technologies provides an excellent opportunity for developing single-nucleotide polymorphisms (SNPs) for linkage map construction and QTL analysis of complex quantitative traits. In this study, a high-throughput and cost-effective RAD-seq approach was employed to generate a high-density genetic map for foxtail millet. A total of 2,668,587 SNP loci were detected according to the reference genome sequence; meanwhile, 9,968 SNP markers were used to genotype 124 F-2 progenies derived from the cross between Hongmiaozhangu and Changnong35; a high-density genetic map spanning 1648.8 cM, with an average distance of 0.17 cM between adjacent markers was constructed; 11 major QTLs for eight agronomic traits were identified; five co-dominant DNA markers were developed. These findings will be of value for the identification of candidate genes and marker-assisted selection in foxtail millet.	[Wang, Jun; Wang, Zhilan; Du, Xiaofen; Yang, Huiqing; Yuan, Feng; Zhang, Linyi; Peng, Shuzhong; Guo, Erhu] Shanxi Acad Agr Sci, Millet Res Inst, Changzhi, Shanxi, Peoples R China; [Wang, Jun; Wang, Zhilan; Du, Xiaofen; Yang, Huiqing; Yuan, Feng; Zhang, Linyi; Peng, Shuzhong; Guo, Erhu] Shanxi Key Lab Genet Resources & Breeding Minor C, Changzhi, Shanxi, Peoples R China; [Han, Fang] Res Inst Agr Sci Yanan, Yanan, Shaanxi, Peoples R China; [Han, Yuanhuai] Shanxi Agr Univ, Taigu, Shanxi, Peoples R China	Shanxi Agricultural University; Shanxi Agricultural University	Wang, J; Guo, EH (corresponding author), Shanxi Acad Agr Sci, Millet Res Inst, Changzhi, Shanxi, Peoples R China.; Wang, J; Guo, EH (corresponding author), Shanxi Key Lab Genet Resources & Breeding Minor C, Changzhi, Shanxi, Peoples R China.	128wan@163.com; guoerhu2003@163.com			Science and Technology Independent Innovation Ability Upgrading Project of Shanxi Province Academy of Agricultural Sciences [2015ZZCX-09, 2016ZZCX-9]; Shanxi Province Youth Fund [2015021143]; Agricultural Science and Technology Innovation Research Project of Shanxi Academy of Agricultural Sciences [ZDSYS1504]; Chinese Agricultural Research System [CRRS-07]	Science and Technology Independent Innovation Ability Upgrading Project of Shanxi Province Academy of Agricultural Sciences; Shanxi Province Youth Fund; Agricultural Science and Technology Innovation Research Project of Shanxi Academy of Agricultural Sciences; Chinese Agricultural Research System	This research was supported by the Science and Technology Independent Innovation Ability Upgrading Project of Shanxi Province Academy of Agricultural Sciences (2015ZZCX-09,2016ZZCX-9), Shanxi Province Youth Fund (2015021143), the Agricultural Science and Technology Innovation Research Project of Shanxi Academy of Agricultural Sciences (ZDSYS1504), and the Chinese Agricultural Research System (CRRS-07).	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Bai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073514; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barakat MN, 2013, BIOL PLANTARUM, V57, P79, DOI 10.1007/s10535-012-0138-7; Barton L, 2009, P NATL ACAD SCI USA, V106, P5523, DOI 10.1073/pnas.0809960106; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Bolger ME, 2014, CURR OPIN BIOTECH, V26, P31, DOI 10.1016/j.copbio.2013.08.019; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Brutnell TP, 2010, PLANT CELL, V22, P2537, DOI 10.1105/tpc.110.075309; Cabezas JA, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-153; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Davey JL, 2010, BRIEF FUNCT GENOMICS, V9, P416, DOI 10.1093/bfgp/elq031; Doust AN, 2004, P NATL ACAD SCI USA, V101, P9045, DOI 10.1073/pnas.0402892101; Fang XM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2628-z; Gupta S, 2011, GENOME, V54, P586, DOI [10.1139/G11-020, 10.1139/g11-020]; Hackett CA, 2003, HEREDITY, V90, P33, DOI 10.1038/sj.hdy.6800173; Herlina L, 2016, MAKARA J SCI, V20, P17, DOI 10.7454/mss.v20i1.5657; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Hudson CJ, 2012, TREE GENET GENOMES, V8, P339, DOI 10.1007/s11295-011-0444-9; Jia GQ, 2013, NAT GENET, V45, P957, DOI 10.1038/ng.2673; Jia XP, 2007, GENET RESOUR CROP EV, V54, P233, DOI 10.1007/s10722-006-9139-8; Jia XP, 2009, THEOR APPL GENET, V118, P821, DOI 10.1007/s00122-008-0942-9; Kumari K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067742; Lata C, 2013, CRIT REV BIOTECHNOL, V33, P328, DOI 10.3109/07388551.2012.716809; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li HJ, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0503-9; Li PH, 2011, J EXP BOT, V62, P3031, DOI 10.1093/jxb/err096; Li W, 2016, PHYSIOL PLANTARUM, V157, P24, DOI 10.1111/ppl.12405; Liu MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071067; Liu MinXuan, 2013, Acta Agronomica Sinica, V39, P398, DOI 10.3724/SP.J.1006.2013.00398; Liu SanCai, 2009, Scientia Agricultura Sinica, V42, P3812; Liu XT, 2016, J EXP BOT, V67, P3237, DOI 10.1093/jxb/erw135; MARKLUND S, 1995, ANIM GENET, V26, P193, DOI 10.1111/j.1365-2052.1995.tb03162.x; Masumoto H, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0481-z; Mauro-Herrera M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151346; Mauro-Herrera M, 2013, G3-GENES GENOM GENET, V3, P283, DOI 10.1534/g3.112.005207; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Muthamilarasan M, 2015, THEOR APPL GENET, V128, P1, DOI 10.1007/s00122-014-2399-3; Obidiegwu ON, 2013, GENES GENOM, V35, P609, DOI 10.1007/s13258-013-0110-8; Pandey G, 2013, DNA RES, V20, P197, DOI 10.1093/dnares/dst002; Pfender WF, 2011, THEOR APPL GENET, V122, P1467, DOI 10.1007/s00122-011-1546-3; Qie LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101868; Raman H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-277; Richards PM, 2013, MOL ECOL, V22, P3077, DOI 10.1111/mec.12262; Sato K, 2013, MOL BREEDING, V31, P675, DOI 10.1007/s11032-012-9825-5; [邵丽华 Shao Lihua], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P1265; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Takagi H, 2013, PLANT J, V74, P174, DOI 10.1111/tpj.12105; Tasma IM, 2016, JURNAL AGROBIOGEN, V4, P1; Tomaszewski C, 2012, PLANT BREEDING, V131, P345, DOI 10.1111/j.1439-0523.2011.01944.x; Wang HaiGang, 2016, Acta Agronomica Sinica, V42, P19; [王晓宇 Wang Xiaoyu], 2013, [植物遗传资源学报, Journal of Plant Genetic Resources], V14, P871; Wang ZM, 1998, THEOR APPL GENET, V96, P31, DOI 10.1007/s001220050705; Wu YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000212; Xue CX, 2016, CROP SCI, V56, P95, DOI 10.2135/cropsci2015.05.0331; Yadav CB, 2015, DNA RES, V22, P79, DOI 10.1093/dnares/dsu039; Zeng DL, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.31; Zhai HJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01617; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhang S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-78	61	31	39	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179717	10.1371/journal.pone.0179717	http://dx.doi.org/10.1371/journal.pone.0179717			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644843	Green Published, Green Submitted, gold			2022-12-27	WOS:000404145100035
J	Bernaudo, S; Khazai, S; Honarparvar, E; Kopteva, A; Peng, C				Bernaudo, Stefanie; Khazai, Shahin; Honarparvar, Eilyad; Kopteva, Alina; Peng, Chun			Epidermal growth factor promotes cyclin G2 degradation via calpain-mediated proteolysis in gynaecological cancer cells	PLOS ONE			English	Article							EPITHELIAL OVARIAN-CANCER; KAPPA-B-ALPHA; PHOSPHORYLATION SITES; DOWN-REGULATION; EXPRESSION; PROTEIN; KINASE; UBIQUITIN; ACTIVATION; PATHWAY	Cyclin G2 (CCNG2) is an atypical cyclin that functions to inhibit cell cycle progression and is often dysregulated in human cancers. We have previously shown that cyclin G2 is highly unstable and can be degraded through the ubiquitin/proteasome pathway. Furthermore, cyclin G2 contains a PEST domain, which has been suggested to act as a signal for degradation by multiple proteases. In this study, we determined if calpains, a family of calciumdependent proteases, are also involved in cyclin G2 degradation. The addition of calpain inhibitors or silencing of calpain expression by siRNAs strongly enhanced cyclin G2 levels. On the other hand, incubation of cell lysates with purified calpains or increasing the intracellular calcium concentration resulted in a decrease in cyclin G2 levels. Interestingly, the effect of calpain was found to be dependent on the phosphorylation of cyclin G2. Using a kinase inhibitor library, we found that Epidermal Growth Factor (EGF) Receptor is involved in cyclin G2 degradation and treatment with its ligand, EGF, induced cyclin G2 degradation. In addition, the presence of the PEST domain is necessary for calpain and EGF action. When the PEST domain was completely removed, calpain or EGF treatment failed to trigger degradation of cyclin G2. Taken together, these novel findings demonstrate that EGF-induced, calpain-mediated proteolysis contributes to the rapid destruction of cyclin G2 and that the PEST domain is critical for EGF/calpain actions.	[Bernaudo, Stefanie; Khazai, Shahin; Honarparvar, Eilyad; Kopteva, Alina; Peng, Chun] York Univ, Dept Biol, Toronto, ON, Canada; [Peng, Chun] York Univ, Fac Sci, Ctr Res Biomol Interact, Toronto, ON, Canada	York University - Canada; York University - Canada	Peng, C (corresponding author), York Univ, Dept Biol, Toronto, ON, Canada.; Peng, C (corresponding author), York Univ, Fac Sci, Ctr Res Biomol Interact, Toronto, ON, Canada.	cpeng@yorku.ca			Canadian Institutes of Health Research [MOP-89931]; Ontario Graduate Scholarship; National Science and Engineering Research Council of Canada Graduate Studentship; York University Susan Mann Dissertation Scholarships	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); National Science and Engineering Research Council of Canada Graduate Studentship; York University Susan Mann Dissertation Scholarships	This study was supported by an operating grant from Canadian Institutes of Health Research to CP (MOP-89931). SB was supported by Ontario Graduate Scholarship, The National Science and Engineering Research Council of Canada Graduate Studentship, and The York University Susan Mann Dissertation Scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2012, MOL CANCER RES, V10, P636, DOI 10.1158/1541-7786.MCR-11-0502; Alberti C, 2012, ONCOGENE, V31, P4139, DOI 10.1038/onc.2011.572; Bennin DA, 2002, J BIOL CHEM, V277, P27449, DOI 10.1074/jbc.M111693200; Bernaudo S, 2016, ONCOGENE, V35, P4828, DOI 10.1038/onc.2016.65; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Cheng C, 2016, MOL MED REP, V13, P3763, DOI 10.3892/mmr.2016.5037; Cheng JC, 2010, MOL ENDOCRINOL, V24, P1569, DOI 10.1210/me.2010-0034; Don ASA, 2006, EXP CELL RES, V312, P4181, DOI 10.0116/j.yexcr.2006.09.023; Fan X., 2014, PLOS ONE, V9; Fu G, 2011, ONCOGENE, V30, P3953, DOI 10.1038/onc.2011.127; Gali-Muhtasib H, 2002, CURR CANCER DRUG TAR, V2, P309, DOI 10.2174/1568009023333809; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Glading A, 2001, J BIOL CHEM, V276, P23341, DOI 10.1074/jbc.M008847200; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Han W, 2012, CANCER LETT, V318, P124, DOI 10.1016/j.canlet.2012.01.011; HERSHKO A, 1991, J BIOL CHEM, V266, P16376; Horne MC, 1996, J BIOL CHEM, V271, P6050, DOI 10.1074/jbc.271.11.6050; Ito Y, 2003, ANTICANCER RES, V23, P2335; Jeong KJ, 2013, MOL ONCOL, V7, P121, DOI 10.1016/j.molonc.2012.10.001; Khorchid A, 2002, NAT STRUCT BIOL, V9, P239, DOI 10.1038/nsb0402-239; Kiernan RE, 2001, MOL CELL BIOL, V21, P7956, DOI 10.1128/MCB.21.23.7956-7970.2001; Kim Y, 2004, CANCER RES, V64, P8980, DOI 10.1158/0008-5472.CAN-04-1926; Kong L, 2011, MOL CELL BIOCHEM, V348, P11, DOI 10.1007/s11010-010-0632-1; Korch C, 2012, GYNECOL ONCOL, V127, P241, DOI 10.1016/j.ygyno.2012.06.017; Le XF, 2007, MOL CANCER THER, V6, P2843, DOI 10.1158/1535-7163.MCT-07-0109; Liu J, 2004, WORLD J GASTROENTERO, V10, P1357; Martinez LO, 2003, J BIOL CHEM, V278, P37368, DOI 10.1074/jbc.M307161200; Mourgues L, 2015, LEUKEMIA, V29, P1993, DOI 10.1038/leu.2015.112; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Narayanan R, 2012, INT J ONCOL, V40, P13, DOI 10.3892/ijo.2011.1211; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Ohno S, 2016, SCI REP-UK, V6, DOI 10.1038/srep39091; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; PINES J, 1995, BIOCHEM J, V308, P697, DOI 10.1042/bj3080697; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; SAIDO TC, 1994, FASEB J, V8, P814, DOI 10.1096/fasebj.8.11.8070630; Sandoval A, 2006, EUR J NEUROSCI, V23, P2311, DOI 10.1111/j.1460-9568.2006.04749.x; Schrevel M, 2011, MODERN PATHOL, V24, P720, DOI 10.1038/modpathol.2010.239; Shen J, 2001, J IMMUNOL, V167, P4919, DOI 10.4049/jimmunol.167.9.4919; Shiraha H, 2002, MOL CELL BIOL, V22, P2716, DOI 10.1128/MCB.22.8.2716-2727.2002; Shumway SD, 1999, J BIOL CHEM, V274, P30874, DOI 10.1074/jbc.274.43.30874; So WK, 2015, FEBS LETT, V589, P302, DOI 10.1016/j.febslet.2014.12.012; Stossi F, 2006, J BIOL CHEM, V281, P16272, DOI 10.1074/jbc.M513405200; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; van Duijn PW, 2010, PROSTATE, V70, P135, DOI 10.1002/pros.21045; Wang S, 2016, MOL MED REP, V13, P273, DOI 10.3892/mmr.2015.4557; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Xu GX, 2008, MOL BIOL CELL, V19, P4968, DOI 10.1091/mbc.E08-03-0259; Xu GX, 2004, J CLIN ENDOCR METAB, V89, P5523, DOI 10.1210/jc.2004-0893; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; Ye G, 2011, J CELL SCI, V124, P359, DOI 10.1242/jcs.072223; Yin GZ, 2016, ONCOL REP, V36, P1111, DOI 10.3892/or.2016.4876; Zimmermann M, 2016, CELL CYCLE, V15, P3278, DOI 10.1080/15384101.2016.1243189	54	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179906	10.1371/journal.pone.0179906	http://dx.doi.org/10.1371/journal.pone.0179906			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640887	Green Published, Green Submitted, gold			2022-12-27	WOS:000404135800081
J	Casonato, A; Daidone, V; Galletta, E; Bertomoro, A				Casonato, Alessandra; Daidone, Viviana; Galletta, Eva; Bertomoro, Antonella			Type 2B von Willebrand disease with or without large multimers: A distinction of the two sides of the disorder is long overdue	PLOS ONE			English	Article							1-DESAMINO-8-D-ARGININE VASOPRESSIN DDAVP; IIB VONWILLEBRANDS DISEASE; PLATELET-AGGREGATION; THROMBOCYTOPENIA; BINDING; RISTOCETIN; PLASMA; MUTATIONS; PATIENT; PSEUDOTHROMBOCYTOPENIA	Most, but not all patients with type 2B von Willebrand disease (VWD) D which features gain-of- function mutations in the A1 domain of von Willebrand factor (VWF) D have no circulating large VWF multimers. Similarities and differences were analysed in 33 type 2B patients, 12 with a normal and 21 with an abnormal multimer pattern, to see whether they should be considered separately. The minimum aggregating dose of ristocetin was similarly reduced in both patient groups, and modulated by their underlying VWF mutations. Platelet VWF content was normal in all patients lacking in large multimers, but sometimes reduced in those with a normal multimer pattern. All the former patients and none of the latter had persistent or transient thrombocytopenia. A short VWF half-life (affecting plasma VWF levels) was seen in both groups, but more pronounced in patients without large multimers. Bleeding scores were also high in all patients, but more so in those without large multimers, apparently regardless of their platelet count. The marked phenotypic heterogeneity of type 2B VWD concerns not only patients' VWF multimer pattern, but also their bleeding risk, and consequently their appropriate treatment too. Hence the need to clearly distinguish between type 2B VWD with normal or abnormal VWF multimers.	[Casonato, Alessandra; Daidone, Viviana; Galletta, Eva] Univ Padua, Dept Med, Thrombohaemorrhag Disorders Unit, Padua, Italy; [Bertomoro, Antonella] Univ Padua, Dept Med, Internal Med, Padua, Italy	University of Padua; University of Padua	Casonato, A (corresponding author), Univ Padua, Dept Med, Thrombohaemorrhag Disorders Unit, Padua, Italy.	sandra.casonato@unipd.it			Ministero dell'Universita e della Ricerca Scientifica e Tecnologica	Ministero dell'Universita e della Ricerca Scientifica e Tecnologica(Ministry of Education, Universities and Research (MIUR))	This work was supported by a grant from the Ministero dell'Universita e della Ricerca Scientifica e Tecnologica(60%, 2014). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CASONATO A, 1991, BLOOD COAGUL FIBRIN, V2, P33, DOI 10.1097/00001721-199102000-00005; CASONATO A, 1994, BLOOD COAGUL FIBRIN, V5, P959, DOI 10.1097/00001721-199412000-00013; Casonato A, 1997, J LAB CLIN MED, V129, P251, DOI 10.1016/S0022-2143(97)90147-5; CASONATO A, 1989, BLOOD, V74, P2028; CASONATO A, 1990, EUR J HAEMATOL, V45, P36; CASONATO A, 1990, THROMB HAEMOSTASIS, V64, P117; Casonato A, 1999, THROMB HAEMOSTASIS, V81, P224; Casonato A, 2007, THROMB HAEMOSTASIS, V98, P1182, DOI 10.1160/TH07-05-0347; Casonato A, 2015, BRIT J HAEMATOL, V171, P845, DOI 10.1111/bjh.13785; Casonato A, 2010, HAEMATOL-HEMATOL J, V95, P1366, DOI 10.3324/haematol.2009.019927; COONEY KA, 1991, J CLIN INVEST, V87, P1227, DOI 10.1172/JCI115123; DEMARCO L, 1987, J CLIN INVEST, V80, P475, DOI 10.1172/JCI113095; DEMARCO L, 1985, P NATL ACAD SCI USA, V82, P7424; Federici AB, 2009, BLOOD, V113, P526, DOI 10.1182/blood-2008-04-152280; Gallinaro L, 2008, BLOOD, V111, P3540, DOI 10.1182/blood-2007-11-122945; GRALNICK HR, 1981, BLOOD, V58, P387; HOLMBERG L, 1993, J CLIN INVEST, V91, P2169, DOI 10.1172/JCI116443; HOLMBERG L, 1983, NEW ENGL J MED, V309, P816, DOI 10.1056/NEJM198310063091402; HOWARD MA, 1973, BLOOD, V41, P687, DOI 10.1182/blood.V41.5.687.687; HOWARD MA, 1971, THROMB DIATH HAEMOST, V26, P362; HOYER LW, 1980, BLOOD, V55, P1056; Hulstein JJJ, 2005, BLOOD, V106, P3035, DOI 10.1182/blood-2005-03-1153; HULTIN MB, 1990, AM J HEMATOL, V33, P64, DOI 10.1002/ajh.2830330113; Jackson SC, 2009, BLOOD, V113, P3348, DOI 10.1182/blood-2008-06-165233; MANCUSO DJ, 1989, J BIOL CHEM, V264, P19514; Ozeki M, 2010, THROMB RES, V125, pE17, DOI 10.1016/j.thromres.2009.08.012; RANDI AM, 1991, J CLIN INVEST, V87, P1220, DOI 10.1172/JCI115122; Rayes J, 2007, J THROMB HAEMOST, V5, P321, DOI 10.1111/j.1538-7836.2007.02296.x; RICK ME, 1987, BLOOD, V69, P786; RUGGERI ZM, 1980, NEW ENGL J MED, V302, P1047, DOI 10.1056/NEJM198005083021902; Ruggeri ZM, 2004, J THROMB HAEMOST, V2, P2, DOI 10.1111/j.1538-7836.2003.00523.x; RUGGERI ZM, 1981, BLOOD, V57, P1140; WEISS HJ, 1986, BLOOD, V68, P149	33	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179566	10.1371/journal.pone.0179566	http://dx.doi.org/10.1371/journal.pone.0179566			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640903	Green Published, gold, Green Submitted			2022-12-27	WOS:000404135800039
J	Li, YY; Chen, QZ; Nan, HY; Li, XM; Lu, SJ; Zhao, XH; Liu, BH; Guo, CH; Kong, FJ; Cao, D				Li, Yuanyuan; Chen, Quanzhen; Nan, Haiyang; Li, Xiaoming; Lu, Sijia; Zhao, Xiaohui; Liu, Baohui; Guo, Changhong; Kong, Fanjiang; Cao, Dong			Overexpression of GmFDL19 enhances tolerance to drought and salt stresses in soybean	PLOS ONE			English	Article							BZIP TRANSCRIPTION FACTOR; REACTIVE OXYGEN; SALINITY; GENE; IDENTIFICATION; RESISTANCE; ACID	The basic leucine zipper (bZIP) family of transcription factors plays an important role in the growth and developmental process as well as responds to various abiotic stresses, such as drought and high salinity. Our previous work identified GmFDL19, a bZIP transcription factor, as a flowering promoter in soybean, and the overexpression of GmFDL19 caused early flowering in transgenic soybean plants. Here, we report that GmFDL19 also enhances tolerance to drought and salt stress in soybean. GmFDL19 was determined to be a group A member, and its transcription expression was highly induced by abscisic acid (ABA), polyethylene glycol (PEG 6000) and high salt stresses. Overexpression of GmFDL19 in soybean enhanced drought and salt tolerance at the seedling stage. The relative plant height (RPH) and relative shoot dry weight (RSDW) of transgenic plants were significantly higher than those of the WT after PEG and salt treatments. In addition, the germination rate and plant height of the transgenic soybean were also significantly higher than that of WT plants after various salt treatments. Furthermore, we also found that GmFDL19 could reduce the accumulation of Na+ ion content and up-regulate the expression of several ABA/stressresponsive genes in transgenic soybean. We also found that GmFDL19 overexpression increased the activities of several antioxidative enzyme and chlorophyll content but reduced malondialdehyde content. These results suggested that GmFDL19 is involved in soybean abiotic stress responses and has potential utilization to improve multiple stress tolerance in transgenic soybean.	[Li, Yuanyuan; Guo, Changhong] Harbin Normal Univ, Coll Life Sci & Technol, Key Lab Mol Cytogenet & Genet Breeding Heilongjia, Harbin, Peoples R China; [Li, Yuanyuan; Chen, Quanzhen; Nan, Haiyang; Li, Xiaoming; Lu, Sijia; Zhao, Xiaohui; Liu, Baohui; Kong, Fanjiang; Cao, Dong] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Soybean Mol Design Breeding, Harbin, Peoples R China; [Li, Xiaoming] Univ Chinese Acad Sci, Beijing, Peoples R China; [Lu, Sijia; Zhao, Xiaohui; Liu, Baohui; Kong, Fanjiang] Guangzhou Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China	Harbin Normal University; Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Guangzhou University	Guo, CH (corresponding author), Harbin Normal Univ, Coll Life Sci & Technol, Key Lab Mol Cytogenet & Genet Breeding Heilongjia, Harbin, Peoples R China.; Kong, FJ; Cao, D (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Soybean Mol Design Breeding, Harbin, Peoples R China.; Kong, FJ (corresponding author), Guangzhou Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China.	kaku3008@163.com; kongfj@iga.ac.cn; caodong@iga.ac.cn	Kong, Fanjiang/AGQ-2334-2022; li, yuanyuan/GZA-4435-2022	Kong, Fanjiang/0000-0001-7138-1478	National Natural Science Foundation of China [31430065, 31371643, 31571686]; Open Foundation of the Key Laboratory of Soybean Molecular Design Breeding, Chinese Academy of Sciences; Strategic Action Plan for Science and Technology Innovation of the Chinese Academy of Sciences [XDA08030108]; Heilongjiang Natural Science Foundation of China [ZD201001, JC201313]; Research and Development of Applied Technology Project, Harbin [2014RFQY055]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Foundation of the Key Laboratory of Soybean Molecular Design Breeding, Chinese Academy of Sciences; Strategic Action Plan for Science and Technology Innovation of the Chinese Academy of Sciences; Heilongjiang Natural Science Foundation of China(Natural Science Foundation of Heilongjiang Province); Research and Development of Applied Technology Project, Harbin	This work was supported in part by the National Natural Science Foundation of China (grants 31430065, 31371643, and 31571686), the Open Foundation of the Key Laboratory of Soybean Molecular Design Breeding, Chinese Academy of Sciences, the Strategic Action Plan for Science and Technology Innovation of the Chinese Academy of Sciences (XDA08030108) to B. Liu and F. Kong; the Heilongjiang Natural Science Foundation of China [ZD201001, JC201313]; the Research and Development of Applied Technology Project, Harbin [2014RFQY055].	Cao D, 2011, PLANT CELL TISS ORG, V107, P541, DOI 10.1007/s11240-011-0005-9; Chen HT, 2014, PLANT GROWTH REGUL, V73, P299, DOI 10.1007/s10725-014-9890-3; Deshmukh R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00244; Do TD, 2016, SCI REP-UK, P6, DOI DOI 10.1038/S41598-016-0015-2; Dong LD, 2015, J EXP BOT, V66, P2635, DOI 10.1093/jxb/erv078; Fath A, 2001, NEW PHYTOL, V151, P99, DOI 10.1046/j.1469-8137.2001.00153.x; Fujita Y, 2013, PHYSIOL PLANTARUM, V147, P15, DOI 10.1111/j.1399-3054.2012.01635.x; Gao SQ, 2011, PLANT MOL BIOL, V75, P537, DOI 10.1007/s11103-011-9738-4; Gong X, 2015, PLANT CELL REP, V34, P1963, DOI 10.1007/s00299-015-1843-4; Guan RX, 2014, PLANT J, V80, P937, DOI 10.1111/tpj.12695; Hao YJ, 2011, PLANT J, V68, P302, DOI 10.1111/j.1365-313X.2011.04687.x; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Jogaiah S, 2013, CRIT REV BIOTECHNOL, V33, P23, DOI 10.3109/07388551.2012.659174; Khan MS, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00792; Ko KP, 2013, J EPIDEMIOL, V23, P337, DOI 10.2188/jea.JE20120232; Li WYF, 2008, NEW PHYTOL, V178, P80, DOI 10.1111/j.1469-8137.2007.02356.x; Li YuanYuan, 2017, Soybean Science, V36, P351; Liao H, 2003, GENE, V318, P103, DOI 10.1016/S0378-1119(03)00764-9; Liao Y, 2008, PLANTA, V228, P225, DOI 10.1007/s00425-008-0731-3; Liao Y, 2008, J INTEGR PLANT BIOL, V50, P221, DOI 10.1111/j.1744-7909.2007.00593.x; Liu CT, 2014, PLANT MOL BIOL, V84, P19, DOI 10.1007/s11103-013-0115-3; Manavalan LP, 2009, PLANT CELL PHYSIOL, V50, P1260, DOI 10.1093/pcp/pcp082; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mizoi J, 2013, PLANT PHYSIOL, V161, P346, DOI 10.1104/pp.112.204875; Nan HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097669; Thao NP, 2012, CRIT REV BIOTECHNOL, V32, P349, DOI 10.3109/07388551.2011.643463; Nie WX, 2015, PROTOPLASMA, V252, P127, DOI 10.1007/s00709-014-0663-7; Phang TH, 2008, J INTEGR PLANT BIOL, V50, P1196, DOI 10.1111/j.1744-7909.2008.00760.x; Qi DH, 2014, J TAIWAN INST CHEM E, V45, P504, DOI 10.1016/j.jtice.2013.06.021; Qi XP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5340; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Ruan CJ, 2011, CRIT REV BIOTECHNOL, V31, P153, DOI 10.3109/07388551.2010.505908; Sulieman S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/687213; Sun YX, 2006, CHINESE SCI BULL, V51, P1306, DOI 10.1007/s11434-006-1306-y; Tran LSP, 2010, FUNCT INTEGR GENOMIC, V10, P447, DOI 10.1007/s10142-010-0178-z; Tuyen DD, 2010, THEOR APPL GENET, V121, P229, DOI 10.1007/s00122-010-1304-y; Wang F, 2015, PLANT J, V83, P224, DOI 10.1111/tpj.12879; Wang HY, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00067; Xu ZL, 2016, SCI REP-UK, V6, DOI 10.1038/srep20366; Yan JH, 2014, PLANT CELL PHYSIOL, V55, P74, DOI 10.1093/pcp/pct159; Ying S, 2012, PLANTA, V235, P253, DOI 10.1007/s00425-011-1496-7; Zhang LN, 2015, PHYSIOL PLANTARUM, V153, P538, DOI 10.1111/ppl.12261; Zhang X, 2011, PLANT MOL BIOL, V75, P365, DOI 10.1007/s11103-011-9732-x; Zhou GA, 2010, PLANT MOL BIOL, V72, P357, DOI 10.1007/s11103-009-9575-x; Zhou L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-181	45	43	45	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179554	10.1371/journal.pone.0179554	http://dx.doi.org/10.1371/journal.pone.0179554			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640834	Green Published, gold, Green Submitted			2022-12-27	WOS:000404135800037
J	Almquist, M; von Allmen, RS; Carradice, D; Oosterling, SJ; McFarlane, K; Wijnhoven, B				Almquist, Martin; von Allmen, Regula S.; Carradice, Dan; Oosterling, Steven J.; McFarlane, Kirsty; Wijnhoven, Bas			A prospective study on an innovative online forum for peer reviewing of surgical science	PLOS ONE			English	Article							RANDOMIZED-CONTROLLED-TRIAL; QUALITY; BIAS; PUBLICATION; ARTICLES	Background Peer review is important to the scientific process. However, the present system has been criticised and accused of bias, lack of transparency, failure to detect significant breakthrough and error. At the British Journal of Surgery (BJS), after surveying authors' and reviewers' opinions on peer review, we piloted an open online forum with the aim of improving the peer review process. Methods In December 2014, a web-based survey assessing attitudes towards open online review was sent to reviewers with a BJS account in Scholar One. From April to June 2015, authors were invited to allow their manuscripts to undergo online peer review in addition to the standard peer review process. The quality of each review was evaluated by editors and editorial assistants using a validated instrument based on a Likert scale. Results The survey was sent to 6635 reviewers. In all, 1454 (21.9%) responded. Support for online peer review was strong, with only 10% stating that they would not subject their manuscripts to online peer review. The most prevalent concern was about intellectual property, being highlighted in 118 of 284 comments (41.5%). Out of 265 eligible manuscripts, 110 were included in the online peer review trial. Around 7000 potential reviewers were invited to review each manuscript. In all, 44 of 110 manuscripts (40%) received 100 reviews from 59 reviewers, alongside 115 conventional reviews. The quality of the open forum reviews was lower than for conventional reviews (2.13 (+/- 0.75) versus 2.84 (+/- 0.71), P<0.001). Conclusion Open online peer review is feasible in this setting, but it attracts few reviews, of lower quality than conventional peer reviews.	[Almquist, Martin] Skane Univ Hosp, Dept Surg, Lund, Sweden; [Almquist, Martin] Lund Univ, Inst Clin Sci, Lund, Sweden; [von Allmen, Regula S.] Kantonsspital St Gallen, Clin Vasc Surg, St Gallen, Switzerland; [Carradice, Dan] Hull York Med Sch, Acad Vasc Surg Unit, Kingston Upon Hull, N Humberside, England; [Oosterling, Steven J.] Spaarne Gasthuis Hosp, Dept Surg, Haarlem, Netherlands; [McFarlane, Kirsty] John Wiley & Sons, BJS, Oxford, England; [Wijnhoven, Bas] Univ Med Ctr Rotterdam, Erasmus MC, Dept Surg, Rotterdam, Netherlands	Lund University; Skane University Hospital; Lund University; Kantonsspital St. Gallen; University of Hull; University of York - UK; Spaarne Hospital; Erasmus University Rotterdam; Erasmus MC	Almquist, M (corresponding author), Skane Univ Hosp, Dept Surg, Lund, Sweden.; Almquist, M (corresponding author), Lund Univ, Inst Clin Sci, Lund, Sweden.	martin.almquist@med.lu.se	Almquist, Martin/H-7209-2019; Wijnhoven, Bas/AAF-4838-2020	Almquist, Martin/0000-0002-0953-1188; Carradice, Daniel/0000-0002-7733-3925; von Allmen, Regula/0000-0003-0221-1656	BJS/John Wiley and Sons; National Institute for Health Research [CL-2011-03-001] Funding Source: researchfish	BJS/John Wiley and Sons; National Institute for Health Research(National Institute for Health Research (NIHR))	All authors had financial support from the BJS/John Wiley and Sons for the submitted work; there were no other financial relationships with any organisations that might have an interest in the submitted work in the previous three years; and no other relationships or activities that could appear to have influenced the submitted work. The funder provided support in the form of salary for one of the co-authors (KMcF), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	[Anonymous], 2009, PEER REV SURV; [Anonymous], 2009, BBC; Bernstein J, 2013, CLIN ORTHOP RELAT R, V471, P3093, DOI 10.1007/s11999-013-3216-z; Bohannon J, 2013, SCIENCE, V342, P60, DOI 10.1126/science.342.6154.60; Bornmann L, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011344, 10.1371/journal.pone.0013327]; CAMPANARIO JM, 1995, SCI COMMUN, V16, P304, DOI 10.1177/1075547095016003004; Ceci S J, 1982, Change, V14, P44; Ceci SJ, 2011, P NATL ACAD SCI USA, V108, P3157, DOI 10.1073/pnas.1014871108; Emerson GB, 2010, ARCH INTERN MED, V170, P1934, DOI 10.1001/archinternmed.2010.406; Godlee F, 1998, JAMA-J AM MED ASSOC, V280, P237, DOI 10.1001/jama.280.3.237; GOODMAN SN, 1994, ANN INTERN MED, V121, P11, DOI 10.7326/0003-4819-121-1-199407010-00003; Hauser M, 2007, PLOS BIOL, V5, P703, DOI 10.1371/journal.pbio.0050107; Jackson JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022475; Kachewar Sushil Ghanshyam, 2013, Mens Sana Monogr, V11, P274, DOI 10.4103/0973-1229.109347; Lee KP, 2006, MED J AUSTRALIA, V184, P621, DOI 10.5694/j.1326-5377.2006.tb00418.x; Link AM, 1998, JAMA-J AM MED ASSOC, V280, P246, DOI 10.1001/jama.280.3.246; Lynch JR, 2007, J BONE JOINT SURG AM, V89A, P1010, DOI 10.2106/JBJS.F.01152; Olson CM, 2002, JAMA-J AM MED ASSOC, V287, P2825, DOI 10.1001/jama.287.21.2825; Opthof T, 2002, CARDIOVASC RES, V56, P339, DOI 10.1016/S0008-6363(02)00712-5; Pierie JPEN, 1996, LANCET, V348, P1480, DOI 10.1016/S0140-6736(96)05016-7; Smith R, 1999, BRIT MED J, V318, P4; van Rooyen S, 1998, JAMA-J AM MED ASSOC, V280, P234, DOI 10.1001/jama.280.3.234; van Rooyen S, 1999, BRIT MED J, V318, P23; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Wenneras C, 1997, NATURE, V387, P341, DOI 10.1038/387341a0	25	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179031	10.1371/journal.pone.0179031	http://dx.doi.org/10.1371/journal.pone.0179031			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662046	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300014
J	Liu, YQ; Gao, Y; Liang, GM; Lu, YH				Liu, Yongqiang; Gao, Yu; Liang, Gemei; Lu, Yanhui			Chlorantraniliprole as a candidate pesticide used in combination with the attracticides for lepidopteran moths	PLOS ONE			English	Article							ARMIGERA HUBNER LEPIDOPTERA; SPODOPTERA-LITURA LEPIDOPTERA; VOLATILE-BASED ATTRACTICIDE; HELICOVERPA-ARMIGERA; AGROTIS-IPSILON; NOCTUIDAE; INSECTICIDES; RESISTANCE; MIGRATION; TOXICITY	Methomyl is currently used as a toxicant for the attracticide BioAttract in cotton and vegetables in China. However, methomyl is highly toxic to non-target organisms and a more environmental friendly acceptable alternative is required. Larvae of three lepidopteran insects Helicoverpa armigera, Agrotis ipsilon and Spodoptera litura are important pests of these crops in China. In the present study, the toxicity of 23 commonly used insecticides were tested on H. armigera, then tested the susceptibility of A. ipsilon and S. litura moths to the insecticides which were the most toxic to H. armigera, and the acute toxicity of the most efficacious insecticides were further investigated under laboratory conditions. Chlorantraniliprole, emamectin benzoate, spinetoram, spinosad and methomyl exhibited high levels of toxicity to H. armigera moths with a mortality of 86.67%, 91.11%, 73.33%, 57.78% and 80.00%, respectively, during 24 h period at the concentration of 1 mg a.i.L-1. Among these five insecticides, A. ipsilon and S. litura moths were more sensitive to chlorantraniliprole, emamectin benzoate and methomyl. The lethal time (LT50) values of chlorantraniliprole and methomyl were shorter than emamectin benzoate for all three lepidopteran moth species at 1000 mg a.i.L-1 compared to concentrations of 500, 100 and 1 mg a.i L-1. Chlorantraniliprole was found to have similar levels of toxicity and lethal time on the three lepidopteran moths tested to the standard methomyl, and therefore, can be used as an alternative insecticide to methomyl in the attracticide for controlling these pest species.	[Liu, Yongqiang; Gao, Yu; Liang, Gemei; Lu, Yanhui] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Lu, YH (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China.	yhlu@ippcaas.cn		Lu, Yanhui/0000-0002-6552-0248	National Natural Science Foundation of China [31621064]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the National Natural Science Foundation of China (grant number 31621064). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brugger KE, 2010, PEST MANAG SCI, V66, P1075, DOI 10.1002/ps.1977; Cordova D, 2006, PESTIC BIOCHEM PHYS, V84, P196, DOI 10.1016/j.pestbp.2005.07.005; Del Socorro AP, 2010, AUST J ENTOMOL, V49, P10, DOI 10.1111/j.1440-6055.2009.00733.x; Del Socorro AP, 2010, AUST J ENTOMOL, V49, P31, DOI 10.1111/j.1440-6055.2009.00735.x; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Farre M, 2002, ANAL BIOANAL CHEM, V373, P704, DOI 10.1007/s00216-002-1413-9; Feng HQ, 2004, J ECON ENTOMOL, V97, P1874, DOI 10.1603/0022-0493-97.6.1874; Gao M., 2011, AGROCHEMIC RES APPL, V15, P17; Gregg PC, 2016, J CHEM ECOL, V42, P666, DOI 10.1007/s10886-016-0725-8; Gu SH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-636; IPPCAAS (Institute of Plant Protection Chinese Academy of Agricultural Sciences) CSPP (China Society of Plant Protection), 2015, CROP DIS INS PESTS C, V1-3; Kong D.S., 2016, SHANDONG AGR, V48, P102; Lahm GP, 2009, BIOORGAN MED CHEM, V17, P4127, DOI 10.1016/j.bmc.2009.01.018; Leonova IN, 1996, ARCH INSECT BIOCHEM, V32, P157, DOI 10.1002/(SICI)1520-6327(1996)32:2&lt;157::AID-ARCH1&gt;3.0.CO;2-W; Liang GM, 2008, J INVERTEBR PATHOL, V97, P142, DOI 10.1016/j.jip.2007.09.007; Liu YQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep39060; Liu YQ, 2015, ANN ENTOMOL SOC AM, V108, P519, DOI 10.1093/aesa/sav050; Lopez JD, 2011, PEST MANAG SCI, V67, P220, DOI 10.1002/ps.2055; Lopez JD, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.8901; Ma X.F., 2013, THE J, V41, P6697; Ma XF, 2013, J ANHUI AGR SCI, V41, P6709; Mensah RK, 2013, CROP PASTURE SCI, V64, P763, DOI 10.1071/CP13060; Murata M, 1998, APPL ENTOMOL ZOOL, V33, P419, DOI 10.1303/aez.33.419; Saleem MA, 2008, J ECON ENTOMOL, V101, P1667, DOI 10.1603/0022-0493(2008)101[1667:RTSOOC]2.0.CO;2; Shad SA, 2012, J PEST SCI, V85, P153, DOI 10.1007/s10340-011-0404-z; Su Jian-Wei, 2001, Entomological Knowledge, V38, P405; Sun BB, 2013, ARCH INSECT BIOCHEM, V82, P1, DOI 10.1002/arch.21067; Wang Y.H., 2016, THE J, V44, P149; Witzgall P, 2010, J CHEM ECOL, V36, P80, DOI 10.1007/s10886-009-9737-y; [谢圣华 Xie Shenghua], 2010, [植物保护, Plant Protection], V36, P175; Yang YH, 2013, J ECON ENTOMOL, V106, P375, DOI 10.1603/EC12286; Younger CD, 2000, THESIS	32	17	22	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180255	10.1371/journal.pone.0180255	http://dx.doi.org/10.1371/journal.pone.0180255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658277	Green Submitted, gold, Green Published			2022-12-27	WOS:000404607900070
J	Fernandez, KC; Fisher, AJ; Chi, C				Fernandez, Katya C.; Fisher, Aaron J.; Chi, Cyrus			Development and initial implementation of the Dynamic Assessment Treatment Algorithm (DATA)	PLOS ONE			English	Article							MODEL; INDEXES; ANXIETY	Given the recent increase in transdiagnostic research, it is important to discern how dimensional models of psychopathology could be used to guide personalized, dynamic assessment and treatment of symptoms. Using the person-specific approach described by Fisher (2015), we devised an initial 4-step algorithm for devising a treatment plan based on modular cognitive behavioral therapy using results obtained from within-person factor analyses and dynamic factor models. Then, we describe the improvement and digitization of the algorithm, termed Dynamic Assessment Treatment Algorithm (DATA). The development, structure, and clinical implications of DATA are discussed.	[Fernandez, Katya C.; Fisher, Aaron J.; Chi, Cyrus] Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA; [Fernandez, Katya C.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Chi, Cyrus] Emory Univ, Dept Psychol, Atlanta, GA 30322 USA	University of California System; University of California Berkeley; Stanford University; Emory University	Fernandez, KC (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.; Fernandez, KC (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.	katyaf@stanford.edu	Chi, Cyrus/AAI-7287-2021					American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Barlow D. H., 2018, UNIFIED PROTOCOL TRA, V2nd; Barlow DH, 2011, UNIFIED PROTOCOL TRA, P159; Bentler P.M., 2005, EQS STRUCTURAL EQUAT; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bienvenu OJ, 2007, AM J PSYCHIAT, V164, P1714, DOI 10.1176/appi.ajp.2007.06101667; Brown T.A., 2014, ANXIETY RELATED DISO; Brown TA, 1998, J ABNORM PSYCHOL, V107, P179, DOI 10.1037/0021-843X.107.2.179; Cattell RB, 1947, PSYCHOMETRIKA, V12, P267, DOI 10.1007/BF02288941; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; DeRubeis RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083875; Fisher AJ, 2015, CURR OPIN PSYCHOL, V4, P67, DOI 10.1016/j.copsyc.2015.03.031; Fisher AJ, J CONSULTIN IN PRESS; Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304; Harvey AG, 2011, CLIN PSYCHOL REV, V31, P225, DOI 10.1016/j.cpr.2010.04.003; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; Mineka S, 1998, ANNU REV PSYCHOL, V49, P377, DOI 10.1146/annurev.psych.49.1.377; Molenaar P. C. M., 2004, MEASUREMENT, V2, P201, DOI [10.1207/s15366359mea0204_1, DOI 10.1207/S15366359MEA0204_1]; National Institute of Mental Health, 2021, NIMH POS VAL SYST; Nesselroade JR, 2007, MEAS-INTERDISCIP RES, V5, P217, DOI 10.1080/15366360701741807; Spinhoven P, 2014, BEHAV THER, V45, P840, DOI 10.1016/j.beth.2014.07.001; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Van Der Krieke L, 2016, INT J METH PSYCH RES, V25, P123, DOI 10.1002/mpr.1495; Westen D, 2001, J CONSULT CLIN PSYCH, V69, P875, DOI 10.1037//0022-006X.69.6.875	25	35	35	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0178806	10.1371/journal.pone.0178806	http://dx.doi.org/10.1371/journal.pone.0178806			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ2LT	28654667	Green Published, gold, Green Submitted			2022-12-27	WOS:000404541500004
J	Post, DMB; Schilling, B; Reinders, LM; D'Souza, AK; Ketterer, MR; Kiel, SJ; Chande, AT; Apicella, MA; Gibson, BW				Post, Deborah M. B.; Schilling, Birgit; Reinders, Lorri M.; D'Souza, Alexandria K.; Ketterer, Margaret R.; Kiel, Steven J.; Chande, Aroon T.; Apicella, Michael A.; Gibson, Bradford W.			Identification and characterization of AckA-dependent protein acetylation in Neisseria gonorrhoeae	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; ACETYLOME ANALYSIS REVEALS; LARGE GENE LISTS; LYSINE ACETYLATION; SALMONELLA-ENTERICA; PROTEOMIC ANALYSIS; METABOLIC ENZYMES; HEME OXYGENASE; COA SYNTHETASE; COLI	Neisseria gonorrhoeae, the causative agent of gonorrhea, has a number of factors known to contribute to pathogenesis; however, a full understanding of these processes and their regulation has proven to be elusive. Post-translational modifications (PTMs) of bacterial proteins are now recognized as one mechanism of protein regulation. In the present study, Western blot analyses, with an anti-acetyl-lysine antibody, indicated that a large number of gonococcal proteins are post-translationally modified. Previous work has shown that Ne-lysine acetylation can occur non-enzymatically with acetyl-phosphate (AcP) as the acetyl donor. In the current study, an acetate kinase mutant (1291ackA), which accumulates AcP, was generated in N. gonorrhoeae. Broth cultures of N. gonorrhoeae 1291wt and 1291ackA were grown, proteins extracted and digested, and peptides containing acetylated-lysines (K-acetyl) were affinity-enriched from both strains. Mass spectrometric analyses of these samples identified a total of 2686 unique acetylation sites. Label-free relative quantitation of the K-acetyl peptides derived from the ackA and wild-type (wt) strains demonstrated that 109 acetylation sites had an ackA/wt ratio>2 and p-values <0.05 in at least 2/3 of the biological replicates and were designated as "AckA-dependent". Regulated K-acetyl sites were found in ribosomal proteins, central metabolism proteins, iron acquisition and regulation proteins, pilus assembly and regulation proteins, and a two-component response regulator. Since AckA is part of a metabolic pathway, comparative growth studies of the ackA mutant and wt strains were performed. The mutant showed a growth defect under aerobic conditions, an inability to grow anaerobically, and a defect in biofilm maturation. In conclusion, the current study identified AckA-dependent acetylation sites in N. gonorrhoeae and determined that these sites are found in a diverse group of proteins. This work lays the foundation for future studies focusing on specific acetylation sites that may have relevance in gonococcal pathogenesis and metabolism.	[Post, Deborah M. B.; Schilling, Birgit; Reinders, Lorri M.; D'Souza, Alexandria K.; Gibson, Bradford W.] Buck Inst Res Aging, Novato, CA 94945 USA; [Ketterer, Margaret R.; Kiel, Steven J.; Chande, Aroon T.; Apicella, Michael A.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Gibson, Bradford W.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Chande, Aroon T.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	Buck Institute for Research on Aging; University of Iowa; University of California System; University of California San Francisco; University System of Georgia; Georgia Institute of Technology	Post, DMB; Gibson, BW (corresponding author), Buck Inst Res Aging, Novato, CA 94945 USA.; Gibson, BW (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	dpost@buckinstitute.org; bgibson@buckinstitute.org		Schilling, Birgit/0000-0001-9907-2749; Chande, Aroon/0000-0001-5260-3135	National Institutes of Health [R01 A108255]; National Center for Research Resources shared instrumentation [1S10 0D016281, 1 S10 RR025439-01]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources shared instrumentation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Institutes of Health Grant R01 A108255 (to MAA and BWG). The purchase of the TripleTOF instrument was supported by an National Center for Research Resources shared instrumentation grant 1S10 0D016281 (to BWG). The purchase of the Zeiss LSM710 confocal microscope was supported by National Center for Research Resources shared instrumentation grant 1 S10 RR025439-01 to the CMRF at the University of Iowa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; APICELLA MA, 1974, J INFECT DIS, V130, P619, DOI 10.1093/infdis/130.6.619; Barnard E, 2015, J CLIN MICROBIOL, V53, P1149, DOI 10.1128/JCM.02460-14; Bozicevic I, 2006, SEX TRANSM DIS, V33, P289, DOI 10.1097/01.olq.0000194582.44222.c9; Centers for Disease Control and Prevention (CDC), 2015, SEX TRANSM DIS SURV; Chen A, 2003, AIDS, V17, P625, DOI 10.1097/00002030-200303070-00019; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Crosby HA, 2012, J BIOL CHEM, V287, P15590, DOI 10.1074/jbc.M112.352104; D'Souza A. K., 2013, P 61 ANN ASMS C MASS; Edwards JL, 2001, CELL MICROBIOL, V3, P611, DOI 10.1046/j.1462-5822.2001.00140.x; Farley TA, 2003, PREV MED, V36, P502, DOI 10.1016/S0091-7435(02)00058-0; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Friedman J, 2003, J BIOL CHEM, V278, P34654, DOI 10.1074/jbc.M302985200; HANSFIELD HH, 2005, PRINCIPLES PRACTICE, P2514; Hentchel KL, 2015, MICROBIOL MOL BIOL R, V79, P321, DOI 10.1128/MMBR.00020-15; Hook EW., 2008, SEX TRANSM DIS, V4th ed., P627; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang D, 2015, APPL MICROBIOL BIOT, V99, P1399, DOI 10.1007/s00253-014-6144-2; Isabella VM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-51; Kim D, 2013, PROTEOMICS, V13, P1726, DOI 10.1002/pmic.201200001; Kim GW, 2011, TRENDS BIOCHEM SCI, V36, P211, DOI 10.1016/j.tibs.2010.10.001; KNAPP JS, 1984, INFECT IMMUN, V46, P176, DOI 10.1128/IAI.46.1.176-181.1984; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kuhn ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094816; Lee DW, 2013, PROTEOMICS, V13, P2278, DOI 10.1002/pmic.201200072; Liao GJ, 2014, J PROTEOMICS, V106, P260, DOI 10.1016/j.jprot.2014.04.017; Liu FY, 2014, MOL CELL PROTEOMICS, V13, P3352, DOI 10.1074/mcp.M114.041962; Lynnes T, 2013, FEMS MICROBIOL LETT, V344, P95, DOI 10.1111/1574-6968.12174; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; MCCORMACK WM, 1977, LANCET, V1, P1182; Mo R, 2015, J PROTEOME RES, V14, P1275, DOI 10.1021/pr501275a; Okanishi H, 2013, J PROTEOME RES, V12, P3952, DOI 10.1021/pr400245k; Ouidir T, 2016, PROTEOMICS, V16, P301, DOI 10.1002/pmic.201500258; Ouidir T, 2015, PROTEOMICS, V15, P2152, DOI 10.1002/pmic.201500056; Pan JY, 2014, J PROTEOME RES, V13, P3294, DOI 10.1021/pr500133t; PEDERSEN A H B, 1971, Northwest Medicine, V70, P255; Phillips NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038303; Pruss BM, 2010, ARCH MICROBIOL, V192, P715, DOI 10.1007/s00203-010-0599-z; Rardin MJ, 2013, P NATL ACAD SCI USA, V110, P6601, DOI 10.1073/pnas.1302961110; Rohde KH, 2003, FRONT BIOSCI-LANDMRK, V8, pD1186, DOI 10.2741/1133; Rychli K, 2014, METHODS MOL BIOL, V1157, P187, DOI 10.1007/978-1-4939-0703-8_16; Schilling B, 2015, MOL MICROBIOL; Schilling B, 2012, MOL CELL PROTEOMICS, V11, P202, DOI 10.1074/mcp.M112.017707; Sharma V, 2014, J PROTEOME RES, V13, P4205, DOI 10.1021/pr5006636; Sheikh MA, 2009, MOL MICROBIOL, V72, P1208, DOI 10.1111/j.1365-2958.2009.06718.x; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Starai VJ, 2004, J MOL BIOL, V340, P1005, DOI 10.1016/j.jmb.2004.05.010; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Steichen CT, 2011, INFECT IMMUN, V79, P1504, DOI 10.1128/IAI.01162-10; Sule P, 2009, LETT APPL MICROBIOL, V49, P299, DOI 10.1111/j.1472-765X.2009.02659.x; Unemo M, 2014, CLIN MICROBIOL REV, V27, P587, DOI 10.1128/CMR.00010-14; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Weinert BT, 2013, MOL CELL, V51, P265, DOI 10.1016/j.molcel.2013.06.003; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Wolfe AJ, 2016, CURR GENET, V62, P335, DOI 10.1007/s00294-015-0552-4; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; World Health Organization, 2012, GLOB ACT PLAN CONTR; Wu X, 2013, J PROTEOMICS, V79, P60, DOI 10.1016/j.jprot.2012.12.001; Xiong Y, 2012, J CELL BIOL, V198, P155, DOI 10.1083/jcb.201202056; Yu JL, 2011, J PROTEOME RES, V10, P2992, DOI 10.1021/pr101177g; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhu WM, 2000, J BACTERIOL, V182, P6783, DOI 10.1128/JB.182.23.6783-6790.2000; Zhu WM, 2000, J BACTERIOL, V182, P439, DOI 10.1128/JB.182.2.439-447.2000; Zielke RA, 2016, MOL CELL PROTEOMICS, V15, P2338, DOI 10.1074/mcp.M116.058800	66	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179621	10.1371/journal.pone.0179621	http://dx.doi.org/10.1371/journal.pone.0179621			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654654	Green Published, Green Submitted, gold			2022-12-27	WOS:000404541500022
J	Akiyama, T; Katsumura, T; Nakagome, S; Lee, SI; Joh, K; Soejima, H; Fujimoto, K; Kimura, R; Ishida, H; Hanihara, T; Yasukouchi, A; Satta, Y; Higuchi, S; Oota, H				Akiyama, Tokiho; Katsumura, Takafumi; Nakagome, Shigeki; Lee, Sang-il; Joh, Keiichiro; Soejima, Hidenobu; Fujimoto, Kazuma; Kimura, Ryosuke; Ishida, Hajime; Hanihara, Tsunehiko; Yasukouchi, Akira; Satta, Yoko; Higuchi, Shigekazu; Oota, Hiroki			An ancestral haplotype of the human PERIOD2 gene associates with reduced sensitivity to light-induced melatonin suppression	PLOS ONE			English	Article							DIURNAL PREFERENCE; CLOCK GENE; NATURAL-SELECTION; POLYMORPHISM; EVOLUTION; MOUSE; POPULATIONS; MELANOPSIN; SECRETION; INSIGHTS	Humans show various responses to the environmental stimulus in individual levels as "physiological variations." However, it has been unclear if these are caused by genetic variations. In this study, we examined the association between the physiological variation of response to light-stimulus and genetic polymorphisms. We collected physiological data from 43 subjects, including light-induced melatonin suppression, and performed haplotype analyses on the clock genes, PER2 and PER3, exhibiting geographical differentiation of allele frequencies. Among the haplotypes of PER3, no significant difference in light sensitivity was found. However, three common haplotypes of PER2 accounted for more than 96% of the chromosomes in subjects, and 1 of those 3 had a significantly low-sensitive response to light-stimulus (P < 0.05). The homozygote of the low-sensitive PER2 haplotype showed significantly lower percentages of melatonin suppression (P 0.05), and the heterozygotes of the haplotypes varied their ratios, indicating that the physiological variation for light-sensitivity is evidently related to the PER2 polymorphism. Compared with global haplotype frequencies, the haplotype with a low-sensitive response was more frequent in Africans than in non-Africans, and came to the root in the phylogenetic tree, suggesting that the low light-sensitive haplotype is the ancestral type, whereas the other haplotypes with high sensitivity to light are the derived types. Hence, we speculate that the high light-sensitive haplotypes have spread throughout the world after the Out-of-Africa migration of modern humans.	[Akiyama, Tokiho; Katsumura, Takafumi; Hanihara, Tsunehiko; Oota, Hiroki] Kitasato Univ, Sch Med, Dept Anat, Sagamihara, Kanagawa, Japan; [Akiyama, Tokiho] Kitasato Univ, Sch Sci, Dept Biosci, Sagamihara, Kanagawa, Japan; [Akiyama, Tokiho; Satta, Yoko] SOKENDAI, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa, Japan; [Nakagome, Shigeki] Inst Stat Math, Dept Math Anal & Stat Inference, Tachikawa, Tokyo, Japan; [Nakagome, Shigeki] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Lee, Sang-il; Yasukouchi, Akira; Higuchi, Shigekazu] Kyushu Univ, Fac Design, Dept Human Sci, Minami Ku, Fukuoka, Japan; [Joh, Keiichiro; Soejima, Hidenobu] Saga Univ, Fac Med, Dept Biomol Sci, Div Mol Genet & Epigenet, Saga, Japan; [Fujimoto, Kazuma] Saga Univ, Fac Med, Dept Internal Med, Saga, Japan; [Kimura, Ryosuke; Ishida, Hajime] Univ Ryukyus, Fac Med, Dept Human Biol & Anat, Nishihara, Okinawa, Japan; [Hanihara, Tsunehiko; Oota, Hiroki] Kitasato Univ, Grad Sch Med Sci, Dept Biol Struct, Sagamihara, Kanagawa, Japan	Kitasato University; Kitasato University; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan; University of Chicago; Kyushu University; Saga University; Saga University; University of the Ryukyus; Kitasato University	Oota, H (corresponding author), Kitasato Univ, Sch Med, Dept Anat, Sagamihara, Kanagawa, Japan.; Higuchi, S (corresponding author), Kyushu Univ, Fac Design, Dept Human Sci, Minami Ku, Fukuoka, Japan.; Oota, H (corresponding author), Kitasato Univ, Grad Sch Med Sci, Dept Biol Struct, Sagamihara, Kanagawa, Japan.	higu-s@design.kyushu-u.ac.jp; hiroki_oota@med.kitasato-u.ac.jp	HIGUCHI, Shigekazu/AAM-5800-2020	Satta, Yoko/0000-0002-5305-493X; Nakagome, Shigeki/0000-0001-9613-975X; Akiyama, Tokiho/0000-0002-9050-1014; Lee, Sangil/0000-0001-8998-5827; higuchi, shigekazu/0000-0001-7131-0792; Soejima, Hidenobu/0000-0001-5076-6563	Japan Society for the Promotion of Science (JSPS) [22370087]; University of the Ryukyus Strategic Research Grant; JSPS [24370102, 25251046, 24370099]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); University of the Ryukyus Strategic Research Grant; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	HI was supported by Grants-in-Aid for Scientific Research (B) (22370087) from the Japan Society for the Promotion of Science (JSPS) and University of the Ryukyus Strategic Research Grant. SH was supported by Grant-in-Aid for Scientific Research (B) (24370102) from JSPS. AY and HO were supported by Grant-in-Aid for Scientific Research (A) (25251046) from JSPS. HO was supported by Grant-in-Aid for Scientific Research (B) (24370099) from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; Albrecht U, 2001, J BIOL RHYTHM, V16, P100, DOI 10.1177/074873001129001791; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Arendt J, 2006, CHRONOBIOL INT, V23, P21, DOI 10.1080/07420520500464361; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Cajochen C, 2007, SLEEP MED REV, V11, P453, DOI 10.1016/j.smrv.2007.07.009; Carpen JD, 2005, J SLEEP RES, V14, P293, DOI 10.1111/j.1365-2869.2005.00471.x; Chellappa SL, 2012, J CLIN ENDOCR METAB, V97, pE433, DOI 10.1210/jc.2011-2391; Chiaromonte F, 2002, Pac Symp Biocomput, P115; Ciarleglio CM, 2008, J BIOL RHYTHM, V23, P330, DOI 10.1177/0748730408320284; COSTA R, 1992, P ROY SOC B-BIOL SCI, V250, P43, DOI 10.1098/rspb.1992.0128; Cruciani F, 2008, EUR J HUM GENET, V16, P1526, DOI 10.1038/ejhg.2008.105; CZEISLER CA, 1986, SCIENCE, V233, P667, DOI 10.1126/science.3726555; Daneault V, 2016, J PHYSIOL ANTHROPOL, V35, DOI 10.1186/s40101-016-0091-9; Ebisawa T, 2007, J PHARMACOL SCI, V103, P150, DOI 10.1254/jphs.FMJ06003X5; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gamlin PDR, 2007, VISION RES, V47, P946, DOI 10.1016/j.visres.2006.12.015; Gooley Joshua J., 2003, Journal of Neuroscience, V23, P7093; Gooley Joshua J, 2011, J Clin Endocrinol Metab, V96, pE463, DOI 10.1210/jc.2010-2098; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Gronau I, 2011, NAT GENET, V43, P1031, DOI 10.1038/ng.937; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Han Y, 2007, AM J HUM GENET, V80, P441, DOI 10.1086/512485; Harris K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003521; Hebert M, 2002, J PINEAL RES, V33, P198, DOI 10.1034/j.1600-079X.2002.01885.x; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hennig S, 2009, PLOS BIOL, V7, P836, DOI 10.1371/journal.pbio.1000094; Higuchi S, 2008, NEUROSCI LETT, V440, P23, DOI 10.1016/j.neulet.2008.05.037; Higuchi S, 2007, AM J PHYSIOL-REG I, V292, pR2352, DOI 10.1152/ajpregu.00355.2006; Higuchi S, 2007, CHRONOBIOL INT, V24, P31, DOI 10.1080/07420520601139805; Higuchi S, 2014, J CLIN ENDOCR METAB, V99, P3298, DOI 10.1210/jc.2014-1629; Hirayama J, 2005, CURR OPIN GENET DEV, V15, P548, DOI 10.1016/j.gde.2005.07.003; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Hu YN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10448; ISHIHARA K, 1984, PERCEPT MOTOR SKILL, V59, P863, DOI 10.2466/pms.1984.59.3.863; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; Kidd KK, 2004, J HERED, V95, P406, DOI 10.1093/jhered/esh060; LAAKSO ML, 1991, NATO ADV SCI I A-LIF, V204, P307; Lee HJ, 2011, BEHAV GENET, V41, P273, DOI 10.1007/s10519-010-9396-3; LEWY AJ, 1980, SCIENCE, V210, P1267, DOI 10.1126/science.7434030; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lockley SW, 2006, CURR BIOL, V16, pR795, DOI 10.1016/j.cub.2006.08.039; Martin SK, 2002, CHRONOBIOL INT, V19, P695, DOI 10.1081/CBI-120006080; Matsuo M, 2007, SLEEP BIOL RHYTHMS, V5, P141, DOI 10.1111/j.1479-8425.2007.00264.x; Moller M, 2002, CELL TISSUE RES, V309, P139, DOI 10.1007/s00441-002-0580-5; Nadkarni NA, 2005, J BIOL RHYTHM, V20, P490, DOI 10.1177/0748730405281332; Nakagome S, 2012, MOL BIOL EVOL, V29, P1569, DOI 10.1093/molbev/mss006; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nei M., 2000, MOL EVOLUTION PHYLOG; Ojeda DA, 2013, NEUROSCI LETT, V553, P52, DOI 10.1016/j.neulet.2013.08.016; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Oota H, 2004, ANN HUM GENET, V68, P93, DOI 10.1046/j.1529-8817.2003.00060.x; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rosato E, 1997, GENET RES, V69, P89, DOI 10.1017/S001667239700267X; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Satoh K, 2003, SLEEP, V26, P416, DOI 10.1093/sleep/26.4.416; Satta Y, 2004, J MOL EVOL, V59, P478, DOI 10.1007/s00239-004-2639-2; Sawyer LA, 2006, GENETICS, V174, P465, DOI 10.1534/genetics.106.058792; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Song HM, 2016, CHRONOBIOL INT, V33, P1455, DOI 10.1080/07420528.2016.1231199; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Takahata N, 1998, GENETICA, V102-3, P157, DOI 10.1023/A:1017029613342; Tamanini F, 2005, METHOD ENZYMOL, V393, P418, DOI 10.1016/S0076-6879(05)93020-6; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Ukai H, 2010, ANNU REV PHYSIOL, V72, P579, DOI 10.1146/annurev-physiol-073109-130051; Wright KP, 2001, P NATL ACAD SCI USA, V98, P14027, DOI 10.1073/pnas.201530198; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Yasukouchi Akira, 2005, Journal of Physiological Anthropology and Applied Human Science, V24, P243, DOI 10.2114/jpa.24.243	83	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0178373	10.1371/journal.pone.0178373	http://dx.doi.org/10.1371/journal.pone.0178373			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650999	Green Published, gold, Green Submitted			2022-12-27	WOS:000404537300001
J	Pashaei, E; Pashaei, E; Ahmady, M; Ozen, M; Aydin, N				Pashaei, Elnaz; Pashaei, Elham; Ahmady, Maryam; Ozen, Mustafa; Aydin, Nizamettin			Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CELL-PROLIFERATION; BIOCHEMICAL RECURRENCE; GROWTH; RISK; MYC; ADENOCARCINOMA; TUMORIGENESIS; SUPPRESSION; PROGRESSION	Background Prostate cancer (PCa) is a leading reason of death in men and the most diagnosed malignancies in the western countries at the present time. After radical prostatectomy (RP), nearly 30% of men develop clinical recurrence with high serum prostate-specific antigen levels. An important challenge in PCa research is to identify effective predictors of tumor recurrence. The molecular alterations in microRNAs are associated with PCa initiation and progression. Several miRNA microarray studies have been conducted in recurrence PCa, but the results vary among different studies. Methods We conducted a meta-analysis of 6 available miRNA expression datasets to identify a panel of co-deregulated miRNA genes and overlapping biological processes. The meta-analysis was performed using the 'MetaDE' package, based on combined P-value approaches (adaptive weight and Fisher's methods), in R version 3.3.1. Results Meta-analysis of six miRNA datasets revealed miR-125A, miR-199A-3P, miR-28-5P, miR301B, miR-324-5P, miR-361-5P, miR-363*, miR-449A, miR-484, miR-498, miR-579, miR637, miR-720, miR-874 and miR-98 are commonly upregulated miRNA genes, while miR-1, miR-133A, miR-133B, miR-137, miR-221, miR-340, miR-370, miR-449B, miR-489, miR492, miR-496, miR-541, miR-572, miR-583, miR-606, miR-624, miR-636, miR-639, miR661, miR-760, miR-890, and miR-939 are commonly downregulated miRNA genes in recurrent PCa samples in comparison to non-recurrent PCa samples. The network-based analysis showed that some of these miRNAs have an established prognostic significance in other cancers and can be actively involved in tumor growth. Gene ontology enrichment revealed many target genes of co-deregulated miRNAs are involved in "regulation of epithelial cell proliferation" and "tissue morphogenesis". Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis indicated that these miRNAs regulate cancer pathways. The PPI hub proteins analysis identified CTNNB1 as the most highly ranked hub protein. Besides, common pathway analysis showed that TCF3, MAX, MYC, CYP26A1, and SREBF1 significantly interact with those DE miRNA genes. The identified genes have been known as tumor suppressors and biomarkers which are closely related to several cancer types, such as colorectal cancer, breast cancer, PCa, gastric, and hepatocellular carcinomas. Additionally, it was shown that the combination of DE miRNAs can assist in the more specific detection of the PCa and prediction of biochemical recurrence (BCR). Conclusion We found that the identified miRNAs through meta-analysis are candidate predictive markers for recurrent PCa after radical prostatectomy.	[Pashaei, Elnaz; Pashaei, Elham; Aydin, Nizamettin] Yildiz Tech Univ, Dept Comp Engn, Istanbul, Turkey; [Ahmady, Maryam] Payame Noor Univ, Dept Comp Engn & IT, Tehran, Iran; [Ozen, Mustafa] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA	Yildiz Technical University; Payame Noor University; Baylor College of Medicine	Aydin, N (corresponding author), Yildiz Tech Univ, Dept Comp Engn, Istanbul, Turkey.	naydin@yildiz.edu.tr	PASHAEI, ELNAZ/AAI-7928-2021; Pashaei, Elham/AAP-8599-2021; AYDIN, Nizamettin/AAZ-6030-2020	PASHAEI, ELNAZ/0000-0001-9391-9785; Pashaei, Elham/0000-0001-7401-4964; AYDIN, Nizamettin/0000-0003-0022-2247; Ozen, Mustafa/0000-0002-6142-5294				Alvarado S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074009; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Barron N, 2012, PROSTATE, V72, P1193, DOI 10.1002/pros.22469; Bell EH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118745; Bhatnagar N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.85; Chen Y, 2015, NEOPLASMA, V62, P191, DOI 10.4149/neo_2015_024; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Daniunaite K, 2017, HUM MOL GENET; Fattore L, 2016, P NATL ACAD SCI USA, V113, pE5005, DOI 10.1073/pnas.1607753113; Fendler A, 2011, INT J ONCOL, V39, P1183, DOI 10.3892/ijo.2011.1128; Fu Y, 2015, ONCOTARGETS THER, V8, P3827, DOI 10.2147/OTT.S92314; GIRINSKY T, 1995, CANCER RES, V55, P3726; Guo DL, 2014, CURR PHARM DESIGN, V20, P2619, DOI 10.2174/13816128113199990486; Guo YJ, 2016, EUR REV MED PHARMACO, V20, P101; Han C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/428371; Hochberg Y, 1995, J ROYAL STAT SOC B; Hong FX, 2008, BIOINFORMATICS, V24, P374, DOI 10.1093/bioinformatics/btm620; Hsu CM, 2012, TUMOR BIOL, V33, P1933, DOI 10.1007/s13277-012-0454-8; Hu SH, 2016, EUR REV MED PHARMACO, V20, P5002; Huang K, 2016, ONCOL REP, V35, P887, DOI 10.3892/or.2015.4458; Jain AK, 2013, CELL CYCLE, V12, P1598, DOI 10.4161/cc.24741; Jang JY, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.1; Karatas OF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098675; Kibel AS, 2003, CANCER RES, V63, P2033; Kristensen H, 2016, ONCOTARGET, V7, P30760, DOI [10.18632/oncotarget.8953, 10.16632/oncotarget.8953]; Kron K, 2012, CLIN CANCER RES, V18, P2896, DOI 10.1158/1078-0432.CCR-11-2901; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kuo WT, 2016, ANTICANCER RES, V36, P5189, DOI 10.21873/anticanres.11089; Leite KRM, 2015, J CANCER, V6, P292, DOI 10.7150/jca.11038; Lin ZY, 2014, CANCER SCI, V105, P1288, DOI 10.1111/cas.12499; Liu DC, 2014, BIOCHEM BIOPH RES CO, V445, P151, DOI 10.1016/j.bbrc.2014.01.140; Liu G, 2017, APMIS; Liu Y, 2017, ONCOL REP, V37, P1521, DOI 10.3892/or.2017.5378; Long Q, 2011, AM J PATHOL, V179, P46, DOI 10.1016/j.ajpath.2011.03.008; Lu YJ, 2016, TUMOR BIOL, V37, P12685, DOI 10.1007/s13277-016-5241-5; Mortensen MM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16018; Mortensen MM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-859; Nilsson EM, 2015, ONCOTARGET, V6, P35710, DOI 10.18632/oncotarget.5958; Noonan EJ, 2009, ONCOGENE, V28, P1714, DOI 10.1038/onc.2009.19; Noonan EJ, 2010, ONCOTARGET, V1, P349, DOI 10.18632/oncotarget.167; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Patel D, 2015, AM J CANCER RES, V5, P3407; Peng LP, 2015, MOL CELL BIOCHEM, V405, P73, DOI 10.1007/s11010-015-2397-z; Qu F, 2017, ONCOTARGET; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; Romero OA, 2014, CANCER DISCOV, V4, P292, DOI 10.1158/2159-8290.CD-13-0799; Ross-Adams H, 2015, EBIOMEDICINE, V2, P1133, DOI 10.1016/j.ebiom.2015.07.017; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Sun WD, 2017, ONCOL REP, V37, P341, DOI 10.3892/or.2016.5223; Sun YJ, 2009, PROSTATE, V69, P1119, DOI 10.1002/pros.20961; Tao J, 2012, ONCOL REP, V27, P1967, DOI 10.3892/or.2012.1711; Ting HJ, 2013, J BIOL CHEM, V288, P1, DOI 10.1074/jbc.M112.395947; Tong AW, 2009, CANCER GENE THER, V16, P206, DOI 10.1038/cgt.2008.77; Wang XB, 2012, BIOINFORMATICS, V28, P2534, DOI 10.1093/bioinformatics/bts485; Wu AH, 2016, BIOMED PHARMACOTHER, V77, P92, DOI 10.1016/j.biopha.2015.12.005; Wu ZH, 2012, ELSEV INSIGHT, P1, DOI 10.1016/B978-0-12-398510-1.00001-7; Xiong Y, 2015, BIOMED PHARMACOTHER, V71, P64, DOI 10.1016/j.biopha.2015.02.020; Xu J, 2017, INT J ONCOL; Yang DS, 2014, IEEE ENG MED BIO, P4780, DOI 10.1109/EMBC.2014.6944693; Yun S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108913; Zhang XY, 2017, ONCOTARGET, V8, P29535, DOI 10.18632/oncotarget.17402; Zheng QZ, 2014, PROSTATE, V74, P1655, DOI 10.1002/pros.22883	62	82	84	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179543	10.1371/journal.pone.0179543	http://dx.doi.org/10.1371/journal.pone.0179543			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651018	Green Published, Green Submitted, gold			2022-12-27	WOS:000404537300011
J	Ferdman, S; Minkov, E; Bekkerman, R; Gefen, D				Ferdman, Sela; Minkov, Einat; Bekkerman, Ron; Gefen, David			Quantifying the web browser ecosystem	PLOS ONE			English	Article							LINK-PREDICTION	Contrary to the assumption that web browsers are designed to support the user, an examination of a 900,000 distinct PCs shows that web browsers comprise a complex ecosystem with millions of addons collaborating and competing with each other. It is possible for addons to "sneak in" through third party installations or to get "kicked out" by their competitors without user involvement. This study examines that ecosystem quantitatively by constructing a large-scale graph with nodes corresponding to users, addons, and words (terms) that describe addon functionality. Analyzing addon interactions at user level using the Personalized PageRank (PPR) random walk measure shows that the graph demonstrates ecological resilience. Adapting the PPR model to analyzing the browser ecosystem at the level of addon manufacturer, the study shows that some addon companies are in symbiosis and others clash with each other as shown by analyzing the behavior of 18 prominent addon manufacturers. Results may herald insight on how other evolving internet ecosystems may behave, and suggest a methodology for measuring this behavior. Specifically, applying such a methodology could transform the addon market.	[Ferdman, Sela] Univ Haifa, Dept Comp Sci, Haifa, Israel; [Minkov, Einat] Univ Haifa, Dept Informat Syst, Haifa, Israel; [Bekkerman, Ron] Univ Haifa, Dept Informat & Knowledge Management, Haifa, Israel; [Gefen, David] Drexel Univ, LeBow Coll Business, Philadelphia, PA 19104 USA	University of Haifa; University of Haifa; University of Haifa; Drexel University	Bekkerman, R (corresponding author), Univ Haifa, Dept Informat & Knowledge Management, Haifa, Israel.	ronb@univ.haifa.ac.il		Minkov, Einat/0000-0001-8421-5209				Adamic LA, 2016, P 9 ACM INT C WEB SE; Agirre E, 2009, P 12 C EUR CHAPT ACL; [Anonymous], [No title captured]; [Anonymous], P SPEC INT TRACKS PO; Bao SH, 2008, IEEE T KNOWL DATA EN, V20, P1297, DOI 10.1109/TKDE.2008.98; Blincoe K, 2015, 12TH WORKING CONFERENCE ON MINING SOFTWARE REPOSITORIES (MSR 2015), P202, DOI 10.1109/MSR.2015.26; Bolton P., 2005, CONTRACT THEORY; Budalakoti S., 2012, P 21 INT WORLD WID W; Christensen HB, 2014, INFORM SOFTWARE TECH, V56, P1476, DOI 10.1016/j.infsof.2014.05.002; Cohen F., 1987, Computers & Security, V6, P22, DOI 10.1016/0167-4048(87)90122-2; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; de Kerchove C, 2008, P 2008 SIAM INT C DA; Dhungana Deepak, 2010, P 4 EUROPEAN C SOFTW, P96; Dix A., 2009, HUMAN COMPUTER INTER; EISENHARDT KM, 1989, ACAD MANAGE REV, V14, P57, DOI 10.2307/258191; Elzer S, 2007, WEBIST 2007: PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON WEB INFORMATION SYSTEMS AND TECHNOLOGIES, VOL WIA, P59; Fogaras D, 2004, LECT NOTES COMPUT SC, V3243, P105; Franceschet M, 2011, COMMUN ACM, V54, P92, DOI 10.1145/1953122.1953146; Freschi V., 2007, BIOINF BIOENG 2007 B, P42, DOI DOI 10.1109/BIBE.2007.4375543; Gefen D, 2008, MIS QUART, V32, P531; Getoor L., 2005, ACM SIGKDD EXPLORATI, V7, P3, DOI DOI 10.1145/1117454.1117456; Gunderson LH, 2000, ANNU REV ECOL SYST, V31, P425, DOI 10.1146/annurev.ecolsys.31.1.425; Haveliwava T. H., 2002, P 11 INT C WORLD WID, P517, DOI [DOI 10.1145/511446.511513, 10.1145/511446.511513]; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Iansiti M, 2004, HARVARD BUS REV, V82, P68; Ibsen-Jensen R, 2015, P NATL ACAD SCI USA, V112, P15636, DOI 10.1073/pnas.1511366112; Jaccard P., 1912, NEW PHYTOL, V11, P37, DOI [10.1111/j.1469-8137.1912.tb05611.x, DOI 10.1111/J.1469-8137.1912.TB05611.X, DOI 10.1371/journal.pbio.1001889]; Jansen S, 2013, SOFTWARE ECOSYSTEMS: ANALYZING AND MANAGING BUSINESS NETWORKS IN THE SOFTWARE INDUSTRY, P1, DOI 10.4337/9781781955635; Jansen S, 2013, SOFTWARE ECOSYSTEMS: ANALYZING AND MANAGING BUSINESS NETWORKS IN THE SOFTWARE INDUSTRY, P1; Jeh G., 2003, P 12 INT C WORLD WID, P271, DOI DOI 10.1145/775152.775191; Kunegis J, 2008, P INT WORLD WID WEB; Leontiadis I., 2012, P 12 WORKSH MOB COMP; Leskovec J., 2010, P INT C WORLD WID WE, P641, DOI DOI 10.1109/ICDE.2018.00077; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; Lungu M.F, 2009, REVERSE ENG SOFTWARE; Manikas K, 2013, J SYST SOFTWARE, V86, P1294, DOI 10.1016/j.jss.2012.12.026; Messick DM, 2005, LEAS ORG MAN SERIES, P1; Minkov E, 2010, ACM T INFORM SYST, V29, DOI 10.1145/1877766.1877770; MOORE JF, 1993, HARVARD BUS REV, V71, P75; Olfati-Saber R, 2007, P IEEE, V95, P215, DOI 10.1109/JPROC.2006.887293; Page Lawrence, 1999, 199966 STANF INFOLAB; Prakash BA, 2014, KNOWL INF SYST, V38, P35, DOI 10.1007/s10115-013-0671-5; Ross B, 2005, USENIX Association Proceedings of the 14th USENIX Security Symposium, P17; Russell S., 2016, ARXIV160203506; Sangkeun L., 2011, P 5 ACM C REC SYST, P93, DOI DOI 10.1145/2043932.2043952; Sarkar P., 2010, TRACTABLE ALGORITHMS; Schaefer V, 2009, RESTOR ECOL, V17, P171, DOI 10.1111/j.1526-100X.2008.00513.x; Sun Y, 2012, P ACM INT C WEB SEAR; Sun Y, 2012, ACM SIGKDD EXPLORATI; Tilman David, 1996, P3; Tong H., 2006, P 12 ACM SIGKDD INT, P404, DOI DOI 10.1145/1150402.1150448; Tong HH, 2008, KNOWL INF SYST, V14, P327, DOI 10.1007/s10115-007-0094-2; Voorhees E.M., 2000, P 2 INT C LANGUAGE R, P77; Weng J., 2010, P 3 ACM INT C WEB SE, P261, DOI [10.1145/1718487.1718520, DOI 10.1145/1718487.1718520]; Yang Y, 2012, P ACM INT C INF KNOW	57	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179281	10.1371/journal.pone.0179281	http://dx.doi.org/10.1371/journal.pone.0179281			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644833	gold, Green Published, Green Submitted			2022-12-27	WOS:000404145100012
J	Haugaard, AM				Haugaard, Asger M.			Predicting the bounds of large chaotic systems using low-dimensional manifolds	PLOS ONE			English	Article							LYAPUNOV EXPONENTS; NONLINEAR DYNAMICS; TIME; MODELS; SIMULATION; CANCER	Predicting extrema of chaotic systems in high-dimensional phase space remains a challenge. Methods, which give extrema that are valid in the long term, have thus far been restricted to models of only a few variables. Here, a method is presented which treats extrema of chaotic systems as belonging to discretised manifolds of low dimension (low-D) embedded in high-dimensional (high-D) phase space. As a central feature, the method exploits that strange attractor dimension is generally much smaller than parent system phase space dimension. This is important, since the computational cost associated with discretised manifolds depends exponentially on their dimension. Thus, systems that would otherwise be associated with tremendous computational challenges, can be tackled on a laptop. As a test, bounding manifolds are calculated for high-D modifications of the canonical Duffing system. Parameters can be set such that the bounding manifold displays harmonic behaviour even if the underlying system is chaotic. Thus, solving for one post transient forcing cycle of the bounding manifold predicts the extrema of the underlying chaotic problem indefinitely.	[Haugaard, Asger M.] Univ Oxford, Med Sci Div, Oxford OX3 9DU, England; [Haugaard, Asger M.] Kings Coll Hosp London, Weston Educ Ctr, 1st Floor,Denmark Hill, London SE5 9RS, England	University of Oxford; King's College Hospital NHS Foundation Trust; King's College Hospital	Haugaard, AM (corresponding author), Univ Oxford, Med Sci Div, Oxford OX3 9DU, England.; Haugaard, AM (corresponding author), Kings Coll Hosp London, Weston Educ Ctr, 1st Floor,Denmark Hill, London SE5 9RS, England.	haugaard@doctors.org.uk						Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042; Arevalo HJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11437; BABLOYANTZ A, 1986, P NATL ACAD SCI USA, V83, P3513, DOI 10.1073/pnas.83.10.3513; Baum M, 1999, EUR J CANCER, V35, P886, DOI 10.1016/S0959-8049(99)00067-2; Birman J., 1983, CONT MATH, V20, P1, DOI DOI 10.1090/CONM/020/718132; BIRMAN JS, 1983, TOPOLOGY, V22, P47, DOI 10.1016/0040-9383(83)90045-9; Borghesi C, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.066118; BRANDSTATER A, 1983, PHYS REV LETT, V51, P1442, DOI 10.1103/PhysRevLett.51.1442; Byrne HM, 2010, NAT REV CANCER, V10, P221, DOI 10.1038/nrc2808; CHIALVO DR, 1987, NATURE, V330, P749, DOI 10.1038/330749a0; Danforth CM, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.144102; FARMER JD, 1982, PHYSICA D, V4, P366, DOI 10.1016/0167-2789(82)90042-2; FARMER JD, 1987, PHYS REV LETT, V59, P845, DOI 10.1103/PhysRevLett.59.845; FOIAS C, 1988, J DIFFER EQUATIONS, V73, P309, DOI 10.1016/0022-0396(88)90110-6; FREEMAN WJ, 1987, BIOL CYBERN, V56, P139, DOI 10.1007/BF00317988; Gao Q, 2009, NONLINEAR DYNAM, V58, P209, DOI 10.1007/s11071-009-9472-5; Giacomini H., 1997, PHYS LETT A, V240, P157; Gilmore R., 2011, TOPOLOGY CHAOS; Ginoux J.-M, 2017, ARCHIMEDES SERIES, V49; Gorban AN, 2004, PHYS REP, V396, P197, DOI 10.1016/j.physrep.2004.03.006; Gorbana M, ARXIV161005450; GUEVARA MR, 1982, J MATH BIOL, V14, P1, DOI 10.1007/BF02154750; HSIEH DA, 1991, J FINANC, V46, P1839, DOI 10.2307/2328575; Huang P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11517; Ispolatov I, 2015, SCI REP-UK, V5, DOI 10.1038/srep12506; Kanatnikov AN, 2009, DIFF EQUAT+, V45, P46, DOI 10.1134/S0012266109010054; KENNEDY MP, 1986, IEEE T CIRCUITS SYST, V33, P974, DOI 10.1109/TCS.1986.1085855; Krishchenko A.P., 2005, DIFF URAVN, V41, P1597; LEVEN RW, 1981, PHYS LETT A, V86, P71, DOI 10.1016/0375-9601(81)90167-5; Li DM, 2005, CHAOS SOLITON FRACT, V23, P529, DOI 10.1016/j.chaos.2004.05.021; LORENZ EN, 1963, J ATMOS SCI, V20, P130, DOI 10.1175/1520-0469(1963)020<0130:DNF>2.0.CO;2; Lorenz EN, 2004, PREDICTABILITY PROBL; Luther S, 2011, NATURE, V475, P235, DOI 10.1038/nature10216; Mirams GR, 2011, ANN NY ACAD SCI, V1245, P44, DOI 10.1111/j.1749-6632.2011.06324.x; Momiji H, 2008, J THEOR BIOL, V254, P784, DOI 10.1016/j.jtbi.2008.07.013; NOBLE D, 1962, J PHYSIOL-LONDON, V160, P317, DOI 10.1113/jphysiol.1962.sp006849; NOBLE D, 1960, NATURE, V188, P495, DOI 10.1038/188495b0; Noble D, 2008, J PHARMACOL SCI, V107, P107, DOI 10.1254/jphs.CR0070042; Oczkowski M, 2005, J ATMOS SCI, V62, P1135, DOI 10.1175/JAS3403.1; OTT E, 1990, PHYS REV LETT, V64, P1196, DOI 10.1103/PhysRevLett.64.1196; PACKARD NH, 1980, PHYS REV LETT, V45, P712, DOI 10.1103/PhysRevLett.45.712; Pan I, 2012, NONLINEAR DYNAM, V70, P2554; Reynolds AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep23492; RICHARDS D, 1990, BEHAV SCI, V35, P219, DOI 10.1002/bs.3830350305; ROSSLER OE, 1976, PHYS LETT A, V57, P397, DOI 10.1016/0375-9601(76)90101-8; SABIN GCW, 1993, MATH BIOSCI, V113, P91, DOI 10.1016/0025-5564(93)90010-8; Sato Y, 2002, P NATL ACAD SCI USA, V99, P4748, DOI 10.1073/pnas.032086299; Shadden SC, 2005, PHYSICA D, V212, P271, DOI 10.1016/j.physd.2005.10.007; Shang YL, 2017, CHAOS, V27, DOI 10.1063/1.4976959; Silk D, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1496; Sprott JC, 2000, PHYS LETT A, V266, P19, DOI 10.1016/S0375-9601(00)00026-8; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; Thompson JMT, 1988, PHYS LETT A, V125, P419; THOMSEN JJ, 1992, J SOUND VIB, V153, P239, DOI 10.1016/S0022-460X(05)80005-7; Wang LZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11323; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9	57	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179507	10.1371/journal.pone.0179507	http://dx.doi.org/10.1371/journal.pone.0179507			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644871	Green Submitted, Green Published, gold			2022-12-27	WOS:000404145100020
J	Shanmugasundaram, B; Aher, YD; Aradska, J; Ilic, M; Feyissa, DD; Kalaba, P; Aher, NY; Dragacevic, V; Marouf, BS; Langer, T; Sitte, HH; Hoeger, H; Lubec, G; Korz, V				Shanmugasundaram, Bharanidharan; Aher, Yogesh D.; Aradska, Jana; Ilic, Marija; Feyissa, Daniel Daba; Kalaba, Predrag; Aher, Nilima Y.; Dragacevic, Vladimir; Marouf, Babak Saber; Langer, Thierry; Sitte, Harald H.; Hoeger, Harald; Lubec, Gert; Korz, Volker			R-Modafinil exerts weak effects on spatial memory acquisition and dentate gyrus synaptic plasticity	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DOPAMINE TRANSPORTER; REACTION-TIME; IN-VIVO; ARMODAFINIL; PERFORMANCE; DRUG; MAZE; RATS; STIMULATION	Modafinil is a wake promoting drug approved for clinical use and also has cognitive enhancing properties. Its enantiomer R-Modafinil (R-MO) is not well studied in regard to cognitive enhancing properties. Hence we studied its effect in a spatial memory paradigm and its possible effects on dentate gyrus long-term potentiation (DG-LTP). Clinically relevant doses of R-MO, vehicle dimethyl sulfoxide (DMSO) or saline were administered for three days during the hole-board test and in in vivo DG-LTP. Synaptic levels of dopamine receptors D1R, D2R, dopamine transporter (DAT), and its phosphorylated form (ph-DAT) in DG tissue 4 h after LTP induction were quantified by western blot analysis. Monoamine reuptake and release assays were performed by using transfected HEK-293 cells. Possible neurotoxic side effects on general behaviour were also studied. R-MO at both doses significantly enhanced spatial reference memory during the last training session and during memory retrieval compared to DMSO vehicle but not when compared to saline treated rats. Similarly, R-MO rescues DG-LTP from impairing effects of DMSO. DMSO reduced memory performance and LTP magnitude when compared to saline treated groups. The synaptic DR1 levels in R-MO groups were significantly decreased compared to DMSO group but were comparable with saline treated animals. We found no effect of R-MO in neurotoxicity tests. Thus, our results support the notion that LTP-like synaptic plasticity processes could be one of the factors contributing to the cognitive enhancing effects of spatial memory traces. D1R may play an important regulatory role in these processes.	[Shanmugasundaram, Bharanidharan; Aher, Yogesh D.; Aradska, Jana; Feyissa, Daniel Daba; Korz, Volker] Med Univ Vienna, Dept Pediat, Vienna, Austria; [Ilic, Marija; Kalaba, Predrag; Aher, Nilima Y.; Dragacevic, Vladimir; Marouf, Babak Saber; Langer, Thierry] Univ Vienna, Dept Pharmaceut Chem, Vienna, Austria; [Sitte, Harald H.] Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, Vienna, Austria; [Sitte, Harald H.] Med Univ Vienna, Ctr Addict Res & Sci, Vienna, Austria; [Hoeger, Harald] Med Univ Vienna, Div Lab Anim Sci & Genet, Core Unit Biomed Res, Himberg, Austria; [Lubec, Gert] Neuroprote Lab, Sci Pk, Bratislava, Slovakia	Medical University of Vienna; University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Korz, V (corresponding author), Med Univ Vienna, Dept Pediat, Vienna, Austria.; Lubec, G (corresponding author), Neuroprote Lab, Sci Pk, Bratislava, Slovakia.	gert.lubec@lubeclab.com; volker.korz@medunwien.ac.at	Sitte, Harald/N-2681-2013; Kalaba, Predrag/D-4227-2018; Langer, Thierry/U-8621-2017	Sitte, Harald/0000-0002-1339-7444; Langer, Thierry/0000-0002-5242-1240; Kalaba, Predrag/0000-0003-0480-2337; Lubec, Jana/0000-0003-0657-7647; Feyissa, Daniel/0000-0002-5623-3693	Medical University of Viennato GL	Medical University of Viennato GL	This work was supported by the Medical University of Viennato GL.	Andrade C, 2016, J CLIN PSYCHIAT, V77, pE25, DOI 10.4088/JCP.15f10580; Andrade C, 2015, J CLIN PSYCHIAT, V76, P1633, DOI 10.4088/JCP.15f10514; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Barch DM, 2004, PSYCHOPHARMACOLOGY, V174, P126, DOI 10.1007/s00213-003-1732-3; Baumann MH, 2013, NEUROPSYCHOPHARMACOL, V38, P552, DOI 10.1038/npp.2012.204; Borgkvist A, 2012, INT J NEUROPSYCHOPH, V15, P531, DOI 10.1017/S1461145711000812; Budinich CS, 2013, PHARMACOL BIOCHEM BE, V108, P66, DOI 10.1016/j.pbb.2013.04.001; Burgos H, 2010, BRAIN RES BULL, V83, P238, DOI 10.1016/j.brainresbull.2010.08.010; Burrows BT, 2015, J DRUG ALCOHOL RES, V4; Cao BJ, 1996, BEHAV PHARMACOL, V7, P810; Chapman JL, 2016, EUR RESPIR J, V47, P1420, DOI 10.1183/13993003.01509-2015; Darwish M, 2009, CLIN DRUG INVEST, V29, P613, DOI 10.2165/11315280-000000000-00000; DRAYER DE, 1986, CLIN PHARMACOL THER, V40, P125, DOI 10.1038/clpt.1986.150; Engber TM, 1998, NEUROSCIENCE, V87, P905, DOI 10.1016/S0306-4522(98)00015-3; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Gangarossa G, 2014, HIPPOCAMPUS, V24, P1466, DOI 10.1002/hipo.22327; Gilbert ME, 2006, BRAIN RES, V1069, P10, DOI 10.1016/j.brainres.2005.10.049; Hamilton TJ, 2010, P NATL ACAD SCI USA, V107, P18185, DOI 10.1073/pnas.1011558107; Hassert DL, 2004, BEHAV NEUROSCI, V118, P79, DOI 10.1037/0735-7044.118.1.79; Hilaire ZD, 2001, NEUROREPORT, V12, P3533, DOI 10.1097/00001756-200111160-00032; JARBE TUC, 1994, PHARMACOL BIOCHEM BE, V47, P113, DOI 10.1016/0091-3057(94)90119-8; Karabacak Y, 2015, FRONT BEHAV NEUROSCI, V9, DOI [10.3339/fnbeh.2015.00215, 10.3389/fnbeh.2015.00215]; KNOWLES WD, 1981, J NEUROSCI, V1, P318; Korz V, 2007, LEARN MEMORY, V14, P160, DOI 10.1101/lm.459807; KRUG M, 1983, BRAIN RES BULL, V11, P1, DOI 10.1016/0361-9230(83)90048-5; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Loland CJ, 2012, BIOL PSYCHIAT, V72, P405, DOI 10.1016/j.biopsych.2012.03.022; Madras BK, 2006, J PHARMACOL EXP THER, V319, P561, DOI 10.1124/jpet.106.106583; Manahan-Vaughan D, 2003, CEREB CORTEX, V13, P123, DOI 10.1093/cercor/13.2.123; Markvartova V, 2013, NEUROSCI LETT, V543, P142, DOI 10.1016/j.neulet.2013.03.034; McElhiney M, 2013, J CLIN EXP NEUROPSYC, V35, P718, DOI 10.1080/13803395.2013.823910; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Mehta MA, 2006, CURR PHARM DESIGN, V12, P2487, DOI 10.2174/138161206777698891; MIGNOT E, 1994, SLEEP, V17, P436, DOI 10.1093/sleep/17.5.436; Minzenberg MJ, 2008, SCIENCE, V322, P1700, DOI 10.1126/science.1164908; Morgan RE, 2007, PHARMACOL BIOCHEM BE, V86, P531, DOI 10.1016/j.pbb.2007.01.015; Murillo-Rodriguez E, 2007, BEHAV BRAIN RES, V176, P353, DOI 10.1016/j.bbr.2006.10.016; Niu L, 2009, HIPPOCAMPUS, V19, P649, DOI 10.1002/hipo.20540; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Penazzi L, 2017, NEUROPHARMACOLOGY, V113, P434, DOI 10.1016/j.neuropharm.2016.10.020; Rao Y, 2007, J CLIN INVEST, V117, P4022, DOI 10.1172/JCI32829; Sabine S., 2011, DISSECTION RODENT BR, P13; Saper CB, 2004, SLEEP, V27, P11; Saroja SR, 2016, BEHAV BRAIN RES, V312, P127, DOI 10.1016/j.bbr.2016.06.011; Sase A, 2016, NEUROPHARMACOLOGY, V102, P186, DOI 10.1016/j.neuropharm.2015.07.039; Scholze P, 2000, J PHARMACOL EXP THER, V293, P870; Shanmugasundaram B, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00220; Shuman T, 2009, BEHAV NEUROSCI, V123, P257, DOI 10.1037/a0014366; Spencer RC, 2015, BIOL PSYCHIAT, V77, P940, DOI 10.1016/j.biopsych.2014.09.013; STANTON PK, 1985, BRAIN RES, V361, P276, DOI 10.1016/0006-8993(85)91299-5; Stanton PK, 2006, SYNAPTIC PLASTICITY; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Sutton LP, 2015, NEUROPHARMACOLOGY, V99, P610, DOI 10.1016/j.neuropharm.2015.08.024; Taneja I, 2005, HYPERTENSION, V45, P612, DOI 10.1161/01.HYP.0000158267.66763.63; Tsanov M, 2010, NEUROPHARMACOLOGY, V59, P9, DOI 10.1016/j.neuropharm.2010.03.010; Waters KA, 2005, J PSYCHOPHARMACOL, V19, P149, DOI 10.1177/0269881105048995; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Wisor JP, 2001, J NEUROSCI, V21, P1787, DOI 10.1523/JNEUROSCI.21-05-01787.2001; Wittkampf LC, 2012, THER ADV PSYCHOPHARM, V2, P115, DOI 10.1177/2045125312441815; Yang K, 2014, J NEUROSCI, V34, P15888, DOI 10.1523/JNEUROSCI.2400-14.2014	60	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179675	10.1371/journal.pone.0179675	http://dx.doi.org/10.1371/journal.pone.0179675			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644892	Green Submitted, Green Published, gold			2022-12-27	WOS:000404145100031
J	Claudel, M; Massaro, E; Santi, P; Murray, F; Ratti, C				Claudel, Matthew; Massaro, Emanuele; Santi, Paolo; Murray, Fiona; Ratti, Carlo			An exploration of collaborative scientific production at MIT through spatial organization and institutional affiliation	PLOS ONE			English	Article							NETWORK ANALYSIS; INNOVATION; EVOLUTION; CLUSTERS; SCIENCE	Academic research is increasingly cross-disciplinary and collaborative, between and within institutions. In this context, what is the role and relevance of an individual's spatial position on a campus? We examine the collaboration patterns of faculty at the Massachusetts Institute of Technology, through their academic output (papers and patents), and their organizational structures (institutional affiliation and spatial configuration) over a 10-year time span. An initial comparison of output types reveals: 1. diverging trends in the composition of collaborative teams over time (size, faculty versus non-faculty, etc.); and 2. substantively different patterns of cross-building and cross-disciplinary collaboration. We then construct a multi-layered network of authors, and find two significant features of collaboration on campus: 1. a network topology and community structure that reveals spatial versus institutional collaboration bias; and 2. a persistent relationship between proximity and collaboration, well fit with an exponential decay model. This relationship is consistent for both papers and patents, and present also in exclusively cross-disciplinary work. These insights contribute an architectural dimension to the field of scientometrics, and take a first step toward empirical space-planning policy that supports collaboration within institutions.	[Claudel, Matthew] MIT, Lab Innovat Sci & Policy, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Claudel, Matthew; Massaro, Emanuele; Santi, Paolo; Ratti, Carlo] MIT, Senseable City Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Santi, Paolo] CNR, Ist Informat & Telemat, Pisa, Italy; [Murray, Fiona] MIT, Sloan Sch Management, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Consiglio Nazionale delle Ricerche (CNR); Istituto di Informatica e Telematica (IIT-CNR); Massachusetts Institute of Technology (MIT)	Claudel, M (corresponding author), MIT, Lab Innovat Sci & Policy, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Claudel, M; Massaro, E (corresponding author), MIT, Senseable City Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	claudel@mit.edu; emassaro@mit.edu	Massaro, Emanuele/AAW-4262-2021	Massaro, Emanuele/0000-0002-9287-3743				Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A., 2013, DYNAMICAL PROCESSES; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Berge LR, 2016, PAP REG SCI; Bikard M, 2015, MANAGE SCI, V61, P1473, DOI 10.1287/mnsc.2014.2052; Bjork BC, 2013, J INFORMETR, V7, P914, DOI 10.1016/j.joi.2013.09.001; Borner K, 2004, P NATL ACAD SCI USA, V101, P5266, DOI 10.1073/pnas.0307625100; Boschma RA, 2005, REG STUD, V39, P61, DOI 10.1080/0034340052000320887; Breschi S, 2010, RES POLICY, V39, P14, DOI 10.1016/j.respol.2009.11.004; Catalini C., 2012, SSRN ELECT J; Catini R, 2015, RES POLICY, V44, P1749, DOI 10.1016/j.respol.2015.01.011; Chatterji A., 2014, INNOVATION POLICY EC, V14, P129, DOI [https://doi.org/10.1086/674023, DOI 10.1086/674023]; Ducruet C, 2014, NETW SPAT ECON, V14, P297, DOI 10.1007/s11067-013-9222-6; Engel JS, 2015, CALIF MANAGE REV, V57, P36, DOI 10.1525/cmr.2015.57.2.36; Fortunato S, 2016, PHYS REP, V659, P1, DOI 10.1016/j.physrep.2016.09.002; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Hillier B, 2005, SOCIAL LOGIC SPACE R; Jones BF, 2008, SCIENCE, V322, P1259, DOI 10.1126/science.1158357; Kabo F, 2015, ENVIRON BEHAV, V47, P57, DOI 10.1177/0013916513493909; Knorr-Cetina K., 1995, HDB SCI TECHNOLOGY S, P140; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Lazega E, 2008, SOC NETWORKS, V30, P159, DOI 10.1016/j.socnet.2008.02.001; Linkov Igor, 2016, Environment Systems & Decisions, V36, P331, DOI 10.1007/s10669-016-9614-5; Massaro E, 2012, COMMUN NONLINEAR SCI, V17, P4294, DOI 10.1016/j.cnsns.2012.03.023; MIT News Office, 2012, MIT NEWS OFFICE 0704; Newman MEJ, 2012, NAT PHYS, V8, P25, DOI 10.1038/nphys2162; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Owen-Smith J, 2004, ORGAN SCI, V15, P5, DOI 10.1287/orsc.1030.0054; Parolo PD, 2015, J INFORMETR, V9, P734, DOI 10.1016/j.joi.2015.07.006; Peponis J, 1998, ENVIRON PLANN B, V25, P559, DOI 10.1068/b250559; Peponis J, 2007, ENVIRON BEHAV, V39, P815, DOI 10.1177/0013916506297216; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Wineman J, 2014, ENVIRON PLANN B, V41, P1100, DOI 10.1068/b130074p; Wineman JD, 2009, ENVIRON BEHAV, V41, P427, DOI 10.1177/0013916508314854	39	22	22	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179334	10.1371/journal.pone.0179334	http://dx.doi.org/10.1371/journal.pone.0179334			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY6ZV	28640829	Green Published, Green Submitted, gold			2022-12-27	WOS:000404135800029
J	Droz, BA; Sneed, BL; Jackson, CV; Zimmerman, KM; Michael, MD; Emmerson, PJ; Coskun, T; Peterson, RG				Droz, Brian A.; Sneed, Bria L.; Jackson, Charles V.; Zimmerman, Karen M.; Michael, M. Dodson; Emmerson, Paul J.; Coskun, Tamer; Peterson, Richard G.			Correlation of disease severity with body weight and high fat diet in the FATZO/Pco mouse	PLOS ONE			English	Article							OBESE-HYPERGLYCEMIC MICE; BETA-CELL FUNCTION; METABOLIC SYNDROME; INSULIN-RESISTANCE; LEPTIN; C57BL/6J; INFLAMMATION; ONSET; OUTCOMES; STRAINS	Obesity in many current pre-clinical animal models of obesity and diabetes is mediated by monogenic mutations; these are rarely associated with the development of human obesity. A new mouse model, the FATZO mouse, has been developed to provide polygenic obesity and a metabolic pattern of hyperglycemia and hyperinsulinemia, that support the presence of insulin resistance similar to metabolic disease in patients with insulin resistance/type 2 diabetes. The FATZO mouse resulted from a cross of C57BL/6J and AKR/J mice followed by selective inbreeding for obesity, increased insulin and hyperglycemia. Since many clinical studies have established a close link between higher body weight and the development of type 2 diabetes, we investigated whether time to progression to type 2 diabetes or disease severity in FATZO mice was dependent on weight gain in young animals. Our results indicate that lighter animals developed metabolic disturbances much slower and to a lesser magnitude than their heavier counterparts. Consumption of a diet containing high fat, accelerated weight gain in parallel with disease progression. A naturally occurring and significant variation in the body weight of FATZO offspring enables these mice to be identified as low, mid and high body weight groups at a young age. These weight groups remain into adulthood and correspond to slow, medium and accelerated development of type 2 diabetes. Thus, body weight inclusion criteria can optimize the FATZO model for studies of prevention, stabilization or treatment of type 2 diabetes.	[Droz, Brian A.; Michael, M. Dodson; Emmerson, Paul J.; Coskun, Tamer] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Sneed, Bria L.] Ball State Univ, Muncie, IN 47306 USA; [Jackson, Charles V.; Zimmerman, Karen M.; Peterson, Richard G.] Crown Biosci Indiana, Indianapolis, IN 46268 USA	Eli Lilly; Ball State University	Peterson, RG (corresponding author), Crown Biosci Indiana, Indianapolis, IN 46268 USA.	rpeterson@crownbio.com	Coskun, Tamer/AAR-8422-2021	Michael, Mervyn/0000-0002-0224-1065	SBIR grant from NIH [2R44DK082065]; Eli Lilly and Company; Crown Bioscience Indiana	SBIR grant from NIH; Eli Lilly and Company(Eli Lilly); Crown Bioscience Indiana	This project was partially funded by an SBIR grant from NIH (2R44DK082065) to PreClinOmics. The remainder of the funding was supplied by Eli Lilly and Company in the form of salaries for authors BAD, BLS, MDM, PJE, and TC but it did not have any additional role in the study design, data collection and analysis. Funding was also supplied by PreClinOmics (now Crown Bioscience Indiana) for authors CVJ, KMZ, and RGP in the form of salaries and other compensation. RGP was one of the owners and CSO for PreClinOmics and was the principal investigator on the SBIR grants and as such was responsible for the animal model development before, during and after the tenure of the SBIR funding and as such, was involved in study design, data collection, data analysis and manuscript production. CVJ is the general manager and CSO of Crown Bioscience Indiana and as such, since March 2016, was partially responsible for the continued support of the project in the form of material, salaries, study design, data collection, data analysis and manuscript production. The other specific roles of these authors are articulated in the "author contributions" section.	Alexander J, 2006, INT J OBESITY, V30, P50, DOI 10.1038/sj.ijo.0803110; Anunciado-Koza RP, 2016, BIOCHIMIE, V124, P134, DOI 10.1016/j.biochi.2015.05.007; Artham SM, 2009, OCHSNER J, V9, P124; Aydin S, 2014, NUTRITION, V30, P1, DOI 10.1016/j.nut.2013.05.013; Bowles L, 2001, J CLIN PATHOL, V54, P1, DOI 10.1136/jcp.54.1.1; Cottrell Elizabeth C, 2012, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-24716-3_1; Crespo PS, 2007, PUBLIC HEALTH NUTR, V10, P1121, DOI 10.1017/S1368980007000596; Dagdeviren S, 2016, MOL CELL BIOL, V36, P2956, DOI 10.1128/MCB.00181-16; Davis RC, 2010, DIABETES, V59, P1616, DOI 10.2337/db09-0878; DeBoer MD, 2013, NUTRITION, V29, P379, DOI 10.1016/j.nut.2012.07.003; Deshmukh VL, 2016, J OBSTET GYN INDIA, V66, P192, DOI 10.1007/s13224-015-0825-3; Do OH, 2016, DIABETOLOGIA, V59, P1222, DOI 10.1007/s00125-016-3942-3; DUBUC PU, 1982, HORM METAB RES, V14, P532, DOI 10.1055/s-2007-1019069; Fellmann L, 2013, PHARMACOL THERAPEUT, V137, P331, DOI 10.1016/j.pharmthera.2012.11.004; Funcke Jan-Bernd, 2014, Mol Cell Pediatr, V1, P3, DOI 10.1186/s40348-014-0003-1; Goday A, 2016, NUTR DIABETES, V6, DOI 10.1038/nutd.2016.36; Grundy SM, 2016, TRENDS CARDIOVAS MED, V26, P364, DOI 10.1016/j.tcm.2015.10.004; Hannema SE, 2016, HORM RES PAEDIAT, V85, P412, DOI 10.1159/000444055; Imai Y, 2008, PHYSIOL GENOMICS, V36, P43, DOI 10.1152/physiolgenomics.00050.2008; Kanat M, 2015, WORLD J DIABETES, V6, P1207, DOI 10.4239/wjd.v6.i12.1207; Kozak LP, 2002, ANN NY ACAD SCI, V967, P80; Krug EG, 2016, LANCET, V387, P1485, DOI 10.1016/S0140-6736(16)30163-5; Leow MK, 2015, NEW ENGL J MED, V372, P1266, DOI 10.1056/NEJMc1501146; Lewis SR, 2007, PHYSIOL BEHAV, V90, P82, DOI 10.1016/j.physbeh.2006.08.028; Lichtenstein AH, 1998, NUTR REV, V56, pS3; Lindstrom P, 2007, THESCIENTIFICWORLDJO, V7, P666, DOI 10.1100/tsw.2007.117; Lindstrom P, 2010, ADV EXP MED BIOL, V654, P463, DOI 10.1007/978-90-481-3271-3_20; Ling C, 2016, DIABETOLOGIA, V59, P2295, DOI 10.1007/s00125-016-4109-y; Lopez-Candales Angel, 2001, Journal of Medicine (Westbury), V32, P283; Lowe LP, 2010, J CLIN ENDOCR METAB, V95, P5427, DOI 10.1210/jc.2010-1662; Madan JC, 2009, CYTOKINE, V47, P61, DOI 10.1016/j.cyto.2009.05.004; Medina-Gomez G, 2009, DIS MODEL MECH, V2, P582, DOI 10.1242/dmm.003251; Mingrone G, 2016, SURG OBES RELAT DIS, V12, P1199, DOI 10.1016/j.soard.2016.05.013; Mirhashemi F, 2008, OBESITY FACTS, V1, P292, DOI 10.1159/000176064; Nagayama D, 2016, J HYPERTENS, V34, pE73, DOI 10.1097/01.hjh.0000500040.08261.74; Narayan KMV, 2007, DIABETES CARE, V30, P1562, DOI 10.2337/dc06-2544; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nicolau J, 2015, ACTA DIABETOL, V52, P1037, DOI 10.1007/s00592-015-0742-z; NISHINA PM, 1993, J LIPID RES, V34, P1413; Peterson RG, 2017, GLUCOSE DYSREGULATIO; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Reaven GM, 2009, CAN MED ASSOC J, V180, P601, DOI 10.1503/cmaj.090092; Rossmeisl M, 2003, DIABETES, V52, P1958, DOI 10.2337/diabetes.52.8.1958; Scheithauer TPM, 2016, MOL METAB, V5, P759, DOI 10.1016/j.molmet.2016.06.002; Sepah SC, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4052; Shafrir E, 1999, ANN NY ACAD SCI, V892, P223, DOI 10.1111/j.1749-6632.1999.tb07798.x; Smith BK, 2000, AM J PHYSIOL-REG I, V278, pR797, DOI 10.1152/ajpregu.2000.278.4.R797; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; Stanford J, 2012, J DIABETES MELLITUS, V2, P126, DOI DOI 10.4236/JDM.2012.21021; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Uchoa M.F., 2016, FRONT NEUROENDOCRINO; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Wabitsch M, 2015, J CLIN ENDOCR METAB, V100, P3227, DOI 10.1210/jc.2015-2263; Wabitsch M, 2015, NEW ENGL J MED, V372, P48, DOI 10.1056/NEJMoa1406653; Wang BX, 2014, CURR DIABETES REV, V10, P131, DOI 10.2174/1573399810666140508121012; Weker Halina, 2006, Med Wieku Rozwoj, V10, P3; WEST DB, 1992, AM J PHYSIOL, V262, pR1025, DOI 10.1152/ajpregu.1992.262.6.R1025	61	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179808	10.1371/journal.pone.0179808	http://dx.doi.org/10.1371/journal.pone.0179808			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640904	Green Submitted, Green Published, gold			2022-12-27	WOS:000404135800068
J	Jiang, C; Geng, JJ; Hu, HD; Ma, HJ; Gao, XS; Ren, HQ				Jiang, Cong; Geng, Jinju; Hu, Haidong; Ma, Haijun; Gao, Xingsheng; Ren, Hongqiang			Impact of selected non-steroidal anti-inflammatory pharmaceuticals on microbial community assembly and activity in sequencing batch reactors	PLOS ONE			English	Article							WASTE-WATER TREATMENT; AEROBIC GRANULAR SLUDGE; PERSONAL CARE PRODUCTS; SEWAGE-TREATMENT PLANTS; ACTIVATED-SLUDGE; MEMBRANE BIOREACTOR; BACTERIAL COMMUNITIES; ACIDIC PHARMACEUTICALS; PYROSEQUENCING REVEALS; OXIDATIVE STRESS	This study covers three widely detected non-steroidal anti-inflammatory pharmaceuticals (NSAIDs), diclofenac (DCF), ibuprofen (IBP) and naproxen (NPX), as NSAIDs pollutants. The objective is to evaluate the impact of NSAIDs at their environmental concentrations on microbial community assembly and activity. The exposure experiments were conducted under three conditions (5 mu g L-1 DCF, 5 mu g L-1 DCF+5 mu g L-1 IBP and 5 mu g L-1 DCF+5 mu g L-1 IBP+5 mu g L-1 NPX) in sequencing batch reactors (SBRs) for 130 days. Removals of COD and NH4+-N were not affected but total nitrogen (TN) removal decreased. IBP and NPX had the high removal efficiencies (79.96% to 85.64%), whereas DCF was more persistent (57.24% to 64.12%). In addition, the decreased removals of TN remained the same under the three conditions (p > 0.05). The results of oxidizing enzyme activities, live cell percentages and extracellular polymeric substances (EPS) indicated that NSAIDs damaged the cell walls or microorganisms and the mixtures of the three NSAIDs increased the toxicity. The increased Shannon-Wiener diversity index suggested that bacterial diversity was increased with the addition of selected NSAIDs. Bacterial ribosomal RNA small subunit (16S) gene sequencing results indicated that Actinobacteria and Bacteroidetes were enriched, while Micropruina and Nakamurella decreased with the addition of NSAIDs. The enrichment of Actinobacteria and Bacteroidetes indicated that both of them might have the ability to degrade NSAIDs and thereby could adapt well with the presence of NSAIDs.	[Jiang, Cong; Geng, Jinju; Hu, Haidong; Ma, Haijun; Gao, Xingsheng; Ren, Hongqiang] Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Sch Environm, Nanjing, Jiangsu, Peoples R China	Nanjing University	Geng, JJ (corresponding author), Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Sch Environm, Nanjing, Jiangsu, Peoples R China.	jjgeng@nju.edu.cn	hq, ren/AGA-1128-2022	Hu, Haidong/0000-0003-0193-0333; Ren, Hong-qiang/0000-0001-6136-800X	National Natural Science Foundation of China [21677071, 51278241]; Jiangsu Natural Science Foundation [BK20161474]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province)	This work was supported by the National Natural Science Foundation of China (http://www.nstc.gov.cn/) (No. 21677071, 51278241) and the Jiangsu Natural Science Foundation (http://www.jstd.gov.cn/) (No. BK20161474). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (No. 21677071, 51278241) and the Jiangsu Natural Science Foundation (No. BK20161474).	American Public Health Association (APHA), 2005, STANDARD METHODS EXA; Amorim CL, 2014, WATER RES, V50, P101, DOI 10.1016/j.watres.2013.10.043; Arriaga S, 2016, WATER RES, V107, P37, DOI 10.1016/j.watres.2016.10.046; Bag S, 1995, ECOTOX ENVIRON SAFE, V42, P163; Martin MMB, 2011, J IND MICROBIOL BIOT, V38, P1171, DOI 10.1007/s10295-010-0892-5; Brozinski JM, 2013, ENVIRON SCI TECHNOL, V47, P342, DOI 10.1021/es303013j; Caracciolo AB, 2015, J PHARMACEUT BIOMED, V106, P25, DOI 10.1016/j.jpba.2014.11.040; Carr DL, 2011, WATER AIR SOIL POLL, V216, P633, DOI 10.1007/s11270-010-0558-y; Comeau F, 2008, SCI TOTAL ENVIRON, V396, P132, DOI 10.1016/j.scitotenv.2008.02.031; Cycon M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01969; Delgado LF, 2010, BIORESOURCE TECHNOL, V101, P527, DOI 10.1016/j.biortech.2009.08.051; Diniz MS, 2015, SCI TOTAL ENVIRON, V505, P282, DOI 10.1016/j.scitotenv.2014.09.103; Domaradzka D, 2015, REV ENVIRON SCI BIO, V14, P229, DOI 10.1007/s11157-015-9364-8; Drury B, 2013, APPL ENVIRON MICROB, V79, P1897, DOI 10.1128/AEM.03527-12; Duan YP, 2013, ENVIRON SCI POLLUT R, V20, P108, DOI 10.1007/s11356-012-1000-3; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; El-Megharbel SM, 2015, SPECTROCHIM ACTA A, V135, P915, DOI 10.1016/j.saa.2014.07.101; Frolund B, 1996, WATER RES, V30, P1749, DOI 10.1016/0043-1354(95)00323-1; Gargouri B, 2014, J CHEM TECHNOL BIOT, V89, P978, DOI 10.1002/jctb.4188; Grenni P, 2014, ENVIRON SCI POLLUT R, V21, P13470, DOI 10.1007/s11356-014-3276-y; Huang MH, 2015, J HAZARD MATER, V298, P303, DOI 10.1016/j.jhazmat.2015.05.039; Kermia AEB, 2016, CR CHIM, V19, P963, DOI 10.1016/j.crci.2016.05.005; Kimura K, 2007, ENVIRON SCI TECHNOL, V41, P3708, DOI 10.1021/es061684z; Kor-Bicakci G, 2016, BIORESOURCE TECHNOL, V206, P65, DOI 10.1016/j.biortech.2016.01.069; Kraigher B, 2008, WATER RES, V42, P4578, DOI 10.1016/j.watres.2008.08.006; Kruglova A, 2014, SCI TOTAL ENVIRON, V499, P394, DOI 10.1016/j.scitotenv.2014.08.069; Lawrence JR, 2007, ENVIRON TOXICOL CHEM, V26, P573, DOI 10.1897/06-340R.1; Li D, 2011, WATER RES, V45, P6063, DOI 10.1016/j.watres.2011.09.002; Louvet JN, 2010, PROCESS BIOCHEM, V45, P1787, DOI 10.1016/j.procbio.2010.03.036; Ma SJ, 2016, BIORESOURCE TECHNOL, V214, P645, DOI 10.1016/j.biortech.2016.04.132; Okuda T, 2009, ENVIRON INT, V35, P815, DOI 10.1016/j.envint.2009.01.006; Pala-Ozkok I, 2014, BIOCHEM ENG J, V90, P195, DOI 10.1016/j.bej.2014.06.003; Prior JE, 2010, APPL MICROBIOL BIOT, V85, P625, DOI 10.1007/s00253-009-2135-0; Quan XC, 2015, SCI TOTAL ENVIRON, V506, P226, DOI [10.1016/j.sdtotenv.2014.11.015, 10.1016/j.scitotenv.2014.11.015]; Radjenovic J, 2009, WATER RES, V43, P831, DOI 10.1016/j.watres.2008.11.043; Sastre J, 2003, FREE RADICAL BIO MED, V35, P1, DOI 10.1016/S0891-5849(03)00184-9; Schnell A, 2000, WATER RES, V34, P493, DOI 10.1016/S0043-1354(99)00160-8; Shi YJ, 2013, BIORESOURCE TECHNOL, V139, P170, DOI 10.1016/j.biortech.2013.03.037; Sui Q, 2011, ENVIRON SCI TECHNOL, V45, P3341, DOI 10.1021/es200248d; Ternes TA, 1998, WATER RES, V32, P3245, DOI 10.1016/S0043-1354(98)00099-2; Tixier C, 2003, ENVIRON SCI TECHNOL, V37, P1061, DOI 10.1021/es025834r; Verlicchi P, 2012, SCI TOTAL ENVIRON, V429, P123, DOI 10.1016/j.scitotenv.2012.04.028; Vieno N, 2014, ENVIRON INT, V69, P28, DOI 10.1016/j.envint.2014.03.021; Wakelin S, 2012, J GEOCHEM EXPLOR, V112, P262, DOI 10.1016/j.gexplo.2011.09.005; Wang S, 2008, ENVIRON SCI TECHNOL, V42, P1091, DOI 10.1021/es072026x; Wang SY, 2011, WATER RES, V45, P3398, DOI 10.1016/j.watres.2011.03.055; Wang SY, 2011, CHEMOSPHERE, V82, P565, DOI 10.1016/j.chemosphere.2010.10.007; Wang XC, 2016, APPL MICROBIOL BIOT, V100, P8213, DOI 10.1007/s00253-016-7577-6; Wang ZW, 2009, WATER RES, V43, P2504, DOI 10.1016/j.watres.2009.02.026; Wang ZC, 2016, BIORESOURCE TECHNOL, V205, P213, DOI 10.1016/j.biortech.2016.01.067; Zhang DQ, 2016, ECOL ENG, V90, P215, DOI 10.1016/j.ecoleng.2015.12.043; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188; Zhang Y, 2015, ECOTOX ENVIRON SAFE, V119, P132, DOI 10.1016/j.ecoenv.2015.04.034; Zhang YY, 2016, SCI TOTAL ENVIRON, V571, P479, DOI 10.1016/j.scitotenv.2016.07.014; Zhao X, 2015, APPL MICROBIOL BIOT, V99, P425, DOI 10.1007/s00253-014-5984-0; Zhu Y, 2015, BIORESOURCE TECHNOL, V180, P345, DOI 10.1016/j.biortech.2015.01.006	56	21	24	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179236	10.1371/journal.pone.0179236	http://dx.doi.org/10.1371/journal.pone.0179236			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640897	Green Submitted, Green Published, gold			2022-12-27	WOS:000404135800024
J	Kosmidis, P; Bonzheim, I; Dufke, C; Colak, S; Hentrich, T; Schroeder, C; Bauer, P; Adam, P; Fend, F				Kosmidis, Perikles; Bonzheim, Irina; Dufke, Claudia; Colak, Sema; Hentrich, Thomas; Schroeder, Christopher; Bauer, Peter; Adam, Patrick; Fend, Falko			Next generation sequencing of the clonal IGH rearrangement detects ongoing mutations and interfollicular trafficking in in situ follicular neoplasia	PLOS ONE			English	Article							HEAVY-CHAIN GENE; B-CELL LYMPHOMA; VARIABLE-REGION; HEALTHY-INDIVIDUALS; SOMATIC MUTATIONS; GERMINAL-CENTERS; IMMUNOGLOBULIN; TRANSLOCATION; PROGRESSION; EVOLUTION	Follicular lymphoma (FL) is characterized genetically by a significant intraclonal diversity of rearranged immunoglobulin heavy chain (IGH) genes and a substantial cell migration activity (follicular trafficking). Recently, in situ follicular neoplasia (ISFN), characterized by accumulations of immunohistochemically strongly BCL2-positive, t(14;18)+ clonal B cells confined to germinal centers in reactive lymph nodes, has been identified as a precursor lesion of FL with low risk of progression to manifest FL. The extent of ongoing somatic hypermutation of rearranged IGH genes and interfollicular trafficking in ISFN is not known. In this study we performed an in depth analysis of clonal evolution and cell migration patterns in a case of pure ISFN involving multiple lymph nodes. Using laser microdissection and next generation sequencing (NGS) we documented significant intraclonal diversity of the rearranged IGH gene and extensive interfollicular migration between germinal centers of the same lymph node as well as between different lymph nodes. Furthermore, we identified N-glycosylation motifs characteristic for FL in the CDR3 region.	[Kosmidis, Perikles; Bonzheim, Irina; Colak, Sema; Adam, Patrick; Fend, Falko] Eberhard Karls Univ Tubingen, Inst Pathol & Neuropathol, Tubingen, Germany; [Kosmidis, Perikles; Bonzheim, Irina; Colak, Sema; Adam, Patrick; Fend, Falko] Univ Hosp Tubingen, Comprehens Canc Ctr, Tubingen, Germany; [Dufke, Claudia; Hentrich, Thomas; Schroeder, Christopher; Bauer, Peter] Univ Hosp Tubingen, Inst Med Genet & Appl Genom, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Bonzheim, I (corresponding author), Eberhard Karls Univ Tubingen, Inst Pathol & Neuropathol, Tubingen, Germany.; Bonzheim, I (corresponding author), Univ Hosp Tubingen, Comprehens Canc Ctr, Tubingen, Germany.	irina.bonzheim@med.uni-tuebingen.de	Hentrich, Thomas/N-9336-2019	Hentrich, Thomas/0000-0002-1488-9096	IZKF fortune program, University of Tubingen [F14.63209]; Karl-Thiemig-Stiftung	IZKF fortune program, University of Tubingen; Karl-Thiemig-Stiftung	This work was supported by the IZKF fortune program (F14.63209), University of Tubingen (PA, https:www.medizin.uni-tuebingen.de/Forschung/Forschungsf%C3%B6rderung/Interne+Forschungsf%C31%B6rderung/Junior+Academy/fort%C3%BCne.html. PK and PA were in part supported by the Karl-Thiemig-Stiftung.	Aarts WM, 2000, BLOOD, V95, P2922, DOI 10.1182/blood.V95.9.2922.009k38_2922_2929; Adam P, 2007, CYTOGENET GENOME RES, V118, P328, DOI 10.1159/000108317; Adam P, 2005, AM J SURG PATHOL, V29, P1661, DOI 10.1097/01.pas.0000173233.29741.38; Adam P, 2013, HUM PATHOL; Anastasov N, 2010, HAEMATOL-HEMATOL J, V95, P760, DOI 10.3324/haematol.2009.014050; BAHLER DW, 1992, P NATL ACAD SCI USA, V89, P6770, DOI 10.1073/pnas.89.15.6770; Bende RJ, 2007, LEUKEMIA, V21, P18, DOI 10.1038/sj.leu.2404426; Bonzheim I, 2011, BLOOD, V118, P3442, DOI 10.1182/blood-2011-07-368944; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Chang B, 1995, ANN NY ACAD SCI, V764, P170; Cheung MC, 2009, LEUKEMIA, V23, P1176, DOI 10.1038/leu.2009.9; CLEARY ML, 1986, CELL, V44, P97, DOI 10.1016/0092-8674(86)90488-5; Coelho V, 2010, P NATL ACAD SCI USA, V107, P18587, DOI 10.1073/pnas.1009388107; Cong PJ, 2002, BLOOD, V99, P3376, DOI 10.1182/blood.V99.9.3376; Dolken G, 1996, J CLIN ONCOL, V14, P1333; Henopp T, 2011, HISTOPATHOLOGY, V59, P139, DOI 10.1111/j.1365-2559.2011.03897.x; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Jegalian AG, 2011, BLOOD, V118, P2976, DOI 10.1182/blood-2011-05-355255; Koch I, 2006, DIAGN MOL PATHOL, V15, P149, DOI 10.1097/01.pdm.0000213450.99655.54; LIU YF, 1994, P NATL ACAD SCI USA, V91, P8910, DOI 10.1073/pnas.91.19.8910; Mamessier E, 2015, HAEMATOLOGICA, V100, pE155, DOI 10.3324/haematol.2014.115782; Montes-Moreno S, 2010, HISTOPATHOLOGY, V56, P658, DOI 10.1111/j.1365-2559.2010.03529.x; Roulland S, 2006, J EXP MED, V203, P2425, DOI 10.1084/jem.20061292; Roulland S, 2014, J CLIN ONCOL, V32, P1347, DOI 10.1200/JCO.2013.52.8190; Roulland S, 2011, ADV IMMUNOL, V111, P1, DOI 10.1016/B978-0-12-385991-4.00001-5; Schmidt J, 2014, LEUKEMIA, V28, P1103, DOI 10.1038/leu.2013.307; Schneider D, 2015, BLOOD, V125, P3287, DOI 10.1182/blood-2014-11-609404; Schuler F, 2003, SEMIN CANCER BIOL, V13, P203, DOI 10.1016/S1044-579X(03)00016-6; Sotlar K, 2003, AM J PATHOL, V162, P737, DOI 10.1016/S0002-9440(10)63870-9; Spencer DH, 2013, J MOL DIAGN, V15, P623, DOI 10.1016/j.jmoldx.2013.05.004; Stevenson FK, 2012, BLOOD, V119, P3659, DOI 10.1182/blood-2011-11-367730; Sungalee S, 2014, J CLIN INVEST, V124, P5337, DOI 10.1172/JCI72415; Swerdlow SH, 2008, WHO CLASSIFICATION T; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Wartenberg M, 2013, HAEMATOLOGICA, V98, P1433, DOI 10.3324/haematol.2012.074252; Zhu DL, 2002, BLOOD, V99, P2562, DOI 10.1182/blood.V99.7.2562; Zuckerman NS, 2010, INT IMMUNOL, V22, P875, DOI 10.1093/intimm/dxq441	37	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0178503	10.1371/journal.pone.0178503	http://dx.doi.org/10.1371/journal.pone.0178503			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640838	Green Submitted, Green Published, gold			2022-12-27	WOS:000404135800006
J	Martinez-Garcia, M; Martinez, LM; Malo, J				Martinez-Garcia, Marina; Martinez, Luis M.; Malo, Jesus			Topographic Independent Component Analysis reveals random scrambling of orientation in visual space	PLOS ONE			English	Article							CELL RECEPTIVE-FIELDS; FUNCTIONAL ARCHITECTURE; STRIATE CORTEX; RETINOTOPIC ORGANIZATION; SPATIAL STRUCTURE; NATURAL IMAGES; GAIN-CONTROL; MAPS; MODEL; COLUMNS	Neurons at primary visual cortex (V1) in humans and other species are edge filters organized in orientation maps. In these maps, neurons with similar orientation preference are clustered together in iso-orientation domains. These maps have two fundamental properties: (1) retinotopy, i.e. correspondence between displacements at the image space and displacements at the cortical surface, and (2) a trade-off between good coverage of the visual field with all orientations and continuity of iso-orientation domains in the cortical space. There is an active debate on the origin of these locally continuous maps. While most of the existing descriptions take purely geometric/mechanistic approaches which disregard the network function, a clear exception to this trend in the literature is the original approach of Hyvarinen and Hoyer based on infomax and Topographic Independent Component Analysis (TICA). Although TICA successfully addresses a number of other properties of V1 simple and complex cells, in this work we question the validity of the orientation maps obtained from TICA. We argue that the maps predicted by TICA can be analyzed in the retinal space, and when doing so, it is apparent that they lack the required continuity and retinotopy. Here we show that in the orientation maps reported in the TICA literature it is easy to find examples of violation of the continuity between similarly tuned mechanisms in the retinal space, which suggest a random scrambling incompatible with the maps in primates. The new experiments in the retinal space presented here confirm this guess: TICA basis vectors actually follow a random salt-and-pepper organization back in the image space. Therefore, the interesting clusters found in the TICA topology cannot be interpreted as the actual cortical orientation maps found in cats, primates or humans. In conclusion, Topographic ICA does not reproduce cortical orientation maps.	[Martinez-Garcia, Marina; Martinez, Luis M.] CSIC, Inst Neurociencias, Alicante, Spain; [Martinez-Garcia, Marina; Malo, Jesus] Univ Valencia, Image Proc Lab, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); University of Valencia	Malo, J (corresponding author), Univ Valencia, Image Proc Lab, Valencia, Spain.	jesus.malo@uv.es	Malo, Jesus/K-9235-2017	Malo, Jesus/0000-0002-5684-8591; Martinez Garcia, marina/0000-0002-2228-4396	Spanish Ministry of Economy and Competitiveness (MINECO) - European Regional Development Fund (ERDF) [TIN2015-71130-REDT, BFU2014-58776-R, TIN2013-50520-EXP]; Severo Ochoa Program for Centers of Excellence in R+D (SEV)	Spanish Ministry of Economy and Competitiveness (MINECO) - European Regional Development Fund (ERDF); Severo Ochoa Program for Centers of Excellence in R+D (SEV)	The authors acknowledge the financial support received from the Spanish Ministry of Economy and Competitiveness (MINECO) under the grants TIN2015-71130-REDT, BFU2014-58776-R, TIN2013-50520-EXP, co-financed by the European Regional Development Fund (ERDF), and the Severo Ochoa Program for Centers of Excellence in R+D (SEV-2013-0317). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBUS K, 1975, EXP BRAIN RES, V24, P159, DOI 10.1007/BF00234061; Bednar JA, 2012, J PHYSIOL-PARIS, V106, P194, DOI 10.1016/j.jphysparis.2011.12.001; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Bosking WH, 2002, NAT NEUROSCI, V5, P874, DOI 10.1038/nn908; Buccigrossi RW, 1999, IEEE T IMAGE PROCESS, V8, P1688, DOI 10.1109/83.806616; Buzas P, 2003, EUR J NEUROSCI, V18, P957, DOI 10.1046/j.1460-9568.2003.02808.x; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Cardoso JF, 2004, J MACH LEARN RES, V4, P1177, DOI 10.1162/jmlr.2003.4.7-8.1177; Cossell L, 2015, NATURE, V518, P399, DOI 10.1038/nature14182; Cover TM, 2006, ELEMENTS OF INFORMAT; Das A, 1997, NATURE, V387, P594, DOI 10.1038/42461; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Frazor RA, 2007, LECT NOTES COMPUT SC, V4729, P30; Fregnac Y, 2015, NEURON, V88, P110, DOI 10.1016/j.neuron.2015.09.041; Gilbert CD, 2012, NEURON, V75, P250, DOI 10.1016/j.neuron.2012.06.030; Hore VRA, 2012, VISUAL NEUROSCI, V29, P283, DOI 10.1017/S0952523812000338; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hyvarinen A, 2001, NEUROCOMPUTING, V38, P1307, DOI 10.1016/S0925-2312(01)00490-8; Hyvarinen A, 2001, NEURAL COMPUT, V13, P1527, DOI 10.1162/089976601750264992; Hyvarinen A, 2001, VISION RES, V41, P2413, DOI 10.1016/S0042-6989(01)00114-6; Hyvarinen A., 2009, NATURAL IMAGE STAT P; Hyvarinen A, 2001, IMAGEICA MATLAB TOOL; Kaschube M, 2014, CURR OPIN NEUROBIOL, V24, P95, DOI 10.1016/j.conb.2013.08.017; Kaschube M, 2010, SCIENCE, V330, P1113, DOI 10.1126/science.1194869; Kavukcuoglu K, 2009, PROC CVPR IEEE, P1605, DOI 10.1109/CVPRW.2009.5206545; Keil W, 2012, SCIENCE, V336, DOI 10.1126/science.1206416; Koulakov AA, 2001, NEURON, V29, P519, DOI 10.1016/S0896-6273(01)00223-9; Lampl I, 2001, NEURON, V30, P263, DOI 10.1016/S0896-6273(01)00278-1; Laparra V, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00557; Laparra V, 2010, J MACH LEARN RES, V11, P873; LINSKER R, 1986, P NATL ACAD SCI USA, V83, P8779, DOI 10.1073/pnas.83.22.8779; Liu J, 2001, IEEE T IMAGE PROCESS, V10, P1647, DOI 10.1109/83.967393; Ma LB, 2008, NEUROCOMPUTING, V71, P2217, DOI 10.1016/j.neucom.2007.06.013; Malo J, 2006, IEEE T IMAGE PROCESS, V15, P68, DOI 10.1109/TIP.2005.860325; Malo J, 2006, NETWORK-COMP NEURAL, V17, P85, DOI 10.1080/09548980500439602; Malo J, 2010, NEURAL COMPUT, V22, P3179, DOI 10.1162/NECO_a_00046; Martinez-Garcia M, 2016, P MODVIS; Meng YC, 2012, SCIENCE, V336, DOI 10.1126/science.1205737; OBERMAYER K, 1992, PHYS REV A, V45, P7568, DOI 10.1103/PhysRevA.45.7568; OBERMAYER K, 1990, P NATL ACAD SCI USA, V87, P8345, DOI 10.1073/pnas.87.21.8345; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Paik SB, 2011, NAT NEUROSCI, V14, P919, DOI 10.1038/nn.2824; POLAT U, 1994, P NATL ACAD SCI USA, V91, P1206, DOI 10.1073/pnas.91.4.1206; Ringach DL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000251; Ringach DL, 2002, J NEUROPHYSIOL, V88, P455, DOI 10.1152/jn.2002.88.1.455; Schottdorf M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086139; Schuett S, 2002, J NEUROSCI, V22, P6549; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; Stettler DD, 2002, NEURON, V36, P739, DOI 10.1016/S0896-6273(02)01029-2; Swindale NV, 1996, NETWORK-COMP NEURAL, V7, P161, DOI 10.1088/0954-898X/7/2/002; TOOTELL RBH, 1988, J NEUROSCI, V8, P1531; TOOTELL RBH, 1982, SCIENCE, V218, P902, DOI 10.1126/science.7134981; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P811, DOI 10.1073/pnas.95.3.811; Watson AB, 1997, J OPT SOC AM A, V14, P2379, DOI 10.1364/JOSAA.14.002379; Wilson SP, DEV NEUROBIOLOGY, V75, P667	59	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0178345	10.1371/journal.pone.0178345	http://dx.doi.org/10.1371/journal.pone.0178345			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640816	gold, Green Published			2022-12-27	WOS:000404135800005
J	Wu, YH; Cheng, H; Xu, L; Jin, XB; Wang, CS; Xu, XW				Wu, Yue-Hong; Cheng, Hong; Xu, Lin; Jin, Xiong-Bin; Wang, Chun-Sheng; Xu, Xue-Wei			Physiological and genomic features of a novel violacein-producing bacterium isolated from surface seawater	PLOS ONE			English	Article							POLYSACCHARIDE-PRODUCING BACTERIUM; DEEP-SEA SEDIMENT; SP-NOV.; MAXIMUM-LIKELIHOOD; SEQUENCE DATA; GEN. NOV.; RNA GENES; SOFTWARE; SERVER; ENVIRONMENT	Strains JW1(T) and JW3, isolated from surface seawater of the Arabian Sea, were subjected to polyphasic taxonomic analysis. Cells of both strains were Gram-stain-negative, aerobic, and rod-shaped. They formed violet pigment and produced violacein. On the basis of 16S rRNA gene sequence analysis, strains JW1(T) and JW3 showed high 16S rRNA gene sequence similarity with Pseudoalteromonas byunsanensis JCM12483(T) (98.2%), P. shioyasakiensis SE3(T) (97.8%), P. arabiensis JCM 17292(T) (97.3%), and P. gelatinilytica NH153(T) (97.1%). The 16S rRNA gene sequence similarity between JW1T and JW3 was 100%. Phylogenetic analyses revealed that both strains fell within the cluster of the genus Pseudoalteromonas and represented an independent lineage. The average nucleotide identity and in silico DNA-DNA hybridization values between JW1(T) and type strains of the closely related Pseudoalteromonas species were 70.9-83.3% and 20.0-26.4%, respectively. The sole respiratory quinone in both strains is ubiquinone 8 (Q-8). The principal fatty acids are summed feature 3 (C-16: 1.omega 7c and/or iso-C-15:0 2OH), C-18: 1 omega 7c, and C-16:0. The major polar lipids are phosphatidylethanolamine, phosphatidylglycerol, one unidentified glycolipid, one unidentified aminolipid, and one unidentified phospholipid. The DNA G+C content was 43.3 mol%. Differential phylogenetic distinctiveness, chemotaxonomic differences, and phenotypic properties indicated that strains JW1(T) and JW3 could be differentiated from the Pseudoalteromonas species with validly published names. Therefore, it is proposed that strains JW1(T) and JW3 represent a novel species of the genus Pseudoalteromonas, for which the name Pseudoalteromonas amylolytica sp. nov. (type strain, JW1(T) = CGMCC 1.15681(T) = KCTC 52406(T) = MCCC 1K02162(T)) is proposed.	[Wu, Yue-Hong; Cheng, Hong; Xu, Lin; Jin, Xiong-Bin; Wang, Chun-Sheng; Xu, Xue-Wei] State Ocean Adm, Inst Oceanog 2, Key Lab Marine Ecosyst & Biogeochem, Hangzhou, Zhejiang, Peoples R China	State Oceanic Administration	Xu, XW (corresponding author), State Ocean Adm, Inst Oceanog 2, Key Lab Marine Ecosyst & Biogeochem, Hangzhou, Zhejiang, Peoples R China.	xuxw@sio.org.cn			National Natural Science Foundation of China [41406174]; National Key Basic Research Program of China [2014CB441503]; Natural Science Foundation of Zhejiang Province [LR17D060001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Natural Science Foundation of China granted to YW (no. 41406174, http://ww.nstc.gov.cn/publish/portal-1/); the National Key Basic Research Program of China granted to XX (2014CB441503, htt:// most.gov.cn/); the Natural Science Foundation of Zhejiang Province granted to XX (LR17D060001, http://www.zjnst.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aye AM, 2015, MICROBIOL-SGM, V161, P2039, DOI 10.1099/mic.0.000147; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Balibar CJ, 2006, BIOCHEMISTRY-US, V45, P15444, DOI 10.1021/bi061998z; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bowman JP, 2005, BERGEYS MANUAL SYSTE, P467; Chen C, 2017, INT J SYST EVOL MICR, V67, P778, DOI 10.1099/ijsem.0.001580; Dong XZ, 2001, DETERMINATIVE MANUAL; Duran M, 2012, MED CHEM RES, V21, P1524, DOI 10.1007/s00044-011-9654-9; Farmer J.J., 2005, BERGEYS MANUAL SYSTE, V2, P494; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; GAUTHIER G, 1995, INT J SYST BACTERIOL, V45, P755, DOI 10.1099/00207713-45-4-755; Hoshino T, 2011, APPL MICROBIOL BIOT, V91, P1463, DOI 10.1007/s00253-011-3468-z; Ivanova E.P., 2014, PROKARYOTES, V28, P575, DOI [10.1007/978-3-642-38922-1_229, DOI 10.1007/978-3-642-38922-1_229]; Ivanova EP, 2004, INT J SYST EVOL MICR, V54, P1773, DOI 10.1099/ijs.0.02997-0; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KOMAGATA K, 1987, METHOD MICROBIOL, V19, P161; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lee I, 2016, INT J SYST EVOL MICR, V66, P1100, DOI 10.1099/ijsem.0.000760; LEIFSON E, 1963, J BACTERIOL, V85, P1183, DOI 10.1128/JB.85.5.1183-1184.1963; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lowe TM, 2016, NUCLEIC ACIDS RES, V44, pW54, DOI 10.1093/nar/gkw413; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Matsuyama H, 2014, INT J SYST EVOL MICR, V64, P101, DOI 10.1099/ijs.0.055558-0; Matsuyama H, 2013, INT J SYST EVOL MICR, V63, P1805, DOI 10.1099/ijs.0.043604-0; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Park YD, 2005, INT J SYST EVOL MICR, V55, P2519, DOI 10.1099/ijs.0.63750-0; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Romanenko LA, 2003, INT J SYST EVOL MICR, V53; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sun HN, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0545-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tindall B. J., 2007, METHODS GEN MOL MICR, P330, DOI DOI 10.1128/9781555817497.CH15; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; Wu YH, 2015, INT J SYST EVOL MICR, V65, P3645, DOI 10.1099/ijsem.0.000469; Wu YH, 2014, INT J SYST EVOL MICR, V64, P116, DOI 10.1099/ijs.0.052951-0; Xu XW, 2007, INT J SYST EVOL MICR, V57, P1619, DOI 10.1099/ijs.0.65022-0; Xu XW, 2010, INT J SYST EVOL MICR, V60, P2176, DOI 10.1099/ijs.0.017673-0; Yada S, 2008, MAR BIOTECHNOL, V10, P128, DOI 10.1007/s10126-007-9046-9; Yan J, 2016, INT J SYST EVOL MICR, V66, P3538, DOI 10.1099/ijsem.0.001224; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001	50	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179997	10.1371/journal.pone.0179997	http://dx.doi.org/10.1371/journal.pone.0179997			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640915	Green Published, gold, Green Submitted			2022-12-27	WOS:000404135800089
J	Hasan, S; Wang, XM; Khoo, YB; Foliente, G				Hasan, Samiul; Wang, Xiaoming; Khoo, Yong Bing; Foliente, Greg			Accessibility and socio-economic development of human settlements	PLOS ONE			English	Article							GROWTH; INFRASTRUCTURE; RESILIENCE	Access to facilities, services and socio-economic opportunities plays a critical role in the growth and decline of cities and human settlements. Previous attempts to explain changes in socio-economic indicators by differences in accessibility have not been convincing as countries with highly developed transport infrastructure have only seen marginal benefits of infrastructure improvements. Australia offers an ideal case for investigating the effects of accessibility on development since it is seen as home to some of the most liveable cities in the world while, at the same time, it also has some of the most isolated settlements. We investigate herein the connectivity and accessibility of all 1814 human settlements (population centers exceeding 200 persons) in Australia, and how they relate to the socio-economic characteristics of, and opportunities in, each population center. Assuming population as a proxy indicator of available opportunities, we present a simple ranking metric for a settlement using the number of population and the distance required to access all other settlements (and the corresponding opportunities therein). We find a strikingly unequal distribution of access to opportunities in Australia, with a marked prominence of opportunities in capital cities in four of the eight states. The two largest cities of Sydney and Melbourne have a dominant position across all socio-economic indicators, compared to all the other cities. In general, we observe across all the settlements that a decrease in access to opportunities is associated with relatively greater socio-economic disadvantage including increased median age and unemployment rate and decreased median household income. Our methodology can be used to better understand the potential benefits of improved accessibility based on infrastructure development, especially for remote areas and for cities and towns with many socio-economically disadvantaged population.	[Hasan, Samiul] Univ Cent Florida, Civil Environm & Construct Engn, Orlando, FL USA; [Wang, Xiaoming; Khoo, Yong Bing] CSIRO Land & Water, Clayton, Vic, Australia; [Foliente, Greg] Univ Melbourne, Dept Infrastruct Engn, Parkville, Vic, Australia	State University System of Florida; University of Central Florida; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Melbourne	Hasan, S (corresponding author), Univ Cent Florida, Civil Environm & Construct Engn, Orlando, FL USA.	samiul.hasan@ucf.edu	Foliente, Greg/ABD-1712-2020; Wang, Xiaoming/A-3804-2008; Hasan, Samiul/J-7539-2013	Foliente, Greg/0000-0003-1968-4978; Wang, Xiaoming/0000-0002-6648-0057; Hasan, Samiul/0000-0002-5828-3352	CSIRO	CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	CSIRO provided support in the form of salaries for authors [SH, XW, YBK and GF], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Alsnih R, 2003, TRANSPORT RES A-POL, V37, P903, DOI 10.1016/S0965-8564(03)00073-9; Arcaute E, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0745; Australian Bureau of Statistics, 2013, TECHN PAP SOC IND AR; Banister D., 2001, J TRANSP GEOGR, V9, P209, DOI [10.1016/s0966-6923(01)00013-8, DOI 10.1016/S0966-6923(01)00013-8]; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Behrens K, 2014, ECON J, V124, P1371, DOI 10.1111/ecoj.12099; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2013, SCIENCE, V340, P1438, DOI 10.1126/science.1235823; Biehl D., 1991, INFRASTRUCTURE REGIO, P3; Brelsford C, 2017, P NATL ACAD SCI USA, DOI DOI 10.1073/PNAS.160603311428461489; Martin JC, 2007, TRANSPORT REV, V27, P551, DOI 10.1080/01441640701322610; Commonwealth of Australia, 2015, OUR N OUR FUT WHIT P; Conde?o-Melhorado A., 2014, ACCESSIBILITY SPATIA; Demurger S, 2001, J COMP ECON, V29, P95, DOI 10.1006/jcec.2000.1693; DHAC (Department of Health and Aged Care), 2001, MEAS REM ACC REM IND; Economist Intelligence Unit, 2015, GLOB LIV RANK; FOTHERINGHAM AS, 1989, PAP REG SCI ASSOC, V67, P55, DOI 10.1007/BF01934667; FRIEDMANN J, 1986, DEV CHANGE, V17, P69, DOI 10.1111/j.1467-7660.1986.tb00231.x; Fullerton B, 1988, REGIONAL IMPACT COMM, P88; Handy S., 1993, REGIONAL VERSUS LOCA; Handy SL, 1997, ENVIRON PLANN A, V29, P1175, DOI 10.1068/a291175; HANSEN WG, 1959, J AM I PLANNERS, V25, P73, DOI 10.1080/01944365908978307; Lawrence, 2001, FUTURE REGIONAL AUST; Litman T.A., 2010, DICT TRANSPORTANAL, P1; Luck GW, DEMOGRAPHIC CHANGE A, P353; MAKSE HA, 1995, NATURE, V377, P608, DOI 10.1038/377608a0; McKenzie FH, 2011, RANGELAND J, V33, P353, DOI 10.1071/RJ11024; National Rural Health Alliance INC, 2013, SNAPSH POV RUR REG A; Reggiani A, 2015, TRANSPORT RES A-POL, V81, P4, DOI 10.1016/j.tra.2014.12.012; Reggiani A, 2012, NECTAR SER TRANSP, P15; Rietveld P, 1993, EUROPEAN TRANSPORT E, P130; Sarkar S, 2016, ENV PLAN B; Smith MS, 2008, RANGELAND J, V30, P3, DOI 10.1071/RJ07063; Sornette D., 2009, SWISS FINANC I RES P; Taylor MAP, 2012, TRANSPORT RES A-POL, V46, P761, DOI 10.1016/j.tra.2012.02.008; United Nations, 2015, WORLD URB PROSP 2014; Vickerman R, 1999, REG STUD, V33, P1, DOI 10.1080/00343409950118878; VICKERMAN RW, 1994, J COMMON MARK STUD, V32, P1, DOI 10.1111/j.1468-5965.1994.tb00482.x; Wolf DA., 2001, INT J POPULATION GEO, V7, P281, DOI [10.1002/ijpg.227, DOI 10.1002/IJPG.227]	39	10	10	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179620	10.1371/journal.pone.0179620	http://dx.doi.org/10.1371/journal.pone.0179620			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY6UH	28636630	gold, Green Published			2022-12-27	WOS:000404118300042
J	Dallora, AL; Eivazzadeh, S; Mendes, E; Berglund, J; Anderberg, P				Dallora, Ana Luiza; Eivazzadeh, Shahryar; Mendes, Emilia; Berglund, Johan; Anderberg, Peter			Machine learning and microsimulation techniques on the prognosis of dementia: A systematic literature review	PLOS ONE			English	Review							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; PREDICTING CONVERSION; STATISTICAL-METHODS; PART I; MODELS; MCI; CLASSIFICATION; PROGRESSION; BIOMARKERS	Background Dementia is a complex disorder characterized by poor outcomes for the patients and high costs of care. After decades of research little is known about its mechanisms. Having prognostic estimates about dementia can help researchers, patients and public entities in dealing with this disorder. Thus, health data, machine learning and microsimulation techniques could be employed in developing prognostic estimates for dementia. Objective The goal of this paper is to present evidence on the state of the art of studies investigating and the prognosis of dementia using machine learning and microsimulation techniques. Method To achieve our goal we carried out a systematic literature review, in which three large data-bases -Pubmed, Socups and Web of Science were searched to select studies that employed machine learning or microsimulation techniques for the prognosis of dementia. A single backward snowballing was done to identify further studies. A quality checklist was also employed to assess the quality of the evidence presented by the selected studies, and low quality studies were removed. Finally, data from the final set of studies were extracted in summary tables. Results In total 37 papers were included. The data summary results showed that the current research is focused on the investigation of the patients with mild cognitive impairment that will evolve to Alzheimer's disease, using machine learning techniques. Microsimulation studies were concerned with cost estimation and had a populational focus. Neuroimaging was the most commonly used variable. Conclusions Prediction of conversion from MCI to AD is the dominant theme in the selected studies. Most studies used ML techniques on Neuroimaging data. Only a few data sources have been recruited by most studies and the ADNI database is the one most commonly used. Only two studies have investigated the prediction of epidemiological aspects of Dementia using either ML or MS techniques. Finally, care should be taken when interpreting the reported accuracy of ML techniques, given studies' different contexts.	[Dallora, Ana Luiza; Mendes, Emilia] Blekinge Inst Technol, Dept Comp Sci, Karlskrona, Sweden; [Eivazzadeh, Shahryar; Berglund, Johan; Anderberg, Peter] Blekinge Inst Technol, Dept Hlth, Karlskrona, Sweden	Blekinge Institute Technology; Blekinge Institute Technology	Dallora, AL (corresponding author), Blekinge Inst Technol, Dept Comp Sci, Karlskrona, Sweden.	ana.luiza.moraes@bth.se	Sanmartin Berglund, Johan/HGB-0471-2022; Anderberg, Peter/B-5541-2012	Anderberg, Peter/0000-0001-9870-8477; Eivazzadeh, Shahryar/0000-0002-0316-548X				Adaszewski S, 2013, NEUROBIOL AGING, V34, P2815, DOI 10.1016/j.neurobiolaging.2013.06.015; Aguilar C, 2013, PSYCHIAT RES-NEUROIM, V212, P89, DOI 10.1016/j.pscychresns.2012.11.005; Aksu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025074; [Anonymous], DEM PUBL HLTH PRIOR; Boman M, 2004, SYSTEMS APPROACHES AND THEIR APPLICATION: EXAMPLES FROM SWEDEN, P95; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Cabral C, 2015, COMPUT BIOL MED, V58, P101, DOI 10.1016/j.compbiomed.2015.01.003; Chen R, 2012, NEURORADIOL J, V25, P5, DOI 10.1177/197140091202500101; Cheng J, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P101; Clark TG, 2003, BRIT J CANCER, V89, P232, DOI 10.1038/sj.bjc.6601118; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Costafreda SG, 2011, NEUROIMAGE, V56, P212, DOI 10.1016/j.neuroimage.2011.01.050; Craig-Schapiro R, 2011, PLOS ONE, V6; Cruz JA, 2006, CANCER INFORM, V2, P59; Cui Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021896; Cuingnet R, 2011, NEUROIMAGE, V56, P766, DOI 10.1016/j.neuroimage.2010.06.013; Dallora AL, 2016, PROCEDIA COMPUT SCI, V100, P480, DOI 10.1016/j.procs.2016.09.185; Dayhoff JE, 2001, CANCER, V91; Demiroz G, 1997, LECT NOTES ARTIF INT, V1224, P85; Escudero J, 2012, J ALZHEIMERS DIS, V32, P997, DOI 10.3233/JAD-2012-121024; Ferrarini L, 2009, J ALZHEIMERS DIS, V17, P643, DOI 10.3233/JAD-2009-1082; Fonteijn HM, 2012, NEUROIMAGE, V60, P1880, DOI 10.1016/j.neuroimage.2012.01.062; Furiak NM, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-24; Gaser C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067346; Gilbert N., 2008, AGENT BASED MODELS; Guerrero R, 2014, NEUROIMAGE, V94, P275, DOI 10.1016/j.neuroimage.2014.03.036; Hinrichs C, 2011, NEUROIMAGE, V55, P574, DOI 10.1016/j.neuroimage.2010.10.081; Jagger C, 2000, NEUROLOGY, V54, pS16; Jennings LA, 2015, J AM GERIATR SOC, V63, P282, DOI 10.1111/jgs.13251; KELLER JM, 1985, IEEE T SYST MAN CYB, V15, P580, DOI 10.1109/TSMC.1985.6313426; Kitchenham B., 2007, GUIDELINES PERFORMIN, V5; Kloppel S, 2015, J ALZHEIMERS DIS, V47, P939, DOI 10.3233/JAD-150334; Komlagan M, 2014, LECT NOTES COMPUT SC, V8679, P141, DOI 10.1007/978-3-319-10581-9_18; Kourou K, 2015, COMPUT STRUCT BIOTEC, V13, P8, DOI 10.1016/j.csbj.2014.11.005; Kudus N, 2009, RECENT ADV TECHNOLOG; Larranaga P, 2006, BRIEF BIOINFORM, V7, P86, DOI 10.1093/bib/bbk007; Li H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082450; Li Y, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.11.008; Liu F, 2014, NEUROIMAGE, V84, P466, DOI 10.1016/j.neuroimage.2013.09.015; Llano DA, 2013, ALZ DIS ASSOC DIS, V27, P233, DOI 10.1097/WAD.0b013e31826d597a; Llano DA, 2011, ALZ DIS ASSOC DIS, V25, P73, DOI 10.1097/WAD.0b013e3181f5b8d8; Louridas P, 2016, IEEE SOFTWARE, V33, P110, DOI 10.1109/MS.2016.114; Mallett S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-21; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Melis RJF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084014; Mitchell T. M., 1997, MACH LEARN, P432, DOI DOI 10.5555/541177; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Moradi E, 2014, SEMISUPERVISED LEARN; Moradi E, 2015, NEUROIMAGE, V104, P398, DOI 10.1016/j.neuroimage.2014.10.002; Nho Kwangsik, 2010, AMIA Annu Symp Proc, V2010, P542; Ohno-Machado L, 2001, J BIOMED INFORM, V34, P428, DOI 10.1006/jbin.2002.1038; Ota K, 2014, J NEUROSCI METH, V221, P139, DOI 10.1016/j.jneumeth.2013.10.003; Pai M, 2004, NATL MED J INDIA, V17, P86; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Phyu, 2009, P INT MULT ENG COMP, V1, P18; Plant C, 2010, NEUROIMAGE, V50, P162, DOI 10.1016/j.neuroimage.2009.11.046; Poblador-Plou B, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-84; Prinja Shankar, 2010, Indian J Community Med, V35, P217, DOI 10.4103/0970-0218.66859; Ripley BD, 2007, CLIN APPL ARTIFICIAL; Ritchie LJ, 2011, ARCH CLIN NEUROPSYCH, V26, P16, DOI 10.1093/arclin/acq089; Rutter CM, 2011, MED DECIS MAKING, V31, P10, DOI 10.1177/0272989X10369005; Salvatore C, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00307; Stallard E, 2010, MED DECIS MAKING, V30, P625, DOI 10.1177/0272989X10363479; Strimbu K, 2010, CURR OPIN HIV AIDS, V5, P463, DOI 10.1097/COH.0b013e32833ed177; Struyf J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-531; Suh GH, 2001, ACTA PSYCHIAT SCAND, V104, P4, DOI 10.1034/j.1600-0447.2001.00210.x; Suk HI, 2013, LECT NOTES COMPUT SC, V8150, P583, DOI 10.1007/978-3-642-40763-5_72; Tandon R, 2006, ARTIF INTELL MED, V36, P245, DOI 10.1016/j.artmed.2005.10.007; Tibshirani R, 2003, STAT SCI, V18, P104, DOI 10.1214/ss/1056397488; Tripepi G, 2010, NEPHROL DIAL TRANSPL, V25, P1399, DOI 10.1093/ndt/gfq018; Tripepi G, 2010, NEPHROL DIAL TRANSPL, V25, P1402, DOI 10.1093/ndt/gfq046; van de Vorst IE, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008897; van Gerven MAJ, 2008, J BIOMED INFORM, V41, P515, DOI 10.1016/j.jbi.2008.01.006; Weiner MW, 2010, ALZHEIMERS DEMENT, V6, P202, DOI 10.1016/j.jalz.2010.03.007; Winblad B, 2016, LANCET NEUROL, V15, P455, DOI 10.1016/S1474-4422(16)00062-4; Ye JP, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-46; Young J, 2013, NEUROIMAGE-CLIN, V2, P735, DOI 10.1016/j.nicl.2013.05.004; Yu W, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-16; Zhang DQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033182	80	30	30	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179804	10.1371/journal.pone.0179804	http://dx.doi.org/10.1371/journal.pone.0179804			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662070	Green Submitted, Green Published, gold			2022-12-27	WOS:000404608300049
J	Haufe, S; Wiechmann, K; Stein, L; Kuck, M; Smith, A; Meineke, S; Zirkelbach, Y; Duarte, SR; Drupp, M; Tegtbur, U				Haufe, Sven; Wiechmann, Klaus; Stein, Lothar; Kueck, Momme; Smith, Andrea; Meineke, Stefan; Zirkelbach, Yvonne; Duarte, Samuel Rodriguez; Drupp, Michael; Tegtbur, Uwe			Low-dose, non-supervised, health insurance initiated exercise for the treatment and prevention of chronic low back pain in employees. Results from a randomized controlled trial	PLOS ONE			English	Article							OSWESTRY DISABILITY INDEX; PHYSICAL-ACTIVITY; HIGH-INTENSITY; WORK ABILITY; FOLLOW-UP; GRADED ACTIVITY; CARE; INTERVENTION; PROGRAM; LIFE	Objective Back pain is a major problem requiring pragmatic interventions, low in costs for health care providers and feasible for individuals to perform. Our objective was to test the effectiveness of a low-dose 5-month exercise intervention with small personnel investment on low back strength and self-perceived pain. Methods Two hundred twenty-six employees (age: 42.7 +/- 10.2 years) from three mid-size companies were randomized to 5-month non-supervised training at home (3 times/week for 20 minutes) or wait-list-control. Health insurance professionals instructed the participants on trunk exercises at the start and then supervised participants once a month. Results Muscle strength for back extension increased after the 5-month intervention with a significant between-group difference (mean 27.4 Newton [95% CI 2.2; 60.3]) favoring the exercise group (p = 0.035). Low back pain was reduced more in subjects after exercise than control (mean difference -0.74 cm [95% CI-1.17; -0.27], p = 0.002). No between-group differences were observed for back pain related disability and work ability. After stratified analysis only subjects with preexisting chronic low back pain showed a between-group difference (exercise versus controls) after the intervention in their strength for back extension (mean 55.7 Newton [95% CI 2.8; 108.5], p = 0.039), self-perceived pain (mean -1.42 cm [95% CI-2.32; -0.51], p = 0.003) and work ability (mean 2.1 points [95% CI 0.2; 4.0], p = 0.032). Significant between-group differences were not observed in subjects without low back pain: strength for back extension (mean 23.4 Newton [95% CI -11.2; 58.1], p = 0.184), self-perceived pain (mean-0.48 cm [95% CI -0.99; 0.04], p = 0.067) and work ability (mean -0.1 points [95% CI -0.9; 0.9], p = 0.999). An interaction between low back pain subgroups and the study intervention (exercise versus control) was exclusively observed for the work ability index (p = 0.016). Conclusion In middle-aged employees a low-dose, non-supervised exercise program implemented over 20 weeks improved trunk muscle strength and low back pain, and in those with preexisting chronic low back pain improved work ability.	[Haufe, Sven; Wiechmann, Klaus; Stein, Lothar; Kueck, Momme; Tegtbur, Uwe] Hannover Med Sch, Inst Sports Med, Hannover, Germany; [Haufe, Sven] Hannover Med Sch, Inst Clin Pharmacol, Hannover, Germany; [Smith, Andrea] Hannover Med Sch, Inst Biometry, Hannover, Germany; [Meineke, Stefan; Zirkelbach, Yvonne; Duarte, Samuel Rodriguez; Drupp, Michael] AOK Hlth Insurance, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Haufe, S (corresponding author), Hannover Med Sch, Inst Sports Med, Hannover, Germany.; Haufe, S (corresponding author), Hannover Med Sch, Inst Clin Pharmacol, Hannover, Germany.	haufe.sven@mh-hannover.de	Haufe, Sven/G-1944-2011	Haufe, Sven/0000-0002-5259-4352	OK health insurance	OK health insurance	The study was a cooperation project between Hannover Medical School and AOK health insurance. Part of the study was supported by AOK health insurance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavinia SM, 2009, SCAND J WORK ENV HEA, V35, P325, DOI 10.5271/sjweh.1340; Andersen LN, 2015, SCAND J PUBLIC HEALT, V43, P694, DOI 10.1177/1403494815591687; Bailey DM, 2013, STROKE, V44, P3235, DOI 10.1161/STROKEAHA.113.002589; Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Bruce-Low S, 2012, ERGONOMICS, V55, P500, DOI 10.1080/00140139.2011.644329; Bullinger M., 1996, REHABILITATION STUTT, V35, pXVII; Carpenter DM, 1999, MED SCI SPORT EXER, V31, P18, DOI 10.1097/00005768-199901000-00005; Chou R, 2009, SPINE, V34, P1094, DOI 10.1097/BRS.0b013e3181a105fc; Frey I, 1999, SOZ PRAVENTIV MED, V44, P55, DOI 10.1007/BF01667127; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Hagen EM, 2003, SPINE, V28, P2309, DOI 10.1097/01.BRS.0000085817.33211.3F; Harts CC, 2008, AUST J PHYSIOTHER, V54, P23, DOI 10.1016/S0004-9514(08)70062-X; Hayden JA, 2005, ANN INTERN MED, V142, P776, DOI 10.7326/0003-4819-142-9-200505030-00014; Helmhout PH, 2004, EUR SPINE J, V13, P537, DOI 10.1007/s00586-004-0671-y; HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302; Hemmila HM, 2002, SPINE, V27, P647, DOI 10.1097/00007632-200203150-00015; Heymans MW, 2006, SPINE, V31, P1075, DOI 10.1097/01.brs.0000216443.46783.4d; Jacobs W, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008326.pub2; Karjalainen K, 2004, SPINE, V29, P1069, DOI 10.1097/00007632-200405150-00004; Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273; Kenchaiah S, 2009, CIRCULATION, V119, P44, DOI 10.1161/CIRCULATIONAHA.108.807289; Kettunen O, 2014, INT J ENV RES PUB HE, V11, P3859, DOI 10.3390/ijerph110403859; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Kuijpers T, 2011, EUR SPINE J, V20, P40, DOI 10.1007/s00586-010-1541-4; Lamb SE, 2010, LANCET, V375, P916, DOI 10.1016/S0140-6736(09)62164-4; Lambeek LC, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1035; LINDSTROM I, 1992, PHYS THER, V72, P279, DOI 10.1093/ptj/72.4.279; Mannion AF, 2006, EUR SPINE J, V15, P55, DOI 10.1007/s00586-004-0815-0; Marras WS, 2007, SPINE, V32, P2387, DOI 10.1097/BRS.0b013e3181557be9; MCNEILL T, 1980, SPINE, V5, P529, DOI 10.1097/00007632-198011000-00008; Mehra M, 2012, J MED ECON, V15, P245, DOI 10.3111/13696998.2011.642090; Moon HJ, 2013, ANN REHABIL MED-ARM, V37, P110, DOI 10.5535/arm.2013.37.1.110; Nurminen E, 2002, SCAND J WORK ENV HEA, V28, P85, DOI 10.5271/sjweh.652; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; Pohjonen T, 2001, PREV MED, V32, P465, DOI 10.1006/pmed.2001.0837; RISCH SV, 1993, SPINE, V18, P232, DOI 10.1097/00007632-199302000-00010; Schaafsma FG, 2013, COCHRANE DB SYST REV, V8, DOI DOI 10.1002/14651858.CD001822.PUB2; Scheuer R, 2010, ARCH PHYS MED REHAB, V91, P1878, DOI 10.1016/j.apmr.2010.09.009; Schmidt CO, 2007, SPINE, V32, P2005, DOI 10.1097/BRS.0b013e318133fad8; Schneider S, 2007, EUR J PAIN, V11, P387, DOI 10.1016/j.ejpain.2006.05.005; Smeets R, 2011, ARTHRIT CARE RES, V63, pS158, DOI 10.1002/acr.20542; Staal JB, 2004, ANN INTERN MED, V140, P77, DOI 10.7326/0003-4819-140-2-200401200-00007; Torstensen TA, 1998, SPINE, V23, P2616, DOI 10.1097/00007632-199812010-00017; TUOMI K, 1991, SCAND J WORK ENV HEA, V17, P58; van den Berg TIJ, 2009, OCCUP ENVIRON MED, V66, P211, DOI 10.1136/oem.2008.039883; van Middelkoop M, 2011, EUR SPINE J, V20, P19, DOI 10.1007/s00586-010-1518-3; White AP, 2011, SPINE, V36, pS131, DOI 10.1097/BRS.0b013e31822f178f	47	8	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0178585	10.1371/journal.pone.0178585	http://dx.doi.org/10.1371/journal.pone.0178585			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662094	Green Submitted, gold, Green Published			2022-12-27	WOS:000404608300006
J	Hawley, D; Ding, J; Thotakura, S; Haskett, S; Aluri, H; Kublin, C; Michel, A; Clapisson, L; Mingueneau, M; Zoukhri, D				Hawley, Dillon; Ding, Jian; Thotakura, Suharika; Haskett, Scott; Aluri, Hema; Kublin, Claire; Michel, Audrey; Clapisson, Lisa; Mingueneau, Michael; Zoukhri, Driss			RNA-Seq and CyTOF immuno-profiling of regenerating lacrimal glands identifies a novel subset of cells expressing muscle-related proteins	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR-MATRIX; SJOGRENS-SYNDROME; RADIATION-INJURY; GENE-EXPRESSION; TGF-BETA; MORPHOGENESIS; INTERLEUKIN-1-BETA; INFLAMMATION; IRRADIATION	The purpose of the present studies was to use CyTOF and RNA-Seq technologies to identify cells and genes involved in lacrimal gland repair that could be targeted to treat diseases of lacrimal gland dysfunction. Lacrimal glands of female BALB/c mice were experimentally injured by intra-glandular injection of interleukin 1 alpha (IL-1 alpha). The lacrimal glands were harvested at various time points following injury (1 to 14 days) and used to either prepare single cell suspensions for CyTOF immuno-phenotyping analyses or to extract RNA for gene expression studies using RNA-Seq. CyTOF immuno-phenotyping identified monocytes and neutrophils as the major infiltrating populations 1 and 2 days post injury. Clustering of significantly differentially expressed genes identified 13 distinct molecular signatures: 3 associated with immune/inflammatory processes included genes up-regulated at days 1-2 and 3 associated with reparative processes with genes up-regulated primarily between days 4 and 5. Finally, clustering identified 65 genes which were specifically up-regulated 2 days post injury which was enriched for muscle specific genes. The expression of select muscle-related proteins was confirmed by immunohistochemistry which identified a subset of cells expressing these proteins. Double staining experiments showed that these cells are distinct from the myoepithelial cells. We conclude that experimentally induced injury to the lacrimal gland leads to massive infiltration by neutrophils and monocytes which resolved after 3 days. RNAseq and immunohistochemistry identified a group of cells, other than myoepithelial cells, that express muscle-related proteins that could play an important role in lacrimal gland repair.	[Hawley, Dillon; Thotakura, Suharika; Aluri, Hema; Kublin, Claire; Michel, Audrey; Clapisson, Lisa; Zoukhri, Driss] Tufts Univ, Sch Dent Med, Dept Comprehens Care, Boston, MA 02111 USA; [Ding, Jian; Haskett, Scott; Mingueneau, Michael] Biogen, Immunol Res, Cambridge, MA USA; [Zoukhri, Driss] Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA	Tufts University; Biogen; Tufts University	Zoukhri, D (corresponding author), Tufts Univ, Sch Dent Med, Dept Comprehens Care, Boston, MA 02111 USA.; Zoukhri, D (corresponding author), Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA.	driss.zoukhri@tufts.edu	Mingueneau, Michael/O-5313-2019; Aluri, Hema/F-2807-2018	Mingueneau, Michael/0000-0002-3873-7329; Aluri, Hema/0000-0002-7592-8466; Hawley, Dillon/0000-0003-0053-9842	National Institutes of Health/National Eye Institute [RO1 EY12383]; Biogen; NATIONAL EYE INSTITUTE [R01EY012383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Biogen(Biogen); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institutes of Health/National Eye Institute (https://nei.nih.gov/) grant RO1 EY12383. An unrestricted research grant from Biogen (https://www.biogen.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigildeev AE, 2013, CYTOKINE, V64, P131, DOI 10.1016/j.cyto.2013.07.003; Burgess RW, 2006, J NEUROSCI, V26, P5756, DOI 10.1523/JNEUROSCI.0736-06.2006; Chiquet-Ehrismann R., 2011, COLD SPRING HARBOR P, V3; Chiquet-Ehrismann R, 2014, MATRIX BIOL, V37, P112, DOI 10.1016/j.matbio.2014.01.007; Dartt DA, 2009, PROG RETIN EYE RES, V28, P155, DOI 10.1016/j.preteyeres.2009.04.003; de la Cuadra-Blanco C, 2003, J ANAT, V203, P531, DOI 10.1046/j.1469-7580.2003.00233.x; Fang Y, 2005, INVEST OPHTH VIS SCI, V46, P461, DOI 10.1167/iovs.04-0677; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Gattazzo F, 2014, BBA-GEN SUBJECTS, V1840, P2506, DOI 10.1016/j.bbagen.2014.01.010; Haskett S, 2016, J IMMUNOL, V197, P3806, DOI 10.4049/jimmunol.1600407; Hodges RR, 2003, INT REV CYTOL, V231, P129, DOI 10.1016/S0074-7696(03)31004-6; Hogan BLM, 1998, CURR OPIN GENET DEV, V8, P481, DOI 10.1016/S0959-437X(98)80121-4; Horowitz A, 2008, CIRC RES, V103, P784, DOI 10.1161/CIRCRESAHA.108.181818; Irvine KM, 2009, J LEUKOCYTE BIOL, V85, P278, DOI 10.1189/jlb.0808497; Johnston CJ, 1996, RADIAT RES, V145, P762, DOI 10.2307/3579368; Karrich JJ, 2012, BLOOD, V119, P5191, DOI 10.1182/blood-2011-07-370239; Kim D, 2011, J NEUROSCI, V31, P2167, DOI 10.1523/JNEUROSCI.5254-10.2011; Linard C, 2004, INT J RADIAT ONCOL, V58, P427, DOI 10.1016/j.ijrobp.2003.09.039; Liu YZ, 2016, GENE, V581, P152, DOI 10.1016/j.gene.2016.01.036; Makarenkova Helen P, 2015, Curr Mol Biol Rep, V1, P115; Makarenkova HP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000304; Mingueneau M, 2016, J ALLERGY CLIN IMMUN, V137, P1809, DOI 10.1016/j.jaci.2016.01.024; Mingueneau M, 2014, P NATL ACAD SCI USA, V111, P16466, DOI 10.1073/pnas.1419337111; Moustakas A, 2014, BBA-GEN SUBJECTS, V1840, P2621, DOI 10.1016/j.bbagen.2014.02.004; Nagasawa M, 2008, EUR J IMMUNOL, V38, P2389, DOI 10.1002/eji.200838470; Neidhardt J, 2003, MOL CELL NEUROSCI, V23, P193, DOI 10.1016/S1044-7431(03)00012-5; Nguyen DH, 2004, PHYSIOL GENOMICS, V18, P108, DOI 10.1152/physiolgenomics.00011.2004; Park C., 2007, J INEQUAL APPL, V2007, P13; Peri Y, 2012, BEST PRACT RES CL RH, V26, P105, DOI 10.1016/j.berh.2012.01.012; Porsch H, 2013, ONCOGENE, V32, P4355, DOI 10.1038/onc.2012.475; Sadler T, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0193-6; Sanjurjo L, 2015, J LEUKOCYTE BIOL, V98, P173, DOI 10.1189/jlb.3RU0215-074R; Simian M, 2001, DEVELOPMENT, V128, P3117; STEPHENS LC, 1986, AM J PATHOL, V124, P469; STEPHENS LC, 1991, CANCER, V67, P1539, DOI 10.1002/1097-0142(19910315)67:6<1539::AID-CNCR2820670613>3.0.CO;2-Q; STEPHENS LC, 1986, RADIOTHER ONCOL, V7, P165; Suliman Bandar Ali, 2012, Front Oncol, V2, P74, DOI 10.3389/fonc.2012.00074; Tedder TF, 1997, ANNU REV IMMUNOL, V15, P481, DOI 10.1146/annurev.immunol.15.1.481; Voronov D, 2013, INVEST OPHTH VIS SCI, V54, P3115, DOI 10.1167/iovs.13-11791; Weiser M, 2016, INFLAMM BOWEL DIS, V22, pS2; You S, 2012, INVEST OPHTH VIS SCI, V53, P126, DOI 10.1167/iovs.11-7893; You S, 2011, CELL TISSUE RES, V346, P317, DOI 10.1007/s00441-011-1271-x; Zhou Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep17901; Zoukhri D, 2007, EXP EYE RES, V84, P894, DOI 10.1016/j.exer.2007.01.015; Zoukhri D, 2006, EXP EYE RES, V82, P885, DOI 10.1016/j.exer.2005.10.018; Zoukhri D, 2010, OCUL SURF, V8, P60, DOI 10.1016/S1542-0124(12)70070-8	46	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179385	10.1371/journal.pone.0179385	http://dx.doi.org/10.1371/journal.pone.0179385			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662063	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300020
J	Ma, XL; Li, XC; Tian, FJ; Zhang, SM; Liu, XR; Zhang, Y; Fan, JX; Lin, Y				Ma, Xiao-Ling; Li, Xiao-Cui; Tian, Fu-Ju; Zhang, Si-Ming; Liu, Xiao-Rui; Zhang, Yan; Fan, Jian-Xia; Lin, Yi			Effect of the p53-tristetraprolin-stathmin-1 pathway on trophoblasts at maternal-fetal interface	PLOS ONE			English	Article							CANCER-CELL-LINES; MESSENGER-RNA; TRANSCRIPTIONAL ACTIVITY; RECURRENT MISCARRIAGE; PREGNANCY LOSS; EMBRYO LOSS; MUTANT P53; TRISTETRAPROLIN; EXPRESSION; STATHMIN	Problem To reveal the effect of p53-tristetraprolin-stathmin-1 signaling on trophoblasts and recurrent spontaneous abortion (RSA). Method of study Stathmin-1 (STMN1), p53, and tristetraprolin (TTP) expression in paraffin-embedded villus tissue was determined using immunohistochemistry. HTR-8/SVneo cells were treated with doxorubicin to activate p53; STMN1 and TTP levels were detected by quantitative reverse transcription-PCR and western blotting. Western blotting and immunofluorescence were used to investigate STMN1 expression after TTP overexpression or knockdown in HTR-8 cells. Results STMN1 was downregulated and p53 was upregulated in the villus tissue from patients with RSA. Doxorubicin decreased STMN1 expression but enhanced TTP expression in HTR-8 cells. In vitro, TTP overexpression inhibited STMN1 production; TTP knockdown promoted it. TTP downregulated STMN1 expression in trophoblasts by directly binding its 3 A untranslated region. Conclusions TTP modulates trophoblast function and interacts with STMN1 and p53, and is related to pregnancy outcomes.	[Ma, Xiao-Ling; Tian, Fu-Ju; Zhang, Si-Ming; Liu, Xiao-Rui; Fan, Jian-Xia; Lin, Yi] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Inst Embryo Fetal Original Adult Dis, Shanghai, Peoples R China; [Li, Xiao-Cui] Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Shanghai, Peoples R China; [Zhang, Yan] Wuhan Univ, Renmin Hosp, Dept Obstet & Gynecol, Wuhan, Peoples R China	Shanghai Jiao Tong University; Tongji University; Wuhan University	Lin, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Inst Embryo Fetal Original Adult Dis, Shanghai, Peoples R China.	yilinonline@126.com	MA, XIAO/HHN-5611-2022	Tian, FuJu/0000-0002-3638-8620	National Basic Research Program of China [2013CB967404]; National Natural Science Foundation of China [81401274, 81401218, 81370767, 81501250, 31671567]; Fund for Outstanding Academic Leaders in Shanghai, China [2013-049]; Shanghai Natural Science Fund Project [14ZR1443800]; key projects of Shanghai Municipal Health and Family Planning Commission [201640012]; key support projects of Health and Family Planning Commission, Hubei Province [WJ2017Z002]; Shanghai Municipal Commission of Health and Family Planning Program [15GWZK0701]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund for Outstanding Academic Leaders in Shanghai, China; Shanghai Natural Science Fund Project; key projects of Shanghai Municipal Health and Family Planning Commission; key support projects of Health and Family Planning Commission, Hubei Province; Shanghai Municipal Commission of Health and Family Planning Program	This work was supported by the National Basic Research Program of China (No. 2013CB967404), the National Natural Science Foundation of China (No. 81401274, 81401218, 81370767, 81501250 and 31671567), the Fund for Outstanding Academic Leaders in Shanghai, China (2013-049), the Shanghai Natural Science Fund Project (No. 14ZR1443800), key projects of Shanghai Municipal Health and Family Planning Commission (201640012), key support projects of Health and Family Planning Commission, Hubei Province (No.WJ2017Z002), and Shanghai Municipal Commission of Health and Family Planning Program (No.15GWZK0701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alli E, 2007, ONCOGENE, V26, P1003, DOI 10.1038/sj.onc.1209864; Balmer MT, 2014, CANCER BIOL THER, V15, P1000, DOI 10.4161/cbt.29112; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Branch DW, 2010, NEW ENGL J MED, V363, P1740, DOI 10.1056/NEJMcp1005330; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carrick DM, 2007, ARCH BIOCHEM BIOPHYS, V462, P278, DOI 10.1016/j.abb.2007.04.011; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Curmi PA, 1999, CELL STRUCT FUNCT, V24, P345; Fraga LR, 2014, MOL BIOL REP, V41, P1871, DOI 10.1007/s11033-014-3036-6; Hardle L, 2015, SCI REP-UK, V5, DOI 10.1038/srep15112; Jalonen U, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/40691; Johnsen JI, 2000, INT J CANCER, V88, P685, DOI 10.1002/1097-0215(20001201)88:5<685::AID-IJC1>3.0.CO;2-Z; Khalaj K, 2015, AM J REPROD IMMUNOL, V73, P402, DOI 10.1111/aji.12347; Lee HH, 2010, J BIOL CHEM, V285, P17329, DOI 10.1074/jbc.M109.094235; Lee JY, 2013, NUCLEIC ACIDS RES, V41, P5614, DOI 10.1093/nar/gkt222; Li LP, 2012, J IMMUNOL, V188, P4681, DOI 10.4049/jimmunol.1102628; Li LP, 2013, CELL IMMUNOL, V286, P1, DOI 10.1016/j.cellimm.2013.10.007; Li LP, 2013, J MATERN-FETAL NEO M, V26, P1212, DOI 10.3109/14767058.2013.773307; Lin Y, 2005, J REPROD IMMUNOL, V68, P39, DOI 10.1016/j.jri.2005.05.002; Lin YT, 2011, AD HOC NETW, V9, P713, DOI 10.1016/j.adhoc.2010.07.001; Lin Y, 2008, CLIN IMMUNOL, V126, P104, DOI 10.1016/j.clim.2007.09.006; Lin Y, 2006, J IMMUNOL, V176, P4147, DOI 10.4049/jimmunol.176.7.4147; Ogilvie RL, 2009, J BIOL CHEM, V284, P11216, DOI 10.1074/jbc.M901229200; Qin CM, 2016, AM J REPROD IMMUNOL, V76, P38, DOI 10.1111/aji.12515; Qin XL, 2014, AM J REPROD IMMUNOL, V71, P229, DOI 10.1111/aji.12194; Rai R, 2006, LANCET, V368, P601, DOI 10.1016/S0140-6736(06)69204-0; Ramos SBV, 2004, DEVELOPMENT, V131, P4883, DOI 10.1242/dev.01336; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Shang W, 2013, EUR REV MED PHARMACO, V17, P3376; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Sivaraman L, 2001, P NATL ACAD SCI USA, V98, P12379, DOI 10.1073/pnas.221459098; Sonego M, 2013, EMBO MOL MED, V5, P707, DOI 10.1002/emmm.201201504; Stoecklin G, 2001, RNA, V7, P1578; Tamura K, 2003, ENDOCRINOLOGY, V144, P1464, DOI 10.1210/en.2002-220834; Taylor GA, 1996, MOL ENDOCRINOL, V10, P140, DOI 10.1210/me.10.2.140; Tian FJ, 2015, AM J PATHOL, V185, P2709, DOI 10.1016/j.ajpath.2015.06.010; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Werno C, 2010, AM J PATHOL, V177, P1104, DOI 10.2353/ajpath.2010.091212; Yin GJ, 2011, J CELL BIOCHEM, V112, P773, DOI 10.1002/jcb.22893	42	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179852	10.1371/journal.pone.0179852	http://dx.doi.org/10.1371/journal.pone.0179852			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658321	Green Published, gold, Green Submitted			2022-12-27	WOS:000404607900043
J	Yukimori, A; Oikawa, Y; Morita, K; Nguyen, CTK; Harada, H; Yamaguchi, S; Kayamori, K; Yamaguchi, A; Ikeda, T; Sakamoto, K				Yukimori, Akane; Oikawa, Yu; Morita, Kei-ichi; Chi Thi Kim Nguyen; Harada, Hiroyuki; Yamaguchi, Satoshi; Kayamori, Kou; Yamaguchi, Akira; Ikeda, Tohru; Sakamoto, Kei			Genetic basis of calcifying cystic odontogenic tumors	PLOS ONE			English	Article							BETA-CATENIN; BRAF V600E; MUTATIONS; CRANIOPHARYNGIOMA; AMELOBLASTOMAS; PILOMATRIXOMA; EXPRESSION; MELANOMA; CELLS	Calcifying cystic odontogenic tumors (CCOTs) are benign cystic tumors that form abnormally keratinized ghost cells. Mutations in CTNNB1, which encodes beta-catenin, have been implicated in the development of these tumors, but a causal relationship has not been definitively established. Thus, mutational hot spots in 50 cancer genes were examined by targeted next-generation sequencing in 11 samples of CCOT. Mutations in CTNNB1, but not in other genes, were observed in 10 of 11 cases. These mutations constitutively activate beta-catenin signaling by abolishing the phosphorylation sites Asp32, Ser33, or Ser37, and are similar to those reported in pilomatrixoma and adamantinomatous craniopharyngioma. In contrast, BRAF or NRAS mutations were observed in 12 and two control samples of ameloblastoma, respectively. In HEK293 cells, overexpression of mutated CTNNB1 also upregulated hair keratin, a marker of ghost cells. Furthermore, ghost cells were present in two cases of ameloblastoma with BRAF and CTNNB1 mutations, indicating that ghost cells form due to mutations in CTNNB1. The data suggest that mutations in CTNNB1 are the major driver mutations of CCOT, and that CCOT is the genetic analog of pilomatrixoma and adamantinomatous craniopharyngioma in odontogenic tissue.	[Yukimori, Akane; Chi Thi Kim Nguyen; Kayamori, Kou; Ikeda, Tohru; Sakamoto, Kei] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Pathol, Tokyo, Japan; [Oikawa, Yu; Harada, Hiroyuki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral & Maxillofacial Surg, Tokyo, Japan; [Morita, Kei-ichi; Yamaguchi, Satoshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Maxillofacial Surg, Tokyo, Japan; [Morita, Kei-ichi] Tokyo Med & Dent Univ, Dept Bioresource Res Ctr, Tokyo, Japan; [Yamaguchi, Akira] Tokyo Dent Coll, Dept Oral Hlth Sci Ctr, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Dental College	Sakamoto, K (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Pathol, Tokyo, Japan.	s-kei.mpa@tmd.ac.jp	Yamaguchi, Akira/AAX-9286-2020		Japanese Ministry of Education, Culture, Sports, Science and Technology [KAKENHI 25462848, KAKENHI 16K11438]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid from the Japanese Ministry of Education, Culture, Sports, Science and Technology (KAKENHI 25462848 and KAKENHI 16K11438 to KS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES L, 2005, PATHOLOGY GENETICS; Barras David, 2015, Biomark Cancer, V7, P9, DOI 10.4137/BIC.S25248; Brastianos PK, 2014, NAT GENET, V46, P161, DOI 10.1038/ng.2868; Brown NA, 2014, CLIN CANCER RES, V20, P5517, DOI 10.1158/1078-0432.CCR-14-1069; Buslei R, 2005, ACTA NEUROPATHOL, V109, P589, DOI 10.1007/s00401-005-1004-x; Chan EF, 1999, NAT GENET, V21, P410, DOI 10.1038/7747; de Sousa SF, 2016, ORAL ONCOL, V57, pE1, DOI 10.1016/j.oraloncology.2016.04.010; Guadarrama-Orozco JA, 2016, CLIN TRANSL ONCOL, V18, P863, DOI 10.1007/s12094-015-1469-6; Hassanein AM, 2003, AM J CLIN PATHOL, V120, P732, DOI 10.1309/EALEG7LD6W7167PX; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Karim RZ, 2004, PATHOLOGY, V36, P120, DOI 10.1080/00313020410001671957; Kleihues P, 2000, PATHOLOGY GENETICS T; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Kurppa KJ, 2014, J PATHOL, V232, P492, DOI 10.1002/path.4317; Kusama K, 2005, AM J CLIN PATHOL, V123, P376, DOI 10.1309/WVTR-R1DX-YMC8-PBMK; LeBoit P.E., 2006, PATHOLOGY GENETICS S; Ledesma-Montes C, 2008, J ORAL PATHOL MED, V37, P302, DOI 10.1111/j.1600-0714.2007.00623.x; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Ni D, 2016, IMMUNOBLOTTING IMMUN, V10; PRAETORIUS F, 1981, ACTA ODONTOL SCAND, V39, P227, DOI 10.3109/00016358109162284; Rajesh E, 2015, J PHARM BIOALLIED SC, V7, pS142, DOI 10.4103/0975-7406.155864; Robinson RA, 2012, TUMORS CYSTS JAWS AM; Roden AC, 2016, ARCH PATHOL LAB MED, V140, P230, DOI 10.5858/arpa.2015-0246-RA; Rumayor A, 2015, J ORAL PATHOL MED, V44, P284, DOI 10.1111/jop.12234; Sekine S, 2003, AM J PATHOL, V163, P1707, DOI 10.1016/S0002-9440(10)63528-6; Sweeney RT, 2014, NAT GENET, V46, P722, DOI 10.1038/ng.2986; Wu SW, 2014, CANCER CAUSE CONTROL, V25, P1379, DOI 10.1007/s10552-014-0443-x	27	31	31	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180224	10.1371/journal.pone.0180224	http://dx.doi.org/10.1371/journal.pone.0180224			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658279	gold, Green Submitted, Green Published			2022-12-27	WOS:000404607900067
J	Cerda, IA; Chinsamy, A; Pol, D; Apaldetti, C; Otero, A; Powell, JE; Martinez, RN				Alejandro Cerda, Ignacio; Chinsamy, Anusuya; Pol, Diego; Apaldetti, Cecilia; Otero, Alejandro; Eduardo Powell, Jaime; Nestor Martinez, Ricardo			Novel insight into the origin of the growth dynamics of sauropod dinosaurs	PLOS ONE			English	Article							BONE-HISTOLOGY; PHYLOGENETIC-RELATIONSHIPS; DEVELOPMENTAL PLASTICITY; PLATEOSAURUS-ENGELHARDTI; BASAL SAUROPODOMORPH; HINDLIMB MUSCULATURE; PROSAUROPOD DINOSAUR; SEXUAL-MATURITY; LIFE-HISTORY; SOUTH-AFRICA	Sauropod dinosaurs include the largest terrestrial animals and are considered to have uninterrupted rapid rates of growth, which differs from their more basal relatives, which have a slower cyclical growth. Here we examine the bone microstructure of several sauropodo-morph dinosaurs, including basal taxa, as well as the more derived sauropods. Although our results agree that the plesiomorphic condition for Sauropodomorpha is cyclical growth dynamics, we found that the hypothesized dichotomy between the growth patterns of basal and more derived sauropodomorphs is not supported. Here, we show that sauropod-like growth dynamics of uninterrupted rapid growth also occurred in some basal sauropodomorphs, and that some basal sauropods retained the plesiomorphic cyclical growth patterns. Among the sauropodomorpha it appears that the basal taxa exploited different growth strategies, but the more derived Eusauropoda successfully utilized rapid, uninterrupted growth strategies.	[Alejandro Cerda, Ignacio] Univ Nacl Rio Negro, CONICET, Inst Invest Paleobiol & Geol, Museo Carlos Ameghino, Cipolletti, Rio Negro, Argentina; [Chinsamy, Anusuya] Univ Cape Town, Dept Biol Sci, Rondebosch, South Africa; [Pol, Diego; Apaldetti, Cecilia] Consejo Nacl Invest Cient & Tecn, Museo Paleontol Egidio Feruglio, Trelew, Chubut, Argentina; [Apaldetti, Cecilia; Nestor Martinez, Ricardo] Univ Nacl San Juan, IMCN, San Juan, Argentina; [Otero, Alejandro] Museo La Plata, CONICET, Div Paleontol Vertebrados, La Plata, Buenos Aires, Argentina; [Eduardo Powell, Jaime] Univ Nacl Tucuman, Fac Ciencias Nat, CONICET, San Miguel De Tucuman, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Cape Town; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de San Juan; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata; Universidad Nacional de Tucuman	Cerda, IA (corresponding author), Univ Nacl Rio Negro, CONICET, Inst Invest Paleobiol & Geol, Museo Carlos Ameghino, Cipolletti, Rio Negro, Argentina.	nachocerda6@yahoo.com.ar	Pol, Diego/A-8007-2008	Pol, Diego/0000-0002-9690-7517; Chinsamy-Turan, Anusuya/0000-0002-9786-5080	National Geographic Society, Ministerio de Ciencia, Tecnologia e Innovacion Productiva of the Repliblica Argentina; National Research Foundation (NRF), South Africa, Agencia Nacional de Promocion Cientifica y Tecnica, African Origins platform	National Geographic Society, Ministerio de Ciencia, Tecnologia e Innovacion Productiva of the Repliblica Argentina; National Research Foundation (NRF), South Africa, Agencia Nacional de Promocion Cientifica y Tecnica, African Origins platform	This work was supported by National Geographic Society, Ministerio de Ciencia, Tecnologia e Innovacion Productiva of the Repliblica Argentina and the National Research Foundation (NRF), South Africa, Agencia Nacional de Promocion Cientifica y Tecnica, African Origins platform.	Amprino R., 1947, ARCH BIOL SCI, V58, P315; Apaldetti C, 2013, PALAEONTOLOGY, V56, P277, DOI 10.1111/j.1475-4983.2012.01198.x; Apaldetti C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026964; Gallina PA, 2012, AMEGHINIANA, V49, P289, DOI 10.5710/AMGH.v49i3(519); Bennell KL, 1996, BRIT J SPORT MED, V30, P200, DOI 10.1136/bjsm.30.3.200; Benton MJ, 2000, J VERTEBR PALEONTOL, V20, P77, DOI 10.1671/0272-4634(2000)020[0077:AASOTP]2.0.CO;2; Bonaparte J.F., 1986, P247; Bonaparte J.F., 1972, OPERA LILLOANA, V22, P1; Bonaparte JF, 1999, AMEGHINIANA, V36, P115; BONAPARTE JF, 1979, SCIENCE, V205, P1377, DOI 10.1126/science.205.4413.1377; Botha-Brink J, 2011, J VERTEBR PALEONTOL, V31, P1238, DOI 10.1080/02724634.2011.621797; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Carballido JL, 2014, J SYST PALAEONTOL, V12, P335, DOI 10.1080/14772019.2013.764935; Carballido JL, 2011, J VERTEBR PALEONTOL, V31, P93, DOI 10.1080/02724634.2011.539651; Carrano MT, 2002, J MORPHOL, V253, P207, DOI 10.1002/jmor.10018; CASTANET J, 1991, Amphibia-Reptilia, V12, P81, DOI 10.1163/156853891X00356; Castanet J., 1993, BONE, P245; Cerda IA, 2014, ANAT REC, V297, P1385, DOI 10.1002/ar.22954; Chinsamy A., 1992, Palaeontologia Africana, V29, P39; Chinsamy Anusuya, 1993, Modern Geology, V18, P319; Chinsamy Turan A., 2005, MICROSTRUCTURE DINOS; Colombi Carina E, 2015, Rev. Asoc. Geol. Argent., V72, P445; Company J, 2011, NATURWISSENSCHAFTEN, V98, P67, DOI 10.1007/s00114-010-0742-3; Cooper M. R, 1981, NATURAL SCI, V6, P689; Currey J.D., 2002, BONES STRUCTURE MECH; Curry KA, 1999, J VERTEBR PALEONTOL, V19, P654, DOI 10.1080/02724634.1999.10011179; D'Emic MD, 2013, J SYST PALAEONTOL, V11, P707, DOI 10.1080/14772019.2012.667446; de Fabregues CP, 2016, PEERJ, V4, DOI 10.7717/peerj.1639; de Ricqles A., 1983, Acta Palaeontologica Polonica, V28, P225; De Ricqles A., 1968, ANN U MADAGASCAR, V6, P157; de Ricqles A, 2008, ANN PALEONTOL, V94, P57, DOI 10.1016/j.annpal.2008.03.002; Erickson GM, 2007, BIOL LETTERS, V3, P558, DOI 10.1098/rsbl.2007.0254; Fechner R., 2010, THESIS; Fostowicz Frelik L, 2010, LETHAIA, V43, P137; Francillon-Vieillot H., 1990, P471; Galton P.M., 1990, P320; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P232; Goloboff P.A., 2008, TNT TREE ANAL USING; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Griebeler EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067012; Hedrick BP, 2014, ACTA PALAEONTOL POL, V59, P295, DOI 10.4202/app.2012.0049; Hofmann R, 2014, PEERJ, V2, DOI 10.7717/peerj.458; Houssaye A, 2016, BIOL J LINN SOC, V117, P350, DOI 10.1111/bij.12660; Ikejiri T, 2012, ANAT REC, V295, P18, DOI 10.1002/ar.21495; Irmis RB, 2007, J VERTEBR PALEONTOL, V27, P350, DOI 10.1671/0272-4634(2007)27[350:ASOITP]2.0.CO;2; Klein N, 2008, PALEOBIOLOGY, V34, P247, DOI 10.1666/0094-8373(2008)034[0247:OSITLB]2.0.CO;2; Klein N, 2007, SP PALAEONT, P169; Klein N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036907; Klein N, 2009, GEOL SOC SPEC PUBL, V315, P217, DOI 10.1144/SP315.15; Knonsue W., 2010, TROPICAL NATURAL HIS, V10, P181; Lacovara KJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06196; Lamm ET, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P55; Langer Max Cardoso, 2003, Paleobios, V23, P1; Lee AH, 2008, P NATL ACAD SCI USA, V105, P582, DOI 10.1073/pnas.0708903105; Martinez RN, 2009, J VERTEBR PALEONTOL, V29, P142, DOI 10.1671/039.029.0102; Otero A, 2008, AMEGHINIANA, V45, P333; Otero A, 2015, ZOOL J LINN SOC-LOND, V174, P589, DOI 10.1111/zoj.12247; Otero A, 2013, J VERTEBR PALEONTOL, V33, P1138, DOI 10.1080/02724634.2013.769444; Otero A, 2010, HERPETOL J, V20, P173; OXNARD CE, 1993, J BIOMECH, V26, P63, DOI 10.1016/0021-9290(93)90080-X; Petermann H, 2013, J ANAT, V222, P419, DOI 10.1111/joa.12028; Pol D, 2007, SPEC PAP PALAEONTOL, P223; Pol D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014572; Reid REH., 1996, GEOLOGY STUDIES, V41, P25; Reisz RR, 2012, P NATL ACAD SCI USA, V109, P2428, DOI 10.1073/pnas.1109385109; Reisz RR, 2005, SCIENCE, V309, P761, DOI 10.1126/science.1114942; Ricqles A., 1991, BONE BONE MATRIX BON, V3, P1, DOI DOI 10.1111/J.0021-8782.2004.00275.X; Rimblot-Baly Frederique, 1995, Annales de Paleontologie, V81, P49; Sander P. Martin, 2011, P276; Sander PM, 2006, NATURE, V441, P739, DOI 10.1038/nature04633; Sander PM, 2005, SCIENCE, V310, P1800, DOI 10.1126/science.1120125; Sander PM, 2004, ORG DIVERS EVOL, V4, P165, DOI 10.1016/j.ode.2003.12.002; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Sereno PC, 2007, SPEC PAP PALAEONTOL, P261; Stein K., 2010, THESIS; Stein K, 2014, BIOL REV, V89, P24, DOI 10.1111/brv.12041; Stein K, 2010, P NATL ACAD SCI USA, V107, P9258, DOI 10.1073/pnas.1000781107; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Woodward HN, 2009, J VERTEBR PALEONTOL, V29, P807, DOI 10.1671/039.029.0310; Yates Adam M., 2007, Historical Biology, V19, P93, DOI 10.1080/08912960600866953; Yates Adam M., 2010, Palaeontologia Africana, V45, P7	81	43	44	35	196	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179707	10.1371/journal.pone.0179707	http://dx.doi.org/10.1371/journal.pone.0179707			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654696	Green Published, Green Submitted, gold			2022-12-27	WOS:000404541500026
J	de Castilho, FM; Ribeiro, ALP; da Silva, JLP; Nobre, V; de Sousa, MR				de Castilho, Fabio M.; Ribeiro, Antonio Luiz P.; da Silva, Jose Luiz P.; Nobre, Vandack; de Sousa, Marcos R.			Heart rate variability as predictor of mortality in sepsis: A prospective cohort study	PLOS ONE			English	Article							SEPTIC SHOCK; DEFINITIONS; ACTIVATION; STATEMENT; ENDOTOXIN; RELEASE	Background Sepsis is a serious medical condition with increasing prevalence and high mortality. The role of the autonomic nervous system in pathophysiology of sepsis has been increasingly researched. The objective of this study is to evaluate the Heart rate variability (HRV) as a predictor of mortality in septic patients. Methods This was a prospective cohort of patients diagnosed with sepsis. Patient recruitment was carried out at ICU in tertiary university hospital between March 2012 and February 2014. Clinical data and laboratory exams were collected at admission. Each patient underwent a 20-minute Holter and a 24-hour Holter on the first day of enrollment. The primary outcome was the 28-day all-cause mortality. Results A total of 63 patients were included. Patients were categorized into nonsurvivor group (n = 16) or survivor group (n = 47) depending on this endpoint. Survivors were younger (48.6 years vs. 63.0 years), had better renal function and lower values in severity scores (APACHE II and SOFA) compared to nonsurvivors. In the 20-minute Holter, SDNN, Total Power, VLF Power, LF Power and LF/HF of nonsurvivors were significantly lower than those of survivors (p = < 0.001, p = 0.003, p = 0.002, p = 0.006, p = 0.009 respectively). ROC curve of SDNN was built, showing area under the curve of 0.772 (0.638-0.906) for mortality. The value of 17ms was chosen as best SDNN cutoff to discriminate survivors and nonsurvivors. In the Cox proportional regression, adjusted for SOFA score and for APACHE II, a SDNN <= 17ms was associated with a greater risk of death, with hazard ratios of 6.3 (1.4-28.0; p = 0.015) and 5.5 (1,2-24,8; p = 0.027), respectively. The addition of the dichotomized SDNN to the SOFA model reduced AIC and increased the concordance statistic and the R-2, indicating that predictive power of the SDNN + SOFA model is better than predictive power of SOFA only. Conclusions Several HRV parameters are reduced in nonsurviving septic patients. SDNN <= 17 is a risk factor for death in septic patients, even after adjusting for severity scores.	[de Castilho, Fabio M.; Ribeiro, Antonio Luiz P.; Nobre, Vandack; de Sousa, Marcos R.] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil; [de Castilho, Fabio M.; Ribeiro, Antonio Luiz P.; Nobre, Vandack; de Sousa, Marcos R.] Univ Fed Minas Gerais, Sch Med, Belo Horizonte, MG, Brazil; [da Silva, Jose Luiz P.] Univ Fed Minas Gerais, Dept Stat, Belo Horizonte, MG, Brazil; [Nobre, Vandack] Univ Fed Minas Gerais, NIIMI, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	de Castilho, FM (corresponding author), Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil.; de Castilho, FM (corresponding author), Univ Fed Minas Gerais, Sch Med, Belo Horizonte, MG, Brazil.	fabiomorcastilho@gmail.com	Ribeiro, Ana Cristina/HHN-7466-2022; Ribeiro, Antonio L/C-2707-2009	Ribeiro, Ana Cristina/0000-0002-0493-8376; Ribeiro, Antonio L/0000-0002-2740-0042	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG, Foundation for the Support of Research in the state of Minas Gerais - APQ) [04713-10]; ICU team; Pro-Rectory of Research of UFMG	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG, Foundation for the Support of Research in the state of Minas Gerais - APQ); ICU team; Pro-Rectory of Research of UFMG	This study received financial support from the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG http://www.fapemig.br, Foundation for the Support of Research in the state of Minas Gerais - APQ-04713-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the ICU team and Pro-Rectory of Research of UFMG for their support.	Aboab J, 2008, CRIT CARE MED, V36, P1481, DOI 10.1097/CCM.0b013e31816f48f2; AKSMSBIM C, 2004, REV SOC CARDIOLOGIA, V03, P1; Alamili M, 2015, ACTA ANAESTH SCAND, V59, P457, DOI 10.1111/aas.12472; Annane D, 1999, AM J RESP CRIT CARE, V160, P458, DOI 10.1164/ajrccm.160.2.9810073; Barnaby D, 2002, ACAD EMERG MED, V9, P661, DOI 10.1111/j.1553-2712.2002.tb02143.x; Billman GE, 2013, FRONT PHYSIOL, V4, DOI [10.3389/fphys.2013.00222, 10.3389/fphys.2013.00026]; BONE RC, 1992, CRIT CARE MED, V20, P724, DOI 10.1097/00003246-199206000-00002; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Camm AJ, 1996, CIRCULATION, V93, P1043; Chen WL, 2008, AM J EMERG MED, V26, P395, DOI 10.1016/j.ajem.2007.06.016; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; Ebelt H, 2015, CLIN EXP PHARMACOL P, V42, P874, DOI 10.1111/1440-1681.12415; ESLER M, 1990, PHYSIOL REV, V70, P963, DOI 10.1152/physrev.1990.70.4.963; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; Fleshner M, 1998, J NEUROIMMUNOL, V86, P134, DOI 10.1016/S0165-5728(98)00026-5; Florkowski Christopher M, 2008, Clin Biochem Rev, V29 Suppl 1, pS83; GAYKEMA RPA, 1995, ENDOCRINOLOGY, V136, P4717, DOI 10.1210/en.136.10.4717; Duque MG, 2012, MED INTENSIVA, V36, P343, DOI 10.1016/j.medin.2011.11.008; Kim GM, 2011, J KOREAN MED SCI, V26, P1293, DOI 10.3346/jkms.2011.26.10.1293; Klockner U, 2011, J MOL CELL CARDIOL, V51, P226, DOI 10.1016/j.yjmcc.2011.05.004; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Korach M, 2001, CRIT CARE MED, V29, P1380, DOI 10.1097/00003246-200107000-00013; Lahiri MK, 2008, J AM COLL CARDIOL, V51, P1725, DOI 10.1016/j.jacc.2008.01.038; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Vanderlei LCM, 2009, REV BRAS CIR CARDIOV, V24, P205, DOI 10.1590/S0102-76382009000200018; Pagani M, 1984, J HYPERTENS        S, V2, P5383; Papaioannou VE, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2008.11.010; Parrish WR, 2008, MOL MED, V14, P567, DOI 10.2119/2008-00079.Parrish; Pavon A, 2013, CRIT CARE MED, V41, P2600, DOI 10.1097/CCM.0b013e31829a6e89; R Core Team, 2021, R LANGUAGE ENV STAT; Sassi R, 2015, EUROPACE, V17, P1341, DOI 10.1093/europace/euv015; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Stearns-Kurosawa DJ, 2011, ANNU REV PATHOL-MECH, V6, P19, DOI 10.1146/annurev-pathol-011110-130327; Steyerberg EW, 2009, CLIN PREDICTION MODE, Vxxviii; Tang CHH, 2009, IEEE ENG MED BIO, P1781, DOI 10.1109/IEMBS.2009.5334005; Tateishi Y, 2007, SHOCK, V28, P549, DOI 10.1097/shk.0b013e3180638d1; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; von Elm E, 2007, PREV MED, V45, P247, DOI 10.1016/j.ypmed.2007.08.012; Walkey AJ, 2013, CRIT CARE MED, V41, P1450, DOI 10.1097/CCM.0b013e31827caa89; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Zhao YD, 2008, STAT MED, V27, P462, DOI 10.1002/sim.2912; Zygmunt A, 2010, ARCH MED SCI, V6, P11, DOI 10.5114/aoms.2010.13500	42	42	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0180060	10.1371/journal.pone.0180060	http://dx.doi.org/10.1371/journal.pone.0180060			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654692	Green Submitted, gold, Green Published			2022-12-27	WOS:000404541500052
J	Guan, M; Wu, XW; Chu, PG; Chow, WA				Guan, Min; Wu, Xiwei; Chu, Peiguo; Chow, Warren A.			Fatty acid synthase reprograms the epigenome in uterine leiomyosarcomas	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN-1; SOFT-TISSUE SARCOMAS; BREAST-CANCER CELLS; PROSTATE-CANCER; INHIBITION; APOPTOSIS; PHENOTYPE; MEDIATOR; GROWTH; GRADE	SK-UT-1 uterine leiomyosarcomas (Ut-LMS) cells were transduced with a fatty acid synthase (FASN)-containing retroviral vector to recapitulate the "lipogenic phenotype of cancer." Consistent with this model, forced expression of FASN enhanced SK-UT-1 proliferation, migration, and cellular motion. Further investigation showed FASN promotes tri-methylation of H3K9 (H3K9me3) and acetylation of H3K27 (H3K27ac) in SK-UT-1 cells. In contrast, siRNA targeting of FASN in high endogenous FASN expressing SK-LMS-1 UtLMS cells inhibits tri-methylation of H3K9 and acetylation of H3K27. Palmitate, the predominant fatty acid product of FASN, increased H3K9me3, H3K27ac and H3K27me3 detection in SK-UT-1 cells. FASN promoted histone 3 methylation and acetylation through alteration of histone 3-modifying enzymatic activities (HDAC, HDM, HMT and HAT). ChIP-seq in SKUT- 1-FASN cells with anti-H3K9me3 antibody identified regions of enriched binding compared to vector-only cells. One differentially-enriched gene, CRISP1, was investigated further by ChIP-PCR. The transcriptionally repressive function of H3K9me3 was confirmed in CRISP1. Our results provide mechanistic insight into the pathobiology of the "lipogenic phenotype of cancer." Here, FASN reprograms the Ut-LMS epigenome through chromatin remodeling to promote the "malignant phenotype."	[Guan, Min; Chow, Warren A.] City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA; [Wu, Xiwei] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA USA; [Chu, Peiguo] City Hope Natl Med Ctr, Dept Pathol, Duarte, CA USA	City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope	Chow, WA (corresponding author), City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA.	wchow@coh.org		Chow, Warren/0000-0003-0889-5841	National Cancer Institute of the National Institutes of Health [P30CA033572]	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute of the National Institutes of Health, Award Number: P30CA033572, Grant Recipient: Warren Chow.	Bandyopadhyay S, 2006, CANCER RES, V66, P5934, DOI 10.1158/0008-5472.CAN-05-3197; Coindre JM, 2001, CANCER-AM CANCER SOC, V91, P1914, DOI 10.1002/1097-0142(20010515)91:10<1914::AID-CNCR1214>3.0.CO;2-3; D'Angelo E, 2010, GYNECOL ONCOL, V116, P131, DOI 10.1016/j.ygyno.2009.09.023; Dean E FG, 2016, J CLIN ONCOL, p2512a; Furuta E, 2008, CANCER RES, V68, P1003, DOI 10.1158/0008-5472.CAN-07-2489; Garcia CB, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-189; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Guan M, 2012, FEBS J, V279, P2399, DOI 10.1111/j.1742-4658.2012.08619.x; Hensley ML, 2013, CANCER-AM CANCER SOC, V119, P1555, DOI 10.1002/cncr.27942; Keung EZ, 2015, J CLIN INVEST, V125, P2965, DOI 10.1172/JCI77976; Knowles LM, 2008, J BIOL CHEM, V283, P31378, DOI 10.1074/jbc.M803384200; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; Little JL, 2007, CANCER RES, V67, P1262, DOI 10.1158/0008-5472.CAN-06-1794; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Magana MM, 1996, J BIOL CHEM, V271, P32689, DOI 10.1074/jbc.271.51.32689; Pizer ES, 2000, CANCER RES, V60, P213; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Richter GHS, 2009, P NATL ACAD SCI USA, V106, P5324, DOI 10.1073/pnas.0810759106; Shah US, 2006, HUM PATHOL, V37, P401, DOI 10.1016/j.humpath.2005.11.022; Svensson RU, 2016, NATURE MED; Takahiro T, 2003, CLIN CANCER RES, V9, P2204; Taylor BS, 2011, CANCER DISCOV, V1, P587, DOI 10.1158/2159-8290.CD-11-0181; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou WB, 2003, CANCER RES, V63, P7330	26	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179692	10.1371/journal.pone.0179692	http://dx.doi.org/10.1371/journal.pone.0179692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654693	Green Published, Green Submitted, gold			2022-12-27	WOS:000404541500025
J	Miyake, M; Kuroda, M; Kiyonari, H; Takehana, K; Hisanaga, S; Morimoto, M; Zhang, J; Oyadomari, M; Sakaue, H; Oyadomari, S				Miyake, Masato; Kuroda, Masashi; Kiyonari, Hiroshi; Takehana, Kenji; Hisanaga, Satoshi; Morimoto, Masatoshi; Zhang, Jun; Oyadomari, Miho; Sakaue, Hiroshi; Oyadomari, Seiichi			Ligand-induced rapid skeletal muscle atrophy in HSA-Fv2E-PERK transgenic mice	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UBIQUITIN-PROTEASOME PATHWAY; AMINO-ACID-METABOLISM; PROTEIN-SYNTHESIS; TRANSLATION INITIATION; INSULIN SENSITIVITY; POSTABSORPTIVE RATS; GLYCOGEN-SYNTHASE; CANCER CACHEXIA; ER STRESS	Background Formation of 43S and 48S preinitiation complexes plays an important role in muscle protein synthesis. There is no muscle-wasting mouse model caused by a repressed 43S preinitiation complex assembly. Objective The aim of the present study was to develop a convenient mouse model of skeletal muscle wasting with repressed 43S preinitiation complex assembly. Material and methods A ligand-activatable PERK derivative Fv2E-PERK causes the phosphorylation of eukaryotic initiation factor 2 alpha (eIF2 alpha), which inhibits 43S preinitiation complex assembly. Thus, muscle atrophic phenotypes, intracellular signaling pathways, and intracellular free amino acid profiles were investigated in human skeletal muscle alpha-actin (HSA) promoter-driven Fv2EPERK transgenic (Tg) mice. Results HSA-Fv2E-PERK Tg mice treated with the artificial dimerizer AP20187 phosphorylates eIF2a in skeletal muscles and leads to severe muscle atrophy within a few days of ligand injection. Muscle atrophy was accompanied by a counter regulatory activation of mTORC1 signaling. Moreover, intracellular free amino acid levels were distinctively altered in the skeletal muscles of HSA-Fv2E-PERK Tg mice. Conclusions As a novel model of muscle wasting, HSA-Fv2E-PERK Tg mice provide a convenient tool for studying the pathogenesis of muscle loss and for assessing putative therapeutics.	[Miyake, Masato; Hisanaga, Satoshi; Morimoto, Masatoshi; Zhang, Jun; Oyadomari, Miho; Oyadomari, Seiichi] Tokushima Univ, Inst Adv Med Sci, Inst Genome Res, Div Mol Biol, Tokushima, Japan; [Miyake, Masato; Zhang, Jun; Oyadomari, Miho; Sakaue, Hiroshi; Oyadomari, Seiichi] Tokushima Univ, Dept Mol Res, Diabet Therapeut & Res Ctr, Tokushima, Japan; [Miyake, Masato; Oyadomari, Seiichi] Tokushima Univ, Fujii Mem Inst Med Sci, Tokushima, Japan; [Kuroda, Masashi; Sakaue, Hiroshi] Tokushima Univ, Grad Sch, Inst Biomed Sci, Dept Nutr & Metab, Tokushima, Japan; [Kiyonari, Hiroshi] RIKEN, Ctr Life Sci Technol, Anim Resource Dev Unit, Kobe, Hyogo, Japan; [Kiyonari, Hiroshi] RIKEN, Ctr Life Sci Technol, Genet Engn Team, Kobe, Hyogo, Japan; [Takehana, Kenji] EA Pharma Co Ltd, Dept R&D Planning, Tokyo, Japan	Tokushima University; Tokushima University; Tokushima University; Tokushima University; RIKEN; RIKEN; Eisai Co Ltd	Oyadomari, S (corresponding author), Tokushima Univ, Inst Adv Med Sci, Inst Genome Res, Div Mol Biol, Tokushima, Japan.; Oyadomari, S (corresponding author), Tokushima Univ, Dept Mol Res, Diabet Therapeut & Res Ctr, Tokushima, Japan.; Oyadomari, S (corresponding author), Tokushima Univ, Fujii Mem Inst Med Sci, Tokushima, Japan.	oyadomar@tokushima-u.ac.jp	Oyadomari, Seiichi/GZA-7157-2022; Sakaue, Hiroshi/ABE-2337-2021; Oyadomari, Seiichi/GZA-7072-2022	Sakaue, Hiroshi/0000-0002-2468-2363; Miyake, Masato/0000-0003-2242-1706	Ministry of Education, Culture, Sports, Science and Culture (MEXT) of Japan; Japan Society for Promotion of Science (JSPS); Inoue Foundation for Science; Mitsubishi Foundation; Uehara Memorial Foundation; Naito Foundation; Cell Science Research Foundation; Takeda Science Foundation; Sankyo Foundation; Ono Medical Research Foundation; Mochida Memorial Foundation; Ube Foundation; Kowa Life Science Foundation; Suzuken Memorial Foundation; Kanae Foundation; Japan Diabetes Foundation; Grants-in-Aid for Scientific Research [16H05222] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Culture (MEXT) of Japan; Japan Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Inoue Foundation for Science(Inoue Foundation for Science); Mitsubishi Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Cell Science Research Foundation(Cell Science Research Foundation, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Sankyo Foundation; Ono Medical Research Foundation; Mochida Memorial Foundation; Ube Foundation(UBE Foundation); Kowa Life Science Foundation; Suzuken Memorial Foundation; Kanae Foundation; Japan Diabetes Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported mainly by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Culture (MEXT) of Japan and Grants-in-Aid for Young Scientist from Japan Society for Promotion of Science (JSPS), and partly by the Inoue Foundation for Science, the Mitsubishi Foundation, the Uehara Memorial Foundation, the Naito Foundation, the Cell Science Research Foundation, Takeda Science Foundation, Sankyo Foundation, Ono Medical Research Foundation, Mochida Memorial Foundation, the Ube Foundation, Kowa Life Science Foundation, Suzuken Memorial Foundation, Kanae Foundation and Japan Diabetes Foundation. The funders provided support in the form of research grant for SO or MM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript	Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Anthony JC, 2000, J NUTR, V130, P2413; Anthony JC, 2000, J NUTR, V130, P139, DOI 10.1093/jn/130.2.139; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bienso RS, 2012, DIABETES, V61, P1090, DOI 10.2337/db11-0884; Biolo G, 1997, AM J PHYSIOL-ENDOC M, V273, pE122, DOI 10.1152/ajpendo.1997.273.1.E122; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bohnert KR, 2016, FASEB J, V30, P3053, DOI 10.1096/fj.201600250RR; Bongers KS, 2013, AM J PHYSIOL-ENDOC M, V305, pE907, DOI 10.1152/ajpendo.00380.2013; Bowen TS, 2015, J CACHEXIA SARCOPENI, V6, P197, DOI 10.1002/jcsm.12043; Chalil S, 2015, BIOCHEM BIOPH RES CO, V468, P702, DOI 10.1016/j.bbrc.2015.11.019; Constantin D, 2011, J PHYSIOL-LONDON, V589, P3883, DOI 10.1113/jphysiol.2011.206193; Ebert SM, 2012, J BIOL CHEM, V287, P27290, DOI 10.1074/jbc.M112.374777; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Gordon BS, 2013, INT J BIOCHEM CELL B, V45, P2147, DOI 10.1016/j.biocel.2013.05.039; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hershey JW, 2012, COLD SPRING HARB PER, V4; Hinnebusch AG, 2012, COLD SPRING HARB PER, V4; Huang J, 1998, P NATL ACAD SCI USA, V95, P12100, DOI 10.1073/pnas.95.21.12100; Hwee DT, 2009, J GERONTOL A-BIOL, V64, P618, DOI 10.1093/gerona/glp026; Ikezoe K, 2007, ACTA NEUROPATHOL, V114, P527, DOI 10.1007/s00401-007-0267-9; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Jagoe RT, 2001, CURR OPIN CLIN NUTR, V4, P183, DOI 10.1097/00075197-200105000-00003; Jiao GY, 2017, MOL MED REP, V15, P366, DOI 10.3892/mmr.2016.6014; Kimball SR, 1998, J BIOL CHEM, V273, P30945, DOI 10.1074/jbc.273.47.30945; Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S; Mavalli MD, 2010, J CLIN INVEST, V120, P4007, DOI 10.1172/JCI42447; McElhinny AS, 2002, J CELL BIOL, V157, P125, DOI 10.1083/jcb.200108089; Miyake M, 2016, FASEB J, V30, P798, DOI 10.1096/fj.15-275990; Neel BA, 2013, TRENDS ENDOCRIN MET, V24, P635, DOI 10.1016/j.tem.2013.09.004; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Volpi E, 2003, AM J CLIN NUTR, V78, P250, DOI 10.1093/ajcn/78.2.250; Welsh GI, 1998, FEBS LETT, V421, P125, DOI 10.1016/S0014-5793(97)01548-2; White JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024650; Wu J, 2011, CELL METAB, V13, P160, DOI 10.1016/j.cmet.2011.01.003; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	45	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179955	10.1371/journal.pone.0179955	http://dx.doi.org/10.1371/journal.pone.0179955			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644884	gold, Green Submitted, Green Published			2022-12-27	WOS:000404145100052
J	Liu, CY; Lai, S; Kawel-Boehm, N; Chahal, H; Venkatesh, BA; Lima, JAC; Bluemke, DA				Liu, Chia-Ying; Lai, Shenghan; Kawel-Boehm, Nadine; Chahal, Harjit; Venkatesh, Bharath Ambale; Lima, Joao A. C.; Bluemke, David A.			Healthy aging of the left ventricle in relationship to cardiovascular risk factors: The Multi-Ethnic Study of Atherosclerosis (MESA)	PLOS ONE			English	Article							CARDIAC MAGNETIC-RESONANCE; EXTRACELLULAR VOLUME; HEART; MASS; AGE; HYPERTROPHY; INSIGHTS; OUTCOMES; DISEASE; OBESITY	Background Understanding the relationship of cardiovascular structure and function to age is confounded by the high prevalence of traditional risk factors in the United States. The purpose of the study is to compare left ventricular (LV) and aortic structural, and functional parameters in individuals with and without traditional risk factors in a population-based cohort. Methods and results 3015 study participants (48% men, age 55-94, mean 69.01 +/- 9.17 years) in the Multi-Ethnic Study of Atherosclerosis (MESA) underwent cardiovascular magnetic resonance (CMR) imaging from 2010-2012. Absence of cardiovascular (CV) risk factors (no hypertension, diabetes or impaired fasting glucose, obesity, smoking or hypercholesterolemia) was infrequent, occurring in just 314 (10.4%, 38% men) of 3015 participants. In multivariable analyses adjusting for age, sex and race, individuals with CV risk factors had significantly larger LV mass index (by 17%) and lower LV contractibility (circumference strain, lower by 14%). Indexed LV volumes and stroke volume were inversely associated with age, but such relationships were not statistically significant in risk-free male subjects (p>0.05). Men with CV risk factors showed positive association of CMR T1 indices of myocardial fibrosis with age. Aortic function was similar in individuals with and without risk factors; age was associated with decline of aortic function in both CV and no CV risk factor groups. Conclusion Our results support that LV structure and function are better preserved in senescent hearts in the absence of traditional cardiovascular risk factors, and such protection is more prominent in men than in women.	[Liu, Chia-Ying; Kawel-Boehm, Nadine; Bluemke, David A.] NIH, Radiol & Imaging Sci, Bldg 10, Bethesda, MD 20892 USA; [Lai, Shenghan] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD USA; [Kawel-Boehm, Nadine] Clin Radiol, Kantonsspital Graubuenden, Chur, Switzerland; [Chahal, Harjit; Venkatesh, Bharath Ambale; Lima, Joao A. C.] Johns Hopkins Univ Hosp, Dept Radiol, Baltimore, MD 21287 USA	National Institutes of Health (NIH) - USA; Johns Hopkins University; Johns Hopkins Medicine; Kantonsspital Graubunden; Johns Hopkins University; Johns Hopkins Medicine	Bluemke, DA (corresponding author), NIH, Radiol & Imaging Sci, Bldg 10, Bethesda, MD 20892 USA.	bluemked@nih.gov	Ambale Venkatesh, Bharath/F-4941-2016; Bluemke, David/GYU-8169-2022	Ambale Venkatesh, Bharath/0000-0002-2330-2373; Bluemke, David/0000-0002-8323-8086	National Heart, Lung, and Blood Institute [N01-HC-95159]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000072] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research was supported by contracts N01-HC-95159 from the National Heart, Lung, and Blood Institute. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank all investigators, staff, and participants of the MESA Study for their valuable contributions. A full list of participating MESA Investigators and institutions can be found at http://www.mesa-nhlbi.org. This research was supported by contracts N01-HC-95159 from the National Heart, Lung, and Blood Institute. This manuscript has been reviewed by the MESA Investigators for scientific content and consistency of data interpretation with previous MESA publications and significant comments have been incorporated prior to submission for publication.	Akasheva DU, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135883; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Cheng S, 2009, CIRC-CARDIOVASC IMAG, V2, P191, DOI 10.1161/CIRCIMAGING.108.819938; Cuspidi C, 2014, J HYPERTENS, V32, P16, DOI 10.1097/HJH.0b013e328364fb58; GARDIN JM, 1995, CIRCULATION, V92, P380, DOI 10.1161/01.CIR.92.3.380; Gidding SS, 2010, J AM SOC ECHOCARDIOG, V23, P816, DOI 10.1016/j.echo.2010.05.023; Heckbert SR, 2006, J AM COLL CARDIOL, V48, P2285, DOI 10.1016/j.jacc.2006.03.072; Lakatta EG, 2003, CIRCULATION, V107, P346, DOI 10.1161/01.CIR.0000048893.62841.F7; LEVY D, 1988, DRUGS, V35, P1, DOI 10.2165/00003495-198800355-00002; Lieb W, 2014, JACC-CARDIOVASC IMAG, V7, P870, DOI 10.1016/j.jcmg.2014.05.008; Lieb W, 2009, CIRCULATION, V119, P3085, DOI 10.1161/CIRCULATIONAHA.108.824243; Lindsey ML, 2005, CARDIOVASC RES, V66, P410, DOI 10.1016/j.cardiores.2004.11.029; Liu CY, 2013, J AM COLL CARDIOL, V62, P1280, DOI 10.1016/j.jacc.2013.05.078; Maceira AM, 2006, J CARDIOVASC MAGN R, V8, P417, DOI 10.1080/10976640600572889; Messroghli DR, 2004, MAGN RESON MED, V52, P141, DOI 10.1002/mrm.20110; Mizukoshi K, 2016, J AM SOC ECHOCARDIOG, V29, P51, DOI 10.1016/j.echo.2015.09.009; Movahed MR, 2009, OBESITY, V17, P606, DOI 10.1038/oby.2008.563; Nikitin NP, 2006, INT J CARDIOL, V108, P76, DOI 10.1016/j.ijcard.2005.04.009; Ohyama Y, 2016, EUROPEAN HEART J CAR; OLIVETTI G, 1991, CIRC RES, V68, P1560, DOI 10.1161/01.RES.68.6.1560; RAIZADA V, 1994, J MOL CELL CARDIOL, V26, P293, DOI 10.1006/jmcc.1994.1037; Roth DA, 1998, J APPL PHYSIOL, V84, P177, DOI 10.1152/jappl.1998.84.1.177; Sado DM, 2012, HEART, V98, P1436, DOI 10.1136/heartjnl-2012-302346; Sandstede J, 2000, EUR RADIOL, V10, P438, DOI 10.1007/s003300050072; Ugander M, 2012, EUR HEART J, V33, P1268, DOI 10.1093/eurheartj/ehr481; Vishram JKK, 2014, DAN MED J, V61; Yeon SB, 2015, J MAGN RESON IMAGING, V41, P1038, DOI 10.1002/jmri.24649; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	29	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179947	10.1371/journal.pone.0179947	http://dx.doi.org/10.1371/journal.pone.0179947			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640873	Green Published, gold, Green Submitted			2022-12-27	WOS:000404135800084
J	Naziroglu, M; Cig, B; Blum, W; Vizler, C; Buhala, A; Marton, A; Katona, R; Josvay, K; Schwaller, B; Olah, Z; Pecze, L				Naziroglu, Mustafa; Cig, Bilal; Blum, Walter; Vizler, Csaba; Buhala, Andrea; Marton, Annamaria; Katona, Robert; Josvay, Katalin; Schwaller, Beat; Olah, Zoltan; Pecze, Laszlo			Targeting breast cancer cells by MRS1477, a positive allosteric modulator of TRPV1 channels	PLOS ONE			English	Article							RECEPTOR POTENTIAL VANILLOID-1; CAPSAICIN RECEPTOR; OXIDATIVE STRESS; ION-CHANNEL; ACTIVATION; APOPTOSIS; EXPRESSION; TOXICITY; RELEASE; NEURONS	There is convincing epidemiological and experimental evidence that capsaicin, a potent natural transient receptor potential cation channel vanilloid member 1 (TRPV1) agonist, has anticancer activity. However, capsaicin cannot be given systemically in large doses, because of its induction of acute pain and neurological inflammation. MRS1477, a dihydropyridine derivative acts as a positive allosteric modulator of TRPV1, if added together with capsaicin, but is ineffective, if given alone. Addition of MRS1477 evoked Ca2+ signals in MCF7 breast cancer cells, but not in primary breast epithelial cells. This indicates that MCF7 cells not only express functional TRPV1 channels, but also produce endogenous TRPV1 agonists. We investigated the effects of MRS1477 and capsaicin on cell viability, caspase-3 and -9 activities and reactive oxygen species production in MCF7 cells. The fraction of apoptotic cells was increased after 3 days incubation with capsaicin (10 mu M) paralleled by increased reactive oxygen species production and caspase activity. These effects were even more pronounced, when cells were incubated with MRS1477 (2 mu M) either alone or together with CAPS (10 mu M). Capsazepine, a TRPV1 blocker, inhibited both the effect of capsaicin and MRS1477. Whole-cell patch clamp recordings revealed that capsaicinevoked TRPV1-mediated current density levels were increased after 3 days incubation with MRS1477 (2 mu M). However, the tumor growth in MCF7 tumor-bearing immunodeficient mice was not significantly decreased after treatment with MRS1477 (10 mg/kg body weight, i.p., injection twice a week). In conclusion, in view of a putative in vivo treatment with MRS1477 or similar compounds further optimization is required.	[Naziroglu, Mustafa] Suleyman Demirel Univ, Neurosci Res Ctr, Isparta, Turkey; [Naziroglu, Mustafa; Cig, Bilal] Suleyman Demirel Univ, Hlth Sci Inst, Dept Neurosci, Isparta, Turkey; [Blum, Walter; Schwaller, Beat; Pecze, Laszlo] Univ Fribourg, Dept Med, Unit Anat, Fribourg, Switzerland; [Vizler, Csaba; Buhala, Andrea; Marton, Annamaria; Katona, Robert; Josvay, Katalin] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, Szeged, Hungary; [Olah, Zoltan] Univ Miskolc, Fac Mat Sci & Engn, Inst Chem, Miskolc, Hungary; [Olah, Zoltan] Acheuron Ltd, Szeged, Hungary	Suleyman Demirel University; Suleyman Demirel University; University of Fribourg; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Miskolc	Pecze, L (corresponding author), Univ Fribourg, Dept Med, Unit Anat, Fribourg, Switzerland.	laszlo.pecze@unifr.ch	ÇİĞ, BILAL/A-1747-2018; Blum, Walter/A-5996-2016	ÇİĞ, BILAL/0000-0001-7832-066X; Schwaller, Beat/0000-0002-8277-7555; Blum, Walter/0000-0003-2219-9180	Swiss National Science Foundation SNSF [130680]; Acheuron Ltd.;  [GINOP-2.3.2-15-2016-00001];  [GINOP-2.3.2-15-201600039]	Swiss National Science Foundation SNSF(Swiss National Science Foundation (SNSF)); Acheuron Ltd.; ; 	This project was supported by GINOP-2.3.2-15-2016-00001 and GINOP-2.3.2-15-201600039 to VC and the Swiss National Science Foundation SNSF grant # 130680 to BS. Acheuron Ltd. provided support in the form of salaries for the author ZO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of authors are articulated in the 'author contributions' section.	Azimi I, 2014, BRIT J PHARMACOL, V171, P945, DOI 10.1111/bph.12486; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Barar J, 2012, BIOIMPACTS, V2, P1, DOI 10.5681/bi.2012.001; Bevan S, 2014, HANDB EXP PHARMACOL, V222, P207, DOI 10.1007/978-3-642-54215-2_9; Bode AM, 2011, CANCER RES, V71, P2809, DOI 10.1158/0008-5472.CAN-10-3756; BRUCE RD, 1985, FUND APPL TOXICOL, V5, P151, DOI 10.1016/0272-0590(85)90059-4; Carnevale V, 2016, PHARMACEUTICALS-BASE, V9, DOI 10.3390/ph9030052; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cetin ES, 2017, J RECEPT SIG TRANSD, V37, P84, DOI 10.3109/10799893.2016.1160931; Cig B, 2015, BBA-BIOMEMBRANES, V1848, P2756, DOI 10.1016/j.bbamem.2015.02.013; Czifra G, 2009, J CANCER RES CLIN, V135, P507, DOI 10.1007/s00432-008-0482-3; Ding XZ, 2001, INT J CANCER, V94, P630, DOI 10.1002/ijc.1527.abs; GAO X, 1995, UROLOGY, V46, P227, DOI 10.1016/S0090-4295(99)80198-8; Gerry AB, 2014, ATHEROSCLEROSIS, V233, P537, DOI 10.1016/j.atherosclerosis.2014.01.014; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; JANCSOGABOR A, 1970, J PHYSIOL-LONDON, V206, P495, DOI 10.1113/jphysiol.1970.sp009027; Jankovic Bojana, 2010, Can Urol Assoc J, V4, pE9; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Karai L, 2004, J CLIN INVEST, V113, P1344, DOI 10.1172/JCI200420449; Kaszas K, 2012, J PHARMACOL EXP THER, V340, P152, DOI 10.1124/jpet.111.183053; Kato Y, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-89; Kosar PA, 2016, J MEMBRANE BIOL, V249, P129, DOI 10.1007/s00232-015-9855-0; Lebovitz EE, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-70; Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009; Lv J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3942; Mori A, 2006, CANCER RES, V66, P3222, DOI 10.1158/0008-5472.CAN-05-0087; Natarajan Rama, 1998, Frontiers in Bioscience, V3, pE81; Neelands TR, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-28; Nie D, 1998, CANCER RES, V58, P4047; Olah Z, 2002, J BIOL CHEM, V277, P35752, DOI 10.1074/jbc.M201551200; Olah Z, 2001, J BIOL CHEM, V276, P31163, DOI 10.1074/jbc.M101607200; Olah Z, 2001, J BIOL CHEM, V276, P11021, DOI 10.1074/jbc.M008392200; Olah Z, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000545; Pecze L, 2016, BBA-MOL CELL RES, V1863, P2905, DOI 10.1016/j.bbamcr.2016.09.013; Pecze L, 2016, BBA-MOL CELL RES, V1863, P2054, DOI 10.1016/j.bbamcr.2016.05.007; Pecze L, 2013, BBA-MOL CELL RES, V1833, P1680, DOI 10.1016/j.bbamcr.2012.08.018; Pecze L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003419; Pecze L, 2009, CAN J NEUROL SCI, V36, P234, DOI 10.1017/S0317167100006600; Pidgeon GP, 2007, CANCER METAST REV, V26, P503, DOI 10.1007/s10555-007-9098-3; Roh EJ, 2008, BIOORGAN MED CHEM, V16, P9349, DOI 10.1016/j.bmc.2008.08.048; Sanchez AM, 2006, APOPTOSIS, V11, P89, DOI 10.1007/s10495-005-3275-z; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Spindler SA, 1997, BIOCHEM BIOPH RES CO, V239, P775, DOI 10.1006/bbrc.1997.7471; STAMPFER MR, 1982, IN VITRO CELL DEV B, V18, P531; Stampfer MR, 2002, CULTURE EPITHELIAL C, P95; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Uguz AC, 2009, J MEMBRANE BIOL, V232, P15, DOI 10.1007/s00232-009-9212-2; van der Stelt M, 2004, EUR J BIOCHEM, V271, P1827, DOI 10.1111/j.1432-1033.2004.04081.x; Vercelli C, 2014, J BREAST CANCER, V17, P332, DOI 10.4048/jbc.2014.17.4.332; Veronesi B, 1999, NEUROPEPTIDES, V33, P447, DOI 10.1054/npep.1999.0761; Weber LV, 2016, BREAST CANCER-TARGET, V8, P243, DOI 10.2147/BCTT.S121610; Wen HR, 2012, J BIOL CHEM, V287, P13868, DOI 10.1074/jbc.M111.334896; Wu C LY, 2012, CANC RES S, V72; Wu TTL, 2014, CELL CALCIUM, V56, P59, DOI 10.1016/j.ceca.2014.04.006; Xie CQ, 2011, ENDOCRINOLOGY, V152, P3811, DOI 10.1210/en.2011-0141; Zhou YiMing, 2013, Nature Communications, V4, P2408; Zygmunt PM, 2000, EUR J PHARMACOL, V396, P39, DOI 10.1016/S0014-2999(00)00207-7	59	22	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179950	10.1371/journal.pone.0179950	http://dx.doi.org/10.1371/journal.pone.0179950			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640864	gold, Green Published, Green Submitted			2022-12-27	WOS:000404135800085
J	Zhao, TT; Wang, ZM; Su, LY; Sun, XM; Cheng, J; Zhang, LL; Karungo, SK; Han, YP; Li, SH; Xin, HP				Zhao, Tingting; Wang, Zemin; Su, Lingye; Sun, Xiaoming; Cheng, Jun; Zhang, Langlang; Karungo, Sospeter Karanja; Han, Yuepeng; Li, Shaohua; Xin, Haiping			An efficient method for transgenic callus induction from Vitis amurensis petiole	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; SOMATIC EMBRYOGENESIS; PLANT-REGENERATION; VINIFERA L.; GENETIC-TRANSFORMATION; TRANSCRIPTION FACTOR; SHOOT ORGANOGENESIS; MUSCADINE GRAPE; COLD-STRESS; ARABIDOPSIS	Transformation is the main platform for genetic improvement and gene function studies in plants. However, the established somatic embryo transformation system for grapevines is time-consuming and has low efficiency, which limits its utilization in functional genomics research. Vitis amurensis is a wild Vitis species with remarkable cold tolerance. The lack of an efficient genetic transformation system for it has significantly hindered the functional identification of cold stress related genes in the species. Herein, an efficient method was established to produce transformed calli of V. amurensis. Segments of petioles from micro-propagated plantlets of V. amurensis exhibited better capacity to differentiate calli than leaf-discs and stem segments, and thus was chosen as target tissue for Agrobacterium-mediated transformation. Both neomycin phosphotransferase II (NPTII) and enhanced green fluorescent protein (eGFP) genes were used for simultaneous selection of transgenic calli based on kanamycin resistance and eGFP fluorescence. Several parameters affecting the transformation efficiency were optimized including the concentration of kanamycin, Agrobacterium stains, bacterial densities, infection treatments and co-cultivation time. The transgenic callus lines were verified by checking the integration of NPTII gene into calli genomes, the expression of eGFP gene and the fluorescence of eGFP. Up to 20% of the petiole segments produced transformed calli after 2 months of cultivation. This efficient transformation system will facilitate the functional analysis of agronomic characteristics and related genes not only in V. amurensis but also in other grapevine species.	[Zhao, Tingting; Wang, Zemin; Sun, Xiaoming; Zhang, Langlang; Karungo, Sospeter Karanja; Han, Yuepeng; Li, Shaohua; Xin, Haiping] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Peoples R China; [Zhao, Tingting; Su, Lingye; Zhang, Langlang; Karungo, Sospeter Karanja] Univ Chinese Acad Sci, Beijing, Peoples R China; [Su, Lingye; Sun, Xiaoming; Cheng, Jun; Li, Shaohua] Chinese Acad Sci, Beijing Key Lab Grape Sci & Enol, Inst Bot, CAS Key Lab Plant Resources, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Botany, CAS	Xin, HP (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Peoples R China.	xinhaiping215@hotmail.com	Sun, Xiaoming/AHA-6034-2022	Sun, Xiaoming/0000-0002-0788-3382; Wang, Zemin/0000-0001-7936-5229; Xin, Haiping/0000-0002-4652-1683	National Natural Science Foundation of China [31471857, 31672132]; Youth Innovation Promotion Association of CAS [2015281]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association of CAS	This study was supported by the National Natural Science Foundation of China, no. 31471857, HX, ham://www.nsfc.gov.cn/; the National Natural Science Foundation of China, no. 31672132, HX, http://wtwvwl.nsfc.gov.cn/; and the Youth Innovation Promotion Association of CAS, no. 2015281, HX, http://www.yicas.cn/.	Aguero CB, 2006, VITIS, V45, P1; Ahmed M, 2015, VEGETOS, V28, P171; Bolwell GP, 1997, PHYSIOL MOL PLANT P, V51, P347, DOI 10.1006/pmpp.1997.0129; CHENG ZM, 1989, PLANT CELL REP, V8, P403, DOI 10.1007/BF00270079; CLOG E, 1990, PLANT CELL REP, V8, P726, DOI 10.1007/BF00272104; COLBY SM, 1990, PLANT CELL REP, V9, P237, DOI 10.1007/BF00232291; Das DK, 2002, PLANT CELL REP, V20, P999, DOI 10.1007/s00299-002-0441-4; Dhekney SA, 2008, PLANT CELL REP, V27, P865, DOI 10.1007/s00299-008-0512-2; Fan CH, 2008, PLANT CELL TISS ORG, V92, P197, DOI 10.1007/s11240-007-9324-2; Fang LC, 2016, J EXP BOT, V67, P2829, DOI 10.1093/jxb/erw122; Fennell A., 2004, Journal of Crop Improvement, V10, P201, DOI 10.1300/J411v10n01_09; Franks T, 1998, MOL BREEDING, V4, P321, DOI 10.1023/A:1009673619456; GRAY DJ, 1987, PLANT CELL TISS ORG, V9, P73, DOI 10.1007/BF00046081; GRAY DJ, 1992, AM J BOT, V79, P542, DOI 10.2307/2444865; Harst M, 2000, VITIS, V39, P99; Iocco P, 2001, TRANSGENIC RES, V10, P105, DOI 10.1023/A:1008989610340; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Li ZT, 2006, IN VITRO CELL DEV-PL, V42, P220, DOI 10.1079/IVP2006770; Li ZJT, 2008, PLANT CELL TISS ORG, V93, P311, DOI 10.1007/s11240-008-9378-9; Lopez-Perez AJ, 2008, PLANT CELL TISS ORG, V94, P189, DOI 10.1007/s11240-008-9404-y; MARTINELLI L, 1993, PLANT CELL REP, V12, P207, DOI 10.1007/BF00237055; Mezzetti Bruno, 2002, BMC Biotechnol, V2, P18, DOI 10.1186/1472-6750-2-18; Mochida K, 2011, PLANT CELL PHYSIOL, V52, P2017, DOI 10.1093/pcp/pcr153; MULLINS MG, 1976, J EXP BOT, V27, P1022, DOI 10.1093/jxb/27.5.1022; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; ROBACKER C, 1993, HORTSCIENCE, V28, P53, DOI 10.21273/HORTSCI.28.1.53; Salunkhe CK, 1997, PLANT CELL REP, V17, P65, DOI 10.1007/s002990050353; STAMP JA, 1990, PLANT CELL TISS ORG, V22, P127, DOI 10.1007/BF00043688; STAMP JA, 1990, J AM SOC HORTIC SCI, V115, P1038, DOI 10.21273/JASHS.115.6.1038; Sun X. X., 2016, SCI REP, V6; Tillett RL, 2012, PLANT BIOTECHNOL J, V10, P105, DOI 10.1111/j.1467-7652.2011.00648.x; Torregrosa L, 2002, AM J ENOL VITICULT, V53, P183; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Vidal JR, 2006, TRANSGENIC RES, V15, P69, DOI 10.1007/s11248-005-4423-5; Wang HL, 2015, SCI HORTIC-AMSTERDAM, V191, P82, DOI 10.1016/j.scienta.2015.04.039; Wang QC, 2005, PLANT SCI, V168, P565, DOI 10.1016/j.plantsci.2004.09.033; Xie XQ, 2016, PLANT CELL TISS ORG, V126, P541, DOI 10.1007/s11240-016-1023-4; Xin HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058740; Xu W., 2014, MATER RES LETT, V2, P1, DOI DOI 10.1371/J0URNAL.P0NE.0102303; Xu WR, 2014, PLANT MOL BIOL, V86, P527, DOI 10.1007/s11103-014-0245-2; Xu WR, 2014, MOL BIOL REP, V41, P5329, DOI 10.1007/s11033-014-3404-2; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yuan YY, 2016, PLANT CELL REP, V35, P655, DOI 10.1007/s00299-015-1910-x; Zhao FX, 2011, AGR SCI CHINA, V10, P686, DOI 10.1016/S1671-2927(11)60051-5; Zhou Q, 2014, PLANT CELL TISS ORG, V118, P157, DOI 10.1007/s11240-014-0471-y; Zottini M, 2008, PLANT CELL REP, V27, P845, DOI 10.1007/s00299-008-0510-4	46	15	15	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179730	10.1371/journal.pone.0179730	http://dx.doi.org/10.1371/journal.pone.0179730			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640905	Green Published, gold, Green Submitted			2022-12-27	WOS:000404135800057
J	Khadaroo, RG; Churchill, TA; Tso, V; Madsen, KL; Lukowski, C; Salim, SY				Khadaroo, Rachel G.; Churchill, Thomas A.; Tso, Victor; Madsen, Karen L.; Lukowski, Chris; Salim, Saad Y.			Metabolomic profiling to characterize acute intestinal ischemia/reperfusion injury	PLOS ONE			English	Article							ACUTE MESENTERIC ISCHEMIA; MULTIPLE ORGAN FAILURE; BACTERIAL TRANSLOCATION; CRITICALLY-ILL; KIDNEY-TRANSPLANTS; REPERFUSION INJURY; HEMORRHAGIC-SHOCK; XANTHINE-OXIDASE; GUT; PERMEABILITY	Sepsis and septic shock are the leading causes of death in critically ill patients. Acute intestinal ischemia/reperfusion (AII/R) is an adaptive response to shock. The high mortality rate from AII/R is due to the severity of the disease and, more importantly, the failure of timely diagnosis. The objective of this investigation is to use nuclear magnetic resonance (NMR) analysis to characterize urine metabolomic profile of AII/R injury in a mouse model. Animals were exposed to sham, early (30 min) or late (60 min) acute intestinal ischemia by complete occlusion of the superior mesenteric artery, followed by 2 hrs of reperfusion. Urine was collected and analyzed by NMR spectroscopy. Urinary metabolite concentrations demonstrated that different profiles could be delineated based on the duration of the intestinal ischemia. Metabolites such as allantoin, creatinine, proline, and methylamine could be predictive of AII/R injury. Lactate, currently used for clinical diagnosis, was found not to significantly contribute to the classification model for either early or late ischemia. This study demonstrates that patterns of changes in urinary metabolites are effective at distinguishing AII/R progression in an animal model. This is a proof-of-concept study to further support examination of metabolites in the clinical diagnosis of intestinal ischemia reperfusion injury in patients. The discovery of a fingerprint metabolite profile of AII/R will be a major advancement in the diagnosis, treatment, and prevention of systemic injury in critically ill patients.	[Khadaroo, Rachel G.; Churchill, Thomas A.; Lukowski, Chris; Salim, Saad Y.] Univ Alberta, Fac Med & Dent, Dept Surg, Edmonton, AB, Canada; [Khadaroo, Rachel G.] Univ Alberta, Fac Med & Dent, Div Gen Surg, Edmonton, AB, Canada; [Khadaroo, Rachel G.] Univ Alberta, Fac Med & Dent, Div Crit Care Med, Edmonton, AB, Canada; [Khadaroo, Rachel G.; Tso, Victor; Madsen, Karen L.; Lukowski, Chris; Salim, Saad Y.] Univ Alberta, Fac Med & Dent, CEGIIR, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta	Khadaroo, RG (corresponding author), Univ Alberta, Fac Med & Dent, Dept Surg, Edmonton, AB, Canada.; Khadaroo, RG (corresponding author), Univ Alberta, Fac Med & Dent, Div Gen Surg, Edmonton, AB, Canada.; Khadaroo, RG (corresponding author), Univ Alberta, Fac Med & Dent, Div Crit Care Med, Edmonton, AB, Canada.; Khadaroo, RG (corresponding author), Univ Alberta, Fac Med & Dent, CEGIIR, Edmonton, AB, Canada.	khadaroo@ualberta.ca	Madsen, Karen L/H-5898-2011					Adams JM, 2001, CRIT CARE MED, V29, P2194, DOI 10.1097/00003246-200111000-00023; Dayal SD, 2002, J TRAUMA, V52, P1048, DOI 10.1097/00005373-200206000-00005; De Preter Vicky, 2013, World J Gastrointest Pharmacol Ther, V4, P97, DOI 10.4292/wjgpt.v4.i4.97; de Smet AMGA, 2009, NEW ENGL J MED, V360, P20, DOI 10.1056/NEJMoa0800394; De-Souza DA, 2005, CRIT CARE MED, V33, P1125, DOI 10.1097/01.CCM.0000162680.52397.97; Deitch EA, 2002, SURGERY, V131, P241, DOI 10.1067/msy.2002.116408; DEITCH EA, 1994, SHOCK, V1, P141, DOI 10.1097/00024382-199402000-00010; Demir IE, 2012, DIGEST SURG, V29, P226, DOI 10.1159/000338086; Drake KJ, 2012, EXP BIOL MED, V237, P1369, DOI 10.1258/ebm.2012.012025; Dryland P.A., 2008, OPEN BIOACTIVE COMPO, V1, P6; Fahrner R, 2012, J SURG RES; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Glenister KM, 2004, ANZ J SURG, V74, P260, DOI 10.1111/j.1445-2197.2004.02956.x; Goytia M, 2010, INFECT IMMUN, V78, P3187, DOI 10.1128/IAI.01301-09; GRANGER DN, 1988, AM J PHYSIOL, V255, pH1269, DOI 10.1152/ajpheart.1988.255.6.H1269; Heyland DK, 2003, JPEN-PARENTER ENTER, V27, P355, DOI 10.1177/0148607103027005355; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Kand'ar R, 2006, CLIN CHIM ACTA, V365, P249, DOI 10.1016/j.cca.2005.09.002; Kassahun WT, 2008, LANGENBECK ARCH SURG, V393, P163, DOI 10.1007/s00423-007-0263-5; Khadaroo RG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115242; Khadaroo RG, 2008, CRIT CARE, V12, DOI 10.1186/cc7001; Kim Seoung Bum, 2008, Stat Anal Data Min, V1, P57, DOI 10.1002/sam.10005; Klempnauer J, 1997, SURGERY, V121, P239, DOI 10.1016/S0039-6060(97)90351-2; Kohler I, 2016, BIOANALYSIS, V8, P1509, DOI 10.4155/bio-2016-0090; MARSHALL JC, 1993, ANN SURG, V218, P111, DOI 10.1097/00000658-199308000-00001; MCKELVEY TG, 1988, AM J PHYSIOL, V254, pG753, DOI 10.1152/ajpgi.1988.254.5.G753; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; Nieuwenhuijzen G A, 1999, Curr Opin Clin Nutr Metab Care, V2, P399, DOI 10.1097/00075197-199909000-00008; NISHINO T, 1994, J BIOCHEM, V116, P1; Pastores SM, 1996, AM J GASTROENTEROL, V91, P1697; Pelantova H, 2016, ANAL BIOANAL CHEM, V408, P567, DOI 10.1007/s00216-015-9133-0; Perez-Chanona E, 2014, AM J PATHOL, V184, P2965, DOI 10.1016/j.ajpath.2014.07.014; Rotstein O D, 2000, Surg Infect (Larchmt), V1, P217, DOI 10.1089/109629600750018141; Sabatine MS, 2005, CIRCULATION, V112, P3868, DOI 10.1161/CIRCULATIONAHA.105.569137; Sainani KL, 2014, PM&R, V6, P275, DOI 10.1016/j.pmrj.2014.02.001; Salim SY, 2013, BENEF MICROBES, V4, P357, DOI 10.3920/BM2013.0026; Salim SY, 2016, J SURG RES; Sekirov I, 2006, NAT MED, V12, P736, DOI 10.1038/nm0706-736; Serkova N, 2005, KIDNEY INT, V67, P1142, DOI 10.1111/j.1523-1755.2005.00181.x; SHENG ZY, 1991, CHINESE MED J-PEKING, V104, P897; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Slupsky CM, 2007, ANAL CHEM, V79, P6995, DOI 10.1021/ac0708588; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Swank GM, 1996, WORLD J SURG, V20, P411, DOI 10.1007/s002689900065; Taylor D E, 1998, Respir Care Clin N Am, V4, P611; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; WILCOX MG, 1995, DIGEST DIS SCI, V40, P709, DOI 10.1007/BF02064966; Wishart DS, 2006, CURR OPIN NEPHROL HY, V15, P637, DOI 10.1097/01.mnh.0000247499.64291.52; Yap IKS, 2008, J PROTEOME RES, V7, P3718, DOI 10.1021/pr700864x; Yardim-Akaydin S, 2006, SCAND J RHEUMATOL, V35, P61, DOI 10.1080/03009740510026878; Yoav B, 1995, J ROY STAT SOC, V57, P289	51	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179326	10.1371/journal.pone.0179326	http://dx.doi.org/10.1371/journal.pone.0179326			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662085	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300019
J	Khoury, AL; Morey, MC; Wong, TC; McNeil, DL; Humphries, B; Frankey, K; Pieper, CF; Hicks, CB; Huffman, K; McKellar, MS				Khoury, Audrey L.; Morey, Miriam C.; Wong, Tammy C.; McNeil, Donna Lynn; Humphries, Barlett; Frankey, Katherine; Pieper, Carl F.; Hicks, Charles B.; Huffman, Kim; McKellar, Mehri S.			Diminished physical function in older HIV infected adults in the Southeastern US despite successful antiretroviral therapy	PLOS ONE			English	Article							PERFORMANCE-MEASURES; REFERENCE VALUES; 6-MINUTE WALK; AGE; ASSOCIATION; IMPAIRMENT; DECLINE; SPEED; TIME	Background As antiretroviral therapy efficacy improves, HIV is gradually being recognized more as a chronic disease within the aging HIV-infected population. While these individuals are surviving into old age, they may, however, be experiencing "accelerated aging" with greater declines in physical function than that observed among comparably matched individuals free of HIV. This decline is not well understood and it remains unclear if physical decline correlates with the degree of immunosuppression based on CD4 lymphocyte nadir. Methods In a cross-sectional study of accelerated aging in the older HIV-infected population on antiretroviral therapy (ART), physical performance evaluations were completed on a cohort of 107 HIV-infected subjects, age 50 years or older (with no HIV-1 RNA >200 copies/mL in the prior 12 months), and compared to reference ranges for age-and gender-matched HIV uninfected persons. Physical performance testing consisted of four validated assessments: the 2.4-meter walk, 30-second chair stand, grip strength and 6-minute walk test. Results When compared to age-and gender-matched HIV-uninfected reference controls, older HIV infected persons had diminished physical function. No correlation was found between physical function and degree of immunosuppression as determined by pre-ART CD4 nadir. Conclusions Despite improved survival, HIV infected adults on suppressive ART have diminished physical function compared to HIV-uninfected persons. The degree of HIV-associated immunosuppression does not correlate with the observed degree of physical function decline in older HIV-infected persons, suggesting the decline is mediated by other mechanisms.	[Khoury, Audrey L.; Wong, Tammy C.] Univ North Carolina Chapel Hill, Sch Med, Chapel Hill, NC USA; [Morey, Miriam C.; Pieper, Carl F.; Huffman, Kim; McKellar, Mehri S.] Duke Univ, Sch Med, Dept Med, Claude D Pepper Older Amer Independence Ctr, Durham, NC 27706 USA; [Morey, Miriam C.] Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Durham, NC USA; [McNeil, Donna Lynn] Duke Canc Inst, Off Res Support, Durham, NC USA; [Humphries, Barlett; Frankey, Katherine] Duke Univ, Med Ctr, Ctr Appl Genom & Precis Med, Durham, NC USA; [Pieper, Carl F.] Duke Dept Biostat & Bioinformat, Durham, NC USA; [Hicks, Charles B.] Univ Calif San Diego, Sch Med, Div Infect Dis, San Diego, CA 92103 USA; [Huffman, Kim] Duke Univ, Sch Med, Duke Mol Physiol Inst, Durham, NC USA; [McKellar, Mehri S.] Duke Univ, Med Ctr, Div Infect Dis, Durham, NC 27708 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Duke University; Duke University; University of California System; University of California San Diego; Duke University; Duke University	McKellar, MS (corresponding author), Duke Univ, Sch Med, Dept Med, Claude D Pepper Older Amer Independence Ctr, Durham, NC 27706 USA.; McKellar, MS (corresponding author), Duke Univ, Med Ctr, Div Infect Dis, Durham, NC 27708 USA.	mehri.mckellar@duke.edu		Pieper, Carl/0000-0003-4809-1725	Duke University Center for AIDS Research (CFAR) [A1064518]; Duke Claude D Pepper Older Americans Independence Center (OAIC) [P30 AG028716]; NIH funded program [5P30 AI064518]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028716] Funding Source: NIH RePORTER	Duke University Center for AIDS Research (CFAR); Duke Claude D Pepper Older Americans Independence Center (OAIC); NIH funded program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was supported by the following: Duke University Center for AIDS Research (CFAR grant number A1064518) - MSM; and Duke Claude D Pepper Older Americans Independence Center (OAIC grant number P30 AG028716) - MSM. The funders contributed to the study design and preparation of this manuscript.; This publication resulted (in part) from research supported by the Duke University Center for AIDS Research (CFAR), an NIH funded program (5P30 AI064518). Additionally, research funding was obtained from the Duke Claude D Pepper Older Americans Independence Center (P30 AG028716). The authors would also like to thank the subjects for their participation.	Asher L, 2012, AGE AGEING, V41, P690, DOI 10.1093/ageing/afs076; Beans J, 2013, J AIDS CLIN RES, V4, DOI [DOI 10.4172/2155-6113.S9-003, 10.4172/2155-6113.S9-003]; Bohannon RW, 2006, PHYSIOTHERAPY, V92, P11, DOI 10.1016/j.physio.2005.05.003; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Capeau J, 2011, CLIN INFECT DIS, V53, P1127, DOI 10.1093/cid/cir628; Centers for Disease Control and Prevention, HIV SO US; Centers for Disease Control and Prevention, 2013, HIV SURVEILLANCE S, V18; Enright PL, 1998, AM J RESP CRIT CARE, V158, P1384, DOI 10.1164/ajrccm.158.5.9710086; Erlandson KM, 2016, AIDS, V30, P445, DOI 10.1097/QAD.0000000000000932; Erlandson KM, 2013, J INFECT DIS, V208, P249, DOI 10.1093/infdis/jit147; Erlandson KM, 2013, JAIDS-J ACQ IMM DEF, V63, P209, DOI 10.1097/QAI.0b013e318289bb7e; Erlandson KM, 2012, HIV CLIN TRIALS, V13, P324, DOI 10.1310/hct1306-324; Erlandson KM, 2012, JAIDS-J ACQ IMM DEF, V61, P484, DOI 10.1097/QAI.0b013e3182716e38; Gill CJ, 2002, J ACQ IMMUN DEF SYND, V30, P485, DOI 10.1097/00126334-200208150-00004; Greene M, 2014, AIDS, V28, P2711, DOI 10.1097/QAD.0000000000000507; Greene M, 2013, JAMA-J AM MED ASSOC, V309, P1397, DOI 10.1001/jama.2013.2963; High KP, 2012, JAIDS-J ACQ IMM DEF, V60, pS1, DOI 10.1097/QAI.0b013e31825a3668; Kohler JJ, 2007, ENVIRON MOL MUTAGEN, V48, P166, DOI 10.1002/em.20223; Luna-Heredia E, 2005, CLIN NUTR, V24, P250, DOI 10.1016/j.clnu.2004.10.007; Milanovic Z, 2013, CLIN INTERV AGING, V8, DOI 10.2147/CIA.S44112; North Carolina Health and Human Services, FACTS FIG N CAR HIV; Oursler KK, 2011, AIDS PATIENT CARE ST, V25, P13, DOI 10.1089/apc.2010.0242; Perera S, 2006, J AM GERIATR SOC, V54, P743, DOI 10.1111/j.1532-5415.2006.00701.x; Richert L, 2014, AIDS, V28, P1441, DOI 10.1097/QAD.0000000000000246; Richert L, 2011, AIDS, V25, P797, DOI 10.1097/QAD.0b013e3283455dff; Rikli RE, 2013, GERONTOLOGIST, V53, P255, DOI 10.1093/geront/gns071; SAS Institute Inc, 2013, SAS 9 4 SOFTW; Schrack JA, 2015, JAIDS-J ACQ IMM DEF, V70, P370, DOI 10.1097/QAI.0000000000000731; Steffen TM, 2002, PHYS THER, V82, P128, DOI 10.1093/ptj/82.2.128; United States Census Bureau, 2015 INT POP EST PRO; Wilson IB, 1996, MED CARE, V34, P610, DOI 10.1097/00005650-199606000-00010; Wright AA, 2011, J ORTHOP SPORT PHYS, V41, P319, DOI 10.2519/jospt.2011.3515	32	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179874	10.1371/journal.pone.0179874	http://dx.doi.org/10.1371/journal.pone.0179874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662079	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300063
J	Chang, YS; Weng, SF; Chang, C; Wang, JJ; Chen, HI; Ko, SY; Tu, IT; Chien, CC; Wang, JJ; Wang, CM; Jan, RL				Chang, Yuh-Shin; Weng, Shih-Feng; Chang, Chun; Wang, Jhi-Joung; Chen, Hong-I; Ko, Shun-Yao; Tu, I-Te; Chien, Chih-Chiang; Wang, Jian-Jhong; Wang, Ching-Min; Jan, Ren-Long			Risk of serous retinal detachment in patients with end-stage renal disease on dialysis	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; PIGMENT EPITHELIAL DETACHMENTS; PREVALENCE; HEMODIALYSIS; INFLAMMATION; OCCLUSION; IMPACT; COHORT; CKD	The aim of this retrospective, nationwide, matched cohort study was to investigate the association of serous retinal detachment with having end-stage renal disease (ESRD) while on dialysis. The cohort study included 94,024 patients with ESRD on dialysis registered between January 2000 to December 2009 in the Taiwan National Health Insurance Research Database. An age-and sex-matched control group comprised 94,024 patients selected from the Taiwan Longitudinal Health Insurance Database 2000. Information for each patient was collected from the index date until December 2011. Twenty-seven ESRD patients and 11 controls developed serous retinal detachment (P < 0.001) during follow-up, demonstrating a significantly increased risk of serous retinal detachment in patients with ESRD on dialysis compared with controls (incidence rate ratio = 3.39, 95% confidence interval [CI] = 1.68 +/- 6.83). After adjustment for potential confounders, patients were 3.86 times more likely to develop serous retinal detachment than the full cohort (adjusted HR = 3.86, 95% CI = 1.15 +/- 12.96). In conclusion, patients with ESRD on dialysis demonstrate an increased risk of serous retinal detachment. Interdisciplinary collaboration between nephrologists and ophthalmologists is important to deal with serous retinal detachment in patients with ESRD on dialysis and prevent impairments of visual acuity.	[Chang, Yuh-Shin] Chi Mei Med Ctr, Dept Ophthalmol, Tainan, Taiwan; [Chang, Yuh-Shin; Chen, Hong-I; Ko, Shun-Yao] Chang Jung Christian Univ, Coll Hlth Sci, Grad Inst Med Sci, Tainan, Taiwan; [Weng, Shih-Feng] Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan; [Chang, Chun] Univ Taipei, Dept Educ, Taipei, Taiwan; [Wang, Jhi-Joung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Wang, Jhi-Joung] Chi Mei Med Ctr, Dept Anesthesiol, Tainan, Taiwan; [Tu, I-Te; Wang, Jian-Jhong; Wang, Ching-Min] Chi Mei Med Ctr, Dept Internal Med, Tainan, Taiwan; [Chien, Chih-Chiang] Chi Mei Med Ctr, Dept Internal Med, Tainan, Taiwan; [Jan, Ren-Long] Natl Cheng Kung Univ, Grad Inst Clin Med, Tainan, Taiwan; [Jan, Ren-Long] Chi Mei Med Ctr, Dept Pediat, Tainan, Taiwan	Chi Mei Hospital; Chang Jung Christian University; Kaohsiung Medical University; University of Taipei; Chi Mei Hospital; Chi Mei Hospital; Chi Mei Hospital; Chi Mei Hospital; National Cheng Kung University; Chi Mei Hospital	Jan, RL (corresponding author), Natl Cheng Kung Univ, Grad Inst Clin Med, Tainan, Taiwan.; Jan, RL (corresponding author), Chi Mei Med Ctr, Dept Pediat, Tainan, Taiwan.	renlongjan@gmail.com		Weng, Shih-Feng/0000-0001-8684-3487; Wang, Jian-Jhong/0000-0002-5530-0719				Basu S, 2010, INDIAN J OPHTHALMOL, V58, P261, DOI 10.4103/0301-4738.62670; BRODY JM, 1995, ACTA OPHTHALMOL SCAN, V73, P81; Chang YS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003174; Chang YS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003474; Chang YS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003281; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; GANGAN PA, 1994, AM J OPHTHALMOL, V118, P212, DOI 10.1016/S0002-9394(14)72901-0; GASS JDM, 1992, GRAEF ARCH CLIN EXP, V230, P454; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; GOLDSTEIN M, 1979, ANN OPHTHALMOL, V11, P923; Hassan K, 2015, J INT MED RES, V43, P42, DOI 10.1177/0300060514550013; Hsu CC, 2006, AM J KIDNEY DIS, V48, P727, DOI 10.1053/j.ajkd.2006.07.018; Hwang SJ, 2010, NEPHROLOGY, V15, P3, DOI 10.1111/j.1440-1797.2010.01304.x; JABS DA, 1988, ARCH OPHTHALMOL-CHIC, V106, P230; Jumper JM, 2000, RETINA-J RET VIT DIS, V20, P190, DOI 10.1097/00006982-200003000-00012; Kuo HW, 2007, AM J KIDNEY DIS, V49, P46, DOI 10.1053/j.ajkd.2006.10.007; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; McClellan W, 2006, J AM SOC NEPHROL, V17, P1710, DOI 10.1681/ASN.2005111200; Mullaem G, 2012, SEMIN DIALYSIS, V25, P403, DOI 10.1111/j.1525-139X.2012.01098.x; MURPHY JA, 1991, CLIN LAB HAEMATOL, V13, P217; RAO NA, 1995, INT OPHTHALMOL CLIN, V35, P69, DOI 10.1097/00004397-199503520-00007; Rathinam SR, 1998, OCUL IMMUNOL INFLAMM, V6, P155, DOI 10.1076/ocii.6.3.155.4041; Reddy SC, 1998, ACTA OPHTHALMOL SCAN, V76, P700, DOI 10.1034/j.1600-0420.1998.760614.x; Schortgen F, 2000, AM J RESP CRIT CARE, V162, P197, DOI 10.1164/ajrccm.162.1.9907098; Troiano P, 1998, NEPHROL DIAL TRANSPL, V13, P2135, DOI 10.1093/ndt/13.8.2135; WAGDI S, 1978, CAN J OPHTHALMOL, V13, P157; Wang AYM, 2011, SEMIN NEPHROL, V31, P159, DOI 10.1016/j.semnephrol.2011.01.005; Wang IK, 2016, RETINA-J RET VIT DIS, V36, P1866, DOI 10.1097/IAE.0000000000001011; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Weng SF, 2016, SCI REP-UK, V6, DOI 10.1038/srep28675; Wolfensberger T J, 2000, Curr Opin Ophthalmol, V11, P455, DOI 10.1097/00055735-200012000-00012; ZACCHEI AC, 1995, AM J OPHTHALMOL, V120, P796, DOI 10.1016/S0002-9394(14)72734-5	33	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180133	10.1371/journal.pone.0180133	http://dx.doi.org/10.1371/journal.pone.0180133			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658289	Green Published, gold, Green Submitted			2022-12-27	WOS:000404607900063
J	Natt, M; Lonnstedt, OM; McCormick, MI				Natt, Michael; Lonnstedt, Oona M.; McCormick, Mark I.			Coral reef fish predator maintains olfactory acuity in degraded coral habitats	PLOS ONE			English	Article							CHEMICAL ALARM CUES; RISK-ASSESSMENT; OCEAN ACIDIFICATION; PREY INTERACTIONS; CLIMATE-CHANGE; DEGRADATION; IMPACTS; PROSPECTUS; MORTALITY; ECOLOGY	Coral reefs around the world are rapidly degrading due to a range of environmental stress ors. Habitat degradation modifies the sensory landscape within which predator-prey interactions occur, with implications for olfactory-mediated behaviours. Predator na ve settlement stage damselfish rely on conspecific damage-released odours (i.e., alarm odours) to inform risk assessments. Yet, species such as the Ambon damselfish, Pomacentrus amboinensis, become unable to respond appropriately to these cues when living in dead-degraded coral habitats, leading to increased mortality through loss of vigilance. Reef fish predators also rely on odours from damaged prey to locate, assess prey quality and engage in prey-stealing, but it is unknown whether their responses are also modified by the change to dead degraded coral habitats. Implications for prey clearly depend on how their predatory counterparts are affected, therefore the present study tested whether olfactory-mediated foraging responses in the dusky dottyback, Pseudochromis fuscus, a common predator of P. amboinensis, were similarly affected by coral degradation. A y-maze was used to measure the ability of Ps. fuscus to detect and move towards odours, against different background water sources. Ps. fuscus were exposed to damage-released odours from juvenile P. amboinensis, or a control cue of seawater, against a background of seawater treated with either healthy or dead-degraded hard coral. Predators exhibited an increased time allocation to the chambers of y-mazes injected with damage-released odours, with comparable levels of response in both healthy and dead-degraded coral treated waters. In control treatments, where damage-released odours were replaced with a control seawater cue, fish showed no increased preference for either chamber of the y-maze. Our results suggest that olfactory-mediated foraging behaviours may persist in Ps. fuscus within dead-degraded coral habitats. Ps. fuscus may consequently gain a sensory advantage over P. amboinensis, potentially altering the outcome of predator-prey interactions.	[Natt, Michael; McCormick, Mark I.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Natt, Michael; McCormick, Mark I.] James Cook Univ, Dept Marine Biol & Aquaculture, Townsville, Qld, Australia; [Lonnstedt, Oona M.] Uppsala Univ, Dept Ecol & Genet, Limnol, Uppsala, Sweden	James Cook University; James Cook University; Uppsala University	McCormick, MI (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia.; McCormick, MI (corresponding author), James Cook Univ, Dept Marine Biol & Aquaculture, Townsville, Qld, Australia.	mark.mccormick@jcu.edu.au	McCormick, Mark I/J-8301-2014	McCormick, Mark I/0000-0001-9289-1645	Australian Research Council Centre of Excellence for Coral Reef Studies [E1140100117]; Australian Research Council [DP170103372]	Australian Research Council Centre of Excellence for Coral Reef Studies(Australian Research Council); Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council Centre of Excellence for Coral Reef Studies (E1140100117) to MIM and the Australian Research Council (DP170103372) to MIM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2006, CORAL REEFS, V25, P19, DOI 10.1007/s00338-005-0044-y; Ashworth EC, 2014, J FISH BIOL, V84, P1031, DOI 10.1111/jfb.12343; Atema J, 2002, MAR ECOL PROG SER, V241, P151, DOI 10.3354/meps241151; Bellwood DR, 2006, GLOBAL CHANGE BIOL, V12, P1587, DOI 10.1111/j.1365-2486.2006.01204.x; Brooker R. M., 2016, CHEM SIGNALS VERTEBR, V13, P17; Bruintjes R, 2014, PEERJ, V2, DOI 10.7717/peerj.594; Caiger PE, 2012, MAR ECOL PROG SER, V466, P225, DOI 10.3354/meps09933; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Chivers DP, 2016, SCI REP-UK, V6, DOI 10.1038/srep32542; Chivers DP, 2013, ECOL EVOL, V3, P3925, DOI 10.1002/ece3.760; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Coker DJ, 2009, BEHAV ECOL, V20, P1204, DOI 10.1093/beheco/arp113; Cripps IL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022736; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Erftemeijer PLA, 2012, MAR POLLUT BULL, V64, P1737, DOI 10.1016/j.marpolbul.2012.05.008; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Feeney WE, 2012, CORAL REEFS, V31, P909, DOI 10.1007/s00338-012-0894-z; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; Ferrari MCO, 2017, P ROY SOC B, V284; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gill AC, 2004, S AFRICAN I AQUATIC; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Holmes TH, 2010, BEHAV PROCESS, V83, P299, DOI 10.1016/j.beproc.2010.01.013; Holmes TH, 2010, MAR ECOL PROG SER, V399, P273, DOI 10.3354/meps08337; Holmes TH, 2009, OECOLOGIA, V159, P401, DOI 10.1007/s00442-008-1220-x; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Lienart GDH, 2014, ANIM BEHAV, V89, P199, DOI 10.1016/j.anbehav.2013.12.031; Lonnstedt OM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2038; Lonnstedt OM, 2014, J ANIM ECOL, V83, P1178, DOI 10.1111/1365-2656.12209; Lonnstedt OM, 2013, ECOL EVOL, V3, P3565, DOI 10.1002/ece3.684; Lonnstedt OM, 2013, SCI REP-UK, V3, DOI 10.1038/srep02259; Lonnstedt OM, 2013, ECOL EVOL, V3, P38, DOI 10.1002/ece3.388; Lonnstedt OM, 2011, ANIM BEHAV, V82, P213, DOI 10.1016/j.anbehav.2011.04.015; Lonnstedt OM, 2012, OECOLOGIA, V168, P651, DOI 10.1007/s00442-011-2116-8; Mathuru AS, 2012, CURR BIOL, V22, P538, DOI 10.1016/j.cub.2012.01.061; McCormick MI, 2007, CORAL REEFS, V26, P571, DOI 10.1007/s00338-007-0221-2; Mccormick MI, 2008, ANIM BEHAV, V75, P1973, DOI 10.1016/j.anbehav.2007.12.007; McCormick MI, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00521-0; McCormick MI, 2013, ECOL EVOL, V3, P4221, DOI 10.1002/ece3.793; McCormick MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042590; McCormick MI, 2006, J FISH BIOL, V68, P969, DOI 10.1111/j.1095-8649.2006.00982.x; McCormick MI, 2016, P BIOL SCI, V283; McCormick MI, 2016, GLOB CHANG BIOL; Meekan MG, 2001, MAR BIOL, V139, P373; Mitchell MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015764; Stewart BD, 2001, MAR BIOL, V138, P383, DOI 10.1007/s002270000468; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; Wenger AS, 2013, CORAL REEFS, V32, P369, DOI 10.1007/s00338-012-0991-z	48	6	6	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179300	10.1371/journal.pone.0179300	http://dx.doi.org/10.1371/journal.pone.0179300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658295	Green Published, gold, Green Accepted			2022-12-27	WOS:000404607900020
J	Kim, SH; Park, WS; Park, EY; Park, B; Joo, J; Joung, JY; Seo, HK; Lee, KH; Chung, J				Kim, Sung Han; Park, Weon Seo; Park, Eun Young; Park, Boram; Joo, Jungnam; Joung, Jae Young; Seo, Ho Kyung; Lee, Kang Hyun; Chung, Jinsoo			The prognostic value of BAP1, PBRM1, pS6, PTEN, TGase2, PD-L1, CA9, PSMA, and Ki-67 tissue markers in localized renal cell carcinoma: A retrospective study of tissue microarrays using immunohistochemistry	PLOS ONE			English	Article							CARBONIC-ANHYDRASE-IX; CANCER INCIDENCE; EXPRESSION; METASTASES; SURVIVAL; MORTALITY; OUTCOMES; PROTEIN; TUMORS; KI67	Objective To assess the prognostic roles of BAP1, PBRM1, pS6, PTEN, TGase2, PD-L1, CA9, PSMA, and Ki-67 tissue biomarkers in localized renal cell carcinoma (RCC). Methods Patients who underwent a nephrectomy during 1992-2015 and had a primary specimen of their kidney tumor were included. The nine tissue biomarkers were immunohistochemically stained on tissue microarrays of RCC, and the semi-quantitative H-score, including intensity score, was used to grade the sample. The Cox proportional hazards model was used to evaluate tissue markers significant for overall survival (OS), cancer-specific survival (CSS), and recurrence-free survival (RFS) after adjusting for significant clinicopathological parameters. Results Samples from 351 RCC patients were included. The mean age of the patients was 53.9 years; the rates of pathologic T1-2/>= T3 stage, Fuhrman 1+2/3+4 grade, recurrence, and death were 269/65(80.5/19.5%), 222/107 (67.5/32.5%), 6.6%, and 10.5%, respectively. Median OS, CSS, and RFS were 220.6, 220.6, and 147.1 months, respectively. The multi-variable analysis showed that pathologic T stage and Fuhrman nuclear grade were significantly associated with OS and CSS. Pathologic T stage and tumor size were associated with RFS. After adjusting for these significant prognostic clinicopathological factors, Ki-67 was significantly associated with OS (hazard ratio [HR], 2.7), CSS (HR, 3.82), and RFS (HR, 4.85) and pS6 was associated with CSS (HR, 8.63) and RFS (HR, 8.51) in the multivariable model (p<0.05). Conclusion pS6 and Ki-67 are significant prognostic factors of RCC; however, BAP1, PBRM1, TGase 2, PD-L1, CA9, PTEN loss, and PSMA markers did not show this association.	[Kim, Sung Han; Park, Weon Seo; Joung, Jae Young; Seo, Ho Kyung; Lee, Kang Hyun; Chung, Jinsoo] Res Inst & Hosp Natl Canc Ctr, Dept Urol, Ctr Prostate Canc, Goyang, South Korea; [Park, Weon Seo] Res Inst & Hosp Natl Canc Ctr, Dept Pathol, Ctr Prostate Canc, Goyang, South Korea; [Park, Eun Young; Park, Boram; Joo, Jungnam] Res Inst & Hosp Natl Canc Ctr, Div Canc Epidemiol & Prevent, Biometr Res Branch, Goyang, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Chung, J (corresponding author), Res Inst & Hosp Natl Canc Ctr, Dept Urol, Ctr Prostate Canc, Goyang, South Korea.	cjs5225@ncc.re.kr		Park, Boram/0000-0003-2683-8795; KIM, Sung Han/0000-0002-1689-5203	Korean National Cancer Center [1510650-1, 1710100-1]	Korean National Cancer Center	This study was supported by the Korean National Cancer Center Grants (nos. 1510650-1 and 1710100-1). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brugarolas J, 2014, J CLIN ONCOL, V32, P1968, DOI 10.1200/JCO.2012.45.2003; Bui MHT, 2004, J UROLOGY, V171, P2461, DOI 10.1097/01.ju.0000116444.08690.e2; Chang SS, 1999, CANCER RES, V59, P3192; Choueiri TK, 2015, CLIN CANCER RES, V21, P1071, DOI 10.1158/1078-0432.CCR-14-1993; da Costa WH, 2012, INT BRAZ J UROL, V38, P456, DOI 10.1590/S1677-55382012000400004; de la Fouchardiere A, 2015, CLIN GENET, V88, P273, DOI 10.1111/cge.12472; Dumas F, 1999, INT J CANCER, V80, P799, DOI 10.1002/(SICI)1097-0215(19990315)80:6<799::AID-IJC1>3.3.CO;2-L; Ebru T, 2017, INT BRAZ J UROL, V43, P440, DOI [10.1590/S1677-5538.IBJU.2015.0521, 10.1590/s1677-5538.ibju.2015.0521]; Gayed BA, 2014, BJU INT, V113, P668, DOI 10.1111/bju.12263; Hager M, 2012, PATHOL ONCOL RES, V18, P277, DOI 10.1007/s12253-011-9439-y; Jilaveanu LB, 2014, J CANCER, V5, P166, DOI 10.7150/jca.8167; Jonasch E, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4797; Joseph RW, 2016, J UROLOGY, V195, P180, DOI 10.1016/j.juro.2015.07.113; Joseph RW, 2014, CANCER-AM CANCER SOC, V120, P1059, DOI 10.1002/cncr.28521; Jung KW, 2016, CANCER RES TREAT, V48, P451, DOI 10.4143/crt.2016.092; Kang JH, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.14; Kapur P, 2013, LANCET ONCOL, V14, P159, DOI 10.1016/S1470-2045(12)70584-3; Kim SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122498; Ku BM, 2014, J CANCER RES CLIN, V140, P757, DOI 10.1007/s00432-014-1623-5; Li P, 2015, EUR UROL, V67, P1134, DOI 10.1016/j.eururo.2014.11.001; Liontos M, 2017, WORLD J UROL, V35, P411, DOI 10.1007/s00345-016-1890-7; Moch H, 2016, PATHOLOGE, V37, P355, DOI 10.1007/s00292-016-0171-y; Phuoc NB, 2008, ONCOL REP, V20, P525, DOI 10.3892/or_00000037; Semeniuk-Wojtas A, 2016, UROL ONCOL-SEMIN ORI, V34, P215, DOI 10.1016/j.urolonc.2015.12.013; Skolarikos AA, 2006, AM J NEPHROL, V26, P218, DOI 10.1159/000093631; Stewart GD, 2014, EUR UROL, V66, P85, DOI 10.1016/j.eururo.2014.03.004; Tan PH, 2013, AM J SURG PATHOL, V37, P1518, DOI 10.1097/PAS.0b013e318299f12e; Vogel UF, 2006, AM J CLIN PATHOL, V126, P342, DOI 10.1309/F2Q38DXN1V1V4GQM; Zhou M, 2005, CLIN LAB MED, V25, P247, DOI 10.1016/j.cll.2005.01.004; Znaor A, 2015, EUR UROL, V67, P519, DOI 10.1016/j.eururo.2014.10.002	30	33	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179610	10.1371/journal.pone.0179610	http://dx.doi.org/10.1371/journal.pone.0179610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654655	Green Published, gold, Green Submitted			2022-12-27	WOS:000404541500019
J	Luo, QW; Egger, S; Yu, XQ; Smith, DP; O'Connell, DL				Luo, Qingwei; Egger, Sam; Yu, Xue Qin; Smith, David P.; O'Connell, Dianne L.			Validity of using multiple imputation for "unknown" stage at diagnosis in populationbased cancer registry data	PLOS ONE			English	Article							NEW-SOUTH-WALES; PROSTATE-CANCER; SURVIVAL; VALUES	Background The multiple imputation approach to missing data has been validated by a number of simulation studies by artificially inducing missingness on fully observed stage data under a prespecified missing data mechanism. However, the validity of multiple imputation has not yet been assessed using real data. The objective of this study was to assess the validity of using multiple imputation for "unknown' prostate cancer stage recorded in the New South Wales Cancer Registry (NSWCR) in real-world conditions. Methods Data from the population-based cohort study NSW Prostate Cancer Care and Outcomes Study (PCOS) were linked to 2000-2002 NSWCR data. For cases with "unknown" NSWCR stage, PCOS-stage was extracted from clinical notes. Logistic regression was used to evaluate the missing at random assumption adjusted for variables from two imputation models: a basic model including NSWCR variables only and an enhanced model including the same NSWCR variables together with PCOS primary treatment. Cox regression was used to evaluate the performance of MI. Results Of the 1864 prostate cancer cases 32.7% were recorded as having "unknown" NSWCR stage. The missing at random assumption was satisfied when the logistic regression included the variables included in the enhanced model, but not those in the basic model only. The Cox models using data with imputed stage from either imputation model provided generally similar estimated hazard ratios but with wider confidence intervals compared with those derived from analysis of the data with PCOS-stage. However, the complete-case analysis of the data provided a considerably higher estimated hazard ratio for the low socioeconomic status group and rural areas in comparison with those obtained from all other datasets. Conclusions Using MI to deal with "unknown" stage data recorded in a population-based cancer registry appears to provide valid estimates. We would recommend a cautious approach to the use of this method elsewhere.	[Luo, Qingwei; Egger, Sam; Yu, Xue Qin; Smith, David P.; O'Connell, Dianne L.] NSW Canc Council, Canc Res Div, Sydney, NSW, Australia; [Luo, Qingwei; Yu, Xue Qin; Smith, David P.; O'Connell, Dianne L.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia; [Smith, David P.] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia; [O'Connell, Dianne L.] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW, Australia	Cancer Council New South Wales; University of Sydney; Griffith University; Menzies Health Institute Queensland; University of Newcastle	Luo, QW (corresponding author), NSW Canc Council, Canc Res Div, Sydney, NSW, Australia.; Luo, QW (corresponding author), Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia.	qingweil@nswcc.org.au	Yu, Xue Qin/E-7405-2013; Luo, Qingwei/I-4143-2016	Yu, Xue Qin/0000-0001-8638-7979; Luo, Qingwei/0000-0002-8902-6869; Egger, Sam/0000-0003-1808-6909	Australian National Health and Medical Research Council Training Fellowship [App1016598]; Cancer Institute NSW Career Development Fellowship [E16/00130]	Australian National Health and Medical Research Council Training Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW Career Development Fellowship	David Smith was supported by an Australian National Health and Medical Research Council Training Fellowship (App1016598). David Smith was the recipient of a Cancer Institute NSW Career Development Fellowship (E16/00130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics, 2003, ASGC REM CLASS PURP; Australian Bureau of Statistics, 2001, INF PAP 2001 CENS SO; Bartlett JW, 2011, BRAIN, V134, DOI 10.1093/brain/awr061; Bodner TE, 2008, STRUCTURAL EQUATION, V15, P5; Cancer Council Australia Advanced Prostate Cancer Guidelines Working Party, 2015, MAN LOC ADV MET PROS; Carpenter J. R., 2013, MULTIPLE IMPUTATION; Carpenter JR, 2007, STAT METHODS MED RES, V16, P259, DOI 10.1177/0962280206075303; Cook VJ, 2011, STAT BIOSCI, V3, P208, DOI 10.1007/s12561-010-9031-0; Eisemann N, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-129; Escarela G, 2016, STAT METHODS MED RES, V25, P1579, DOI 10.1177/0962280213492406; ESTEBAN D, 1995, 10 IARC; Falcaro M, 2015, EPIDEMIOLOGY, V26, P421, DOI 10.1097/EDE.0000000000000283; Goldsbury DE, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-253; Graham J. W., 1997, SCI PREVENTION METHO, P325, DOI DOI 10.1037/10222-010; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Gurney J, 2013, CANCER EPIDEMIOL, V37, P498, DOI 10.1016/j.canep.2013.03.005; Hamilton BH, 2010, J AM COLL SURGEONS, V210, P125, DOI 10.1016/j.jamcollsurg.2009.10.021; Hosmer DWJ., 2008, APPL SURVIVAL ANAL; Klassen AC, 2006, AM J PREV MED, V30, pS77, DOI 10.1016/j.amepre.2005.09.010; Little R.J.A., 2002, STAT ANAL MISSING DA; Luo QW, 2015, CANCER EPIDEMIOL, V39, P617, DOI 10.1016/j.canep.2015.04.013; Luo QW, 2013, CANCER EPIDEMIOL, V37, P813, DOI 10.1016/j.canep.2013.09.008; Marshall A, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-57; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Newgard CD, 2006, ACAD EMERG MED, V13, P314, DOI 10.1197/j.aem.2005.09.011; Nur U, 2010, INT J EPIDEMIOL, V39, P118, DOI 10.1093/ije/dyp309; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Rubin DB, 2004, MULTIPLE IMPUTATION; Smith DP, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4817; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; White IR, 2009, STAT MED, V28, P1982, DOI 10.1002/sim.3618; Worthington Julie L, 2008, Cancer Detect Prev, V32, P251, DOI 10.1016/j.cdp.2008.08.006; Young JJ, 2001, 014969 NIH; Yu XQ, 2006, INT J CANCER, V119, P894, DOI 10.1002/ijc.21909; Yu XQ, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000104	36	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0180033	10.1371/journal.pone.0180033	http://dx.doi.org/10.1371/journal.pone.0180033			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654653	Green Published, Green Submitted, gold			2022-12-27	WOS:000404541500048
J	Proschel, M; Kraner, ME; Horn, AHC; Schafer, L; Sonnewald, U; Sticht, H				Proeschel, Marlene; Kraner, Max E.; Horn, Anselm H. C.; Schaefer, Lena; Sonnewald, Uwe; Sticht, Heinrich			Probing the potential of CnaB-type domains for the design of tag/catcher systems	PLOS ONE			English	Article							INTRAMOLECULAR ISOPEPTIDE BONDS; SPYTAG-SPYCATCHER CHEMISTRY; MOLECULAR-DYNAMICS; CROSS-LINKS; STREPTOCOCCUS-PYOGENES; SURFACE-PROTEINS; THIOESTER BOND; PEPTIDE TAG; PILUS; ADHESIN	Building proteins into larger, post-translational assemblies in a defined and stable way is still a challenging task. A promising approach relies on so-called tag/catcher systems that are fused to the proteins of interest and allow a durable linkage via covalent intermolecular bonds. Tags and catchers are generated by splitting protein domains that contain intramolecular isopeptide or ester bonds that form autocatalytically under physiological conditions. There are already numerous biotechnological and medical applications that demonstrate the usefulness of covalent linkages mediated by these systems. Additional covalent tag/catcher systems would allow creating more complex and ultra-stable protein architectures and networks. Two of the presently available tag/catcher systems were derived from closely related CnaB-domains of Streptococcus pyogenes and Streptococcus dysgalactiae proteins. However, it is unclear whether domain splitting is generally tolerated within the CnaBfamily or only by a small subset of these domains. To address this point, we have selected a set of four CnaB domains of low sequence similarity and characterized the resulting tag/catcher systems by computational and experimental methods. Experimental testing for intermolecular isopeptide bond formation demonstrated two of the four systems to be functional. For these two systems length and sequence variations of the peptide tags were investigated revealing only a relatively small effect on the efficiency of the reaction. Our study suggests that splitting into tag and catcher moieties is tolerated by a significant portion of the naturally occurring CnaB-domains, thus providing a large reservoir for the design of novel tag/catcher systems.	[Proeschel, Marlene; Kraner, Max E.; Sonnewald, Uwe] Friedrich Alexander Univ Erlangen Nurnberg, Dept Biol, Lehrstuhl Biochem, Erlangen, Germany; [Horn, Anselm H. C.; Schaefer, Lena; Sticht, Heinrich] Friedrich Alexander Univ Erlangen Nurnberg, Bioinformat, Inst Biochem, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Sonnewald, U (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Dept Biol, Lehrstuhl Biochem, Erlangen, Germany.; Sticht, H (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Bioinformat, Inst Biochem, Erlangen, Germany.	uwe.sonnewald@fau.de; heinrich.sticht@fau.de	Sonnewald, Uwe/J-7875-2012	Sonnewald, Uwe/0000-0003-1835-5339; Horn, Anselm/0000-0003-3539-8103; Sticht, Heinrich/0000-0001-5644-045X	Emerging Fields Initiative from the Friedrich-Alexander-Universitat-Erlangen-Nurnberg (FAU), project "Synthetic Biology"; Deutsche Forschungsgemeinschaft; Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing; Emerging Fields Initiative from the Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU), project "Synthetic Biology"	Emerging Fields Initiative from the Friedrich-Alexander-Universitat-Erlangen-Nurnberg (FAU), project "Synthetic Biology"; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing; Emerging Fields Initiative from the Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU), project "Synthetic Biology"	This work was supported by the Emerging Fields Initiative from the Friedrich-Alexander-Universitat-Erlangen-Nurnberg (FAU), project "Synthetic Biology" to US and HS (http://www.archiv.efi.tau.eu/projects/synthetc-biology/). We acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Emerging Fields Initiative from the Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU), project "Synthetic Biology" to US and HS. We acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing. We thank Benedikt Schmid (Lehrstuhl fur Biotechnik, FAU) for help with the CD-spectroscopic analysis.	Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Brune KD, 2016, SCI REP-UK, V6, DOI 10.1038/srep19234; Budzik JM, 2009, P NATL ACAD SCI USA, V106, P19992, DOI 10.1073/pnas.0910887106; Case D.A., 2014, AMBER, V14, P29; Cheatham TE, 1999, J BIOMOL STRUCT DYN, V16, P845, DOI 10.1080/07391102.1999.10508297; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Fierer JO, 2014, P NATL ACAD SCI USA, V111, pE1176, DOI 10.1073/pnas.1315776111; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Gaspar AH, 2005, J BACTERIOL, V187, P4646, DOI 10.1128/JB.187.13.4646-4655.2005; Giessen TW, 2016, CHEMBIOCHEM, V17, P1931, DOI 10.1002/cbic.201600431; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; Horn AHC, 2010, J PHYS CHEM B, V114, P2219, DOI 10.1021/jp100023q; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jardin C, 2015, J MOL MODEL, V21, DOI 10.1007/s00894-015-2597-1; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kahler A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070521; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2014, ACTA CRYSTALLOGR D, V70, P1190, DOI 10.1107/S1399004714001400; Kang HJ, 2011, TRENDS BIOCHEM SCI, V36, P227, DOI 10.1016/j.tibs.2010.09.007; Kang HJ, 2009, J BIOL CHEM, V284, P20729, DOI 10.1074/jbc.M109.014514; Krishnan V, 2007, STRUCTURE, V15, P893, DOI 10.1016/j.str.2007.06.015; Krishnan V, 2015, IUBMB LIFE, V67, P533, DOI 10.1002/iub.1400; Kwon H, 2014, P NATL ACAD SCI USA, V111, P1367, DOI 10.1073/pnas.1316855111; Laursen T, 2015, TRENDS PLANT SCI, V20, P20, DOI 10.1016/j.tplants.2014.11.002; Leonard JD, 2015, MOL CELL, V57, P850, DOI 10.1016/j.molcel.2015.01.008; Li L, 2014, J MOL BIOL, V426, P309, DOI 10.1016/j.jmb.2013.10.021; Linke-Winnebeck C, 2014, J BIOL CHEM, V289, P177, DOI 10.1074/jbc.M113.523761; Liu ZD, 2014, SCI REP-UK, V4, DOI 10.1038/srep07266; Oke Muse, 2010, Journal of Structural and Functional Genomics, V11, P167, DOI 10.1007/s10969-010-9090-y; Paterson NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022095; Pointon JA, 2010, J BIOL CHEM, V285, P33858, DOI 10.1074/jbc.M110.149385; Proschel M, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00168; Qiagen, 1997, QLAEXPRESSIONIST HDB; Reddington SC, 2015, CURR OPIN CHEM BIOL, V29, P94, DOI 10.1016/j.cbpa.2015.10.002; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Schoene C, 2016, SCI REP-UK, V6, DOI 10.1038/srep21151; Schoene C, 2014, ANGEW CHEM INT EDIT, V53, P6101, DOI 10.1002/anie.201402519; Schwarz-Linek U, 2014, P NATL ACAD SCI USA, V111, P1229, DOI 10.1073/pnas.1322482111; Shaik MM, 2014, J BIOL CHEM, V289, P16988, DOI 10.1074/jbc.M114.555854; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sun F, 2014, P NATL ACAD SCI USA, V111, P11269, DOI 10.1073/pnas.1401291111; Tan LL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165074; Veggiani G, 2016, P NATL ACAD SCI USA, V113, P1202, DOI 10.1073/pnas.1519214113; Veggiani G, 2014, TRENDS BIOTECHNOL, V32, P506, DOI 10.1016/j.tibtech.2014.08.001; Walden M, 2015, ELIFE, V4, DOI 10.7554/eLife.06638; Wang JD, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0490-5; Young PG, 2017, CHEM COMMUNICATIONS; Zakeri B, 2015, CHEMBIOCHEM, V16, P2277, DOI 10.1002/cbic.201500372; Zakeri B, 2012, P NATL ACAD SCI USA, V109, pE690, DOI 10.1073/pnas.1115485109; Zakeri B, 2010, J AM CHEM SOC, V132, P4526, DOI 10.1021/ja910795a; Zhang WB, 2013, J AM CHEM SOC, V135, P13988, DOI 10.1021/ja4076452	53	20	23	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179740	10.1371/journal.pone.0179740	http://dx.doi.org/10.1371/journal.pone.0179740			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654665	Green Submitted, Green Published, gold			2022-12-27	WOS:000404541500030
J	Rueda-Roa, D; Mendoza, J; Muller-Karger, F; Cardenas, JJ; Achury, A; Astor, Y				Rueda-Roa, Digna; Mendoza, Jeremy; Muller-Karger, Frank; Cardenas, Juan Jose; Achury, Alina; Astor, Yrene			Spatial variability of Spanish sardine (Sardinella aurita) abundance as related to the upwelling cycle off the southeastern Caribbean Sea	PLOS ONE			English	Article							GENERALIZED ADDITIVE-MODELS; PELAGIC FISH; SURFACE TEMPERATURE; CURRENT ECOSYSTEM; HABITAT; POPULATIONS; PACIFIC; ANCHOVY; COAST; SAGAX	The Sardinella aurita fishery off northeastern Venezuela, region of seasonal wind-driven coastal-upwelling, accounts for 90% of the Caribbean Sea small pelagic catch. This law-protected artisanal fishery takes place up to similar to 10 km offshore. The spatial distribution, number of schools, and biomass of S. aurita were studied using eight hydro-acoustic surveys (1995-1998). The study included the analysis of satellite-derived sea surface temperature and chlorophyll-a. Surveys were grouped by strong, weak, and transitional upwelling seasons. Relationships between these observations were analyzed using Generalized Additive Models. Results show that during the primary upwelling season (January-May) sardines were widely distributed in upwelling plumes that extended up to 70 km offshore. In the other hand, during the weak upwelling season (September-October) higher sardine densities were found within 10 Km off the coastal upwelling foci. The number of small pelagic schools was directly correlated with small pelagic densities; however, regardless of the season, higher numbers of small pelagic schools were always closer to the shoreline, especially during warm conditions. These two behaviors increase the availability and catchability of sardines for the artisanal fishery during the warm season, regardless of the total stock size. Using this evidence, we pose the hypothesis that the collapse of the regional S. aurita fishery in 2005 was due to a combination of stressful habitat conditions sustained since 2004. These included bottom-up factors due to food scarcity caused by weak upwelling, combined with top-down stress due to overfishing, as sardines accumulated in narrow diminished upwelling plumes located close to the coast. The increased catchability within easily accessible upwelling foci led to the demise of this biological resource, which as of 2014 had not yet recovered. Environmental conditions affecting the sardine habitat needs to be taken into account for the management of this stock. For example, during years with weak upwelling, special measures should be taken during the warm season on the second half of the year to avoid further pressure on the stock.	[Rueda-Roa, Digna; Muller-Karger, Frank] Univ S Florida, Coll Marine Sci, St Petersburg, FL USA; [Mendoza, Jeremy] Univ Oriente, Inst Oceanog Venezuela, Cumana, Estado Sucre, Venezuela; [Cardenas, Juan Jose] Nature Conservancy, Caracas, Distrito Capita, Venezuela; [Achury, Alina; Astor, Yrene] Fdn Salle Ciencias Nat, Estn Invest Marinas, Punta De Piedras, Estado Nueva Es, Venezuela	State University System of Florida; University of South Florida	Rueda-Roa, D (corresponding author), Univ S Florida, Coll Marine Sci, St Petersburg, FL USA.	druedaro@mail.usf.edu	Rueda, Digna/J-8045-2019; Rueda-Roa, Digna/AHD-3202-2022	Rueda-Roa, Digna/0000-0003-4621-009X	National Science Foundation (NSF, USA) [OCE-0752139, OCE-9216626, OCE-9729284, OCE-9401537, OCE-9729697, OCE-9415790, OCE-9711318, OCE-0326268, OCE-0963028]; National Aeronautics and Space Administration (NASA, USA) [NAG5-6448, NAS5-97128]; Consejo Nacional de Investgaciones Cientificas y Tecnologicas (CONICIT, VENEZUELA) [96280221]; Fondo Nacional de Investigaciones Cientificas y Tecnologicas (FONACIT, Venezuela) [2000001702, 2011000353]; LOCTI [CON-EDIMAR 23914]; European Union [UE-VECEP ALA 92/43]; Directorate For Geosciences [1259043] Funding Source: National Science Foundation	National Science Foundation (NSF, USA)(National Science Foundation (NSF)); National Aeronautics and Space Administration (NASA, USA)(National Aeronautics & Space Administration (NASA)); Consejo Nacional de Investgaciones Cientificas y Tecnologicas (CONICIT, VENEZUELA); Fondo Nacional de Investigaciones Cientificas y Tecnologicas (FONACIT, Venezuela); LOCTI; European Union(European Commission); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was carried out under the CARIACO Time-Series program, funded by: the National Science Foundation (NSF, USA, Grants OCE-0752139, OCE-9216626, OCE-9729284, OCE-9401537, OCE-9729697, OCE-9415790, OCE-9711318, OCE-0326268 and OCE-0963028), the National Aeronautics and Space Administration (NASA, USA, Grants NAG5-6448 and NAS5-97128), the Consejo Nacional de Investgaciones Cientificas y Tecnologicas (CONICIT, VENEZUELA, Grant 96280221), the Fondo Nacional de Investigaciones Cientificas y Tecnologicas (FONACIT, Venezuela, Grant 2000001702 and 2011000353), and LOCTI (Grant CON-EDIMAR 23914). Acoustic surveys were funded by the Regional Technical Cooperation Fishing Programme VECEP (UE-VECEP ALA 92/43) between the European Union and Venezuela. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agenbag JJ, 2003, PROG OCEANOGR, V59, P275, DOI 10.1016/j.pocean.2003.07.004; [Anonymous], [No title captured]; Aparicio R., 2003, SARDINA SARDINELLA A, P171; Barange M, 1997, FISH OCEANOGR, V6, P94, DOI 10.1046/j.1365-2419.1997.00032.x; Barange M, 1997, ICES J MAR SCI, V62, P645; Barrios Alexander, 2010, Zootecnia Trop., V28, P457; Bertrand A, 2004, FISH FISH, V5, P296, DOI 10.1111/j.1467-2679.2004.00165.x; Bertrand A, 2016, PROG OCEANOGR, V146, P199, DOI 10.1016/j.pocean.2016.07.002; BINET D, 1982, OCEANOL ACTA, V5, P443; BLAXTER J. H. S., 1963, ADVAN MAR BIOL, V1, P261, DOI 10.1016/S0065-2881(08)60261-8; Brierley AS, 2015, CURR BIOL, V25, P75, DOI 10.1016/j.cub.2014.10.062; Brown AM, 2006, IDENTITIES WORK, P13; BROWN OB, 1985, J GEOPHYS RES-OCEANS, V90, P1667, DOI 10.1029/JC090iC06p11667; Cardenas J., 2003, SARDINA SARDINELLA A, P401; CARDENAS JJ, 2000, MEMORIA SOCIEDAD CIE, V154, P39; Castillo J, 2000, EVALUACION ACITSTICA; Cellamare Maria, 2007, Boletin del Instituto Oceanografico de Venezuela Universidad de Oriente, V46, P23; Cole J, 1998, REV FISH BIOL FISHER, V8, P445, DOI 10.1023/A:1008861224731; Demer DA, 2012, FISH B-NOAA, V110, P52; FAO, FISH GLOB INF SYST F; Foote K., 1987, ICES COOP RES REP, V144, P69; Freon P, 1997, MAR BIOL, V128, P363, DOI 10.1007/s002270050102; Freon P, 2005, B MAR SCI, V76, P385; Freon P, 2003, SARDINE SARDINELLA A, P451; Freon P, 2003, SARDINE SARDINELLA A; Gassman JPD, 2012, 3 C VEN DIV BIOL LIB, p[148, 148]; GERLOTTO F, 1986, Proceedings of the Gulf and Caribbean Fisheries Institute, P67; Gerlotto F., 1993, THESIS; Gerlotto FY, 1988, MEMORIA SOC CIENCIAS, V3; GOMEZ G., 1998, ZOOTECNIA TROPICAL, V16, P149; Gomez Gaspar Alfredo, 2012, Boletin del Instituto Oceanografico de Venezuela Universidad de Oriente, V51, P173; Gonzalez Leo W., 2007, Boletin del Centro de Investigaciones Biologicas Universidad del Zulia, V41, P457; Gonzalez LW, 2005, B CTR INVEST BIOL, V39, P197; Gu H, 2010, J COMPUT GRAPH STAT, V19, P531, DOI 10.1198/jcgs.2010.07139; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Gutierrez M, 2007, FISH OCEANOGR, V16, P155, DOI 10.1111/j.1365-2419.2006.00422.x; Guzman R., 2003, SARDINE SARDINELLA A, P427; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; HERRERA L. E., 1975, B I OCEANOGR U ORIEN, V14, P165; Hu CM, 2009, IEEE T GEOSCI REMOTE, V47, P1607, DOI 10.1109/TGRS.2008.2007425; Jablonski S, 2004, SCI MAR, V68, P385, DOI 10.3989/scimar.2004.68n3385; Johannesson KA, 1983, FAO FISH TECH PAP, V240; Lanz E, 2009, CAL COOP OCEAN FISH, V50, P134; Larsson M, 2012, CURR ZOOL, V58, P116, DOI 10.1093/czoolo/58.1.116; Longhurst AR, 1971, OCEANOGR MAR BIOL AN, V9, P349; Lopez H., 1976, INF TEC, V46, P1; MacLennan DN, 2002, ICES J MAR SCI, V59, P365, DOI 10.1006/jmsc.2001.1158; Mais K., 1974, Fish Bull California, VNo. 162, P1; MARAVELIAS CD, 1995, SCI MAR, V59, P427; Maravelias CD, 1999, CAN J FISH AQUAT SCI, V56, P437, DOI 10.1139/cjfas-56-3-437; Masse J., 1988, DR88030RHNANTES IFRE; McClain E. P., 1982, Advances in Space Research, V2, P43, DOI 10.1016/0273-1177(82)90120-X; Mendoza J, 1998, GLOBAL VERSUS LOCAL CHANGES IN UPWELLING SYSTEMS, P293; Mendoza J, 2003, SARDINA SARDINELLA A, P473; Mendoza J., 2015, WORKING PAPER SERIES; MINNETT PJ, 1991, J GEOPHYS RES-OCEANS, V96, P18475, DOI 10.1029/91JC01816; Morrell LJ, 2008, BEHAV ECOL, V19, P909, DOI 10.1093/beheco/arn050; MULLERKARGER FE, 1994, CONT SHELF RES, V14, P199, DOI 10.1016/0278-4343(94)90013-2; MULLERKARGER FE, 1989, PROG OCEANOGR, V23, P23, DOI 10.1016/0079-6611(89)90024-4; Murase H, 2009, ICES J MAR SCI, V66, P1417, DOI 10.1093/icesjms/fsp105; Niquen M, 2004, DEEP-SEA RES PT II, V51, P563, DOI 10.1016/j.dsr2.2004.03.001; O'Reilly J. E., 2000, SEAWIFS POSTLAUNCH C, P9, DOI [DOI 10.1029/98JC02160, DOI 10.1103/PHYSREVLETT.104.255302]; Odegaard J, 1971, 32 MACPNUDFAO; Odegaard J, 1971, 33 MACPNUDFAO; Odriozola AL, 2007, CONT SHELF RES, V27, P1447, DOI 10.1016/j.csr.2007.01.012; Overland JE, 2010, J MARINE SYST, V79, P305, DOI 10.1016/j.jmarsys.2008.12.009; Pavlov D.S., 2000, J ICHTHYOL+, V40, pS163; Peltonen H, 2007, ICES J MAR SCI, V64, P487, DOI 10.1093/icesjms/fsl044; Peng RD, 2006, J R STAT SOC A STAT, V169, P179, DOI 10.1111/j.1467-985X.2006.00410.x; RCore Team, 2020, R LANG ENV STAT COMP; RICHARDS FA, 1960, DEEP-SEA RES, V7, P163, DOI 10.1016/0146-6313(60)90023-X; Rincon F, 2008, MEMORIA FDN SALLE CI, V2007, P7; Rueda-Roa DT, 2013, DEEP-SEA RES PT I, V78, P102, DOI 10.1016/j.dsr.2013.04.008; Schismenou E, 2008, HYDROBIOLOGIA, V612, P201, DOI 10.1007/s10750-008-9502-1; Simmonds EJ, 1992, ACOUSTIC SURVEY DESI, V187; Smtersdal G, 1999, FAO FISHERIES TECHNI, V391; Stroemme T, 1989, REPORTS SURVEYS F NA, V1; STRONG AE, 1984, B AM METEOROL SOC, V65, P138, DOI 10.1175/1520-0477(1984)065<0138:IOSTFS>2.0.CO;2; Taylor GT, 2012, P NATL ACAD SCI USA, V109, P19315, DOI 10.1073/pnas.1207514109; THOMAS AC, 1988, J GEOPHYS RES-OCEANS, V93, P15733, DOI 10.1029/JC093iC12p15733; Thomas RM, 1985, COLLN SCI PAP INT CO, V12, P181; Tilman J, 1999, EC FISHERIES B, V12, P45; Tsikliras AC, 2006, SCI MAR, V70, P281, DOI 10.3989/scimar.2006.70n2281; Varela R, 2003, SARDINA MEDIO AMBIEN, P263; WALTON CC, 1988, J APPL METEOROL, V27, P115, DOI 10.1175/1520-0450(1988)027<0115:NMAFES>2.0.CO;2; Whitehead P. J. P., 1985, FAO FISH SYNOP 2, V7, P305; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood S., 2015, R PACKAGE VERSION, V1, P729; Zwolinski JP, 2011, ICES J MAR SCI, V68, P867, DOI 10.1093/icesjms/fsr038	89	7	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179984	10.1371/journal.pone.0179984	http://dx.doi.org/10.1371/journal.pone.0179984			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654685	Green Submitted, Green Published, gold			2022-12-27	WOS:000404541500046
J	Seo, JW; Moon, H; Kim, SY; Moon, JY; Jeong, KH; Lee, YH; Kim, YG; Lee, TW; Ihm, CG; Kim, CD; Chung, BH; Kim, YH; Lee, SH				Seo, Jung-Woo; Moon, Haena; Kim, Se-Yun; Moon, Ju-Young; Jeong, Kyung Hwan; Lee, Yu-Ho; Kim, Yang-Gyun; Lee, Tae-Won; Ihm, Chun-Gyoo; Kim, Chan-Duck; Chung, Byung Ha; Kim, Yeong Hoon; Lee, Sang Ho			Both absolute and relative quantification of urinary mRNA are useful for non-invasive diagnosis of acute kidney allograft rejection	PLOS ONE			English	Article							DROPLET DIGITAL PCR; REAL-TIME PCR; DNA COPY NUMBER; MITOCHONDRIAL-DNA; QUANTITATIVE PCR; GENE-EXPRESSION; NORMALIZATION; OPTIMIZATION	Urinary mRNA analysis with three-gene set (18S rRNA, CD3 epsilon, and IP-10) has been suggested as a non-invasive biomarker of acute rejection (AR) in kidney transplant recipients using quantitative real-time PCR (qPCR). Application of droplet digital PCR (ddPCR), which has been suggested to provide higher sensitivity, accuracy, and absolute quantification without standard curves, could be a useful method for the quantifying low concentration of urinary mRNA. We investigated the urinary expression of these three genes in Korean patients with kidney transplantation and also evaluated the usefulness of ddPCR. 90 urine samples were collected at time of allograft biopsy in kidney recipients (n = 67) and from patients with stable renal function more than 10 years (n = 23). Absolute quantification with both PCR system showed significant higher mRNA levels of CD3 epsilon and IP-10 in AR patients compared with stable transplants (STA), but there was no difference in 18S rRNA expression across the patient groups. To evaluate discrimination between AR and STA, ROC curve analyses of CTOT-4 formula yielded area under the curve values of 0.72 (95% CI 0.60-0.83) and 0.77 (95% CI 0.66-0.88) for qPCR and ddPCR, respectively. However, 18S normalization of absolute quantification and relative quantification with 18S showed better discrimination of AR from STA than those of the absolute method. Our data indicate that ddPCR system without standard curve would be useful to determine the absolute quantification of urinary mRNA from kidney transplant recipients. However, comparative method also could be useful and convenient in both qPCR and ddPCR analysis.	[Seo, Jung-Woo; Kim, Se-Yun; Moon, Ju-Young; Jeong, Kyung Hwan; Lee, Yu-Ho; Kim, Yang-Gyun; Lee, Tae-Won; Ihm, Chun-Gyoo; Lee, Sang Ho] Kyung Hee Univ, Div Nephrol, Dept Internal Med, Coll Med, Seoul, South Korea; [Moon, Haena] Kyung Hee Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Kim, Chan-Duck] Kyung Pook Natl Univ, Div Nephrol, Dept Internal Med, Sch Med, Daegu, South Korea; [Chung, Byung Ha] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med,Div Nephrol, Seoul, South Korea; [Kim, Yeong Hoon] Inje Univ, Coll Med, Busan Paik Hosp, Dept Internal Med,Div Nephrol, Busan, South Korea	Kyung Hee University; Kyung Hee University; Kyungpook National University; Catholic University of Korea; Seoul St. Mary's Hospital; Inje University	Lee, SH (corresponding author), Kyung Hee Univ, Div Nephrol, Dept Internal Med, Coll Med, Seoul, South Korea.	lshkidney@khu.ac.kr	KIM, YANG GYUN/AAI-9821-2020; /W-5371-2019	KIM, YANG GYUN/0000-0002-3497-5514; 	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C1232]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This work was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (grant no. HI13C1232). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharuthram A, 2014, INFECT GENET EVOL, V25, P28, DOI 10.1016/j.meegid.2014.03.028; Day E, 2013, METHODS, V59, P101, DOI 10.1016/j.ymeth.2012.08.001; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; Furness PN, 2001, KIDNEY INT, V60, P1998, DOI 10.1046/j.1523-1755.2001.00030.x; Galichon P, 2016, AM J TRANSPLANT; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Li BG, 2001, NEW ENGL J MED, V344, P947, DOI 10.1056/NEJM200103293441301; Li L, 2012, AM J TRANSPLANT, V12, P2710, DOI 10.1111/j.1600-6143.2012.04253.x; Li XY, 2015, MOL MED REP, V11, P1304, DOI 10.3892/mmr.2014.2841; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; Medeiros M, 2003, J IMMUNOL METHODS, V279, P135, DOI 10.1016/S0022-1759(03)00237-0; Mikeska T, 2010, EPIGENOMICS-UK, V2, P561, DOI 10.2217/EPI.10.32; Miotke L, 2014, ANAL CHEM, V86, P2618, DOI 10.1021/ac403843j; Podlesniy P, 2013, ANN NEUROL, V74, P655, DOI 10.1002/ana.23955; Roedder S, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001759; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Suthanthiran M, 2013, NEW ENGL J MED, V369, P20, DOI 10.1056/NEJMoa1215555; Szeto CC, 2005, NEPHROL DIAL TRANSPL, V20, P105, DOI 10.1093/ndt/gfh574; Taylor SD, 2014, AGING CELL, V13, P29, DOI 10.1111/acel.12146; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Whale AS, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks203; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Williams WW, 2012, NAT REV NEPHROL, V8, P110, DOI 10.1038/nrneph.2011.213; Zhao LM, 2014, ASIAN PAC J CANCER P, V15, P5815, DOI 10.7314/APJCP.2014.15.14.5815	27	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0180045	10.1371/journal.pone.0180045	http://dx.doi.org/10.1371/journal.pone.0180045			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654700	Green Published, Green Submitted, gold			2022-12-27	WOS:000404541500050
J	Braga, JU; Bressan, C; Dalvi, APR; Calvet, GA; Daumas, RP; Rodrigues, N; Wakimoto, M; Nogueira, RMR; Nielsen-Saines, K; Brito, C; de Filippis, AMB; Brasil, P				Braga, Jose Ueleres; Bressan, Clarisse; Razal Dalvi, Ana Paula; Amaral Calvet, Guilherme; Daumas, Regina Paiva; Rodrigues, Nadia; Wakimoto, Mayumi; Ribeiro Nogueira, Rita Maria; Nielsen-Saines, Karin; Brito, Carlos; Bispo de Filippis, Ana Maria; Brasil, Patricia			Accuracy of Zika virus disease case definition during simultaneous Dengue and Chikungunya epidemics	PLOS ONE			English	Article							OUTBREAK; ILLNESS; BRAZIL	Background Zika is a new disease in the American continent and its surveillance is of utmost importance, especially because of its ability to cause neurological manifestations as Guillain-Barre A syndrome and serious congenital malformations through vertical transmission. The detection of suspected cases by the surveillance system depends on the case definition adopted. As the laboratory diagnosis of Zika infection still relies on the use of expensive and complex molecular techniques with low sensitivity due to a narrow window of detection, most suspected cases are not confirmed by laboratory tests, mainly reserved for pregnant women and new-borns. In this context, an accurate definition of a suspected Zika case is crucial in order for the surveillance system to gauge the magnitude of an epidemic. Methodology We evaluated the accuracy of various Zika case definitions in a scenario where Dengue and Chikungunya viruses co-circulate. Signs and symptoms that best discriminated PCR confirmed Zika from other laboratory confirmed febrile or exanthematic diseases were identified to propose and test predictive models for Zika infection based on these clinical features. Results and discussion Our derived score prediction model had the best performance because it demonstrated the highest sensitivity and specificity, 86.6% and 78.3%, respectively. This Zika case definition also had the highest values for auROC (0.903) and R-2 (0.417), and the lowest Brier score 0.096. Conclusions In areas where multiple arboviruses circulate, the presence of rash with pruritus or conjunctival hyperemia, without any other general clinical manifestations such as fever, petechia or anorexia is the best Zika case definition.	[Braga, Jose Ueleres; Razal Dalvi, Ana Paula; Daumas, Regina Paiva; Rodrigues, Nadia] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil; [Braga, Jose Ueleres] Univ Estado Rio de Janeiro, Inst Med Social, Rio De Janeiro, Brazil; [Bressan, Clarisse; Amaral Calvet, Guilherme; Wakimoto, Mayumi; Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil; [Ribeiro Nogueira, Rita Maria; Bispo de Filippis, Ana Maria] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Referencia Flavivirus, Rio De Janeiro, Brazil; [Nielsen-Saines, Karin] David Geffen UCLA Sch Med, Los Angeles, CA USA; [Brito, Carlos] Univ Fed Pernambuco, Dept Clin Med, Recife, PE, Brazil	Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Universidade Federal de Pernambuco	Braga, JU (corresponding author), Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil.; Braga, JU (corresponding author), Univ Estado Rio de Janeiro, Inst Med Social, Rio De Janeiro, Brazil.	ueleres@gmail.com	Braga, Jose Ueleres/AAB-1326-2021; Brasil, Patricia/P-3536-2014; Calvet, GA/G-6959-2013; DAUMAS, REGINA P/M-9387-2013; amsalu, ribka/G-8780-2019; Barros de Castro, Daniel/J-9358-2016	Braga, Jose Ueleres/0000-0001-5247-007X; Calvet, GA/0000-0002-3545-5238; DAUMAS, REGINA P/0000-0002-8923-7711; Brasil, Patricia/0000-0001-9555-7976; Barros de Castro, Daniel/0000-0001-5969-544X	Departamento de Ciencia e Tecnologia (DECIT) do Ministerio da Saude do Brasil; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [CAPES/88887.116627/2016-01]; NATIONAL EYE INSTITUTE [R21EY028318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI129534] Funding Source: NIH RePORTER	Departamento de Ciencia e Tecnologia (DECIT) do Ministerio da Saude do Brasil; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding Departamento de Ciencia e Tecnologia (DECIT) do Ministerio da Saude do Brasil and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/88887.116627/2016-01).	de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P537, DOI 10.1590/0037-8682-0328-2016; Brasil. Ministerio da Saude Secretaria de Vigilancia em Sande Departamento de Vigilancia das Doencas Transmissiveis, 2016, SECR VIG SANDE DEP V; Brasil. Secretaria de Vigilancia em Saude - Ministerio da Saude, 2016, SECRETARIA VIGILANCI; Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Lorenzi OD, 2013, AM J TROP MED HYG, V88, P472, DOI 10.4269/ajtmh.12-0373; Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14; Pan American Health Organization / World Health Organization, 2015, EP UPD ZIK VIR  1016; Pan American Health Organization / World Health Organization (PAHO / WHO), 2014, EP AL CHIK DENG FEV; Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201; Rezza G, 2014, EMERG INFECT DIS, V20, P1351, DOI 10.3201/eid2008.131615; Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P58, DOI 10.1016/j.tmaid.2015.09.001; Solet J. L., 2007, PLOS BIOL, V77, P727; World Health Organization, 2016, ZIKA VIRUS DIS  0212; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization, 2017, SIT REP	17	47	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179725	10.1371/journal.pone.0179725	http://dx.doi.org/10.1371/journal.pone.0179725			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650987	Green Submitted, Green Published, gold			2022-12-27	WOS:000404537300015
J	Cespedes, N; Suen, CSNLW; Koepfli, C; Franca, CT; Felger, I; Nebie, I; Arevalo-Herrera, M; Mueller, I; Corradin, G; Herrera, S				Cespedes, Nora; Suen, Connie S. N. Li Wai; Koepfli, Cristian; Franca, Camila T.; Felger, Ingrid; Nebie, Issa; Arevalo-Herrera, Myriam; Mueller, Ivo; Corradin, Giampietro; Herrera, Socrates			Natural immune response to Plasmodium vivax alpha-helical coiled coil protein motifs and its association with the risk of P. vivax malaria	PLOS ONE			English	Article							FALCIPARUM; ANTIBODIES; INFECTION; ANTIGENS; EPIDEMIOLOGY; DOMAINS; DISEASE; FORCE	Protein alpha-helical coiled coil structures are known to induce antibodies able to block critical functions in different pathogens. In a previous study, a total of 50 proteins of Plasmodium vivax erythrocytic asexual stages containing alpha-helical coiled coil structural motifs were identified in silico, and the corresponding peptides were chemically synthesized. A total of 43 peptides were recognized by naturally acquired antibodies in plasma samples from both Papua New Guinea (PNG) and Colombian adult donors. In this study, the association between IgG antibodies to these peptides and clinical immunity was further explored by measuring total IgG antibody levels to 24 peptides in baseline samples from a longitudinal study of children aged 1-3 years (n = 164) followed for 16 months. Samples were reactive to all peptides tested. Eight peptides were recognized by >50% of individuals, whereas only one peptide had < 20% reactivity. Children infected at baseline were seropositive to 23/24 peptides. No significant association was observed between antibody titers and age or molecular force of infection, suggesting that antibody levels had already reached an equilibrium. There was a strong association between antibody levels to all peptides and protection against P. vivax clinical episodes during the 16 months follow-up. These results suggest that the selected coiled coil antigens might be good markers of both exposure and acquired immunity to P. vivax malaria, and further preclinical investigation should be performed to determine their potential as P. vivax vaccine antigens.	[Cespedes, Nora; Arevalo-Herrera, Myriam; Herrera, Socrates] Malaria Vaccine & Drug Dev Ctr MVDC, Cali, Colombia; [Cespedes, Nora; Arevalo-Herrera, Myriam] Univ Valle, Sch Hlth, Cali, Colombia; [Suen, Connie S. N. Li Wai; Koepfli, Cristian; Franca, Camila T.; Mueller, Ivo] Walter & Eliza Hall Inst Med Res, Populat Hlth & Immun Div, Parkville, Vic, Australia; [Suen, Connie S. N. Li Wai; Koepfli, Cristian; Franca, Camila T.; Mueller, Ivo] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Felger, Ingrid] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Nebie, Issa] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Mueller, Ivo] Inst Pasteur, Dept Parasites & Insect Vectors, Malaria Parasites & Hosts Unit, Paris, France; [Mueller, Ivo] Barcelona Inst Global Hlth ISGLOBAL, Barcelona, Spain; [Corradin, Giampietro] Univ Lausanne, Biochem Dept, Epalinges, Switzerland; [Herrera, Socrates] Caucaseco Sci Res Ctr, Cali, Colombia	Universidad del Valle; Walter & Eliza Hall Institute; University of Melbourne; University of Basel; Swiss Tropical & Public Health Institute; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; ISGlobal; University of Lausanne	Herrera, S (corresponding author), Malaria Vaccine & Drug Dev Ctr MVDC, Cali, Colombia.; Herrera, S (corresponding author), Caucaseco Sci Res Ctr, Cali, Colombia.	sherrera@inmuno.org	Koepfli, Cristian/H-8772-2019; Franca, Camila/I-4877-2019	Koepfli, Cristian/0000-0002-9354-0414; Franca, Camila/0000-0001-5885-4410; Li Wai Suen, Connie/0000-0003-0529-0804; Nebie, Issa/0000-0003-3051-3600	Colciencias [278-2008, 360-2011, 719-2013]; NIAID (ICEMR) [U19A1089702]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089702] Funding Source: NIH RePORTER	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); NIAID (ICEMR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Colciencias (Contract 278-2008, Contract 360-2011 and Contract 719-2013) and a grant from NIAID (ICEMR grant U19A1089702). Also, this work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agak GW, 2008, VACCINE, V26, P1963, DOI 10.1016/j.vaccine.2008.02.020; ATHERTON E, 1981, H-S Z PHYSIOL CHEM, V362, P833, DOI 10.1515/bchm2.1981.362.2.833; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; Cespedes N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100440; Cham GKK, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-108; Chan JA, 2012, J CLIN INVEST, V122, P3227, DOI 10.1172/JCI62182; Corradin Giarnpietro, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P259, DOI 10.2174/187153007782794371; Dembele L, 2014, NAT MED, V20, P307, DOI 10.1038/nm.3461; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Franca CT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005014; Franca CT, 2016, PLOS NEGLECT TROP D, V10, DOI [10.1371/journal.pntd.0004639, 10.1371/journal.pntd.0005091]; Geleta G, 2016, MALAR RES TREAT, V2016; Gupta Bal Kishan, 2015, Infect Dis (Auckl), V8, P45, DOI 10.4137/IDRT.S34039; Gustchina E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078187; Hoffman SL, 2015, AM J PREV MED, V49, pS319, DOI 10.1016/j.amepre.2015.09.011; Impagliazzo A, 2015, SCIENCE, V349, P1301, DOI 10.1126/science.aac7263; Jiang ZQ, 2016, BIOPOLYMERS, V106, P144, DOI 10.1002/bip.22808; John CC, 2005, AM J TROP MED HYG, V73, P222, DOI 10.4269/ajtmh.2005.73.222; Koepfli C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002403; Kulangara C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005419; Lin E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009047; malERA Consultative Group on Vaccines, 2011, PLOS MED, V8; McKenzie FE, 2007, J PARASITOL, V93, P627, DOI 10.1645/GE-1052R.1; Michon P, 2007, AM J TROP MED HYG, V76, P997, DOI 10.4269/ajtmh.2007.76.997; Mitra S, 2015, J VECTOR DIS, V52, P281; Mueller I, 2015, VACCINE, V33, P7489, DOI 10.1016/j.vaccine.2015.09.060; Mueller I, 2012, P NATL ACAD SCI USA, V109, P10030, DOI 10.1073/pnas.1200841109; Mueller Ivo, 2009, Malar J, V8, P41, DOI 10.1186/1475-2875-8-41; Nicolete VC, 2016, J INFECT DIS, V214, P1539, DOI 10.1093/infdis/jiw407; Olugbile S, 2011, VACCINE, V29, P7090, DOI 10.1016/j.vaccine.2011.06.122; Schoepflin S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-250; Smith T, 2001, T ROY SOC TROP MED H, V95, P1, DOI 10.1016/S0035-9203(01)90314-1; Stanisic DI, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002498; Team RC, 2016, R LANG ENV STAT COMP; Tripet B, 2006, J STRUCT BIOL, V155, P176, DOI 10.1016/j.jsb.2006.03.019; Versiani FG, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-294; Villard V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000645; White MT, 2014, ELIFE, V3, DOI 10.7554/eLife.04692; WHO, 2015, WORLD MAL REP 2015	39	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179863	10.1371/journal.pone.0179863	http://dx.doi.org/10.1371/journal.pone.0179863			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651021	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000404537300026
J	Madon-Simon, M; Grad, I; Bayo, P; Perez, P; Picard, D				Madon-Simon, Marta; Grad, Iwona; Bayo, Pilar; Perez, Paloma; Picard, Didier			Defective glucocorticoid receptor signaling and keratinocyte-autonomous defects contribute to skin phenotype of mouse embryos lacking the Hsp90 co-chaperone p23	PLOS ONE			English	Article							MOLECULAR CHAPERONE; ATPASE CYCLE; CELL-DEATH; COCHAPERONE P23; PROTEIN P23; APOPTOSIS; DYNAMICS; CANCER; MICE; DNA	p23 is a small acidic protein with intrinsic molecular chaperone activity. It is best known as a co-chaperone of the major cytosolic molecular chaperone Hsp90. p23 binds the N-terminus of Hsp90 and stabilizes the ATP-bound and N-terminally closed Hsp90 dimer. It is in this configuration that many Hsp90 clients are most stably bound. Considering the important role of p23 in the Hsp90 cycle, it came as a surprise that it is not absolutely essential for viability in the budding yeast or for mouse development. Mice without p23 develop quite normally until birth and then all die perinatally because of immature lungs. The only other apparent phenotype of late stage embryos and newborns is a skin defect, which we have further characterized here. We found that skin differentiation is impaired, and that both apoptosis and cell proliferation are augmented in the absence of p23; the consequences are a severe thinning of the stratum corneum and reduced numbers of hair follicles. The altered differentiation, spontaneous apoptosis and proliferation are all mimicked by isolated primary keratinocytes indicating that they do require p23 functions in a cell-autonomous fashion. Since the phenotype of p23-null embryos is strikingly similar to that of embryos lacking the glucocorticoid receptor, a paradigmatic Hsp90-p23 client protein, we investigated glucocorticoid signaling. We discovered that it is impaired in vivo and for some aspects in isolated keratinocytes. Our results suggest that part of the phenotype of p23-null embryos can be explained by an impact on this particular Hsp90 client, but do not exclude that p23 by itself or in association with Hsp90 affects skin development and homeostasis through yet other pathways.	[Madon-Simon, Marta; Grad, Iwona; Picard, Didier] Univ Geneva, Dept Biol Cellulaire, Sci 3, 30 Quai Ernest Ansermet, Geneva 4, Switzerland; [Bayo, Pilar; Perez, Paloma] CSIC, IBV, Jaime Roig 11, Valencia, Spain	University of Geneva; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV)	Picard, D (corresponding author), Univ Geneva, Dept Biol Cellulaire, Sci 3, 30 Quai Ernest Ansermet, Geneva 4, Switzerland.	didier.picard@unige.ch	Perez, Paloma/K-8841-2017	Perez, Paloma/0000-0002-7166-2824	Swiss National Science Foundation; Canton de Geneve	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canton de Geneve	This work was supported by the Swiss National Science Foundation and the Canton de Geneve. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Lilia Bernasconi, Diana Wider, and Rocio Tapia Pastrana for their technical assistance. This work was supported by the Swiss National Science Foundation and the Canton de Geneve.	ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; Bayo P, 2008, ENDOCRINOLOGY, V149, P1377, DOI 10.1210/en.2007-0814; Boix J, 2016, J INVEST DERMATOL, V136, P2417, DOI 10.1016/j.jid.2016.07.018; Bose S, 1996, SCIENCE, V274, P1715, DOI 10.1126/science.274.5293.1715; Cato Laura, 2014, Nucl Recept Signal, V12, pe005, DOI 10.1621/nrs.12005; Cheng CF, 2010, CURR SIGNAL TRANSD T, V5, P121, DOI 10.2174/157436210791112208; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Dittmar KD, 1996, J BIOL CHEM, V271, P12833, DOI 10.1074/jbc.271.22.12833; Echeverria PC, 2010, BBA-MOL CELL RES, V1803, P641, DOI 10.1016/j.bbamcr.2009.11.012; Echtenkamp FJ, 2016, MOL CELL, V64, P888, DOI 10.1016/j.molcel.2016.09.040; Echtenkamp FJ, 2014, CURR PROTEIN PEPT SC, V15, P216, DOI 10.2174/1389203715666140331112230; Echtenkamp FJ, 2012, BBA-MOL CELL RES, V1823, P668, DOI 10.1016/j.bbamcr.2011.08.011; Freeman BC, 2000, GENE DEV, V14, P422; Freeman BC, 1996, SCIENCE, V274, P1718, DOI 10.1126/science.274.5293.1718; Gausdal G, 2004, LEUKEMIA, V18, P1989, DOI 10.1038/sj.leu.2403508; Grad I, 2006, MOL CELL BIOL, V26, P8976, DOI 10.1128/MCB.00734-06; Grad I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015770; Grad W, 2007, MOL CELL ENDOCRINOL, V275, P2, DOI 10.1016/j.mce.2007.05.018; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Jimenez-Canino R, 2016, ENDOCRINOLOGY, V157, P2515, DOI 10.1210/en.2015-2055; Johnson JL, 2009, CELL STRESS CHAPERON, V14, P83, DOI 10.1007/s12192-008-0058-9; JOHNSON JL, 1994, MOL CELL BIOL, V14, P1956, DOI 10.1128/MCB.14.3.1956; JOHNSON JL, 1994, J BIOL CHEM, V269, P24989; Kirschke E, 2014, CELL, V157, P1685, DOI 10.1016/j.cell.2014.04.038; Krebs J, 2002, BBA-PROTEINS PROTEOM, V1600, P68, DOI 10.1016/S1570-9639(02)00446-6; Latorre V, 2013, J INVEST DERMATOL, V133, P2771, DOI 10.1038/jid.2013.255; Li W, 2000, NEUROSCIENCE, V96, P161, DOI 10.1016/S0306-4522(99)00531-X; Li W, 2013, INT REV CEL MOL BIO, V303, P203, DOI 10.1016/B978-0-12-407697-6.00005-2; Li W, 2012, BBA-MOL CELL RES, V1823, P730, DOI 10.1016/j.bbamcr.2011.09.009; Lovgren AK, 2007, MOL CELL BIOL, V27, P4416, DOI 10.1128/MCB.02314-06; Martinet W, 2003, CARDIOVASC RES, V60, P259, DOI 10.1016/S0008-6363(03)00537-6; McLaughlin SH, 2006, J MOL BIOL, V356, P746, DOI 10.1016/j.jmb.2005.11.085; McLaughlin SH, 2002, J MOL BIOL, V315, P787, DOI 10.1006/jmbi.2001.5245; Mollerup J, 2005, FEBS LETT, V579, P4187, DOI 10.1016/j.febslet.2005.06.045; Nakatani Y, 2007, BIOCHEM BIOPH RES CO, V362, P387, DOI 10.1016/j.bbrc.2007.07.180; Patwardhan CA, 2013, J BIOL CHEM, V288, P7313, DOI 10.1074/jbc.M112.427328; Perez P, 2011, DERM-ENDOCRINOL, V3, P166, DOI [10.4161/derm.3.3.15332, 10.4161/derm.15332]; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; Picard D, 2006, EXP CELL RES, V312, P3949, DOI 10.1016/j.yexcr.2006.08.026; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; RAFESTINOBLIN ME, 1989, J BIOL CHEM, V264, P9304; Rao RV, 2006, CELL DEATH DIFFER, V13, P415, DOI 10.1038/sj.cdd.4401761; Reebye V, 2012, MOL ENDOCRINOL, V26, P1694, DOI 10.1210/me.2012-1056; Richter K, 2004, J MOL BIOL, V342, P1403, DOI 10.1016/j.jmb.2004.07.064; Sevilla LM, 2013, J INVEST DERMATOL, V133, P361, DOI 10.1038/jid.2012.281; Sevilla LM, 2010, MOL ENDOCRINOL, V24, P2166, DOI 10.1210/me.2010-0183; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; Slominski Andrzej, 2008, Drug Discov Today Dis Mech, V5, P137; Slominski AT, 2015, STEROIDS, V103, P72, DOI 10.1016/j.steroids.2015.04.006; Slominski AT, 2015, J STEROID BIOCHEM, V151, P25, DOI 10.1016/j.jsbmb.2014.11.010; Slominski AT, 2014, EXP DERMATOL, V23, P369, DOI 10.1111/exd.12376; Stavreva DA, 2004, MOL CELL BIOL, V24, P2682, DOI 10.1128/MCB.24.7.2682-2697.2004; Sullivan WP, 2002, J BIOL CHEM, V277, P45942, DOI 10.1074/jbc.M207754200; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; Toogun OA, 2007, P NATL ACAD SCI USA, V104, P5765, DOI 10.1073/pnas.0701442104; Voss AK, 2000, DEVELOPMENT, V127, P1; Weikl T, 1999, J MOL BIOL, V293, P685, DOI 10.1006/jmbi.1999.3172; Wintermantel TM, 2004, HORM METAB RES, V36, P387, DOI 10.1055/s-2004-814567; Zelin E, 2012, MOL CELL, V48, P459, DOI 10.1016/j.molcel.2012.08.026	60	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0180035	10.1371/journal.pone.0180035	http://dx.doi.org/10.1371/journal.pone.0180035			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650975	Green Published, gold, Green Submitted			2022-12-27	WOS:000404537300037
J	Aubry, KB; Raley, CM; McKelvey, KS				Aubry, Keith B.; Raley, Catherine M.; McKelvey, Kevin S.			The importance of data quality for generating reliable distribution models for rare, elusive, and cryptic species	PLOS ONE			English	Article							ANECDOTAL OCCURRENCE DATA; FISHER MARTES-PENNANTI; MAXIMUM-ENTROPY; GEOGRAPHIC DISTRIBUTIONS; ROCKY-MOUNTAINS; PACIFIC STATES; SAMPLE-SIZE; HABITAT; PERFORMANCE; SELECTION	The availability of spatially referenced environmental data and species occurrence records in online databases enable practitioners to easily generate species distribution models (SDMs) for a broad array of taxa. Such databases often include occurrence records of unknown reliability, yet little information is available on the influence of data quality on SDMs generated for rare, elusive, and cryptic species that are prone to misidentification in the field. We investigated this question for the fisher (Pekania pennanti), a forest carnivore of conservation concern in the Pacific States that is often confused with the more common Pacific marten (Martes caurina). Fisher occurrence records supported by physical evidence (verifiable records) were available from a limited area, whereas occurrence records of unknown quality (unscreened records) were available from throughout the fisher's historical range. We reserved 20% of the verifiable records to use as a test sample for both models and generated SDMs with each dataset using Maxent. The verifiable model performed substantially better than the unscreened model based on multiple metrics including AUC(test) values (0.78 and 0.62, respectively), evaluation of training and test gains, and statistical tests of how well each model predicted test localities. In addition, the verifiable model was consistent with our knowledge of the fisher's habitat relations and potential distribution, whereas the unscreened model indicated a much broader area of high-quality habitat (indices > 0.5) that included large expanses of high-elevation habitat that fishers do not occupy. Because Pacific martens remain relatively common in upper elevation habitats in the Cascade Range and Sierra Nevada, the SDM based on unscreened records likely reflects primarily a conflation of marten and fisher habitat. Consequently, accurate identifications are far more important than the spatial extent of occurrence records for generating reliable SDMs for the fisher in this region. We strongly recommend that practitioners avoid using anecdotal occurrence records to build SDMs but, if such data are used, the validity of resulting models should be tested with verifiable occurrence records.	[Aubry, Keith B.; Raley, Catherine M.] US Forest Serv, USDA, Pacific Northwest Res Stn, Olympia, WA 98512 USA; [McKelvey, Kevin S.] US Forest Serv, USDA, Rocky Mt Res Stn, Missoula, MT USA	United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service	Aubry, KB (corresponding author), US Forest Serv, USDA, Pacific Northwest Res Stn, Olympia, WA 98512 USA.	kaubry@fs.fed.us						Aubry KB, 2003, BIOL CONSERV, V114, P79, DOI 10.1016/S0006-3207(03)00003-X; Aubry KB, 2004, MARTES CARNIVORE COM, P159; Aubry KB, 2013, J WILDLIFE MANAGE, V77, P965, DOI 10.1002/jwmg.563; Aubry Keith B., 1993, Northwestern Naturalist, V73, P69, DOI 10.2307/3536711; Baldwin RA, 2009, ENTROPY, V11, P854, DOI 10.3390/e11040854; Beck J, 2014, ECOL INFORM, V19, P10, DOI 10.1016/j.ecoinf.2013.11.002; Blackard JA, 2008, MAPPING US FOREST BI; Braunisch V, 2010, ECOGRAPHY, V33, P826, DOI 10.1111/j.1600-0587.2009.05891.x; Buskirk Steven W., 1994, P283; Carroll C, 2001, ECOL APPL, V11, P961, DOI 10.1890/1051-0761(2001)011[0961:CAFSFC]2.0.CO;2; Centre for Forest Conservation Genetics (CFCG), 2014, CLIMATEWNA V4 84; Corsi F, 2000, METH C CONS, P389; Costa H, 2015, ISPRS INT J GEO-INF, V4, P2496, DOI 10.3390/ijgi4042496; Davis FW, 2007, ECOL APPL, V17, P2195, DOI 10.1890/06-1484.1; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Ensing DJ, 2013, BOTANY, V91, P137, DOI 10.1139/cjb-2012-0205; Frey Jennifer K., 2013, Animals, V3, P327, DOI 10.3390/ani3020327; Gould GI, 1987, W65R4 CAL DEP FISH G; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Jenness J., 2013, LAND FACET CORRIDOR; JOHNSON RE, 1997, WASHINGTON STATE GAP, V3; Krohn W, 2004, MARTENS AND FISHERS (MARTES) IN HUMAN-ALTERED ENVIRONMENTS: AN INTERNATIONAL PERSPECTIVE, P115; Krohn William B., 1997, P211; Landscape Ecology Modeling Mapping and Analysis (LEMMA), 2012, GNN STRUCT SPEC SIZ; Lewis J.C., 1998, WASHINGTON STATE STA; Lewis JC, 2004, FEASIBILITY ASSESSME; Lofroth E.C., 2010, CONSERVATION FISHERS, VI; Lozier JD, 2009, J BIOGEOGR, V36, P1623, DOI 10.1111/j.1365-2699.2009.02152.x; McKelvey KS, 2008, BIOSCIENCE, V58, P549, DOI 10.1641/B580611; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Olson LE, 2014, BIOL CONSERV, V169, P89, DOI 10.1016/j.biocon.2013.10.022; Osborne PE, 2009, DIVERS DISTRIB, V15, P671, DOI 10.1111/j.1472-4642.2009.00572.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2013, ECOLOGY, V94, P1409, DOI 10.1890/12-1520.1; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Powell R.A., 2012, BIOL CONSERVATION MA, P93, DOI DOI 10.7591/9780801466076-009; RAINE RM, 1983, CAN J ZOOL, V61, P25, DOI 10.1139/z83-002; Raley CM., 2012, BIOL CONSERVATION MA, P231; Schempf PF, 1977, CALIFORNIA REGION; Schwartz MK, 2013, FOREST ECOL MANAG, V305, P103, DOI 10.1016/j.foreco.2013.05.014; Spencer W, 2011, BIOL CONSERV, V144, P788, DOI 10.1016/j.biocon.2010.10.027; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; U. S. Fish and Wildlife Service, 2014, FED REGISTER, V79, P60419; U.S. Fish and Wildlife Service, 2016, FINAL SPECIES REPORT; U.S. Geological Survey, 2015, 30M DEM US GEOL SURV; Wiken E., 2011, N AM TERRESTRIAL ECO; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Yost AC, 2008, ECOL INFORM, V3, P375, DOI 10.1016/j.ecoinf.2008.08.004; Zielinski WJ, 1995, CALIF FISH GAME, V81, P104; Zielinski WJ, 2001, J MAMMAL, V82, P478, DOI 10.1644/1545-1542(2001)082&lt;0478:SOAMIC&gt;2.0.CO;2	53	38	38	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179152	10.1371/journal.pone.0179152	http://dx.doi.org/10.1371/journal.pone.0179152			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640819	Green Published, Green Submitted, gold			2022-12-27	WOS:000404135800018
J	Di Ruscio, F; Bjornholt, JV; Leegaard, TM; Moen, AEF; de Blasio, BF				Di Ruscio, Francesco; Bjornholt, Jorgen Vildershoj; Leegaard, Truls Michael; Moen, Aina E. Fossum; de Blasio, Birgitte Freiesleben			MRSA infections in Norway: A study of the temporal evolution, 2006-2015	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; EPIDEMIOLOGY; COMMUNITY; DENMARK; SWEDEN	Background Norway has one of the lowest prevalences of methicillin-resistant Staphylococcus aureus (MRSA) infections in the world. This study exploits the extensive data on MRSA infections in the Norwegian surveillance system to investigate the important factors defining the MRSA epidemiology. Methods We performed a quasi-Poisson regression of the monthly notification rate (NR) of MRSA infections reported from January 2006 to December 2015, comparing the time trend among people with an immigrant vs. Norwegian background and domestic vs. imported infections, stratified by age groups. Findings A total of 5289 MRSA infections were reported during the study period, of which 2255 (42.6%) were acquired in Norway, 1370 (25.9%) abroad, and 1664 (31.5%) with an unknown place of acquisition. Overall, the monthly NR increased significantly from 2006 to 2015 (+0.8% each month). The monthly increase in immigrants (+1.3%) was steeper than that in people with a Norwegian background (+0.6%). There was a significant growth (+0.4%) in the rate of domestically acquired infections, however, the NR of infections acquired abroad increased faster (+0.8%). For both imported and domestic infections, the increase occurred in persons aged < 70 years. Interpretation Our analysis suggests that immigration and importation, especially among persons aged < 40 years, represent important factors for the increasing notification rate of MRSA infections in Norway.	[Di Ruscio, Francesco; Bjornholt, Jorgen Vildershoj; de Blasio, Birgitte Freiesleben] Norwegian Inst Publ Hlth, Div Infect Dis Control, Dept Infect Dis Epidemiol, Oslo, Norway; [Di Ruscio, Francesco; de Blasio, Birgitte Freiesleben] Univ Oslo, Inst Basic Med Sci, Dept Biostat, Oslo, Norway; [Di Ruscio, Francesco; Leegaard, Truls Michael] Akershus Univ Hosp, Dept Microbiol & Infect Control, Lorenskog, Norway; [Bjornholt, Jorgen Vildershoj; Leegaard, Truls Michael; Moen, Aina E. Fossum] Univ Oslo, Inst Clin Med, Oslo, Norway; [Moen, Aina E. Fossum] Akershus Univ Hosp, Div Med, Dept Clin Mol Biol EpiGen, Lorenskog, Norway; [Bjornholt, Jorgen Vildershoj] Oslo Univ Hosp, Dept Clin Microbiol, Oslo, Norway	Norwegian Institute of Public Health (NIPH); University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Di Ruscio, F (corresponding author), Norwegian Inst Publ Hlth, Div Infect Dis Control, Dept Infect Dis Epidemiol, Oslo, Norway.; Di Ruscio, F (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Biostat, Oslo, Norway.; Di Ruscio, F (corresponding author), Akershus Univ Hosp, Dept Microbiol & Infect Control, Lorenskog, Norway.	f.d.ruscio@medisin.uio.no	Moen, Aina/M-5209-2019	Moen, Aina/0000-0002-1892-846X; Bjornholt, Jorgen Vildershoj/0000-0002-0079-8062	South-Eastern Norway Regional Health Authority [2014002]	South-Eastern Norway Regional Health Authority	This study was funded by a grant from the South-Eastern Norway Regional Health Authority, https./www.helse-sorost.no (project number 2014002) to TML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the South-Eastern Norway Regional Health Authority (project number 2014002).	Bartels MD, 2007, EMERG INFECT DIS, V13, P1533, DOI 10.3201/eid1310.070503; Center for Disease Dynamics and Policy, 2015, STAT WORLDS ANT 2015; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; ECDC, 2014, ANN EP REP 2014; Elstrom P, 2012, J HOSP INFECT, V80, P36, DOI 10.1016/j.jhin.2011.10.004; Glasner C, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.09.010; Hanssen AM, 2005, J CLIN MICROBIOL, V43, P2118, DOI 10.1128/JCM.43.5.2118-2124.2005; Kock R, 2011, DTSCH ARZTEBL INT, V108, P761, DOI 10.3238/arztebl.2011.0761; Kristiansen JE, 2015, STAT SENTRALBYRA SSB; Larsen AR, 2008, J CLIN MICROBIOL, V46, P62, DOI 10.1128/JCM.01381-07; Larsson AK, 2014, EUR J CLIN MICROBIOL, V33, P61, DOI 10.1007/s10096-013-1929-2; Moen AEF, 2013, APMIS, V121, P1091, DOI 10.1111/apm.12077; Moen AEF, 2010, FEMS IMMUNOL MED MIC, V58, P374, DOI 10.1111/j.1574-695X.2009.00649.x; Monecke S, 2014, APMIS, V122, P580, DOI 10.1111/apm.12181; Moxnes JF, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007163; Moxnes JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070499; National Institute of Public Health, 2009, NORW DIR HLTH; NORM/NORM-VET, 2015, US ANT AG OCC ANT RE; Norwegian Institute of Public Health, NORW SURV SYST COMM; R Core Team, 2018, R LANG ENV STAT COMP; Rolo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034768; Song JH, 2011, J ANTIMICROB CHEMOTH, V66, P1061, DOI 10.1093/jac/dkr024; Steens A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-57; Stenhem M, 2010, EMERG INFECT DIS, V16, P189, DOI 10.3201/eid1602.081655; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; World Health Organization, 2014, ANT RES GLOB REP SUR; Zhou YP, 2014, J TRAVEL MED, V21, P272, DOI 10.1111/jtm.12133	27	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179771	10.1371/journal.pone.0179771	http://dx.doi.org/10.1371/journal.pone.0179771			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640901	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000404135800062
J	Wu, YT; Li, X; Liu, ZL; Xu, Z; Dai, W; Zhang, K; Wu, JS; Arshad, B; Wu, KN; Kong, LQ				Wu, Yu-Tuan; Li, Xin; Liu, Zi-li; Xu, Zhou; Dai, Wei; Zhang, Ke; Wu, Jiu-song; Arshad, Bilal; Wu, Kai-nan; Kong, Ling-quan			Hepatitis B virus reactivation and antiviral prophylaxis during lung cancer chemotherapy: A systematic review and meta-analysis	PLOS ONE			English	Article							RECEIVING CYTOTOXIC CHEMOTHERAPY; COST-EFFECTIVENESS; IDENTIFICATION; EPIDEMIOLOGY; MANAGEMENT; LAMIVUDINE; UPDATE; INFECTION; CARRIERS	Background Antiviral drugs have been recommended as prophylaxis for the reactivation of hepatitis B virus (HBV) infection in cancer patients undergoing chemotherapy. However, screening and antiviral prophylaxis for lung cancer remain controversial because of insufficient evidence. Purpose In this study, we investigate the absolute risk for HBV reactivation and the prophylactic effects of antiviral drugs in hepatitis B surface antigen (HBsAg)-positive lung cancer patients during chemotherapy. Methods We searched Pubmed, Embase, Cochrane, Web of Science and SinoMed from inception until 28 November 2016, and identified all potential relevant references with or without prophylactic use of antiviral therapy in HBsAg-positive lung cancer patients during chemotherapy. The primary outcome was the incidence of HBV reactivation, the secondary outcomes were the incidence of hepatitis, chemotherapy disruption and mortality. Results Eleven studies involving 794 patients were analyzed. The incidences of HBV reactivation in control group and antiviral prophylaxis group ranged from 0% to 38% (median, 21%, 95% CI: 0.17-0.25) and 0% to 7% (median, 4%, 95% CI: 0.02-0.06), respectively. Antiviral prophylaxis had significantly reduced the risk for HBV reactivation (RR, 0.22 [95% CI: 0.13-0.37], p<0.0001), hepatitis (RR, 0.35 [95% CI: 0.22-0.56], p<0.0001) and chemotherapy disruption (RR: 0.29 [95% CI, 0.15-0.55], p<0.0002) compared to those without antiviral prophylaxis. There was no significant heterogeneity in the comparisons, and a fixed-model was used. Conclusion The risks of HBV reactivation and relevant complications are high in HBsAg-positive lung cancer patients receiving chemotherapy, and available evidences support HBV screening for antiviral prophylaxis before initiation of chemotherapy for lung cancer patients.	[Wu, Yu-Tuan; Li, Xin; Liu, Zi-li; Xu, Zhou; Dai, Wei; Zhang, Ke; Wu, Jiu-song; Arshad, Bilal; Wu, Kai-nan; Kong, Ling-quan] Chongqing Med Univ, Dept Endocrine & Breast Surg, Affiliated Hosp 1, Chongqing, Peoples R China	Chongqing Medical University	Kong, LQ (corresponding author), Chongqing Med Univ, Dept Endocrine & Breast Surg, Affiliated Hosp 1, Chongqing, Peoples R China.	huihuikp@163.com		Xu, Zhou/0000-0002-4287-1272; Kong, Ling-quan/0000-0001-5705-9001	Graduate Student's Science Innovation Project of Chongqing [CYS16124]; National Natural Science Foundation of China (NSFC) [81372851]; Department of Endocrine and Breast Surgery, the First Affiliated Hospital of Chongqing Medical University	Graduate Student's Science Innovation Project of Chongqing; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Department of Endocrine and Breast Surgery, the First Affiliated Hospital of Chongqing Medical University	This study was funded by Graduate Student's Science Innovation Project of Chongqing (CYS16124), National Natural Science Foundation of China (NSFC) (81372851) and Department of Endocrine and Breast Surgery, the First Affiliated Hospital of Chongqing Medical University.	Alexopoulos CG, 1999, BRIT J CANCER, V81, P69, DOI 10.1038/sj.bjc.6690652; Artz AS, 2010, J CLIN ONCOL, V28, P3199, DOI 10.1200/JCO.2010.30.0673; Bessone F, 2016, WORLD J HEPATOL, V8, P385, DOI 10.4254/wjh.v8.i8.385; Booth A, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-2; Bozza C, 2016, CRIT REV ONCOL HEMAT, V98, P137, DOI 10.1016/j.critrevonc.2015.10.017; Che Dehai, 2014, PRACTICAL ONCOLOGY J, V28, P7; Chen WL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137979; Cui Y, 2013, J GASTROEN HEPATOL, V28, P7, DOI 10.1111/jgh.12220; Day FL, 2011, J CLIN ONCOL, V29, P3270, DOI 10.1200/JCO.2011.35.1635; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duan Lincan, 2009, Zhongguo Fei Ai Za Zhi, V12, P893, DOI 10.3779/j.issn.1009-3419.2009.08.12; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eren OO, 2009, MED ONCOL, V26, P386, DOI 10.1007/s12032-008-9133-4; Hoofnagle JH, 2009, HEPATOLOGY, V49, pS156, DOI 10.1002/hep.22945; Li H, 2015, CLIN RES HEPATOL GAS, V39, P80, DOI 10.1016/j.clinre.2014.07.010; Lin GN, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0119-0; Ling WHY, 2013, BRIT J CANCER, V108, P1931, DOI 10.1038/bjc.2013.225; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Mozessohn L, 2013, J CLIN ONCOLOGY, V31; Nishida T, 2013, HEPATOL RES, V43, P339, DOI 10.1111/j.1872-034X.2012.01073.x; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Paul S, 2016, ANN INTERN MED, V164, P30, DOI 10.7326/M15-1121; Rossi G, 2001, BRIT J HAEMATOL, V115, P58, DOI 10.1046/j.1365-2141.2001.03099.x; Sarin SK, 2016, HEPATOL INT, V10, P1, DOI 10.1007/s12072-015-9675-4; Schwartz AG, 2016, ADV EXP MED BIOL, V893, P21, DOI 10.1007/978-3-319-24223-1_2; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Weinbaum Cindy M., 2008, Morbidity and Mortality Weekly Report, V57, P1, DOI 10.1002/hep.22882; Wong WWL, 2015, BREAST CANCER RES TR, V151, P639, DOI 10.1007/s10549-015-3382-7; [严岳 Yan Yue], 2012, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V39, P465; Yeo W, 2006, HEPATOLOGY, V43, P209, DOI 10.1002/hep.21051; Yeo W, 2004, BRIT J CANCER, V90, P1306, DOI 10.1038/sj.bjc.6601699; Yeo W, 2000, J MED VIROL, V62, P299, DOI 10.1002/1096-9071(200011)62:3&lt;299::AID-JMV1&gt;3.0.CO;2-0; Zampino R, 2015, WORLD J GASTROENTERO, V21, P11941, DOI 10.3748/wjg.v21.i42.11941; Zheng L, 2014, CHINESE J CANC PREVE, V21, P771; Zheng Liang, 2016, MED J QILU, P4; Zheng Liang, 2016, MED J QILU, P9; Zheng YH, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.6496	40	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179680	10.1371/journal.pone.0179680	http://dx.doi.org/10.1371/journal.pone.0179680			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640902	Green Published, gold, Green Submitted			2022-12-27	WOS:000404135800051
J	Altszyler, E; Ventura, AC; Colman-Lerner, A; Chernomoretz, A				Altszyler, Edgar; Ventura, Alejandra C.; Colman-Lerner, Alejandro; Chernomoretz, Ariel			Ultrasensitivity in signaling cascades revisited: Linking local and global ultrasensitivity estimations	PLOS ONE			English	Article							PROTEIN-KINASE CASCADES; MULTISITE PHOSPHORYLATION; COVALENT MODIFICATION; SWITCH-LIKE; SEQUESTRATION; BISTABILITY; RESPONSES; FEEDBACK; BIOLOGY; SYSTEMS	Ultrasensitive response motifs, capable of converting graded stimuli into binary responses, are well-conserved in signal transduction networks. Although it has been shown that a cascade arrangement of multiple ultrasensitive modules can enhance the system's ultrasensitivity, how a given combination of layers affects a cascade's ultrasensitivity remains an open question for the general case. Here, we introduce a methodology that allows us to determine the presence of sequestration effects and to quantify the relative contribution of each module to the overall cascade's ultrasensitivity. The proposed analysis framework provides a natural link between global and local ultrasensitivity descriptors and it is particularly well suited to characterize and understand mathematical models used to study real biological systems. As a case study, we have considered three mathematical models introduced by O'Shaughnessy et al. to study a tunable synthetic MAPK cascade, and we show how our methodology can help modelers better understand alternative models.	[Altszyler, Edgar] Univ Buenos Aires, Dept Comp, Lab Inteligencia Artificial Aplicada, CONICET, Ciudad Univ,Pabellon 1,C1428EHA, Buenos Aires, DF, Argentina; [Ventura, Alejandra C.; Colman-Lerner, Alejandro] Univ Buenos Aires, IFIBYNE, CONICET, Ciudad Univ,Pabellon 2,C1428EHA, Buenos Aires, DF, Argentina; [Ventura, Alejandra C.; Colman-Lerner, Alejandro] Univ Buenos Aires, Dept Fisiol Biol Mol & Celular, Fac Ciencias Exactas & Nat, Ciudad Univ,Pabellon 2,C1428EHA, Buenos Aires, DF, Argentina; [Chernomoretz, Ariel] UBA, Dept Fis, FCEN, IFIBA,CONICET, Ciudad Univ,Pabellon 1,C1428EHA, Buenos Aires, DF, Argentina; [Chernomoretz, Ariel] Fdn Inst Leloir, Ave Patricias Argentinas 435,C1405BWE, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Leloir Institute	Chernomoretz, A (corresponding author), UBA, Dept Fis, FCEN, IFIBA,CONICET, Ciudad Univ,Pabellon 1,C1428EHA, Buenos Aires, DF, Argentina.; Chernomoretz, A (corresponding author), Fdn Inst Leloir, Ave Patricias Argentinas 435,C1405BWE, Buenos Aires, DF, Argentina.	ariel@df.uba.ar	Colman-Lerner, Alejandro/ABC-3808-2020	Colman-Lerner, Alejandro/0000-0002-2557-8883	Argentine Agency of Research and Technology [PICT2010-2248, PICT2013-2210, PICT2014-2701]; National Institute of General Medical Sciences, National Institutes of Health [1R01GM097479-01, 0000713502]; University of Buenos Aires [20020130100582BA]	Argentine Agency of Research and Technology; National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Buenos Aires(University of Buenos Aires)	ACL acknowledges that this work was supported by grants PICT2010-2248 and PICT2013-2210 from the Argentine Agency of Research and Technology, and grant 1R01GM097479-01, subaward 0000713502 from the National Institute of General Medical Sciences, National Institutes of Health. AC acknowledges support from grant 20020130100582BA from University of Buenos Aires, and grant PICT2014-2701 from the Argentine Agency of Research and Technology.	Altszyler E, 2014, PHYS BIOL, V11, DOI 10.1088/1478-3975/11/6/066003; Ang J, 2013, ACS SYNTH BIOL, V2, P547, DOI 10.1021/sb4000564; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Bluthgen N, 2006, FEBS J, V273, P895, DOI 10.1111/j.1742-4658.2006.05105.x; Bluthgen N, 2003, J THEOR BIOL, V225, P293, DOI 10.1016/S0022-5193(03)00247-9; Bluthgen N., 2001, 2 WORKSH COMP BIOCH, P55; Brown GC, 1997, TRENDS BIOCHEM SCI, V22, P288, DOI 10.1016/S0968-0004(97)82216-5; Buchler NE, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.30; Buchler NE, 2008, J MOL BIOL, V384, P1106, DOI 10.1016/j.jmb.2008.09.079; Del Vecchio D, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100204; Ferrell JE, 2014, TRENDS BIOCHEM SCI, V39, P612, DOI 10.1016/j.tibs.2014.10.002; Ferrell JE, 2014, TRENDS BIOCHEM SCI, V39, P556, DOI 10.1016/j.tibs.2014.09.003; Ferrell JE, 2014, TRENDS BIOCHEM SCI, V39, P496, DOI 10.1016/j.tibs.2014.08.003; Ferrell JE, 1997, TRENDS BIOCHEM SCI, V22, P288, DOI 10.1016/S0968-0004(97)82217-7; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Gomez-Uribe C, 2007, PLOS COMPUT BIOL, V3, P2487, DOI 10.1371/journal.pcbi.0030246; Gunawardena J, 2005, P NATL ACAD SCI USA, V102, P14617, DOI 10.1073/pnas.0507322102; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Karsten R., 1997, BIF FUTURA, V12, P20; Kholodenko BN, 1997, FEBS LETT, V414, P430, DOI 10.1016/S0014-5793(97)01018-1; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; Kittleson JT, 2012, CURR OPIN CHEM BIOL, V16, P329, DOI 10.1016/j.cbpa.2012.06.009; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; O'Shaughnessy EC, 2011, CELL, V144, P119, DOI 10.1016/j.cell.2010.12.014; Racz E, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/3/036004; Srividhya J, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/046005; Tsvetanova NG, 2016, MOL PHARM; Ventura AC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000041; Ventura AC, 2010, P NATL ACAD SCI USA, V107, P10032, DOI 10.1073/pnas.0913815107; Wang G., 2016, SCI REPORTS, V6; Zechner C, 2016, P NATL ACAD SCI USA, V113, P4729, DOI 10.1073/pnas.1517109113; Zhang Q, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130031	35	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180083	10.1371/journal.pone.0180083	http://dx.doi.org/10.1371/journal.pone.0180083			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662096	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300101
J	Wang, YP; Guo, SG; Tian, SW; Zhang, J; Ren, Y; Sun, HH; Gong, GY; Zhang, HY; Xu, Y				Wang, Yanping; Guo, Shaogui; Tian, Shouwei; Zhang, Jie; Ren, Yi; Sun, Honghe; Gong, Guoyi; Zhang, Haiying; Xu, Yong			Abscisic acid pathway involved in the regulation of watermelon fruit ripening and quality trait evolution	PLOS ONE			English	Article							TRIGGERING ETHYLENE BIOSYNTHESIS; STRAWBERRY FRUIT; 9-CIS-EPOXYCAROTENOID DIOXYGENASE; GENE-EXPRESSION; ABA; SUPPRESSION; METABOLISM; LYCOPENE; SLNCED1; ENZYMES	Watermelon (Citrullus lanatus (Thunb.) Matsum. & Nakai) is a non-climacteric fruit. The modern sweet-dessert watermelon is the result of years of cultivation and selection for fruits with desirable qualities. To date, the mechanisms of watermelon fruit ripening, and the role of abscisic acid (ABA) in this process, has not been well understood. We quantified levels of free and conjugated ABA contents in the fruits of cultivated watermelon (97103; C. lanatus subsp. vulgaris), semi-wild germplasm (PI179878; C. lanatus subsp. mucosospermus), and wild germplasm (PI296341-FR; C. lanatus subsp. lanatus). Results showed that ABA content in the fruits of 97103 and PI179878 increased during fruit development and ripening, but maintained a low steady state in the center flesh of PI296341-FR fruits. ABA levels in fruits were highest in 97103 and lowest in PI296341-FR, but no obvious differences in ABA levels were observed in seeds of these lines. Examination of 31 representative watermelon accessions, including different C. lanatus subspecies and ancestral species, showed a correlation between soluble solids content (SSC) and ABA levels in ripening fruits. Furthermore, injection of exogenous ABA or nordihydroguaiaretic acid (NDGA) into 97103 fruits promoted or inhibited ripening, respectively. Transcriptomic analyses showed that the expression levels of several genes involved in ABA metabolism and signaling, including Cla009779 (NCED), Cla005404 (NCED), Cla020673 (CYP707A), Cla006655 (UG7) and Cla020180 (SnRK2), varied significantly in cultivated and wild watermelon center flesh. Three SNPs (-738, C/A;-1681, C/T;-1832, G/T) in the promoter region of Cla020673 (CYP707A) and one single SNP (-701, G/A) in the promoter of Cla020180 (SnRK2) exhibited a high level of correlation with SSC variation in the 100 tested accessions. Our results not only demonstrate for the first time that ABA is involved in the regulation of watermelon fruit ripening, but also provide insights into the evolutionary mechanisms of this phenomenon.	[Wang, Yanping; Guo, Shaogui; Tian, Shouwei; Zhang, Jie; Ren, Yi; Sun, Honghe; Gong, Guoyi; Zhang, Haiying; Xu, Yong] Beijing Acad Agr & Forestry Sci, Natl Engn Res Ctr Vegetables, Key Lab Biol & Genet Improvement Hort Crops North, Beijing Key Lab Vegetable Germplasm Improvement, Beijing, Peoples R China	Beijing Academy of Agriculture & Forestry	Xu, Y (corresponding author), Beijing Acad Agr & Forestry Sci, Natl Engn Res Ctr Vegetables, Key Lab Biol & Genet Improvement Hort Crops North, Beijing Key Lab Vegetable Germplasm Improvement, Beijing, Peoples R China.	xuyong@nercv.org			Beijing Municipal Science and Technology Commission of China [6141001, Z161100004916081, 2014000021223TD03, 2016000021223ZK19]; Beijing Scholar Program [BSP026]; Ministry of Agriculture of China [CARS-26]; National Natural Science Foundation of China [31401893, 31361140355]; Ministry of Science and Technology of China [2016YFD0100506]; BAAFS Innovation Team [JNKYT301601]	Beijing Municipal Science and Technology Commission of China; Beijing Scholar Program; Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); BAAFS Innovation Team	This work was supported by grants from Beijing Municipal Science and Technology Commission of China (SG, 6141001; JZ, Z161100004916081; SG, 2014000021223TD03; JZ, 2016000021223ZK19; http://www.bjkw.gov.cn/), Beijing Scholar Program (YX, BSP026), Ministry of Agriculture of China (YX, CARS-26; http://www.moa.gov.cn/), National Natural Science Foundation of China (JZ, 31401893; YX, 31361140355; http://www.nsfc.gov.cn/), Ministry of Science and Technology of China (YR, 2016YFD0100506; littp://www.most.gov.cn/), and BAAFS Innovation Team (YX, JNKYT301601; http://www.baafs.net.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry CS, 2007, J PLANT GROWTH REGUL, V26, P143, DOI 10.1007/s00344-007-9002-y; Chai L, 2016, SCI HORTIC-AMSTERDAM, V210, P34, DOI 10.1016/j.scienta.2016.07.015; Chai YM, 2011, J EXP BOT, V62, P5079, DOI 10.1093/jxb/err207; Chen S, 1988, ACTA HORT SINICA, V25, P313; Chernys JT, 2000, PLANT PHYSIOL, V124, P343, DOI 10.1104/pp.124.1.343; Chomicki G, 2015, NEW PHYTOL, V205, P526, DOI 10.1111/nph.13163; COOMBE B G, 1989, Acta Horticulturae (Wageningen), P149; Cutting J. G. M., 1989, Yearbook - South African Avocado Growers' Association, V12, P53; ELKASHIF ME, 1989, J AM SOC HORTIC SCI, V114, P81; ELKASHIF ME, 1988, J AM SOC HORTIC SCI, V113, P378; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Galpaz N, 2008, PLANT J, V53, P717, DOI 10.1111/j.1365-313X.2007.03362.x; Giovannoni JJ, 2007, CURR OPIN PLANT BIOL, V10, P283, DOI 10.1016/j.pbi.2007.04.008; Guo S, 2015, PLOS ONE, V10, P16; Han Y, 2015, PLANT PHYSIOL, V167, P915, DOI 10.1104/pp.114.251314; Huang CongLin, 2001, Acta Horticulturae Sinica, V28, P385; INABA A, 1976, J JPN SOC HORTIC SCI, V45, P245, DOI 10.2503/jjshs.45.245; Ji K, 2014, J EXP BOT, V65, P5243, DOI 10.1093/jxb/eru288; Ji K, 2012, FUNCT PLANT BIOL, V39, P351, DOI 10.1071/FP11293; Jia HF, 2011, PLANT PHYSIOL, V157, P188, DOI 10.1104/pp.111.177311; Jia HF, 2016, J PLANT GROWTH REGUL, V35, P987, DOI 10.1007/s00344-016-9597-y; Karakurt Y, 2002, PHYSIOL PLANTARUM, V116, P398, DOI 10.1034/j.1399-3054.2002.1160316.x; Kojima K., 1996, Chemical Regulation of Plants, V31, P68; Li D, 2016, SCI REP; Li Q, 2015, J EXP BOT, V66, P3765, DOI 10.1093/jxb/erv169; Li Q, 2013, PLANT J, V76, P24, DOI 10.1111/tpj.12272; Li Q, 2012, J PLANT PHYSIOL, V169, P78, DOI 10.1016/j.jplph.2011.08.005; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Paris HS, 2015, ANN BOT-LONDON, V116, P133, DOI 10.1093/aob/mcv077; Perkins-Veazie P., 1995, Hortscience, V30, P825; Reddy UK, 2015, J HERED, V106, P166, DOI 10.1093/jhered/esu077; Ren J, 2010, J PLANT PHYSIOL, V167, P1486, DOI 10.1016/j.jplph.2010.05.027; Rodrigo MJ, 2003, J EXP BOT, V54, P727, DOI 10.1093/jxb/erg083; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Sun L, 2012, J EXP BOT, V63, P3097, DOI 10.1093/jxb/ers026; Sun L, 2012, PLANT PHYSIOL, V158, P283, DOI 10.1104/pp.111.186866; Sun L, 2011, J EXP BOT, V62, P5659, DOI 10.1093/jxb/err252; Sun Y, 2013, J PLANT GROWTH REGUL, V32, P233, DOI 10.1007/s00344-012-9293-5; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; van der Knaap E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00227; Villalobos-Gonzalez L, 2016, PLANT PHYSIOL BIOCH, V105, P213, DOI 10.1016/j.plaphy.2016.04.012; Wang XH, 2016, SCI HORTIC-AMSTERDAM, V201, P175, DOI 10.1016/j.scienta.2015.12.024; Wang YP, 2013, PLANT PHYSIOL BIOCH, V64, P70, DOI 10.1016/j.plaphy.2012.12.015; Wechter WP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-275; Yoshida R, 2006, J BIOL CHEM, V281, P5310, DOI 10.1074/jbc.M509820200; Zaharah SS, 2013, POSTHARVEST BIOL TEC, V75, P37, DOI 10.1016/j.postharvbio.2012.07.009; Zhang J, 2016, NEW PHYTOL; Zhang M, 2009, J EXP BOT, V60, P1579, DOI 10.1093/jxb/erp026; Zhang Y, 2011, ACTA BOT BOREALI-OCC, V6, P17; Zhong SL, 2013, NAT BIOTECHNOL, V31, P154, DOI 10.1038/nbt.2462; Zhou M, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-016-2248-x	52	31	32	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179944	10.1371/journal.pone.0179944	http://dx.doi.org/10.1371/journal.pone.0179944			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662086	Green Submitted, Green Published, gold			2022-12-27	WOS:000404608300077
J	Rodgveller, CJ; Hutchinson, CE; Harris, JP; Vulstek, SC; Guthrie, CM				Rodgveller, Cara J.; Hutchinson, Charles E.; Harris, Jeremy P.; Vulstek, Scott C.; Guthrie, Charles M., III			Otolith shape variability and associated body growth differences in giant grenadier, Albatrossia pectoralis	PLOS ONE			English	Article							STOCK DISCRIMINATION; SPAWNING AREAS; COD; TOOL; IDENTIFICATION; SEPARATION; SEBASTES; REDFISH; GULF	Fish stocks can be defined by differences in their distribution, life history, and genetics. Managing fish based on stock structure is integral to successful management of a species because fishing may affect stocks disproportionately. Genetic and environmental differences can affect the shape and growth of otoliths and these differences may be indicative of stock structure. To investigate the potential for speciation or stock structure in giant grenadier, Albatrossia pectoralis, we quantified the shape of female giant grenadier otoliths and compared body growth rates for fish with three otolith shapes; shape types were classified visually by an experienced giant grenadier age reader, and were not defined by known distribution or life history differences. We found extreme variation in otolith shape among individuals; however, the shapes were a gradation and not clearly defined into three groups. The two more extreme shapes, visually defined as "hatchet" and "comb", were discernable based on principal component analyses of elliptical Fourier descriptors, and the "mixed" shape overlapped both of the extreme shapes. Fish with hatchet-shaped otoliths grew faster than fish with comb-shaped otoliths. A genetic test (cytochrome coxidase 1 used by the Fish Barcode of Life Initiative) showed almost no variability among samples, indicating that the samples were all from one species. The lack of young specimens makes it difficult to link otolith shape and growth difference to life history. In addition, shape could not be correlated with adult movement patterns because giant grenadiers experience 100% mortality after capture and, therefore, cannot be tagged and released. Despite these limitations, the link between body growth and otolith shape indicates measurable differences that deserve more study.	[Rodgveller, Cara J.; Vulstek, Scott C.; Guthrie, Charles M., III] NOAA, Auke Bay Labs, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Juneau, AK 99802 USA; [Hutchinson, Charles E.; Harris, Jeremy P.] NOAA, Resource Ecol & Fisheries Management Div, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA	National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Rodgveller, CJ (corresponding author), NOAA, Auke Bay Labs, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Juneau, AK 99802 USA.	cara.rodgveller@noaa.gov			National Oceanic and Atmospheric Administration, National Marine Fisheries Service	National Oceanic and Atmospheric Administration, National Marine Fisheries Service(National Oceanic Atmospheric Admin (NOAA) - USA)	This work was supported by the National Oceanic and Atmospheric Administration, National Marine Fisheries Service.	Begg GA, 1999, FISH RES, V43, P35, DOI 10.1016/S0165-7836(99)00065-X; Bonhomme V, 2014, J STAT SOFTW, V56, P1; CAMPANA SE, 1993, CAN J FISH AQUAT SCI, V50, P1062, DOI 10.1139/f93-123; Cardinale M, 2004, CAN J FISH AQUAT SCI, V61, P158, DOI 10.1139/F03-151; Claude J, 2008, MORPHOMETRICS R; Clausen DM, 2008, AM FISH S S, V63, P413; Clausen DM, 2013, NMFSAFSC247 NOAA US; CRAMPTON JS, 1995, LETHAIA, V28, P179, DOI 10.1111/j.1502-3931.1995.tb01611.x; DeVries DA, 2002, FISH RES, V57, P51, DOI 10.1016/S0165-7836(01)00332-0; Ferguson GJ, 2011, FISH RES, V110, P75, DOI 10.1016/j.fishres.2011.03.014; Galley EA, 2006, ICES J MAR SCI, V63, P1710, DOI 10.1016/j.icesjms.2006.06.014; Godiken JA, 2015, PLOS ONE, V10; HILBORN R, 1992; Hussy K, 2008, J EXP MAR BIOL ECOL, V364, P35, DOI 10.1016/j.jembe.2008.06.026; Hussy K, 2016, FISH RES, V174, P210, DOI 10.1016/j.fishres.2015.10.010; Ivanova NV, 2007, MOL ECOL NOTES, V7, P544, DOI 10.1111/j.1471-8286.2007.01748.x; Jonsdottir IG, 2006, ICES J MAR SCI, V63, P1501, DOI 10.1016/j.icesjms.2006.05.006; Keating JP, 2014, FISH RES, V157, P1, DOI 10.1016/j.fishres.2014.03.009; Legua J, 2013, LAT AM J AQUAT RES, V41, P479, DOI 10.3856/vol41-issue3-fulltext-11; Mahe K, 2016, CAN J FISH AQUAT SCI, V73, P1363, DOI 10.1139/cjfas-2015-0332; Orlov AM, 2008, AM FISH S S, V63, P225; Paul K, 2013, J APPL ICHTHYOL, V29, P743, DOI 10.1111/jai.12145; Petursdottir G, 2006, FISH RES, V80, P182, DOI 10.1016/j.fishres.2006.05.002; Ponton D, 2006, J MORPHOL, V267, P750, DOI 10.1002/jmor.10439; R Core Team, 2013, R LANG ENV STAT COMP; Rodgveller C, 2016, ASSESSMENT GRENADIER, P1; Rodgveller CJ, 2010, MAR COAST FISH, V2, P73, DOI 10.1577/C09-028.1; Rutecki TL, 2016, NATL MARINE FISHERIE; Sadighzadeh Z, 2014, FISH RES, V155, P59, DOI 10.1016/j.fishres.2014.02.024; SAS Institute Inc, 2015, JMP VERS 12; Stransky C, 2005, ICES J MAR SCI, V62, P1691, DOI 10.1016/j.icesjms.2005.05.012; Stransky C, 2005, CAN J FISH AQUAT SCI, V62, P2265, DOI 10.1139/F05-143; Stransky C, 2008, FISH RES, V90, P26, DOI 10.1016/j.fishres.2007.09.009; Tracey SR, 2006, FISH RES, V77, P138, DOI 10.1016/j.fishres.2005.10.013; Treinen-Crespo C, 2012, REVMAR-REV CIENC MAR, V4, P157; von Bertalanffy L, 1938, HUM BIOL, V10, P181, DOI DOI 10.2307/41447359; Zar JH., 2010, BIOSTAT ANAL, V5th	37	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180020	10.1371/journal.pone.0180020	http://dx.doi.org/10.1371/journal.pone.0180020			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658326	Green Submitted, gold, Green Published			2022-12-27	WOS:000404607900053
J	Winkler, MT; Bushey, RT; Gottlin, EB; Campa, MJ; Guadalupe, ES; Volkheimer, AD; Weinberg, JB; Patz, EF				Winkler, Mark T.; Bushey, Ryan T.; Gottlin, Elizabeth B.; Campa, Michael J.; Guadalupe, Eross S.; Volkheimer, Alicia D.; Weinberg, J. Brice; Patz, Edward F., Jr.			Enhanced CDC of B cell chronic lymphocytic leukemia cells mediated by rituximab combined with a novel anti-complement factor H antibody	PLOS ONE			English	Article							DEPENDENT CYTOTOXICITY; REGULATORY PROTEINS; EXPRESSION; OFATUMUMAB; LYMPHOMAS; EFFICACY; IMPROVES; THERAPY; CANCER; CD59	Rituximab therapy for B cell chronic lymphocytic leukemia (B-CLL) has met with mixed success. Among several factors to which resistance can be attributed is failure to activate complement dependent cytotoxicity (CDC) due to protective complement regulatory proteins, including the soluble regulator complement factor H (CFH). We hypothesized that rituximab killing of non-responsive B-CLL cells could be augmented by a novel human monoclonal antibody against CFH. The B cells from 11 patients with B-CLL were tested ex vivo in CDC assays with combinations of CFH monoclonal antibody, rituximab, and a negative control antibody. CDC of rituximab non-responsive malignant B cells from CLL patients could in some cases be augmented by the CFH monoclonal antibody. Antibody-mediated cytotoxicity of cells was dependent upon functional complement. In one case where B-CLL cells were refractory to CDC by the combination of rituximab plus CFH monoclonal antibody, additionally neutralizing the membrane complement regulatory protein CD59 allowed CDC to occur. Inhibiting CDC regulatory proteins such as CFH holds promise for overcoming resistance to rituximab therapy in B-CLL.	[Winkler, Mark T.; Bushey, Ryan T.; Gottlin, Elizabeth B.; Campa, Michael J.; Patz, Edward F., Jr.] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA; [Guadalupe, Eross S.; Volkheimer, Alicia D.; Weinberg, J. Brice] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Volkheimer, Alicia D.; Weinberg, J. Brice] Durham VA Med Ctr, Durham, NC USA; [Weinberg, J. Brice] Duke Univ, Dept Immunol, Med Ctr, Durham, NC USA; [Patz, Edward F., Jr.] Duke Univ, Dept Pharmacol & Canc Biol, Med Ctr, Durham, NC 27708 USA	Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Duke University	Patz, EF (corresponding author), Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA.; Patz, EF (corresponding author), Duke Univ, Dept Pharmacol & Canc Biol, Med Ctr, Durham, NC 27708 USA.	patz0002@mc.duke.edu		Gottlin, Elizabeth/0000-0003-0886-0024; Cooper-Volkheimer, Alicia/0000-0002-0275-4450; Patz, Edward/0000-0003-3374-1596	Veterans Affairs Research Service	Veterans Affairs Research Service(US Department of Veterans Affairs)	This research was supported in part by funding from the Veterans Affairs Research Service to Dr.Weinberg. There was no additional external fundin greceived for this study. The funders had no role in study design, data collection and analysis, decision to publish, orpreparation of the manuscript.	Bushey RT, 2016, CELL REP, V15, P1505, DOI 10.1016/j.celrep.2016.04.038; Campa MJ, 2015, CANCER IMMUNOL RES, V3, P1325, DOI 10.1158/2326-6066.CIR-15-0122; Di Gaetano N, 2003, J IMMUNOL, V171, P1581, DOI 10.4049/jimmunol.171.3.1581; Dwojak M, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.27; Ferreira VP, 2010, MOL IMMUNOL, V47, P2187, DOI 10.1016/j.molimm.2010.05.007; Golay J, 2001, BLOOD, V98, P3383, DOI 10.1182/blood.V98.12.3383; Guc D, 2000, EUR J HAEMATOL, V64, P3, DOI 10.1034/j.1600-0609.2000.80097.x; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Harjunpaa A, 2000, SCAND J IMMUNOL, V51, P634; Horl S, 2013, LEUKEMIA, V27, P2200, DOI 10.1038/leu.2013.169; Horl S, 2013, HAEMATOLOGICA, V98, P1939, DOI 10.3324/haematol.2013.089615; Hu WG, 2011, CANCER RES, V71, P2298, DOI 10.1158/0008-5472.CAN-10-3016; Jamroziak K, 2017, CURR TREAT OPTION ON, V18, DOI 10.1007/s11864-017-0448-2; Makou E, 2013, BIOCHEMISTRY-US, V52, P3949, DOI 10.1021/bi4003452; Mamidi S, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.979688; Middleton O, 2015, LEUKEMIA, V29, P107, DOI 10.1038/leu.2014.146; Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018; Perez-Callejo D, 2015, CANCER TREAT REV, V41, P680, DOI 10.1016/j.ctrv.2015.05.007; Schmidt CQ, 2008, CLIN EXP IMMUNOL, V151, P14, DOI 10.1111/j.1365-2249.2007.03553.x; Smolewski P, 2015, EXPERT OPIN DRUG DIS, V10, P791, DOI 10.1517/17460441.2015.1045295; van Meerten T, 2006, CLIN CANCER RES, V12, P4027, DOI 10.1158/1078-0432.CCR-06-0066; Volkheimer AD, 2007, BLOOD, V109, P1559, DOI 10.1182/blood-2006-05-020644; Weinberg JB, 2007, AM J HEMATOL, V82, P1063, DOI 10.1002/ajh.20987; Weiner GJ, 2010, SEMIN HEMATOL, V47, P115, DOI 10.1053/j.seminhematol.2010.01.011; Zelenetz AD, 2015, J NATL COMPR CANC NE, V13, P326, DOI 10.6004/jnccn.2015.0045	25	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179841	10.1371/journal.pone.0179841	http://dx.doi.org/10.1371/journal.pone.0179841			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658265	Green Published, Green Submitted, gold			2022-12-27	WOS:000404607900042
J	de Miguel, A; Tapia-Rojo, R; Utesch, T; Mroginski, MA				de Miguel, Alejandra; Tapia-Rojo, Rafael; Utesch, Tillmann; Mroginski, Maria Andrea			Structure, dynamics and kinetics of two-component Lantibiotic Lichenicidin	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; BACILLUS-LICHENIFORMIS; FORCE-FIELD; SIMULATIONS; BACTERIOCINS; PEPTIDES; PARAMETERS; PROTEINS; IMMUNITY	Two variants of the two-component Lantibiotic Lichenicidin, produced by the strains B. Licheniformis VK21 and I89 (Lch alpha/Lch beta and Bli alpha/Bli beta peptides, respectively) have been investigated by means of 2 mu s-long all-atom molecular dynamics simulations combined with Markov State Models. This rigorous statistical analysis enabled to evaluate the dynamic and kinetic properties of the aforementioned systems which are not accessible via experimental techniques. The structural flexibility characteristic of these small peptides is understood by a delicate equilibrium between random coil, alpha-helices and beta-sheet structures. The undergoing secondary structure transitions from an alpha-helix to a beta-sheet observed for Lch alpha and Lch beta peptides, were not present in the Bli alpha component and provide new insights to understand their mechanism of action.	[de Miguel, Alejandra; Utesch, Tillmann; Mroginski, Maria Andrea] Tech Univ Berlin, Inst Chem, Dept Biophys Chem, Berlin, Germany; [Tapia-Rojo, Rafael] Univ Zaragoza, Dept Fis Mat Condensada, Zaragoza, Spain; [Tapia-Rojo, Rafael] Univ Zaragoza, Inst Biocomputac & Fis Sistemas Complejos, Zaragoza, Spain; [Tapia-Rojo, Rafael] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Technical University of Berlin; University of Zaragoza; University of Zaragoza; Columbia University	Mroginski, MA (corresponding author), Tech Univ Berlin, Inst Chem, Dept Biophys Chem, Berlin, Germany.	andrea.mroginski@tu-berlin.de	Tapia-Rojo, Rafael/AAX-3028-2020	Tapia-Rojo, Rafael/0000-0002-9460-2859	Cluster of Excellence Unifying Concepts in Catalysis	Cluster of Excellence Unifying Concepts in Catalysis(German Research Foundation (DFG))	This work was funded by grants from the Cluster of Excellence Unifying Concepts in Catalysis launched by the German federal government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Becker O.M., 2001, COMPUTATIONAL BIOCH; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bolintineanu DS, 2011, PEPTIDES, V32, P188, DOI 10.1016/j.peptides.2010.10.006; Bowman Gregory R., 2014, INTRO MARKOV STATE M; Caetano T, 2011, CHEM BIOL, V18, P90, DOI 10.1016/j.chembiol.2010.11.010; Chapple DS, 2004, ANTIMICROB AGENTS CH, V48, P2190, DOI 10.1128/AAC.48.6.2190-2198.2004; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dennington Roy, 2009, GAUSSVIEW 5 CITATION; Durrant JD, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-71; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Frisch G.T. M., 2009, GAUSSIAN 09 CITATION; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Giangaspero A, 2001, EUR J BIOCHEM, V268, P5589; Guder A, 2000, BIOPOLYMERS, V55, P62, DOI 10.1002/1097-0282(2000)55:1<62::AID-BIP60>3.3.CO;2-P; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hwang S, 2011, J PHYS CHEM B, V115, P6653, DOI 10.1021/jp111448a; JACK RW, 1995, MICROBIOL REV, V59, P171, DOI 10.1128/MMBR.59.2.171-200.1995; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Langham A, 2010, METHODS MOL BIOL, V618, P267, DOI 10.1007/978-1-60761-594-1_17; Lindorff-Larsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032131; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mendo S, 2004, BIOTECHNOL LETT, V26, P115, DOI 10.1023/B:BILE.0000012888.72489.3f; Nawrot R, 2014, FOLIA MICROBIOL, V59, P181, DOI 10.1007/s12223-013-0280-4; Perez-Hernandez G, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4811489; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023; Prada-Gracia D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000415; Prinz JH, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3565032; Rebuffat S, 2011, PROKARYOTIC ANTIMICROBIAL PEPTIDES: FROM GENES TO APPLICATIONS, P55, DOI 10.1007/978-1-4419-7692-5_4; Rey MW, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r77; Rollins-Smith LA, 2009, BBA-BIOMEMBRANES, V1788, P1593, DOI 10.1016/j.bbamem.2009.03.008; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salas CE, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/102129; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Shenkarev ZO, 2010, BIOCHEMISTRY-US, V49, P6462, DOI 10.1021/bi100871b; Thormann M, 1998, J MOL STRUC-THEOCHEM, V431, P79, DOI 10.1016/S0166-1280(97)00422-3; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Turpin ER, 2014, RSC ADV, V4, P48621, DOI 10.1039/c4ra09897h; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Wiedemann I, 2006, MOL MICROBIOL, V61, P285, DOI 10.1111/j.1365-2958.2006.05223.x; Xiao Yao, 2011, Biomol Concepts, V2, P27, DOI 10.1515/bmc.2011.006; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9; Yang D, 2001, CELL MOL LIFE SCI, V58, P978, DOI 10.1007/PL00000914; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zhou N, 2004, BIOMETALS, V17, P217, DOI 10.1023/B:BIOM.0000027695.99874.ea	49	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179962	10.1371/journal.pone.0179962	http://dx.doi.org/10.1371/journal.pone.0179962			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654661	gold, Green Submitted, Green Published			2022-12-27	WOS:000404541500041
J	Doustmohammadian, A; Omidvar, N; Keshavarz-Mohammadi, N; Abdollahi, M; Amini, M; Eini-Zinab, H				Doustmohammadian, Aazam; Omidvar, Nasrin; Keshavarz-Mohammadi, Nastaran; Abdollahi, Morteza; Amini, Maryam; Eini-Zinab, Hassan			Developing and validating a scale to measure Food and Nutrition Literacy (FNLIT) in elementary school children in Iran	PLOS ONE			English	Article							HEART HEALTH-PROMOTION; GOODNESS-OF-FIT; HOME ECONOMICS; DIETARY-INTAKE; ADOLESCENTS; OBESITY; KNOWLEDGE; PROGRAM; TRANSITION; CHALLENGE	Background Food and nutrition literacy is an emerging term which is increasingly used in policy and research. Though research in this area is growing, progression is limited by the lack of an accepted method to measure food and nutrition literacy. The aim of this study is to develop a valid and reliable questionnaire to assess food and nutrition literacy in elementary school children in the city of Tehran. Methods The study was conducted in three phases. To develop Food and Nutrition Literacy (FNLIT) questionnaire, a comprehensive literature review and a qualitative study were initially performed to identify food and nutrition literacy dimensions and its components. Content and face validity of the questionnaire were evaluated by an expert panel as well as students. In the second phase, construct validity of the scale was evaluated using Explanatory Factor Analyses (EFA) and Confirmatory Factor Analyses (CFA). In the last phase (confirmatory phase), the final version of the questionnaire was evaluated on 400 students. Results Findings show Content Validity Ratio (CVR) and Content Validity Index (CVI) of the 62-item questionnaire at acceptable levels of 0.87 and 0.92, respectively. EFA suggested a six-factor construct, namely, understanding food and nutrition information, knowledge, functional, interactive, food choice, and critical. The results of CFA indicated acceptable fit indices for the proposed models. All subscales demonstrated satisfactory internal consistency (Cron-bach's alpha >= 0.70), except for critical skill subscale (0.48). The intraclass correlation coefficient (ICC = 0.90, CI: 0.83-0.94) indicated that Food and Nutrition Literacy (FNLIT) scale had satisfactory stability. Each phase of development progressively improved the questionnaire, which resulted in a 46-item (42 likert-type items and 4 true-false items) Food and Nutrition Literacy (FNLIT) scale. The questionnaire measured two domains with 6 sub-scales, including: 1) cognitive domain: understanding and knowledge; 2) skill domain: functional, food choice, interactive, and critical skills. Conclusion The developed food and nutrition literacy scale is a valid and reliable instrument to measure food and nutrition literacy in children. This measure lays a solid empirical and theoretical foundation for future research and tailored interventions to promote food and nutrition literacy in this age group.	[Doustmohammadian, Aazam; Omidvar, Nasrin; Eini-Zinab, Hassan] Shahid Beheshti Univ Med Sci, Dept Community Nutr, Natl Nutr & Food Technol Res Inst, Tehran, Iran; [Doustmohammadian, Aazam; Omidvar, Nasrin; Abdollahi, Morteza; Amini, Maryam; Eini-Zinab, Hassan] Shahid Beheshti Univ Med Sci, Fac Nutr Sci & Food Technol, Tehran, Iran; [Keshavarz-Mohammadi, Nastaran] Shahid Beheshti Univ Med Sci, Sch Publ Hlth, Tehran, Iran; [Abdollahi, Morteza; Amini, Maryam] Shahid Beheshti Univ Med Sci, Dept Nutr Res, Natl Nutr & Food Technol Res Inst, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Eini-Zinab, H (corresponding author), Shahid Beheshti Univ Med Sci, Dept Community Nutr, Natl Nutr & Food Technol Res Inst, Tehran, Iran.; Eini-Zinab, H (corresponding author), Shahid Beheshti Univ Med Sci, Fac Nutr Sci & Food Technol, Tehran, Iran.	hassan.eini@gmail.com	Doustmohammadian, Azam/ABA-8003-2020; Eini-Zinab, Hassan/R-8992-2016; Amini, Maryam/G-1642-2016; Omidvar, Nasrin/ABG-9093-2021; Amini, Maryam/H-6238-2019; mohammadi, nastaran keshavarz-/AAT-5225-2021	Doustmohammadian, Azam/0000-0001-6249-2520; Eini-Zinab, Hassan/0000-0002-6895-034X; Amini, Maryam/0000-0002-5279-213X; Amini, Maryam/0000-0002-5279-213X; Abdollahi, Morteza/0000-0003-0310-2021	NNFTRI	NNFTRI	The authors hereby express their gratitude to the Shahid Beheshti University of Medical Sciences, National Nutrition and Food Technology Research Institute (NNFTRI), all coordinators, interviewers, and all the students participated in this study. This research was conducted by the approval and funding of the NNFTRI.	Amos Arbuckle JL, 2006, AMOS; Azadbakht L, 2012, IRAN RED CRESCENT ME, V14, P204; Begley A, 2010, NUTR DIET, V67, P41, DOI 10.1111/j.1747-0080.2010.01392.x; Bellotti B., 2010, AGR SCI REV, V22, P29; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; Birch LL, 2015, APPETITE, V88, P11, DOI 10.1016/j.appet.2014.11.021; Block LG, 2011, J PUBLIC POLICY MARK, V30, P5, DOI 10.1509/jppm.30.1.5; Brug J., 2007, PUBLIC HLTH NUTR PRI, P100; Bublitz M.G., 2011, J RES CONSUM, V19, P1; Caraher M, 2010, HEALTH EDUC J, V69, P200, DOI 10.1177/0017896910364834; Carbone ET, 2012, J ACAD NUTR DIET, V112, P254, DOI 10.1016/j.jada.2011.08.042; Cardwell V. B., 2005, Journal of Natural Resources and Life Sciences Education, V34, P112; Choi Eun-Suil, 2008, Nutr Res Pract, V2, P308, DOI 10.4162/nrp.2008.2.4.308; Courtney M., 2013, PRACTICAL ASSESSM RE, V18, DOI [10.7275/9cf5-2m72, DOI 10.7275/9CF5-2M72]; Cullen T, 2015, CAN J DIET PRACT RES, V76, P140, DOI 10.3148/cjdpr-2015-010; Cullerton Katherine, 2012, REV FOOD LITERACY IN; Davis L.L., 1992, APPL NURS RES, V5, P194, DOI [10.1016/S0897-1897(05)80008-4, DOI 10.1016/S0897-1897(05)80008-4]; Desjardins E., 2013, MAKING SOMETHING OUT; Diamond JJ, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-5; Diethelm K, 2012, PUBLIC HEALTH NUTR, V15, P386, DOI 10.1017/S1368980011001935; Elrick H, 2002, NUTR RES, V22, P1101, DOI 10.1016/S0271-5317(02)00422-0; Escott-Stump SA, 2011, J AM DIET ASSOC, V111, P979, DOI 10.1016/j.jada.2011.05.024; Fordyce-Voorham S, 2011, J NUTR EDUC BEHAV, V43, P116, DOI 10.1016/j.jneb.2009.12.002; George D, 2003, SPSS WINDOWS STEP ST; Ghanbari S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149202; Ghassemi H, 2002, PUBLIC HEALTH NUTR, V5, P149, DOI 10.1079/PHN2001287; Gibbs H, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120267; Hoddinott J, 2016, MATERN CHILD NUTR, V12, P885, DOI 10.1111/mcn.12355; Howard A., 2013, WHATS EAT IMPROVING; HU LT, 1992, PSYCHOL BULL, V112, P351, DOI 10.1037//0033-2909.112.2.351; Kelishadi R, 2008, CHILD CARE HLTH DEV, V34, P44, DOI 10.1111/j.1365-2214.2007.00744.x; Kelishadi R, 2004, PREV MED, V39, P760, DOI 10.1016/j.ypmed.2004.02.047; Kelishadi R, 2003, PEDIATR INT, V45, P435, DOI 10.1046/j.1442-200X.2003.01738.x; Kelishadi R, 2007, HORM RES, V67, P46, DOI 10.1159/000096121; LAWSHE CH, 1975, PERS PSYCHOL, V28, P563, DOI 10.1111/j.1744-6570.1975.tb01393.x; Lin W, 2007, ASIA PAC J CLIN NUTR, V16, P534; Macdiarmid JI, 2011, PUBLIC HEALTH NUTR, V14, P729, DOI 10.1017/S1368980010002168; Margaret M. B., 2013, GLOBAL HDB NONCOMMUN, P417, DOI [10.1007/978-1-4614-7594-1_28, DOI 10.1007/978-1-4614-7594-1_28]; MARSH HW, 1988, PSYCHOL BULL, V103, P391, DOI 10.1037/0033-2909.103.3.391; Murimi MW, 2013, J NUTR EDUC BEHAV, V45, P195, DOI 10.1016/j.jneb.2013.03.014; National Academies of Sciences Engineering and Medicine, 2016, FOOD LIT COMM MARK I; Ndahura NB., 2012, THESIS OSLO AKERSHUS; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P183, DOI 10.1093/heapro/15.3.183; Nutbeam D, 2008, SOC SCI MED, V67, P2072, DOI 10.1016/j.socscimed.2008.09.050; Oldewage-Theron W, 2015, ECOL FOOD NUTR, V54, P138, DOI 10.1080/03670244.2014.959944; Pallant J., 2005, SPSS SURVIVAL MANUAL, V2; Pendergast D, 2011, FAM CONSUM SCI RES J, V39, P415, DOI 10.1111/j.1552-3934.2011.02079.x; Pettersen S., 2009, 19 INT C NUTR; Polit DF, 2007, RES NURS HEALTH, V30, P459, DOI 10.1002/nur.20199; Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI [10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557]; Rawl R, 2008, J NUTR EDUC BEHAV, V40, P49, DOI 10.1016/j.jneb.2007.04.372; Rawl R, 2006, FAM MED, V38, P690; Reynolds JS, 2012, J NUTR EDUC BEHAV, V44, P262, DOI 10.1016/j.jneb.2011.09.006; Sacco J, 2016, PERSPECT PUBLIC HLTH; Sadegholvad S., 2014, Journal of Nutrition & Intermediary Metabolism, V1, P11, DOI 10.1016/j.jnim.2014.10.031; Sharma S, 2005, J BUS RES, V58, P935, DOI 10.1016/j.jbusres.2003.10.007; Silk KJ, 2008, J NUTR EDUC BEHAV, V40, P3, DOI 10.1016/j.jneb.2007.08.012; Slater J, 2013, INT J CONSUM STUD, V37, DOI 10.1111/ijcs.12042; Sumner J., 2015, STUDIES ED ADULTS, V47, P128, DOI [10.1080/02660830.2015.11661680, DOI 10.1080/02660830.2015.11661680]; SVANHOLM H, 1989, APMIS, V97, P689, DOI 10.1111/j.1699-0463.1989.tb00464.x; Thomas Heather Mc, 2011, BMC Res Notes, V4, P495, DOI 10.1186/1756-0500-4-495; Vaitkeviciute R, 2015, PUBLIC HEALTH NUTR, V18, P649, DOI 10.1017/S1368980014000962; Vanderkooy P., 2010, REGION WATERLOO PUBL; Velardo S, 2015, J NUTR EDUC BEHAV, V47, P385, DOI 10.1016/j.jneb.2015.04.328; Vidgen HA, WHAT IS FOOD LITERAC; Vidgen HA, 2014, APPETITE, V76, P50, DOI 10.1016/j.appet.2014.01.010; Wall Catherine L, 2014, N Z Med J, V127, P30; Weiss BD, 2005, ANN FAM MED, V3, P514, DOI 10.1370/afm.405; Whati LH., 2005, DEV VALID RELIABLE N; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2010, STRENGTH HLTH SECT R; Yeung WLTL, 2010, J NUTR EDUC BEHAV, V42, P250, DOI 10.1016/j.jneb.2009.05.008; Zoellner J, 2009, PREV CHRONIC DIS, V6	73	44	52	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179196	10.1371/journal.pone.0179196	http://dx.doi.org/10.1371/journal.pone.0179196			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ2LT	28654646	Green Published, Green Submitted, gold			2022-12-27	WOS:000404541500006
J	Kaese, S; Larbig, R; Rohrbeck, M; Frommeyer, G; Dechering, D; Olligs, J; Schonhofer-Merl, S; Wessely, R; Klingel, K; Seebohm, G; Eckardt, L				Kaese, Sven; Larbig, Robert; Rohrbeck, Matthias; Frommeyer, Gerrit; Dechering, Dirk; Olligs, Jan; Schoenhofer-Merl, Sabine; Wessely, Rainer; Klingel, Karin; Seebohm, Guiscard; Eckardt, Lars			Electrophysiological alterations in a murine model of chronic coxsackievirus B3 myocarditis	PLOS ONE			English	Article							ENTEROVIRUS-INDUCED MYOCARDITIS; DILATED CARDIOMYOPATHY; HEART-FAILURE; POSTREPOLARIZATION REFRACTORINESS; INDUCED PANCREATITIS; TRANSGENIC MICE; REPOLARIZATION; INFECTION; MOUSE; OVEREXPRESSION	Introduction Coxsackievirus B3 (CVB3) is known to induce acute and chronic myocarditis. Most infections are clinically unapparent but some patients suffer from ventricular arrhythmias (VA) and sudden cardiac death (SCD). Studies showed that acute CVB3 infection may cause impaired function of cardiac ion channels, creating a proarrhythmic substrate. However, it is unknown whether low level CVB3+ expression in myocytes may cause altered cardiac electrophysiology leading to VA. Methods Cellular electrophysiology was used to analyze cellular action potentials (APs) and occurrence of afterdepolarizations from isolated cardiomyocytes of wildtype (WT) and transgenic CVB3.VP0 (CVB3+) mice. Further, we studied surface ECGs, monophasic APs, ventricular effective refractory period (VERP) and inducibility of VAs in Langendorff-perfused whole hearts. All used cardiomyocytes and whole hearts originated from male mice. Results Cellular action potential duration (APD) in WT and CVB3+ myocytes was unchanged. No difference in mean occurrence or amplitude of afterdepolarizations in WT and CVB3+ myocytes was found. Interestingly, resting membrane potential in CVB3+ myocytes was significantly hyperpolarized (WT: -90.0 +/- 2.2 mV, n = 7; CVB3+: -114.1 +/- 3.0 mV, n = 14; p < 0.005). Consistently, in Langendorff-perfused hearts, APDs were also not different between WT and CVB3+ whole hearts. Within both groups, we found a heart rate dependent shortening of ADP90 with increasing heart rate in Langendorff-perfused hearts. VERP was significantly prolonged in CVB3+ hearts compared to WT ( WT: 36.0 +/- 2.7 ms, n = 5; CVB3+: 47.0 +/- 2.0 ms, n = 7; p = 0.018). Resting heart rate ( HR) in Langendorff-perfused hearts was not significantly different between both genotypes. Electrical pacing protocols induced no VA in WT and CVB3+ hearts. Conclusion In CVB3+ mice, prolonged ventricular refractoriness and hyperpolarized resting membrane potentials in presence of unchanged APD were observed, suggesting that low level CVB3 expression does not promote VA by altered cardiac electrophysiology in this type of chronic myocarditis. These findings may suggest that other mechanisms such as chronic myocardial inflammation or fibrosis may account for arrhythmias observed in patients with chronic enteroviral myocarditis.	[Kaese, Sven; Larbig, Robert; Frommeyer, Gerrit; Dechering, Dirk; Olligs, Jan; Eckardt, Lars] Univ Munster, Dept Cardiovasc Med, Div Electrophysiol, Munster, Germany; [Rohrbeck, Matthias; Seebohm, Guiscard] Univ Munster, Dept Cardiovasc Med, IfGH Myocellular Electrophysiol, Munster, Germany; [Rohrbeck, Matthias; Seebohm, Guiscard] Univ Munster, Fac Med, Interdisciplinary Ctr Clin Res IZKF, Munster, Germany; [Schoenhofer-Merl, Sabine; Wessely, Rainer] Univ Technol, Klinikum Rechts Isar, Deutsch Herzzentrum, Munich, Germany; [Schoenhofer-Merl, Sabine; Wessely, Rainer] Univ Technol, Klinikum Rechts Isar, Med Klin, Munich, Germany; [Wessely, Rainer] Zentrum Herz & Gefassmed, Mediapk 2, Cologne, Germany; [Klingel, Karin] Univ Tubingen, Dept Mol Pathol, Tubingen, Germany	University of Munster; University of Munster; University of Munster; German Heart Center Berlin; German Heart Centre Munich; Technical University of Munich; Technical University of Munich; Eberhard Karls University of Tubingen	Kaese, S (corresponding author), Univ Munster, Dept Cardiovasc Med, Div Electrophysiol, Munster, Germany.	sven.kaese@ukmuenster.de			Deutsche Forschungsgemeinschaft [Se1077(3-3), KL595/2-3]; Innovative Medizinische Forschung [IMF140919]; Interdisciplinary Centre for Clinical Research IZKF Munster [See1/012/13]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Innovative Medizinische Forschung; Interdisciplinary Centre for Clinical Research IZKF Munster	GS was supported by Deutsche Forschungsgemeinschaft (http://www.dfg.de/) grant Se1077(3-3), Innovative Medizinische Forschung (https://campus.uni-muenster.de/imf/das-imf/) IMF140919 and Interdisciplinary Centre for Clinical Research IZKF Munster (https://campus.uni-muenster.de/izkf.html) grant See1/012/13. KK was was supported by Deutsche Forschungsgemeinschaft (http://www.dfg.de/) grant KL595/2-3. LE holds the Peter Osypka Professorship of Experimental and Clinical Electrophysiology (http://www.osypka.de/index.php?lang=de&cat=2&art=931). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babij P, 1998, CIRC RES, V83, P668, DOI 10.1161/01.RES.83.6.668; Baumann S., 2006, THESIS; Bogeholz N, 2015, CIRC-ARRHYTHMIA ELEC, V8, P1210, DOI 10.1161/CIRCEP.115.002927; Bouin A, 2016, EMERG INFECT DIS, V22, P1488, DOI 10.3201/eid2208.160186; Boulaksil M, 2010, EUR J HEART FAIL, V12, P913, DOI 10.1093/eurjhf/hfq092; Brouillette J, 2005, CARDIOVASC RES, V65, P148, DOI 10.1016/j.cardiores.2004.09.012; Brouillette J, 2003, J PHYSIOL-LONDON, V546, P403, DOI 10.1113/jphysiol.2002.030460; Carthy CM, 2003, VIROLOGY, V313, P147, DOI 10.1016/S0042-6822(03)00242-3; Chapman NM, 2008, CURR TOP MICROBIOL, V323, P275; Connolly AJ, 2016, CLIN MED INSIGHTS-CA, V10, P27, DOI 10.4137/CMC.S39708; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; Daley AJ, 1998, J PAEDIATR CHILD H, V34, P196, DOI 10.1046/j.1440-1754.1998.00176.x; Drici MD, 1998, CIRC RES, V83, P95, DOI 10.1161/01.RES.83.1.95; Fabritz L, 2003, CARDIOVASC RES, V57, P1085, DOI 10.1016/S0008-6363(02)00839-8; Fabritz L, 2003, BASIC RES CARDIOL, V98, P25, DOI 10.1007/s00395-003-0386-y; Feuer R, 2003, AM J PATHOL, V163, P1379, DOI 10.1016/S0002-9440(10)63496-7; Frommeyer G, 2012, J CARD FAIL, V18, P939, DOI 10.1016/j.cardfail.2012.10.017; Huber S, 2004, VIRAL IMMUNOL, V17, P358, DOI 10.1089/vim.2004.17.358; Hunziker IP, 2004, VIROLOGY, V330, P196, DOI 10.1016/j.virol.2004.09.035; Kaese S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00345; KANDOLF R, 1985, J MOL CELL CARDIOL, V17, P167, DOI 10.1016/S0022-2828(85)80019-5; KANDOLF R, 1993, INTERVIROLOGY, V35, P140, DOI 10.1159/000150305; Kim KS, 2001, REV MED VIROL, V11, P355, DOI 10.1002/rmv.326; KLINGEL K, 1992, P NATL ACAD SCI USA, V89, P314, DOI 10.1073/pnas.89.1.314; Kuhl U, 2005, CIRCULATION, V111, P887, DOI 10.1161/01.CIR.0000155616.07901.35; Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078; Larbig R, 2010, J PHYSIOL-LONDON, V588, P3266, DOI 10.1113/jphysiol.2010.187708; Maass K, 2009, CARDIOVASC RES, V84, P361, DOI 10.1093/cvr/cvp250; MARTINO TA, 1994, CIRC RES, V74, P182, DOI 10.1161/01.RES.74.2.182; Massilamany C, 2014, INT J CARDIOL, V177, P330, DOI 10.1016/j.ijcard.2014.09.136; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Milberg P, 2012, J CARDIOVASC PHARM, V59, P92, DOI 10.1097/FJC.0b013e3182377a11; MITRA R, 1985, AM J PHYSIOL, V249, P1056, DOI 10.1152/ajpheart.1985.249.5.H1056; Nerbonne JM, 2004, TRENDS CARDIOVAS MED, V14, P83, DOI 10.1016/j.tcm.2003.12.006; Podrid PJ, 2005, CLIN CARDIOL, V28, pI3; Pott C, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0247-7; Ramsingh AI, 2008, CURR TOP MICROBIOL, V323, P241; Rohrbeck M, 2015, THESIS; Schultz JC, 2009, MAYO CLIN PROC, V84, P1001, DOI [10.4065/84.11.1001, 10.1016/S0025-6196(11)60670-8]; SIPIDO KR, 1995, CIRC RES, V76, P102, DOI 10.1161/01.RES.76.1.102; Steinke K, 2013, FASEB J, V27, P4108, DOI 10.1096/fj.13-230193; Tracy S, 2000, J MED VIROL, V62, P70, DOI 10.1002/1096-9071(200009)62:1<70::AID-JMV11>3.0.CO;2-R; Trepanier-Boulay W, 2001, CIRC RES, V89, P437, DOI 10.1161/hh1701.095644; Verheule S, 2004, CIRC RES, V94, P1458, DOI 10.1161/01.RES.0000129579.59664.9d; Wessely R, 1998, CIRCULATION, V98, P450, DOI 10.1161/01.CIR.98.5.450; Wessely R, 1998, J CLIN INVEST, V102, P1444, DOI 10.1172/JCI1972	46	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0180029	10.1371/journal.pone.0180029	http://dx.doi.org/10.1371/journal.pone.0180029			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644868	Green Submitted, gold, Green Published			2022-12-27	WOS:000404145100058
J	Matono, T; Kutsuna, S; Kato, Y; Katanami, Y; Yamamoto, K; Takeshita, N; Hayakawa, K; Kanagawa, S; Kaku, M; Ohmagari, N				Matono, Takashi; Kutsuna, Satoshi; Kato, Yasuyuki; Katanami, Yuichi; Yamamoto, Kei; Takeshita, Nozomi; Hayakawa, Kayoko; Kanagawa, Shuzo; Kaku, Mitsuo; Ohmagari, Norio			Role of classic signs as diagnostic predictors for enteric fever among returned travellers: Relative bradycardia and eosinopenia	PLOS ONE			English	Article							TYPHOID-FEVER; TROPICAL DISEASES; BONE-MARROW; RECTAL-SWAB; CASE SERIES; SEPSIS; BLOOD; PATTERNS; CULTURES; TYPHUS	Background The lack of characteristic clinical findings and accurate diagnostic tools has made the diagnosis of enteric fever difficult. We evaluated the classic signs of relative bradycardia and eosinopenia as diagnostic predictors for enteric fever among travellers who had returned from the tropics or subtropics. Methods This matched case-control study used data from 2006 to 2015 for culture-proven enteric fever patients as cases. Febrile patients (> 38.3 degrees C) with non-enteric fever, who had returned from the tropics or subtropics, were matched to the cases in a 1: 3 ratio by age (+/- 3 years), sex, and year of diagnosis as controls. Cunha's criteria were used for relative bradycardia. Absolute eosinopenia was defined as an eosinophilic count of 0/mu L. Results Data from 160 patients (40 cases and 120 controls) were analysed. Cases predominantly returned from South Asia (70% versus 18%, p < 0.001). Relative bradycardia (88% versus 51%, p < 0.001) and absolute eosinopenia (63% versus 38%, p = 0.008) were more frequent in cases than controls. In multivariate logistic regression analysis, return from South Asia (aOR: 21.6; 95% CI: 7.17-64.9) and relative bradycardia (aOR: 11.7; 95% CI: 3.21-42.5) were independent predictors for a diagnosis of enteric fever. The positive likelihood ratio was 4.00 (95% CI: 2.58-6.20) for return from South Asia, 1.72 (95% CI: 1.39-2.13) for relative bradycardia, and 1.63 (95% CI: 1.17-2.27) for absolute eosinopenia. The negative predictive values of the three variables were notably high (83-92%);. however, positive predictive values were 35-57%. Conclusions The classic signs of relative bradycardia and eosinopenia were not specific for enteric fever; however both met the criteria for being diagnostic predictors for enteric fever. Among febrile returned travellers, relative bradycardia and eosinopenia should be re-evaluated for predicting a diagnosis of enteric fever in non-endemic areas prior to obtaining blood cultures.	[Matono, Takashi; Kutsuna, Satoshi; Kato, Yasuyuki; Katanami, Yuichi; Yamamoto, Kei; Takeshita, Nozomi; Hayakawa, Kayoko; Kanagawa, Shuzo; Ohmagari, Norio] Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Tokyo, Japan; [Matono, Takashi; Kaku, Mitsuo] Tohoku Univ, Grad Sch Med, Dept Infect Control & Lab Diagnost, Internal Med, Sendai, Miyagi, Japan	National Center for Global Health & Medicine - Japan; Tohoku University	Kato, Y (corresponding author), Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Tokyo, Japan.	ykato@hosp.ncgm.go.jp	Hayakawa, Kayoko/GNW-2394-2022; Ohmagari, Norio/GLN-5290-2022	Ohmagari, Norio/0000-0002-4622-8970; Matono, Takashi/0000-0001-9957-0510	Japan Agency for Medical Research and Development; AMED [15fk0108046h0003]	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); AMED	This study was supported in part by research grants from the Japan Agency for Medical Research and Development, AMED (15fk0108046h0003).The funder had no role in this study such as study design, data collection, or decision to publish.	Abidi K, 2008, CRIT CARE, V12, DOI 10.1186/cc6883; Andualem Gizachew, 2014, BMC Res Notes, V7, P653, DOI 10.1186/1756-0500-7-653; BASS DA, 1980, J CLIN INVEST, V65, P1265, DOI 10.1172/JCI109789; Cunha BA, 2004, INFECT DIS CLIN N AM, V18, P111, DOI 10.1016/S0891-5520(03)00094-1; Cunha BA, 2000, CLIN MICROBIOL INFEC, V6, P633, DOI 10.1046/j.1469-0691.2000.0194f.x; Date KA, 2016, CLIN INFECT DIS, V63, P322, DOI 10.1093/cid/ciw232; Davis TME, 1999, CLIN INFECT DIS, V28, P582, DOI 10.1086/515143; Ganesh R, 2010, INDIAN J PEDIATR, V77, P1089, DOI 10.1007/s12098-010-0196-9; Garnacho-Montero J, 2014, CRIT CARE, V18, DOI 10.1186/cc13908; GILMAN RH, 1975, LANCET, V1, P1211; Goodacre S, 2002, BRIT MED J, V324, P594, DOI 10.1136/bmj.324.7337.594; GOTUZZO E, 1994, ANTIMICROB AGENTS CH, V38, P558, DOI 10.1128/AAC.38.3.558; Hamaguchi S, 2015, AM J TROP MED HYG, V92, P972, DOI 10.4269/ajtmh.14-0806; HOFFMAN SL, 1984, J INFECT DIS, V149, P157, DOI 10.1093/infdis/149.2.157; Jensenius M, 2013, AM J TROP MED HYG, V88, P397, DOI 10.4269/ajtmh.12-0551; Jog S, 2008, J Assoc Physicians India, V56, P237; Kimura Masatsugu, 1997, Parasitology International, V46, P91, DOI 10.1016/S1383-5769(97)00013-5; Koizumi N, 2008, JPN J INFECT DIS, V61, P465; Kuvandik C, 2009, NEW MICROBIOL, V32, P25; Lateef A, 2007, EMERG INFECT DIS, V13, P650, DOI 10.3201/eid1304.061212; Lokhandwala A, 2012, IBNOSIMA J MED BS, V4, P249; Mangrum JM, 2000, NEW ENGL J MED, V342, P703, DOI 10.1056/NEJM200003093421006; Matono T, 2016, AM J TROP MED HYG, V95, P19, DOI 10.4269/ajtmh.15-0714; Mogasale V, 2014, LANCET GLOB HEALTH, V2, pE570, DOI 10.1016/S2214-109X(14)70301-8; Olsen SJ, 2004, J CLIN MICROBIOL, V42, P1885, DOI 10.1128/JCM.42.5.1885-1889.2004; Osler W., 1892, PRINCIPLES PRACTICES, P2; Ostergaard L, 1996, J INFECTION, V33, P185, DOI 10.1016/S0163-4453(96)92225-2; Patel TA, 2010, AM J TROP MED HYG, V82, P1121, DOI 10.4269/ajtmh.2010.10-0007; Pitman MC, 2013, CRIT CARE MED, V41, pE286, DOI 10.1097/CCM.0b013e3182923755; Rothenberg ME, 1998, NEW ENGL J MED, V338, P1592, DOI 10.1056/NEJM199805283382206; Spira AM, 2003, LANCET, V361, P1459, DOI 10.1016/S0140-6736(03)13141-8; Vollaard AM, 2005, T ROY SOC TROP MED H, V99, P440, DOI 10.1016/j.trstmh.2004.09.012; Wain J, 2015, LANCET, V385, P1136, DOI 10.1016/S0140-6736(13)62708-7; Wilson ME, 2007, CLIN INFECT DIS, V44, P1560, DOI 10.1086/518173; World Health Organization, IMM VACC BIOL VACC D	35	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179814	10.1371/journal.pone.0179814	http://dx.doi.org/10.1371/journal.pone.0179814			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644847	Green Submitted, Green Published, gold			2022-12-27	WOS:000404145100039
J	Hanke, CA; Gohlke, H				Hanke, Christian A.; Gohlke, Holger			Ligand-mediated and tertiary interactions cooperatively stabilize the P1 region in the guanine-sensing riboswitch	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; CROSS-CORRELATION ANALYSIS; PROTEIN FLEXIBILITY; PURINE RIBOSWITCH; APTAMER DOMAIN; RIGIDITY PERCOLATION; FOLDING KINETICS; GENE-EXPRESSION; FORCE-FIELDS; INDUCED FIT	Riboswitches are genetic regulatory elements that control gene expression depending on ligand binding. The guanine-sensing riboswitch (Gsw) binds ligands at a three-way junction formed by paired regions P1, P2, and P3. Loops L2 and L3 cap the P2 and P3 helices and form tertiary interactions. Part of P1 belongs to the switching sequence dictating the fate of the mRNA. Previous studies revealed an intricate relationship between ligand binding and presence of the tertiary interactions, and between ligand binding and influence on the P1 region. However, no information is available on the interplay among these three main regions in Gsw. Here we show that stabilization of the L2-L3 region by tertiary interactions, and the ligand binding site by ligand binding, cooperatively influences the structural stability of terminal base pairs in the P1 region in the presence of Mg2+ ions. The results are based on molecular dynamics simulations with an aggregate simulation time of similar to 10 mu s across multiple systems of the unbound state of the Gsw aptamer and a G37A/C61U mutant, and rigidity analyses. The results could explain why the three-way junction is a central structural element also in other riboswitches and how the cooperative effect could become contextual with respect to intracellular Mg2+ concentration. The results suggest that the transmission of allosteric information to P1 can be entropy-dominated.	[Hanke, Christian A.; Gohlke, Holger] Heinrich Heine Univ Dusseldorf, Inst Pharmazeut & Med Chem, Math Nat Wissensch Fak, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Gohlke, H (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Pharmazeut & Med Chem, Math Nat Wissensch Fak, Dusseldorf, Germany.	gohlke@uni-duesseldorf.de		Hanke, Christian A./0000-0002-4826-4908	Heinrich Heine University Dusseldorf; supercomputer JUROPA at julich Supercomputing Center (JSC) (NIC) [4722, HDD08]	Heinrich Heine University Dusseldorf; supercomputer JUROPA at julich Supercomputing Center (JSC) (NIC)	This work was supported by institutional funds of Heinrich Heine University Dusseldorf. We gratefully acknowledge the computing time granted by the John von Neumann Institute for Computing (NIC) and provided on the supercomputer JUROPA at julich Supercomputing Center (JSC) (NIC project 4722, HDD08). Additional computational support was provided by the "Center for Information and Media Technology" (ZIM) at the Heinrich-Heine-University of Dusseldorf (Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the computing time granted by the John von Neumann Institute for Computing (NIC) and provided on the supercomputer JUROPA at Julich Supercomputing Center (JSC) (NIC project 4722, HDD08). Additional computational support was provided by the "Center for Information and Media Technology" (ZIM) at the Heinrich-Heine-University of Dusseldorf (Germany).	Abseher R, 1998, J MOL BIOL, V279, P911, DOI 10.1006/jmbi.1998.1807; Allner O, 2013, RNA, V19, P916, DOI 10.1261/rna.037549.112; AQVIST J, 1990, J PHYS CHEM-US, V94, P8021, DOI 10.1021/j100384a009; AQVIST J, 1992, J MOL STRUC-THEOCHEM, V88, P135, DOI 10.1016/0166-1280(92)87163-T; Auffinger P., 2012, RNA 3D STRUCTURE ANA, P299; Baird NJ, 2010, RNA, V16, P598, DOI 10.1261/rna.1852310; Banas P, 2012, J PHYS CHEM B, V116, P12721, DOI 10.1021/jp309230v; Banas P, 2010, J CHEM THEORY COMPUT, V6, P3836, DOI 10.1021/ct100481h; Batey RT, 2012, Q REV BIOPHYS, V45, P345, DOI 10.1017/S0033583512000078; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Breaker RR, 2011, MOL CELL, V43, P867, DOI 10.1016/j.molcel.2011.08.024; Brenner MD, 2010, BIOCHEMISTRY-US, V49, P1596, DOI 10.1021/bi9019912; Buck J, 2007, P NATL ACAD SCI USA, V104, P15699, DOI 10.1073/pnas.0703182104; Buck J, 2011, NUCLEIC ACIDS RES, V39, P9768, DOI 10.1093/nar/gkr664; Buck J, 2010, NUCLEIC ACIDS RES, V38, P4143, DOI 10.1093/nar/gkq138; Case D. A., 2012, AMBER 13; Case D.A., 2022, AMBER 2020; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cheatham TE, 2013, BIOPOLYMERS, V99, P969, DOI 10.1002/bip.22331; Chen SJ, 2008, ANNU REV BIOPHYS, V37, P197, DOI 10.1146/annurev.biophys.37.032807.125957; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; Dann CE, 2007, CELL, V130, P878, DOI 10.1016/j.cell.2007.06.051; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de la Pena M, 2009, RNA, V15, P1949, DOI 10.1261/rna.1889509; Di Palma F, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S9-S6; Di Palma F, 2013, RNA, V19, P1517, DOI 10.1261/rna.040493.113; Draper DE, 2005, ANNU REV BIOPH BIOM, V34, P221, DOI 10.1146/annurev.biophys.34.040204.144511; Furtig B, 2015, CURR OPIN STRUC BIOL, V30, P112, DOI 10.1016/j.sbi.2015.02.007; Fulle S, 2008, BIOPHYS J, V94, P4202, DOI 10.1529/biophysj.107.113415; Fulle S, 2010, J CHEM INF MODEL, V50, P1489, DOI 10.1021/ci100101w; Fulle S, 2009, METHODS, V49, P181, DOI 10.1016/j.ymeth.2009.04.004; Fulle S, 2009, J MOL BIOL, V387, P502, DOI 10.1016/j.jmb.2009.01.037; Galindo-Murillo R, 2015, BBA-GEN SUBJECTS, V1850, P1041, DOI 10.1016/j.bbagen.2014.09.007; Garst AD, 2009, BBA-GENE REGUL MECH, V1789, P584, DOI 10.1016/j.bbagrm.2009.06.004; Gilbert SD, 2007, BIOCHEMISTRY-US, V46, P13297, DOI 10.1021/bi700410g; Gilbert SD, 2006, J MOL BIOL, V359, P754, DOI 10.1016/j.jmb.2006.04.003; Gohlke H, 2004, PROTEINS, V56, P322, DOI 10.1002/prot.20116; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Gohlke H, 2017, J CHEM THEORY COMPUT, V13, P1495, DOI 10.1021/acs.jctc.7b00014; Hanke CA, 2015, METHOD ENZYMOL, V553, P163, DOI 10.1016/bs.mie.2014.10.056; HARNED HS, 1951, J AM CHEM SOC, V73, P5880, DOI 10.1021/ja01156a523; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; HUNENBERGER PH, 1995, J MOL BIOL, V252, P492, DOI 10.1006/jmbi.1995.0514; JACOBS DJ, 1995, PHYS REV LETT, V75, P4051, DOI 10.1103/PhysRevLett.75.4051; Jacobs DJ, 2001, PROTEINS, V44, P150, DOI 10.1002/prot.1081; Jacobs DJ, 1997, J COMPUT PHYS, V137, P346, DOI 10.1006/jcph.1997.5809; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karplus M, 1996, J MOL BIOL, V263, P120, DOI 10.1006/jmbi.1996.0562; Lescoute A, 2006, RNA, V12, P83, DOI 10.1261/rna.2208106; Liberman JA, 2012, WIRES RNA, V3, P369, DOI 10.1002/wrna.114; Mamonova T, 2005, PHYS BIOL, V2, pS137, DOI 10.1088/1478-3975/2/4/S08; Mandal M, 2004, NAT REV MOL CELL BIO, V5, P451, DOI 10.1038/nrm1403; Mills R., 1989, SELF DIFFUSION ELECT; Mlynsky V, 2010, J PHYS CHEM B, V114, P6642, DOI 10.1021/jp1001258; Nguyen PH, 2009, J PHYS CHEM B, V113, P9340, DOI 10.1021/jp902013s; Noeske J, 2009, LIGAND BINDING CONFO; Noeske J, 2007, NUCLEIC ACIDS RES, V35, P572, DOI 10.1093/nar/gkl1094; Nozinovic S, 2014, RNA BIOL, V11, P655, DOI 10.4161/rna.29439; OHTAKI H, 1993, CHEM REV, V93, P1157, DOI 10.1021/cr00019a014; Ottink OM, 2007, RNA, V13, P2202, DOI 10.1261/rna.635307; Ottink OM, 2010, BIOMOL NMR ASSIGN, V4, P89, DOI 10.1007/s12104-010-9215-z; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Pfleger C, 2013, J CHEM INF MODEL, V53, P1007, DOI 10.1021/ci400044m; Porter EB, 2014, BBA-GENE REGUL MECH, V1839, P919, DOI 10.1016/j.bbagrm.2014.02.014; Prychyna O, 2009, BIOPOLYMERS, V91, P953, DOI 10.1002/bip.21283; Quarta G, 2012, PLOS COMPUTATIONAL B; Rader AJ, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016002; Rader AJ, 2002, P NATL ACAD SCI USA, V99, P3540, DOI 10.1073/pnas.062492699; Rathi PC, 2012, J BIOTECHNOL, V159, P135, DOI 10.1016/j.jbiotec.2012.01.027; Reblova K, 2003, BIOPHYS J, V84, P3564, DOI 10.1016/S0006-3495(03)75089-9; Reblova K, 2006, BIOPOLYMERS, V82, P504, DOI 10.1002/bip.20503; Reining A, 2013, NATURE, V499, P355, DOI 10.1038/nature12378; Robinson H, 2000, NUCLEIC ACIDS RES, V28, P1760, DOI 10.1093/nar/28.8.1760; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Sanbonmatsu KY, 2014, BBA-GENE REGUL MECH, V1839, P1046, DOI 10.1016/j.bbagrm.2014.06.010; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Serganov A, 2013, CELL, V152, P17, DOI 10.1016/j.cell.2012.12.024; Serganov A, 2012, ANNU REV BIOPHYS, V41, P343, DOI 10.1146/annurev-biophys-101211-113224; Sharma M, 2009, RNA, V15, P1673, DOI 10.1261/rna.1675809; Sklenovsky P, 2011, J CHEM THEORY COMPUT, V7, P2963, DOI 10.1021/ct200204t; Sponer J, 2014, J PHYS CHEM LETT, V5, P1771, DOI 10.1021/jz500557y; Sponer J, 2012, METHODS, V57, P25, DOI 10.1016/j.ymeth.2012.04.005; Stoddard CD, 2008, RNA, V14, P675, DOI 10.1261/rna.736908; Stoddard CD, 2013, J MOL BIOL, V425, P1596, DOI 10.1016/j.jmb.2013.02.023; Stoddard CD, 2010, STRUCTURE, V18, P787, DOI 10.1016/j.str.2010.04.006; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Tucker BJ, 2005, CURR OPIN STRUC BIOL, V15, P342, DOI 10.1016/j.sbi.2005.05.003; Villa A, 2009, NUCLEIC ACIDS RES, V37, P4774, DOI 10.1093/nar/gkp486; Wakeman CA, 2014, J BACTERIOL, V196, P1206, DOI 10.1128/JB.01238-13; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang YM, 2004, J STRUCT BIOL, V147, P302, DOI 10.1016/j.jsb.2004.01.005; Whitty A, 2008, NAT CHEM BIOL, V4, P435, DOI 10.1038/nchembio0808-435; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Woodson SA, 2005, CURR OPIN CHEM BIOL, V9, P104, DOI 10.1016/j.cbpa.2005.02.004; Zgarbova M, 2011, J CHEM THEORY COMPUT, V7, P2886, DOI 10.1021/ct200162x	98	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179271	10.1371/journal.pone.0179271	http://dx.doi.org/10.1371/journal.pone.0179271			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640851	Green Published, Green Submitted, gold			2022-12-27	WOS:000404135800027
J	Leijendekkers, RA; van Hinte, G; Sman, AD; Staal, JB; Nijhuis-van der Sanden, MWG; Hoogeboom, TJ				Leijendekkers, Ruud A.; van Hinte, Gerben; Sman, Amy D.; Staal, J. Bart; Nijhuis-van der Sanden, Maria W. G.; Hoogeboom, Thomas J.			Clinimetric properties of hip abduction strength measurements obtained using a handheld dynamometer in individuals with a lower extremity amputation	PLOS ONE			English	Article							MUSCLE STRENGTH; RELIABILITY; VALIDITY; AMPUTEES; WALKING; GAIT; REHABILITATION; STABILIZATION; AGREEMENT; FIXATION	Introduction Suitable handheld dynamometer (HHD)-techniques to test hip abduction strength in individuals with a lower extremity amputation, irrespective of their amputation level are absent. The aim of this study was to optimise a HHD-technique and to test its reproducibility and validity. Methods This study involved three phases, in which two techniques were evaluated. Both HHD-techniques used a lever-arm of 22 centimetre. HHD-technique 1 used a break-technique. After obtaining within-session test-retest reproducibility (phase 1) we optimised the HHD-technique by adding a fixation-belt and using a make-technique (HHD-technique 2). We tested the within-session test-retest and inter-rater reproducibility (phase 2) and the validity (phase 3) of HHD-technique 2 using an isokinetic dynamometer. New cohorts of participants were recruited for each phase. Results Phase 1: we tested HHD-technique 1 in 26 participants with a lower extremity amputation. It was test-retest reproducible (ICC3.1(agreement): 0.80-0.92, standard error of measurement (SEM): 3.1-4.4 Nm and smallest detectable change (SDC): 8.6-12.3 Nm). There were questions regarding the validity of the measurement, because the mean muscle torque of the residual limb and sound limb were similar, which is uncommon. Phase 2: reproducibility of HHD-technique 2 was tested in 44 participants with a lower extremity amputation. It was test-retest reproducible (ICC3.1(agreement): 0.96-0.97, SEM: 3.9-4.7 Nm and SDC: 10.9-12.9 Nm) but not inter-rater reproducible despite having good reliability (ICC3.1(agreement:) 0.92, SEM: 6.9-7.6 Nm and SDC: 19.2-21.2 Nm). Systematic bias and bias related to the magnitude of the muscle torque was suspected. Phase 3: the concurrent validity was established in 30 healthy participants (r = 0.84). Systematic bias in measurement error was present, including a consistent overestimation of the muscle torque of 28% using the HHD. Conclusion HHD-technique 2 is a test-retest reproducible and valid measuring technique The technique may be further optimised by the use of an external device to stabilise the HHD.	[Leijendekkers, Ruud A.; van Hinte, Gerben; Sman, Amy D.; Nijhuis-van der Sanden, Maria W. G.] Radboud Univ Nijmegen, Med Ctr, Dept Orthopaed, Phys Therapy, Nijmegen, Netherlands; [Staal, J. Bart; Nijhuis-van der Sanden, Maria W. G.; Hoogeboom, Thomas J.] Radboud Univ Nijmegen, Radboud Inst Hlth Sci, IQ Healthcare, Med Ctr, Nijmegen, Netherlands; [Staal, J. Bart] HAN Univ Appl Sci, Res Grp Musculoskeletal Rehabil, Nijmegen, Netherlands; [Nijhuis-van der Sanden, Maria W. G.] Radboud Univ Nijmegen, Med Ctr, Dept Rehabil, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Leijendekkers, RA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Orthopaed, Phys Therapy, Nijmegen, Netherlands.	Ruud.Leijendekkers@radboudumc.nl	van Hinte, MSc G.J./L-4374-2015; Hoogeboom, Thomas J/G-8767-2015; der Sanden, Maria WG Nijhuis-van/B-3463-2012; Sman, Amy D/C-1705-2014; Staal, J. Bart/A-9632-2014; Leijendekkers, R.A./L-4485-2015; Staal, Bart/ABA-4313-2020	van Hinte, MSc G.J./0000-0001-9357-5388; Hoogeboom, Thomas J/0000-0003-2103-419X; der Sanden, Maria WG Nijhuis-van/0000-0003-2637-6877; Sman, Amy D/0000-0002-2052-0818; Staal, J. Bart/0000-0002-0083-6380; Leijendekkers, R.A./0000-0002-6158-6901; Staal, Bart/0000-0002-0083-6380				Aramaki Hidefumi, 2016, J Phys Ther Sci, V28, P2123, DOI 10.1589/jpts.28.2123; Atsma F, 2005, J CLIN EPIDEMIOL, V58, P1282, DOI 10.1016/j.jclinepi.2005.04.005; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Burns SP, 2005, ARCH PHYS MED REHAB, V86, P1420, DOI 10.1016/j.apmr.2004.12.041; Byrt T, 1996, EPIDEMIOLOGY, V7, P561, DOI 10.1097/00001648-199609000-00030; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; de Vet HW, 2011, MEASUREMENT MED PRAC; Donachy JE, 2004, DISABIL REHABIL, V26, P495, DOI 10.1080/09638280410001663067; Fenter PC, 2003, BRIT J SPORT MED, V37, P331, DOI 10.1136/bjsm.37.4.331; Hagberg K, 2009, J REHABIL RES DEV, V46, P331, DOI 10.1682/JRRD.2008.06.0080; Hebert LJ, 2011, PEDIATR PHYS THER, V23, P289, DOI 10.1097/PEP.0b013e318227ccff; Heitzmann DWW, 2013, BIOMED ENG-BIOMED TE, V58, P195, DOI 10.1515/bmt-2012-0036; International Standards Organization, 1993, 85482 ISO; Jackson SM, 2017, MUSCULOSKEL SCI PRAC, V27, P137, DOI 10.1016/j.math.2016.07.010; JAEGERS SMHJ, 1995, ARCH PHYS MED REHAB, V76, P736, DOI 10.1016/S0003-9993(95)80528-1; JAEGERS SMHJ, 1995, CLIN ORTHOP RELAT R, P276; Keating JL, 1996, PHYS THER, V76, P866, DOI 10.1093/ptj/76.8.866a; Kowal M, 2014, BIOMED HUM KINET, V6, P63, DOI 10.2478/bhk-2014-0011; Krause DA, 2007, ARCH PHYS MED REHAB, V88, P37, DOI 10.1016/j.apmr.2006.09.011; Krause DA, 2014, J SPORT REHABIL, V23, P56, DOI [10.1123/JSR.2012-0070, 10.1123/jsr.2012-0070]; Leijendekkers RA, 2017, PHYSIOTHER THEOR PR, V33, P147, DOI 10.1080/09593985.2016.1265620; Leijendekkers RA, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1341-z; Li RC, 2006, ARCH PHYS MED REHAB, V87, P411, DOI 10.1016/j.apmr.2005.11.011; Lu YM, 2011, J STRENGTH COND RES, V25, P1065, DOI 10.1519/JSC.0b013e3181d650a6; Malliaras P, 2009, BRIT J SPORT MED, V43, P739, DOI 10.1136/bjsm.2008.055749; Martin HJ, 2006, GERONTOLOGY, V52, P154, DOI 10.1159/000091824; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Molina-Rueda F, 2014, BRAZ J PHYS THER, V18, P252, DOI 10.1590/bjpt-rbf.2014.0032; Nadollek Heidi, 2002, Physiother Res Int, V7, P203, DOI 10.1002/pri.260; Nolan L, 2012, J REHABIL MED, V44, P241, DOI 10.2340/16501977-0921; Paul DJ, 2014, J SPORT SCI, V32, P1318, DOI 10.1080/02640414.2014.927069; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Pua YH, 2008, ARCH PHYS MED REHAB, V89, P1146, DOI 10.1016/j.apmr.2007.10.028; RYSER DK, 1988, ARCH PHYS MED REHAB, V69, P840; Salsich GB, 1997, CLIN REHABIL, V11, P60, DOI 10.1177/026921559701100109; Schalk SAF, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001416; Stark T, 2011, PM&R, V3, P472, DOI 10.1016/j.pmrj.2010.10.025; STRATFORD PW, 1994, J ORTHOP SPORT PHYS, V19, P28, DOI 10.2519/jospt.1994.19.1.28; SULLIVAN S J, 1988, Journal of Orthopaedic and Sports Physical Therapy, V10, P213; SURBURG PR, 1992, ARCH PHYS MED REHAB, V73, P535; Thorborg K, 2010, SCAND J MED SCI SPOR, V20, P493, DOI 10.1111/j.1600-0838.2009.00958.x; Thorborg K, 2013, KNEE SURG SPORT TR A, V21, P550, DOI 10.1007/s00167-012-2115-2; TRUDELLEJACKSON E, 1994, J ORTHOP SPORT PHYS, V20, P302, DOI 10.2519/jospt.1994.20.6.302; VANDERPLOEG RJO, 1991, J NEUROL NEUROSUR PS, V54, P248, DOI 10.1136/jnnp.54.3.248; Visser JMA, 2011, PROSTHET ORTHOT INT, V35, P451, DOI 10.1177/0309364611422268; Wong CK, 2016, PROSTHET ORTHOT INT, V40, P8, DOI 10.1177/0309364614546926	46	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179887	10.1371/journal.pone.0179887	http://dx.doi.org/10.1371/journal.pone.0179887			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640926	Green Published, Green Submitted, gold			2022-12-27	WOS:000404135800078
J	Pucken, VB; Knubben-Schweizer, G; Dopfer, D; Groll, A; Hafner-Marx, A; Hormansdorfer, S; Sauter-Louis, C; Straubinger, RK; Zimmermann, P; Hartnack, S				Pucken, Valerie-Beau; Knubben-Schweizer, Gabriela; Dopfer, Dorte; Groll, Andreas; Hafner-Marx, Angela; Hoermansdorfer, Stefan; Sauter-Louis, Carola; Straubinger, Reinhard K.; Zimmermann, Pia; Hartnack, Sonja			Evaluating diagnostic tests for bovine tuberculosis in the southern part of Germany: A latent class analysis	PLOS ONE			English	Article							GAMMA-INTERFERON ASSAY; MYCOBACTERIUM-BOVIS; ENVIRONMENTAL MYCOBACTERIA; DISEASE PREVALENCE; MORTEM DIAGNOSIS; ERROR RATES; SKIN-TEST; CATTLE; HERDS; IDENTIFICATION	Germany has been officially free of bovine tuberculosis since 1996. However, in the last years there has been an increase of bovine tuberculosis cases, particularly in the southern part of Germany, in the Allgau region. As a consequence a one-time tuberculosis surveillance program was revisited with different premortal and postmortal tests. The aim of this paper was to estimate diagnostic sensitivities and specificities of the different tests used within this surveillance program. In the absence of a perfect test with 100% sensitivity and 100% specificity, thus in the absence of a gold standard, a Bayesian latent class approach with two different datasets was performed. The first dataset included 389 animals, tested with single intra-dermal comparative cervical tuberculin (SICCT) test, PCR and pathology; the second dataset contained 175 animals, tested with single intra-dermal cervical tuberculin (SICT) test, Bovigam (R) assay, pathology and culture. Two-way conditional dependencies were considered within the models. Additionally, inter-laboratory agreement (five officially approved laboratories) of the Bovigam (R) assay was assessed with Cohen's kappa test (21 blood samples). The results are given in posterior means and 95% credibility intervals. The specificities of the SICT test, SICCT test, PCR and pathology ranged between 75.8% [68.8-82.2%] and 99.0% [96.8-100%]. The Bovigam (R) assay stood out with a very low specificity (6.9% [3.6-11.1%]), though it had the highest sensitivity (95.7% [91.3-99.2%]). The sensitivities of the SICCT test, PCR, SICT test, pathology and culture varied from 57.8% [48.0-67.6%] to 88.9% [65.5-99.7%]. The prevalences were 19.8% [14.6-26.5%] (three-test dataset) and 7.7% [4.2-12.3%] (four-test dataset). Among all pairwise comparisons the highest agreement was 0.62 [0.15-1]). In conclusion, the specificity of the Bovigam (R) assay and the inter-laboratory agreement were lower than expected.	[Pucken, Valerie-Beau; Knubben-Schweizer, Gabriela] Ludwig Maximilians Univ Munchen, Clin Ruminants Ambulatory & Herd Hlth Serv, Ctr Clin Vet Med, Oberschleissheim, Germany; [Dopfer, Dorte] Univ Wisconsin, Sch Vet Med, Food Anim Prod Med, Madison, WI 53706 USA; [Groll, Andreas] Ludwig Maximilians Univ Munchen, Dept Math, Workgrp Financial Math, Munich, Germany; [Hafner-Marx, Angela; Hoermansdorfer, Stefan; Zimmermann, Pia] Bavarian Hlth & Food Safety Author, Oberschleissheim, Germany; [Sauter-Louis, Carola] Friedrich Loeffler Inst, Inst Epidemiol, Greifswald, Germany; [Straubinger, Reinhard K.] Ludwig Maximilians Univ Munchen, Inst Infect Dis & Zoonoses, Dept Vet Sci, Munich, Germany; [Hartnack, Sonja] Univ Zurich, Vetsuisse Fac, Sect Epidemiol, Zurich, Switzerland	University of Munich; University of Wisconsin System; University of Wisconsin Madison; University of Munich; Bavarian Health & Food Safety Authority; Friedrich Loeffler Institute; University of Munich; University of Zurich	Pucken, VB (corresponding author), Ludwig Maximilians Univ Munchen, Clin Ruminants Ambulatory & Herd Hlth Serv, Ctr Clin Vet Med, Oberschleissheim, Germany.	valerie.pucken@vetsuisse.unibe.ch	Knubben-Schweizer, Gabriela/A-4068-2019; Sauter-Louis, Carola/ABB-1186-2021; Straubinger, Reinhard K/D-1719-2010; Hartnack, Sonja/B-4328-2010; Groll, Andreas/AAP-3627-2021	Knubben-Schweizer, Gabriela/0000-0002-0928-5933; Sauter-Louis, Carola/0000-0002-6440-1933; Hartnack, Sonja/0000-0002-5757-5708; Groll, Andreas/0000-0001-6787-9118; Straubinger, Reinhard/0000-0001-8382-7182; Pucken, Valerie-Beau/0000-0001-8517-9350	Bayerisches Staatsministerium fur Ernahrung, Landwirtschaft und Forsten [A/13/37]	Bayerisches Staatsministerium fur Ernahrung, Landwirtschaft und Forsten	This research was funded by Bayerisches Staatsministerium fur Ernahrung, Landwirtschaft und Forsten (www.stmelf.bayern.de/) (grant number: A/13/37, awarded to VBP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2010, PREV VET MED, V96, P161, DOI 10.1016/j.prevetmed.2010.06.007; Alvarez J, 2012, VET MICROBIOL, V155, P38, DOI 10.1016/j.vetmic.2011.07.034; Amos W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058245; [Anonymous], 2015, OFF COLL METH, P1; [Anonymous], 2006, SB4008; Antognoli MC, 2011, PREV VET MED, V101, P35, DOI 10.1016/j.prevetmed.2011.05.012; Bakker D, 2014, 6 INT M BOV C; Barry C, 2011, VET MED INT, V2011, DOI DOI 10.4061/2011/145092; Beath K, 2017, RANDOM EFFECTS LATEN; Berkvens D, 2006, EPIDEMIOLOGY, V17, P145, DOI 10.1097/01.ede.0000198422.64801.8d; Bermingham ML, 2015, SCI REPORTS, P5; Bezos J, 2014, RES VET SCI, V97, pS44, DOI 10.1016/j.rvsc.2014.04.002; Bottcher J, 2010, 1 C EUR ASS VET LAB; Buddle BM, 2003, VET REC, V153, P615, DOI 10.1136/vr.153.20.615; Cagiola M, 2004, CLIN DIAGN LAB IMMUN, V11, P952, DOI 10.1128/CDLI.11.5.952-956.2004; Claridge J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1840; Clegg TA, 2011, VET MICROBIOL, V151, P68, DOI 10.1016/j.vetmic.2011.02.027; Coad M, 2007, VET REC, V160, P660, DOI 10.1136/vr.160.19.660; Cooney R, 1997, IRISH VET J, V50, P370; CORNER LA, 1990, AUST VET J, V67, P389, DOI 10.1111/j.1751-0813.1990.tb03020.x; CORNER LA, 1994, VET MICROBIOL, V40, P53, DOI 10.1016/0378-1135(94)90046-9; Courcoul A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090334; Cousins DN., 2014, MANUAL DIAGNOSTIC TE, P1; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; Dohoo I., 2014, VET EPIDEMIOLOGIC RE, V2nd; Donoghue HD, 1997, J APPL MICROBIOL, V82, P57, DOI 10.1111/j.1365-2672.1997.tb03297.x; Fay MP, 2010, R J, V2, P53; Faye S, 2011, VET MICROBIOL, V151, P60, DOI 10.1016/j.vetmic.2011.02.026; Gerstmair E-M, 2011, VALIDIERUNG MOLEKULA; Good M, 2011, VET MICROBIOL, V151, P77, DOI 10.1016/j.vetmic.2011.02.028; Gormley E, 2004, VET IMMUNOL IMMUNOP, V102, P413, DOI 10.1016/j.vetimm.2004.08.002; Gormley E, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-117; HARTNACK S., 2012, J MYCOBACTERIAL DIS, V2, P120, DOI DOI 10.4172/2161-1068.1000120; Heigl F, 2013, RINDER ROTWILD TUBER; Hui S L, 1998, Stat Methods Med Res, V7, P354, DOI 10.1191/096228098671192352; HUI SL, 1980, BIOMETRICS, V36, P167, DOI 10.2307/2530508; Hunermund G, 2006, Pneumologie, V60, P772, DOI 10.1055/s-2006-944284; Kohler H, 2012, TUBERKULOSE RINDES W; Koohler H, 2013, 16 INT S WORLD ASS V; Lauzi S, 2000, VET J, V160, P17, DOI 10.1053/tvjl.1999.0444; Lewis FI, 2012, EMERG THEMES EPIDEMI, V9, DOI 10.1186/1742-7622-9-9; Livingstone PG, 2014, N Z VET J SUPPL 1, V63, P4, DOI DOI 10.1080/; Lopes LB, 2012, PESQUI VET BRASIL, V32, P279, DOI 10.1590/S0100-736X2012000400001; Miller RS, 2013, PREV VET MED, V110, P119, DOI 10.1016/j.prevetmed.2012.11.021; MONAGHAN ML, 1994, VET MICROBIOL, V40, P111, DOI 10.1016/0378-1135(94)90050-7; Moser I, 2014, TIERAERZTL PRAX G N, V42, P240; Norby B, 2004, J VET DIAGN INVEST, V16, P126, DOI 10.1177/104063870401600206; OIE, 2012, STAND OP PROC OIE RE; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Pucken VB, 2015, TIERARZTLICHE PRAXIS; Qu YS, 1996, BIOMETRICS, V52, P797, DOI 10.2307/2533043; Quirin R, 2001, ONDERSTEPOORT J VET, V68, P231; Robinson P.K., 2015, EPIDEMIOL INFECT, P1; RODRIGUEZ JG, 1995, MICROBIOL-SGM, V141, P2131, DOI 10.1099/13500872-141-9-2131; Rolle M, 2011, TIERMEDIZINISCHE MIK; Rothel JS, 1993, AUSTRALIAN STANDARD; Ryan TJ, 2000, RES VET SCI, V69, P57, DOI 10.1053/rvsc.2000.0386; Sattelmair H, 2005, TUBERKULOSE RINDES B; Schiller I, 2010, VET IMMUNOL IMMUNOP, V136, P1, DOI 10.1016/j.vetimm.2010.02.007; Schiller I, 2009, CLIN VACCINE IMMUNOL, V16, P1196, DOI 10.1128/CVI.00150-09; SEARS PM, 1978, J DAIRY SCI, V61, P974, DOI 10.3168/jds.S0022-0302(78)83676-5; Spiegelhalter DJ, 2014, J R STAT SOC B, V76, P485, DOI 10.1111/rssb.12062; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Szmaragd C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043116; Taylor G Michael, 2007, BMC Vet Res, V3, P12, DOI 10.1186/1746-6148-3-12; VACEK PM, 1985, BIOMETRICS, V41, P959, DOI 10.2307/2530967; van Dijk J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063961; van Smeden M, 2013, AM J EPIDEMIOLOGY; Vordermeier M, 2006, TB RES GROUP VLA; WALTER SD, 1988, J CLIN EPIDEMIOL, V41, P923, DOI 10.1016/0895-4356(88)90110-2; Ward EJ, 2008, ECOL MODEL, V211, P1, DOI 10.1016/j.ecolmodel.2007.10.030; Wood PR, 2001, TUBERCULOSIS, V81, P147, DOI 10.1054/tube.2000.0272; Zellner G, 2013, GESUNDHEIT BSFUU; Zinsstag J, 2008, EC BOVINE TUBERCULOS, P68	74	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179847	10.1371/journal.pone.0179847	http://dx.doi.org/10.1371/journal.pone.0179847			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640908	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000404135800073
J	Yuan, B; Liang, S; Jin, YX; Zhang, MJ; Zhang, JB; Kim, NH				Yuan, Bao; Liang, Shuang; Jin, Yong-Xun; Zhang, Ming-Jun; Zhang, Jia-Bao; Kim, Nam-Hyung			Toxic effects of atrazine on porcine oocytes and possible mechanisms of action	PLOS ONE			English	Article							IN-VITRO; DNA-DAMAGE; AROMATASE EXPRESSION; EXPOSURE; STEROIDOGENESIS; MATURATION; PESTICIDE; PHOSPHODIESTERASE; DIFFERENTIATION; PROLIFERATION	Because atrazine is a widely used herbicide, its adverse effects on the reproductive system have been extensively researched. In this study, we investigated the effects of atrazine exposure on porcine oocyte maturation and the possible mechanisms. Our results showed that the rates of oocyte maturation significantly decreased after treatment with 200 mu M atrazine in vitro. Atrazine treatment resulted in abnormal spindle morphology but did not affect actin distribution. Atrazine exposure not only triggered a DNA damage response but also decreased MPF levels in porcine oocytes. Our results also revealed that atrazine worsened porcine oocyte quality by causing excessive accumulation of superoxide radicals, increasing cathepsin B activity, and decreasing the GSH level and mitochondrial membrane potential. Furthermore, atrazine decreased developmental competence of porcine oocytes up to the blastocyst stage and changed some properties: cell numbers, apoptosis, and related gene expression levels. Collectively, our results indicate that porcine oocyte maturation is defective after atrazine treatment at least through disruption of spindle morphology, MPF activity, and mitochondrial function and via induction of DNA damage, which probably reduces developmental competence.	[Yuan, Bao; Liang, Shuang; Jin, Yong-Xun; Zhang, Ming-Jun; Zhang, Jia-Bao; Kim, Nam-Hyung] Jilin Univ, Dept Lab Anim, Coll Anim Sci, Changchun, Jilin, Peoples R China; [Yuan, Bao; Liang, Shuang; Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Mol Embryol Lab, Cheongju, Chungbuk, South Korea	Jilin University; Chungbuk National University	Zhang, JB; Kim, NH (corresponding author), Jilin Univ, Dept Lab Anim, Coll Anim Sci, Changchun, Jilin, Peoples R China.; Kim, NH (corresponding author), Chungbuk Natl Univ, Dept Anim Sci, Mol Embryol Lab, Cheongju, Chungbuk, South Korea.	zjb515@126.com; nhkim@chungbuk.ac.kr			BioGreen 21 Program [PJ011126]; National Natural Science Foundation of China [31572400, 31501954]	BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the BioGreen 21 Program (No. PJ011126) and the National Natural Science Foundation of China (31572400, 31501954). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarikwu SO, 2013, TOXICOL IN VITRO, V27, P700, DOI 10.1016/j.tiv.2012.11.005; Abarikwu SO, 2011, FREE RADICAL RES, V45, P1061, DOI 10.3109/10715762.2011.593177; Alleva R, 2016, MOL NUTR FOOD RES, V60, P2243, DOI 10.1002/mnfr.201600005; Basso E, 2016, MUTAT RES-GEN TOX EN, V806, P40, DOI 10.1016/j.mrgentox.2016.07.005; Belzunces B, 2017, J COMPUT CHEM, V38, P133, DOI 10.1002/jcc.24530; Casas E, 2010, TOXICOL IN VITRO, V24, P224, DOI 10.1016/j.tiv.2009.09.004; Chen JY, 2015, FOOD CHEM TOXICOL, V76, P61, DOI 10.1016/j.fct.2014.11.026; Chen XP, 2015, ENVIRON TOXICOL CHEM, V34, P1770, DOI 10.1002/etc.2980; Chromcova L, 2013, NEUROENDOCRINOL LETT, V34, P95; Dhali A, 2009, THERIOGENOLOGY, V71, P1408, DOI 10.1016/j.theriogenology.2009.01.011; Fan WQ, 2007, ENVIRON HEALTH PERSP, V115, P720, DOI 10.1289/ehp.9758; Fan W, 2007, BIOCHEM BIOPH RES CO, V355, P1012, DOI 10.1016/j.bbrc.2007.02.062; Friedmann AS, 2002, REPROD TOXICOL, V16, P275, DOI 10.1016/S0890-6238(02)00019-9; Ghodageri MG, 2013, DRUG CHEM TOXICOL, V36, P217, DOI 10.3109/01480545.2012.710623; Hayes TB, 2010, P NATL ACAD SCI USA, V107, P4612, DOI 10.1073/pnas.0909519107; Hu KB, 2016, INT J ONCOL, V48, P2166, DOI 10.3892/ijo.2016.3433; Hyun SY, 2015, ONCOTARGET, V6, P4804, DOI 10.18632/oncotarget.3103; Jacquet P, 2015, MUTAT RES-GEN TOX EN, V792, P26, DOI 10.1016/j.mrgentox.2015.09.001; Ji QC, 2016, TOXICOL IN VITRO, V32, P63, DOI 10.1016/j.tiv.2015.12.006; Jin YX, 2013, GEN COMP ENDOCR, V184, P120, DOI 10.1016/j.ygcen.2013.01.010; Kaith S, 2015, REPROD DOMEST ANIM, V50, P214, DOI 10.1111/rda.12472; Karami-Mohajeri S, 2014, HUM EXP TOXICOL, V33, P251, DOI 10.1177/0960327113493300; Karmaus AL, 2015, TOXICOL SCI, V148, P544, DOI 10.1093/toxsci/kfv204; Kloas W, 2009, ANN NY ACAD SCI, V1163, P437, DOI 10.1111/j.1749-6632.2009.04456.x; Kucka M, 2012, TOXICOL APPL PHARM, V265, P19, DOI 10.1016/j.taap.2012.09.019; Lee SK, 2014, J REPROD DEVELOP, V60, P128, DOI 10.1262/jrd.2013-098; Li XX, 2013, THERIOGENOLOGY, V79, P291, DOI 10.1016/j.theriogenology.2012.08.019; Lin ZL, 2014, REPROD DOMEST ANIM, V49, P219, DOI 10.1111/rda.12254; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mukherjee I, 2009, B ENVIRON CONTAM TOX, V83, P832, DOI 10.1007/s00128-009-9849-7; Murphy MB, 2006, AQUAT TOXICOL, V76, P230, DOI 10.1016/j.aquatox.2005.09.010; Omran NE, 2016, TOXICOL IND HEALTH, V32, P656, DOI 10.1177/0748233713506959; Papoulias DM, 2014, AQUAT TOXICOL, V154, P230, DOI 10.1016/j.aquatox.2014.05.022; Pogrmic-Majkic K, 2016, TOXICOLOGY, V368, P37, DOI 10.1016/j.tox.2016.08.016; Pogrmic-Majkic K, 2012, ENVIRON TOXICOL PHAR, V34, P495, DOI 10.1016/j.etap.2012.06.004; Ptak G, 2012, HUM REPROD, V27, P1034, DOI 10.1093/humrep/der454; Rein ID, 2015, CELL CYCLE, V14, P3248, DOI 10.1080/15384101.2015.1085137; Riffle BW, 2014, REPROD TOXICOL, V47, P59, DOI 10.1016/j.reprotox.2014.05.008; Roberge M, 2004, TOXICOL LETT, V154, P61, DOI 10.1016/j.toxlet.2004.07.005; Roberge MT, 2006, FOOD CHEM TOXICOL, V44, P885, DOI 10.1016/j.fct.2005.11.014; Sass JB, 2006, INT J OCCUP ENV HEAL, V12, P260; Sharma A, 2012, J HAZARD MATER, V221, P275, DOI 10.1016/j.jhazmat.2012.04.045; Solomon KR, 2013, ENVIRON TOXICOL CHEM, V32, P10, DOI 10.1002/etc.2050; Thueson LE, 2015, TOXICOL SCI, V143, P418, DOI 10.1093/toxsci/kfu242; Traba HM, 2017, J ENV SCI HLTH B, P1; Victor-Costa AB, 2010, REPROD TOXICOL, V29, P323, DOI 10.1016/j.reprotox.2009.12.006; Wu BJ, 2017, CELL CYCLE, V16, P82, DOI 10.1080/15384101.2016.1252884; Yuan B, 2016, PEERJ, V4, DOI 10.7717/peerj.2454; Zhang DX, 2010, MOL REPROD DEV, V77, P38, DOI 10.1002/mrd.21095	49	22	22	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179861	10.1371/journal.pone.0179861	http://dx.doi.org/10.1371/journal.pone.0179861			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640859	Green Published, gold, Green Submitted			2022-12-27	WOS:000404135800075
J	Riva, A; Borgesen, M; Guldmann-Christensen, M; Kyneb, MH; Voogd, K; Andersen, C; Epistolio, S; Merlo, E; Wolff, TY; Hamilton-Dutoit, S; Lorenzen, J; Christensen, UB; Frattini, M				Riva, Alice; Borgesen, Michael; Guldmann-Christensen, Mariann; Kyneb, Majbritt Hauge; Voogd, Kirsten; Andersen, Christina; Epistolio, Samantha; Merlo, Elisabetta; Wolff, Tine Yding; Hamilton-Dutoit, Stephen; Lorenzen, Jan; Christensen, Ulf Bech; Frattini, Milo			SensiScreen (R) KRAS exon 2-sensitive simplex and multiplex real-time PCR-based assays for detection of KRAS exon 2 mutations	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; CELL LUNG-CANCER; INTERCALATING NUCLEIC-ACIDS; ANTI-EGFR THERAPY; K-RAS MUTATIONS; ENRICHED PCR; RESISTANCE; PREDICTION; FAMILY; GENES	Activating mutations in codon 12 and codon 13 of the KRAS (Kirsten rat sarcoma viral oncogene homolog) gene are implicated in the development of several human cancer types and influence their clinical evaluation, treatment and prognosis. Numerous different methods for KRAS genotyping are currently available displaying a wide range of sensitivities, time to answer and requirements for laboratory equipment and user skills. Here we present Sen-siScreen (R) KRAS exon 2 simplex and multiplex CE vertical bar VDassays, that use a novel real-time PCR-based method for KRAS mutation detection based on PentaBase's proprietary DNA analogue technology and designed to work on standard real-time PCR instruments. By means of the included BaseBlocker (TM) technology, we show that SensiScreen (R) specifically amplifies the mutated alleles of interest with no or highly subdued amplification of the wild type allele. Furthermore, serial dilutions of mutant DNA in a wild type background demonstrate that all SensiScreen (R) assays display a limit of detection that falls within the range of 0.25-1%. Finally, in three different colorectal cancer patient populations, SensiScreen (R) assays confirmed the KRAS genotype previously determined by commonly used methods for KRAS mutation testing, and notably, in two of the populations, SensiScreen (R) identified additional mutant positive cases not detected by common methods.	[Riva, Alice; Epistolio, Samantha; Merlo, Elisabetta; Frattini, Milo] Inst Pathol, Lab Mol Pathol, Locarno, Switzerland; [Borgesen, Michael; Andersen, Christina; Christensen, Ulf Bech] PentaBase Aps, Odense, Denmark; [Guldmann-Christensen, Mariann; Voogd, Kirsten; Hamilton-Dutoit, Stephen] Aarhus Univ Hosp, Lab Res & Dev, Dept Pathol, Aarhus, Denmark; [Kyneb, Majbritt Hauge; Wolff, Tine Yding; Lorenzen, Jan] Danish Technol Inst, Life Sci Div, Aarhus, Denmark; [Voogd, Kirsten] Univ Southern Denmark, Odense, Denmark; [Wolff, Tine Yding] Aarhus Sch Engn, Aarhus, Denmark	Aarhus University; University of Southern Denmark; Aarhus University	Frattini, M (corresponding author), Inst Pathol, Lab Mol Pathol, Locarno, Switzerland.; Christensen, UB (corresponding author), PentaBase Aps, Odense, Denmark.	ubc@PentaBase.com; milo.frattini@ti.ch		Epistolio, Samantha/0000-0003-1236-2722; Hamilton-Dutoit, Stephen/0000-0003-2158-3885	Danish Agency for Science Technology and Innovation [E!7034]; Fondazione Ticinese per la Ricerca controil Cancro; Institute of Pathology, Locarno, Switzerland; Aarhus University Hospital, Aarhus, Denmark	Danish Agency for Science Technology and Innovation; Fondazione Ticinese per la Ricerca controil Cancro; Institute of Pathology, Locarno, Switzerland; Aarhus University Hospital, Aarhus, Denmark	Eurostars provided support in the form of salaries fo rauthors MB, CA, UBC, MF, AR, MHK & JL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. PentaBase ApS provided salaries for UBC, CA and MB and took part in the designing of the SensiScreen products, but not the testing and analysis of patient material nor in the conclusions of the performance of SensiScreen against competing technologies. The specific roles of these authors are articulated in the' author contributions' section. The funders had no additional role in study design, data collection and analysis, decision to publish, orpreparation of the manuscript. Support for this study was also provided by Danish Agency for Science Technology and Innovation [E!7034 ONSET diagnostics] and Fondazione Ticinese per la Ricerca controil Cancro. The Institute of Pathology, Locarno, Switzerland, and Aarhus University Hospital, Aarhus, Denmark performed\some analyses using their own funding	Altimari A, 2013, ONCOTARGETS THER, V6, P1057, DOI 10.2147/OTT.S42369; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bearzatto A, 2002, CLIN CANCER RES, V8, P3782; Chang YY, 2016, AM J SURG, V212, P537, DOI 10.1016/j.amjsurg.2016.02.013; CHEN J, 1991, ANAL BIOCHEM, V195, P51, DOI 10.1016/0003-2697(91)90293-3; Christensen UB, 2004, NUCLEOS NUCLEOT NUCL, V23, P207, DOI 10.1081/NCN-120027829; Christensen UB, 2002, NUCLEIC ACIDS RES, V30, P4918, DOI 10.1093/nar/gkf624; Davidson CJ, 2012, BIOTECHNIQUES, V53, P182, DOI 10.2144/000113913; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Dienstmann R, 2016, CANCER J, V22, P149, DOI 10.1097/PPO.0000000000000191; Edkins S, 2009, CANC BIOL THR, V5, P928; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Gao J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009532; Graham DM, 2016, CURR COLORECT CANC R, V12, P141, DOI 10.1007/s11888-016-0312-y; Gulbake A, 2016, WORLD J GASTROENTERO, V22, P582, DOI 10.3748/wjg.v22.i2.582; Jancik S, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-79; KAHN SM, 1991, ONCOGENE, V6, P1079; Kocarnik JM, 2015, GASTROENTEROL REP, V3, P269, DOI 10.1093/gastro/gov046; Kudryavtseva AV, 2016, ONCOTARGET, V7, P53959, DOI 10.18632/oncotarget.9796; Laurent-Puig P, 2015, CLIN CANCER RES, V21, P1087, DOI 10.1158/1078-0432.CCR-14-0983; Lee S., 2015, J MOL BIOMARK, V6; Linardou H, 2008, LANCET ONCOL, V9, P962, DOI 10.1016/S1470-2045(08)70206-7; Loupakis F, 2009, J CLIN ONCOL, V27, P2622, DOI 10.1200/JCO.2008.20.2796; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; MITSUDOMI T, 1991, ONCOGENE, V6, P1353; Molinari F, 2011, CLIN CANCER RES, V17, P4901, DOI 10.1158/1078-0432.CCR-10-3137; Nollau P, 1996, INT J CANCER, V66, P332, DOI 10.1002/(SICI)1097-0215(19960503)66:3<332::AID-IJC11>3.0.CO;2-D; Pekin D, 2011, LAB CHIP, V11, P2156, DOI 10.1039/c1lc20128j; Samowitz WS, 2007, MOL CANCER RES, V5, P165, DOI 10.1158/1541-7786.MCR-06-0398; Simen BB, 2015, ARCH PATHOL LAB MED, V139, P508, DOI 10.5858/arpa.2013-0710-OA; Tsiatis AC, 2010, J MOL DIAGN, V12, P425, DOI 10.2353/jmoldx.2010.090188; van Krieken JHJM, 2008, VIRCHOWS ARCH, V453, P417, DOI 10.1007/s00428-008-0665-y; Winder T, 2009, ONCOL REP, V21, P1283, DOI 10.3892/or_00000352; Xu WD, 2016, FRONT BIOSCI-LANDMRK, V21, P410, DOI 10.2741/4397	34	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0178027	10.1371/journal.pone.0178027	http://dx.doi.org/10.1371/journal.pone.0178027			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636636	Green Submitted, Green Published, gold			2022-12-27	WOS:000404118300007
J	Vancraenenbroeck, R; Kunzelmann, S; Webb, MR				Vancraenenbroeck, Renee; Kunzelmann, Simone; Webb, Martin R.			Development of a range of fluorescent reagentless biosensors for ATP, based on malonyl-coenzyme A synthetase	PLOS ONE			English	Article							INORGANIC-PHOSPHATE; DIMER FORMATION; LESS BIOSENSOR; PROTEIN; DYES	The range of ATP concentrations that can be measured with a fluorescent reagentless biosensor for ATP has been increased by modulating its affinity for this analyte. The ATP biosensor is an adduct of two tetramethylrhodamines with MatB from Rhodopseudomonas palustris. Mutations were introduced into the binding site to modify ATP binding affinity, while aiming to maintain the concomitant fluorescence signal. Using this signal, the effect of mutations in different parts of the binding site was measured. This mutational analysis revealed three variants in particular, each with a single mutation in the phosphate-binding loop, which had potentially beneficial changes in ATP binding properties but preserving a fluorescence change of similar to 3-fold on ATP binding. Two variants (T167A and T303A) weakened the binding, changing the dissociation constant from the parent's 6 mu M to 123 mu M and 42 mu M, respectively. Kinetic measurements showed that the effect of these mutations on affinity was by an increase in dissociation rate constants. These variants widen the range of ATP concentration that can be measured readily by this biosensor to > 100 mu M. In contrast, a third variant, S170A, decreased the dissociation constant of ATP to 3.8 mu M and has a fluorescence change of 4.2 on binding ATP. This variant has increased selectivity for ATP over ADP of > 200-fold. This had advantages over the parent by increasing sensitivity as well as increasing selectivity during ATP measurements in which ADP is present.	[Vancraenenbroeck, Renee; Webb, Martin R.] Francis Crick Inst, London, England; [Kunzelmann, Simone] Francis Crick Inst, Struct Biol Sci Technol Platform, London, England; [Vancraenenbroeck, Renee] Weizmann Inst Sci, Dept Struct Biol, Rehovot, Israel	Francis Crick Institute; Francis Crick Institute; Weizmann Institute of Science	Webb, MR (corresponding author), Francis Crick Inst, London, England.	martin.webb@crick.ac.uk		Vancraenenbroeck, Renee/0000-0003-2685-2749; Webb, Martin/0000-0002-0134-9621	Francis Crick Institute which receives its core - Cancer Research UK [FC001211]; UK Medical Research Council [FC001211]; Wellcome Trust [FC001211]; The Francis Crick Institute [10211, 10015] Funding Source: researchfish	Francis Crick Institute which receives its core - Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); The Francis Crick Institute	This work was supported by the Francis Crick Institute which receives its core funding from Cancer Research UK (FC001211), the UK Medical Research Council (FC001211), and the Wellcome Trust (FC001211).	Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Brun MA, 2011, J AM CHEM SOC, V133, P16235, DOI 10.1021/ja206915m; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; CHAMBERS RW, 1974, J PHYS CHEM-US, V78, P380, DOI 10.1021/j100597a012; CORRIE JET, 1994, J CHEM SOC PERK T 1, P2967, DOI 10.1039/p19940002967; Crosby HA, 2012, APPL ENVIRON MICROB, V78, P6619, DOI 10.1128/AEM.01733-12; FORSTER T, 1957, Z ELEKTROCHEM, V61, P344; Gu H, 2006, FEBS LETT, V580, P5885, DOI 10.1016/j.febslet.2006.09.048; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; Hamman BD, 1996, J BIOL CHEM, V271, P7568, DOI 10.1074/jbc.271.13.7568; He ZH, 1997, J PHYSIOL-LONDON, V501, P125, DOI 10.1111/j.1469-7793.1997.125bo.x; KASHA M, 1963, RADIAT RES, V20, P55, DOI 10.2307/3571331; Khakh BS, 2009, SCI AM, V301, P84, DOI 10.1038/scientificamerican1209-84; Kunzelmann S., 2014, FLUORESCENT METHODS, V105, P25, DOI DOI 10.1007/978-3-0348-0856-9_; Kunzelmann S, 2010, ACS CHEM BIOL, V5, P415, DOI 10.1021/cb9003173; Leatherbarrow R.J., 2009, GRAFIT VERSION 7; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Okoh MP, 2006, BIOCHEMISTRY-US, V45, P14764, DOI 10.1021/bi060960j; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Rawls H.R., 1965, PURE APPL CHEM, V11, P371, DOI [10.1351/pac196511030371, 10.1002/anie.201002307]; SCHOLES GD, 1994, J PHYS CHEM-US, V98, P4580, DOI 10.1021/j100068a017; SELWYN JE, 1972, J PHYS CHEM-US, V76, P762, DOI 10.1021/j100649a026; Solscheid C, 2015, BIOCHEMISTRY-US, V54, P5054, DOI 10.1021/acs.biochem.5b00449; Vancraenenbroeck R, 2015, ACS CHEM BIOL, V10, P2650, DOI 10.1021/acschembio.5b00346; Wang RE, 2011, CURR MED CHEM, V18, P4175; Wilkins MR, 1999, METH MOL B, V112, P531	26	2	2	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179547	10.1371/journal.pone.0179547	http://dx.doi.org/10.1371/journal.pone.0179547			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636641	gold, Green Published, Green Submitted			2022-12-27	WOS:000404118300041
J	Schulz, J; Boklund, A; Halasa, THB; Toft, N; Lentz, HHK				Schulz, Jana; Boklund, Anette; Halasa, Tariq H. B.; Toft, Nils; Lentz, Hartmut H. K.			Network analysis of pig movements: Loyalty patterns and contact chains of different holding types in Denmark	PLOS ONE			English	Article							PORK SUPPLY CHAIN; INFECTIOUS-DISEASES; NORTHERN GERMANY; SPREAD; EPIDEMIOLOGY; ONTARIO; CATTLE	Understanding animal movements is an important factor for the development of meaningful surveillance and control programs, but also for the development of disease spread models. We analysed the Danish pig movement network using static and temporal network analysis tools to provide deeper insight in the connection between holdings dealing with pigs, such as breeding and multiplier herds, production herds, slaughterhouses or traders. Pig movements, which occurred between 1st January 2006 and 31st December 2015 in Denmark, were summarized to investigate temporal trends such as the number of active holdings, the number of registered movements and the number of pigs moved. To identify holdings and holding types with potentially higher risk for introduction or spread of diseases via pig movements, we determined loyalty patterns, annual network components and contact chains for the 24 registered holding types. The total number of active holdings as well as the number of pig movements decreased during the study period while the holding sizes increased. Around 60-90% of connections between two pig holdings were present in two consecutive years and around one third of the connections persisted within the considered time period. Weaner herds showed the highest level of in-loyalty, whereas we observed an intermediate level of in-loyalty for all breeding sites and for production herds. Boar stations, production herds and trade herds showed a high level of out-loyalty. Production herds constituted the highest proportion of holdings in the largest strongly connected component. All production sites showed low levels of in-going contact chains and we observed a high level of out-going contact chain for breeding and multiplier herds. Except for livestock auctions, all transit sites also showed low levels of out-going contact chains. Our results reflect the pyramidal structure of the underlying network. Based on the considered disease, the time frame for the calculation of network measurements needs to be adapted. Using these adapted values for loyalty and contact chains might help to identify holdings with high potential of spreading diseases and thus limit the outbreak size or support control or eradication of the considered pathogen.	[Schulz, Jana; Boklund, Anette; Halasa, Tariq H. B.; Toft, Nils] Tech Univ Denmark, Natl Vet Inst, Lyngby, Denmark; [Lentz, Hartmut H. K.] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Epidemiol, Greifswald, Insel Riems, Germany	Technical University of Denmark; Friedrich Loeffler Institute	Schulz, J (corresponding author), Tech Univ Denmark, Natl Vet Inst, Lyngby, Denmark.	janson@vet.dtu.dk	Boklund, Anette/HGE-8502-2022; Schulz, Jana/AAL-5493-2021	Schulz, Jana/0000-0002-5719-4542; Halasa, Tariq/0000-0003-1112-0254; Lentz, Hartmut/0000-0002-1713-9506; Boklund, Anette/0000-0001-6359-3403	Ministry of Environment and Food of Denmark through The Danish Agrifish Agency [33010-NIFA-14-612]	Ministry of Environment and Food of Denmark through The Danish Agrifish Agency	This study was supported by a grant from the Ministry of Environment and Food of Denmark through The Danish Agrifish Agency (J. no. 33010-NIFA-14-612). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bager F, 2015, DANMAP 2015; Bigras-Poulin M, 2007, PREV VET MED, V80, P143, DOI 10.1016/j.prevetmed.2007.02.004; Borgatti S. P, 2006, COMPUT MATH ORGAN TH, V12, P21, DOI DOI 10.1007/S10588-006-7084-X; Buttner K, 2015, TRANSBOUND EMERG DIS, V62, P188, DOI 10.1111/tbed.12106; Buttner K, 2016, PREV VET MED, V129, P1, DOI 10.1016/j.prevetmed.2016.05.005; Buttner K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074292; Buttner K, 2013, PREV VET MED, V110, P418, DOI 10.1016/j.prevetmed.2013.01.008; Catry B, 2010, EPIDEMIOL INFECT, V138, P626, DOI 10.1017/S0950268810000014; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Danish Veterinary and Food Administration, 2015, CENTR HUSB REG FRONT; Danon L., 2011, Interdisciplinary Perspectives on Infectious Diseases, V2011, P284909, DOI 10.1155/2011/284909; Dorjee S, 2013, PREV VET MED, V112, P118, DOI 10.1016/j.prevetmed.2013.06.008; Dorogovtsev SN, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.025101; Dube C, 2011, PREV VET MED, V99, P102, DOI 10.1016/j.prevetmed.2011.01.013; Fritzemeier J, 2000, VET MICROBIOL, V77, P29, DOI 10.1016/S0378-1135(00)00254-6; Grontvedt CA, 2016, MRSA CC398 HUMANS PI, P2014; Holme P, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003142; Kiss IZ, 2006, J R SOC INTERFACE, V3, P669, DOI 10.1098/rsif.2006.0129; Lebl K, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00048; Lentz HHK, 2016, DIS SPREAD ANIMAL MO, P1; Lindstrom T, 2010, PREV VET MED, V95, P23, DOI 10.1016/j.prevetmed.2010.03.002; Martinez-Lopez B, 2009, TRANSBOUND EMERG DIS, V56, P109, DOI 10.1111/j.1865-1682.2009.01073.x; Michel I, 2000, P INT SOC VET EP EC; Nicosia V., 2013, TEMPORAL NETWORKS; Nielsen AC, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-S1-S3; Noremark M, 2009, ACTA VET SCAND, V51, P15; Noremark M, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-71; Noremark M, 2011, PREV VET MED, V99, P78, DOI 10.1016/j.prevetmed.2010.12.009; Relun A, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00004; Rocadembosch J, 2016, PORCINE HEALTH MANAG, V2, DOI 10.1186/s40813-016-0027-0; SEGES, 2017, REGL OPF; Valdano E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004152; van Duijkeren E, 2008, VET MICROBIOL, V126, P383, DOI 10.1016/j.vetmic.2007.07.021; Vernon MC, 2009, P ROY SOC B-BIOL SCI, V276, P469, DOI 10.1098/rspb.2008.1009	34	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179915	10.1371/journal.pone.0179915	http://dx.doi.org/10.1371/journal.pone.0179915			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662077	gold, Green Published, Green Submitted			2022-12-27	WOS:000404608300069
J	Torske, MO; Krokstad, S; Stamatakis, E; Bauman, A				Torske, Magnhild Oust; Krokstad, Steinar; Stamatakis, Emmanuel; Bauman, Adrian			Dog ownership and all-cause mortality in a population cohort in Norway: The HUNT study	PLOS ONE			English	Article							NORD-TRONDELAG HEALTH; PHYSICAL-ACTIVITY; PET OWNERSHIP; NATIONAL-SURVEY; OLDER CAT; WALKING; ADULTS; DEPRESSION; VALIDITY; (HUNT)-3	Objective There has been increased interest in human-animal interactions and their possible effects on human health. Some of this research has focused on human physical activity levels, mediated through increased dog walking. Much of the reported research has been cross sectional, and very few epidemiological studies have examined the association between dog ownership and mortality in populations. Methods We used data from the Norwegian county population-based Nord-Trondelag HUNT Study (HUNT2, 1995-1997). Cox proportional hazards models were fitted to analyse the relationship between dog ownership and all-cause mortality. The median follow-up time was 18.5 years and the maximum follow-up time was 19.7 years. Results In this population, dog owners were no more physically active than non-dog owners, both groups reporting a total of just over 3 hours/week of light and vigorous activity. Dog owners (n = 25,031, with 1,587 deaths during follow-up; 504,017 person-years of time at risk) had virtually the same hazard of dying as non-dog owners (Hazard ratio 1.00, 95% CI 0.91-1.09). Conclusions We found no evidence for an association between the presence of a dog in the household and all-cause mortality or physical activity levels in this Norwegian population. Further epidemiological research is needed to clarify this relationship, as methodological limitations and an active Norwegian population sample means that generalizable evidence is not yet clear on dog ownership and mortality.	[Torske, Magnhild Oust; Krokstad, Steinar; Bauman, Adrian] NTNU Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Publ Hlth & Nursing, HUNT Res Ctr, Levanger, Norway; [Krokstad, Steinar] Nord Trondelag Hosp Trust, Levanger Hosp, Levanger, Norway; [Stamatakis, Emmanuel; Bauman, Adrian] Univ Sydney, Sydney Sch Publ Hlth, Prevent Res Collaborat, Camperdown, NSW, Australia	Norwegian University of Science & Technology (NTNU); University of Sydney	Torske, MO (corresponding author), NTNU Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Publ Hlth & Nursing, HUNT Res Ctr, Levanger, Norway.	magnhild.o.torske@ntnu.no	Stamatakis, Emmanuel/C-4958-2009	Stamatakis, Emmanuel/0000-0001-7323-3225; Krokstad, Steinar/0000-0002-2932-6675; Torske, Magnhild Oust/0000-0001-6439-051X				Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Brown SG, 2006, AM J PREV MED, V30, P131, DOI 10.1016/j.amepre.2005.10.007; Cherniack EP, 2014, CURRENT GERONTOLOGY, V2014; Christian HE, 2013, J PHYS ACT HEALTH, V10, P750, DOI 10.1123/jpah.10.5.750; Cutt H, 2007, HEALTH PLACE, V13, P261, DOI 10.1016/j.healthplace.2006.01.003; Dembicki Diane, 1996, Journal of Nutrition for the Elderly, V15, P15, DOI 10.1300/J052v15n03_02; Enmarker I, 2015, AGING MENT HEALTH, V19, P347, DOI 10.1080/13607863.2014.933310; Enmarker I, 2012, SCAND J PUBLIC HEALT, V40, P718, DOI 10.1177/1403494812465031; Garcia DO, 2015, PREV MED, V70, P33, DOI 10.1016/j.ypmed.2014.10.030; Gillum RF, 2010, INT J ENV RES PUB HE, V7, P2452, DOI 10.3390/ijerph7062452; Headey B, 1999, SOC INDIC RES, V47, P233, DOI 10.1023/A:1006892908532; Holmen J, 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI DOI 10.1093/eurheartj/eht019; Kleinbaum DG, 2012, STAT BIOL HEALTH, P97, DOI 10.1007/978-1-4419-6646-9_3; Krokstad S, 2013, INT J EPIDEMIOL, V42, P968, DOI 10.1093/ije/dys095; Kurtze N, 2007, EUR J EPIDEMIOL, V22, P379, DOI 10.1007/s10654-007-9110-9; Levine GN, 2013, CIRCULATION, V127, P2353, DOI 10.1161/CIR.0b013e31829201e1; Matchock RL, 2015, CURR OPIN PSYCHIATR, V28, P386, DOI 10.1097/YCO.0000000000000183; Michell AR, 1999, VET REC, V145, P625, DOI 10.1136/vr.145.22.625; Ogechi I., 2016, HIGH BLOOD PRESSURE; Qureshi AI, 2012, JVIN, V2; Richards EA, 2016, CLIN NURS RES; Richards EA, 2016, AM J HEALTH PROMOT, V30, P323, DOI 10.1177/0890117116646335; SERPELL J, 1991, J ROY SOC MED, V84, P717, DOI 10.1177/014107689108401208; Shibata A, 2012, AM J PREV MED, V43, P429, DOI 10.1016/j.amepre.2012.06.019; Toohey AM, 2013, HEALTH PLACE, V22, P75, DOI 10.1016/j.healthplace.2013.03.007; Utz RL, 2014, SOC INDIC RES, V116, P327, DOI 10.1007/s11205-013-0299-6; Westgarth C, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3660-2; Yabroff KR, 2008, J PHYS ACT HEALTH, V5, P216, DOI 10.1123/jpah.5.2.216; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	29	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179832	10.1371/journal.pone.0179832	http://dx.doi.org/10.1371/journal.pone.0179832			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JX	28662069	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300054
J	Wang, CC; Fang, YB; Zhang, P; Zhu, X; Hong, B; Xu, Y; Liu, JM; Huang, QH				Wang, Chuan-Chuan; Fang, Yi-Bin; Zhang, Ping; Zhu, Xuan; Hong, Bo; Xu, Yi; Liu, Jian-Min; Huang, Qing-Hai			Reconstructive endovascular treatment of vertebral artery dissecting aneurysms with the Low-profile Visualized Intraluminal Support (LVIS) device	PLOS ONE			English	Article							PIPELINE EMBOLIZATION DEVICE; STENT; FUSIFORM; OCCLUSION	Introduction The Low-profile Visualized Intraluminal Support (LVIS) device is a new generation of self expanding braided stent recently introduced in China for stent assisted coiling of intracranial aneurysms. The aim of our study is to evaluate the feasibility, safety, and efficacy of the LVIS device in reconstructive treatment of vertebral artery dissecting aneurysms (VADAs). Methods We retrospectively reviewed the neurointerventional database of our institution from June 2014 to May 2016. Patients who underwent endovascular treatment of VADAs with LVIS stents were included in this study. Clinical presentation, aneurysmal characteristics, technical feasibility, procedural complications, and angiographic and clinical follow-up results were evaluated. Results 38 patients with VADAs who underwent treatment with LVIS stent were identified, including 3 ruptured VADAs. All VADAs were successfully treated with reconstructive techniques including the stent-assisted coiling (n = 34) and stenting only (n = 4). Post-procedural complications developed in 3 patients (7.9%) including two small brainstem infarctions and one delayed thromboembolic event. Complications resulted in one case of minor permanent morbidity (2.6%). There was no procedure-related mortality. The follow-up angiogram was available in 30 patients at an average of 8.3 months (range, 2 to 30 months), which revealed complete occlusion in 23 patients (76.7%), residual neck in five patients (16.7%), and residual sac in two patients (6.7%). The follow-up of 25 aneurysms with incomplete immediate occlusion revealed 22 aneurysms (88%) with improvement in the Raymond class. One aneurysm (3.3%) showed recanalization and required retreatment. Clinical followed-up at 5-28 months (mean 14.1 months) was achieved in 36 patients because two patients died of pancreatic cancer and basal ganglia hemorrhage, respectively. No new neurologic deterioration or aneurysm (re)bleeding was observed. Conclusions Our preliminary experience with reconstruction of VADAs with the LVIS device demonstrates that this treatment approach is feasible with good short-term angiographic and clinical outcomes. Long-term and larger cohort studies are necessary to determine long-term outcomes of this therapy.	[Wang, Chuan-Chuan; Fang, Yi-Bin; Hong, Bo; Xu, Yi; Liu, Jian-Min; Huang, Qing-Hai] Second Mil Med Univ, Changhai Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Fang, Yi-Bin; Zhang, Ping; Zhu, Xuan; Hong, Bo; Xu, Yi; Liu, Jian-Min; Huang, Qing-Hai] Second Mil Med Univ, Changhai Hosp, Changhai Stroke Ctr, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Liu, JM; Huang, QH (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Neurosurg, Shanghai, Peoples R China.; Liu, JM; Huang, QH (corresponding author), Second Mil Med Univ, Changhai Hosp, Changhai Stroke Ctr, Shanghai, Peoples R China.	chstroke@163.com; ocinhqh@163.com			National key research and development program of China [2016YFC1300700]; National Natural Science Foundation of China [81301004]; Key Program of Shanghai Science and Technology Commission Foundation [13411950300]	National key research and development program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of Shanghai Science and Technology Commission Foundation	This work was supported by National key research and development program of China during the 13th Five-Year Plan Period (2016YFC1300700), National Natural Science Foundation of China (81301004), and Key Program of Shanghai Science and Technology Commission Foundation (13411950300).	Faria MD, 2011, AM J NEURORADIOL, V32, P2192, DOI 10.3174/ajnr.A2671; Fang YB, 2016, CLIN NEURORADIOL; Fang YB, 2015, CARDIOVASC INTER RAD, V38, P592, DOI 10.1007/s00270-014-0981-3; Fiorella D, 2010, NEUROSURGERY, V67, DOI 10.1227/01.NEU.0000383875.08681.23; Fusco MR, 2011, NEUROSURGERY, V68, P242, DOI 10.1227/NEU.0b013e3182012323; Guan J., 2016, J NEUROINTERV SURG; Huang QH, 2011, AM J NEURORADIOL, V32, P1721, DOI 10.3174/ajnr.A2597; Kai Y, 2011, NEUROSURGERY, V69, P1085, DOI 10.1227/NEU.0b013e3182262adf; Klisch J, 2011, AM J NEURORADIOL, V32, P627, DOI 10.3174/ajnr.A2571; Kuhn AL, 2016, J NEUROINTERV SURG, V8, P1048, DOI 10.1136/neurintsurg-2015-012028; Lee JM, 2010, ACTA NEUROCHIR, V152, P1455, DOI 10.1007/s00701-010-0683-9; Leibowitz R, 2003, AM J NEURORADIOL, V24, P902; Levitt MR, 2016, POSTERIOR INFERIOR C, V37, P487; Li HQ, 2016, SOL ENERGY, V126, P243, DOI 10.1016/j.solener.2015.12.045; Mazur MD, 2016, J NEUROINTERV SURG, V8, P1041, DOI 10.1136/neurintsurg-2015-012040; Natarajan SK, 2016, J NEUROSURG, V125, P111, DOI 10.3171/2015.6.JNS1565; Roy D, 2001, STROKE, V32, P1998, DOI 10.1161/hs0901.095600; Sonmez O, 2015, AM J NEURORADIOL, V36, P1293, DOI 10.3174/ajnr.A4360; Suh SH, 2009, J NEUROSURG, V111, P48, DOI 10.3171/2009.2.JNS081418; US FDA, 2011, SUMM SAF EFF DAT; Wakhloo AK, 2008, STROKE, V39, P3288, DOI 10.1161/STROKEAHA.107.512996; Wang C, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0959-9; Yeung TW, 2012, J NEUROSURG, V116, P882, DOI 10.3171/2011.12.JNS111514; Zhang XG, 2017, J NEUROINTERV SURG, V9, P553, DOI 10.1136/neurintsurg-2016-012403; Zhao KJ, 2014, EUR RADIOL, V24, P2088, DOI 10.1007/s00330-014-3225-7; Zhao KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067169	26	22	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180079	10.1371/journal.pone.0180079	http://dx.doi.org/10.1371/journal.pone.0180079			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662097	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300100
J	Graci, JD; Michaels, D; Chen, GM; Lester, GMS; Nodder, S; Weetall, M; Karp, GM; Gu, ZX; Colacino, JM; Henderson, AJ				Graci, Jason D.; Michaels, Daniel; Chen, Guangming; Lester, Gillian M. Schiralli; Nodder, Sarah; Weetall, Marla; Karp, Gary M.; Gu, Zhengxian; Colacino, Joseph M.; Henderson, Andrew J.			Identification of benzazole compounds that induce HIV-1 transcription	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; VALPROIC ACID; GENE-EXPRESSION; LATENT HIV-1; HIV-1-INFECTED PATIENTS; DEACETYLASE INHIBITORS; COMBINATION THERAPY; VIRAL RESERVOIRS	Despite advances in antiretroviral therapy, HIV-1 infection remains incurable in patients and continues to present a significant public health burden worldwide. While a number of factors contribute to persistent HIV-1 infection in patients, the presence of a stable, long-lived reservoir of latent provirus represents a significant hurdle in realizing an effective cure. One potential strategy to eliminate HIV-1 reservoirs in patients is reactivation of latent provirus with latency reversing agents in combination with antiretroviral therapy, a strategy termed "shock and kill". This strategy has shown limited clinical effectiveness thus far, potentially due to limitations of the few therapeutics currently available. We have identified a novel class of benzazole compounds effective at inducing HIV-1 expression in several cellular models. These compounds do not act via histone deacetylase inhibition or T cell activation, and show specificity in activating HIV-1 in vitro. Initial exploration of structure-activity relationships and pharmaceutical properties indicates that these compounds represent a potential scaffold for development of more potent HIV-1 latency reversing agents.	[Graci, Jason D.; Chen, Guangming; Weetall, Marla; Karp, Gary M.; Gu, Zhengxian; Colacino, Joseph M.] PTC Therapeut Inc, South Plainfield, NJ 07080 USA; [Michaels, Daniel; Nodder, Sarah; Henderson, Andrew J.] Boston Univ, Sch Med, Dept Med & Microbiol, Infect Dis Sect, Boston, MA 02118 USA; [Lester, Gillian M. Schiralli] Univ Rochester, Med Ctr, Dept Pediat, Neonatol,Sch Med & Dent, Rochester, NY 14642 USA; [Gu, Zhengxian] WuXi AppTec Shanghai Co Ltd, Shanghai, Peoples R China	Boston University; University of Rochester	Colacino, JM (corresponding author), PTC Therapeut Inc, South Plainfield, NJ 07080 USA.; Henderson, AJ (corresponding author), Boston Univ, Sch Med, Dept Med & Microbiol, Infect Dis Sect, Boston, MA 02118 USA.	jcolacino@ptcbio.com; Andrew.Henderson@bmc.org	Belkina, Anna C/F-4816-2014	Belkina, Anna C/0000-0001-7967-6254; Schiralli Lester, Gillian/0000-0002-1750-7751; Graci, Jason/0000-0002-6329-9164	Bill & Melinda Gates Foundation through the Grand Challenges Explorations initiative [OPP1045786]; National Institutes of Health [1R21A1108447, A1097117]; PTC Therapeutics, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI108447, R56AI118682, P30AI042853] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation through the Grand Challenges Explorations initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PTC Therapeutics, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in part by a grant from the Bill & Melinda Gates Foundation through the Grand Challenges Explorations initiative (OPP1045786 to Z.G.) and National Institutes of Health grants 1R21A1108447 (to A.J.H. and J.D.G.) and A1097117 (to A.J.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PTC Therapeutics, Inc. provided support in the form of financial compensation for authors J.D.G, G.C, M.W., G.W.K, Z.G, and J.M.C and experimental compounds but did not have any additional role in the study design, data collection and analysis, decision to publish other than providing approval for disclosure, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agosto LM, 2015, GENES-BASEL, V6, P957, DOI 10.3390/genes6040957; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009390; Archin NM, 2008, AIDS, V22, P1131, DOI 10.1097/QAD.0b013e3282fd6df4; Archin NM, 2014, J INFECT DIS, V210, P728, DOI 10.1093/infdis/jiu155; Balimane PV, 2006, AAPS J, V8, pE1, DOI 10.1208/aapsj080101; Banerjee C, 2012, J LEUKOCYTE BIOL, V92, P1147, DOI 10.1189/jlb.0312165; Blanche S, 1999, LANCET, V354, P1084, DOI 10.1016/S0140-6736(99)07219-0; Blankson JN, 2002, ANNU REV MED, V53, P557, DOI 10.1146/annurev.med.53.082901.104024; Blankson JN, 2014, INFECT DIS CLIN N AM, V28, P633, DOI 10.1016/j.idc.2014.08.007; Boshoff C, 1998, BLOOD, V91, P1671, DOI 10.1182/blood.V91.5.1671.1671_1671_1679; Burnett JC, 2010, J VIROL, V84, P5958, DOI 10.1128/JVI.00161-10; Carr A, 2000, AIDS, V14, pF25, DOI 10.1097/00002030-200002180-00001; Chun TW, 2000, NAT MED, V6, P757, DOI 10.1038/77481; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Chun TW, 1999, NAT MED, V5, P651, DOI 10.1038/9498; Cillo AR, 2016, CURR OPIN VIROL, V18, P14, DOI 10.1016/j.coviro.2016.02.001; CLOUSE KA, 1989, J IMMUNOL, V142, P431; Corbeil A, 2001, GENOME RES, V11, P1198, DOI 10.1101/gr.GR-1802R; Dar RD, 2014, SCIENCE, V344, P1392, DOI 10.1126/science.1250220; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; Deeks SG, 2012, NATURE, V487, P439, DOI 10.1038/487439a; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Elliott JH, 2015, LANCET HIV, V2, pE520, DOI 10.1016/S2352-3018(15)00226-X; Elliott JH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004473; Emiliani S, 1996, P NATL ACAD SCI USA, V93, P6377, DOI 10.1073/pnas.93.13.6377; Fakhari FD, 2002, J VIROL, V76, P6213, DOI 10.1128/JVI.76.12.6213-6223.2002; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; FOLKS T, 1986, SCIENCE, V231, P600, DOI 10.1126/science.3003906; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; Gandhi RT, 2010, J INFECT DIS, V201, P293, DOI 10.1086/649569; Graci Jason D., 2009, Antiviral Chemistry & Chemotherapy, V19, P177; He GC, 2002, DNA CELL BIOL, V21, P697, DOI 10.1089/104454902760599672; He GC, 2002, MOL CELL BIOL, V22, P2965, DOI 10.1128/MCB.22.9.2965-2973.2002; Hiscott J, 2001, J CLIN INVEST, V107, P143, DOI 10.1172/JCI11918; Kaczmarek Katarzyna, 2013, Virology (Auckl), V2013, P41; Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3; Krishnan V, 2004, J VIROL, V78, P9458, DOI 10.1128/JVI.78.17.9458-9473.2004; Kubota N, 2008, J VIROL METHODS, V147, P26, DOI 10.1016/j.jviromet.2007.08.012; Kulkosky J, 2002, J INFECT DIS, V186, P1403, DOI 10.1086/344357; Laird GM, 2015, J CLIN INVEST, V125, P1901, DOI 10.1172/JCI80142; Lassen K, 2004, TRENDS MOL MED, V10, P525, DOI 10.1016/j.molmed.2004.09.006; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Lenasi T, 2008, CELL HOST MICROBE, V4, P123, DOI 10.1016/j.chom.2008.05.016; Leth S, 2016, LANCET HIV, V3, pE463, DOI 10.1016/S2352-3018(16)30055-8; Li YM, 2003, COMB CHEM HIGH T SCR, V6, P757; Lorenzo-Redondo R, 2016, NATURE, V530, P51, DOI 10.1038/nature16933; Margolis DM, 2011, CURR OPIN HIV AIDS, V6, P25, DOI 10.1097/COH.0b013e328341242d; Mcgee B, 2006, HIV CLIN TRIALS, V7, P142, DOI 10.1310/AW2H-TP5C-NP43-K6BY; Micheva-Viteva S, 2005, ANTIMICROB AGENTS CH, V49, P5185, DOI 10.1128/AAC.49.12.5185-5188.2005; Micheva-Viteva S, 2011, J BIOL CHEM, V286, P21083, DOI 10.1074/jbc.M110.195537; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Natarajan M, 2013, J BIOL CHEM, V288, P25995, DOI 10.1074/jbc.M113.496489; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Persaud D, 2003, J VIROL, V77, P1659, DOI 10.1128/JVI.77.3.1659-1665.2003; Prins JM, 1999, AIDS, V13, P2405, DOI 10.1097/00002030-199912030-00012; PULVERTA.RJ, 1965, J CLIN PATHOL, V18, P261, DOI 10.1136/jcp.18.3.261; Rasmussen TA, 2014, LANCET HIV, V1, pE13, DOI 10.1016/S2352-3018(14)70014-1; Reuse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006093; Richman DD, 2001, NATURE, V410, P995, DOI 10.1038/35073673; Routy JP, 2012, HIV MED, V13, P291, DOI 10.1111/j.1468-1293.2011.00975.x; Sagot-Lerolle N, 2008, AIDS, V22, P1125, DOI 10.1097/QAD.0b013e3282fd6ddc; Schiralli Lester Gillian M, 2012, Mol Biol Int, V2012, P614120, DOI 10.1155/2012/614120; Siliciano JD, 2007, J INFECT DIS, V195, P833, DOI 10.1086/511823; Sogaard OS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005142; SPATZENEGGER M, 1995, DRUG METAB REV, V27, P397, DOI 10.3109/03602539508998329; Spivak AM, 2016, TRENDS MOL MED, V22, P10, DOI 10.1016/j.molmed.2015.11.004; Spivak AM, 2014, CLIN INFECT DIS, V58, P883, DOI 10.1093/cid/cit813; Steel A, 2006, AIDS, V20, P1681, DOI 10.1097/01.aids.0000238421.36313.fa; Stellbrink HJ, 2002, AIDS, V16, P1479, DOI 10.1097/00002030-200207260-00004; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Trono D, 2010, SCIENCE, V329, P174, DOI 10.1126/science.1191047; UNAIDS, 2015, AIDS NUMB 2015; Weinberg MS, 2006, DNA CELL BIOL, V25, P223, DOI 10.1089/dna.2006.25.223; Williams SAF, 2005, TRENDS MICROBIOL, V13, P137, DOI 10.1016/j.tim.2005.02.006; Williams SA, 2007, CYTOKINE, V39, P63, DOI 10.1016/j.cyto.2007.05.017; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Xing SF, 2013, DRUG DISCOV TODAY, V18, P541, DOI 10.1016/j.drudis.2012.12.008; Ylisastigui L, 2004, AIDS, V18, P1101, DOI 10.1097/00002030-200405210-00003; Yukl S, 2009, VIROLOGY, V387, P98, DOI 10.1016/j.virol.2009.01.013; Zhu J, 2012, CELL REP, V2, P807, DOI 10.1016/j.celrep.2012.09.008	83	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179100	10.1371/journal.pone.0179100	http://dx.doi.org/10.1371/journal.pone.0179100			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658263	Green Submitted, gold, Green Published			2022-12-27	WOS:000404607900015
J	Ivanov, VZ; Nordsletten, A; Mataix-Cols, D; Serlachius, E; Lichtenstein, P; Lundstrom, S; Magnusson, PKE; Kuja-Halkola, R; Ruck, C				Ivanov, Volen Z.; Nordsletten, Ashley; Mataix-Cols, David; Serlachius, Eva; Lichtenstein, Paul; Lundstrom, Sebastian; Magnusson, Patrik K. E.; Kuja-Halkola, Ralf; Ruck, Christian			Heritability of hoarding symptoms across adolescence and young adulthood: A longitudinal twin study	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE SYMPTOMS; AGE-OF-ONSET; OLDER-ADULTS; EPIDEMIOLOGY; COMORBIDITY; DISORDER; FEATURES; CHILDREN	Background Twin studies of hoarding symptoms indicate low to moderate heritability during adolescence and considerably higher heritability in older samples, suggesting dynamic developmental etiological effects. The aim of the current study was to estimate the relative contribution of additive genetic and environmental effects to hoarding symptoms during adolescence and young adulthood and to estimate the sources of stability and change of hoarding symptoms during adolescence. Methods Univariate model-fitting was conducted in three cohorts of twins aged 15 (n = 7,905), 18 (n = 2,495) and 20-28 (n = 6,218). Longitudinal analyses were conducted in a subsample of twins for which data on hoarding symptoms was available at both age 15 and 18 (n = 1,701). Results Heritability estimates for hoarding symptoms at ages 15, 18 and 20-28 were 41% (95% confidence interval [CI]: 36-45%), 31% (95% CI: 22-39%) and 29% (95% CI: 24-34%) respectively. Quantitative sex-differences emerged in twins aged 15 at which point the heritability in boys was 33% (95% CI: 22-41%) and 17% (95% CI: 0-36%) in girls. Shared environmental effects played a negligible role across all samples with the exception of girls aged 15 where they accounted for a significant proportion of the variance (22%; 95% CI 6-36%). The longitudinal bivariate analyses revealed a significant phenotypic correlation of hoarding symptoms between ages 15 and 18 (0.40; 95% CI: 0.36-0.44) and a strong but imperfect genetic correlation (0.75; 95% CI: 0.57-0.94). The bivariate heritability was estimated to 65% (95% CI: 50-79%). Conclusions Hoarding symptoms are heritable from adolescence throughout young adulthood, although heritability appears to slightly decrease over time. Shared environmental effects contribute to hoarding symptoms only in girls at age 15. The stability of hoarding symptoms between ages 15 and 18 is largely explained by genetic factors, while non-shared environmental factors primarily have a time-specific effect. The findings indicate that dynamic developmental etiological effects may be operating across the life span.	[Ivanov, Volen Z.; Nordsletten, Ashley; Mataix-Cols, David; Serlachius, Eva; Ruck, Christian] Karolinska Inst, Ctr Psychiat Res, Dept Clin Neurosci, Stockholm, Sweden; [Ivanov, Volen Z.; Mataix-Cols, David; Serlachius, Eva; Ruck, Christian] Stockholm Cty Council, Stockholm Hlth Care Serv, Stockholm, Sweden; [Ivanov, Volen Z.; Lichtenstein, Paul; Magnusson, Patrik K. E.; Kuja-Halkola, Ralf] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Lundstrom, Sebastian] Univ Gothenburg, Ctr Eth Law & Mental Hlth, Gothenburg, Sweden; [Lundstrom, Sebastian] Univ Gothenburg, Inst Neurosci & Physiol, Gillberg Neuropsychiatry Ctr, Gothenburg, Sweden	Karolinska Institutet; Stockholm County Council; Karolinska Institutet; University of Gothenburg; University of Gothenburg	Ivanov, VZ (corresponding author), Karolinska Inst, Ctr Psychiat Res, Dept Clin Neurosci, Stockholm, Sweden.; Ivanov, VZ (corresponding author), Stockholm Cty Council, Stockholm Hlth Care Serv, Stockholm, Sweden.; Ivanov, VZ (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	volen.ivanov@ki.se	Mataix-Cols, David/G-3843-2010; Mataix-Cols, David/AAF-3347-2021; Kuja-Halkola, Ralf/ABA-5061-2020; Magnusson, Patrik KE/C-4458-2017; Serlachius, Eva/E-8956-2013	Mataix-Cols, David/0000-0002-4545-0924; Mataix-Cols, David/0000-0002-4545-0924; Kuja-Halkola, Ralf/0000-0002-3765-2067; Magnusson, Patrik KE/0000-0002-7315-7899; Serlachius, Eva/0000-0001-7115-6422	Swedish Research Council [K2013-61P-22168]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	CR is supported by the Swedish Research Council (K2013-61P-22168). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Anckarsater H, 2011, TWIN RES HUM GENET, V14, P495, DOI 10.1375/twin.14.6.495; Ayers CR, 2013, INT J GERIATR PSYCH, V28, P1175, DOI 10.1002/gps.3940; Burton CL, 2016, J AM ACAD CHILD PSY, V55, P114, DOI 10.1016/j.jaac.2015.11.014; Cath DC, 2016, AM J GERIATRIC PSYCH, V10, P30300; Cath DC, 2016, AM J GERIATRIC PSYCH; Crawford TN, 2001, J RES ADOLESCENCE, V11, P95, DOI 10.1111/1532-7795.00005; Davies PT, 1997, DEV PSYCHOL, V33, P657, DOI 10.1037/0012-1649.33.4.657; Dozier ME, 2016, AGING MENT HEALTH, V20, P736, DOI 10.1080/13607863.2015.1033684; Dozier ME, 2016, INT J GERIATRIC PSYC, V14; Frost RO, 2011, J CLIN PSYCHOL, V67, P456, DOI 10.1002/jclp.20790; Frost RO, 2011, DEPRESS ANXIETY, V28, P876, DOI 10.1002/da.20861; Grisham JR, 2006, J ANXIETY DISORD, V20, P675, DOI 10.1016/j.janxdis.2005.07.004; Hall BJ, 2013, DEPRESS ANXIETY, V30, P67, DOI 10.1002/da.22015; Hannelius U, 2007, TWIN RES HUM GENET, V10, P604, DOI 10.1375/twin.10.4.604; Iervolino AC, 2009, AM J PSYCHIAT, V166, P1156, DOI 10.1176/appi.ajp.2009.08121789; Ivanov VZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069140; Krebs G, 2015, PSYCHOL MED, V45, P1539, DOI 10.1017/S0033291714002761; Landau D, 2011, J ANXIETY DISORD, V25, P192, DOI 10.1016/j.janxdis.2010.09.002; Magnusson PKE, 2013, TWIN RES HUM GENET, V16, P317, DOI 10.1017/thg.2012.104; Mataix-Cols D, 2013, PSYCHOL MED, V43, P837, DOI 10.1017/S0033291712001560; Mataix-Cols D, 2008, J AM ACAD CHILD PSY, V47, P773, DOI 10.1097/CHI.0b013e31816b73c0; Mathews CA, 2014, PSYCHOL MED, V44, P2867, DOI 10.1017/S0033291714000269; Neale MC, 2016, PSYCHOMETRIKA, V81, P535, DOI 10.1007/s11336-014-9435-8; Nordsletten AE, 2013, BRIT J PSYCHIAT, V203, P445, DOI 10.1192/bjp.bp.113.130195; R Core Team, 2021, R LANGUAGE ENV STAT; Samuels J, 2014, J OBSESS-COMPULS REL, V3, P325, DOI 10.1016/j.jocrd.2014.08.001; Storch EA, 2007, COMPR PSYCHIAT, V48, P313, DOI 10.1016/j.comppsych.2007.03.001; Taylor S, 2010, J ABNORM PSYCHOL, V119, P672, DOI 10.1037/a0021132; Timpano KR, 2016, J PSYCHIATR RES, V83, P8, DOI 10.1016/j.jpsychires.2016.07.022; Timpano KR, 2011, J CLIN PSYCHIAT, V72, P780, DOI 10.4088/JCP.10m06380; Tolin DF, 2008, PSYCHIAT RES, V160, P200, DOI 10.1016/j.psychres.2007.08.008; Tolin DF, 2010, DEPRESS ANXIETY, V27, P829, DOI 10.1002/da.20684; Tolin DF, 2010, PSYCHIAT RES, V178, P147, DOI 10.1016/j.psychres.2009.05.001; Tolin DF, 2010, COGNITIVE THER RES, V34, P69, DOI 10.1007/s10608-008-9217-7; van Grootheest DS, 2007, BIOL PSYCHIAT, V61, P308, DOI 10.1016/j.biopsych.2006.05.035; Zilhao NR, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00120	38	18	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179541	10.1371/journal.pone.0179541	http://dx.doi.org/10.1371/journal.pone.0179541			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JT	28658283	gold, Green Published, Green Submitted			2022-12-27	WOS:000404607900031
J	Santosa, E; Lian, CL; Sugiyama, N; Misra, RS; Boonkorkaew, P; Thanomchit, K				Santosa, Edi; Lian, Chun Lan; Sugiyama, Nobuo; Misra, Raj Shekhar; Boonkorkaew, Patchareeya; Thanomchit, Kanokwan			Population structure of elephant foot yams (Amorphophallus paeoniifolius (Dennst.) Nicolson) in Asia	PLOS ONE			English	Article							MICROSATELLITE MARKERS; GENE FLOW; PROGRAM; ARACEAE; COLLECTIONS; INFERENCE; SOFTWARE; DISTANCE; PLANTS	The corms and leaves of elephant foot yams (Amorphophallus paeoniifolius (Dennst.) Nicolson) are important foods in the local diet in many Asian regions. The crop has high productivity and wide agroecological adaptation and exhibits suitability for the agroforestry system. Although the plant is assumed to reproduce via panmixia, a comprehensive study on the genetic background across regions to enhance wider consumer palatability is still lacking. Here, ten informative microsatellites were analyzed in 29 populations across regions in India, Indonesia and Thailand to understand the genetic diversity, population structure and distribution to improve breeding and conservation programs. The genetic diversity was high among and within regions. Some populations exhibited excess heterozygosity and bottlenecking. Pairwise FST indicated very high genetic differentiation across regions (F-ST = 0.274), and the Asian population was unlikely to be panmictic. Phylogenetic tree construction grouped the populations according to country of origin with the exception of the Medan population from Indonesia. The current gene flow was apparent within the regions but was restricted among the regions. The present study revealed that Indonesia and Thailand populations could be alternative centers of the gene pool, together with India. Consequently, regional action should be incorporated in genetic conservation and breeding efforts to develop new varieties with global acceptance.	[Santosa, Edi] Bogor Agr Univ, Fac Agr, Dept Agron & Hort, Bogor, West Java, Indonesia; [Lian, Chun Lan] Univ Tokyo, Asian Nat Environm Sci Ctr, Nishitokyo, Tokyo, Japan; [Sugiyama, Nobuo] Univ Tokyo, Dept Hort, Fac Agr, Bunkyo Ku, Tokyo, Japan; [Misra, Raj Shekhar] Cent Tuber Crops Res Inst, Thiruvananthapuram, Kerala, India; [Boonkorkaew, Patchareeya; Thanomchit, Kanokwan] Kasetsart Univ, Dept Hort, Fac Agr, Bangkok, Thailand; [Sugiyama, Nobuo] Tokyo Univ Agr, Dept Hort Sci, Fac Agr, Atsugi, Kanagawa, Japan	Bogor Agricultural University; University of Tokyo; University of Tokyo; Indian Council of Agricultural Research (ICAR); ICAR - Central Tuber Crops Research Institute; Kasetsart University; Tokyo University of Agriculture	Santosa, E (corresponding author), Bogor Agr Univ, Fac Agr, Dept Agron & Hort, Bogor, West Java, Indonesia.	edisang@gmail.com	Santosa, Edi/CAJ-0748-2022; Santosa, Edi/S-1975-2017	Santosa, Edi/0000-0001-5560-4598; Santosa, Edi/0000-0001-5560-4598	Japan Society for the Promotion of Science; Japan Science Foundation [16-007]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science Foundation	The research was financially supported by Grant-In-Aid from Japan Society for the Promotion of Science (https://www.jsps.go.jp); and Japan Science Foundation Grant No. 16-007 (http://www2.jsf.or.jp) to ES.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDORF FW, 1986, ZOO BIOL, V5, P181, DOI 10.1002/zoo.1430050212; Anil S. R., 2014, International Journal of Vegetable Science, V20, P305, DOI 10.1080/19315260.2013.803509; Anil SR, 2011, GENET RESOUR CROP EV, V58, P1263, DOI 10.1007/s10722-011-9752-z; Archita Behera, 2014, International Journal of Pharmacy and Life Sciences (IJPLS), V5, P3512; Azmi C., 2006, THESIS; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; Chair H, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0157712, 10.13]; Devi A.A., 2013, J ROOT CROPS, V39, P51; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Gautam R, 2007, J ETHNOPHARMACOL, V110, P200, DOI 10.1016/j.jep.2006.12.031; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Greenbaum G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115203; Hetterscheid W., 1996, AROIDEANA, V19, P7; Hetterscheid WLA, 2014, BOT STUD, V55, DOI 10.1186/1999-3110-55-2; HOLDEN S, 1995, AGR SYST, V49, P237, DOI 10.1016/0308-521X(94)00046-T; Kabir ME, 2008, BIOTROPICA, V40, P95, DOI 10.1111/j.1744-7429.2007.00346.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kite GC, 1997, PHYTOCHEMISTRY, V46, P71, DOI 10.1016/S0031-9422(97)00221-5; Kurniawan A., 2011, BIODIVERSITAS, V12, P7; LEINBACH TR, 1989, HABITAT INT, V13, P81, DOI 10.1016/0197-3975(89)90023-4; Lian CL, 2001, J PLANT RES, V114, P381, DOI 10.1007/PL00014001; Lukitaningsih E, 2012, J NATURAL, V12, P1; Mandal R, 2016, BRAZ ARCH BIOL TECHN, V59, DOI 10.1590/1678-4324-2016160439; Maneenoon K, 2015, J ETHNOBIOL ETHNOMED, V11, DOI 10.1186/s13002-015-0031-5; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Matthews P.J., 1995, TROPICS, V4, P105, DOI [10.3759/tropics.4.105, DOI 10.3759/TROPICS.4.105]; Mekkerdchoo O., 2011, Thai Journal of Agricultural Science, V44, P129; Mekkerdchoo O, 2016, PHYTOTAXA, V282, P81, DOI 10.11646/phytotaxa.282.2.1; Murray J., 1910, REPORTS SCI EXPEDITI, P17; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Paul K.K., 2013, J SCI RES, V5, P371, DOI [10.3329/jsr.v5i2.13853, DOI 10.3329/JSR.V5I2.13853]; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peckover W. S., 1985, AROIDEANA, V8, P70; Phornvillay S., 2015, Advances in Bio Research, V6, P128; Piry S, 1999, BOTTLENECK PROGRAM D; Pritchard JK, 2000, GENETICS, V155, P945; Punekar SA, 2010, FLORA; Putman AI, 2014, ECOL EVOL, V4, P4399, DOI 10.1002/ece3.1305; Ravi V., 2009, J ROOT CROPS, V35, P131; Redd AJ, 2002, CURR BIOL, V12, P673, DOI 10.1016/S0960-9822(02)00789-3; Roullier C, 2013, P NATL ACAD SCI USA, V110, P2205, DOI 10.1073/pnas.1211049110; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sankaran M, 2008, P NAT SEM AM INN TEC, P91; Santosa E., 2006, Japanese Journal of Tropical Agriculture, V50, P87; Santosa E., 2004, Japanese Journal of Tropical Agriculture, V48, P235; Santosa E., 2003, Japanese Journal of Tropical Agriculture, V47, P83; Santosa E., 2002, Japanese Journal of Tropical Agriculture, V46, P265; Santosa E, 2007, MOL ECOL NOTES, V7, P814, DOI 10.1111/j.1471-8286.2007.01713.x; Santosa E., 2016, Tropical Agriculture and Development, V60, P53; Santosa E., 2010, Journal of Applied Horticulture (Lucknow), V12, P125; Shepherd LD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152455; Shi H, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-45; Shilpi JA, 2005, FITOTERAPIA, V76, P367, DOI 10.1016/j.fitote.2005.03.024; Singh A., 2016, INT J FOOD STUDIES, V5, P146; Singh A., 2014, INT J PHARM SCI REV, V24, P55; Sprintall J, 2014, NAT GEOSCI, V7, P487, DOI [10.1038/NGEO2188, 10.1038/ngeo2188]; Stanyon Roscoe, 2009, Journal of Biology (London), V8, P18, DOI 10.1186/jbiol115; Sugiyama N., 2006, Japanese Journal of Tropical Agriculture, V50, P215; Sugiyama N., 2010, Tropical Agriculture and Development, V54, P33; Sugiyama N., 2008, EDIBLE AMORPHOPHALLU; Takezaki N, 2009, MOL BIOL EVOL; Utami AR, 2008, THESIS; Van der Wilk, 1996, PLANT RESOURCES S E, P45; Wahyuni S, 2012, PROS SEM NAS PERH IL, P183; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WIDJAJA E A, 1987, Reinwardtia, V10, P271; Yuzammi A., 2017, AMORPHOPHALLUS INDON	68	8	8	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180000	10.1371/journal.pone.0180000	http://dx.doi.org/10.1371/journal.pone.0180000			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658282	gold, Green Published, Green Submitted			2022-12-27	WOS:000404607900049
J	Arora, S; Mahato, AK; Singh, S; Mandal, P; Bhutani, S; Dutta, S; Kumawat, G; Singh, BP; Chaudhary, AK; Yadav, R; Gaikwad, K; Sevanthi, AM; Datta, S; Raje, RS; Sharma, TR; Singh, NK				Arora, Sheetal; Mahato, Ajay Kumar; Singh, Sangeeta; Mandal, Paritra; Bhutani, Shefali; Dutta, Sutapa; Kumawat, Giriraj; Singh, Bikram Pratap; Chaudhary, A. K.; Yadav, Rekha; Gaikwad, K.; Sevanthi, Amitha Mithra; Datta, Subhojit; Raje, Ranjeet S.; Sharma, Tilak R.; Singh, Nagendra Kumar			A high-density intraspecific SNP linkage map of pigeonpea (Cajanas cajan L. Millsp.)	PLOS ONE			English	Article							GENETIC-MAP; WILD RELATIVES; DIVERSITY; SOFTWARE; MARKERS; TRAITS	Pigeonpea (Cajanus cajan (L.) Millsp.) is a major food legume cultivated in semi-arid tropical regions including the Indian subcontinent, Africa, and Southeast Asia. It is an important source of protein, minerals, and vitamins for nearly 20% of the world population. Due to high carbon sequestration and drought tolerance, pigeonpea is an important crop for the development of climate resilient agriculture and nutritional security. However, pigeonpea productivity has remained low for decades because of limited genetic and genomic resources, and sparse utilization of landraces and wild pigeonpea germplasm. Here, we present a dense intraspecific linkage map of pigeonpea comprising 932 markers that span a total adjusted map length of 1,411.83 cM. The consensus map is based on three different linkage maps that incorporate a large number of single nucleotide polymorphism (SNP) markers derived from next generation sequencing data, using Illumina GoldenGate bead arrays, and genotyping with restriction site associated DNA (RAD) sequencing. The genotyping-by-sequencing enhanced the marker density but was met with limited success due to lack of common markers across the genotypes of mapping population. The integrated map has 547 bead-array SNP, 319 RAD-SNP, and 65 simple sequence repeat (SSR) marker loci. We also show here correspondence between our linkage map and published genome pseudomole-cules of pigeonpea. The availability of a high-density linkage map will help improve the anchoring of the pigeonpea genome to its chromosomes and the mapping of genes and quantitative trait loci associated with useful agronomic traits.	[Arora, Sheetal; Mahato, Ajay Kumar; Singh, Sangeeta; Mandal, Paritra; Bhutani, Shefali; Dutta, Sutapa; Kumawat, Giriraj; Singh, Bikram Pratap; Gaikwad, K.; Sevanthi, Amitha Mithra; Sharma, Tilak R.; Singh, Nagendra Kumar] Natl Res Ctr Plant Biotechnol, Pusa Campus, New Delhi, India; [Chaudhary, A. K.; Datta, Subhojit] Indian Inst Pulses Res, Kanpur, Uttar Pradesh, India; [Yadav, Rekha] Indian Agr Res Inst, Div Genet, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB); Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Pulses Research; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Singh, NK (corresponding author), Natl Res Ctr Plant Biotechnol, Pusa Campus, New Delhi, India.	nksingh4@gmail.com	Singh, Nouratan/N-9377-2017; Kumawat, Giriraj/AAK-1121-2020; Datta, Subhojit/AAR-8209-2021	Singh, Nouratan/0000-0002-8063-8375; Kumawat, Giriraj/0000-0003-3380-1173; Datta, Subhojit/0000-0002-5924-4355; MAHATO, AJAY KUMAR/0000-0003-1359-6643; SINGH, SANGEETA/0000-0003-3600-9982	NPTC Project of the Indian Council of Agricultural Research (ICAR) [3052]	NPTC Project of the Indian Council of Agricultural Research (ICAR)	This study was financially supported by the NPTC Project Grant No-3052 of the Indian Council of Agricultural Research (ICAR).	Bohra A, 2012, THEOR APPL GENET, V125, P1325, DOI 10.1007/s00122-012-1916-5; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cannon SB, 2009, PLANT PHYSIOL, V151, P970, DOI 10.1104/pp.109.144659; CHAKRAVARTI A, 1991, GENETICS, V128, P175; Dutta S, 2013, PLANT BREEDING, V132, P191, DOI 10.1111/pbr.12014; Dutta S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-17; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Gnanesh BN, 2011, FIELD CROP RES, V123, P53, DOI 10.1016/j.fcr.2011.04.011; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Greilhuber J, 1998, PLANT SYST EVOL, V212, P135, DOI 10.1007/BF00985225; Holtz Y, 2017, BIOINFORMATICS, V33, P1387, DOI 10.1093/bioinformatics/btw816; Kumawat G, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-84; Lorieux M, 2012, MOL BREEDING, V30, P1231, DOI 10.1007/s11032-012-9706-y; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Odeny D A, 2009, BMC Res Notes, V2, P35, DOI 10.1186/1756-0500-2-35; Ooijen Van, JOUNMAP 4 0 SOFTWAR; RATNAPARKHE MB, 1995, THEOR APPL GENET, V91, P893, DOI 10.1007/BF00223897; Singh NK, 2004, FUNCT INTEGR GENOMIC, V4, P102, DOI 10.1007/s10142-004-0109-y; Singh NK, 2012, J PLANT BIOCHEM BIOT, V21, P98, DOI 10.1007/s13562-011-0088-8; Varshney RK, 2010, MOL BREEDING, V26, P393, DOI 10.1007/s11032-009-9327-2; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Yang SY, 2011, J GENET, V90, P103, DOI 10.1007/s12041-011-0050-5; Yang SY, 2006, THEOR APPL GENET, V113, P585, DOI 10.1007/s00122-006-0317-z	24	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179747	10.1371/journal.pone.0179747	http://dx.doi.org/10.1371/journal.pone.0179747			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654689	gold, Green Published, Green Submitted			2022-12-27	WOS:000404541500031
J	Constantinou, AC; Fenton, N				Constantinou, Anthony C.; Fenton, Norman			The future of the London Buy-To-Let property market: Simulation with temporal Bayesian Networks	PLOS ONE			English	Article							INFERENCE; FOOTBALL; MODELS	In 2015 the British government announced a number of major tax reforms for individual landlords. To give landlords time to adjust, some of these tax measures are being introduced gradually from April 2017, with full effect in tax year 2020/21. The changes in taxation have received much media attention since there has been widespread belief that the new measures were sufficiently skewed against landlords that they could signal the end of the Buy-To-Let (BTL) investment era in the UK. This paper assesses the prospective performance of BTL investments in London from the investor's perspective, and examines the impact of incoming tax reforms using a novel Temporal Bayesian Network model. The model captures uncertainties of interest by simulating the impact of changing circumstances and the interventions available to an investor at various time-steps of a BTL investment portfolio. The simulation results suggest that the new tax reforms are likely to have a detrimental effect on net profits from rental income, and this hits risk-seeking investors who favour leverage much harder than risk-averse investors who do not seek to expand their property portfolio. The impact on net profits also poses substantial risks for lossmaking returns excluding capital gains, especially in the case of rising interest rates. While this makes it less desirable or even non-viable for some to continue being a landlord, based on the current status of all factors taken into consideration for simulation, investment prospects are still likely to remain good within a reasonable range of interest rate and capital growth rate variations. The results also suggest that the recent trend of property prices in London increasing faster than rents will not continue for much longer; either capital growth rates will have to decrease, rental growth rates will have to increase, or we shall observe a combination of the two events.	[Constantinou, Anthony C.; Fenton, Norman] Queen Mary Univ London, Risk & Informat Management RIM Res Grp, Sch Elect Engn & Comp Sci, London, England	University of London; Queen Mary University London	Constantinou, AC (corresponding author), Queen Mary Univ London, Risk & Informat Management RIM Res Grp, Sch Elect Engn & Comp Sci, London, England.	anthony@constantinou.info	Fenton, Norman/L-5861-2019	Fenton, Norman/0000-0003-2924-0510	European Research Council (ERC) [ERC-2013-AdG339182-BAYES_KNOWLEDGE]	European Research Council (ERC)(European Research Council (ERC))	We acknowledge the financial support by the European Research Council (ERC) for funding this research project, ERC-2013-AdG339182-BAYES_KNOWLEDGE, and Agena Ltd for software support.	Agena, 2016, BAYES NETW SIM SOFTW; [Anonymous], 2015, DAILY MAIL; [Anonymous], 2005, Q A ERM BLACK WEDN; Bank of England, 2016, OFF BANK RAT HIST; Bendtsen M, 2016, INT J APPROX REASON, V69, P58, DOI 10.1016/j.ijar.2015.11.002; Coid JW, 2016, PROGRAMME GRANTS APP, V4; Constantinou A, 2017, KNOWL-BASED SYST, V124, P93, DOI 10.1016/j.knosys.2017.03.005; Constantinou AC, 2012, KNOWL-BASED SYST, V36, P322, DOI 10.1016/j.knosys.2012.07.008; Constantinou AC, 2016, EXPERT SYST APPL, V56, P197, DOI 10.1016/j.eswa.2016.02.050; Constantinou AC, 2016, ARTIF INTELL MED, V67, P75, DOI 10.1016/j.artmed.2016.01.002; Constantinou AC, 2015, DECIS SUPPORT SYST, V80, P42, DOI 10.1016/j.dss.2015.09.006; de Zoete J, 2015, SCI JUSTICE, V55, P209, DOI 10.1016/j.scijus.2014.11.005; Department for Communities and Local Government (DCLG), 2016, LIV TABL RENTS LETT; Druzdzel M. J., 1995, Uncertainty in Artificial Intelligence. Proceedings of the Eleventh Conference (1995), P141; Fenton N, 2017, P 26 C SUBJ PROB UT; Fenton N, 2012, RISK ASSESSMENT DECI, DOI 10.1201/b13102; Fenton N, 2016, KNOWL-BASED SYST, V113, P39, DOI 10.1016/j.knosys.2016.09.012; Fenton N, 2011, NATURE, V479, P36, DOI 10.1038/479036a; Foxtons, 2016, LANDL FEES; Ghosh G, 2007, AM AGR EC ASS ANN M; Gomes S, 2015, HOUSING MARKET DYNAM; Gupta R, 2010, J REAL ESTATE FINANC, V41, P294, DOI 10.1007/s11146-008-9163-x; Hearty P, 2009, IEEE T SOFTWARE ENG, V35, P124, DOI 10.1109/TSE.2008.76; HM Revenue & Customs, 2015, REF WEAR TEAR ALL; HM Revenue & Customs, 2015, RESTR FIN COST REL I; HM Treasury, 2016, HIGH RAT STAMP DUT L; HM Treasury, 2014, STAMP DUT REF RES PR; Hubbard DW, 2014, MEASURE ANYTHING FIN; Hui SK, 2010, INT REAL ESTATE REV, V13, P1; International Monetary Fund (IMF), 2009, WORLD EC OUTL CRIS R; KOLLER D., 2009, PROBABILISTIC GRAPHI; Kuo CL, 1997, J REAL ESTATE FINANC, V14, P113, DOI 10.1023/A:1007724103085; Kyrimi E., 2016, C PROBABILISTIC GRAP, P275; Land Registry, 2016, LAND REG OP DAT; Lendlnvest, 2016, RENT YIELDS 2010 201; Marsden J, 2015, HOUSE PRICES LONDON; Mayer E, 2013, OPEN ECON REV, V24, P919, DOI 10.1007/s11079-013-9276-6; MoneySuperMarket, 2016, COMP BEST MORTG RAT; Nationwide, 2016, HOUS PRIC IND; Neapolitan R.E., 2007, PROBABILISTIC METHOD, P177; Neil M, 2007, STAT COMPUT, V17, P219, DOI 10.1007/s11222-007-9018-y; O'Hagan A., 2006, UNCERTAIN JUDGMENTS; Office for National Statistics, 2016, CPI CONS PRIC IND CH; Pearl J, 2009, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; Portico, 2016, BUY TO LET LOND REN; Renooij S, 2001, KNOWL ENG REV, V16, P255, DOI 10.1017/S0269888901000145; Revenue Scotland, 2015, LAND BUILD T TAX; Russell SP, 2010, ARTIFICIAL INTELLIGE; Savills, 2016, LANDL CHARG; Shang YL, 2016, PHYSICA A, V456, P157, DOI 10.1016/j.physa.2016.03.021; Shepherd K, 2015, NATURE, V523, P152, DOI 10.1038/523152a; Smit NM, 2016, CRIME SCI, V5, DOI 10.1186/s40163-016-0057-6; Stadelmann D, 2010, J HOUS ECON, V19, P180, DOI 10.1016/j.jhe.2010.07.002; UK Government, 2016, CAP GAINS TAX; UK Government, 2016, INC TAX RAT PERS ALL; UK Government, 2016, CAP GAINS TAX ALL; Valuation Office Agency, 2016, PRIV RENT MARK STAT; van der Gaag LC, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P647; van Gerven MAJ, 2008, J BIOMED INFORM, V41, P515, DOI 10.1016/j.jbi.2008.01.006; Wheeler D, 2013, PAPERS REGIONAL SCI, V93, P1435; Xiang YP, 2002, COMPUT BIOL MED, V32, P85, DOI 10.1016/S0010-4825(01)00036-1; Yao XQ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-49; Yet B, 2016, EXPERT SYST APPL, V60, P141, DOI 10.1016/j.eswa.2016.05.005; Yet B, 2014, J BIOMED INFORM, V48, P28, DOI 10.1016/j.jbi.2013.10.012	64	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179297	10.1371/journal.pone.0179297	http://dx.doi.org/10.1371/journal.pone.0179297			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654698	Green Submitted, Green Published, gold			2022-12-27	WOS:000404541500009
J	Hargreaves-Allen, VA; Mourato, S; Milner-Gulland, EJ				Hargreaves-Allen, Venetia Alexa; Mourato, Susana; Milner-Gulland, Eleanor Jane			Drivers of coral reef marine protected area performance	PLOS ONE			English	Article							CONSERVATION; MANAGEMENT; SHORTFALLS; GOVERNANCE; BENEFITS; RESERVES; COSTS; LESSONS; SUCCESS; SYSTEMS	Coral reefs are severely threatened and a principal strategy for their conservation is marine protected areas (MPAs). However the drivers of MPA performance are complex and there are likely to be trade-offs between different types of performance (e.g. conservation or welfare related outcomes). We compiled a global dataset from expert knowledge for 76 coral reef MPAs in 33 countries and identified a set of performance measures reflecting ecological and socio-economic outcomes, achievement of aims and reduction of threats, using spatial or temporal comparisons wherever possible. We wanted to test the extent to which distinct types of performance occurred simultaneously, understood as win-win outcomes. Although certain performance measures were correlated, most were not, suggesting trade-offs that limit the usefulness of composite performance scores. Hypotheses were generated as to the impact of MPA features, aims, location, management and contextual variables on MPA performance from the literature. A multivariate analysis was used to test hypotheses as to the relative importance of these "drivers" on eight uncorrelated performance measures. The analysis supported some hypotheses (e.g. benefit provision for the local community improved performance), but not others (e.g. higher overall budget and more research activity did not). Factors endogenous to the MPA (such as size of the no-take area) were generally more significant drivers of performance than exogenous ones (such as national GDP). Different types of performance were associated with different drivers, exposing the tradeoffs inherent in management decisions. The study suggests that managers are able to influence MPA performance in spite of external threats and could inform adaptive management by providing an approach to test for the effects of MPA features and management actions in different contexts and so to inform decisions for allocation of effort or funds to achieve specific goals.	[Hargreaves-Allen, Venetia Alexa] Imperial Coll, Ctr Environm Policy, London, England; [Mourato, Susana] London Sch Econ & Polit Sci, Dept Geog & Environm, London, England; [Milner-Gulland, Eleanor Jane] Imperial Coll London, Dept Life Sci, Silwood Pk, Ascot, Berks, England; [Milner-Gulland, Eleanor Jane] Univ Oxford, Dept Zool, Oxford, England	Imperial College London; University of London; London School Economics & Political Science; Imperial College London; University of Oxford	Hargreaves-Allen, VA (corresponding author), Imperial Coll, Ctr Environm Policy, London, England.	vhargreavesallen@gmail.com			UK government (NERC-ESRC)	UK government (NERC-ESRC)	The authors received no funding specific to this work. The lead author had a general academic scholarship from the UK government (NERC-ESRC), but this was for open-ended research.	Agardy T, 2011, MAR POLICY, V35, P226, DOI 10.1016/j.marpol.2010.10.006; Ahmadia GN, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0275; Aswani S, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00050; Axford JC, 2008, ECOL SOC, V13; Balmford A, 2004, P NATL ACAD SCI USA, V101, P9694, DOI 10.1073/pnas.0403239101; Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; Ban NC, 2012, AQUAT CONSERV, V22, P262, DOI 10.1002/aqc.2224; Bennett NJ, 2014, MAR POLICY, V50, P96, DOI 10.1016/j.marpol.2014.05.005; Bennett NJ, 2014, MAR POLICY, V44, P107, DOI 10.1016/j.marpol.2013.08.017; Bhagwat S, 2001, SCIENCE, V293, P1045; Brooks JS, 2012, P NATL ACAD SCI USA, V109, P21265, DOI 10.1073/pnas.1207141110; Browning LJ, 2006, CONSERV BIOL SER, P419; Bruner AG, 2004, BIOSCIENCE, V54, P1119, DOI 10.1641/0006-3568(2004)054[1119:FCASOM]2.0.CO;2; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Bunce M, 2010, ENVIRON SCI POLICY, V13, P485, DOI 10.1016/j.envsci.2010.06.003; Burke L., 1998, REEFS RISK MAP BASED; Charles A, 2009, ICES J MAR SCI, V66, P6, DOI 10.1093/icesjms/fsn182; Christie P, 2007, CORAL REEFS, V26, P1047, DOI 10.1007/s00338-007-0235-9; Christie P, 2002, J ENVIRON MANAGE, V66, P441, DOI 10.1006/jema.2002.0595; Christie P, 2004, AM FISHERIES SOC S S; Christie P, 2009, COAST MANAGE, V37, P349, DOI 10.1080/08920750902851740; Cicin-Sain B, 2005, OCEAN COAST MANAGE, V48, P847, DOI 10.1016/j.ocecoaman.2006.01.001; Cinner JE, 2012, P NATL ACAD SCI USA, V109, P5219, DOI 10.1073/pnas.1121215109; Cinner JE, 2009, CURR BIOL, V19, P206, DOI 10.1016/j.cub.2008.11.055; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Dalton T, 2015, MAR POLICY, V54, P69, DOI 10.1016/j.marpol.2014.12.009; Day J, 2008, MAR POLICY, V32, P823, DOI 10.1016/j.marpol.2008.03.023; deFontaubert C., 1996, BIODIVERSITY SEAS PR; DIXON JA, 1993, OCEANUS, V36, P35; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Evans L, 2011, J ENVIRON MANAGE, V92, P1983; Ferraro P., 2009, ENV PROGRAM POLICY E, P75, DOI [10.1002/ev.297, DOI 10.1002/EV.297]; Ferraro PJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0267; Ferraro PJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0270; Ferraro PJ, 2011, ENVIRON RESOUR ECON, V48, P269, DOI 10.1007/s10640-010-9408-z; Fox HE, 2014, COAST MANAGE, V42, P207, DOI 10.1080/08920753.2014.904178; Fox HE, 2012, CONSERV LETT, V5, P1, DOI 10.1111/j.1755-263X.2011.00207.x; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Gill DA, 2017, NATURE, V543, P665, DOI 10.1038/nature21708; Gravestock P, 2008, OCEAN COAST MANAGE, V51, P272, DOI 10.1016/j.ocecoaman.2007.09.004; Gurney GG, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0277; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; HALLS AS, 2002, INTERDISCIPLINARY MU; Halpern BS, 2003, ECOL APPL, V13, pS117; Halpern BS, 2003, P ROY SOC B-BIOL SCI, V270, P1871, DOI 10.1098/rspb.2003.2405; Hargreaves-Allen V, 2011, ENVIRON MANAGE, V47, P684, DOI 10.1007/s00267-011-9616-5; Heck N, 2011, OCEAN COAST MANAGE, V54, P687, DOI 10.1016/j.ocecoaman.2011.07.003; Hockings M, 2003, BIOSCIENCE, V53, P823, DOI 10.1641/0006-3568(2003)053[0823:SFATEO]2.0.CO;2; Hockings M., 2003, EVALUATING EFFECTIVE, V2; Horigue V, 2014, OCEAN COAST MANAGE, V95, P11, DOI 10.1016/j.ocecoaman.2014.03.023; Jameson SC, 2002, MAR POLLUT BULL, V44, P1177, DOI 10.1016/S0025-326X(02)00258-8; Jentoft S, 2007, HUM ECOL, V35, P611, DOI 10.1007/s10745-007-9125-6; Keller BD, 2009, ENVIRON MANAGE, V44, P1069, DOI 10.1007/s00267-009-9346-0; Leisher C., 2007, NATURES INVESTMENT B; Leisher C, 2012, MAR POLICY, V36, P1005, DOI 10.1016/j.marpol.2012.02.022; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Leverington F., 2008, MANAGEMENT EFFECTIVE; Luna B, 2009, ICES J MAR SCI, V66, P517, DOI 10.1093/icesjms/fsp020; Lundquist CJ, 2005, CONSERV BIOL, V19, P1771, DOI 10.1111/j.1523-1739.2005.00279.x; Mascia, 2004, MARINE RESERVES GUID, P154; Mascia MB, 1999, COAST MANAGE, V27, P391, DOI 10.1080/089207599263794; Mascia MB, 2014, BIOL CONSERV, V169, P258, DOI 10.1016/j.biocon.2013.11.017; McClanahan T, 2005, ENVIRON CONSERV, V32, P42, DOI 10.1017/S0376892904001791; McClanahan TR, 2006, CURR BIOL, V16, P1408, DOI 10.1016/j.cub.2006.05.062; Milazzo M, 2002, MAR ECOL-P S Z N I, V23, P280, DOI 10.1111/j.1439-0485.2002.tb00026.x; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Mora C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000131; Pavese HB, 2007, NAT CONSERVACAO, V5, P152; Plaganyi EE, 2013, P NATL ACAD SCI USA, V110, P3639, DOI 10.1073/pnas.1217822110; Pollnac R, 2011, ENVIRON MANAGE, V47, P584, DOI 10.1007/s00267-010-9540-0; Pollnac R, 2010, P NATL ACAD SCI USA, V107, P18262, DOI 10.1073/pnas.0908266107; Pomeroy R. S., 2007, FAO EXP WORKSH MAR P, P149; Pomeroy RS, 2006, MAR POLICY, V30, P786, DOI 10.1016/j.marpol.2006.02.003; Pomeroy RS, 2005, OCEAN COAST MANAGE, V48, P485, DOI 10.1016/j.ocecoaman.2005.05.004; Pressey RL, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0280; Roberts CM, 2003, ECOL APPL, V13, pS215; Roberts CM, 2000, FULLY PROTECED MARIN; Rudd MA, 2003, FISH FISH, V4, P65, DOI 10.1046/j.1467-2979.2003.00110.x; Russ GR, 2004, ECOL APPL, V14, P597, DOI 10.1890/03-5076; Salm R.V., 2000, MARINE COASTAL PROTE; Sanchirico J.N., 2000, MARINE PROTECTED ARE; Sanchirico J.N., 2002, 0226 RES FUT; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; STAUB F, 2003, SCORE CARD ASSESS PR; Stem C, 2005, CONSERV BIOL, V19, P295, DOI 10.1111/j.1523-1739.2005.00594.x; Stern M.J., 2006, MEASURING CONSERVATI; STONE R, 1993, J ROY STAT SOC B MET, V55, P455; SYMS C, 2001, GUID MEAS MAN EFF MA; Torell E, 2010, COAST MANAGE, V38, P216, DOI 10.1080/08920753.2010.483166; Toropova C., 2010, GLOBAL OCEAN PROTECT; TUPPER M, 2008, REEFBASE GLOBAL INFO; TUPPER M, 2008, LESSONS LEARNED BEST; Vandeperre F, 2011, FISH FISH, V12, P412, DOI 10.1111/j.1467-2979.2010.00401.x; Warner TE, 2012, MAR POLICY, V36, P922, DOI 10.1016/j.marpol.2012.01.003; Watson JEM, 2014, NATURE, V515, P67, DOI 10.1038/nature13947; Wells S, 2006, CONSERV BIOL SER, P314; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Wilkinson C, 2006, CONSERV BIOL SER, P3; Wood LJ, 2008, ORYX, V42, P340, DOI 10.1017/S003060530800046X	99	19	19	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179394	10.1371/journal.pone.0179394	http://dx.doi.org/10.1371/journal.pone.0179394			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY7CO	28644890	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000404145100013
J	Paz-Levy, D; Schreiber, L; Erez, O; Goshen, S; Richardson, J; Drunov, V; Chacham, OS; Shany, E				Paz-Levy, Dorit; Schreiber, Letizia; Erez, Offer; Goshen, Sharon; Richardson, Justin; Drunov, VIadimir; Chacham, Orna Staretz; Shany, Eilon			Inflammatory and vascular placental lesions are associated with neonatal amplitude integrated EEG recording in early premature neonates	PLOS ONE			English	Article							SONOGRAPHIC SHORT CERVIX; PRETERM INFANTS YOUNGER; VAGINAL PROGESTERONE; ELECTROENCEPHALOGRAPHIC ACTIVITY; HISTOLOGICAL CHORIOAMNIONITIS; PREGNANT-WOMEN; CEREBRAL-PALSY; BIRTH; PREVENTION; CERCLAGE	Introduction Placental histologic examination can assist in revealing the mechanism leading to preterm birth. Accumulating evidence suggests an association between intrauterine pathological processes, morbidity and mortality of premature infants, and their long term outcome. Neonatal brain activity is increasingly monitored in neonatal intensive care units by amplitude integrated EEG (aEEG) and indices of background activity and sleep cycling patterns were correlated with long term outcome. We hypothesized an association between types of placental lesions and abnormal neonatal aEEG patterns. Objective To determine the association between the placental lesions observed in extreme preterm deliveries, and their neonatal aEEG patterns and survival. Patients and methods This prospective cohort study included extreme premature infants, who were born <= 28 weeks of gestation, their placentas were available for histologic examination, and had a continues aEEG, soon after birth)n = 34). Infants and maternal clinical data were collected. aEEG data was assessed for percentage of depressed daily activity in the first 3 days of life and for sleep cycling. Associations of placental histology with clinical findings and aEEG activity were explored using parametric and non-parametric statistics. Results Twenty two out of the 34 newborns survived to discharge. Preterm prelabor rupture of membranes (PPROM) or chorioamnionitis were associated with placental lesions consistent with fetal amniotic fluid infection (AFI) or maternal under perfusion (MUP) (P < 0.05). Lesions consistent with fetal response to AFI were associated with absence of SWC pattern during the 1st day of life. Fetal-vascular-thrombo-occlusive lesions of inflammatory type were negatively associated with depressed cerebral activity during the 1st day of life, and with aEEG cycling during the 2nd day of life (P<0.05). Placental lesions associated with MUP were associated with depressed neonatal cerebral activity during the first 3 days of life (P = 0.007). Conclusions Depressed neonatal aEEG patterns are associated with placental lesions consistent with maternal under perfusion, and amniotic fluid infection of fetal type, but not with fetal thrombo-oclusive vascular disease of inflammatory type. Our findings highlight the association between the intrauterine mechanisms leading to preterm parturition and subsequent depressed neonatal cerebral function early after birth, which eventually may put premature infants at risk for abnormal neurodevelopmental outcome.	[Paz-Levy, Dorit; Erez, Offer] Ben Gurion Univ Negev Beer Sheva, Sch Med, Fac Hlth Sci, Dept Obstet & Gynecol,Soroka Univ Med Ctr, Beer Sheva, Israel; [Schreiber, Letizia] Wolfson Med Ctr, Pathol Inst, Hulon, Israel; [Goshen, Sharon] Ben Gurion Univ Negev, Sch Med, Dept Epidemiol, Fac Hlth Sci, Beer Sheva, Israel; [Goshen, Sharon; Richardson, Justin; Chacham, Orna Staretz; Shany, Eilon] Ben Gurion Univ Negev, Sch Med, Fac Hlth Sci, Dept Neonatol,Soroka Univ Med Ctr, Beer Sheva, Israel; [Drunov, VIadimir] Ben Gurion Univ Negev, Fac Hlth Sci, Sch Med, Dept Pathol,Soroka Univ Med Ctr, Beer Sheva, Israel	Ben Gurion University; Soroka Medical Center; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center	Erez, O (corresponding author), Ben Gurion Univ Negev Beer Sheva, Sch Med, Fac Hlth Sci, Dept Obstet & Gynecol,Soroka Univ Med Ctr, Beer Sheva, Israel.	erezof@bgu.ac.il	Shany, Eilon/F-2108-2012	Shany, Eilon/0000-0003-4142-3707				Adams-Chapman Ira, 2002, J Perinatol, V22, P236, DOI 10.1038/sj.jp.7210685; Alfirevic Z, 2013, ULTRASOUND OBST GYN, V41, P146, DOI 10.1002/uog.12300; Amiel-Tison C, 1976, Curr Probl Pediatr, V7, P1, DOI 10.1016/S0045-9380(76)80008-4; Amiel-Tison C, 1978, Ciba Found Symp, P107; Amiel-Tison C, 2002, PEDIATR NEUROL, V27, P196, DOI 10.1016/S0887-8994(02)00436-8; AMIELTISON C, 1968, ARCH DIS CHILD, V43, P89, DOI 10.1136/adc.43.227.89; Aylward GP, 2004, J PEDIATR PSYCHOL, V29, P555, DOI 10.1093/jpepsy/jsh057; Aylward GP, 2000, DEV MED CHILD NEUROL, V42, P25, DOI 10.1017/S0012162200000062; Barinov SV, 2016, J MATERN-FETAL NEO M, P1; Berghella V, 2011, OBSTET GYNECOL, V117, P663, DOI 10.1097/AOG.0b013e31820ca847; Conde-Agudelo A, 2016, AM J OBSTET GYNECOL, V214, P235, DOI 10.1016/j.ajog.2015.09.102; Erdemir G, 2013, PEDIATR NEONATOL, V54, P267, DOI 10.1016/j.pedneo.2013.03.012; Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59; GIBBS RS, 1980, AM J OBSTET GYNECOL, V136, P709, DOI 10.1016/0002-9378(80)90445-7; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6; Gotsch F, 2009, J MATERN-FETAL NEO M, V22, P5, DOI 10.1080/14767050902860690; Goya M, 2016, AM J OBSTET GYNECOL, V214, P145, DOI 10.1016/j.ajog.2015.11.012; Harteman JC, 2012, PLACENTA, V33, P839, DOI 10.1016/j.placenta.2012.06.014; Hassan SS, 2011, ULTRASOUND OBST GYN, V38, P18, DOI 10.1002/uog.9017; Hellstrom-Westas L., 2006, NEOREVIEWS, DOI [DOI 10.1542/NEO.7-2-E76, 10.1542/neo.7-2-e76]; Henderson JJ, 2012, J MATERN-FETAL NEO M, V25, P642, DOI 10.3109/14767058.2011.597899; Hirvonen M, 2014, PEDIATRICS, V134, pE1584, DOI 10.1542/peds.2014-0945; Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS53, DOI 10.1016/j.ajog.2015.08.041; Kim CJ, 2010, MODERN PATHOL, V23, P1000, DOI 10.1038/modpathol.2010.73; Klebermass K, 2006, BIOL NEONATE, V89, P120, DOI 10.1159/000088912; Klebermass K, 2011, PEDIATR RES, V70, P102, DOI 10.1203/PDR.0b013e31821ba200; Kuint J, 2007, J CHILD NEUROL, V22, P277, DOI 10.1177/0883073807299860; Lamblin MD, 1999, NEUROPHYSIOL CLIN, V29, P123, DOI 10.1016/S0987-7053(99)80051-3; Lee J, 2013, PLACENTA, V34, P681, DOI 10.1016/j.placenta.2013.04.014; Lee J, 2013, AM J REPROD IMMUNOL, V70, P265, DOI 10.1111/aji.12142; Liu ZW, 2014, PEDIATR NEONATOL, V55, P35, DOI 10.1016/j.pedneo.2013.05.007; Markham KB, 2014, CLIN PERINATOL, V41, P773, DOI 10.1016/j.clp.2014.08.003; Martin Joyce A, 2015, Natl Vital Stat Rep, V64, P1; Mathiasen R, 2010, PEDIATRICS, V126, pE1553, DOI 10.1542/peds.2009-0829; MAYNARD D, 1969, ELECTROEN CLIN NEURO, V27, P672; Mercer BM, 2004, CLIN PERINATOL, V31, P765, DOI 10.1016/j.clp.2004.06.004; Mercer BM, 1997, JAMA-J AM MED ASSOC, V278, P989, DOI 10.1001/jama.278.12.989; Moscuzza F, 2011, GYNECOL ENDOCRINOL, V27, P319, DOI 10.3109/09513590.2010.487619; Nijman TAJ, 2016, PLACENTA, V48, P56, DOI 10.1016/j.placenta.2016.10.006; Olischar M, 2004, PEDIATRICS, V113, pE61, DOI 10.1542/peds.113.1.e61; Owen J, 2012, OBSTET GYN CLIN N AM, V39, P25, DOI 10.1016/j.ogc.2011.12.001; Owen J, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.08.015; PHELAN JP, 1987, J REPROD MED, V32, P540; Pri-Paz S, 2012, ULTRASOUND OBST GYN, V39, P648, DOI 10.1002/uog.10093; PRIOR PF, 1971, BRIT MED J, V2, P736, DOI 10.1136/bmj.2.5764.736; Redline RW, 2007, PEDIATR DEVEL PATHOL, V10, P282, DOI 10.2350/06-12-0203.1; Redline RW, 2007, SEMIN DIAGN PATHOL, V24, P5, DOI 10.1053/j.semdp.2007.01.001; Redline RW, 2015, AM J OBSTET GYNECOL, V213, pS21, DOI 10.1016/j.ajog.2015.05.056; Redline RW, 2015, SEMIN PERINATOL, V39, P2, DOI 10.1053/j.semperi.2014.10.002; Redline RW, 2005, AM J OBSTET GYNECOL, V192, P452, DOI 10.1016/j.ajog.2004.07.030; Redline RW, 2005, PLACENTA, V26, pS114, DOI 10.1016/j.placenta.2005.02.009; Roescher AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089419; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Romero R, 1998, AM J OBSTET GYNECOL, V179, P186, DOI 10.1016/S0002-9378(98)70271-6; Romero R, 2016, ULTRASOUND OBST GYN, V48, P308, DOI 10.1002/uog.15953; Romero R, 2017, ULTRASOUND OBSTET GY; Romero R, 2014, AM J REPROD IMMUNOL, V72, P458, DOI 10.1111/aji.12296; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Romero R, 2014, SEMIN FETAL NEONAT M, V19, P15, DOI 10.1016/j.siny.2013.10.004; Romero R, 2013, J PERINAT MED, V41, P27, DOI 10.1515/jpm-2012-0272; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Sentilhes L, 2017, EUR J OBSTET GYN R B, V210, P217, DOI 10.1016/j.ejogrb.2016.12.035; Song J, 2015, SCI REP-UK, V5, DOI 10.1038/srep13810; Soraisham AS, 2013, J PERINATOL, V33, P70, DOI 10.1038/jp.2012.49; Szychowski JM, 2012, J MATERN-FETAL NEO M, V25, P2686, DOI 10.3109/14767058.2012.717128; Wikstrom S, 2012, ACTA PAEDIATR, V101, P719, DOI 10.1111/j.1651-2227.2012.02677.x; Wood SL, 2016, CLIN OBSTET GYNECOL, V59, P302, DOI 10.1097/GRF.0000000000000190; Wood SL, 2016, CLIN OBSTET GYNECOL, V59, P270, DOI 10.1097/GRF.0000000000000191; Yoon BH, 2000, AM J OBSTET GYNECOL, V182, P675, DOI 10.1067/mob.2000.104207; Yoon BH, 2000, AM J OBSTET GYNECOL, V183, P1124, DOI 10.1067/mob.2000.109035	71	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179481	10.1371/journal.pone.0179481	http://dx.doi.org/10.1371/journal.pone.0179481			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644831	Green Submitted, Green Published, gold			2022-12-27	WOS:000404145100016
J	Yang, Y; Kim, HJ; Woo, KJ; Cho, D; Bang, SI				Yang, Yoolhee; Kim, Hee Jung; Woo, Kyong-Je; Cho, Daeho; Bang, Sa Ik			Lipo-PGE1 suppresses collagen production in human dermal fibroblasts via the ERK/Ets-1 signaling pathway	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; GENE-EXPRESSION; CATHELICIDIN LL-37; PEPTIDE LL-37; TGF-BETA; FIBROSIS; ACTIVATION; ERK; SCLERODERMA; KELOIDS	Dysregulation of collagen production contributes to various pathological processes, including tissue fibrosis as well as impaired wound healing. Lipo-prostaglandin E1 (Lipo-PGE1), a lipid microsphere-incorporated prostaglandin E1, is used as a vasodilator for the treatment of peripheral vascular diseases. Lipo-PGE1 was recently shown to enhance human dermal fibroblast (HDF) migration and in vivo wound healing. No published study has characterized the role of Lipo-PGE1 in collagen regulation in HDFs. Here, we investigated the cellular signaling mechanism by which Lipo-PGE1 regulates collagen in HDFs. Collagen production was evaluated by the Sircol collagen assay, Western blot analysis of type I collagen and real time PCR. Unexpectedly, Lipo-PGE1 decreased mRNA expression of collagen 1A1, 1A2, and 3A1. Lipo-PGE1 markedly inhibited type I collagen and total soluble collagen production. In addition, Lipo-PGE1 inhibited transforming growth factor-beta-induced collagen expression via Smad2 phosphorylation. To further investigate whether extracellular signalregulated kinase (ERK)/Ets-1 signaling, a crucial pathway in collagen regulation, is involved in Lipo-PGE1-inhibited collagen production, cells were pretreated with an ERK-specific inhibitor, PD98059, prior to the addition of Lipo-PGE1. Lipo-PGE1-inhibited collagen mRNA expression and total soluble collagen production were recovered by pretreatment with PD98059. Moreover, Lipo-PGE1 directly induced the phosphorylation of ERK. Furthermore, silencing of Ets-1 recovered Lipo- PGE1-inhibited collagen production and PD98059 blocked Lipo-PGE1-enhanced Ets-1 expression. The present study reveals an important role for Lipo-PGE1 as a negative regulator of collagen gene expression and production via ERK/Ets-1 signaling. These results suggest that Lipo-PGE1 could potentially be a therapeutic target in diseases with deregulated collagen turnover.	[Yang, Yoolhee; Woo, Kyong-Je; Bang, Sa Ik] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Plast Surg, Seoul, South Korea; [Kim, Hee Jung] Yonsei Univ, Coll Med, Dept Obstet & Gynecol, Inst Womens Life Med Sci, Seoul, South Korea; [Cho, Daeho] Sookmyung Womens Univ, Dept Life Syst, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University Health System; Sookmyung Women's University	Bang, SI (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Plast Surg, Seoul, South Korea.; Cho, D (corresponding author), Sookmyung Womens Univ, Dept Life Syst, Seoul, South Korea.	cdhkor@sookmyung.ac.kr; si55.bang@samsung.com	Kim, Hee Jung/O-4581-2019	Kim, Hee Jung/0000-0002-6122-6906	National Research Foundation of Korea (NRF)-Ministry of Education [S-2016-1852-000]; National Research Foundation of Korea (NRF)-Ministry of Science, ICT and Future Planning [2016M3D1A1021387]	National Research Foundation of Korea (NRF)-Ministry of Education; National Research Foundation of Korea (NRF)-Ministry of Science, ICT and Future Planning	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (S-2016-1852-000) and the Creative Materials Discovery Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (2016M3D1A1021387).	Bhogal RK, 2005, J CLIN IMMUNOL, V25, P592, DOI 10.1007/s10875-005-7827-3; Carretero M, 2008, J INVEST DERMATOL, V128, P223, DOI 10.1038/sj.jid.5701043; Cevikbas F, 2011, EXP DERMATOL, V20, P69, DOI 10.1111/j.1600-0625.2010.01184.x; Czuwara-Ladykowska J, 2002, J BIOL CHEM, V277, P20399, DOI 10.1074/jbc.M200206200; Czuwara-Ladykowska J, 2001, J BIOL CHEM, V276, P20839, DOI 10.1074/jbc.M010133200; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; FRIEDMAN DW, 1993, J SURG RES, V55, P214, DOI 10.1006/jsre.1993.1132; Ghosh AK, 2002, EXP BIOL MED, V227, P301, DOI 10.1177/153537020222700502; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; Jeon BJ, 2013, EXP CELL RES, V319, P2526, DOI 10.1016/j.yexcr.2013.04.014; Leask Andrew, 2004, Keio Journal of Medicine, V53, P74, DOI 10.2302/kjm.53.74; Lee DJ, 2000, EXP CELL RES, V257, P190, DOI 10.1006/excr.2000.4866; Lim IJ, 2003, J BIOL CHEM, V278, P40851, DOI 10.1074/jbc.M305759200; MAUVIEL A, 1994, J BIOL CHEM, V269, P25; McCormick LL, 1999, J IMMUNOL, V163, P5693; Mizui M, 2006, KIDNEY INT, V70, P298, DOI 10.1038/sj.ki.5001541; Niyonsaba F, 2002, IMMUNOLOGY, V106, P20, DOI 10.1046/j.1365-2567.2002.01398.x; Park HJ, 2010, EXP DERMATOL, V19, pE258, DOI 10.1111/j.1600-0625.2010.01070.x; Park HJ, 2009, J INVEST DERMATOL, V129, P843, DOI 10.1038/jid.2008.320; Salvado MD, 2013, ARTERIOSCL THROM VAS, V33, P1965, DOI 10.1161/ATVBAHA.113.301851; Sobota RM, 2008, BIOCHEM J, V412, P65, DOI 10.1042/BJ20071572; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Yang Y, 2012, EXP DERMATOL, V21, P75, DOI 10.1111/j.1600-0625.2011.01406.x	23	10	10	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179614	10.1371/journal.pone.0179614	http://dx.doi.org/10.1371/journal.pone.0179614			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644845	Green Submitted, Green Published, gold			2022-12-27	WOS:000404145100025
J	Zhang, YC; Boxberger, KH; Hagenbuch, B				Zhang, Yuchen; Boxberger, Kelli H.; Hagenbuch, Bruno			Organic anion transporting polypeptide 1B3 can form homo- and hetero-oligomers	PLOS ONE			English	Article							TRANSMEMBRANE DOMAIN 10; BILE-ACID TRANSPORTER; HUMAN OATP1B1; EXPRESSION; PROTEIN; BOSENTAN; LIVER; DISPOSITION; SILDENAFIL	OATP1B3 is a 12 transmembrane domain protein expressed at the basolateral membrane of human hepatocytes where it mediates the uptake of numerous drugs and endogenous compounds. Previous western blot results suggest the formation of OATP1B3 multimers. In order to better understand the function of OATP1B3 under normal physiological conditions, we investigated its oligomerization status. We transiently transfected OATP1B3 with a C-terminal His-, FLAG- or HA-tag in HEK293 cells and used co-immunoprecipitation and a Proximity Ligation Assay to detect interactions between the different constructs. All three constructs retained similar transport rates as wild-type OATP1B3. Immunofluorescence experiments indicated that in contrast to wild-type, His- and FLAG- tagged OATP1B3, where the C-terminal end is on the cytoplasmic side of the membrane, the C-terminal end of HA-tagged OATP1B3 is extracellular. After cross-linking, anti-FLAG antibodies were able to pull down FLAG- tagged OATP1B3 (positive control) and co-transfected His- or HA-tagged OATP1B3, demonstrating the formation of homo-oligomers and suggesting that the C-terminal part is not involved in oligomer formation. We confirmed co-localization of His- and FLAG- tagged OATP1B3 in transfected HEK293 cells with the Proximity Ligation Assay. Transport studies with a non-functional OATP1B3 mutant suggest that the individual sub-units and not the whole oligomer are the functional units in the homo-oligomers. In addition, we also detected OATP1B3-FLAG co-localization with OATP1B1-His or NTCP-His, suggesting that OATP1B3 also hetero-oligomerizes with other transport proteins. Using the Proximity Ligation Assay with transporter specific antibodies, we demonstrate close association of OATP1B3 with NTCP in frozen human liver tissue. These findings demonstrate that OATP1B3 can form homo- and hetero-oligomers and suggest a potential co-regulation of the involved transporters.	[Zhang, Yuchen; Boxberger, Kelli H.; Hagenbuch, Bruno] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Hagenbuch, B (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.	bhagenbuch@kumc.edu	Zhang, Yuchen/GYI-8858-2022; Hagenbuch, Bruno/M-5294-2016	Hagenbuch, Bruno/0000-0002-2938-8630	National Institute of General Medical Sciences [GM077336, P20GM103549, P30GM118247]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077336, P30GM118247] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the National Institute of General Medical Sciences GM077336 (BH). The Cell Isolation Core and the Analytical Core in the Department of Pharmacology, Toxicology and Therapeutics at University of Kansas Medical Center were supported in part by grants from the National Institute of General Medical Sciences P20GM103549 and P30GM118247. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2001, GASTROENTEROLOGY, V120, P1689, DOI 10.1053/gast.2001.24804; Bijsmans ITGW, 2012, BIOCHEM J, V441, P1007, DOI 10.1042/BJ20111234; Burgess G, 2008, EUR J CLIN PHARMACOL, V64, P43, DOI 10.1007/s00228-007-0408-z; da Silva TC, 2013, MOL ASPECTS MED, V34, P252, DOI 10.1016/j.mam.2012.07.004; Fernandes CF, 2007, BIOCHEM BIOPH RES CO, V361, P26, DOI 10.1016/j.bbrc.2007.06.160; Godoy JR, 2007, EUR J CELL BIOL, V86, P445, DOI 10.1016/j.ejcb.2007.06.001; Gui C, 2008, BIOCHEMISTRY-US, V47, P9090, DOI 10.1021/bi8008455; Gui C, 2008, EUR J PHARMACOL, V584, P57, DOI 10.1016/j.ejphar.2008.01.042; Gui CS, 2009, PROTEIN SCI, V18, P2298, DOI 10.1002/pro.240; Hagenbuch B, 2013, MOL ASPECTS MED, V34, P396, DOI 10.1016/j.mam.2012.10.009; Kandel SE, 2014, CHEM RES TOXICOL, V27, P1474, DOI 10.1021/tx500203s; Keller T, 2008, BIOCHEMISTRY-US, V47, P4552, DOI 10.1021/bi800060w; Kindla J, 2011, DRUG METAB DISPOS, V39, P1047, DOI 10.1124/dmd.110.037622; Konig J, 2013, PHARMACOL REV, V65, P944, DOI 10.1124/pr.113.007518; Kramer W, 2001, J BIOL CHEM, V276, P36020, DOI 10.1074/jbc.M104665200; Leuthold S, 2009, AM J PHYSIOL-CELL PH, V296, pC570, DOI 10.1152/ajpcell.00436.2008; Martinez-Becerra P, 2011, MOL PHARMACOL, V79, P596, DOI 10.1124/mol.110.069971; Mayati A, 2015, BIOCHEM PHARMACOL, V98, P703, DOI 10.1016/j.bcp.2015.10.007; Moore-Hoon ML, 2000, BIOCHEMISTRY-US, V39, P3718, DOI 10.1021/bi992301v; Ni CX, 2017, MOL PHARMACEUT, V14, P359, DOI 10.1021/acs.molpharmaceut.6b00649; Obaidat A, 2012, ANNU REV PHARMACOL, V52, P135, DOI 10.1146/annurev-pharmtox-010510-100556; Ohnishi S, 2014, BIOCHEMISTRY-US, V53, P2261, DOI 10.1021/bi500176e; Powell John, 2014, Drug Metab Dispos, V42, P1964, DOI 10.1124/dmd.114.056945; Ramsden Diane, 2014, Drug Metab Dispos, V42, P1940, DOI 10.1124/dmd.114.057901; Roth M, 2012, BRIT J PHARMACOL, V165, P1260, DOI 10.1111/j.1476-5381.2011.01724.x; Roth M, 2011, DRUG METAB DISPOS, V39, P920, DOI 10.1124/dmd.110.036640; Stieger B, 2014, CURR TOP MEMBR, V73, P205, DOI 10.1016/B978-0-12-800223-0.00005-0; Svoboda M, 2011, CURR DRUG METAB, V12, P139, DOI 10.2174/138920011795016863; Teese MG, 2015, BIOCHEMISTRY-US, V54, P5125, DOI 10.1021/acs.biochem.5b00495; Treiber A, 2007, DRUG METAB DISPOS, V35, P1400, DOI 10.1124/dmd.106.013615; van Giersbergen PLM, 2007, CLIN PHARMACOL THER, V81, P414, DOI 10.1038/sj.clpt.6100075; Yan H, 2014, ELIFE, P3; Zhang YC, 2013, J NAT PROD, V76, P368, DOI 10.1021/np3007292; Zhao W, 2015, TOXICOL SCI, V146, P363, DOI 10.1093/toxsci/kfv102	34	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0180257	10.1371/journal.pone.0180257	http://dx.doi.org/10.1371/journal.pone.0180257			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644885	gold, Green Published, Green Submitted			2022-12-27	WOS:000404145100066
J	Angessa, TT; Zhang, XQ; Zhou, GF; Broughton, S; Zhang, WY; Li, CD				Angessa, Tefera Tolera; Zhang, Xiao-Qi; Zhou, Gaofeng; Broughton, Sue; Zhang, Wenying; Li, Chengdao			Early growth stages salinity stress tolerance in CM72 x Gairdner doubled haploid barley population	PLOS ONE			English	Article							HORDEUM-VULGARE L.; QUANTITATIVE TRAIT LOCI; SALT TOLERANCE; GERMINATION STAGE; CULTIVARS; SODIUM; GENES; WHEAT; QTLS	A doubled haploid (DH) population of barley (Hordeum vulgare L.) generated from salinity tolerant genotype CM72 and salinity sensitive variety Gairdner was studied for salinity stress tolerance at germination, seedling emergence and first leaf full expansion growth stages. Germination study was conducted with deionized water, 150 mM and 300 mM NaCl treatments. Seedling stage salinity tolerance was conducted with three treatments: control, 150 mM NaCl added at seedling emergence and first leaf full expansion growth stages. Results from this study revealed transgressive phenotypic segregations for germination percentage and biomass at seedling stage. Twelve QTL were identified on chromosomes 2H-6H each explaining 10-25% of the phenotypic variations. A QTL located at 176.5 cM on chromosome 3H was linked with fresh weight per plant and dry weight per plant in salinity stress induced at first leaf full expansion growth stage, and dry weight per plant in salinity stress induced at seedling emergence. A stable QTL for germination at both 150 and 300 mM salinity stress was mapped on chromosome 2H but distantly located from a QTL linked with seedling stage salinity stress tolerance. QTL, associated markers and genotypes identified in this study play important roles in developing salinity stress tolerant barley varieties.	[Angessa, Tefera Tolera; Zhang, Xiao-Qi; Zhou, Gaofeng; Li, Chengdao] Murdoch Univ, Sch Vet & Life Sci VLS, Western Barley Genet Alliance, Murdoch, WA, Australia; [Broughton, Sue; Li, Chengdao] Dept Agr & Food WA, Grains Ind, S Perth, WA, Australia; [Zhang, Wenying] Yangtze Univ, Hubei Collaborat Innovat Ctr Grain Ind, Coll Agr, Jingzhou, Hubei, Peoples R China	Murdoch University; Government of Western Australia; Department of Agriculture & Food - Western Australia; Yangtze University	Li, CD (corresponding author), Murdoch Univ, Sch Vet & Life Sci VLS, Western Barley Genet Alliance, Murdoch, WA, Australia.; Li, CD (corresponding author), Dept Agr & Food WA, Grains Ind, S Perth, WA, Australia.; Zhang, WY (corresponding author), Yangtze Univ, Hubei Collaborat Innovat Ctr Grain Ind, Coll Agr, Jingzhou, Hubei, Peoples R China.	wyzhang2006@gmail.com; C.Li@Murdoch.edu.au	Angessa, Tefera/GLU-7090-2022; Zhang, Wenying/P-2509-2018	Zhang, Wenying/0000-0002-9926-4115; Angessa, Tefera Tolera/0000-0002-2400-1732	Australian Grains Research and Development Corporation (GRDC) [UMU00046]	Australian Grains Research and Development Corporation (GRDC)(Grains R&D Corp)	We thank the Australian Grains Research and Development Corporation (GRDC) for funding the project UMU00046 within which this paper is published. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Australian Grains Research and Development Corporation (GRDC) for funding the project UMU00046 within which this paper is published.	Ahmed IM, 2013, PLANT PHYSIOL BIOCH, V63, P49, DOI 10.1016/j.plaphy.2012.11.004; Boyd WJR, 2003, AUST J AGR RES, V54, P1277, DOI 10.1071/AR03014; Campoli C, 2014, ADV BOT RES, V72, P131, DOI 10.1016/B978-0-12-417162-6.00005-5; Colmer TD, 2005, AUST J EXP AGR, V45, P1425, DOI 10.1071/EA04162; Ellis RP, 2002, J EXP BOT, V53, P1163, DOI 10.1093/jexbot/53.371.1163; Flowers TJ, 2001, PLANT SOIL, V231, P1, DOI 10.1023/A:1010372213938; Fricke W, 2006, J EXP BOT, V57, P1079, DOI 10.1093/jxb/erj095; Gong X, 2014, EUPHYTICA, V197, P355, DOI 10.1007/s10681-014-1072-x; GORHAM J, 1994, J EXP BOT, V45, P895, DOI 10.1093/jxb/45.7.895; IBM Corp, 2013, IBM SPSS STAT WINDOW; Jia QJ, 2009, FUNCT INTEGR GENOMIC, V9, P255, DOI 10.1007/s10142-009-0120-4; Liu XH, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3380-0; Mano Y, 1997, BREEDING SCI, V47, P353; Mano Y, 1997, EUPHYTICA, V94, P263, DOI 10.1023/A:1002968207362; Mano Y, 1996, BREEDING SCI, V46, P227; MARTINEZCOB A, 1987, PLANT SOIL, V104, P53, DOI 10.1007/BF02370624; MUNNS R, 1995, AUST J PLANT PHYSIOL, V22, P561, DOI 10.1071/PP9950561; Ooijen V., 2004, MAPQTL5 0 SOFTWARE M; Qiu L, 2011, THEOR APPL GENET, V122, P695, DOI 10.1007/s00122-010-1479-2; Sbei H, 2014, BREEDING SCI, V64, P378, DOI 10.1270/jsbbs.64.378; Shavrukov Y, 2010, FUNCT INTEGR GENOMIC, V10, P277, DOI 10.1007/s10142-009-0153-8; TAL M, 1994, IN VITRO CELL DEV-PL, V30P, P175; Utz HF, 1997, PLABSTAT A COMPUTER; Xu RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043079; Xu YH, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-016-0964-4; Xue DW, 2009, EUPHYTICA, V169, P187, DOI 10.1007/s10681-009-9919-2; Zhang HX, 2010, ANN BOT-LONDON, V106, P1027, DOI 10.1093/aob/mcq204; Zhou GF, 2012, MOL BREEDING, V29, P427, DOI 10.1007/s11032-011-9559-9	29	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179715	10.1371/journal.pone.0179715	http://dx.doi.org/10.1371/journal.pone.0179715			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640858	Green Published, Green Submitted, gold			2022-12-27	WOS:000404135800055
J	Arora, V; Ghosh, MK; Pal, S; Gangopadhyay, G				Arora, Vivek; Ghosh, M. K.; Pal, Soumili; Gangopadhyay, Gaurab			Allele specific CAPS marker development and characterization of chalcone synthase gene in Indian mulberry (Morus spp., family Moraceae)	PLOS ONE			English	Article							BIOSYNTHETIC GENES; EXPRESSION; ACCUMULATION; FLAVONOIDS; ACID	Chalcone synthase (CHS) is an essential enzyme in the phenylpropanoid pathway that catalyzes the first step in flavonoid biosynthesis in plants under diverse environmental stress. We have used CHS as a candidate gene in mulberry and developed Single Nucleotide Polymorphism (SNP) based co-dominant Cleaved Amplified Polymorphic Sequence (CAPS) marker associated with the CHS locus. The segregation pattern of the marker was studied in an F-1 population derived from a hybridization program between two mulberry genotypes showing polymorphism for the CHS locus. Differential CHS activity of the recombinants has been correlated with the segregation pattern of the marker. Homology modelling and docking studies are performed for both the identified CHS alleles and correlated with respective CHS activity. Phenotyping of Powdery Mildew infected F-1 population indicated a probable association with the CAPS marker.	[Arora, Vivek; Pal, Soumili; Gangopadhyay, Gaurab] Bose Inst, Div Plant Biol, Main Campus, Kolkata, India; [Ghosh, M. K.] Cent Sericultural Res & Training Inst, Berhampur, India	Department of Science & Technology (India); Bose Institute	Gangopadhyay, G (corresponding author), Bose Inst, Div Plant Biol, Main Campus, Kolkata, India.	gaurab@jcbose.ac.in		arora, vivek/0000-0001-6202-0689	Bose Institute, Department of Science and Technology, Government of India; University Grants Commission of India for research fellowship	Bose Institute, Department of Science and Technology, Government of India(Department of Science & Technology (India)); University Grants Commission of India for research fellowship	GG is funded by Bose Institute, Department of Science and Technology, Government of India. VA is funded by University Grants Commission of India for research fellowship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora V., 2014, International Research Journal of Biological Sciences, V3, P40; Arora V., 2014, INT J GENET ENG BIOT, V52, P191; Bargsten JW, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0330-3; Bhan N, 2015, PROTEIN SCI, V24, P167, DOI 10.1002/pro.2600; Cardoso DC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-66; Dao TTH, 2011, PHYTOCHEM REV, V10, P397, DOI 10.1007/s11101-011-9211-7; Das M, 2011, TRANSGENIC RES, V20, P231, DOI 10.1007/s11248-010-9405-6; Deng N, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00174; Fini A, 2011, PLANT SIGNAL BEHAV, V6, P709, DOI 10.4161/psb.6.5.15069; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Lillo C, 2008, PLANT CELL ENVIRON, V31, P587, DOI 10.1111/j.1365-3040.2007.01748.x; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Martens S, 2005, PHYTOCHEMISTRY, V66, P2399, DOI 10.1016/j.phytochem.2005.07.013; MOUSTAFA E, 1967, PHYTOCHEMISTRY, V6, P625, DOI 10.1016/S0031-9422(00)86001-X; Obinata N., 2003, Plant Biotechnology, V20, P105, DOI 10.5511/plantbiotechnology.20.105; Pasold S, 2010, MOL PLANT PATHOL, V11, P545, DOI [10.1111/J.1364-3703.2010.00628.X, 10.1111/j.1364-3703.2010.00628.x]; Qi XW, 2014, MOL GENET GENOMICS, V289, P783, DOI 10.1007/s00438-014-0851-3; Rao A.A., 2002, EXPERT CONSULTATION, P21; Schroder J, 1997, TRENDS PLANT SCI, V2, P373, DOI 10.1016/S1360-1385(97)01104-7; Taylor LP, 2005, CURR OPIN PLANT BIOL, V8, P317, DOI 10.1016/j.pbi.2005.03.005; Vijayan K., 2007, INT J IND ENTOMOL, V15, P1; Wang CH, 2016, PLOS ONE, P1; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; Xin Mingming, 2012, Genomics Proteomics & Bioinformatics, V10, P94, DOI 10.1016/j.gpb.2012.05.002; Zhao S, 2015, J AGR FOOD CHEM, V63, P8622, DOI 10.1021/acs.jafc.5b03221	29	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179189	10.1371/journal.pone.0179189	http://dx.doi.org/10.1371/journal.pone.0179189			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640826	gold, Green Published, Green Submitted			2022-12-27	WOS:000404135800021
J	Ferrari, M; Konig, B				Ferrari, Manuela; Konig, Barbara			No evidence for punishment in communally nursing female house mice (Mus musculus domesticus)	PLOS ONE			English	Article							KIN RECOGNITION; SOCIAL-BEHAVIOR; MATERNAL-CARE; PARENTAL CARE; LACTATION; EVOLUTION; REPRODUCTION; COOPERATION; PATERNITY; BENEFITS	Punishment is claimed as an important mechanism to stabilise costly cooperation in humans, but its importance in social animals has been questioned recently due to both conceptual considerations and a lack of empirical evidence (only few published studies). We empirically tested whether there is evidence for punishment in communally nursing house mice (Mus musculus domesticus, direct descendants of "wild" animals). Communally breeding females pool their litters and raise all offspring together, indiscriminately caring for own and other offspring. Such a situation resembles a public good and provides scope for exploitation if females vary in their relative contributions to the joint nest (offspring number). We allowed two females to communally breed and conducted removal experiments both in the presence and absence of pups. We aimed to test whether reduced investment by one of the females (induced through separation from the partner and their combined offspring for 4 or 12 hours) leads to increased aggression by the other female after the reunion. We found no evidence for punishment, on the contrary, females increased socio-positive behaviours. The costs of losing a partner in a communally breeding species might be too high and hinder the evolution of punishment. Our findings add to a growing list of examples questioning the role of punishment in cooperating non-human animals and emphasise the importance of empirical testing of its assumptions and predictions.	[Ferrari, Manuela; Konig, Barbara] Univ Zurich, Dept Evolutionary Biol & Environm Studies, Zurich, Switzerland	University of Zurich	Ferrari, M (corresponding author), Univ Zurich, Dept Evolutionary Biol & Environm Studies, Zurich, Switzerland.	manuela.ferrari@ieu.uzh.ch	Ferrari, Manuela/K-7909-2019	Ferrari, Manuela/0000-0003-4610-2806; Konig, Barbara/0000-0001-7696-4736	University of Zurich	University of Zurich	This project was funded by the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Gabriele Stichel and Sally Steinert for animal care taking. We further thank Anna K. Lindholm for support and for commenting on the manuscript, and Andreas Sutter for statistical advice. The editor and 3 anonymous referees provided very helpful comments. The study was funded by the University of Zurich.	Auclair Y, 2014, ANIM BEHAV, V92, P143, DOI 10.1016/j.anbehav.2014.03.008; Balshine-Earn S, 1998, BEHAV ECOL, V9, P432, DOI 10.1093/beheco/9.5.432; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; BROWN JL, 1978, ANNU REV ECOL SYST, V9, P123, DOI 10.1146/annurev.es.09.110178.001011; Budaev SV, 2010, ETHOLOGY, V116, P472, DOI 10.1111/j.1439-0310.2010.01758.x; BURKE T, 1989, NATURE, V338, P249, DOI 10.1038/338249a0; Cant MA, 2014, P NATL ACAD SCI USA, V111, P326, DOI 10.1073/pnas.1312626111; Carlson AA, 2006, P ROY SOC B-BIOL SCI, V273, P571, DOI 10.1098/rspb.2005.3087; Chuang-Dobbs HC, 2001, ANIM BEHAV, V62, P83, DOI 10.1006/anbe.2001.1733; CLUTTONBROCK TH, 1989, NATURE, V337, P260, DOI 10.1038/337260a0; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; DAWES RM, 1980, ANNU REV PSYCHOL, V31, P169, DOI 10.1146/annurev.ps.31.020180.001125; dos Santos M, 2011, P ROY SOC B-BIOL SCI, V278, P371, DOI 10.1098/rspb.2010.1275; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Ferrari M, 2015, ANIM BEHAV, V110, P133, DOI 10.1016/j.anbehav.2015.09.018; GASTON AJ, 1978, AM NAT, V112, P1091, DOI 10.1086/283348; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Harrison N, 2016, ETHOLOGY, V122, P571, DOI 10.1111/eth.12505; HOLMES WG, 1982, AM ZOOL, V22, P491; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Jacobs DS, 1996, BEHAV ECOL SOCIOBIOL, V39, P401, DOI 10.1007/s002650050307; Jesseau SA, 2009, ANIM BEHAV, V78, P1183, DOI 10.1016/j.anbehav.2009.07.037; Jones CB, 2002, FOLIA PRIMATOL, V73, P140, DOI 10.1159/000064794; KNIGHT CH, 1982, J PHYSIOL-LONDON, V327, P17, DOI 10.1113/jphysiol.1982.sp014216; Konig B, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P191, DOI 10.1007/3-540-28277-7_11; Koenig WD, 2004, ECOLOGY AND EVOLUTIO; Koford R, 1990, COOPERATIVE BREEDING, P335; KONIG B, 1994, ANIM BEHAV, V48, P1449, DOI 10.1006/anbe.1994.1381; KONIG B, 1989, ETHOLOGY, V82, P328; Konig B, 1997, NATURWISSENSCHAFTEN, V84, P95, DOI 10.1007/s001140050356; KONIG B, 1988, J ZOOL, V216, P195; Konig B., 2012, EVOLUTION HOUSE MOUS, P114, DOI [DOI 10.1017/CBO9781139044547.007, 10.1017/CBO9781139044547.007]; KRACKOW S, 1989, J REPROD FERTIL, V86, P341, DOI 10.1530/jrf.0.0860341; Kramer J, 2016, ETHOLOGY, V122, P389, DOI 10.1111/eth.12486; Leighton GM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150953; LIDICKER WZ, 1976, J ANIM ECOL, V45, P677, DOI 10.2307/3575; MANNING CJ, 1995, ANIM BEHAV, V50, P741; McDonald PG, 2008, ANIM BEHAV, V75, P1319, DOI 10.1016/j.anbehav.2007.09.005; MULDER RA, 1993, ANIM BEHAV, V45, P830, DOI 10.1006/anbe.1993.1100; Nomano FY, 2015, BEHAV ECOL, V26, P986, DOI 10.1093/beheco/arv023; NORRIS ML, 1981, LAB ANIM, V15, P273, DOI 10.1258/002367781780893858; Palanza P, 1996, BEHAVIOUR, V133, P863, DOI 10.1163/156853996X00288; R Core Team, 2021, R LANGUAGE ENV STAT; Raihani NJ, 2012, TRENDS ECOL EVOL, V27, P288, DOI 10.1016/j.tree.2011.12.004; Rankin DJ, 2007, TRENDS ECOL EVOL, V22, P643, DOI 10.1016/j.tree.2007.07.009; REEVE HK, 1992, NATURE, V358, P147, DOI 10.1038/358147a0; REYER HU, 1986, BEHAVIOUR, V96, P277, DOI 10.1163/156853986X00522; Riehl C, 2016, PHILOSOPHICAL TRANSA, V371; Rios-Cardenas O, 2005, BEHAV ECOL, V16, P914, DOI 10.1093/beheco/ari076; Samuk K, 2013, BEHAV ECOL SOCIOBIOL, V67, P1275, DOI 10.1007/s00265-013-1555-0; SAYLER A, 1971, BEHAVIOUR, V40, P62, DOI 10.1163/156853971X00339; Solomon N. G., 1997, COOPERATIVE BREEDING; WATKINS LC, 1981, AM MIDL NAT, V105, P258, DOI 10.2307/2424744; Weidt A, 2008, ANIM BEHAV, V75, P801, DOI 10.1016/j.anbehav.2007.06.017; Weidt A, 2014, NATURWISSENSCHAFTEN, V101, P73, DOI 10.1007/s00114-013-1130-6; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; WILKINSON GS, 1988, ETHOLOGY, V77, P103; Young AJ, 2006, P NATL ACAD SCI USA, V103, P12005, DOI 10.1073/pnas.0510038103	61	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179683	10.1371/journal.pone.0179683	http://dx.doi.org/10.1371/journal.pone.0179683			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640850	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000404135800052
J	Proto, JD; Lu, A; Dorronsoro, A; Scibetta, A; Robbins, PD; Niedernhofer, LJ; Huard, J				Proto, Jonathan D.; Lu, Aiping; Dorronsoro, Akaitz; Scibetta, Alex; Robbins, Paul D.; Niedernhofer, Laura J.; Huard, Johnny			Inhibition of NF-kappa B improves the stress resistance and myogenic differentiation of MDSPCs isolated from naturally aged mice	PLOS ONE			English	Article							MUSCLE STEM-CELLS; SKELETAL-MUSCLE; LIFE-SPAN; REGENERATIVE CAPACITY; HEMATOPOIETIC STEM; PROGENITOR CELLS; CANCER-THERAPY; CYCLIN D1; SENESCENCE; ACTIVATION	A decline in the regenerative capacity of adult stem cells with aging is well documented. As a result of this decline, the efficacy of autologous stem cell therapies is likely to decline with increasing donor age. In these cases, strategies to restore the function of aged stem cells would have clinical utility. Globally, the transcription factor NF-kappa B is up-regulated in aged tissues. Given the negative role that NF-kappa B plays in myogenesis, we investigated whether the age-related decline in the function of muscle-derived stem/progenitor cells (MDSPCs) could be improved by inhibition of NF-kappa B. Herein, we demonstrate that pharmacologic or genetic inhibition of NF-kappa B activation increases myogenic differentiation and improves resistance to oxidative stress. Our results suggest that MDSPC "aging" may be reversible, and that pharmacologic targeting of pathways such as NF-kappa B may enhance the efficacy of cell-based therapies.	[Proto, Jonathan D.] Columbia Univ, Div Mol Med, Dept Med, New York, NY USA; [Lu, Aiping; Scibetta, Alex; Huard, Johnny] Univ Texas Hlth Sci Ctr Houston, Dept Orthopaed Surg, Inst Mol Med, McGovern Med Sch, Houston, TX 77030 USA; [Lu, Aiping; Huard, Johnny] Steadman Philippon Res Inst, Ctr Regenerat Sports Med, Vail, CO 81657 USA; [Dorronsoro, Akaitz; Robbins, Paul D.; Niedernhofer, Laura J.] Scripps Res Inst, Dept Metab & Aging, Jupiter, FL USA; [Proto, Jonathan D.] Sanofi Genzyme, Framingham, MA USA	Columbia University; University of Texas System; University of Texas Health Science Center Houston; Steadman Philippon Research Institute; Scripps Research Institute; Sanofi-Aventis; Genzyme Corporation	Huard, J (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Orthopaed Surg, Inst Mol Med, McGovern Med Sch, Houston, TX 77030 USA.; Huard, J (corresponding author), Steadman Philippon Res Inst, Ctr Regenerat Sports Med, Vail, CO 81657 USA.	johnny.huard@uth.tmc.edu	Dorronsoro, Akaitz/O-8905-2017	Dorronsoro, Akaitz/0000-0001-6141-8484; Niedernhofer, Laura/0000-0002-1074-1385; Robbins, Paul/0000-0003-1068-7099	National Institutes of Health [AG043376]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health grant AG043376 (Project 2 and Core A: PDR, Project 1 and Core B: LJN, Project 3: JH).	Adams PD, 2015, CELL STEM CELL, V16, P601, DOI 10.1016/j.stem.2015.05.002; Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Carlson ME, 2007, AGING CELL, V6, P371, DOI 10.1111/j.1474-9726.2007.00286.x; Castorina A, 2015, NEURAL REGEN RES, V10, P850, DOI 10.4103/1673-5374.158352; Conboy IM, 2005, CELL CYCLE, V4, P407, DOI 10.4161/cc.4.3.1518; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Dahlman JM, 2009, J CELL BIOCHEM, V106, P42, DOI 10.1002/jcb.21976; Deasy BM, 2003, STEM CELLS, V21, P536, DOI 10.1634/stemcells.21-5-536; Dimmeler S, 2008, CIRC RES, V102, P1319, DOI 10.1161/CIRCRESAHA.108.175943; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Gharaibeh B, 2008, NAT PROTOC, V3, P1501, DOI 10.1038/nprot.2008.142; Gosselin K, 2003, EXP GERONTOL, V38, P1271, DOI 10.1016/j.exger.2003.09.007; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hu ZL, 2008, CELL BIOL INT, V32, P761, DOI 10.1016/j.cellbi.2008.03.004; Kaltschmidt B, 2000, EUR J BIOCHEM, V267, P3828, DOI 10.1046/j.1432-1327.2000.01421.x; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kim D, 2015, STEM CELL TRANSL MED, V4, P1144, DOI 10.5966/sctm.2015-0011; Kuhnel F, 2000, J BIOL CHEM, V275, P6421, DOI 10.1074/jbc.275.9.6421; Kuranda K, 2011, AGING CELL, V10, P542, DOI 10.1111/j.1474-9726.2011.00675.x; Kuroda R, 2006, ARTHRITIS RHEUM-US, V54, P433, DOI 10.1002/art.21632; Lavasani M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1611; Liang Y, 2005, BLOOD, V106, P1479, DOI 10.1182/blood-2004-11-4282; Lu AP, 2012, MOL THER, V20, P661, DOI 10.1038/mt.2011.261; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Luo Y, 2014, TRANSPLANTATION, V97, P20, DOI 10.1097/TP.0b013e3182a7fcf8; Maier AB, 2007, ANN NY ACAD SCI, V1100, P323, DOI 10.1196/annals.1395.035; Nerlich AG, 2007, ANN NY ACAD SCI, V1096, P239, DOI 10.1196/annals.1397.090; Oh J, 2016, AGING-US, V8, P2871, DOI 10.18632/aging.101098; Okada M, 2012, MOL THER, V20, P138, DOI 10.1038/mt.2011.229; Oshima H, 2005, MOL THER, V12, P1130, DOI 10.1016/j.ymthe.2005.07.686; Proto JD, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.66; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Radhakrishnan SK, 2006, BBA-REV CANCER, V1766, P53, DOI 10.1016/j.bbcan.2006.02.001; Salminen A, 2009, J CLIN IMMUNOL, V29, P397, DOI 10.1007/s10875-009-9296-6; Si YL, 2010, AGEING RES REV; Song MJ, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt183; Soria-Valles C, 2015, NAT CELL BIOL, V17, P1004, DOI 10.1038/ncb3207; Strong R, 2008, AGING CELL, V7, P641, DOI 10.1111/j.1474-9726.2008.00414.x; Takayama K, 2016, J ORTHOPAEDIC RES OF; Tilstra JS, 2012, J CLIN INVEST, V122, P2601, DOI 10.1172/JCI45785; Urish KL, 2009, MOL BIOL CELL, V20, P509, DOI 10.1091/mbc.E08-03-0274; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06; Warner HR, 2015, AGE, V37, DOI 10.1007/s11357-015-9761-5; Wright VJ, 2002, MOL THER, V6, P169, DOI 10.1006/mthe.2002.0654	46	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179270	10.1371/journal.pone.0179270	http://dx.doi.org/10.1371/journal.pone.0179270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640861	Green Published, gold, Green Submitted			2022-12-27	WOS:000404135800026
J	Mohan, P; Sinu, PA				Mohan, Prabitha; Sinu, Palatty Allesh			Parasitoid wasp usurps its host to guard its pupa against hyperparasitoids and induces rapid behavioral changes in the parasitized host	PLOS ONE			English	Article							TOBACCO HORNWORM; MANDUCA-SEXTA; BODYGUARD; INCREASES	Some parasites have an ability to fabricate the behavior of their host and impel the host to guard parasites' offspring, which is popularly called as bodyguard manipulation. Psalis pennatula larva parasitized by a braconid parasitoid wasp Microplitis pennatula exhibits some behavioral changes including the guarding of the parasitoid pupa from its natural enemies. We hypothesized that these behavioral change exhibited by the parasitized host larva are induced by the parasitoid and can be considered as an example of bodyguard manipulation. Even though hyperparasitoids are the more specialized natural enemy of parasitoids than predators, very few studies tested the success of guarding parasitoid pupa against hyperparasitoids. This study analyzed the success of guarding behavior of the parasitized host against hyperparasitoids. The onsets of parasite-induced phenotypic alterations (PIPAs) in the parasitized host were inspected to analyze whether these behavioral changes in the host larva manifests gradually or abruptly. The study concludes that parasitized host larva defends the parasitoid pupa from hyperparasitoids and the PIPAs in the parasitized host develops abruptly only after the egression of parasitoid prepupa.	[Mohan, Prabitha; Sinu, Palatty Allesh] Cent Univ Kerala, Dept Anim Sci, Kasargod, Kerala, India; [Sinu, Palatty Allesh] Univ Arizona, Dept Ecol & Evolut Biol, Tucson, AZ 85721 USA	Central University of Kerala; University of Arizona	Mohan, P (corresponding author), Cent Univ Kerala, Dept Anim Sci, Kasargod, Kerala, India.	prabitha87@gmail.com	Mohan, Prabitha/I-2738-2016; Sinu, Palatty Allesh/ABE-2620-2021	Mohan, Prabitha/0000-0002-3045-7621; Sinu, Palatty Allesh/0000-0001-7391-7133	CSIR New Delhi; Central University of Kerala	CSIR New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Central University of Kerala	The authors received no specific funding for this work, but Prabitha Mohan thanks CSIR New Delhi for a Junior and Senior Research Fellowship and the Central University of Kerala for facilities and support.	Adamo SA, 2005, ARCH INSECT BIOCHEM, V60, P185, DOI 10.1002/arch.20068; Adamo SA, 1997, J EXP BIOL, V200, P117; Ann L, 2013, BIOL CONTROL, V67, P39; [Anonymous], 2014, R LANG ENV STAT COMP; Beckage NE, 1998, PARASITOLOGY, V116, pS57, DOI 10.1017/S0031182000084948; Berdoy M, 2000, P ROY SOC B-BIOL SCI, V267, P1591, DOI 10.1098/rspb.2000.1182; BRODEUR J, 1994, ANIM BEHAV, V48, P187, DOI 10.1006/anbe.1994.1225; BRODEUR J, 1990, J INSECT BEHAV, V3, P751, DOI 10.1007/BF01065963; Dawkins R., 1982, pi; Dheilly NM, 2015, INFECT GENET EVOL, V34, P251, DOI 10.1016/j.meegid.2015.05.027; Dheilly NM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2773; Grosman AH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002276; Harvey JA, 2008, PHYSIOL ENTOMOL, V33, P217, DOI 10.1111/j.1365-3032.2008.00623.x; Harvey JA, 2013, ENTOMOL EXP APPL, V149, P219, DOI 10.1111/eea.12127; Harvey JA, 2011, ANIM BEHAV, V81, P1281, DOI 10.1016/j.anbehav.2011.03.019; Koella JC, 1998, P ROY SOC B-BIOL SCI, V265, P763, DOI 10.1098/rspb.1998.0358; Maure F, 2011, BIOL LETTERS, V7, P843, DOI 10.1098/rsbl.2011.0415; Thomas F, 2002, J EVOLUTION BIOL, V15, P356, DOI 10.1046/j.1420-9101.2002.00410.x; Thomas F, 2010, OIKOS, V119, P1217, DOI 10.1111/j.1600-0706.2009.18077.x	19	8	9	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0178108	10.1371/journal.pone.0178108	http://dx.doi.org/10.1371/journal.pone.0178108			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636632	Green Published, gold, Green Submitted			2022-12-27	WOS:000404118300009
J	Newman, M; Halter, L; Lim, A; Lardelli, M				Newman, Morgan; Halter, Lena; Lim, Anne; Lardelli, Michael			Mitochondrion to endoplasmic reticulum apposition length in zebrafish embryo spinal progenitors is unchanged in response to perturbations associated with Alzheimer's disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; DEFICIENT HIPPOCAMPAL-NEURONS; GAMMA-SECRETASE; PRESENILIN GENE; OXIDASE; MUTATIONS; MEMBRANE; CLEAVAGE; STRESS; MODEL	Mutations in the human genes PRESENILIN1 (PSEN1), PRESENILIN2 (PSEN2) and AMYLOID BETA A4 PRECURSOR PROTEIN (APP) have been identified in familial Alzheimer's disease (AD). The length of mitochondrion-endoplasmic reticulum (M-ER) appositions is increased in Psen1(-/-)/PsenZ(-/-) double knockout murine embryonic fibroblasts and in fibroblasts from AD-affected individuals. Development of an easily accessible, genetically manipulable, in vivo system for studying M-ER appositions would be valuable so we attempted to manipulate M-ER apposition length in zebrafish (Danio rerio) embryos. We injected fertilized zebrafish eggs with antisense morpholino oligonucleotides (MOs) that inhibit expression of zebrafish familial AD gene orthologues psen1 and psen2. Furthermore, we treated zebrafish embryos with DAPT (a highly specific y-secretase inhibitor) or with sodium azide (to mimic partially hypoxic conditions). We then analyzed M-ER apposition in an identified, presumably proliferative neural cell type using electron microscopy. Our analysis showed no significant differences in M-ER apposition lengths at 48 hours post fertilization (hpf) between psen1 & psen2 MO co-injected embryos, embryos treated with DAPT, or sodium azide, and control embryos. Instead, the distribution of M-ER apposition lengths into different length classes was close to identical. However, this indicates that it is feasible to reproducibly measure M-ER size distributions in zebrafish embryos. While our observations differ from those of murine and human studies, this may be due to differences in cellular differentiation and metabolic state, cell age, or species-specific responses. In particular, by focusing on a presumably proliferative embryonic cell type, we may have selected a cell heavily already reliant on anaerobic glycolysis and less responsive to factors affecting M-ER apposition. Future examination of more differentiated, more secretory cell types may reveal measurable responses of M-ER apposition to environmental and genetic manipulation.	[Newman, Morgan; Halter, Lena; Lim, Anne; Lardelli, Michael] Univ Adelaide, Sch Biol Sci, Ctr Mol Pathol, Alzheimers Dis Genet Lab, Adelaide, SA, Australia	University of Adelaide	Newman, M; Lardelli, M (corresponding author), Univ Adelaide, Sch Biol Sci, Ctr Mol Pathol, Alzheimers Dis Genet Lab, Adelaide, SA, Australia.	morgan.newman@adelaide.edu.au; michael.lardelli@adelaide.edu.au	, Morgan/Y-5204-2019	Newman, Morgan/0000-0002-4930-4529	Adelaide Graduate Scholarship from the University of Adelaide; NHMRC [GNT1061006]; School of Biological Sciences of the University of Adelaide	Adelaide Graduate Scholarship from the University of Adelaide; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); School of Biological Sciences of the University of Adelaide	AL was supported by an Adelaide Graduate Scholarship from the University of Adelaide. MN was supported by NHMRC GNT1061006. Funding was provided by postgraduate student support funds from the School of Biological Sciences of the University of Adelaide.	Alexandre P, 2010, NAT NEUROSCI, V13, P673, DOI 10.1038/nn.2547; Ankarcrona M, 2002, BIOCHEM BIOPH RES CO, V295, P766, DOI 10.1016/S0006-291X(02)00735-0; Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Area-Gomez E, 2012, EMBO J, V31, P4106, DOI 10.1038/emboj.2012.202; Area-Gomez E, 2009, AM J PATHOL, V175, P1810, DOI 10.2353/ajpath.2009.090219; Bernales S, 2012, FRONT AGING NEUROSCI, V4, DOI 10.3389/fnagi.2012.00005; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Cottrell DA, 2001, NEUROLOGY, V57, P260, DOI 10.1212/WNL.57.2.260; Cottrell DA, 2002, NEUROPATH APPL NEURO, V28, P390, DOI 10.1046/j.1365-2990.2002.00414.x; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; Dahm R, 2006, MAR BIOTECHNOL, V8, P329, DOI 10.1007/s10126-006-5139-0; Davis RE, 1997, P NATL ACAD SCI USA, V94, P4526, DOI 10.1073/pnas.94.9.4526; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Di Marco LY, 2015, NEUROBIOL DIS, V82, P593, DOI 10.1016/j.nbd.2015.08.014; Filadi R, 2016, CELL REP, V15, P2226, DOI 10.1016/j.celrep.2016.05.013; Gao J, 2007, NEUROCHEM INT, V50, P379, DOI 10.1016/j.neuint.2006.09.007; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Gellerich FN, 2010, BBA-BIOENERGETICS, V1797, P1018, DOI 10.1016/j.bbabio.2010.02.005; Gibson GE, 1998, J NEURAL TRANSM, V105, P855, DOI 10.1007/s007020050099; Giorgi C, 2015, ANTIOXID REDOX SIGN, V22, P995, DOI 10.1089/ars.2014.6223; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Groth C, 2002, DEV GENES EVOL, V212, P486, DOI 10.1007/s00427-002-0269-5; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772; Kang DE, 2002, CELL, V110, P751, DOI 10.1016/S0092-8674(02)00970-4; Kelleher RJ, 2017, P NATL ACAD SCI USA, V114, P629, DOI 10.1073/pnas.1619574114; Kimura N, 2001, BRAIN RES, V922, P30, DOI 10.1016/S0006-8993(01)03146-8; Leadsham JE, 2013, CELL METAB, V18, P279, DOI 10.1016/j.cmet.2013.07.005; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Leimer U, 1999, BIOCHEMISTRY-US, V38, P13602, DOI 10.1021/bi991453n; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li JH, 1997, CELL, V90, P917, DOI 10.1016/S0092-8674(00)80356-6; Li JL, 2015, MECH DEVELOP, V137, P33, DOI 10.1016/j.mod.2015.04.001; Love S, 2016, ACTA NEUROPATHOL, V131, P645, DOI 10.1007/s00401-015-1522-0; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Moussavi Nik SH, 2015, HUM MOL GENET; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Musa A, 2001, DEV GENES EVOL, V211, P563, DOI 10.1007/s00427-001-0189-9; Newman M, 2014, HUM MOL GENET, V23, P602, DOI 10.1093/hmg/ddt448; Newman M, 2009, J ALZHEIMERS DIS, V16, P133, DOI 10.3233/JAD-2009-0945; Nik SHM, 2011, EXP CELL RES, V317, P1503, DOI 10.1016/j.yexcr.2011.04.004; Nornes S, 2008, HUM MOL GENET, V17, P402, DOI 10.1093/hmg/ddm317; Nornes S, 2009, EXP CELL RES, V315, P2791, DOI 10.1016/j.yexcr.2009.06.023; Panza F, 2010, CNS NEUROSCI THER, V16, P272, DOI 10.1111/j.1755-5949.2010.00164.x; PARKER WD, 1994, NEUROLOGY, V44, P1086, DOI 10.1212/WNL.44.6.1086; Parks AL, 2007, TRENDS GENET, V23, P140, DOI 10.1016/j.tig.2007.01.008; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; Pratico D, 2001, J NEUROSCI, V21, P4183, DOI 10.1523/JNEUROSCI.21-12-04183.2001; Qian ZM, 2001, TRENDS MOL MED, V7, P103, DOI 10.1016/S1471-4914(00)01910-9; Raturi A, 2013, BBA-MOL CELL RES, V1833, P213, DOI 10.1016/j.bbamcr.2012.04.013; Schon EA, 2012, MOL CELL NEUROSCI; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sosa MAG, 2010, AM J PATHOL, V176, P353, DOI 10.2353/ajpath.2010.090482; Sun LF, 2017, P NATL ACAD SCI USA, V114, pE476, DOI 10.1073/pnas.1618657114; Tambini MD, 2016, EMBO REP, V17, P27, DOI 10.15252/embr.201540614; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; UITENBROEK D. G, 1997, SISA BINOMIAL; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Vance JE., 2013, BIOCH BIOPHYS ACTA; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Voisin T, 2009, DRUG AGING, V26, P135, DOI 10.2165/0002512-200926020-00005; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Xu XL, 2013, CELL METAB, V18, P325, DOI 10.1016/j.cmet.2013.06.005; Yang T, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-15	65	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179859	10.1371/journal.pone.0179859	http://dx.doi.org/10.1371/journal.pone.0179859			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636676	gold, Green Published, Green Submitted			2022-12-27	WOS:000404118300060
J	Cosgarea, R; Heumann, C; Juncar, R; Tristiu, R; Lascu, L; Salvi, GE; Arweiler, NB; Sculean, A				Cosgarea, Raluca; Heumann, Christian; Juncar, Raluca; Tristiu, Roxana; Lascu, Liana; Salvi, Giovanni E.; Arweiler, Nicole B.; Sculean, Anton			One year results of a randomized controlled clinical study evaluating the effects of non-surgical periodontal therapy of chronic periodontitis in conjunction with three or seven days systemic administration of amoxicillin/metronidazole	PLOS ONE			English	Article							GENERALIZED AGGRESSIVE PERIODONTITIS; METRONIDAZOLE PLUS AMOXICILLIN; ACUTE OTITIS-MEDIA; BACTEROIDES-FRAGILIS GROUP; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; ANTIMICROBIAL SUSCEPTIBILITY; ANTIBIOTIC-RESISTANCE; ADULT PERIODONTITIS; PORPHYROMONAS-GINGIVALIS; MICROBIOLOGICAL BENEFITS	Background To evaluate the clinical outcomes 12 months after systemic administration of amoxicillin (AMX) and metronidazole (MET) adjunctive to subgingival debridement (SD) in patients with severe chronic periodontitis (sChP). Material and methods 102 patients with sChP were treated randomly as follows: SD within 2 consecutive days and placebo for 7 days (group A), SD+AMX+MET (both 500mg x3 times daily TID) for 3 days (group B), SD+AMX+MET (both 500mg x 3 TID) for 7 days (group C). At baseline, at 3-, 6-, and 12-months post-treatment probing pocket depth (PD), clinical attachment level (CAL), furcation involvement, bleeding on probing (BOP), full-mouth plaque score (FMPS) were determined. The reduction in the number of sites with PD >= 6mm was defined as main outcome variable. Results 75 patients completed the study. At 12 months, all three treatment groups showed statistically significant improvements (p<0.001) of mean PD, CAL, BOP and number of sites with PD >= 6mm compared to baseline. Mean residual PD were statistically significantly lower and CAL gain statistically significantly greater in the two antibiotic groups as compared to placebo. While PD reductions (p = 0.012) and CAL gain (p = 0.017) were statistically significantly higher in group C compared to group A, only the 3- day AB group showed statistically significantly fewer sites with PD >= 6mm at 12 m (p = 0.003). The reduction in the number of sites with PD >= 6 mm (primary outcome) showed no statistical significant differences between the 3 treatment groups. However, in both antibiotic groups significantly more patients compared to the placebo group reached a low risk for disease progression at 12 months (<= 4 sites with PD >= 5mm). Conclusion At 12 months, both adjunctive antibiotic protocols resulted in statistically significantly greater clinical improvements compared to placebo.	[Cosgarea, Raluca; Arweiler, Nicole B.] Philipps Univ, Clin Periodontol, Marburg, Germany; [Cosgarea, Raluca; Juncar, Raluca; Tristiu, Roxana; Lascu, Liana] Univ Med & Pharm Iuliu Hatieganu, Clin Prosthodont, Cluj Napoca, Romania; [Heumann, Christian] Ludwig Maximilians Univ Munchen, Dept Stat, Munich, Germany; [Salvi, Giovanni E.; Sculean, Anton] Univ Bern, Dept Periodontol, Bern, Switzerland	Philipps University Marburg; Iuliu Hatieganu University of Medicine & Pharmacy; University of Munich; University of Bern	Cosgarea, R (corresponding author), Philipps Univ, Clin Periodontol, Marburg, Germany.; Cosgarea, R (corresponding author), Univ Med & Pharm Iuliu Hatieganu, Clin Prosthodont, Cluj Napoca, Romania.	ralucacosgarea@gmail.com	Cosgarea, Raluca/GQQ-0229-2022; Juncar, Raluca Iulia/AAC-3929-2022; Arweiler, Nicole/GWU-7159-2022	Cosgarea, Raluca/0000-0003-2148-9645; 				AINAMO J, 1975, INT DENT J, V25, P229; Altamimi S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004872.pub3; Altamimi S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004872.pub2; Ammenheuser MM, 1997, ENVIRON MOL MUTAGEN, V30, P131, DOI 10.1002/(SICI)1098-2280(1997)30:2<131::AID-EM5>3.0.CO;2-Q; Ardila CM, 2010, J PERIODONTAL RES, V45, P557, DOI 10.1111/j.1600-0765.2010.01274.x; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Barbosa TM, 2000, DRUG RESIST UPDATE, V3, P303, DOI 10.1054/drup.2000.0167; Barnett ED, 1997, PEDIATRICS, V99, P23, DOI 10.1542/peds.99.1.23; Carvalho LH, 2005, J CLIN PERIODONTOL, V32, P406, DOI 10.1111/j.1600-051X.2005.00720.x; Chastre J, 2003, JAMA-J AM MED ASSOC, V290, P2588, DOI 10.1001/jama.290.19.2588; Cionca N, 2010, J PERIODONTOL, V81, P15, DOI 10.1902/jop.2009.090390; Cionca N, 2009, J PERIODONTOL, V80, P364, DOI [10.1902/jop.2009.080540, 10.1902/jop.2009.080540 ]; Cosgarea R, 2016, J CLIN PERIODONTOL, V43, P767, DOI 10.1111/jcpe.12559; Cugini MA, 2000, J CLIN PERIODONTOL, V27, P30, DOI 10.1034/j.1600-051x.2000.027001030.x; Dahlen G, 1996, J PERIODONTOL, V67, P879, DOI 10.1902/jop.1996.67.9.879; Oliveira APD, 2012, J CLIN PERIODONTOL, V39, P295, DOI 10.1111/j.1600-051X.2011.01817.x; deBoer WA, 1997, ALIMENT PHARM THERAP, V11, P109, DOI 10.1046/j.1365-2036.1997.121292000.x; Dunbar LM, 2003, CLIN INFECT DIS, V37, P752, DOI 10.1086/377539; Ehmke B, 2005, J PERIODONTOL, V76, P749, DOI 10.1902/jop.2005.76.5.749; EuropeanMedicineAgency, 2013, BACT CHALL TIM REACT; Fair RJ, 2014, PERSPECT MED CHEM, V6, P25, DOI 10.4137/PMC.S14459; Faveri M, 2014, J PERIODONTOL, V85, P581, DOI 10.1902/jop.2013.130278; Feres M, 2002, J CLIN PERIODONTOL, V29, P724, DOI 10.1034/j.1600-051X.2002.290809.x; Feres M, 2012, J CLIN PERIODONTOL, V39, P1149, DOI 10.1111/jcpe.12004; Flemmig TF, 1998, J CLIN PERIODONTOL, V25, P380, DOI 10.1111/j.1600-051X.1998.tb02459.x; Gooch WM, 1996, PEDIATR INFECT DIS J, V15, P157, DOI 10.1097/00006454-199602000-00013; Goodson JM, 2012, J CLIN PERIODONTOL, V39, P526, DOI 10.1111/j.1600-051X.2012.01870.x; Goutoudi P, 2004, J DENT, V32, P511, DOI 10.1016/j.jdent.2004.04.003; GREEN SM, 1993, PEDIATRICS, V91, P23; Griffiths GS, 2011, J CLIN PERIODONTOL, V38, P43, DOI 10.1111/j.1600-051X.2010.01632.x; GROSSI SG, 1994, J PERIODONTOL, V65, P260, DOI 10.1902/jop.1994.65.3.260; Guerrero A, 2005, J CLIN PERIODONTOL, V32, P1096, DOI 10.1111/j.1600-051X.2005.00814.x; Haffajee A D, 1994, Periodontol 2000, V5, P78, DOI 10.1111/j.1600-0757.1994.tb00020.x; Haffajee Anne D, 2003, Ann Periodontol, V8, P115, DOI 10.1902/annals.2003.8.1.115; Harks I, 2015, J CLIN PERIODONTOL, V42, P832, DOI 10.1111/jcpe.12441; Hedrick Traci L, 2006, Surg Infect (Larchmt), V7, P419, DOI 10.1089/sur.2006.7.419; Heller D, 2011, J CLIN PERIODONTOL, V38, P355, DOI 10.1111/j.1600-051X.2011.01707.x; Herrera D, 2002, J CLIN PERIODONTOL, V29, P136, DOI 10.1034/j.1600-051X.29.s3.8.x; Herrera D, 2008, J CLIN PERIODONTOL, V35, P106, DOI 10.1111/j.1600-051X.2007.01170.x; Hughes FJ, 2006, J CLIN PERIODONTOL, V33, P671, DOI 10.1111/j.1600-051X.2006.00965.x; Jaramillo A, 2005, J CLIN PERIODONTOL, V32, P1213, DOI 10.1111/j.1600-051X.2005.00839.x; Joshi JM, 2011, LUNG INDIA, V28, P193, DOI 10.4103/0970-2113.83977; Karlowsky JA, 2012, ANTIMICROB AGENTS CH, V56, P1247, DOI 10.1128/AAC.05823-11; Katchman EA, 2005, AM J MED, V118, P1196, DOI 10.1016/j.amjmed.2005.02.005; Keestra JAJ, 2015, J PERIODONTAL RES, V50, P294, DOI 10.1111/jre.12221; Kulik EM, 2008, J ANTIMICROB CHEMOTH, V61, P1087, DOI 10.1093/jac/dkn079; Lang Niklaus P, 2003, Oral Health Prev Dent, V1, P7; Lassmann B, 2007, CLIN INFECT DIS, V44, P895, DOI 10.1086/512197; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; Lipsitch M, 1997, ANTIMICROB AGENTS CH, V41, P363, DOI 10.1128/AAC.41.2.363; LOESCHE WJ, 1993, J CLIN PERIODONTOL, V20, P96, DOI 10.1111/j.1600-051X.1993.tb00336.x; Lopez NJ, 2000, J PERIODONTOL, V71, P79, DOI 10.1902/jop.2000.71.1.79; Lundgren D, 2001, J CLIN PERIODONTOL, V28, P23, DOI 10.1034/j.1600-051x.2001.280104.x; Matarazzo F, 2008, J CLIN PERIODONTOL, V35, P885, DOI 10.1111/j.1600-051X.2008.01304.x; Matuliene G, 2010, J CLIN PERIODONTOL, V37, P191, DOI 10.1111/j.1600-051X.2009.01508.x; Matuliene G, 2008, J CLIN PERIODONTOL, V35, P685, DOI 10.1111/j.1600-051X.2008.01245.x; Mestnik MJ, 2012, J CLIN PERIODONTOL, V39, P955, DOI 10.1111/j.1600-051X.2012.01932.x; Mestnik MJ, 2010, J CLIN PERIODONTOL, V37, P353, DOI 10.1111/j.1600-051X.2010.01538.x; Michael M, 2003, COCHRANE DB SYST REV, V1, DOI [10.1002/14651858.CD003966, DOI 10.1002/14651858.CD003966]; MOMBELLI A, 1994, J PERIODONTOL, V65, P820, DOI 10.1902/jop.1994.65.9.820; Mombelli A, 2000, J PERIODONTOL, V71, P14, DOI 10.1902/jop.2000.71.1.14; Musher DM, 2002, NEW ENGL J MED, V346, P630, DOI 10.1056/NEJM200202213460820; Nagy E, 2011, CLIN MICROBIOL INFEC, V17, P371, DOI 10.1111/j.1469-0691.2010.03256.x; OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; OLSVIK B, 1995, J CLIN PERIODONTOL, V22, P391, DOI 10.1111/j.1600-051X.1995.tb00166.x; Prevention C. f.D.C.a., 2013, ANTIBIOTIC RESISTANC; RENVERT S, 1990, J CLIN PERIODONTOL, V17, P345, DOI 10.1111/j.1600-051X.1990.tb00029.x; Ribeiro ED, 2009, J PERIODONTOL, V80, P1254, DOI 10.1902/jop.2009.080403; Roberts SA, 2006, J ANTIMICROB CHEMOTH, V57, P992, DOI 10.1093/jac/dkl052; Rodrigues AS, 2012, J PERIODONTOL, V83, P744, DOI 10.1902/jop.2011.110333; Rooney J, 2002, J CLIN PERIODONTOL, V29, P342, DOI 10.1034/j.1600-051X.2002.290410.x; Sawyer RG, 2015, NEW ENGL J MED, V372, P1996, DOI 10.1056/NEJMoa1411162; Schrag SJ, 2001, JAMA-J AM MED ASSOC, V286, P49, DOI 10.1001/jama.286.1.49; Seppala H, 1997, NEW ENGL J MED, V337, P441, DOI 10.1056/NEJM199708143370701; Shehab N, 2008, CLIN INFECT DIS, V47, P735, DOI 10.1086/591126; Silva MP, 2011, J CLIN PERIODONTOL, V38, P828, DOI 10.1111/j.1600-051X.2011.01763.x; Snydman DR, 2010, CLIN INFECT DIS, V50, pS26, DOI 10.1086/647940; SOCRANSKY SS, 1992, J PERIODONTOL, V63, P322, DOI 10.1902/jop.1992.63.4s.322; Van der Velden U, 2003, J CLIN PERIODONTOL, V30, P603, DOI 10.1034/j.1600-051X.2003.00080.x; van Winkelhoff AJ, 1999, J CLIN PERIODONTOL, V26, P764; van Winkelhoff AJ, 2000, J CLIN PERIODONTOL, V27, P79, DOI 10.1034/j.1600-051x.2000.027002079.x; van Winkelhoff AJ, 2005, J CLIN PERIODONTOL, V32, P893, DOI 10.1111/j.1600-051X.2005.00782.x; VANWINKELHOFF AJ, 1991, J CLIN MICROBIOL, V29, P723, DOI 10.1128/JCM.29.4.723-725.1991; VANWINKELHOFF AJ, 1989, J CLIN PERIODONTOL, V16, P128; Varela VM, 2011, J PERIODONTOL, V82, P1121, DOI 10.1902/jop.2011.100656; VOGELMAN B, 1986, J PEDIATR-US, V108, P835, DOI 10.1016/S0022-3476(86)80754-5; Walker CB, 1996, PERIODONTOL 2000, V10, P79, DOI 10.1111/j.1600-0757.1996.tb00069.x; Walker CB, 1996, PERIODONTOL 2000, V10, P12, DOI 10.1111/j.1600-0757.1996.tb00066.x; Winkel EG, 2001, J CLIN PERIODONTOL, V28, P296, DOI 10.1034/j.1600-051x.2001.028004296.x; Yek EC, 2010, J PERIODONTOL, V81, P964, DOI 10.1902/jop.2010.090522	90	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179592	10.1371/journal.pone.0179592	http://dx.doi.org/10.1371/journal.pone.0179592			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662049	Green Published, gold			2022-12-27	WOS:000404608300035
J	Lopes, D; Calheiros, MM; Patricio, JN; Garrido, MV				Lopes, Diniz; Calheiros, Maria Manuela; Patricio, Joana Nunes; Garrido, Margarida Vaz			Development and validation of a Social Images Evaluation Questionnaire for youth in residential care	PLOS ONE			English	Article							PERCEIVED STIGMATIZATION; STEREOTYPES; CHILDREN; SELF; DISCRIMINATION; ADOLESCENTS; PERCEPTION; BELIEFS; INDEXES; SCALE	Social images are defined as prevailing shared ideas about specific groups or societies without concrete or objective evidence of their accuracy or truthfulness. These images frequently have a negative impact on individuals and groups. Although of outmost importance, the study of the social images of youth in residential care is still scarce. In this article we present two studies for the development and validation of the Social Images Evaluation Questionnaire (SIEQ). In study 1, participants were asked to freely generate words that could be associated to youth in residential care in order to obtain a list of attributes to be used in the SIEQ. In study 2, the main psychometric characteristics of the SIEQ were tested with samples of laypeople and professionals. The main results support the proposal of a new and psychometrically sound measurement-the SIEQ-to analyze the social images of youth in residential care.	[Lopes, Diniz; Calheiros, Maria Manuela; Patricio, Joana Nunes; Garrido, Margarida Vaz] CIS IUL, Inst Univ Lisboa ISCTE IUL, Lisbon, Portugal	Instituto Universitario de Lisboa	Lopes, D (corresponding author), CIS IUL, Inst Univ Lisboa ISCTE IUL, Lisbon, Portugal.	diniz.lopes@iscte.pt	Calheiros, Maria Manuela/C-2616-2015; Lopes, Diniz/I-7691-2012; Calheiros, Maria Manuela/W-8607-2019; Garrido, Margarida/J-4083-2013	Calheiros, Maria Manuela/0000-0002-4768-9613; Lopes, Diniz/0000-0002-4353-2248; Calheiros, Maria Manuela/0000-0002-4768-9613; Garrido, Margarida/0000-0003-3651-9245	Portuguese Foundation for Science and Technology [PTDC/MHC-PSC/4122/2012, PTDC/MHC-PCN/5217/2014]; Marie Curie fellowship [631673]; Fundação para a Ciência e a Tecnologia [PTDC/MHC-PSC/4122/2012] Funding Source: FCT	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Marie Curie fellowship(European Commission); Fundação para a Ciência e a Tecnologia	This work was funded by the Portuguese Foundation for Science and Technology (PTDC/MHC-PSC/4122/2012 awarded to the second author and PTDC/MHC-PCN/5217/2014 awarded to the last author) and partially funded by a Marie Curie fellowship (FP7-PEOPLE-2013-CIG; Grant Number 631673) awarded to the last author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpini DM, 2003, REPENSANDO PERSPECTI, V23, P70; Baams L, 2013, ARCH SEX BEHAV, V42, P765, DOI 10.1007/s10508-012-0055-z; Bar-Tal D., 1990, GROUP BELIEFS CONCEP; Bar-Tal D, 2000, SHARED BELIEFS SOC S; Barchard KA, 2008, BEHAV RES METHODS, V40, P1111, DOI 10.3758/BRM.40.4.1111; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; BROWNE MW, 1989, MULTIVAR BEHAV RES, V24, P445, DOI 10.1207/s15327906mbr2404_4; Byrne B.M., 2012, STRUCTURAL EQUATION; Calheiros MM, 2015, CHILD YOUTH SERV REV, V55, P159, DOI 10.1016/j.childyouth.2015.06.004; Calheiros MM, 2014, J CHILD FAM STUD, V23, P461, DOI 10.1007/s10826-012-9702-1; Codol J., 1984, SOCIAL DIMENSION, V1, P314; Corsini R.J., 1999, DICT PSYCHOL; Costello AB, 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [DOI 10.7275/JYJ1-4868, DOI 10.1316/S0782-051X03024046-9]; Diario da Republica, DIARIO REPUBLIC 0901; Dorrer N, 2010, CHILD GEOGR, V8, P247, DOI 10.1080/14733285.2010.494863; Erikson E. H., IDENTITY YOUTH CRISI; Freake H, 2007, J ADOLESCENCE, V30, P639, DOI 10.1016/j.adolescence.2006.06.001; Gallagher S, PHENOMENOLOGICAL MIN; Garrido MV, 2016, J COMMUNITY APPL SOC, V26, P439, DOI 10.1002/casp.2273; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Hamilton D. L., 2000, ENCY PSYCHOL, V7, P466, DOI [10.1037/10522-195, DOI 10.1037/10522-195]; Hancock GR, 2001, STRUCTURAL EQUATION, P195, DOI DOI 10.12691/EDUCATION-3-1-10; Howarth C, 2006, J COMMUNITY APPL SOC, V16, P442, DOI 10.1002/casp.898; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Ibrahim RW, 2011, CHILD YOUTH SERV REV, V33, P2469, DOI 10.1016/j.childyouth.2011.08.019; Inzlicht M., 2012, STEREOTYPE THREAT TH, P107; J_oreskog K.G., 1984, LISREL 6 USERS GUIDE, Vthird; Katz D, 1933, J ABNORM SOC PSYCH, V28, P280, DOI 10.1037/h0074049; Kools SM, 1997, FAM RELAT, V46, P263, DOI 10.2307/585124; Krueger J, 1996, EUR J SOC PSYCHOL, V26, P961, DOI 10.1002/(SICI)1099-0992(199611)26:6<961::AID-EJSP799>3.3.CO;2-6; Kuznetsova TI, 2005, RUSS EDUC SOC, V47, P19, DOI 10.1080/10609393.2005.11056948; Leber C, 2012, CHILD YOUTH SERV REV, V34, P1633, DOI 10.1016/j.childyouth.2012.04.027; Major B, 2005, ANNU REV PSYCHOL, V56, P393, DOI 10.1146/annurev.psych.56.091103.070137; Martins A, 2012, PSYCHOL ASSESSMENT, V24, P973, DOI 10.1037/a0028582; Masnari O, 2012, J PLAST RECONSTR AES, V65, P1664, DOI 10.1016/j.bjps.2012.06.004; Massey SG, 2010, PSYCHOL SEX, V1, P115, DOI 10.1080/19419899.2010.484593; Mead G. H, MIND SELF SOC; Mello SL, 1999, ARTIMANHAS EXCLUSAO, P129; Muthen B.O., 2012, MPLUS USERS GUIDE, V7th; Nario-Redmond MR, 2010, BRIT J SOC PSYCHOL, V49, P471, DOI 10.1348/014466609X468411; Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059; Puhl RM, 2013, BEST PRACT RES CL EN, V27, P117, DOI 10.1016/j.beem.2012.12.002; Rauktis ME, 2011, CHILD YOUTH SERV REV, V33, P1224, DOI 10.1016/j.childyouth.2011.02.012; Stangor C., 1995, STEREOTYPE ACCURACY, P275, DOI DOI 10.1037/10495-011; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Tabachnick B. G., 2013, USING MULTIVARIATE S; Tiedemann J, 2000, J EDUC PSYCHOL, V92, P144, DOI 10.1037/0022-0663.92.1.144; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Van Brakel Wim H, 2006, Psychol Health Med, V11, P307, DOI 10.1080/13548500600595160; Woods T, 2005, J YOUTH ADOLESCENCE, V34, P437, DOI 10.1007/s10964-005-7261-0; Yeung KT, 2003, SOC FORCES, V81, P843, DOI 10.1353/sof.2003.0048; Yuan KH, 2000, SOCIOL METHODOL, V30, P165, DOI 10.1111/0081-1750.00078; Zafar S, 2013, J CHILD SEX ABUS, V22, P358, DOI 10.1080/10538712.2013.743955	53	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179890	10.1371/journal.pone.0179890	http://dx.doi.org/10.1371/journal.pone.0179890			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JX	28662056	Green Submitted, Green Published, gold			2022-12-27	WOS:000404608300064
J	Yuste-Checa, P; Vega, AI; Martin-Higueras, C; Medrano, C; Gamez, A; Desviat, LR; Ugarte, M; Perez-Cerda, C; Perez, B				Yuste-Checa, Patricia; Vega, Ana I.; Martin-Higueras, Cristina; Medrano, Celia; Gamez, Alejandra; Desviat, Lourdes R.; Ugarte, Magdalena; Perez-Cerda, Celia; Perez, Belen			DPAGT1-CDG: Functional analysis of disease causing pathogenic mutations and role of endoplasmic reticulum stress	PLOS ONE			English	Article							CONGENITAL MYASTHENIC SYNDROME; N-LINKED GLYCOSYLATION; CDG-IJ; DISORDER; MECHANISM	Pathogenic mutations in DPAGT1 are manifested as two possible phenotypes: congenital disorder of glycosylation DPAGT1-CDG (also known as CDG-Ij), and limb-girdle congenital myasthenic syndrome (CMS) with tubular aggregates. UDP-N-acetylglucosamine-dolichylphosphate N-acetylglucosamine phosphotransferase (GPT), the protein encoded by DPAGT1, is an endoplasmic reticulum (ER)-resident protein involved in an initial step in the N-glycosylation pathway. The aim of the present study was to examine the effect of six variants in DPAGT1 detected in patients with DPAGT1-CDG, and the role of endoplasmic reticulum stress, as part of the search for therapeutic strategies to use against DPAGT1-CDG. The effect of the six mutations, i.e., c.358C>A (p.Leu120Met), c.791T>G (p.Val264Gly), c.901C>T (p.Arg301Cys), c.902G>A (p.Arg301 His), c.1154T>G (p.Leu385Arg), and of the novel mutation c.329T>C (p.Phe110Ser), were examined via the analysis of DPAGT1 transcriptional profiles and GTP levels in patient-derived fibroblasts. In addition, the transient expression of different mutations was analysed in COS-7 cells. The results obtained, together with those of bioinformatic studies, revealed these mutations to affect the splicing process, the stability of GTP, or the ability of this protein to correctly localise in the ER membrane. The unfolded protein response (UPR; the response to ER stress) was found not to be active in patient-derived fibroblasts, unlike that seen in cells from patients with PMM2-CDG or DPM1-CDG. Even so, the fibroblasts of patients with DPAGT1-CDG seemed to be more sensitive to the stressor tunicamycin. The present work improves our knowledge of DPAGT1-CDG and provides bases for developing tailored splicing and folding therapies.	[Yuste-Checa, Patricia; Vega, Ana I.; Martin-Higueras, Cristina; Medrano, Celia; Gamez, Alejandra; Desviat, Lourdes R.; Ugarte, Magdalena; Perez-Cerda, Celia; Perez, Belen] Univ Autonoma Madrid, Ctr Biol Mol SO UAM CSIC, Ctr Diagnost Enfermedades Mol, Campus Cantoblanco, Madrid, Spain; [Yuste-Checa, Patricia; Vega, Ana I.; Martin-Higueras, Cristina; Medrano, Celia; Gamez, Alejandra; Desviat, Lourdes R.; Ugarte, Magdalena; Perez-Cerda, Celia; Perez, Belen] CIBERER, Madrid, Spain; [Yuste-Checa, Patricia; Vega, Ana I.; Martin-Higueras, Cristina; Medrano, Celia; Gamez, Alejandra; Desviat, Lourdes R.; Ugarte, Magdalena; Perez-Cerda, Celia; Perez, Belen] Inst Invest Hosp Univ La Paz IdiPAZ, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario La Paz	Perez, B (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol SO UAM CSIC, Ctr Diagnost Enfermedades Mol, Campus Cantoblanco, Madrid, Spain.; Perez, B (corresponding author), CIBERER, Madrid, Spain.; Perez, B (corresponding author), Inst Invest Hosp Univ La Paz IdiPAZ, Madrid, Spain.	bperez@cbm.csic.es	Martin-Higueras, Cristina/AAU-3749-2020; Gamez, Alejandra/T-6898-2017; Medrano, Celia/ABF-8994-2021; DESVIAT, LOURDES R/L-3055-2013	Martin-Higueras, Cristina/0000-0003-1139-4642; Gamez, Alejandra/0000-0002-2414-2586; Medrano, Celia/0000-0001-9634-7874; DESVIAT, LOURDES R/0000-0003-0492-3323; Yuste Checa, Patricia/0000-0002-1056-3849	Fundacion Isabel Gemio [PI16/00573]	Fundacion Isabel Gemio	This work was funded by grant PI16/00573 (www.isciii.es/ISCIII/es) and Fundacion Isabel Gemio (www.fundacionsabelgemio.com).	Carrera IA, 2012, AM J MED GENET A, V158A, P2027, DOI 10.1002/ajmg.a.35472; Belaya K, 2012, ANN NY ACAD SCI, V1275, P29, DOI 10.1111/j.1749-6632.2012.06790.x; Belaya K, 2012, AM J HUM GENET, V91, P193, DOI 10.1016/j.ajhg.2012.05.022; Braakman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013201; Cline A, 2012, MOL BIOL CELL, V23, P4175, DOI 10.1091/mbc.E12-05-0411; Denny RA, 2013, BIOORG MED CHEM LETT, V23, P1935, DOI 10.1016/j.bmcl.2013.01.089; Dey I, 2016, J GENET SYNDR GENE T, V7; Esposito Speranza, 2016, Mol Cell Pediatr, V3, P13, DOI 10.1186/s40348-016-0040-z; Finlayson S, 2013, J NEUROL NEUROSUR PS, V84, P1119, DOI 10.1136/jnnp-2012-304716; Ganetzky R, 2015, AM J MED GENET A, V167, P2411, DOI 10.1002/ajmg.a.37184; Gao NG, 2005, J BIOL CHEM, V280, P17901, DOI 10.1074/jbc.M500510200; Garcia-Silva MT, 2004, J INHERIT METAB DIS, V27, P591, DOI 10.1023/B:BOLI.0000042984.42433.d8; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; HEIFETZ A, 1979, BIOCHEMISTRY-US, V18, P2186, DOI 10.1021/bi00578a008; Houlden H, 2013, BRAIN, V136, P692, DOI 10.1093/brain/awt042; Imtiaz F, 2012, JIMD REP, V2, P107, DOI 10.1007/8904_2011_57; Jaeken J, 2015, EUR J HUM GENET, V23, DOI 10.1038/ejhg.2014.146; Lecca MR, 2004, FASEB J, V18, P240, DOI 10.1096/fj.04-2397fje; Lehrman MA, 2006, CRIT REV BIOCHEM MOL, V41, P51, DOI 10.1080/10409230500542575; MARQUARDT T, 1995, EUR J CELL BIOL, V66, P268; Muntau AC, 2014, J INHERIT METAB DIS, V37, P505, DOI 10.1007/s10545-014-9701-z; Ozcan L, 2012, ANNU REV MED, V63, P317, DOI 10.1146/annurev-med-043010-144749; Selcen D, 2014, NEUROLOGY, V82, P1822, DOI 10.1212/WNL.0000000000000435; Shang J, 2002, GLYCOBIOLOGY, V12, P307, DOI 10.1093/glycob/12.5.307; Sun LW, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-52; Wolfe LA, 2013, DEV DISABIL RES REV, V17, P211, DOI 10.1002/ddrr.1115; Wu XH, 2003, HUM MUTAT, V22, P144, DOI 10.1002/humu.10239; Wurde AE, 2012, MOL GENET METAB, V105, P634, DOI 10.1016/j.ymgme.2012.01.001; Xu CC, 2015, NAT REV MOL CELL BIO, V16, P742, DOI 10.1038/nrm4073; Yuste-Checa P, 2015, HUM MUTAT, V36, P851, DOI 10.1002/humu.22817	30	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179456	10.1371/journal.pone.0179456	http://dx.doi.org/10.1371/journal.pone.0179456			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662078	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300023
J	Smid, J; Kalousova, M; Mandak, B; Houska, J; Chladova, A; Pinedo, M; Lojka, B				Smid, Jans; Kalousova, Marie; Mandak, Bohumil; Houska, Jakub; Chladova, Anna; Pinedo, Mario; Lojka, Bohdan			Morphological and genetic diversity of camu-camu [Myrciaria dubia (Kunth) McVaugh] in the Peruvian Amazon	PLOS ONE			English	Article							HBK MCVAUGH; DIFFERENTIATION; MYRTACEAE; PROGRAM; FRUIT	Camu-camu [Myrciaria dubia (Kunth) McVaugh] is currently an important and promising fruit species grown in the Peruvian Amazon, as well as in Brazil, Colombia, and Bolivia. The species is valued for its high content of fruit-based vitamin C. Large plantations have been established only in the last two decades, and a substantial part of the production is still obtained by collecting fruits from the wild. Domestication of the species is at an early stage; most farmers cultivate the plants without any breeding, or only through a simple mass selection process. The main objective of the study was to characterize morphological and genetic variation within and among cultivated and natural populations of camu-camu in the Peruvian Amazon. In total, we sampled 13 populations: ten wild in the Iquitos region, and three cultivated in the Pucallpa region in the Peruvian Amazon. To assess the genetic diversity using seven microsatellite loci, we analyzed samples from ten individual trees per each population (n = 126). Morphological data was collected from five trees from each population (n = 65). The analysis did not reveal statistically significant differences for most of the morphological descriptors. For wild and cultivated populations, the observed heterozygosity was 0.347 and 0.404 (expected 0.516 and 0.506), and the fixation index was 0.328 and 0.200, respectively. Wild populations could be divided into two groups according to the UPGMA and STRUCTURE analysis. In cultivated populations, their approximate origin was determined. Our findings indicate a high genetic diversity among the populations, but also a high degree of inbreeding within the populations. This can be explained by either the isolation of these populations from each other or the low number of individuals in some populations. This high level of genetic diversity can be explored for the selection of superior individuals for further breeding.	[Smid, Jans; Kalousova, Marie; Chladova, Anna; Lojka, Bohdan] Czech Univ Life Sci, Fac Trop AgriSci, Dept Crop Sci & Agroforestry, Kamycka 129, Prague, Czech Republic; [Mandak, Bohumil] Czech Univ Life Sci, Fac Environm Sci, Dept Ecol, Kamycka 129, Prague, Czech Republic; [Mandak, Bohumil; Houska, Jakub] Acad Sci Czech Republ, Inst Bot, Zamek 1, Pruhonice, Czech Republic; [Houska, Jakub] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Soil Sci & Soil Protect, Prague, Czech Republic; [Pinedo, Mario] IIAP PROBOSQUES, Peruvian Amazon Res Inst, Av Abelardo Quinones, Iquitos, Peru	Czech University of Life Sciences Prague; Czech University of Life Sciences Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Czech University of Life Sciences Prague	Lojka, B (corresponding author), Czech Univ Life Sci, Fac Trop AgriSci, Dept Crop Sci & Agroforestry, Kamycka 129, Prague, Czech Republic.	lojka@ftz.czu.cz	Houska, Jakub/K-4404-2012; Lojka, Bohdan/O-6131-2016; Kalousová, Marie/AAM-3253-2020	Houska, Jakub/0000-0003-2163-4486; Lojka, Bohdan/0000-0002-5059-1975; Chladova, Anna/0000-0001-8427-062X; Mandak, Bohumil/0000-0002-9545-7497; Kalousova, Marie/0000-0001-7078-4064	Internal Grant Agency of CULS Prague [20145005, 20175017]; National University of Ucayali, Peru; Foundation Nadace Nadani Josefa, Mariea Zdenky Hlavkovych, Czech Republic (Foundation Grant); Foundation of the Czech Literature Fund	Internal Grant Agency of CULS Prague; National University of Ucayali, Peru; Foundation Nadace Nadani Josefa, Mariea Zdenky Hlavkovych, Czech Republic (Foundation Grant); Foundation of the Czech Literature Fund	This study was funded by several research grants provided by The Internal Grant Agency of CULS Prague (No. 20145005, No. 20175017); The Scholarship of the National University of Ucayali, Peru; The Foundation Nadace Nadani Josefa, Mariea Zdenky Hlavkovych, Czech Republic (Foundation Grant); The Foundation of the Czech Literature Fund.	Andrade J. S., 1995, Acta Horticulturae, P177; [Anonymous], 2021, LANG ENV STAT COMP; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; Chirinos R, 2010, FOOD CHEM, V120, P1019, DOI 10.1016/j.foodchem.2009.11.041; Doyle J. J., 1987, PHYTOCHEM B, P11; Ehrich D, 2007, MOL ECOL, V16, P2542, DOI 10.1111/j.1365-294X.2007.03299.x; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Franceschinelli EV, 2007, J TROP ECOL, V23, P361, DOI 10.1017/S0266467407004099; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hammer H. Q., 2001, PALAEONTOL ELECTRON, V4, P9, DOI DOI 10.1016/J.BCP.2008.05.025; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Justi KC, 2000, ARCH LATINOAM NUTR, V50, P405; Khan Suphiya, 2010, Physiology and Molecular Biology of Plants, V16, P149, DOI 10.1007/s12298-010-0016-8; Koshikene D., 2009, THESIS; Kuo CH, 2004, CONSERV GENET, V5, P425, DOI 10.1023/B:COGE.0000041020.54140.45; Martin MP, 2014, ECON BOT, V68, P169, DOI 10.1007/s12231-014-9269-4; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Penn JW, 2008, FOCUS GEOGR, V51, P18, DOI DOI 10.1111/J.1949-8535.2008.TB00222.X; Peters C. M., 1990, Advances in Economic Botany, V8, P159; Pinedo M, 2004, PLAN MEJORAMIENTO GE; Pritchard JK, 2000, GENETICS, V155, P945; Rodrigues R. B., 2006, Ernahrung, V30, P376; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Rojas S., 2011, Revista Corpoica - Ciencia y Tecnologia Agropecuarias, V12, P51; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sommano S, 2013, INT J FOOD PROP, V16, P1394, DOI 10.1080/10942912.2011.580485; Tchoundjeu P, 2007, INDIGENOUS FRUIT TRE; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Williams DJ, 2014, FOOD RES INT, V66, P100, DOI 10.1016/j.foodres.2014.09.003; ZAPATA SM, 1993, J SCI FOOD AGR, V61, P349, DOI 10.1002/jsfa.2740610310	33	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179886	10.1371/journal.pone.0179886	http://dx.doi.org/10.1371/journal.pone.0179886			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658316	Green Published, Green Submitted, gold			2022-12-27	WOS:000404607900045
J	Sakowicz, A; Pietrucha, T; Rybak-Krzyszkowska, M; Huras, H; Gach, A; Sakowicz, B; Banaszczyk, M; Grzesiak, M; Biesiada, L				Sakowicz, Agata; Pietrucha, Tadeusz; Rybak-Krzyszkowska, Magda; Huras, Hubert; Gach, Agnieszka; Sakowicz, Bartosz; Banaszczyk, Mateusz; Grzesiak, Mariusz; Biesiada, Lidia			Double hit of NEMO gene in preeclampsia	PLOS ONE			English	Article							NF-KAPPA-B; MESSENGER-RNA STABILITY; REGULATORY RNA; TARGET GENES; EXPRESSION; MECHANISMS; REGIONS; CELLS; FETAL; GAMMA	The precise etiology of preeclampsia is unknown. Family studies indicate that both genetic and environmental factors influence its development. One of these factors is NFkB, whose activation depends on NEMO (NFkB essential modulator. This is the first study to investigate the association between the existence of single nucleotide variant of the NEMO gene and the appearance of preeclampsia. A total of 151 women (72 preeclamptic women and 79 controls) and their children were examined. Sanger sequencing was performed to identify variants in the NEMO gene in the preeclamptic mothers. The maternal identified variants were then sought in the studied groups of children, and in the maternal and child controls, using RFLP-PCR. Real-time RT-PCR was performed to assess NEMO gene expression in maternal blood, umbilical cord blood and placentas. The sequencing process indicated the existence of two different variants in the 3'UTR region of the NEMO gene of preeclamptic women (IKBKG: c.*368C > A and IKBKG: c.*402C > T). The simultaneous occurrence of the TT genotype in the mother and the TT genotype in the daughter or a T allele in the son increased the risk of preeclampsia development 2.59 fold. Additionally, we found that the configuration of maternal/fetal genotypes (maternal TT/daughter TT or maternal TT/son T) of IKBKG: c.*402C/T variant is associated with the level of NEMO gene expression. Our results showed that, the simultaneous occurrence of the maternal TT genotype (IKBKG: c.*402C > T variants) and TT genotype in the daughter or T allele in the son correlates with the level of NEMO gene expression and increases the risk of preeclampsia development. Our observations may offer a new insight into the genetic etiology and pathogenesis of preeclampsia.	[Sakowicz, Agata; Pietrucha, Tadeusz] Med Univ Lodz, Dept Med Biotechnol, Lodz, Poland; [Rybak-Krzyszkowska, Magda; Huras, Hubert] Univ Hosp Krakow, Dept Obstet & Perinatol, Krakow, Poland; [Gach, Agnieszka] Polish Mothers Mem Hosp, Res Inst Lodz, Dept Genet, Lodz, Poland; [Sakowicz, Bartosz] Lodz Univ Technol, Dept Microelect & Comp Sci, Lodz, Poland; [Banaszczyk, Mateusz] Med Univ Lodz, Dept Tumor Biol, Lodz, Poland; [Grzesiak, Mariusz; Biesiada, Lidia] Polish Mothers Mem Hospital, Res Inst Lodz, Dept Obstet & Gynecol, Lodz, Poland	Medical University Lodz; Polish Mother's Memorial Hospital - Research Institute; Lodz University of Technology; Medical University Lodz	Sakowicz, A (corresponding author), Med Univ Lodz, Dept Med Biotechnol, Lodz, Poland.	agata.sakowicz@gmail.com	Rybak-Krzyszkowska, Magda/AAX-7848-2021; Sakowicz, Bartosz/Q-2809-2019; Huras, Hubert/U-3179-2018	Rybak-Krzyszkowska, Magda/0000-0002-6993-8078; Sakowicz, Bartosz/0000-0001-5153-2398; Sakowicz, Agata/0000-0002-5083-2046; Huras, Hubert/0000-0001-6661-6893; Grzesiak, Mariusz/0000-0002-6900-4347; Pietrucha, Tadeusz/0000-0002-0806-4899; Gach, Agnieszka/0000-0002-6590-5797	National Science Center (Poland) [DEC-2013/11/D/NZ5/01783]; National Science Center (NCN), Poland [DEC-2013/11/D/NZ5/01783]	National Science Center (Poland); National Science Center (NCN), Poland	This work was supported by grant DEC-2013/11/D/NZ5/01783 from the National Science Center (Poland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Grant no. DEC-2013/11/D/NZ5/01783 funded by The National Science Center (NCN), Poland. We also thank all mothers who agreed to participate in this study.	Akdeli N, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-87; Akehurst C, 2015, J HYPERTENS, V33, P2068, DOI 10.1097/HJH.0000000000000656; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chang TH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S4; Chappell S, 2006, CLIN SCI, V110, P443, DOI 10.1042/CS20050323; Cnattingius S, 2004, AM J MED GENET A, V130A, P365, DOI 10.1002/ajmg.a.30257; Fu JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002431; Fusco F, 2006, GENE, V383, P99, DOI 10.1016/j.gene.2006.07.022; Fusco F, 2015, INT REV IMMUNOL, V34, P445, DOI 10.3109/08830185.2015.1055331; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guo L, 2013, PLACENTA, V34, P599, DOI 10.1016/j.placenta.2013.04.007; Harwood FG, 2000, J BIOL CHEM, V275, P10023, DOI 10.1074/jbc.275.14.10023; Huang HY, 2006, NUCLEIC ACIDS RES, V34, pW429, DOI 10.1093/nar/gkl333; Hutcheon JA, 2011, BEST PRACT RES CL OB, V25, P391, DOI 10.1016/j.bpobgyn.2011.01.006; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Karumanchi SA, 2005, KIDNEY INT, V67, P2101, DOI 10.1111/j.1523-1755.2005.00316.x; Kawai T, 2012, ALLERGOL INT, V61, P207, DOI 10.2332/allergolint.12-RAI-0446; Knapinska AM, 2005, CURR GENOMICS, V6, P471, DOI 10.2174/138920205774482954; Kumar A, 2012, GENOMICS, V100, P352, DOI 10.1016/j.ygeno.2012.08.006; Kuntz TB, 2001, PEDIATR RES, V50, P743, DOI 10.1203/00006450-200112000-00019; Laivuori H, 2007, FRONT BIOSCI-LANDMRK, V12, P2372, DOI 10.2741/2239; Laresgoiti-Servitje E, 2010, HUM REPROD UPDATE, V16, P510, DOI 10.1093/humupd/dmq007; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Li X, 2010, RNA, V16, P1096, DOI 10.1261/rna.2017210; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Luppi P, 2006, AM J REPROD IMMUNOL, V56, P135, DOI 10.1111/j.1600-0897.2006.00386.x; Maiti GP, 2015, BBA-MOL BASIS DIS, V1852, P1059, DOI 10.1016/j.bbadis.2015.02.009; Martinez-Varea A, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/210241; Mooster JL, 2010, J ALLERGY CLIN IMMUN, V126, P127, DOI 10.1016/j.jaci.2010.04.026; Mouillet JF, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110049; Nemchenko A, 2010, CIRC RES, V106, P10, DOI 10.1161/CIRCRESAHA.109.211185; Nenci A, 2006, HUM MOL GENET, V15, P531, DOI 10.1093/hmg/ddi470; Noris M, 2005, NAT CLIN PRACT NEPHR, V1, P98, DOI 10.1038/ncpneph0035; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pennington KA, 2012, DIS MODEL MECH, V5, P9, DOI 10.1242/dmm.008516; Perez-Sepulveda A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00244; Rahardjo B, 2014, PREGNANCY HYPERTENS, V4, P187, DOI 10.1016/j.preghy.2014.03.001; Sakowicz A, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.11.002; Salgado SS, 2011, JCPSP-J COLL PHYSICI, V21, P482, DOI 08.2011/JCPSP.482486; Sankar KD, 2013, ANAT CELL BIOL, V46, P285, DOI 10.5115/acb.2013.46.4.285; Skjaerven R, 2005, BRIT MED J, V331, P877, DOI 10.1136/bmj.38555.462685.8F; Staines-Urias E, 2012, INT J EPIDEMIOL, V41, P1764, DOI 10.1093/ije/dys162; Vaughan JE, 2012, HYPERTENS PREGNANCY, V31, P243, DOI 10.3109/10641955.2011.642436; Wang J, 2014, INT J CLIN EXP MED, V7, P5303	45	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0180065	10.1371/journal.pone.0180065	http://dx.doi.org/10.1371/journal.pone.0180065			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654673	Green Submitted, Green Published, gold			2022-12-27	WOS:000404541500053
J	Abraham, PR; Pathak, N; Pradhan, G; Sumanlatha, G; Mukhopadhyay, S				Abraham, Philip Raj; Pathak, Niteen; Pradhan, Gourango; Sumanlatha, Gaddam; Mukhopadhyay, Sangita			The N-terminal domain of Mycobacterium tuberculosis PPE17 (Rv1168c) protein plays a dominant role in inducing antibody responses in active TB patients	PLOS ONE			English	Article							B-CELL RESPONSE; LOW-INCOME COUNTRIES; PULMONARY TUBERCULOSIS; IMMUNE-RESPONSE; EXPRESSION; DIAGNOSIS; GENE; IDENTIFICATION; PATHOGENICITY; ANTIGENS	The PPE (proline-proline-glutamic acid) proteins of Mycobacterium tuberculosis are characterized by a conserved N-terminal domain of approximately 180 amino acids and variable Cterminal domain. Since last decade, these proteins have gained much importance in the serodiagnosis of tuberculosis (TB) as they act as a source of antigenic variation. We have demonstrated earlier that one of the PPE proteins PPE17 (Rv1168c) induces strong B-cell and T-cell responses in active TB disease and also displays a higher antibody titer compared to immunodominant antigens such as ESAT-6, Hsp60 and PPD. However, the immunodominant domain of PPE17 (N-terminal or C-terminal) was not examined in detail. In the present study, we observed that antibody responses elicited in TB patients were directed mostly towards the N-terminal domain of PPE17 (N-PPE17). The antibody generated against NPPE17 in TB patients did not significantly cross-react with N-terminal domains of other PPE proteins used in this study. Our data suggest that the N-terminal domain of PPE17 protein is immunodominant and could be used as a better serodiagnostic marker than the full-length PPE17 protein.	[Abraham, Philip Raj; Pathak, Niteen; Pradhan, Gourango; Mukhopadhyay, Sangita] Ctr DNA Fingerprinting & Diagnost CDFD, Lab Mol Cell Biol, Hyderabad, Andhra Pradesh, India; [Pradhan, Gourango] Manipal Univ, Grad Studies, Manipal, Karnataka, India; [Sumanlatha, Gaddam] Bhagwan Mahavir Med Res Ctr, Hyderabad, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Manipal Academy of Higher Education (MAHE)	Mukhopadhyay, S (corresponding author), Ctr DNA Fingerprinting & Diagnost CDFD, Lab Mol Cell Biol, Hyderabad, Andhra Pradesh, India.	sangita@cdfd.org.in		Pradhan, Gourango/0000-0002-4206-9634; Mukhopadhyay, Sangita/0000-0002-5511-3315	Indian Council of Medical Research, Government of India [80/796/2013-ECD]; Department of Biotechnology, Government of India [BT/PR11605/NNT/28/758/2014, BT/PR12817/COE/34/23/2015]	Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	PRA was supported by the Research Associateship from the Indian Council of Medical Research, Government of India (80/796/2013-ECD). This work was supported by the Grants from Department of Biotechnology, Government of India (BT/PR11605/NNT/28/758/2014 and BT/PR12817/COE/34/23/2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham PR, 2016, INFECT GENET EVOL, V40, P339, DOI 10.1016/j.meegid.2015.09.005; Abraham PR, 2014, INFECT GENET EVOL, V22, P244, DOI 10.1016/j.meegid.2013.06.023; Ahmed A, 2015, IUBMB LIFE, V67, P414, DOI 10.1002/iub.1387; Bacon J, 2004, TUBERCULOSIS, V84, P205, DOI 10.1016/j.tube.2003.12.011; Baumann R, 2014, J INFECTION, V69, P581, DOI 10.1016/j.jinf.2014.05.014; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Bhat KH, 2012, J BIOL CHEM, V287, P16930, DOI 10.1074/jbc.M111.327825; Bonanni D, 2005, J MED MICROBIOL, V54, P443, DOI 10.1099/jmm.0.45960-0; Chakhaiyar P, 2004, J INFECT DIS, V190, P1237, DOI 10.1086/423938; Choudhary RK, 2003, INFECT IMMUN, V71, P6338, DOI 10.1128/IAI.71.11.6338-6343.2003; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dona V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057517; Fol M, 2015, ACTA BIOCHIM POL, V62, P633, DOI 10.18388/abp.2015_1130; Herrera V, 2011, CLIN INFECT DIS, V52, P1031, DOI 10.1093/cid/cir068; Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Ireton GC, 2010, CLIN VACCINE IMMUNOL, V17, P1539, DOI 10.1128/CVI.00198-10; Khalilullah SA, 2014, EGYPT J CHEST DIS TU, V63, P173, DOI 10.1016/j.ejcdt.2013.12.002; Khan N, 2008, CLIN VACCINE IMMUNOL, V15, P974, DOI 10.1128/CVI.00485-07; Khubaib M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00719; Lv Z, 2017, BIOMED RES INT; Marchetti G, 1998, J CLIN MICROBIOL, V36, P1512, DOI 10.1128/JCM.36.6.1512-1517.1998; Monterrubio-Lopez GP, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/483150; MOORE DF, 1995, J CLIN MICROBIOL, V33, P2686, DOI 10.1128/JCM.33.10.2686-2691.1995; Mukhopadhyay S, 2011, TUBERCULOSIS, V91, P441, DOI 10.1016/j.tube.2011.04.004; Muttucumaru D, 2002, TUBERCULOSIS EDINB, V84, P239; Nair S, 2011, J IMMUNOL, V186, P5413, DOI 10.4049/jimmunol.1000773; Nair S, 2009, J IMMUNOL, V183, P6269, DOI 10.4049/jimmunol.0901367; Pfyffer GE, 2012, J CLIN MICROBIOL, V50, P4188, DOI 10.1128/JCM.02283-12; Longhi RMP, 2013, BRAZ J INFECT DIS, V17, P363, DOI 10.1016/j.bjid.2012.11.001; Raja A, 2004, INDIAN J MED RES, V120, P213; Rindi L, 2007, FEMS IMMUNOL MED MIC, V51, P381, DOI 10.1111/j.1574-695X.2007.00315.x; Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Siddiqi K, 2003, LANCET INFECT DIS, V3, P288, DOI 10.1016/S1473-3099(03)00609-1; Steingart KR, 2009, CLIN VACCINE IMMUNOL, V16, P260, DOI 10.1128/CVI.00355-08; Trebucq A, 2011, INT J TUBERC LUNG D, V15, P1567, DOI 10.5588/ijtld.11.0392; Tundup S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003586; Udgata A, 2016, J IMMUNOL, V197, P1776, DOI 10.4049/jimmunol.1501816; World Health Organization, GLOB TUB REP 2015; Xu JN, 2012, CLIN VACCINE IMMUNOL, V19, P536, DOI 10.1128/CVI.05708-11; Zhang Guoqiang, 2009, Genomics Proteomics & Bioinformatics, V7, P107, DOI 10.1016/S1672-0229(08)60039-X; Zhang HM, 2007, CLIN MICROBIOL INFEC, V13, P139, DOI 10.1111/j.1469-0691.2006.01561.x	43	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179965	10.1371/journal.pone.0179965	http://dx.doi.org/10.1371/journal.pone.0179965			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651002	Green Published, gold, Green Submitted			2022-12-27	WOS:000404537300034
J	Singh, A; Sharma, AK; Singh, NK; Sharma, TR				Singh, Akshay; Sharma, Ajay Kumar; Singh, Nagendra Kumar; Sharma, Tilak Raj			PpTFDB: A pigeonpea transcription factor database for exploring functional genomics in legumes	PLOS ONE			English	Article								Pigeonpea (Cajanus cajan L.), a diploid legume crop, is a member of the tribe Phaseoleae. This tribe is descended from the millettioid (tropical) clade of the subfamily Papilionoideae, which includes many important legume crop species such as soybean (Glycine max), mung bean (Vigna radiata), cowpea (Vigna ungiculata), and common bean (Phaseolus vulgaris). It plays major role in food and nutritional security, being rich source of proteins, minerals and vitamins. We have developed a comprehensive Pigeonpea Transcription Factors Database (PpTFDB) that encompasses information about 1829 putative transcription factors (TFs) and their 55 TF families. PpTFDB provides a comprehensive information about each of the identified TFs that includes chromosomal location, protein physicochemical properties, sequence data, protein functional annotation, simple sequence repeats (SSRs) with primers derived from their motifs, orthology with related legume crops, and gene ontology (GO) assignment to respective TFs. (PpTFDB: http://14.139.229.199/PpTFDB/Home. aspx) is a freely available and user friendly web resource that facilitates users to retrieve the information of individual members of a TF family through a set of query interfaces including TF ID or protein functional annotation. In addition, users can also get the information by browsing interfaces, which include browsing by TF Categories and by, GO Categories. This PpTFDB will serve as a promising central resource for researchers as well as breeders who are working towards crop improvement of legume crops.	[Singh, Akshay; Singh, Nagendra Kumar; Sharma, Tilak Raj] Natl Res Ctr Plant Biotechnol, Pusa Campus, New Delhi, India; [Singh, Akshay] Dr APJ Abdul Kalam Tech Univ, Lucknow, Uttar Pradesh, India; [Sharma, Ajay Kumar] Meerut Inst Engn & Technol, Meerut, Uttar Pradesh, India; [Sharma, Tilak Raj] Natl Agri Food Biotechnol Inst, Mohali, Punjab, India	Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB); Meerut Institute of Engineering & Technology; Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI)	Sharma, TR (corresponding author), Natl Res Ctr Plant Biotechnol, Pusa Campus, New Delhi, India.; Sharma, TR (corresponding author), Natl Agri Food Biotechnol Inst, Mohali, Punjab, India.	trsharma@nabi.res.in	Sharma, Ajay Kumar/HHC-1334-2022; Singh, Nouratan/N-9377-2017; Singh, Akshay/AAZ-8886-2020	Singh, Nouratan/0000-0002-8063-8375; Singh, Akshay/0000-0001-7599-6699	Indian Council of Agricultural Research-Network Project on Transgenics in Crops (ICAR-NPTC) [2049-3004]	Indian Council of Agricultural Research-Network Project on Transgenics in Crops (ICAR-NPTC)	This work was carried out under the Indian Council of Agricultural Research-Network Project on Transgenics in Crops (ICAR-NPTC) project code (2049-3004). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was carried out under the Indian Council of Agricultural Research-Network Project on Transgenics in Crops (ICAR-NPTC) project code (2049-3004).	Agarwal G., 2016, PLANT BIOTECHNOL J, P1; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambawat S, 2013, PHYSIOL MOL BIOL PLA, V19, P307, DOI 10.1007/s12298-013-0179-1; Bhawna Bonthala VS, 2016, DATABASE OXFORD; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dash S, 2016, NUCLEIC ACIDS RES, V44, pD1181, DOI 10.1093/nar/gkv1159; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Franco-Zorrilla JM, 2014, P NATL ACAD SCI USA, V111, P2367, DOI 10.1073/pnas.1316278111; Garg R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088947; Huaiyu M, 2015, NUCLEIC ACIDS RES, V44, pD336; Jinpu J, 2016, NUCL ACIDS RES; Liu ZJ, 2008, PROTEINS, V72, P1114, DOI 10.1002/prot.22002; Maibam A., 2015, MOL PLANT BREED, V6, P1; Malviya N, 2015, MOL BIOL REP, V42, P535, DOI 10.1007/s11033-014-3797-y; Priyanka B, 2010, MOL GENET GENOMICS, V283, P273, DOI 10.1007/s00438-010-0516-9; Qiao ZZ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00034; Rathi D, 2016, PROTEOMICS, V16, P310, DOI 10.1002/pmic.201500257; Satheesh V, 2014, MOL BIOL REP, V41, P7763, DOI 10.1007/s11033-014-3669-5; Seo E, 2015, BRIEF FUNCT GENOMICS, V14, P260, DOI 10.1093/bfgp/elv011; Singh NK, 2012, J PLANT BIOCHEM BIOT, V21, P98, DOI 10.1007/s13562-011-0088-8; Sirhindi G, 2016, J PLANT BIOCHEM BIOT, V25, P301, DOI 10.1007/s13562-015-0342-6; Varshney RK, 2010, MOL BREEDING, V26, P393, DOI 10.1007/s11032-009-9327-2; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Yanagisawa S, 1998, J PLANT RES, V111, P363, DOI 10.1007/BF02507800; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	25	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179736	10.1371/journal.pone.0179736	http://dx.doi.org/10.1371/journal.pone.0179736			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651001	Green Published, Green Submitted, gold			2022-12-27	WOS:000404537300017
J	Pennino, MG; Arcangeli, A; Fonseca, VP; Campana, I; Pierce, GJ; Rotta, A; Bellido, JM				Grazia Pennino, Maria; Arcangeli, Antonella; Prado Fonseca, Vinicius; Campana, Ilaria; Pierce, Graham J.; Rotta, Andrea; Maria Bellido, Jose			A spatially explicit risk assessment approach: Cetaceans and marine traffic in the Pelagos Sanctuary (Mediterranean Sea)	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; FIN WHALES; HABITAT; ARCHIPELAGO; MODELS; HARBOR; SHIPS	Spatially explicit risk assessment is an essential component of Marine Spatial Planning (MSP), which provides a comprehensive framework for managing multiple uses of the marine environment, minimizing environmental impacts and conflicts among users. In this study, we assessed the risk of the exposure to high intensity vessel traffic areas for the three most abundant cetacean species (Stenella coeruleoalba, Tursiops truncatus and Balaenoptera physalus) in the southern area of the Pelagos Sanctuary, which is the only pelagic Marine Protected Area (MPA) for marine mammals in the Mediterranean Sea. In particular, we modeled the occurrence of the three cetacean species as a function of habitat variables in June by using hierarchical Bayesian spatial-temporal models. Similarly, we modelled the marine traffic intensity in order to find high risk areas and estimated the potential conflict due to the overlap with the cetacean home ranges. Results identified two main hot-spots of high intensity marine traffic in the area, which partially overlap with the area of presence of the studied species. Our findings emphasize the need for nationally relevant and transboundary planning and management measures for these marine species.	[Grazia Pennino, Maria; Prado Fonseca, Vinicius; Maria Bellido, Jose] Univ Valencia, Dept Estadist & Invest Operat, Stat Modeling Ecol Grp, Valencia, Spain; [Grazia Pennino, Maria; Maria Bellido, Jose] Ctr Oceanog Murcia, Inst Espanol Oceanog, Murcia, Spain; [Arcangeli, Antonella] ISPRA Dept Nat Conservat, Rome, Italy; [Prado Fonseca, Vinicius] Univ Fed Rio Grande do Norte, Dept Ecol, Natal, RN, Brazil; [Campana, Ilaria] Tuscia Univ, Ichthyogen Expt Marine Ctr CISMAR, Dept Ecol & Biol Sci, Viterbo, Italy; [Campana, Ilaria] Accademia Leviatano, Rome, Italy; [Pierce, Graham J.] Univ Aberdeen, Sch Biol Sci, Oceanlab, Newburgh, Aberdeen, Scotland; [Pierce, Graham J.] Univ Aveiro, Dept Biol, Aveiro, Portugal; [Pierce, Graham J.] Univ Aveiro, CESAM, Aveiro, Portugal; [Pierce, Graham J.] CSIC, Inst Invest Marinas, Vigo, Spain; [Rotta, Andrea] Univ Sassari, Dipartimento Med Vet, Sassari, Italy	University of Valencia; Spanish Institute of Oceanography; Italian Institute for Environmental Protection & Research (ISPRA); Universidade Federal do Rio Grande do Norte; Tuscia University; University of Aberdeen; Universidade de Aveiro; Universidade de Aveiro; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); University of Sassari	Pennino, MG (corresponding author), Univ Valencia, Dept Estadist & Invest Operat, Stat Modeling Ecol Grp, Valencia, Spain.; Pennino, MG (corresponding author), Ctr Oceanog Murcia, Inst Espanol Oceanog, Murcia, Spain.	grazia.pennino@mu.ieo.es	Grazia, Maria/E-3454-2015; Pierce, Graham/A-5404-2018; Bellido-Millán, J.M./ABG-5128-2020; Arcangeli, Antonella/I-1209-2019	Grazia, Maria/0000-0002-7577-2617; Pierce, Graham/0000-0002-4744-4501; Bellido-Millán, J.M./0000-0002-6887-4391; Arcangeli, Antonella/0000-0003-2156-9987; CAMPANA, ILARIA/0000-0003-0801-0927; Rotta, Alexandre/0000-0002-4406-2276	"Banco di Sardegna" Foundation [BAN6077]	"Banco di Sardegna" Foundation(Fondazione Banco di Sardegna)	This work was supported by the "Banco di Sardegna" Foundation (BAN6077). The funder had no role instudy design, data collection and analysis, decision to publish, o rpreparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; [Anonymous], PROT SPEC PROT AR BI; Arcangeli A., 2014, SCI REP PORT CROS NA, V28, P37, DOI DOI 10.1111/MAEC.12272; Arcangeli A, 2016, MAR ECOL-EVOL PERSP, V37, P269, DOI 10.1111/maec.12272; Buckland S.T., 2001, pi; Campana I, 2017, MAR POLLUT BULL, V115, P282, DOI 10.1016/j.marpolbul.2016.12.008; Campana I, 2015, MAR ENVIRON RES, V109, P1, DOI 10.1016/j.marenvres.2015.05.009; Coomber FG, 2016, MAR POLICY, V69, P102, DOI 10.1016/j.marpol.2016.04.013; Cribb N., 2015, OPEN J MAR SCI, V5, P335, DOI [10.4236/ojms.2015.53028, DOI 10.4236/OJMS.2015.53028]; Crowder LB, 2006, SCIENCE, V313, P617, DOI 10.1126/science.1129706; Druon JN, 2012, MAR ECOL PROG SER, V464, P289, DOI 10.3354/meps09810; EC, MOT SEA IMPL ART 12A; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Foley MM, 2010, MAR POLICY, V34, P955, DOI 10.1016/j.marpol.2010.02.001; Freeman E., 2012, PACKAGE PRESENCEABSE; Grech A, 2011, MAR POLICY, V35, P560, DOI 10.1016/j.marpol.2011.03.003; Hijmans R.J., 2015, CIRCLES, V9, P1; HIJMANS RJ, 2015, GEOGRAPHIC DATA ANAL; Hooker Sascha K., 2011, Endangered Species Research, V13, P203, DOI 10.3354/esr00322; ISPRA (Italian Institute for Environmental Research and Protection), 2012, FIX LIN TRANS US FER; Kahru M., 2010, WINDOW IMAGE MANAGER; Laist DW, 2001, MAR MAMMAL SCI, V17, P35, DOI 10.1111/j.1748-7692.2001.tb00980.x; Latimer AM, 2006, ECOL APPL, V16, P33, DOI 10.1890/04-0609; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Notarbartolo-Di-Sciara G, 2008, AQUAT CONSERV, V18, P367, DOI 10.1002/aqc.855; Olesiuk PF, 2002, MAR MAMMAL SCI, V18, P843, DOI 10.1111/j.1748-7692.2002.tb01077.x; Panigada S, 2015, REMOTESENS ENV, V112, P3400; Panigada S, 2006, MAR POLLUT BULL, V52, P1287, DOI 10.1016/j.marpolbul.2006.03.014; Panigada S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022878; Pennino M. G., 2016, HYDROBIOLOGIA, P1; Pennino MG, 2015, HYDROBIOLOGIA, V747, P69, DOI 10.1007/s10750-014-2127-7; Pennino MG, 2016, DEEP SEA 2 IN PRESS; Pirotta E, 2011, MAR ECOL PROG SER, V436, P257, DOI 10.3354/meps09236; R Development Core Team, 2016, R LANG ENV STAT COMP; Rako N, 2013, MAR POLLUT BULL, V68, P77, DOI 10.1016/j.marpolbul.2012.12.019; Redfern JV, 2013, CONSERV BIOL, V27, P292, DOI 10.1111/cobi.12029; Sergio F, 2006, J APPL ECOL, V43, P1049, DOI 10.1111/j.1365-2664.2006.01218.x; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; Sini MI, 2005, J MAR BIOL ASSOC UK, V85, P1547, DOI 10.1017/S0025315405012774; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Vaes, 2013, MAPPING POTENTIAL RI, DOI 10.2788/8520; VIEILLEDENT G, 2014, HSDM HIERARCHICAL BA; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	44	30	30	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179686	10.1371/journal.pone.0179686	http://dx.doi.org/10.1371/journal.pone.0179686			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644882	Green Submitted, gold, Green Published			2022-12-27	WOS:000404145100034
J	Taylor, O; Van Laeken, N; Polis, I; Dockx, R; Vlerick, L; Dobbeleir, A; Goethals, I; Saunders, J; Sadones, N; Baeken, C; De Vos, F; Peremans, K				Taylor, Olivia; Van Laeken, Nick; Polis, Ingeborgh; Dockx, Robrecht; Vlerick, Lise; Dobbeleir, Andre; Goethals, Ingeborg; Saunders, Jimmy; Sadones, Nele; Baeken, Chris; De Vos, Filip; Peremans, Kathelijne			Estimation of the optimal dosing regimen of escitalopram in dogs: A dose occupancy study with [C-11] DASB	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; SEROTONIN TRANSPORTER; CITALOPRAM	Although the favourable characteristics of escitalopram as being the most selective serotonin reuptake inhibitor and having an increased therapeutic efficacy via binding on an additional allosteric binding site of the serotonin transporter, its dosing regimen has not yet been optimized for its use in dogs. This study aimed to estimate the optimal dosing frequency and the required dose for achieving 80% occupancy of the serotonin transporters in the basal ganglia. The dosing frequency was investigated by determining the elimination half-life after a four day oral pre-treatment period with 0.83 mg/kg escitalopram (3 administrations/day) and a subsequent i. v. injection 0.83 mg/ kg. Blood samples were taken up to 12 hours after i. v. injection and the concentration of escitalopram in plasma was analysed via LC-MSMS. The dose-occupancy relationship was then determined by performing two PET scans in five adult beagles: a baseline PET scan and a second scan after steady state conditions were achieved following oral treatment with a specific dose of escitalopram ranging from 0.5 to 2.5 mg/kg/day. As the elimination half-life was determined to be 6.7 hours a dosing frequency of three administrations a day was proposed for the second part of the study. Further it was opted for a treatment period of four days, which well exceeded the minimum period to achieve steady state conditions. The optimal dosing regimen to achieve 80% occupancy in the basal ganglia and elicit a therapeutic effect, was calculated to be 1.85 mg/kg/day, divided over three administrations. Under several circumstances, such as insufficient response to other SSRIs, concurrent drug intake or in research studies focused on SERT, the use of escitalopram can be preferred over the use of the already for veterinary use registered fluoxetine, however, in case of long-term treatment with escitalopram, regularly cardiac screening is recommended.	[Taylor, Olivia; Polis, Ingeborgh; Dockx, Robrecht; Vlerick, Lise; Saunders, Jimmy; Peremans, Kathelijne] Univ Ghent, Dept Vet Med, Ghent, Belgium; [Van Laeken, Nick; De Vos, Filip] Univ Ghent, Lab Radiopharm, Ghent, Belgium; [Dockx, Robrecht; Baeken, Chris] Univ Ghent, Dept Psychiat & Med Psychol, Ghent, Belgium; [Dobbeleir, Andre; Goethals, Ingeborg] Ghent Univ Hosp, Dept Nucl Med, Ghent, Belgium; [Sadones, Nele] Univ Ghent, Toxicol Lab, Ghent, Belgium	Ghent University; Ghent University; Ghent University; Ghent University; Ghent University Hospital; Ghent University	Van Laeken, N (corresponding author), Univ Ghent, Lab Radiopharm, Ghent, Belgium.	nick.vanlaeken@ugent.be	Baeken, Chris/D-6790-2013					Andree B, 2000, NUCL MED BIOL, V27, P515, DOI 10.1016/S0969-8051(00)00121-9; Baldinger P, 2014, NEUROIMAGE, V88, P252, DOI 10.1016/j.neuroimage.2013.10.002; Brmstrup C, 2004, INT J PSYCHIAT CL S1, V8, P11; Dua-Sharma S., 1970, CANINE BRAIN STEREOT; Hume SP, 1998, EUR J NUCL MED, V25, P173, DOI 10.1007/s002590050211; Le Bloc'h Y, 2003, THER DRUG MONIT, V25, P600, DOI 10.1097/00007691-200310000-00010; Lim R. K. S., 1960, STEREOTAXIC ATLAS DO; Marken Patricia A., 2000, Prim Care Companion J Clin Psychiatry, V2, P205; Meyer JH, 2004, AM J PSYCHIAT, V161, P826, DOI 10.1176/appi.ajp.161.5.826; NIGROVIC V, 1993, BRIT J ANAESTH, V71, P908, DOI 10.1093/bja/71.6.908; OVERO KF, 1982, PROG NEURO-PSYCHOPH, V6, P297, DOI 10.1016/S0278-5846(82)80180-2; Passchier J, 2002, METHODS, V27, P278, DOI 10.1016/S1046-2023(02)00084-1; Rao N, 2007, CLIN PHARMACOKINET, V46, P281, DOI 10.2165/00003088-200746040-00002; Sanchez C, 2014, INT CLIN PSYCHOPHARM, V29, P185, DOI 10.1097/YIC.0000000000000023; Taylor O, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0622-3; Toutain PL, 2010, HANDB EXP PHARMACOL, V199, P19, DOI 10.1007/978-3-642-10324-7_2; Van Laeken N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148943; Van Laeken N, 2013, APPL RADIAT ISOTOPES, V78, P62, DOI 10.1016/j.apradiso.2013.04.009; Waade RB, 2014, EUR J CLIN PHARMACOL, V70, P933, DOI 10.1007/s00228-014-1696-8; Wilson AA, 2002, NUCL MED BIOL, V29, P509, DOI 10.1016/S0969-8051(02)00316-5	20	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179927	10.1371/journal.pone.0179927	http://dx.doi.org/10.1371/journal.pone.0179927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644875	gold, Green Published, Green Submitted			2022-12-27	WOS:000404145100051
J	Peterson, RG; Van Jackson, C; Zimmerman, KM; Alsina-Fernandez, J; Michael, MD; Emmerson, PJ; Coskun, T				Peterson, Richard G.; Van Jackson, Charles; Zimmerman, Karen M.; Alsina-Fernandez, Jorge; Michael, M. Dodson; Emmerson, Paul J.; Coskun, Tamer			Glucose dysregulation and response to common anti-diabetic agents in the FATZO/Pco mouse	PLOS ONE			English	Article							DIET-INDUCED OBESITY; INSULIN-RESISTANCE; METABOLIC SYNDROME; LEPTIN RESISTANCE; C57BL/6J MICE; GLP-1 ANALOG; WEIGHT-LOSS; HIGH-FAT; METFORMIN; EXPRESSION	The FATZO/Pco mouse is the result of a cross of the C57BL/6J and AKR/J strains. The crossing of these two strains and the selective inbreeding for obesity, insulin resistance and hyperglycemia has resulted in an inbred strain exhibiting obesity in the presumed presence of an intact leptin pathway. Routinely used rodent models for obesity and diabetes research have a monogenic defect in leptin signaling that initiates obesity. Given that obesity and its sequelae in humans are polygenic in nature and not associated with leptin signaling defects, the FATZO mouse may represent a more translatable rodent model for study of obesity and its associated metabolic disturbances. The FATZO mouse develops obesity spontaneously when fed a normal chow diet. Glucose intolerance with increased insulin levels are apparent in FATZO mice as young as 6 weeks of age. These progress to hyperglycemia/pre-diabetes and frank diabetes with decreasing insulin levels as they age. The disease in these mice is multi-faceted, similar to the metabolic syndrome apparent in obese individuals, and thus provides a long pre-diabetic state for determining the preventive value of new interventions. We have assessed the utility of this new model for the pre-clinical screening of agents to stop or slow progression of the metabolic syndrome to severe diabetes. Our assessment included: 1) characterization of the spontaneous development of disease, 2) comparison of metabolic disturbances of FATZO mice to control mice and 3) validation of the model with regard to the effectiveness of current and emerging anti-diabetic agents; rosiglitazone, metformin and semaglutide. Conclusion: Male FATZO mice spontaneously develop significant metabolic disease when compared to normal controls while maintaining hyperglycemia in the presence of high leptin levels and hyperinsulinemia. The disease condition responds to commonly used antidiabetic agents.	[Peterson, Richard G.; Van Jackson, Charles; Zimmerman, Karen M.] Crown Biosci Indiana, Indianapolis, IN 46268 USA; [Alsina-Fernandez, Jorge; Michael, M. Dodson; Emmerson, Paul J.; Coskun, Tamer] Eli Lilly & Co, Indianapolis, IN 46285 USA	Eli Lilly	Peterson, RG (corresponding author), Crown Biosci Indiana, Indianapolis, IN 46268 USA.	rpeterson@crownbio.com	Coskun, Tamer/AAR-8422-2021	Michael, Mervyn/0000-0002-0224-1065	SBIR grant from NIH [2R44DK082065]; Eli Lilly and Company; Crown Bioscience Indiana; SBIR	SBIR grant from NIH; Eli Lilly and Company(Eli Lilly); Crown Bioscience Indiana; SBIR	This project was partially funded by an SBIR grant from NIH (2R44DK082065) to PreClinOmics. Additional funding was supplied by Eli Lilly and Company in the form of salaries for authors MDM, PJE, JAF and TC but it did not have any additional role in the study design, data collection and analysis. There was also a contract from Eli Lilly and Company to do the semaglutide experiment. Funding was also supplied by PreClinOmics (now Crown Bioscience Indiana) for authors CVJ, KMZ, and RGP in the form of salaries and other compensation. RGP was one of the owners and CSO for PreClinOmics and was the principal investigator on the SBIR grants and as such was responsible for the animal model development before, during and after the tenure of the SBIR funding and as such, was involved in study design, data collection, data analysis and manuscript production. CVJ is the general manager and CSO of Crown Bioscience Indiana and as such, since March 2016, was partially responsible for the continued support of the project in the form of material, salaries study design, data collection, data analysis and manuscript production. The other specific roles of these authors are articulated in the author contributions section.	Al-Barazanji K, 2015, J PHARMACOL EXP THER, V353, P496, DOI 10.1124/jpet.115.222828; Alexander J, 2006, INT J OBESITY, V30, P50, DOI 10.1038/sj.ijo.0803110; Anderson J, 2016, POSTGRAD MED; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Anthony J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077946; Bolen S, 2016, DIABETES MEDICATIONS; Bowles L, 2001, J CLIN PATHOL, V54, P1, DOI 10.1136/jcp.54.1.1; Brietzke SA, 2015, MED CLIN N AM, V99, P87, DOI 10.1016/j.mcna.2014.08.012; Brown ML, 2011, OBESITY, V19, P1940, DOI 10.1038/oby.2011.97; Buckingham RE, 2008, DIABETES OBES METAB, V10, P312, DOI 10.1111/j.1463-1326.2006.00700.x; Cinti S, 2009, AM J PHYSIOL-ENDOC M, V297, pE977, DOI 10.1152/ajpendo.00183.2009; Coelho MS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154310; Cottrell EC, 2012, HDB EXP PHARM, V3-21; Diamant M, 2003, DRUGS, V63, P1373, DOI 10.2165/00003495-200363130-00004; Diaz MB, 2006, PHYSIOL BEHAV, V88, P191, DOI 10.1016/j.physbeh.2006.03.028; DIXON FJ, 1953, P SOC EXP BIOL MED, V83, P287; DIXON FJ, 1952, J EXP MED, V96, P313, DOI 10.1084/jem.96.4.313; Droz BA, 2017, CORRELATION DIS SEVE; Eliasson B, 2014, ADIPOCYTE, V3, P314, DOI 10.4161/adip.34425; Ervin RB., 2009, NATL HLTH STAT REPOR, V13; Eschwege E, 2000, ARCH MAL COEUR VAISS, V93, P13; Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040; Filippatos TD, 2013, ARCH MED SCI, V9, P788, DOI 10.5114/aoms.2013.38671; Firouzjaei A, 2016, NUTR DIABETES, V6, DOI 10.1038/nutd.2016.16; FRIEDMAN JM, 1991, MAMM GENOME, V1, P130, DOI 10.1007/BF00351059; Fu YL, 2015, NEPHRON, V129, P68, DOI 10.1159/000370254; Funcke Jan-Bernd, 2014, Mol Cell Pediatr, V1, P3, DOI 10.1186/s40348-014-0003-1; Gentilella R, 2009, DIABETES OBES METAB, V11, P544, DOI 10.1111/j.1463-1326.2008.01018.x; Glueck CJ, 2001, METABOLISM, V50, P856, DOI 10.1053/meta.2001.24192; Grundy SM, 2016, TRENDS CARDIOVAS MED, V26, P364, DOI 10.1016/j.tcm.2015.10.004; Hadjadj S, 2016, DIABETES CARE, V39, P1718, DOI 10.2337/dc16-0522; Hannema SE, 2016, HORM RES PAEDIAT, V85, P412, DOI 10.1159/000444055; Harris KB, 2016, PHARMACOTHERAPY; Harzallah A, 2016, ARCH PHYSIOL BIOCHEM, V122, P75, DOI 10.3109/13813455.2016.1148053; Henderson SJ, 2016, DIABETES OBES METAB; Hostalek U, 2015, DRUGS, V75, P1071, DOI 10.1007/s40265-015-0416-8; Huang TTK, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0767-x; HUNDAL HS, 1992, ENDOCRINOLOGY, V131, P1165, DOI 10.1210/en.131.3.1165; Joost HG, 2014, MAMM GENOME, V25, P401, DOI 10.1007/s00335-014-9514-2; Kay JP, 2001, METABOLISM, V50, P1457, DOI 10.1053/meta.2001.28078; Kennedy AJ, 2010, DIS MODEL MECH, V3, P156, DOI 10.1242/dmm.003467; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; Kim EK, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/5813030; Kim GW, 2016, NUTR DIABETES, V6, DOI 10.1038/nutd.2016.18; Kim HJ, 2013, PHYSIOL BEHAV, V110, P213, DOI 10.1016/j.physbeh.2013.01.011; Kong APS, 2016, BEST PRACT RES CL EN, V30, P345, DOI 10.1016/j.beem.2016.06.003; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Ktorza A, 1997, DIABETES METAB, V23, P38; Lau J, 2015, J MED CHEM, V58, P7370, DOI 10.1021/acs.jmedchem.5b00726; Lawson HA, 2010, EMIDDTABS23; Leiter EH, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/165327; Leow MK, 2015, NEW ENGL J MED, V372, P1266, DOI 10.1056/NEJMc1501146; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; Lindstrom P, 2007, THESCIENTIFICWORLDJO, V7, P666, DOI 10.1100/tsw.2007.117; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Mearns ES, 2015, DIABETIC MED, V32, P1530, DOI 10.1111/dme.12837; Mithieux G, 1996, REPROD NUTR DEV, V36, P357, DOI 10.1051/rnd:19960402; Mota Maria, 2004, Rom J Intern Med, V42, P247; Nauck MA, 2016, DIABETES CARE, V39, P231, DOI 10.2337/dc15-0165; Nilsson C, 2012, ACTA PHARMACOL SIN, V33, P173, DOI 10.1038/aps.2011.203; O'Harte FP, 2016, DIABETES OBES METAB; Ogden CL, 2016, JAMA-J AM MED ASSOC, V315, P2292, DOI 10.1001/jama.2016.6361; Oh H, 2015, EUR J PHARMACOL, V768, P139, DOI 10.1016/j.ejphar.2015.10.042; Peterson RG, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/487816; Prpic V, 2003, ENDOCRINOLOGY, V144, P1155, DOI 10.1210/en.2002-220835; Reaven Gerald M, 2003, Curr Atheroscler Rep, V5, P364, DOI 10.1007/s11883-003-0007-0; Reaven GM, 2009, CAN MED ASSOC J, V180, P601, DOI 10.1503/cmaj.090092; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Reuter T.Y., 2007, DRUG DISCOV, V4, P3, DOI [10.1016/j.ddmod.2007.09.004, DOI 10.1016/J.DDMOD.2007.09.004]; Rhee MK, 2010, DIABETES CARE, V33, P49, DOI 10.2337/dc09-0341; Rossmeisl M, 2003, DIABETES, V52, P1958, DOI 10.2337/diabetes.52.8.1958; Rotella CM, 2005, J ENDOCRINOL INVEST, V28, P746, DOI 10.1007/BF03347560; Roth JD, 2008, INT J OBESITY, V32, P1201, DOI 10.1038/ijo.2008.91; Rynders CA, 2014, J CLIN ENDOCR METAB, V99, P220, DOI 10.1210/jc.2013-2687; Seifarth C, 2013, EXP CLIN ENDOCR DIAB, V121, P27, DOI 10.1055/s-0032-1327734; Shang Wen-Bin, 2013, Zhongguo Zhong Yao Za Zhi, V38, P4119; Shapiro H, 2011, THESCIENTIFICWORLDJO, V11, P2509, DOI 10.1100/2011/397971; Sun L, 2016, BIOCHEM PHARMACOL, p[110, 80]; Tomas E, 2010, TRENDS ENDOCRIN MET, V21, P59, DOI 10.1016/j.tem.2009.11.007; van den Hoek AM, 2008, J NEUROENDOCRINOL, V20, P120, DOI 10.1111/j.1365-2826.2007.01626.x; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Wabitsch M, 2015, J CLIN ENDOCR METAB, V100, P3227, DOI 10.1210/jc.2015-2263; Wabitsch M, 2015, NEW ENGL J MED, V372, P48, DOI 10.1056/NEJMoa1406653; WEST DB, 1992, AM J PHYSIOL, V262, pR1025, DOI 10.1152/ajpregu.1992.262.6.R1025; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Wu J, 2013, ENDOCRINE, V44, P87, DOI 10.1007/s12020-012-9826-5; Xin ZL, 2006, J MED CHEM, V49, P4459, DOI 10.1021/jm060461g; Zhang J, 2015, JAMA-J AM MED ASSOC, V315, P2292; Zhang J, 2016, CHEM BIOL DRUG DES	90	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179856	10.1371/journal.pone.0179856	http://dx.doi.org/10.1371/journal.pone.0179856			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640857	Green Published, gold, Green Submitted			2022-12-27	WOS:000404135800074
J	Bacanu, SA				Bacanu, Silviu-Alin			Sharing extended summary data from contemporary genetics studies is unlikely to threaten subject privacy	PLOS ONE			English	Article							ASSOCIATION	Background Starting from a forensic problem, Homer et al. showed that it was possible to detect if an individual contributes only 0.5% of the DNA in a pool. The finding was extended to prove the possibility of detecting whether a subject participated in a small homogeneous GWAS. We denote this as the detection of a subject belonging to a certain cohort (SBCC). Subsequently, Visscher and Hill showed that the power to detect SBCC signal for an ethnically homogeneous cohort depends roughly on the ratio of the number of independent markers and total sample size. However, it is not clear if the same holds for more ethnically diverse cohorts. Later, Masca et al. propose running as SBCC test a regression of departure from assumed population frequency of i) subject genotype on ii) cohort of interest frequency. They use simulations to show that the approach has better SBCC detection power than the original Homer method but is impeded by population stratification. Approach To investigate the possibility of SBCC detection in multi-ethnic cohorts, we generalize the Masca et al. approach by theoretically deriving the correlation between a subject genotype and the cohort reference allele frequencies (RAFs) for stratified cohorts. Based on the derived formula, we theoretically show that, due to background stratification noise, SBCC detection is unlikely even for mildly stratified cohorts of size greater than around a thousand subjects. Thus, for the vast majority of contemporary cohorts, the fear of compromising privacy via SBCC detection is unfounded.	[Bacanu, Silviu-Alin] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Dept Psychiat, Richmond, VA 23284 USA	Virginia Commonwealth University	Bacanu, SA (corresponding author), Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Dept Psychiat, Richmond, VA 23284 USA.	silviu-alin.bacanu@vcuhealth.org		Bacanu, Silviu-Alin/0000-0002-4364-1583				Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Casella G, 1990, STAT INFERENCE BROOK; Clayton D, 2010, BIOSTATISTICS, V11, P661, DOI 10.1093/biostatistics/kxq035; Heath SC, 2008, EUR J HUM GENET, V16, P1413, DOI 10.1038/ejhg.2008.210; Homer N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000167; Masca N, 2011, INT J EPIDEMIOL, V40, P1629, DOI 10.1093/ije/dyr149; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Visscher PM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000628	10	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179504	10.1371/journal.pone.0179504	http://dx.doi.org/10.1371/journal.pone.0179504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662067	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300027
J	West, SK; Munoz, B; Mkocha, H; Dize, L; Gaydos, CA; Swenor, B; Ervin, AM; Quinn, TC				West, Sheila K.; Munoz, Beatriz; Mkocha, Harran; Dize, Laura; Gaydos, Charlotte A.; Swenor, Bonnie; Ervin, Ann-Margret; Quinn, Thomas C.			Treating village newcomers and travelers for trachoma: Results from ASANTE cluster randomized trial	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS; MASS TREATMENT; HYPERENDEMIC COMMUNITY; INFECTION; AZITHROMYCIN; TANZANIA; ELIMINATION; COVERAGE; RISK	Trial design Trachoma is targeted for global elimination. Infection rates with Chlamydia trachomatis are higher in new arrivals to a community and in travelers who leave for extended periods, suggesting they are sources of re-infection. This community-randomized, clinical trial was designed to determine if a surveillance program that targeted newcomers and travelers, identified weekly, would result in more communities achieving levels of infection of <= 1%. Methods 52 communities were randomly allocated 1:1 to the control (annual MDA alone if warranted) or intervention arm (annual MDA if warranted, plus a surveillance program to identify and treat newcomers and travelers). In each community, surveys were completed every six months on a random sample of 100 children ages 1-9 years for trachoma and infection. The primary outcome was the proportion of communities in the intervention arm, compared to the control arm, which had a prevalence of infection at <= 1% by 24 months. Registered: clinicaltrials. gov(NCT01767506). Results Intervention communities experienced an average of 110 surveillance events per month. At 24 months, 7 (27%) of 26 intervention communities achieved a prevalence of infection <= 1% compared to 4 (15%) of the 26 control communities (odds ratio = 2.6, 95% CI = 0.56 -11.9). At 24 months, the average infection prevalence in the intervention communities was 4.8, compared to 6.9 in the control communities (p = .06). Conclusion Despite surveillance programs for community newcomers and travelers, the proportion of intervention communities with a level of infection <= 1% was lower than expected and not significantly different from control communities.	[West, Sheila K.; Munoz, Beatriz; Swenor, Bonnie] Johns Hopkins Univ, Sch Med, Dana Ctr Prevent Ophthalmol, Baltimore, MD USA; [Mkocha, Harran] Kongwa Trachoma Project, Kongwa, Tanzania; [Dize, Laura; Gaydos, Charlotte A.] Johns Hopkins Sch Med, Int Chlamydia Lab, Baltimore, MD USA; [Ervin, Ann-Margret] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Quinn, Thomas C.] NIAID, Div Intramural Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	West, SK (corresponding author), Johns Hopkins Univ, Sch Med, Dana Ctr Prevent Ophthalmol, Baltimore, MD USA.	shwest@jhmi.edu	Swenor, Bonnie/ABH-1542-2021; Gaydos, Charlotte A./E-9937-2010	Swenor, Bonnie/0000-0002-6044-0951; 	National Eye Institute [EY022584]; Dr. Quinn's laboratory was provided by the Division of Intramural Research, National Institute for Allergy and Infectious Diseases; NATIONAL EYE INSTITUTE [U10EY022584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000358] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Dr. Quinn's laboratory was provided by the Division of Intramural Research, National Institute for Allergy and Infectious Diseases; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Eye Institute, EY022584. Support for Dr. Quinn's laboratory was provided by the Division of Intramural Research, National Institute for Allergy and Infectious Diseases. Azithromycin was provided without charge to the Tanzania Neglected Tropical Disease programme by the International Trachoma Initiative through a donation programme of Pfizer, Inc. The funding agencies had no role in the design, conduct, data analyses, or data interpretation of this trial.	Burton MJ, 2005, LANCET, V365, P1321, DOI 10.1016/S0140-6736(05)61029-X; Burton MJ, 2010, PLOS NEGLECT TROP D, P4; D'Amaral Rosa Kazuye Koda, 2005, Cad. Saúde Pública, V21, P1701, DOI 10.1590/S0102-311X2005000600017; Dize L, 2015, DIAGN MICR INFEC DIS, V81, P102, DOI 10.1016/j.diagmicrobio.2014.11.010; Dize L, 2013, DIAGN MICR INFEC DIS, V77, P289, DOI 10.1016/j.diagmicrobio.2013.08.005; Ervin AMMH, 2016, OPHTHALMIC EPIDEMIOL; Lee JS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002761; Mariotti SP, 2009, BRIT J OPHTHALMOL, V93, P563, DOI 10.1136/bjo.2008.148494; Moulton Lawrence H, 2004, Clin Trials, V1, P297, DOI 10.1191/1740774504cn024oa; Shah NA, 2010, OPHTHAL EPIDEMIOL, V17, P113, DOI 10.3109/09286581003624921; Sheik-Mohamed A, 1999, TROP MED INT HEALTH, V4, P695, DOI 10.1046/j.1365-3156.1999.00473.x; Solomon AW, 2004, NEW ENGL J MED, V351, P1962, DOI 10.1056/NEJMoa040979; Stare D, 2011, OPHTHAL EPIDEMIOL, V18, P20, DOI 10.3109/09286586.2010.545500; Taylor HR, 2014, LANCET, V384, P2142, DOI 10.1016/S0140-6736(13)62182-0; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; West ES, 2005, INVEST OPHTH VIS SCI, V46, P83, DOI 10.1167/iovs.04-0327; West S., 2014, J INFECT DIS; West SK, 2015, OPHTHAL EPIDEMIOL, V22, P170, DOI 10.3109/09286586.2015.1010687; West SK, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002415; West SK, 2011, INVEST OPHTH VIS SCI, V52, P6040, DOI 10.1167/iovs.11-7372; West SK, 2005, LANCET, V366, P1296, DOI 10.1016/S0140-6736(05)67529-0; *WHO, 1998, WHA5111 WHO; WHO, 2014, WEEKLY EPIDEMIOLOGIC, V39, P421; World Health Organization, 2015, TECHN CONS TRACH SUR	24	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0178595	10.1371/journal.pone.0178595	http://dx.doi.org/10.1371/journal.pone.0178595			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662043	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300007
J	Goncharova, K; Lozinska, L; Sureda, EA; Wolinski, J; Westrom, B; Pierzynowski, S				Goncharova, Kateryna; Lozinska, Liudmyla; Sureda, Ester Arevalo; Wolinski, Jaroslaw; Westrom, Bjorn; Pierzynowski, Stefan			Importance of neonatal immunoglobulin transfer for hippocampal development and behaviour in the newborn pig	PLOS ONE			English	Article							INTRAVENOUS IMMUNOGLOBULIN; PRETERM BIRTH; CEREBROSPINAL-FLUID; BRAIN CONNECTIVITY; GROWTH RESTRICTION; SPINE APPARATUS; SYNAPTOPODIN; EXPRESSION; RECOGNITION; COLOSTRUM	Neurological disorders are among the main clinical problems affecting preterm children and often result in the development of communication and learning disabilities later in life. Several factors are of importance for brain development, however the role of immunoglobulins (passive immunity transfer) has not yet been investigated. Piglets are born agammaglobulinemic, as a result of the lack of transfer of maternal immunoglobulins in utero, thus, they serve as an ideal model to mimic the condition of immunoglobulin deficiency in preterm infants. Thirty six, unsuckled newborn piglets were fed an infant formula or colostrum and supplemented orally or intravenously with either species-specific or foreign immunoglobulin and then compared to both newborn and sow-reared piglets. Two days after the piglets were born behavioural tests (novel recognition and olfactory discrimination of conspecifics scent) were performed, after which the piglets were sacrificed and blood, cerebrospinal fluid and hippocampi samples were collected for analyses. Both parameters of neuronal plasticity (neuronal maturation and synapse-associated proteins) and behavioural test parameters appeared to be improved by the appearance of species-specific porcine immunoglulin in the circulation and cerebrospinal fluid of the piglets. In conclusion, we postulate possible positive clinical effects following intravenous infusion of human immunoglobulin in terms of neuronal plasticity and cognitive function in preterm infants born with low blood immunoglobulin levels.	[Goncharova, Kateryna; Lozinska, Liudmyla; Sureda, Ester Arevalo; Westrom, Bjorn; Pierzynowski, Stefan] Lund Univ, Dept Biol, Lund, Sweden; [Goncharova, Kateryna; Lozinska, Liudmyla; Pierzynowski, Stefan] R&D Anara AB, Trelleborg, Sweden; [Goncharova, Kateryna; Wolinski, Jaroslaw] Polish Acad Sci, Kielanowski Inst Anim Physiol & Nutr, Dept Anim Physiol, Jablonna, Poland; [Pierzynowski, Stefan] Inst Rural Hlth, Dept Med Biol, Lublin, Poland	Lund University; Polish Academy of Sciences; Kielanowski Institute of Animal Physiology & Nutrition of the Polish Academy of Sciences; Institute of Rural Health in Lublin, Poland	Goncharova, K (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.; Goncharova, K (corresponding author), R&D Anara AB, Trelleborg, Sweden.; Goncharova, K (corresponding author), Polish Acad Sci, Kielanowski Inst Anim Physiol & Nutr, Dept Anim Physiol, Jablonna, Poland.	Katerina.Goncharova@biol.lu.se	Woliński, Jarosław/AAH-3109-2021; Sureda, Ester Arévalo/AAN-2171-2020; Arevalo Sureda, Ester/GPF-8594-2022; Pierzynowski, Stefan Grzegorz/AAU-6107-2021; Weström, Björn R/N-2232-2016	Woliński, Jarosław/0000-0001-8645-1045; Sureda, Ester Arévalo/0000-0002-3299-1510; Pierzynowski, Stefan Grzegorz/0000-0002-0308-3214; Weström, Björn R/0000-0001-9296-2845; Pierzynowska, Kateryna/0000-0002-3290-339X	Royal Physiographic Society of Lund; COST Action [FM401]; Anara AB, Sweden	Royal Physiographic Society of Lund; COST Action(European Cooperation in Science and Technology (COST)); Anara AB, Sweden	The study was funded by The Royal Physiographic Society of Lund (http://www.fysiografen.se) and COST Action FM401 (http://www.cost.eu/COST_Actions/fa/FA1401). Anara AB, Sweden provided support in the form of salaries for authors KG, LL and SGP. All the funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AD, 2016, AM J PHYSIOL-REG I, V310, pR481, DOI 10.1152/ajpregu.00349.2015; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Bayry J, 2003, TRANSFUS CLIN BIOL, V10, P165, DOI 10.1016/S1246-7820(03)00035-1; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Botton PH, 2010, BEHAV BRAIN RES, V214, P254, DOI 10.1016/j.bbr.2010.05.034; Brewster AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057808; Calhoun ME, 1996, J NEUROCYTOL, V25, P821, DOI 10.1007/BF02284844; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Dachet F, 2015, BRAIN, V138, P356, DOI 10.1093/brain/awu350; Dehmelt L, 2005, GENOME BIOL, V6; Deller T, 2003, P NATL ACAD SCI USA, V100, P10494, DOI 10.1073/pnas.1832384100; Deller T, 2000, J COMP NEUROL, V418, P164, DOI 10.1002/(SICI)1096-9861(20000306)418:2<164::AID-CNE4>3.0.CO;2-0; Di Rosa R, 2014, EUR J INTERN MED, V25, P511, DOI 10.1016/j.ejim.2014.05.002; Eastwood SL, 2006, HIPPOCAMPUS, V16, P645, DOI 10.1002/hipo.20194; EASTWOOD SL, 1994, NEUROSCIENCE, V59, P881, DOI 10.1016/0306-4522(94)90292-5; Eiby YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068763; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; ERZURUMLU RS, 1990, J COMP NEUROL, V292, P443, DOI 10.1002/cne.902920310; FAHEY JL, 1965, J IMMUNOL, V94, P84; Fischi-Gomez E, 2015, CEREB CORTEX, V25, P2793, DOI 10.1093/cercor/bhu073; Foulder-Hughes LA, 2003, DEV MED CHILD NEUROL, V45, P97, DOI 10.1017/S0012162203000197; Gardiner J, 2011, SYNAPSE, V65, P249, DOI 10.1002/syn.20841; Grodzki AC, 2010, METHODS MOL BIOL, V588, P15, DOI 10.1007/978-1-59745-324-0_3; Grujic D, 2017, J BIOL REGUL HOMEOST, V31, P87; Harada E, 2002, J VET MED A, V49, P358, DOI 10.1046/j.1439-0442.2002.00457.x; Heegaard PM, 2016, SCI REP, V6, P36816; Held S, 2000, ANIM BEHAV, V59, P569, DOI 10.1006/anbe.1999.1322; HIRAYAMA H, 1986, INT J CLIN PHARM TH, V24, P109; Kornum BR, 2007, BEHAV BRAIN RES, V181, P210, DOI 10.1016/j.bbr.2007.04.007; Kristensen HH, 2001, APPL ANIM BEHAV SCI, V72, P321, DOI 10.1016/S0168-1591(00)00209-4; Lodygensky GA, 2008, PEDIATR RES, V63, P438, DOI 10.1203/PDR.0b013e318165c005; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lunemann JD, 2016, NEUROTHERAPEUTICS, V13, P34, DOI 10.1007/s13311-015-0391-5; Modanlou HD, 1996, CAN J PHYSIOL PHARM, V74, P368, DOI 10.1139/cjpp-74-4-368; Neve RL, 1998, J NEUROSCI, V18, P7757; Nosarti C, 2014, NEUROIMAGE-CLIN, V6, P180, DOI 10.1016/j.nicl.2014.08.005; Ohlsson A., 2013, COCHRANE DB SYST REV, V7; Okubo-Suzuki R, 2008, MOL CELL NEUROSCI, V38, P266, DOI 10.1016/j.mcn.2008.03.001; Oygucu SE, 2014, INT IMMUNOPHARMACOL, V21, P51, DOI 10.1016/j.intimp.2014.04.002; Ozdemir SA, 2016, J MATERN-FETAL NEO M, V29, P972, DOI 10.3109/14767058.2015.1027680; Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646; Pammi M, 2015, EXPERT REV ANTI-INFE, V13, P487, DOI 10.1586/14787210.2015.1008450; Pandit AS, 2014, CEREB CORTEX, V24, P2324, DOI 10.1093/cercor/bht086; Pavlova MA, 2013, BRAIN, V136, P998, DOI 10.1093/brain/aws334; Pierzynowski S, 2014, INT J DEV NEUROSCI, V35, P64, DOI 10.1016/j.ijdevneu.2014.03.003; Piorkowska K, 2014, DEV NEUROSCI-BASEL, V36, P465, DOI 10.1159/000363696; Relkin N, 2014, CLIN EXP IMMUNOL, V178, P27, DOI 10.1111/cei.12500; Salmaso N, 2014, NAT NEUROSCI, V17, P341, DOI 10.1038/nn.3604; Shen RL, 2015, AM J PHYSIOL-GASTR L, V309, pG310, DOI 10.1152/ajpgi.00163.2015; Sretavan DW, 1998, J NEUROSCI, V18, P10502; Sutton PS, 2013, J TROP PEDIATRICS, V59, P258, DOI 10.1093/tropej/fmt012; Tarsa L, 2002, P NATL ACAD SCI USA, V99, P1012, DOI 10.1073/pnas.022575999; Urbanska M, 2008, ACTA NEUROBIOL EXP, V68, P264; van den Berg JP, 2011, EARLY HUM DEV, V87, P67, DOI 10.1016/j.earlhumdev.2010.11.003; Villani F, 2002, NEUROL SCI, V23, pS33, DOI 10.1007/s100720200013; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	57	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180002	10.1371/journal.pone.0180002	http://dx.doi.org/10.1371/journal.pone.0180002			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658291	Green Published, gold, Green Submitted			2022-12-27	WOS:000404607900051
J	Sukenik, N; Iluz, D; Amar, Z; Varvak, A; Workman, V; Shamir, O; Ben-Yosef, E				Sukenik, Naama; Iluz, David; Amar, Zohar; Varvak, Alexander; Workman, Vanessa; Shamir, Orit; Ben-Yosef, Erez			Early evidence (late 2nd millennium BCE) of plant-based dyeing of textiles from Timna, Israel	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHY; EXTRACTION METHODS; TYRIAN PURPLE; AGE; INSIGHTS; ANTHRAQUINONES; IDENTIFICATION; DYESTUFFS; ECONOMY; DYES	In this article, we focus on the analysis of dyed textile fragments uncovered at an early Iron Age (11th-10th centuries BCE) copper smelting site during new excavations in the Timna Valley conducted by the Central Timna Valley (CTV) Project, as well as those found by the Arabah Expedition at the Hathor Temple (Site 200), dated to the Late Bronze/early Iron Ages (13th-11th centuries BCE). Analysis by HPLC-DAD identified two organic dyestuffs, Rubia tinctorum L. and indigotin, from a plant source (probably Isatis tinctoria L.). They are among the earliest plants known in the dyeing craft and cultivated primarily for this purpose. This study provides the earliest evidence of textiles dyed utilizing a chemical dyeing process based on an industrial dyeing plant from the Levant. Moreover, our results shed new light on the society operating the copper mines at the time, suggesting the existence of an elite that was interested in these high quality textiles and invested efforts in procuring them by longdistance trade.	[Sukenik, Naama; Shamir, Orit] Israel Antiqu Author, Natl Treasures Dept, Jerusalem, Israel; [Iluz, David; Varvak, Alexander] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Amar, Zohar] Bar Ilan Univ, Martin Szusz Dept Land Israel Studies & Archaeol, Ramat Gan, Israel; [Workman, Vanessa; Ben-Yosef, Erez] Tel Aviv Univ, Dept Archaeol & Ancient Near Eastern Cultures, Tel Aviv, Israel; [Sukenik, Naama] Beth Shemesh Ind Zone West, Natl Treasures Dept, Israel Antiqu Author, Beth Shemesh Storage & Res Facil, Jerusalem, Israel	Bar Ilan University; Bar Ilan University; Tel Aviv University	Sukenik, N (corresponding author), Israel Antiqu Author, Natl Treasures Dept, Jerusalem, Israel.; Sukenik, N (corresponding author), Beth Shemesh Ind Zone West, Natl Treasures Dept, Israel Antiqu Author, Beth Shemesh Storage & Res Facil, Jerusalem, Israel.	naamasuk@gmail.com		Workman, Vanessa/0000-0003-4436-7130	Marie Curie FP7-PEOPLE-CIG [334274]; Yad Hanadiv The Rothschild Foundation, through the Yizhar Hirschfeld Memorial Fellowships in Archaeology [5171]	Marie Curie FP7-PEOPLE-CIG; Yad Hanadiv The Rothschild Foundation, through the Yizhar Hirschfeld Memorial Fellowships in Archaeology	This study was partially supported by the Marie Curie FP7-PEOPLE-2012-CIG grant #334274 to E.B.Y. The field work related to the current research was provided by the Yad Hanadiv The Rothschild Foundation, through the Yizhar Hirschfeld Memorial Fellowships in Archaeology Grant #5171 to E.B.Y. There was no additional external (or internal) funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar Z, 2012, FLORA BIBLE NEW INVE; [Anonymous], 2004, COLOURFUL ORIGINS CH; Avner U., 2002, STUDIES MAT SPIRITUA; Ben-Yosef E, 2016, J ARCHAEOL SCI, V72, P71, DOI 10.1016/j.jas.2016.05.010; Ben-Yosef E., 2010, TECHNOLOGY SOCIAL PR; Ben-Yosef E., 2012, TEL AVIV, V367, P31; Ben-Yosef E., 2016, B AM SCH ORIENT RES, V376, P169, DOI [10.5615/bullamerschoorie.376.0169, DOI 10.5615/BULLAMERSCHOORIE.376.0169]; Ben-Yosef E, 2017, J ARCHAEOL SCI-REP, V11, P411, DOI 10.1016/j.jasrep.2016.12.010; Bertman Stephen, 1961, BIBLIC ARCHAEOL, V24, P119; Boertien JH, 2013, UNRAVELLING FABRIC T; Bohmer H., 2003, DYE HIST ARCHAEOL, V19, P88; Brenner Yosef Haim, 1977, STORIES ESSAYS SCH H; Bruins H.J., 2006, CROSSING RIFT RESOUR, P29; Brunello F., 1973, ART DYEING HIST MANK; Cardon D, 2007, NATURAL DYES SOURCES; Cardon D., 2010, TEXT SOC AM S P TEXT, P1; Chenciner R., 2000, MADDER RED HIST LUXU; Conrad H.G, 1980, ANTIKES KUPFER TIMNA; Cooksey CJ, 2001, MOLECULES, V6, P736, DOI 10.3390/60900736; Daniels V., 2014, BRIT MUSEUM TECHNICA, P13; Danin A., 1983, DESERT VEGETATION IS; Derksen GCH, 2002, J CHROMATOGR A, V978, P119, DOI 10.1016/S0021-9673(02)01412-7; Eastwood G., 1985, AMARNA REPORTS, p191 ; Eliade Mircea., 1978, FORGE CRUCIBLE; Epigraphic Survey, 1986, EP SURV BATTL REL KI; Forbes RJ., 1964, BITUMEN PETROLEUM AN; Freud L., 2008, TEL AVIV, V35, P169; Gaspa S., 2013, TEXTILE PRODUCTION C, V12, P224; Gleba M., 2014, GOTARC, P145; Gleba M, 2013, ARCHAEOL INT, V16, P54, DOI 10.5334/ai.1602; Glueck N., 1935, EXPLORATIONS E PALES, V15, p1 ; Good I, 2001, ANNU REV ANTHROPOL, V30, P209, DOI 10.1146/annurev.anthro.30.1.209; Gromer K., 2016, ART PREHISTORIC TEXT; Hanan L., 1988, EGYPTIAN MINING TEMP, p246 ; Hanan L., 1988, EGYPTIAN MINING TEMP, P241; Hartl A, 2015, J ARCHAEOL SCI-REP, V2, P9, DOI 10.1016/j.jasrep.2014.12.001; Hauptmann A, 2007, NAT SCI ARCHAEOL, P1, DOI 10.1007/978-3-540-72238-0; Hoskin NA, 2011, JARCE, V47, p199 ; Iluz D, 2009, JUD SAMARIA RES STUD, V18, p223 ; Karapanagiotis I, 2013, MICROCHEM J, V110, P70, DOI 10.1016/j.microc.2013.02.008; Keijzer R. Hofmann-de, 2013, NESAT, P125; Kemp B.J., 2001, ANCIENT TEXTILE IND; Kislev ME., 1988, EGYPTIAN MINING TEMP, P236; Koren Z.C., 1999, ATIQOT, V38, P129; Koren Z. C., 2008, DYES HIST ARCHAEOLOG, V21, P26; Koren ZC, 1996, ACS SYM SER, V625, P269, DOI 10.1021/bk-1996-0625.ch021; Koren ZC, 1998, CAVE WARRIOR 4 MILLE, P100; Koren ZC, 1995, DYE HIST ARCHAEOL, V13, P27; Koren ZC, 2008, P ART2008 9 INT C NO; Koren ZC, 1994, MASADA 4 YIGAEL YADI, p257 ; Koren ZC, 2006, INDIRUBIN, THE RED SHADE OF INDIGO, P45; Koren ZC, 2013, ACS SYM SER, V1147, P43; Kramell A, 2014, QUATERN INT, V348, P214, DOI 10.1016/j.quaint.2014.05.012; Lucas, 1948, ANCIENT EGYPTIAN MAT; Mantzouris D, 2014, MICROCHEM J, V115, P78, DOI 10.1016/j.microc.2014.02.010; Melamed Y., 2005, ATIQOT, V49, P139; Mouri C, 2012, MICROCHIM ACTA, V179, P105, DOI 10.1007/s00604-012-0868-4; Na'aman N., 2015, MAARAV, V20.1, P39; Namdar D, 2013, MEDITERR ARCHAEOL AR, V13, P1; Pinch Geraldine, 1993, VOTIVE OFFERINGS HAT; Robinson Stuart, 1969, HIST DYED TEXTILES; Rothenberg B., 1988, EGYPTIAN MINING TEMP; Rothenberg B, 1990, ANCIENT METALLURGY C; Rothenberg B., 1972, TIMNA VALLEY BIBLICA; Sanyova J, 2006, J CULT HERIT, V7, P229, DOI 10.1016/j.culher.2006.06.003; Sapir-Hen L, MINING ANCI IN PRESS; Sapir-Hen L, 2014, ANTIQUITY, V88, P775, DOI 10.1017/S0003598X00050687; Schick T., 1998, CAVE WARRIOR 4 MILLE, P6; Serrano A, 2013, J CHROMATOGR A, V1318, P102, DOI 10.1016/j.chroma.2013.09.062; Shamir O, 1993, ARCHEOL TEXT NEWSL, V16, p9 ; Shamir O., 2014, PREHISTORIC ANCIENT, p297 ; Shamir O, 2013, HOARDS GENIZOT CHAPT, P87; Shamir O., 2014, GLOBAL TEXTILE ENCOU; Shamir O., 2007, MAYER EXCAVATIONS KA, P255; Sheffer A., 2012, KUNTILLET AJRUD HORV, P289; Sheffer A, 1991, ATIQOT, V20, P1; Sheffer A, 1994, MASADA 4, P153; Sheffer A, 1988, EGYPTIAN MINING TEMP, p224 ; Singer-Avitz, 2006, TEL AVIV, V33, P196; Spector N., 2017, NBC NEWS 0902; Strand EA, 2010, EUR J ARCHAEOL, V13, P149, DOI 10.1177/1461957110365513; Sukenik N, 2013, ARCHAEOL TEXT REV, V55, P46; Sukenik N, 2015, J ARCHAEOL SCI-REP, V3, P565, DOI 10.1016/j.jasrep.2015.08.003; Sukenik Naama, 2013, THESIS; Taylor GW, 1986, REV PROG COLOR RELAT, V16, P53, DOI [DOI 10.1111/J.1478-4408.1986.TB03744.X, 10.1111/j.1478-4408.1986.tb03744.x]; Tebes J.-M., 2014, UNEARTHING WILDERNES, V45, P103; Vajanto K, 2014, FENNOSCANDIA ARCHAEO, VXXXI, P61; Vanden Berghe I, 2009, J ARCHAEOL SCI, V36, P1910, DOI 10.1016/j.jas.2009.04.019; Vogelsang-Eastwo G., TEXTILES, P57; Workman V., 2016, THESIS; Wouters J., 1985, STUD CONSERV, V30; Wouters J., 2005, SCI ANAL ANCIENT HIS, P187; Yadin Y, 1963, IEJ; Zhang X, 2005, ANAL CHEM, V77, P2022, DOI 10.1021/ac048380k; Zhang X, 2008, J ARCHAEOL SCI, V35, P1095, DOI 10.1016/j.jas.2007.08.001; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001; Zohary M, 1978, FLORA PALAESTINA	97	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179014	10.1371/journal.pone.0179014	http://dx.doi.org/10.1371/journal.pone.0179014			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658314	Green Published, gold, Green Submitted			2022-12-27	WOS:000404607900011
J	Tian, D; Xie, GX; Tian, J; Tseng, KH; Shum, CK; Lee, J; Liang, S				Tian, Di; Xie, Gengxin; Tian, Jing; Tseng, Kuo-Hsin; Shum, C. K.; Lee, Jiyoung; Liang, Song			Spatiotemporal variability and environmental factors of harmful algal blooms (HABs) over western Lake Erie	PLOS ONE			English	Article							ADAPTIVE REGRESSION SPLINES; CLIMATE-CHANGE; GREAT-LAKES; TOXIC CYANOBACTERIA; EUTROPHICATION; IMPACTS; WATER; PHYCOCYANIN; MODELS	Over the past decades, numerous studies have been carried out in understanding causes of Harmful Algal Blooms (HABs) and their dynamics, yielding great knowledge in this field. Lake Erie, the fourth-largest lake of the five Great Lake, is among those highly vulnerable to the impacts of HABs and has received substantial attention from the public, water management sectors, and academic field. Building upon previous work, this study aims to characterize spatiotemporal variability of Chlorophyll a (Chl-a), which is an important indicator of HABs, and to explore relative importance of environmental factors associated with HABs in the west Lake Erie. Ten years of biweekly Chl-a information over western Lake Erie were derived from MERIS data at the pixel scale. Based on the MERIS-derived information high concentrations of Chl-a were observed in the south near shore area in spring and fall and in the west corner area of western Lake Erie in all three seasons except winter. Wavelet analysis suggested that the 0.5- and 1-year periods were dominant modes for the Chl-a series. The Multivariate Adaptive Regression Splines (MARS) analysis was performed to explore factors associated with the dynamics of Chl-a. The results suggested that overall both phenological (e.g. wind) and ecological (e.g. nutrient levels) factors exhibited significant correlations with the remotely-sensed imagery based observations of Chl-a despite spatial and temporal variations. The important phenological and ecological factors include solar radiation and wind speed in spring, water temperature, solar radiation, and total Kjeldahl nitrogen concentration in summer, wind speed in fall, and water temperature and streamflow in winter. Both consistency and differences of findings of the study with others in the region may suggest strengths and limitations of the remotely sensed imagery-based analysis, offering valuable information for future work.	[Tian, Di] Auburn Univ, Coll Agr & Climate Human & Earth Syst Sci Cluster, Dept Crop Soil & Environm Sci, Auburn, AL 36849 USA; [Xie, Gengxin] Chongqing Univ, Coll Urban Construct & Environm Engn, Chongqing, Peoples R China; [Tian, Jing] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Biostat, Gainesville, FL USA; [Tseng, Kuo-Hsin] Natl Cent Univ, Ctr Space & Remote Sensing Res, Taoyuan, Taiwan; [Shum, C. K.] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA; [Lee, Jiyoung] Ohio State Univ, Coll Publ Hlth, Div Environm Hlth Sci, Columbus, OH 43210 USA; [Liang, Song] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL USA; [Liang, Song] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA	Auburn University System; Auburn University; Chongqing University; State University System of Florida; University of Florida; National Central University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Lee, J (corresponding author), Ohio State Univ, Coll Publ Hlth, Div Environm Hlth Sci, Columbus, OH 43210 USA.; Liang, S (corresponding author), Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL USA.; Liang, S (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.	jlee@cph.osu.edu; songliang@ufl.edu		Tian, Di/0000-0001-7752-947X; Shum, C K/0000-0001-9378-4067	EPA STAR Program [RD835192010]; Auburn University; Emerging Pathogens Institute, University of Florida; Chongqing University, China; University of Florida Open Access Publishing Fund	EPA STAR Program(United States Environmental Protection Agency); Auburn University; Emerging Pathogens Institute, University of Florida(University of Florida); Chongqing University, China; University of Florida Open Access Publishing Fund	This study was funded by the EPA STAR Program (funding # RD835192010). DT was supported in part by Auburn University. SL was supported in part by the Emerging Pathogens Institute, University of Florida. GX acknowledges the support from Chongqing University, China. Publication of this article was funded in part by the University of Florida Open Access Publishing Fund.	Adamowski J, 2012, J HYDROINFORM, V14, P731, DOI 10.2166/hydro.2011.044; Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Anderson Donald M., 2000, Protist, V151, P97, DOI 10.1078/1434-4610-00010; Anderson DM, 2008, HARMFUL ALGAE, V8, P39, DOI 10.1016/j.hal.2008.08.017; [Anonymous], [No title captured]; Botana L.M, 2015, PHYCOTOXINS CHEM BIO; Carmichael W, 2008, ADV EXP MED BIOL, V619, P105, DOI 10.1007/978-0-387-75865-7_4; Cheung MY, 2013, J MICROBIOL, V51, P1, DOI 10.1007/s12275-013-2549-3; De Veaux RD, 1994, SELECTING MODELS DAT, P393; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; HALLEGRAEFF GM, 1993, PHYCOLOGIA, V32, P79, DOI 10.2216/i0031-8884-32-2-79.1; Hastie T., 2009, ELEMENTS STAT LEARNI, DOI [10.1007/b94608, DOI 10.1007/B94608]; Heisler J, 2008, HARMFUL ALGAE, V8, P3, DOI 10.1016/j.hal.2008.08.006; Ho JC, 2015, J GREAT LAKES RES, V41, P317, DOI 10.1016/j.jglr.2015.01.001; Hudnell H.K., 2008, CYANOBACTERIAL HARMF; Jones ML, 2006, CAN J FISH AQUAT SCI, V63, P457, DOI 10.1139/F05-239; Jonsson P, 2004, 10TH INTERNATIONAL SYMPOSIUM ON SOFTWARE METRICS, PROCEEDINGS, P108, DOI 10.1109/METRIC.2004.1357895; Kisi O, 2016, J HYDROL, V534, P104, DOI 10.1016/j.jhydrol.2015.12.014; Kroll CN, 2013, WATER RESOUR RES, V49, P3756, DOI 10.1002/wrcr.20315; Leon LF, 2011, J GREAT LAKES RES, V37, P41, DOI 10.1016/j.jglr.2010.12.007; Magnuson JJ, 1997, HYDROL PROCESS, V11, P825; Michalak AM, 2013, P NATL ACAD SCI USA, V110, P6448, DOI 10.1073/pnas.1216006110; Milborrow S, 2013, NOTES EARTH PACKAGE; Millie DF, 2009, AQUAT ECOL, V43, P915, DOI 10.1007/s10452-009-9238-7; Moore SK, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-S2-S4; Murphy R. J., 2003, TECHNICAL REPORT SER, V16; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Obenour DR, 2014, WATER RESOUR RES, V50, P7847, DOI 10.1002/2014WR015616; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Paerl HW, 2011, SCI TOTAL ENVIRON, V409, P1739, DOI 10.1016/j.scitotenv.2011.02.001; Paerl HW, 2010, ENVIRON SCI TECHNOL, V44, P7756, DOI 10.1021/es102665e; Paul VJ, 2008, ADV EXP MED BIOL, V619, P239, DOI 10.1007/978-0-387-75865-7_11; Rinta-Kanto JM, 2005, ENVIRON SCI TECHNOL, V39, P4198, DOI 10.1021/es048249u; Rinta-Kanto JM, 2009, HARMFUL ALGAE, V8, P665, DOI 10.1016/j.hal.2008.12.004; Samat SB, 2000, BRIT J RADIOL, V73, P867, DOI 10.1259/bjr.73.872.11026863; Sellner KG, 2003, J IND MICROBIOL BIOT, V30, P383, DOI 10.1007/s10295-003-0074-9; Simis SGH, 2005, LIMNOL OCEANOGR, V50, P237, DOI 10.4319/lo.2005.50.1.0237; Simis SGH, 2007, REMOTE SENS ENVIRON, V106, P414, DOI 10.1016/j.rse.2006.09.008; Steffen MM, 2014, J GREAT LAKES RES, V40, P215, DOI 10.1016/j.jglr.2013.12.012; Stumpf RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042444; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Trumpickas J, 2009, J GREAT LAKES RES, V35, P454, DOI 10.1016/j.jglr.2009.04.005; Van Dolah FM, 2001, J AOAC INT, V84, P1617; Vincent RK, 2004, REMOTE SENS ENVIRON, V89, P381, DOI 10.1016/j.rse.2003.10.014; Wynne TT, 2015, TOXINS, V7, P1649, DOI 10.3390/toxins7051649; Wynne TT, 2010, LIMNOL OCEANOGR, V55, P2025, DOI 10.4319/lo.2010.55.5.2025; York TP, 2006, STAT MED, V25, P1355, DOI 10.1002/sim.2292; Zhou YT, 2015, ENVIRON SCI TECHNOL, V49, P800, DOI 10.1021/es503981n	49	10	10	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179622	10.1371/journal.pone.0179622	http://dx.doi.org/10.1371/journal.pone.0179622			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658260	Green Published, gold, Green Submitted			2022-12-27	WOS:000404607900035
J	Liu, TZ; Wang, FZ; Zhang, S; Wang, F; Meng, QL; Zhang, GM; Cui, FQ; Dunzhu, D; Yin, WJ; Bi, SL; Shen, LP				Liu, Tiezhu; Wang, Fuzhen; Zhang, Shuang; Wang, Feng; Meng, Qingling; Zhang, Guomin; Cui, Fuqiang; Dunzhu, Dorji; Yin, Wenjiao; Bi, Shengli; Shen, Liping			Whole-gene analysis of two groups of hepatitis B virus C/D inter-genotype recombinant strains isolated in Tibet, China	PLOS ONE			English	Article							IDENTIFICATION; SUBGENOTYPES; HISTORY	Tibet is a highly hepatitis B virus (HBV) endemic area. Two types of C/D recombinant HBV are commonly isolated in Tibet and have been previously described. In an effort to better understand the molecular characteristic of these C/D recombinant strains from Tibet, we undertook a multistage random sampling project to collect HBsAg positive samples. Molecular epidemiological and bio-informational technologies were used to analyze the characteristics of the sequences found in this study. There were 60 samples enrolled in the survey, and we obtained 19 whole-genome sequences. 19 samples were all C/D recombinant, and could be divided into two sub-types named C/D1 and C/D2 according to the differences in the location of the recombinant breakpoint. The recombination breakpoint of the 10 strains belonging to the C/D1 sub-type was located at nt750, while the 9 stains belonging to C/D2 had their recombination break point at nt1530. According to whole-genome sequence analysis, the 19 identified strains belong to genotype C, but the nucleotide distance was more than 5% between the 19 strains and sub-genotypes C1 to C15. The distance between C/D1with C2 was 5.8 +/- 2.1%, while the distance between C/D2 with C2 was 6.4 +/- 2.1%. The parental strain was most likely sub-genotype C2. C/D1 strains were all collected in the middle and northern areas of Tibet including Lhasa, Linzhi and Ali, while C/D2 was predominant in Shannan in southern Tibet. This indicates that the two recombinant genotypes are regionally distributed in Tibet. These results provide important information for the study of special HBV recombination events, gene features, virus evolution, and the control and prevention policy of HBV in Tibet.	[Liu, Tiezhu; Zhang, Shuang; Wang, Feng; Meng, Qingling; Yin, Wenjiao; Bi, Shengli; Shen, Liping] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Wang, Fuzhen; Zhang, Guomin; Cui, Fuqiang] Chinese Ctr Dis Control & Prevent, Natl Immunizat Program, Beijing, Peoples R China; [Dunzhu, Dorji] Tibetan Ctr Dis Control & Prevent, Lhasa, Tibet, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention	Shen, LP (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	shenlp@ivdc.chinacdc.cn		Bi, Shengli/0000-0002-0380-5790	Chinese National Science and Technology Major Project [2012ZX10002-001-005-001, 2012ZX10002-001-005]	Chinese National Science and Technology Major Project	This research is supported by the Chinese National Science and Technology Major Project (Grant No. 2012ZX10002-001-005-001; No. 2012ZX10002-001-005 to SLB). The funders had no role in study design, data collection and analysis and preparation of the manuscript.	Araujo NM, 2013, J GEN VIROL, V94, P150, DOI 10.1099/vir.0.047324-0; BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J; Chauhan R, 2008, WORLD J GASTROENTERO, V14, P6228, DOI 10.3748/wjg.14.6228; Chekaraou MA, 2010, J GEN VIROL, V91, P1609, DOI 10.1099/vir.0.018127-0; Gandhe SS, 2003, J MED VIROL, V69, P324, DOI 10.1002/jmv.10292; Huy TTT, 2008, J VIROL, V82, P5657, DOI 10.1128/JVI.02556-07; Kurbanov F, 2008, J VIROL, V82, P8241, DOI 10.1128/JVI.00793-08; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Mayerat C, 1999, J VIRAL HEPATITIS, V6, P299, DOI 10.1046/j.1365-2893.1999.00174.x; McMahon BJ, 2009, HEPATOL INT, V3, P334, DOI 10.1007/s12072-008-9112-z; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; Pourkarim MR, 2014, WORLD J GASTROENTERO, V20, P7152, DOI 10.3748/wjg.v20.i23.7152; Sayan M, 2012, HEPAT MON, V12, P118, DOI [10.5812/hepatmon.4878, 10.5812/hepatmon.826]; Shen LP, 2014, J MED VIROL, V86, P1307, DOI 10.1002/jmv.23965; Shi WF, 2013, INFECT GENET EVOL, V16, P355, DOI 10.1016/j.meegid.2013.03.021; Simmonds P, 2005, J VIROL, V79, P15467, DOI 10.1128/JVI.79.24.15467-15476.2005; Su HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084005; Sugauchi F, 2002, J VIROL, V76, P5985, DOI 10.1128/JVI.76.12.5985-5992.2002; Sumi H, 2003, HEPATOLOGY, V37, P19, DOI 10.1053/jhep.2003.50036; Yin JH, 2010, CANCER EPIDEM BIOMAR, V19, P777, DOI 10.1158/1055-9965.EPI-09-1001; Yousif M, 2013, HEPATOL RES, V43, P355, DOI 10.1111/j.1872-034X.2012.01090.x; Zhao Shu Ming, 2001, Asian Pac J Cancer Prev, V2, P299; Zhou B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018708	23	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179846	10.1371/journal.pone.0179846	http://dx.doi.org/10.1371/journal.pone.0179846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654691	gold, Green Published, Green Submitted			2022-12-27	WOS:000404541500036
J	Zielinski, DP; Sorensen, PW				Zielinski, Daniel P.; Sorensen, Peter W.			Silver, bighead, and common carp orient to acoustic particle motion when avoiding a complex sound	PLOS ONE			English	Article							DIPOLE SOURCE LOCALIZATION; PLAINFIN MIDSHIPMAN FISH; LATERAL-LINE; PORICHTHYS-NOTATUS; ATLANTIC SALMON; MOTTLED SCULPIN; ILLINOIS RIVER; ASIAN CARP; RESPONSES; HEARING	Behavioral responses of silver carp (Hypopthalmichthys molitrix), bighead carp (H. nobilis), and common carp (Cyprinus carpio) to a complex, broadband sound were tested in the absence of visual cues to determine whether these species are negatively phonotaxic and the roles that sound pressure and particle motion might play mediating this response. In a dark featureless square enclosure, groups of 3 fish were tracked and the distance of each fish from speakers and their swimming trajectories relative to sound pressure and particle acceleration were analyzed before, and then while an outboard motor sound was played. All three species exhibited negative phonotaxis during the first two exposures after which they ceased responding. The median percent time fish spent near the active speaker for the first two trials decreased from 7.0% to 1.3% for silver carp, 7.9% to 1.1% for bighead carp, and 9.5% to 3% for common carp. Notably, when close to the active speaker fish swam away from the source and maintained a nearly perfect 0 degrees orientation to the axes of particle acceleration. Fish did not enter sound fields greater than 140 dB (ref. 1 mu Pa). These results demonstrate that carp avoid complex sounds in darkness and while initial responses may be informed by sound pressure, sustained oriented avoidance behavior is likely mediated by particle motion. This understanding of how invasive carp use particle motion to guide avoidance could be used to design new acoustic deterrents to divert them in dark, turbid river waters.	[Zielinski, Daniel P.; Sorensen, Peter W.] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA; [Zielinski, Daniel P.] Great Lakes Fishery Commiss, Millersburg, MI USA	University of Minnesota System; University of Minnesota Twin Cities	Zielinski, DP (corresponding author), Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA.	dzielinski@usgs.gov	Zielinski, Daniel/GPF-5806-2022	Sorensen, Peter/0000-0003-0321-1279	Minnesota Environment and Natural Resources Trust Fund	Minnesota Environment and Natural Resources Trust Fund	Funding for this project was provided by the Minnesota Environment and Natural Resources Trust Fund as recommended by the Legislative Citizen Commission on Minnesota Resources (LCCMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the Minnesota Environmental and Natural Resources Trust Fund as recommended by the Legislative-Citizen Commission on Minnesota Resources (LCCMR) and administered by the Minnesota Aquatic Invasive Species Research Center. We thank Dan Krause, Reid Swanson, and Clark Dennis III for their help with fish care, construction of experimental equipment, and data collection.	ACRCC (Asian Carp Regional Coordinating Committee), 2014, AS CARP CONTR STRAT; Akamatsu T, 2002, J ACOUST SOC AM, V112, P3073, DOI 10.1121/1.1515799; BALON EK, 1995, AQUACULTURE, V129, P3, DOI 10.1016/0044-8486(94)00227-F; Batschelet E, 1981, CIRCULAR STAT BIOL; BOMFORD M, 1990, WILDLIFE SOC B, V18, P411; Braun Christopher B., 2008, V32, P99; Coffin AB, 2014, J EXP BIOL, V217, P2078, DOI 10.1242/jeb.093831; CONOVER W. J, 1980, PRACTICAL NONPARAMET; Coombs S, 1997, J COMP PHYSIOL A, V180, P387, DOI 10.1007/s003590050057; Coombs S, 1997, J COMP PHYSIOL A, V180, P401, DOI 10.1007/s003590050058; Fay Richard R., 2008, V32, P49; Gray MD, 2016, ADV EXP MED BIOL, V875, P363, DOI 10.1007/978-1-4939-2981-8_43; Hansen A, 2014, J EXP BIOL, V217, P3945, DOI 10.1242/jeb.107870; Higgs DM, 2013, J EXP BIOL, V216, P1484, DOI 10.1242/jeb.078816; Higgs Dennis M., 2006, P389; Huntingford FA, 2010, J FISH BIOL, V76, P1576, DOI 10.1111/j.1095-8649.2010.02582.x; Irons KS, 2007, J FISH BIOL, V71, P258, DOI 10.1111/j.1095-8649.2007.01670.x; Kalmijn A.J., 1988, P83; Karlsen HE, 2004, J EXP BIOL, V207, P4185, DOI 10.1242/jeb.01274; KNUDSEN FR, 1992, J FISH BIOL, V40, P523, DOI 10.1111/j.1095-8649.1992.tb02602.x; Ladich F, 2013, REV FISH BIOL FISHER, V23, P317, DOI 10.1007/s11160-012-9297-z; Lovell JM, 2006, COMP BIOCHEM PHYS A, V143, P286, DOI 10.1016/j.cbpa.2005.11.015; Lu ZM, 2001, J COMP PHYSIOL A, V187, P453, DOI 10.1007/s003590100218; Matsumoto T, 2005, FISHERIES SCI, V71, P350, DOI 10.1111/j.1444-2906.2005.00971.x; Mensinger A., 2016, P M ACOUS, V27, P010032, DOI [10.1121/2.0000314, DOI 10.1121/2.0000314]; Murchy KA, 2017, FISHERIES MANAG ECOL, V24, P208, DOI 10.1111/fme.12220; Nestler John M., 1992, North American Journal of Fisheries Management, V12, P667, DOI 10.1577/1548-8675(1992)012<0667:ROBHTH>2.3.CO;2; Noatch MR, 2012, ENVIRON REV, V20, P71, DOI [10.1139/A2012-001, 10.1139/a2012-001]; Pegg MA, 2004, ANS0101 ILL IND SEA; Plachta DTT, 2003, ACOUST RES LETT ONL, V4, P25, DOI 10.1121/1.1558376; POPPER AN, 1993, BRAIN BEHAV EVOLUT, V41, P14, DOI 10.1159/000113821; POPPER AN, 1972, J ACOUST SOC AM, V52, P1714, DOI 10.1121/1.1913305; Popper AN, 2011, HEARING RES, V273, P25, DOI 10.1016/j.heares.2009.12.023; Rogers PH, 2016, ADV EXP MED BIOL, V875, P933, DOI 10.1007/978-1-4939-2981-8_115; Romine JG, 2015, N AM J FISH MANAGE, V35, P440, DOI 10.1080/02755947.2015.1012279; Ruebush BC, 2012, AQUAT INVASIONS, V7, P37, DOI 10.3391/ai.2012.7.1.005; Sampson SJ, 2009, BIOL INVASIONS, V11, P483, DOI 10.1007/s10530-008-9265-7; Sass GG, 2014, J GREAT LAKES RES, V40, P911, DOI 10.1016/j.jglr.2014.08.010; Schrank SJ, 2003, T AM FISH SOC, V132, P1222, DOI 10.1577/T02-071; SCHUIJF A, 1975, J COMP PHYSIOL, V98, P307, DOI 10.1007/BF00709803; SCHUIJF A, 1983, NATURE, V302, P143, DOI 10.1038/302143a0; Sisler SP, 2008, BEHAVIOUR, V145, P1409, DOI 10.1163/156853908785765881; Standdon JR, 1993, ADAPT BEHAV, V1, P421; Taylor RM, 2005, FISHERIES MANAG ECOL, V12, P283, DOI 10.1111/j.1365-2400.2005.00446.x; Vetter BJ, 2016, J GREAT LAKES RES, P1; Vetter BJ, 2015, BIOL INV, P1; Webb JJ, 2008, BIOACOUSTICS LATERAL, P145; Weber M. J., 2009, Reviews in Fisheries Science, V17, P524, DOI 10.1080/10641260903189243; Welton JS, 2002, FISHERIES MANAG ECOL, V9, P11, DOI 10.1046/j.1365-2400.2002.00252.x; Wilson M, 2008, J ACOUST SOC AM, V124, pEL243, DOI 10.1121/1.2960899; Wilson M, 2011, J EXP BIOL, V214, P22, DOI 10.1242/jeb.043323; Wysocki LE, 2006, BIOL CONSERV, V128, P501, DOI 10.1016/j.biocon.2005.10.020; Zeddies DG, 2012, J EXP BIOL, V215, P152, DOI 10.1242/jeb.064998; Zeddies DG, 2010, J ACOUST SOC AM, V127, P3104, DOI 10.1121/1.3365261; Zielinski DP, 2016, N AM J FISH MANAGE, V36, P267, DOI 10.1080/02755947.2015.1120834; Zielinski DP, 2015, FISHERIES MANAG ECOL, V22, P181, DOI 10.1111/fme.12108; Zielinski DP, 2014, ECOL ENG, V67, P95, DOI 10.1016/j.ecoleng.2014.03.003; [No title captured]	58	22	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0180110	10.1371/journal.pone.0180110	http://dx.doi.org/10.1371/journal.pone.0180110			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654676	Green Published, gold, Green Submitted			2022-12-27	WOS:000404541500056
J	Gao, S; Yan, QD; Chen, LX; Song, YB; Li, JM; Fu, CX; Dong, M				Gao, Song; Yan, Qiaodi; Chen, Luxi; Song, Yaobin; Li, Junmin; Fu, Chengxin; Dong, Ming			Effects of ploidy level and haplotype on variation of photosynthetic traits: Novel evidence from two Fragaria species	PLOS ONE			English	Article							GEOGRAPHIC STRUCTURE; LEAF ANATOMY; POLYPLOIDY; PERFORMANCE; PLANTS; WHEAT; DNA; ALLOPOLYPLOIDY; RESPONSES; GENOTYPES	To reveal the effects of ploidy level and haplotype on photosynthetic traits, we chose 175 genotypes of wild strawberries belonging to two haplotypes at two types of ploidy levels (diploidy and tetraploidy) and measured photosynthetic traits. Our results revealed that ploidy significantly affected the characteristics of light-response curves, CO2-response curves, and leaf gas exchange parameters, except intercellular CO2 concentration (C-i). Tetraploid species had a lower light saturation point (LSP) and CO2 saturation point (CSP), higher light compensation point (LCP), dark respiration (Rd), and CO2 compensation point (CCP) than diploid species. Furthermore, tetraploid species have lower photosynthetic capacity than diploid species, including net photosynthetic rate (P-n), stomatal conductivity (G(s)), and transpiration rate (T-r). In addition, haplotype had a significant effect on LSP, CSP, T-r, and C-i as well as a significant interactive effect between ploidy and haplotype on the maximal photosynethic rate of the light-response curve and R-d. Most of the variance existed within haplotypes among individuals. These results suggest that polyploidization was the main driver for the evolution of photosynthesis with increasing ploidy level (i.e. from diploidy to tetraploidy in Fragaria species), while the origin of a chromosome could also affect the photosynthetic traits and the polyploidization effect on photosynthetic traits.	[Gao, Song; Fu, Chengxin] Zhejiang Univ, Minist Educ, Key Lab Conservat Biol Endangered Wildlife, Hangzhou, Zhejiang, Peoples R China; [Gao, Song; Fu, Chengxin] Zhejiang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Gao, Song] Zhejiang Univ Taizhou, Res Inst, Taizhou, Peoples R China; [Gao, Song; Yan, Qiaodi; Chen, Luxi; Li, Junmin] Taizhou Univ, Zhejiang Prov Key Lab Plant Evolutionary Ecol & C, Taizhou 318000, Zhejiang, Peoples R China; [Song, Yaobin; Dong, Ming] Hangzhou Normal Univ, Key Lab Hangzhou City Ecosyst Protect & Restorat, Hangzhou, Zhejiang, Peoples R China; [Song, Yaobin; Dong, Ming] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Taizhou University; Hangzhou Normal University; Hangzhou Normal University	Fu, CX (corresponding author), Zhejiang Univ, Minist Educ, Key Lab Conservat Biol Endangered Wildlife, Hangzhou, Zhejiang, Peoples R China.; Fu, CX (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.; Li, JM (corresponding author), Taizhou Univ, Zhejiang Prov Key Lab Plant Evolutionary Ecol & C, Taizhou 318000, Zhejiang, Peoples R China.; Dong, M (corresponding author), Hangzhou Normal Univ, Key Lab Hangzhou City Ecosyst Protect & Restorat, Hangzhou, Zhejiang, Peoples R China.; Dong, M (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China.	lijm@tzc.edu.cn; cxfu@zju.edu.cn; dongming@hznu.edu.cn	李, 钧敏/L-7390-2019		National Natural Science Foundation of China [31261120580]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (no. 31261120580) for MD and JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plt056; Alpert P, 2003, J ECOL, V91, P27, DOI 10.1046/j.1365-2745.2003.00737.x; AUSTIN RB, 1982, ANN BOT-LONDON, V49, P177, DOI 10.1093/oxfordjournals.aob.a086238; Bilgrami SS, 2015, J ANIM PLANT SCI, V25, P1633; Burdick RK, 2003, J QUAL TECHNOL, V35, P342, DOI 10.1080/00224065.2003.11980232; Coate JE, 2012, AM J BOT, V99, P55, DOI 10.3732/ajb.1100465; Du LS, 2016, ACTA OECOL, V71, P22, DOI 10.1016/j.actao.2016.01.003; Evans JR, 2013, PLANT PHYSIOL, V162, P1780, DOI 10.1104/pp.113.219006; Fullana-Pericas M, 2017, PHOTOSYNTHETICA, V55, P121, DOI 10.1007/s11099-016-0653-4; HAMID A, 1990, PHOTOSYNTHETICA, V24, P96; Harbut RM, 2010, CAN J PLANT SCI, V90, P885, DOI 10.4141/CJPS09144; Hinchliff CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098986; Howey R, 2015, AM J HUM GENET, V97, P419, DOI 10.1016/j.ajhg.2015.07.016; Hull-Sanders HM, 2009, AM J BOT, V96, P762, DOI 10.3732/ajb.0800200; Isidore E, 2005, GENOME RES, V15, P526, DOI 10.1101/gr.3131005; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; KAMINSKI A, 1990, ANN BOT-LONDON, V66, P359, DOI 10.1093/oxfordjournals.aob.a088035; Kozlov MV, 2015, PEERJ, V3, DOI 10.7717/peerj.1027; Lei JiaJun, 2006, Acta Horticulturae Sinica, V33, P1; Levin DA, 2013, ANN BOT-LONDON, V112, P1201, DOI 10.1093/aob/mct194; [李茂松 LI MaoSong], 2008, [生态学报, Acta Ecologica Sinica], V28, P5385; Li QH, 2014, SCI WORLD J, DOI [10.1155/2014/347461, 10.1155/2014/894018]; Luo WeiCheng, 2013, Acta Prataculturae Sinica, V22, P273; Mayrose I, 2011, SCIENCE, V333, P1257, DOI 10.1126/science.1207205; McLean N, 2016, ECOL LETT, V19, P595, DOI 10.1111/ele.12599; Miller M, 2012, G3-GENES GENOM GENET, V2, P505, DOI 10.1534/g3.112.002162; Nathewet P, 2009, SCI HORTIC-AMSTERDAM, V120, P431, DOI 10.1016/j.scienta.2008.11.027; Ning HuSen, 2014, Scientia Silvae Sinicae, V50, P173; Oates KM, 2012, HORTSCIENCE, V47, P1217, DOI 10.21273/HORTSCI.47.9.1217; Offermann S, 2014, CURR OPIN PLANT BIOL, V19, P105, DOI 10.1016/j.pbi.2014.05.010; Ohi T, 2003, AM J BOT, V90, P1645, DOI 10.3732/ajb.90.11.1645; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Pan RZ., 2004, PLANT PHYSIOL, P80; Parisod C, 2012, NEW PHYTOL, V193, P297, DOI 10.1111/j.1469-8137.2011.04008.x; Parisod C, 2010, NEW PHYTOL, V186, P5, DOI 10.1111/j.1469-8137.2009.03142.x; RomeroAranda R, 1997, ANN BOT-LONDON, V79, P153, DOI 10.1006/anbo.1996.0326; Segraves KA, 1999, MOL ECOL, V8, P253, DOI 10.1046/j.1365-294X.1999.00562.x; Soltis DE, 2010, TAXON, V59, P1387, DOI 10.1002/tax.595006; Srivalli B, 2004, PHOTOSYNTHETICA, V42, P393, DOI 10.1023/B:PHOT.0000046158.60446.07; Steenhuisen SL, 2012, PLANT SYST EVOL, V298, P857, DOI 10.1007/s00606-012-0589-5; Suda J, 2006, CYTOM PART A, V69A, P273, DOI 10.1002/cyto.a.20253; Thuiller W, 2004, ECOLOGY, V85, P1688, DOI 10.1890/03-0148; VONCAEMMERER S, 1981, PLANTA, V153, P376, DOI 10.1007/BF00384257; Vyas P, 2007, FUNCT PLANT BIOL, V34, P673, DOI 10.1071/FP07020; Wan CY, 2008, ACTA ECOLOGICA SINIC, V28, P3277; WARNER DA, 1993, PHOTOSYNTH RES, V35, P135, DOI 10.1007/BF00014744; WARNER DA, 1989, PLANT PHYSIOL, V91, P1143, DOI 10.1104/pp.91.3.1143; WARNER DA, 1988, PLANT SCI, V56, P85, DOI 10.1016/0168-9452(88)90190-2; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106; Ye ZP, 2013, PLANTA, V237, P837, DOI 10.1007/s00425-012-1790-z; Yu DJ, 1974, FLORA CHINA, V37; Zhao XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119259	52	11	13	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179899	10.1371/journal.pone.0179899	http://dx.doi.org/10.1371/journal.pone.0179899			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644876	Green Submitted, gold, Green Published			2022-12-27	WOS:000404145100047
J	Gutierrez, A; Ortuno, A				Gutierrez, Aaron; Ortuno, Armando			High speed rail and coastal tourism: Identifying passenger profiles and travel behaviour	PLOS ONE			English	Article							INTERNATIONAL TOURISM; EMPIRICAL-EVIDENCE; REGIONAL TOURISM; AIR TRANSPORT; DEMAND; DESTINATION; COMPETITION; IMPACT; CHINA	In this paper, we characterise tourists most likely to visit a coastal destination by high-speed rail (HSR). Our data came from a survey conducted among HSR passengers during 2014' s high season (July and August) at Spain's Camp de Tarragona and Alicante Stations, each of which is near a mass tourism destination on the Mediterranean coast: the Costa Daurada and the Costa Blanca, respectively. We used responses to the survey, which presented binary discrete-choice situations, to construct a database necessary for a logistic regression model that allowed us to examine how passenger profile, trip characteristics, and stay conditions influenced the use of HSR services on visits to each coastal destination. Results highlighted significant differences in the profiles of tourists who arrived at each destination by HSR and, in turn, that no specific tourist profile is associated with HSR, even for two stations that serve sunny beach destinations. Among its implications, to analyse travellers that HSR can attract, it is vital to consider the specific characteristics of each destination and its current market.	[Gutierrez, Aaron] Rovira & Virgili Univ, Dept Geog, Tarragona, Spain; [Ortuno, Armando] Univ Alicante, Dept Bldg & Urbanism, Alicante, Spain	Universitat Rovira i Virgili; Universitat d'Alacant	Gutierrez, A (corresponding author), Rovira & Virgili Univ, Dept Geog, Tarragona, Spain.	aaron.gutierrez@urv.cat	Gutiérrez, Aaron/ABH-3586-2020	Gutiérrez, Aaron/0000-0003-0557-6319	Spanish Ministry of Science and Innovation [GLOBALTUR-CSO2011-23004/GEOG, MOVETUR-CS02014-51785-R]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was funded by the Spanish Ministry of Science and Innovation (GLOBALTUR-CSO2011- 23004/GEOG; MOVETUR-CS02014-51785-R) to AG.	Albalate D, 2016, TRANSPORT RES A-POL, V85, P174, DOI 10.1016/j.tra.2016.01.009; Clave SA, 2015, J AIR TRANSP MANAG, V42, P213, DOI 10.1016/j.jairtraman.2014.11.001; Bazin S, 2011, EC MANAGEMENT TOURIS, P115; Bazin S., 2013, CAHIERS SCI TRANSPOR, V63, P33; Becker C, 2011, TOURISM GEOGR, V13, P381, DOI 10.1080/14616688.2011.570779; Behrens C, 2012, J URBAN ECON, V71, P278, DOI 10.1016/j.jue.2011.12.005; Bellet C, 2012, TRANS MOBIL SER, P163; Bieger T, 2006, J AIR TRANSP MANAG, V12, P40, DOI 10.1016/j.jairtraman.2005.09.007; BONNAFOUS A, 1987, TRANSPORTATION, V14, P127, DOI 10.1007/BF00837589; Caceres J, 2010, ELS USUARIS ESTACIO; Chen Z, 2012, TOURISM IND HIGH SPE, V14; Chen ZH, 2015, APPL ECON LETT, V22, P57, DOI 10.1080/13504851.2014.925043; Coronado J., 2013, RTS RECHERCHE TRANSP, V29, P161, DOI DOI 10.4074/S0761898013003026; Delaplace M., 2012, RECHERCHE TRANSPORTS, V28, P290, DOI DOI 10.1007/S13547-012-0041-9; Delaplace M, 2014, PROCD SOC BEHV, V111, P166, DOI 10.1016/j.sbspro.2014.01.049; Dobruszkes F, 2014, TRANSPORT RES A-POL, V69, P461, DOI 10.1016/j.tra.2014.09.004; Dobruszkes F, 2013, J AIR TRANSP MANAG, V29, P23, DOI 10.1016/j.jairtraman.2013.02.001; Dobruszkes F, 2011, TRANSPORT POLICY, V18, P870, DOI 10.1016/j.tranpol.2011.06.002; Domenech A, 2017, ISPRS INT J GEO-INF, V6, DOI 10.3390/ijgi6030083; Martinez LD, 2016, SCRIPTA NOVA, V20; Facchinetti-Mannone V, 2013, CAHIERS SCI TRANSPOR, V63, P3; Garmendia M, 2012, CITIES, V29, pS26, DOI 10.1016/j.cities.2012.06.005; Givoni M, 2006, TRANSPORT POLICY, V13, P386, DOI 10.1016/j.tranpol.2006.02.001; Givoni M, 2013, TRANSPORT REV, V33, P720, DOI 10.1080/01441647.2013.853707; Guirao B, 2008, THE SUSTAINABLE CITY; Guirao B, 2015, J TRANSP GEOGR, V47, P37, DOI 10.1016/j.jtrangeo.2015.07.010; Gutierrez A, 2009, GEOGRAFIA TERRITORIO, P383; Gutierrez A, 2016, REV GEOGR NORTE GD, P65, DOI 10.4067/S0718-34022016000300004; GUTIERREZ J., 2004, INVESTIGACIONES REGI, V5, P199; Khadaroo J, 2008, TOURISM MANAGE, V29, P831, DOI 10.1016/j.tourman.2007.09.005; Lumson L, 2004, ADV TOURISM RES SERI; Masson S, 2009, TECHNOVATION, V29, P611, DOI 10.1016/j.technovation.2009.05.013; Mazon T, 2006, TOUR PLAN DEV, V3, P89, DOI 10.1080/14790530600938261; Menerault P, 1998, NETCOM, V12, P161; Menerault P, 1998, NETWORKS COMMUNICATI, V12, P1; Ortulio Padilla A, 2016, OPEN TRANSPORTATION, V10, P97; Page SJ, 2005, TOURISM TRANSPORT GL; Pagliara F, 2015, TRANSPORT POLICY, V37, P187, DOI 10.1016/j.tranpol.2014.10.015; Plassard F, 1992, TRANSPORTS URBAINS, V74, P3; Prideaux B, 2000, TOURISM MANAGE, V21, P53, DOI 10.1016/S0261-5177(99)00079-5; Roman C, 2007, J AIR TRANSP MANAG, V13, P277, DOI 10.1016/j.jairtraman.2007.04.009; Saladie O, 2016, BELGEO REV BELGE GEO, V3; Santos JM, 2006, ANALES GEOGRAFIA, V26, P147; South East England Development Agency, 2008, HST IMP STUD FIN REP; Todorovitch P, 2011, HIGH SPEED RAIL INT; Urena JM, 2009, CITIES, V26, P266, DOI 10.1016/j.cities.2009.07.001; Van den Berg L, 1998, EUROPEAN HIGH SPEED; Vickerman R, 1999, REG STUD, V33, P1, DOI 10.1080/00343409950118878; Wang DG, 2014, ASIA PAC J TOUR RES, V19, P890, DOI 10.1080/10941665.2013.818049; Wang WeiChing, 2010, World Leisure Journal, V52, P14; Wang X, 2012, TOUR MANAG PERSPECT, V1, P34, DOI 10.1016/j.tmp.2011.10.001; Witt SF, 1995, INT J FORECASTING, V11, P447, DOI 10.1016/0169-2070(95)00591-7	52	5	5	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179682	10.1371/journal.pone.0179682	http://dx.doi.org/10.1371/journal.pone.0179682			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY7CO	28644893	Green Submitted, Green Published, gold			2022-12-27	WOS:000404145100033
J	Zhu, XS; Chen, YH; Li, YJ; Deng, ZJ				Zhu, Xiaoshuang; Chen, Yinghe; Li, Yanjun; Deng, Zhijun			Automatic non-symbolic numerosity processing in preschoolers	PLOS ONE			English	Article							NUMBER-SIZE INTERFERENCE; APPROXIMATE NUMBER; ARABIC NUMERALS; YOUNG-CHILDREN; MAGNITUDE; ACUITY; TASK; REPRESENTATIONS; PERFORMANCE; JUDGMENTS	There has recently been an increasing focus on the development of automatic processing of numerical magnitude. However, little effort has been made to explore automatic access to non-symbolic numerical magnitude in preschool children. In experiment 1, we used a non symbolic physical size comparison task in 3- to 6-year-olds to examine developmental changes and the effect of ratio and counting principle knowledge. Results showed that the existence of automatic non-symbolic numerical processing began at age 3-4 years and size congruity effects tended to reduce with increasing age from 4 years old. The study also found that non-counting-principle knowers had a larger congruity effect, and in low ratio conditions the size congruity effect was more easily found. In addition, symbolic number comparison ability was negatively related to size congruity effect. In experiment 2, we explored the relationship between inhibition skill and size congruity effects, as well as interference and facilitatory components in children aged 4 years old. Results showed no correlation between inhibition skills and the size congruity effect and only interference effects were found. We also found a larger interference effect in low ratio conditions than in high ratio conditions.	[Zhu, Xiaoshuang; Chen, Yinghe; Li, Yanjun; Deng, Zhijun] Beijing Normal Univ, Inst Dev Psychol, Fac Psychol, Beijing, Peoples R China	Beijing Normal University	Chen, YH (corresponding author), Beijing Normal Univ, Inst Dev Psychol, Fac Psychol, Beijing, Peoples R China.	chenyinghe@bnu.edu.cn	zhu, xiaoshuang/GYV-0942-2022		Major Project of the National Social Science Foundation of China [14ZDB160]; National Natural Science Foundation of China [31271106]	Major Project of the National Social Science Foundation of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by Major Project of the National Social Science Foundation of China (14ZDB160;http://www.npopss-cn.gov.cn) and National Natural Science Foundation of China (31271106;http://www.nstc.gov.cn). The funders support the decision to publish and data collection.	Bugden S, 2011, COGNITION, V118, P32, DOI 10.1016/j.cognition.2010.09.005; Chan WWL, 2011, J EXP CHILD PSYCHOL, V109, P263, DOI 10.1016/j.jecp.2011.01.010; Clayton S, 2015, ZDM-MATH EDUC, V47, P759, DOI 10.1007/s11858-014-0655-2; Cohen HH, 2014, J EXP CHILD PSYCHOL, V121, P96, DOI 10.1016/j.jecp.2013.11.005; Condry KF, 2008, J EXP PSYCHOL GEN, V137, P22, DOI 10.1037/0096-3445.137.1.22; DEHAENE S, 1995, J EXP PSYCHOL LEARN, V21, P314, DOI 10.1037/0278-7393.21.2.314; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; FUENTES LJ, 1993, ACTA PSYCHOL, V84, P213, DOI 10.1016/0001-6918(93)90061-U; Fuhs MW, 2013, DEVELOPMENTAL SCI, V16, P136, DOI 10.1111/desc.12013; Fujioka T, 2004, J COGNITIVE NEUROSCI, V16, P1010, DOI 10.1162/0898929041502706; Gebuis T, 2012, J EXP PSYCHOL GEN, V141, P642, DOI 10.1037/a0026218; Gebuis T, 2010, NEUROPSYCHOLOGIA, V48, P394, DOI 10.1016/j.neuropsychologia.2009.09.027; Gebuis T, 2009, EUR J NEUROSCI, V30, P1999, DOI 10.1111/j.1460-9568.2009.06994.x; Gebuis T, 2009, COGN PROCESS, V10, P133, DOI 10.1007/s10339-008-0219-x; GERSTADT CL, 1994, COGNITION, V53, P129, DOI 10.1016/0010-0277(94)90068-X; Gilmore C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067374; Girelli L, 2000, J EXP CHILD PSYCHOL, V76, P104, DOI 10.1006/jecp.2000.2564; Huntley-Fenner G, 2000, PSYCHOL SCI, V11, P147, DOI 10.1111/1467-9280.00230; Jiang T, 2016, MEM COGNITION, V44, P162, DOI 10.3758/s13421-015-0542-2; Kadosh RC, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00002; Kaufmann L, 2006, NEUROREPORT, V17, P587, DOI 10.1097/00001756-200604240-00007; Kiselev S, 2009, J EXP CHILD PSYCHOL, V102, P150, DOI 10.1016/j.jecp.2008.02.002; Landerl K, 2009, J EXP CHILD PSYCHOL, V103, P546, DOI 10.1016/j.jecp.2008.12.006; Le Corre M, 2007, COGNITION, V105, P395, DOI 10.1016/j.cognition.2006.10.005; MACLEOD CM, 1988, J EXP PSYCHOL LEARN, V14, P126, DOI 10.1037/0278-7393.14.1.126; MacLeod CM, 2000, TRENDS COGN SCI, V4, P383, DOI 10.1016/S1364-6613(00)01530-8; Merkley R, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01903; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Mussolin C, 2007, J CLIN EXP NEUROPSYC, V29, P225, DOI 10.1080/13803390600629759; Negen J, 2015, BRIT J DEV PSYCHOL, V33, P92, DOI 10.1111/bjdp.12071; Odic D, 2013, DEV PSYCHOL, V49, P1103, DOI 10.1037/a0029472; Patro K, 2012, J EXP CHILD PSYCHOL, V111, P534, DOI 10.1016/j.jecp.2011.09.006; Pina V, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00375; Rousselle L, 2004, J EXP CHILD PSYCHOL, V87, P57, DOI 10.1016/j.jecp.2003.10.005; Rousselle L, 2008, DEV PSYCHOL, V44, P544, DOI 10.1037/0012-1649.44.2.544; Rubinsten O, 2002, J EXP CHILD PSYCHOL, V81, P74, DOI 10.1006/jecp.2001.2645; Santens S, 2011, COGNITION, V118, P94, DOI 10.1016/j.cognition.2010.10.014; Sasanguie D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087739; Schwarz W, 2003, J EXP PSYCHOL HUMAN, V29, P507, DOI 10.1037/0096-1523.29.3.507; Soltesz F, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-13; Stock P, 2009, LEARN INDIVID DIFFER, V19, P419, DOI 10.1016/j.lindif.2009.03.002; Szucs D, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-23; Szucs D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00444; Tzelgov J, 1996, J EXP PSYCHOL LEARN, V22, P336; TZELGOV J, 1992, MEM COGNITION, V20, P727, DOI 10.3758/BF03202722; Zhou XL, 2007, MEM COGNITION, V35, P464, DOI 10.3758/BF03193286	46	0	0	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0178396	10.1371/journal.pone.0178396	http://dx.doi.org/10.1371/journal.pone.0178396			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY7CO	28644834	Green Submitted, Green Published, gold			2022-12-27	WOS:000404145100004
J	Galvin, M; Ryan, P; Maguire, S; Heverin, M; Madden, C; Vajda, A; Normand, C; Hardiman, O				Galvin, Miriam; Ryan, Padhraig; Maguire, Sinead; Heverin, Mark; Madden, Caoifa; Vajda, Alice; Normand, Charles; Hardiman, Orla			The path to specialist multidisciplinary care in amyotrophic lateral sclerosis: A population-based study of consultations, interventions and costs	PLOS ONE			English	Article							ALS; MANAGEMENT; TIMELINES; SURVIVAL; SYSTEM	Background Amyotrophic Lateral Sclerosis (ALS) is a devastating neurological condition that requires coordinated, multidisciplinary clinical management. ALS is prone to misdiagnosis as its signs and symptoms may be non-specific, which may prolong patients' journey to multidisciplinary ALS care. Methods Using chart review and national register data, we have detailed the journey of a national cohort of ALS patients (n = 155) from the time of first symptom to presentation at a multidisciplinary clinic (MDC). Key milestones were analysed, including frequency of consultations, clinical interventions, and associated economic cost. Results A majority of patients was male (60%), 65 years of age and over (54%), and had spinal onset ALS (72%). Time from onset of first symptoms to ALS diagnosis was a mean of 15.1 months (median, 11). There was a mean interval of 17.4 months (median 12.5) from first symptoms to arrival at the MDC, and a mean of 4.09 (median, 4) consultations with health care professionals. Electromyography and nerve conduction studies were among the most common interventions. Direct referral by a general practitioner (GP) to a neurologist was associated with reduced cost, but not reduced diagnostic delay. Bulbar ALS was associated with shorter time from symptom onset to diagnosis. Neurologist consultation in the first three consultations was associated with lower costs prior to the ALS clinic attendance but not a shorter time from first symptom to final diagnosis. Mean cost prior to attending the MDC was (sic)3,486 per patient. Conclusions Expedited referral to the multidisciplinary ALS clinic would have reduced costs by an estimated (sic)2,072 per patient. Development of a standardised pathway with early referral to neurology of patients with suspected symptoms of ALS could limit unnecessary interventions and reduce cost of care.	[Galvin, Miriam; Heverin, Mark; Madden, Caoifa; Vajda, Alice; Hardiman, Orla] Trinity Coll Dublin, Acad Unit Neurol, Trinity Biomed Sci Inst, Dublin, Ireland; [Ryan, Padhraig; Normand, Charles] Trinity Coll Dublin, Dept Hlth Policy & Management, Dublin, Ireland; [Maguire, Sinead; Hardiman, Orla] Beaumont Hosp, Natl ALS Clin, Dept Neurol, Natl Neurosci Ctr, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin	Galvin, M (corresponding author), Trinity Coll Dublin, Acad Unit Neurol, Trinity Biomed Sci Inst, Dublin, Ireland.	GALVINMI@tcd.ie	Hardiman, Orla/Y-3441-2019	Hardiman, Orla/0000-0003-2610-1291; Normand, Charles/0000-0002-0885-5754; Galvin, Miriam/0000-0002-8232-8020; Ryan, Padhraig/0000-0001-7852-5606; Vajda, Alice/0000-0001-9105-6680	Irish Health Research Board Dublin, as part of the HRB Interdisciplinary Capacity Enhancement Awards [ICE/2012/]	Irish Health Research Board Dublin, as part of the HRB Interdisciplinary Capacity Enhancement Awards	This research was supported by funding from the Irish Health Research Board Dublin (http://www.hrb.ie), as part of the HRB Interdisciplinary Capacity Enhancement Awards (ICE/2012/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PM, 2012, EUR J NEUROL, V19, P360, DOI 10.1111/j.1468-1331.2011.03501.x; Cellura E, 2012, CLIN NEUROL NEUROSUR, V114, P550, DOI 10.1016/j.clineuro.2011.11.026; Chio A, 2006, NEUROLOGY, V67, P902, DOI 10.1212/01.wnl.0000233840.41688.df; Cristini Jacqueline, 2006, JAAPA, V19, P29; Department of Health Ireland, 2016, DHA39 PRINC PROC AG; Elamin M, 2013, NEUROLOGY, V80, P1590, DOI 10.1212/WNL.0b013e31828f18ac; Galvin M, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1229-x; Hardiman O, 2011, NAT REV NEUROL, V7, P639, DOI 10.1038/nrneurol.2011.153; Hobson E, 2015, CLIN REV MOTOR NEURO; Miller RG, 2009, NEUROLOGY, V73, P1227, DOI 10.1212/WNL.0b013e3181bc01a4; Mitchell JD, 2010, AMYOTROPH LATERAL SC, V11, P537, DOI 10.3109/17482968.2010.495158; Motor Neurone Disease Association and Royal College of General Practitioners, 2014, PROGR WEAKN COULD BE; O'Brien MR, 2011, AMYOTROPH LATERAL SC, V12, P97, DOI 10.3109/17482968.2010.546414; Paganoni S, 2015, NEUROREHABILITATION, V37, P53, DOI 10.3233/NRE-151240; Paganoni S, 2014, AMYOTROPH LAT SCL FR, V15, P453, DOI 10.3109/21678421.2014.903974; Roche JC, 2012, BRAIN, V135, P847, DOI 10.1093/brain/awr351; Rooney J, 2015, J NEUROL NEUROSUR PS, V86, P496, DOI 10.1136/jnnp-2014-309601; Rooney J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074733; Srinivasan J, 2006, MUSCLE NERVE, V34, P359, DOI 10.1002/mus.20555; Stephens HE, 2015, AMYOTROPH LAT SCL FR, V16, P196, DOI 10.3109/21678421.2014.994530; Tramacere I, 2015, J NEUROL NEUROSUR PS, V86, P1180, DOI 10.1136/jnnp-2014-310176; Van Der Steen I, 2009, AMYOTROPH LATERAL SC, V10, P27, DOI 10.1080/17482960802103131	22	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179796	10.1371/journal.pone.0179796	http://dx.doi.org/10.1371/journal.pone.0179796			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640860	Green Published, Green Submitted, gold			2022-12-27	WOS:000404135800067
J	Lee, ES; Lee, MY; Kwon, MH; Kim, HM; Kang, JS; Kim, YM; Lee, EY; Chung, CH				Lee, Eun Soo; Lee, Mi Young; Kwon, Mi-Hye; Kim, Hong Min; Kang, Jeong Suk; Kim, You Mi; Lee, Eun Young; Chung, Choon Hee			Sarpogrelate hydrochloride ameliorates diabetic nephropathy associated with inhibition of macrophage activity and inflammatory reaction in db/db mice	PLOS ONE			English	Article							INCREASES CIRCULATING ADIPONECTIN; ACTIVATED PROTEIN-KINASE; INSULIN-RESISTANCE; RECEPTOR ANTAGONIST; HUMAN MONOCYTES; SEROTONIN; OBESITY; SERUM; SIRT1; CELL	The aim of this study was to evaluate the effects of sarpogrelate hydrochloride (SH), a selective serotonin 2A receptor antagonist, on diabetic nephropathy in a type 2 diabetes mouse model. We treated db/m and db/db mice with SH (30 mg/kg/day) for 12 weeks. Rat renal proximal tubule cells (NRK-52E) and mouse macrophages (Raw 264.7) were stimulated by high glucose (30 mM glucose) or LPS (100 ng/ml) with or without SH (20 mu M). We found that SH treatment increased serum adiponectin level and decreased urinary albumin, macrophage infiltration to glomeruli, and renal inflammatory and fibrosis signals, which were highly expressed in diabetic mice. Proximal tubule cells treated with high glucose (30 mM) also showed increased inflammatory and fibrosis signals. However, SH (20 mu M) treatment reduced these changes. Moreover, SH treatment inhibited LPS-stimulated macrophage migration and activation. These findings suggest that SH ameliorates diabetic nephropathy not only by suppressing macrophage infiltration, but also by anti-inflammatory and antifibrotic effects.	[Lee, Eun Soo; Lee, Mi Young; Kwon, Mi-Hye; Kim, Hong Min; Kim, You Mi; Chung, Choon Hee] Yonsei Univ, Dept Internal Med, Wonju Coll Med, Wonju, South Korea; [Kang, Jeong Suk; Lee, Eun Young] Soonchunhyang Univ, Dept Internal Med, Cheonan Hosp, Cheonan, South Korea	Yonsei University; Soonchunhyang University	Chung, CH (corresponding author), Yonsei Univ, Dept Internal Med, Wonju Coll Med, Wonju, South Korea.	cchung@yonsei.ac.kr	Lee, Eun Young/Q-6592-2019	Lee, Eun Young/0000-0002-4513-9888; Chung, Choon/0000-0003-1144-7206	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2015R1D1A1A02060785, 2015R1A6A1A03032522]; Yonsei University Wonju College of Medicine [YUWCM-2009-23]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Yonsei University Wonju College of Medicine	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2015R1D1A1A02060785, 2015R1A6A1A03032522) to EYL, and the research grant from Yonsei University Wonju College of Medicine (YUWCM-2009-23) to MYL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2015R1D1A1A02060785, 2015R1A6A1A03032522) and the research grant from Yonsei University Wonju College of Medicine (YUWCM-2009-23).	Awad AS, 2011, AM J PHYSIOL-RENAL, V301, pF1358, DOI 10.1152/ajprenal.00332.2011; Cai XL, 2015, INT J DISTRIB SENS N, DOI 10.1155/2015/976127; Curat CA, 2004, DIABETES, V53, P1285, DOI 10.2337/diabetes.53.5.1285; Daha MR, 2000, NEPHROL DIAL TRANSPL, V15, P41, DOI 10.1093/ndt/15.suppl_6.41; Dong J, 2014, J LIPID RES, V55, P363, DOI 10.1194/jlr.M038786; Durk T, 2005, INT IMMUNOL, V17, P599, DOI 10.1093/intimm/dxh242; Eller K, 2011, DIABETES, V60, P2954, DOI 10.2337/db11-0358; Fioretto P, 2007, SEMIN NEPHROL, V27, P195, DOI 10.1016/j.semnephrol.2007.01.012; FLACHAIRE E, 1990, CLIN CHEM, V36, P2117; Galkina E, 2006, J AM SOC NEPHROL, V17, P368, DOI 10.1681/ASN.2005080859; Goyal RK, 2011, J CARDIOVASC PHARM T, V16, P380, DOI 10.1177/1074248410384708; Hasegawa K, 2013, NAT MED, V19, P1496, DOI 10.1038/nm.3363; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Ka SO, 2015, J ENDOCRINOL, V224, P109, DOI 10.1530/JOE-14-0527; Kasho M, 1998, KIDNEY INT, V54, P1083, DOI 10.1046/j.1523-1755.1998.00114.x; Kim DH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153965; Kim MY, 2013, DIABETOLOGIA, V56, P204, DOI 10.1007/s00125-012-2747-2; King GL, 2008, J PERIODONTOL, V79, P1527, DOI 10.1902/jop.2008.080246; Kobayashi S, 2008, CLIN EXP NEPHROL, V12, P119, DOI 10.1007/s10157-007-0011-8; LANE PH, 1992, KIDNEY INT, V41, P1085, DOI 10.1038/ki.1992.165; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Lee YJ, 2010, AM J PHYSIOL-RENAL, V298, pF1263, DOI 10.1152/ajprenal.00475.2009; Lim AKH, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/146154; Lorenowicz MJ, 2006, J LEUKOCYTE BIOL, V80, P1542, DOI 10.1189/jlb.0506357; Malyszko J, 1995, Pol Arch Med Wewn, V94, P26; MALYSZKO J, 1994, THROMB RES, V75, P569, DOI 10.1016/0049-3848(94)90231-3; MONTERO A, 1995, FUNDAM CLIN PHARM, V9, P175, DOI 10.1111/j.1472-8206.1995.tb00278.x; NEBIGIL CG, 1995, AM J PHYSIOL-RENAL, V268, pF122, DOI 10.1152/ajprenal.1995.268.1.F122; Ni W, 2006, CLIN EXP PHARMACOL P, V33, P575, DOI 10.1111/j.1440-1681.2006.04410.x; Nomura S, 2005, BLOOD COAGUL FIBRIN, V16, P423, DOI 10.1097/01.mbc.0000176197.48134.08; Nymark M, 2009, DIABETES CARE, V32, P1689, DOI 10.2337/dc09-0467; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Qualls JE, 2006, J LEUKOCYTE BIOL, V80, P802, DOI 10.1189/jlb.1205734; RAPPORT MM, 1948, J BIOL CHEM, V176, P1243; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; Sakai N, 2015, KIDNEY INT, V87, P11, DOI 10.1038/ki.2014.322; SAXENA PR, 1990, J CARDIOVASC PHARM, V15, pS17, DOI 10.1097/00005344-199001001-00004; Seok SJ, 2013, NEPHROL DIAL TRANSPL, V28, P1700, DOI 10.1093/ndt/gfs555; Soga F, 2007, J INVEST DERMATOL, V127, P1947, DOI 10.1038/sj.jid.5700824; Sowers James R, 2008, Clin Cornerstone, V9, P32, DOI 10.1016/S1098-3597(08)60026-5; Szabo A, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00358; Tajima T, 2008, J PHARMACOL EXP THER, V326, P493, DOI 10.1124/jpet.108.137992; Takahashi T, 2002, DIABETES RES CLIN PR, V58, P123, DOI 10.1016/S0168-8227(02)00105-5; TAKAHASHI T, 1992, J CARDIOVASC PHARM, V20, P779, DOI 10.1097/00005344-199211000-00014; Takishita E, 2004, J CARDIOVASC PHARM, V43, P266, DOI 10.1097/00005344-200402000-00015; Tsuchiya R, 2008, J VET MED SCI, V70, P181, DOI 10.1292/jvms.70.181; Veron D, 2010, KIDNEY INT, V77, P989, DOI 10.1038/ki.2010.64; Wada J, 2013, CLIN SCI, V124, P139, DOI 10.1042/CS20120198; Xiao JH, 2016, INT J MOL MED, V37, P659, DOI 10.3892/ijmm.2016.2486; Yamakawa J, 2003, DIABETES CARE, V26, P2477, DOI 10.2337/diacare.26.8.2477; Yang ZG, 2010, J BIOL CHEM, V285, P19051, DOI 10.1074/jbc.M110.123620; Yoon MJ, 2006, DIABETES, V55, P2562, DOI 10.2337/db05-1322; Zhao L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113398	54	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179221	10.1371/journal.pone.0179221	http://dx.doi.org/10.1371/journal.pone.0179221			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640832	Green Submitted, gold, Green Published			2022-12-27	WOS:000404135800022
J	Liao, KH; Chang, SJ; Chang, HC; Chien, CL; Huang, TS; Feng, TC; Lin, WW; Shih, CC; Yang, MH; Yang, SH; Lin, CH; Hwang, WL; Lee, OK				Liao, Ko-Hsun; Chang, Shing-Jyh; Chang, Hsin-Chuan; Chien, Chen-Li; Huang, Tse-Shun; Feng, Te-Chia; Lin, Wen-Wei; Shih, Chuan-Chi; Yang, Muh-Hwa; Yang, Shung-Haur; Lin, Chi-Hung; Hwang, Wei-Lun; Lee, Oscar K.			Endothelial angiogenesis is directed by RUNX1T1-regulated VEGFA, BMP4 and TGF-beta 2 expression	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; PROGENITOR-CELL; GROWTH-FACTOR; BONE-MARROW; FAMILY PROTEINS; MECHANISMS; DIFFERENTIATION; PROLIFERATION; ETO; VASCULOGENESIS	Tissue angiogenesis is intimately regulated during embryogenesis and postnatal development. Defected angiogenesis contributes to aberrant development and is the main complication associated with ischemia-related diseases. We previously identified the increased expression of RUNX1T1 in umbilical cord blood-derived endothelial colony-forming cells (ECFCs) by gene expression microarray. However, the biological relevance of RUNX1T1 in endothelial lineage is not defined clearly. Here, we demonstrate RUNX1T1 regulates the survival, motility and tube forming capability of ECFCs and EA. hy926 endothelial cells by loss-and gain-of function assays, respectively. Second, embryonic vasculatures and quantity of bone marrow-derived angiogenic progenitors are found to be reduced in the established Runx1t1 heterozygous knockout mice. Finally, a central RUNX1T1-regulated signature is uncovered and VEGFA, BMP4 as well as TGF-beta 2 are demonstrated to mediate RUNX1T1-orchested angiogenic activities. Taken together, our results reveal that RUNX1T1 serves as a common angiogenic driver for vaculogenesis and functionality of endothelial lineage cells. Therefore, the discovery and application of pharmaceutical activators for RUNX1T1 will improve therapeutic efficacy toward ischemia by promoting neovascularization.	[Liao, Ko-Hsun; Chang, Hsin-Chuan; Chien, Chen-Li; Huang, Tse-Shun; Lin, Wen-Wei; Lin, Chi-Hung] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei, Taiwan; [Chang, Shing-Jyh; Shih, Chuan-Chi] Hsinchu Mackay Mem Hosp, Dept Obstet & Gynecol, Hsinchu, Taiwan; [Feng, Te-Chia; Hwang, Wei-Lun] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Translat Med, Taipei, Taiwan; [Yang, Muh-Hwa; Lee, Oscar K.] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Yang, Muh-Hwa] Natl Yang Ming Univ, Immun & Inflammat Res Ctr, Taipei, Taiwan; [Yang, Muh-Hwa] Natl Yang Ming Univ, Canc Res Ctr, Taipei, Taiwan; [Yang, Muh-Hwa] Taipei Vet Gen Hosp, Div Hematol Oncol, Dept Med, Taipei, Taiwan; [Yang, Muh-Hwa] Acad Sinica, Genom Res Ctr, Taipei, Taiwan; [Yang, Shung-Haur] Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan; [Yang, Shung-Haur] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Lee, Oscar K.] Natl Yang Ming Univ, Stem Cell Res Ctr, Taipei, Taiwan; [Lee, Oscar K.] Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan; [Lee, Oscar K.] Taipei City Hosp, Taipei, Taiwan	National Yang Ming Chiao Tung University; Mackay Memorial Hospital; Taipei Medical University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Academia Sinica - Taiwan; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei City Hospital	Hwang, WL (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, PhD Program Translat Med, Taipei, Taiwan.; Lee, OK (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan.; Lee, OK (corresponding author), Natl Yang Ming Univ, Stem Cell Res Ctr, Taipei, Taiwan.; Lee, OK (corresponding author), Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan.; Lee, OK (corresponding author), Taipei City Hosp, Taipei, Taiwan.	wlhwang930@tmu.edu.tw; DAV47@tpech.gov.tw	Yang, Muh-Hwa/AAE-4691-2020		Ministry of Science and Technology (MOST) [104-2321-B-101-027, 103-2314-B-010-053-MY3, 104-0210-01-09-02, 103-2633-H-010-001, 105-2320-B-038-009-MY2]; Yuan's General Hospital [106YGH-TMU-02]; Hsinchu Mackay Memorial Hospital [MMH-HB-10614]; Taipei Medical University [TMU104-AE1-B11]	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); Yuan's General Hospital; Hsinchu Mackay Memorial Hospital; Taipei Medical University	This work is supported by Ministry of Science and Technology (MOST; 104-2321-B-101-027 to S.H.Y; 103-2314-B-010-053-MY3 to O.K.L; 104-0210-01-09-02, and 103-2633-H-010-001 to M.H.Y and 105-2320-B-038-009-MY2 to W.L.H), Yuan's General Hospital (106YGH-TMU-02 to W.L. H), Hsinchu Mackay Memorial Hospital (MMH-HB-10614 to C.C.S) and Taipei Medical University (TMU104-AE1-B11 to W.L.H).r The authors dedicate this work to the memory of Professor Hsei-Wei Wang (Apr. 1969-Sep. 2015). Dr. Hsei-Wei Wang focused on bioinformatics and molecular biology research; without his long-term devotion to EPC research this paper could not have been completed. The authors would like to thank Dr. Tzong-Shyuan Lee and Dr. Po-Hsun Huang for their advice and helpful comments. The authors also acknowledge the technical services provided by the Microarray & Gene Expression Analysis Core Facility and Instrument Resource Center of the National Yang-Ming University. The Runxl tl knock-out mice were generated under the supervision of the Transgenic Mouse Model Core Facility of the National Core Facility Program for Biotechnology, National Science Council (NSC) and the Gene Knockout Mouse Core Laboratory of National Taiwan University Center of Genomic Medicine. The authors also acknowledge the technical supports provided by Flow cytometry Core Facility of National Yang Ming University and Imaging Core Facility of Nanotechnology of the UST-YMU. This work is supported by Ministry of Science and Technology (MOST; 104-2321-B-101-027 to S. H.Y; 103-2314-B-010-053-MY3 to O.K.L; 104-0210-01-09-02, and 103-2633-H-010-001 to M. H.Y; and 105-2320-B-038-009-MY2 to W.L.H), Yuan's General Hospital (106YGH-TMU-02 to W.L.H), Hsinchu Mackay Memorial Hospital (MMH-HB-10614 to C.C.S) and Taipei Medical University (TMU104-AE1-B11 to W.L.H).	Aaker JD, 2010, NEUROSCI LETT, V474, P46, DOI 10.1016/j.neulet.2010.03.004; Alfayez M, 2016, ANTICANCER RES, V36, P5257, DOI 10.21873/anticanres.11096; Amann JM, 2001, MOL CELL BIOL, V21, P6470, DOI 10.1128/MCB.21.19.6470-6483.2001; Ardila DC, 2015, BIOMATERIALS, V37, P164, DOI 10.1016/j.biomaterials.2014.10.021; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Baby N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089326; Bauer SM, 2006, J VASC SURG, V43, P134, DOI 10.1016/j.jvs.2005.08.038; Benitez CM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004645; Borselli C, 2010, P NATL ACAD SCI USA, V107, P3287, DOI 10.1073/pnas.0903875106; Boyd NL, 2007, EXP BIOL MED, V232, P833; BREIER G, 1995, DEV DYNAM, V204, P228, DOI 10.1002/aja.1002040303; Calabi F, 2001, MOL CELL BIOL, V21, P5658, DOI 10.1128/MCB.21.16.5658-5666.2001; Cao Y, 2002, MECH DEVELOP, V119, P35, DOI 10.1016/S0925-4773(02)00285-X; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Cheng CC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-182; Cho HJ, 2007, J EXP MED, V204, P3257, DOI 10.1084/jem.20070166; Dai L, 2012, INT J CANCER, V131, P834, DOI 10.1002/ijc.26428; de Guzman CG, 2002, MOL CELL BIOL, V22, P5506, DOI 10.1128/MCB.22.15.5506-5517.2002; Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545; Erickson PF, 1996, BLOOD, V88, P1813; Ferguson JE, 2005, ARTERIOSCL THROM VAS, V25, P2246, DOI 10.1161/01.ATV.0000183609.55154.44; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Gendron RL, 1996, DEV BIOL, V177, P332, DOI 10.1006/dbio.1996.0167; Hayashi Shigemi, 2002, Gene Expression Patterns, V2, P93, DOI 10.1016/S0925-4773(02)00292-7; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Jialal I, 2010, ATHEROSCLEROSIS, V211, P297, DOI 10.1016/j.atherosclerosis.2010.01.036; Junge A, 2017, GENE, V615, P35, DOI 10.1016/j.gene.2017.03.015; Karamysheva AF, 2008, BIOCHEMISTRY-MOSCOW+, V73, P751, DOI 10.1134/S0006297908070031; Kim H, 2010, CIRC RES, V107, P602, DOI 10.1161/CIRCRESAHA.110.218396; Kota Sunil K, 2012, Indian J Endocrinol Metab, V16, P918, DOI 10.4103/2230-8210.102992; Koyano-Nakagawa N, 2005, DEV BIOL, V278, P22, DOI 10.1016/j.ydbio.2004.10.010; Lam K, 2012, FRONT BIOSCI-LANDMRK, V17, P1120, DOI 10.2741/3977; Lee Poay Sian Sabrina, 2014, World J Stem Cells, V6, P355, DOI 10.4252/wjsc.v6.i3.355; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107127; Lutter S, 2012, J CELL BIOL, V197, P837, DOI 10.1083/jcb.201110132; Marcelo KL, 2013, CIRC RES, V112, P1272, DOI 10.1161/CIRCRESAHA.113.300506; Melnick AM, 2000, MOL CELL BIOL, V20, P2075, DOI 10.1128/MCB.20.6.2075-2086.2000; Merkestein M, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/521381; MIYOSHI H, 1993, EMBO J, V12, P2715, DOI 10.1002/j.1460-2075.1993.tb05933.x; Moreno-Miralles I, 2009, CURR OPIN HEMATOL, V16, P195, DOI 10.1097/MOH.0b013e32832a07d6; Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296; Nelson J, 2015, FASEB J, V29, P3085, DOI 10.1096/fj.14-267989; Okumura AJ, 2007, EXP HEMATOL, V35, P978, DOI 10.1016/j.exphem.2007.03.002; POOLE TJ, 1989, J EXP ZOOL, V251, P224, DOI 10.1002/jez.1402510210; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Radu M, 2013, JOVE-J VIS EXP, DOI 10.3791/50062; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Rochford JJ, 2004, MOL CELL BIOL, V24, P9863, DOI 10.1128/MCB.24.22.9863-9872.2004; Savolainen SM, 2009, TOXICOL PATHOL, V37, P395, DOI 10.1177/0192623309335060; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Torry DS, 1997, AM J REPROD IMMUNOL, V37, P21; van de Locht LT, 1994, LEUKEMIA, V8; Wang HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098070; Wang HW, 2014, ARTERIOSCL THROM VAS, V34, P857, DOI 10.1161/ATVBAHA.113.303001; Wang HW, 2004, NAT GENET, V36, P687, DOI 10.1038/ng1384; Wang S, 2015, J NANOSCI NANOTECHNO, V15, P4239, DOI 10.1166/jnn.2015.9785; Wildonger J, 2005, DEV BIOL, V286, P507, DOI 10.1016/j.ydbio.2005.08.026; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Wolford JK, 1998, GENE, V212, P103, DOI 10.1016/S0378-1119(98)00141-3; Yeh JRJ, 2008, DEVELOPMENT, V135, P401, DOI 10.1242/dev.008904; Yoder MC, 2013, J MOL MED, V91, P285, DOI 10.1007/s00109-013-1002-8; Yu J, 2013, TOXICOL LETT, V218, P224, DOI 10.1016/j.toxlet.2013.01.028; Zhao TQ, 2010, MICROVASC RES, V80, P188, DOI 10.1016/j.mvr.2010.03.014	64	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179758	10.1371/journal.pone.0179758	http://dx.doi.org/10.1371/journal.pone.0179758			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640846	gold, Green Published, Green Submitted			2022-12-27	WOS:000404135800061
J	Himori, K; Tatebayashi, D; Kanzaki, K; Wada, M; Westerblad, H; Lanner, JT; Yamada, T				Himori, Koichi; Tatebayashi, Daisuke; Kanzaki, Keita; Wada, Masanobu; Westerblad, Hakan; Lanner, Johanna T.; Yamada, Takashi			Neuromuscular electrical stimulation prevents skeletal muscle dysfunction in adjuvant-induced arthritis rat	PLOS ONE			English	Article							DESMIN-RELATED CARDIOMYOPATHY; RHEUMATOID-ARTHRITIS; SOLEUS MUSCLE; FATIGUE; DISEASE; PEROXYNITRITE; IMPAIRMENT; PREVALENCE; MECHANISMS; EXPRESSION	Skeletal muscle weakness is a prominent feature in patients with rheumatoid arthritis (RA). In this study, we investigated whether neuromuscular electrical stimulation (NMES) training protects against skeletal muscle dysfunction in rats with adjuvant-induced arthritis (AIA). AIA was produced by intraarticular injection of complete Freund's adjuvant into the knees of Wistar rats. For NMES training, dorsiflexor muscles were stimulated via a surface electrode (0.5 ms pulse, 50 Hz, 2 s on/4 s off). NMES training was performed every other day for three weeks and consisted of three sets produced at three min intervals. In each set, the electrical current was set to achieve 60% of the initial maximum isometric torque and the current was progressively increased to maintain this torque; stimulation was stopped when the 60% torque could no longer be maintained. After the intervention period, extensor digitorum longus (EDL) muscles were excised and used for physiological and biochemical analyses. There was a reduction in specific force production (i.e. force per cross-sectional area) in AIA EDL muscles, which was accompanied by aggregation of the myofibrillar proteins actin and desmin. Moreover, the protein expressions of the pro-oxidative enzymes NADPH oxidase, neuronal nitric oxide synthase, p62, and the ratio of the autophagosome marker LC3bII/LC3bI were increased in AIA EDL muscles. NMES training prevented all these AIA-induced alterations. The present data suggest that NMES training prevents AIA-induced skeletal muscle weakness presumably by counteracting the formation of actin and desmin aggregates. Thus, NMES training can be an effective treatment for muscle dysfunction in patients with RA.	[Himori, Koichi; Tatebayashi, Daisuke; Yamada, Takashi] Sapporo Med Univ, Grad Sch Hlth Sci, Sapporo, Hokkaido, Japan; [Kanzaki, Keita] Okayama Prefectural Univ, Fac Hlth & Welf Sci, Soja, Okayama, Japan; [Wada, Masanobu] Hiroshima Univ, Grad Sch Integrated Arts & Sci, Higashihiroshima, Japan; [Westerblad, Hakan; Lanner, Johanna T.] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden	Sapporo Medical University; Okayama Prefectural University; Hiroshima University; Karolinska Institutet	Yamada, T (corresponding author), Sapporo Med Univ, Grad Sch Hlth Sci, Sapporo, Hokkaido, Japan.	takashi.yamada1976@sapmed.ac.jp	Yamada, Takashi/U-8443-2019; Yamada, Takashi/AAZ-6212-2021	Yamada, Takashi/0000-0003-1797-3880; Yamada, Takashi/0000-0003-1797-3880; Westerblad, Hakan/0000-0002-8180-3029	Japan Society for the Promotion of Science [26702021]; Ake Wiberg Foundation [M14-0210]; KI Rheumatology fund [2014reum42670]; Reumatikerforbundet [R-481591]; Swedish Research Council [521-2012-1645]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ake Wiberg Foundation; KI Rheumatology fund; Reumatikerforbundet; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by the Japan Society for the Promotion of Science: 26702021, https://www.isps.go.ip/english/; Ake Wiberg Foundation: M14-0210, http://akeddiberdse/; KI Rheumatology fund: 2014reum42670, http:// fonder.ki.se/; Reumatikerforbundet: R-481591, https://www.reumatikerforbundet.org/; and Swedish Research Council: 521-2012-1645, https://www.vr.se.	Adams GR, 2004, J APPL PHYSIOL, V96, P1613, DOI 10.1152/japplphysiol.01162.2003; ALLEN DG, 1995, EXP PHYSIOL, V80, P497, DOI 10.1113/expphysiol.1995.sp003864; Bhuiyan MS, 2013, J CLIN INVEST, V123, P5284, DOI 10.1172/JCI70877; Biol AJ, 2007, J NEUROPATH EXP NEUR, V66, P711, DOI 10.1097/nen.0b013e3181256b4c; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carnio S, 2014, CELL REP, V8, P1509, DOI 10.1016/j.celrep.2014.07.061; Pimenta AD, 2007, EUR J APPL PHYSIOL, V102, P119, DOI 10.1007/s00421-007-0542-4; Dalle-Donne I, 2001, FREE RADICAL BIO MED, V31, P1075, DOI 10.1016/S0891-5849(01)00690-6; Fedorova M, 2009, BBA-MOL BASIS DIS, V1792, P1185, DOI 10.1016/j.bbadis.2009.09.011; Gondin J, 2005, MED SCI SPORT EXER, V37, P1291, DOI 10.1249/01.mss.0000175090.49048.41; Gondin J, 2011, EUR J APPL PHYSIOL, V111, P2473, DOI 10.1007/s00421-011-2101-2; Gondin J, 2010, MUSCLE NERVE, V41, P667, DOI 10.1002/mus.21572; Gregory CM, 2005, PHYS THER, V85, P358, DOI 10.1093/ptj/85.4.358; Hakkinen A, 2001, ARTHRITIS RHEUM-US, V44, P515; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Maffiuletti NA, 2010, EUR J APPL PHYSIOL, V110, P223, DOI 10.1007/s00421-010-1502-y; Maloyan A, 2007, P NATL ACAD SCI USA, V104, P5995, DOI 10.1073/pnas.0609202104; McLendon PM, 2011, AM J PHYSIOL-HEART C, V301, pH1220, DOI 10.1152/ajpheart.00601.2011; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Munneke M, 2005, ARTHRIT RHEUM-ARTHR, V53, P410, DOI 10.1002/art.21165; Munro R, 1997, ANN RHEUM DIS, V56, P326, DOI 10.1136/ard.56.5.326; Ohishi S, 1997, CLIN EXP PHARMACOL P, V24, P326, DOI 10.1111/j.1440-1681.1997.tb01196.x; OLDHAM JA, 1989, J HAND SURG-BRIT EUR, V14B, P294, DOI 10.1016/0266-7681(89)90085-5; Panagopoulou P, 2008, J CELL BIOL, V181, P761, DOI 10.1083/jcb.200710049; Pigna E, 2016, SCI REP-UK, V6, DOI 10.1038/srep26991; Reid MB, 2011, J PHYSIOL-LONDON, V589, P2171, DOI 10.1113/jphysiol.2010.203356; Segard BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076361; Supinski G, 1999, J APPL PHYSIOL, V87, P776, DOI 10.1152/jappl.1999.87.2.776; Tiago T, 2006, BIOCHEM BIOPH RES CO, V342, P44, DOI 10.1016/j.bbrc.2006.01.112; Viner RI, 1996, FREE RADICAL RES, V24, P243, DOI 10.3109/10715769609088022; von Haehling S, 2014, J CACHEXIA SARCOPENI, V5, P261, DOI 10.1007/s13539-014-0164-8; Westerblad H, 2000, EUR J APPL PHYSIOL, V83, P166, DOI 10.1007/s004210000275; Yamada T, 2015, ANN RHEUM DIS, V74, P1907, DOI 10.1136/annrheumdis-2013-205007; Yamada T, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0045-7; Yamada T, 2009, ARTHRITIS RHEUM-US, V60, P3280, DOI 10.1002/art.24907	35	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179925	10.1371/journal.pone.0179925	http://dx.doi.org/10.1371/journal.pone.0179925			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636643	Green Submitted, Green Published, gold			2022-12-27	WOS:000404118300063
J	Sanderson, WC; Scherbov, S; Gerland, P				Sanderson, Warren C.; Scherbov, Sergei; Gerland, Patrick			Probabilistic population aging	PLOS ONE			English	Article							COUNTRIES; FORECASTS	We merge two methodologies, prospective measures of population aging and probabilistic population forecasts. We compare the speed of change and variability in forecasts of the old age dependency ratio and the prospective old age dependency ratio as well as the same comparison for the median age and the prospective median age. While conventional measures of population aging are computed on the basis of the number of years people have already lived, prospective measures are computed also taking account of the expected number of years they have left to live. Those remaining life expectancies change over time and differ from place to place. We compare the probabilistic distributions of the conventional and prospective measures using examples from China, Germany, Iran, and the United States. The changes over time and the variability of the prospective indicators are smaller than those that are observed in the conventional ones. A wide variety of new results emerge from the combination of methodologies. For example, for Germany, Iran, and the United States the likelihood that the prospective median age of the population in 2098 will be lower than it is today is close to 100 percent.	[Sanderson, Warren C.] SUNY Stony Brook, Dept Econ, Stony Brook, NY 11794 USA; [Sanderson, Warren C.; Scherbov, Sergei] WU, VID OAW, IIASA, World Populat Program,Wittgenstein Ctr Demog & Gl, Schlosspl 1, Laxenburg, Austria; [Scherbov, Sergei] Austrian Acad Sci, Vienna Inst Demog, Vienna, Austria; [Scherbov, Sergei] Russian Presidential Acad Natl Econ & Publ Adm RA, Moscow, Russia; [Gerland, Patrick] United Nations Org, DESA, Populat Div, Two UN Plaza,Room DC2-1934, New York, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; International Institute for Applied Systems Analysis (IIASA); Austrian Academy of Sciences; Russian Presidential Academy of National Economy & Public Administration	Sanderson, WC (corresponding author), SUNY Stony Brook, Dept Econ, Stony Brook, NY 11794 USA.; Sanderson, WC (corresponding author), WU, VID OAW, IIASA, World Populat Program,Wittgenstein Ctr Demog & Gl, Schlosspl 1, Laxenburg, Austria.	warren.sanderson@stonybrook.edu	Sanderson, Warren/R-3398-2019; Scherbov, Sergey/F-3158-2019; Gerland, Patrick/F-7390-2013	Scherbov, Sergey/0000-0001-5902-3790; Scherbov, Sergei/0000-0002-0881-1073; Gerland, Patrick/0000-0002-2082-3122; Sanderson, Warren/0000-0002-2205-948X	European Research Council under the European Union's Seventh Frame work Programme / ERC [ERC2012-AdG323947-Re-Ageing]	European Research Council under the European Union's Seventh Frame work Programme / ERC(European Research Council (ERC))	We thank the Population Division of the United Nations for providing access to asubset of trajectories of probabilistic population projections and associated abridged life tables based on the World Population Prospects: The 2015 Revision. There search leading to these results has received funding from the European Research Council under the European Union's Seventh Frame work Programme (FP7/2007-2013) / ERC grant agreement no ERC2012-AdG323947-Re-Ageing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views and opinions expressed in this paper are those of the authors and do not necessarily represent those of the United Nations.	AbbasiShavazi MJ, 2009, FERTILITY TRANSITION IN IRAN: REVOLUTION AND REPRODUCTION, P1; Bordone V, 2015, INTELLIGENCE, V52, P90, DOI 10.1016/j.intell.2015.07.005; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; He W, 2016, P95161; International Labour Organization (ILO), 2011, EC ACT POP EST PROJ; Keilman N, 2004, INT STAT REV, V72, P5; Keilman N., 2002, DEMOGR RES, V6, P409, DOI [10.4054/DemRes.2002.6.15, DOI 10.4054/DEMRES.2002.6.15]; Keilman N, 2008, POPUL DEV REV, V34, P137, DOI 10.1111/j.1728-4457.2008.00209.x; KEYFITZ N, 1981, POPUL DEV REV, V7, P579, DOI 10.2307/1972799; LEE RD, 1992, J AM STAT ASSOC, V87, P659, DOI 10.2307/2290201; Lee RD, 2014, POP AG GEN EC GLOB P; Lee RD., 1999, FRONTIERS POPULATI S, V24, P156; Lutz W, 2001, NATURE, V412, P543, DOI 10.1038/35087589; Lutz W, 2004, INT STAT REV, V72, P1, DOI 10.1111/j.1751-5823.2004.tb00219.x; Lutz W, 1997, NATURE, V387, P803, DOI 10.1038/42935; Lutz W, 1999, FRONTIERS POPULATION, V24, P139; OECD, 2014, OECD PENS OUTL 2014; OECD, 2013, PENS GLANC 2013 RET; Raftery AE, 2012, P NATL ACAD SCI USA, V109, P13915, DOI 10.1073/pnas.1211452109; RYDER NB, 1975, POPUL INDEX, V41, P3, DOI 10.2307/2734140; Sanderson WC, 2013, POPUL DEV REV, V39, P673, DOI 10.1111/j.1728-4457.2013.00633.x; Sanderson WC, 2010, SCIENCE, V329, P1287, DOI 10.1126/science.1193647; Sanderson WC, 2005, NATURE, V435, P811, DOI 10.1038/nature03593; Sanderson WC, 2004, POPUL ENVIRON, V26, P173, DOI 10.1007/s11111-004-0839-8; Scherbov S., 2014, WORLD POPULATION HUM, P563; Sevcikova H, 2015, ARXIV150305215; United Nations, 2015, ESAPWP241 UN; United Nations, 2015, STESASERA390; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; WHO US National Institute of Aging, 2011, US NATL I AG GLOB HL	30	19	19	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179171	10.1371/journal.pone.0179171	http://dx.doi.org/10.1371/journal.pone.0179171			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY6UH	28636675	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000404118300028
J	Dossou-Yovo, ER; Baggie, I; Djagba, JF; Zwart, SJ				Dossou-Yovo, Elliott Ronald; Baggie, Idriss; Djagba, Justin Fagnombo; Zwart, Sander Jaap			Diversity of inland valleys and opportunities for agricultural development in Sierra Leone	PLOS ONE			English	Article							SUSTAINABLE DEVELOPMENT; SOIL; SCHISTOSOMIASIS; AFRICA; WETLANDS	Inland valleys are becoming increasingly important agricultural production areas for rural households in sub-Saharan Africa due to their relative high and secure water availability and soil fertility. In addition, inland valleys are important as water buffer and biodiversity hot spots and they provide local communities with forest, forage, and fishing resources. As different inland-valley ecosystem functions may conflict with agricultural objectives, indiscriminate development should be avoided. This study aims to analyze the diversity of inland valleys in Sierra Leone and to develop guidelines for more precise interventions. Land use, biophysical and socio-economic data were analyzed on 257 inland valleys using spatial and multivariate techniques. Five cluster groups of inland valleys were identified: (i) semi -permanently flooded with high soil organic carbon (4.2%) and moderate available phosphorus (10.2 ppm), mostly under natural vegetation; (ii) semi -permanently flooded with low soil organic carbon (1.5%) and very low available phosphorus (3.1 ppm), abandoned by farmers; (iii) seasonally flooded with moderate soil organic carbon (3.1%) and low available phosphorus (8.3 ppm), used for rainfed rice and off-season vegetables produced without fertilizer application for household consumption and market; (iv) well drained with moderate soil organic carbon (3.8%) and moderate available phosphorus (10.0 ppm), used for rainfed rice and off-season vegetables produced with fertilizer application for household consumption and market; and (v) well drained with moderate soil organic carbon (3.6%) and moderate available phosphorus (11 ppm), used for household consumption without fertilizer application. Soil organic carbon, available phosphorus, hydrological regime, physical accessibility and market opportunity were the major factors affecting agricultural intensification of inland valleys. Opening up the areas in which inland valleys occur through improved roads and markets, and better water control through drainage infrastructures along with an integrated nutrient management would promote the sustainable agricultural use of inland valleys.	[Dossou-Yovo, Elliott Ronald; Djagba, Justin Fagnombo; Zwart, Sander Jaap] Africa Rice Ctr AfricaRice, Geog Informat Syst & Remote Sensing Unit, Cotonou, Benin; [Baggie, Idriss] SLARI, RARC, Rokupr, Sierra Leone	CGIAR; Africa Rice Center	Dossou-Yovo, ER (corresponding author), Africa Rice Ctr AfricaRice, Geog Informat Syst & Remote Sensing Unit, Cotonou, Benin.	e.dossou-yovo@cgiar.org	Zwart, Sander J/D-8366-2011; Zwart, Sander/GQA-3460-2022	Zwart, Sander J/0000-0002-5091-1801; Dossou-Yovo, Elliott/0000-0002-3565-8879	European Union [C-ECG-65-WARDA]	European Union(European Commission)	This research was conducted in the framework of the project "Realizing the agricultural potential of the inland valley lowlands in sub-Saharan Africa while maintaining their environmental services" (RAP-IV), funded by the European Union (C-ECG-65-WARDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS WM, 1993, GEOGR J, V159, P209, DOI 10.2307/3451412; ANDRIESSE W, 1994, NETH J AGR SCI, V42, P159; Andriesse W., 1986, P INT WETL UT RIC PR, P15; Balasubramanian V, 2007, ADV AGRON, V94, P55, DOI 10.1016/S0065-2113(06)94002-4; Becker L, 1992, CHARACTERISATION CLA; Bontemps D, 2013, ELECTRON J STAT, V7, P2344, DOI 10.1214/13-EJS844; Conteh A. M. H., 2012, Agricultural Sciences, V3, P462, DOI 10.4236/as.2012.34054; Crowley EL, 2000, HUM ECOL, V28, P383, DOI 10.1023/A:1007005514841; Diagne A, 2013, REALIZING AFRICA'S RICE PROMISE, P35, DOI 10.1079/9781845938123.0035; Dixon AB, 2003, NAT RESOUR FORUM, V27, P117, DOI 10.1111/1477-8947.00047; DOXSEYWHITFIELD E, 2015, PAP APPL GEOGR, V0001; Drechsel P, 2001, ECOL ECON, V38, P251, DOI 10.1016/S0921-8009(01)00167-7; Dugan PJ., 1990, WETLAND CONSERVATION; Erenstein O, 2006, AGR ECOSYST ENVIRON, V117, P205, DOI 10.1016/j.agee.2006.03.033; Frausin V, 2014, HUM ECOL, P1; GBAKIMA AA, 1994, PUBLIC HEALTH, V108, P149, DOI 10.1016/S0033-3506(05)80020-4; Giller KE, 2006, AGR SYST, V88, P8, DOI 10.1016/j.agsy.2005.06.016; Hodges MH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001694; Issaka RN, 1997, GEODERMA, V75, P99, DOI 10.1016/S0016-7061(96)00083-3; Issaka RN, 1996, SOIL SCI PLANT NUTR, V42, P71, DOI 10.1080/00380768.1996.10414690; Kamara AR, 2010, IRRIGATION W AFRICA, P287; Kassam A, 2011, PADDY WATER ENVIRON, V9, P163, DOI 10.1007/s10333-011-0259-1; Kiepe P., 2006, Integrated irrigation and aquaculture in West Africa: concepts, practices and potential, P1; Koroma JB, 2011, OPHTHAL EPIDEMIOL, V18, P150, DOI 10.3109/09286586.2011.594204; Lynch K, 1999, GEOFORUM, V30, P171, DOI 10.1016/S0016-7185(99)00014-7; Lynch K, 2013, APPL GEOGR, V36, P31, DOI 10.1016/j.apgeog.2012.06.007; Masiyandima M, 2003, WETLANDS BASED LIVEL; McCartney M. P., 2004, SUSTAINABLE DEV MANA; McCartney MP, 2009, NAT RESOUR FORUM, V33, P99, DOI 10.1111/j.1477-8947.2009.01214.x; Narteh L.T., 2007, GHANA J AGR SCI, V40, P141; Novella NS, 2013, J APPL METEOROL CLIM, V52, P588, DOI 10.1175/JAMC-D-11-0238.1; Olindo P., 1992, P KWWGS SEM WETL KEN, P173; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rebelo LM, 2010, WETL ECOL MANAG, V18, P557, DOI 10.1007/s11273-009-9142-x; Reeuwijk L., 1986, 9 INT SOIL REF INF C; Rodenburg J, 2014, AGR SYST, V123, P1, DOI 10.1016/j.agsy.2013.09.004; Rodenburg J, 2013, REALIZING AFRICA'S RICE PROMISE, P276, DOI 10.1079/9781845938123.0276; Saito K, 2013, REALIZING AFRICA'S RICE PROMISE, P188, DOI 10.1079/9781845938123.0188; Sakane N, 2011, WETLANDS, V31, P1103, DOI 10.1007/s13157-011-0221-4; Sys C, 1993, LAND EVALUATION AGR, V7, P67; Verhoeven JTA, 2010, ANN BOT-LONDON, V105, P155, DOI 10.1093/aob/mcp172; Windmeijer P, 1993, INT I LAND RECLAMATI; Wood A, 2008, 33 FOOD AGR ORG UN R; Yapi YG, 2005, ACTA TROP, V93, P201, DOI 10.1016/j.actatropica.2004.11.005	45	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180059	10.1371/journal.pone.0180059	http://dx.doi.org/10.1371/journal.pone.0180059			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JX	28662093	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300095
J	Bocalini, DS; Bergamin, M; Evangelista, AL; Rica, RL; Pontes, FL; Figueira, A; Serra, AJ; Rossi, EM; Tucci, PJF; dos Santos, L				Bocalini, Danilo Sales; Bergamin, Marco; Evangelista, Alexandre Lopes; Rica, Roberta Luksevicius; Pontes Junior, Francisco Luciano; Figueira Junior, Aylton; Serra, Andrey Jorge; Rossi, Emilly Martinelli; Ferreira Tucci, Paulo Jose; dos Santos, Leonardo			Post-exercise hypotension and heart rate variability response after water- and landergometry exercise in hypertensive patients	PLOS ONE			English	Article							AMBULATORY BLOOD-PRESSURE; PHYSICAL-EXERCISE; IMMERSION; REDUCTION; FITNESS; HUMANS	Background systemic arterial hypertension is the most prevalent cardiovascular disease; physical activity for hypertensive patients is related to several beneficial cardiovascular adaptations. This paper evaluated the effect of water- and land-ergometry exercise sessions on post-exercise hypotension (PEH) of healthy normotensive subjects versus treated or untreated hypertensive patients. Methods Forty-five older women composed three experimental groups: normotensive (N, n = 10), treated hypertensive (TH, n = 15) and untreated hypertensive (UH, n = 20). The physical exercise acute session protocol was performed at 75% of maximum oxygen consumption (VO2max) for 45 minutes; systolic (SBP), diastolic (DBP) and mean (MBP) blood pressure were evaluated at rest, peak and at 15, 30, 45, 60, 75 and 90 minutes after exercise cessation. Additionally, the heart rate variability (HRV) was analyzed by R-R intervals in the frequency domain for the assessment of cardiac autonomic function. Results In both exercise modalities, equivalent increases in SBP were observed from rest to peak exercise for all groups, and during recovery, significant PEH was noted. At 90 minutes after the exercise session, the prevalence of hypotension was significantly higher in water-than in the land-based protocol. Moreover, more pronounced reductions in SBP and DBP were observed in the UH patients compared to TH and N subjects. Finally, exercise in the water was more effective in restoring HRV during recovery, with greater effects in the untreated hypertensive group. Conclusion Our data demonstrated that water-ergometry exercise was able to induce expressive PEH and improve cardiac autonomic modulation in older normotensive, hypertensive treated or hypertensive untreated subjects when compared to conventional land-ergometry.	[Bocalini, Danilo Sales; Rica, Roberta Luksevicius; Figueira Junior, Aylton] Univ Sao Judas Tadeu, Postgrad Program Phys Educ, Translat Physiol Lab, Sao Paulo, Brazil; [Bocalini, Danilo Sales] Univ Sao Judas Tadeu, Postgrad Program Aging, Sao Paulo, Brazil; [Bergamin, Marco] Univ Padua, Dept Med, Sport & Exercise Med Div, Padua, Italy; [Evangelista, Alexandre Lopes] Univ Sao Paulo, Dept Phys Educ, Sao Paulo, Brazil; [Pontes Junior, Francisco Luciano] Univ Sao Paulo, Sch Arts Sci & Humanities, Sao Paulo, Brazil; [Serra, Andrey Jorge] Nove de Julho Univ, Postgrad Biophoton Appl Hlth Sci, Sao Paulo, Brazil; [Rossi, Emilly Martinelli; dos Santos, Leonardo] Univ Fed Espirito Santo, Dept Physiol Sci, Espirito Santo, Brazil; [Ferreira Tucci, Paulo Jose] Univ Fed Sao Paulo, Sao Paulo Med Sch, Div Cardiol, Dept Med, Sao Paulo, Brazil	Universidade Sao Judas Tadeu; Universidade Sao Judas Tadeu; University of Padua; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Nove de Julho; Universidade Federal do Espirito Santo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	dos Santos, L (corresponding author), Univ Fed Espirito Santo, Dept Physiol Sci, Espirito Santo, Brazil.	leodossantos@hotmail.com	Serra, Andrey Jorge/E-7460-2015; dos Santos, Leonardo/B-6509-2013; Júnior, Francisco Luciano Pontes/ABG-1497-2020; Figueira, Aylton Jose/AAO-2458-2021; Evangelista, Alexandre L/S-2409-2016	Serra, Andrey Jorge/0000-0002-5407-8183; dos Santos, Leonardo/0000-0002-4340-6364; Júnior, Francisco Luciano Pontes/0000-0002-8358-0260; Figueira Junior, Aylton/0000-0002-6635-8019				[Anonymous], 2010, IND RISK PROT FACT; Anunciacao PG, 2011, ARQ BRAS CARDIOL, V96, pE100, DOI 10.1590/S0066-782X2011005000025; Aquatic Exercise Association, 2006, AQ FITN MAN; Bartels EM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005523.pub2; Bocalini DS, 2008, GERIATR GERONTOL INT, V8, P265, DOI 10.1111/j.1447-0594.2008.00485.x; Bocalini DS, 2010, CLINICS, V65, P1305, DOI 10.1590/S1807-59322010001200013; Jardim PCBV, 2016, ARQ BRAS CARDIOL, V107, P93, DOI 10.5935/abc.20160120; Casonatto J, 2009, REV BRAS MED ESPORTE, V15, P151, DOI 10.1590/S1517-86922009000200014; Cozza IC, 2012, HYPERTENS RES, V35, P82, DOI 10.1038/hr.2011.162; Elvan-Taspinar A, 2006, AM J OBSTET GYNECOL, V195, P1590, DOI 10.1016/j.ajog.2006.05.007; EPSTEIN M, 1992, PHYSIOL REV, V72, P563, DOI 10.1152/physrev.1992.72.3.563; FERNHALL B, 1992, MED SCI SPORT EXER, V24, P139; Fitz-Simon Nicola, 2005, Ther Clin Risk Manag, V1, P93, DOI 10.2147/tcrm.1.2.93.62915; Forjaz CLM, 2004, J SPORT MED PHYS FIT, V44, P54; Gabrielsen A, 1996, J Gravit Physiol, V3, P22; Gabrielsen A, 2000, AM J PHYSIOL-REG I, V278, pR1583, DOI 10.1152/ajpregu.2000.278.6.R1583; Goto C, 2003, CIRCULATION, V108, P530, DOI 10.1161/01.CIR.0000080893.55729.28; Graef Fabiane Inês, 2006, Rev Bras Med Esporte, V12, P221, DOI 10.1590/S1517-86922006000400011; Guimaraes GV, 2013, BLOOD PRESS MONIT, V18, P342, DOI 10.1097/MBP.0000000000000000; Halliwill J R, 2001, Exerc Sport Sci Rev, V29, P65, DOI 10.1097/00003677-200104000-00005; Kanavos P, 2007, HIGH BLOOD PRESSURE; Kulics JM, 1999, AM J PHYSIOL-HEART C, V276, pH27, DOI 10.1152/ajpheart.1999.276.1.H27; LIN YC, 1984, UNDERSEA BIOMED RES, V11, P123; Lovato NS, 2012, REV BRAS MED ESPORTE, V18, P22, DOI 10.1590/S1517-86922012000100004; MacDonald JR, 2000, J HUM HYPERTENS, V14, P125, DOI 10.1038/sj.jhh.1000953; Malliani Alberto, 2005, Eur J Intern Med, V16, P12, DOI 10.1016/j.ejim.2004.06.016; Manikonda JP, 2008, J HUM HYPERTENS, V22, P138, DOI 10.1038/sj.jhh.1002275; Meyer K, 2004, MED SCI SPORT EXER, V36, P2017, DOI 10.1249/01.MSS.0000147591.19416.39; Park Kwon Sik, 1999, Applied Human Science, V18, P233; Perkins SE, 2016, J SCI MED SPORT, V16, P30152; PESCATELLO LS, 1991, CIRCULATION, V83, P1557, DOI 10.1161/01.CIR.83.5.1557; Pescatello LS, 2004, MED SCI SPORT EXER, V36, P533, DOI 10.1249/01.MSS.0000115224.88514.3A; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Pontes FL, 2008, INT IMMUNOPHARMACOL, V8, P261, DOI 10.1016/j.intimp.2007.09.001; Pontes Júnior Francisco Luciano, 2010, Rev. Bras. Ciênc. Esporte, V32, P229; Quinn TJ, 2000, J HUM HYPERTENS, V14, P547, DOI 10.1038/sj.jhh.1001106; Reilly T, 2003, J SPORT SCI, V21, P959, DOI 10.1080/02640410310001641368; Rodriguez D, 2011, INT J GEN MED, V4, P549, DOI 10.2147/IJGM.S23094; Rondon MUP, 2002, J AM COLL CARDIOL, V39, P676, DOI 10.1016/S0735-1097(01)01789-2; Routledge FS, 2010, CAN J CARDIOL, V26, P303, DOI 10.1016/S0828-282X(10)70395-0; Serra AJ, 2009, CONSCIENTIAE SAUDE, V8, P19, DOI [10.1364/OE.22.031568, DOI 10.1364/OE.22.031568]; [Anonymous], 2010, Arq. Bras. Cardiol., V95, pI, DOI 10.1590/S0066-782X2010001700001; Takeshima N, 2002, MED SCI SPORT EXER, V34, P544, DOI 10.1097/00005768-200203000-00024; Tuomainen P, 2005, LIFE SCI, V77, P2723, DOI 10.1016/j.lfs.2005.05.023; Wallace JP, 1999, J HUM HYPERTENS, V13, P361, DOI 10.1038/sj.jhh.1000797; Watenpaugh DE, 2000, J APPL PHYSIOL, V89, P621, DOI 10.1152/jappl.2000.89.2.621; WHO, 2002, RED RISKS PROM HLTH	47	25	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180216	10.1371/journal.pone.0180216	http://dx.doi.org/10.1371/journal.pone.0180216			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658266	Green Submitted, Green Published, gold			2022-12-27	WOS:000404607900066
J	Junot, S; Keroak, S; Del Castillo, JRE; Ayoub, JY; Paquet, C; Bonnet-Garin, JM; Troncy, E				Junot, Stephane; Keroak, Stephanie; Del Castillo, Jerome R. E.; Ayoub, Jean-Yves; Paquet, Christian; Bonnet-Garin, Jeanne-Marie; Troncy, Eric			Inhaled nitric oxide prevents NSAID-induced renal impairment in pseudo-normovolaemic piglets	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; BLOOD-FLOW; MECHANISMS; RISK; NO; CYCLOOXYGENASE-2; METAANALYSIS; ANESTHETICS; THERAPY	Objective Inhaled nitric oxide (iNO) is commonly used as a treatment of pulmonary hypertension. Its action is purported to be specific to the lung, but extrapulmonary effects have been reported. The objective of this study was to evaluate if iNO could compensate the renal impairment induced by ketoprofen, a conventional non-steroidal anti-inflammatory drug (NSAID), during general anaesthesia. Methods Under pseudo-normovolaemic condition, thirty piglets were randomly assigned into 5 equal groups and equipped for renal and systemic parameters measurements. A first experiment was carried out to validate methods and reproduce the renal effects of iNO (40 ppm) in comparison with a placebo (100% oxygen). In a second experiment, iNO was inhaled for 120 minutes right after NSAID treatment (ketoprofen 2 mgxkg(-1) IV, and 40 ppm iNO; group KiNO) and its effects were compared to ketoprofen alone (2 mgxkg(-1) IV; group K) and placebo (saline; group C). Results In this model, iNO increased significantly renal blood flow measured by ultrasonic (RBFUL: +53.2 +/- 17.2%; p = 0.008) and by PAH clearance (RBFPAH: +78.6 +/- 37.6%; p = 0.004) methods, glomerular filtration rate (GFR: +72.6 +/- 32.5%; p = 0.006) and urinary output (UO: +47.4 +/- 24.2%; p = 0.01). In the second experiment, no significant temporal variation was noted for renal parameters in groups KiNO and C, whereas a significant and constant decrease was observed in the group K for RBFUL (max - 19.0 +/- 7.1%), GFR (max -26.6 +/- 10.4%) and UO (max -30.3 +/- 10.5%). Clinical significance Our experiments show that iNO, released from its transport forms after its inhalation, can improve renal safety of NSAIDs. This result is promising regarding the use of NSAIDs in critical conditions, but needs to receive clinical confirmation.	[Junot, Stephane; Ayoub, Jean-Yves; Paquet, Christian; Bonnet-Garin, Jeanne-Marie] Univ Lyon, VetAgro Sup, APCSE unit, Vet Campus Lyon, Marcy Letoile, France; [Keroak, Stephanie; Del Castillo, Jerome R. E.; Troncy, Eric] Univ Montreal, Fac Vet Med, Dept Vet Biomed, GREPAQ Res Grp Anim Pharmacol Quebec, St Hyacinthe, PQ, Canada	VetAgro Sup; Universite de Montreal	Junot, S (corresponding author), Univ Lyon, VetAgro Sup, APCSE unit, Vet Campus Lyon, Marcy Letoile, France.	stephane.junot@vetagro-sup.fr	del Castillo, Jérôme RE/J-6976-2013; Troncy, Eric/J-6650-2013; del Castillo, Jerome/AAM-9409-2020	del Castillo, Jérôme RE/0000-0001-5046-7926; Troncy, Eric/0000-0003-0209-5261; del Castillo, Jerome/0000-0001-5046-7926; Bonnet Garin, Jeanne-Marie/0000-0001-5350-338X	Scientific Council of Ecole Nationale Veterinaire de Lyon; Canadian Institutes of Health Research Strategic and Training Initiative in Health Research; Gasotransmitter REsearch And Training (GREAT) Program; Canada Foundation for Innovation [9483]; French Agriculture Ministry [EA4173]	Scientific Council of Ecole Nationale Veterinaire de Lyon; Canadian Institutes of Health Research Strategic and Training Initiative in Health Research(Canadian Institutes of Health Research (CIHR)); Gasotransmitter REsearch And Training (GREAT) Program; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); French Agriculture Ministry	This study has been supported by an unrestricted operating grant (Troncy) from the Scientific Council of Ecole Nationale Veterinaire de Lyon, a Canadian Institutes of Health Research Strategic and Training Initiative in Health Research: Gasotransmitter REsearch And Training (GREAT) Program grant, a Canada Foundation for Innovation (#9483,Troncy) supporting materials, and internal grant from French Agriculture Ministry (EA4173). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DSC, 2009, CLIN DRUG INVEST, V29, p703 ; BATTILANA C, 1991, AM J PHYSIOL, V261, pF726, DOI 10.1152/ajprenal.1991.261.4.F726; Beierwaltes WH, 2002, AM J PHYSIOL-RENAL, V283, pF68, DOI 10.1152/ajprenal.00364.2001; Bennett WM, 1996, AM J KIDNEY DIS, V28, pS56, DOI 10.1016/S0272-6386(96)90570-3; Brater DC, 1999, AM J MED, V107, P65, DOI [10.1016/s0002-9343(99)00369-1, DOI 10.1016/S0002-9343(99)00369-1]; Calvert S, 2012, PERIOPER MED-LONDON, V1, DOI 10.1186/2047-0525-1-6; Cannon RO, 2001, J CLIN INVEST, V108, P279, DOI 10.1172/JCI12761; Crawford JH, 2015, FUTUR SCI OA, V1, DOI 10.4155/FSO.15.34; Cuzzocrea S, 2007, KIDNEY INT, V71, P290, DOI 10.1038/sj.ki.5002058; Decosterd LA, 1997, J CHROMATOGR B, V703, P25, DOI 10.1016/S0378-4347(97)00396-4; Finlay S, 2013, CLIN MED, V13, P233, DOI 10.7861/clinmedicine.13-3-233; Fox-Robichaud A, 1998, J CLIN INVEST, V101, P2497, DOI 10.1172/JCI2736; FROSTELL C, 1991, CIRCULATION, V83, P2038, DOI 10.1161/01.CIR.83.6.2038; Fukazawa K, 2014, J AM SOC NEPHROL, V25, P884, DOI 10.1681/ASN.2013111215; Gameiro J, 2016, CLIN KIDNEY J, V9, P192, DOI 10.1093/ckj/sfv144; Gianetti J, 2004, J THORAC CARDIOV SUR, V127, P44, DOI 10.1016/j.jtcvs.2002.08.001; Goranson SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096594; Goren O, 2015, BRIT J ANAESTH, V115, P3, DOI 10.1093/bja/aev380; Horl WH, 2010, PHARMACEUTICALS, V3, P2291, DOI 10.3390/ph3072291; Junot S, 2008, CAN J PHYSIOL PHARM, V86, P55, DOI [10.1139/Y07-123, 10.1139/y07-123]; Kam PCA, 2001, ANAESTHESIA, V56, P494, DOI 10.1046/j.1365-2044.2001.02047-18.x; KING AJ, 1991, J AM SOC NEPHROL, V1, P1271; KUEHNLE HF, 1992, NEPHRON, V62, P104, DOI 10.1159/000187006; Lang JD, 2007, J CLIN INVEST, V117, P2583, DOI 10.1172/JCI31892; Lewington AJP, 2013, KIDNEY INT, V84, P457, DOI 10.1038/ki.2013.153; LINK L, 1985, PFLUG ARCH EUR J PHY, V405, P66, DOI 10.1007/BF00591099; Littell RC, 2000, STAT MED, V19, P1793, DOI 10.1002/1097-0258(20000715)19:13<1793::AID-SIM482>3.3.CO;2-H; Mathru M, 2007, ANESTHESIOLOGY, V106, P275, DOI 10.1097/00000542-200702000-00015; McMahon Timothy J, 2006, Proc Am Thorac Soc, V3, P153, DOI 10.1513/pats.200507-066BG; Mockel M, 2001, KIDNEY INT, V59, P1439, DOI 10.1046/j.1523-1755.2001.0590041439.x; Mount PF, 2006, ACTA PHYSIOL, V187, P433, DOI 10.1111/j.1748-1716.2006.01582.x; Norregaard R, 2015, KIDNEY RES CLIN PRAC, V34, P194, DOI 10.1016/j.krcp.2015.10.004; Onuigbo MAC, 2015, J RENAL INJ PREV, V4, P61, DOI 10.12861/jrip.2015.13; Ruan SY, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0880-2; SMITH HW, 1945, J CLIN INVEST, V24, P388, DOI 10.1172/JCI101618; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Swindle MM, 2012, VET PATHOL, V49, P344, DOI 10.1177/0300985811402846; Toto R D, 1995, Curr Opin Nephrol Hypertens, V4, P505, DOI 10.1097/00041552-199511000-00009; Troncy E, 1997, BRIT J ANAESTH, V79, P631, DOI 10.1093/bja/79.5.631; Troncy E, 2006, NITRIC OXIDE-BIOL CH, V14, P261, DOI 10.1016/j.niox.2006.01.004; Ungprasert P, 2015, EUR J INTERN MED, V26, P285, DOI 10.1016/j.ejim.2015.03.008; Vane JR, 1998, INFLAMM RES, V47, pS78; Wang TL, 2003, CAN J ANAESTH, V50, P839, DOI 10.1007/BF03019384; Whelton A., 1999, AM J MED, V106, p13S, DOI [10.1016/s0002-9343(99)00113-8, DOI 10.1016/S0002-9343(99)00113-8]; Wraight WM, 2001, BRIT J ANAESTH, V86, P267, DOI 10.1093/bja/86.2.267; Yoo YC, 2014, KIDNEY INT, V86, P414, DOI 10.1038/ki.2013.532; Ziyyat A, 1996, BRIT J PHARMACOL, V119, P388, DOI 10.1111/j.1476-5381.1996.tb15998.x	47	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179475	10.1371/journal.pone.0179475	http://dx.doi.org/10.1371/journal.pone.0179475			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658254	Green Published, gold, Green Submitted			2022-12-27	WOS:000404607900025
J	Abriouel, H; Montoro, BP; Munoz, MDC; Knapp, CW; Galvez, A; Benomar, N				Abriouel, Hikmate; Perez Montoro, Beatriz; Casado Munoz, Maria del Carmen; Knapp, Charles W.; Galvez, Antonio; Benomar, Nabil			In silico genomic insights into aspects of food safety and defense mechanisms of a potentially probiotic Lactobacillus pentosus MP-10 isolated from brines of naturally fermented Alorena green table olives	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; ANTIBIOTIC-RESISTANCE; ANTIVIRAL DEFENSE; IDENTIFICATION; SEQUENCE; GENES; PROKARYOTES; ANNOTATION; DIVERSITY; EMPHASIS	Lactobacillus pentosus MP-10, isolated from brines of naturally fermented Alorena green table olives, exhibited high probiotic potential. The genome sequence of L. pentosus MP10 is currently considered the largest genome among lactobacilli, highlighting the microorganism's ecological flexibility and adaptability. Here, we analyzed the complete genome sequence for the presence of acquired antibiotic resistance and virulence determinants to understand their defense mechanisms and explore its putative safety in food. The annotated genome sequence revealed evidence of diverse mobile genetic elements, such as prophages, transposases and transposons involved in their adaptation to brine-associated niches. In-silico analysis of L. pentosus MP-10 genome sequence identified a CRISPR (clustered regularly interspaced short palindromic repeats)/cas (CRISPR-associated protein genes) as an immune system against foreign genetic elements, which consisted of six arrays (4-12 repeats) and eleven predicted cas genes [CRISPR1 and CRISPR2 consisted of 3 (Type II-C) and 8 (Type I) genes] with high similarity to L. pentosus KCA1. Bioinformatic analyses revealed L. pentosus MP-10 to be absent of acquired antibiotic resistance genes, and most resistance genes were related to efflux mechanisms; no virulence determinants were found in the genome. This suggests that L. pentosus MP-10 could be considered safe and with high-adaptation potential, which could facilitate its application as a starter culture and probiotic in food preparations.	[Abriouel, Hikmate; Perez Montoro, Beatriz; Casado Munoz, Maria del Carmen; Galvez, Antonio; Benomar, Nabil] Univ Jaen, Area Microbiol, Dept Ciencias Salud, Fac Ciencias Expt, Jaen, Spain; [Knapp, Charles W.] Univ Strathclyde, Dept Civil & Environm Engn, Glasgow, Lanark, Scotland	Universidad de Jaen; University of Strathclyde	Abriouel, H (corresponding author), Univ Jaen, Area Microbiol, Dept Ciencias Salud, Fac Ciencias Expt, Jaen, Spain.	hikmate@ujaen.es	Galvez, Antonio/M-2359-2014; Abriouel, Hikmate/K-9769-2017; Knapp, Charles W/D-3373-2009	Galvez, Antonio/0000-0002-5894-5029; Knapp, Charles W/0000-0001-7997-8543; Abriouel, Hikmate/0000-0002-0666-3978; CASADO MUNOZ, MARIA DEL CARMEN/0000-0002-1526-424X	Ministerio de Economia y Competitividad, MINECO, FEDER [AGL2013-43571-P]; Plan Propio UJA [UJA2014/07/02];  [EI_BI01_2017]	Ministerio de Economia y Competitividad, MINECO, FEDER; Plan Propio UJA; 	Research grant AGL2013-43571-P (Ministerio de Economia y Competitividad, MINECO, FEDER), HA. Research grant UJA2014/07/02 (Plan Propio UJA), HA. Research Team EI_BI01_2017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge research grants AGL2013-43571-P (Ministerio de Economia y Competitividad, MINECO, FEDER), UJA2014/07/02 (Plan Propio UJA) and Research Team EI_BIO01_2017.	Abriouel H, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00854-16; Abriouel H, 2011, J BACTERIOL, V193, P4559, DOI 10.1128/JB.05171-11; Al-Attar S, 2011, BIOL CHEM, V392, P277, DOI 10.1515/BC.2011.042; Altermann E, 2005, P NATL ACAD SCI USA, V102, P3906, DOI 10.1073/pnas.0409188102; Andreoletti O, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.923; Anukam KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059239; Bartkiene E, 2013, FOOD TECHNOL BIOTECH, V51, P471; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cammarota M, 2009, INT J FOOD MICROBIOL, V135, P90, DOI 10.1016/j.ijfoodmicro.2009.08.022; Munoz MDC, 2016, INT J FOOD MICROBIOL, V222, P8, DOI 10.1016/j.ijfoodmicro.2016.01.012; Chang JH, 2010, J APPL MICROBIOL, V109, P220, DOI 10.1111/j.1365-2672.2009.04648.x; Di Cagno R, 2010, FOOD MICROBIOL, V27, P381, DOI 10.1016/j.fm.2009.11.012; Dorscht J, 2009, J BACTERIOL, V191, P7206, DOI 10.1128/JB.01041-09; Florez AB, 2006, FEMS MICROBIOL LETT, V263, P21, DOI 10.1111/j.1574-6968.2006.00371.x; Food and Agriculture Organization of the United Nations World Health Organization, 2002, REP JOINT FAO WHO WO; Fournier B, 2000, J BACTERIOL, V182, P664, DOI 10.1128/JB.182.3.664-671.2000; Granato D, 2010, COMPR REV FOOD SCI F, V9, P292, DOI 10.1111/j.1541-4337.2010.00110.x; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jaomanjaka F, 2013, INT J FOOD MICROBIOL, V166, P331, DOI 10.1016/j.ijfoodmicro.2013.06.032; Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lang AS, 2012, NAT REV MICROBIOL, V10, P472, DOI 10.1038/nrmicro2802; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Maldonado-Barragan A, 2011, J BACTERIOL, V193, P5605, DOI 10.1128/JB.05736-11; Mercanti DJ, 2016, APPL ENVIRON MICROB, V82, P95, DOI 10.1128/AEM.02723-15; O'Sullivan O, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-50; Peres CM, 2012, TRENDS FOOD SCI TECH, V26, P31, DOI 10.1016/j.tifs.2012.01.006; Ranadheera RDCS, 2010, FOOD RES INT, V43, P1, DOI 10.1016/j.foodres.2009.09.009; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Shanahan F, 2012, GASTROENTEROL CLIN N, V41, P869, DOI 10.1016/j.gtc.2012.08.006; Siezen RJ, 2012, J BACTERIOL, V194, P195, DOI 10.1128/JB.06275-11; Spurr Harvey W. Jr., 1994, P11; Swain MR, 2012, BIOTECHNOL RES INT, V2014; van Hemert S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-293; Venema K, 2015, PROBIOTICS AND PREBIOTICS: CURRENT RESEARCH AND FUTURE TRENDS, P29; Ventura M, 2009, NAT REV MICROBIOL, V7, P61, DOI 10.1038/nrmicro2047; Wacher C., 2010, FERMENTED FOODS BEVE, P149, DOI DOI 10.1201/EBK1420094954-C5; Wei YZ, 2015, GENE DEV, V29, P356, DOI 10.1101/gad.257550.114; Yoon BH, 2011, ARCH VIROL, V156, P1681, DOI 10.1007/s00705-011-1048-2; Yoshida K, 2004, J BACTERIOL, V186, P5640, DOI 10.1128/JB.186.17.5640-5648.2004; Young JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038077; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhang WY, 2010, INT J DAIRY TECHNOL, V63, P413, DOI 10.1111/j.1471-0307.2010.00576.x; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	47	10	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0176801	10.1371/journal.pone.0176801	http://dx.doi.org/10.1371/journal.pone.0176801			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651019	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000404537300044
J	Chen, YY; Ho, SY; Lee, PC; Wu, CK; Gau, SSF				Chen, Ying-Yeh; Ho, Suk-Yin; Lee, Pei-Chen; Wu, Chia-Kai; Gau, Susan Shur-Fen			Parent-child discrepancies in the report of adolescent emotional and behavioral problems in Taiwan	PLOS ONE			English	Article							PSYCHOPATHOLOGY RATING-SCALES; CROSS-INFORMANT CORRELATIONS; PSYCHIATRIC-DISORDERS; INTERRATER AGREEMENT; STRUCTURED INTERVIEW; SYMPTOMS; DEPRESSION; SOCIETIES; TEACHERS; MOTHERS	The majority of studies on parent-child discrepancies in the assessment of adolescent emotional and behavioral problems have been conducted in Western countries. It is believed that parent-adolescent agreement would be higher in societies with a strong culture of familism. We examined whether parent-adolescent discrepancies in the rating of adolescent emotional and behavioral problems are related to parental and family factors in Taiwan. Participants included 1,421 child-parent pairs of 7th-grade students from 12 middle schools in Northern Taiwan and their parents. We calculated Pearson's correlation coefficients to assess the relationship between parental (Child Behavior Checklist, CBCL) and adolescent (Youth Self Report, YSR) report of emotional/behavioral problem syndromes. Regression models were used to assess parent-adolescent differences in relation to parental psychopathology and family factors. We found that parent-adolescent agreement was moderate (r = 0.37). Adolescents reported higher symptom scores than their parents (Mean Total Problem Score: CBCL: 20.79, YSR: 33.14). Parental psychopathology was related to higher parental ratings and better informant agreement. Parents with higher socioeconomic status (SES) tended to report lower scores for adolescent problem syndromes, resulting in higher levels of disagreement. Greater maternal care was related to higher parent-adolescent agreement. Based on our study findings, we conclude that familism values do not seem to improve parent-child agreement in the assessment of adolescent problem syndromes. The finding that higher SES was related to increased discrepancies speaks to the need to explore the culture-specific mechanisms giving rise to informant discrepancies.	[Chen, Ying-Yeh] Taipei City Hosp, Taipei City Psychiat Ctr, Taipei, Taiwan; [Chen, Ying-Yeh] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Chen, Ying-Yeh] Natl Yang Ming Univ, Dept Publ Hlth, Taipei, Taiwan; [Ho, Suk-Yin] Taipei City Hosp, Child Dev Assessment & Intervent Ctr, Taipei, Taiwan; [Lee, Pei-Chen; Wu, Chia-Kai] Natl Taipei Univ Nursing & Hlth Sci, Taipei, Taiwan; [Gau, Susan Shur-Fen] Natl Taiwan Univ Hosp & Coll Med, Dept Psychiat, Taipei, Taiwan; [Gau, Susan Shur-Fen] Natl Taiwan Univ, Grad Inst Brain & Mind Sci, Coll Med, Taipei, Taiwan; [Gau, Susan Shur-Fen] Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Sch Occupat Therapy, Dept Psychol, Taipei, Taiwan	Taipei City Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital; National Taipei University of Nursing & Health Science (NTUNHS); National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Gau, SSF (corresponding author), Natl Taiwan Univ Hosp & Coll Med, Dept Psychiat, Taipei, Taiwan.; Gau, SSF (corresponding author), Natl Taiwan Univ, Grad Inst Brain & Mind Sci, Coll Med, Taipei, Taiwan.; Gau, SSF (corresponding author), Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Sch Occupat Therapy, Dept Psychol, Taipei, Taiwan.	gaushufe@ntu.edu.tw	Chen, Ying-Yeh/AAY-1478-2021; Gau, Susan Shur-Fen/P-4726-2017	Gau, Susan Shur-Fen/0000-0002-2718-8221; , Pei-Chen/0000-0001-7813-0823; Chen, Ying-Yeh/0000-0001-5543-5704	National Taiwan University Hospital, Taiwan [NTUH-91-N005]; National Science Council, Taiwan [NSC91-2314-B002-223]; Ministry of Science and Technology [MOST 105-2314-B-532-004 MY3]; Department of Health, Taipei City Government [10501-62-062]	National Taiwan University Hospital, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Department of Health, Taipei City Government	SSG was supported by National Taiwan University Hospital, Taiwan (NTUH-91-N005) and National Science Council, Taiwan (NSC91-2314-B002-223). Y -Y.C. was supported by the Ministry of Science and Technology (Grant number: MOST 105-2314-B-532-004 MY3) and the Department of Health, Taipei City Government (Grant number: 10501-62-062).	Achenbach TM, 2006, CURR DIR PSYCHOL SCI, V15, P94, DOI 10.1111/j.0963-7214.2006.00414.x; Achenbach TM, 2011, J CLIN CHILD ADOLESC, V40, P80, DOI 10.1080/15374416.2011.533416; ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; ANGOLD A, 1987, J CHILD PSYCHOL PSYC, V28, P901, DOI 10.1111/j.1469-7610.1987.tb00678.x; [Anonymous], 1991, MANUAL CHILD BEHAV C; BIDAUTRUSSELL M, 1995, J ABNORM CHILD PSYCH, V23, P641, DOI 10.1007/BF01447667; BRESLAU N, 1988, PSYCHIAT RES, V24, P345, DOI 10.1016/0165-1781(88)90115-1; Chao R., 2002, HDB PARENTING, P59, DOI DOI 10.4324/9781410612168; CHAO RK, 1995, ETHOS, V23, P328, DOI 10.1525/eth.1995.23.3.02a00030; Chen YY, 2013, INT J EPIDEMIOL, V42, P1381, DOI 10.1093/ije/dyt129; CHENG TA, 1986, PSYCHOL MED, V16, P415, DOI 10.1017/S0033291700009247; CONRAD M, 1989, J CONSULT CLIN PSYCH, V57, P663, DOI 10.1037/0022-006X.57.5.663; COSTELLO EJ, 1985, J AM ACAD CHILD PSY, V24, P771, DOI 10.1016/S0002-7138(10)60122-7; De Los Reyes A, 2005, PSYCHOL BULL, V131, P483, DOI 10.1037/0033-2909.131.4.483; De Los Reyes A., 2011, J CLIN CHILD ADOLESC, V40, P1, DOI DOI 10.1080/15374416.2011.533405; De Los Reyes A, 2015, PSYCHOL BULL, V141, P858, DOI 10.1037/a0038498; De Los Reyes A, 2013, DEV PSYCHOPATHOL, V25, P669, DOI 10.1017/S0954579413000096; De Los Reyes Andres, 2006, J Child Fam Stud, V15, P643; EDELBROCK C, 1986, J CHILD PSYCHOL PSYC, V27, P181, DOI 10.1111/j.1469-7610.1986.tb02329.x; Ederer E.M., 2004, PSYCHOL TEST ASSESS, V46, P123; Gau SSF, 2006, J CHILD ADOL PSYCHOP, V16, P286, DOI 10.1089/cap.2006.16.286; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Grills AE, 2002, CLIN CHILD FAM PSYCH, V5, P57, DOI 10.1023/A:1014573708569; Hawley KM, 2003, J CONSULT CLIN PSYCH, V71, P62, DOI 10.1037/0022-006X.71.1.62; Huang Huei-Lin, 1994, Kaohsiung Journal of Medical Sciences, V10, P157; JENSEN PS, 1988, J AM ACAD CHILD PSY, V27, P442, DOI 10.1097/00004583-198807000-00012; JENSEN PS, 1988, J AM ACAD CHILD PSY, V27, P451, DOI 10.1097/00004583-198807000-00013; Kawabata Y, 2012, J ABNORM CHILD PSYCH, V40, P177, DOI 10.1007/s10802-011-9556-9; KAZDIN AE, 1983, J ABNORM CHILD PSYCH, V11, P167, DOI 10.1007/BF00912083; KOLKO DJ, 1993, J CHILD PSYCHOL PSYC, V34, P991, DOI 10.1111/j.1469-7610.1993.tb01103.x; PHARES V, 1994, J ABNORM CHILD PSYCH, V22, P721, DOI 10.1007/BF02171998; Renk K, 2005, J CLIN PSYCHOL, V61, P235, DOI 10.1002/jclp.20018; Rescorla LA, 2017, J CLIN CHILD ADOLESC, V46, P74, DOI 10.1080/15374416.2016.1266642; Rescorla LA, 2014, J CLIN CHILD ADOLESC, V43, P627, DOI 10.1080/15374416.2014.900719; Rescorla LA, 2013, J CLIN CHILD ADOLESC, V42, P262, DOI 10.1080/15374416.2012.717870; Salbach-Andrae H, 2009, EUR CHILD ADOLES PSY, V18, P136, DOI 10.1007/s00787-008-0710-z; Salbach-Andrae H, 2009, EUR PSYCHIAT, V24, P345, DOI 10.1016/j.eurpsy.2008.07.008; Schwartz SJ, 2007, J SOC PSYCHOL, V147, P101, DOI 10.3200/SOCP.147.2.101-118; Shang CY, 2006, J SLEEP RES, V15, P63, DOI 10.1111/j.1365-2869.2006.00492.x; SILVERMAN WK, 1992, J AM ACAD CHILD PSY, V31, P117, DOI 10.1097/00004583-199201000-00018; THURBER S, 1993, J GENET PSYCHOL, V154, P25, DOI 10.1080/00221325.1993.9914718; Treutler CM, 2003, J ABNORM CHILD PSYCH, V31, P13, DOI 10.1023/A:1021765114434; Tsai FJ, 2013, J FORMOS MED ASSOC, V112, P396, DOI 10.1016/j.jfma.2011.08.022; Tseng WL, 2013, J CHILD PSYCHOL PSYC, V54, P996, DOI 10.1111/jcpp.12072; Tzeng WC, 2004, QUAL HEALTH RES, V14, P345, DOI 10.1177/1049732303262057; Van Roy B, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-56; Wang JN, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-114; WEISSMAN MM, 1987, ARCH GEN PSYCHIAT, V44, P747; Wong Y., 2007, SELF CONSCIOUS EMOTI, P209; Yang HJ, 2000, J AM ACAD CHILD PSY, V39, P232, DOI 10.1097/00004583-200002000-00024; Yang HJ, 2001, J AM ACAD CHILD PSY, V40, P1045, DOI 10.1097/00004583-200109000-00013	51	22	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0178863	10.1371/journal.pone.0178863	http://dx.doi.org/10.1371/journal.pone.0178863			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY7CO	28644832	Green Published, Green Submitted, gold			2022-12-27	WOS:000404145100009
J	Takai, Y; Tanito, M; Omura, T; Kawasaki, R; Kawasaki, Y; Ohira, A				Takai, Yasuyuki; Tanito, Masaki; Omura, Tetsuro; Kawasaki, Ryo; Kawasaki, Yumiko; Ohira, Akihiro			Comparisons of retinal vessel diameter and glaucomatous parameters between both eyes of subjects with clinically unilateral pseudoexfoliation syndrome	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; OPTICAL COHERENCE TOMOGRAPHY; BLUE-MOUNTAINS-EYE; FIBER LAYER THICKNESS; LOXL1 GENE VARIANTS; EXFOLIATION SYNDROME; BLOOD-FLOW; JAPANESE PATIENTS; PERIPAPILLARY RETINA; VEIN OCCLUSION	Purpose Pseudoexfoliation syndrome (PEX), the most common identifiable cause of open-angle glaucoma, might affect the retinal hemodynamics. To test this, we compared retinal vessel diameter and glaucoma-related parameters between eyes with pseudoexfoliation material (PE+) and fellow unaffected (PE-) eyes of patients with clinically unilateral PEX. Methods The medical records of 30 consecutive Japanese subjects were reviewed retrospectively. The retinal vessel diameters were measured and expressed as the central retinal arteriolar equivalent (CRAE) and central retinal venular equivalent (CRVE) using standardized software. During the chart review, we recorded glaucoma-related parameters including intraocular pressure (IOP), visual field mean deviation (MD) value, planimetrically measured vertical cup-to-disc (C/D) ratio, circumpapillary retinal nerve fiber layer thickness (cpRNFLT) and macular inner retinal thickness (mIRT) measured by spectral-domain optical coherence tomography, anterior chamber flare (ACF), corneal endothelial cell density (CECD), and number of antiglaucoma medications. Results Compared with PE- eyes, the CRAE, CRVE, MD, cpRNFLT and mIRT, and CECD were significantly lower in PE+ eyes; the IOP, vertical C/D ratio, number of antiglaucoma medications, and ACF were significantly higher in PE+ eyes (P<0.0001 for all comparisons). The CRAE, cpRNFLT, and MD were correlated positively with each other (rho=0.456-0.499, P<0.0001-0.0002) and negatively with the IOP (rho = -0.562- -0.432, P<0.0001-0.0006). The vertical C/D ratio was correlated positively with the IOP (rho=0.483, P<0.0001) and negatively with the CRAE, cpRNFLT, and MD (rho = -0.745- -0.479, P<0.0001-0.0001). Conclusions Deposition of PE can cause retinal vessel narrowing in arterioles and venules. The roles and mechanisms of retinal vessel narrowing in glaucoma pathogenesis need clarification.	[Takai, Yasuyuki; Tanito, Masaki; Omura, Tetsuro; Ohira, Akihiro] Shimane Univ, Fac Med, Dept Ophthalmol, Izumo, Shimane, Japan; [Tanito, Masaki] Matsue Red Cross Hosp, Div Ophthalmol, Matsue, Shimane, Japan; [Kawasaki, Ryo; Kawasaki, Yumiko] Yamagata Univ, Grad Sch Med Sci, Dept Publ Hlth, Yamagata, Japan	Shimane University; Yamagata University	Takai, Y (corresponding author), Shimane Univ, Fac Med, Dept Ophthalmol, Izumo, Shimane, Japan.	takai611@med.shimane-u.ac.jp	Kawasaki, Ryo/B-7266-2009; Kawasaki, Ryo/H-9716-2019	Kawasaki, Ryo/0000-0002-7492-6303; TAKAI, YASUYUKI/0000-0003-3881-3624				Amerasinghe N, 2008, INVEST OPHTH VIS SCI, V49, P5397, DOI 10.1167/iovs.08-2142; Arnarsson A, 2007, ACTA OPHTHALMOL SCAN, V85, P822, DOI 10.1111/j.1600-0420.2007.01051.x; Arnarsson A, 2013, ACTA OPHTHALMOL, V91, P157, DOI 10.1111/j.1755-3768.2011.02334.x; Chang M, 2011, AM J OPHTHALMOL, V151, P100, DOI 10.1016/j.ajo.2010.07.025; Dayanir Volkan, 2009, International Ophthalmology, V29, P27, DOI 10.1007/s10792-008-9193-7; Evans DW, 1999, J GLAUCOMA, V8, P12; Georgopoulos GT, 2002, ACTA OPHTHALMOL SCAN, V80, P54, DOI 10.1034/j.1600-0420.2002.800111.x; Hara K, 2011, MOL VIS, V17, P3309; Harju M, 2008, CLIN EXP OPHTHALMOL, V36, P738, DOI 10.1111/j.1442-9071.2008.01884.x; Hollo G, 1998, J GLAUCOMA, V7, P105; Hubbard LD, 2011, ARCH OPHTHALMOL-CHIC, V129, P718, DOI 10.1001/archophthalmol.2011.136; JONAS JB, 1989, INVEST OPHTH VIS SCI, V30, P1599; Kawasaki R, 2013, OPHTHALMOLOGY, V120, P84, DOI 10.1016/j.ophtha.2012.07.007; Knudtson MD, 2003, CURR EYE RES, V27, P143, DOI 10.1076/ceyr.27.3.143.16049; Kothy P, 2001, Acta Physiol Hung, V88, P281, DOI 10.1556/APhysiol.88.2001.3-4.10; KUCHLE M, 1995, OPHTHALMIC RES, V27, P136; Leung H, 2003, CLIN EXP OPHTHALMOL, V31, P326, DOI 10.1046/j.1442-9071.2003.00661.x; Liew G, 2008, ARCH OPHTHALMOL-CHIC, V126, P1404, DOI 10.1001/archopht.126.10.1404; LITTMANN H, 1982, KLIN MONATSBL AUGENH, V180, P286, DOI 10.1055/s-2008-1055068; Mitchell P, 1996, OPHTHALMOLOGY, V103, P1661, DOI 10.1016/S0161-6420(96)30449-1; Mitchell P, 2005, OPHTHALMOLOGY, V112, P245, DOI 10.1016/j.ophtha.2004.08.015; Morooka S, 2012, INVEST OPHTH VIS SCI, V53, P4805, DOI 10.1167/iovs.12-9870; Naumann GOH, 2000, OPHTHALMOLOGY, V107, P1111, DOI 10.1016/S0161-6420(00)00087-7; Ocakoglu O, 2004, ACTA OPHTHALMOL SCAN, V82, P49, DOI 10.1046/j.1600-0420.2003.00196.x; Omura T, 2014, ACTA OPHTHALMOL, V92, pE412, DOI 10.1111/aos.12348; Ozmen MC, 2015, INT J OPHTHALMOL-CHI, V8, P332, DOI 10.3980/j.issn.2222-3959.2015.02.21; Papastathopoulos KI, 1999, BRIT J OPHTHALMOL, V83, P285, DOI 10.1136/bjo.83.3.285; Parodi MB, 2008, EYE, V22, P49, DOI 10.1038/sj.eye.6702602; Puska P, 2000, GRAEF ARCH CLIN EXP, V238, P659, DOI 10.1007/s004170000159; PUSKA P, 1994, ACTA OPHTHALMOL, V72, P290; REPO LP, 1993, OPHTHALMOLOGY, V100, P352; Saatci Osman A., 1999, International Ophthalmology, V23, P75, DOI 10.1023/A:1026557029227; Schlotzer-Schrehardt U, 2008, AM J PATHOL, V173, P1724, DOI 10.2353/ajpath.2008.080535; SCHLOTZERSCHREHARDT U, 1995, INVEST OPHTH VIS SCI, V36, P1750; SCHLOTZERSCHREHARDT U, 1991, ARCH OPHTHALMOL-CHIC, V109, P565, DOI 10.1001/archopht.1991.01080040133044; SHIMIZU T, 1985, Nippon Ganka Gakkai Zasshi, V89, P562; Tanito M, 2015, ACTA OPHTHALMOL, V93, pe214, DOI 10.1111/aos.12534; Tanito M, 2014, JPN J OPHTHALMOL, V58, P56, DOI 10.1007/s10384-013-0280-6; Tanito M, 2008, MOL VIS, V14, P1898; Thorleifsson G, 2007, SCIENCE, V317, P1397, DOI 10.1126/science.1146554; VANNAS S, 1960, Br J Ophthalmol, V44, P583, DOI 10.1136/bjo.44.10.583; Visontai Z, 2006, BRIT J OPHTHALMOL, V90, P563, DOI 10.1136/bjo.2005.087908; Wang LL, 1999, OPHTHALMOLOGICA, V213, P387, DOI 10.1159/000027460; Wang SA, 2007, CLIN EXP OPHTHALMOL, V35, P800, DOI 10.1111/j.1442-9071.2007.01627.x; Yuksel N, 2007, OPHTHALMOLOGICA, V221, P299, DOI 10.1159/000104759; Zheng XD, 2011, INVEST OPHTH VIS SCI, V52, P5679, DOI 10.1167/iovs.11-7274	46	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179663	10.1371/journal.pone.0179663	http://dx.doi.org/10.1371/journal.pone.0179663			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644852	Green Published, gold			2022-12-27	WOS:000404145100030
J	Vojtechova, Z; Zavadil, J; Klozar, J; Grega, M; Tachezy, R				Vojtechova, Zuzana; Zavadil, Jiri; Klozar, Jan; Grega, Marek; Tachezy, Ruth			Comparison of the miRNA expression profiles in fresh frozen and formalin-fixed paraffin-embedded tonsillar tumors	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; MICRORNA EXPRESSION; HUMAN-PAPILLOMAVIRUS; DOWN-REGULATION; HEPATOBLASTOMA PATIENTS; MESENCHYMAL TRANSITION; CERVICAL-CANCER; PROGNOSTIC ROLE; HUMAN TISSUE; PROLIFERATION	MicroRNAs are considered as promising prognostic and diagnostic biomarkers of human cancer since their profiles differ between tumor types. Most of the tumor profiling studies were performed on rarely available fresh frozen (FF) samples. Alternatively, archived formalin-fixed paraffin-embedded (FFPE) tissue samples are also well applicable to larger-scale retrospective miRNA profiling studies. The aim of this study was to perform systematic comparison of the miRNA expression profiles between FF and macrodissected FFPE tonsillar tumors using the TaqMan Low Density Array system, with the data processed by different software programs and two types of normalization methods. We observed a marked correlation between the miRNA expression profiles of paired FF and FFPE samples; however, only 27-38% of the differentially deregulated miRNAs overlapped between the two source systems. The comparison of the results with regard to the distinct modes of data normalization revealed an overlap in 58-67% of differentially expressed miRNAs, with no influence of the choice of software platform. Our study highlights the fact that for an accurate comparison of the miRNA expression profiles from published studies, it is important to use the same type of clinical material and to test and select the best-performing normalization method for data analysis.	[Vojtechova, Zuzana; Tachezy, Ruth] Charles Univ Prague, Dept Genet & Microbiol, Fac Sci, Prague, Czech Republic; [Vojtechova, Zuzana; Tachezy, Ruth] Inst Hematol & Blood Transfus, Dept Immunol, Prague, Czech Republic; [Zavadil, Jiri] Int Agcy Res Canc, Mol Mech & Biomarkers Grp, Lyon, France; [Klozar, Jan] Charles Univ Prague, Motol Univ Hosp, Fac Med 1, Dept Otorhinolaryngol & Head & Neck Surg, Prague, Czech Republic; [Grega, Marek] Charles Univ Prague, Fac Med 2, Dept Pathol & Mol Med, Prague, Czech Republic	Charles University Prague; Institute of Hematology Prague; World Health Organization; International Agency for Research on Cancer (IARC); Charles University Prague; Motol University Hospital; Charles University Prague	Tachezy, R (corresponding author), Charles Univ Prague, Dept Genet & Microbiol, Fac Sci, Prague, Czech Republic.; Tachezy, R (corresponding author), Inst Hematol & Blood Transfus, Dept Immunol, Prague, Czech Republic.	ruth.tachezy@natur.cuni.cz	Zavadil, Jiri/ABG-1780-2020; Vojtěchová, Zuzana/S-5757-2017; Tachezy, Ruth/H-3785-2017	Zavadil, Jiri/0000-0003-0640-5562; Vojtěchová, Zuzana/0000-0002-7524-008X; Tachezy, Ruth/0000-0001-7689-9727	Ministry of Education, Youth and Sports of CR [LQ1604]; BIOCEV [CZ.1.05/1.1.00/02.0109]	Ministry of Education, Youth and Sports of CR(Ministry of Education, Youth & Sports - Czech Republic); BIOCEV	The paper was supported by the Ministry of Education, Youth and Sports of CR (http://www. msmt.cz/) within the National Sustainability Program II (project BIOCEV-FAR) LQ1604 and by the project "BIOCEV" (CZ.1.05/1.1.00/02.0109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Blanka Langova and Stephanie Villar for technical assistance. Thanks are also due to the Institute of Pathological Physiology, 1st Faculty of Medicine, Charles University, Prague, for the opportunity to use their equipment for TLDA card analysis and to the Genetics Services Platform of the International Agency for Research on Cancer for help with additional TLDA card processing. The paper was supported by grant by the Ministry of Education, Youth and Sports of CR within the National Sustainability Program II (Project BIOCEV-FAR) LQ1604 and by the project "BIOCEV" (CZ.1.05/1.1.00/02.0109).	Al-Khalaf HH, 2014, J BIOL CHEM, V289, P31433, DOI 10.1074/jbc.M114.593004; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bufalino A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136599; Chatterjee A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10438; Chen YX, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-88; Das AV, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0247-4; de Biase D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035596; Doleshal M, 2008, J MOL DIAGN, V10, P203, DOI 10.2353/jmoldx.2008.070153; Ganci F, 2014, LUNG CANCER, V85, P197, DOI 10.1016/j.lungcan.2014.04.008; Gao G, 2013, CANCER-AM CANCER SOC, V119, P72, DOI 10.1002/cncr.27696; Gao YP, 2016, CELL PHYSIOL BIOCHEM, V38, P427, DOI 10.1159/000438641; Gee HE, 2010, CANCER-AM CANCER SOC, V116, P2148, DOI 10.1002/cncr.25009; Glud M, 2009, J INVEST DERMATOL, V129, P1219, DOI 10.1038/jid.2008.347; Goswami RS, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-47; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; He SQ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/751672; Hoefig KP, 2008, ANTICANCER RES, V28, P119; Hou YY, 2016, ONCOL LETT, V11, P4013, DOI 10.3892/ol.2016.4491; Hui ABY, 2013, CLIN CANCER RES, V19, P2154, DOI 10.1158/1078-0432.CCR-12-3572; Hui ABY, 2009, LAB INVEST, V89, P597, DOI 10.1038/labinvest.2009.12; Jay C, 2007, DNA CELL BIOL, V26, P293, DOI 10.1089/dna.2006.0554; Jia LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108435; Jung M, 2010, CLIN CHEM, V56, P998, DOI 10.1373/clinchem.2009.141580; Kinoshita T, 2013, BRIT J CANCER, V109, P2636, DOI 10.1038/bjc.2013.607; Ko YH, 2014, PATHOL INT, V64, P499, DOI 10.1111/pin.12201; Kong XM, 2015, INT J CLIN EXP PATHO, V8, P12845; Kumar B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037601; Leichter AL, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0099-9; Leite KRM, 2011, UROL ONCOL-SEMIN ORI, V29, P533, DOI 10.1016/j.urolonc.2009.05.008; Lerner C, 2016, J CANCER RES CLIN, V142, P757, DOI 10.1007/s00432-015-2087-y; Li HY, 2015, MED SCI MONITOR, V21, P3929, DOI 10.12659/MSM.895407; Li JH, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-36; Liu WJ, 2014, ONCOTARGET, V5, P11620, DOI 10.18632/oncotarget.2599; Lu YY, 2014, 2014 TENTH INTERNATIONAL CONFERENCE ON INTELLIGENT INFORMATION HIDING AND MULTIMEDIA SIGNAL PROCESSING (IIH-MSP 2014), P1, DOI 10.1109/IIH-MSP.2014.8; Lu ZM, 2014, ONCOTARGETS THER, V7, P525, DOI 10.2147/OTT.S59871; Mao YJ, 2016, J INT MED RES, V44, P231, DOI 10.1177/0300060515576556; Meng W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064393; Miller DL, 2015, AM J PATHOL, V185, P679, DOI 10.1016/j.ajpath.2014.11.018; Mortarino M, 2010, LEUKEMIA RES, V34, P1070, DOI 10.1016/j.leukres.2009.10.023; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Osawa S, 2011, ONCOL LETT, V2, P613, DOI 10.3892/ol.2011.313; Park JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057900; Qin Q, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-50; Romero-Cordoba S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031904; Salem O, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2869-x; Sasahira T, 2012, BRIT J CANCER, V107, P700, DOI 10.1038/bjc.2012.330; Schober A, 2014, NAT MED, V20, P368, DOI 10.1038/nm.3487; Siow MY, 2014, ORAL DIS, V20, P345, DOI 10.1111/odi.12118; Sun SS, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0487-x; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Venkatesh T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054643; Vojtechova Z, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2430-y; Vojtechova Z, 2016, INT J CANCER, V138, P386, DOI 10.1002/ijc.29712; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang LN, 2015, GENE, V572, P252, DOI 10.1016/j.gene.2015.07.017; Wang RJ, 2015, CANCER LETT, V356, P568, DOI 10.1016/j.canlet.2014.10.003; Wang XH, 2014, P NATL ACAD SCI USA, V111, P4262, DOI 10.1073/pnas.1401430111; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Yamamoto N, 2013, INT J ONCOL, V43, P1855, DOI 10.3892/ijo.2013.2145; Zeng F, 2016, BIOMED PHARMACOTHER, V79, P294, DOI 10.1016/j.biopha.2016.02.033; Zhang KC, 2015, INT J CLIN EXP MED, V8, P1931; Zhang X, 2008, J MOL DIAGN, V10, P513, DOI 10.2353/jmoldx.2008.080077; Zhang Y., 2016, J AM HEART ASS, V5; Zhu JW, 2015, INT J MOL MED, V36, P1377, DOI 10.3892/ijmm.2015.2352; Zhu L, 2012, MED ONCOL, V29, P1037, DOI 10.1007/s12032-011-9975-z; Zou MX, 2014, INT J CLIN EXP PATHO, V7, P4877	66	9	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179645	10.1371/journal.pone.0179645	http://dx.doi.org/10.1371/journal.pone.0179645			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644855	Green Published, gold, Green Submitted			2022-12-27	WOS:000404145100027
J	Davoine, C; Abreu, IN; Khajeh, K; Blomberg, J; Kidd, BN; Kazan, K; Schenk, PM; Gerber, L; Nilsson, O; Moritz, T; Bjorklund, S				Davoine, Celine; Abreu, Ilka N.; Khajeh, Khalil; Blomberg, Jeanette; Kidd, Brendan N.; Kazan, Kemal; Schenk, Peer M.; Gerber, Lorenz; Nilsson, Ove; Moritz, Thomas; Bjorklund, Stefan			Functional metabolomics as a tool to analyze Mediator function and structure in plants	PLOS ONE			English	Article							RNA-POLYMERASE-II; GLUCOSINOLATE-DERIVED ISOTHIOCYANATES; ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTORS; SALICYLIC-ACID; SUBUNIT MED25; COMPLEX; DEFENSE; RESISTANCE; JASMONATE	Mediator is a multiprotein transcriptional co-regulator complex composed of four modules; Head, Middle, Tail, and Kinase. It conveys signals from promoter-bound transcriptional regulators to RNA polymerase II and thus plays an essential role in eukaryotic gene regulation. We describe subunit localization and activities of Mediator in Arabidopsis through metabolome and transcriptome analyses from a set of Mediator mutants. Functional metabolomic analysis based on the metabolite profiles of Mediator mutants using multivariate statistical analysis and heat-map visualization shows that different subunit mutants display distinct metabolite profiles, which cluster according to the reported localization of the corresponding subunits in yeast. Based on these results, we suggest localization of previously unassigned plant Mediator subunits to specific modules. We also describe novel roles for individual subunits in development, and demonstrate changes in gene expression patterns and specific metabolite levels in med18 and med25, which can explain their phenotypes. We find that med18 displays levels of phytoalexins normally found in wild type plants only after exposure to pathogens. Our results indicate that different Mediator subunits are involved in specific signaling pathways that control developmental processes and tolerance to pathogen infections.	[Davoine, Celine; Khajeh, Khalil; Blomberg, Jeanette; Bjorklund, Stefan] Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden; [Abreu, Ilka N.; Gerber, Lorenz; Nilsson, Ove; Moritz, Thomas] Swedish Univ Agr Sci, Umea Plant Sci Ctr, Dept Forest Genet & Plant Physiol, Umea, Sweden; [Kidd, Brendan N.; Schenk, Peer M.] Univ Queensland, Plant Microbe Interact Lab, Sch Agr & Food Sci, St Lucia, Qld, Australia; [Kidd, Brendan N.; Kazan, Kemal] CSIRO Agr & Food, Queensland Biosci Precinct, 306 Carmody Rd, St Lucia, Qld, Australia; [Kazan, Kemal] Univ Queensland, QAAFI, St Lucia, Qld, Australia; [Kidd, Brendan N.] CSIRO Agr & Food, Ctr Environm & Life Sci, Floreat, WA, Australia	Umea University; Swedish University of Agricultural Sciences; Umea University; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Bjorklund, S (corresponding author), Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden.	stefan.bjorklund@umu.se	Kidd, Brendan N/D-9801-2017; Kazan, Kemal/B-8032-2008; Schenk, Peer/B-7879-2016; Kidd, Brendan/J-9672-2014	Kazan, Kemal/0000-0002-5169-8934; Schenk, Peer/0000-0003-4878-3799; Abreu, Ilka N/0000-0003-4728-0161; Kidd, Brendan/0000-0003-1770-1404; Moritz, Thomas/0000-0002-4258-3190	Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning; Swedish Cancer Society [15 0537]; Swedish Research Council; Swedish Governmental Agency for Innovation Systems; Knut and Alice Wallenberg Foundation; Kempe Foundation; Australian Research Council [DP110104354]	Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning(Swedish Research Council Formas); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Governmental Agency for Innovation Systems(Vinnova); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Kempe Foundation; Australian Research Council(Australian Research Council)	This work was supported by grants from the Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning (www.formas.se) to TM; the Swedish Cancer Society (www.cancerfonden.se Grant no. 15 0537) to SB; the Swedish Research Council (www.vr.se) to SB and ON; the Swedish Governmental Agency for Innovation Systems (www.vinnova.se/en) to SB and ON; the Knut and Alice Wallenberg Foundation (www.wallenberg.com/kaw) to SB and TM, the Kempe Foundation (www.kempe.com) to SB, TM, and the Australian Research Council (http://www.arc.gov.au, Grant no. DP110104354) to PMS, BK and KK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu IN, 2011, J CHEM ECOL, V37, P857, DOI 10.1007/s10886-011-9991-7; An CF, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23182; Andersson MX, 2006, J BIOL CHEM, V281, P31528, DOI 10.1074/jbc.M604820200; Backstrom S, 2007, MOL CELL, V26, P717, DOI 10.1016/j.molcel.2007.05.007; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Blomberg J, 2012, NUCLEIC ACIDS RES, V40, P5938, DOI 10.1093/nar/gks265; Bottcher C, 2007, PLANTA, V226, P629, DOI 10.1007/s00425-007-0511-5; Bonawitz ND, 2012, J BIOL CHEM, V287, P5434, DOI 10.1074/jbc.M111.312298; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Bylesjo M, 2007, PLANT J, V52, P1181, DOI 10.1111/j.1365-313X.2007.03293.x; Caillaud MC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001732; Cerdan PD, 2003, NATURE, V423, P881, DOI 10.1038/nature01636; Cevik V, 2012, PLANT PHYSIOL, V160, P541, DOI 10.1104/pp.112.202697; Chen R, 2012, PLANT CELL, V24, P2898, DOI 10.1105/tpc.112.098277; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Dombrecht B, 2007, PLANT CELL, V19, P2225, DOI 10.1105/tpc.106.048017; Dotson MR, 2000, P NATL ACAD SCI USA, V97, P14307, DOI 10.1073/pnas.260489497; Edgar CI, 2006, AUSTRALAS PLANT PATH, V35, P581, DOI 10.1071/AP06060; Elfving N, 2011, P NATL ACAD SCI USA, V108, P8245, DOI 10.1073/pnas.1002981108; Elmlund H, 2006, P NATL ACAD SCI USA, V103, P15788, DOI 10.1073/pnas.0607483103; Fallath T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176022; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; Glawischnig E, 2007, PHYTOCHEMISTRY, V68, P401, DOI 10.1016/j.phytochem.2006.12.005; Gobel C, 2009, PHYTOCHEMISTRY, V70, P1485, DOI 10.1016/j.phytochem.2009.07.040; Gullberg J, 2004, ANAL BIOCHEM, V331, P283, DOI 10.1016/j.ab.2004.04.037; Iven T, 2012, MOL PLANT, V5, P1389, DOI 10.1093/mp/sss044; Kidd BN, 2009, PLANT CELL, V21, P2237, DOI 10.1105/tpc.109.066910; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Kim YJ, 2011, EMBO J, V30, P814, DOI 10.1038/emboj.2011.3; KOLESKE AJ, 1994, NATURE, V368, P466, DOI 10.1038/368466a0; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Koyama T, 2007, PLANT CELL, V19, P473, DOI 10.1105/tpc.106.044792; La Camera S, 2005, PLANT J, V44, P810, DOI 10.1111/j.1365-313X.2005.02578.x; Lai ZB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4064; LI Y, 1995, P NATL ACAD SCI USA, V92, P10864, DOI 10.1073/pnas.92.24.10864; Mathur S, 2011, PLANT PHYSIOL, V157, P1609, DOI 10.1104/pp.111.188300; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Pinto RC, 2012, ANAL CHEM, V84, P8675, DOI 10.1021/ac301869p; Rogers EE, 1996, MOL PLANT MICROBE IN, V9, P748, DOI 10.1094/MPMI-9-0748; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Schweizer F, 2013, PLANT CELL, V25, P3117, DOI 10.1105/tpc.113.115139; Stotz HU, 2011, PLANT J, V67, P81, DOI 10.1111/j.1365-313X.2011.04578.x; Takagi Y, 2006, MOL CELL, V23, P355, DOI 10.1016/j.molcel.2006.06.007; Tierens KFMJ, 2001, PLANT PHYSIOL, V125, P1688, DOI 10.1104/pp.125.4.1688; Tsai KL, 2014, CELL, V157, P1430, DOI 10.1016/j.cell.2014.05.015; van den Burg HA, 2010, PLANT CELL, V22, P1998, DOI 10.1105/tpc.109.070961; Wasternack C., 2007, ANN BOT, V4, P1933; Yang WY, 2007, J BIOL CHEM, V282, P18116, DOI 10.1074/jbc.M700405200; Yang Y, 2014, PLANT J, V77, P838, DOI 10.1111/tpj.12440; Zhang Y, 2008, PLANT CELL, V20, P1437, DOI 10.1105/tpc.108.058891; Zheng ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053924	54	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179640	10.1371/journal.pone.0179640	http://dx.doi.org/10.1371/journal.pone.0179640			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640868	Green Published, gold, Green Submitted			2022-12-27	WOS:000404135800047
J	Dulau, V; Estrade, V; Fayan, J				Dulau, Violaine; Estrade, Vanessa; Fayan, Jacques			Identifying key demographic parameters of a small island-associated population of Indo-Pacific bottlenose dolphins (Reunion, Indian Ocean)	PLOS ONE			English	Article							ESTIMATE TEMPORARY EMIGRATION; CAPTURE-RECAPTURE DATA; TURSIOPS-ADUNCUS; SITE FIDELITY; ROBUST DESIGN; VIABILITY ANALYSIS; COASTAL WATERS; SOUTH-AFRICA; ALGOA BAY; SIZE	Photo-identification surveys of Indo-Pacific bottlenose dolphins were conducted from 2009 to 2014 off Reunion Island (55 degrees E33'/21 degrees S07'), in the Indian Ocean. Robust Design models were applied to produce the most reliable estimate of population abundance and survival rate, while accounting for temporary emigration from the survey area (west coast). The sampling scheme consisted of a five-month (June-October) sampling period in each year of the study. The overall population size at Reunion was estimated to be 72 individuals (SE = 6.17, 95% CI = 61-85), based on a random temporary emigration (gamma") of 0.096 and a proportion of 0.70 (SE = 0.03) distinct individuals. The annual survival rate was 0.93 (+/- 0.018 SE, 95% CI = 0.886-0.958) and was constant over time and between sexes. Models considering gender groups indicated different movement patterns between males and females. Males showed null or quasi-null temporary emigration (gamma" = gamma' < 0.01), while females showed a random temporary emigration (gamma") of 0.10, suggesting that a small proportion of females was outside the survey area during each primary sampling period. Sex-specific temporary migration patterns were consistent with movement and residency patterns observed in other areas. The Robust Design approach provided an appropriate sampling scheme for deriving island-associated population parameters, while allowing to restrict survey effort both spatially (i.e. west coast only) and temporally (five months per year). Although abundance and survival were stable over the six years, the small population size of fewer than 100 individuals suggested that this population is highly vulnerable. Priority should be given to reducing any potential impact of human activity on the population and its habitat.	[Dulau, Violaine; Estrade, Vanessa] GLOBICE Reunion, St Pierre, Reunion Island, France; [Fayan, Jacques] BNOI ONCFS, Parc Providence, St Denis, Reunion Island, France		Dulau, V (corresponding author), GLOBICE Reunion, St Pierre, Reunion Island, France.	violaine.dulau@globice.org		Dulau-Drouot, Violaine/0000-0002-2228-3959	Direction de l'Environnement de l'Amenagement et du Logement [DEAL/CP02011/11, CP02014/02]; Office Nationale de la Chasse et de la Faune Sauvage [BN01/2011-14]; GLOBICE; Conseil Regional Reunion [DEE/20151302]	Direction de l'Environnement de l'Amenagement et du Logement; Office Nationale de la Chasse et de la Faune Sauvage; GLOBICE; Conseil Regional Reunion	Data collection was funded by Direction de l'Environnement de l'Amenagement et du Logement (DEAL/CP02011/11, CP02014/02), http://www.reunion.developmetn-durable.gouv. fr/; Office Nationale de la Chasse et de la Faune Sauvage (BN01/2011-14), http://www.oncfs.gouv. fr/ and GLOBICE, http://globice.org/. Data analysis and preparation of the manuscript was funded by Conseil Regional Reunion (DEE/20151302), http:// www.regionreunion.com.	Amir Omar A., 2002, Western Indian Ocean Journal of Marine Science, V1, P155; Ansmann IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065239; Ansmann IC, 2012, MOL ECOL, V21, P4472, DOI 10.1111/j.1365-294X.2012.05722.x; Berube M, 1996, MOL ECOL, V5, P283; Borchers D.L., 2002, ESTIMATING ANIMAL AB; Bouveroux T., 2014, Journal of Cetacean Research and Management, V14, P37; Bradford Amanda L., 2008, Endangered Species Research, V6, P1, DOI 10.3354/esr00106; Brown AM, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00004; Burkhart SM, 2003, NEW ZEAL J MAR FRESH, V37, P553, DOI 10.1080/00288330.2003.9517189; Burnham K.P., 1987, MONOGRAPH, V5; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cantor M, 2012, MAR MAMMAL SCI, V28, P63, DOI 10.1111/j.1748-7692.2010.00456.x; Chilvers BL, 2003, MAR MAMMAL SCI, V19, P85, DOI 10.1111/j.1748-7692.2003.tb01094.x; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Condet M, 2016, CONT SHELF RES, V125, P18, DOI 10.1016/j.csr.2016.06.010; Connor RC, 2000, CETACEAN SOCIETIES, P91; Crone EE, 2001, EVOLUTION, V55, P2611; Dirtu AC, 2016, ENVIRON RES, V146, P263, DOI 10.1016/j.envres.2016.01.006; Dulau-Drouot V, 2008, J MAR BIOL ASSOC UK, V88, P1263, DOI 10.1017/S0025315408001069; Friday N, 2000, MAR MAMMAL SCI, V16, P355, DOI 10.1111/j.1748-7692.2000.tb00930.x; Fury CA, 2008, MAR FRESHWATER RES, V59, P1015, DOI 10.1071/MF08109; Fury CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052987; Heithaus MR, 2016, MAR MAMM SC IN PRESS; Huang S-L, 2013, J BIODIVERS ENDANGER, V1, P115; IUCN MNHN SEOR ARDA, 2013, LIST ROUG MEN FRANC; Kendall WL, 1997, ECOLOGY, V78, P563; Kendall WL, 2001, BIOMETRICS, V57, P1113, DOI 10.1111/j.0006-341X.2001.01113.x; KENDALL WL, 1995, BIOMETRICS, V51, P293, DOI 10.2307/2533335; Kendall WL, 1995, J APPL STAT, V22, P751, DOI 10.1080/02664769524595; Kinkead KE, 2007, HERPETOLOGICA, V63, P151, DOI 10.1655/0018-0831(2007)63[151:ESSAAP]2.0.CO;2; Manlik O, 2016, ECOL EVOL, V6, P3496, DOI 10.1002/ece3.2130; Mansur RM, 2012, MAR MAMMAL SCI, V28, P561, DOI 10.1111/j.1748-7692.2011.00520.x; McCarthy MA, 2001, ANIM CONSERV, V4, P351, DOI 10.1017/S136794300100141X; Moeller L. M., 2002, Australian Mammalogy, V24, P11; Moller LM, 2004, MOL ECOL, V13, P1607, DOI 10.1111/j.1365-294X.2004.02137.x; Moller LM, 2007, MAR FRESHWATER RES, V58, P640, DOI 10.1071/MF06218; Natoli A, 2008, CONSERV GENET, V9, P627, DOI 10.1007/s10592-007-9379-y; Nicholson K, 2012, MAR FRESHWATER RES, V63, P1059, DOI 10.1071/MF12210; OTIS DL, 1978, WILDLIFE MONOGR, P1; Patterson E. M., 2012, THESIS; Perez-Jorge S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133265; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; POLLOCK KH, 1982, J WILDLIFE MANAGE, V46, P752, DOI 10.2307/3808568; Pusineri C, 2014, ENDANGER SPECIES RES, V23, P23, DOI 10.3354/esr00555; Randic S, 2012, P ROY SOC B-BIOL SCI, V279, P3083, DOI 10.1098/rspb.2012.0264; Reisinger RR, 2010, MAR MAMMAL SCI, V26, P86, DOI 10.1111/j.1748-7692.2009.00324.x; ROSS GJB, 1987, S AFR J ZOOL, V22, P50; Sarnblad A, 2011, MAR MAMMAL SCI, V27, P431, DOI 10.1111/j.1748-7692.2010.00416.x; Silva MA, 2009, MAR ECOL PROG SER, V392, P263, DOI 10.3354/meps08233; Smith HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076574; Song KJ, 2014, PAC SCI, V68, P555, DOI 10.2984/68.4.9; Sprogis KR, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00012; Sprogis KR, 2016, MAR MAMMAL SCI, V32, P287, DOI 10.1111/mms.12260; Stensland E, 2006, MAR MAMMAL SCI, V22, P667, DOI 10.1111/j.1748-7692.2006.00051.x; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Thompson PM, 2000, CONSERV BIOL, V14, P1253, DOI 10.1046/j.1523-1739.2000.00099-410.x; Traill LW, 2007, BIOL CONSERV, V139, P159, DOI 10.1016/j.biocon.2007.06.011; Tyne JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086132; Vermeulen E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119182; Webster I, 2014, AFRICAN J MARINE SCI, P1, DOI https://doi.org/10.2989/1814232X.2014.946448; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wilson B, 1999, ECOL APPL, V9, P288, DOI 10.1890/1051-0761(1999)009[0288:ESAATI]2.0.CO;2; Wiszniewski J, 2010, CONSERV GENET, V11, P1405, DOI 10.1007/s10592-009-9968-z; Zanardo N, 2013, MAR MAMMAL SCI, V32, P1381	64	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179780	10.1371/journal.pone.0179780	http://dx.doi.org/10.1371/journal.pone.0179780			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640918	Green Published, Green Submitted, gold			2022-12-27	WOS:000404135800064
J	Mascia, C; Vita, S; Zuccal, P; Marocco, R; Tieghi, T; Savinelli, S; Rossi, R; Iannetta, M; Pozzetto, I; Furlan, C; Mengoni, F; Mastroianni, CM; Vullo, V; Lichtner, M				Mascia, Claudia; Vita, Serena; Zuccal, Paola; Marocco, Raffaella; Tieghi, Tiziana; Savinelli, Stefano; Rossi, Raffaella; Iannetta, Marco; Pozzetto, Irene; Furlan, Caterina; Mengoni, Fabio; Mastroianni, Claudio Maria; Vullo, Vincenzo; Lichtner, Miriam			Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; MACROPHAGE ACTIVATION MARKER; INNATE IMMUNE-RESPONSE; VIRUS-INFECTION; SOLUBLE CD163; LIVER FIBROSIS; INDUCIBLE PROTEIN-10; FREE THERAPY; EXPRESSION; GAMMA	Background and aims Increased levels of chemokine interferon-gamma (IFN-gamma)-inducible protein-10 (CXCL10), soluble CD163 (sCD163) and soluble CD14 (sCD14) have been reported in HCV infection. The aim of this study was to compare, sCD163 and sCD14 levels in HCV-infected patients undergoing direct acting antiviral (DAA)-containing regimens with or without interferon (IFN). Methods sCD163, sCD14 and CXCL10 were longitudinally measured by ELISA in 159 plasma samples from 25 HCV-infected patients undergoing IFN-based treatment plus telaprevir or boceprevir and 28 HCV infected subjects treated with DAA IFN-free regimens. Twenty-five healthy donors (HD) were included as controls. Results At baseline CXCL10, sCD163 and sCD14 levels were higher in HCV-infected patients than in HD. CXCL10 and sCD163 levels were significantly decreased in responder (R) patients who achieved sustained virological response (SVR), with both IFN-based and IFN-free regimens, while they were persistently elevated in non-responders (NR) patients who stopped IFN-based treatments because of failure or adverse events. Conversely, sCD14 levels were apparently unchanged during therapy, but at the end of treatment the levels reached normal ranges. Comparing the two regimens, the extent of CXCL10 reduction was more pronounced in patients undergoing DAA IFN-free therapies, whereas sCD163 and sCD14 reduction was similar in the two groups. Interestingly, only in IFN-based regimens baseline sCD163 levels were significantly higher in NR than in R patients, while in the IFN-free treatment group also patients with high sCD163 plasma levels obtained SVR. At the end of therapy, even if the biomarkers were largely decreased, their levels remained significantly higher compared to HD. Only in the early fibrosis stages, sCD163 values tended to normalize. Conclusions These results indicate that IFN-free regimens including newer DAA induce an early and marked decrease in circulating inflammatory biomarkers. However, the full normalization of biomarkers was not obtained, especially in patients with advanced fibrosis, thus underlying the need for a treatment in the early stages of HCV infection.	[Mascia, Claudia; Vita, Serena; Zuccal, Paola; Marocco, Raffaella; Tieghi, Tiziana; Savinelli, Stefano; Rossi, Raffaella; Iannetta, Marco; Pozzetto, Irene; Furlan, Caterina; Mengoni, Fabio; Mastroianni, Claudio Maria; Vullo, Vincenzo; Lichtner, Miriam] Sapienza Univ, Dept Publ Hlth & Infect Dis, Rome, Italy; [Marocco, Raffaella; Tieghi, Tiziana; Pozzetto, Irene; Mastroianni, Claudio Maria; Lichtner, Miriam] Sapienza Univ, SM Goretti Hosp, Infect Dis Unit, Latina, Italy	Sapienza University Rome; Sapienza University Rome	Mascia, C (corresponding author), Sapienza Univ, Dept Publ Hlth & Infect Dis, Rome, Italy.	claumascia@tiscali.it	Iannetta, Marco/M-4619-2019; Vita, Serena/AAC-3345-2022; Iannetta, Marco/B-5596-2017; MASTROIANNI, Claudio Maria/O-9741-2019	Iannetta, Marco/0000-0002-6938-8627; Iannetta, Marco/0000-0002-6938-8627; MASTROIANNI, Claudio Maria/0000-0002-1286-467X				Ahlenstiel G, 2010, GASTROENTEROLOGY, V138, P325, DOI 10.1053/j.gastro.2009.08.066; Andersen ES, 2014, EUR J CLIN MICROBIOL, V33, P117, DOI 10.1007/s10096-013-1936-3; Aristoteli LP, 2006, ATHEROSCLEROSIS, V184, P342, DOI 10.1016/j.atherosclerosis.2005.05.004; Askarieh G, 2010, HEPATOLOGY, V51, P1523, DOI 10.1002/hep.23509; Bility MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep39520; Brownell J, 2013, J HEPATOL, V59, P701, DOI 10.1016/j.jhep.2013.06.001; Burdo TH, 2013, AIDS, V27, P1387, DOI 10.1097/QAD.0b013e32836010bd; Butt AA, 2009, CLIN INFECT DIS, V49, P225, DOI 10.1086/599371; de Ledinghen V, 2006, JAIDS-J ACQ IMM DEF, V41, P175; Diago M, 2006, GUT, V55, P374, DOI 10.1136/gut.2005.074062; Dultz G, 2016, J VIRAL HEPATITIS, V23, P267, DOI 10.1111/jvh.12488; Freiberg MS, 2011, CIRC-CARDIOVASC QUAL, V4, P425, DOI 10.1161/CIRCOUTCOMES.110.957415; Harvey CE, 2003, J LEUKOCYTE BIOL, V74, P360, DOI 10.1189/jlb.0303093; Jirillo E, 1998, IMMUNOPHARM IMMUNOT, V20, P1, DOI 10.3109/08923979809034805; Kazankov K, 2014, HEPATOLOGY, V60, P521, DOI 10.1002/hep.27129; Kostadinova L, 2016, J INFECT DIS, V214, P1438, DOI 10.1093/infdis/jiw372; Lam BP, 2015, THER ADV GASTROENTER, V8, P298, DOI 10.1177/1756283X15587481; Larrea E, 1996, HEPATOLOGY, V23, P210, DOI 10.1002/hep.510230203; Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; Liao CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031527; Lin JC, 2014, J INFECT DIS, V210, P1881, DOI 10.1093/infdis/jiu325; Litzman J, 2012, CLIN EXP IMMUNOL, V170, P321, DOI 10.1111/j.1365-2249.2012.04655.x; Malone DFG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105665; Mihm S, 2003, J MED VIROL, V70, P562, DOI 10.1002/jmv.10431; Missale G, 2012, GUT, V61, P1076, DOI 10.1136/gutjnl-2011-300515; Mochizuki K, 1997, HEPATOLOGY, V25, P713, DOI 10.1002/hep.510250337; Moller HJ, 2012, SCAND J CLIN LAB INV, V72, P1, DOI 10.3109/00365513.2011.626868; Moreno JA, 2012, EUR HEART J, V33, P252, DOI 10.1093/eurheartj/ehr123; Narumi S, 1997, J IMMUNOL, V158, P5536; Negash AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003330; Ogawa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065211; Romero AI, 2006, J INFECT DIS, V194, P895, DOI 10.1086/507307; Sacchi P, 2015, DIGEST LIVER DIS, V47, P218, DOI 10.1016/j.dld.2014.11.012; Sandler NG, 2011, GASTROENTEROLOGY, V141, P1220, DOI 10.1053/j.gastro.2011.06.063; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Serti E, 2015, GASTROENTEROLOGY, V149, P190, DOI 10.1053/j.gastro.2015.03.004; Shaked I, 2014, ARTERIOSCL THROM VAS, V34, P1085, DOI 10.1161/ATVBAHA.113.303153; Szabo G, 2007, SEMIN LIVER DIS, V27, P339, DOI 10.1055/s-2007-991511; Werner CR, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0261-0; You CR, 2011, GUT LIVER, V5, P506, DOI 10.5009/gnl.2011.5.4.506; Zeremski M, 2011, J INFECT DIS, V204, P832, DOI 10.1093/infdis/jir424	41	26	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179400	10.1371/journal.pone.0179400	http://dx.doi.org/10.1371/journal.pone.0179400			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636655	gold, Green Published, Green Submitted			2022-12-27	WOS:000404118300034
J	Salerno, S; Mehrmohamadi, M; Liberti, MV; Wan, MT; Wells, MT; Booth, JG; Locasale, JW				Salerno, Stephen, Jr.; Mehrmohamadi, Mahya; Liberti, Maria V.; Wan, Muting; Wells, Martin T.; Booth, James G.; Locasale, Jason W.			RRmix: A method for simultaneous batch effect correction and analysis of metabolomics data in the absence of internal standards	PLOS ONE			English	Article							MASS-SPECTROMETRY; GAS-CHROMATOGRAPHY; GENE-EXPRESSION; MICROARRAY; STRATEGY; LIMMA	With the surge of interest in metabolism and the appreciation of its diverse roles in numerous biomedical contexts, the number of metabolomics studies using liquid chromatography coupled to mass spectrometry (LC-MS) approaches has increased dramatically in recent years. However, variation that occurs independently of biological signal and noise (i.e. batch effects) in metabolomics data can be substantial. Standard protocols for data normalization that allow for cross-study comparisons are lacking. Here, we investigate a number of algorithms for batch effect correction and differential abundance analysis, and compare their performance. We show that linear mixed effects models, which account for latent (i.e. not directly measurable) factors, produce satisfactory results in the presence of batch effects without the need for internal controls or prior knowledge about the nature and sources of unwanted variation in metabolomics data. We further introduce an algorithm-RRmix-within the family of latent factor models and illustrate its suitability for differential abundance analysis in the presence of strong batch effects. Together this analysis provides a framework for systematically standardizing metabolomics data.	[Salerno, Stephen, Jr.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Mehrmohamadi, Mahya; Locasale, Jason W.] Cornell Univ, Dept Mol Biol & Genet, Field Genom Genet & Dev, Ithaca, NY 14850 USA; [Mehrmohamadi, Mahya; Liberti, Maria V.; Locasale, Jason W.] Duke Univ, Sch Med, Duke Canc Inst, Duke Mol Physiol Inst, Durham, NC 27708 USA; [Mehrmohamadi, Mahya; Liberti, Maria V.; Locasale, Jason W.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Liberti, Maria V.; Locasale, Jason W.] Cornell Univ, Dept Mol Biol & Genet, Field Biochem Mol & Cell Biol, Ithaca, NY 14850 USA; [Wan, Muting; Wells, Martin T.; Booth, James G.] Cornell Univ, Dept Stat Sci, Ithaca, NY USA	University of Michigan System; University of Michigan; Cornell University; Duke University; Duke University; Cornell University; Cornell University	Locasale, JW (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Field Genom Genet & Dev, Ithaca, NY 14850 USA.; Locasale, JW (corresponding author), Duke Univ, Sch Med, Duke Canc Inst, Duke Mol Physiol Inst, Durham, NC 27708 USA.; Locasale, JW (corresponding author), Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.; Locasale, JW (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Field Biochem Mol & Cell Biol, Ithaca, NY 14850 USA.	jason.locasale@duke.edu	Locasale, Jason W/ABE-6505-2020	Locasale, Jason W/0000-0002-7766-3502; mehrmohamadi, mahya/0000-0002-6681-0810; Liberti, Maria/0000-0002-4120-3686; Salerno, Stephen/0000-0003-2763-0494	National Institutes of Health (NIH) [R00CA168997, P30CA014236, R01CA193256, U19AI111143, T32GM007617]; NCI [F99CA212457]; Duke University School of Medicine; NATIONAL CANCER INSTITUTE [K00CA212457, R00CA168997, R01CA193256, F99CA212457, P30CA014236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI111143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007617] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Duke University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants R00CA168997, P30CA014236, R01CA193256 to JWL and grant U19AI111143 to MTW from the National Institutes of Health (NIH). MVL was Sloan Foundation and the National Science Foundation. MM was supported by T32GM007617 from the NIH, F99CA212457 from the NCI, and a Graduate Fellowship from the Duke University School of Medicine.	Bar H, 2010, STAT SCI, V25, P388, DOI 10.1214/10-STS339; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; Brunius C, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1124-4; Causeur D, 2011, J STAT SOFTWARE, V40; Chen JQ, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0469-8; De Livera AM, 2015, ANAL CHEM, V87, P3606, DOI 10.1021/ac502439y; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; Fernandez-Albert F, 2014, BIOINFORMATICS, V30, P2899, DOI 10.1093/bioinformatics/btu423; Gao C, 2014, BIOINFORMATICS, V30, P369, DOI 10.1093/bioinformatics/btt690; Gowda G A Nagana, 2014, Methods Mol Biol, V1198, P3, DOI 10.1007/978-1-4939-1258-2_1; Johnson CH, 2016, NAT REV MOL CELL BIO, V17, P451, DOI 10.1038/nrm.2016.25; Karpievitch YV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116221; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lazar C, 2013, BRIEF BIOINFORM, V14, P469, DOI 10.1093/bib/bbs037; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Liu XJ, 2017, TRENDS BIOCHEM SCI, V42, P274, DOI 10.1016/j.tibs.2017.01.004; Liu XJ, 2014, ANAL CHEM, V86, P2175, DOI 10.1021/ac403845u; Mehrmohamadi M, 2014, CELL REP, V9, P1507, DOI 10.1016/j.celrep.2014.10.026; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; R Core Team, 2013, R LANG ENV STAT COMP; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stokvis E, 2005, RAPID COMMUN MASS SP, V19, P401, DOI 10.1002/rcm.1790; Wan M., 2015, THESIS; Wang SY, 2013, ANAL CHEM, V85, P1037, DOI 10.1021/ac302877x; Wehrens R, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1015-8; Wieling J, 2002, CHROMATOGRAPHIA, V55, pS107, DOI 10.1007/BF02493365; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Zamboni N, 2015, MOL CELL, V58, P699, DOI 10.1016/j.molcel.2015.04.021; Zhao YN, 2016, ANAL CHEM, V88, P2234, DOI 10.1021/acs.analchem.5b03912	33	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179530	10.1371/journal.pone.0179530	http://dx.doi.org/10.1371/journal.pone.0179530			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662051	Green Submitted, gold, Green Published			2022-12-27	WOS:000404608300031
J	Acevedo, A; Conejeros, R; Aroca, G				Acevedo, Alejandro; Conejeros, Raul; Aroca, German			Ethanol production improvement driven by genome-scale metabolic modeling and sensitivity analysis in Scheffersomyces stipitis	PLOS ONE			English	Article							YEAST PICHIA-STIPITIS; CONSTRAINT-BASED MODELS; SACCHAROMYCES-CEREVISIAE; XYLOSE FERMENTATION; NADH AVAILABILITY; ESCHERICHIA-COLI; CARBON SOURCE; GROWTH; OPTIMIZATION; GENE	The yeast Scheffersomyces stipitis naturally produces ethanol from xylose, however reaching high ethanol yields is strongly dependent on aeration conditions. It has been reported that changes in the availability of NAD(H/(+)) cofactors can improve fermentation in some microorganisms. In this work genome-scale metabolic modeling and phenotypic phase plane analysis were used to characterize metabolic response on a range of uptake rates. Sensitivity analysis was used to assess the effect of ARC on ethanol production indicating that modifying ARC by inhibiting the respiratory chain ethanol production can be improved. It was shown experimentally in batch culture using Rotenone as an inhibitor of the mitochondria) NADH dehydrogenase complex I (CINADH), increasing ethanol yield by 18%. Furthermore, trajectories for uptakes rates, specific productivity and specific growth rate were determined by modeling the batch culture, to calculate ARC associated to the addition of CI NADH inhibitor. Results showed that the increment in ethanol production via respiratory inhibition is due to excess in ARC, which generates an increase in ethanol production. Thus ethanol production improvement could be predicted by a change in ARC.	[Acevedo, Alejandro; Conejeros, Raul; Aroca, German] Pontificia Univ Catolica Valparaiso, Escuela Ingn Bioquim, Ave Brasil 2085, Valparaiso, Chile; [Acevedo, Alejandro] Univ Chile, Fac Ciencias, Inst Milenio Biol, Las Encinas 3370, Santiago, Chile	Pontificia Universidad Catolica de Valparaiso; Universidad de Chile	Conejeros, R (corresponding author), Pontificia Univ Catolica Valparaiso, Escuela Ingn Bioquim, Ave Brasil 2085, Valparaiso, Chile.	raul.conejeros@pucv.cl	Aroca, German/ABG-6714-2020; Conejeros, Raul/ABG-5517-2020; Conejeros, Raul/A-2466-2011; Aroca, German/B-3798-2011	Conejeros, Raul/0000-0002-1273-535X; Aroca, German/0000-0003-1376-7940	CONICYT; FONDECYT [1151295]; PUCV [DI 037.424]; INNOVA CHILE Project Technological Consortium Bioenercel S.A. [208-7320]	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); PUCV; INNOVA CHILE Project Technological Consortium Bioenercel S.A.	Financial support granted to A. Acevedo by CONICYT's Doctoral Scholarship is gratefully acknowledged. The authors would like to acknowledge as well the financial support of project FONDECYT 1151295, PUCV research grant DI 037.424 and the support of INNOVA CHILE Project 208-7320 Technological Consortium Bioenercel S.A. The funder provided support in the form of salaries for authors AA, RC and GA, but did	Acevedo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087494; Balagurunathan B, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-27; Baranyi J., 2010, DOCTORAL SCH INFORM, V13, P6720; Berrios-Rivera SJ, 2002, METAB ENG, V4, P217, DOI 10.1006/mben.2002.0227; Bordbar A, 2014, NAT REV GENET, V15, P107, DOI 10.1038/nrg3643; BRUINENBERG PM, 1983, EUR J APPL MICROBIOL, V18, P287, DOI 10.1007/BF00500493; Caspeta L, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-24; Chowdhury A, 2015, COMPUT CHEM ENG, V72, P363, DOI 10.1016/j.compchemeng.2014.06.007; Damiani AL, 2015, BIOTECHNOL BIOENG, V112, P1250, DOI 10.1002/bit.25535; DEDEKEN RH, 1966, J GEN MICROBIOL, V44, P149, DOI 10.1099/00221287-44-2-149; DELLWEG H, 1989, J BIOTECHNOL, V12, P111, DOI 10.1016/0168-1656(89)90010-2; Duarte NC, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-63; DUPREEZ JC, 1994, ENZYME MICROB TECH, V16, P944, DOI 10.1016/0141-0229(94)90003-5; Edwards JS, 2002, BIOTECHNOL BIOENG, V77, P27, DOI 10.1002/bit.10047; Farias D, 2014, APPL BIOCHEM BIOTECH, V172, P361, DOI 10.1007/s12010-013-0546-y; Freese S, 2011, YEAST, V28, P309, DOI 10.1002/yea.1840; Garcia-Ochoa F, 2009, BIOTECHNOL ADV, V27, P153, DOI 10.1016/j.biotechadv.2008.10.006; Gelfand I, 2013, NATURE, V493, P514, DOI 10.1038/nature11811; Ghosh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027316; Girio FM, 2010, BIORESOURCE TECHNOL, V101, P4775, DOI 10.1016/j.biortech.2010.01.088; Goldemberg J, 2007, SCIENCE, V315, P808, DOI 10.1126/science.1137013; HAHNHAGERDAL B, 1994, ENZYME MICROB TECH, V16, P933, DOI 10.1016/0141-0229(94)90002-7; Hanly TJ, 2014, BIOTECHNOL BIOENG, V111, P272, DOI 10.1002/bit.25101; Hanly TJ, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-44; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hou J, 2010, APPL ENVIRON MICROB, V76, P851, DOI 10.1128/AEM.02040-09; Huang EL, 2012, J IND MICROBIOL BIOT, V39, P1507, DOI 10.1007/s10295-012-1147-4; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Jeffries TW, 2009, FEMS YEAST RES, V9, P793, DOI 10.1111/j.1567-1364.2009.00525.x; Kuhad RC, 2011, RENEW SUST ENERG REV, V15, P4950, DOI 10.1016/j.rser.2011.07.058; Kurtzman CP, 2010, MYCOSCIENCE, V51, P2, DOI 10.1007/s10267-009-0011-5; Lee T.Y., 2000, BIOTECHNOL BIOPROC E, V5, P27, DOI [10.1007/BF02932349, DOI 10.1007/bf02932349]; Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737; Liang M, 2014, ACS SUSTAIN CHEM ENG, V2, P38, DOI 10.1021/sc400265g; LIGHTHELM ME, 1988, APPL MICROBIOL BIOT, V29, P67, DOI 10.1007/BF00258353; Mo ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-37; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Papini M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-136; Portugal-Nunes D, 2015, BIORESOURCES BIOPROC, V2, P1; POSTMA E, 1989, APPL ENVIRON MICROB, V55, P468, DOI 10.1128/AEM.55.2.468-477.1989; Reznik E, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003195; RIZZI M, 1989, BIOTECHNOL BIOENG, V34, P509, DOI 10.1002/bit.260340411; SAVINELL JM, 1992, J THEOR BIOL, V154, P421, DOI 10.1016/S0022-5193(05)80161-4; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schellenberger J, 2011, BIOPHYS J, V100, P544, DOI 10.1016/j.bpj.2010.12.3707; Shi NQ, 2002, YEAST, V19, P1203, DOI 10.1002/yea.915; Shi NQ, 1999, YEAST, V15, P1021, DOI 10.1002/(SICI)1097-0061(199908)15:11<1021::AID-YEA429>3.0.CO;2-V; Silva JPA, 2012, RENEW ENERG, V37, P259, DOI 10.1016/j.renene.2011.06.032; Silva JPA, 2010, APPL BIOCHEM BIOTECH, V162, P1306, DOI 10.1007/s12010-009-8867-6; SKOOG K, 1990, APPL ENVIRON MICROB, V56, P3389, DOI 10.1128/AEM.56.11.3389-3394.1990; SKOOG K, 1992, APPL BIOCHEM BIOTECH, V34-5, P369, DOI 10.1007/BF02920560; Slininger PJ, 2014, BIOTECHNOL BIOENG, V111, P1532, DOI 10.1002/bit.25215; SLININGER PJ, 1991, BIOTECHNOL BIOENG, V37, P973, DOI 10.1002/bit.260371012; SONNLEITNER B, 1986, BIOTECHNOL BIOENG, V28, P927, DOI 10.1002/bit.260280620; Su YK, 2015, BIOTECHNOL BIOENG, V112, P457, DOI 10.1002/bit.25445; Szappanos B, 2011, NAT GENET, V43, P656, DOI 10.1038/ng.846; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Unrean P, 2013, APPL BIOCHEM BIOTECH, V169, P1895, DOI 10.1007/s12010-013-0100-y; Unrean P, 2012, BIOTECHNOL PROGR, V28, P1119, DOI 10.1002/btpr.1595; VARMA A, 1993, J THEOR BIOL, V165, P477, DOI 10.1006/jtbi.1993.1202; Vemuri GN, 2007, P NATL ACAD SCI USA, V104, P2402, DOI 10.1073/pnas.0607469104; Wang YP, 2013, CURR OPIN BIOTECH, V24, P994, DOI 10.1016/j.copbio.2013.03.022; Yuan TZ, 2011, APPL MICROBIOL BIOT, V92, P1237, DOI 10.1007/s00253-011-3607-6	63	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180074	10.1371/journal.pone.0180074	http://dx.doi.org/10.1371/journal.pone.0180074			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658270	Green Published, Green Submitted, gold			2022-12-27	WOS:000404607900056
J	Griffith, JC; Lee, WG; Orlovich, DA; Summerfield, TC				Griffith, Jocelyn C.; Lee, William G.; Orlovich, David A.; Summerfield, Tina C.			Contrasting bacterial communities in two indigenous Chionochloa (Poaceae) grassland soils in New Zealand	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; MICROBIAL COMMUNITIES; NITROGEN-FIXATION; DIAZOTROPH COMMUNITY; DIVERSITY; GENES; FERTILIZATION; HISTORY; BIODIVERSITY; ORGANIZATION	The cultivation of grasslands can modify both bacterial community structure and impact on nutrient cycling as well as the productivity and diversity of plant communities. In this study, two pristine New Zealand grassland sites dominated by indigenous tall tussocks (Chiono-chloa pallens or C. teretifolia) were examined to investigate the extent and predictability of variation of the bacterial community. The contribution of free-living bacteria to biological nitrogen fixation is predicted to be ecologically significant in these soils; therefore, the diazo-trophic community was also examined. The C. teretifolia site had N-poor and poorly-drained peaty soils, and the C. pallens had N-rich and well-drained fertile soils. These soils also differ in the proportion of organic carbon (C), Olsen phosphorus (P) and soil pH. The nutrien-trich soils showed increased relative abundances of some copiotrophic bacterial taxa (including members of the Proteobacteria, Bacteroidetes and Firmicutes phyla). Other copiotrophs, Actinobacteria and the oliogotrophic Acidobacteria showed increased relative abundance in nutrient-poor soils. Greater diversity based on 16S rRNA gene sequences and the Tax4Fun prediction of enhanced spore formation associated with nutrient-rich soils could indicate increased resilience of the bacterial community. The two sites had distinct diazotrophic communities with higher diversity in C. teretifolia soils that had less available nitrate and ammonium, potentially indicating increased resilience of the diazotroph community at this site. The C. teretifolia soils had more 16S rRNA gene and nifH copies per g soil than the nutrient rich site. However, the proportion of the bacterial community that was diazotrophic was similar in the two soils. We suggest that edaphic and vegetation factors are contributing to major differences in the composition and diversity of total bacterial and diazotrophic communities at these sites. We predict the differences in the communities at the two sites will result in different responses to environmental change.	[Griffith, Jocelyn C.; Orlovich, David A.; Summerfield, Tina C.] Univ Otago, Dept Bot, Dunedin, New Zealand; [Lee, William G.] Landcare Res, Dunedin, New Zealand	University of Otago; Landcare Research - New Zealand	Summerfield, TC (corresponding author), Univ Otago, Dept Bot, Dunedin, New Zealand.	tina.summerfield@otago.ac.nz	Orlovich, David Allan/L-8581-2013	Orlovich, David Allan/0000-0002-9266-2188; Summerfield, Tina/0000-0003-1878-7019	Miss EL Hellaby Indigenous Grasslands Research Trust	Miss EL Hellaby Indigenous Grasslands Research Trust	The work was funded by the Miss EL Hellaby Indigenous Grasslands Research Trust.	Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Anderson M.J., 2005, PERMUTATIONAL MULTIV; Apprill A, 2015, AQUAT MICROB ECOL, V75, P129, DOI 10.3354/ame01753; Asshauer KP, 2015, BIOINFORMATICS, V31, P2882, DOI 10.1093/bioinformatics/btv287; Barron AR, 2009, NAT GEOSCI, V2, P42, DOI 10.1038/NGEO366; Berthrong ST, 2014, APPL ENVIRON MICROB, V80, P3103, DOI 10.1128/AEM.04034-13; Bier RL, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv113; Blair JM, 2014, ECOLOGY ENV, P389, DOI DOI 10.1007/978-1-4614-7501-9_14; Buckley DH, 2006, APPL ENVIRON MICROB, V72, P4522, DOI 10.1128/AEM.00149-06; Buckley DH, 2003, ENVIRON MICROBIOL, V5, P441, DOI 10.1046/j.1462-2920.2003.00404.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cavaletti L, 2006, APPL ENVIRON MICROB, V72, P4360, DOI 10.1128/AEM.00132-06; Chang YJ, 2011, STAND GENOMIC SCI, V5, P97, DOI 10.4056/sigs.2114901; Chien YT, 1996, J BACTERIOL, V178, P143, DOI 10.1128/jb.178.1.143-148.1996; CHRISTIANSENWENIGER C, 1991, BIOL FERT SOILS, V12, P100, DOI 10.1007/BF00341483; Coleman DC, 2018, FUNDAMENTALS SOIL EC, P77, DOI DOI 10.1016/B978-0-12-805251-8.00004; CONNOR HE, 1991, NEW ZEAL J BOT, V29, P219, DOI 10.1080/0028825X.1991.10416605; Coolon JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067884; Crews TE, 2000, ECOSYSTEMS, V3, P386, DOI 10.1007/s100210000034; Cusack DF, 2009, ECOSYSTEMS, V12, P1299, DOI 10.1007/s10021-009-9290-0; DIMENNA ME, 1966, NEW ZEAL J AGR RES, V9, P218, DOI 10.1080/00288233.1966.10420775; DuBois John D, 1983, Am J Bot, V70, P8, DOI [10.2307/2443198, 10.1002/j.1537-2197.1983.tb12426.x]; Duc L, 2009, MICROB ECOL, V57, P179, DOI 10.1007/s00248-008-9408-5; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; FRITZSHERIDAN RP, 1988, J PHYCOL, V24, P302, DOI 10.1111/j.1529-8817.1988.tb04470.x; Gaby JC, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau001; Gaby JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042149; Gaby JC, 2011, ENVIRON MICROBIOL, V13, P1790, DOI 10.1111/j.1462-2920.2011.02488.x; Griffiths BS, 2013, FEMS MICROBIOL REV, V37, P112, DOI 10.1111/j.1574-6976.2012.00343.x; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Halloy SRP, 2003, ARCT ANTARCT ALP RES, V35, P248, DOI 10.1657/1523-0430(2003)035[0248:CEOAPB]2.0.CO;2; Hayden HL, 2010, SOIL BIOL BIOCHEM, V42, P1774, DOI 10.1016/j.soilbio.2010.06.015; Herzog S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145575; Hsu SF, 2009, ISME J, V3, P124, DOI 10.1038/ismej.2008.82; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kowalchuk GA, 2001, ANNU REV MICROBIOL, V55, P485, DOI 10.1146/annurev.micro.55.1.485; Koyama A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00516; Lamarche J, 2007, APPL ENVIRON MICROB, V73, P6577, DOI 10.1128/AEM.00812-07; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Lauber CL, 2013, ISME J, V7, P1641, DOI 10.1038/ismej.2013.50; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; LEE WG, 1989, J ECOL, V77, P704, DOI 10.2307/2260980; Leff JW, 2015, P NATL ACAD SCI USA, V112, P10967, DOI 10.1073/pnas.1508382112; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Leppanen SM, 2013, ENVIRON EXP BOT, V90, P62, DOI 10.1016/j.envexpbot.2012.12.006; Liengen T, 1999, CAN J MICROBIOL, V45, P573, DOI 10.1139/cjm-45-7-573; Lindsay EA, 2010, APPL ENVIRON MICROB, V76, P5547, DOI 10.1128/AEM.03054-09; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Luo CW, 2014, APPL ENVIRON MICROB, V80, P1777, DOI 10.1128/AEM.03712-13; Mark AF, 2005, NEW ZEAL J BOT, V43, P235; Mark AF, 1969, ECOLOGY SNOW TUSSOCK, V18, P289; Mark AF, 2013, ECOSYSTEM SERVICES IN NEW ZEALAND: CONDITIONS AND TRENDS, P1; McAlpine KG, 2009, CONSERVATION DELIVER, P81; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Niederberger TD, 2012, FEMS MICROBIOL ECOL, V82, P376, DOI 10.1111/j.1574-6941.2012.01390.x; Nylander J.A.A., MRMODELTEST V2 PROGR; O'Brien SL, 2016, ENVIRON MICROBIOL, V18, P2039, DOI 10.1111/1462-2920.13231; OCONNOR KF, 1983, NEW ZEAL J ECOL, V6, P1; Pan Y, 2014, FEMS MICROBIOL ECOL, V90, P195, DOI 10.1111/1574-6941.12384; Penton CR, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00746; Pereira e Silva MC, 2013, PLOS ONE, V8; Pirie MD, 2010, J BIOGEOGR, V37, P379, DOI 10.1111/j.1365-2699.2009.02205.x; Poly F, 2001, APPL ENVIRON MICROB, V67, P2255, DOI 10.1128/AEM.67.5.2255-2262.2001; R Core Team, 2021, R LANGUAGE ENV STAT; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Ramirez KS, 2010, ECOLOGY, V91, P3463, DOI 10.1890/10-0426.1; Raymond J, 2004, MOL BIOL EVOL, V21, P541, DOI 10.1093/molbev/msh047; Reed SC, 2011, ANNU REV ECOL EVOL S, V42, P489, DOI 10.1146/annurev-ecolsys-102710-145034; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosch C, 2002, APPL ENVIRON MICROB, V68, P3818, DOI 10.1128/AEM.68.8.3818-3829.2002; Rosenberg E, 2014, FAMILY BRADYRHIZOBIA, P135; Sangwan P, 2004, APPL ENVIRON MICROB, V70, P5875, DOI 10.1128/AEM.70.10.5875-5881.2004; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Steenwerth KL, 2002, SOIL BIOL BIOCHEM, V34, P1599, DOI 10.1016/S0038-0717(02)00144-X; STIENSTRA AW, 1994, FEMS MICROBIOL ECOL, V14, P45, DOI 10.1111/j.1574-6941.1994.tb00089.x; Tanentzap AJ, 2012, ECOLOGY, V93, P462, DOI 10.1890/11-1750.1; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; UEDA T, 1995, J BACTERIOL, V177, P1414, DOI 10.1128/jb.177.5.1414-1417.1995; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Wagg C, 2014, P NATL ACAD SCI USA, V111, P5266, DOI 10.1073/pnas.1320054111; Wakelin SA, 2013, SOIL BIOL BIOCHEM, V57, P675, DOI 10.1016/j.soilbio.2012.07.003; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Q, 2013, MBIO, V4, DOI 10.1128/mBio.00592-13; Warnes GR, 2013, GPLOTS VARIOUS R PRO, P2; Weber CF, 2014, SOIL BIOL BIOCHEM, V69, P242, DOI 10.1016/j.soilbio.2013.11.010; White R.P., 2000, GRASSLAND ECOSYSTEMS; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; WILLIAMS P A, 1976, New Zealand Journal of Botany, V14, P29; Youssef NH, 2009, ISME J, V3, P305, DOI 10.1038/ismej.2008.106; Zehr JP, 2003, ENVIRON MICROBIOL, V5, P539, DOI 10.1046/j.1462-2920.2003.00451.x; Zhalnina K, 2015, MICROB ECOL, V69, P395, DOI 10.1007/s00248-014-0530-2	99	10	10	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179652	10.1371/journal.pone.0179652	http://dx.doi.org/10.1371/journal.pone.0179652			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658306	gold, Green Published, Green Submitted			2022-12-27	WOS:000404607900036
J	Hung, YM; Lin, LC; Chen, CM; Chiou, JY; Wang, YH; Wang, PYP; Wei, JCC				Hung, Yao-Min; Lin, Lichi; Chen, Chyong-Mei; Chiou, Jeng-Yuan; Wang, Yu-Hsun; Wang, Paul Yung-Pou; Wei, James Cheng-Chung			The effect of anti-rheumatic medications for coronary artery diseases risk in patients with rheumatoid arthritis might be changed over time: A nationwide population-based cohort study	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; INSURANCE RESEARCH DATABASE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ENDOTHELIAL FUNCTION; PSORIATIC-ARTHRITIS; CELECOXIB; ROFECOXIB; EVENTS; ATHEROSCLEROSIS	Objectives To determine whether anti-rheumatic drug usage is associated with risk of coronary artery diseases (CAD) in incident Rheumatoid Arthritis (RA) patients. Methods Data were obtained from the Taiwan National Health Insurance Research Database. The study cohort comprised 6260 patients who were newly diagnosed with RA between 20012010. The study endpoint was occurrence of CAD according to the ICD-9-CM codes. We used the WHO Defined Daily Dose (DDD) as a tool to assess the drugs exposure. The Cox proportional hazards regression model was used to estimate the hazard ratio (HR) of disease after controlling for demographic and other co-morbidities. When the proportionality assumption is violated, a spline curve of the Scaled Schoenfeld residuals is fitted to demonstrate the estimated effect on CAD over time for drug usage. Results Among RA patients, use of celecoxib, and etoricoxib was associated with significantly decreased incidence of CAD. The adjusted HR(95% CI) of CAD for low-dose celecoxib (DDD1) and high-dose user were 0.47(0.34, 0.65) and 0.37(0.24, 0.58) during the 4 year follow-up time; however, it became 0.98(0.70, 1.37) and1.29(0.85, 1.95). Adjusted HR(95% CI) of CAD for etoricoxib users remained 0.47(0.26, 0.84). Conclusions This study revealed association of decreased CAD risk in RA patients taking 2 different kinds of COX -2i in comparison with nonusers. The effect might be changed over time, after about 4 years.	[Hung, Yao-Min] Kaohsiung Vet Gen Hosp, Dept Emergency Med, Kaohsiung, Taiwan; [Hung, Yao-Min; Chen, Chyong-Mei] Natl Yang Ming Univ, Sch Med, Inst Publ Hlth, Taipei, Taiwan; [Hung, Yao-Min] Yuhing Jr Coll Hlth Care & Management, Kaohsiung, Taiwan; [Lin, Lichi] Oklahoma State Univ, Dept Stat, Stillwater, OK 74078 USA; [Lin, Lichi; Wei, James Cheng-Chung] Chung Shan Med Univ Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Lin, Lichi; Wei, James Cheng-Chung] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Chiou, Jeng-Yuan] Chung Shan Med Univ, Sch Hlth Policy & Management, Taichung, Taiwan; [Wang, Yu-Hsun] Chung Shan Med Univ, Dept Med Res, Taichung, Taiwan; [Wang, Paul Yung-Pou] Kaiser Permanente Baldwin Pk Med Ctr, Div Nephrol, Baldwin Pk, CA USA; [Wei, James Cheng-Chung] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan	Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Oklahoma State University System; Oklahoma State University - Stillwater; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Kaiser Permanente; China Medical University Taiwan	Wei, JCC (corresponding author), Chung Shan Med Univ Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan.; Wei, JCC (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.; Chiou, JY (corresponding author), Chung Shan Med Univ, Sch Hlth Policy & Management, Taichung, Taiwan.; Wei, JCC (corresponding author), China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan.	tom@csmu.edu.tw; jccwei@gmail.com	Wei, James Cheng-Chung/AAL-8947-2020	Wei, James Cheng-Chung/0000-0002-1235-0679	Chung Shan Medical University [CSMU-INT-104-04]	Chung Shan Medical University	This work was supported by the Chung Shan Medical University grant number CSMU-INT-104-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari MC, 2012, SEMIN ARTHRITIS RHEU, V41, P669, DOI 10.1016/j.semarthrit.2011.08.003; ANDERSON TJ, 1995, AM J CARDIOL, V75, pB71, DOI 10.1016/0002-9149(95)80017-M; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Bernatsky S, 2005, RHEUMATOLOGY, V44, P677, DOI 10.1093/rheumatology/keh610; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; Bhosale Uma A, 2014, Niger Med J, V55, P417, DOI 10.4103/0300-1652.140386; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P1468, DOI 10.1016/0735-1097(94)90141-4; Chen HH, 2013, ANN RHEUM DIS, V72, P1206, DOI 10.1136/annrheumdis-2012-201593; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Chenevard R, 2003, CIRCULATION, V107, P405, DOI 10.1161/01.CIR.0000051361.69808.3A; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Chung CP, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2098; Crowson CS, 2013, AM HEART J, V166, P622, DOI 10.1016/j.ahj.2013.07.010; del Rincon I, 2015, ANN RHEUM DIS, V74, P1118, DOI 10.1136/annrheumdis-2013-205058; Dixon WG, 2007, ARTHRITIS RHEUM, V56, P2905, DOI 10.1002/art.22809; FitzGerald GA, 2004, NEW ENGL J MED, V351, P1709, DOI 10.1056/NEJMp048288; FitzGerald GA, 2017, CIRCULATION, V135, P113, DOI 10.1161/CIRCULATIONAHA.116.026324; Food and Drug Administration [Internet]. Silver Spring MD, FDA BRIEF INF; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; Han CL, 2006, J RHEUMATOL, V33, P2167; Hermann M, 2003, CIRCULATION, V108, P2308, DOI 10.1161/01.CIR.0000101683.30157.0B; Hollan I, 2013, AUTOIMMUN REV, V12, P1004, DOI 10.1016/j.autrev.2013.03.013; Jacobsson LTH, 2005, J RHEUMATOL, V32, P1213; Johnsen SP, 2005, ARCH INTERN MED, V165, P978, DOI 10.1001/archinte.165.9.978; Kaplan MJ, 2010, RHEUM DIS CLIN N AM, V36, P405, DOI 10.1016/j.rdc.2010.02.002; Kimmel SE, 2005, ANN INTERN MED, V142, P157, DOI 10.7326/0003-4819-142-3-200502010-00005; Lai CH, 2012, CLIN EXP RHEUMATOL, V30, P358; Levi EH, 2016, AUTOIMMUN REV, V15, P393, DOI 10.1016/j.autrev.2016.01.006; Meune C, 2010, ARCH CARDIOVASC DIS, V103, P253, DOI 10.1016/j.acvd.2010.03.007; Meune C, 2009, RHEUMATOLOGY, V48, P1309, DOI 10.1093/rheumatology/kep252; Naranjo A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2383; Nissen SE, 2016, NEW ENGL J MED, V375, P2519, DOI 10.1056/NEJMoa1611593; Ogdie A, 2015, ANN RHEUM DIS, V74, P326, DOI 10.1136/annrheumdis-2014-205675; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; R Core Team, 2013, R LANG ENV STAT COMP; Ray WA, 2002, LANCET, V360, P1071, DOI 10.1016/S0140-6736(02)11131-7; Roman MJ, 2007, CIRCULATION, V116, P2346, DOI 10.1161/CIRCULATIONAHA.106.678334; Schachinger V, 2000, CIRCULATION, V101, P1899, DOI 10.1161/01.CIR.101.16.1899; Sharma TS, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002867; Solomon DH, 2008, ARTHRIT RHEUM-ARTHR, V59, P1097, DOI 10.1002/art.23911; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Suissa S, 2006, ARTHRIT RHEUM-ARTHR, V55, P531, DOI 10.1002/art.22094; Tam HW, 2017, INT J RHEUM DIS, V20, P363, DOI 10.1111/1756-185X.12986; Therneau T.M., 2000, MODELING SURVIVAL DA; Thomas SL, 2008, ARTHRIT RHEUM-ARTHR, V59, P1314, DOI 10.1002/art.24015; van Halm VP, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2045; World Health Organization, DEF INTR DEF DAILY D; Wu LC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004792	51	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179081	10.1371/journal.pone.0179081	http://dx.doi.org/10.1371/journal.pone.0179081			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658301	Green Published, gold, Green Submitted			2022-12-27	WOS:000404607900014
J	Barnes, DKA; Sands, CJ				Barnes, David K. A.; Sands, Chester J.			Functional group diversity is key to Southern Ocean benthic carbon pathways	PLOS ONE			English	Article							BIODIVERSITY; ECOSYSTEM; GEORGIA; SHELF; SEA	High latitude benthos are globally important in terms of accumulation and storage of ocean carbon, and the feedback this is likely to have on regional warming. Understanding this ecosystem service is important but difficult because of complex taxonomic diversity, history and geography of benthic biomass. Using South Georgia as a model location (where the history and geography of benthic biology is relatively well studied) we investigated whether the composition of functional groups were critical to benthic accumulation, immobilization and burial pathway to sequestration-and also aid their study through simplification of identification. We reclassified [1], [2]) morphotype and carbon mass data to 13 functional groups, for each sample of 32 sites around the South Georgia continental shelf. We investigated the influence on carbon accumulation, immobilization and sequestration estimate by multiple factors including the compositions of functional groups. Functional groups showed high diversity within and between sites, and within and between habitat types. Carbon storage was not linked to a functional group in particular but accumulation and immobilization increased with the number of functional groups present and the presence of hard substrata. Functional groups were also important to carbon burial rate, which increased with the presence of mixed (hard and soft substrata). Functional groups showed high surrogacy for taxonomic composition and were useful for examining contrasting habitat categorization. Functional groups not only aid marine carbon storage investigation by reducing time and the need for team size and speciality, but also important to benthic carbon pathways per se. There is a distinct geography to seabed carbon storage; seabed boulder-fields are hotspots of carbon accumulation and immobilization, whilst the interface between such boulder-fields and sediments are key places for burial and sequestration.	[Barnes, David K. A.; Sands, Chester J.] British Antarctic Survey, Nat Environm Res Council, Cambridge, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Barnes, DKA (corresponding author), British Antarctic Survey, Nat Environm Res Council, Cambridge, England.	dkab@bas.ac.uk		Sands, Chester/0000-0003-1028-0328; Barnes, David/0000-0002-9076-7867	Darwin Initiative (DEFRA) [18-019, EIDCF013]; Darwin Initiative grants, DEFRA [18-019, EIDCF013]; Natural Environment Research Council [bas0100036] Funding Source: researchfish; NERC [bas0100036] Funding Source: UKRI	Darwin Initiative (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA)); Darwin Initiative grants, DEFRA; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The funders Darwin Initiative (DEFRA), through grants 18-019 and EIDCF013, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the crew of RRS James Clark Ross and the scientists who participated on benthic scientific cruises JR262 and JR287. The South Georgia component of both cruises was funded by Darwin Initiative grants (18-019 and EIDCF013), DEFRA. Thanks also to Carl Robinson for technical development of the Shelf Underwater Camera System (SUCS) and Laura Gerrish for construction of the map in Fig 1. Finally we thank K Mintenbeck and an anonymous referee for helpful suggestions leading to an improved ms. Neither authors have conflicts of interest to declare. This work forms part of the Antarctic Seabed Carbon Capture Change project (www.asece.co.uk)	Arrigo KR, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004551; Barlow NLM, 2016, QUATERNARY SCI REV, V154, P157, DOI 10.1016/j.quascirev.2016.11.007; Barnes DKA, 2015, CURR BIOL, V25, pR789, DOI 10.1016/j.cub.2015.07.042; Barnes DKA, 2017, GLOBAL CHANGE BIOL, V23, P2649, DOI 10.1111/gcb.13523; Barnes DKA, 2016, J BIOGEOGR, V43, P2391, DOI 10.1111/jbi.12855; Barnes DKA, 2016, GLOBAL CHANGE BIOL, V22, P1110, DOI 10.1111/gcb.13157; Barnes DKA, 2016, GLOB CHANGE BIOL; Bates NR, 2009, BIOGEOSCIENCES, V6, P2433, DOI 10.5194/bg-6-2433-2009; Bates NR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027028; Benedet RA, 2015, BOTTOM LONGLINE FISH; Bremner J, 2003, MAR ECOL PROG SER, V254, P11, DOI 10.3354/meps254011; Buschke FT, 2011, AFR INVERTEBR, V52, P217, DOI 10.5733/afin.052.0112; Douglass LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100551; Dunlop KM, 2014, POLAR BIOL, V37, P1741, DOI 10.1007/s00300-014-1558-y; Fillinger L, 2013, CURR BIOL, V23, P1330, DOI 10.1016/j.cub.2013.05.051; Findlay HS, 2015, POLAR RES, V34; Francois F, 2002, MAR ECOL PROG SER, V229, P127, DOI 10.3354/meps229127; Giller PS, 2004, OIKOS, V104, P423, DOI 10.1111/j.0030-1299.2004.13253.x; Graham AGC, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC001993; Grant S., 2006, BIOREGIONALISATION S; Gutt J, 2015, GLOBAL CHANGE BIOL, V21, P1434, DOI 10.1111/gcb.12794; Heemsbergen DA, 2004, SCIENCE, V306, P1019, DOI 10.1126/science.1101865; Hodgson DA, 2014, QUATERNARY SCI REV, V89, P129, DOI 10.1016/j.quascirev.2013.12.005; Hogg OT, 2016, SCI REP-UK, V6, DOI 10.1038/srep33163; Hogg OT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019795; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; Norling K, 2007, MAR ECOL PROG SER, V332, P11, DOI 10.3354/meps332011; Parker SJ, 2009, WGTASO20099 CCAMI, V9; Pearson TH, 2001, OCEANOGR MAR BIOL, V39, P233; Peck LS, 2010, GLOBAL CHANGE BIOL, V16, P2614, DOI 10.1111/j.1365-2486.2009.02071.x; Pinkerton MH, 2010, CCAMLR SCI, V17, P1; Rodrigues ASL, 2007, ANNU REV ECOL EVOL S, V38, P713, DOI 10.1146/annurev.ecolsys.38.091206.095737; ROWE GT, 1988, CONT SHELF RES, V8, P511, DOI 10.1016/0278-4343(88)90066-0; SALONEN K, 1976, LIMNOL OCEANOGR, V21, P724, DOI 10.4319/lo.1976.21.5.0724; Schmidt K, 2016, CURR BIOL, V26, P2667, DOI 10.1016/j.cub.2016.07.058	36	25	25	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179735	10.1371/journal.pone.0179735	http://dx.doi.org/10.1371/journal.pone.0179735			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654664	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000404541500028
J	Tarleton, EK; Littenberg, B; MacLean, CD; Kennedy, AG; Daley, C				Tarleton, Emily K.; Littenberg, Benjamin; MacLean, Charles D.; Kennedy, Amanda G.; Daley, Christopher			Role of magnesium supplementation in the treatment of depression: A randomized clinical trial	PLOS ONE			English	Article							MAJOR DEPRESSION; PRIMARY-CARE; DOUBLE-BLIND; ANXIETY; ADULTS; PREVALENCE; SYMPTOMS; VALIDITY; THERAPY; HEALTH	Current treatment options for depression are limited by efficacy, cost, availability, side effects, and acceptability to patients. Several studies have looked at the association between magnesium and depression, yet its role in symptom management is unclear. The objective of this trial was to test whether supplementation with over-the-counter magnesium chloride improves symptoms of depression. An open-label, blocked, randomized, crossover trial was carried out in outpatient primary care clinics on 126 adults (mean age 52; 38% male) diagnosed with and currently experiencing mild-to-moderate symptoms with Patient Health Questionnaire-9 (PHQ-9) scores of 5-19. The intervention was 6 weeks of active treatment (248 mg of elemental magnesium per day) compared to 6 weeks of control (no treatment). Assessments of depression symptoms were completed at bi-weekly phone calls. The primary outcome was the net difference in the change in depression symptoms from baseline to the end of each treatment period. Secondary outcomes included changes in anxiety symptoms as well as adherence to the supplement regimen, appearance of adverse effects, and intention to use magnesium supplements in the future. Between June 2015 and May 2016, 112 participants provided analyzable data. Consumption of magnesium chloride for 6 weeks resulted in a clinically significant net improvement in PHQ-9 scores of -6.0 points (CI -7.9, -4.2; P < 0.001) and net improvement in Generalized Anxiety Disorders-7 scores of -4.5 points (CI -6.6, -2.4; P < 0.001). Average adherence was 83% by pill count. The supplements were well tolerated and 61% of participants reported they would use magnesium in the future. Similar effects were observed regardless of age, gender, baseline severity of depression, baseline magnesium level, or use of antidepressant treatments. Effects were observed within two weeks. Magnesium is effective for mild-to-moderate depression in adults. It works quickly and is well tolerated without the need for close monitoring for toxicity.	[Tarleton, Emily K.; Littenberg, Benjamin; MacLean, Charles D.; Kennedy, Amanda G.] Univ Vermont, Ctr Clin & Translat Sci, Burlington, VT 05405 USA; [Littenberg, Benjamin; MacLean, Charles D.; Kennedy, Amanda G.] Univ Vermont, Dept Med, Burlington, VT USA; [Daley, Christopher] Univ Vermont, Dept Psychiat, Burlington, VT USA	University of Vermont; University of Vermont; University of Vermont	Tarleton, EK (corresponding author), Univ Vermont, Ctr Clin & Translat Sci, Burlington, VT 05405 USA.	Emily.tarleton@uvm.edu		Littenberg, Benjamin/0000-0002-7647-1808; Kennedy, Amanda/0000-0002-7540-4961	University of Vermont	University of Vermont	This work was supported by the Henry and Carleen Tufo fund of the University of Vermont. The sponsor had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript.	Bagis S, 2013, RHEUMATOL INT, V33, P167, DOI 10.1007/s00296-011-2334-8; Barragan-Rodriguez L, 2008, MAGNESIUM RES, V21, P218; Camardese G, 2012, NUTR NEUROSCI, V15, P78, DOI 10.1179/1476830512Y.0000000002; Chacko SA, 2011, AM J CLIN NUTR, V93, P463, DOI 10.3945/ajcn.110.002949; Cheungpasitporn W, 2015, INTERN MED J, V45, P436, DOI 10.1111/imj.12682; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; De Souza MC, 2000, J WOMEN HEALTH GEN-B, V9, P131, DOI 10.1089/152460900318623; Derom ML, 2013, NUTR NEUROSCI, V16, P191, DOI 10.1179/1476830512Y.0000000044; Derom ML, 2012, J NUTR, V142, P1053, DOI 10.3945/jn.111.155572; Durlach J, 2005, MAGNESIUM RES, V18, P187; Eby GA, 2006, MED HYPOTHESES, V67, P362, DOI 10.1016/j.mehy.2006.01.047; Grober U, 2015, NUTRIENTS, V7, P8199, DOI 10.3390/nu7095388; Hamilton CM, 2011, AM J EPIDEMIOL, V174, P253, DOI 10.1093/aje/kwr193; Hoifodt RS, 2011, FAM PRACT, V28, P489, DOI 10.1093/fampra/cmr017; Huang JH, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-41; Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, 1997, DIET REF INT CALC PH; ISERI LT, 1984, AM HEART J, V108, P188, DOI 10.1016/0002-8703(84)90572-6; Jacka FN, 2009, AUST NZ J PSYCHIAT, V43, P45, DOI 10.1080/00048670802534408; Jahnen-Dechent W, 2012, CLIN KIDNEY J, V5, P3, DOI 10.1093/ndtplus/sfr163; Kessler RC, 2012, INT J METH PSYCH RES, V21, P169, DOI 10.1002/mpr.1359; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Littenberg Benjamin, 2006, BMC Med Res Methodol, V6, P20, DOI 10.1186/1471-2288-6-20; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P664, DOI 10.1016/j.pnpbp.2010.06.014; Martin R W, 1998, J Miss State Med Assoc, V39, P180; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Nechifor M, 2009, MAGNESIUM RES, V22, p163S; Nutting PA, 2002, J GEN INTERN MED, V17, P103, DOI 10.1046/j.1525-1497.2002.10128.x; Pinto-Meza A, 2005, J GEN INTERN MED, V20, P738, DOI 10.1111/j.1525-1497.2005.0144.x; Rajizadeh A, 2017, NUTRITION, V35, P56, DOI 10.1016/j.nut.2016.10.014; Sarris J, 2016, AM J PSYCHIAT, V173, P575, DOI 10.1176/appi.ajp.2016.15091228; Serefko A, 2013, PHARMACOL REP, V65, P547, DOI 10.1016/S1734-1140(13)71032-6; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Tarleton EK, 2015, J AM BOARD FAM MED, V28, P249, DOI 10.3122/jabfm.2015.02.140176; Trevino K, 2014, ANN CLIN PSYCHIATRY, V26, P222; U.S. Department of Veteran Affairs, 2020, VADOD CLIN PRACTICE; Wittayanukorn S, 2014, GEN HOSP PSYCHIAT, V36, P330, DOI 10.1016/j.genhosppsych.2013.12.009; Yary T, 2016, J AFFECT DISORDERS, V193, P94, DOI 10.1016/j.jad.2015.12.056	37	51	51	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0180067	10.1371/journal.pone.0180067	http://dx.doi.org/10.1371/journal.pone.0180067			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654669	Green Published, gold			2022-12-27	WOS:000404541500054
J	Han, ZP; Gao, Y; Gao, Y; Huang, QY				Han, Zengpeng; Gao, Yue; Gao, Yue; Huang, Qingyang			Functional annotation of Alzheimer's disease associated loci revealed by GWASs	PLOS ONE			English	Article							PROTEIN INTERACTION NETWORKS; GENOME-WIDE IDENTIFICATION; VARIANTS; BINDING; ONSET; SNPS; PHOSPHORYLATION; POLYMORPHISMS; EXPRESSION; COMMON	Genome-wide association studies (GWASs) discovered a number of SNPs and genes associated with Alzheimer's disease (AD). However, how these SNPs and genes influence the liability to AD is not fully understood. We deployed computational approaches to explore the function and action mechanisms of AD -related SNPs and genes identified by GWASs, including the effects of 195 GWAS lead SNPs and 338 proxy SNPs on miRNAs binding and protein phosphorylation, their RegulomeDB and 3DSNP scores, and gene ontology, pathway enrichment and protein-protein interaction network of 126 AD-associated genes. Our computational analysis identified 6 lead SNPs (rs10119, rs1048699, rs148763909, rs610932, rs6857 and rs714948) and 2 proxy SNPs (rs12539172 and rs2847655) that potentially impacted the miRNA binding. Lead SNP rs2296160 and proxy SNPs rs679620 and rs2228145 were identified as PhosSNPs potentially influencing protein phosphorylation. AD-associated genes showed enrichment of "regulation of beta-amyloid formation", "regulation of neurofibrillary tangle assembly", "leukocyte mediated immunity" and "protein-lipid complex assembly" signaling pathway. Protein-protein interaction network and functional module analyses identified highly-interconnected "hub" genes (APOE, PICALM, BIN1, ABCA7, CD2AP, CLU, CR1, MS4A4E and MS4A6A) and bottleneck genes (APOE, TOMM40, NME8, PICALM, CD2AP, ZCWPW1, FAM180B, GAB2 and PTK2B) that created three tight subnetworks. Our results provided the targets for further experimental assessment and further insight on AD pathophysiology.	[Han, Zengpeng; Gao, Yue; Gao, Yue; Huang, Qingyang] Cent China Normal Univ, Sch Life Sci, Wuhan, Peoples R China	Central China Normal University	Huang, QY (corresponding author), Cent China Normal Univ, Sch Life Sci, Wuhan, Peoples R China.	huangqy@mail.ccnu.cn		Han, Zengpeng/0000-0001-7451-6390	National Natural Science Foundation of China [31371275]; Students Innovation Training Plan Project of Central China Normal University [62015186]; self-determined research funds of Central China Normal University [CCNU16JCZX03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Students Innovation Training Plan Project of Central China Normal University; self-determined research funds of Central China Normal University	This work was supported by the National Natural Science Foundation of China (No. 31371275), Students Innovation Training Plan Project of Central China Normal University (No. 62015186) and self-determined research funds of Central China Normal University (No. CCNU16JCZX03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (No. 31371275), Students Innovation Training Plan Project of Central China Normal University (No. B2015186) and self-determined research funds of Central China Normal University (No. CCNU16JCZX03).	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Cheng MR, 2017, J DIABETES, V9, P362, DOI 10.1111/1753-0407.12421; Claussnitzer M, 2014, CELL, V156, P343, DOI 10.1016/j.cell.2013.10.058; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Czerwinska U, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0189-4; Delay C, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0186-x; Deng FY, 2013, J BONE MINER RES, V28, P2498, DOI 10.1002/jbmr.1997; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Ghanbari M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28387; Ghanbari M, 2015, CIRC-CARDIOVASC GENE, V8, P473, DOI 10.1161/CIRCGENETICS.114.000968; Gjoneska E, 2015, NATURE, V518, P365, DOI 10.1038/nature14252; Gong J, 2015, DATABASE, V2015, P1; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hauw JJ, 2002, CR BIOL, V325, P655, DOI 10.1016/S1631-0691(02)01479-8; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Huang QY, 2015, J GENET GENOMICS, V42, P87, DOI 10.1016/j.jgg.2015.02.001; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Karch Celeste M, 2015, Biol Psychiatry, V77, P43, DOI 10.1016/j.biopsych.2014.05.006; Ki CS, 2002, NEUROSCI LETT, V319, P75, DOI 10.1016/S0304-3940(01)02559-9; Lambert JC, 2010, J ALZHEIMERS DIS, V20, P1107, DOI 10.3233/JAD-2010-100018; Lu YM, 2017, NUCLEIC ACIDS RES, V45, pD643, DOI 10.1093/nar/gkw1022; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Meyer JM, 1998, AM J MED GENET, V81, P92, DOI 10.1002/(SICI)1096-8628(19980207)81:1<92::AID-AJMG16>3.0.CO;2-R; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Niu TH, 2016, J BONE MINER RES, V31, P358, DOI 10.1002/jbmr.2687; Qin LJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150070; Ren J, 2010, MOL CELL PROTEOMICS, V9, P623, DOI 10.1074/mcp.M900273-MCP200; Rosenthal SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095152; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030	40	23	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179677	10.1371/journal.pone.0179677	http://dx.doi.org/10.1371/journal.pone.0179677			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650998	Green Published, Green Submitted, gold			2022-12-27	WOS:000404537300006
J	Nishigami, T; Mibu, A; Tanaka, K; Yamashita, Y; Yamada, E; Wand, BM; Catley, MJ; Stanton, TR; Moseley, GL				Nishigami, Tomohiko; Mibu, Akira; Tanaka, Katsuyoshi; Yamashita, Yuh; Yamada, Eiji; Wand, Benedict M.; Catley, Mark J.; Stanton, Tasha R.; Moseley, G. Lorimer			Development and psychometric properties of knee-specific body-perception questionnaire in people with knee osteoarthritis: The Fremantle Knee Awareness Questionnaire	PLOS ONE			English	Article							LOW-BACK-PAIN; GENERIC CORE SCALES; RASCH ANALYSIS; MOTOR IMAGERY; SELF-PERCEPTION; TACTILE ACUITY; VERSION; PROPRIOCEPTION; SENSITIZATION; ASSOCIATIONS	Background Recent systematic reviews have demonstrated that pain associated with knee osteoarthritis (OA) is a complex phenomenon that involves various contributors. People with knee OA exhibit symptoms of impaired body-perception, including reduced tactile acuity, impairments in limb laterality recognition, and degraded proprioceptive acuity. The Fremantle Back Awareness Questionnaire (FreBAQ) was developed to assess body-perception specific to the back in people with chronic low back pain. The aim of this study was to develop and assess the psychometric properties of a knee-specific version of the FreBAQ-J (FreKAQ-J), determine whether people with knee pain experience perceptual impairments and investigate the relationship between disturbed self-perception and clinical status. Methods Sixty-five people with knee OA completed the FreKAQ-J. A subset of the participants completed the FreKAQ-J again two-weeks later. Rasch analysis was used to assess item order, targeting, category ordering, unidimensionality, person fit, internal consistency, and differential item functioning. Validity was investigated by examining the relationship between the FreKAQ-J and clinical valuables. Results The FreKAQ-J had acceptable internal consistency, unidimensionality, good test-retest reliability, and was functional on the category rating scale. The FreKAQ-J was significantly correlated with pain in motion, disability, pain-related catastrophizing, fear of movement, and anxiety symptomatology. Conclusions We developed FreKAQ-J by modifying the FreBAQ-J. The FreKAQ-J fits the Rasch measurement model well and is suitable for use in people with knee OA. Altered body perception may be worth evaluating when managing people with knee OA.	[Nishigami, Tomohiko] Konan Womans Univ, Dept Nursing & Phys Therapy, Kobe, Hyogo, Japan; [Mibu, Akira; Tanaka, Katsuyoshi] Tanabe Orthopaed, Dept Rehabil, Osaka, Osaka, Japan; [Yamashita, Yuh] Morinaga Orthoped Clin, Dept Rehabil, Saga, Saga, Japan; [Yamada, Eiji] Kaisei Hosp, Joint Surg Ctr, Sakaide, Kagawa, Japan; [Wand, Benedict M.] Univ Notre Dame Australia, Sch Physiotherapy, Fremantle, WA, Australia; [Catley, Mark J.; Stanton, Tasha R.; Moseley, G. Lorimer] Univ South Australia, Sansom Inst Hlth Res, Adelaide, SA, Australia; [Stanton, Tasha R.; Moseley, G. Lorimer] Neurosci Res Australia, Sydney, NSW, Australia	University of Notre Dame Australia; University of South Australia; Neuroscience Research Australia	Nishigami, T (corresponding author), Konan Womans Univ, Dept Nursing & Phys Therapy, Kobe, Hyogo, Japan.	t-nishi@konan-wu.ac.jp	Moseley, Lorimer/A-7095-2009; Stanton, Tasha/F-4038-2013; Catley, Mark J/K-5939-2015	Moseley, Lorimer/0000-0002-3750-4945; Stanton, Tasha/0000-0001-7106-4456; Catley, Mark J/0000-0002-1582-4390; Wand, Benedict/0000-0002-0297-0292				ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Baliki MN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106133; Baliki MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026010; Bedson J, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-116; Bijlsma JWJ, 2011, LANCET, V377, P2115, DOI 10.1016/S0140-6736(11)60243-2; Birklein F, 2015, PAIN, V156, pS94, DOI 10.1097/01.j.pain.0000460344.54470.20; Bond TG., 2020, APPL RASCH MODEL FUN; Bowering KJ, 2014, CLIN J PAIN, V30, P1070, DOI 10.1097/AJP.0000000000000066; Branco M, 2016, EUR J PHYS REHAB MED, V52, P422; Bray H, 2011, BRIT J SPORT MED, V45, P168, DOI 10.1136/bjsm.2009.061978; Cakir S, 2014, AM J PHYS MED REHAB, V93, P405, DOI 10.1097/PHM.0000000000000033; Cammarata ML, 2012, ARTHRIT CARE RES, V64, P735, DOI 10.1002/acr.21589; Catley MJ, 2014, J PAIN, V15, P985, DOI 10.1016/j.jpain.2014.06.009; Chang AH, 2014, J BIOMECH, V47, P360, DOI 10.1016/j.jbiomech.2013.11.024; Cronbach LJ, 2004, EDUC PSYCHOL MEAS, V64, P391, DOI 10.1177/0013164404266386; Dawson J, 1998, J BONE JOINT SURG BR, V80B, P63, DOI 10.1302/0301-620X.80B1.7859; Fingleton C, 2015, OSTEOARTHR CARTILAGE, V23, P1043, DOI 10.1016/j.joca.2015.02.163; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Fleiss JL, 1999, DESIGN ANAL CLIN EXP; Hungi N, 2005, APPL RASCH MEASUREME; Jafari P, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-27; Kikuchi N, 2015, J ORTHOP SCI, V20, P985, DOI 10.1007/s00776-015-0751-3; Kook SH, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-41; Kugaya A, 1998, JPN J CLIN ONCOL, V28, P333, DOI 10.1093/jjco/28.5.333; Lee AS, 2010, ARCH PHYS MED REHAB, V91, P1327, DOI 10.1016/j.apmr.2010.06.004; Lewis JS, 2010, PAIN, V149, P463, DOI 10.1016/j.pain.2010.02.007; Linacre JM., 2012, USERS GUIDE WINSTEPS; Linacre John M, 2002, J Appl Meas, V3, P85; Lluch E, 2014, EUR J PAIN, V18, P1367, DOI 10.1002/j.1532-2149.2014.499.x; Lotze Martin, 2007, Curr Rheumatol Rep, V9, P488; Mallinson T, 2007, OPTOMETRY VISION SCI, V84, P675, DOI 10.1097/OPX.0b013e3181339f44; Matsudaira T, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-42; Matsuoka H., 2007, SHINSHIN IGAKU, V47, P95, DOI DOI 10.15064/jjpm.47.2_95; Moreton BJ, 2015, J REHABIL MED, V47, P655, DOI 10.2340/16501977-1977; Moseley GL, 2008, PAIN, V140, P239, DOI 10.1016/j.pain.2008.08.001; Moseley GL, 2004, NEUROLOGY, V62, P2182, DOI 10.1212/01.WNL.0000130156.05828.43; Nishigami T, PAIN PRACT IN PRESS; Pleger B, 2006, NEUROIMAGE, V32, P503, DOI 10.1016/j.neuroimage.2006.03.045; Raiche G., 2005, RASCH MEASUREMENT T, V19, P1012; Ramp M, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-58; Rasch G., 1960, PROBABILISTIC MODELS; Rodriguez-Raecke R, 2009, J NEUROSCI, V29, P13746, DOI 10.1523/JNEUROSCI.3687-09.2009; Shanahan CJ, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0676-4; Silverwood V, 2015, OSTEOARTHR CARTILAGE, V23, P507, DOI 10.1016/j.joca.2014.11.019; Stanton TR, 2013, RHEUMATOLOGY, V52, P1509, DOI 10.1093/rheumatology/ket139; Stanton TR, 2012, RHEUMATOLOGY, V51, P1455, DOI 10.1093/rheumatology/kes048; Sterzi S, 2016, EUR J PHYS REHAB MED, V52, P321; Streiner D. L., 2003, HLTH MEASUREMENT SCA; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Szebenyi B, 2006, ARTHRITIS RHEUM-US, V54, P230, DOI 10.1002/art.21534; Takeuchi R, 2011, ARCH ORTHOP TRAUM SU, V131, P247, DOI 10.1007/s00402-010-1185-1; Tennant A, 2004, VALUE HEALTH, V7, pS22, DOI 10.1111/j.1524-4733.2004.7s106.x; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Urquhart DM, 2015, SEMIN ARTHRITIS RHEU, V44, P445, DOI 10.1016/j.semarthrit.2014.07.005; VLAEYEN JWS, 1995, PAIN, V62, P363, DOI 10.1016/0304-3959(94)00279-N; Wand BM, 2010, PHYSIOTHERAPY, V96, P317, DOI 10.1016/j.physio.2010.02.005; Wand BM, 2016, J PAIN, V17, P1001, DOI 10.1016/j.jpain.2016.06.003; Wand BM, 2014, J BACK MUSCULOSKELET, V27, P463, DOI 10.3233/BMR-140467; Wright BD., 1994, RASCH MEASUREMENT T, V8, P370, DOI DOI 10.1177/01461672012710004; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	60	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179225	10.1371/journal.pone.0179225	http://dx.doi.org/10.1371/journal.pone.0179225			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650969	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000404537300003
J	Wang, BY; Yang, J; Li, ST; Lv, M; Chen, ZL; Li, EX; Yi, M; Yang, J				Wang, Biyuan; Yang, Jiao; Li, Shuting; Lv, Meng; Chen, Zheling; Li, Enxiao; Yi, Min; Yang, Jin			Tumor location as a novel high risk parameter for stage II colorectal cancers	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; SIDED COLON-CANCER; SURGICAL ADJUVANT BREAST; MISMATCH REPAIR STATUS; MICROSATELLITE-INSTABILITY; BRAF MUTATION; DUKES-B; CHEMOTHERAPY; FLUOROURACIL; SURVIVAL	Current studies do not accurately evaluate the influence of tumor location on survival of colorectal cancer patients. This study aimed to explore whether tumor location could be identified as another high-risk factor in stage II colorectal cancer by using data identified from the Surveillance, Epidemiology, and End Results database. All colorectal cancer patients between 2004 and 2008 were grouped into three according to tumor location. Of 33,789 patients diagnosed with stage II colorectal cancer, 46.8% were right colon cancer, 37.5% were left colon cancer and 15.7% were rectal cancer. The 5-year cancer specific survivals were examined. Right colon cancer was associated with the female sex, older age (> 50), and having over 12 lymph nodes resected. Conversely, rectal cancer was associated with the male sex, patients younger than 50 years of age and insufficient lymph node resection. The characteristics of left colon cancer were between them and associated with Asian or Pacific Islander populations, T4 stage, and Grade II patients. The prognostic differences between three groups were significant and retained after stratification by T stage, histological grade, number of regional nodes dissected, age at diagnose, race and sex. Furthermore, the significant difference of location was retained as an independent high-risk parameter. Thus, stage II colorectal cancers of different locations have different clinic-pathological features and cancer-specific survivals, and tumor location should be recognized as another high-risk parameter in stage II colorectal cancer.	[Wang, Biyuan; Yang, Jiao; Li, Shuting; Lv, Meng; Chen, Zheling; Li, Enxiao; Yang, Jin] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Oncol 1Med, Xian, Shaanxi Provinc, Peoples R China; [Yi, Min] Univ Texas MD Anderson Canc Ctr, Breast Surg Oncol, Houston, TX 77030 USA	Xi'an Jiaotong University; University of Texas System; UTMD Anderson Cancer Center	Yang, J (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Oncol 1Med, Xian, Shaanxi Provinc, Peoples R China.	yangjin@mail.xjtu.edu	Chen, Zheling/L-6089-2019					Andre T, 2015, J CLIN ONCOL, V33, P4176, DOI 10.1200/JCO.2015.63.4238; Andreoni Bruno, 2007, World J Surg Oncol, V5, P73, DOI 10.1186/1477-7819-5-73; [Anonymous], 1985, NEW ENGL J MED, V312, P1465; Arrington AK, 2012, INT J MOL SCI, V13, P12153, DOI 10.3390/ijms131012153; Benedix F, COLON CARCINOMA CLAS, P1532; Benedix F, 2010, DIS COLON RECTUM, V53, P57, DOI 10.1007/DCR.0b013e3181c703a4; Benson AB, 2004, J CLIN ONCOL, V22, P3408, DOI 10.1200/JCO.2004.05.063; Bertagnolli MM, 2011, J CLIN ONCOL, V29, P3153, DOI 10.1200/JCO.2010.33.0092; Cancer Genome Atlas Network, 2012, NATURE, V487, P330, DOI [10.1038/nature11252, DOI 10.1038/NATURE11252]; Colussi D, 2013, INT J MOL SCI, V14, P16365, DOI 10.3390/ijms140816365; Cunningham JM, 1998, CANCER RES, V58, P3455; Elsaleh H, 2000, LANCET, V355, P1745, DOI 10.1016/S0140-6736(00)02261-3; Figueredo A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005390.pub2; Gervaz P, 2001, DIS COLON RECTUM, V44, P364, DOI 10.1007/BF02234734; Gryfe R, 2000, NEW ENGL J MED, V342, P69, DOI 10.1056/NEJM200001133420201; Hughes LAE, 2012, BBA-REV CANCER, V1825, P77, DOI 10.1016/j.bbcan.2011.10.005; Iacopetta B, 2002, INT J CANCER, V101, P403, DOI 10.1002/ijc.10635; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jernvall P, 1999, EUR J CANCER, V35, P197, DOI 10.1016/S0959-8049(98)00306-2; Joern F, 2015, INT J COLORECTAL DIS, V30, P797, DOI 10.1007/s00384-015-2219-5; Kim CW, 2013, ANN SURG ONCOL, V20, P2914, DOI 10.1245/s10434-013-2919-4; KIM HG, 1994, AM J PATHOL, V145, P148; Klingbiel D, 2015, ANN ONCOL, V26, P126, DOI 10.1093/annonc/mdu499; Kocarnik JM, 2015, GASTROENTEROL REP, V3, P269, DOI 10.1093/gastro/gov046; KROOK JE, 1991, NEW ENGL J MED, V324, P709, DOI 10.1056/NEJM199103143241101; Kudryavtseva AV, 2016, ONCOTARGET, V7, P53959, DOI 10.18632/oncotarget.9796; LaPointe LC, MAP DIFFERENTIAL TRA, P1531; Lee S, 2008, PATHOL INT, V58, P104, DOI 10.1111/j.1440-1827.2007.02197.x; Lee YA, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063255, 10.1371/journal.pone.0054889]; Leggett B, 2010, GASTROENTEROLOGY, V138, P2088, DOI 10.1053/j.gastro.2009.12.066; Mamounas E, 1999, J CLIN ONCOL, V17, P1349, DOI 10.1200/JCO.1999.17.5.1349; Marsoni S, 2001, SEMIN ONCOL, V28, P14, DOI 10.1053/sonc.2001.19723; Meguid RA, 2008, ANN SURG ONCOL, V15, P2388, DOI 10.1245/s10434-008-0015-y; Minoo, 2010, INT J ONCOLOGY, V37; Missiaglia E, 2014, ANN ONCOL, V25, P1995, DOI 10.1093/annonc/mdu275; Nawa T, 2008, J GASTROEN HEPATOL, V23, P418, DOI 10.1111/j.1440-1746.2007.04923.x; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Quah HM, 2008, DIS COLON RECTUM, V51, P503, DOI 10.1007/s10350-008-9246-z; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Roth AD, 2010, J CLIN ONCOL, V28, P466, DOI 10.1200/JCO.2009.23.3452; Rutter CM, 2013, JNCI-J NATL CANCER I, V105, P1806, DOI 10.1093/jnci/djt299; Sargent DJ, 2010, J CLIN ONCOL, V28, P3219, DOI 10.1200/JCO.2009.27.1825; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sinicrope FA, 2011, JNCI-J NATL CANCER I, V103, P863, DOI 10.1093/jnci/djr153; Sinicrope FA, 2010, NAT REV CLIN ONCOL, V7, P174, DOI 10.1038/nrclinonc.2009.235; TAYLOR I, 1985, BRIT J SURG, V72, P359, DOI 10.1002/bjs.1800720509; Teufel A, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1404-9; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Weiss JM, 2011, J CLIN ONCOL, V29, P4401, DOI 10.1200/JCO.2011.36.4414; WOLMARK N, 1990, J CLIN ONCOL, V8, P1466, DOI 10.1200/JCO.1990.8.9.1466; Worthley DL, DNA METHYLATION NORM, P1476; Yamauchi M, 2012, GUT, V61, P794, DOI 10.1136/gutjnl-2012-302014; Yang J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167540; Yokota T, 2012, ANTI-CANCER AGENT ME, V12, P163, DOI 10.2174/187152012799014968	55	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179910	10.1371/journal.pone.0179910	http://dx.doi.org/10.1371/journal.pone.0179910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644878	Green Submitted, gold, Green Published			2022-12-27	WOS:000404145100049
J	Bwogi, J; Jere, KC; Karamagi, C; Byarugaba, DK; Namuwulya, P; Baliraine, FN; Desselberger, U; Iturriza-Gomara, M				Bwogi, Josephine; Jere, Khuzwayo C.; Karamagi, Charles; Byarugaba, Denis K.; Namuwulya, Prossy; Baliraine, Frederick N.; Desselberger, Ulrich; Iturriza-Gomara, Miren			Whole genome analysis of selected human and animal rotaviruses identified in Uganda from 2012 to 2014 reveals complex genome reassortment events between human, bovine, caprine and porcine strains	PLOS ONE			English	Article							GROUP-A ROTAVIRUS; SEQUENCE-INDEPENDENT AMPLIFICATION; ACUTE DIARRHEA; MOLECULAR CHARACTERIZATION; ZOONOTIC TRANSMISSION; WA-LIKE; DIVERSITY; CHILDREN; EPIDEMIOLOGY; CLASSIFICATION	Rotaviruses of species A (RVA) are a common cause of diarrhoea in children and the young of various other mammals and birds worldwide. To investigate possible interspecies transmission of RVAs, whole genomes of 18 human and 6 domestic animal RVA strains identified in Uganda between 2012 and 2014 were sequenced using the Illumina HiSeq platform. The backbone of the human RVA strains had either a Wa - or a DS-1-like genetic constellation. One human strain was a Wa-like mono-reassortant containing a DS-1-like VP2 gene of possible animal origin. All eleven genes of one bovine RVA strain were closely related to those of human RVAs. One caprine strain had a mixed genotype backbone, suggesting that it emerged from multiple reassortment events involving different host species. The porcine RVA strains had mixed genotype backbones with possible multiple reassortant events with strains of human and bovine origin. Overall, whole genome characterisation of rotaviruses found in domestic animals in Uganda strongly suggested the presence of human-to animal RVA transmission, with concomitant circulation of multi-reassortant strains potentially derived from complex interspecies transmission events. However, whole genome data from the human RVA strains causing moderate and severe diarrhoea in under-fives in Uganda indicated that they were primarily transmitted from person-to-person.	[Bwogi, Josephine; Namuwulya, Prossy] Uganda Virus Res Inst, EPI Lab, Entebbe, Uganda; [Bwogi, Josephine; Karamagi, Charles] Makerere Univ, Dept Paediat & Child Hlth, Coll Hlth Sci, Kampala, Uganda; [Jere, Khuzwayo C.; Iturriza-Gomara, Miren] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool, Merseyside, England; [Jere, Khuzwayo C.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Dept Med Lab Sci, Blantyre, Malawi; [Byarugaba, Denis K.] Makerere Univ, Dept Microbiol, Coll Vet Med & Biosecur, Kampala, Uganda; [Baliraine, Frederick N.] LeTourneau Univ, Dept Biol & Kinesiol, Longview, TX USA; [Desselberger, Ulrich] Univ Cambridge, Dept Med, Cambridge, England	Uganda Virus Research Institute; Makerere University; University of Liverpool; University of Malawi; Makerere University; University of Cambridge	Bwogi, J (corresponding author), Uganda Virus Res Inst, EPI Lab, Entebbe, Uganda.; Bwogi, J (corresponding author), Makerere Univ, Dept Paediat & Child Hlth, Coll Hlth Sci, Kampala, Uganda.	josephinebwn@yahoo.co.uk	Bwogi, Josephine/AGJ-4829-2022; Gomara, Miren Iturriza/B-4351-2013; Baliraine, Frederick/AAU-8437-2021	Bwogi, Josephine/0000-0001-6975-7106; Gomara, Miren Iturriza/0000-0001-5816-6423; Byarugaba, Denis K./0000-0002-4175-5659; Jere, Khuzwayo/0000-0003-3376-8529	THRiVE; Wellcome Trust [087540]; Cambridge Alborado Research funds; WHO; Uganda Virus Research Institute and Laboratory for Viral infections, Almaty, Kazakhstan [105508]; Medical Research Council [MR/K002279/1, G0900753] Funding Source: researchfish; MRC [G0900753, MR/K002279/1] Funding Source: UKRI	THRiVE; Wellcome Trust(Wellcome Trust); Cambridge Alborado Research funds; WHO(World Health Organization); Uganda Virus Research Institute and Laboratory for Viral infections, Almaty, Kazakhstan; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by THRiVE, Wellcome Trust grant no. 087540 and Cambridge Alborado Research funds to JB, WHO funds for laboratory twinning initiative between Health Protection Agency (now Public Health England), Uganda Virus Research Institute and Laboratory for Viral infections, Almaty, Kazakhstan (Project no 105508) and WHO funds for rotavirus surveillance in Uganda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amimo JO, 2015, VET MICROBIOL, V175, P195, DOI 10.1016/j.vetmic.2014.11.027; Banyai K, 2017, INFECT GENET EVOL, V48, P19, DOI 10.1016/j.meegid.2016.12.002; Banyai K, 2012, VACCINE, V30, pA122, DOI 10.1016/j.vaccine.2011.09.111; Dulgheroff ACB, 2016, BRAZ J MICROBIOL, V47, P731, DOI 10.1016/j.bjm.2016.04.012; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Bwogi J, 2016, ARCH VIROL, V161, P999, DOI 10.1007/s00705-015-2742-2; Chakraborty P, 2016, EPIDEMIOL INFECT, V144, P2780, DOI 10.1017/S0950268816000807; De Grazia S, 2016, INFECT GENET EVOL, V44, P85, DOI 10.1016/j.meegid.2016.06.039; Delogu R, 2016, INFECT GENET EVOL, V44, P303, DOI 10.1016/j.meegid.2016.07.018; Dennis FE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100699; Desselberger U, 2014, VIRUS RES, V190, P75, DOI 10.1016/j.virusres.2014.06.016; Doan YH, 2013, J CLIN MICROBIOL, V51, P182, DOI 10.1128/JCM.02062-12; Dong HJ, 2013, INFECT GENET EVOL, V20, P155, DOI 10.1016/j.meegid.2013.08.024; Donker NC, 2011, INFECT GENET EVOL, V11, P1602, DOI 10.1016/j.meegid.2011.05.024; Doro R, 2015, EXPERT REV ANTI-INFE, V13, P1337, DOI 10.1586/14787210.2015.1089171; DUARTE EA, 1994, INFECT AGENT DIS, V3, P201; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Esona MD, 2009, J MED VIROL, V81, P937, DOI 10.1002/jmv.21468; Estes MK, 2001, NOVART FDN SYMP, V238, P82; Ghosh S, 2007, ARCH VIROL, V152, P423, DOI 10.1007/s00705-006-0848-2; Ghosh S, 2012, INFECT GENET EVOL, V12, P471, DOI 10.1016/j.meegid.2011.12.012; Ghosh S, 2010, J GEN VIROL, V91, P2367, DOI 10.1099/vir.0.022244-0; Giammanco GM, 2014, J GEN VIROL, V95, P91, DOI 10.1099/vir.0.056788-0; Greenberg HB, 2009, GASTROENTEROLOGY, V136, P1939, DOI 10.1053/j.gastro.2009.02.076; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Heylen E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100953; Ianiro G, 2014, INFECT GENET EVOL, V21, P129, DOI 10.1016/j.meegid.2013.10.029; Iturriza-Gomara M, 2009, EPIDEMIOL INFECT, V137, P922, DOI 10.1017/S0950268808001556; Jere KC, 2012, VET MICROBIOL, V159, P245, DOI 10.1016/j.vetmic.2012.03.040; Jere KC, 2011, J MED VIROL, V83, P2018, DOI 10.1002/jmv.22207; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kirkwood CD, 2010, J INFECT DIS, V202, pS43, DOI 10.1086/653548; Kobayashi N, 2007, COMMUNICATING CURREN, P847; Komoto S, 2014, INFECT GENET EVOL, V27, P277, DOI 10.1016/j.meegid.2014.08.002; Uriarte ELL, 2014, VET MICROBIOL, V171, P189, DOI 10.1016/j.vetmic.2014.03.013; Maes P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-238; Malik YS, 2014, INDIAN J ANIM SCI, V84, P1035; Martella V, 2010, VET MICROBIOL, V140, P246, DOI 10.1016/j.vetmic.2009.08.028; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Martinez M, 2014, INFECT GENET EVOL, V27, P402, DOI 10.1016/j.meegid.2014.08.015; Matthijnssens J, 2008, ARCH VIROL, V153, P1621, DOI 10.1007/s00705-008-0155-1; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Matthijnssens J, 2006, J CLIN MICROBIOL, V44, P1801, DOI 10.1128/JCM.44.5.1801-1809.2006; Matthijnssens J, 2012, ARCH VIROL, V157, P1177, DOI 10.1007/s00705-012-1273-3; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Matthijnssens J, 2010, EMERG INFECT DIS, V16, P625, DOI 10.3201/eid1604.091591; Midgley SE, 2012, VET MICROBIOL, V156, P238, DOI 10.1016/j.vetmic.2011.10.027; Mihalov-Kovacs E, 2015, EMERG INFECT DIS, V21, P660, DOI 10.3201/eid2104.141370; Mwenda JM, 2010, J INFECT DIS, V202, pS5, DOI 10.1086/653557; Nakagomi T, 2011, MOL CHARACTERIZATION; Ndze VN, 2014, INFECT GENET EVOL, V28, P537, DOI 10.1016/j.meegid.2014.10.009; Nyaga MM, 2015, INFECT GENET EVOL, V31, P321, DOI 10.1016/j.meegid.2015.02.011; Papp H, 2013, INFECT GENET EVOL, V19, P71, DOI 10.1016/j.meegid.2013.06.013; Phan TG, 2007, J VIROL, V81, P10188, DOI 10.1128/JVI.00337-07; Potgieter AC, 2009, J GEN VIROL, V90, P1423, DOI 10.1099/vir.0.009381-0; Rahman M, 2007, J VIROL, V81, P2382, DOI 10.1128/JVI.01622-06; Rajendran P, 2014, VACCINE, V32, pA89, DOI 10.1016/j.vaccine.2014.03.026; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Steyer A, 2008, J GEN VIROL, V89, P1690, DOI 10.1099/vir.0.2008/001206-0; Stupka JA, 2012, J CLIN VIROL, V54, P162, DOI 10.1016/j.jcv.2012.02.011; Tacharoenmuang R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139381; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tate JE, 2016, CLIN INFECT DIS, V62, pS96, DOI 10.1093/cid/civ1013; Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0; van der Heide R, 2005, J CLIN MICROBIOL, V43, P669, DOI 10.1128/JCM.43.2.669-675.2005; Wangchuk S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110795	66	37	38	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0178855	10.1371/journal.pone.0178855	http://dx.doi.org/10.1371/journal.pone.0178855			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640820	Green Published, gold, Green Submitted			2022-12-27	WOS:000404135800011
J	Gertler, M; Czogiel, I; Stark, K; Wilking, H				Gertler, Maximilian; Czogiel, Irina; Stark, Klaus; Wilking, Hendrik			Assessment of recall error in self-reported food consumption histories among adults-Particularly delay of interviews decrease completeness of food histories-Germany, 2013	PLOS ONE			English	Article							ESCHERICHIA-COLI; OUTBREAK; CHALLENGES; INFECTIONS	Introduction Poor recall during investigations of foodborne outbreaks may lead to misclassifications in exposure ascertainment. We conducted a simulation study to assess the frequency and determinants of recall errors. Methods Lunch visitors in a cafeteria using exclusively cashless payment reported their consumption of 13 food servings available daily in the three preceding weeks using a self-administered paper-questionnaire. We validated this information using electronic payment information. We calculated associated factors on misclassification of recall according to time, age, sex, education level, dietary habits and type of servings. Results We included 145/226 (64%) respondents who reported 27,095 consumed food items. Sensitivity of recall was 73%, specificity 96%. In multivariable analysis, for each additional day of recall period, the adjusted chance for false-negative recall increased by 8% (OR: 1.1; 95%CI: 1.06, 1.1), for false-positive recall by 3% (OR: 1.03; 95%-CI: 1.02, 1.05), for indecisive recall by 12% (OR: 1.1; 95%-CI: 1.08, 1.15). Sex and education-level had minor effects. Discussion Forgetting to report consumed foods is more frequent than reporting food-items actually not consumed. Bad recall is strongly enhanced by delay of interviews and may make hypothesis generation and testing very challenging. Side dishes are more easily missed than main courses. If available, electronic payment data can improve food-history information.	[Gertler, Maximilian; Czogiel, Irina; Stark, Klaus; Wilking, Hendrik] RKI, Dept Infect Dis Epidemiol, Berlin, Germany; [Gertler, Maximilian; Czogiel, Irina] RKI, Postgrad Training Appl Epidemiol PAE, Berlin, Germany; [Gertler, Maximilian] ECDC, European Programme Intervent Epidemiol Training, Stockholm, Sweden	Robert Koch Institute; Robert Koch Institute; European Centre for Disease Prevention & Control	Gertler, M (corresponding author), RKI, Dept Infect Dis Epidemiol, Berlin, Germany.; Gertler, M (corresponding author), RKI, Postgrad Training Appl Epidemiol PAE, Berlin, Germany.; Gertler, M (corresponding author), ECDC, European Programme Intervent Epidemiol Training, Stockholm, Sweden.	maximilian.gertler@charite.de		Wilking, Hendrik/0000-0002-8574-5831; Gertler, Maximilian/0000-0002-6384-9162	Robert Koch Institute, Berlin, Germany; European Centers for Disease Control	Robert Koch Institute, Berlin, Germany; European Centers for Disease Control	The funder of the study is the Robert Koch Institute, Berlin, Germany, as all authors of the manuscript and other contributors are employees of the institute and provided contributions during their normal working time. IC is partially contracted by the European Centers for Disease Control. No other institutions contributed funds or personnel to the project.	Behravesh CB, 2011, NEW ENGL J MED, V364, P918, DOI 10.1056/NEJMoa1005741; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; Centers for Disease Control and Prevention (CDC), 2008, INV OUTBR, DOI [10.1007/s12082-008-0148-1, DOI 10.1007/S12082-008-0148-1]; DECKER MD, 1986, AM J EPIDEMIOL, V124, P859, DOI 10.1093/oxfordjournals.aje.a114464; Ethelberg S, 2009, CLIN INFECT DIS, V48, pE78, DOI 10.1086/597502; European Centre for Disease Prevention and Control (ECDC), 2008, TOOLK INV RESP FOOD, DOI [10.1007/s12082-008-0148-1, DOI 10.1007/S12082-008-0148-1]; Frank C, 2011, EURO SURVEILL, V16; Fretz R, 2010, EUROSURVEILLANCE, V15, P2; MANN JM, 1981, AM J PUBLIC HEALTH, V71, P1362, DOI 10.2105/AJPH.71.12.1362; Robert Koch Institute (RKI), 2008, UNT LEB AUSBR, DOI [10.1007/s12082-008-0148-1, DOI 10.1007/S12082-008-0148-1]; Shah L, 2009, EMERG INFECT DIS, V15, P1286, DOI 10.3201/eid1508.081585; Taylor E, 2010, J PUBLIC HEALTH MAN, V16, P221, DOI 10.1097/PHH.0b013e3181b3a3e4; Werber D, 2013, AM J EPIDEMIOL, V178, P984, DOI 10.1093/aje/kwt069; Wilking H, 2012, EMERG INFECT DIS, V18, P169, DOI 10.3201/eid1801.111044	15	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179121	10.1371/journal.pone.0179121	http://dx.doi.org/10.1371/journal.pone.0179121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640839	Green Published, gold			2022-12-27	WOS:000404135800017
J	Kuracha, MR; Thomas, P; Loggie, BW; Govindarajan, V				Kuracha, Murali R.; Thomas, Peter; Loggie, Brian W.; Govindarajan, Venkatesh			Bilateral blockade of MEK- and PI3K-mediated pathways downstream of mutant KRAS as a treatment approach for peritoneal mucinous malignancies	PLOS ONE			English	Article							COLORECTAL-CANCER; PSEUDOMYXOMA-PERITONEI; TUMOR-GROWTH; IN-VITRO; INHIBITION; CARCINOMA; BRAF; PROGNOSIS; KINASE; MUC2	Mucinous colorectal adenocarcinomas (MCAs) are clinically and morphologically distinct from nonmucinous colorectal cancers (CRCs), show a distinct spectrum of genetic alterations (higher KRAS mutations, lower p53, high MUC2), exhibit more aggressive behavior (more prone to peritoneal dissemination and lymph node involvement) and are associated with poorer response to chemotherapy with limited treatment options. Here, we report the effectiveness of combinatorial targeting of two KRAS-mediated parallel pathways in reducing MUC2 production and mucinous tumor growth in vitro and in vivo. By knockdown of mutant KRAS we show that, mutant KRAS (a) is necessary for MUC2 production in vitro and (b) synergistically engages PI3K/AKT and MEK/ERK pathways to maintain MUC2 expression in MCA cells. These results define a novel and a previously undescribed role for oncogenic KRAS in mucinous cancers. MCA cells were sensitive to MEK inhibition suggesting cellular dependence ('addiction') of KRAS-mutant MCA cells on hyperactivation of the MEKdriven pathway. Interestingly, MCA cells, though initially sensitive, were later resistant to PI3K single agent inhibition. Our studies suggest that this resistance involves dynamic rewiring of signaling circuits mediated through relief of RTK inhibition and MEK-ERK rebound activation. This resistance however, could be overcome by co-targeting of PI3K and MEK. Our studies thus provide a rational basis for MEK-and PI3K-targeted combination therapy for not only KRAS mutant MCA but also for other related mucinous neoplasms that overproduce MUC2 and have a high rate of KRAS mutations such as pseudomyxoma peritonei.	[Kuracha, Murali R.; Thomas, Peter; Loggie, Brian W.] Creighton Univ, Dept Surg, Omaha, NE 68178 USA; [Govindarajan, Venkatesh] Creighton Univ, Dept Biomed Sci, Omaha, NE 68178 USA	Creighton University; Creighton University	Govindarajan, V (corresponding author), Creighton Univ, Dept Biomed Sci, Omaha, NE 68178 USA.	g.v@creighton.edu			Nebraska's excise tax on cigarettes; National Organization of Rare Disorders (NORD); Cancer Development grant [LB595]; Creighton University [G20RR024001]; Creighton University	Nebraska's excise tax on cigarettes; National Organization of Rare Disorders (NORD); Cancer Development grant; Creighton University; Creighton University	These studies were supported by revenue from Nebraska's excise tax on cigarettes awarded to Creighton University through the Nebraska Department of Health & Human Services (DHHS). Its contents represent the views of the authors and do not necessarily represent the official views of the State of Nebraska or DHHS. This research was supported by National Organization of Rare Disorders (NORD) (VG), LB595 Cancer Development grant (VG), G20RR024001 (Creighton University) and Creighton University patient cancer research funds (BWL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Catalano V, 2009, BRIT J CANCER, V100, P881, DOI 10.1038/sj.bjc.6604955; Caunt CJ, 2015, NAT REV CANCER, V15, P577, DOI 10.1038/nrc4000; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Choudry HA, 2012, J SURG ONCOL, V106, P911, DOI 10.1002/jso.23146; Corcoran RB, 2015, J CLIN ONCOL, V33, P4023, DOI 10.1200/JCO.2015.63.2471; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Dilly AK, 2015, TRANSL RES, V166, P344, DOI 10.1016/j.trsl.2015.03.004; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Hanski C, 1997, J PATHOL, V182, P385, DOI 10.1002/(SICI)1096-9896(199708)182:4<385::AID-PATH861>3.0.CO;2-Q; Hoeflich KP, 2012, CANCER RES, V72, P210, DOI 10.1158/0008-5472.CAN-11-1515; Hugen N, 2014, ANN ONCOL, V25, P651, DOI 10.1093/annonc/mdt591; Hugen N, MOLECULAR BACKGROUND; Hyngstrom JR, 2012, ANN SURG ONCOL, V19, P2814, DOI 10.1245/s10434-012-2321-7; Josephs Debra H, 2015, Transl Oncogenomics, V7, P33, DOI 10.4137/TOG.S30529; Kopetz S, 2010, ASCO ANN M P; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Makinen MJ, 2001, J PATHOL, V193, P286, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH800>3.0.CO;2-2; Masoumi-Moghaddam S, 2016, CLIN TRANSL ONCOL; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Mekenkamp LJM, 2012, EUR J CANCER, V48, P501, DOI 10.1016/j.ejca.2011.12.004; Miller Mark Steven, 2012, Frontiers in Genetics, V2, P100, DOI 10.3389/fgene.2011.00100; Mizoshita T, 2007, HISTOL HISTOPATHOL, V22, P251, DOI 10.14670/HH-22.251; Mulvihill MJ, 2009, FUTURE MED CHEM, V1, P1153, DOI 10.4155/FMC.09.89; O'Connell JT, 2002, AM J PATHOL, V161, P551, DOI 10.1016/S0002-9440(10)64211-3; O'Connell JT, 2002, MODERN PATHOL, V15, P958, DOI 10.1097/01.MP.0000026617.52466.9F; Quinlan MP, 2008, MOL CELL BIOL, V28, P2659, DOI 10.1128/MCB.01661-07; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Rusnak DW, 2001, MOL CANCER THER, V1, P85; Shapiro G, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.3005; Sheng YH, 2012, J GASTROEN HEPATOL, V27, P28, DOI 10.1111/j.1440-1746.2011.06909.x; Shetty S, 2013, J SURG RES, V180, P97, DOI 10.1016/j.jss.2012.10.053; Shimizu T, 2012, CLIN CANCER RES, V18, P2316, DOI 10.1158/1078-0432.CCR-11-2381; Tanaka H, 2006, INT J CANCER, V118, P2765, DOI 10.1002/ijc.21701; TIBBETTS LM, 1988, CANCER RES, V48, P3751; TOM BH, 1976, IN VITRO CELL DEV B, V12, P180; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang MT, 2015, CELL, V163, P1237, DOI 10.1016/j.cell.2015.10.041; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	42	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179510	10.1371/journal.pone.0179510	http://dx.doi.org/10.1371/journal.pone.0179510			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640835	Green Submitted, Green Published, gold			2022-12-27	WOS:000404135800035
J	Li, YM; Zhuge, RS; Zhang, ZT; Tian, YM; Ding, N				Li, Yong-Mei; Zhuge, Rui-Shen; Zhang, Zu-Tai; Tian, Yue-Ming; Ding, Ning			The effect of subpressure on the bond strength of resin to zirconia ceramic	PLOS ONE			English	Article							SURFACE-ROUGHNESS; SYSTEMS; CEMENT	Objective This study was conducted to investigate the effect of subpressure on the bond strength of resin to zirconia ceramic. The subpressure would create a pressure gradient which could clean out the bubbles in the adhesives or bonding interface. Methods Twenty-eight pre-sintered zirconia discs were fabricated. Half of them were polished (group P, n = 14), and the rest were sandblasted (group S, n = 14). After sintered, the surface roughness of the zirconia discs was measured. Then, they were randomly divided into two subgroups (n = 7). The groups were named as follows: PC: P + no additional treatments; PP: P + 0.04 MPa after application of adhesives; SC: S + no additional treatments; and SP: S + 0.04 MPa after application of adhesives. Resin columns were bonded to the zirconia specimens to determine shear bond strength (SBS). The bonding interfaces were observed and the fracture modes were evaluated. Statistical analysis was performed on all data. Results The surface roughness of group S was significantly higher than that of group P (P<0.05). The SBS values were PC = 13.48 +/- 0.7 MPa, PP = 15.22 +/- 0.8 MPa, SC = 17.23 +/- 0.7 MPa and SP = 21.68 +/- 1.4 MPa. There were significant differences among the groups (P<0.05). Scanning electron microscopy (SEM) results showed that the adhesives of group SP and PP were closer and denser to the zirconia ceramic than that of group PC and SC. The proportion of the mixed fracture mode significantly increased after adding subpressure (P<0.05). Conclusion Subpressure can improve the shear bond strength of resin to zirconia ceramics and increase micro-infiltration between the adhesives and the zirconia ceramics, especially on the rough surfaces.	[Li, Yong-Mei; Zhuge, Rui-Shen; Zhang, Zu-Tai; Tian, Yue-Ming; Ding, Ning] Capital Med Univ, Sch Stomatol, Beijing, Peoples R China	Capital Medical University	Zhang, ZT (corresponding author), Capital Med Univ, Sch Stomatol, Beijing, Peoples R China.	zutaizhang@ccmu.edu.cn	li, yong/HDN-3885-2022		National Natural Science Foundation of China [81371175, 81671027]; Beijing Natural Science Foundation [7152065]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study was supported by the National Natural Science Foundation of China [Grant No. 81371175, 81671027] and the Beijing Natural Science Foundation [Grant No. 7152065]. http://www.nsfc.gov.cn/.	Aboushelib MN, 2007, J PROSTHETIC DENT, V98; Ahmad I, 1999, Pract Periodontics Aesthet Dent, V11, P197; Akin GE, 2015, PHOTOMED LASER SURG, V33, P246, DOI 10.1089/pho.2014.3861; Blatz MB, 2007, QUINTESSENCE INT, V38, P745; Budhe S., 2015, APPL ADHES SCI, V3, P20, DOI [DOI 10.1186/s40563-015-0050-4, DOI 10.1186/S40563-015-0050-4]; Bulbul M, 2010, J PROSTHET DENT, V103, P303, DOI 10.1016/S0022-3913(10)60063-7; Cavalcanti AN, 2009, PHOTOMED LASER SURG, V27, P473, DOI 10.1089/pho.2008.2293; Derand P, 2000, INT J PROSTHODONT, V13, P131; Fischer J, 2010, J PROSTHET DENT, V103, P267, DOI 10.1016/S0022-3913(10)60056-X; Golafshan N, 2017, BIOFABRICATION, V9, DOI 10.1088/1758-5090/aa68ed; Goracci C, 2011, AUST DENT J, V56, P77, DOI 10.1111/j.1834-7819.2010.01298.x; Harding AB, 2012, J PROSTHODONT, V21, P346, DOI 10.1111/j.1532-849X.2012.00843.x; Hata U, 2008, PROSTHODONT RES PRAC, V7, P153; He M, 2014, DENT MAT J, V33; Hwang DS, 2010, SOFT MATTER, V6, P3232, DOI 10.1039/c002632h; Inokoshi M, 2014, J DENT RES, V93, P329, DOI 10.1177/0022034514524228; Kadir MRA, 2008, IFMBE PROC, V21, P457; Kasraei Shahin, 2014, Restor Dent Endod, V39, P296, DOI 10.5395/rde.2014.39.4.296; KEITH O, 1994, AM J ORTHOD DENTOFAC, V106, P605, DOI 10.1016/S0889-5406(94)70085-0; Kitayama S, 2010, DENT MATER, V26, P426, DOI 10.1016/j.dental.2009.11.159; Landsiedel R, 2012, ARCH TOXICOL, V86, P1021, DOI 10.1007/s00204-012-0858-7; Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008; Martin J, 2009, LANGMUIR ACS J SURFA, V25; Michida SM, 2015, J APPL BIOMATERIALS, V13; Moezzizadeh M, 2017, DENT MATER J, V36, P54, DOI 10.4012/dmj.2015-382; Montes AMJR, 2001, J DENT, V29, P435; Moon JE, 2011, DENT MATER, V27, P651, DOI 10.1016/j.dental.2011.03.005; Nobutaka A, 2016, DENT MATER J, V36, P19; Nordahl N, 2015, J ORAL SCI, V57, P255, DOI 10.2334/josnusd.57.255; Ozcan M, 2008, DENT MATER J, V27, P99; Paranhos MPG, 2011, QUINTESSENCE INT, V42, P79; Pozzobon JL, 2017, J ADHES SCI TECHNOL, V19, P7; Rashid Haroon, 2014, Eur J Dent, V8, P571, DOI 10.4103/1305-7456.143646; Saito A, 2010, J PROSTHET DENT, V104, P247, DOI 10.1016/S0022-3913(10)60133-3; Thompson JY, 2011, DENT MATER, V27, P71, DOI 10.1016/j.dental.2010.10.022; Vogt UF, 2010, J EUR CERAM SOC, V30, P3005, DOI 10.1016/j.jeurceramsoc.2010.06.003; von Steyern PV, 2006, J ORAL REHABIL, V33, P682, DOI 10.1111/j.1365-2842.2005.01604.x; Wei YH, 2013, DENT MATER J, V32, P564, DOI 10.4012/dmj.2013-007; Yang B, 2010, DENT MATER, V26, P44, DOI 10.1016/j.dental.2009.08.008; Yildirim M, 2000, INT J PERIODONT REST, V20, P81; Zhou W, 2016, SCI REP-UK, V6, DOI 10.1038/srep22269	41	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179668	10.1371/journal.pone.0179668	http://dx.doi.org/10.1371/journal.pone.0179668			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640855	gold, Green Published, Green Submitted			2022-12-27	WOS:000404135800049
J	Zhao, JL; Duan, FQ; Pan, ZK; Wu, ZK; Li, JH; Deng, QQ; Li, XN; Zhou, MQ				Zhao, Junli; Duan, Fuqing; Pan, Zhenkuan; Wu, Zhongke; Li, Jinhua; Deng, Qingqiong; Li, Xiaona; Zhou, Mingquan			Craniofacial similarity analysis through sparse principal component analysis	PLOS ONE			English	Article							3D FACE RECOGNITION; RECONSTRUCTION; SELECTION; SKULL; MODEL; SHAPE	The computer-aided craniofacial reconstruction (CFR) technique has been widely used in the fields of criminal investigation, archaeology, anthropology and cosmetic surgery. The evaluation of craniofacial reconstruction results is important for improving the effect of craniofacial reconstruction. Here, we used the sparse principal component analysis (SPCA) method to evaluate the similarity between two sets of craniofacial data. Compared with principal component analysis (PCA), SPCA can effectively reduce the dimensionality and simultaneously produce sparse principal components with sparse loadings, thus making it easy to explain the results. The experimental results indicated that the evaluation results of PCA and SPCA are consistent to a large extent. To compare the inconsistent results, we performed a subjective test, which indicated that the result of SPCA is superior to that of PCA. Most importantly, SPCA can not only compare the similarity of two craniofacial datasets but also locate regions of high similarity, which is important for improving the craniofacial reconstruction effect. In addition, the areas or features that are important for craniofacial similarity measurements can be determined from a large amount of data. We conclude that the craniofacial contour is the most important factor in craniofacial similarity evaluation. This conclusion is consistent with the conclusions of psychological experiments on face recognition and our subjective test. The results may provide important guidance for three-or two-dimensional face similarity evaluation, analysis and face recognition.	[Zhao, Junli; Li, Jinhua; Li, Xiaona] Qingdao Univ, Sch Data Sci & Software Engn, Qingdao, Peoples R China; [Zhao, Junli] Qingdao Univ, Coll Automat & Elect Engn, Qingdao, Peoples R China; [Duan, Fuqing; Wu, Zhongke; Deng, Qingqiong; Zhou, Mingquan] Minist Educ, Engn Res Ctr Virtual Real & Applicat, Beijing, Peoples R China; [Duan, Fuqing; Wu, Zhongke; Deng, Qingqiong; Zhou, Mingquan] Beijing Normal Univ, Coll Informat Sci & Technol, Beijing, Peoples R China; [Pan, Zhenkuan] Qingdao Univ, Coll Comp Sci & Technol, Qingdao, Peoples R China	Qingdao University; Qingdao University; Beijing Normal University; Qingdao University	Duan, FQ (corresponding author), Minist Educ, Engn Res Ctr Virtual Real & Applicat, Beijing, Peoples R China.; Duan, FQ (corresponding author), Beijing Normal Univ, Coll Informat Sci & Technol, Beijing, Peoples R China.; Pan, ZK (corresponding author), Qingdao Univ, Coll Comp Sci & Technol, Qingdao, Peoples R China.	fqduan@bnu.edu.cn; zkpan@126.com		Zhao, Junli/0000-0002-2034-6426; Duan, Fuqing/0000-0002-3849-8532	National Natural Science Foundation of China [61572078]; Natural Science Foundation of Beijing Municipality [4152027, 4152028]; Open Research Fund of the Ministry of Education Engineering Research Center of Virtual Reality Application [MEOBNUEVRA201601]; National Science & Technology Pillar Program during the Twelfth Five-year Plan Period [2013BAI01603]; National High-tech R&D Program (863 Program) of China [2015AA020506]; Program for New Century Excellent Talents in University [NCET-13-0051]; Xianyang Hospital	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing Municipality(Beijing Natural Science Foundation); Open Research Fund of the Ministry of Education Engineering Research Center of Virtual Reality Application; National Science & Technology Pillar Program during the Twelfth Five-year Plan Period; National High-tech R&D Program (863 Program) of China(National High Technology Research and Development Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Xianyang Hospital	This work was funded by the National Natural Science Foundation of China (no. 61572078), Natural Science Foundation of Beijing Municipality (CN) (no. 4152027 and no. 4152028), and the Open Research Fund of the Ministry of Education Engineering Research Center of Virtual Reality Application (MEOBNUEVRA201601). It was also partially supported by grants from Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (no. 2013BAI01603), National High-tech R&D Program (863 Program) of China (no. 2015AA020506) and the Program for New Century Excellent Talents in University (NCET-13-0051).; The authors gratefully appreciate the anonymous reviewers for all of their helpful comments. We also acknowledge the support of Xianyang Hospital for providing CT images.	Achermann B, 2000, INT C PATT RECOG, P809, DOI 10.1109/ICPR.2000.906199; Berretti S, 2010, P ACM WORKSH 3D OBJ, P81, DOI DOI 10.1145/1877808.1877825; Berretti S, 2010, IEEE T PATTERN ANAL, V32, P2162, DOI 10.1109/TPAMI.2010.43; Blanz V, 2003, IEEE T PATTERN ANAL, V25, P1063, DOI 10.1109/TPAMI.2003.1227983; Chang KI, 2003, ACM WORKSH MULT US A, P25; Chin-Seng Chua, 2000, Proceedings Fourth IEEE International Conference on Automatic Face and Gesture Recognition (Cat. No. PR00580), P233, DOI 10.1109/AFGR.2000.840640; Claes P, 2006, FORENSIC SCI INT, V159, pS147, DOI 10.1016/j.forsciint.2006.02.035; Cook J, 2004, 2ND INTERNATIONAL SYMPOSIUM ON 3D DATA PROCESSING, VISUALIZATION, AND TRANSMISSION, PROCEEDINGS, P502, DOI 10.1109/TDPVT.2004.1335279; Deng QQ, 2011, FORENSIC SCI INT, V208, P95, DOI 10.1016/j.forsciint.2010.11.011; Duan FQ, 2014, IEEE T INF FOREN SEC, V9, P1322, DOI 10.1109/TIFS.2014.2332981; Feng J, 2008, IMAGE VISION COMPUT, V26, P761, DOI 10.1016/j.imavis.2007.08.018; GORDON GG, 1991, P SOC PHOTO-OPT INS, V1570, P234, DOI 10.1117/12.48428; HELMER RP, 1993, FORENSIC ANAL SKULL, P229; Hesher C, 2003, SEVENTH INTERNATIONAL SYMPOSIUM ON SIGNAL PROCESSING AND ITS APPLICATIONS, VOL 2, PROCEEDINGS, P201, DOI 10.1109/ISSPA.2003.1224850; Hongyan Li, 2011, 2011 4th International Conference on Biomedical Engineering and Informatics, P2114, DOI 10.1109/BMEI.2011.6098733; Hu YL, 2013, MULTIMED TOOLS APPL, V64, P345, DOI 10.1007/s11042-012-1005-4; Ip HHS, 2002, P 15 INT C VIS INT, P314; Jahanbin S, 2008, BIOM THEOR APPL SYST, P1; Kurtek S, 2015, COMPUT GRAPH-UK, V51, P52, DOI 10.1016/j.cag.2015.05.027; Lee JC, 1990, COMP VIS 1990 P 3 IN, P722; Lee WJ, 2016, FORENSIC SCI INT, V269, P21, DOI 10.1016/j.forsciint.2016.11.003; Lee Y, 2003, PROCEEDINGS EC-VIP-MC 2003, VOLS 1 AND 2, P429; Lee YH, 2004, IEEE IMAGE PROC, P1429; Lorensen W.E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI [DOI 10.1145/37402.37422, 10.1145/37401.37422]; Lu XG, 2006, IEEE T PATTERN ANAL, V28, P31, DOI 10.1109/TPAMI.2006.15; Medioni G., 2003, IEEE WORKSH AMFG; NAGAMINE T, 1992, 11TH IAPR INTERNATIONAL CONFERENCE ON PATTERN RECOGNITION, PROCEEDINGS, VOL I, P324, DOI 10.1109/ICPR.1992.201567; Pan G, 2003, 2003 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH, AND SIGNAL PROCESSING, VOL III, PROCEEDINGS, P193; Papatheodorou T, 2005, LECT NOTES COMPUT SC, V3546, P997; Passalis G., 2005, P IEEE WORKSH FAC RE, P171, DOI DOI 10.1109/CVPR.2005.573; Russ T., 2006, P IEEE COMP SOC C CO, P1391, DOI [10.1109/CVPR.2006.13, DOI 10.1109/CVPR.2006.13]; Sjostrand K, 2006, MED IMAGING 2006 IMA, V6144, P1579; SNOW CC, 1970, AM J PHYS ANTHROPOL, V33, P221, DOI 10.1002/ajpa.1330330207; Stephan CN, 2001, J FORENSIC SCI, V46, P432; Tanaka H. T., 1996, Proceedings of the 13th International Conference on Pattern Recognition, P638, DOI 10.1109/ICPR.1996.547024; ter Haar FB, 2008, IEEE INTERNATIONAL CONFERENCE ON SHAPE MODELING AND APPLICATIONS 2008, PROCEEDINGS, P259, DOI 10.1109/SMI.2008.4547996; Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x; VaneZis M., 2008, FORENSIC FACIAL RECO; Wang G., 2011, HUMAN FACE PERCETION, P5; Wang YH, 2011, FACE RECOGNITION PRI, P16; Wong HS, 2004, PATTERN RECOGN, V37, P2307, DOI [10.1016/S0031-3203(04)00192-X, 10.1016/j.patcog.2004.05.004]; Yuan X, 2005, IEEE INT SYMP CIRC S, P3211; Zhao J, 2014, COMPUTATIONAL MATH M, V2014; Zhu Xin-yi, 2011, 2011 4th International Conference on Biomedical Engineering and Informatics, P942, DOI 10.1109/BMEI.2011.6098426; Zhu Xin-yi, 2010, Application Research of Computers, V27, P3153, DOI 10.3969/j.issn.1001-3695.2010.08.093; [朱新懿 Zhu Xinyi], 2012, [中国图象图形学报, Journal of Image and Graphics], V17, P568; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Zou H, 2006, J COMPUT GRAPH STAT, V15, P265, DOI 10.1198/106186006X113430	50	2	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179671	10.1371/journal.pone.0179671	http://dx.doi.org/10.1371/journal.pone.0179671			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640836	gold, Green Submitted, Green Published			2022-12-27	WOS:000404135800050
J	Fosmark, S; Hellwege, S; Dahlrot, RH; Jensen, KL; Derand, H; Lohse, J; Sorensen, MD; Hansen, S; Kristensen, BW				Fosmark, Sigurd; Hellwege, Sofie; Dahlrot, Rikke H.; Jensen, Kristian L.; Derand, Helene; Lohse, Jesper; Sorensen, Mia D.; Hansen, Steinbjorn; Kristensen, Bjarne W.			APNG as a prognostic marker in patients with glioblastoma	PLOS ONE			English	Article							BASE EXCISION-REPAIR; O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; DNA GLYCOSYLASE; ADJUVANT TEMOZOLOMIDE; GRADE GLIOMAS; RADIOTHERAPY; EXPRESSION; RESISTANCE; 3-METHYLADENINE; SENSITIVITY	Aim Expression of the base excision repair enzyme alkylpurine-DNA-N-glycosylase (APNG) has been correlated to temozolomide resistance. Our aim was to evaluate the prognostic value of APNG in a population-based cohort with 242 gliomas including 185 glioblastomas (GBMs). Cellular heterogeneity of GBMs was taken into account by excluding APNG expression in non-tumor cells from the analysis. Methods APNG expression was evaluated using automated image analysis and a novel quantitative immunohistochemical (IHC) assay (qIHC), where APNG protein expression was evaluated through countable dots. Non-tumor cells were excluded using an IHC/qIHC double-staining. For verification, APNG was measured by a quantitative double-immunofluorescence (IF) assay. As validation APNG mRNA expression was evaluated using independent TCGA data. Results Using qIHC, high levels of APNG were associated with better overall survival (OS) in univariate (HR = 0.50; P < 0.001) and multivariate analysis (HR = 0.53; P = 0.001). Patients with methylated MGMT promoters and high APNG expression demonstrated better OS, than patients with methylated MGMT promoters and low APNG expression (HR = 0.59; P = 0.08). Retesting the cohort using IF showed similar results in both univariate (HR = 0.61; P = 0.002) and multivariate analysis (HR = 0.81; P = 0.2). The results were supported by data from the TCGA database. Conclusions Using two different assays combined with quantitative image analysis excluding non-tumour cells, APNG was an independent prognostic factor among patients with a methylated MGMT promoter. We expect that APNG qIHC can potentially identify GBM patients who will not benefit from treatment with temozolomide.	[Fosmark, Sigurd; Hellwege, Sofie; Sorensen, Mia D.; Kristensen, Bjarne W.] Odense Univ Hosp, Dept Pathol, Odense, Denmark; [Fosmark, Sigurd; Hellwege, Sofie; Sorensen, Mia D.; Hansen, Steinbjorn; Kristensen, Bjarne W.] Univ Southern Denmark, Dept Clin Res, Odense, Denmark; [Dahlrot, Rikke H.; Hansen, Steinbjorn] Odense Univ Hosp, Dept Oncol, Odense, Denmark; [Jensen, Kristian L.; Derand, Helene; Lohse, Jesper] DAKO Denmark AS, Glostrup, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital	Kristensen, BW (corresponding author), Odense Univ Hosp, Dept Pathol, Odense, Denmark.; Kristensen, BW (corresponding author), Univ Southern Denmark, Dept Clin Res, Odense, Denmark.	bjarne.winther.kristensen@rsyd.dk	Kristensen, Bjarne Winther/A-6690-2012; Kristensen, Bjarne Winther/AAX-5491-2020	Kristensen, Bjarne Winther/0000-0002-6352-0826; Kristensen, Bjarne Winther/0000-0002-6352-0826; Hansen, Steinbjorn/0000-0001-5651-6493; Dahlrot, Rikke/0000-0003-1538-4361	Kretens Bekarnpelse; The Danish Cancer Society [R74-A4929] Funding Source: researchfish	Kretens Bekarnpelse; The Danish Cancer Society(Danish Cancer Society)	This study was supported by Kretens Bekarnpelse, www.cancer.dk. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri S, 2012, J CLIN INVEST, V122, P253, DOI 10.1172/JCI59334; Andersson U, 2004, CLIN NEUROPATHOL, V23, P21; Araki Y, 2011, BRAIN TUMOR PATHOL, V28, P25, DOI 10.1007/s10014-010-0004-2; Bleeker FE, 2012, J NEURO-ONCOL, V108, P11, DOI 10.1007/s11060-011-0793-0; Bobola MS, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00176; Bobola MS, 2001, CLIN CANCER RES, V7, P613; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Chiesa-Vottero AG, 2003, AM J CLIN PATHOL, V120, P902, DOI 10.1309/8UAUFK2NBDMVTNU; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chinot OL, 2007, J CLIN ONCOL, V25, P1470, DOI 10.1200/JCO.2006.07.4807; Christensen K, 2008, J NEURO-ONCOL, V90, P157, DOI 10.1007/s11060-008-9648-8; Dahlrot RH, 2014, INT J CLIN EXP PATHO, V7, P3739; Dahlrot RH, 2013, J NEURO-ONCOL, V115, P453, DOI 10.1007/s11060-013-1246-8; Dahlrot RH, 2013, J NEURO-ONCOL, V114, P309, DOI 10.1007/s11060-013-1186-3; Dahlrot RH, 2013, INT J CLIN EXP PATHO, V6, P31; DENNY BJ, 1994, BIOCHEMISTRY-US, V33, P9045, DOI 10.1021/bi00197a003; Engelward BP, 1996, EMBO J, V15, P945, DOI 10.1002/j.1460-2075.1996.tb00429.x; Fishel ML, 2007, CLIN CANCER RES, V13, P260, DOI 10.1158/1078-0432.CCR-06-1920; Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Jensen K, 2016, MODERN PATHOLOGY OFF; Lalezari S, 2013, NEURO-ONCOLOGY, V15, P370, DOI 10.1093/neuonc/nos308; Liu C, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/760679; Lohse J, 2014, BIOCONJUGATE CHEM, V25, P1036, DOI 10.1021/bc400311g; Malmstrom A, 2012, LANCET ONCOL, V13, P916, DOI 10.1016/S1470-2045(12)70265-6; Music D, 2016, J NEUROONCOLOGY; Nakagawa T, 2009, NEUROPATHOLOGY, V29, P379, DOI 10.1111/j.1440-1789.2008.00983.x; Quillien V, 2012, CANCER-AM CANCER SOC, V118, P4201, DOI 10.1002/cncr.27392; Rinne ML, 2005, NUCLEIC ACIDS RES, V33, P2859, DOI 10.1093/nar/gki601; Smith SA, 2000, NUCLEIC ACIDS RES, V28, P3294, DOI 10.1093/nar/28.17.3294; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tang JB, 2011, NEURO-ONCOLOGY, V13, P471, DOI 10.1093/neuonc/nor011; The WHO, 2020, CLASSIFICATION TUMOU; Trivedi RN, 2008, MOL PHARMACOL, V74, P505, DOI 10.1124/mol.108.045112; Wick W, 2012, LANCET ONCOL, V13, P707, DOI 10.1016/S1470-2045(12)70164-X; Zhang Jihong, 2012, Curr Mol Pharmacol, V5, P102	37	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0178693	10.1371/journal.pone.0178693	http://dx.doi.org/10.1371/journal.pone.0178693			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662073	Green Submitted, Green Published, gold			2022-12-27	WOS:000404608300008
J	Ruf, F; Fraunholz, M; Ochsner, K; Kaderschabek, J; Wegener, C				Ruf, Franziska; Fraunholz, Martin; Oechsner, Konrad; Kaderschabek, Johann; Wegener, Christian			WEclMon - A simple and robust camera-based system to monitor Drosophila eclosion under optogenetic manipulation and natural conditions	PLOS ONE			English	Article							ECDYSIS-TRIGGERING HORMONE; TARGETED GENE-EXPRESSION; MANDUCA-SEXTA; CIRCADIAN OSCILLATION; TOBACCO HORNWORM; ENDOCRINE SYSTEM; DELIA-ANTIQUA; FRUIT-FLY; ONION FLY; MELANOGASTER	Eclosion in flies and other insects is a circadian-gated behaviour under control of a central and a peripheral clock. It is not influenced by the motivational state of an animal, and thus presents an ideal paradigm to study the relation and signalling pathways between central and peripheral clocks, and downstream peptidergic regulatory systems. Little is known, however, about eclosion rhythmicity under natural conditions, and research into this direction is hampered by the physically closed design of current eclosion monitoring systems. We describe a novel open eclosion monitoring system (WEclMon) that allows the puparia to come into direct contact with light, temperature and humidity. We demonstrate that the system can be used both in the laboratory and outdoors, and shows a performance similar to commercial closed funnel-type monitors. Data analysis is semi-automated based on a macro toolset for the open imaging software Fiji. Due to its open design, the WEclMon is also well suited for optogenetic experiments. A small screen to identify putative neuroendocrine signals mediating time from the central clock to initiate eclosion showed that optogenetic activation of ETH-, EH and myosuppressin neurons can induce precocious eclosion. Genetic ablation of myosuppressin-expressing neurons did, however, not affect eclosion rhythmicity.	[Ruf, Franziska; Oechsner, Konrad; Wegener, Christian] Univ Wurzburg, Bioctr, Theodor Boveri Inst, Neurobiol & Genet, Wurzburg, Germany; [Fraunholz, Martin] Univ Wurzburg, Bioctr, Theodor Boveri Inst, Microbiol, Wurzburg, Germany; [Kaderschabek, Johann] Univ Wurzburg, Bioctr, Theodor Boveri Inst, Cent Workshop, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Wegener, C (corresponding author), Univ Wurzburg, Bioctr, Theodor Boveri Inst, Neurobiol & Genet, Wurzburg, Germany.	christian.wegener@biozentrum.uni-wuerzburg.de		Fraunholz, Martin/0000-0002-4581-6244; Wegener, Christian/0000-0003-4481-3567	Deutsche Forschungsgemeinschaft (DFG) [SFB1047]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (DFG), collaborative research center SFB1047 "Insecttiming", project B2 to CW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; Beltrami M, 2010, EVOL ECOL, V24, P347, DOI 10.1007/s10682-009-9310-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUNNING ERWIN, 1935, BER DEUTSCH BOT GES, V53, P594; Cole SH, 2005, J BIOL CHEM, V280, P14948, DOI 10.1074/jbc.M414197200; COPENHAVER PF, 1982, J INSECT PHYSIOL, V28, P695, DOI 10.1016/0022-1910(82)90148-2; Dawydow A, 2014, P NATL ACAD SCI USA, V111, P13972, DOI 10.1073/pnas.1408269111; De J, 2012, J BIOL RHYTHM, V27, P280, DOI 10.1177/0748730412448360; Diao FC, 2016, GENETICS, V202, P175, DOI 10.1534/genetics.115.182121; ENGELMANN W, 1978, J COMP PHYSIOL, V127, P229, DOI 10.1007/BF01350113; Ewer J, 1997, J EXP BIOL, V200, P869; Ewer J., 2007, NEUROENDOCRINOLOGY E; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; GODOYHERRERA R, 1989, ANIM BEHAV, V37, P820, DOI 10.1016/0003-3472(89)90066-3; Green EW, 2015, P NATL ACAD SCI USA, V112, P8702, DOI 10.1073/pnas.1506093112; Helfrich-Foerster C., 2002, P94; Kalmus H., 1935, Biologia Generalis Wien, V11, P93; Kim DH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005513; Kim YJ, 2006, CURR BIOL, V16, P1395, DOI 10.1016/j.cub.2006.06.027; Kingan TG, 1997, J EXP BIOL, V200, P3245; KLEMM E, 1976, PHOTOCHEM PHOTOBIOL, V24, P369, DOI 10.1111/j.1751-1097.1976.tb06838.x; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Kruger E, 2015, DEVELOPMENT, V142, P4279, DOI 10.1242/dev.126995; Lankinen P, 1982, DROSOPHILA INFORMATI, V58, P161; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; McNabb SL, 1997, NEURON, V19, P813, DOI 10.1016/S0896-6273(00)80963-0; McNabb SL, 2008, J EXP BIOL, V211, P2263, DOI 10.1242/jeb.015818; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Mena W, 2016, ELIFE, V5, DOI 10.7554/eLife.19686; Menegazzi P, 2013, J BIOL RHYTHM, V28, P3, DOI 10.1177/0748730412471303; Miao YS, 1998, J NEUROBIOL, V37, P469; Monastirioti M, 1999, MICROSC RES TECHNIQ, V45, P106, DOI 10.1002/(SICI)1097-0029(19990415)45:2<106::AID-JEMT5>3.3.CO;2-V; Myers EM, 2003, CURR BIOL, V13, P526, DOI 10.1016/S0960-9822(03)00167-2; Nassel DR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-90; O'Brien MA, 1998, J EXP BIOL, V201, P193; Park D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001896; Park Y, 2002, DEVELOPMENT, V129, P493; PITTENDRIGH CS, 1954, P NATL ACAD SCI USA, V40, P1018, DOI 10.1073/pnas.40.10.1018; Predel R, 2004, J COMP NEUROL, V474, P379, DOI 10.1002/cne.20145; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schlichting M, 2015, J BIOL RHYTHM, V30, P117, DOI 10.1177/0748730415575245; Schlichting M, 2015, METHOD ENZYMOL, V552, P105, DOI 10.1016/bs.mie.2014.10.017; SCHNEBEL EM, 1986, EXPERIENTIA, V42, P600, DOI 10.1007/BF01955553; Selcho M, 2017, NAT COMMUN IN PRESS; Sellami A, 2010, PEPTIDES, V31, P1383, DOI 10.1016/j.peptides.2010.04.015; Shiga S, 2003, MICROSC RES TECHNIQ, V62, P114, DOI 10.1002/jemt.10366; Siegmund T, 2001, J COMP NEUROL, V431, P481, DOI 10.1002/1096-9861(20010319)431:4<481::AID-CNE1084>3.0.CO;2-7; Simoni A, 2014, SCIENCE, V343, P525, DOI 10.1126/science.1245710; Sitaraman D, 2012, J NEUROGENET, V26, P238, DOI 10.3109/01677063.2012.666298; SOKOLOWSKI MB, 1985, J INSECT PHYSIOL, V31, P857, DOI 10.1016/0022-1910(85)90103-9; Tanaka K, 2003, NATURWISSENSCHAFTEN, V90, P76, DOI 10.1007/s00114-002-0390-3; Tanaka K, 2016, INT J BIOMETEOROL; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Thakurdas P, 2009, CHRONOBIOL INT, V26, P1575, DOI 10.3109/07420520903529765; TRUMAN JW, 1980, J EXP BIOL, V88, P327; TRUMAN JW, 1972, Z VERGL PHYSIOL, V76, P32, DOI 10.1007/BF00395499; Vanin S, 2012, NATURE, V484, P371, DOI 10.1038/nature10991; Watari Y, 2002, J INSECT PHYSIOL, V48, P881, DOI 10.1016/S0022-1910(02)00157-9; Wegener C, 2006, J NEUROCHEM, V96, P1362, DOI 10.1111/j.1471-4159.2005.03634.x; ZIMMERMAN WF, 1968, J INSECT PHYSIOL, V14, P669, DOI 10.1016/0022-1910(68)90226-6; Zitnan D, 1996, SCIENCE, V271, P88, DOI 10.1126/science.271.5245.88; Zitnan D., 2012, INSECT ENDOCNNOLOGY, P253, DOI DOI 10.1016/B978-0-12-384749-2.10007-X	64	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180238	10.1371/journal.pone.0180238	http://dx.doi.org/10.1371/journal.pone.0180238			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658318	Green Published, gold, Green Submitted			2022-12-27	WOS:000404607900069
J	Epskamp, S; Kruis, J; Marsman, M				Epskamp, Sacha; Kruis, Joost; Marsman, Maarten			Estimating psychopathological networks: Be careful what you wish for	PLOS ONE			English	Article							BAYESIAN INFORMATION CRITERIA; MODEL SELECTION; DEPRESSION; SYMPTOMS; COMORBIDITY; ANXIETY	Network models, in which psychopathological disorders are conceptualized as a complex interplay of psychological and biological components, have become increasingly popular in the recent psychopathological literature (Borsboom, et. al., 2011). These network models often contain significant numbers of unknown parameters, yet the sample sizes available in psychological research are limited. As such, general assumptions about the true network are introduced to reduce the number of free parameters. Incorporating these assumptions, however, means that the resulting network will lead to reflect the particular structure assumed by the estimation method-a crucial and often ignored aspect of psychopathological networks. For example, observing a sparse structure and simultaneously assuming a sparse structure does not imply that the true model is, in fact, sparse. To illustrate this point, we discuss recent literature and show the effect of the assumption of sparsity in three simulation studies.	[Epskamp, Sacha; Kruis, Joost; Marsman, Maarten] Univ Amsterdam, Dept Psychol Methods, Amsterdam, Netherlands	University of Amsterdam	Epskamp, S (corresponding author), Univ Amsterdam, Dept Psychol Methods, Amsterdam, Netherlands.	s.epskamp@uva.nl	Epskamp, Sacha/I-4515-2019	Kruis, Joost/0000-0001-8700-0326	NWO (Netherlands Organisation for Scientific Research) [406-11-06]	NWO (Netherlands Organisation for Scientific Research)(Netherlands Organization for Scientific Research (NWO))	This work was supported by NWO (Netherlands Organisation for Scientific Research) "research talent" Grant Number 406-11-06 (http.//WWW.nwo.nl/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 1990, CATEGORICAL DATA ANA, pXV; [Anonymous], [No title captured]; Barber RF, 2015, ELECTRON J STAT, V9, P567, DOI 10.1214/15-EJS1012; Beard C, 2016, PSYCHOL MED, V46, P3359, DOI 10.1017/S0033291716002300; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; Borsboom D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027407; Boschloo L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137621; Chandrasekaran V, 2012, ANN STAT, V40, P1935, DOI 10.1214/11-AOS949; Chen JH, 2008, BIOMETRIKA, V95, P759, DOI 10.1093/biomet/asn034; Chen Y., 2016, ARXIV160608925; COX DR, 1993, STAT SCI, V8, P204, DOI 10.1214/ss/1177010887; Cramer AOJ, 2012, PSYCHOL MED, V42, P957, DOI 10.1017/S003329171100211X; Cramer AOJ, 2010, BEHAV BRAIN SCI, V33, P137, DOI 10.1017/S0140525X09991567; Dalege J, 2016, PSYCHOL REV, V123, P2, DOI 10.1037/a0039802; Epskamp S., 2014, ISINGSAMPLER SAMPLIN; Epskamp S., 2017, PSYCHOMETRIKA; Epskamp S., HDB PSYCHOM IN PRESS; Epskamp S., 2016, ELASTICISING ISING N; Epskamp S., 2016, ARXIV160408462; Epskamp S, 2016, ARXIV160701367; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Foygel R., 2010, ARXIV10116640; Fried EI, 2017, SOC PSYCH PSYCH EPID, V52, P1, DOI 10.1007/s00127-016-1319-z; Fried EI, 2015, J ABNORM PSYCHOL, V124, P256, DOI 10.1037/abn0000028; Hastie T.J., 2001, ELEMENTS STAT LEARNI; Ising E, 1925, Z PHYS, V31, P253, DOI 10.1007/BF02980577; Isvoranu A. M., 2016, SCHIZOPHRENIA B; Kac M., 1966, MATH MECH PHASE TRAN; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kossakowski JJ, 2016, QUAL LIFE RES, V25, P781, DOI 10.1007/s11136-015-1127-z; Kruis J, 2016, SCI REPORTS, P6; Kruis J, 2015, THESIS; Langley DJ, 2015, ECIS 2015 RES IN PRO; Lauritzen S.L.., 1996, GRAPHICAL MODELS; Levinson CA, 2017, J ABNORM PSYCHOL, V126, P340, DOI 10.1037/abn0000254; Pan J., PSYCHOL MET IN PRESS; Reckase MD, 2009, STAT SOC BEHAV SC, P1, DOI 10.1007/978-0-387-89976-3_1; Rhemtulla M, 2016, DRUG ALCOHOL DEPEN, V161, P230, DOI 10.1016/j.drugalcdep.2016.02.005; Schmittmann VD, 2013, NEW IDEAS PSYCHOL, V31, P43, DOI 10.1016/j.newideapsych.2011.02.007; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van Borkulo C.D., 2014, R PACKAG VERSION; van Borkulo C, 2015, JAMA PSYCHIAT, V72, P1219, DOI 10.1001/jamapsychiatry.2015.2079; van Borkulo CD, 2014, SCI REP-UK, V4, DOI 10.1038/srep05918; Voets E, 2015, SCI REP-UK, V5, DOI 10.1038/srep14798; Wichers M, 2016, PSYCHOTHER PSYCHOSOM, V85, P114, DOI 10.1159/000441458	46	111	111	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179891	10.1371/journal.pone.0179891	http://dx.doi.org/10.1371/journal.pone.0179891			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY7CO	28644856	Green Published, Green Submitted, gold			2022-12-27	WOS:000404145100046
J	Sinharoy, P; Bratz, IN; Sinha, S; Showalter, LE; Andrei, SR; Damron, DS				Sinharoy, Pritam; Bratz, Ian N.; Sinha, Sayantani; Showalter, Loral E.; Andrei, Spencer R.; Damron, Derek S.			TRPA1 and TRPV1 contribute to propofol-mediated antagonism of U46619-induced constriction in murine coronary arteries	PLOS ONE			English	Article							SENSORY NEURONS; CARDIOVASCULAR-DISEASE; NITRIC-OXIDE; CHANNELS; ACTIVATION; CAPSAICIN; CA2+; PATHOPHYSIOLOGY; DESENSITIZATION; VASODILATION	Background Transient receptor potential (TRP) ion channels have emerged as key components contributing to vasoreactivity. Propofol, an anesthetic is associated with adverse side effects including hypotension and acute pain upon infusion. Our objective was to determine the extent to which TRPA1 and/or TRPV1 ion channels are involved in mediating propofol-induced vasorelaxation of mouse coronary arterioles in vitro and elucidate the potential cellular signal transduction pathway by which this occurs. Methods Hearts were excised from anesthetized mice and coronary arterioles were dissected from control C57Bl/6J, TRPA1(-/-), TRPV1(-/-) and double-knockout mice (TRPAV(-/-)). Isolated micro-vessels were cannulated and secured in a temperature-controlled chamber and allowed to equilibrate for 1 hr. Vasoreactivity studies were performed in microvessels pre-constricted with U46619 to assess the dose-dependent relaxation effects of propofol on coronary microvascular tone. Results Propofol-induced relaxation was unaffected in vessels obtained from TRPV1(-/-) mice, markedly attenuated in pre-constricted vessels obtained from TRPA1(-/-) mice and abolished in vessels obtained from TRPAV (-/-) mice. Furthermore, NOS inhibition with L-NAME or endothelium denuding abolished the proporfol-induced depressor response in pre-constricted vessels obtained from all mice. In the absence of L-NAME, BKCa inhibition with penitrem A markedly attenuated propofol-mediated relaxation in vessels obtained from wild-type mice and to a lesser extent in vessels obtained from TRPV1(-/-), mice with no effect in vessels obtained from TRPA1(-/-) or TRPAV(-/-) mice. Conclusions TRPA1 and TRPV1 appear to contribute to the propofol-mediated antagonism of U46619-induced constriction in murine coronary microvessels that involves activation of NOS and BKCa.	[Sinharoy, Pritam] Stanford Sch Med, Dept Anesthesia Perioperat & Pain Med, Stanford, CA USA; [Bratz, Ian N.] Northeast Ohio Med Coll, Dept Integrat Med Sci, Rootstown, OH USA; [Sinha, Sayantani] Childrens Hosp Philadelphia, Dept Surg, Div Orthoped Surg, Philadelphia, PA 19104 USA; [Showalter, Loral E.; Andrei, Spencer R.; Damron, Derek S.] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA	Stanford University; Northeast Ohio Medical University (NEOMED); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Damron, DS (corresponding author), Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA.	ddamron@kent.edu	Roy, Pritam Sinha/P-7955-2019; Sinha, Sayantani/S-9063-2019	Roy, Pritam Sinha/0000-0002-6322-260X; 	National Heart, Lung, and Blood Institute [HL 65701-12]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065701] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, and Blood Institute, HL 65701-12 to DSD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao M, 1996, AM J PHYSIOL-LUNG C, V271, pL719, DOI 10.1152/ajplung.1996.271.5.L719; Akopian AN, 2008, J NEUROSCI, V28, P1064, DOI 10.1523/JNEUROSCI.1565-06.2008; Akopian AN, 2007, J PHYSIOL-LONDON, V583, P175, DOI 10.1113/jphysiol.2007.133231; Akopian AN, 2011, CURR PHARM BIOTECHNO, V12, P89; Andrei SR, 2016, CHANNELS, V10, P395, DOI 10.1080/19336950.2016.1185579; Aubdool AA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6732; Bratz IN, 2008, AM J PHYSIOL-HEART C, V294, pH2489, DOI 10.1152/ajpheart.01191.2007; Byrne MF, 2008, CAN J GASTROENTEROL, V22, P457, DOI 10.1155/2008/268320; CHANG KSK, 1993, ANESTH ANALG, V76, P24; Cornett PM, 2008, MOL PHARMACOL, V74, P1261, DOI 10.1124/mol.108.049684; Earley S, 2009, CIRC RES, V104, P987, DOI 10.1161/CIRCRESAHA.108.189530; Eilers H, 2010, ANESTHESIOLOGY, V112, P1452, DOI 10.1097/ALN.0b013e3181d94e00; Fischer MJM, 2014, PFLUG ARCH EUR J PHY, V466, P2229, DOI 10.1007/s00424-014-1497-z; Fischer MJM, 2010, J BIOL CHEM, V285, P34781, DOI 10.1074/jbc.M110.143958; Guarini G, 2012, AM J PHYSIOL-HEART C, V303, pH216, DOI 10.1152/ajpheart.00011.2012; Hiett SC, 2014, CARDIOVASC RES, V103, P607, DOI 10.1093/cvr/cvu152; Hopps JJ, 2012, EUR J PHARMACOL, V681, P88, DOI 10.1016/j.ejphar.2012.02.019; Inoue R, 2009, PHARMACOL THERAPEUT, V123, P371, DOI 10.1016/j.pharmthera.2009.05.009; Klockgether-Radke AP, 2004, EUR J ANAESTH, V21, P226, DOI 10.1017/S0265021504003126; Kwan HY, 2007, BBA-MOL BASIS DIS, V1772, P907, DOI 10.1016/j.bbadis.2007.02.013; Lam CF, 2010, CRIT CARE RESUSC, V12, P186; Liu Y, 2009, VASC PHARMACOL, V51, P182, DOI 10.1016/j.vph.2009.06.003; Marelli-Berg FM, 2000, J IMMUNOL METHODS, V244, P205, DOI 10.1016/S0022-1759(00)00258-1; Matta JA, 2008, P NATL ACAD SCI USA, V105, P8784, DOI 10.1073/pnas.0711038105; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; PARK KW, 1995, ANESTH ANALG, V81, P1191, DOI 10.1097/00000539-199512000-00013; Patil MJ, 2010, NEUROSCIENCE, V171, P1109, DOI 10.1016/j.neuroscience.2010.09.031; Pozsgai G, 2010, CARDIOVASC RES, V87, P760, DOI 10.1093/cvr/cvq118; Robbins N, 2013, TRANSL RES, V161, P469, DOI 10.1016/j.trsl.2013.02.003; Salas MM, 2009, EUR J NEUROSCI, V29, P1568, DOI 10.1111/j.1460-9568.2009.06702.x; Sinha S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122189; Sinharoy P, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.153; Spahn V, 2013, MOL PHARM; Staruschenko A, 2010, J BIOL CHEM, V285, P15167, DOI 10.1074/jbc.M110.106153; STONE DJ, 1989, ANESTHESIOLOGY, V71, P126, DOI 10.1097/00000542-198907000-00021; Vasile B, 2003, INTENS CARE MED, V29, P1417, DOI 10.1007/s00134-003-1905-x; Watanabe H, 2008, PHARMACOL THERAPEUT, V118, P337, DOI 10.1016/j.pharmthera.2008.03.008; Wickley PJ, 2010, ANESTHESIOLOGY, V113, P833, DOI 10.1097/ALN.0b013e3181eaa9a0; YAMANOUE T, 1994, ANESTHESIOLOGY, V81, P443, DOI 10.1097/00000542-199408000-00023; Yao XQ, 2005, CIRC RES, V97, P853, DOI 10.1161/01.RES.0000187473.85419.3e; Zhang HY, 2011, ANESTHESIOLOGY, V114, P1169, DOI 10.1097/ALN.0b013e31820dee67	41	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0180106	10.1371/journal.pone.0180106	http://dx.doi.org/10.1371/journal.pone.0180106			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644897	Green Published, gold, Green Submitted			2022-12-27	WOS:000404145100063
J	Zhu, H				Zhu, Hua			Floristic characteristics and affinities in Lao PDR, with a reference to the biogeography of the Indochina peninsula	PLOS ONE			English	Article							YUNNAN; ASIA; FRAMEWORK; EVOLUTION; FLORA; SHEAR	The flora of Laos is composed of 5,005 species in 1,373 genera and 188 families of seed plants. Floristic and geographical attributes of the flora were analyzed. Tropical floristic elements at the family and generic levels contributed a majority (62.23% of the families and 82.30% of the genera) of the flora, of which the dominant geographical elements were pantropical distribution (42.02% of families) and tropical Asian distribution (30.08% of genera). This revealed that the flora of Lao PDR is tropical in nature and has a conspicuously tropical Asian affinity. Compared with the neighbouring countries of the Indochina peninsula, the flora of Laos has similar floristic composition and geographical elements. The floras of these Indochinese countries have similarities of more than 77.84% at the generic level, which suggests that they compose an affiliated biogeographical region. However, the flora of Laos showed the highest similarity to the flora of Vietnam (92.13%), followed by Myanmar (86.01%) at the generic level, but has less East Asian and North Temperate elements than Vietnam, and less North Temperate elements than Myanmar. These differences among the compared countries could be explained by the extrusion of the Indochinese block with the uplift of the Himalayas.	[Zhu, Hua] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Ctr Integrat Conservat, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS	Zhu, H (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Ctr Integrat Conservat, Kunming, Yunnan, Peoples R China.	zhuh@xtbg.ac.cn	Hua, Zhu/AFO-6233-2022		national science foundation of China	national science foundation of China(National Natural Science Foundation of China (NSFC))	The research funded by the national science foundation of China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubreville A., 1960, FLORA CAMBODGE LAOS; Blasco F, 1996, J VEG SCI, V7, P623, DOI 10.2307/3236374; Blasco F, 2000, BIOL CONSERV, V95, P175, DOI 10.1016/S0006-3207(00)00032-X; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Callaghan M., 2004, CHECKLIST LAO PLANT; Chan L. T., 1999, SOME BASIC CHARACTER; Chase MW, 2009, BOT J LINN SOC, V161, P122, DOI 10.1111/j.1095-8339.2009.01002.x; Fortey R. A., 1998, P43; Jain AK, 2014, CURR SCI INDIA, V106, P254; Kress W. John, 2003, Contributions from the United States National Herbarium, V45, P1; Lecomte H., 1907, FLORA GEN INDOCHINE; Lee TY, 1995, TECTONOPHYSICS, V251, P85, DOI 10.1016/0040-1951(95)00023-2; Leloup PH, 1995, TECTONOPHYSICS, V251, P3, DOI 10.1016/0040-1951(95)00070-4; Lou reiro J.D, 1790, FLORA COCHINCHINENSE; Mabberley D. J., 2008, MABBERLEYS PLANT BOO; Messerli Peter, 2008, GEOGRAPHY POVERTY IN; Metcalfe I, 2014, GONDWANA RES, V26, P1159, DOI 10.1016/j.gr.2013.09.004; Metcalfe I, 2013, J ASIAN EARTH SCI, V66, P1, DOI 10.1016/j.jseaes.2012.12.020; Metcalfe I, 2011, GONDWANA RES, V19, P3, DOI 10.1016/j.gr.2010.02.016; MITCHELL AHG, 1993, J GEOL SOC LONDON, V150, P1089, DOI 10.1144/gsjgs.150.6.1089; Newman M, 2007, CHECKLIST VASCULAR P; Smitinand T., 2001, THAI PLANT NAMESS; TAPPONNIER P, 1990, NATURE, V343, P431, DOI 10.1038/343431a0; TAPPONNIER P, 1982, GEOLOGY, V10, P611, DOI 10.1130/0091-7613(1982)10<611:PETIAN>2.0.CO;2; Vidal J., 1960, Bois et Forets des Tropiques, P5; Vidal J., 1959, EXTRAIT B ECOLE FRAN, VXLIX; Vidal J., 1972, VEGETATION LAOS; Watkinson I, 2008, J STRUCT GEOL, V30, P1554, DOI 10.1016/j.jsg.2008.09.001; Wu Z.Y., 2006, AREAL TYPES SEED PLA; Wu Zheng-Yi, 2003, Acta Botanica Yunnanica, V25, P245; Wu Zhongliang, 1991, Acta Seismologica Sinica, V13, P1; Zhu H., 2004, Telopea, V10, P639; Zhu H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151941; Zhu H, 2009, BOT STUD, V50, P467; Zhu H, 2008, ANN MO BOT GARD, V95, P661, DOI 10.3417/2006081; [朱华 Zhu Hua], 2003, [中山大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Sunyatseni], V42, P98	36	7	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179966	10.1371/journal.pone.0179966	http://dx.doi.org/10.1371/journal.pone.0179966			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644895	Green Submitted, Green Published, gold			2022-12-27	WOS:000404145100054
J	Elmesmari, R; Reilly, JJ; Martin, A; Paton, JY				Elmesmari, Rabha; Reilly, John J.; Martin, Anne; Paton, James Y.			Accelerometer measured levels of moderateto-vigorous intensity physical activity and sedentary time in children and adolescents with chronic disease: A systematic review and meta-analysis	PLOS ONE			English	Review							CONGENITAL HEART; OBJECTIVE MEASUREMENT; PEDIATRIC-PATIENTS; BEHAVIOR; FITNESS; YOUTH; CALIBRATION; EXERCISE; PRESCHOOLERS; PREVENTION	Context Moderate-to-vigorous physical activity (MVPA) and sedentary time (ST) are important for child and adolescent health. Objective To examine habitual levels of accelerometer measured MVPA and ST in children and adolescents with chronic disease, and how these levels compare with healthy peers. Methods Data sources: An extensive search was carried out in Medline, Cochrane library, EMBASE, SPORTDiscus and CINAHL from 2000-2017. Study selection: Studies with accelerometer-measured MVPA and/or ST (at least 3 days and 6 hours/day to provide estimates of habitual levels) in children 0-19 years of age with chronic diseases but without co-morbidities that would present major impediments to physical activity. In all cases patients were studied while well and clinically stable. Results Out of 1592 records, 25 studies were eligible, in four chronic disease categories: cardiovascular disease (7 studies), respiratory disease (7 studies), diabetes (8 studies), and malignancy (3 studies). Patient MVPA was generally below the recommended 60 min/day and ST generally high regardless of the disease condition. Comparison with healthy controls suggested no marked differences in MVPA between controls and patients with cardiovascular disease (1 study, n = 42) and type 1 diabetes (5 studies, n = 400; SMD -0.70, 95% CI -1.89 to 0.48, p = 0.25). In patients with respiratory disease, MVPA was lower in patients than controls (4 studies, n = 470; SMD -0.39, 95% CI -0.80, 0.02, p = 0.06). Meta-analysis indicated significantly lower MVPA in patients with malignancies than in the controls (2 studies, n = 90; SMD - 2.2, 95% CI - 4.08 to - 0.26, p = 0.03). Time spent sedentary was significantly higher in patients in 4/10 studies compared with healthy control groups, significantly lower in 1 study, while 5 studies showed no significant group difference. Conclusions MVPA in children/adolescents with chronic disease appear to be well below guideline recommendations, although comparable with activity levels of their healthy peers except for children with malignancies. Tailored and disease appropriate intervention strategies may be needed to increase MVPA and reduce ST in children and adolescents with chronic disease.	[Elmesmari, Rabha; Paton, James Y.] Univ Glasgow, Coll Med Vet & Life Sci, Sch Med, Glasgow, Lanark, Scotland; [Elmesmari, Rabha] Benghazi Univ, Al Fatah Hosp, Med Sch, Benghazi, Libya; [Reilly, John J.] Univ Strathclyde, Phys Act Hlth Grp, Glasgow, Lanark, Scotland; [Martin, Anne] Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland	University of Glasgow; University of Benghazi; University of Strathclyde	Paton, JY (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Sch Med, Glasgow, Lanark, Scotland.	James.Paton@glasgow.ac.uk		Martin, Anne/0000-0003-1614-6525	Libyan government	Libyan government	There are no financial relationships relevant to this article to disclose. Dr. R.E. was supported by the Libyan government and no specific funding was received from any bodies in the public, commercial to carry out the work described in this manuscript.	[Anonymous], 2010, GLOB REC PHYS ACT HL; Aznar S, 2006, APPL PHYSIOL NUTR ME, V31, P407, DOI 10.1139/H06-014; Aznar S, 2014, J CYST FIBROS, V13, P335, DOI 10.1016/j.jcf.2013.10.004; Banks L, 2013, MED SCI SPORT EXER, V45, P615, DOI 10.1249/MSS.0b013e31827b0b20; Banks L, 2012, PEDIATR TRANSPLANT, V16, P716, DOI 10.1111/j.1399-3046.2012.01706.x; Bender JM, 2005, MED SCI SPORT EXER, V37, P1409, DOI 10.1249/01.mss.0000174906.38722.2e; Byun W, 2012, J KOREAN MED SCI, V27, P388, DOI 10.3346/jkms.2012.27.4.388; Cochrane C., 2012, REV MANAGER REVMAN C; Colley R.C., 2012, PHYS ACTIVITY SEDENT; Cuenca-Garcia M, 2012, DIABETIC MED, V29, pe369, DOI 10.1111/j.1464-5491.2012.03740.x; De Bock F, 2010, MED SCI SPORT EXER, V42, P2237, DOI 10.1249/MSS.0b013e3181e27b5d; Duncombe S.L., 2017, J AM HEART ASSOC, DOI DOI 10.1161/JAHA.116.004665; Durstine JL, 2013, J SPORT HEALTH SCI, V2, P3, DOI 10.1016/j.jshs.2012.07.009; Durstine JL, 2013, J SPORT HEALTH SCI, V2, P1, DOI 10.1016/j.jshs.2012.12.002; Elhakeem A, 2015, INT J BEHAV NUTR PHY, V12, DOI [10.1186/s12966-015-0250-0, 10.1186/s12966-015-0274-5]; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Ewalt LA, 2012, CARDIOL YOUNG, V22, P34, DOI 10.1017/S1047951111000837; Fredriksen PM, 2000, CARDIOL YOUNG, V10, P107, DOI 10.1017/S1047951100006557; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Gardner R.F., 2016, CAN J CARDIOL; Gotte M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172216; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Health U.D.o. and H. Services, 2008, ODPHP PUBL; Jones RA, 2013, AM J PREV MED, V44, P651, DOI 10.1016/j.amepre.2013.03.001; Kahn JA, 2008, J ADOLESCENT HEALTH, V42, P369, DOI 10.1016/j.jadohealth.2007.11.143; Kilbride E, 2012, ISRN PULMONOLOGY, V2012; Kriska A, 2013, PEDIATRICS, V131, pE850, DOI 10.1542/peds.2012-0620; Logan S., 2008, WORLD, V198, P127; Longmuir PE, 2011, AM HEART J, V161, P411, DOI 10.1016/j.ahj.2010.11.019; MacMillan F, 2014, PRACT DIABETES, V31, P228, DOI 10.1002/pdi.1874; Maggio ABR, 2010, EUR J PEDIATR, V169, P1187, DOI 10.1007/s00431-010-1199-2; Martin A, 2016, PEDIATR EXERC SCI, V28, P353, DOI 10.1123/pes.2015-0207; McCrindle BW, 2007, ARCH DIS CHILD, V92, P509, DOI 10.1136/adc.2006.105239; Moher David, 2009, Open Med, V3, pe123; Nyberg G, 2009, SCAND J MED SCI SPOR, V19, P30, DOI 10.1111/j.1600-0838.2007.00756.x; Pastore E, 2001, PEDIATR TRANSPLANT, V5, P425, DOI 10.1034/j.1399-3046.2001.t01-2-00032.x; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pate RR, 2010, MED SCI SPORT EXER, V42, P508, DOI 10.1249/MSS.0b013e3181cea116; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; Reilly JJ, 2008, ARCH DIS CHILD, V93, P614, DOI 10.1136/adc.2007.133272; Reilly J.J., 2016, HLTH BEHAV POLICY RE; Reilly JJ, 2010, MED SCI SPORT EXER, V42, P502, DOI 10.1249/MSS.0b013e3181cea100; Reybrouck T, 2005, EUR J CARDIOV PREV R, V12, P498, DOI 10.1097/01.hjr.0000176510.84165.eb; Riddoch CJ, 2007, ARCH DIS CHILD, V92, P963, DOI 10.1136/adc.2006.112136; Sarnblad S, 2005, DIABETIC MED, V22, P893, DOI 10.1111/j.1464-5491.2005.01544.x; Schweiger B, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/328318; Smith MP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161461; Sundberg F, 2012, ACTA PAEDIATR, V101, P1164, DOI 10.1111/j.1651-2227.2012.02803.x; Takken T, 2012, EUR J PREV CARDIOL, V19, P1034, DOI 10.1177/1741826711420000; Tan SY, 2013, LEUKEMIA RES, V37, P14, DOI 10.1016/j.leukres.2012.09.005; Tanaka C, 2014, OBES REV, V15, P791, DOI 10.1111/obr.12195; Nguyen T, 2015, PEDIATR DIABETES, V16, P48, DOI 10.1111/pedi.12117; Tooth L, 2005, AM J EPIDEMIOL, V161, P280, DOI 10.1093/aje/kwi042; Toschke JA, 2007, CLIN NUTR, V26, P416, DOI 10.1016/j.clnu.2007.03.009; Tremblay MS, 2011, APPL PHYSIOL NUTR ME, V36, P36, DOI [10.1139/H11-009, 10.1139/H11-010]; Trigona B, 2010, J PEDIATR-US, V157, P533, DOI 10.1016/j.jpeds.2010.04.023; Tsai SY, 2012, NURS RES, V61, P252, DOI 10.1097/NNR.0b013e318255679c; Twisk JWR, 2001, SPORTS MED, V31, P617, DOI 10.2165/00007256-200131080-00006; Vahlkvist S, 2010, ALLERGY, V65, P1464, DOI 10.1111/j.1398-9995.2010.02406.x; van Gent R, 2007, PEDIATR PULM, V42, P1018, DOI 10.1002/ppul.20672; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Yiallouros PK, 2015, PEDIATR PULM, V50, P317, DOI 10.1002/ppul.23045	62	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179429	10.1371/journal.pone.0179429	http://dx.doi.org/10.1371/journal.pone.0179429			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640907	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000404135800032
J	Kim, MJ; Park, I; Park, JM; Kim, KH; Park, J; Shin, DW				Kim, Min Joung; Park, Incheol; Park, Joon Min; Kim, Kyung Hwan; Park, Junseok; Shin, Dong Wun			Systematic review and meta-analysis of initial management of pneumothorax in adults: Intercostal tube drainage versus other invasive methods	PLOS ONE			English	Review							MANUAL ASPIRATION; NEEDLE ASPIRATION; TRIAL; THERAPY	Objectives The ideal invasive management as initial approach for pneumothorax (PTX) is still under debate. The purpose of this systematic review and meta-analysis was to examine the evidence for the effectiveness of intercostal tube drainage and other various invasive methods as the initial approach to all subtypes of PTX in adults. Methods Three databases were searched from inception to May 29, 2016: MEDLINE, EMBASE, and the Cochrane CENTRAL. Randomised controlled trials that evaluated intercostal tube drainage as the control and various invasive methods as the intervention for the initial approach to PTX in adults were included. The primary outcome was the early success rate of each method, and the risk ratios (RRs) were used for an effect size measure. The secondary outcomes were recurrence rate, hospitalization rate, hospital stay, and complications. Results Seven studies met our inclusion criteria. Interventions were aspiration in six studies and catheterization connected to a one-way valve in one study. Meta-analyses were conducted for early success rate, recurrence rate, hospitalization rate, and hospital stay. Aspiration was inferior to intercostal tube drainage in terms of early success rate (RR = 0.82, confidence interval [CI] = 0.72 to 0.95, I-2 = 0%). While aspiration and intercostal tube drainage showed no significant difference in the recurrence rate (RR = 0.84, CI = 0.57 to 1.23, I-2 = 0%), aspiration had shorter hospital stay than intercostal tube drainage (mean difference = -1.73, CI = -2.33 to -1.13, I-2 = 0%). Aspiration had lower hospitalization rate than intercostal tube drainage, but marked heterogeneity was present (RR = 0.38, CI = 0.19 to 0.76, I-2 = 85%). Conclusion Aspiration was inferior to intercostal tube drainage in terms of early resolution, but it had shorter hospital stay. The recurrence rate of aspiration and intercostal tube drainage did not differ significantly. The efficacy of catheterization connected to a one-way valve was inconclusive because of the small number of relevant studies.	[Kim, Min Joung; Park, Incheol] Yonsei Univ, Coll Med, Dept Emergency Med, Seoul, South Korea; [Park, Joon Min; Kim, Kyung Hwan; Park, Junseok; Shin, Dong Wun] Inje Univ, Ilsan Paik Hosp, Dept Emergency Med, Goyang, South Korea	Yonsei University; Yonsei University Health System; Inje University	Park, JM (corresponding author), Inje Univ, Ilsan Paik Hosp, Dept Emergency Med, Goyang, South Korea.	aero7@outlook.kr		Park, Incheol/0000-0001-7033-766X; Kim, Min Joung/0000-0003-1634-5209; Park, Joon Min/0000-0001-7258-8892				Aguinagalde B, 2010, EUR J CARDIO-THORAC, V37, P1129, DOI 10.1016/j.ejcts.2009.12.008; ANDRIVET P, 1995, CHEST, V108, P335, DOI 10.1378/chest.108.2.335; Ayed AK, 2006, EUR RESPIR J, V27, P477, DOI 10.1183/09031936.06.00091505; Baumann MH, 2001, CHEST, V119, P590, DOI 10.1378/chest.119.2.590; BENSE L, 1987, CHEST, V92, P1009, DOI 10.1378/chest.92.6.1009; Brims FJH, 2013, THORAX, V68, P664, DOI 10.1136/thoraxjnl-2012-202875; Chambers Anthony, 2009, Interact Cardiovasc Thorac Surg, V9, P1003, DOI 10.1510/icvts.2009.216473; De Leyn P, 2005, ACTA CHIR BELG, V105, P265; Ramirez MAG, 2012, J AM COLL SURGEONS, V215, pS100; Gupta D, 2000, THORAX, V55, P666, DOI 10.1136/thorax.55.8.666; HARVEY J, 1994, BRIT MED J, V309, P1338, DOI 10.1136/bmj.309.6965.1338; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ho KK, 2011, AM J EMERG MED, V29, P1152, DOI 10.1016/j.ajem.2010.05.017; Korczynski P, 2015, ADV EXP MED BIOL, V866, P15, DOI 10.1007/5584_2015_146; MacDuff A, 2010, THORAX, V65, P18, DOI 10.1136/thx.2010.136986; MELTON LJ, 1979, AM REV RESPIR DIS, V120, P1379; Nishiuma T, 2012, INTERNAL MED, V51, P1329, DOI 10.2169/internalmedicine.51.6919; Noppen M, 2002, AM J RESP CRIT CARE, V165, P1240, DOI 10.1164/rccm.200111-078OC; Parlak M, 2012, RESP MED, V106, P1600, DOI 10.1016/j.rmed.2012.08.005; Roggla M, 1996, WIEN KLIN WOCHENSCHR, V108, P330; Schramel FMNH, 1997, EUR RESPIR J, V10, P1372, DOI 10.1183/09031936.97.10061372; Thelle A, 2014, EUROPEAN RESP J; Voisin F, 2014, ANN EMERG MED, V64, P222, DOI 10.1016/j.annemergmed.2013.12.017; Wakai A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004479.pub2; Zehtabchi S, 2008, ANN EMERG MED, V51, P91, DOI 10.1016/j.annemergmed.2007.06.009	26	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0178802	10.1371/journal.pone.0178802	http://dx.doi.org/10.1371/journal.pone.0178802			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640890	gold, Green Published			2022-12-27	WOS:000404135800009
J	Ota, S; Ogawa, Y; Ota, H; Fujiwara, T; Sugiyama, T; Ochi, A				Ota, Susumu; Ogawa, Yukari; Ota, Hiroki; Fujiwara, Tomoya; Sugiyama, Tadashi; Ochi, Akira			Beneficial effects of a gait used while wearing a kimono to decrease the knee adduction moment in healthy adults	PLOS ONE			English	Article							HIP ABDUCTOR FUNCTION; MEDIAL CONTACT FORCE; TOE-OUT GAIT; DISEASE PROGRESSION; FLEXION MOMENTS; JOINT LOAD; BASE-LINE; OSTEOARTHRITIS; PEOPLE; INDIVIDUALS	The knee adduction moment (KAM) relates to medial knee osteoarthritis (OA). Several gait modifications to reduce the KAM for the prevention of knee OA have been studied. Most of the modifications, however, involve voluntary changes in leg alignment. Here we investigated the biomechanical effects for reducing the KAM of a walking style with a small trunk rotation and arm swing gait, which is a natural walking style used while wearing a kimono (Nanba walk) that shifts the ground reaction force toward the stance leg (reduced lever arm). Twenty-nine healthy adults (21.5 +/- 0.6 years) participated in the present study. A three-dimensional analysis system with 10 cameras and 1 force plate was used to obtain the KAM and other biomechanical data. Surface electromyography (EMG) of the hip and trunk muscles (internal obliquus abdominal muscle: IO, external obliquus abdominal muscle: EO, multifidus muscle: MF, and gluteus medius muscle: Gmed) was also assessed, and integrated EMG (iEMG) of the four muscles was assessed in the first and second halves of the stance phase. The 1st and 2nd peak KAMs were significantly decreased during Nanba walking (0.40 +/- 0.09 and 0.37 +/- 0.13 Nm/kg) compared with normal walking (0.45 +/- 0.09 and 0.45 +/- 0.13 Nm/kg; P = 0.002, P<0.001, respectively). The lever arm lengths at the 1st and 2nd peak KAMs were also significantly decreased during Nanba walking compared with normal walking (p = 0.023 and p<0.001, respectively). The iEMGs of IO, EO and Gmed muscles during the first half, and the iEMGs of EO and GM during the second half of the stance phase were significantly increased during Nanba walking compared with normal walking. The Nanba gait modification could be a useful strategy for reducing the KAM with high activation of the trunk and hip joint muscles for the prevention and/or treatment of medial knee OA.	[Ota, Susumu; Ochi, Akira] Seijoh Univ, Dept Rehabil & Care, Tokai, Ibaraki, Japan; [Ogawa, Yukari; Ota, Hiroki] Nagoya Tokushukai Gen Hosp, Dept Phys Med & Rehabil, Kasugai, Aichi, Japan; [Fujiwara, Tomoya] Yachiyo Hosp, Rehabil Ctr, Anjo, Japan; [Sugiyama, Tadashi] Natl Ctr Geriatr & Gerontol, Dept Rehabil Med, Obu, Japan	National Center for Geriatrics & Gerontology	Ota, S (corresponding author), Seijoh Univ, Dept Rehabil & Care, Tokai, Ibaraki, Japan.	ota-s@seijoh-u.ac.jp		Ochi, Akira/0000-0003-2754-7383	 [15H03047];  [24500577]	; 	The present study was partially supported by a Grant-in-Aid for Scientific Research [B] (15H03047) and [C] (24500577). There was no additional external funding received for this study.; The present study was partially supported by a Grant-in-Aid for Scientific Research [B] (15H03047) and [C] (24500577).	Ae M., 1992, BIOMECHANISM, V11, P23; Magalhaes CMB, 2013, J ELECTROMYOGR KINES, V23, P1243, DOI 10.1016/j.jelekin.2013.05.013; Bennell KL, 2010, OSTEOARTHR CARTILAGE, V18, P621, DOI 10.1016/j.joca.2010.01.010; Biomedical Health and Research Program of the European Union, SENIAM PROJ; CAPPOZZO A, 1995, CLIN BIOMECH, V10, P171, DOI 10.1016/0268-0033(95)91394-T; Chang A, 2005, ARTHRITIS RHEUM-US, V52, P3515, DOI 10.1002/art.21406; Chang AH, 2015, OSTEOARTHR CARTILAGE, V23, P1099, DOI 10.1016/j.joca.2015.02.005; Chehab EF, 2014, OSTEOARTHR CARTILAGE, V22, P1833, DOI 10.1016/j.joca.2014.08.009; Criswell E., 2011, CRAMS INTRO SURFACE; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; Henriksen M, 2009, J BIOMECH, V42, P1236, DOI 10.1016/j.jbiomech.2009.03.021; Hinman RS, 2010, ARTHRIT CARE RES, V62, P1190, DOI 10.1002/acr.20199; Hunt MA, 2014, OSTEOARTHR CARTILAGE, V22, P904, DOI 10.1016/j.joca.2014.04.007; Hunt MA, 2011, KNEE, V18, P231, DOI 10.1016/j.knee.2010.05.014; Jenkyn TR, 2008, J BIOMECH, V41, P276, DOI 10.1016/j.jbiomech.2007.09.015; Kemp G, 2008, ARTHRIT RHEUM-ARTHR, V59, P609, DOI 10.1002/art.23578; Kidera E, 2004, HONTOUNO NANBA NAMIA; Lu TW, 1999, J BIOMECH, V32, P129, DOI 10.1016/S0021-9290(98)00158-4; Miyazaki T, 2002, ANN RHEUM DIS, V61, P617, DOI 10.1136/ard.61.7.617; Ogata M, 2006, J HUM MOVEMENT STUD, V50, P171; Ota S, 2015, J ARTHRITIS, V4; Ota S, 2015, J PHYS THER SCI, V27, P3077, DOI 10.1589/jpts.27.3077; Perry J., 1992, GAIT ANAL NORMAL PAT; Pijnappels M, 2010, EXP BRAIN RES, V201, P689, DOI 10.1007/s00221-009-2088-7; Robbins SMK, 2009, GAIT POSTURE, V30, P543, DOI 10.1016/j.gaitpost.2009.08.236; Rutherford DJ, 2014, CLIN BIOMECH, V29, P545, DOI 10.1016/j.clinbiomech.2014.03.009; Shull PB, 2013, J ORTHOP RES, V31, P1020, DOI 10.1002/jor.22340; Simic M, 2013, OSTEOARTHR CARTILAGE, V21, P1272, DOI 10.1016/j.joca.2013.06.001; Simic M, 2012, ARTHRIT CARE RES, V64, P1545, DOI 10.1002/acr.21724; Simic M, 2011, ARTHRIT CARE RES, V63, P405, DOI 10.1002/acr.20380; Takacs J, 2012, J BIOMECH, V45, P2791, DOI 10.1016/j.jbiomech.2012.08.041; van den Noort JC, 2013, HUM MOVEMENT SCI, V32, P412, DOI 10.1016/j.humov.2012.02.009; Walter JP, 2010, J ORTHOP RES, V28, P1348, DOI 10.1002/jor.21142; Watarai K, 2007, UTSUKUSHIKU TATSU; Yamaguchi T, 2009, J BIOMECHANICAL SCI, V4, P468; Yang HS, 2015, GAIT POSTURE, V42, P430, DOI 10.1016/j.gaitpost.2015.07.010; Zhao D, 2007, J ORTHOP RES, V25, P789, DOI 10.1002/jor.20379	38	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179260	10.1371/journal.pone.0179260	http://dx.doi.org/10.1371/journal.pone.0179260			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640896	gold, Green Submitted, Green Published			2022-12-27	WOS:000404135800025
J	Hobaiter, C; Samuni, L; Mullins, C; Akankwasa, WJ; Zuberbuhler, K				Hobaiter, Catherine; Samuni, Liran; Mullins, Caroline; Akankwasa, Walter John; Zuberbuhler, Klaus			Variation in hunting behaviour in neighbouring chimpanzee communities in the Budongo forest, Uganda	PLOS ONE			English	Article							GOMBE-NATIONAL-PARK; WILD CHIMPANZEES; PAN-TROGLODYTES; MAHALE MOUNTAINS; PREDATION; FOOD; HARASSMENT; HABITUATION; RECIPROCITY; MAMMALS	Hunting and sharing of meat is seen across all chimpanzee sites, with variation in prey preferences, hunting techniques, frequencies, and success rates. Here, we compared hunting and meat-eating behaviour in two adjacent chimpanzee communities (Pan troglodytes schweinfurthii) of Budongo Forest, Uganda: the Waibira and Sonso communities. We observed consistent between-group differences in prey-species preferences and in post-hunting behaviour. Sonso chimpanzees show a strong prey preference for Guereza colobus monkeys (Colobus guereza occidentalis; 74.9% hunts), and hunt regularly (1-2 times a month) but with large year-to-year and month-to-month variation. Waibira chimpanzee prey preferences are distributed across primate and duiker species, and resemble those described in an early study of Sonso hunting. Waibira chimpanzees (which include ex-Sonso immigrants) have been observed to feed on red duiker (Cephalophus natalensis; 25%, 9/36 hunts), a species Sonso has never been recorded to feed on (18 years data, 27 years observations), despite no apparent differences in prey distribution; and show less rank-related harassment of meat possessors. We discuss the two most likely and probably interrelated explanations for the observed intergroup variation in chimpanzee hunting behaviour, that is, long-term disruption of complex group-level behaviour due to human presence and possible socially transmitted differences in prey preferences.	[Hobaiter, Catherine; Mullins, Caroline; Zuberbuhler, Klaus] Univ St Andrews, Sch Psychol & Neurosci, Ctr Social Learning & Cognit Evolut, St Andrews, Fife, Scotland; [Hobaiter, Catherine; Mullins, Caroline; Zuberbuhler, Klaus] Univ St Andrews, Sch Psychol & Neurosci, Scottish Primate Res Grp, St Andrews, Fife, Scotland; [Hobaiter, Catherine; Samuni, Liran; Mullins, Caroline; Akankwasa, Walter John; Zuberbuhler, Klaus] Budongo Conservat Field Stn, Masindi, Uganda; [Samuni, Liran] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Akankwasa, Walter John] Makerere Univ, Sch Vet Med & Anim Resources, Kampala, Uganda; [Zuberbuhler, Klaus] Univ Neuchatel, Inst Biol, Dept Comparat Cognit, Neuchatel, Switzerland	University of St Andrews; University of St Andrews; Max Planck Society; Makerere University; University of Neuchatel	Hobaiter, C (corresponding author), Univ St Andrews, Sch Psychol & Neurosci, Ctr Social Learning & Cognit Evolut, St Andrews, Fife, Scotland.; Hobaiter, C (corresponding author), Univ St Andrews, Sch Psychol & Neurosci, Scottish Primate Res Grp, St Andrews, Fife, Scotland.; Hobaiter, C (corresponding author), Budongo Conservat Field Stn, Masindi, Uganda.	clh42@st-andrews.ac.uk	Zuberbühler, Klaus/A-9053-2011	Zuberbühler, Klaus/0000-0001-8378-088X; Hobaiter, Cat/0000-0002-3893-0524	Leverhulme Trust Research Leadership [F/00268/AP]; British Academy [SG411998]	Leverhulme Trust Research Leadership; British Academy	This research was funded by the Leverhulme Trust Research Leadership Award F/00268/AP (http://www.leverhulme.ac.uk/) and the British Academy grant SG411998 (http://www.brit. ac.uk).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Babweteera F., 2012, ECOLOGICAL IMPACT LO, P31; Bertolani P, 2008, FOLIA PRIMATOL, V79, P162, DOI 10.1159/000111720; BOESCH C, 1994, ANIM BEHAV, V48, P653, DOI 10.1006/anbe.1994.1285; BOESCH C, 1989, AM J PHYS ANTHROPOL, V78, P547, DOI 10.1002/ajpa.1330780410; Boesch C, 2002, HUM NATURE-INT BIOS, V13, P27, DOI 10.1007/s12110-002-1013-6; Boesch C., 2000, CHIMPANZEES TAR FORE; Brown GR, 2004, ADV STUD BEHAV, V34, P265, DOI 10.1016/S0065-3454(04)34007-6; Brown J.L., 1987, HELPING COMMUNAL BRE; Carter GG, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2573; De Kort SR, 2006, ANIM BEHAV, V72, P297, DOI 10.1016/j.anbehav.2005.10.016; Eggling WJ, 1969, J ECOL, V34, P20; Elbroch LM, 2017, CURR ZOOL, V63, P357, DOI 10.1093/cz/zow080; EVANS CS, 1994, ANIM BEHAV, V47, P1159, DOI 10.1006/anbe.1994.1154; FRAGASZY DM, 1992, AM J PRIMATOL, V26, P259, DOI 10.1002/ajp.1350260404; Fragaszy DM., 2003, BIOL TRADITIONS MODE, P1, DOI DOI 10.1017/CBO9780511584022.002; Gilby IC, 2008, ANIM BEHAV, V75, P351, DOI 10.1016/j.anbehav.2007.06.008; Gilby IC, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0005; Gilby IC, 2010, J HUM EVOL, V59, P44, DOI 10.1016/j.jhevol.2010.02.006; Gilby IC, 2006, ANIM BEHAV, V71, P953, DOI 10.1016/j.anbehav.2005.09.009; Gomes CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005116; Goodall J., 1986, CHIMPANZEES GOMBE PA; Gruber T, 2012, J COMP PSYCHOL, V126, P446, DOI 10.1037/a0028702; Gwynne DT, 2008, ANNU REV ENTOMOL, V53, P83, DOI 10.1146/annurev.ento.53.103106.093423; HEINRICH B, 1988, BEHAV ECOL SOCIOBIOL, V23, P141, DOI 10.1007/BF00300349; Hicks TC, 2013, FOLIA PRIMATOL, V84, P135, DOI 10.1159/000350650; Hobaiter C, 2017, WAIBIRA CHIMPANZEE D; HOELZEL AR, 1991, BEHAV ECOL SOCIOBIOL, V29, P197, DOI 10.1007/BF00166401; Hohmann G., 1996, FOOD STATUS QUEST, P47; Holekamp KE, 1997, J ZOOL, V242, P1, DOI 10.1111/j.1469-7998.1997.tb02925.x; Hosaka K., 2016, MAHALE CHIMPANZEES 5, P275; Humle T, 2002, AM J PRIMATOL, V58, P133, DOI 10.1002/ajp.10055; Kaburu SSK, 2015, ANIM BEHAV, V99, P61, DOI 10.1016/j.anbehav.2014.10.018; Kalan AK, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0167-8; Kalan AK, 2015, ECOL INDIC, V54, P217, DOI 10.1016/j.ecolind.2015.02.023; Kingdon J, 2011, KINGDON FIELD GUIDE, V4th; Kuhl HS, PLOS ONE; Laland KN, 2006, TRENDS ECOL EVOL, V21, P542, DOI 10.1016/j.tree.2006.06.005; Langergraber KE, 2007, P NATL ACAD SCI USA, V104, P7786, DOI 10.1073/pnas.0611449104; Laporte MNC, 2010, ANIM BEHAV, V80, P467, DOI 10.1016/j.anbehav.2010.06.005; Luncz LV, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0348; McGrew W.C., 1992, CHIMPANZEE MAT CULTU; Mitani JC, 2001, ANIM BEHAV, V61, P915, DOI 10.1006/anbe.2000.1681; Mobius Y, 2008, ANIM BEHAV, V76, P37, DOI 10.1016/j.anbehav.2008.01.008; Newton-Fisher NE, 2002, FOLIA PRIMATOL, V73, P281, DOI 10.1159/000067454; Newton-Fisher NE., 2014, HDB PALAEOANTHROPOLO, V2, P1; NISHIDA T, 1979, Primates, V20, P1, DOI 10.1007/BF02373826; NISHIDA T, 1983, J HUM EVOL, V12, P467, DOI 10.1016/S0047-2484(83)80142-0; Nishida T., 2011, CHIMPANZEES LAKESHOR; Nishida Toshisada, 1992, P159; Peres Carlos A., 1999, Neotropical Primates, V7, P11; Plumptre AJ, 2000, J APPL ECOL, V37, P356, DOI 10.1046/j.1365-2664.2000.00499.x; Plumptre AJ, 2003, ALBERTINE RIFT TECHN, P105; Pruetz JD, R SOC OPEN SCI; Pruetz Jill D., 2006, P161; Pruetz JD, 2007, CURR BIOL, V17, P412, DOI 10.1016/j.cub.2006.12.042; Reynolds V., 2005, CHIMPANZEES BUDONGO; SAKALUK SK, 1984, SCIENCE, V223, P609, DOI 10.1126/science.223.4636.609; Samuni L, 2014, ANIM COGN, V17, P997, DOI 10.1007/s10071-014-0731-6; SCHEEL D, 1991, ANIM BEHAV, V41, P697, DOI 10.1016/S0003-3472(05)80907-8; Silk JB, 2013, ANIM BEHAV, V85, P941, DOI 10.1016/j.anbehav.2013.02.014; STANFORD CB, 1994, AM J PHYS ANTHROPOL, V94, P213, DOI 10.1002/ajpa.1330940206; Stevens JR, 2004, P ROY SOC B-BIOL SCI, V271, P451, DOI 10.1098/rspb.2003.2625; TAKAHATA Y, 1984, INT J PRIMATOL, V5, P213, DOI 10.1007/BF02735758; Takahata Y., 1986, HUM EVOL, V1, P277; Tennie C, 2009, BEHAV ECOL SOCIOBIOL, V63, P421, DOI 10.1007/s00265-008-0676-3; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Uehara S, 1997, PRIMATES, V38, P193, DOI 10.1007/BF02382009; Uehara Shigeo, 1992, P143; Watts DP, 2013, AM J PRIMATOL, V75, P927, DOI 10.1002/ajp.22157; Watts DP, 2002, INT J PRIMATOL, V23, P1, DOI 10.1023/A:1013270606320; WHITE LJT, 1994, J ANIM ECOL, V63, P499, DOI 10.2307/5217; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; WILKINSON GS, 1984, NATURE, V308, P181, DOI 10.1038/308181a0; Wittig RM, 2003, BEHAV ECOL SOCIOBIOL, V54, P491, DOI 10.1007/s00265-003-0654-8; Woolfenden GE, 1984, FLORIDA SCRUB JAY DE, V20; Wrangham R. W., 1975, THESIS; Yamagiwa J, 1999, PRIMATES, V40, P87, DOI 10.1007/BF02557704; Yamamoto S, 2015, BEHAVIOUR, V152, P335, DOI 10.1163/1568539X-00003257	79	28	28	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0178065	10.1371/journal.pone.0178065	http://dx.doi.org/10.1371/journal.pone.0178065			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY6UH	28636646	gold, Green Published			2022-12-27	WOS:000404118300008
J	Hou, J; Brouwer, WP; Kreefft, K; Gama, L; Price, SL; Janssen, HLA; French, PJ; Vanwolleghem, T; Boonstra, A				Hou, Jun; Brouwer, Willem P.; Kreefft, Kim; Gama, Lucio; Price, Sarah L.; Janssen, Harry L. A.; French, Pim J.; Vanwolleghem, Thomas; Boonstra, Andre			Unique intrahepatic transcriptomics profiles discriminate the clinical phases of a chronic HBV infection	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; DENDRITIC CELLS; PROGRESSION; MICROARRAY; MONOCYTES; LIVER; KIR	Chronic hepatitis B is a highly heterogeneous liver disease characterized by phases with fluctuations in viral replication and progressive liver damage in some, but not all infected individuals. Despite four decades of research, insight into host determinants underlying these distinct clinical phases-immunotolerant, immune active, inactive carrier, and HBeAg-negative hepatitis-remains elusive. We performed an in-depth transcriptome analysis of archived FFPE liver biopsies of each clinical phase to address host determinants associated with the natural history. Therefore, we determined, for the first time, intrahepatic global expression profiles of well-characterized chronic HBV patients at different clinical phases. Our data, obtained by microarray, demonstrate that B cells and NK/cytotoxic-related genes in the liver, including CD19, TNFRSF13C, GZMH, and KIR2DS3, were differentially expressed across the clinical HBV phases, which was confirmed by modular analysis and also Nanostring arrays in an independent cohort. Compared to the immunotolerant phase, 92 genes were differentially expressed in the liver during the immune active phase, 46 in the inactive carrier phase, and 71 in the HBeAg-negative phase. Furthermore, our study also revealed distinctive transcription of genes associated with cell cycle activity, NF B-K signaling, cytotoxic function and mitochondrial respiration between clinical phases. Our data define for the first time using microarray unique transcriptomes in the HBV-infected liver during consecutive clinical phases. We demonstrate that fluctuations of viral loads and liver damage coincide with fluctuations in the liver transcriptome and point to functional immune and non-immune- components contributing to the clinical phenotype in patients.	[Hou, Jun; Brouwer, Willem P.; Kreefft, Kim; Janssen, Harry L. A.; Vanwolleghem, Thomas; Boonstra, Andre] Univ Med Ctr Rotterdam, Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Gama, Lucio; Price, Sarah L.] Johns Hopkins Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD USA; [Janssen, Harry L. A.] Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada; [French, Pim J.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Neurol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Johns Hopkins University; Johns Hopkins Medicine; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Erasmus University Rotterdam; Erasmus MC	Boonstra, A (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands.	p.a.boonstra@erasmusmc.nl	Brouwer, Willem Pieter/P-5444-2014; Vanwolleghem, Thomas/AAD-4094-2022; Hou, Jun/AGJ-0692-2022	Brouwer, Willem Pieter/0000-0001-8713-1481; Boonstra, Andre/0000-0001-8607-1616; French, Pim/0000-0002-0668-9529; Price, Sarah/0000-0002-4392-7506; Vanwolleghem, Thomas/0000-0002-0572-8741	Virgo consortium - Dutch government [FES0908]	Virgo consortium - Dutch government	This work was supported by the Virgo consortium, funded by the Dutch government project number FES0908. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer KJ, 2010, BRIEF BIOINFORM, V11, P244, DOI 10.1093/bib/bbp055; Brouwer WP, 2015, LIVER INT, V35, P438, DOI 10.1111/liv.12695; Cao WP, 2012, J IMMUNOL, V189, P2257, DOI 10.4049/jimmunol.1200168; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chen XM, 2015, CANCER PREV RES, V8, P455, DOI 10.1158/1940-6207.CAPR-14-0384; Chin R, 2010, VIRUS RES, V147, P7, DOI 10.1016/j.virusres.2009.09.012; Fattovich G, 2008, J HEPATOL, V48, P335, DOI 10.1016/j.jhep.2007.11.011; Fletcher SP, 2012, HEPATOLOGY, V56, P820, DOI 10.1002/hep.25730; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; Hoofnagle JH, 2007, HEPATOLOGY, V45, P1056, DOI 10.1002/hep.21627; Hou J, 2014, ANTIVIR RES, V109, P116, DOI 10.1016/j.antiviral.2014.06.020; Kerr MK, 2001, P NATL ACAD SCI USA, V98, P8961, DOI 10.1073/pnas.161273698; Lamontagne J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005438; Lebosse F, 2016, J HEPATOL; Marangon AV, 2011, HUM IMMUNOL, V72, P1074, DOI 10.1016/j.humimm.2011.08.017; Moretta A, 2009, CLIN EXP IMMUNOL, V157, P325, DOI 10.1111/j.1365-2249.2009.03983.x; Movita D, 2015, J VIROL, V89, P4809, DOI 10.1128/JVI.03733-14; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Rosen DB, 2008, J IMMUNOL, V180, P6508, DOI 10.4049/jimmunol.180.10.6508; Rueger S, 2014, GUT; Saxena N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111256; Schoeman JC, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0318-8; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Shen P, 2015, NAT REV IMMUNOL, V15, P441, DOI 10.1038/nri3857; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Taylor J, 2005, BIOSTATISTICS, V6, P111, DOI 10.1093/biostatistics/kxh021; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van de Garde MDB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166094; Vanwolleghem T, 2015, HEPATOLOGY, V62, P87, DOI 10.1002/hep.27805; Warita K, 2012, J TOXICOL SCI, V37, P287, DOI 10.2131/jts.37.287; Wieland S, 2004, P NATL ACAD SCI USA, V101, P6669, DOI 10.1073/pnas.0401771101; Yim HJ, 2006, HEPATOLOGY, V43, pS173, DOI 10.1002/hep.20956; Zou LY, 2015, ONCOL REP, V33, P2461, DOI 10.3892/or.2015.3852	33	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179920	10.1371/journal.pone.0179920	http://dx.doi.org/10.1371/journal.pone.0179920			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662087	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300071
J	Aki, A; Nagasaki, M; Malynn, BA; Ma, A; Kagari, T				Aki, Anri; Nagasaki, Miyuki; Malynn, Barbara Ann; Ma, Averil; Kagari, Takashi			Hypomorphic A20 expression confers susceptibility to psoriasis	PLOS ONE			English	Article							NF-KAPPA-B; MODIFYING ENZYME A20; RESTRICTS UBIQUITINATION; INHIBITION; CELLS; PROTEIN; INTERLEUKIN-17; INFLAMMATION; REVEALS; ABSENCE	Psoriasis is a common inflammatory skin disease that affects approximately 1% of the population worldwide. Tumor necrosis factor-alpha-induced protein 3 (TNFAIP3) gene polymorphisms have been strongly associated with psoriasis susceptibility. In this study, we investigate how TNFAIP3, also known as A20, may regulate psoriasis susceptibility. We found that haplo-insufficient A20(+/-) mice develop severe toll-like receptor (TLR)-induced skin inflammation compared to wild type mice owing to amplified production of interleukin (IL)-17 and IL-23. Examination of TNFAIP3 mRNA expression in skin biopsies from patients with psoriasis revealed reduced expression in both involved and uninvolved skin. Our results demonstrate the clinical importance of reduced dermal expression of A20 in psoriasis and suggest that A20 restriction of the IL-23/17 axis protects against psoriasis.	[Aki, Anri; Nagasaki, Miyuki; Kagari, Takashi] Daiichi Sankyo Co Ltd, R&D Div, Oncol Funct, Biol & Immunooncol Labs, Tokyo, Japan; [Malynn, Barbara Ann; Ma, Averil] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	Daiichi Sankyo Company Limited; University of California System; University of California San Francisco	Kagari, T (corresponding author), Daiichi Sankyo Co Ltd, R&D Div, Oncol Funct, Biol & Immunooncol Labs, Tokyo, Japan.	kagari.takashi.z4@daiichisankyo.co.jp		Aki, Anri/0000-0002-2369-2770	National Institutes of Health; Daiichi Sankyo Co., Ltd.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI117908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Daiichi Sankyo Co., Ltd.(Daiichi Sankyo Company Limited); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (AM). Daiichi Sankyo Co., Ltd. provided support in the form of salaries for AA, MN, and TK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becher B, 2012, NAT MED, V18, P1748, DOI 10.1038/nm.3016; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Duong BH, 2015, IMMUNITY, V42, P55, DOI 10.1016/j.immuni.2014.12.031; Garg AV, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003699; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gisondi P, 2014, DERMATOLOGY THER, V4, P1, DOI 10.1007/s13555-014-0042-5; Hammer GE, 2011, NAT IMMUNOL, V12, P1184, DOI 10.1038/ni.2135; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Kirkham BW, 2014, IMMUNOLOGY, V141, P133, DOI 10.1111/imm.12142; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lippens S, 2011, CELL DEATH DIFFER, V18, P1845, DOI 10.1038/cdd.2011.55; Lonnberg AS, 2014, CLIN COSMET INVESTI, V7, P251, DOI 10.2147/CCID.S67534; Lu TT, 2013, IMMUNITY, V38, P896, DOI 10.1016/j.immuni.2013.03.008; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Onizawa M, 2015, NAT IMMUNOL, V16, P618, DOI 10.1038/ni.3172; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; Reich K, 2015, EXP DERMATOL, V24, P529, DOI 10.1111/exd.12710; SARMA V, 1995, J BIOL CHEM, V270, P12343, DOI 10.1074/jbc.270.21.12343; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Tavares RM, 2010, IMMUNITY, V33, P181, DOI 10.1016/j.immuni.2010.07.017; Tejasvi T, 2012, J INVEST DERMATOL, V132, P593, DOI 10.1038/jid.2011.376; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Vande Walle L, 2014, NATURE, V512, P69, DOI 10.1038/nature13322; Wang S, 2016, GENES IMMUN, V17, P165, DOI 10.1038/gene.2016.4; Wang SF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003750; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wertz IE, 2015, NATURE, V528, P370, DOI 10.1038/nature16165; Yao YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002737; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou Q, 2016, NAT GENET, V48, P67, DOI 10.1038/ng.3459	31	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180481	10.1371/journal.pone.0180481	http://dx.doi.org/10.1371/journal.pone.0180481			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658319	gold, Green Published, Green Submitted			2022-12-27	WOS:000404607900073
J	Laudy, AE; Rog, P; Smolinska-Krol, K; Cmiel, M; Sloczynska, A; Patzer, J; Dzierzanowska, D; Wolinowska, R; Starosciak, B; Tyski, S				Laudy, Agnieszka E.; Rog, Patrycja; Smolinska-Krol, Katarzyna; Cmiel, Milena; Sloczynska, Alicja; Patzer, Jan; Dzierzanowska, Danuta; Wolinowska, Renata; Starosciak, Bohdan; Tyski, Stefan			Prevalence of ESBL-producing Pseudomonas aeruginosa isolates in Warsaw, Poland, detected by various phenotypic and genotypic methods	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; FIELD GEL-ELECTROPHORESIS; RESISTANCE; MECHANISMS; BAUMANNII; BACTERIA; CLASS-1; VARIANT; STRAIN	Knowledge of the prevalence of ESBL enzymes among P. aeruginosa strains compared to the Enterobacteraiceae family is limited. The phenotypic tests recommended by EUCAST for the detection of ESBL-producing Enterobacteriaceae are not always suited for P. aeruginosa strains. This is mainly due to the presence of other families of ESBLs in P. aeruginosa isolates more often than in Enterobacteriaceae, production of natural AmpC cephalosporinase and its overexpression, and co-production of metallo-beta-lactamases. The aim of this study was to determine the occurrence of ESBLs in P. aeruginosa isolated from patients from hospitals in Warsaw, to evaluate the ESBL production of these isolates using currently available phenotypic tests, their modifications, multiplex PCR and molecular typing of ESBL-positive isolates by PFGE. Clinical isolates of P. aeruginosa were collected in 2000-2014 from four Warsaw hospitals. Based on the data obtained in this study, we suggest using three DDST methods with inhibitors, such as clavulanic acid, sulbactam and imipenem, to detect ESBL-producing P. aeruginosa strains. Depending on the appearance of the plates, we suggest a reduction in the distance between discs with antibiotics to 15 mm and the addition of boronic acid at 0.4 mg per disc. The analysed isolates carried genes encoding ESBL from the families VEB (69 isolates with VEB-9), GES (6 with GES-1, 1 GES-5, 5 GES-13 and 2 with GES-15), OXA-2 (12 with OXA-15, 1 OXA-141, 1 OXA-210, 1 OXA-543 and 1 with OXA-544) and OXA-10 (5 isolates with OXA-74 and one with OXA-142). The most important result of this study was the discovery of three new genes, bla(GES)-15, bla(OXA)-141 and bla(OXA)-142; their nucleotide sequences have been submitted to the NCBI GenBank. It is also very important to note that this is the first report on the epidemiological problem of VEB-9-producing bacterial strains, not only in Poland but also worldwide.	[Laudy, Agnieszka E.; Rog, Patrycja; Smolinska-Krol, Katarzyna; Cmiel, Milena; Sloczynska, Alicja; Wolinowska, Renata; Starosciak, Bohdan; Tyski, Stefan] Med Univ Warsaw, Dept Pharmaceut Microbiol, Warsaw, Poland; [Patzer, Jan; Dzierzanowska, Danuta] Childrens Mem Hlth Inst, Dept Clin Microbiol & Immunol, Warsaw, Poland; [Tyski, Stefan] Natl Med Inst, Dept Antibiot & Microbiol, Warsaw, Poland	Medical University of Warsaw; Children's Memorial Health Institute; National Medicines Institute Lekow (NIL)	Laudy, AE (corresponding author), Med Univ Warsaw, Dept Pharmaceut Microbiol, Warsaw, Poland.	alaudy@wp.pl	Wolinowska, Renata/V-6945-2018; Laudy, Agnieszka/M-4930-2018; Tyski, Stefan/W-5271-2018; Laudy, Agnieszka/AAC-1000-2022	Wolinowska, Renata/0000-0002-2338-556X; Laudy, Agnieszka/0000-0002-5989-4462; Tyski, Stefan/0000-0003-3352-038X; 	State Committee for Scientific Research (KBN) "The presence of extended-spectrum beta-lactamases among the drug-resistant isolates of Pseudomonas aeruginosa" [2PO5D 018 30]; Foundation for the Development of Diagnostics and Therapy, Warsaw, Poland [REGON:006220910, NIP:5262173856, KRS:0000195643]; Medical University of Warsaw	State Committee for Scientific Research (KBN) "The presence of extended-spectrum beta-lactamases among the drug-resistant isolates of Pseudomonas aeruginosa"; Foundation for the Development of Diagnostics and Therapy, Warsaw, Poland; Medical University of Warsaw	The study was funded partially by a grant from the State Committee for Scientific Research (KBN) "The presence of extended-spectrum beta-lactamases among the drug-resistant isolates of Pseudomonas aeruginosa" (grant no. 2PO5D 018 30), AEL, JP, DD, RW, BS, and Foundation for the Development of Diagnostics and Therapy, Warsaw, Poland. REGON:006220910, NIP:5262173856, KRS:0000195643, AEL, ST, and Medical University of Warsaw, statutory funds, AEL, ST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae IK, 2007, DIAGN MICR INFEC DIS, V58, P465, DOI 10.1016/j.diagmicrobio.2007.02.013; Bae IK, 2014, DIAGN MICR INFEC DIS, V79, P373, DOI 10.1016/j.diagmicrobio.2014.03.007; Celenza G, 2006, J ANTIMICROB CHEMOTH, V57, P975, DOI 10.1093/jac/dkl055; CLSI, 2016, M100S CLSI; Danel F, 1997, ANTIMICROB AGENTS CH, V41, P785, DOI 10.1128/AAC.41.4.785; Drieux L, 2008, CLIN MICROBIOL INFEC, V14, P90, DOI 10.1111/j.1469-0691.2007.01846.x; Empel J, 2007, J CLIN MICROBIOL, V45, P2829, DOI 10.1128/JCM.00997-07; EUCAST, 2013, EUCAST GUID DET RES; EUCAST, 2017, EUCAST DISK DIFF MET; Garza-Ramos U, 2015, DIAGN MICR INFEC DIS, V81, P135, DOI 10.1016/j.diagmicrobio.2014.09.029; Glupczynski Y, 2010, J ANTIMICROB CHEMOTH, V65, P866, DOI 10.1093/jac/dkq048; Goldstein C, 2001, ANTIMICROB AGENTS CH, V45, P723, DOI 10.1128/AAC.45.3.723-726.2001; Hunter SB, 2005, J CLIN MICROBIOL, V43, P1045, DOI 10.1128/JCM.43.3.1045-1050.2005; Jiang XF, 2006, ANTIMICROB AGENTS CH, V50, P2990, DOI 10.1128/AAC.01511-05; Juan C, 2013, J ANTIMICROB CHEMOTH, V68, P619, DOI 10.1093/jac/dks439; Kos VN, 2016, ANTIMICROB AGENTS CH, V60, P3856, DOI 10.1128/AAC.03113-15; Kotsakis SD, 2010, ANTIMICROB AGENTS CH, V54, P1331, DOI 10.1128/AAC.01561-09; Kotsakis SD, 2010, ANTIMICROB AGENTS CH, V54, P4864, DOI 10.1128/AAC.00771-10; Libisch B, 2008, FEMS IMMUNOL MED MIC, V54, P330, DOI 10.1111/j.1574-695X.2008.00483.x; Lin SP, 2012, J MICROBIOL IMMUNOL, V45, P200, DOI 10.1016/j.jmii.2011.11.015; Maurya AP, 2014, ANTIMICROB AGENTS CH, V58, P6966, DOI 10.1128/AAC.02365-14; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pfeifer Y, 2010, INT J MED MICROBIOL, V300, P371, DOI 10.1016/j.ijmm.2010.04.005; Poirel L, 2005, ANTIMICROB AGENTS CH, V49, P3743, DOI 10.1128/AAC.49.9.3743-3748.2005; Poirel L, 2001, EMERG INFECT DIS, V7, P468, DOI 10.3201/eid0703.017322; Poirel L, 2012, INFECT GENET EVOL, V12, P883, DOI 10.1016/j.meegid.2012.02.008; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P24, DOI 10.1128/AAC.01512-08; Potron A, 2015, INT J ANTIMICROB AG, V45, P568, DOI 10.1016/j.ijantimicag.2015.03.001; Santajit S, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2475067; Seifert H, 2005, J CLIN MICROBIOL, V43, P4328, DOI 10.1128/JCM.43.9.4328-4335.2005; Sepehri S, 2014, CAN J INFECT DIS MED, V25, P229, DOI 10.1155/2014/657047; Singla P, 2014, J CLIN DIAGN RES, V8, pDC16, DOI 10.7860/JCDR/2014/8008.4289; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; The European Committee on Antimicrobial Susceptibility Testing, 2017, BREAKP TABL INT MIC; Tian GB, 2011, ANTIMICROB AGENTS CH, V55, P2710, DOI 10.1128/AAC.01660-10; Vatcheva-Dobrevska R, 2013, MICROB DRUG RESIST, V19, P355, DOI 10.1089/mdr.2013.0004; Weldhagen GF, 2003, ANTIMICROB AGENTS CH, V47, P2385, DOI 10.1128/AAC.47.8.2385-2392.2003; Woodford N, 2008, J ANTIMICROB CHEMOTH, V62, P1265, DOI 10.1093/jac/dkn400	38	50	50	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180121	10.1371/journal.pone.0180121	http://dx.doi.org/10.1371/journal.pone.0180121			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658322	Green Published, gold, Green Submitted			2022-12-27	WOS:000404607900062
J	Nakajima, R; Sato, T; Ogawa, T; Okano, H; Noce, T				Nakajima, Ryusuke; Sato, Takuya; Ogawa, Takehiko; Okano, Hideyuki; Noce, Toshiaki			A noncoding RNA containing a SINE-B1 motif associates with meiotic metaphase chromatin and has an indispensable function during spermatogenesis	PLOS ONE			English	Article							SYNAPTONEMAL COMPLEX; MOUSE; PROTEIN; EXPRESSION; GENE; B1; SPERMATOCYTES; TRANSCRIPTION; LOCALIZATION; CHROMOSOMES	A search for early response genes that are activated following germ cell induction from mouse embryonic stem cells in vitro led us to the isolation of a long noncoding RNA that contains a SINE (short interspersed element)-B1F motif that was named R53. In situ hybridization and northern blot analyses revealed that the R53 subfragment RNA bears a B1F motif, is processed from the primary transcript, is expressed in adult testis and is predominantly localized in meiotic metaphase chromatin during spermatogenesis. Recent studies of chromosome-associated RNAs have explored novel functions of noncoding RNAs. Specifically, chromosome-bound noncoding RNAs function not only as structural components of chromosome but also as scaffolds that recruit epigenetic modulators for transcriptional regulation, and they are dynamically rearranged during the cell cycle. However, few studies have explored meiotic chromatin; thus, R53 RNA appears to be the first long noncoding RNA to be tightly associated with the metaphase chromatin during spermatogenesis. Furthermore, R53 knockdown using a lentivirus-mediated RNAi injected into mouse testis and organ culture of the fragments revealed a remarkable reduction in postmeiotic cells and irregular up-regulation of several postmeiotic genes, which suggests the possibility that the SINE-B1-derived noncoding RNA R53 plays an indispensable role in the transcriptional regulation of key spermatogenesis genes.	[Nakajima, Ryusuke; Okano, Hideyuki; Noce, Toshiaki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, 35 Shinamomachi, Tokyo, Japan; [Sato, Takuya; Ogawa, Takehiko] Yokohama City Univ Assoc Med Sci, Inst Mol Med & Life Sci, Lab Prote, Yokohama, Kanagawa, Japan	Keio University	Nakajima, R; Noce, T (corresponding author), Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, 35 Shinamomachi, Tokyo, Japan.	rnakajima@a3.keio.jp; noce@z5.keio.jp	Sato, Takuya/X-9143-2019; Okano, Hideyuki/X-9131-2019; Sato, Takuya/F-8251-2017; Okano, Hideyuki/I-7584-2019	Sato, Takuya/0000-0002-6198-2234; Okano, Hideyuki/0000-0001-7482-5935; Sato, Takuya/0000-0002-6198-2234; 	Japan Society for the Challenging Research Exploratory [26650129]; Promotion of Science Research Fellowship Program [26-7577]	Japan Society for the Challenging Research Exploratory; Promotion of Science Research Fellowship Program	Grant-in-Aids from the Japan Society for the Challenging Research Exploratory (26650129) and the Promotion of Science Research Fellowship Program (26-7577). http://www.mext.go.jp/a_menu/shinkou/hojyo/main5_a5.htm.	Anguera MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002248; Arun G, 2012, MOL CELL BIOL, V32, P3140, DOI 10.1128/MCB.00006-12; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Britten RJ, 2010, P NATL ACAD SCI USA, V107, P19945, DOI 10.1073/pnas.1014330107; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Ding DQ, 2012, SCIENCE, V336, P732, DOI 10.1126/science.1219518; Ganesan G, 2008, RNA, V14, P1399, DOI 10.1261/rna.838308; Garcia-Lopez J, 2015, RNA, V21, P946, DOI 10.1261/rna.048215.114; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Hall LL, 2014, CELL, V156, P907, DOI 10.1016/j.cell.2014.01.042; Haygood R, 2010, P NATL ACAD SCI USA, V107, P7853, DOI 10.1073/pnas.0911249107; Hernandez-Hernandez A, 2008, CHROMOSOMA, V117, P77, DOI 10.1007/s00412-007-0128-2; Ichiyanagi K, 2013, GENES GENET SYST, V88, P19, DOI 10.1266/ggs.88.19; Ichiyanagi K, 2011, GENOME RES, V21, P2058, DOI 10.1101/gr.123679.111; Koziol MJ, 2010, CURR OPIN GENET DEV, V20, P142, DOI 10.1016/j.gde.2010.03.003; Kramerov DA, 2011, WIRES RNA, V2, P772, DOI 10.1002/wrna.91; Kroutter EN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000458; Li LJ, 2014, TRENDS CELL BIOL, V24, P594, DOI 10.1016/j.tcb.2014.06.003; Lin D, 2008, MOL CELL BIOL, V28, P3008, DOI 10.1128/MCB.01800-07; McCarrey JR, 2006, GENESIS, V34, P257; Meng YC, 2016, NUCLEIC ACIDS RES, V44, P4934, DOI 10.1093/nar/gkw195; Mondal T, 2010, GENOME RES, V20, P899, DOI 10.1101/gr.103473.109; Muslimov IA, 2002, J CELL SCI, V115, P1243; NOCE T, 1992, DEV BIOL, V153, P356, DOI 10.1016/0012-1606(92)90120-6; OAKBERG EF, 1956, AM J ANAT, V99, P391, DOI 10.1002/aja.1000990303; Ohnishi Y, 2012, MOL BIOL REP, V39, P903, DOI 10.1007/s11033-011-0815-1; Ohta S, 2010, CELL, V142, P810, DOI 10.1016/j.cell.2010.07.047; QUENTIN Y, 1989, J MOL EVOL, V28, P299, DOI 10.1007/BF02103425; Roman AC, 2008, P NATL ACAD SCI USA, V105, P1632, DOI 10.1073/pnas.0708366105; Sato T, 2013, NAT PROTOC, V8, P2098, DOI 10.1038/nprot.2013.138; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Schmitz J, 2012, GENOME DYNAM, V7, P92, DOI 10.1159/000337117; Schmitz SU, 2016, CELL MOL LIFE SCI, V73, P2491, DOI 10.1007/s00018-016-2174-5; Sun J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075750; Tanaka SS, 2000, GENE DEV, V14, P841; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Tsunekawa N, 1999, J VET MED SCI, V61, P381, DOI 10.1292/jvms.61.381; Vassetzky NS, 2003, GENE, V319, P149, DOI 10.1016/S0378-1119(03)00805-9; Werner MS, 2015, CELL REP, V12, P1089, DOI 10.1016/j.celrep.2015.07.033; West NC, 2002, J MOL BIOL, V321, P423, DOI 10.1016/S0022-2836(02)00542-9; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Yoneda R, 2016, MOL REPROD DEV, V83, P541, DOI 10.1002/mrd.22650; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9	45	8	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179585	10.1371/journal.pone.0179585	http://dx.doi.org/10.1371/journal.pone.0179585			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658256	gold, Green Published, Green Submitted			2022-12-27	WOS:000404607900034
J	Veiga, AK; Saraiva, AM; Chapman, AD; Morris, PJ; Gendreau, C; Schigel, D; Robertson, TJ				Veiga, Allan Koch; Saraiva, Antonio Mauro; Chapman, Arthur David; Morris, Paul John; Gendreau, Christian; Schigel, Dmitry; Robertson, Tim James			A conceptual framework for quality assessment and management of biodiversity data	PLOS ONE			English	Article							INFORMATION QUALITY; DIMENSIONS; DATABASES; DIVERSITY; TAXONOMY; TRUST	The increasing availability of digitized biodiversity data worldwide, provided by an increasing number of institutions and researchers, and the growing use of those data for a variety of purposes have raised concerns related to the "fitness for use" of such data and the impact of data quality (DQ) on the outcomes of analyses, reports, and decisions. A consistent approach to assess and manage data quality is currently critical for biodiversity data users. However, achieving this goal has been particularly challenging because of idiosyncrasies inherent in the concept of quality. DQ assessment and management cannot be performed if we have not clearly established the quality needs from a data user's standpoint. This paper defines a formal conceptual framework to support the biodiversity informatics community allowing for the description of the meaning of "fitness for use" from a data user's perspective in a common and standardized manner. This proposed framework defines nine concepts organized into three classes: DQ Needs, DQ Solutions and DQ Report. The framework is intended to formalize human thinking into well-defined components to make it possible to share and reuse concepts of DQ needs, solutions and reports in a common way among user communities. With this framework, we establish a common ground for the collaborative development of solutions for DQ assessment and management based on data fitness for use principles. To validate the framework, we present a proof of concept based on a case study at the Museum of Comparative Zoology of Harvard University. In future work, we will use the framework to engage the biodiversity informatics community to formalize and share DQ profiles related to DQ needs across the community.	[Veiga, Allan Koch; Saraiva, Antonio Mauro] Univ Sao Paulo, Res Ctr Biodivers & Comp, Sao Paulo, Brazil; [Chapman, Arthur David] Australian Biodivers Informat Serv, Ballan, Vic, Australia; [Morris, Paul John] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Gendreau, Christian] Univ Montreal, Inst Rech Biol Vegetale, Montreal, PQ, Canada; [Schigel, Dmitry; Robertson, Tim James] Secretariat, Global Biodivers Informat Facil, Copenhagen, Denmark	Universidade de Sao Paulo; Harvard University; Universite de Montreal	Veiga, AK; Saraiva, AM (corresponding author), Univ Sao Paulo, Res Ctr Biodivers & Comp, Sao Paulo, Brazil.	allan.kv@gmail.com; saraiva@usp.br	Saraiva, Antonio M/B-6350-2011; Veiga, Allan/C-7476-2013	Saraiva, Antonio M/0000-0003-2283-1123; Gendreau, Christian/0000-0003-4898-4291; Chapman, Arthur/0000-0003-1700-6962; Veiga, Allan/0000-0003-2672-8115; Schigel, Dmitry/0000-0002-2919-1168; Morris, Paul/0000-0002-3673-444X	Brazilian Governmental National Research Agency Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [233676/2014-7, 308326/2010-5, 311531/2014-8]; Research Centeron Biodiversity and Computing, BioComp [11.1.9359.1.2]; Sao Paulo Research Foundation, FAPESP [2015/241683]	Brazilian Governmental National Research Agency Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Research Centeron Biodiversity and Computing, BioComp; Sao Paulo Research Foundation, FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The study is part of the Doctorate Degree thesis of AKV, who was supported by a Brazilian Governmental National Research Agency Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES. In addition, the author AKV was granted an exchange scholarship by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (grant #233676/2014-7). The author AMS is a profess or at Universidade de Sao Paulo,which supported the Research Centeron Biodiversity and Computing, BioComp (grant #11.1.9359.1.2). AMS was also supported by Conselho Nacionalde Desenvolvimento Cientifico e Tecnologico (grants #308326/2010-5 and #311531/2014-8), and by Sao Paulo Research Foundation, FAPESP, (grant #2015/241683).The funders had no role in study design, data collection and analysis, decisionto publish,or preparation of the manuscript.	ABRS, 2004, AUSTR FAUN DIR; ASC [Association of Systematics Collections], 1992, BIOL COLL DAT STAND; Askham N., 2013, 6 PRIMARY DIMENSION; BDQ Toolkit, 2017, BDQ TOOLK BDQ TOOLK; BDQIG, 2015, GBIF TDWG BIOD DAT Q; Beck J, 2014, ECOL INFORM, V19, P10, DOI 10.1016/j.ecoinf.2013.11.002; Berndt DJ, 2001, COMPUTER, V34, P56, DOI 10.1109/2.970578; Bishop M., 2003, COMPUTER SECURITY AR; Busby JR, 1979, AUSTR BIOTAXONOMIC I, P25; Chapman AD, 1992, P SEM ORG COMM LAND; Chapman AD, 2005, PRINCIPLES METHODS D, P75; Chapman AD, 2006, GLOBAL BIODIVERSITY; Chapman AD, 1991, AUSTRAL FL FAUNA SER, V12-15, P1; Chapman AD, 2005, PRINCIPLES DATA QUAL, P61; Chapman AD, 2004, APPENDIX 1 SISTEMA I; Chengalur-Smith IN, 1999, IEEE T KNOWL DATA EN, V11, P853, DOI 10.1109/69.824597; Chrisman NR, 1983, ROLE QUALITY INFORM, V2, P303; Conn BJ, 1996, HISPID3 HERBARIUM IN; Croft J. R., 1989, HISPID HERBARIUM INF; Dalcin E. C., 2005, THESIS; Dou L, 2012, PROCEDIA COMPUT SCI, V9, P1614, DOI 10.1016/j.procs.2012.04.177; Edwards JL, 2000, SCIENCE, V289, P2312, DOI 10.1126/science.289.5488.2312; Eppler M, 2006, MANAGING INFORM QUAL; FOX C, 1994, INFORM PROCESS MANAG, V30, P9, DOI 10.1016/0306-4573(94)90020-5; GBIF [Global Biodiversity Information Facility], 2015, DWCA VAL; GBIF [Global Biodiversity Information Facility], 2015, WHAT IS GBIF; Ge M, 2007, REV INFORM QUALITY R, P76; Huang KT, 1999, INFORM KNOWLEDGE MAN; JOHNSON JR, 1981, ACCOUNT REV, V56, P270; Kaplan D, 1998, COMMUN ACM, P72; KLOBAS JE, 1995, J INFORM SCI, V21, P95, DOI 10.1177/016555159502100204; Lee Y.W., 2006, JOURNEY DATA QUALITY; Lee YW, 2002, INFORM MANAGE-AMSTER, V40, P133, DOI 10.1016/S0378-7206(02)00043-5; Maldonado C, 2015, GLOBAL ECOL BIOGEOGR, V24, P973, DOI 10.1111/geb.12326; McGilvray D, 2008, EXECUTING DATA QUALI; MVZ [Museum of Vertebrate Zoology Berkeley], 1996, MVZ COLL INF MOD; Nelson D, 2004, J BACTERIOL, V186, P7029, DOI 10.1128/JB.186.21.7029-7031.2004; Nicolaou AI, 2006, INFORM SYST RES, V17, P332, DOI 10.1287/isre.1060.0103; Noy N.F., WHAT IS ONTOLOGY WHY; Otegui J, 2016, BIOINFORMATICS; Otegui J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055144; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Pipino L.L., 2002, COMMUN ACM, V45, P211, DOI DOI 10.1145/505248.506010; Research Data Alliance [RDA], 2016, ASS DAT FITN US RDA; ROSENBERG G, 1993, AM MALACOL BULL, V10, P257; SearchCIO, 2005, WHAT IS TOT QUAL MAN; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Strong DM, 1997, COMMUN ACM, V40, P103, DOI 10.1145/253769.253804; Stvilia B, 2006, J AM SOC INFORM SCI; Sunderland ME, 2013, ENDEAVOUR, V37, P150, DOI 10.1016/j.endeavour.2013.04.001; TDWG [Biodiversity Information Standards], 2015, TASK GROUP CHART BDQ; TDWG [Biodiversity Information Standards], 2007, HISPID3 HERB INF STA; Teflian M., 1999, INFORM LIQUIDITY; Veiga AK, 2014, IEEE LAT AM T, V12, P683, DOI 10.1109/TLA.2014.6868870; Veiga AK, 2012, ICT AGR RURAL DEV EN; Wand Y, 1996, COMMUN ACM, V39, P86, DOI 10.1145/240455.240479; Wang R. Y., 1996, Journal of Management Information Systems, V12, P5; WANG RY, 1995, DECIS SUPPORT SYST, V13, P349, DOI 10.1016/0167-9236(93)E0050-N; Wang RY, 1998, COMMUNICATIONS A FEB, P58; Wang Y. Y. R., 2001, DATA QUALITY; Williams SM., 1979, DOCUMENTATION STANDA, Vvii, P48; Yesson C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001124	64	14	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0178731	10.1371/journal.pone.0178731	http://dx.doi.org/10.1371/journal.pone.0178731			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658288	Green Published, Green Submitted, gold			2022-12-27	WOS:000404607900008
J	Fomenkov, A; Sun, ZY; Dila, DK; Anton, BP; Roberts, RJ; Raleigh, EA				Fomenkov, Alexey; Sun, Zhiyi; Dila, Deborah K.; Anton, Brian P.; Roberts, Richard J.; Raleigh, Elisabeth A.			EcoBLMcrX, a classical modification-dependent restriction enzyme in Escherichia coli B: Characterization in vivo and in vitro with a new approach to cleavage site determination	PLOS ONE			English	Article							MCRA PROTEIN; DNA; GENOME; ENDONUCLEASES; EXPRESSION; SEQUENCES; CLONING; 5-HYDROXYMETHYLCYTOSINE; 5-FORMYLCYTOSINE; BACTERIOPHAGES	Here we characterize the modification-dependent restriction enzyme (MDE) EcoBLMcrX in vivo, in vitro and in its genomic environment. MDE cleavage of modified DNAs protects prokaryote populations from lethal infection by bacteriophage with highly modified DNA, and also stabilizes lineages by reducing gene import when sparse modification occurs in the wrong context. The function and distribution of MDE families are thus important. Here we describe the properties of EcoBLMcrX, an enzyme of the E. coli B lineage, in vivo and in vitro. Restriction in vivo and the genome location of its gene, ecoBLmcrX, were determined during construction and sequencing of a B/K-12 hybrid, ER2566. In classical restriction literature, this B system was named r(6) or rglA(B). Like many genome defense functions, ecoBLmcrX is found within a genomic island, where gene content is variable among natural E. coli isolates. In vitro, EcoBLMcrX was compared with two related enzymes, BceYI and NhoI. All three degrade fully cytosine-modified phage DNA, as expected for EcoBLMcrX from classical T4 genetic data. A new method of characterizing MDE specificity was developed to better understand action on fully-modified targets such as the phage that provide major evolutionary pressure for MDE maintenance. These enzymes also cleave plasmids with C-m5 in particular motifs, consistent with a role in lineage-stabilization. The recognition sites were characterized using a site-ranking approach that allows visualization of preferred cleavage sites when fully-modified substrates are digested. A technical constraint on the method is that ligation of one-nucleotide 5' extensions favors G:C over A:T approximately five-fold. Taking this bias into account, we conclude that EcoBLMcrX can cleave 3' to the modified base in the motif (RC)-C-m5 vertical bar. This is compatible with, but less specific than, the site reported by others. Highly-modified site contexts, such as those found in base-substituted virulent phages, are strongly preferred.	[Fomenkov, Alexey; Sun, Zhiyi; Dila, Deborah K.; Anton, Brian P.; Roberts, Richard J.; Raleigh, Elisabeth A.] New England Biolabs Inc, Res Dept, Ipswich, MA 01938 USA; [Dila, Deborah K.] Univ Wisconsin, Milwaukee, WI 53201 USA	New England Biolabs; University of Wisconsin System; University of Wisconsin Milwaukee	Raleigh, EA (corresponding author), New England Biolabs Inc, Res Dept, Ipswich, MA 01938 USA.	raleigh@neb.com		Sun, Zhiyi/0000-0002-6106-5356	New England Biolabs	New England Biolabs	This work was supported by New England Biolabs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton BP, 2004, J BACTERIOL, V186, P5699, DOI 10.1128/JB.186.17.5699-5707.2004; Anton BP, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00230-16; Anton BP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127446; Bair CL, 2007, J MOL BIOL, V366, P779, DOI 10.1016/j.jmb.2006.11.049; Bujnicki JM, 2000, MOL MICROBIOL, V37, P1280, DOI 10.1046/j.1365-2958.2000.02010.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; DEMEREC M, 1966, GENETICS, V54, P61; DHARMALINGAM K, 1976, NATURE, V260, P454, DOI 10.1038/260454a0; DHARMALINGAM K, 1979, VIROLOGY, V96, P404, DOI 10.1016/0042-6822(79)90098-9; Dixit PD, 2015, P NATL ACAD SCI USA, V112, P9070, DOI 10.1073/pnas.1510839112; GEORGOPOULOS CP, 1971, VIROLOGY, V44, P271, DOI 10.1016/0042-6822(71)90259-5; Gonchar D.A., 2016, BIOTECHNOLOGY-PAKIST, V12, P175; HIOM K, 1991, J BACTERIOL, V173, P7368, DOI 10.1128/jb.173.22.7368-7373.1991; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Iurlaro M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1001-5; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; Johnston C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003178; Kamps-Hughes N, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt257; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lebreton F, 2013, MBIO, V4, DOI 10.1128/mBio.00534-13; LEUNG DW, 1979, NUCLEIC ACIDS RES, V6, P17, DOI 10.1093/nar/6.1.17; lida S, 1987, VIROLOGY, V157, P156; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P56, DOI 10.1093/nar/gkt747; Molineux IJ, 2013, NAT REV MICROBIOL, V11, P194, DOI 10.1038/nrmicro2988; Monk IR, 2012, MBIO, V3, DOI 10.1128/mBio.00277-11; Mulligan EA, 2008, PROTEIN EXPRES PURIF, V62, P98, DOI 10.1016/j.pep.2008.06.016; Mulligan EA, 2010, NUCLEIC ACIDS RES, V38, P1997, DOI 10.1093/nar/gkp1120; Nandi T, 2015, GENOME RES, V25, P129, DOI 10.1101/gr.177543.114; Ordway JM, 2006, CARCINOGENESIS, V27, P2409, DOI 10.1093/carcin/bgl161; RALEIGH EA, 1989, GENETICS, V122, P279; RAMALINGAM R, 1992, J BIOSCIENCE, V17, P217, DOI 10.1007/BF02703150; Samuelson JC, 2004, NUCLEIC ACIDS RES, V32, P3661, DOI 10.1093/nar/gkh674; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Stephanou AS, 2009, J MOL BIOL, V391, P565, DOI 10.1016/j.jmb.2009.06.020; Stucken K, 2013, BIOL RES, V46, P373, DOI 10.4067/S0716-97602013000400009; Sun ZY, 2015, MOL CELL, V57, P750, DOI 10.1016/j.molcel.2014.12.035; SUTHERLAND E, 1992, J MOL BIOL, V225, P327, DOI 10.1016/0022-2836(92)90925-A; SZYBALSKI W, 1988, GENE, V74, P279; Tarasova GV, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-7; WAITEREES PA, 1991, J BACTERIOL, V173, P5207, DOI 10.1128/jb.173.16.5207-5219.1991; Wang H, 2011, NUCLEIC ACIDS RES, V39, P9294, DOI 10.1093/nar/gkr607; Wang S, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150130; Weigele P, 2016, CHEM REV, V116, P12655, DOI 10.1021/acs.chemrev.6b00114; Xu SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep28579; Xu SY, 2011, NUCLEIC ACIDS RES, V39, P5597, DOI 10.1093/nar/gkr098; Yang HX, 2015, PLANT J, V81, P268, DOI 10.1111/tpj.12726	48	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179853	10.1371/journal.pone.0179853	http://dx.doi.org/10.1371/journal.pone.0179853			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654677	gold, Green Published, Green Submitted			2022-12-27	WOS:000404541500037
J	Termini, JM; Silver, ZA; Connor, B; Antonopoulos, A; Haslam, SM; Dell, A; Desrosiers, RC				Termini, James M.; Silver, Zachary A.; Connor, Bryony; Antonopoulos, Aristotelis; Haslam, Stuart M.; Dell, Anne; Desrosiers, Ronald C.			HEK293T cell lines defective for O-linked glycosylation	PLOS ONE			English	Article							EPIMERASE-DEFICIENCY GALACTOSEMIA; MAMMALIAN-CELLS; LELOIR PATHWAY; MUTANTS; GLYCANS; ENZYMES; SYSTEMS; MOUSE	Here we describe derivatives of the HEK293T cell line that are defective in their ability to generate mucin-type O-linked glycosylation. Using CRISPR/Cas9 and a single-cell GFP-sorting procedure, the UDP-galactose-4-epimerase (GALE), galactokinase 1 (GALK1), and galactokinase 2 (GALK2) genes were knocked out individually and in combinations with greater than 90% of recovered clones having the desired mutations. Although HEK293T cells are tetraploid, we found this approach to be an efficient method to target and disrupt all 4 copies of the target gene. Deficient glycosylation in the GALE knockout cell line could be rescued by the addition of galactose and N-acetylgalactosamine (GalNAc) to the cell culture media. However, when key enzymes of the galactose/GalNAc salvage pathways were disrupted in tandem (GALE+GALK1 or GALE+GALK2), O-glycosylation was eliminated and could not be rescued by the addition of either galactose plus GalNAc or UDP-galactose plus UDP-GalNAc. GALK1 and GALK2 are key enzymes of the galactose/GalNAc salvage pathways. Mass spectrometry was performed on whole cell lysate of the knockout cell lines to verify the glycosylation phenotype. As expected, the GALE knockout was almost completely devoid of all O-glycosylation, with minimal glycosylation as a result of functional salvage pathways. However, the GALE+GALK1 and GALE+GALK2 knockout lines were devoid of all O-glycans. Mass spectrometry analysis revealed that the disruption of GALE, GALK1, and GALE+GALK2 had little effect on the N-glycome. But when GALE was knocked out in tandem with GALK1, N-glycans were exclusively of the high mannose type. Due to the well-characterized nature of these five knockout cell lines, they will likely prove useful for a wide variety of applications.	[Termini, James M.; Silver, Zachary A.; Desrosiers, Ronald C.] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA; [Connor, Bryony; Antonopoulos, Aristotelis; Haslam, Stuart M.; Dell, Anne] Imperial Coll London, Dept Life Sci, London, England	University of Miami; Imperial College London	Desrosiers, RC (corresponding author), Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA.	r.desrosiers@med.miami.edu		Desrosiers, Ronald/0000-0001-6851-3003; Dell, Anne/0000-0003-1380-2347	National Institute of Allergy and Infectious Diseases (NIAID) [R01 AI104523]; State of Florida contract CODMR; Biotechnology and Biological Sciences Research Council [BB/K016164/1]; BBSRC [BB/K016164/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104523] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); State of Florida contract CODMR; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID) (https://www.niaid.nih.gov/) R01 AI104523. This study was also partially supported by State of Florida contract CODMR (http://hivaidsinstitute.med.miami.edu/) and grant BB/K016164/1 from the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/) (to A.D., and S.M.H.). A.D. is a Wellcome Trust Senior Research Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloch N, 2017, J BIOL CHEM, V292, P1068, DOI 10.1074/jbc.M116.743740; Butler M, 2014, CURR OPIN BIOTECH, V30, P107, DOI 10.1016/j.copbio.2014.06.010; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Cherepanova NA, 2016, SCI REP-UK, V6, DOI 10.1038/srep20946; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cummings R.D., 2015, ESSENTIALS GLYCOBIOL, P435; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; Fridovich-Keil J, 1993, GENEREVIEWS R; Holden HM, 2003, J BIOL CHEM, V278, P43885, DOI 10.1074/jbc.R300025200; Hossler P, 2009, GLYCOBIOLOGY, V19, P936, DOI 10.1093/glycob/cwp079; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; KRIEGER M, 1981, J MOL BIOL, V150, P167, DOI 10.1016/0022-2836(81)90447-2; KRIEGER M, 1989, METHOD CELL BIOL, V32, P57; Lai K, 2009, IUBMB LIFE, V61, P1063, DOI 10.1002/iub.262; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Openo KK, 2006, AM J HUM GENET, V78, P89, DOI 10.1086/498985; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Rehwinkel J, 2014, CELL MOL LIFE SCI, V71, P3749, DOI 10.1007/s00018-014-1646-8; Schulz JM, 2005, J BIOL CHEM, V280, P13493, DOI 10.1074/jbc.M414045200; STANLEY P, 1992, GLYCOBIOLOGY, V2, P99, DOI 10.1093/glycob/2.2.99; STANLEY P, 1984, ANNU REV GENET, V18, P525, DOI 10.1146/annurev.ge.18.120184.002521; Stanley P, 1996, GLYCOBIOLOGY, V6, P695, DOI 10.1093/glycob/6.7.695; Stansell E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124784; Stansell E, 2011, J VIROL, V85, P582, DOI 10.1128/JVI.01871-10; Timson DJ, 2013, GENE, V526, P318, DOI 10.1016/j.gene.2013.05.027; Timson DJ, 2006, IUBMB LIFE, V58, P83, DOI 10.1080/15216540600644846; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Wohlers TM, 1999, AM J HUM GENET, V64, P462, DOI 10.1086/302263	31	14	14	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179949	10.1371/journal.pone.0179949	http://dx.doi.org/10.1371/journal.pone.0179949			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654657	Green Published, gold, Green Submitted			2022-12-27	WOS:000404541500040
J	Daaboul, GG; Freedman, DS; Scherr, SM; Carter, E; Rosca, A; Bernstein, D; Mire, CE; Agans, KN; Hoenen, T; Geisbert, TW; Unlu, MS; Connor, JH				Daaboul, George G.; Freedman, David S.; Scherr, Steven M.; Carter, Erik; Rosca, Alexandru; Bernstein, David; Mire, Chad E.; Agans, Krystle N.; Hoenen, Thomas; Geisbert, Thomas W.; Unlu, M. Selim; Connor, John H.			Enhanced light microscopy visualization of virus particles from Zika virus to filamentous ebolaviruses	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; CRYOELECTRON TOMOGRAPHY; ELECTRON-MICROSCOPY; EBOLA-VIRUS; INFECTIVITY; VIRIONS; MASS	Light microscopy is a powerful tool in the detection and analysis of parasites, fungi, and pro-karyotes, but has been challenging to use for the detection of individual virus particles. Unlabeled virus particles are too small to be visualized using standard visible light microscopy. Characterization of virus particles is typically performed using higher resolution approaches such as electron microscopy or atomic force microscopy. These approaches require purification of virions away from their normal millieu, requiring significant levels of expertise, and can only enumerate small numbers of particles per field of view. Here, we utilize a visible light imaging approach called Single Particle Interferometric Reflectance Imaging Sensor (SP-IRIS) that allows automated counting and sizing of thousands of individual virions. Virions are captured directly from complex solutions onto a silicon chip and then detected using a reflectance interference imaging modality. We show that the use of different imaging wavelengths allows the visualization of a multitude of virus particles. Using Violet/UV illumination, the SP-IRIS technique is able to detect individual flavivirus particles (similar to 40 nm), while green light illumination is capable of identifying and discriminating between vesicular stomatitis virus and vaccinia virus (similar to 360 nm). Strikingly, the technology allows the clear identification of filamentous infectious ebolavirus particles and virus-like particles. The ability to differentiate and quantify unlabeled virus particles extends the usefulness of traditional light microscopy and can be embodied in a straightforward benchtop approach allowing widespread applications ranging from rapid detection in biological fluids to analysis of virus-like particles for vaccine development and production.	[Daaboul, George G.; Freedman, David S.; Rosca, Alexandru; Bernstein, David] nanoView Diagnost Inc, Boston, MA USA; [Scherr, Steven M.] Boston Univ, Dept Mech Engn, Boston, MA 02215 USA; [Carter, Erik; Connor, John H.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Mire, Chad E.; Agans, Krystle N.; Geisbert, Thomas W.] Galveston Natl Lab, Galveston, TX USA; [Mire, Chad E.; Agans, Krystle N.; Geisbert, Thomas W.] Dept Microbiol, Galveston, TX USA; [Mire, Chad E.; Agans, Krystle N.; Geisbert, Thomas W.] Univ Texas Med Branch, Immunol, Galveston, TX 77555 USA; [Hoenen, Thomas] NIAID, LabVirol, Div Intramural Res, NIH,Rocky Mt Labs, Hamilton, MT 59840 USA; [Hoenen, Thomas] Friedrich Loeffler Inst, Inst Mol Virol & Cell Biol, Greifswald, Germany; [Unlu, M. Selim] Boston Univ, Dept Elect Engn, Boston, MA 02215 USA; [Unlu, M. Selim; Connor, John H.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Unlu, M. Selim] Boston Univ, Dept Phys, 590 Commonwealth Ave, Boston, MA 02215 USA	Boston University; Boston University; University of Texas System; University of Texas Medical Branch Galveston; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Friedrich Loeffler Institute; Boston University; Boston University; Boston University	Connor, JH (corresponding author), Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA.; Connor, JH (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.	jhconnor@bu.edu	Mire, Chad/Z-6338-2019; Hoenen, Thomas/H-8990-2019	Mire, Chad/0000-0001-7596-1808; Hoenen, Thomas/0000-0002-5829-6305; Connor, John/0000-0002-8867-7256; Unlu, Selim/0000-0002-8594-892X	National Institutes of Allergy and Infectious Diseases [R01Al1096159, 1R43Al118254]	National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in part by the National Institutes of Allergy and Infectious Diseases through awards to John H Connor (R01Al1096159) and David S Freedman (1R43Al118254). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. nanoView Diagnostics Inc provided support in the form of salaries for authors [GD, DS, AR, DB] and played a role in the study design, data collection and analysis, decision to publish, and prepare of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bharat TAM, 2012, P NATL ACAD SCI USA, V109, P4275, DOI 10.1073/pnas.1120453109; Bharat TAM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001196; Cretich M, 2004, ANAL BIOCHEM, V332, P67, DOI 10.1016/j.ab.2004.05.041; Cyrklaff M, 2005, P NATL ACAD SCI USA, V102, P2772, DOI 10.1073/pnas.0409825102; Daaboul GG, 2010, NANO LETT, V10, P4727, DOI 10.1021/nl103210p; Daaboul GG, 2016, SCI REP-UK, V6, DOI 10.1038/srep37246; Daaboul GG, 2014, ACS NANO, V8, P6047, DOI 10.1021/nn501312q; Daaboul GG, 2014, ACS NANO; Dadonaite B, 2016, J GEN VIROL, V97, P1755, DOI 10.1099/jgv.0.000535; Garbutt M, 2004, J VIROL, V78, P5458, DOI 10.1128/JVI.78.10.5458-5465.2004; Gaudin R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7022; Goldsmith CS, 2009, CLIN MICROBIOL REV, V22, P552, DOI 10.1128/CMR.00027-09; Heider S, 2014, VIROLOGY, V462, P199, DOI 10.1016/j.virol.2014.06.005; Kuznetsov YG, 2011, MICROBIOL MOL BIOL R, V75, P268, DOI 10.1128/MMBR.00041-10; LEFRANCOIS L, 1982, VIROLOGY, V121, P157, DOI 10.1016/0042-6822(82)90125-8; Ma L, 2016, ANGEW CHEM; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Monroe MR, 2011, ANAL CHEM, V83, P9485, DOI 10.1021/ac202212k; Piliarik M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5495; Scherr SM, 2016, ACS NANO; Scherr SM, 2017, LAB CHIP, V17, P917, DOI 10.1039/c6lc01528j; Spiegelberg L, 2011, J GEN VIROL, V92, P2900, DOI 10.1099/vir.0.036863-0; Steen HB, 2004, CYTOM PART A, V57A, P94, DOI 10.1002/cyto.a.10115; Sugita Y, 2011, J GEN VIROL, V92, P2485, DOI 10.1099/vir.0.036715-0; THOMAS D, 1985, J VIROL, V54, P598, DOI 10.1128/JVI.54.2.598-607.1985; Vijayakrishnan S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003413; Wang SP, 2010, P NATL ACAD SCI USA, V107, P16028, DOI 10.1073/pnas.1005264107; Watt A, 2014, J VIROL, V88, P10511, DOI 10.1128/JVI.01272-14; Ymeti A, 2007, NANO LETT, V7, P394, DOI 10.1021/nl062595n	29	16	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179728	10.1371/journal.pone.0179728	http://dx.doi.org/10.1371/journal.pone.0179728			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651016	Green Published, Green Submitted, gold			2022-12-27	WOS:000404537300016
J	Fuh, YK; Lai, ZH; Kau, LH; Huang, HJ				Fuh, Yiin-Kuen; Lai, Zheng-Hong; Kau, Li-Han; Huang, Hung-Jui			A lab-on-phone instrument with varifocal microscope via a liquid-actuated aspheric lens (LAL)	PLOS ONE			English	Article							SPHERICAL-ABERRATION; MICROLENS	In this paper, we introduce a novel concept of liquid-actuated aspheric lens (LAL) with a built-in aspheric polydimethylsiloxane lens (APL) to enable the design of compact optical systems with varifocal microscopic imaging. The varifocal lens module consists of a sandwiched structures such as 3d printed syringe pump functionally serves as liquid controller. Other key components include two acrylic cylinders, a rigid separator, a APL/membrane composite (APLMC) embedded PDMS membrane. In functional operation, the fluidic controller was driven to control the pressure difference and ALPMC deformation. The focal length can be changed through the pressure difference. This is achieved by the adjustment of volume change of injected liquid such that a widely tunable focal length. The proposed LAL can transform to 3 modes: microscopic mode (APLMC only), convex-concave mode and biconcave mode. It is noticeable that LAL in the operation of microscopic mode is tunable in focus via the actuation of APLMC (focal length is from 4.3 to 2.3 mm and magnification 50X) and can rival the images quality of commercial microscopes. A new lab-on-phone device is economically feasible and functionally versatile to offer a great potential in the point of care applications.	[Fuh, Yiin-Kuen; Lai, Zheng-Hong; Kau, Li-Han; Huang, Hung-Jui] Natl Cent Univ, Inst Optomechatron Engn, Jhongli, Taoyuan County, Taiwan; [Fuh, Yiin-Kuen] Natl Cent Univ, Dept Mech Engn, Jhongli, Taoyuan County, Taiwan	National Central University; National Central University	Fuh, YK (corresponding author), Natl Cent Univ, Inst Optomechatron Engn, Jhongli, Taoyuan County, Taiwan.; Fuh, YK (corresponding author), Natl Cent Univ, Dept Mech Engn, Jhongli, Taoyuan County, Taiwan.	mikefuh@cc.ncu.edu.tw			Ministry of Science and Technology, Taiwan [MOST 103-2221-E-008-098]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This paper was supported under the contract number of MOST 103-2221-E-008-098, Ministry of Science and Technology, Taiwan.	Berge B, 2000, EUR PHYS J E, V3, P159, DOI 10.1007/s101890070029; Castillo-Santiago G, 2014, APPL OPTICS, V53, P4939, DOI 10.1364/AO.53.004939; Chen J, 2004, J MICROMECH MICROENG, V14, P675, DOI 10.1088/0960-1317/14/5/003; Dong L, 2006, NATURE, V442, P551, DOI 10.1038/nature05024; Fuh YK, 2016, J MOD OPTIC, V63, P1129, DOI 10.1080/09500340.2015.1128007; Fuh YK, 2015, OPT EXPRESS, V23, P21771, DOI 10.1364/OE.23.021771; Fuh YK, 2012, OPT LASER ENG, V50, P1677, DOI 10.1016/j.optlaseng.2012.07.013; Gunasekaran RA, 2005, OPT LASER ENG, V43, P686, DOI 10.1016/j.optlaseng.2004.09.012; Jeong KH, 2004, OPT EXPRESS, V12, P2494, DOI 10.1364/OPEX.12.002494; Kang M., 2007, NANO MICRO ENG MOL S, P357; Khoramnia R, 2015, KLIN MONATSBL AUGENH, V232, P181, DOI 10.1055/s-0034-1382849; Koha S, 2014, CONTACT LENS ANTERIO, V37, P273, DOI 10.1016/j.clae.2013.12.003; Kuiper S, 2004, APPL PHYS LETT, V85, P1128, DOI 10.1063/1.1779954; Lee DK, 2008, J KOREAN PHYS SOC, V53, P2527, DOI 10.3938/jkps.53.2527; Lee S. W., 2007, APPL PHYS LETT, V90; Lee WM, 2014, BIOMED OPT EXPRESS, V5, P1626, DOI 10.1364/BOE.5.001626; Liang WL, 2014, APPL OPTICS, V53, P3696, DOI 10.1364/AO.53.003696; Mishra K, 2014, SCI REP-UK, V4, DOI 10.1038/srep06378; Nochez Y, 2012, J CATARACT REFR SURG, V38, P633, DOI 10.1016/j.jcrs.2011.11.030; Oku H, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3143624; Ren H, 2011, OPT EXPRESS, V19, P1985, DOI 10.1364/OE.19.001985; Ren HW, 2010, OPT COMMUN, V283, P3255, DOI 10.1016/j.optcom.2010.04.045; Ren HW, 2010, OPT EXPRESS, V18, P11904, DOI 10.1364/OE.18.011904; Ren HW, 2004, J PHYS D APPL PHYS, V37, P400, DOI 10.1088/0022-3727/37/3/015; Ren HW, 2005, OPT COMMUN, V247, P101, DOI 10.1016/j.optcom.2004.11.033; Ren HW, 2004, OPT COMMUN, V230, P267, DOI 10.1016/j.optcom.2003.11.033; Seo SW, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.052404; Sung YL, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.4.047005; Tadmor R, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.266101; TOATES FM, 1972, PHYSIOL REV, V52, P828, DOI 10.1152/physrev.1972.52.4.828; Xu S, 2009, OPT EXPRESS, V17, P17590, DOI 10.1364/OE.17.017590; Yu HB, 2011, SENSOR ACTUAT A-PHYS, V167, P602, DOI 10.1016/j.sna.2011.03.005; Zhang DY, 2004, OPT LETT, V29, P2855, DOI 10.1364/OL.29.002855; Zhang DY, 2004, APPL PHYS LETT, V84, P4194, DOI 10.1063/1.1756679	34	2	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179389	10.1371/journal.pone.0179389	http://dx.doi.org/10.1371/journal.pone.0179389			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650971	Green Submitted, gold, Green Published			2022-12-27	WOS:000404537300007
J	Carvallo, L; Lopez, L; Fajardo, JE; Jaureguiberry-Bravo, M; Fiser, A; Berman, JW				Carvallo, Loreto; Lopez, Lillie; Fajardo, Jorge E.; Jaureguiberry-Bravo, Matias; Fiser, Andras; Berman, Joan W.			HIV-Tat regulates macrophage gene expression in the context of neuroAIDS	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; AMYLOID PRECURSOR PROTEIN; CENTRAL-NERVOUS-SYSTEM; CHROMATIN-REMODELING COMPLEX; BLOOD-BRAIN-BARRIER; RNA-POLYMERASE-II; NEUROCOGNITIVE DISORDERS; T-CELLS; TRANSCRIPTIONAL ACTIVITY; REPRESSES TRANSCRIPTION	Despite the success of cART, greater than 50% of HIV infected people develop cognitive and motor deficits termed HIV-associated neurocognitive disorders (HAND). Macrophages are the major cell type infected in the CNS. Unlike for T cells, the virus does not kill macrophages and these long-lived cells may become HIV reservoirs in the brain. They produce cytokines/chemokines and viral proteins that promote inflammation and neuronal damage, playing a key role in HIV neuropathogenesis. HIV Tat is the transactivator of transcription that is essential for replication and transcriptional regulation of the virus and is the first protein to be produced after HIV infection. Even with successful cART, Tat is produced by infected cells. In this study we examined the role of the HIV Tat protein in the regulation of gene expression in human macrophages. Using THP-1 cells, a human monocyte/macrophage cell line, and their infection with lentivirus, we generated stable cell lines that express Tat-Flag. We performed ChIP-seq analysis of these cells and found 66 association sites of Tat in promoter or coding regions. Among these are C5, CRLF2/TSLPR, BDNF, and APBA1/Mint1, genes associated with inflammation/damage. We confirmed the association of Tat with these sequences by ChIP assay and expression of these genes in our THP-1 cell lines by qRT-PCR. We found that HIV Tat increased expression of C5, APBA1, and BDNF, and decreased CRLF2. The K50A Tat-mutation dysregulated expression of these genes without affecting the binding of the Tat complex to their gene sequences. Our data suggest that HIV Tat, produced by macrophage HIV reservoirs in the brain despite successful cART, contributes to neuropathogenesis in HIV-infected people.	[Carvallo, Loreto; Lopez, Lillie; Jaureguiberry-Bravo, Matias; Berman, Joan W.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Fajardo, Jorge E.; Fiser, Andras] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10467 USA; [Berman, Joan W.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Berman, JW (corresponding author), Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA.; Berman, JW (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	joan.berman@einstein.yu.edu	Carvallo, Loreto/C-2237-2019	Carvallo, Loreto/0000-0001-9943-1342; Fajardo, Jorge/0000-0001-9701-8546; Jaureguiberry, Matias/0000-0001-9937-7008	National Institutes of Health Grants [R01MH075679, R01MH090958, R01MH077542, R21MH102113]; Einstein (Epigenomics Shared Facility for massively-parallel sequencing assays); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075679] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Einstein (Epigenomics Shared Facility for massively-parallel sequencing assays); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grants R01MH075679, R01MH090958, R01MH077542 (JWB), R21MH102113 (JWB, LC), and Pilot Funding from Einstein (Epigenomics Shared Facility for massively-parallel sequencing assays to JWB, LC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas W, 2015, VIRUSES-BASEL, V7, P1578, DOI 10.3390/v7041578; Agbottah E, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-48; Al-Shami A, 2005, J EXP MED, V202, P829, DOI 10.1084/jem.20050199; Albrecht D, 2006, AIDS RES HUM RETROV, V22, P248, DOI 10.1089/aid.2006.22.248; Ambrosino C, 1997, J BIOL CHEM, V272, P14883, DOI 10.1074/jbc.272.23.14883; Ances BM, 2007, SEMIN NEUROL, V27, P86, DOI 10.1055/s-2006-956759; Andras IE, 2008, MOL PHARMACOL, V73, P1424, DOI 10.1124/mol.107.042028; Anthony IC, 2005, J NEUROPATH EXP NEUR, V64, P529, DOI 10.1093/jnen/64.6.529; Aziz M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027685; Bachani M, 2013, J NEUROVIROL, V19, P82, DOI 10.1007/s13365-012-0144-8; Bachis A, 2012, J NEUROSCI, V32, P9477, DOI 10.1523/JNEUROSCI.0865-12.2012; Bazdar DA, 2009, J INFECT DIS, V199, P1019, DOI 10.1086/597210; Benkirane M, 1998, J BIOL CHEM, V273, P24898, DOI 10.1074/jbc.273.38.24898; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Borjabad A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002213; Bouwman RD, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-53; Brabers NACH, 2006, EUR J CLIN INVEST, V36, P447, DOI 10.1111/j.1365-2362.2006.01657.x; Buckner CM, 2006, J NEUROIMMUNE PHARM, V1, P160, DOI 10.1007/s11481-006-9017-3; Bukrinsky M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-49; Caldwell RL, 2006, J LEUKOCYTE BIOL, V79, P192, DOI 10.1189/jlb.0405194; Caldwell RL, 2000, J IMMUNOL, V165, P7035, DOI 10.4049/jimmunol.165.12.7035; Carroll IR, 1998, MOL IMMUNOL, V35, P1171, DOI 10.1016/S0161-5890(98)00107-2; Carvallo L, 2008, J CELL PHYSIOL, V214, P740, DOI 10.1002/jcp.21267; Chun RF, 1998, J VIROL, V72, P2615, DOI 10.1128/JVI.72.4.2615-2629.1998; Chun TW, 2015, NAT IMMUNOL, V16, P584, DOI 10.1038/ni.3152; Colten H R, 1979, Ann N Y Acad Sci, V332, P482, DOI 10.1111/j.1749-6632.1979.tb47142.x; Dadachova E, 2015, NAT METHODS, V12, P399, DOI 10.1038/nmeth.3373; Datta A, 2011, J PROTEOME RES, V10, P5199, DOI 10.1021/pr200673y; DAVIS LE, 1992, NEUROLOGY, V42, P1736, DOI 10.1212/WNL.42.9.1736; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dorr A, 2002, EMBO J, V21, P2715, DOI 10.1093/emboj/21.11.2715; Easley R, 2010, BBA-GENE REGUL MECH, V1799, P275, DOI 10.1016/j.bbagrm.2009.08.008; Eugenin EA, 2007, J NEUROSCI, V27, P12844, DOI 10.1523/JNEUROSCI.4154-07.2007; Eugenin EA, 2007, P NATL ACAD SCI USA, V104, P3438, DOI 10.1073/pnas.0611699104; Faller EM, 2006, JAIDS-J ACQ IMM DEF, V43, P257, DOI 10.1097/01.qai.0000230319.78288.f4; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Fields J, 2014, J NEUROIMMUNE PHARM, V9, P102, DOI 10.1007/s11481-013-9520-2; Fiume G, 2012, NUCLEIC ACIDS RES, V40, P3548, DOI 10.1093/nar/gkr1224; Gartner S, 2000, SCIENCE, V287, P602, DOI 10.1126/science.287.5453.602; Gatignol A, 2007, ADV PHARMACOL, V55, P137, DOI 10.1016/S1054-3589(07)55004-0; GERARD C, 1994, ANNU REV IMMUNOL, V12, P775, DOI 10.1146/annurev.iy.12.040194.004015; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Han HW, 2013, J IMMUNOL, V190, P904, DOI 10.4049/jimmunol.1201808; HARTUNG HP, 1983, SPRINGER SEMIN IMMUN, V6, P283, DOI 10.1007/BF02116277; Herbein G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-33; Herbein G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-34; Hidalgo-Estevez AM, 2006, J GEN VIROL, V87, P1603, DOI 10.1099/vir.0.81637-0; Ho A, 2008, J NEUROSCI, V28, P14392, DOI 10.1523/JNEUROSCI.2481-08.2008; HOWCROFT TK, 1993, SCIENCE, V260, P1320, DOI 10.1126/science.8493575; Jacobs EH, 2006, NEUROSCIENCE, V138, P511, DOI 10.1016/j.neuroscience.2005.11.017; Jongen PJH, 2000, ACTA NEUROL SCAND, V101, P116, DOI 10.1034/j.1600-0404.2000.101002116.x; Kamat A, 2012, JAIDS-J ACQ IMM DEF, V60, P234, DOI 10.1097/QAI.0b013e318256f3bc; Kanazawa S, 2000, IMMUNITY, V12, P61, DOI 10.1016/S1074-7613(00)80159-4; Kanmogne Georgette D, 2007, J Cereb Blood Flow Metab, V27, P123, DOI 10.1038/sj.jcbfm.9600330; KASHANCHI F, 1994, NATURE, V367, P295, DOI 10.1038/367295a0; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Kim Joonseok, 2013, Case Rep Med, V2013, P131395, DOI 10.1155/2013/131395; Kim N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001103; KIRSCHENBAUM B, 1995, P NATL ACAD SCI USA, V92, P210, DOI 10.1073/pnas.92.1.210; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; Lambotte O, 2003, BRAIN PATHOL, V13, P95, DOI 10.1111/j.1750-3639.2003.tb00010.x; Lin CW, 2012, J DRUG TARGET, V20, P515, DOI 10.3109/1061186X.2012.693496; LONGO F, 1995, BIOCHEM BIOPH RES CO, V206, P326, DOI 10.1006/bbrc.1995.1045; Lorenzo-Redondo R, 2016, NATURE, V530, P51, DOI 10.1038/nature16933; Mahmoudi T, 2006, J BIOL CHEM, V281, P19960, DOI 10.1074/jbc.M603336200; MARDER SR, 1985, J IMMUNOL, V134, P3325; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Mavankal G, 1996, P NATL ACAD SCI USA, V93, P2089, DOI 10.1073/pnas.93.5.2089; McArthur JC, 2004, ARCH NEUROL-CHICAGO, V61, P1687, DOI 10.1001/archneur.61.11.1687; Mediouni Sonia, 2012, Infectious Disorders - Drug Targets, V12, P81; Mercier F, 2008, CLIN EXP IMMUNOL, V152, P72, DOI 10.1111/j.1365-2249.2008.03610.x; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Mujtaba S, 2002, MOL CELL, V9, P575, DOI 10.1016/S1097-2765(02)00483-5; MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.biochem.57.1.321; Nakajima K, 2001, J NEUROSCI RES, V65, P322, DOI 10.1002/jnr.1157; Nath A, 1999, J BIOL CHEM, V274, P17098, DOI 10.1074/jbc.274.24.17098; Nath A, 2015, J NEUROVIROL, V21, P227, DOI 10.1007/s13365-014-0291-1; Nath S, 2012, J NEUROVIROL, V18, P445, DOI 10.1007/s13365-012-0122-1; OOI YM, 1979, J IMMUNOL, V123, P2494; OOI YM, 1980, J IMMUNOL, V124, P2077; Ott M, 1999, CURR BIOL, V9, P1489, DOI 10.1016/S0960-9822(00)80120-7; Ott M, 1997, SCIENCE, V275, P1481, DOI 10.1126/science.275.5305.1481; Ott M, 2011, CELL HOST MICROBE, V10, P426, DOI 10.1016/j.chom.2011.11.002; Pagans S, 2005, PLOS BIOL, V3, P210, DOI 10.1371/journal.pbio.0030041; Parisiadou L, 2007, NEUROBIOL AGING, V28, P377, DOI 10.1016/j.neurobiolaging.2005.12.015; Park LS, 2000, J EXP MED, V192, P659, DOI 10.1084/jem.192.5.659; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pulliam L, 2009, J NEUROIMMUNE PHARM, V4, P213, DOI 10.1007/s11481-009-9151-9; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rackstraw S, 2011, PSYCHOL HEALTH MED, V16, P548, DOI 10.1080/13548506.2011.579992; Rappaport J, 1999, J LEUKOCYTE BIOL, V65, P458, DOI 10.1002/jlb.65.4.458; Rappaport J, 2015, J NEUROVIROL, V21, P235, DOI 10.1007/s13365-015-0346-y; Reche PA, 2001, J IMMUNOL, V167, P336, DOI 10.4049/jimmunol.167.1.336; Reeder JE, 2015, ELIFE, V4, DOI 10.7554/eLife.08955; Remoli AL, 2006, BIOCHEM J, V396, P371, DOI 10.1042/BJ20051570; Rempel HC, 2005, AIDS, V19, P127, DOI 10.1097/00002030-200501280-00004; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Sastre M, 1998, J BIOL CHEM, V273, P22351, DOI 10.1074/jbc.273.35.22351; Sewell DL, 2004, J NEUROIMMUNOL, V155, P55, DOI 10.1016/j.jneuroim.2004.06.003; Soederholm A, 2007, EUR J IMMUNOL, V37, P2156, DOI 10.1002/eji.200636820; Speth C, 2002, J VIROL, V76, P3179, DOI 10.1128/JVI.76.7.3179-3188.2002; Speth C, 2001, J VIROL, V75, P2604, DOI 10.1128/JVI.75.6.2604-2516.2001; Stoiber H, 1997, ANNU REV IMMUNOL, V15, P649, DOI 10.1146/annurev.immunol.15.1.649; Sullivan SE, 2014, J BIOL CHEM, V289, P15374, DOI 10.1074/jbc.M113.541003; Taylor BC, 2009, J EXP MED, V206, P655, DOI 10.1084/jem.20081499; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Tong J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082030; Treand C, 2006, EMBO J, V25, P1690, DOI 10.1038/sj.emboj.7601074; Van Duyne R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-40; Vardabasso C, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-8; Vehmas A, 2004, J NEUROIMMUNOL, V157, P99, DOI 10.1016/j.jneuroim.2004.08.035; VESCHAMBRE P, 1995, J MOL BIOL, V250, P169, DOI 10.1006/jmbi.1995.0368; Williams DW, 2012, J LEUKOCYTE BIOL, V91, P401, DOI 10.1189/jlb.0811394; Williams KC, 2002, ANNU REV NEUROSCI, V25, P537, DOI 10.1146/annurev.neuro.25.112701.142822; Wong I, 2010, BRAIN BEHAV IMMUN, V24, P585, DOI 10.1016/j.bbi.2010.01.001; Woods SP, 2009, NEUROPSYCHOL REV, V19, P152, DOI 10.1007/s11065-009-9102-5; Woollard SM, 2014, J CEREBR BLOOD F MET, V34, P1047, DOI 10.1038/jcbfm.2014.54; Wu DT, 2000, J NEUROVIROL, V6, pS82; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Xing HQ, 2009, NEUROPATHOLOGY, V29, P433, DOI 10.1111/j.1440-1789.2008.00996.x; Yadav A, 2009, J NEUROIMMUNE PHARM, V4, P430, DOI 10.1007/s11481-009-9174-2; Zhang XD, 2008, NAT METHODS, V5, P163, DOI [10.1038/nmeth1170, 10.1038/NMETH1170]; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang ZT, 1997, EMBO J, V16, P6141, DOI 10.1093/emboj/16.20.6141; Zhong J, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau007	125	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179882	10.1371/journal.pone.0179882	http://dx.doi.org/10.1371/journal.pone.0179882			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640909	gold, Green Submitted, Green Published			2022-12-27	WOS:000404135800077
J	van Riel, ACMJ; Systrom, DM; Oliveira, RKF; Landzberg, MJ; Mulder, BJM; Bouma, BJ; Maron, BA; Shah, AM; Waxman, AB; Opotowsky, AR				van Riel, Annelieke C. M. J.; Systrom, David M.; Oliveira, Rudolf K. F.; Landzberg, Michael J.; Mulder, Barbara J. M.; Bouma, Berto J.; Maron, Bradley A.; Shah, Amil M.; Waxman, Aaron B.; Opotowsky, Alexander R.			Hemodynamic and metabolic characteristics associated with development of a right ventricular outflow tract pressure gradient during upright exercise	PLOS ONE			English	Article							PULMONARY ARTERIAL-PRESSURE; CONGENITAL HEART-DISEASE; SYSTEMIC-SCLEROSIS; HYPERTROPHIC CARDIOMYOPATHY; STRESS ECHOCARDIOGRAPHY; VASCULAR-RESISTANCE; HYPERTENSION; OBSTRUCTION; FAILURE; PATIENT	Background We recently reported a novel observation that many patients with equal resting supine right ventricular(RV) and pulmonary artery(PA) systolic pressures develop an RV outflow tract (RVOT) pressure gradient during upright exercise. The current work details the characteristics of patients who develop such an RVOT gradient. Methods We studied 294 patients (59.7 +/- 15.5 years-old, 49% male) referred for clinical invasive cardiopulmonary exercise testing, who did not have a resting RVOT pressure gradient defined by the simultaneously measured peak-to-peak difference between RV and PA systolic pressures. Results The magnitude of RVOT gradient did not correspond to clinical or hemodynamic findings suggestive of right heart failure; rather, higher gradients were associated with favorable exercise findings. The presence of a high peak RVOT gradient (90th percentile, >= 33mmHg) was associated with male sex (70 vs. 46%, p = 0.01), younger age (43.6 +/- 17.7 vs. 61.8 +/- 13.9 years, p<0.001), lower peak right atrial pressure (5 [3-7] vs. 8 [4-12] mmHg, p<0.001), higher peak heart rate (159 +/- 19 vs. 124 +/- 26 beats per minute, p<0.001), and higher peak cardiac index (8.3 +/- 2.3 vs. 5.7 +/- 1.9 L/min/m(2), p<0.001). These associations persisted when treating peak RVOT as a continuous variable and after age and sex adjustment. At peak exercise, patients with a high exercise RVOT gradient had both higher RV systolic pressure (78 +/- 11 vs. 66 +/- 17 mmHg, p<0.001) and lower PA systolic pressure (34 +/- 8 vs. 50 +/- 19 mmHg, p<0.001). Conclusions Development of a systolic RV-PA pressure gradient during upright exercise is not associated with an adverse hemodynamic exercise response and may represent a normal physiologic finding in aerobically fit young people.	[van Riel, Annelieke C. M. J.; Mulder, Barbara J. M.; Bouma, Berto J.] Acad Med Ctr, Dept Cardiol, Amsterdam, Netherlands; [van Riel, Annelieke C. M. J.; Mulder, Barbara J. M.] Netherlands Heart Inst, Utrecht, Netherlands; [Systrom, David M.; Oliveira, Rudolf K. F.; Waxman, Aaron B.] Brigham & Womens Hosp, Dept Med, Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA; [Systrom, David M.; Oliveira, Rudolf K. F.; Landzberg, Michael J.; Maron, Bradley A.; Shah, Amil M.; Waxman, Aaron B.; Opotowsky, Alexander R.] Harvard Med Sch, Boston, MA USA; [Oliveira, Rudolf K. F.] Fed Univ Sao Paulo UNIFESP, Dept Med, Div Resp Dis, Sao Paulo, SP, Brazil; [Landzberg, Michael J.; Opotowsky, Alexander R.] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA; [Landzberg, Michael J.; Maron, Bradley A.; Shah, Amil M.; Opotowsky, Alexander R.] Brigham & Womens Hosp, Dept Med, Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Maron, Bradley A.] Vet Affairs Boston Healthcare Syst, Boston, MA USA	University of Amsterdam; Academic Medical Center Amsterdam; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Universidade Federal de Sao Paulo (UNIFESP); Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Opotowsky, AR (corresponding author), Harvard Med Sch, Boston, MA USA.; Opotowsky, AR (corresponding author), Boston Childrens Hosp, Dept Cardiol, Boston, MA USA.; Opotowsky, AR (corresponding author), Brigham & Womens Hosp, Dept Med, Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA.	alexander.opotowsky@cardio.chboston.org	Waxman, Aaron/L-7450-2019; Oliveira, Rudolf/A-8409-2013; Waxman, Aaron/I-8659-2019; van Riel, Annelieke/GRO-1553-2022; Opotowsky, Alexander/AAL-1481-2020	Oliveira, Rudolf/0000-0002-2252-8119; Waxman, Aaron/0000-0001-7797-0361; Opotowsky, Alexander/0000-0002-6107-2281; Bouma, Berto/0000-0002-1433-9692	Netherlands Heart Institute; ZON-MW; Dunlevie Family Fund; Sao Paulo Research Foundation (FAPESP) [2014/12212-5]; Brazilian National Council for Scientific and Techological Development (CNPq) [232643/2014-8]; National Institutes of Health [U01HL125215, K08HL116792, 1K08HL11207-01A1]; American Heart Association [14CRP20380422, AHA15GRNT25080016]; Pulmonary Hypertension Association; Cardiovascular Medical Research and Education Fund	Netherlands Heart Institute; ZON-MW(Netherlands Organization for Health Research and Development); Dunlevie Family Fund; Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Council for Scientific and Techological Development (CNPq); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Pulmonary Hypertension Association; Cardiovascular Medical Research and Education Fund	The work in this study was supported by a fellowship grant provided by Netherlands Heart Institute (ACMJ van Riel) and a travel grant provided by ZON-MW (ACM Jvan Riel). AR Opotowsky and MJ Landzberg are supported by the Dunlevie Family Fund.RKF Oliveira received funds from the Sao Paulo Research Foundation (FAPESP), grant#2014/12212-5 and from the Brazilian National Council for Scientific and Techological Development (CNPq), grant #232643/2014-8. ABW axman and DM Systrom are supported by grant funding from the National Institutes of Health (U01HL125215). AM Shahis supported by the National Institutes of Health (K08HL116792) and the American Heart Association (14CRP20380422). BA Maronis supported by the National Institutes of Health (1K08HL11207-01A1), American Heart Association (AHA15GRNT25080016), Pulmonary Hypertension Association, and the Cardiovascular Medical Research and Education Fund.The funders had no role in study design,data collection and analysis,decision to publish,or preparation of the manuscript.	Abbas AE, 2003, J AM COLL CARDIOL, V41, P1021, DOI 10.1016/S0735-1097(02)02973-X; Argiento P, 2010, EUR RESPIR J, V35, P1273, DOI 10.1183/09031936.00076009; Bae S, 2012, ANN RHEUM DIS, V71, P1335, DOI 10.1136/annrheumdis-2011-200546; Berry NC, 2015, PULM CIRC, V5, P610, DOI 10.1086/683815; Canivet Jean-Luc, 2008, J Intensive Care Med, V23, P281, DOI 10.1177/0885066608318662; Claessen G, 2015, JACC CARDIOVASC IMAG; D'Alto M, 2011, HEART, V97, P112, DOI 10.1136/hrt.2010.203471; DELLITALIA LJ, 1991, CURR PROB CARDIOLOGY, V16, P659; Denault AY, 2006, J THORAC CARDIOV SUR, V132, P43, DOI 10.1016/j.jtcvs.2006.03.014; El Mahmoud R, 2008, AM HEART J, V156, P543, DOI 10.1016/j.ahj.2008.05.002; Geva T, 1998, CIRCULATION, V98, P339, DOI 10.1161/01.CIR.98.4.339; Gorcsan J 3rd, 1993, J Am Soc Echocardiogr, V6, P324; Ha JW, 2009, HEART, V95, P490, DOI 10.1136/hrt.2007.139295; HAMILTON DR, 1994, CIRCULATION, V90, P2492, DOI 10.1161/01.CIR.90.5.2492; HANSEN JE, 1984, AM REV RESPIR DIS, V129, pS49, DOI 10.1164/arrd.1984.129.2P2.S49; Humbert M, 2012, EUR RESPIR REV, V21, P306, DOI 10.1183/09059180.00005112; KAPLAN JD, 1994, AM HEART J, V127, P1572, DOI 10.1016/0002-8703(94)90388-3; KEITH A, 1924, LANCET, V204, P1267; Kirshbom PM, 1996, CHEST, V109, P575, DOI 10.1378/chest.109.2.575; Kovacs G, 2009, EUR RESPIR J, V34, P888, DOI 10.1183/09031936.00145608; Kovacs G, 2010, CHEST, V138, P270, DOI 10.1378/chest.09-2099; Kovacs G, 2009, AM J RESP CRIT CARE, V180, P881, DOI 10.1164/rccm.200904-0563OC; Lau EMT, 2015, NAT REV CARDIOL, V12, P143, DOI 10.1038/nrcardio.2014.191; MARCH HW, 1962, AM J MED, V32, P835, DOI 10.1016/0002-9343(62)90030-X; Maron BJ, 2009, J AM COLL CARDIOL, V54, P191, DOI 10.1016/j.jacc.2008.11.069; Maron BA, 2016, CIRCULATION, V133, P1240, DOI 10.1161/CIRCULATIONAHA.115.020207; Mingo S, 2006, INT J CARDIOL, V112, P393, DOI 10.1016/j.ijcard.2005.07.075; MOLS P, 1993, CHEST, V103, P1381, DOI 10.1378/chest.103.5.1381; Oldham WM, 2016, PULM CIRC, V6, P55, DOI 10.1086/685054; Oliveira RK, 2015, EUR RESP J; Opotowsky AR, 2013, AM J CARDIOL, V112, P873, DOI 10.1016/j.amjcard.2013.05.016; Pignone A, 2007, ANN NY ACAD SCI, V1108, P291, DOI 10.1196/annals.1422.031; RAINES RA, 1976, AM J PHYSIOL, V231, P1395, DOI 10.1152/ajplegacy.1976.231.5.1395; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Saggar R, 2012, ARTHRITIS RHEUM-US, V64, P4072, DOI 10.1002/art.34614; STIERLE U, 1987, JPN HEART J, V28, P115; THADANI U, 1978, AM J CARDIOL, V41, P52, DOI 10.1016/0002-9149(78)90131-5; TOBIN JR, 1965, CIRC RES, V16, P162, DOI 10.1161/01.RES.16.2.162; Tolle JJ, 2008, CIRCULATION, V118, P2183, DOI 10.1161/CIRCULATIONAHA.108.787101; Turhan H, 2007, INT J CARDIOL, V118, P124, DOI 10.1016/j.ijcard.2006.06.035; Valerio CJ, 2013, ARTHRITIS RHEUM-US, V65, P1074, DOI 10.1002/art.37838; Van De Bruaene A, 2011, CIRC-CARDIOVASC IMAG, V4, P237, DOI 10.1161/CIRCIMAGING.110.962571; van Riel ACMJ, 2017, J AM COLL CARDIOL, V69, P595, DOI 10.1016/j.jacc.2016.11.039; van Riel ACMJ, 2015, INT J CARDIOL, V197, P312, DOI 10.1016/j.ijcard.2015.06.062	44	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179053	10.1371/journal.pone.0179053	http://dx.doi.org/10.1371/journal.pone.0179053			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636647	Green Published, Green Submitted, gold			2022-12-27	WOS:000404118300023
J	Men, QL; Xue, GX; Mu, D; Hu, QL; Huang, MY				Men, Qiulei; Xue, Guoxi; Mu, Dan; Hu, Qingling; Huang, Minyi			Mitochondrial DNA markers reveal high genetic diversity and strong genetic differentiation in populations of Dendrolimus kikuchii Matsumura (Lepidoptera: Lasiocampidae)	PLOS ONE			English	Article							MOTH LEPIDOPTERA; CODLING MOTH; TORTRICIDAE; FLOW; L.; APPLE; RATES	Dendrolimus kikuchii Matsumura, 1927 is a serious forest pest causing great damage to coniferous trees in China. Despite its economic importance, the population genetics of this pest are poorly known. We used three mitochondrial genes (COI, COII and Cytb) to investigate the genetic diversity and genetic differentiation of 15 populations collected from the main distribution regions of D. kikuchii in China. Populations show high haplotype and nucleotide diversity. Haplotype network and phylogenetic analysis divides the populations into three major clades, the central and southeastern China (CC+SEC) clade, the eastern China (EC) clade, and the southwestern China (SWC) clade. Populations collected from adjacent localities share the same clade, which is consistent with the strong relationship of isolation by distance (r = 0.74824, P = 0.00001). AMOVA analysis indicated that the major portion of this molecular genetic variation is found among the three groups of CC+ SEC, EC and SWC (61.26%). Of 105 pairwise FST comparisons, 93 show high genetic differentiation. Populations of Puer (PE), Yangshuo (YS) and Leishan (LS) are separated from other populations by a larger genetic distance. Distributions of pairwise differences obtained with single and combined gene data from the overall populations are multimodal, suggesting these populations had no prior population expansion in southern China. The nonsignificant neutral test on the basis of Tajima' D and Fu's Fs, and the lack of a star-shaped haplotype network together with the multiple haplotypes support this hypothesis. Pleistocene climatic fluctuations, combined with the host specificity to Pinus species, made these regions of south China into a refuge for D. kikuchii. The high level of population genetic structuring is related to their weak flight capacity, their variations of life history and the geographic distance among populations.	[Men, Qiulei; Mu, Dan; Huang, Minyi] Anqing Normal Univ, Sch Life Sci, Res Ctr Aquat Organism Conservat & Water Ecosyst, Prov Key Lab Biodivers Study & Ecol Conservat Sou, Anqing, Anhui, Peoples R China; [Xue, Guoxi] Zhengzhou Univ Light Ind, Sch Food & Bioengn, Zhengzhou, Henan, Peoples R China; [Hu, Qingling] Weinan Normal Univ, Sch Chem & Environm, Weinan, Shaanxi, Peoples R China	Anqing Normal University; Zhengzhou University of Light Industry; Weinan Normal University	Men, QL (corresponding author), Anqing Normal Univ, Sch Life Sci, Res Ctr Aquat Organism Conservat & Water Ecosyst, Prov Key Lab Biodivers Study & Ecol Conservat Sou, Anqing, Anhui, Peoples R China.	menqiulei888@126.com		Mu, Dan/0000-0001-5416-9723; Qu, Yi/0000-0002-9993-8810	National Natural Science Foundation of China [31300551]; Young Talent Support Program from the Association for Science and Technology of Colleges in Shaanxi Province [20160235]; Special Fondation for Young Scientist of Weinan Normal University [15ZRRC03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Talent Support Program from the Association for Science and Technology of Colleges in Shaanxi Province; Special Fondation for Young Scientist of Weinan Normal University	Funded by agrant from the National Natural Science Foundation of China (31300551), the Young Talent Support Program from the Association for Science and Technology of Colleges in Shaanxi Province (20160235), and the Special Fondation for Young Scientist of Weinan Normal University (15ZRRC03).	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Boivin T, 2004, BIOL J LINN SOC, V83, P341, DOI 10.1111/j.1095-8312.2004.00392.x; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Bouvier JC, 2001, HEREDITY, V87, P456, DOI 10.1046/j.1365-2540.2001.00928.x; Calcagno V, 2007, J EVOLUTION BIOL, V20, P1720, DOI 10.1111/j.1420-9101.2007.01391.x; CARDE RT, 1995, ANNU REV ENTOMOL, V40, P559, DOI 10.1146/annurev.en.40.010195.003015; Caterino MS, 1999, MOL PHYLOGENET EVOL, V11, P122, DOI 10.1006/mpev.1998.0549; Chen MH, 2010, B ENTOMOL RES, V100, P75, DOI 10.1017/S0007485309006786; Dai QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032544; Du YL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157609; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fan Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089873; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Francisco MR, 2007, MOL ECOL, V16, P4908, DOI 10.1111/j.1365-294X.2007.03519.x; Fuentes-Contreras E, 2008, J ECON ENTOMOL, V101, P190, DOI 10.1603/0022-0493(2008)101[190:PGSOCM]2.0.CO;2; GOVINDARAJU DR, 1989, J EVOLUTION BIOL, V2, P173, DOI 10.1046/j.1420-9101.1989.2030173.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hou T., 1987, PINE CATERPILLARS CH; Huang QB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067294; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knowles LL, 2007, CURR BIOL, V17, P940, DOI 10.1016/j.cub.2007.04.033; Knowles LL, 2000, EVOLUTION, V54, P1337, DOI 10.1111/j.0014-3820.2000.tb00566.x; Li Y, 2015, B ENTOMOL RES, V105, P485, DOI 10.1017/S0007485315000334; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MANTEL N, 1967, CANCER RES, V27, P209; Men QL, 2013, BIOL INVASIONS, V15, P447, DOI 10.1007/s10530-012-0299-5; Meng XF, 2008, MOL ECOL, V17, P2880, DOI 10.1111/j.1365-294X.2008.03792.x; Miller NJ, 2003, HEREDITY, V91, P217, DOI 10.1038/sj.hdy.6800331; Myers CT, 2006, J ECON ENTOMOL, V99, P1299, DOI 10.1603/0022-0493-99.4.1299; Nason JD, 2002, EVOLUTION, V56, P1475, DOI 10.1111/j.0014-3820.2002.tb01459.x; Reyes PFM, 2007, MOL ECOL, V16, P3554, DOI 10.1111/j.1365-294X.2007.03410.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosetti N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040807; Shen L, 2002, ACTA ECOLOGY SINICA, V22, P1985; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Timm AE, 2006, J ECON ENTOMOL, V99, P341, DOI 10.1603/0022-0493-99.2.341; Tong Q, 2009, J ANHUI AGR SCI, V37, P13122; Wang J, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev063; Wei SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059654; Weng HongBiao, 2008, Scientia Silvae Sinicae, V44, P164; WRIGHT S, 1978, P580; Zhan XJ, 2011, MOL ECOL, V20, P3014, DOI 10.1111/j.1365-294X.2011.05144.x; Zhang AB, 2004, CHINESE BULL ENTOMOL, V2, P146, DOI DOI 10.3969/j.issn.0452-8255.2004.02.011; Zheng Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078476	47	13	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179706	10.1371/journal.pone.0179706	http://dx.doi.org/10.1371/journal.pone.0179706			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662066	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300043
J	Weng, SL; Kao, HJ; Huang, CH; Lee, TY				Weng, Shun-Long; Kao, Hui-Ju; Huang, Chien-Hsun; Lee, Tzong-Yi			MDD-Palm: Identification of protein S-palmitoylation sites with substrate motifs based on maximal dependence decomposition	PLOS ONE			English	Article							PHOSPHORYLATION SITES; SECONDARY STRUCTURE; WEB SERVER; CSS-PALM; PREDICTION; RESOURCE; TRAFFICKING; ASSOCIATION; STABILITY; STRATEGY	S-palmitoylation, the covalent attachment of 16-carbon palmitic acids to a cysteine residue via a thioester linkage, is an important reversible lipid modification that plays a regulatory role in a variety of physiological and biological processes. As the number of experimentally identified S-palmitoylated peptides increases, it is imperative to investigate substrate motifs to facilitate the study of protein S-palmitoylation. Based on 710 non homologous S-palmitoylation sites obtained from published databases and the literature, we carried out a bioinformatics investigation of S-palmitoylation sites based on amino acid composition. Two Sample Logo indicates that positively charged and polar amino acids surrounding S-palmitoylated sites may be associated with the substrate site specificity of protein S-palmitoylation. Additionally, maximal dependence decomposition (MDD) was applied to explore the motif signatures of S-palmitoylation sites by categorizing a large-scale dataset into subgroups with statistically significant conservation of amino acids. Single features such as amino acid composition (AAC), amino acid pair composition (AAPC), position specific scoring matrix (PSSM), position weight matrix (PWM), amino acid substitution matrix (BLOSUM62), and accessible surface area (ASA) were considered, along with the effectiveness of incorporating MDD-identified substrate motifs into a two-layered prediction model. Evaluation by five-fold cross-validation showed that a hybrid of AAC and PSSM performs best at discriminating between S-palmitoylation and non-S-palmitoylation sites, according to the support vector machine (SVM). The two-layered SVM model integrating MDD-identified substrate motifs performed well, with a sensitivity of 0.79, specificity of 0.80, accuracy of 0.80, and Matthews Correlation Coefficient (MCC) value of 0.45. Using an independent testing dataset (613 S-palmitoylated and 5412 non-S-palmitoylated sites) obtained from the literature, we demonstrated that the two-layered SVM model could outperform other prediction tools, yielding a balanced sensitivity and specificity of 0.690 and 0.694, respectively. This two-layered SVM model has been implemented as a web-based system (MDD-Palm), which is now freely available at	[Weng, Shun-Long] Mackay Med Coll, Dept Med, New Taipei, Taiwan; [Weng, Shun-Long] Hsinchu Mackay Mem Hosp, Dept Obstet & Gynecol, Hsinchu, Taiwan; [Weng, Shun-Long] Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan; [Kao, Hui-Ju; Huang, Chien-Hsun; Lee, Tzong-Yi] Yuan Ze Univ, Dept Comp Sci & Engn, Taoyuan, Taiwan; [Huang, Chien-Hsun] Tao Yuan Hosp, Minist Hlth & Welf, Taoyuan, Taiwan; [Lee, Tzong-Yi] Yuan Ze Univ, Innovat Ctr Big Data & Digital Convergence, Taoyuan, Taiwan	Mackay Medical College; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; Yuan Ze University; Yuan Ze University	Huang, CH; Lee, TY (corresponding author), Yuan Ze Univ, Dept Comp Sci & Engn, Taoyuan, Taiwan.; Huang, CH (corresponding author), Tao Yuan Hosp, Minist Hlth & Welf, Taoyuan, Taiwan.; Lee, TY (corresponding author), Yuan Ze Univ, Innovat Ctr Big Data & Digital Convergence, Taoyuan, Taiwan.	lithsunh@gmail.com; francis@saturn.yzu.edu.tw			Ministry of Science and Technology (MOST) of Taiwan [103-2221-E-155-020-MY3, MOST 104-2221-E-155-036-MY2]	Ministry of Science and Technology (MOST) of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology (MOST) of Taiwan under the contract numbers of 103-2221-E-155-020-MY3 and MOST 104-2221-E-155-036-MY2 to TYL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2003, BIOINFORMATICS, V19, P1849, DOI 10.1093/bioinformatics/btg249; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berchtold LA, 2011, P NATL ACAD SCI USA, V108, pE681, DOI 10.1073/pnas.1104384108; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; Bretana NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040694; Bui VM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2299-1; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chang WC, 2009, J COMPUT CHEM, V30, P2526, DOI 10.1002/jcc.21258; Charrin S, 2002, FEBS LETT, V516, P139, DOI 10.1016/S0014-5793(02)02522-X; Chen YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118752; Chen YJ, 2015, NUCLEIC ACIDS RES, V43, pD503, DOI 10.1093/nar/gku1176; Chen YJ, 2010, J PROTEOME RES, V9, P6417, DOI 10.1021/pr100680a; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gould NS, 2015, CHEM BIOL, V22, P965, DOI 10.1016/j.chembiol.2015.06.010; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Hsu JBK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027567; Hu LL, 2011, BIOCHIMIE, V93, P489, DOI 10.1016/j.biochi.2010.10.022; Huang CH, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-015-0246-z; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Huang HD, 2005, J COMPUT CHEM, V26, P1032, DOI 10.1002/jcc.20235; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Huang KY, 2016, NUCLEIC ACIDS RES, V44, pD435, DOI 10.1093/nar/gkv1240; Huang KY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S16-S10; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kumari B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089246; Lee TY, 2012, BIOINFORMATICS, V28, P2293, DOI 10.1093/bioinformatics/bts436; Lee TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021849; Lee TY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-261; Lee TY, 2011, BIOINFORMATICS, V27, P1780, DOI 10.1093/bioinformatics/btr291; Lee TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017331; Li SY, 2015, J CHEM INF MODEL, V55, P2015, DOI 10.1021/acs.jcim.5b00276; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Linder ME, 2003, BIOCHEMISTRY-US, V42, P4311, DOI 10.1021/bi034159a; Lu CT, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/528650; Lu CT, 2013, NUCLEIC ACIDS RES, V41, pD295, DOI 10.1093/nar/gks1229; Lu CT, 2011, J COMPUT AID MOL DES, V25, P987, DOI 10.1007/s10822-011-9477-2; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Pang CNI, 2007, J PROTEOME RES, V6, P1833, DOI 10.1021/pr060674u; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Resh Marilyn D, 2006, Sci STKE, V2006, pre14, DOI 10.1126/stke.3592006re14; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; Saleem AN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000985; Shi SP, 2013, J MOL GRAPH MODEL, V40, P125, DOI 10.1016/j.jmgm.2012.12.006; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Sutton LM, 2013, HUM MOL GENET, V22, P452, DOI 10.1093/hmg/dds441; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Bui VM, 2016, BIOINFORMATICS, V32, P165, DOI 10.1093/bioinformatics/btv558; Wang XB, 2009, PROTEIN ENG DES SEL, V22, P707, DOI 10.1093/protein/gzp055; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Wu HY, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S16-S1; Xie D, 2005, NUCLEIC ACIDS RES, V33, pW105, DOI 10.1093/nar/gki359; Xue Y, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-458; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200; Zhou FF, 2006, BIOINFORMATICS, V22, P894, DOI 10.1093/bioinformatics/btl013	62	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179529	10.1371/journal.pone.0179529	http://dx.doi.org/10.1371/journal.pone.0179529			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662047	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300030
J	Yu, CF; Li, HF; Zhang, QN; He, HY; Chen, XH; Hua, ZY				Yu, Canfeng; Li, Huifan; Zhang, Qiannan; He, Huayun; Chen, Xinhong; Hua, Ziyu			Report about term infants with severe hyperbilirubinemia undergoing exchange transfusion in Southwestern China during an 11-year period, from 2001 to 2011	PLOS ONE			English	Article							WEIGHT-LOSS; NEONATAL HYPERBILIRUBINEMIA; EXTREME HYPERBILIRUBINEMIA; BREAST	Objectives This study was intended to explore the etiology and risk factors of severe neonatal hyperbilirubinemia and to analyze the adverse events associated with ECT (Exchange Transfusion), as well as to identify the factors related to the poor prognosis. Methods All of the full-term neonates who had undergone ECT for hyperbilirubinemia at Children's Hospital of Chongqing Medical University from January 2001 to December 2011 were enrolled in this study. General demographic characteristics, comorbidities, pre- and post-exchange TSB(Total Serum Bilirubin) levels, duration and frequency of ECT, and clinical outcomes were recorded and analyzed anonymously. Results Of 614 total infants, 368 patients (59.9%) with ABO incompatibility were identified, of whom 197 (53.5%) developed acute bilirubin encephalopathy (ABE) and 16 (4.3%) suffered a poor prognosis. The etiology was unidentified in 103 patients (16.8%), of whom 62 (60.1%) developed ABE and 9 (8.7%) had a poor prognosis. Identified adverse events secondary to ECT included thrombocytopenia (54.6%), hyperglycemia (42.8%), apnea (3.3%) and necrotizing enterocolitis (NEC) (1.3%). No ECT-related mortality was documented in this study. Conclusions The etiology, peak TSB level before ECT, and time of ECT had a significant impact on the outcome of severe neonatal hyperbilirubinemia. ABO incompatibility was the most common cause of extreme neonatal hyperbilirubinemia. Pathological weight loss could be involved in the development of extreme hyperbilirubinemia with an unidentified cause.	[Yu, Canfeng; Li, Huifan; Zhang, Qiannan; He, Huayun; Chen, Xinhong; Hua, Ziyu] Chongqing Med Univ, Childrens Hosp, Dept Neonatol, Chongqing, Peoples R China; [Yu, Canfeng; Li, Huifan; Zhang, Qiannan; He, Huayun; Chen, Xinhong; Hua, Ziyu] Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China; [Yu, Canfeng] Key Lab Pediat Chongqing, Chongqing, Peoples R China; [Li, Huifan; Hua, Ziyu] Chongqing Int Sci & Technol Cooperat Ctr Child De, Chongqing, Peoples R China	Chongqing Medical University	Hua, ZY (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Neonatol, Chongqing, Peoples R China.; Hua, ZY (corresponding author), Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China.; Hua, ZY (corresponding author), Chongqing Int Sci & Technol Cooperat Ctr Child De, Chongqing, Peoples R China.	h_ziyu@126.com		zhang, qiannan/0000-0002-6583-0430	National Key Clinical Specialist Construction Programs of China-Neonatology [2011873]; Chongqing Science and Technology Commission [cstc2013jcyjA10020]	National Key Clinical Specialist Construction Programs of China-Neonatology; Chongqing Science and Technology Commission(Natural Science Foundation Project of CQ CSTC)	This research is supported by the grant from National Key Clinical Specialist Construction Programs of China-Neonatology (GrantNo. 2011873) and Chongqing Science and Technology Commission (Grant No. cstc2013jcyjA10020)	American Academy of Pediatrics Subcommittee on Hyperbilirrubinemia, 2004, PEDIATRICS, V114, P297, DOI DOI 10.1542/PEDS.114.1.297; Babu TA, 2012, INDIAN J PEDIATR, V79, P202, DOI 10.1007/s12098-011-0501-2; Campistol J, 2012, NEUROLOGIA, V27, P202, DOI 10.1016/j.nrl.2010.03.013; Chang RJ, 2012, PEDIATR NEONATOL, V53, P41, DOI 10.1016/j.pedneo.2011.11.008; Chen HN, 2008, PEDIATRICS, V122, pE905, DOI 10.1542/peds.2008-0249; Cheng Shao-Wen, 2012, Chang Gung Med J, V35, P148; Christensen RD, 2013, BLOOD CELL MOL DIS, V50, P105, DOI 10.1016/j.bcmd.2012.10.004; Davutoglu M, 2010, TURKISH J PEDIATR, V52, P163; Ding GF, 2000, CHIN J PEDIAT, V38, P624; Du CS, 2000, CHIN J HEMATOL, V21, P174; Duman N, 2004, ACTA PAEDIATR, V93, P361, DOI 10.1080/08035250310007475; Ebbesen F, 2005, ACTA PAEDIATR, V94, P59, DOI 10.1080/08035250410022170; Flaherman VJ, 2013, ARCH DIS CHILD-FETAL, V98, pF488, DOI 10.1136/archdischild-2012-303076; Johnson L, 2009, J PERINATOL, V29, pS25, DOI 10.1038/jp.2008.211; Katar S, 2008, J CHILD NEUROL, V23, P415, DOI 10.1177/0883073807309780; Lam S T, 2002, SE ASIAN J TROP MED, V34, P73; Li QP, 2006, J APPL CLIN PEDIAT, V21, P958; Macdonald PD, 2003, ARCH DIS CHILD-FETAL, V88, pF472, DOI 10.1136/fn.88.6.F472; PALMER DC, 1983, AUST PAEDIATR J, V19, P86; Sakha SH, 2010, TURKISH J PEDIATR, V52, P367; Saluja S, 2010, INT J PEDIATR OTORHI, V74, P1292, DOI 10.1016/j.ijporl.2010.08.007; Sgro M, 2011, J PERINATOL, V31, P392, DOI 10.1038/jp.2010.137; Subspecialty Group of Neonatology Society of Pediatrics Chinese Medical Association, 2012, Zhonghua Er Ke Za Zhi, V50, P331; Wang X. M., 2016, INT J CHEM ENG, V2016, P1, DOI DOI 10.3852/16-100; Xiao M, 2011, PRACTICAL NEONATOLOG, P296; Zhuang Yan, 2013, Zhongguo Dang Dai Er Ke Za Zhi, V15, P332	26	18	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179550	10.1371/journal.pone.0179550	http://dx.doi.org/10.1371/journal.pone.0179550			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662083	Green Submitted, Green Published, gold			2022-12-27	WOS:000404608300033
J	de Wolf, ACMT; van Aalst, S; Ludwig, IS; Bodinham, CL; Lewis, DJ; van der Zee, R; van Eden, W; Broere, F				de Wolf, A. Charlotte M. T.; van Aalst, Susan; Ludwig, Irene S.; Bodinham, Caroline L.; Lewis, David J.; van der Zee, Ruurd; van Eden, Willem; Broere, Femke			Regulatory T cell frequencies and phenotypes following anti-viral vaccination	PLOS ONE			English	Article							INFLUENZA-A VIRUS; INFECTION; EXPRESSION; ADJUVANTS; CD39; LYMPHOCYTES; RESPONSES; EFFECTOR; LIVER	Regulatory T cells (Treg) function in the prevention of excessive inflammation and maintenance of immunological homeostasis. However, these cells may also interfere with resolution of infections or with immune reactions following vaccination. Effects of Treg on vaccine responses are nowadays investigated, but the impact of vaccination on Treg homeostasis is still largely unknown. This may be a relevant safety aspect, since loss of tolerance through reduced Treg may trigger autoimmunity. In exploratory clinical trials, healthy adults were vaccinated with an influenza subunit vaccine plus or minus the adjuvant MF59 (R), an adjuvanted hepatitis B subunit vaccine or a live attenuated yellow fever vaccine. Frequencies and phenotypes of resting (rTreg) and activated (aTreg) subpopulations of circulating CD4(+) Treg were determined and compared to placebo immunization. Vaccination with influenza vaccines did not result in significant changes in Treg frequencies and phenotypes. Vaccination with the hepatitis B vaccine led to slightly increased frequencies of both rTreg and aTreg subpopulations and a decrease in expression of functionality marker CD39 on aTreg. The live attenuated vaccine resulted in a decrease in rTreg frequency, and an increase in expression of activation marker CD25 on both subpopulations, possibly indicating a conversion from resting to migratory aTreg due to vaccine virus replication. To study the more local effects of vaccination on Treg in lymphoid organs, we immunized mice and analyzed the CD4(+) Treg frequency and phenotype in draining lymph nodes and spleen. Vaccination resulted in a transient local decrease in Treg frequency in lymph nodes, followed by a systemic Treg increase in the spleen. Taken together, we showed that vaccination with vaccines with an already established safe profile have only minimal impact on frequencies and characteristics of Treg over time. These findings may serve as a bench-mark of inter-individual variation of Treg frequencies and phenotypes following vaccination.	[de Wolf, A. Charlotte M. T.; van Aalst, Susan; Ludwig, Irene S.; van der Zee, Ruurd; van Eden, Willem; Broere, Femke] Univ Utrecht, Div Immunol, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Bodinham, Caroline L.; Lewis, David J.] Univ Surrey, Surrey Clin Res Ctr, Guildford, Surrey, England	Utrecht University; University of Surrey	Broere, F (corresponding author), Univ Utrecht, Div Immunol, Dept Infect Dis & Immunol, Utrecht, Netherlands.	f.broere@uu.nl		van Eden, Willem/0000-0003-1272-704X; Broere, Femke/0000-0001-9343-0111	European Union's Seventh Framework Programme (FP7) [115308]	European Union's Seventh Framework Programme (FP7)	This work was part of the Bio VacSafe project. The BioVacSafe project has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement no 115308, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution.	Aalaei-Andabili SH, 2012, VACCINE, V30, P5595, DOI 10.1016/j.vaccine.2012.06.063; Bacchetta R, 2016, ANN NEW YORK ACAD SC; BAYRY J, 2014, INDIAN J VIROL, V25, P18, DOI DOI 10.1007/S13337-013-0187-3; Berod L, 2012, MICROB BIOTECHNOL, V5, P260, DOI 10.1111/j.1751-7915.2011.00299.x; Betts RJ, 2012, J VIROL, V86, P2817, DOI 10.1128/JVI.05685-11; Billiau A, 2001, J LEUKOCYTE BIOL, V70, P849; Blom K, 2013, J IMMUNOL, V190, P2150, DOI 10.4049/jimmunol.1202234; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Dietze KK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151717; Dwyer KM, 2010, AM J TRANSPLANT, V10, P2410, DOI 10.1111/j.1600-6143.2010.03291.x; El-Badawy O, 2012, HUM IMMUNOL, V73, P335, DOI 10.1016/j.humimm.2012.01.014; Giamarellos-Bourboulis EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008393; Guo XC, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-215; Hopf S, 2016, VACCINE, V34, P2027, DOI 10.1016/j.vaccine.2015.12.057; Huang Y, 2013, ARCH VIROL, V158, P2267, DOI 10.1007/s00705-013-1692-9; Iellem A, 2001, J EXP MED, V194, P847, DOI 10.1084/jem.194.6.847; Leliefeld PHC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00471; Lewis DJM, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/909406; Li J, 2014, DIGEST DIS SCI, V59, P1475, DOI 10.1007/s10620-013-3022-1; Li Jincheng, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P1046, DOI 10.3969/j.issn.1672-7347.2011.11.003; Liston A, 2014, NAT REV IMMUNOL, V14, P154, DOI 10.1038/nri3605; Mangodt TC, 2015, PEDIATR RES, V78, P483, DOI 10.1038/pr.2015.143; Marek N, 2011, CELL TRANSPLANT, V20, P1747, DOI 10.3727/096368911X566217; Martins MA, 2007, CLIN EXP IMMUNOL, V148, P90, DOI 10.1111/j.1365-2249.2006.03317.x; Mathew RO, 2016, HEMODIAL INT, V20, P242, DOI 10.1111/hdi.12326; Mills KHG, 2009, IMMUNOL LETT, V122, P108, DOI 10.1016/j.imlet.2008.11.007; Miroux C, 2010, EXPERT OPIN BIOL TH, V10, P1563, DOI 10.1517/14712598.2010.529125; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Ndure J, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00477; Nishikawa H, 2014, CURR OPIN IMMUNOL, V27, P1, DOI 10.1016/j.coi.2013.12.005; Oliphant S, 2015, VIRAL IMMUNOL, V28, P580, DOI 10.1089/vim.2015.0039; Perricone C, 2013, J AUTOIMMUN, V47, P1, DOI 10.1016/j.jaut.2013.10.004; Ramsdell F, 2014, NAT REV IMMUNOL, V14, P343, DOI 10.1038/nri3650; Rowe JH, 2012, IMMUNOLOGY, V136, P1, DOI 10.1111/j.1365-2567.2011.03551.x; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Salemi S, 2010, CLIN IMMUNOL, V134, P113, DOI 10.1016/j.clim.2009.09.014; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Spensieri F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157066; Stross L, 2012, HEPATOLOGY, V56, P873, DOI 10.1002/hep.25765; Tang Y, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-17; Valmori D, 2005, J CLIN INVEST, V115, P1953, DOI 10.1172/JCI23963; Walker LSK, 2009, IMMUNOLOGY, V126, P466, DOI 10.1111/j.1365-2567.2009.03053.x	44	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179942	10.1371/journal.pone.0179942	http://dx.doi.org/10.1371/journal.pone.0179942			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658271	Green Published, gold			2022-12-27	WOS:000404607900047
J	Suarez, SE; Brookfield, ME; Catlos, EJ; Stockil, DF				Suarez, Stephanie E.; Brookfield, Michael E.; Catlos, Elizabeth J.; Stockil, Daniel F.			A U-Pb zircon age constraint on the oldest recorded air-breathing land animal	PLOS ONE			English	Article							MIDLAND VALLEY	The oldest-known air-breathing land animal is the millipede Pneumodesmus newmani, found in the Cowie Harbour Fish Bed at Stonehaven, Scotland. Here we report the youngest, most concordant U-238- -Pb-206 zircon age from ash below the fish bed of 413.7 +/- 4.4 Ma (+/- 2 sigma), whereas the youngest age from a tuffaceous sandstone above the fish bed is statistically indistinguishable at 414.3 +/- 7.1 Ma. The Cowie Harbour Fish Bed thus appears to be lowermost Devonian (Lochkovian), contrary to the previously accepted mid-Silurian age based on palynomorphs from adjacent exposures. This has implications for the evolutionary timetable of land colonization, as the Cowie ages overlap late Lochkovian zircon ages reported elsewhere for andesite below the nearby (similar to 50 ml) Rhynie Chert, which has more advanced terrestrial biota. The results postdate the possible late Silurian Ludford Lane locality in Shropshire, England. Pneumodesmus newmani is thus not the earliest air-breathing land animal, unless the Ludford Lane locality is younger than presently assigned.	[Suarez, Stephanie E.; Catlos, Elizabeth J.; Stockil, Daniel F.] Univ Texas Austin, Dept Geol Sci, Jackson Sch Geosci, Austin, TX 78712 USA; [Brookfield, Michael E.] Univ Massachusetts, Environm Earth & Ocean Sci, Boston, MA 02125 USA	University of Texas System; University of Texas Austin; University of Massachusetts System; University of Massachusetts Boston	Catlos, EJ (corresponding author), Univ Texas Austin, Dept Geol Sci, Jackson Sch Geosci, Austin, TX 78712 USA.	ejcatlos@jsg.utexas.edu	Catlos, Elizabeth/AAA-7884-2021	Catlos, Elizabeth/0000-0001-6043-3498; Suarez, Stephanie/0000-0002-1647-0221	Geological Society of America South Central Section	Geological Society of America South Central Section	Funding was provided to Stephanie Suarez from the Geological Society of America South Central Section. This was an undergraduate research award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, SCOTT OUTD ACC COS; Bowring S. A., 2006, PALEONTOLOGICAL SOC, V11, P23; Browne MAE, 2002, BRIT GEOLOGICAL SURV, V67, P1; Cohen KM, 2004, ICS INT CHRONOSTRATI, V36, P199; Davies NS, 2005, NORW J GEOL, V85, P193; DINELEY DL, 1999, FOSSIL FISHES GREAT; Guillong M, 2014, J ANAL ATOM SPECTROM, V29, P963, DOI 10.1039/c4ja00009a; HALLERMEIER RJ, 1981, SEDIMENTOLOGY, V28, P859, DOI 10.1111/j.1365-3091.1981.tb01948.x; Jackson SE, 2004, CHEM GEOL, V211, P47, DOI 10.1016/j.chemgeo.2004.06.017; JERAM AJ, 1990, SCIENCE, V250, P658, DOI 10.1126/science.250.4981.658; Kirkland CL, 2015, LITHOS, V212, P397, DOI 10.1016/j.lithos.2014.11.021; Lavender K, 2002, REV PALAEOBOT PALYNO, V118, P157, DOI 10.1016/S0034-6667(01)00112-9; MARSHALL JEA, 1991, GEOL MAG, V128, P283, DOI 10.1017/S0016756800022135; MARSHALL JEA, 1994, J GEOL SOC LONDON, V151, P425, DOI 10.1144/gsjgs.151.3.0425; Parry SF, 2011, J GEOL SOC LONDON, V168, P863, DOI 10.1144/0016-76492010-043; Scottish Earth Science Education Forum, 2009, EARTH SCI OUTD TEACH; Selden Paul, 2008, Bulletin of the British Myriapod and Isopod Group, V23, P36; Shear W. A., 1998, AM MUS NOVIT, V3231, P1; Slama J, 2008, CHEM GEOL, V249, P1, DOI 10.1016/j.chemgeo.2007.11.005; Smith AG, 2015, GEOL SOC SPEC PUBL, V404, P37, DOI 10.1144/SP404.8; STACEY JS, 1975, EARTH PLANET SC LETT, V26, P207, DOI 10.1016/0012-821X(75)90088-6; Suzuki Y., 2013, EARTH PLANETS SPACE, P65, DOI DOI 10.5047/EPS.2013.03.009; Wellman C.H., 1993, J MICROPALAEONTOL, V12, P47, DOI [10.1144/jm.12.1.47, DOI 10.1144/JM.12.1.47]; Wilson HM, 2004, J PALEONTOL, V78, P169, DOI 10.1666/0022-3360(2004)078<0169:MATOPM>2.0.CO;2	24	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179262	10.1371/journal.pone.0179262	http://dx.doi.org/10.1371/journal.pone.0179262			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658320	Green Published, gold, Green Submitted			2022-12-27	WOS:000404607900018
J	Wang, JN; Du, SL; Wang, JM; Fan, W; Wang, P; Zhang, Z; Xu, PP; Tang, SH; Deng, QL; Yang, WQ; Yu, MX				Wang, June; Du, Shenlin; Wang, Jiamin; Fan, Wei; Wang, Ping; Zhang, Zheng; Xu, Peipei; Tang, Shihui; Deng, Qiaoling; Yang, Weiqing; Yu, Mingxia			The prognostic value of abnormally expressed lncRNAs in colorectal cancer: A meta-analysis	PLOS ONE			English	Article							LONG NONCODING RNA; EPITHELIAL-MESENCHYMAL TRANSITION; MOLECULAR PATHOLOGICAL EPIDEMIOLOGY; AFFECTS CELL-PROLIFERATION; PREDICTS POOR-PROGNOSIS; COLON-CANCER; PROMOTES METASTASIS; BREAST-CANCER; BIOMARKER; PROGRESSION	Background Colorectal cancer (CRC) is the third most prevalent cancer type and the third leading cause of cancer-related deaths worldwide, it is urgently needed to discover a new marker for the progress of CRC. Many long noncoding RNAs (lncRNAs) have been reported to be abnormally expressed in CRC, and may be feasible as effective biomarkers and prognostic factors. The aim of this study was to identify the prognostic value of various lncRNAs in CRC. Methods Pubmed, Web of Science, Embase and Cochrane Library were searched for potentially related studies. A total of 34 eligible studies including 30 on overall survival (OS), 7 on disease-free survival (DFS), 1 on relapse-free survival (RFS), 2 on disease-specific survival (DSS) and 29 on clinicopathological features were qualified from the databases. Results The results showed that the expression levels of lncRNAs were significantly associated with poor OS (hazard ratio (HR) = 2.08, 95% confidence interval (CI) = 1.68-2.57, P<0.001, I-2 = 70%), DFS (HR = 1.79, 95% CI = 1.54-2.08, P<0.001, I-2 = 6%) and DSS (HR = 0.11, 95% CI = 0.02-0.54, P = 0.007, I-2 = 14%). Subgroup analysis further showed that lncRNA transcription level was significantly associated with tumor differentiation (odds ratio (OR) = 0.51, 95% CI = 0.34-0.77, P = 0.001), lymph node metastasis (OR = 1.63, 95% CI = 1.23-2.17, P = 0.0007), distant metastasis (OR = 2.06, 95% CI = 1.29-3.30, P = 0.002), TNM stage (OR = 0.44, 95% CI = 0.32-0.62, P<0.001), tumor invasion depth (OR = 0.48, 95% CI = 0.39-0.60, P<0.001). Conclusions The meta-analysis demonstrated that abnormal lncRNA transcription level may serve as a promising indicator for prognostic of patients with CRC.	[Wang, June; Fan, Wei; Wang, Ping; Zhang, Zheng; Xu, Peipei; Tang, Shihui; Deng, Qiaoling; Yu, Mingxia] Wuhan Univ, Zhongnan Hosp, Dept Clin Lab, Wuhan, Peoples R China; [Wang, June; Fan, Wei; Wang, Ping; Zhang, Zheng; Xu, Peipei; Tang, Shihui; Deng, Qiaoling; Yu, Mingxia] Wuhan Univ, Zhongnan Hosp, Ctr Gene Diag, Wuhan, Peoples R China; [Wang, June; Du, Shenlin; Wang, Jiamin; Yang, Weiqing] Guangdong Med Univ, Guangdong Prov Key Lab Med Mol Diagnost, Dongguan, Peoples R China; [Fan, Wei] Wuhan Univ, Zhongnan Hosp, Dept Pathol, Wuhan, Hubei, Peoples R China	Wuhan University; Wuhan University; Guangdong Medical University; Wuhan University	Yu, MX (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Clin Lab, Wuhan, Peoples R China.; Yu, MX (corresponding author), Wuhan Univ, Zhongnan Hosp, Ctr Gene Diag, Wuhan, Peoples R China.	dewrosy520@163.com		Wang, June/0000-0002-9233-0626; Yu, Mingxia/0000-0002-0529-0030; Du, Shenlin/0000-0001-9278-169X	National Natural Science Funds [81472033, 30901308]; National Science Foundation of Hubei Province [2013CFB233, 2013CFB235]; Scientific and technological project of Wuhan City [2014060101010045]; Hubei Province health and family planning scientific research project [WJ2015Q021]; Training Program of the science and technology innovation from Zhongnan Hospital of Wuhan University [cxpy20160054]	National Natural Science Funds(National Natural Science Foundation of China (NSFC)); National Science Foundation of Hubei Province; Scientific and technological project of Wuhan City; Hubei Province health and family planning scientific research project; Training Program of the science and technology innovation from Zhongnan Hospital of Wuhan University	This study was supported by National Natural Science Funds (No. 81472033 and No. 30901308), the National Science Foundation of Hubei Province (No. 2013CFB233 and No. 2013CFB235), the Scientific and technological project of Wuhan City (No. 2014060101010045), Hubei Province health and family planning scientific research project (WJ2015Q021) and Training Program of the science and technology innovation from Zhongnan Hospital of Wuhan University (cxpy20160054). There was no additional external funding received for this study.	Bian ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep23892; Cao D, 2016, ONCOTARGETS THER, V9, P5417, DOI 10.2147/OTT.S111794; Cheetham SW, 2013, BRIT J CANCER, V108, P2419, DOI 10.1038/bjc.2013.233; Chen N, 2016, ONCOTARGET, V7, P11271, DOI 10.18632/oncotarget.7168; Colussi D, 2013, INT J MOL SCI, V14, P16365, DOI 10.3390/ijms140816365; Deng QW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103022; Dickinson BT, 2015, GUT, V64, P1485, DOI 10.1136/gutjnl-2014-308075; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ge XS, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0588-6; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; Guo XB, 2015, INT J CLIN EXP MED, V8, P15591; Han D, 2016, ONCOTARGET, V7, P22159, DOI 10.18632/oncotarget.8063; Han Y., 2014, J ADV SIGNAL PROCESS, V2014, P1, DOI DOI 10.1097/PAT.0000000000000125; Hansji H, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00379; Hashad D, 2016, J CLIN LAB ANAL, V30, P1100, DOI 10.1002/jcla.21987; He XL, 2014, TUMOR BIOL, V35, P12181, DOI 10.1007/s13277-014-2526-4; Huang RY, 2016, CELL PHYSIOL BIOCHEM, V40, P707, DOI 10.1159/000452582; Iguchi T, 2015, ANTICANCER RES, V35, P1385; Jiang H, 2016, INT J CLIN EXP PATHO, V9, P4241; Ke L, 2016, CLIN TRANSL ONCOL; Kocarnik JM, 2015, GASTROENTEROL REP, V3, P269, DOI 10.1093/gastro/gov046; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Kudryavtseva AV, 2016, ONCOTARGET, V7, P53959, DOI 10.18632/oncotarget.9796; Li CH, 2015, CURR GENOMICS, V16, P319, DOI 10.2174/1389202916666150707155851; Li C, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2719-x; Li YL, 2015, ONCOTARGET, V6, P27641, DOI 10.18632/oncotarget.4737; Liu T, 2016, ONCOTARGETS THER, V9, P1437, DOI 10.2147/OTT.S98268; Liu YJ, 2015, J CHEM-NY, V2015, DOI 10.1155/2015/580950; Lu M, 2016, J CANC RES CLIN ONCO; Lu M, 2017, J CANCER RES CLIN, V143, P71, DOI 10.1007/s00432-016-2252-y; Maurel J, 2015, CURR CANCER DRUG TAR, V15, P703, DOI 10.2174/156800961508151001102822; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Ni BB, 2015, INT J ONCOL, V47, P1329, DOI 10.3892/ijo.2015.3109; Ogino S, 2016, EPIDEMIOLOGY, V27, P602, DOI 10.1097/EDE.0000000000000471; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Qi P, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-122; Qiu JJ, 2015, TUMOR BIOL, V36, P7175, DOI 10.1007/s13277-015-3448-5; Ren YK, 2015, INT J CLIN EXP PATHO, V8, P11458; Rupnarain C, 2004, BIOL CHEM, V385, P449, DOI 10.1515/BC.2004.053; Shi DB, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0031-7; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Sun JF, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0786-z; Sun Y, 2016, MOL MED REP, V14, P1714, DOI 10.3892/mmr.2016.5409; Svoboda M, 2014, CARCINOGENESIS, V35, P1510, DOI 10.1093/carcin/bgu055; Takahashi Y, 2014, BRIT J CANCER, V110, P164, DOI 10.1038/bjc.2013.698; Tampe B, 2017, KIDNEY INT, V91, P157, DOI 10.1016/j.kint.2016.07.042; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Wang F, 2016, BIOMED PHARMACOTHER, V81, P152, DOI 10.1016/j.biopha.2016.04.009; Wang WL, 2016, PATHOL RES PRACT, V212, P690, DOI 10.1016/j.prp.2016.05.003; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Wu ZH, 2014, ONCOL REP, V32, P395, DOI 10.3892/or.2014.3186; Ye LC, 2015, TUMOR BIOL, V36, P8747, DOI 10.1007/s13277-015-3627-4; Yin DD, 2015, TUMOR BIOL, V36, P4851, DOI 10.1007/s13277-015-3139-2; Yin DD, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0253-8; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370; Zheng HT, 2014, INT J CLIN EXP PATHO, V7, P3174; Zhou M, 2016, BIOMEDICINE PHARMACO	58	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179670	10.1371/journal.pone.0179670	http://dx.doi.org/10.1371/journal.pone.0179670			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658310	Green Published, Green Submitted, gold			2022-12-27	WOS:000404607900037
J	Wong, YQ; Tan, LK; Seow, P; Tan, MP; Abd Kadir, KA; Vijayananthan, A; Ramli, N				Wong, Yoke Queen; Tan, Li Kuo; Seow, Pohchoo; Tan, Maw Pin; Abd Kadir, Khairul Azmi; Vijayananthan, Anushya; Ramli, Norlisah			Microstructural integrity of white matter tracts amongst older fallers: A DTI study	PLOS ONE			English	Article							SMALL-VESSEL DISEASE; PARKINSONS-DISEASE; MULTIPLE-SCLEROSIS; BLOOD-PRESSURE; GAIT; AGE; BRAIN; HYPERINTENSITIES; ABNORMALITIES; DISORDERS	Objectives This study assesses the whole brain microstructural integrity of white matter tracts (WMT) among older individuals with a history of falls compared to non-fallers. Methods 85 participants (43 fallers, 42 non-fallers) were evaluated with conventional MRI and diffusion tensor imaging (DTI) sequences of the brain. DTI metrics were obtained from selected WMT using tract-based spatial statistics (TBSS) method. This was followed by binary logistic regression to investigate the clinical variables that could act as confounding elements on the outcomes. The TBSS analysis was then repeated, but this time including all significant predictor variables from the regression analysis as TBSS covariates. Results The mean diffusivity (MD) and axial diffusivity (AD) and to a lesser extent radial diffusivity (RD) values of the projection fibers and commissural bundles were significantly different in fallers (p < 0.05) compared to non-fallers. However, the final logistic regression model obtained showed that only functional reach, white matter lesion volume, hypertension and orthostatic hypotension demonstrated statistical significant differences between fallers and non-fallers. No significant differences were found in the DTI metrics when taking into account age and the four variables as covariates in the repeated analysis. Conclusion This DTI study of 85 subjects, do not support DTI metrics as a singular factor that contributes independently to the fall outcomes. Other clinical and imaging factors have to be taken into account.	[Wong, Yoke Queen; Tan, Li Kuo; Seow, Pohchoo; Abd Kadir, Khairul Azmi; Vijayananthan, Anushya; Ramli, Norlisah] Univ Malaya, Res Imaging Ctr, Dept Biomed Imaging, Fac Med, Kuala Lumpur, Malaysia; [Wong, Yoke Queen] Hosp Selayang, Dept Diagnost Imaging, Batu Caves, Selangor, Malaysia; [Tan, Maw Pin] Univ Malaya, Med Ctr, Dept Geriatr Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Ramli, N (corresponding author), Univ Malaya, Res Imaging Ctr, Dept Biomed Imaging, Fac Med, Kuala Lumpur, Malaysia.	norlisahramli@gmail.com	RAMLI, NORLISAH MOHD/G-5209-2010; Vijayananthan, Anushya/C-8025-2014; Seow, Pohchoo/AAP-6940-2020; ABD KADIR, KHAIRUL AZMI/AAC-7007-2022; Tan, Li Kuo/B-5494-2010; Tan, Maw Pin/G-6917-2011	RAMLI, NORLISAH MOHD/0000-0001-7497-8093; Vijayananthan, Anushya/0000-0001-6341-329X; Tan, Li Kuo/0000-0002-6912-172X; Tan, Maw Pin/0000-0002-3400-8540	UNIVERSITY OF MALAYARESEARCH GRANT (UMRG) [RP008A-13HTM]	UNIVERSITY OF MALAYARESEARCH GRANT (UMRG)	This study was made possible with financial assistance from the UNIVERSITY OF MALAYARESEARCH GRANT (UMRG), grant reference number RP008A-13HTM. The URLs of the funders: https://umresearch.um.edu.my/ download/research-grants/internal-grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Alves GS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/291658; Ambrose AF, 2013, MATURITAS, V75, P51, DOI 10.1016/j.maturitas.2013.02.009; Axer H, 2010, CLIN NEUROL NEUROSUR, V112, P265, DOI 10.1016/j.clineuro.2009.12.015; Baezner H, 2008, NEUROLOGY, V70, P935, DOI 10.1212/01.wnl.0000305959.46197.e6; Ballard C, 2000, ANN NY ACAD SCI, V903, P442, DOI 10.1111/j.1749-6632.2000.tb06396.x; Basile AM, 2006, CEREBROVASC DIS, V21, P315, DOI 10.1159/000091536; Bhadelia RA, 2009, STROKE, V40, P3816, DOI 10.1161/STROKEAHA.109.564765; Blahak C, 2009, J NEUROL NEUROSUR PS, V80, P608, DOI 10.1136/jnnp.2008.154633; Bloem BR, 2003, CURR OPIN NEUROL, V16, P15, DOI 10.1097/00019052-200302000-00003; Bruijn SM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00104; Chan LL, 2014, PARKINSONISM RELAT D, V20, P53, DOI 10.1016/j.parkreldis.2013.09.017; Colloby SJ, 2011, BRIT J PSYCHIAT, V199, P404, DOI 10.1192/bjp.bp.110.090423; de Laat KF, 2011, STROKE, V42, P373, DOI 10.1161/STROKEAHA.110.596502; de Laat KF, 2011, BRAIN, V134, P73, DOI 10.1093/brain/awq343; Englander F, 1996, J FORENSIC SCI, V41, P733; Gaser's C., STRUCT BRAIN MAPP GR; Griebe M, 2011, J NEUROL, V258, P1451, DOI 10.1007/s00415-011-5956-6; Hasan KM, 2008, MAGN RESON MED, V59, P7, DOI 10.1002/mrm.21434; Iseki Kazumi, 2015, J Clin Mov Disord, V2, P1, DOI 10.1186/s40734-014-0011-2; Kafri M, 2012, J NEUROIMAGING, P39; Koo BB, 2012, ARCH NEUROL-CHICAGO, V69, P733, DOI 10.1001/archneurol.2011.2272; Lee SJ, 2009, ARCH GERONTOL GERIAT, V49, P255, DOI 10.1016/j.archger.2008.09.005; Lesion Segmentation Toolbox (LST), STRUCT BRAIN MAPP GR; Lord SR, 2007, FALLS IN OLDER PEOPLE: RISK FACTORS AND STRATEGIES FOR PREVENTION, 2ND EDITION, P1, DOI 10.1017/CBO9780511722233; Maldjian JA, 2013, AM J NEURORADIOL, V34, P2265, DOI 10.3174/ajnr.A3590; Metwalli NS, 2010, BRAIN RES, V1348, P156, DOI 10.1016/j.brainres.2010.05.067; Nucifora PGP, 2007, RADIOLOGY, V245, P367, DOI 10.1148/radiol.2452060445; Oh YS, 2013, J MOV DISORD, V6, P23, DOI 10.14802/jmd.13006; Pantoni L, 2002, CEREBROVASC DIS, V13, P7, DOI 10.1159/000049143; Prins ND, 2005, BRAIN, V128, P2034, DOI 10.1093/brain/awh553; Roosendaal SD, 2009, NEUROIMAGE, V44, P1397, DOI 10.1016/j.neuroimage.2008.10.026; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; Sexton CE, 2014, J NEUROSCI, V34, P15425, DOI 10.1523/JNEUROSCI.0203-14.2014; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Tan MP, 2016, GERIATR GERONTOL INT, V16, P111, DOI 10.1111/ggi.12446; Tan PJ, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-78; TBSS, FMRIB SOFTW LIB V5 0; Veeramuthu V, 2015, J NEUROTRAUM, V13, P1; Vercruysse S, 2015, MOVEMENT DISORD, V30, P567, DOI 10.1002/mds.26130; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Zia A, 2015, POSTGRAD MED, V127, P186, DOI 10.1080/00325481.2015.996505	42	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179895	10.1371/journal.pone.0179895	http://dx.doi.org/10.1371/journal.pone.0179895			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658309	gold, Green Published, Green Submitted			2022-12-27	WOS:000404607900046
J	Wu, MY; Mead, ME; Kim, SC; Rokas, A; Yu, JH				Wu, Ming-Yueh; Mead, Matthew E.; Kim, Sun-Chang; Rokas, Antonis; Yu, Jae-Hyuk			WetA bridges cellular and chemical development in Aspergillus flavus	PLOS ONE			English	Article							ASEXUAL SPORULATION; GENE ONTOLOGY; SECONDARY METABOLISM; PROTEIN FAMILIES; DISTINCT STAGES; BLUE-LIGHT; NIDULANS; ABAA; BRLA; CONIDIOGENESIS	Bridging cellular reproduction and survival is essential for all life forms. Aspergillus fungi primarily reproduce by forming asexual spores called conidia, whose formation and maturation is governed by the central genetic regulatory circuit BrlA -> AbaA -> WetA. Here, we report that WetA is a multi-functional regulator that couples spore differentiation and survival, and governs proper chemical development in Aspergillus flavus. The deletion of wetA results in the formation of conidia with defective cell walls and no intra-cellular trehalose, leading to reduced stress tolerance, a rapid loss of viability, and disintegration of spores. WetA is also required for normal vegetative growth, hyphal branching, and production of aflatoxins. Targeted and genome-wide expression analyses reveal that WetA exerts feedback control of brlA and that 5,700 genes show altered mRNA levels in the mutant conidia. Functional category analyses of differentially expressed genes in Delta wetA RNA-seq data indicate that WetA contributes to spore integrity and maturity by properly regulating the metabolic pathways of trehalose, chitin, alpha-(1,3)-glucan, beta-(1,3)-glucan, melanin, hydrophobins, and secondary metabolism more generally. Moreover, 160 genes predicted to encode transcription factors are differentially expressed by the absence of wetA, suggesting that WetA may play a global regulatory role in conidial development. Collectively, we present a comprehensive model for developmental control that bridges spore differentiation and survival in A. flavus.	[Wu, Ming-Yueh; Yu, Jae-Hyuk] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Wu, Ming-Yueh; Yu, Jae-Hyuk] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Mead, Matthew E.; Rokas, Antonis] Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Kim, Sun-Chang] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejon, South Korea	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Vanderbilt University; Korea Advanced Institute of Science & Technology (KAIST)	Yu, JH (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.; Yu, JH (corresponding author), Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.	jyu1@wisc.edu	Kim, Sun Chang/C-2026-2011; Kim, Sun/GSN-4867-2022; Rokas, Antonis/A-9775-2008; Wu, Ming-Yueh/J-7199-2019; Yu, Jae-Hyuk/A-2343-2008	Rokas, Antonis/0000-0002-7248-6551; Wu, Ming-Yueh/0000-0002-2479-3709; Yu, Jae-Hyuk/0000-0002-6530-8407; Mead, Matthew/0000-0001-9195-7585	Hatch [WIS01665, WIS01889]; Intelligent Synthetic Biology Center of Global Frontier Projects [2015M3A6A8065838]	Hatch(United States Department of Agriculture (USDA)); Intelligent Synthetic Biology Center of Global Frontier Projects	This work was supported by Hatch (WIS01665 and WIS01889) to JHY and the Intelligent Synthetic Biology Center of Global Frontier Projects (2015M3A6A8065838) to SCK and JHY. The sponsors or funders did not play any role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	ADAMS TH, 1988, CELL, V54, P353, DOI 10.1016/0092-8674(88)90198-5; Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; ADRIANOPOULOS A, 1991, PLANT CELL, V3, P747, DOI 10.1105/tpc.3.8.747; Affeldt KJ, 2014, MBIO, V5, DOI 10.1128/mBio.01501-14; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrews S., 2010, FASTQC QUALITY CONTR; ANDRIANOPOULOS A, 1994, MOL CELL BIOL, V14, P2503, DOI 10.1128/MCB.14.4.2503; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bieszke JA, 1999, P NATL ACAD SCI USA, V96, P8034, DOI 10.1073/pnas.96.14.8034; Bieszke JA, 2007, CURR GENET, V52, P149, DOI 10.1007/s00294-007-0148-8; Blumenstein A, 2005, CURR BIOL, V15, P1833, DOI 10.1016/j.cub.2005.08.061; BOYLAN MT, 1987, MOL CELL BIOL, V7, P3113, DOI 10.1128/MCB.7.9.3113; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; CHANG YC, 1993, GENETICS, V133, P29; CLUTTERBUCK AJ, 1969, GENETICS, V63, P317; Desjardins CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002345; Ebbole DJ, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P577; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Erwig LP, 2016, NAT REV MICROBIOL, V14, P163, DOI 10.1038/nrmicro.2015.21; Grice CM, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00026; Han KH, 2004, MOL MICROBIOL, V53, P529, DOI 10.1111/j.1365-2958.2004.04163.x; Hedayati MT, 2007, MICROBIOL-SGM, V153, P1677, DOI 10.1099/mic.0.2007/007641-0; Hicks JK, 1997, EMBO J, V16, P4916, DOI 10.1093/emboj/16.16.4916; Inglis DO, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-91; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kensler TW, 2011, TOXICOL SCI, V120, pS28, DOI 10.1093/toxsci/kfq283; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klich MA, 1988, LAB GUIDE COMMON ASP; Li F, 2015, APPL MICROBIOL BIOT, V99, P827, DOI 10.1007/s00253-014-6124-6; Li L, 2007, ANNU REV MICROBIOL, V61, P423, DOI 10.1146/annurev.micro.61.080706.093432; LILLEHOJ EB, 1967, EXPERIENTIA, V23, P187, DOI 10.1007/BF02136277; Lind AL, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005096; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; MARSHALL MA, 1991, MOL CELL BIOL, V11, P55, DOI 10.1128/MCB.11.1.55; MARTINELLI SD, 1971, J GEN MICROBIOL, V69, P261, DOI 10.1099/00221287-69-2-261; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; MIRABITO PM, 1989, CELL, V57, P859, DOI 10.1016/0092-8674(89)90800-3; Nguyen BA, 2009, BMC BIOINFORMATICS, V10, P202, DOI [10.1186/1471-2105-10-202, DOI 10.1186/1471-2105-10-202]; Ni M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000970; Ogawa M, 2010, FUNGAL GENET BIOL, V47, P10, DOI 10.1016/j.fgb.2009.10.004; Park HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032847, 10.1371/journal.pone.0039921]; Park HS, 2015, SCI REP-UK, V5, DOI 10.1038/srep10199; Payne G.A., 1998, MYCOTOXINS AGR FOOD, P279; Piskacek S, 2007, GENOMICS, V89, P756, DOI 10.1016/j.ygeno.2007.02.003; PRADE RA, 1994, MOL GEN GENET, V244, P539, DOI 10.1007/BF00583905; Purschwitz J, 2008, CURR BIOL, V18, P255, DOI 10.1016/j.cub.2008.01.061; Rodriguez-Romero J, 2010, ANNU REV MICROBIOL, V64, P585, DOI 10.1146/annurev.micro.112408.134000; Seo JA, 2003, GENETICS, V165, P1083; SEWALL TC, 1990, DEV BIOL, V138, P499, DOI 10.1016/0012-1606(90)90215-5; SEWALL TC, 1994, CAN J MICROBIOL, V40, P1035, DOI 10.1139/m94-164; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shin KS, 2015, BIOCHEM BIOPH RES CO, V463, P428, DOI 10.1016/j.bbrc.2015.05.090; Son H, 2014, EUKARYOT CELL, V13, P87, DOI 10.1128/EC.00220-13; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Tao L, 2011, MICROBIOL-SGM, V157, P313, DOI 10.1099/mic.0.044271-0; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; TIMBERLAKE WE, 1993, PLANT CELL, V5, P1453; TIMBERLAKE WE, 1987, A VAN LEEUW J MICROB, V53, P317, DOI 10.1007/BF00400554; TIMBERLAKE WE, 1990, ANNU REV GENET, V24, P5, DOI 10.1146/annurev.ge.24.120190.000253; Udomkun P, 2017, FOOD CONTROL, V76, P127, DOI 10.1016/j.foodcont.2017.01.008; Wang MS, 2015, RES MICROBIOL, V166, P56, DOI 10.1016/j.resmic.2014.12.003; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yu JH, 2005, ANNU REV PHYTOPATHOL, V43, P437, DOI 10.1146/annurev.phyto.43.040204.140214; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001	68	26	27	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179571	10.1371/journal.pone.0179571	http://dx.doi.org/10.1371/journal.pone.0179571			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658268	gold, Green Submitted, Green Published			2022-12-27	WOS:000404607900032
J	Mandage, R; Telford, M; Rodriguez, JA; Farre, X; Layouni, H; Marigorta, UM; Cundiff, C; Heredia-Genestar, JM; Navarro, A; Santpere, G				Mandage, Rajendra; Telford, Marco; Antonio Rodriguez, Juan; Farre, Xavier; Layouni, Hafid; Marigorta, Urko M.; Cundiff, Caitlin; Maria Heredia-Genestar, Jose; Navarro, Arcadi; Santpere, Gabriel			Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; MULTIPLE-SCLEROSIS; DICKKOPF FAMILY; RISK-FACTORS; ASSOCIATION; DNA; SUSCEPTIBILITY; VISUALIZATION; DETERMINANTS; NEUREGULIN-1	Epstein-Barr virus (EBV), human herpes virus 4, has been classically associated with infectious mononucleosis, multiple sclerosis and several types of cancers. Many of these diseases show marked geographical differences in prevalence, which points to underlying genetic and/or environmental factors. Those factors may include a different susceptibility to EBV infection and viral copy number among human populations. Since EBV is commonly used to transform B-cells into lymphoblastoid cell lines (LCLs) we hypothesize that differences in EBV copy number among individual LCLs may reflect differential susceptibility to EBV infection. To test this hypothesis, we retrieved whole-genome sequenced EBV-mapping reads from 1,753 LCL samples derived from 19 populations worldwide that were sequenced within the context of the 1000 Genomes Project. An in silico methodology was developed to estimate the number of EBV copy number in LCLs and validated these estimations by real-time PCR. After experimentally confirming that EBV relative copy number remains stable over cell passages, we performed a genome wide association analysis (GWAS) to try detecting genetic variants of the host that may be associated with EBV copy number. Our GWAS has yielded several genomic regions suggestively associated with the number of EBV genomes per cell in LCLs, unraveling promising candidate genes such as CAND1, a known inhibitor of EBV replication. While this GWAS does not unequivocally establish the degree to which genetic makeup of individuals determine viral levels within their derived LCLs, for which a larger sample size will be needed, it potentially highlighted human genes affecting EBV-related processes, which constitute interesting candidates to follow up in the context of EBV related pathologies.	[Mandage, Rajendra; Telford, Marco; Antonio Rodriguez, Juan; Farre, Xavier; Layouni, Hafid; Marigorta, Urko M.; Maria Heredia-Genestar, Jose; Navarro, Arcadi; Santpere, Gabriel] Univ Pompeu Fabra, PRBB, Dept Ciencies Expt & Salut, Inst Evolutionary Biol UPF CSIC, Barcelona, Catalonia, Spain; [Layouni, Hafid] ESCI UPF, Bioinformat Studies, Pg Pujades 1, Barcelona, Spain; [Marigorta, Urko M.; Cundiff, Caitlin] Georgia Inst Technol, Dept Biol, Atlanta, GA 30332 USA; [Navarro, Arcadi] Natl Inst Bioinformat INB, PRBB, Barcelona, Catalonia, Spain; [Navarro, Arcadi] ICREA, PRBB, Barcelona, Catalonia, Spain; [Navarro, Arcadi] CRG, PRBB, Barcelona, Catalonia, Spain; [Santpere, Gabriel] Yale Sch Med, Dept Neurosci, New Haven, CT 06510 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; University System of Georgia; Georgia Institute of Technology; Pompeu Fabra University; ICREA; Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Yale University	Navarro, A; Santpere, G (corresponding author), Univ Pompeu Fabra, PRBB, Dept Ciencies Expt & Salut, Inst Evolutionary Biol UPF CSIC, Barcelona, Catalonia, Spain.; Navarro, A (corresponding author), Natl Inst Bioinformat INB, PRBB, Barcelona, Catalonia, Spain.; Navarro, A (corresponding author), ICREA, PRBB, Barcelona, Catalonia, Spain.; Navarro, A (corresponding author), CRG, PRBB, Barcelona, Catalonia, Spain.; Santpere, G (corresponding author), Yale Sch Med, Dept Neurosci, New Haven, CT 06510 USA.	arcadi.navarro@upf.edu; gabrielsantperebaro@gmail.com	Ramon, Xavier Farre/AAH-7226-2019; Santpere, Gabriel/I-9437-2014; Rodriguez, Juan Antonio/GQP-1484-2022; Marigorta, Urko M/L-9512-2014	Santpere, Gabriel/0000-0001-5909-8637; Rodriguez, Juan Antonio/0000-0001-5195-315X; Farre Ramon, Xavier/0000-0001-6838-9479; Marigorta, Urko M/0000-0002-9087-6609; Heredia-Genestar, Jose Maria/0000-0002-7970-5016	Institute de Salud Carlos III [RD07/0060, F13/0001/0026]; Spanish Government [BFU2012-38236]; Departament d'Innovacio, Universitats I Empresa, Generalitat de Catalunya [2014SGR1311]; FEDER (Fondo Europeo de Desarrollo Regional)/FSE (Fondo Social Europeo)	Institute de Salud Carlos III(Instituto de Salud Carlos III); Spanish Government(Spanish GovernmentEuropean Commission); Departament d'Innovacio, Universitats I Empresa, Generalitat de Catalunya(Generalitat de Catalunya); FEDER (Fondo Europeo de Desarrollo Regional)/FSE (Fondo Social Europeo)	This work was supported by Institute de Salud Carlos III (ES) (RD07/0060); Spanish Government Grants (BFU2012-38236); Departament d'Innovacio, Universitats I Empresa, Generalitat de Catalunya (2014SGR1311); Institute de Salud Carlos III (F13/0001/0026); FEDER (Fondo Europeo de Desarrollo Regional)/FSE (Fondo Social Europeo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ascherio A, 2007, ANN NEUROL, V61, P504, DOI 10.1002/ana.21141; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Caliskan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107166; Carter CJ, 2012, IMMUNOPHARM IMMUNOT, V34, P21, DOI 10.3109/08923973.2011.572262; Chang CM, 2009, VIRUS RES, V143, P209, DOI 10.1016/j.virusres.2009.07.005; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Gastaldello S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003664; Gastaldello S, 2012, J MOL CELL BIOL, V4, P242, DOI 10.1093/jmcb/mjs012; Gastaldello S, 2010, NAT CELL BIOL, V12, P351, DOI 10.1038/ncb2035; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gulbahce N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002531; Hirata H, 2009, CLIN CANCER RES, V15, P5678, DOI 10.1158/1078-0432.CCR-09-0558; Hjalgrim H., 2007, EPIDEMIOLOGY EBV ITS; Hohaus S, 2011, CLIN CANCER RES, V17, P2885, DOI 10.1158/1078-0432.CCR-10-3327; Houldcroft CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108384; Houldcroft CJ, 2014, REV MED VIROLOGY; Hu N, GENOMIC LANDSCAPE SO, DOI [10.1158/0008-5472.CAN-15-0338, DOI 10.1158/0008-5472.CAN-15-0338]; Huber C, 2008, J BIOL CHEM, V283, P34002, DOI 10.1074/jbc.M803957200; Jarrett RF, 2003, LEUKEMIA LYMPHOMA, V44, pS27, DOI 10.1080/10428190310001623801; Jha HC, 2016, PATHOGENS, P5; Kanakry JA, 2013, BLOOD, V121, P3547, DOI 10.1182/blood-2012-09-454694; Khan G, 1996, IMMUNITY, V5, P173, DOI 10.1016/S1074-7613(00)80493-8; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Korzeniewski N, 2012, NEOPLASIA, V14, P799, DOI 10.1593/neo.12580; Kraus DM, 2006, J IMMUNOL, V176, P4419, DOI 10.4049/jimmunol.176.7.4419; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu HP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002690; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Mao BY, 2003, GENE, V302, P179, DOI 10.1016/S0378-1119(02)01106-X; Maurmann S, 2003, J CLIN MICROBIOL, V41, P5419, DOI 10.1128/JCM.41.12.5419-5428.2003; Mishra A, 2014, TWIN RES HUM GENET, V18, P1; Morris MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep19533; Neparidze Natalia, 2014, Clin Adv Hematol Oncol, V12, P358; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Perry JJP, 2015, CELL REP, V10, P1288, DOI 10.1016/j.celrep.2015.01.054; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Polakis P, 2000, GENE DEV, V14, P1837; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Rezk SA, 2007, HUM PATHOL, V38, P1293, DOI 10.1016/j.humpath.2007.05.020; Rubicz R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003147; Santpere G, 2014, GENOME BIOL EVOL, V6, P846, DOI 10.1093/gbe/evu054; Sato H, 2007, CARCINOGENESIS, V28, P2459, DOI 10.1093/carcin/bgm178; Shackelford J, 2003, P NATL ACAD SCI USA, V100, P15572, DOI 10.1073/pnas.2636947100; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Tugizov SM, 2003, NAT MED, V9, P307, DOI 10.1038/nm830; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van Gent M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003960; Visscher PM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004269; Wang T, 2010, BIOCH BIOPHYSICAL RE; Xiao JQ, 2008, VIROLOGY, V370, P430, DOI 10.1016/j.virol.2007.09.012; Xueling GE, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-33; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JZ, 2003, MOL PSYCHIATR, V8, P706, DOI 10.1038/sj.mp.4001377; Yap LF, 2014, INT J ONCOL, V44, P1774, DOI 10.3892/ijo.2014.2342; Yuan Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep07960; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Zhu J, 2012, CARCINOGENESIS, V33, P2334, DOI 10.1093/carcin/bgs278	64	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179446	10.1371/journal.pone.0179446	http://dx.doi.org/10.1371/journal.pone.0179446			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654678	Green Published, Green Submitted, gold			2022-12-27	WOS:000404541500013
J	Sakai, T; Mikami, A; Suzuki, J; Miyabe-Nishiwaki, T; Matsui, M; Tomonaga, M; Hamada, Y; Matsuzawa, T; Okano, H; Oishi, K				Sakai, Tomoko; Mikami, Akichika; Suzuki, Juri; Miyabe-Nishiwaki, Takako; Matsui, Mie; Tomonaga, Masaki; Hamada, Yuzuru; Matsuzawa, Tetsuro; Okano, Hideyuki; Oishi, Kenichi			Developmental trajectory of the corpus callosum from infancy to the juvenile stage: Comparative MRI between chimpanzees and humans	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; WHITE-MATTER; BRAIN-DEVELOPMENT; PAN-TROGLODYTES; RHESUS-MONKEY; LIFE-SPAN; NEUROBIOLOGICAL MECHANISMS; SEXUAL-DIMORPHISM; FIBER COMPOSITION; LONGITUDINAL MRI	How brains develop during early life is one of the most important topics in neuroscience because it underpins the neuronal functions that mature during this period. A comparison of the neurodevelopmental patterns among humans and nonhuman primates is essential to infer evolutional changes in neuroanatomy that account for higher-order brain functions, especially those specific to humans. The corpus callosum (CC) is the major white matter bundle that connects the cerebral hemispheres, and therefore, relates to a wide variety of neuronal functions. In humans, the CC area rapidly expands during infancy, followed by relatively slow changes. In chimpanzees, based on a cross-sectional study, slow changes in the CC area during the juvenile stage and later have also been reported. However, little is known about the developmental changes during infancy. A longitudinal study is also required to validate the previous cross-sectional observations about the chimpanzee CC. The present longitudinal study of magnetic resonance imaging scans demonstrates that the CC development in chimpanzees and humans is characterized by a rapid increase during infancy, followed by gradual increase during the juvenile stage. Several differences between the two species were also identified. First, there was a tendency toward a greater increase in the CC areas during infancy in humans. Second, there was a tendency toward a greater increase in the rostrum during the juvenile stage in chimpanzees. The rostral body is known to carry fibers between the bilateral prefrontal and premotor cortices, and is involved in behavior planning and control, verbal working memory, and number conception. The rostrum is known to carry fibers between the prefrontal cortices, and is involved in attention control. The interspecies differences in the developmental trajectories of the rostral body and the rostrum might be related to evolutional changes in the brain systems.	[Sakai, Tomoko; Oishi, Kenichi] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA; [Sakai, Tomoko; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo, Japan; [Sakai, Tomoko; Mikami, Akichika; Suzuki, Juri; Miyabe-Nishiwaki, Takako; Tomonaga, Masaki; Hamada, Yuzuru; Matsuzawa, Tetsuro] Kyoto Univ, Primate Res Inst, Inuyama, Aichi, Japan; [Sakai, Tomoko] Japan Soc Promot Sci, Tokyo, Japan; [Mikami, Akichika] Chubu Gakuin Univ, Fac Nursing & Rehabil, Seki, Japan; [Matsui, Mie] Kanazawa Univ, Inst Liberal Arts & Sci, Dept Cognit Sci, Kanazawa, Ishikawa, Japan; [Matsui, Mie] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Dept Psychol, Toyama, Japan; [Okano, Hideyuki] RIKEN, Brain Sci Inst, Lab Marmoset Neural Architecture, Wako, Saitama, Japan	Johns Hopkins University; Keio University; Kyoto University; Japan Society for the Promotion of Science; Kanazawa University; University of Toyama; RIKEN	Sakai, T (corresponding author), Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA.; Sakai, T (corresponding author), Keio Univ, Sch Med, Dept Physiol, Tokyo, Japan.; Sakai, T (corresponding author), Kyoto Univ, Primate Res Inst, Inuyama, Aichi, Japan.; Sakai, T (corresponding author), Japan Soc Promot Sci, Tokyo, Japan.	sakai.tomoko.5w@gmail.com	Matsuzawa, Tetsuro/ABE-9654-2021; Okano, Hideyuki/X-9131-2019; Okano, Hideyuki/I-7584-2019; Oishi, Kenichi/H-1371-2013	Matsuzawa, Tetsuro/0000-0002-8147-2725; Okano, Hideyuki/0000-0001-7482-5935; Oishi, Kenichi/0000-0002-1200-8611	JSPS [213916, 490]; JSPS KAKENHI [26870827, 26590143]; MEXT KAKENHI [16002001, 20002001, 2400001]; MEXT Comprehensive Brain Science Grant; Brain/MINDS; National Center for Research Resources of the National Institutes of Health; National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health; statistician of the Johns Hopkins Biostatistics Center	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT Comprehensive Brain Science Grant; Brain/MINDS; National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); statistician of the Johns Hopkins Biostatistics Center	This study was supported by JSPS Research Fellowships for Young Scientists, 213916, to PhD Tomoko Sakai; JSPS KAKENHI Grant for Young Scientists (B), 26870827, to PhD Tomoko Sakai; JSPS Postdoctoral Fellowships for Research Abroad, 490, to PhD Tomoko Sakai; MEXT KAKENHI Grant, 16002001, 20002001, 2400001, to Prof PhD Tetsuro Matsuzawa; JSPS KAKENHI Grant for Exploratory Research, 26590143, to Prof, PhD Mie Matsui; MEXT Comprehensive Brain Science Grant, and Brain/MINDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank T. Nishimura, A. Watanabe, A. Kaneko, S. Goto, S. Watanabe, K. Kumazaki, N. Maeda, M. Tanaka, M. Hayashi, T. Imura, and K. Matsubayashi for assisting with the care of chimpanzees during scanning. We also thank the personnel at the Centre for Human Evolution Modelling Research at KUPRI for daily care of the chimpanzees. We also thank S. Mori for helpful comments, and M. McAllister for help with manuscript editing. We would like to acknowledge partial support for the statistical analysis from the National Center for Research Resources and the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health, and the statistician of the Johns Hopkins Biostatistics Center, A. Sanyal and C. Thompson.	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Akaike H., 1973, 2 INT S INF THEOR AC; ALLEN LS, 1991, J NEUROSCI, V11, P933; Banich M. T., 2003, PARALLEL BRAIN COGNI, P267; Baumgardner TL, 1996, NEUROLOGY, V47, P477, DOI 10.1212/WNL.47.2.477; CLARKE S, 1989, J COMP NEUROL, V280, P213, DOI 10.1002/cne.902800205; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Connolly JD, 2000, J NEUROPHYSIOL, V84, P1645, DOI 10.1152/jn.2000.84.3.1645; Deacon W. T., 1997, SYMBOLIC SPECIES COE; DELACOSTE MC, 1985, J NEUROPATH EXP NEUR, V44, P578, DOI 10.1097/00005072-198511000-00004; Evangelou N, 2000, BRAIN, V123, P1845, DOI 10.1093/brain/123.9.1845; Faria AV, 2010, NEUROIMAGE, V52, P415, DOI 10.1016/j.neuroimage.2010.04.238; Finlay BL, 2013, TRENDS COGN SCI, V17, P199, DOI 10.1016/j.tics.2013.03.001; Fjell AM, 2010, NEUROIMAGE, V50, P1376, DOI 10.1016/j.neuroimage.2010.01.061; Gao W, 2009, P NATL ACAD SCI USA, V106, P6790, DOI 10.1073/pnas.0811221106; Garel C, 2011, AM J NEURORADIOL, V32, P1436, DOI 10.3174/ajnr.A2542; GIEDD JN, 1994, AM J PSYCHIAT, V151, P665; Giedd JN, 1999, PROG NEURO-PSYCHOPH, V23, P571; HAINLINE L, 1984, VISION RES, V24, P1771, DOI 10.1016/0042-6989(84)90008-7; Hamada Y, 1996, PRIMATES, V37, P279, DOI 10.1007/BF02381860; Hasan KM, 2008, BRAIN RES, V1227, P52, DOI 10.1016/j.brainres.2008.06.030; Highley JR, 1999, BRAIN, V122, P99, DOI 10.1093/brain/122.1.99; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Hopkins WD, 2010, DEV PSYCHOBIOL, V52, P133, DOI 10.1002/dev.20421; Horton JE, 2004, BRAIN, V127, P1741, DOI 10.1093/brain/awh196; Huppi PS, 1998, ANN NEUROL, V43, P224, DOI 10.1002/ana.410430213; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Kaiser J, 2015, SCIENCE, V350, P1013, DOI 10.1126/science.350.6264.1013; Kaiser J, 2013, SCIENCE, V341, P17, DOI 10.1126/science.341.6141.17; Kano F, 2009, P ROY SOC LOND B BIO; Kappers CUA, 1936, COMP ANATOMY NERVOUS; Karatekin C, 2007, DEV REV, V27, P283, DOI 10.1016/j.dr.2007.06.006; Keshavan MS, 2002, LIFE SCI, V70, P1909, DOI 10.1016/S0024-3205(02)01492-3; Klein RG, 2000, EVOL ANTHROPOL, V9, P17, DOI 10.1002/(SICI)1520-6505(2000)9:1<17::AID-EVAN3>3.0.CO;2-A; Krogsrud SK, 2016, NEUROIMAGE, V124, P473, DOI 10.1016/j.neuroimage.2015.09.017; KUYKENDALL KL, 1992, AM J PHYS ANTHROPOL, V89, P379, DOI 10.1002/ajpa.1330890310; LAMANTIA AS, 1990, J NEUROSCI, V10, P2156; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lebel C, 2010, NEUROIMAGE, V52, P20, DOI 10.1016/j.neuroimage.2010.03.072; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Lieberman DE, 2002, P NATL ACAD SCI USA, V99, P1134, DOI 10.1073/pnas.022440799; Liu CR, 2015, NEUROIMAGE, V107, P65, DOI 10.1016/j.neuroimage.2014.11.056; LOVEJOY CO, 1981, SCIENCE, V211, P341, DOI 10.1126/science.211.4480.341; MATSUZAKA Y, 1992, J NEUROPHYSIOL, V68, P653, DOI 10.1152/jn.1992.68.3.653; Matsuzawa J, 2001, CEREB CORTEX, V11, P335, DOI 10.1093/cercor/11.4.335; Matsuzawa T, 2007, DEVELOPMENTAL SCI, V10, P97, DOI 10.1111/j.1467-7687.2007.00570.x; McNally MA, 2010, J CHILD NEUROL, V25, P453, DOI 10.1177/0883073809350221; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nosarti C, 2004, BRAIN, V127, P2080, DOI 10.1093/brain/awh230; Ochiai T, 1997, P 3 INT C ENV ENR SH; Pandya D.N, 1986, TOPOGRAPHY COMMISSUR; PANDYA DN, 1971, BRAIN RES, V32, P31, DOI 10.1016/0006-8993(71)90153-3; Park HJ, 2008, HUM BRAIN MAPP, V29, P503, DOI 10.1002/hbm.20314; Phillips KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031941; Picton TW, 2007, CEREB CORTEX, V17, P826, DOI 10.1093/cercor/bhk031; Plant TM, 2004, HUM REPROD UPDATE, V10, P67, DOI 10.1093/humupd/dmh001; PLANT TM, 1988, NEUROENDOCRINE BASIS; Plant TM, 1994, PUBERTY IN PRIMATES; Prendergast DM, 2015, HUM BRAIN MAPP, V36, P2691, DOI 10.1002/hbm.22800; PUJOL J, 1993, ANN NEUROL, V34, P71, DOI 10.1002/ana.410340113; RAKIC P, 1968, J COMP NEUROL, V132, P45, DOI 10.1002/cne.901320103; Ramaekers G., 1991, EMBRYOLOGY ANATOMY C, P24; RAPOPORT SI, 1990, BRAIN RES REV, V15, P267, DOI 10.1016/0165-0173(90)90004-8; Rilling JK, 2012, SOC COGN AFFECT NEUR, V7, P369, DOI 10.1093/scan/nsr017; Rueckert L, 1996, NEUROPSYCHOLOGIA, V34, P953, DOI 10.1016/0028-3932(96)00016-4; Sakai T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2398; Sakai T, 2012, CURR BIOL, V22, pR791, DOI 10.1016/j.cub.2012.06.062; Sakai T, 2011, CURR BIOL, V21, P1397, DOI 10.1016/j.cub.2011.07.019; Sherwood CC, 2008, J ANAT, V212, P426, DOI 10.1111/j.1469-7580.2008.00868.x; SMITH AH, 1975, FOLIA PRIMATOL, V24, P29, DOI 10.1159/000155684; Smith BH, 1994, YEARB PHYS ANTHROPOL, V37, P177, DOI DOI 10.1002/AJPA.1330370608; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Tanaka-Arakawa MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118760; Terasawa E, 2001, ENDOCR REV, V22, P111, DOI 10.1210/er.22.1.111; TOMASCH J, 1954, ANAT REC, V119, P119, DOI 10.1002/ar.1091190109; Wahl M, 2007, J NEUROSCI, V27, P12132, DOI 10.1523/JNEUROSCI.2320-07.2007; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; WITELSON SF, 1991, BRAIN RES, V545, P175, DOI 10.1016/0006-8993(91)91284-8; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Zarei M, 2006, J ANAT, V209, P311, DOI 10.1111/j.1469-7580.2006.00615.x	81	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179624	10.1371/journal.pone.0179624	http://dx.doi.org/10.1371/journal.pone.0179624			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654656	Green Published, Green Submitted, gold			2022-12-27	WOS:000404541500023
J	Heermann, L; DeAngelis, DL; Borcherding, J				Heermann, Lisa; DeAngelis, Donald L.; Borcherding, Jost			A new mechanistic approach for the further development of a population with established size bimodality	PLOS ONE			English	Article							PERCH PERCA-FLUVIATILIS; THE-YEAR PERCH; ONTOGENIC NICHE SHIFTS; INTRASPECIFIC COMPETITION; PHENOTYPIC PLASTICITY; LARGEMOUTH BASS; FOOD RESOURCES; LIFE-HISTORY; MICROPTERUS-SALMOIDES; GROWTH TRAJECTORIES	Usually, the origin of a within-cohort bimodal size distribution is assumed to be caused by initial size differences or by one discrete period of accelerated growth for one part of the population. The aim of this study was to determine if more continuous pathways exist allowing shifts from the small to the large fraction within a bimodal age-cohort. Therefore, a Eurasian perch population, which had already developed a bimodal size-distribution and had differential resource use of the two size-cohorts, was examined. Results revealed that formation of a bimodal size-distribution can be a continuous process. Perch from the small size-cohort were able to grow into the large size-cohort by feeding on macroinvertebrates not used by their conspecifics. The diet shifts were accompanied by morphological shape changes. Intra-specific competition seemed to trigger the development towards an increasing number of large individuals. A stage-structured matrix model confirmed these assumptions. The fact that bimodality can be a continuous process is important to consider for the understanding of ecological processes and links within ecosystems.	[Heermann, Lisa; Borcherding, Jost] Univ Cologne, Inst Zool, Dept Gen Ecol, Cologne, Germany; [DeAngelis, Donald L.] US Geol Survey, Wetlands & Aquat Res Ctr, Gainesville, FL USA	University of Cologne; United States Department of the Interior; United States Geological Survey	Heermann, L (corresponding author), Univ Cologne, Inst Zool, Dept Gen Ecol, Cologne, Germany.	lisa.heermann@uni-koeln.de	Borcherding, Jost/A-1142-2011	Borcherding, Jost/0000-0003-3411-5861; Heermann, Lisa/0000-0003-4620-4087	German Research Foundation [DFG BO 1507/5-1, DFG BO 1507/5-2]; U.S. Geological Survey's Greater Everglades Priority Ecosystems Science program [KA30CTF]; Greater Everglades Priority Ecosystem Science program	German Research Foundation(German Research Foundation (DFG)); U.S. Geological Survey's Greater Everglades Priority Ecosystems Science program; Greater Everglades Priority Ecosystem Science program	The study was financially supported by the German Research Foundation (http://www.dfg.de) to JB (DFG BO 1507/5-1, 5-2) and by the U.S. Geological Survey's Greater Everglades Priority Ecosystems Science program (http://www.usgs.gov < http://www.usgs.gov >) to DLD (KA30CTF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all helping hands in the field, and comments of Donald Schoolmaster of USGS. DLD was supported by the Greater Everglades Priority Ecosystem Science program. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government. We also thank two anonymous reviewers for comments to an earlier version of the manuscript.	Allen RM, 2008, AM NAT, V171, P225, DOI 10.1086/524952; Beeck P, 2002, FRESHWATER BIOL, V47, P2359, DOI 10.1046/j.1365-2427.2002.01004.x; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Borcherding J, 2007, ECOL FRESHW FISH, V16, P198, DOI 10.1111/j.1600-0633.2006.00212.x; Borcherding J, 2010, J ANIM ECOL, V79, P1101, DOI 10.1111/j.1365-2656.2010.01704.x; BRONMARK C, 1992, SCIENCE, V258, P1348, DOI 10.1126/science.258.5086.1348; CLARKE KR, 1988, MAR ECOL PROG SER, V46, P213, DOI 10.3354/meps046213; CRAIG JF, 1979, J ANIM ECOL, V48, P315, DOI 10.2307/4116; DEANGELIS DL, 1982, T AM FISH SOC, V111, P384, DOI 10.1577/1548-8659(1982)111<384:GOBSDI>2.0.CO;2; Dmitriew CM, 2011, BIOL REV, V86, P97, DOI 10.1111/j.1469-185X.2010.00136.x; Estlander S, 2017, ECOL EVOL, V7, P665, DOI 10.1002/ece3.2658; Garcia-Berthou E, 2002, INT REV HYDROBIOL, V87, P353, DOI 10.1002/1522-2632(200207)87:4<353::AID-IROH353>3.0.CO;2-N; Heermann L, 2007, J FISH BIOL, V70, P1365, DOI 10.1111/j.1095-8649.2007.01417.x; Heermann L, 2013, J APPL ICHTHYOL, V29, P549, DOI 10.1111/jai.12044; Heermann L, 2013, FISHERIES MANAG ECOL, V20, P187, DOI 10.1111/fme.12000; Heermann L, 2009, ECOL FRESHW FISH, V18, P560, DOI 10.1111/j.1600-0633.2009.00371.x; Heermann L, 2014, ECOL FRESHW FISH, V23, P129, DOI 10.1111/eff.12060; Heibo E, 2005, ECOL FRESHW FISH, V14, P344, DOI 10.1111/j.1600-0633.2005.00108.x; Hjelm J, 2000, OECOLOGIA, V122, P190, DOI 10.1007/PL00008846; Huss M, 2008, OECOLOGIA, V158, P249, DOI 10.1007/s00442-008-1140-9; Huss M, 2013, FRESHWATER BIOL, V58, P1416, DOI 10.1111/fwb.12138; Huss M, 2010, OIKOS, V119, P2000, DOI 10.1111/j.1600-0706.2010.18454.x; HUSTON MA, 1987, AM NAT, V129, P678, DOI 10.1086/284666; JUANES F, 1994, J FISH BIOL, V45, P41, DOI 10.1111/j.1095-8649.1994.tb01083.x; Klemetsen A, 2002, ENVIRON BIOL FISH, V64, P39, DOI 10.1023/A:1016062421601; Knudsen R, 2016, HYDROBIOLOGIA, V783, P1, DOI 10.1007/s10750-016-2999-9; Melard C, 1996, J APPL ICHTHYOL, V12, P175, DOI 10.1111/j.1439-0426.1996.tb00085.x; MILINSKI M, 1982, BEHAV ECOL SOCIOBIOL, V11, P109, DOI 10.1007/BF00300099; Mittelbach GG, 1998, CAN J FISH AQUAT SCI, V55, P1454, DOI 10.1139/f98-041; Olsson J, 2005, EVOL ECOL RES, V7, P1109; Peacor SD, 2006, J ANIM ECOL, V75, P990, DOI 10.1111/j.1365-2656.2006.01119.x; Persson L., 1988, P203; Persson L, 2004, ECOL MONOGR, V74, P135, DOI 10.1890/02-4092; Pfister CA, 2002, ECOLOGY, V83, P59; Post DM, 2003, ECOLOGY, V84, P1298, DOI 10.1890/0012-9658(2003)084[1298:IVITTO]2.0.CO;2; Rennie MD, 2008, J ANIM ECOL, V77, P916, DOI 10.1111/j.1365-2656.2008.01412.x; Scharf WR, 2009, FISH RES, V96, P77, DOI 10.1016/j.fishres.2008.09.008; SCHLUTER D, 1993, ECOLOGY, V74, P699, DOI 10.2307/1940797; Svanback R, 2004, J ANIM ECOL, V73, P973, DOI 10.1111/j.0021-8790.2004.00868.x; Svanback R, 2002, OECOLOGIA, V131, P61, DOI 10.1007/s00442-001-0861-9; Svanback R, 2008, OIKOS, V117, P114, DOI 10.1111/j.2007.0030-1299.16267.x; Svanback R, 2007, P ROY SOC B-BIOL SCI, V274, P839, DOI 10.1098/rspb.2006.0198; Tatrai I, 1997, HYDROBIOLOGIA, V345, P117, DOI 10.1023/A:1002919305978; Van Densen WLT, 1985, J APPL ICHTHYOL, V3, P119; WASHINGTON HG, 1984, WATER RES, V18, P653, DOI 10.1016/0043-1354(84)90164-7; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Wintzer AP, 2005, ECOL FRESHW FISH, V14, P311, DOI 10.1111/j.1600-0633.2005.00105.x; Ziemba RE, 1999, OECOLOGIA, V120, P524, DOI 10.1007/s004420050886	48	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179339	10.1371/journal.pone.0179339	http://dx.doi.org/10.1371/journal.pone.0179339			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650963	gold, Green Submitted, Green Published			2022-12-27	WOS:000404537300005
J	Hsueh, PT; Wang, HH; Liu, CL; Ni, WF; Chen, YL; Liu, JK				Hsueh, Pei-Tan; Wang, Hsuan-Han; Liu, Chiu-Lin; Ni, Wei-Fen; Chen, Ya-Lei; Liu, Jong-Kang			Expression of cerebral serotonin related to anxiety-like behaviors in C57BL/6 offspring induced by repeated subcutaneous prenatal exposure to low-dose lipopolysaccharide	PLOS ONE			English	Article							MATERNAL IMMUNE ACTIVATION; BRAIN-DEVELOPMENT; DOPAMINE; MODEL; INFLAMMATION; SYSTEM; MODULATION; DISORDER; EPILEPSY; STRESS	Prenatal exposure to lipopolysaccharide (LPS), which likely occurs due to infection or contact with environmental allergens during pregnancy, is a proposed risk factor that induces anxiety-and autism spectrum disorder-like behaviors in offspring. However, the molecular and behavioral changes in offspring after maternal immune activation have not been completely identified. We hypothesized that a subcutaneous injection of LPS in a pregnant mouse would induce changes in cerebral serotonin (5-HT) in parallel to the appearance of anxiety-like behaviors in the dam's offspring. After LPS injections (total, 100 mu g/Kg), the time spent in the central region during the open field test and the number of times that the mice moved between the light and dark boxes and between the open and closed arms on the elevated plus maze test revealed anxiety-like behaviors in offspring at 5, 6 and 9 weeks of age. The mRNA expression levels of tph2 (5-HT synthesizing enzyme) and slc6a4 (5-HT transporter) were down-regulated in both adolescent (5 weeks of age) and adult (8 weeks of age) brains. Immunohistochemistry revealed that the numbers and sizes of tph2-expressing cells were notably decreased in the raphe nuclei of the midbrain of adults. Moreover, compared with controls (phosphate-buffered saline-treated offspring), the cerebral 5-HT concentration at adolescence and adulthood in LPS-induced offspring was significantly decreased. We concluded that maternal immune activation induced by exposure to a low dose of LPS decreased cerebral 5-HT levels in parallel to the down-regulation of the tph2 and slc6a4 genes and in conjunction with anxiety-like behaviors in offspring.	[Hsueh, Pei-Tan; Liu, Jong-Kang] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung, Taiwan; [Wang, Hsuan-Han; Liu, Chiu-Lin; Ni, Wei-Fen; Chen, Ya-Lei] Natl Kaohsiung Normal Univ, Dept Biotechnol, Kaohsiung, Taiwan	National Sun Yat Sen University; National Kaohsiung Normal University	Liu, JK (corresponding author), Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung, Taiwan.; Chen, YL (corresponding author), Natl Kaohsiung Normal Univ, Dept Biotechnol, Kaohsiung, Taiwan.	dan1001@nknu.edu.tw; jkliu@mail.nsysu.edu.tw			Ministry of Science and Technology (Taiwan) [NSC102-2628-B-017-001-MY3, MOST105-2320-B-017-003-MY3, MOST105-2320-B-017-001]	Ministry of Science and Technology (Taiwan)(Ministry of Science and Technology, Taiwan)	This study was funded by Ministry of Science and Technology (Taiwan); https://www.most.gov.tn; grant number NSC102-2628-B-017-001-MY3; MOST105-2320-B-017-003-MY3; and MOST105-2320-B-017-001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abney M, 2001, AM J HUM GENET, V68, P1302, DOI 10.1086/320112; Accardo JA, 2015, EPILEPSY BEHAV, V47, P202, DOI 10.1016/j.yebeh.2014.09.081; Altemus M, 2014, FRONT NEUROENDOCRIN, V35, P320, DOI 10.1016/j.yfrne.2014.05.004; Altieri SC, 2015, NEUROPSYCHOPHARMACOL, V40, P1456, DOI 10.1038/npp.2014.331; Amrein I, 2011, EUR J NEUROSCI, V34, P978, DOI 10.1111/j.1460-9568.2011.07804.x; Arreola R, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/3160486; Babri S, 2014, BRAIN BEHAV IMMUN, V37, P164, DOI 10.1016/j.bbi.2013.12.003; Beaulieu JM, 2008, P NATL ACAD SCI USA, V105, P1333, DOI 10.1073/pnas.0711496105; Bogdanik LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030217; Boksa P, 2010, BRAIN BEHAV IMMUN, V24, P881, DOI 10.1016/j.bbi.2010.03.005; Careaga M, 2017, BIOL PSYCHIAT, V81, P391, DOI 10.1016/j.biopsych.2016.10.020; Carvey PM, 2003, FRONT BIOSCI-LANDMRK, V8, pS826, DOI 10.2741/1158; Castillo A, 2014, EUR J MED GENET, V57, P654, DOI 10.1016/j.ejmg.2014.08.009; Chakravarty S, 2005, J NEUROSCI, V25, P1788, DOI 10.1523/jneurosci.4268-04.2005; Chen Y., 2016, P IEEE INT C VER LAR, P1, DOI DOI 10.1109/VLSIT.2016.7573429; Claustrat B, 2015, NEUROCHIRURGIE, V61, P77, DOI 10.1016/j.neuchi.2015.03.002; Coutinho AM, 2007, HUM GENET, V121, P243, DOI 10.1007/s00439-006-0301-3; CSORDAS T, 1978, GYNECOL OBSTET INVES, V9, P57, DOI 10.1159/000300971; Dantzer R, 2009, IMMUNOL ALLERGY CLIN, V29, P247, DOI 10.1016/j.iac.2009.02.002; Depino AM, 2015, NEUROSCIENCE, V299, P56, DOI 10.1016/j.neuroscience.2015.04.065; Dutkiewicz J, 2015, ANN AGR ENV MED, V22, P576, DOI 10.5604/12321966.1185757; Estes ML, 2016, SCIENCE, V353, P772, DOI 10.1126/science.aag3194; Fernandez SP, 2012, NEUROPHARMACOLOGY, V62, P144, DOI 10.1016/j.neuropharm.2011.08.049; Gentile MT, 2012, J NEUROCHEM, V123, P963, DOI 10.1111/jnc.12004; Gu F., 2017, J NEUROSCIENCE RES; Hava G, 2006, DEV PSYCHOBIOL, V48, P162, DOI 10.1002/dev.20116; Hong H, 2016, INT NEUROUROL J, V20, pS2, DOI 10.5213/inj.1632604.302; Howerton CL, 2012, HORM BEHAV, V62, P237, DOI 10.1016/j.yhbeh.2012.03.007; Hsueh PT, 2016, MICROBIOL IMMUNOL, V60, P725, DOI 10.1111/1348-0421.12450; Jaunarajs KLE, 2012, NEUROSCIENCE, V218, P243, DOI 10.1016/j.neuroscience.2012.05.052; Karrow NA, 2006, BRAIN BEHAV IMMUN, V20, P144, DOI 10.1016/j.bbi.2005.05.003; Kerns CM, 2014, J AUTISM DEV DISORD, V44, P2851, DOI 10.1007/s10803-014-2141-7; Khananshvili D, 2013, MOL ASPECTS MED, V34, P220, DOI 10.1016/j.mam.2012.07.003; Kim YS, 2011, AM J PSYCHIAT, V168, P904, DOI 10.1176/appi.ajp.2011.10101532; Krishna S, 2016, BEHAV BRAIN RES, V302, P279, DOI 10.1016/j.bbr.2016.01.038; Kubesova A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115439; Lambert JF, 2000, J NEUROSCI METH, V95, P127, DOI 10.1016/S0165-0270(99)00157-0; Li ZS, 2011, J NEUROSCI, V31, P8998, DOI 10.1523/JNEUROSCI.6684-10.2011; Liu B, 2004, BIOL PHARM BULL, V27, P1245, DOI 10.1248/bpb.27.1245; Lowry CA, 2005, STRESS, V8, P233, DOI 10.1080/10253890500492787; Martin ER, 2000, AM J MED GENET, V96, P43, DOI 10.1002/(SICI)1096-8628(20000207)96:1<43::AID-AJMG9>3.0.CO;2-3; Matson JL, 2013, RES DEV DISABIL, V34, P2475, DOI 10.1016/j.ridd.2013.05.021; Money KM, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00260; Ornoy A, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00316; Pernot F, 2010, J NEUROSCI RES, V88, P1000, DOI 10.1002/jnr.22282; Rath MF, 2016, ENDOCRINOLOGY, V157, P2028, DOI 10.1210/en.2015-1888; Rousseau F, 2008, J NEUROSCI, V28, P9755, DOI 10.1523/JNEUROSCI.0509-08.2008; Sakowski SA, 2006, BRAIN RES, V1085, P11, DOI 10.1016/j.brainres.2006.02.047; Sens J, 2017, PHARMACOL BIOCHEM BE, V153, P168, DOI 10.1016/j.pbb.2016.12.016; Simic G, 2017, PROG NEUROBIOL, V151, P101, DOI 10.1016/j.pneurobio.2016.04.001; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stansley BJ, 2013, NEUROPHARMACOLOGY, V67, P243, DOI 10.1016/j.neuropharm.2012.11.010; Takeshima M, 2016, J CLIN BIOCHEM NUTR, V59, P93, DOI 10.3164/jcbn.16-15; Valentini V, 2013, NEUROPHARMACOLOGY, V65, P58, DOI 10.1016/j.neuropharm.2012.08.025; Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801; Vasilache AM, 2013, J NEUROENDOCRINOL, V25, P635, DOI 10.1111/jne.12044; Vasudeva RK, 2011, J CHEM NEUROANAT, V41, P281, DOI 10.1016/j.jchemneu.2011.05.008; Veazey KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027592; Voineagu I, 2013, DIS MARKERS, V2013, P55, DOI 10.1155/2013/476276; Waider J, 2011, PSYCHONEUROENDOCRINO, V36, P393, DOI 10.1016/j.psyneuen.2010.12.012; Wu WL, 2017, BRAIN BEHAV IMMUN, V62, P11, DOI 10.1016/j.bbi.2016.11.007; Xuan ICY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104433; Yan QS, 2001, EUR J PHARMACOL, V418, P55, DOI 10.1016/S0014-2999(01)00913-X; Zager A, 2015, BRAIN BEHAV IMMUN, V43, P159, DOI 10.1016/j.bbi.2014.07.021; Zarrindast MR, 2015, ARCH IRAN MED, V18, P591, DOI 0151809/AIM.009	65	20	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179970	10.1371/journal.pone.0179970	http://dx.doi.org/10.1371/journal.pone.0179970			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650979	Green Published, Green Submitted, gold			2022-12-27	WOS:000404537300035
J	Ostensson, E; Silfverschiold, M; Greiff, L; Asciutto, C; Wennerberg, J; Lydryp, ML; Hakansson, U; Sparen, P; Borgfeldt, C				Ostensson, Ellinor; Silfverschiold, Maria; Greiff, Lennart; Asciutto, Christine; Wennerberg, Johan; Lydryp, Marie-Louise; Hakansson, Ulf; Sparen, Par; Borgfeldt, Christer			The economic burden of human papillomavirus-related precancers and cancers in Sweden	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; VAGINAL INTRAEPITHELIAL NEOPLASIA; COMPARATIVE GENOMIC HYBRIDIZATION; QUADRIVALENT HPV VACCINE; COST-EFFECTIVENESS; POSITIVE TONSILLAR; PROGNOSTIC-FACTOR; DNA DETECTION; VULVAR; LESIONS	Background High-risk (HR) human papillomavirus (HPV) infection is an established cause of malignant disease. We used a societal perspective to estimate the cost of HR HPV-related cervical, vulvar, vaginal, anal, and penile precancer and cancer, and oropharyngeal cancer in Sweden in 2006, 1 year before HPV vaccination became available in the country. Materials and methods This prevalence-based cost-of-illness study used diagnosis-specific data from national registries to determine the number of HR HPV-related precancers and cancers. The HR HPV-attributable fractions of these diseases were derived from a literature review and applied to the total burden to estimate HR HPV-attributable costs. Direct costs were based on health care utilization and indirect costs on loss of productivity due to morbidity (i.e., sick leave and early retirement) and premature mortality. Results The total annual cost of all HR HPV-attributable precancers and cancers was (sic)94 million ((sic)10.3/inhabitant). Direct costs accounted for (sic)31.3 million ((sic)3.4/inhabitant) of the total annual cost, and inpatient care amounted to (sic)20.7 million of direct costs. Indirect costs made up (sic)62.6 million ((sic)6.9/inhabitant) of the total annual cost, and premature mortality amounted to _ 36 million of indirect costs. Cervical precancer and cancer was most costly (total annual cost (sic)58.4 million). Among cancers affecting both genders, anal precancer and cancer, and oropharyngeal cancer were the most costly ((sic)11.2 million and (sic)11.9 million, respectively). For oropharyngeal cancer, males had the highest health care utilization and represented 71% of the total annual cost. Penile precancer and cancer was least costly ((sic)2.6 million). Conclusion The economic burden of HR HPV-related precancers and cancers is substantial. The disease-related management and treatment costs we report are relevant as a point of reference for future economic evaluations investigating the overall benefits of HPV vaccination in females and males in Sweden.	[Ostensson, Ellinor; Sparen, Par] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Ostensson, Ellinor] Karolinska Inst, Dept Womens & Childrens Hlth, Div Obstet & Gynecol, Stockholm, Sweden; [Silfverschiold, Maria; Greiff, Lennart; Wennerberg, Johan] Lund Univ, Skanes Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Lund, Sweden; [Asciutto, Christine; Borgfeldt, Christer] Lund Univ, Skanes Univ Hosp, Dept Obstet & Gynecol, Lund, Sweden; [Lydryp, Marie-Louise] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Hakansson, Ulf] Lund Univ, Skanes Univ Hosp, Dept Urol, Malmo, Sweden	Karolinska Institutet; Karolinska Institutet; Lund University; Lund University; Lund University; Lund University	Ostensson, E (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.; Ostensson, E (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Div Obstet & Gynecol, Stockholm, Sweden.	ellinor.ostensson@ki.se		Borgfeldt, Christer/0000-0003-2267-8325; Sparen, Par/0000-0002-5184-8971; Ostensson, Ellinor/0000-0003-0668-088X	Swedish Cancer Foundation [C8 30305153]	Swedish Cancer Foundation	This work was supported by the Swedish Cancer Foundation (C8 30305153), URL: www.cancerfonden.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen D, 2002, BRIT J CANCER, V86, P924, DOI 10.1038/sj.bjc.6600112; Anayannis NVJ, 2015, ARCH PATHOL LAB MED, V139, P1373, DOI 10.5858/arpa.2014-0554-RA; Andersson S, 2005, BRIT J CANCER, V92, P2195, DOI 10.1038/sj.bjc.6602648; Andersson S, 2004, CANCER DETECT PREV, V29, P37, DOI 10.1016/j.cdp.2004.11.003; Andersson S, 2003, ACTA OBSTET GYN SCAN, V82, P960, DOI 10.1034/j.1600-0412.2003.00263.x; Andersson S, 2001, EUR J CANCER, V37, P246, DOI 10.1016/S0959-8049(00)00376-2; Andersson S, 2013, ONCOL LETT, V6, P215, DOI 10.3892/ol.2013.1350; Armstrong LR, 2000, CLIN INFECT DIS, V31, P107, DOI 10.1086/313914; Attner P, 2010, INT J CANCER, V126, P2879, DOI 10.1002/ijc.24994; Blomqvist P, 2000, J NEUROL NEUROSUR PS, V69, P792, DOI 10.1136/jnnp.69.6.792; Bogaards JA, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2016; Bryndorf T, 2004, CYTOGENET GENOME RES, V106, P43, DOI 10.1159/000078559; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Dahlgren L, 2004, INT J CANCER, V112, P1015, DOI 10.1002/ijc.20490; Daling JR, 2004, CANCER-AM CANCER SOC, V101, P270, DOI 10.1002/cncr.20365; Dayyani F, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-15; Drolet M, 2015, LANCET INFECT DIS, V15, P565, DOI 10.1016/S1473-3099(14)71073-4; Drummond M, 2005, METH EC EV HLTH CARE; Du J, 2011, ACTA ONCOL, V50, P1215, DOI 10.3109/0284186X.2011.584556; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferreira M, 2008, MODERN PATHOL, V21, P968, DOI 10.1038/modpathol.2008.91; Fox PA, 2005, SEX TRANSM INFECT, V81, P142, DOI 10.1136/sti.2003.008318; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; Gold M, 1996, MED CARE, V34, pDS197; Graflund M, 2004, INT J GYNECOL CANCER, V14, P896, DOI 10.1111/j.1048-891X.2004.014527.x; Hammarstedt L, 2006, INT J CANCER, V119, P2620, DOI 10.1002/ijc.22177; Hampl M, 2006, OBSTET GYNECOL, V108, P1361, DOI 10.1097/01.AOG.0000245786.86267.80; Hampl M, 2007, J CANCER RES CLIN, V133, P235, DOI 10.1007/s00432-006-0162-0; Heideman DAM, 2007, J CLIN ONCOL, V25, P4550, DOI 10.1200/JCO.2007.12.3182; Henriksson F, 1998, PHARMACOECONOMICS, V13, P597, DOI 10.2165/00019053-199813050-00012; Herweijer E, 2016, INT J CANCER, V138, P2867, DOI 10.1002/ijc.30035; Herweijer E, 2014, JAMA-J AM MED ASSOC, V311, P597, DOI 10.1001/jama.2014.95; HODGSON TA, 1982, MILBANK FUND Q, V60, P429, DOI 10.2307/3349801; Jemal A, 2013, JNCI-J NATL CANCER I, V105, P175, DOI 10.1093/jnci/djs491; Jit M, 2014, LANCET GLOB HEALTH, V2, pE406, DOI 10.1016/S2214-109X(14)70237-2; Kirrander P, 2011, BJU INT, V108, P355, DOI 10.1111/j.1464-410X.2010.09770.x; KOOPMANSCHAP MA, 1995, J HEALTH ECON, V14, P171, DOI 10.1016/0167-6296(94)00044-5; Krustrup D, 2009, INT J EXP PATHOL, V90, P182, DOI 10.1111/j.1365-2613.2008.00636.x; Kulasingam S, 2007, SEX HEALTH, V4, P165, DOI 10.1071/SH07043; Kulasingam SL, 2003, JAMA-J AM MED ASSOC, V290, P781, DOI 10.1001/jama.290.6.781; Larsson GL, 2013, GYNECOL ONCOL, V129, P406, DOI 10.1016/j.ygyno.2013.02.004; Larsson GL, 2012, INT J GYNECOL CANCER, V22, P1413, DOI 10.1097/IGC.0b013e31826a0471; Laytragoon-Lewin N, 2007, ANTICANCER RES, V27, P4473; Lidgren M, 2007, EUR J HEALTH ECON, V8, P5, DOI 10.1007/s10198-006-0003-8; Liljas B, 1998, PHARMACOECONOMICS, V13, P1, DOI 10.2165/00019053-199813010-00001; Lindell G, 2010, GYNECOL ONCOL, V117, P312, DOI 10.1016/j.ygyno.2009.12.031; Lindquist D, 2012, ANTICANCER RES, V32, P153; Logani S, 2003, MODERN PATHOL, V16, P735, DOI 10.1097/01.MP.0000081051.55284.2A; Lowy DR, 2006, J CLIN INVEST, V116, P1167, DOI 10.1172/JCI28607; Madsen BS, 2008, INT J CANCER, V122, P2827, DOI 10.1002/ijc.23446; Mallen-St Clair J, 2016, BBA-REV CANCER, V1866, P141, DOI 10.1016/j.bbcan.2016.07.005; Menczer J, 2000, EUR J GYNAECOL ONCOL, V21, P30; Miralles-Guri C, 2009, J CLIN PATHOL, V62, P870, DOI 10.1136/jcp.2008.063149; Munoz N, 2009, LANCET, V373, P1949, DOI 10.1016/S0140-6736(09)60691-7; Nasman A, 2015, EUR J CANCER, V51, P55, DOI 10.1016/j.ejca.2014.10.016; Nasman A, 2009, INT J CANCER, V125, P362, DOI 10.1002/ijc.24339; OSTENSSON E, 2015, PLOS ONE, V10; Perez-Ordonez B, 2006, J CLIN PATHOL, V59, P445, DOI 10.1136/jcp.2003.007641; Petersen PE, 2009, ORAL ONCOL, V45, P454, DOI 10.1016/j.oraloncology.2008.05.023; Pinto LA, 2016, J INFECT DIS, V214, P1276, DOI 10.1093/infdis/jiw359; Rice DP, 1996, HLTH EC SERIES, V6; Skapa P, 2007, AM J SURG PATHOL, V31, P1834, DOI 10.1097/PAS.0b013e3180686d10; Sobocki P, 2006, J MENT HEALTH POLICY, V9, P87; Soderlund-Strand A, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.056; Srodon M, 2006, AM J SURG PATHOL, V30, P1513, DOI 10.1097/01.pas.0000213291.96401.48; Statens beredning for medicinsk utvardering SBU, 2008, 20081 SBU; Stockholm County Council, 2003, COST PAT PRIM CAR RE; Sutton BC, 2008, MODERN PATHOL, V21, P345, DOI 10.1038/modpathol.3801010; Swedish Association of Local Authorities and Regions, 2014, 5813 SWED ASS LOC AU; The Dental and Pharmaceutical Benefits Agency (TLV), 2003, GEN GUID EC EV PHARM; Varnai AD, 2006, INT J COLORECTAL DIS, V21, P135, DOI 10.1007/s00384-005-0777-7; Von Krogh G, 2001, EUR J DERMATOL, V11, P598; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Westra WH, 2012, HEAD NECK PATHOL, V6, pS48, DOI 10.1007/s12105-012-0371-6; Wikstrom A, 2012, J EUR ACAD DERMATOL, V26, P325, DOI 10.1111/j.1468-3083.2011.04069.x; Wiley D, 2006, OBSTET GYNECOL SURV, V61, pS3, DOI 10.1097/01.ogx.0000221010.82943.8c; Youk EG, 2001, DIS COLON RECTUM, V44, P236, DOI 10.1007/BF02234299	77	13	14	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179520	10.1371/journal.pone.0179520	http://dx.doi.org/10.1371/journal.pone.0179520			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651012	Green Submitted, Green Published, gold			2022-12-27	WOS:000404537300010
J	Vilela, T; Reid, J				Vilela, Thais; Reid, John			Improving hydropower choices via an online and open access tool	PLOS ONE			English	Article							ENVIRONMENT	This paper describes and validates the HydroCalculator Tool developed by Conservation Strategy Fund. The HydroCalculator Tool allows researchers, policy-makers and citizens to easily assess hydropower feasibility, by calculating traditional financial indicators, such as the levelized cost of energy, as well as greenhouse gas emissions and the economic net present value including emissions costs. Currently, people other than project developers have limited or no access to such information, which stifles informed public debate on electric energy options. Within this context, the use of the HydroCalculator Tool may contribute to the debate, by facilitating access to information. To validate the tool's greenhouse gas calculations, we replicate two peer-reviewed articles that estimate greenhouse gas emissions from different hydropower plants in the Amazon basin. The estimates calculated by the HydroCalculator Tool are similar to the ones found in both peer-reviewed articles. The results show that hydropower plants can lead to greenhouse gas emissions and that, in some cases, these emissions can be larger than those of alternative energy sources producing the same amount of electricity.	[Vilela, Thais; Reid, John] Conservat Strategy Fund, Washington, DC 20009 USA		Vilela, T (corresponding author), Conservat Strategy Fund, Washington, DC 20009 USA.	thais@conservation-strategy.org			Good Energies Foundation [152507]	Good Energies Foundation	The development of the HydroCalculator Tool and this research were supported by Good Energies Foundation (grant no. 152507 - http://www.goodenergies.org). The grant was given to Conservation Strategy Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril G, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002457; [Anonymous], 2015, CARBON DIOXIDE PRICE; [Anonymous], 2006, IPCC GUIDELINES NATL; Bambace LAW, 2007, WORKSH GREEN HOUS GA; Barros N, 2011, NAT GEOSCI, V4, P593, DOI 10.1038/ngeo1211; Corporacion Electrica del Ecuador, 2016, HIDR PROYECT HIDR PA; Corporacion Electrica del Ecuador, 2015, PROY HIDR PAUT CARD; de Faria FAM, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/124019; Ednhofer O., 2011, SPECIAL REPORT INTER; Empresa Nacional de Electricidad, 2015, CONTR NAC INT VIG; Fearnside P. M., 2005, Mitigation and Adaptation Strategies for Global Change, V10, P675, DOI 10.1007/s11027-005-7303-7; Fearnside P M, 2016, ENVIRON RES LETT, P11; Fearnside PM, 2015, ENVIRON SCI POLICY, V50, P225, DOI 10.1016/j.envsci.2015.03.002; Fearnside PM, 2005, ENVIRON MANAGE, V35, P1, DOI 10.1007/s00267-004-0100-3; Fearnside PM, 1999, ENVIRON MANAGE, V24, P483, DOI 10.1007/s002679900248; FEARNSIDE PM, 1989, ENVIRON MANAGE, V13, P401, DOI 10.1007/BF01867675; Genereux DP, 2013, GEOPHYS RES LETT, V40, P2066, DOI 10.1002/grl.50423; International Rivers, 2006, FIZZ SCI LOOS HYDR I; Isagen. Cartilla Sogamoso, 2016, COM; Kossoy A., 2015, CLIMATE CHANGE; Ledec G, 2003, SUSTAINABLE DEV WORK, V16; Makinen K., 2010, Water Alternatives, V3, P91; Malky A, 2012, SERIE TECNICA, P23; Malovic D., 2015, HYDROELECTRIC POWER; Ministerio do Planejamento. PAC, 2015, INFR EN GER EN EL IN; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; RUDD JWM, 1993, AMBIO, V22, P246; Schlomer S., 2014, CLIMATE CHANGE 2014; Steinhurst W, 2012, HYDROPOWER GREENHOUS, V24, P6; Stocker T. F., 2013, CONTRIBUTION WORKING, DOI DOI 10.1017/CBO9781107415324; The Data Shift Portal, 2016, DAT EL GEN EN SOURC; United Stated Environmental Protection Agency, 2016, EPA FACT SHEET; Yang Le, 2014, Acta Ecologica Sinica - International Journal, V34, P204, DOI 10.1016/j.chnaes.2013.05.011	33	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179393	10.1371/journal.pone.0179393	http://dx.doi.org/10.1371/journal.pone.0179393			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650968	Green Published, gold, Green Submitted			2022-12-27	WOS:000404537300008
J	Biesbroek, PS; Amier, RP; Teunissen, PFA; Hofman, MBM; Robbers, LFHJ; van de Ven, PM; Beek, AM; van Rossum, AC; van Royen, N; Nijveldt, R				Biesbroek, P. Stefan; Amier, Raquel P.; Teunissen, Paul. F. A.; Hofman, Mark B. M.; Robbers, Lourens F. H. J.; van de Ven, Peter M.; Beek, Aernout M.; van Rossum, Albert C.; van Royen, Niels; Nijveldt, Robin			Changes in remote myocardial tissue after acute myocardial infarction and its relation to cardiac remodeling: A CMR T1 mapping study	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; EXTRACELLULAR VOLUME QUANTIFICATION; QUANTITATIVE T2; RAT-HEART; EDEMA; INFLAMMATION; REPERFUSION; FIBROSIS; CORONARY; INJURY	Objectives To characterize the temporal alterations in native T1 and extracellular volume (ECV) of remote myocardium after acute myocardial infarction (AMI), and to explore their relation to left ventricular (LV) remodeling. Methods Forty-two patients with AMI successfully treated with primary PCI underwent cardiovascular magnetic resonance after 4-6 days and 3 months. Cine imaging, late gadolinium enhancement, and T1-mapping (MOLLI) was performed at 1.5T. T1 values were measured in the myocardial tissue opposite of the infarct area. Myocardial ECV was calculated from native-and post-contrast T1 values in 35 patients, using a correction for synthetic hematocrit. Results Native T1 of remote myocardium significantly decreased between baseline and follow-up (1002 +/- 39 to 985 +/- 30ms, p<0.01). High remote native T1 at baseline was independently associated with a high C-reactive protein level (standardized Beta 0.32, p = 0.04) and the presence of microvascular injury (standardized Beta 0.34, p = 0.03). ECV of remote myocardium significantly decreased over time in patients with no LV dilatation (29 +/- 3.8 to 27 +/- 2.3%, p<0.01). In patients with LV dilatation, remote ECV remained similar over time, and was significantly higher at follow-up compared to patients without LV dilatation (30 +/- 2.0 versus 27 +/- 2.3%, p = 0.03). Conclusions In reperfused first-time AMI patients, native T1 of remote myocardium decreased from baseline to follow-up. ECV of remote myocardium decreased over time in patients with no LV	[Biesbroek, P. Stefan; Amier, Raquel P.; Teunissen, Paul. F. A.; Robbers, Lourens F. H. J.; Beek, Aernout M.; van Rossum, Albert C.; van Royen, Niels; Nijveldt, Robin] Vrije Univ Amsterdam, Med Ctr, Dept Cardiol, Amsterdam, Netherlands; [Biesbroek, P. Stefan] Netherlands Heart Inst, Utrecht, Netherlands; [Hofman, Mark B. M.] Vrije Univ Amsterdam, Med Ctr, Phys & Med Technol, Amsterdam, Netherlands; [van de Ven, Peter M.] Vrije Univ Amsterdam, Med Ctr, Epidemiol & Biostat, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Nijveldt, R (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Cardiol, Amsterdam, Netherlands.	Robin@Nijveldt.net	Teunissen, Paul/AAC-2908-2020; van Royen, Niels/Q-1097-2017; Nijveldt, Robin/N-8683-2017	Nijveldt, Robin/0000-0003-1530-6363; van Rossum, Albert C./0000-0003-1714-4652; Robbers, Lourens/0000-0002-8826-7628; Teunissen, Paul/0000-0001-7574-9698	Volcano Corporation	Volcano Corporation	This work was supported in part by unrestricted research grants from Volcano Corporation (http//www.volcanocorp.corn/) and Biotronik (https://www.biotronik.com/en-us)(NR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2008, HEART, V94, P737, DOI 10.1136/hrt.2007.115329; Ambale-Venkatesh B, 2015, NAT REV CARDIOL, V12, P18, DOI 10.1038/nrcardio.2014.159; Betgem RP, 2015, NAT REV CARDIOL, V12, P156, DOI 10.1038/nrcardio.2014.188; Brouwer WP, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/1532-429X-16-28; Bulluck H, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003555; Carberry J, 2016, HYPERTENSION, V68, P385, DOI 10.1161/HYPERTENSIONAHA.116.07222; Carrick D, 2015, JACC CARDIOVASC IMAG; CLEUTJENS JPM, 1995, AM J PATHOL, V147, P325; Fernandez-Jimenez R, 2015, J AM COLL CARDIOL, V65, P315, DOI 10.1016/j.jacc.2014.11.004; Ferreira VM, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-42; Flett AS, 2011, JACC-CARDIOVASC IMAG, V4, P150, DOI 10.1016/j.jcmg.2010.11.015; Ghugre NR, 2013, MAGN RESON MED, V70, P1095, DOI 10.1002/mrm.24531; Goebel J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155591; Hirsch A, 2011, EUR HEART J, V32, P1736, DOI 10.1093/eurheartj/ehq449; Kim RJ, 1999, CIRCULATION, V100, P1992, DOI 10.1161/01.CIR.100.19.1992; Lee WW, 2012, J AM COLL CARDIOL, V59, P153, DOI 10.1016/j.jacc.2011.08.066; Lonborg J, 2012, EUR HEART J, V33, P1491, DOI 10.1093/eurheartj/ehr309; Messroghli DR, 2007, J MAGN RESON IMAGING, V26, P1081, DOI 10.1002/jmri.21119; Moon JC, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-92; Park CH, 2013, INT J CARDIOVAS IMAG, V29, P65, DOI 10.1007/s10554-013-0256-0; Park YH, 2008, J AM SOC ECHOCARDIOG, V21, P262, DOI 10.1016/j.echo.2007.08.026; Piechnik SK, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-69; Pokorney Sean D, 2012, J Cardiovasc Magn Reson, V14, P62, DOI 10.1186/1532-429X-14-62; Puri KS, 2009, J POSTGRAD MED, V55, P131, DOI 10.4103/0022-3859.52846; Ruparelia N, 2013, INFLAMM RES, V62, P515, DOI 10.1007/s00011-013-0605-4; Schelbert EB, 2010, CIRC-CARDIOVASC IMAG, V3, P743, DOI 10.1161/CIRCIMAGING.108.835793; Schulz-Menger J, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-35; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Teunissen PFA, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.001786; Treibel TA, 2016, JACC-CARDIOVASC IMAG, V9, P54, DOI 10.1016/j.jcmg.2015.11.008; Tsuda T, 2003, CARDIOVASC RES, V59, P926, DOI 10.1016/S0008-6363(03)00519-4; Ugander M, 2012, JACC-CARDIOVASC IMAG, V5, P596, DOI 10.1016/j.jcmg.2012.01.016; Verhaert D, 2011, JACC-CARDIOVASC IMAG, V4, P269, DOI 10.1016/j.jcmg.2010.09.023; WILLIAMS ES, 1980, J NUCL MED, V21, P449; Zia MI, 2012, CIRC-CARDIOVASC IMAG, V5, P566, DOI 10.1161/CIRCIMAGING.112.973222	35	25	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0180115	10.1371/journal.pone.0180115	http://dx.doi.org/10.1371/journal.pone.0180115			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644903	Green Published, gold, Green Submitted			2022-12-27	WOS:000404145100064
J	Eftimov, T; Seljak, BK; Korosec, P				Eftimov, Tome; Seljak, Barbara Korousic; Korosec, Peter			A rule-based named-entity recognition method for knowledge extraction of evidence based dietary recommendations	PLOS ONE			English	Article							ALGORITHMS	Evidence-based dietary information represented as unstructured text is a crucial information that needs to be accessed in order to help dietitians follow the new knowledge arrives daily with newly published scientific reports. Different named-entity recognition (NER) methods have been introduced previously to extract useful information from the biomedical literature. They are focused on, for example extracting gene mentions, proteins mentions, relationships between genes and proteins, chemical concepts and relationships between drugs and diseases. In this paper, we present a novel NER method, called drNER, for knowledge extraction of evidence-based dietary information. To the best of our knowledge this is the first attempt at extracting dietary concepts. DrNER is a rule-based NER that consists of two phases. The first one involves the detection and determination of the entities mention, and the second one involves the selection and extraction of the entities. We evaluate the method by using text corpora from heterogeneous sources, including text from several scientifically validated web sites and text from scientific publications. Evaluation of the method showed that drNER gives good results and can be used for knowledge extraction of evidence-based dietary recommendations.	[Eftimov, Tome; Seljak, Barbara Korousic; Korosec, Peter] Josef Stefan Inst, Comp Syst Dept, Ljubljana, Slovenia; [Eftimov, Tome] Josef Stefan Int Postgrad Sch, Ljubljana, Slovenia; [Korosec, Peter] Nat Sci & Informat Technol, Fac Math, Koper, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Eftimov, T (corresponding author), Josef Stefan Inst, Comp Syst Dept, Ljubljana, Slovenia.; Eftimov, T (corresponding author), Josef Stefan Int Postgrad Sch, Ljubljana, Slovenia.	tome.eftimov@ijs.si		Korosec, Peter/0000-0003-4492-4603; Eftimov, Tome/0000-0001-7330-1902	ISO-FOOD from the European Union's Seventh Framework Programme for research, technological development and demonstration [621329]	ISO-FOOD from the European Union's Seventh Framework Programme for research, technological development and demonstration	This work was supported by the project ISO-FOOD, which received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no 621329	Alnazzawi N, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/1472-6947-15-S2-S3; Ando RK, 2005, J MACH LEARN RES, V6, P1817; [Anonymous], 2016, P 4 BIONLP SHAR TASK; [Anonymous], 2002, HDB BRAIN THEORY NEU, DOI DOI 10.1007/SPRINGERREFERENCE_71011; [Anonymous], PENN TREEBANK OVERVI, DOI DOI 10.1007/978-94-010-0201-1_1; [Anonymous], 2001, CONDITIONAL RANDOM F; Arighi CN, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau039; Arighi CN, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S8-S1; Aronson AR, 2001, J AM MED INFORM ASSN, P17; Bada M., 2010, P 4 LING ANN WORKSH, P207; Barros M, 2016, Yearb Med Inform, P178; Bishop C.M., 2006, MACH LEARN, V128; Campos D., 2013, BIOCREATIVE CHALL EV, V2, P82; Chaix Estelle, 2016, P 4 BIONLP SHARED TA, P1; Chowdhury GG, 2003, ANNU REV INFORM SCI, V37, P51, DOI 10.1002/aris.1440370103; Comeau DC, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat064; Courtot M, 2011, APPL ONTOL, V6, P23, DOI 10.3233/AO-2011-0087; Doets EL, 2008, EUR J NUTR, V47, P17, DOI [10.1007/s00394-008-1003-5, 10.1007/s00394-007-0691-6]; Dogan RI, 2014, J BIOMED INFORM, V47, P1, DOI 10.1016/j.jbi.2013.12.006; Eddy SR, 1996, CURR OPIN STRUC BIOL, V6, P361, DOI 10.1016/S0959-440X(96)80056-X; Eftimov T, 2016, KDIR: PROCEEDINGS OF THE 8TH INTERNATIONAL JOINT CONFERENCE ON KNOWLEDGE DISCOVERY, KNOWLEDGE ENGINEERING AND KNOWLEDGE MANAGEMENT - VOL. 1, P150, DOI 10.5220/0006032401500157; El-Dosuky MA, 2012, COMM COM INF SC, V322, P423; Espin V., 2015, EXPERT SYSTEMS; Farmakiotou D., 2000, PROC WORKSHOP COMPUT, P75; Ge M., 2015, P 9 ACM C REC SYST, P333, DOI DOI 10.1145/2792838.2796554; Gkoutos GV, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas033; Hornik Kurt, 2015, OPENNLP APACHE OPENN; Huang HS, 2007, P 2 BIOCREATIVE CHAL, P109; Hull DA, 1996, J AM SOC INFORM SCI, V47, P70, DOI 10.1002/(SICI)1097-4571(199601)47:1<70::AID-ASI7>3.0.CO;2-#; Karnaugh M., 1953, T AM I ELECT ENG 1, V72, P593, DOI [DOI 10.1109/TCE.1953.6371932, 10.1109/TCE.1953.6371932]; Kim JD, 2016, BIONLP 2016 P 4 BION, P23; Kim S, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw121; Klinger R., 2007, P 2 BIOCREATIVE CHAL, P89; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Krallinger M, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/1758-2946-7-S1-S2; Kuo CJ, 2007, P 2 BIOCREATIVE CHAL, P105; Leaman R., 2015, P 5 BIOCREATIVE CHAL, P140; Leaman Robert, 2008, Pac Symp Biocomput, P652; Lever J., 2016, P 4 BIONLP SHAR TASK, P42; Li C, 2016, BIONLP SHAR TASK WOR, P32; Lovins JB, 1968, DEV STEMMING ALGORIT; Lowe DM, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/1758-2946-7-S1-S5; Luo Y, 2017, BRIEF BIOINFORM, V18, P160, DOI 10.1093/bib/bbw001; Manning C. D, 1999, FDN STAT NATURAL LAN, V999; Marcus M.P., 1993, COMPUTATIONAL LINGUI, V19, P313, DOI DOI 10.1080/07494460903404410; McCallum Andrew, 2000, P 17 INT C MACH LEAR, P591; McEnery T., 2001, CORPUS LINGUISTICS I; Mika S., 2011, P 2 WORKSH CONT AW I, P25; Miller R A, 1992, Proc Annu Symp Comput Appl Med Care, P86; Nadeau D, 2007, LINGUIST INVESTIG, V30, P3; Nedellec C, 2013, ACL, V2013, P1; Nelson R. J., 1955, J SYMBOLIC LOGIC, V20, P197; Nunes T., 2013, BIOINFORMATICS; Ohta Tomoko, 2012, P WORKSH DET STRUCT, P27; Panyam NC, 2016, ACL 2016, P82; Petasis G, 2001, 39TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P418; Plisson J., 2004, P IS, V3, P83; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Rayson P, 2004, P WORKSH NAM ENT REC; Rebedew D., 2014, FAMILY PRACTICE MANA, V22, P31; Rindflesch T C, 2000, Pac Symp Biocomput, P517; Rocktaschel T, 2012, BIOINFORMATICS, V28, P1633, DOI 10.1093/bioinformatics/bts183; Rusu D., 2007, P 10 INT MULT INF SO; Santorini B., 1990, PART OF SPEECH TAGGI; SCHMID LA, 1994, INT CONF ACOUST SPEE, P41; Smith L, 2008, GENOME BIOL, V9, P1; Suykens JAK, 1999, NEURAL PROCESS LETT, V9, P293, DOI 10.1023/A:1018628609742; Tian Y, 2015, 2015 22ND INTERNATIONAL CONFERENCE ON SOFTWARE ANALYSIS, EVOLUTION, AND REENGINEERING (SANER), P570, DOI 10.1109/SANER.2015.7081879; Tiftikci M, 2016, P 4 BIONLP SHAR TASK, P56; Visser U, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-257; Vorster HH, 2001, S AFR JCLIN NUTR, V14, P3; Voutilainen A., 2003, OXFORD HDB COMPUTATI, P219; Wang QH, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw119; Wei CH, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw032; Wendel S, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-126; Wilson A, 1997, SEMANTIC ANNOTATION; Yusof A. F., 2012, 2012 Proceedings of International Conference on Computer & Information Science (ICCIS 2012), P198, DOI 10.1109/ICCISci.2012.6297239; Zhou XH, 2006, LECT NOTES ARTIF INT, V4099, P1145, DOI 10.1007/978-3-540-36668-3_150	79	47	49	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179488	10.1371/journal.pone.0179488	http://dx.doi.org/10.1371/journal.pone.0179488			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY7CO	28644863	Green Submitted, Green Published, gold			2022-12-27	WOS:000404145100017
J	Saunders, J; Parast, L; Babey, SH; Miles, JV				Saunders, Jessica; Parast, Layla; Babey, Susan H.; Miles, Jeremy V.			Exploring the differences between pet and non-pet owners: Implications for human animal interaction research and policy	PLOS ONE			English	Article							NEIGHBORHOOD CHARACTERISTICS; PHYSICAL-ACTIVITY; ASSISTED THERAPY; DOG OWNERSHIP; WEIGHT STATUS; HUMAN HEALTH; CHILDREN; METAANALYSIS; DISPARITIES; REGRESSION	There is conflicting evidence about whether living with pets results in better mental and physical health outcomes, with the majority of the empirical research evidence being inconclusive due to methodological limitations. We briefly review the research evidence, including the hypothesized mechanisms through which pet ownership may influence health outcomes. This study examines how pet and non-pet owners differ across a variety of sociodemographic and health measures, which has implications for the proper interpretation of a large number of correlational studies that attempt to draw causal attributions. We use a large, population-based survey from California administered in 2003 (n = 42,044) and find that pet owners and non-pet owners differ across many traits, including gender, age, race/ethnicity, living arrangements, and income. We include a discussion about how the factors associated with the selection into the pet ownership group are related to a range of mental and physical health outcomes. Finally, we provide guidance on how to properly model the effects of pet ownership on health to accurately estimate this relationship in the general population.	[Saunders, Jessica; Parast, Layla; Miles, Jeremy V.] RAND Corp, Santa Monica, CA USA; [Babey, Susan H.] Univ Calif Los Angeles, Ctr Hlth Policy Res, Los Angeles, CA USA	RAND Corporation; University of California System; University of California Los Angeles	Parast, L (corresponding author), RAND Corp, Santa Monica, CA USA.	parast@rand.org		Parast, Layla/0000-0002-7288-1009; Babey, Susan/0000-0001-8113-1739	Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01HD066591]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD066591] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by a grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD066591) to Jeremy Miles (https marl nih govfabout/ o mine rib ran chesicd bb/prams/psad/HAI/Pag es/overviekv aspx). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2008, ANNU REV PUBL HEALTH, V29, P235, DOI 10.1146/annurev.publhealth.29.020907.090852; Allen K, 2002, PSYCHOSOM MED, V64, P727, DOI 10.1097/01.PSY.0000024236.11538.41; Anderson KM, 2012, FAR HAVE WE COME RED; [Anonymous], 2012, FRONT PSYCHOL, DOI DOI 10.3389/FPSYG.2012.00234; Barak Y, 2001, ANIMAL ASSISTED THER, P439; Braun Carie, 2009, Complement Ther Clin Pract, V15, P105, DOI 10.1016/j.ctcp.2009.02.008; Braveman P, 2006, ANNU REV PUBL HEALTH, V27, P167, DOI 10.1146/annurev.publhealth.27.021405.102103; Brodie SJ, 1999, J CLIN NURS, V8, P329, DOI 10.1046/j.1365-2702.1999.00255.x; California Health Interview Survey, 2003, 1 UCLA CTR HLTH POL; California Health Interview Survey, 2005, CAL HLTH INT SURV CH; Chang YF, 1997, AM J PUBLIC HEALTH, V87, P1703, DOI 10.2105/AJPH.87.10.1703; Chen CM, 2008, EUR RESPIR J, V31, P963, DOI 10.1183/09031936.00092807; Coleman KJ, 2008, PREV MED, V47, P309, DOI 10.1016/j.ypmed.2008.05.007; Cutt H, 2008, AM J PUBLIC HEALTH, V98, P66, DOI 10.2105/AJPH.2006.103499; Downes M, 2009, PREV VET MED, V92, P140, DOI 10.1016/j.prevetmed.2009.07.005; Friedmann E, 2003, AM J CARDIOL, V91, P718, DOI 10.1016/S0002-9149(02)03412-4; FRIEDMANN E, 1980, PUBLIC HEALTH REP, V95, P307; GERSHMAN KA, 1994, PEDIATRICS, V93, P913; Hahn JY, 2001, ECONOMETRICA, V69, P201, DOI 10.1111/1468-0262.00183; Headey B, 1999, SOC INDIC RES, V47, P233, DOI 10.1023/A:1006892908532; Headey B, 2007, SOC INDIC RES, V80, P297, DOI 10.1007/s11205-005-5072-z; Herzog H, 2011, CURR DIR PSYCHOL SCI, V20, P236, DOI 10.1177/0963721411415220; Kaye AE, 76 ANN C AM SOC OF P; Lee S, 2009, AM J PUBLIC HEALTH, V99, P1811, DOI 10.2105/AJPH.2008.154161; Marino L, 2007, ANTHROZOOS, V20, P239, DOI 10.2752/089279307X224782; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; McCaffrey DF, 2004, PSYCHOL METHODS, V9, P403, DOI 10.1037/1082-989X.9.4.403; McGinnis JM, 2002, HEALTH AFFAIR, V21, P78, DOI 10.1377/hlthaff.21.2.78; Newey WK, 2003, ECONOMETRICA, V71, P1565, DOI 10.1111/1468-0262.00459; Nimer J, 2007, ANTHROZOOS, V20, P225, DOI 10.2752/089279307X224773; O'Haire ME, 2015, DEV PSYCHOBIOL, V57, P584, DOI 10.1002/dev.21310; Olmert M.D., 2009, MADE EACH OTHER BIOL; PAPPAS G, 1993, NEW ENGL J MED, V329, P103, DOI 10.1056/NEJM199307083290207; Parker GB, 2010, ACTA PSYCHIAT SCAND, V121, P65, DOI 10.1111/j.1600-0447.2009.01410.x; Pellmar TC, 2002, AM J HEALTH PROMOT, V16, P206, DOI 10.4278/0890-1171-16.4.206; Ponce NA, 2004, PUBLIC HEALTH REP, V119, P388, DOI 10.1016/j.phr.2004.05.002; RUBIN DB, 1974, J EDUC PSYCHOL, V66, P688, DOI 10.1037/h0037350; Schalamon J, 2006, PEDIATRICS, V117, pE374, DOI 10.1542/peds.2005-1451; Schroeder SA, 2007, NEW ENGL J MED, V357, P1221, DOI 10.1056/NEJMsa073350; Shadish WR, 2008, J AM STAT ASSOC, V103, P1334, DOI 10.1198/016214508000000733; Shepherd AJ, 2008, J AM VET MED ASSOC, V232, P695; Shiloh S, 2003, ANXIETY STRESS COPIN, V16, P387, DOI 10.1080/1061580031000091582; Takkouche B, 2008, ALLERGY, V63, P857, DOI 10.1111/j.1398-9995.2008.01732.x; Timperio A, 2008, HEALTH PROMOT J AUST, V19, P60, DOI 10.1071/HE08060; Vidrine Maureen, 2002, Issues Ment Health Nurs, V23, P587, DOI 10.1080/01612840290052730; Westgarth Carri, 2007, BMC Vet Res, V3, P5, DOI 10.1186/1746-6148-3-5	46	75	76	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179494	10.1371/journal.pone.0179494	http://dx.doi.org/10.1371/journal.pone.0179494			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY7CO	28644848	Green Published, Green Submitted, gold			2022-12-27	WOS:000404145100018
J	Schicho, A; Luerken, L; Stroszczynski, C; Meier, R; Schreyer, AG; Dendl, LM; Schleder, S				Schicho, Andreas; Luerken, Lukas; Stroszczynski, Christian; Meier, Ramona; Schreyer, Andreas G.; Dendl, Lena-Marie; Schleder, Stephan			Vascular geometry as a risk factor for non-penetrating traumatic injuries of the aortic	PLOS ONE			English	Article							MOTOR-VEHICLE CRASHES	Purpose To assess biomechanical factors in aortic arch geometry contributing to the development of non-penetrating aortic arch injury (NAAI) in multiply injured patients with an Injury Severity Score (ISS) >= 16. Material and methods 230 consecutive multiply injured trauma patients with an ISS >= 16 admitted to our Level-I trauma center during a consecutive 24-month period were prospectively included of whom 13 presented with NAAI (5.7%). Standardized whole-body CT in a 2x128-detector-row scanner included a head-and-neck CTA. Aortic arch diameters, width, height, angles and thoracic width and height were measured in individuals with NAAI and ISS-, sex-, age-, and trauma mechanism-matched controls. Results There was no difference between groups regarding sex, age, ISS, and aortic diameters. The aortic arch angle in individuals with NAAI (71.3 degrees +/- 14.9 degrees) was larger than in healthy control (60.7 degrees +/- 8.6 degrees; p*<0.05). In patients with NAAI, the distance between ascendent and descendent aorta was larger (5.2 cm +/- 1.9 cm) than in control (2.8 +/- 0.5 cm; ***p<0.001). The aortic arch is higher above tracheal bifurcation in NAAI (3.6 cm +/- 0.6 cm) than in matched control (2.4 cm +/- 0.3 cm; ***p<0.001). Accordingly, the area under the aortic arch, calculated as half of an eliptic shape, is significantly larger in patients with NAAI (15.0 cm2 +/- 6.5 cm2) when compared to age- and sex- matched controls without NAAI (5.5 cm2 +/- 1.3 cm2; ***p<0.001). Conclusion Besides the magnitude of deceleration and direction of impact, width and height of the aortic arch are the 3rd and 4th factor directly contributing to the risk of developing traumatic NAAI in severely injured patients.	[Schicho, Andreas; Luerken, Lukas; Stroszczynski, Christian; Meier, Ramona; Schreyer, Andreas G.; Dendl, Lena-Marie; Schleder, Stephan] Univ Med Ctr Regensburg, Dept Radiol, Regensburg, Germany	University of Regensburg	Schicho, A (corresponding author), Univ Med Ctr Regensburg, Dept Radiol, Regensburg, Germany.	andreas.schicho@ukr.de	Luerken, Lukas/X-6622-2019; Schreye, Andreas/ABC-3197-2020	Schreyer, Andreas/0000-0002-2539-059X; Schleder, Stephan/0000-0002-7785-3015				Bertrand S, 2008, TRAFFIC INJ PREV, V9, P153, DOI 10.1080/15389580701775777; Dehner Christoph, 2013, Glob J Health Sci, V5, P115, DOI 10.5539/gjhs.v5n3p115; Erbel R, 2006, HEART, V92, P137, DOI 10.1136/hrt.2004.055111; Ernstberger A, 2015, INJURY, V46, pS135, DOI 10.1016/S0020-1383(15)30033-4; Fitzharris M, 2004, J TRAUMA, V57, P582, DOI 10.1097/01.TA.0000088015.83951.D0; Frydrychowicz A, 2012, EUR RADIOL, V22, P1122, DOI 10.1007/s00330-011-2353-6; Martin G, 2016, BRAIN INJURY, V30, P1517, DOI 10.1080/02699052.2016.1192683; Neschis DG, 2008, NEW ENGL J MED, V359, P1708, DOI 10.1056/NEJMra0706159; O'Connor JV, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-42; Schicho A., 2017, VASCULAR GEOMETRY RI; Warwick R, 2013, MED HYPOTHESES, V80, P271, DOI 10.1016/j.mehy.2012.12.002; Wojciechowski J, 2016, SURG TODAY, P1	12	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0180066	10.1371/journal.pone.0180066	http://dx.doi.org/10.1371/journal.pone.0180066			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644901	Green Published, Green Submitted, gold			2022-12-27	WOS:000404145100061
J	Anunciado-Koza, RP; Manuel, J; Mynatt, RL; Zhang, JY; Kozak, LP; Koza, RA				Anunciado-Koza, Rea P.; Manuel, Justin; Mynatt, Randall L.; Zhang, Jingying; Kozak, Leslie P.; Koza, Robert A.			Diet-induced adipose tissue expansion is mitigated in mice with a targeted inactivation of mesoderm specific transcript (Mest)	PLOS ONE			English	Article							ALPHA/BETA-HYDROLASE FOLD; ACTIVATED-RECEPTOR-ALPHA; MESENCHYMAL STEM-CELLS; FAT MASS EXPANSION; GENE-EXPRESSION; EPOXYEICOSATRIENOIC ACIDS; GLUCOSE-HOMEOSTASIS; IMPRINTED GENE; IN-VIVO; ADIPOCYTE DIFFERENTIATION	Interindividual variation of white adipose tissue (WAT) expression of mesoderm specific transcript (Mest), a paternally-expressed imprinted gene belonging to the alpha/beta-hydrolase fold protein family, becomes apparent among genetically inbred mice fed high fat diet (HFD) and is positively associated with adipose tissue expansion (ATE). To elucidate a role for MEST in ATE, mice were developed with global and adipose tissue inactivation of Mest. Mice with homozygous (Mest(gKO)) and paternal allelic (Mest(pKO)) inactivation of Mest were born at expected Mendelian frequencies, showed no behavioral or physical abnormalities, and did not perturb expression of the Mest locus-derived microRNA miR-335. Mest(pKO) mice fed HFD showed reduced ATE and adipocyte hypertrophy, improved glucose tolerance, and reduced WAT expression of genes associated with hypoxia and inflammation compared to littermate controls. Remarkably, caloric intake and energy expenditure were unchanged between genotypes. Mice with adipose tissue inactivation of Mest were phenotypically similar to Mest(pKO), supporting a role for WAT MEST in ATE. Global profiling of WAT gene expression of HFD-fed control and Mest(pKO) mice detected few differences between genotypes; nevertheless, genes with reduced expression in Mest(pKO) mice were associated with immune processes and consistent with improved glucose homeostasis. Ear-derived mesenchymal stem cells (EMSC) from Mest(gKO) mice showed no differences in adipogenic differentiation compared to control cells unless challenged by shRNA knockdown of Gpat4, an enzyme that mediates lipid accumulation in adipocytes. Reduced adipogenic capacity of EMSC from Mest(gKO) after Gpat4 knockdown suggests that MEST facilitates lipid accumulation in adipocytes. Our data suggests that reduced diet-induced ATE in MEST-deficient mice diminishes hypoxia and inflammation in WAT leading to improved glucose tolerance and insulin sensitivity. Since inactivation of Mest in mice has minimal additional effects aside from reduction of ATE, an intervention that mitigates MEST function in adipocytes is a plausible strategy to obviate obesity and type-2-diabetes.	[Anunciado-Koza, Rea P.; Manuel, Justin; Koza, Robert A.] Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME 04070 USA; [Mynatt, Randall L.; Zhang, Jingying] LSU Syst, Pennington Biomed Res Ctr, Transgen Core Facil, Baton Rouge, LA USA; [Kozak, Leslie P.] Polish Acad Sci, Inst Anim Reprod & Food Res, Olsztyn, Poland	Maine Medical Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences	Koza, RA (corresponding author), Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME 04070 USA.	rkoza@mmc.org	zhang, jingying R/R-4262-2018; Mynatt, Randall L/N-1980-2017	Mynatt, Randall L/0000-0003-4399-0019; Koza, Robert/0000-0001-6994-7268	NIDDK [RO1DK090361]; Molecular Phenotyping and the Physiology Core Facilities at Maine Medical Center Research Institute - COBRE [NIGMS P30GM106391]; Viral Vector Core at Maine Medical Center Research Institute - COBRE [NIGMS P30GM103392]; Genomics, Cell Biology and Imaging, and Transgenic Core facilities at Pennington Biomedical Research Center - COBRE [NIGMS P20GM103528]; Genomics, Cell Biology and Imaging, and Transgenic Core facilities at Pennington Biomedical Research Center - NORC [NIDDK P30DK072476]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090361, P30DK072476] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Molecular Phenotyping and the Physiology Core Facilities at Maine Medical Center Research Institute - COBRE; Viral Vector Core at Maine Medical Center Research Institute - COBRE; Genomics, Cell Biology and Imaging, and Transgenic Core facilities at Pennington Biomedical Research Center - COBRE; Genomics, Cell Biology and Imaging, and Transgenic Core facilities at Pennington Biomedical Research Center - NORC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Studies were funded by NIDDK RO1DK090361 (R.A.K). Support was also provided by the Molecular Phenotyping and the Physiology Core Facilities at Maine Medical Center Research Institute funded by COBRE (NIGMS P30GM106391), the Viral Vector Core at Maine Medical Center Research Institute funded by COBRE (NIGMS P30GM103392), and the Genomics, Cell Biology and Imaging, and Transgenic Core facilities at Pennington Biomedical Research Center funded in part by COBRE (NIGMS P20GM103528) and NORC (NIDDK P30DK072476). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anunciado-Koza RP, 2016, ANN NY ACAD SCI, V1363, P50, DOI 10.1111/nyas.12958; Anunciado-Koza RP, 2016, BIOCHIMIE, V124, P134, DOI 10.1016/j.biochi.2015.05.007; Asterholm Ingrid Wernstedt, 2007, Drug Discov Today Dis Models, V4, P17; Barbagallo I, 2016, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00309; Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bluhre M, 2009, EXP CLIN ENDOCR DIAB, V117, P241, DOI 10.1055/s-0029-1192044; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; Bouchard C, 2010, AM J CLIN NUTR, V91, P5, DOI 10.3945/ajcn.2009.28933; Burcelin M, 2002, AM J PHYSIOL-ENDOC M, V282, pE834, DOI 10.1152/ajpendo.00332.2001; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; Chen YQ, 2008, J BIOL CHEM, V283, P10048, DOI 10.1074/jbc.M708151200; Cheng XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038979; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Cowart LA, 2002, J BIOL CHEM, V277, P35105, DOI 10.1074/jbc.M201575200; de Fourmestraux V, 2004, J BIOL CHEM, V279, P50743, DOI 10.1074/jbc.M408014200; Decker M, 2009, ARCH TOXICOL, V83, P297, DOI 10.1007/s00204-009-0416-0; Chu DT, 2014, J BIOL CHEM, V289, P18478, DOI 10.1074/jbc.M114.555821; Dorn C, 2010, INT J CLIN EXP PATHO, V3, P505; El Hajj N, 2013, DIABETES, V62, P1320, DOI 10.2337/db12-0289; Fang X, 2006, AM J PHYSIOL-HEART C, V290, pH55, DOI 10.1152/ajpheart.00427.2005; Fang X, 2005, J PHARMACOL EXP THER, V314, P260, DOI 10.1124/jpet.105.085605; Fuster JJ, 2015, DIABETES, V64, P1235, DOI 10.2337/db14-1164; Hiramuki Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130436; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Huang-Doran I, 2010, J ENDOCRINOL, V207, P245, DOI 10.1677/JOE-10-0272; Ineson J, 2012, J REPROD DEVELOP, V58, P490, DOI 10.1262/jrd.11-115A; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jung H, 2011, BIOCHEM J, V436, P263, DOI 10.1042/BJ20101512; Jura M, 2016, BIOCHIMIE, V124, P124, DOI 10.1016/j.biochi.2015.05.006; Kamei Y, 2007, FEBS LETT, V581, P91, DOI 10.1016/j.febslet.2006.12.002; KANEKOISHINO T, 1995, NAT GENET, V11, P52, DOI 10.1038/ng0995-52; Kanwar YS, 2002, AM J PHYSIOL-RENAL, V282, pF953, DOI 10.1152/ajprenal.00200.2001; Karbiener M, 2015, INT J OBESITY, V39, P1733, DOI 10.1038/ijo.2015.121; Kim DH, 2010, STEM CELLS DEV, V19, P1863, DOI 10.1089/scd.2010.0098; Kotronen A, 2009, DIABETES, V58, P203, DOI 10.2337/db08-1074; Koza RA, 2004, METABOLISM, V53, P799, DOI 10.1016/j.metabol.2003.12.024; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Kozak LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030392; Kozak LP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011015; Kumar RA, 2004, GENESIS, V38, P51, DOI 10.1002/gene.20001; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lefebvre L, 1998, NAT GENET, V20, P163, DOI 10.1038/2464; Lefebvre L, 1997, HUM MOL GENET, V6, P1907, DOI 10.1093/hmg/6.11.1907; Lenfant N, 2013, NUCLEIC ACIDS RES, V41, pD423, DOI 10.1093/nar/gks1154; Li SX, 2010, AM J CLIN NUTR, V91, P184, DOI 10.3945/ajcn.2009.28403; Lin X, 2014, J BONE MINER RES, V29, P1575, DOI 10.1002/jbmr.2163; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Marchot P, 2012, PROTEIN PEPTIDE LETT, V19, P132, DOI 10.2174/092986612799080284; Miyazaki M, 2004, J BIOL CHEM, V279, P35017, DOI 10.1074/jbc.M405327200; Moraes RC, 2003, ENDOCRINOLOGY, V144, P4773, DOI 10.1210/en.2003-0456; Nakanishi N, 2009, BIOCHEM BIOPH RES CO, V385, P492, DOI 10.1016/j.bbrc.2009.05.058; Nikonova L, 2008, FASEB J, V22, P3925, DOI 10.1096/fj.08-108266; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Park SY, 2005, ARCH BIOCHEM BIOPHYS, V436, P276, DOI 10.1016/j.abb.2005.01.010; Pires RC, 2014, APPL PHYSIOL NUTR ME, V39, P895, DOI 10.1139/apnm-2013-0520; Rim JS, 2005, FASEB J, V19, P1205, DOI 10.1096/fj.04-3204fje; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Rutkowski JM, 2015, J CELL BIOL, V208, P501, DOI 10.1083/jcb.201409063; Soubry A, 2015, INT J OBESITY, V39, P650, DOI 10.1038/ijo.2013.193; Soukas A, 2001, J BIOL CHEM, V276, P34167, DOI 10.1074/jbc.M104421200; Soukas A, 2000, GENE DEV, V14, P963; Spector AA, 2007, AM J PHYSIOL-CELL PH, V292, pC996, DOI 10.1152/ajpcell.00402.2006; Spector AA, 2009, J LIPID RES, V50, pS52, DOI 10.1194/jlr.R800038-JLR200; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Takahashi M, 2005, AM J PHYSIOL-ENDOC M, V288, pE117, DOI 10.1152/ajpendo.00244.2004; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Villanueva CJ, 2009, HEPATOLOGY, V50, P434, DOI 10.1002/hep.22980; Voigt A, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0477-z; Waldman M, 2016, STEM CELLS DEV, V25, P1084, DOI 10.1089/scd.2016.0072; Weiss EP, 2006, AM J CLIN NUTR, V84, P1033; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Yang YB, 2014, OBESITY, V22, P2147, DOI 10.1002/oby.20811; Zemany L, 2014, MOL CELL BIOL, V34, P1170, DOI 10.1128/MCB.01106-13; Zha WB, 2014, J LIPID RES, V55, P2124, DOI 10.1194/jlr.M053199; Zhu L, 2014, CELL BIOCHEM BIOPHYS, V68, P283, DOI 10.1007/s12013-013-9708-3; Zietak M, 2016, CELL METAB, V23, P1216, DOI 10.1016/j.cmet.2016.05.001	83	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179879	10.1371/journal.pone.0179879	http://dx.doi.org/10.1371/journal.pone.0179879			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640866	Green Published, Green Submitted, gold			2022-12-27	WOS:000404135800076
J	Delobel, JB; Gnep, K; Ospina, JD; Beckendorf, V; Chira, C; Zhu, J; Bossi, A; Messai, T; Acosta, O; Castelli, J; de Crevoisier, R				Delobel, Jean-Bernard; Gnep, Khemara; David Ospina, Juan; Beckendorf, Veronique; Chira, Ciprian; Zhu, Jian; Bossi, Alberto; Messai, Taha; Acosta, Oscar; Castelli, Joel; de Crevoisier, Renaud			Nomogram to predict rectal toxicity following prostate cancer radiotherapy	PLOS ONE			English	Article							MODULATED RADIATION-THERAPY; CONVENTIONALLY FRACTIONATED RADIOTHERAPY; DOSE-ESCALATION TRIAL; CONFORMAL RADIOTHERAPY; RANDOMIZED-TRIAL; INCREASED RISK; 68 GY; ASSOCIATION; MULTICENTER; FAILURE	Background To identify predictors of acute and late rectal toxicity following prostate cancer radiotherapy (RT), while integrating the potential impact of RT technique, dose escalation, and moderate hypofractionation, thus enabling us to generate a nomogram for individual prediction. Methods In total, 972 patients underwent RT for localized prostate cancer, to a total dose of 70 Gy or 80 Gy, using two different fractionations (2 Gy or 2.5 Gy/day), by means of several RT techniques (3D conformal RT [3DCRT], intensity-modulated RT [IMRT], or image-guided RT [IGRT]). Multivariate analyses were performed to identify predictors of acute and late rectal toxicity. A nomogram was generated based on the logistic regression model used to predict the 3-year rectal toxicity risk, with its accuracy assessed by dividing the cohort into training and validation subgroups. Results Mean follow-up for the entire cohort was 62 months, ranging from 6 to 235. The rate of acute Grade >= 2 rectal toxicity was 22.2%, decreasing when combining IMRT and IGRT, compared to 3DCRT (RR = 0.4, 95% CI: 0.3-0.6, p< 0.01). The 5-year Grade >= 2 risks for rectal bleeding, urgency/tenesmus, diarrhea, and fecal incontinence were 9.9%, 4.5%, 2.8%, and 0.4%, respectively. The 3-year Grade >= 2 risk for overall rectal toxicity increased with total dose (p< 0.01, RR = 1.1, 95% CI: 1.0-1.1) and dose per fraction (2Gy vs. 2.5Gy) (p = 0.03, RR = 3.3, 95% CI: 1.1-10.0), and decreased when combining IMRT and IGRT (RR = 0.50, 95% CI: 0.3-0.8, p< 0.01). Based on these three parameters, a nomogram was generated. Conclusions Dose escalation and moderate hypofractionation increase late rectal toxicity. IMRT combined with IGRT markedly decreases acute and late rectal toxicity. Performing combined IMRT and IGRT can thus be envisaged for dose escalation and moderate hypofractionation. Our nomogram predicts the 3-year rectal toxicity risk by integrating total dose, fraction dose, and RT technique.	[Delobel, Jean-Bernard] Ctr Hosp Univ Pontchaillou, Dept Gastroenterol, Rennes, France; [Gnep, Khemara; David Ospina, Juan; Zhu, Jian; Acosta, Oscar; Castelli, Joel; de Crevoisier, Renaud] Univ Rennes 1, INSERM, U1099, LTSI, Rennes, France; [Gnep, Khemara; Castelli, Joel; de Crevoisier, Renaud] Ctr Eugene Marquis, Rennes, France; [David Ospina, Juan] Univ Nacl Colombia, Escuela Estadist, Medellin, Colombia; [Beckendorf, Veronique; Chira, Ciprian] Ctr Alexis Vautrin, Vandoeuvre Les Nancy, France; [Bossi, Alberto; Messai, Taha] Inst Gustave Roussy, Villejuif, France; [Zhu, Jian] Southeast Univ, Lab Image Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Zhu, Jian; de Crevoisier, Renaud] CRIBs, Rennes, France	CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; UNICANCER; Centre Eugene Marquis; Universidad Nacional de Colombia; UNICANCER; Institut de cancerologie de Lorraine (ICL); UNICANCER; Gustave Roussy; Southeast University - China	Gnep, K (corresponding author), Univ Rennes 1, INSERM, U1099, LTSI, Rennes, France.; Gnep, K (corresponding author), Ctr Eugene Marquis, Rennes, France.	khemara.gnep@gmail.com	de Crevoisier, Renaud/ABD-7321-2020; CASTELLI, joël/P-6142-2018	CASTELLI, joël/0000-0001-6128-1836; Acosta, Oscar/0000-0002-5447-1479				Aluwini S, 2016, LANCET ONCOL, V17, P464, DOI 10.1016/S1470-2045(15)00567-7; Arcangeli S, 2012, INT J RADIAT ONCOL, V84, P1172, DOI 10.1016/j.ijrobp.2012.02.049; Beckendorf V, 2011, INT J RADIAT ONCOL, V80, P1056, DOI 10.1016/j.ijrobp.2010.03.049; Burri RJ, 2008, RADIAT RES, V170, P49, DOI 10.1667/RR1219.1; Cahlon O, 2008, SEMIN RADIAT ONCOL, V18, P48, DOI 10.1016/j.semradonc.2007.09.007; Coates J, 2015, RADIOTHER ONCOL, V115, P107, DOI 10.1016/j.radonc.2015.03.005; COX JD, 1995, INT J RADIAT ONCOL, V31, P1341, DOI 10.1016/0360-3016(95)00060-C; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Damaraju S, 2006, CLIN CANCER RES, V12, P2545, DOI 10.1158/1078-0432.CCR-05-2703; DCTD N NIH, 2006, CANC THER EV PROG CO; De Crevoisier R, 2005, INT J RADIAT ONCOL, V62, P965, DOI 10.1016/j.ijrobp.2004.11.032; Dearnaley D, 2012, LANCET ONCOL, V13, P43, DOI 10.1016/S1470-2045(11)70293-5; Dearnaley DP, 2007, LANCET ONCOL, V8, P475, DOI 10.1016/S1470-2045(07)70143-2; Drean G, 2016, RADIOTHER ONCOL; Engels B, 2009, INT J RADIAT ONCOL, V74, P388, DOI 10.1016/j.ijrobp.2008.08.007; Fiorino C, 2012, INT J RADIAT ONCOL, V83, P38, DOI 10.1016/j.ijrobp.2011.06.1953; Fiorino C, 2009, RADIOTHER ONCOL, V93, P153, DOI 10.1016/j.radonc.2009.08.004; Gami B, 2003, ALIMENT PHARM THER, V18, P987, DOI 10.1046/j.1365-2036.2003.01760.x; Heemsbergen WD, 2007, INT J RADIAT ONCOL, V67, P1418, DOI 10.1016/j.ijrobp.2006.11.014; Hoffman KE, 2014, INT J RADIAT ONCOL, V88, P1074, DOI 10.1016/j.ijrobp.2014.01.015; Incrocci L, 2016, LANCET ONCOL, V17, P1061, DOI 10.1016/S1470-2045(16)30070-5; Kok D, 2013, RADIOTHER ONCOL, V107, P140, DOI 10.1016/j.radonc.2013.04.007; Kuban DA, 2010, INT J RADIAT ONCOL, V78, pS58, DOI 10.1016/j.ijrobp.2010.07.170; Kuban DA, 2008, INT J RADIAT ONCOL, V70, P67, DOI 10.1016/j.ijrobp.2007.06.054; Landoni V, 2016, PHYS MEDICA, V32, P521, DOI 10.1016/j.ejmp.2016.03.003; Lee WR, 2016, J CLIN ONCOL, V34, DOI 10.1200/jco.2016.34.2_suppl.1; Lukka H, 2005, J CLIN ONCOL, V23, P6132, DOI 10.1200/JCO.2005.06.153; Marzi S, 2009, J EXP CLIN CANC RES, V28, P1; Ospina JD, 2014, INT J RADIAT ONCOL, V89, P1024, DOI 10.1016/j.ijrobp.2014.04.027; Peeters STK, 2005, INT J RADIAT ONCOL, V61, P1019, DOI 10.1016/j.ijrobp.2004.07.715; Pergolizzi S, 2013, DIGEST LIVER DIS, V45, P933, DOI 10.1016/j.dld.2013.04.012; Perrier L, 2013, RADIOTHER ONCOL, V106, P50, DOI 10.1016/j.radonc.2012.11.011; Pollack A, 2013, J CLIN ONCOL, V31, P3860, DOI 10.1200/JCO.2013.51.1972; RUBIN P, 1995, INT J RADIAT ONCOL, V31, P1041, DOI 10.1016/0360-3016(95)00057-6; Someya M, 2015, RADIOTHER ONCOL, V115, P235, DOI 10.1016/j.radonc.2015.04.008; Spratt DE, 2013, INT J RADIAT ONCOL, V85, P686, DOI 10.1016/j.ijrobp.2012.05.023; Stenmark MH, 2014, RADIOTHER ONCOL, V110, P291, DOI 10.1016/j.radonc.2014.01.007; Sveistrup J, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-44; Thurner EM, 2014, STRAHLENTHER ONKOL, V190, P304, DOI 10.1007/s00066-013-0485-0; Tucker SL, 2011, INT J RADIAT ONCOL, V81, P600, DOI 10.1016/j.ijrobp.2010.11.080; Valdagni R, 2012, INT J RADIAT ONCOL, V82, P1957, DOI 10.1016/j.ijrobp.2011.03.028; Valdagni R, 2009, INT J RADIAT ONCOL, V74, P1431, DOI 10.1016/j.ijrobp.2008.10.021; Valeriani M, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-137; Varela E, 2009, ALIMENT PHARM THER, V30, P175, DOI 10.1111/j.1365-2036.2009.04019.x; Viani GA, 2009, INT J RADIAT ONCOL, V74, P1405, DOI 10.1016/j.ijrobp.2008.10.091; Wachter S, 2000, RADIOTHER ONCOL, V54, P11, DOI 10.1016/S0167-8140(99)00173-5; Wedlake L, 2008, ALIMENT PHARM THER, V27, P980, DOI 10.1111/j.1365-2036.2008.03663.x; Wortel RC, 2015, INT J RADIAT ONCOL, V91, P737, DOI 10.1016/j.ijrobp.2014.12.017; Yeoh EE, 2011, INT J RADIAT ONCOL, V81, P1271, DOI 10.1016/j.ijrobp.2010.07.1984; Zelefsky MJ, 2012, INT J RADIAT ONCOL, V84, P125, DOI 10.1016/j.ijrobp.2011.11.047	50	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179845	10.1371/journal.pone.0179845	http://dx.doi.org/10.1371/journal.pone.0179845			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640871	gold, Green Published, Green Submitted			2022-12-27	WOS:000404135800072
J	Valigurova, A; Vaskovicova, N; Diakin, A; Paskerova, GG; Simdyanov, TG; Kovacikova, M				Valigurova, Andrea; Vaskovicova, Nadezda; Diakin, Andrei; Paskerova, Gita G.; Simdyanov, Timur G.; Kovacikova, Magdalena			Motility in blastogregarines (Apicomplexa): Native and drug-induced organisation of Siedleckia nematoides cytoskeletal elements	PLOS ONE			English	Article							FINE-STRUCTURE; MOLECULAR PHYLOGENY; GLIDING MOTILITY; FREEZE-FRACTURE; SUBPELLICULAR MICROTUBULES; GREGARINES APICOMPLEXA; TOXOPLASMA-GONDII; ACTIN; PARASITE; HOST	Recent studies on motility of Apicomplexa concur with the so-called glideosome concept applied for apicomplexan zoites, describing a unique mechanism of substrate-dependent gliding motility facilitated by a conserved form of actomyosin motor and subpellicular micro-tubules. In contrast, the gregarines and blastogregarines exhibit different modes and mechanisms of motility, correlating with diverse modifications of their cortex. This study focuses on the motility and cytoskeleton of the blastogregarine Siedleckia nematoides Caullery et Mesnil, 1898 parasitising the polychaete Scoloplos cf. armiger (Muller, 1776). The blastogregarine moves independently on a solid substrate without any signs of gliding motility; the motility in a liquid environment (in both the attached and detached forms) rather resembles a sequence of pendular, twisting, undulation, and sometimes spasmodic movements. Despite the presence of key glideosome components such as pellicle consisting of the plasma membrane and the inner membrane complex, actin, myosin, subpellicular microtubules, micronemes and glycocalyx layer, the motility mechanism of S. nematoides differs from the glideosome machinery. Nevertheless, experimental assays using cytoskeletal probes proved that the polymerised forms of actin and tubulin play an essential role in the S. nematoides movement. Similar to Selenidium archigregarines, the subpellicular microtubules organised in several layers seem to be the leading motor structures in blastogregarine motility. The majority of the detected actin was stabilised in a polymerised form and appeared to be located beneath the inner membrane complex. The experimental data suggest the subpellicular microtubules to be associated with filamentous structures (=cross-linking protein complexes), presumably of actin nature.	[Valigurova, Andrea; Diakin, Andrei; Kovacikova, Magdalena] Masaryk Univ, Fac Sci, Dept Bot & Zool, Kotlarska 2, Brno, Czech Republic; [Vaskovicova, Nadezda] Inst Sci Instruments CAS, Vvi, Kralovopolska 147, Brno, Czech Republic; [Paskerova, Gita G.] St Petersburg State Univ, Fac Biol, Dept Invertebrate Zool, Univ Skaya Emb 7-9, St Petersburg, Russia; [Simdyanov, Timur G.] Lomonosov Moscow State Univ, Dept Invertebrate Zool, Fac Biol, Leninskiye Gory 1-12, Moscow, Russia	Masaryk University Brno; Czech Academy of Sciences; Institute of Scientific Instruments of the Czech Academy of Sciences; Saint Petersburg State University; Lomonosov Moscow State University	Valigurova, A (corresponding author), Masaryk Univ, Fac Sci, Dept Bot & Zool, Kotlarska 2, Brno, Czech Republic.	andreav@sci.muni.cz	Paskerova, Gita G./H-3805-2014; Simdyanov, Timur G/H-8279-2012; Vaškovicová, Naděžda/G-1456-2014; Valigurová, Andrea/B-4522-2012	Paskerova, Gita G./0000-0002-1026-4216; Simdyanov, Timur G/0000-0003-2478-9301; Vaškovicová, Naděžda/0000-0003-4325-8565; Valigurová, Andrea/0000-0001-8313-1580	Czech Science Foundation [GBP505/12/G112]; Department of Botany and Zoology, Faculty of Science, Masaryk University; MEYS CR [L01212]; EC [CZ.1.05/2.1.00/01.0017]; Council of President of the Russian Federation [NSh-7770.2016.4]; Russian Foundation of Basic Researches [15-29-02601]; Czech-Biolmaging large RI project (MEYS CR) [LM2015062]	Czech Science Foundation(Grant Agency of the Czech Republic); Department of Botany and Zoology, Faculty of Science, Masaryk University; MEYS CR; EC(European CommissionEuropean Commission Joint Research Centre); Council of President of the Russian Federation; Russian Foundation of Basic Researches(Russian Foundation for Basic Research (RFBR)); Czech-Biolmaging large RI project (MEYS CR)	AV, AD and MK were funded from the project from Czech Science Foundation No. GBP505/12/G112 (ECIP - Centre of excellence) and acknowledge support from the Department of Botany and Zoology, Faculty of Science, Masaryk University, towards the preparation of this manuscript. NV was supported by MEYS CR (L01212) and its infrastructure by MEYS CR and EC (CZ.1.05/2.1.00/01.0017). TGS was supported by the grants from the Council of President of the Russian Federation NSh-7770.2016.4 and from the Russian Foundation of Basic Researches 15-29-02601. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the staff of the White Sea Biological Station of Lomonosov Moscow State University (WSBS MSU) and the Marine Biological Station of St. Petersburg State University (MBS SPbSU) for providing facilities for field sampling and material processing, as well as their kind and friendly approach. The authors are greatly indebted to the Laboratory of Electron Microscopy, Biology Centre CAS, supported by the Czech-Biolmaging large RI project (LM2015062 funded by MEYS CR) for their support and technical assistance with obtaining of EM data presented in this paper. The present study also utilised equipment of core facility centres 'Culturing of microorganisms', 'Observatory of Environmental Safety' and 'Development of molecular and cell technologies' of St. Petersburg State University. Many thanks to Prof. Dominique Soldati-Favre (University of Geneva) for kindly providing the monoclonal anti-actin antibody.	Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; BAINES I, 1989, CELL BIOL INT REP, V13, P679, DOI 10.1016/0309-1651(89)90044-1; BEAMS HW, 1959, J PROTOZOOL, V6, P136, DOI 10.1111/j.1550-7408.1959.tb03940.x; Beck JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001094; Boucher LE, 2015, J STRUCT BIOL, V190, P93, DOI 10.1016/j.jsb.2015.02.008; BRANTON D, 1975, SCIENCE, V190, P54, DOI 10.1126/science.1166299; Bullen HE, 2009, J BIOL CHEM, V284, P25353, DOI 10.1074/jbc.M109.036772; Caullery, 1898, Compte Rendu des Seances de la Societe de Biologie, Vv, P1093; Chatton E, 1936, CR HEBD ACAD SCI, V203, P505; CHATTON EDOUARD, 1929, ARCH ANAT MICROSC [PARIS], V25, P530; Chatton F, 1929, B ZOOL SOC FR, V54, P28; Chen WJ, 2001, J EUKARYOT MICROBIOL, V48, P537, DOI 10.1111/j.1550-7408.2001.tb00189.x; Crawley H., 1905, P ACAD NAT SCI PHILA, V57, P89; Daher W, 2009, CURR OPIN MICROBIOL, V12, P408, DOI 10.1016/j.mib.2009.06.008; DALLAI R, 1983, Bollettino di Zoologia, V50, P235; Desportes I., 2013, GREGARINES; Diakin A, 2016, PROTIST, V167, P279, DOI 10.1016/j.protis.2016.05.001; Dostal V, 2014, PROTOPLASMA, V251, P991, DOI 10.1007/s00709-014-0633-0; DUBREMETZ JF, 1978, J ULTRA MOL STRUCT R, V62, P94, DOI 10.1016/S0022-5320(78)90012-6; Egarter S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091819; Fowell R. R., 1936, Journal of the Royal Microscopical Society (3), V58, P12; Frenal K, 2010, CELL HOST MICROBE, V8, P343, DOI 10.1016/j.chom.2010.09.002; GHAZALI M, 1993, J EUKARYOT MICROBIOL, V40, P345, DOI 10.1111/j.1550-7408.1993.tb04927.x; GHAZALI M, 1989, BIOL CELL, V67, P173, DOI 10.1016/0248-4900(89)90052-X; Gould SB, 2008, MOL BIOL EVOL, V25, P1219, DOI 10.1093/molbev/msn070; Guha-Niyogi A, 2001, GLYCOBIOLOGY, V11, p45R, DOI 10.1093/glycob/11.4.45R; GUNDERSON J, 1986, J PARASITOL, V72, P107, DOI 10.2307/3281801; Hakansson S, 1999, MOL BIOL CELL, V10, P3539, DOI 10.1091/mbc.10.11.3539; Harding CR, 2014, CELL MICROBIOL, V16, P632, DOI 10.1111/cmi.12285; Hayat MA, 2000, PRINCIPLES AND TECHNIQUES OF ELECTRON MICROSCOPY: BIOLOGICAL APPLICATIONS, FOURTH EDITION, P1; Heintzelman MB, 2008, J PARASITOL, V94, P158, DOI 10.1645/GE-1339.1; Heintzelman MB, 2004, CELL MOTIL CYTOSKEL, V58, P83, DOI 10.1002/cm.10178; HILDEBRAND HF, 1980, Z PARASITENKD, V64, P29, DOI 10.1007/BF00927055; Hliscs M, 2015, CELL MICROBIOL, V17, P207, DOI 10.1111/cmi.12359; KING CA, 1982, EXPERIENTIA, V38, P1051, DOI 10.1007/BF01955361; KING CA, 1981, CELL BIOL INT REP, V5, P297, DOI 10.1016/0309-1651(81)90228-9; KOBAYASHI H, 1988, PROTOPLASMA, V143, P29, DOI 10.1007/BF01282956; Kuhni-Boghenbor K, 2012, CELL MICROBIOL, V14, P1867, DOI 10.1111/cmi.12006; Kumpula EP, 2015, ACTA CRYSTALLOGR F, V71, P500, DOI 10.1107/S2053230X1500391X; Landers SC, 2001, SYST PARASITOL, V48, P55, DOI 10.1023/A:1026572223364; Leander BS, 2007, ZOOL SCR, V36, P213, DOI 10.1111/j.1463-6409.2007.00272.x; Leander BS, 2006, MAR BIOL RES, V2, P178, DOI 10.1080/17451000600724395; Leander BS, 2006, PROTIST, V157, P45, DOI 10.1016/j.protis.2005.10.002; MACGREGO.HC, 1965, J PROTOZOOL, V12, P438, DOI 10.1111/j.1550-7408.1965.tb03239.x; MACKENZIE C, 1983, J PROTOZOOL, V30, P3, DOI 10.1111/j.1550-7408.1983.tb01024.x; MACMILLAN WG, 1973, J PROTOZOOL, V20, P267, DOI 10.1111/j.1550-7408.1973.tb00874.x; Mann T, 2001, MOL BIOCHEM PARASIT, V115, P257, DOI 10.1016/S0166-6851(01)00289-4; MCLAREN DJ, 1979, PARASITOLOGY, V79, P125, DOI 10.1017/S0031182000052021; MELLOR JS, 1980, J EXP BIOL, V87, P149; Menard R, 2001, CELL MICROBIOL, V3, P63, DOI 10.1046/j.1462-5822.2001.00097.x; MILES H B, 1968, Revista Iberica de Parasitologia, V28, P455; MILES H. R., 1966, REV IBERICA PARASITOL, V26, P361; Morrissette NS, 2002, MICROBIOL MOL BIOL R, V66, P21, DOI 10.1128/MMBR.66.1.21-38.2002; Morrissette NS, 2004, MOL BIOL CELL, V15, P1960, DOI 10.1091/mbc.E03-07-0530; Morrissette NS, 2002, J CELL SCI, V115, P1017; Raibaud A, 2001, J STRUCT BIOL, V135, P47, DOI 10.1006/jsbi.2001.4396; RICHTER IE, 1959, PROTOPLASMA, V51, P197, DOI 10.1007/BF01252489; Sampathkumar A, 2011, PLANT CELL, V23, P2302, DOI 10.1105/tpc.111.087940; Santos JM, 2009, INT J PARASITOL, V39, P153, DOI 10.1016/j.ijpara.2008.10.007; SCHREVEL J, 1974, CR ACAD SCI D NAT, V278, P2201; SCHREVEL J, 1971, Protistologica, V7, P101; SCHREVEL J, 1971, J PROTOZOOL, V18, P448, DOI 10.1111/j.1550-7408.1971.tb03355.x; SCHREVEL J, 1983, J CELL SCI, V61, P151; Schrevel J, 2016, PROTIST, V167, P339, DOI 10.1016/j.protis.2016.06.001; Schuler H, 2006, TRAFFIC, V7, P1433, DOI 10.1111/j.1600-0854.2006.00484.x; Simdyanov TG, 2007, EUR J PROTISTOL, V43, P17, DOI 10.1016/j.ejop.2006.09.003; STEBBING.H, 1974, CELL TISSUE RES, V148, P331; Tardieux I, 2016, J CELL BIOL, V214, P507, DOI 10.1083/jcb.201605100; Tran JQ, 2012, EUKARYOT CELL, V11, P206, DOI 10.1128/EC.05161-11; Valigurova A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125063; Valigurova A, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-57; Valigurova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042606; Valigurova A, 2009, INT J PARASITOL, V39, P1235, DOI 10.1016/j.ijpara.2009.04.009; VANDERBERG JP, 1974, J PROTOZOOL, V21, P527, DOI 10.1111/j.1550-7408.1974.tb03693.x; VIVIER E, 1964, J MICROSC-PARIS, V3, P651; Wakeman KC, 2014, PROTIST, V165, P493, DOI 10.1016/j.protis.2014.05.007; WALKER MH, 1984, J ULTRA MOL STRUCT R, V88, P66, DOI 10.1016/S0022-5320(84)90182-5; WARNER FD, 1968, J PROTOZOOL, V15, P59, DOI 10.1111/j.1550-7408.1968.tb02090.x; Whitelaw JA, 2017, BMC BIOL, V15, DOI 10.1186/s12915-016-0343-5	79	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179709	10.1371/journal.pone.0179709	http://dx.doi.org/10.1371/journal.pone.0179709			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640849	Green Published, Green Submitted, gold			2022-12-27	WOS:000404135800054
J	Jiang, SH; Park, S; Challapalli, SD; Fei, JY; Wang, Y				Jiang, Shenghang; Park, Seongjin; Challapalli, Sai Divya; Fei, Jingyi; Wang, Yong			Robust nonparametric quantification of clustering density of molecules in singlemolecule localization microscopy	PLOS ONE			English	Article							PAIR-CORRELATION-ANALYSIS; OPTICAL RECONSTRUCTION MICROSCOPY; SUPERRESOLUTION FLUORESCENCE; QUANTITATIVE-ANALYSIS; SPATIAL-ORGANIZATION; NATURAL PATTERNS; RNA-POLYMERASE; IN-VIVO; REVEALS; RECEPTOR	We report a robust nonparametric descriptor, J'(r), for quantifying the density of clustering molecules in single-molecule localization microscopy. J'(r), based on nearest neighbor distribution functions, does not require any parameter as an input for analyzing point patterns. We show that J'(r) displays a valley shape in the presence of clusters of molecules, and the characteristics of the valley reliably report the clustering features in the data. Most importantly, the position of the J'(r) valley (r(J'm)) depends exclusively on the density of clustering molecules (rho(c)). Therefore, it is ideal for direct estimation of the clustering density of molecules in single-molecule localization microscopy. As an example, this descriptor was applied to estimate the clustering density of ptsG mRNA in E. coli bacteria.	[Jiang, Shenghang; Wang, Yong] Univ Arkansas, Dept Phys, Fayetteville, AR 72701 USA; [Park, Seongjin; Fei, Jingyi] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Challapalli, Sai Divya; Wang, Yong] Univ Arkansas, Microelect & Photon Grad Program, Fayetteville, AR 72701 USA; [Fei, Jingyi] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Wang, Yong] Univ Arkansas, Cell & Mol Biol Program, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Chicago; University of Arkansas System; University of Arkansas Fayetteville; University of Chicago; University of Arkansas System; University of Arkansas Fayetteville	Wang, Y (corresponding author), Univ Arkansas, Dept Phys, Fayetteville, AR 72701 USA.; Wang, Y (corresponding author), Univ Arkansas, Microelect & Photon Grad Program, Fayetteville, AR 72701 USA.; Wang, Y (corresponding author), Univ Arkansas, Cell & Mol Biol Program, Fayetteville, AR 72701 USA.	yongwang@uark.edu	Park, Seongjin/AAU-9963-2020	Wang, Yong/0000-0002-8601-8302	Human Frontier Science Program [LT000752/2014-C]; Arkansas Biosciences Institute [ABI-0189]; Institute for Biophysical Dynamics at The University of Chicago	Human Frontier Science Program(Human Frontier Science Program); Arkansas Biosciences Institute; Institute for Biophysical Dynamics at The University of Chicago	This work was supported partially by the Human Frontier Science Program (http://www.htsp.org LT000752/2014-C to Y.W.) and the Arkansas Biosciences Institute (http://arbiosciences.org/; ABI-0189 to Y.W.). S.P. was supported by the Yen Postdoctoral fellowship from the Institute for Biophysical Dynamics at The University of Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andronov L, 2016, SCI REP-UK, V6, DOI 10.1038/srep24084; Ankerst M, 1999, SIGMOD RECORD, VOL 28, NO 2 - JUNE 1999, P49; [Anonymous], 2021, LANG ENV STAT COMP; Ricci MA, 2015, CELL, V160, P1145, DOI 10.1016/j.cell.2015.01.054; Baddeley A, 1997, ANN STAT, V25, P263; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Baddeley A, 2015, SPATIAL POINT PATTER; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Boettiger AN, 2016, NATURE, V529, P418, DOI 10.1038/nature16496; Buss J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005128; Caetano FA, 2015, PLOS COMPUTATIONAL B, V11, P1; Daszykowski M, 2002, J CHEM INF COMP SCI, V42, P500, DOI 10.1021/ci010384s; Daszykowski M, 2001, CHEMOMETR INTELL LAB, V56, P83, DOI 10.1016/S0169-7439(01)00111-3; Deschout H, 2014, HISTOCHEM CELL BIOL, V142, P5, DOI 10.1007/s00418-014-1217-y; Diggle P., 2003, STAT ANAL SPATIAL PO; Doksani Y, 2013, CELL, V155, P345, DOI 10.1016/j.cell.2013.09.048; Ehmann N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5650; Endesfelder U, 2013, BIOPHYS J, V105, P172, DOI 10.1016/j.bpj.2013.05.048; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Fei JY, 2015, SCIENCE, V347, P1371, DOI 10.1126/science.1258849; Garcia-Parajo MF, 2014, J CELL SCI, V127, P4995, DOI 10.1242/jcs.146340; Haas BL, 2015, MOL MICROBIOL, V96, P4, DOI 10.1111/mmi.12834; Hanisch K.H., 1984, MATH OPER STAT, V15, P409, DOI [DOI 10.1080/02331888408801788, 10.1080/02331888408801788]; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Kerscher M, 1999, ASTROPHYS J, V513, P543, DOI 10.1086/306902; Kiskowski MA, 2009, BIOPHYS J, V97, P1095, DOI 10.1016/j.bpj.2009.05.039; Klein T, 2014, HISTOCHEM CELL BIOL, V141, P561, DOI 10.1007/s00418-014-1184-3; Kopek BG, 2012, P NATL ACAD SCI USA, V109, P6136, DOI 10.1073/pnas.1121558109; Lagache T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080914; Levet F, 2015, NATURE METHODS, V12; Muranyi W, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003198; Nan XL, 2013, P NATL ACAD SCI USA, V110, P18519, DOI 10.1073/pnas.1318188110; RIPLEY BD, 1988, STAT INFERENCE SPATI, DOI DOI 10.1038/NCOMMS5650; Rossy J, 2013, NAT IMMUNOL, V14, P82, DOI 10.1038/ni.2488; Rubin-Delanchy P, 2015, NATURE METHODS, V12; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Scarselli M, 2012, J BIOL CHEM, V287, P16768, DOI 10.1074/jbc.M111.329912; Sengupta P, 2013, NAT PROTOC, V8, P345, DOI 10.1038/nprot.2013.005; Sengupta P, 2012, BIOESSAYS, V34, P396, DOI 10.1002/bies.201200022; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/nmeth.1704, 10.1038/NMETH.1704]; Sherman E, 2011, IMMUNITY, V35, P705, DOI 10.1016/j.immuni.2011.10.004; Stracy M, 2015, P NATL ACAD SCI USA, V112, pE4390, DOI 10.1073/pnas.1507592112; van Lieshout MNM, 1996, STAT ANAL SPATIAL PO; Wang Y, 2016, BIOPHYS J, V111, P467, DOI 10.1016/j.bpj.2016.06.033; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251	46	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179975	10.1371/journal.pone.0179975	http://dx.doi.org/10.1371/journal.pone.0179975			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636661	gold, Green Published, Green Submitted			2022-12-27	WOS:000404118300064
J	Ahmadi, S; Davami, F; Davoudi, N; Nematpour, F; Ahmadi, M; Ebadat, S; Azadmanesh, K; Barkhordari, F; Mahboudi, F				Ahmadi, Samira; Davami, Fatemeh; Davoudi, Noushin; Nematpour, Fatemeh; Ahmadi, Maryam; Ebadat, Saeedeh; Azadmanesh, Kayhan; Barkhordari, Farzaneh; Mahboudi, Fereidoun			Monoclonal antibodies expression improvement in CHO cells by PiggyBac transposition regarding vectors ratios and design	PLOS ONE			English	Article							PROTEIN-PRODUCTION; HIGHLY EFFICIENT; RECOMBINANT; GENERATION; SEQUENCE; IMPACT; LINES	Establishing stable Chinese Hamster Ovary (CHO) cells producing monoclonal antibodies (mAbs) usually pass through the random integration of vectors to the cell genome, which is sensitive to gene silencing. One approach to overcome this issue is to target a highly transcribed region in the genome. Transposons are useful devices to target active parts of genomes, and PiggyBac (PB) transposon can be considered as a good option. In the present study, three PB transposon donor vectors containing both heavy and light chains were constructed, one contained independent expression cassettes while the others utilized either an Internal Ribosome Entry Site (IRES) or 2A element to express mAb. Conventional cell pools were created by transferring donor vectors into the CHO cells, whereas transposon-based cells were generated by transfecting the cells with donor vectors with a companion of a transposase-encoding helper vector, with 1:2.5 helper/donor vectors ratio. To evaluate the influence of helper/donor vectors ratio on expression, the second transposon-based cell pools were generated with 1:5 helper/donor ratio. Expression levels in the transposon-based cells were two to five-folds more than those created by conventional method except for the IRES-mediated ones, in which the observed difference increased more than 100-fold. The results were dependent on both donor vector design and vectors ratios.	[Ahmadi, Samira; Davami, Fatemeh; Davoudi, Noushin; Nematpour, Fatemeh; Ebadat, Saeedeh; Barkhordari, Farzaneh; Mahboudi, Fereidoun] Pasteur Inst Iran, Biotechnol Res Ctr, Tehran, Iran; [Ahmadi, Maryam] Semnan Univ Med Sci, Med Biotechnol Dept, Semnan, Iran; [Azadmanesh, Kayhan] Pasteur Inst Iran, Dept Virol, Tehran, Iran	Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Semnan University of Medical Sciences; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran	Mahboudi, F (corresponding author), Pasteur Inst Iran, Biotechnol Res Ctr, Tehran, Iran.	mahboudi@pasteur.ac.ir	barkhordari, farzaneh/AAB-3783-2020; barkhordari, farzaneh/AAE-1137-2020; Azadmanesh, kayhan/W-2445-2017	barkhordari, farzaneh/0000-0003-0500-1726; Azadmanesh, kayhan/0000-0002-7165-9043	Pasteur Institute of Iran	Pasteur Institute of Iran	This work was supported by Pasteur Institute of Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare no conflict of interest. Also, the authors wish to thank Dr. Ahmad Adeli and Reza Moazzami for their technical supports. The current study was supported by a grant from the Pasteur Institute of Iran.	Ahmadi M, 2016, BIOTECHNOLOGY PROGR; Alattia JR, 2013, BIOTECHNOL BIOENG, V110, P1995, DOI 10.1002/bit.24851; Balasubramanian S, 2016, BIOTECHNOL BIOENG, V113, P1234, DOI 10.1002/bit.25888; Balasubramanian S, 2015, J BIOTECHNOL, V200, P61, DOI 10.1016/j.jbiotec.2015.03.001; Bochkov YA, 2006, BIOTECHNIQUES, V41, P283, DOI 10.2144/000112243; Cacciatore JJ, 2010, BIOTECHNOL ADV, V28, P673, DOI 10.1016/j.biotechadv.2010.04.003; Chng J, 2015, MABS-AUSTIN, V7, P403, DOI 10.1080/19420862.2015.1008351; Chung NPY, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-33; Davies SL, 2011, BIOTECHNOL PROGR, V27, P1689, DOI 10.1002/btpr.692; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Frye C. C., 2013, J BIOTECHNOL, V168, P4, DOI DOI 10.1016/J.JBI0TEC.2013.08.021; Haryadi R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116878; Ho S.-H., 2015, INT J MARKETING STUD, V7, DOI [10.5539/ijms.v7n2p10, DOI 10.5539/IJMS.V7N2P10]; Ho SCL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063247; Ho SCL, 2013, J BIOTECHNOL, V165, P157, DOI 10.1016/j.jbiotec.2013.03.019; Ho SCL, 2012, J BIOTECHNOL, V157, P130, DOI 10.1016/j.jbiotec.2011.09.023; Inada E, 2015, INT J ORAL SCI, V7, P144, DOI 10.1038/ijos.2015.18; Kim A, 2011, MOL CELL BIOCHEM, V354, P301, DOI 10.1007/s11010-011-0832-3; Kim JY, 2011, APPL MICROBIOL BIOT, V89, P1917, DOI 10.1007/s00253-011-3106-9; Kunert R, 2016, APPL MICROBIOL BIOT, V100, P3451, DOI 10.1007/s00253-016-7388-9; Li JD, 2007, J IMMUNOL METHODS, V318, P113, DOI 10.1016/j.jim.2006.10.010; Li M, 2012, MOL THER, V20, P46, DOI 10.1038/mt.2011.197; Liu JM, 2014, PROTEIN J, V33, P174, DOI 10.1007/s10930-014-9550-5; Mason M, 2012, BIOTECHNOL PROGR, V28, P846, DOI 10.1002/btpr.1542; Matasci M, 2011, BIOTECHNOL BIOENG, V108, P2141, DOI 10.1002/bit.23167; Meir YJJ, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-28; Meir YJJ, 2013, FASEB J, V27, P4429, DOI 10.1096/fj.12-223586; Mossine VV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085494; Nematpour F, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-017-0330-0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rajendra Y, 2016, BIOTECHNOLOGY PROGR; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Woodard LE, 2015, TRENDS BIOTECHNOL, V33, P525, DOI 10.1016/j.tibtech.2015.06.009; Ye JX, 2010, BIOTECHNOL PROGR, V26, P1431, DOI 10.1002/btpr.469; Zhao S, 2016, TRANSL LUNG CANCER R, V5, P120, DOI 10.3978/j.issn.2218-6751.2016.01.05	35	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179902	10.1371/journal.pone.0179902	http://dx.doi.org/10.1371/journal.pone.0179902			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662065	Green Submitted, gold, Green Published			2022-12-27	WOS:000404608300068
J	Trucco, LD; Roselli, E; Araya, P; Nunez, NG; Mena, HA; Bocco, JL; Negrotto, S; Maccioni, M				Daniel Trucco, Lucas; Roselli, Emiliano; Araya, Paula; Gonzalo Nunez, Nicolas; Agustina Mena, Hebe; Luis Bocco, Jose; Negrotto, Soledad; Maccioni, Mariana			Downregulation of adaptor protein MyD88 compromises the angiogenic potential of B16 murine melanoma	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; INNATE IMMUNITY; TUMOR-GROWTH; CANCER; CELLS; INFLAMMATION; ACTIVATION; EXPRESSION; HYPOXIA; METASTASIS	The mechanisms that link inflammatory responses to cancer development remain a subject of intense investigation, emphasizing the need to better understand the cellular and molecular pathways that create a tumor promoting microenvironment. The myeloid differentiation primary response protein MyD88 acts as a main adaptor molecule for the signaling cascades initiated from Toll-like receptors (TLRs) and the interleukin 1 receptor (IL-1R). MyD88 has been shown to contribute to tumorigenesis in many inflammation-associated cancer models. In this study, we sought to better define the role of MyD88 in neoplastic cells using a murine melanoma model. Herein, we have demonstrated that MyD88 expression is required to maintain the angiogenic switch that supports B16 melanoma growth. By knocking down MyD88 we reduced TLR-mediated NF-B-K activation with no evident effects over cell proliferation and survival. In addition, MyD88 downregulation was associated with a decrease of HIF1 alpha levels and its target gene VEGF, in correlation with an impaired capability to induce capillary sprouting and tube formation of endothelial cells. Melanomas developed from cells lacking MyD88 showed an enhanced secretion of chemoattractant ligands such as CCL2, CXCL10 and CXCL1 and have an improved infiltration of macrophages to the tumor site. Our results imply that cell-autonomous signaling through MyD88 is required to sustain tumor growth and underscore its function as an important positive modulator of tumor angiogenesis.	[Daniel Trucco, Lucas; Roselli, Emiliano; Araya, Paula; Luis Bocco, Jose; Maccioni, Mariana] Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Bioquim Clin & Inmunol CIBICI, Consejo Nacl Invest Cient & Tecn CONICET,Dept Bio, Cordoba, Argentina; [Gonzalo Nunez, Nicolas] Inst Curie, INSERM, U932, Lab Transfert,Lab Immunol, Paris, France; [Agustina Mena, Hebe; Negrotto, Soledad] Acad Nacl Med Buenos Aires, Lab Trombosis Expt, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Buenos Aires National Academy of Medicine	Maccioni, M (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Bioquim Clin & Inmunol CIBICI, Consejo Nacl Invest Cient & Tecn CONICET,Dept Bio, Cordoba, Argentina.	mmaccioni@fcq.unc.edu.ar	Araya, Paula/AAC-3641-2021	Araya, Paula/0000-0002-0340-5359; Roselli, Emiliano/0000-0001-6048-7170; Mena, Hebe Agustina/0000-0003-1724-8582	Fondo Nacional de Ciencia y Tecnologia-Prestamo [BID PICT 2011 2657/PICT 2013 1068, PIP CONICET 2012/2014 11220110100921]; Institute Nacional del Cancer Convocatoria [SECyT-UNC 366/16]	Fondo Nacional de Ciencia y Tecnologia-Prestamo; Institute Nacional del Cancer Convocatoria	This study was funded by Fondo Nacional de Ciencia y Tecnologia-Prestamo BID PICT 2011 2657/PICT 2013 1068 to MM, PIP CONICET 2012/2014 11220110100921, Institute Nacional del Cancer Convocatoria 2015 to MM, SECyT-UNC 366/16 to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2008, CURR OPIN GENET DEV, V18, P3, DOI 10.1016/j.gde.2008.01.003; Andreani V, 2007, CANCER RES, V67, P10519, DOI 10.1158/0008-5472.CAN-07-0079; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; Banerjee A, 2014, INFECT IMMUN, V82, P356, DOI 10.1128/IAI.01344-13; Cataisson C, 2012, J EXP MED, V209, P1689, DOI 10.1084/jem.20101355; Coste I, 2010, J CLIN INVEST, V120, P3663, DOI 10.1172/JCI42771; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Galluzzi L, 2012, ONCOIMMUNOLOGY, V1, P699, DOI 10.4161/onci.20696; Gatti G, 2009, PROSTATE, V69, P1387, DOI 10.1002/pros.20984; Nunez NG, 2012, CANCER RES, V72, P592, DOI 10.1158/0008-5472.CAN-11-0534; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Je EM, 2012, TUMORI, V98, P663, DOI 10.1700/1190.13209; Jia RJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.71; Kelly MG, 2006, CANCER RES, V66, P3859, DOI 10.1158/0008-5472.CAN-05-3948; Kfoury A, 2013, JNCI-J NATL CANCER I, V105, P937, DOI 10.1093/jnci/djt120; Liang BB, 2013, CLIN CANCER RES, V19, P2905, DOI 10.1158/1078-0432.CCR-12-1245; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Miyake K, 2004, SEMIN IMMUNOL, V16, P11, DOI 10.1016/j.smim.2003.10.007; Moroishi T, 2016, CELL, V167, P1525, DOI 10.1016/j.cell.2016.11.005; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Pradere JP, 2014, ONCOGENE, V33, P3485, DOI 10.1038/onc.2013.302; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Saharinen P, 2011, TRENDS MOL MED, V17, P347, DOI 10.1016/j.molmed.2011.01.015; Sakurai T, 2011, ONCOLOGY-BASEL, V81, P24, DOI 10.1159/000333256; Salcedo R, 2013, TRENDS IMMUNOL, V34, P379, DOI 10.1016/j.it.2013.03.008; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Scheeren FA, 2014, NAT CELL BIOL, V16, P1238, DOI 10.1038/ncb3058; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Swann JB, 2008, P NATL ACAD SCI USA, V105, P652, DOI 10.1073/pnas.0708594105; Tang DL, 2010, BBA-GENE REGUL MECH, V1799, P131, DOI 10.1016/j.bbagrm.2009.11.014; Trucco LD, 2014, FASEB J; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; van Beijnum JR, 2013, ONCOGENE, V32, P363, DOI 10.1038/onc.2012.49; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Wang EL, 2010, BRIT J CANCER, V102, P908, DOI 10.1038/sj.bjc.6605558; Warner N, 2013, J IMMUNOL, V190, P3, DOI 10.4049/jimmunol.1203103; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Zhu Y, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-77	46	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179897	10.1371/journal.pone.0179897	http://dx.doi.org/10.1371/journal.pone.0179897			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662055	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300066
J	Phillips, JS; Pilling, GM; Leroy, B; Evans, K; Usu, T; Lam, CH; Schaefer, KM; Nicol, S				Phillips, Joe Scutt; Pilling, Graham M.; Leroy, Bruno; Evans, Karen; Usu, Thomas; Lam, Chi Hin; Schaefer, Kurt M.; Nicol, Simon			Revisiting the vulnerability of juvenile bigeye (Thunnus obesus) and yellowfin (T-albacares) tuna caught by purse-seine fisheries while associating with surface waters and floating objects	PLOS ONE			English	Article							FISH-AGGREGATING DEVICES; SKIPJACK KATSUWONUS-PELAMIS; EASTERN PACIFIC-OCEAN; TROPICAL TUNA; HABITAT UTILIZATION; VERTICAL MOVEMENTS; SPECIES COMPOSITION; ECOLOGICAL TRAP; BEHAVIOR; CATCHES	Tuna fisheries catch over three million tonnes of skipjack tuna (Katsuwonus pelamis) each year, the majority of which come from purse-seine vessels targeting fish associated with man-made fish aggregating devices (FADs). A significant challenge for fisheries management is to maximize the efficiency of skipjack tuna catches whilst minimizing the bycatch of small and immature bigeye (Thunnus obesus) and yellowfin (T. albacares) tuna, for which long-term sustainability is uncertain in 75% of the world's stocks. To better manage the issues common with this fishing method, an improved understanding of tuna behaviour around FADs is necessary. We probabilistically classified the vertical behavioural patterns of 50 bigeye and 35 yellowfin tuna (mean fork length 72cm and 70cm, respectively) electronically tagged throughout the western and central Pacific Ocean into shallow and deep states, using a state-space modelling approach. The occurrence of surface-association behaviours, defined as an individual remaining in a shallow state for 24-hours, was examined in relation to known capture events and FAD density. In general, surface-association events for both species were short and lasted on average less than three days, although events as long as 28 days were observed, and were more common in yellowfin when in archipelagic waters. Events were longest immediately following tagging in 62% and 17% of bigeye and yellowfin, respectively. Surface-association behaviour was not generally estimated just prior to recapture, being either non-existent or shorter than two days for 85% of bigeye and 74% of yellowfin. Current management measures in purse-seine tuna fisheries involve periodic or spatial closures for FAD use. If the chief benefit to purse-seine fishers of surface-association around floating objects is in locating schools in horizontal space at short-term time-scales, rather than holding fish near the surface for extended periods, controlling the number of sets made on FADs should be explored further as an additional management tool.	[Phillips, Joe Scutt] Univ New South Wales, Climate Change Res Ctr, Sydney, NSW, Australia; [Pilling, Graham M.; Leroy, Bruno] Pacific Community SPC, Ocean Fisheries Programme, Noumes, New Caledonia; [Evans, Karen] CSIRO, Marine & Atmosphere Res, Hobart, Tas, Australia; [Usu, Thomas] Natl Fisheries Author, Port Moresby, Papua N Guinea; [Lam, Chi Hin] Univ Massachusetts, Large Pelag Res Ctr, Gloucester, MA USA; [Schaefer, Kurt M.] Interamer Trop Tuna Commiss, La Jolla, CA USA; [Nicol, Simon] Australian Bur Agr & Resource Econ & Sci, Canberra, ACT, Australia	University of New South Wales Sydney; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Massachusetts System	Phillips, JS (corresponding author), Univ New South Wales, Climate Change Res Ctr, Sydney, NSW, Australia.	j.scuttphillips@unsw.edu.au	evans, karen/D-7110-2012	Nicol, Simon/0000-0001-8193-8719; Evans, Karen/0000-0003-2205-4264	Engineering and Physical Sciences Research Council [EP/G03690X/1JSP]; Lenfest Ocean Program JSP; Australian Research Council [LP140100327]	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Lenfest Ocean Program JSP; Australian Research Council(Australian Research Council)	Funded by Engineering and Physical Sciences Research Council EP/G03690X/1JSP, Lenfest Ocean Program JSP, Australian Research Council LP140100327.	Albert JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115386; Allain V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036701; Bromhead D., 2003, REV IMPACTS FISH AGG; Dagorn L, 1999, CAN J FISH AQUAT SCI, V56, P984, DOI 10.1139/cjfas-56-6-984; Dagorn L, 2000, AQUAT LIVING RESOUR, V13, P203, DOI 10.1016/S0990-7440(00)01065-2; Dagorn L, 2007, MAR BIOL, V151, P595, DOI 10.1007/s00227-006-0511-1; Dagorn L, 2010, FISH RES, V106, P60, DOI 10.1016/j.fishres.2010.07.002; Dempster T, 2004, REV FISH BIOL FISHER, V14, P21, DOI 10.1007/s11160-004-3151-x; Evans K, 2015, MAR POLICY, V59, P94, DOI 10.1016/j.marpol.2015.05.003; Evans K, 2013, DEEP-SEA RES PT II, V88-89, P1, DOI 10.1016/j.dsr2.2012.10.005; Evans K, 2008, CAN J FISH AQUAT SCI, V65, P2427, DOI 10.1139/F08-148; Fernandez E, 2010, SPC FISHERIES NEWSLE, V133, P35; Fonteneau A, 2000, AQUAT LIVING RESOUR, V13, P253, DOI 10.1016/S0990-7440(00)01054-8; Fonteneau A, 1999, WORLDWIDE REV PURSE; Fonteneau A, 2013, AQUAT LIVING RESOUR, V26, P37, DOI 10.1051/alr/2013046; Freon P, 2000, REV FISH BIOL FISHER, V10, P183, DOI 10.1023/A:1016666108540; Fuller DW, 2015, FISH RES, V172, P57, DOI 10.1016/j.fishres.2015.06.024; Fuller DW, 2014, ICES J MAR SCI, V71, P1774, DOI 10.1093/icesjms/fsu012; Girard C, 2004, ANIM BEHAV, V67, P319, DOI 10.1016/j.anbehav.2003.07.007; Guillotreau P, 2011, FISH RES; Hallier JP, 2008, MAR ECOL PROG SER, V353, P255, DOI 10.3354/meps07180; Hampton J, 1992, P INT WORKSH EC FISH, P222; Hampton J., 2010, TUNA FISHERIES STATU; Hare SR, 2015, FISH RES, V172, P361, DOI 10.1016/j.fishres.2015.08.004; Holland K., 1996, SPC FISH AGGREGATING, V2, P2; Hoolihan JP, 2011, ICES J MAR SCI, V68, P880, DOI 10.1093/icesjms/fsr024; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; IATTC, 2013, MULT PROGR CONV TUN; IATTC, 2015, TUN BILLF OTH PEL SP; ISSF, 2016, 201605 ISSF; Jaquemet S, 2011, FISH RES, V107, P283, DOI 10.1016/j.fishres.2010.11.011; Lam CH, 2008, FISH RES, V91, P15, DOI 10.1016/j.fishres.2007.11.002; Leroy BM, 2010, VERTICAL BEHAV OBSER, P21, DOI [10.1007/978-1-4020-9640-210, DOI 10.1007/978-1-4020-9640-210]; Leroy B, 2015, FISH RES, V163, P23, DOI 10.1016/j.fishres.2013.09.001; Leroy B, 2013, AQUAT LIVING RESOUR, V26, P49, DOI 10.1051/alr/2012033; Magnuson J., 1973, FISH B B, V71; Marsac F, 1999, DRIFTING FADS USED T; Matsumoto T, 2013, FISH OCEANOGR, V22, P234, DOI 10.1111/fog.12017; Maufroy A, 2017, ICES J MAR SCI, V74, P215, DOI 10.1093/icesjms/fsw175; Miyake M., 2010, RECENT DEV TUNA IND; Moreno G, 2016, FISH RES, V178, P122, DOI 10.1016/j.fishres.2015.09.021; Moreno G, 2007, CAN J FISH AQUAT SCI, V64, P1517, DOI 10.1139/F07-113; Ohta I, 2005, MAR BIOL, V146, P581, DOI 10.1007/s00227-004-1456-x; Patterson TA, 2009, J ANIM ECOL, V78, P1113, DOI 10.1111/j.1365-2656.2009.01583.x; Phillips JS, 2015, ECOL APPL, V25, P1244, DOI 10.1890/14-0862.1; Pilling G, 2013, 9 REGUL SESS, P1; Pilling GM, 2014, PURSE SEINE CPUE SKI; QGIS Development Team, 2009, QGIS GEOGR INF SYST; Robert M, 2013, MAR ECOL PROG SER, V484, P239, DOI 10.3354/meps10303; Robert M, 2012, MAR BIOL, V159, P907, DOI 10.1007/s00227-011-1868-3; Rudnick DL, 2004, MAR TECHNOL SOC J, V38, P73, DOI 10.4031/002533204787522703; Schaefer KM, 2005, MAR BIOL, V146, P781, DOI 10.1007/s00227-004-1480-x; Schaefer K, 2015, FISH RES, V161, P336, DOI 10.1016/j.fishres.2014.08.018; Schaefer KM, 2007, MAR BIOL, V152, P503, DOI 10.1007/s00227-007-0689-x; Schaefer KM, 2014, FISH OCEANOGR, V23, P65, DOI 10.1111/fog.12047; Schaefer KM, 2013, MAR BIOL, V160, P3005, DOI 10.1007/s00227-013-2290-9; Schaefer KM, 2010, MAR BIOL, V157, P2625, DOI 10.1007/s00227-010-1524-3; Schaefer Kurt M., 2005, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V57, P67; Schaefer KM, 2009, REV-METHODS TECHNOL, V9, P121, DOI 10.1007/978-1-4020-9640-2_8; Sempo G, 2013, J APPL ECOL, V50, P1081, DOI 10.1111/1365-2664.12140; Sippel T, 2014, FISH RES; Trygonis V, 2016, FISH RES, V177, P39, DOI 10.1016/j.fishres.2016.01.013; WCPFC, 2014, FAD MARK MAN DISC PA; Williams P, 2012, OVERVIEW TUNA FISHER; Williams P, 2016, OVERVIEW TUNA FISHER	65	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179045	10.1371/journal.pone.0179045	http://dx.doi.org/10.1371/journal.pone.0179045			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662091	gold, Green Published, Green Submitted			2022-12-27	WOS:000404608300015
J	Wasser, SK; Lundin, JI; Ayres, K; Seely, E; Giles, D; Balcomb, K; Hempelmann, J; Parsons, K; Booth, R				Wasser, Samuel K.; Lundin, Jessica I.; Ayres, Katherine; Seely, Elizabeth; Giles, Deborah; Balcomb, Kenneth; Hempelmann, Jennifer; Parsons, Kim; Booth, Rebecca			Population growth is limited by nutritional impacts on pregnancy success in endangered Southern Resident killer whales (Orcinus orca)	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; PAPIO-CYNOCEPHALUS-CYNOCEPHALUS; THYROID-HORMONE; TURSIOPS-TRUNCATUS; POLYCHLORINATED-BIPHENYLS; EUBALAENA-GLACIALIS; REPRODUCTIVE STATUS; MARINE MAMMALS; DETECTION DOGS; DIVERSE ARRAY	The Southern Resident killer whale population (Orcinus orca) was listed as endangered in 2005 and shows little sign of recovery. These fish eating whales feed primarily on endangered Chinook salmon. Population growth is constrained by low offspring production for the number of reproductive females in the population. Lack of prey, increased toxins and vessel disturbance have been listed as potential causes of the whale's decline, but partitioning these pressures has been difficult. We validated and applied temporal measures of progesterone and testosterone metabolites to assess occurrence, stage and health of pregnancy from genotyped killer whale feces collected using detection dogs. Thyroid and glucocorticoid hormone metabolites were measured from these same samples to assess physiological stress. These methods enabled us to assess pregnancy occurrence and failure as well as how pregnancy success was temporally impacted by nutritional and other stressors, between 2008 and 2014. Up to 69% of all detectable pregnancies were unsuccessful; of these, up to 33% failed relatively late in gestation or immediately post-partum, when the cost is especially high. Low availability of Chinook salmon appears to be an important stressor among these fish-eating whales as well as a significant cause of late pregnancy failure, including unobserved perinatal loss. However, release of lipophilic toxicants during fat metabolism in the nutritionally deprived animals may also provide a contributor to these cumulative effects. Results point to the importance of promoting Chinook salmon recovery to enhance population growth of Southern Resident killer whales. The physiological measures used in this study can also be used to monitor the success of actions aimed at promoting adaptive management of this important apex predator to the Pacific Northwest.	[Wasser, Samuel K.; Lundin, Jessica I.; Ayres, Katherine; Seely, Elizabeth; Booth, Rebecca] Univ Washington, Ctr Conservat Biol, Dept Biol, Seattle, WA 98195 USA; [Giles, Deborah; Balcomb, Kenneth] Ctr Whale Res, Friday Harbor, WA USA; [Hempelmann, Jennifer; Parsons, Kim] Natl Ocean & Atmospher Adm Fisheries, Northwest Fisheries Ctr, Seattle, WA USA	University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA	Wasser, SK (corresponding author), Univ Washington, Ctr Conservat Biol, Dept Biol, Seattle, WA 98195 USA.	wassers@uw.edu	Wasser, Samuel K/I-5542-2015		National Oceanic and Atmospheric Administration (NOAA) [NA10OAR417005]; U.S. Environmental Protection Agency STAR Fellowship Assistance [91735201]	National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); U.S. Environmental Protection Agency STAR Fellowship Assistance	This work was supported by the National Oceanic and Atmospheric Administration (NOAA), award no. NA10OAR417005. No role played by funder. U.S. Environmental Protection Agency STAR Fellowship Assistance Agreement no. 91735201 also supported this work. No role played by funder.	Alava JJ, 2012, ENVIRON SCI TECHNOL, V46, P12655, DOI 10.1021/es303062q; Ayres KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036842; Baird RW, 2001, CAN FIELD NAT, V115, P676; Bianco AC, 2006, J CLIN INVEST, V116, P2571, DOI 10.1172/JCI29812; BONGAARTS J, 1980, SCIENCE, V208, P564, DOI 10.1126/science.7367878; BOON JP, 1994, EUR J PHARM-ENVIRON, V270, P237, DOI 10.1016/0926-6917(94)90068-X; Brent LJN, 2015, CURR BIOL, V25, P746, DOI 10.1016/j.cub.2015.01.037; Brett J.R., 1995, P3; Brouwer A, 1998, TOXICOL IND HEALTH, V14, P59, DOI 10.1177/074823379801400107; Canadian Press, 2013, 1 NAT EXP POLL CHEM; Chinook Albion, 2014, FISHERIES OCEANS CAN; Costa Lucio G, 2008, Acta Biomed, V79, P172; Cullon DL, 2009, ENVIRON TOXICOL CHEM, V28, P148, DOI 10.1897/08-125.1; deSwart RL, 1996, ENVIRON HEALTH PERSP, V104, P823, DOI 10.2307/3432713; Douyon L, 2002, ENDOCRIN METAB CLIN, V31, P173, DOI 10.1016/S0889-8529(01)00023-8; du Dot TJ, 2009, PHYSIOL BIOCHEM ZOOL, V82, P516, DOI 10.1086/603637; Ford JKB, 200542 CAN SCI ADV S; Ford MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144956; Ford MJ, 2011, J HERED, V102, P537, DOI 10.1093/jhered/esr067; Hall AJ, 2006, ENVIRON HEALTH PERSP, V114, P60, DOI 10.1289/ehp.8053; Hanson MB, 2013, J ACOUST SOC AM, V134, P3486, DOI 10.1121/1.4821206; Hanson M. Bradley, 2010, Endangered Species Research, V11, P69, DOI 10.3354/esr00263; Hayward LS, 2010, GEN COMP ENDOCR, V169, P117, DOI 10.1016/j.ygcen.2010.08.004; Hilborn R., 2012, EFFECTS SALMON FISHE; Jepson PD, 2005, ENVIRON TOXICOL CHEM, V24, P238, DOI 10.1897/03-663.1; LAHVIS GP, 1995, ENVIRON HEALTH PERSP, V103, P67, DOI 10.2307/3432414; Lee D, 2014, FASEB J S, V28; Lundin JI, 2016, ENVIRON SCI TECHNOL, V50, P6506, DOI 10.1021/acs.est.6b00825; Lundin JI, 2015, ARCH ENV CONTAM TOXI; Mesa MG, 2006, RIVER RES APPL, V22, P1085, DOI 10.1002/rra.955; Mongillo TM, 2012, MAR ECOL PROG SER, V453, P263, DOI 10.3354/meps09658; Murphy S., 2010, J NORTHWEST ATL FISH, V42, P153, DOI [10.2960/J.v42.m658, DOI 10.2960/J.V42.M658]; National Oceanic and Atmospheric Administration (NOAA), PRIOR ACT 2016 2020; Olesiuk P.F., 1990, Reports of the International Whaling Commission Special Issue, P209; Reddy ML, 2001, SCI TOTAL ENVIRON, V274, P171, DOI 10.1016/S0048-9697(01)00741-0; Robeck TR, 2016, GEN COMP ENDOCR, V236, P83, DOI 10.1016/j.ygcen.2016.07.010; Robeck TR, 2015, J MAMMAL, V96, P1055, DOI 10.1093/jmammal/gyv113; Robeck TR, 2001, CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION, P193; Robeck TR, 2016, GEN COMP ENDOCRINOLO; Rolland RM, 2005, GEN COMP ENDOCR, V142, P308, DOI 10.1016/j.ygcen.2005.02.002; Rolland Rosalind M., 2006, Journal of Cetacean Research and Management, V8, P121; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schwacke LH, 2002, ENVIRON TOXICOL CHEM, V21, P2752, DOI 10.1897/1551-5028(2002)021<2752:PRAORE>2.0.CO;2; Shukovsky P., 1999, TRIBE SOUNDS ALARM F, pA1; Sinha N, 2014, CASE REPORTS CRITICA; SMITH CA, 1947, AM J OBSTET GYNECOL, V53, P599, DOI 10.1016/0002-9378(47)90277-9; Stetz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055967; Velloso AL, 1998, GEN COMP ENDOCR, V112, P96, DOI 10.1006/gcen.1998.7147; Ward E, 2013, NMFSNWFSC123 NOAA; Ward EJ, ECOSPHERE, V7; Ward EJ, 2009, J APPL ECOL, V46, P632, DOI 10.1111/j.1365-2664.2009.01647.x; Wasser SK, 2010, GEN COMP ENDOCR, V168, P1, DOI 10.1016/j.ygcen.2010.04.004; WASSER SK, 1983, Q REV BIOL, V58, P513, DOI 10.1086/413545; WASSER SK, 1994, J REPROD FERTIL, V101, P213; Wasser SK, 2004, CAN J ZOOL, V82, P475, DOI 10.1139/Z04-020; Wasser SK, 2001, FOUND HUM B, P137; Wasser SK, 2000, GEN COMP ENDOCR, V120, P260, DOI 10.1006/gcen.2000.7557; WASSER SK, 1993, J REPROD FERTIL, V97, P569, DOI 10.1530/jrf.0.0970569; West KL, 2014, GEN COMP ENDOCR, V197, P73, DOI 10.1016/j.ygcen.2013.11.021; Wiles G.J., 2016, PERIODIC STATUS REV; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wunderink YS, 2012, COMP BIOCHEM PHYS A, V162, P317, DOI 10.1016/j.cbpa.2012.03.023	62	75	77	6	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179824	10.1371/journal.pone.0179824	http://dx.doi.org/10.1371/journal.pone.0179824			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662095	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300052
J	Amat, SB; Rowan, MJM; Gaffield, MA; Bonnan, A; Kikuchi, C; Taniguchi, H; Christie, JM				Amat, Samantha B.; Rowan, Matthew J. M.; Gaffield, Michael A.; Bonnan, Audrey; Kikuchi, Chikako; Taniguchi, Hiroki; Christie, Jason M.			Using c-kit to genetically target cerebellar molecular layer interneurons in adult mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MOUSE CEREBELLUM; PURKINJE-CELLS; GRANULE CELLS; INHIBITORY INTERNEURONS; CORTICAL-NEURONS; NEURAL CIRCUITS; RAT CEREBELLUM; MAST-CELLS; IN-VIVO	The cerebellar system helps modulate and fine-tune motor action. Purkinje cells (PCs) provide the sole output of the cerebellar cortex, therefore, any cerebellar involvement in motor activity must be driven by changes in PC firing rates. Several different cell types influence PC activity including excitatory input from parallel fibers and inhibition from molecular layer interneurons (MLIs). Similar to PCs, MLI activity is driven by parallel fibers, therefore, MLIs provide feed-forward inhibition onto PCs. To aid in the experimental assessment of how molecular layer inhibition contributes to cerebellar function and motor behavior, we characterized a new knock-in mouse line with Cre recombinase expression under control of endogenous c-kit transcriptional machinery. Using these engineered c-Kit mice, we were able to obtain high levels of conditional MLI transduction in adult mice using Cre-dependent viral vectors without any PC or granule cell labeling. We then used the mouse line to target MLIs for activity perturbation in vitro using opto-and chemogenetics.	[Amat, Samantha B.; Rowan, Matthew J. M.; Gaffield, Michael A.; Bonnan, Audrey; Kikuchi, Chikako; Taniguchi, Hiroki; Christie, Jason M.] Max Planck Florida Inst Neurosci, Jupiter, FL 33458 USA	Max Planck Society	Christie, JM (corresponding author), Max Planck Florida Inst Neurosci, Jupiter, FL 33458 USA.	jason.christie@mpfi.org	Core, Vector/CAF-4832-2022		Max Planck Society; Max Planck Florida Institute for Neuroscience; National Institutes of Health [NS083984, NS083127]; Japan Science and Technology Agency; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS083127, R01NS083894] Funding Source: NIH RePORTER	Max Planck Society(Max Planck Society); Max Planck Florida Institute for Neuroscience; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Max Planck Society (Max Planck Gesellschaft; H.T and J.M.C., https://www.mpg.de/en), the Max Planck Florida Institute for Neuroscience (H.T. and J.M.C., https://www.maxplanckflorida.org), the National Institutes of Health Grants (NS083984 [J.M.C.] and NS083127 [M.J.M.R.], https://www.nih.gov/), and the Japan Science and Technology Agency (JSTP RESTO; H.T., http://www.jst.go.jp/EN/)	Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Astorga G, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00275; Berrozpe G, 2006, MOL CELL BIOL, V26, P5850, DOI 10.1128/MCB.01854-05; Besser S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129934; Boyden ES, 2004, ANNU REV NEUROSCI, V27, P581, DOI 10.1146/annurev.neuro.27.070203.144238; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Carta M, 2004, J NEUROSCI, V24, P3746, DOI 10.1523/JNEUROSCI.0067-04.2004; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Crowley JJ, 2009, NEURON, V63, P843, DOI 10.1016/j.neuron.2009.09.004; D'Angelo E, 2008, FRONT NEUROSCI-SWITZ, V2, P35, DOI 10.3389/neuro.01.008.2008; Deisseroth K, 2015, NAT NEUROSCI, V18, P1213, DOI 10.1038/nn.4091; DETALAMONI NT, 1993, P NATL ACAD SCI USA, V90, P11949, DOI 10.1073/pnas.90.24.11949; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Eccles JC, 1967, CEREBELLUM NEURONAL; Eriksson B, 2000, FEBS LETT, V479, P106, DOI 10.1016/S0014-5793(00)01893-7; Gaffield MA, 2017, J NEUROSCI, V37, P4751, DOI 10.1523/JNEUROSCI.0534-17.2017; Geurts FJ, 2001, NEUROSCIENCE, V104, P499, DOI 10.1016/S0306-4522(01)00058-6; Gibson DA, 2014, NEURON, V81, P1040, DOI 10.1016/j.neuron.2014.01.009; Grimaldi P, 2009, DEV BIOL, V328, P422, DOI 10.1016/j.ydbio.2009.02.008; He M, 2016, NEURON; Heger K, 2014, EUR J IMMUNOL, V44, P296, DOI 10.1002/eji.201343731; Heiney SA, 2014, J NEUROSCI, V34, P2321, DOI 10.1523/JNEUROSCI.4547-13.2014; Huang Z Josh, 2014, Cold Spring Harb Protoc, V2014, P150, DOI 10.1101/pdb.top080374; Jelitai M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13722; Jorntell H, 2010, TRENDS NEUROSCI, V33, P524, DOI 10.1016/j.tins.2010.08.004; Kim J, 2014, CELL REP, V7, P1601, DOI 10.1016/j.celrep.2014.04.047; Klein S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2626; Kuhn B, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00049; Lennartsson J, 2012, PHYSIOL REV, V92, P1619, DOI 10.1152/physrev.00046.2011; Lisberger SG, 2010, NEURON, V66, P477, DOI 10.1016/j.neuron.2010.03.027; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MANOVA K, 1992, J NEUROSCI, V12, P4663; Marillat V, 2002, J COMP NEUROL, V442, P130, DOI 10.1002/cne.10068; Mauk MD, 2000, CURR BIOL, V10, pR522, DOI 10.1016/S0960-9822(00)00584-4; Medina JF, 2011, CURR OPIN NEUROBIOL, V21, P616, DOI 10.1016/j.conb.2011.05.025; MORII E, 1992, DEV BRAIN RES, V65, P123, DOI 10.1016/0165-3806(92)90016-P; Nadal-Ginard B, 2014, CIRC RES, V115, P415, DOI 10.1161/CIRCRESAHA.114.304676; Nathanson JL, 2009, NEUROSCIENCE, V161, P441, DOI 10.1016/j.neuroscience.2009.03.032; OHISHI H, 1994, NEURON, V13, P55, DOI 10.1016/0896-6273(94)90459-6; Palay S. L., 1974, CEREBELLAR CORTEX CY; Paul A, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00037; Rodrigo J, 2001, BRAIN RES, V909, P20, DOI 10.1016/S0006-8993(01)02613-0; Schilling K, 2009, CEREBELLUM, V8, P477, DOI 10.1007/s12311-009-0124-6; Simat M, 2007, J COMP NEUROL, V500, P71, DOI 10.1002/cne.21142; Stachniak TJ, 2014, NEURON, V82, P797, DOI 10.1016/j.neuron.2014.04.008; Sternson SM, 2014, ANNU REV NEUROSCI, V37, DOI 10.1146/annurev-neuro-071013-014048; Sudarov A, 2011, J NEUROSCI, V31, P11055, DOI 10.1523/JNEUROSCI.0479-11.2011; Sultan F, 1998, J COMP NEUROL, V393, P353; Takayama K, 2008, NEUROSCI LETT, V443, P7, DOI 10.1016/j.neulet.2008.07.058; TAKEDA H, 1992, DIFFERENTIATION, V51, P121, DOI 10.1111/j.1432-0436.1992.tb00688.x; Tallini YN, 2009, P NATL ACAD SCI USA, V106, P1808, DOI 10.1073/pnas.0808920106; THACH WT, 1968, J NEUROPHYSIOL, V31, P785, DOI 10.1152/jn.1968.31.5.785; van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309; Vervaeke K, 2012, SCIENCE, V335, P1624, DOI 10.1126/science.1215101; VINCENT SR, 1992, NEUROSCIENCE, V46, P755, DOI 10.1016/0306-4522(92)90184-4	58	9	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179347	10.1371/journal.pone.0179347	http://dx.doi.org/10.1371/journal.pone.0179347			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658323	Green Published, gold, Green Submitted			2022-12-27	WOS:000404607900021
J	Cesnovar, R; Strumbelj, E				Cesnovar, Rok; Strumbelj, Erik			Bayesian Lasso and multinomial logistic regression on GPU	PLOS ONE			English	Article							PARALLEL; COMPUTATION; INFERENCE; MODELS	We describe an efficient Bayesian parallel GPU implementation of two classic statistical models the Lasso and multinomial logistic regression. We focus on parallelizing the key components: matrix multiplication, matrix inversion, and sampling from the full conditionals. Our GPU implementations of Bayesian Lasso and multinomial logistic regression achieve 100-fold speedups on mid-level and high-end GPUs. Substantial speedups of 25 fold can also be achieved on older and lower end GPUs. Samplers are implemented in OpenCL and can be used on any type of GPU and other types of computational units, thereby being convenient and advantageous in practice compared to related work.	[Cesnovar, Rok; Strumbelj, Erik] Univ Ljubljana, Fac Comp & Informat Sci, Vecna Pot 113, Ljubljana 1000, Slovenia	University of Ljubljana	Strumbelj, E (corresponding author), Univ Ljubljana, Fac Comp & Informat Sci, Vecna Pot 113, Ljubljana 1000, Slovenia.	erik.strumbelj@fri.uni-lj.si			Slovenian Research Agency (ARRS) [L1-7542]	Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia)	The work was supported by the Slovenian Research Agency (ARRS, https://www.arrs.gov.si/en/) applied project grant L1-7542. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew R, 2014, PARALLEL COMPUT, V40, P161, DOI 10.1016/j.parco.2014.03.003; Beam AL, 2016, J COMPUT GRAPH STAT, V25, P536, DOI 10.1080/10618600.2015.1035724; Bishop C. M, 2006, PATTERN RECOGNITION; BOX GEP, 1958, ANN MATH STAT, V29, P610, DOI 10.1214/aoms/1177706645; Cossio P, 2017, COMPUT PHYS COMMUN, V210, P163, DOI 10.1016/j.cpc.2016.09.014; da Silva AF, 2010, R J, V2, P48; Demchik V, 2014, COMPUTER SCI, V1, P13; Devroye L, 2009, STAT PROBABIL LETT, V79, P2251, DOI 10.1016/j.spl.2009.07.028; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Johndrow JE, ARXIV160505798; Lai JJ, 2013, INT SYM CODE GENER, P89; Lee A, 2010, J COMPUT GRAPH STAT, V19, P769, DOI 10.1198/jcgs.2010.10039; LOUTERNOOL M, 1992, APPL NUMER MATH, V10, P37, DOI 10.1016/0168-9274(92)90054-H; Luc D., 1986, NONUNIFORM RANDOM VA; Mahfoudhi R, 2012, FED CONF COMPUT SCI, P553; Manssen M, 2012, EUR PHYS J-SPEC TOP, V210, P53, DOI 10.1140/epjst/e2012-01637-8; Marsaglia G., 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i14, DOI 10.18637/JSS.V008.I18, 10.18637/jss.v008.i18]; NVIDIA Corporation, 2007, NVIDIA CUDA COMP UN; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Polson N. G., 2013, BAYESIAN INFERENCE L; Polson NG, 2013, J AM STAT ASSOC, V108, P1339, DOI 10.1080/01621459.2013.829001; Suchard MA, 2010, J COMPUT GRAPH STAT, V19, P419, DOI 10.1198/jcgs.2010.10016; Takaishi T, 2015, J PHYS CONF SER, V574, DOI 10.1088/1742-6596/574/1/012143; Tan G., 2011, P INT C HIGH PERF CO, P1, DOI DOI 10.1145/2063384.2063431; Terenin A, 2016, ARXIV160804329; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Windle J., 2014, ARXIV14050506; Yan F., 2009, ADV NEURAL INFORM PR, V22, P2134	28	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180343	10.1371/journal.pone.0180343	http://dx.doi.org/10.1371/journal.pone.0180343			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658298	gold, Green Published, Green Submitted			2022-12-27	WOS:000404607900072
J	Harmsen, BJ; Foster, RJ; Sanchez, E; Gutierrez-Gonzalez, CE; Silver, SC; Ostro, LET; Kelly, MJ; Kay, E; Quigley, H				Harmsen, Bart J.; Foster, Rebecca J.; Sanchez, Emma; Gutierrez-Gonzalez, Carmina E.; Silver, Scott C.; Ostro, Linde E. T.; Kelly, Marcella J.; Kay, Elma; Quigley, Howard			Long term monitoring of jaguars in the Cockscomb Basin Wildlife Sanctuary, Belize; Implications for camera trap studies of carnivores	PLOS ONE			English	Article							PANTHERA-ONCA; POPULATION VIABILITY; SYMPATRIC JAGUARS; HABITAT USE; CONSERVATION; PUMAS; VARIANCE; DYNAMICS; BEHAVIOR; DENSITY	In this study, we estimate life history parameters and abundance for a protected jaguar population using camera-trap data from a 14-year monitoring program (2002 - 2015) in Belize, Central America. We investigated the dynamics of this jaguar population using 3,075 detection events of 105 individual adult jaguars. Using robust design open population models, we estimated apparent survival and temporary emigration and investigated individual heterogeneity in detection rates across years. Survival probability was high and constant among the years for both sexes (phi = 0.78), and the maximum (conservative) age recorded was 14 years. Temporary emigration rate for the population was random, but constant through time at 0.20 per year. Detection probability varied between sexes, and among years and individuals. Heterogeneity in detection took the form of a dichotomy for males: those with consistently high detection rates, and those with low, sporadic detection rates, suggesting a relatively stable population of 'residents' consistently present and a fluctuating layer of 'transients'. Female detection was always low and sporadic. On average, twice as many males than females were detected per survey, and individual detection rates were significantly higher for males. We attribute sex-based differences in detection to biases resulting from social variation in trail-walking behaviour. The number of individual females detected increased when the survey period was extended from 3 months to a full year. Due to the low detection rates of females and the variable 'transient' male subpopulation, annual abundance estimates based on 3-month surveys had low precision. To estimate survival and monitor population changes in elusive, wide-ranging, low-density species, we recommend repeated surveys over multiple years; and suggest that continuous monitoring over multiple years yields even further insight into population dynamics of elusive predator populations.	[Harmsen, Bart J.; Foster, Rebecca J.; Sanchez, Emma; Kay, Elma] Univ Belize, Environm Res Inst, Belmopan, Belize; [Harmsen, Bart J.; Foster, Rebecca J.; Sanchez, Emma; Quigley, Howard] Panthera, 8 West 40th St,18th Floor, New York, NY 10018 USA; [Gutierrez-Gonzalez, Carmina E.] Univ Autonoma Queretaro, Fac Ciencias Nat, Queretaro, Mexico; [Silver, Scott C.] Wildlife Conservat Soc, 2300 Southern Blvd, Bronx, NY USA; [Ostro, Linde E. T.] New York Acad Sci, World Trade Ctr 7, New York, NY USA; [Kelly, Marcella J.] Virginia Tech, Dept Fisheries & Wildlife Sci, Blacksburg, VA USA	Universidad Autonoma de Queretaro; Wildlife Conservation Society; Virginia Polytechnic Institute & State University	Harmsen, BJ (corresponding author), Univ Belize, Environm Res Inst, Belmopan, Belize.; Harmsen, BJ (corresponding author), Panthera, 8 West 40th St,18th Floor, New York, NY 10018 USA.	bharmsen@panthera.org	Kelly, Marcella/B-4891-2011; Foster, Rebecca/GSM-6886-2022	Kelly, Marcella/0000-0001-9044-3873; FOSTER, REBECCA/0000-0002-6055-422X	Panthera; Wildlife Conservation Society; Natural Environment Research Council; Liz Claiborne Art Ortenberg Foundation; North of England Zoological Society; Brevard Zoo; Woodland Park Zoo; Virginia Tech University; Summerlee Foundation	Panthera; Wildlife Conservation Society; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Liz Claiborne Art Ortenberg Foundation; North of England Zoological Society; Brevard Zoo; Woodland Park Zoo; Virginia Tech University; Summerlee Foundation	This research was funded by Panthera (www.panthera.org) to BJH RJF ESEK, the Wildlife Conservation Society (www.wcs.org) to BJH RJF SCS LETO, the Natural Environment Research Council (UK; www.nerc.ac.uk) to BJH RJF, the Liz Claiborne Art Ortenberg Foundation (www.lcaof.org) to BJH RJF, the North of England Zoological Society (www.chesterzoo.org/global/north-ofengland-zoological-society) to BJH RJF, the Brevard Zoo (https://brevardzoo.org/) to BJH RJF,the Woodland Park Zoo (http://www.zoo.org/)to BJH RJF, Virginia Tech University (http ://www.vt.edu/) to MJK, and the Summerlee Foundation (http://summerlee.org/) to BJH ES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, IUCN RED LIST THREAT; Bailey, 1993, AFRICAN LEOPARD ECOL; Balme G.A., 2004, ECOL J, V6, P1; Balme GA, 2009, BIOL CONSERV, V142, P2681, DOI 10.1016/j.biocon.2009.06.020; Barlow ACD, 2009, J MAMMAL, V90, P472, DOI 10.1644/07-MAMM-A-415.1; Ceballos, 2016, JAGUAR SIGLO 21 PERS, P112; Ceballos G, 2011, TROPICAL CONSERVATIO, V17, P273; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; Connell AF, 2011, CAMERA TRAPS ANIMAL; Creel S, 2016, ECOL APPL, V26, P2347, DOI 10.1002/eap.1377; Crooks KR, 1998, CONSERV BIOL, V12, P889, DOI 10.1046/j.1523-1739.1998.97054.x; Davis ML, 2011, ANIM CONSERV, V14, P56, DOI 10.1111/j.1469-1795.2010.00389.x; de la Torre JA, 2017, ORYX; De Paula RC, 2010, PLANO AC CONSERVAC A; Ecotourism Greve S., 2014, ISCONTOUR TOURISM RE; Fay MP, 2010, J STAT SOFTW, V36, P1; Figueroa O. A., 2013, THESIS U FLORIDA; Figueroa OA, 2016, JAGUAR SIGLO 21 PERS, P112; Foster RJ, 2010, J ZOOL, V280, P309, DOI 10.1111/j.1469-7998.2009.00663.x; Foster RJ, 2012, J WILDLIFE MANAGE, V76, P224, DOI 10.1002/jwmg.275; Foster RJ, 2010, BIOTROPICA, V42, P724, DOI 10.1111/j.1744-7429.2010.00641.x; Foster RJ, 2008, THESIS; Gilbert M, 2014, PLOS ONE, V9, P1; Goodrich JM, 2008, J ZOOL, V276, P323, DOI 10.1111/j.1469-7998.2008.00458.x; Gutierrez-Gonzalez CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137541; Harmsen BJ, 2011, POPUL ECOL, V53, P253, DOI 10.1007/s10144-010-0211-z; Harmsen BJ, 2010, J MAMMAL, V91, P1225, DOI 10.1644/09-MAMM-A-416.1; Harmsen Bart J., 2010, P403; Harmsen BJ, 2009, J MAMMAL, V90, P612, DOI 10.1644/08-MAMM-A-140R.1; Harmsen BJ, 2006, THESIS; Harmsen BJ, 2016, CAT NEWS, P64; Henschel P, 2003, LEOPARDS AFRICAN RAI; Horev A, 2012, BIOL CONSERV, V147, P22, DOI 10.1016/j.biocon.2012.01.012; Hunter L, 2011, CARNIVORES WORLD; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; Karanth KU, 2006, ECOLOGY, V87, P2925, DOI 10.1890/0012-9658(2006)87[2925:ATPDUP]2.0.CO;2; KARANTH KU, 1995, BIOL CONSERV, V71, P333, DOI 10.1016/0006-3207(94)00057-W; Karanth UK, 2002, MONITORING TIGERS TH, P111; Kendall WL, 1997, ECOLOGY, V78, P563; Lambert CMS, 2006, J WILDLIFE MANAGE, V70, P246, DOI 10.2193/0022-541X(2006)70[246:CPDAVI]2.0.CO;2; LaRue MA, 2016, ECOL MODEL, V321, P121, DOI 10.1016/j.ecolmodel.2015.09.026; Logan K.A., 2001, DESERT PUMA EVOLUTIO; Maffei L, 2004, J ZOOL, V262, P295, DOI 10.1017/S0952836903004655; Miquelle DG, 2015, INTEGR ZOOL; PACKER C, 1983, AM NAT, V121, P716, DOI 10.1086/284097; Packer C, 2005, SCIENCE, V307, P390, DOI 10.1126/science.1105122; Paviolo A, 2016, NATURE; Payan E, 2006, CAT NEWS, P25; Powell LA, 2007, CONDOR, V109, P949, DOI 10.1650/0010-5422(2007)109[949:AVODPU]2.0.CO;2; R Core Team, 2012, R LANG ENV STAT COMP; RABINOWITZ AR, 1986, J ZOOL, V210, P149, DOI 10.1111/j.1469-7998.1986.tb03627.x; ROSS PI, 1992, J WILDLIFE MANAGE, V56, P417, DOI 10.2307/3808853; Sanderson EW, 2002, CONSERV BIOL, V16, P58, DOI 10.1046/j.1523-1739.2002.00352.x; Sharma K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101319; Silver S, 2004, ASSESSING JAGUAR ABU; Silver SC, 2004, ORYX, V38, P148, DOI 10.1017/S0030605304000286; SMITH JLD, 1991, CONSERV BIOL, V5, P484, DOI 10.1111/j.1523-1739.1991.tb00355.x; Soisalo MK, 2006, BIOL CONSERV, V129, P487, DOI 10.1016/j.biocon.2005.11.023; Sollman R, 2008, CAT NEWS, P15; Sollmann R, 2011, BIOL CONSERV, V144, P1017, DOI 10.1016/j.biocon.2010.12.011; Steinberg MK, 2016, CONSERV SOC, V14, P13, DOI 10.4103/0972-4923.182801; Sunquist ME, 2002, WILD CATS WORLD; Swanepoel LH, 2015, ORYX, V49, P595, DOI 10.1017/S0030605313001282; Thornton D, 2016, ECOL APPL, V26, P1112, DOI 10.1890/15-0602; Tian Y, 2014, LANDSCAPE ECOL, V29, P621, DOI 10.1007/s10980-014-0009-z; Tobler MW, 2013, BIOL CONSERV, V159, P109, DOI 10.1016/j.biocon.2012.12.009; Watkins A, 2015, ECOL MODEL, V306, P268, DOI 10.1016/j.ecolmodel.2014.10.038; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Zanin M, 2015, J NAT CONSERV, V23, P90, DOI 10.1016/j.jnc.2014.06.003	69	25	29	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179505	10.1371/journal.pone.0179505	http://dx.doi.org/10.1371/journal.pone.0179505			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658274	Green Published, gold, Green Submitted			2022-12-27	WOS:000404607900028
J	Kringel, D; Sisignano, M; Zinn, S; Lotsch, J				Kringel, Dario; Sisignano, Marco; Zinn, Sebastian; Loetsch, Joern			Next-generation sequencing of the human TRPV1 gene and the regulating co-players LTB4R and LTB4R2 based on a custom AmpliSeq (TM) panel	PLOS ONE			English	Article							LEUKOTRIENE B-4 RECEPTOR; ROOT GANGLION NEURONS; ION-CHANNEL; CAPSAICIN RECEPTOR; PAIN SENSITIVITY; BRONCHIAL-ASTHMA; DNA; POLYMORPHISMS; VARIANTS; MUTATION	Background Transient receptor potential cation channel subfamily V member 1 (TRPV1) are sensitive to heat, capsaicin, pungent chemicals and other noxious stimuli. They play important roles in the pain pathway where in concert with proinflammatory factors such as leukotrienes they mediate sensitization and hyperalgesia. TRPV1 is the target of several novel analgesics drugs under development and therefore, TRPV1 genetic variants might represent promising candidates for pharmacogenetic modulators of drug effects. Methods A next-generation sequencing (NGS) panel was created for the human TRPV1 gene and in addition, for the leukotriene receptors BLT1 and BLT2 recently described to modulate TRPV1 mediated sensitisation processes rendering the coding genes LTB4R and LTB4R2 important co-players in pharmacogenetic approaches involving TRPV1. The NGS workflow was based on a custom AmpliSeq (TM) panel and designed for sequencing of human genes on an Ion PGM (TM) Sequencer. A cohort of 80 healthy subjects of Western European descent was screened to evaluate and validate the detection of exomic sequences of the coding genes with 25 base pair exon padding. Results The amplicons covered approximately 97% of the target sequence. A median of 2.81 x 10(6) reads per run was obtained. This identified approximately 140 chromosome loci where nucleotides deviated from the reference sequence GRCh37 hg19 comprising the three genes TRPV1, LTB4R and LTB4R2. Correspondence between NGS and Sanger derived nucleotide sequences was 100%. Conclusions Results suggested that the NGS approach based on AmpliSeq (TM) libraries and Ion Personal Genome Machine (PGM) sequencing is a highly efficient mutation detection method. It is suitable for large-scale sequencing of TRPV1 and functionally related genes. The method adds a large amount of genetic information as a basis for complete analysis of TRPV1 ion channel genetics and its functional consequences.	[Kringel, Dario; Sisignano, Marco; Zinn, Sebastian; Loetsch, Joern] Goethe Univ, Inst Clin Pharmacol, Frankfurt, Germany; [Loetsch, Joern] Fraunhofer Inst Mol Biol & Appl Ecol, Project Grp Translat Med & Pharmacol IME TMP, Frankfurt, Germany	Goethe University Frankfurt; Fraunhofer Gesellschaft	Lotsch, J (corresponding author), Goethe Univ, Inst Clin Pharmacol, Frankfurt, Germany.; Lotsch, J (corresponding author), Fraunhofer Inst Mol Biol & Appl Ecol, Project Grp Translat Med & Pharmacol IME TMP, Frankfurt, Germany.	j.loetsch@em.uni-frankfurt.de		Lotsch, Jorn/0000-0002-5818-6958	European Union Seventh Framework Programme (FP7) [602919]; Else Kroner-Fresenius Foundation (EKFS); Research Training Group Translational Research Innovation - Pharma (TRIP,JL)	European Union Seventh Framework Programme (FP7); Else Kroner-Fresenius Foundation (EKFS); Research Training Group Translational Research Innovation - Pharma (TRIP,JL)	This work has been funded by the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 602919 ("GLORIA", JL). Support of the laboratory equipment was gained from the Landesoffensive zur Entwicklung wissenschaftlich-okonomischer Exzellenz (LOEWE), LOEWE-Zentrum fur Translationale Medizinund Pharmakologie (JL) and personnel support was received from the Else Kroner-Fresenius Foundation (EKFS), Research Training Group Translational Research Innovation - Pharma (TRIP,JL). The funders had no role in study design, data collection and analysis, decision to publish, orpreparation of the manuscript.	Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Boukalova S, 2014, PHYSIOL RES, V63, pS205, DOI 10.33549/physiolres.932658; Brito R, 2014, CELLS-BASEL, V3, P517, DOI 10.3390/cells3020517; Carreno O, 2012, AM J MED GENET B, V159B, P94, DOI 10.1002/ajmg.b.32007; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen CL, 2015, ALLERGY ASTHMA PROC, V36, pE29, DOI 10.2500/aap.2015.36.3828; Cheng W, 2007, J GEN PHYSIOL, V129, P191, DOI 10.1085/jgp.200709731; Cheng W, 2012, J BIOL CHEM, V287, P7279, DOI 10.1074/jbc.M111.305045; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Concolino P, 2014, CLIN CHIM ACTA, V437, P72, DOI 10.1016/j.cca.2014.06.026; Craib SJ, 2001, BRIT J PHARMACOL, V134, P30, DOI 10.1038/sj.bjp.0704223; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; de Leng WWJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149405; Dias AG, 2013, CHEM SENSES, V38, P137, DOI 10.1093/chemse/bjs090; Docherty RJ, 1996, PFLUG ARCH EUR J PHY, V431, P828, DOI 10.1007/BF02332166; Duroudier NP, 2009, ALLERGY, V64, P823, DOI 10.1111/j.1398-9995.2009.02015.x; EMIGH TH, 1980, BIOMETRICS, V36, P627, DOI 10.2307/2556115; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Frank M, 2013, HEALTH ECON REV, V3, DOI 10.1186/2191-1991-3-29; Glotov AS, 2015, CLIN CHIM ACTA, V446, P132, DOI 10.1016/j.cca.2015.04.014; Guimaraes Marilia Z. P., 2007, P151; Gulsuner S, 2011, GENOME RES, V21, P1995, DOI 10.1101/gr.126110.111; Ho Karen W, 2012, Am J Neurodegener Dis, V1, P1; Hwang SW, 2002, CURR OPIN PHARMACOL, V2, P235, DOI 10.1016/S1471-4892(02)00149-2; Jhun EH, 2015, PHARMACOGENOMICS, V16, P1795, DOI 10.2217/pgs.15.126; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Kim H, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.036079; Kim HS, 2004, PAIN, V109, P488, DOI 10.1016/j.pain.2004.02.027; Lin MT, 2014, AM J CLIN PATHOL, V141, P856, DOI 10.1309/AJCPMWGWGO34EGOD; Lohmann K, 2014, NEUROTHERAPEUTICS, V11, P699, DOI 10.1007/s13311-014-0288-8; Malin S, 2011, J NEUROSCI, V31, P10516, DOI 10.1523/JNEUROSCI.2992-10.2011; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; McCourt CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069604; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Millat G, 2014, CLIN CHIM ACTA, V433, P266, DOI 10.1016/j.cca.2014.03.032; Montell C, 2005, PFLUG ARCH EUR J PHY, V451, P19, DOI 10.1007/s00424-005-1426-2; Norton N, 2012, CURR OPIN CARDIOL, V27, P214, DOI 10.1097/HCO.0b013e328352207e; Park JJ, 2007, NEUROSCI LETT, V411, P87, DOI 10.1016/j.neulet.2006.10.046; Park S, 2016, J NUTRIGENET NUTRIGE, V9, P47, DOI 10.1159/000446499; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Portier BP, 2014, AM J CLIN PATHOL, V141, P559, DOI 10.1309/AJCP1JUGQMW7ZNTL; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Ren YF, 2015, PEDIATR RES, V77, P506, DOI 10.1038/pr.2015.11; Rizzo JM, 2012, CANCER PREV RES, V5, P887, DOI 10.1158/1940-6207.CAPR-11-0432; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sie D, 2014, CELL ONCOL, V37, P353, DOI 10.1007/s13402-014-0196-2; Smit LAM, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-26; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Szallasi A, 1999, PHARMACOL REV, V51, P159; Szallasi A, 1999, BRIT J PHARMACOL, V126, P1351, DOI 10.1038/sj.bjp.0702440; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Tager AM, 2003, PROSTAG LEUKOTR ESS, V69, P123, DOI 10.1016/S0952-3278(03)00073-5; Tarabeux J, 2014, STREAMLINED ION TORR, P1476; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Triantafyllou K, 2017, NEUROGASTROENT MOTIL, V29, DOI 10.1111/nmo.12913; Tulah AS, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-110; Tulah AS, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-173; Valdes AM, 2011, ANN RHEUM DIS, V70, P1556, DOI 10.1136/ard.2010.148122; Vigna SR, 2011, PANCREAS, V40, P708, DOI 10.1097/MPA.0b013e318214c8df; Vrabec JT, 2008, OTOL NEUROTOL, V29, P561, DOI 10.1097/MAO.0b013e318168d23b; Wang MY, 2010, J NEUROSURG-SPINE, V12, P694, DOI 10.3171/2009.12.SPINE09621; Wang Qiang, 2009, Wei Sheng Yan Jiu, V38, P516; Wang S, 2016, PAIN, V157, P1515, DOI 10.1097/j.pain.0000000000000556; Winter Z, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-30; Yokomizo T, 2001, J BIOL CHEM, V276, P12454, DOI 10.1074/jbc.M011361200; Zinn S, 2017, J BIOL CHEM, V292, P6123, DOI 10.1074/jbc.M116.769125	71	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180116	10.1371/journal.pone.0180116	http://dx.doi.org/10.1371/journal.pone.0180116			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658281	Green Published, gold, Green Submitted			2022-12-27	WOS:000404607900061
J	Riddler, SA; Husnik, M; Ramjee, G; Premrajh, A; Tutshana, BO; Pather, A; Siva, S; Jeenarain, N; Nair, G; Selepe, P; Kabwigu, S; Palanee-Phillips, T; Panchia, R; Mhlanga, F; Levy, L; Livant, E; Patterson, K; Elharrar, V; Balkus, J				Riddler, Sharon A.; Husnik, Marla; Ramjee, Gita; Premrajh, Anamika; Tutshana, Bomkazi Onini; Pather, Arendevi; Siva, Samantha; Jeenarain, Nitesha; Nair, Gonasagrie; Selepe, Pearl; Kabwigu, Samuel; Palanee-Phillips, Thesla; Panchia, Ravindre; Mhlanga, Felix; Levy, Lisa; Livant, Edward; Patterson, Karen; Elharrar, Vanessa; Balkus, Jennifer			HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial	PLOS ONE			English	Article							ORAL PREEXPOSURE PROPHYLAXIS; DRUG-RESISTANCE; ANTIRETROVIRAL PROPHYLAXIS; AFRICAN WOMEN; PHASE-3 TRIAL; DOUBLE-BLIND; INFECTION; RISK; MEN	Background Little is known regarding HIV disease outcomes among individuals who become infected with HIV while receiving antiretroviral medications for prevention. We compared HIV disease parameters among women who seroconverted while receiving tenofovir-containing oral or vaginal pre-exposure prophylaxis (PrEP) to placebo. Methods Participants with HIV seroconversion in a randomized placebo-controlled trial of oral tenofovir, oral tenofovir/emtricitabine, and vaginal tenofovir gel (MTN-003) were followed in a longitudinal cohort study (MTN-015). The effect of oral and vaginal tenofovir-containing PrEP on HIV disease progression was compared to placebo using linear mixed effects and Cox proportional hazard models, as appropriate. Additional analyses were performed to compare the outcomes among participants with detectable tenofovir or emtricitabine in plasma at the first quarterly visit in MTN-003. Results A total of 224 participants were included in the analysis; 93% from South Africa and 94% clade C virus. No differences in HIV RNA at steady state or the trajectory over 12 months were observed for each active arm compared to placebo; tenofovir gel recipients had higher CD4(+) T cell counts (722 vs 596 cells/mm(3); p = 0.02) at 90 days after estimated HIV seroconversion and higher average rates of change over 12 months compared to placebo (-181 vs -92 cells/mm(3) per year; p = 0.08). With a median follow-up of 31 months, no significant differences were observed for time to CD4(+) T cell count <= 350 cells/mm(3), or the composite endpoint of CD4(+) T cells <= 350 cells/mm(3), initiation of antiretroviral therapy or death for each active arm compared to placebo. Additionally, there were no significant differences in the HIV RNA or CD4+ T cell counts at baseline, the change to month 12, or any disease progression outcomes among participants with oral drug detected and no oral drug detected compared to placebo. Conclusions No clinically significant differences in HIV seroconversion outcomes were observed among women randomized to tenofovir-containing oral or vaginal PrEP regimens, however low overall adherence limits the generalizability of these findings.	[Riddler, Sharon A.] Univ Pittsburgh, Pittsburgh, PA 15260 USA; [Husnik, Marla; Patterson, Karen] SCHARP, Seattle, WA USA; [Ramjee, Gita; Premrajh, Anamika; Tutshana, Bomkazi Onini; Pather, Arendevi; Siva, Samantha; Jeenarain, Nitesha] South African Med Res Council, HIV Prevent Res Unit, Westville, Kwa Zulu Natal, South Africa; [Nair, Gonasagrie] Univ KwaZulu Natal, CAPRISA, Durban, South Africa; [Selepe, Pearl] Aurum Inst, Klerksdorp, South Africa; [Kabwigu, Samuel] Makerere Univ Johns Hopkins Univ Res Collaborat, Kampala, Uganda; [Palanee-Phillips, Thesla] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Panchia, Ravindre] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Mhlanga, Felix] Univ Zimbabwe, UZ UCSF Collaborat Res Programme, Harare, Zimbabwe; [Levy, Lisa] FHI 360, Durham, NC USA; [Livant, Edward] Magee Womens Res Inst, Pittsburgh, PA USA; [Elharrar, Vanessa] NIH, Div Aids, Bldg 10, Bethesda, MD 20892 USA; [Balkus, Jennifer] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Balkus, Jennifer] Univ Washington, Seattle, WA 98195 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fred Hutchinson Cancer Center; South African Medical Research Council; University of Kwazulu Natal; Makerere University; University of Witwatersrand; University of Witwatersrand; University of Zimbabwe; FHI 360; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; National Institutes of Health (NIH) - USA; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Riddler, SA (corresponding author), Univ Pittsburgh, Pittsburgh, PA 15260 USA.	riddler@pitt.edu	Palanee-Phillips, Thesla/ABD-2449-2020	Palanee-Phillips, Thesla/0000-0002-0052-5830	National Institute of Allergy and Infectious Diseases [UM1AI068633, UM1AI068615, UM1AI106707]; Eunice; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069422, UM1AI069453, UM1AI068633, UM1AI069469, UM1AI069436, UM1AI106707, UM1AI069463, UM1AI068615] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Microbicide Trials Network is funded by the National Institute of Allergy and Infectious Diseases (UM1AI068633, UM1AI068615, UM1AI106707),with co-funding from the Eunice	ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baeten JM, 2014, LANCET INFECT DIS, V14, P1055, DOI 10.1016/S1473-3099(14)70937-5; Campbell MS, 2013, J INFECT DIS, V207, P1166, DOI 10.1093/infdis/jit015; Chirwa LI, 2014, AIDS, V28, P223, DOI 10.1097/QAD.0000000000000102; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Dai JY, 2016, J INFECT DIS, V213, P335, DOI 10.1093/infdis/jiv333; Fonner VA, 2016, AIDS, V30, P1973, DOI 10.1097/QAD.0000000000001145; Garrett NJ, 2015, JAIDS-J ACQ IMM DEF, V68, P55, DOI 10.1097/QAI.0000000000000367; Grant RM, 2015, J INFECT DIS, V211, P1202, DOI 10.1093/infdis/jiu678; Grant RM, 2015, AIDS, V29, P331, DOI 10.1097/QAD.0000000000000556; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Kersh EN, 2012, J INFECT DIS, V206, P770, DOI 10.1093/infdis/jis422; Knox DC, 2017, NEW ENGL J MED, V376, P501, DOI 10.1056/NEJMc1611639; Landovitz RJ, 2016, CURR OPIN HIV AIDS, V11, P122, DOI 10.1097/COH.0000000000000219; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Marrazzo JM, 2014, JAMA-J AM MED ASSOC, V312, P390, DOI 10.1001/jama.2014.7999; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Parikh UM, 2016, CURR OPIN HIV AIDS, V11, P49, DOI 10.1097/COH.0000000000000209; Penrose KJ, 2015, J INFECT DIS; Rees H, 2015, C RETR OPP INF FEB 2; Riddler SA, 2016, HIV CLIN TRIALS, P1; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Thomas KK DD, 2016, HIV RNA SET POINT LE; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089118; World Health Organisation, 2007, WHO CAS DEF HIV SURV; World Health Organization, 2015, GUID START ANT THER	29	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0178594	10.1371/journal.pone.0178594	http://dx.doi.org/10.1371/journal.pone.0178594			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658251	gold, Green Published, Green Submitted			2022-12-27	WOS:000404607900006
J	Li, ML; Dai, YB; Lei, J; Tang, J; Zhou, YH; Xia, B; Xia, Y; Yin, GM				Li, Mingliang; Dai, Yingbo; Lei, Jun; Tang, Jin; Zhou, Yihong; Xia, Bing; Xia, Yang; Yin, Guangming			Acute rejection after kidney transplantation promotes graft fibrosis with elevated adenosine level in rat	PLOS ONE			English	Article							TISSUE-DAMAGE; RECEPTORS; FIBROBLASTS; METABOLISM; ACTIVATION; PRIAPISM; HYPOXIA; SYSTEM	Aims Chronic allograft nephropathy is a worldwide issue with the major feature of progressive allograft fibrosis, eventually ending with graft loss. Adenosine has been demonstrated to play an important role in process of fibrosis. Our study aimed to investigate the relationship between adenosine and fibrosis in renal allograft acute rejection in rat. Materials and methods Wistar rats and SD rats were selected as experimental animals. Our study designed two groups. In the allograft transplantation group, kidneys of Wistar rats were orthotopically transplanted into SD rat recipients, the same species but not genetically identical, to induce acute rejection. Kidney transplantations of SD rats to SD rats which were genetically identical were served as the control. We established rat models and detected a series of indicators. All data were analyzed statistically. P<0.05 was considered statistically significant. Results Compared with the control group, levels of adenosine increased significantly in the allograft transplantation group, in which acute rejection was induced (P<0.05). Progressive allograft fibrosis as well as collagen deposition were observed. Conclusions These findings suggested that level of adenosine was upregulated in acute rejection after kidney allograft transplantation in rat. Acute rejection may promote renal allograft fibrosis via the adenosine signaling pathways.	[Li, Mingliang; Dai, Yingbo; Lei, Jun; Tang, Jin; Zhou, Yihong; Xia, Bing; Yin, Guangming] Cent S Univ, Xiangya Hosp 3, Dept Urol, Changsha, Hunan, Peoples R China; [Li, Mingliang] First Peoples Hosp Xiangtan City, Dept Urol, Xiangtan, Peoples R China; [Xia, Yang] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX USA	Central South University; University of Texas System; University of Texas Health Science Center Houston	Yin, GM (corresponding author), Cent S Univ, Xiangya Hosp 3, Dept Urol, Changsha, Hunan, Peoples R China.	yingm75@126.com		li, ming liang/0000-0002-5200-5415	Science and Technology Project of Hunan Province, China [2010FJ4088]	Science and Technology Project of Hunan Province, China	This work was supported by the Science and Technology Project of Hunan Province, China (NO. 2010FJ4088). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackburn MR, 1998, J BIOL CHEM, V273, P5093, DOI 10.1074/jbc.273.9.5093; Chan ESL, 2010, MOD RHEUMATOL, V20, P114, DOI 10.1007/s10165-009-0251-4; Chen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077278; Chen JB, 2012, BRIT J PHARMACOL, V166, P1140, DOI 10.1111/j.1476-5381.2012.01831.x; Dai YB, 2011, J AM SOC NEPHROL, V22, P890, DOI 10.1681/ASN.2010080890; Dai YB, 2009, J SEX MED, V6, P292, DOI 10.1111/j.1743-6109.2008.01187.x; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; Fadili Wafaa, 2013, Arab J Nephrol Transplant, V6, P45; Feoktistov Igor, 2009, Handb Exp Pharmacol, P383, DOI 10.1007/978-3-540-89615-9_13; Ferenbach DA, 2011, KIDNEY INT, V80, P329, DOI 10.1038/ki.2011.167; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Khoa ND, 2001, J IMMUNOL, V167, P4026, DOI 10.4049/jimmunol.167.7.4026; Kim M, 2013, KIDNEY INT, V84, P90, DOI 10.1038/ki.2013.43; Lazzerini PE, 2012, J MOL MED, V90, P331, DOI 10.1007/s00109-011-0824-5; Liao YJ, 2012, WORLD J GASTROENTERO, V18, P5260, DOI 10.3748/wjg.v18.i37.5260; Linden J, 2011, ADV PHARMACOL, V61, P95, DOI 10.1016/B978-0-12-385526-8.00004-7; Nangaku M, 2008, HYPERTENS RES, V31, P175, DOI 10.1291/hypres.31.175; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Tang J, 2015, EXP THER MED, V9, P737, DOI 10.3892/etm.2015.2177; Textor SC, 2004, J AM SOC NEPHROL, V15, P1974, DOI 10.1097/01.ASN.0000133699.97353.24; Wen JM, 2010, FASEB J, V24, P740, DOI 10.1096/fj.09-144147; Zhou Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009224	22	1	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0180211	10.1371/journal.pone.0180211	http://dx.doi.org/10.1371/journal.pone.0180211			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651015	Green Submitted, Green Published, gold			2022-12-27	WOS:000404537300042
J	Bamba, S; Sasaki, M; Takaoka, A; Takahashi, K; Imaeda, H; Nishida, A; Inatomi, O; Sugimoto, M; Andoh, A				Bamba, Shigeki; Sasaki, Masaya; Takaoka, Azusa; Takahashi, Kenichiro; Imaeda, Hirotsugu; Nishida, Atsushi; Inatomi, Osamu; Sugimoto, Mitsushige; Andoh, Akira			Sarcopenia is a predictive factor for intestinal resection in admitted patients with Crohn's disease	PLOS ONE			English	Article							MODERATE ULCERATIVE-COLITIS; INFLAMMATORY-BOWEL-DISEASE; SKELETAL-MUSCLE; ENERGY-EXPENDITURE; JAPANESE PATIENTS; COMPUTED-TOMOGRAPHY; NUTRITIONAL-STATUS; METABOLISM; REMISSION; CONSENSUS	The relationship between skeletal muscle volume and the prognosis of patients with inflammatory bowel disease (IBD) remains undetermined. We conducted a retrospective study of 72 IBD patients who were admitted to the hospital due to disease exacerbation. We enrolled IBD patients who had undergone abdominal computed tomography and assessed the nutritional indices, such as the Onodera's prognostic nutritional index (O-PNI) and the controlling nutritional status (CONUT) index. The L3 skeletal muscle index (SMI), which is the ratio of the cross-sectional area of skeletal muscles at the level of the third lumbar (L3) vertebra to the height squared, was used to identify sarcopenia. Sarcopenia, defined as a low SMI, was observed in 42% of all IBD patients (37% with Crohn's disease (CD) and 48% with ulcerative colitis (UC)). In UC patients, the O-PNI and CONUT values, height, and albumin levels were significantly lower than in CD patients. The SMI strongly correlated with sex, body weight, albumin level, and O-PNI in IBD patients. Multivariate analysis using the Cox regression model demonstrated that the presence of sarcopenia (P = 0.015) and disease type (CD or UC) (P = 0.007) were significant factors predicting intestinal resection. The cumulative operation-free survival rate was significantly lower for sarcopenic patients than in all IBD patients (P = 0.003) and a stratified analysis of CD patients (P = 0.001) using the Kaplan-Meier method and log-rank test. The L3 skeletal muscle area is a prognostic factor for intestinal resection in patients with CD.	[Bamba, Shigeki; Takahashi, Kenichiro; Imaeda, Hirotsugu; Nishida, Atsushi; Inatomi, Osamu; Sugimoto, Mitsushige; Andoh, Akira] Shiga Univ Med Sci, Dept Med, Otsu, Shiga, Japan; [Sasaki, Masaya; Takaoka, Azusa] Shiga Univ Med Sci, Div Clin Nutr, Otsu, Shiga, Japan	Shiga University of Medical Science; Shiga University of Medical Science	Bamba, S (corresponding author), Shiga Univ Med Sci, Dept Med, Otsu, Shiga, Japan.	sb@belle.shiga-med.ac.jp	Andoh, Akira/AAB-9303-2022	Bamba, Shigeki/0000-0002-4108-5894; Inatomi, Osamu/0000-0002-5837-6575	Grants-in-Aid for Scientific Research [15K08948] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Al-Jaouni R, 2002, AM J GASTROENTEROL, V97, P2843; Ban H, 2016, EXP THER MED, V12, P829, DOI 10.3892/etm.2016.3341; Bryant RV, 2013, ALIMENT PHARM THER, V38, P213, DOI 10.1111/apt.12372; Carter MJ, 2004, GUT, V53, DOI 10.1136/gut.2004.043372; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; DETSKY AS, 1987, JPEN-PARENTER ENTER, V11, P8, DOI 10.1177/014860718701100108; Elia M., 2003, DEV USE MALNUTRITION; GASSULL MA, 1986, GUT, V27, P76, DOI 10.1136/gut.27.Suppl_1.76; Hanai T, 2015, NUTRITION, V31, P193, DOI 10.1016/j.nut.2014.07.005; Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370; Hiraoka A, 2015, J GASTROENTEROL, V50, P1206, DOI 10.1007/s00535-015-1068-x; Holt DQ, 2017, ALIMENT PHARM THER, V45, P1255, DOI 10.1111/apt.14018; Hoshikawa Y, 2012, EUR J APPL PHYSIOL, V112, P3487, DOI 10.1007/s00421-012-2335-7; Ignacio de Ulíbarri J., 2005, Nutr. Hosp., V20, P38; Inoue M, 2015, J CLIN BIOCHEM NUTR, V56, P215, DOI 10.3164/jcbn.14-100; Iritani S, 2015, J GASTROENTEROL, V50, P323, DOI 10.1007/s00535-014-0964-9; Itoh S, 2016, HEPATOL RES, V46, P292, DOI 10.1111/hepr.12537; Kondrup J, 2003, CLIN NUTR, V22, P321, DOI 10.1016/S0261-5614(02)00214-5; Krok KL, 2003, CURR OPIN GASTROEN, V19, P148, DOI 10.1097/00001574-200303000-00009; Mitsiopoulos N., 1985, J APPL PHYSIOL, V1998, P115; Montano-Loza AJ, 2012, CLIN GASTROENTEROL H, V10, P166, DOI 10.1016/j.cgh.2011.08.028; Nishida N, 2013, J CLIN BIOCHEM NUTR, V53, P122, DOI 10.3164/jcbn.13-18; Nishikawa H, 2016, HEPATOL RES; Okamoto H, 2011, J CLIN BIOCHEM NUTR, V49, P169, DOI 10.3164/jcbn.11-13; Okumura S, 2016, SURGERY, V159, P821, DOI 10.1016/j.surg.2015.08.047; Onodera T, 1984, Nihon Geka Gakkai Zasshi, V85, P1001; Pariente B, 2011, INFLAMM BOWEL DIS, V17, P1415, DOI 10.1002/ibd.21506; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; RIGAUD D, 1994, AM J CLIN NUTR, V60, P775, DOI 10.1093/ajcn/60.5.775; Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S; Santilli V, 2014, CLIN CASES MINER BON, V11, P177, DOI 10.11138/ccmbm/2014.11.3.177; Sasaki M, 2011, J CLIN BIOCHEM NUTR, V48, P183, DOI 10.3164/jcbn.10-83; Sasaki M, 2010, J CLIN BIOCHEM NUTR, V47, P32, DOI 10.3164/jcbn.10-07; Sasaki M, 2010, J CLIN BIOCHEM NUTR, V46, P68, DOI 10.3164/jcbn.09-55; Schneider SM, 2008, INFLAMM BOWEL DIS, V14, P1562, DOI 10.1002/ibd.20504; Shen W, 2004, J APPL PHYSIOL, V97, P2333, DOI 10.1152/japplphysiol.00744.2004; Subramaniam K, 2015, ALIMENT PHARM THER, V41, P419, DOI 10.1111/apt.13058; Valentini L, 2008, NUTRITION, V24, P694, DOI 10.1016/j.nut.2008.03.018; van Langenberg DR, 2014, J CROHNS COLITIS, V8, P626, DOI 10.1016/j.crohns.2013.11.024; Zhang T, 2016, CLIN NUTR; Zhang TH, 2017, JPEN-PARENTER ENTER, V41, P592, DOI 10.1177/0148607115612054; Zhuang CL, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003164	43	66	66	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0180036	10.1371/journal.pone.0180036	http://dx.doi.org/10.1371/journal.pone.0180036			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644887	Green Submitted, gold, Green Published			2022-12-27	WOS:000404145100059
J	Lan, Y; Zhang, XH; Liu, ZM; Zhou, L; Shen, RH; Zhong, XP; Cui, WJ; Zhou, ZM				Lan, Yao; Zhang, Xiaohuan; Liu, Zhongmei; Zhou, Li; Shen, Ruihua; Zhong, Xianping; Cui, Wenjing; Zhou, Zhemin			Overexpression and characterization of two types of nitrile hydratases from Rhodococcus rhodochrous J1	PLOS ONE			English	Article							RIBOSOME BINDING-SITES; ESCHERICHIA-COLI; PROTEIN; EXPRESSION; MATURATION; STABILITY; MECHANISM; PRODUCT	Nitrile hydratase (NHase) from Rhodococcus rhodochrous J1 is widely used for industrial production of acrylamide and nicotinamide. However, the two types of NHases (L-NHase and H-NHase) from R. rhodochrous J1 were only slightly expressed in E. coli by routine methods, which limits the comprehensive and systematic characterization of the enzyme properties. We successfully expressed the two types of recombinant NHases in E. coli by codon-optimization, engineering of Ribosome Binding Site (RBS) and spacer sequences. The specific activity of the purified L-NHase and H-NHase were 400 U/mg and 234 U/mg, respectively. The molecular mass of L-NHase and H-NHase was identified to be 94 kDa and 504 kDa, respectively, indicating that the quaternary structure of the two types of NHases was the same as those in R. rhodochrous J1. H-NHase exhibited higher substrate and product tolerance than L-NHase. Moreover, higher activity and shorter culture time were achieved in recombinant E. coli, and the whole cell catalyst of recombinant E. coli harboring H-NHase has equivalent efficiency in tolerance to the high-concentration product relative to that in R. rhodochrous J1. These results indicate that biotransformation of nitrile by R. rhodochrous J1 represents a potential alternative to NHase-producing E. coli.	[Lan, Yao; Liu, Zhongmei; Zhou, Li; Cui, Wenjing; Zhou, Zhemin] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Peoples R China; [Zhang, Xiaohuan] ENNova Hlth Sci Technol Co Ltd, ENN Grp, Langfang, Hebei, Peoples R China; [Shen, Ruihua; Zhong, Xianping] Rudong Nantian Nongke Chem Engn Co Ltd, Yangkou Port Econ Dev Zone, Changsha Town, Rudong, Peoples R China	Jiangnan University	Cui, WJ; Zhou, ZM (corresponding author), Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Peoples R China.	wjcui@jiangnan.edu.cn; zhmzhou@jiangnan.edu.cn	Cui, Wenjing/HIR-1471-2022	Zhou, Li/0000-0001-8448-2040	National natural science foundation of China [31400058, 31400078]; Priority Academic Program Development of Jiangsu Higher Education Institutions [111-2-06]; International S&T Innovation Cooperation Key Project [2016YFE0127400]	National natural science foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; International S&T Innovation Cooperation Key Project	National natural science foundation of China, 31400058, www.nsfc.gov.cn/, WC. National natural science foundation of China, 31400078, www.nsfc.gov.cn/, ZL. Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, ZZ. 111 Project, 111-2-06, http://www.dost.moe.edu.cn ZZ. Jiangsu province "Collaborative Innovation Center for Advanced Industrial Fermentation "industry development program ZZ. International S&T Innovation Cooperation Key Project, 2016YFE0127400, www.most.gov.cn/ ZL. Fundamental Research Funds for the Central Universities JUSRP51713B www.moe.gov.cn/ WC. The funder provided support in the form of research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The company Rudong Nantian Nongke Chemical Engineering Co. Ltd and ENNova Health Science Technology Co., Ltd., ENN Group participated in the data analysis and a part of fermentation experiment.	Arakawa T, 2007, J MOL BIOL, V366, P1497, DOI 10.1016/j.jmb.2006.12.011; Arakawa T, 2009, J AM CHEM SOC, V131, P14838, DOI 10.1021/ja903979s; Cui YT, 2014, BIOCHEM BIOPH RES CO, V450, P401, DOI 10.1016/j.bbrc.2014.05.127; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Icev A, 2003, P 3 ACM SIGKDD WORKS, V10, P34; KOBAYASHI M, 1991, BIOCHIM BIOPHYS ACTA, V1129, P23, DOI 10.1016/0167-4781(91)90208-4; Kobayashi M, 1999, EUR J BIOCHEM, V261, P1, DOI 10.1046/j.1432-1327.1999.00186.x; Kobayashi M, 1998, NAT BIOTECHNOL, V16, P733, DOI 10.1038/nbt0898-733; Komeda H, 1996, P NATL ACAD SCI USA, V93, P4267, DOI 10.1073/pnas.93.9.4267; KURIKI Y, 1989, J BACTERIOL, V171, P5452, DOI 10.1128/jb.171.10.5452-5457.1989; Liu Y, 2014, J BIOSCI BIOENG, V118, P249, DOI 10.1016/j.jbiosc.2014.02.015; Liu Y, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-48; Liu YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033225; Miyanaga A, 2004, EUR J BIOCHEM, V271, P429, DOI 10.1046/j.1432-1033.2003.03943.x; Murakami T, 2000, PROTEIN SCI, V9, P1024, DOI 10.1110/ps.9.5.1024; Na D, 2010, BIOINFORMATICS, V26, P2633, DOI 10.1093/bioinformatics/btq458; NAGASAWA T, 1991, EUR J BIOCHEM, V196, P581, DOI 10.1111/j.1432-1033.1991.tb15853.x; Nagasawa T, 1990, APPL MICROBIOL BIOT, V34, P783; Nagashima S, 1998, NAT STRUCT BIOL, V5, P347, DOI 10.1038/nsb0598-347; Noguchi T, 2003, BIOCHEMISTRY-US, V42, P11642, DOI 10.1021/bi035260i; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; VELLANOWETH RL, 1992, MOL MICROBIOL, V6, P1105, DOI 10.1111/j.1365-2958.1992.tb01548.x; Yukl ET, 2012, CURR OPIN CHEM BIOL, V16, P54, DOI 10.1016/j.cbpa.2012.02.010; Zhou ZM, 2010, BIOCHEMISTRY-US, V49, P9638, DOI 10.1021/bi100651v; Zhou ZM, 2009, J BIOL CHEM, V284, P14930, DOI 10.1074/jbc.M808464200; Zhou Z, 2008, P NATL ACAD SCI USA, V105, P14849, DOI 10.1073/pnas.0803428105	26	15	16	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179833	10.1371/journal.pone.0179833	http://dx.doi.org/10.1371/journal.pone.0179833			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644864	Green Published, gold, Green Submitted			2022-12-27	WOS:000404145100043
J	Wu, YL; Chen, YQ; Yao, LD; Wang, WM; Liu, YN				Wu, Yongle; Chen, Yuqing; Yao, Lidan; Wang, Weimin; Liu, Yuanan			An independently reconfigurable dual-mode dual-band substrate integrated waveguide filter	PLOS ONE			English	Article							MICROWAVE	In this paper, a novel perturbation approach for implementing the independently reconfigurable dual-mode dual-band substrate integrated waveguide (SIW) filter is proposed. Dual-frequency manipulation is achieved by adding perturbation via-holes (the first variable) and changing the lengths of the interference slot (the second variable) in each cavity. The independent control of the upper passband only depends on the second variable while the lower passband is independently tuned by combining the two variables. Using such a design method, a two-cavity dual-band SIW filter is designed and experimentally assessed with four via-holes and an interference slot in each cavity. The dual-band filter not only has a frequency ratio (f(R)) ranging from 1.14 to 1.58 but also can be considered as a single passband one with a tunable range of 40.5% from 1.26 GHz to 2.12 GHz. The scattering parameters vertical bar S-11 vertical bar and vertical bar S-21 vertical bar are in the range of -10.72 dB to -37.17 dB and -3.67 dB to -7.22 dB in the operating dual bands, respectively. All the simulated and measured results show an acceptable agreement with the predicted data.	[Wu, Yongle; Chen, Yuqing; Yao, Lidan; Wang, Weimin; Liu, Yuanan] Beijing Univ Posts & Telecommun, Sch Elect Engn, Beijing Key Lab Work Safety Intelligent Monitorin, Beijing, Peoples R China	Beijing University of Posts & Telecommunications	Wu, YL (corresponding author), Beijing Univ Posts & Telecommun, Sch Elect Engn, Beijing Key Lab Work Safety Intelligent Monitorin, Beijing, Peoples R China.	ywu@bupt.edu.cn		Chen, Yuqing/0000-0001-9481-3333; Wu, Yongle/0000-0002-3269-7143	National Natural Science Foundations of China [61422103, 61671084]; National Key Basic Research Program of China [2014CB339900]; Young Elite Scientists Sponsorship Program by CAST [YESS20150118]; Chinese patent [201611080190.8]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); Young Elite Scientists Sponsorship Program by CAST; Chinese patent	This work was supported in part by National Natural Science Foundations of China (no.61422103, and no.61671084), National Key Basic Research Program of China (973 Program) (no. 2014CB339900), and Young Elite Scientists Sponsorship Program by CAST (no. YESS20150118). In addition, the corresponding Chinese patent (no. 201611080190.8) has been pending.	Abdalla MA, 2016, IET MICROW ANTENNA P, V10, P406, DOI 10.1049/iet-map.2015.0515; Cassivi Y, 2002, IEEE MICROW WIREL CO, V12, P333, DOI 10.1109/LMWC.2002.803188; Chen JK, 2018, IEEE T AFFECT COMPUT, V9, P38, DOI 10.1109/TAFFC.2016.2593719; Chen SQ, 2014, OPT MATER EXPRESS, V4, P587, DOI 10.1364/OME.4.000587; Chen ZH, 2016, IEEE MICROW WIREL CO, V26, P92, DOI 10.1109/LMWC.2016.2517153; Fei Liang, 2016, Progress In Electromagnetics Research C, V67, P31; Huang F, 2016, IEEE MICROW WIREL CO, V26, P270, DOI 10.1109/LMWC.2016.2537785; Park SJ, 2010, IEEE T MICROW THEORY, V58, P381, DOI 10.1109/TMTT.2009.2038448; Pistono E, 2005, IEEE T MICROW THEORY, V53, P2506, DOI 10.1109/TMTT.2005.852774; Wu B, 2017, MICROW OPT TECHN LET, V59, P283, DOI 10.1002/mop.30282; Wu Y., 2016, SCI REPORTS, V6; Xu F, 2005, IEEE T MICROW THEORY, V53, P66, DOI 10.1109/TMTT.2004.839303; Yang K, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4894807; You B, 2016, IEEE MICROW WIREL CO, V26, P189, DOI 10.1109/LMWC.2016.2526031; Zhan XW, 2014, MICROWAVE J, V57, P94; Zheng ZW, 2012, OPT EXPRESS, V20, P23201, DOI 10.1364/OE.20.023201; Zhou CX, 2017, IEEE T MICROW THEORY, V65, P147, DOI 10.1109/TMTT.2016.2613053	17	0	0	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179816	10.1371/journal.pone.0179816	http://dx.doi.org/10.1371/journal.pone.0179816			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644854	Green Submitted, Green Published, gold			2022-12-27	WOS:000404145100040
J	Listl, D; Poschlod, P; Reisch, C				Listl, Daniela; Poschlod, Peter; Reisch, Christoph			Phylogeography of a tough rock survivor in European dry grasslands	PLOS ONE			English	Article							WILD EDIBLE PLANTS; CHLOROPLAST DNA PHYLOGEOGRAPHY; CRYPTIC NORTHERN REFUGIA; GENETIC-VARIATION; GLACIAL REFUGIA; HYBRID ZONE; POSTGLACIAL RECOLONIZATION; PHYLOGENETIC-RELATIONSHIPS; POPULATION-STRUCTURE; GEOGRAPHIC PATTERN	Phylogeographic analyses of plants in Europe have revealed common glacial refugia and migration routes for several trees and herbs with arctic-alpine distributions. The postglacial histories of dry grassland species in central Europe have rarely been analyzed, even though the extremely species-rich habitat is threatened. Sedum album (Crassulaceae) is a common inhabitant of rocky sites in central European dry grasslands. We inferred the phylogeographic history of S. album over its distribution range in Europe. Genetic diversity within and differentiation between 34 S. album populations was examined using AFLP markers. Population isolation was indicated based on the rarity of the fragments and by isolation-by-distance effects. We sequenced the trnL-trnF region in 32 populations and used chloroplast microsatellites to analyze chloroplast haplotype distributions. Two distinct S. album lineages were detected. One lineage was comprised of populations from eastern and central parts of central Europe, and the Apennine Peninsula. A second lineage was comprised of populations from the Iberian Peninsula and western and northern parts of central Europe. Glacial refugia were identified based on the accumulation of ancient chloroplast haplotypes, high diversity of AFLP fragments within populations, and high levels of rare fragments in Liguria, Serbia, the Apennine and Iberian peninsulas. Cryptic refugia were detected in the Czech Republic and Slovakia. Isolation by distance was present all over the distribution range, and it was separately detected in southwestern and central Europe. In western Europe, where a contact zone between the two lineages can be expected, no isolation by distance was detected. Our results suggest migration routes of S. album northeastward from glacial refugia in southern Iberia, northward from the Apennine Peninsula, and northward and westward from the southeastern parts of central Europe. Therefore, central European grasslands were recently colonized by northern cryptic populations and source populations originating in the east and the Apennine Peninsula.	[Listl, Daniela; Poschlod, Peter; Reisch, Christoph] Univ Regensburg, Inst Plant Sci, Regensburg, Germany	University of Regensburg	Listl, D (corresponding author), Univ Regensburg, Inst Plant Sci, Regensburg, Germany.	daniela.listl@ur.de	Poschlod, Peter/AAF-7902-2019					Abbott RJ, 2004, NEW PHYTOL, V161, P211, DOI 10.1046/j.1469-8137.2003.00953.x; Albers F, 1998, STANDARDLISTE FARN B; Alsos IG, 2007, SCIENCE, V316, P1606, DOI 10.1126/science.1139178; ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; [Anonymous], 1997, MOL BIOL BIOTECHNOLO; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Bonn S, 1998, AUSBREITUNGSBIOLOGIE; Brandes Dietmar, 1995, P49; Bylebyl K, 2008, MOL ECOL, V17, P3379, DOI 10.1111/j.1365-294X.2008.03836.x; Cakilcioglu U, 2010, J ETHNOPHARMACOL, V132, P165, DOI 10.1016/j.jep.2010.08.017; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; Cottrell JE, 2005, FOREST ECOL MANAG, V206, P71, DOI 10.1016/j.foreco.2004.10.052; Daneck H, 2016, BIOL J LINN SOC, V119, P704, DOI 10.1111/bij.12619; Demesure B, 1996, EVOLUTION, V50, P2515, DOI 10.1111/j.1558-5646.1996.tb03638.x; Despres L, 2002, MOL ECOL, V11, P2337, DOI 10.1046/j.1365-294X.2002.01618.x; Despres L, 2003, MOL PHYLOGENET EVOL, V27, P185, DOI 10.1016/S1055-7903(02)00445-1; di Castri F., 1989, SCOPE, V37, P1; Dobes C., 2000, DOCUMENTED CHROMOSOM; DumolinLapegue S, 1997, GENETICS, V146, P1475; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; Ellenberg H, 1996, VEGETATION MITTELEUR; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Ferris C, 1998, HEREDITY, V80, P584, DOI 10.1046/j.1365-2540.1998.00342.x; Fischer M, 1998, AM J BOT, V85, P811, DOI 10.2307/2446416; Flanagan NS, 1999, J EVOLUTION BIOL, V12, P577, DOI 10.1046/j.1420-9101.1999.00049.x; Gaudeul M, 2004, HEREDITY, V92, P508, DOI 10.1038/sj.hdy.6800443; Grivet D, 2003, CONSERV GENET, V4, P47, DOI 10.1023/A:1021804009832; Grivet D, 2002, MOL ECOL, V11, P1351, DOI 10.1046/j.1365-294X.2002.01522.x; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hamilton MB, 1999, MOL ECOL, V8, P521; Hanotte O, 2002, SCIENCE, V296, P336, DOI 10.1126/science.1069878; Hart H., 1991, Flora Mediterranea, V1, P31; Hedren M, 1997, PLANT SYST EVOL, V204, P21, DOI 10.1007/BF00982529; Heuertz M, 2004, MOL ECOL, V13, P3437, DOI 10.1111/j.1365-294X.2004.02333.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; HEWITT GM, 1975, HEREDITY, V35, P375, DOI 10.1038/hdy.1975.108; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kajtoch L, 2016, BIODIVERS CONSERV, V25, P2309, DOI 10.1007/s10531-016-1065-2; King RA, 1998, MOL ECOL, V7, P1151, DOI 10.1046/j.1365-294x.1998.00432.x; Koch M, 2004, AM J BOT, V91, P115, DOI 10.3732/ajb.91.1.115; KONNERT M, 1995, PLANT SYST EVOL, V196, P19, DOI 10.1007/BF00985333; Kropf M, 2002, MOL ECOL, V11, P447, DOI 10.1046/j.1365-294X.2002.01446.x; Kropf M, 2008, TAXON, V57, P511, DOI 10.2307/25066019; Leipold M, 2017, ECOL EVOL, V7, P1919, DOI 10.1002/ece3.2811; Lugon-Moulin N, 1999, MOL ECOL, V8, P419, DOI 10.1046/j.1365-294X.1999.00595.x; Magri D, 2008, J BIOGEOGR, V35, P450, DOI 10.1111/j.1365-2699.2007.01803.x; MANTEL N, 1967, CANCER RES, V27, P209; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Medail F, 2009, J BIOGEOGR, V36, P1333, DOI 10.1111/j.1365-2699.2008.02051.x; Meindl C, 2012, THESIS; Meindl C, 2016, PLANT SYST EVOL, P1; Meusel H., 1965, VERGLEICHENDE CHOROL, VVolume 1; Mithen S., 2006, ICE GLOBAL HUMAN HIS, V1st ed.; Negrini R, 2007, ANIM GENET, V38, P60, DOI 10.1111/j.1365-2052.2007.01554.x; Feliner GN, 2011, TAXON, V60, P365, DOI 10.1002/tax.602007; Ozgen U, 2004, ECON BOT, V58, P691, DOI 10.1663/0013-0001(2004)058[0691:ESITVO]2.0.CO;2; Palme AE, 2002, MOL ECOL, V11, P1769, DOI 10.1046/j.1365-294X.2002.01581.x; Parisod C, 2008, NEW PHYTOL, V178, P436, DOI 10.1111/j.1469-8137.2007.02361.x; Paun O, 2008, MOL ECOL, V17, P4263, DOI 10.1111/j.1365-294X.2008.03908.x; Peakall R., 2001, GENALEX GENETIC ANAL; Perez-Collazos E, 2009, MOL ECOL, V18, P848, DOI 10.1111/j.1365-294X.2008.04060.x; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Polunin O., 1980, FLOWERS GREECE BALKA; Poschlod P, 1998, ACTA BOT NEERL, V47, P27; Poschlod P., 2015, GESCH KULTURLANDSCHA; Poschlod P., 2013, VEGETATION ECOLOGY, P164, DOI [DOI 10.1002/9781118452592.CH6, 10.1002/9781118452592.ch6]; Pritchard JK, 2000, GENETICS, V155, P945; Redzic SJ, 2006, ECOL FOOD NUTR, V45, P189, DOI 10.1080/03670240600648963; Reisch C, 2003, HEREDITY, V91, P519, DOI 10.1038/sj.hdy.6800350; Reisch C, 2003, BIOL J LINN SOC, V80, P11, DOI 10.1046/j.1095-8312.2003.00215.x; Reisch C, 2008, BIOL J LINN SOC, V93, P385, DOI 10.1111/j.1095-8312.2007.00933.x; Rendell S, 2003, MOL ECOL, V12, P2681, DOI 10.1046/j.1365-294X.2003.01934.x; Rendell S, 2002, MOL ECOL, V11, P69, DOI 10.1046/j.0962-1083.2001.01413.x; Rogers SO, 1994, PLANT MOL BIOL MANUA, P1; Ronikier M, 2008, J BIOGEOGR, V35, P1650, DOI 10.1111/j.1365-2699.2008.01907.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sanz M, 2014, BOT J LINN SOC, V174, P214, DOI 10.1111/boj.12132; Schonswetter P, 2006, MOL ECOL, V15, P709, DOI 10.1111/j.1365-294X.2006.02821.x; Schonswetter P, 2005, TAXON, V54, P725, DOI 10.2307/25065429; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Simkova K, 2015, J APPL BOT FOOD QUAL, V88, P49, DOI 10.5073/JABFQ.2015.088.009; Skrede I, 2006, MOL ECOL, V15, P1827, DOI 10.1111/j.1365-294X.2006.02908.x; SLATKIN M, 1985, EVOLUTION, V39, P53, DOI 10.2307/2408516; Smith G.F., 2010, CACTUS SUCCULENT J U, V82, P41; Soubani E., 2010, THESIS; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tardio J, 2006, BOT J LINN SOC, V152, P27, DOI 10.1111/j.1095-8339.2006.00549.x; Tausch S, 2017, PLANT BIOL IN PRESS; Tutin TG, 1993, FLORA EUROPAEA; Van Ham RCHJ, 1998, AM J BOT, V85, P123, DOI 10.2307/2446561; VEKEMANS X, 2002, AFLP SURV VERSION 1; Vernesi C, 2002, MOL ECOL, V11, P1285, DOI 10.1046/j.1365-294X.2002.01534.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Walter R, 2005, AM J BOT, V92, P92, DOI 10.3732/ajb.92.1.92; Weising K, 1999, GENOME, V42, P9, DOI 10.1139/gen-42-1-9; Wittig Ruediger, 2004, Urban Ecosystems, V7, P323, DOI 10.1007/s11252-005-6833-9; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450	107	8	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179961	10.1371/journal.pone.0179961	http://dx.doi.org/10.1371/journal.pone.0179961			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640885	Green Published, gold, Green Submitted			2022-12-27	WOS:000404135800087
J	Sengupta, B; Sahihi, M; Dehkhodaei, M; Kelly, D; Arany, I				Sengupta, Bidisha; Sahihi, Mehdi; Dehkhodaei, Monireh; Kelly, Darrian; Arany, Istvan			Differential roles of 3-Hydroxyflavone and 7-Hydroxyflavone against nicotine-induced oxidative stress in rat renal proximal tubule cells	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATION; PARTICLE MESH EWALD; BETA-LACTOGLOBULIN; TRANSCRIPTIONAL ACTIVATION; FLAVONOID ANTIOXIDANTS; SUPEROXIDE-DISMUTASE; SIGNALING PATHWAY; BINDING; INJURY; SMOKING	Plant flavonoids are well known as antioxidants against oxidative stress induced by exposure to external pollutants. Nicotine (NIC) is one of those agents which increases renal oxidative stress, an important factor in the pathogenesis of renal epithelial injury in smokers. Although several studies had been conducted on flavonoids and oxidative stress, the mechanism of the protective pathways are not fully understood. Here, we present studies on antioxidant properties of two mono-hydroxyflavone isomers, 3-hydroxyflanove (3HF)- and 7-hydroxyflavone (7HF), against nicotine-associated oxidative stress and injury in cultured renal proximal tubule cells and correlate their antioxidant properties with their chemical structure. Our data clearly demonstrates, for the first time, that while both 3HF and 7HF protect renal cells from NIC-associated cytotoxicity, the mechanism of their action is different: 3HF elicits protective activity via the PKA/CREB/MnSOD pathway while 7HF does so via the ERK/Nrf2/HO-1 pathway. Molecular docking and dynamics simulations with two major signaling pathway proteins showed significant differences in the binding energies of 3HF (-5.67 and -7.39 kcal.mol(-1)) compared to 7HF (-5.41 and -8.55 kcal.mol(-1)) in the matrices of CREB and Keap1-Nrf2 proteins respectively, which corroborate with the observed differences in their protective properties in the renal cells. The implications of this novel explorative study is likely to promote the understanding of the mechanisms of the antioxidative functions of different flavones.	[Sengupta, Bidisha; Kelly, Darrian] Tougaloo Coll, Dept Chem, Tougaloo, MS 39174 USA; [Sahihi, Mehdi; Dehkhodaei, Monireh] Univ Isfahan, Dept Chem, Esfahan, Iran; [Arany, Istvan] Univ Mississippi, Med Ctr, Dept Pediat, Jackson, MS 39216 USA	Tougaloo College; University of Isfahan; University of Mississippi; University of Mississippi Medical Center	Sengupta, B (corresponding author), Tougaloo Coll, Dept Chem, Tougaloo, MS 39174 USA.	bsengupta@tougaloo.edu	Sahihi, Mehdi/AAY-1571-2020	Sahihi, Mehdi/0000-0003-2923-1833; Sengupta, Bidisha/0000-0003-4624-9998	Mississippi I NBRE - Institutional Development Award (I DeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20GM103476]; NSF MS-EPSCoR at Tougaloo College [EPS-0903787]; Department of Pediatrics; Bower Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476] Funding Source: NIH RePORTER	Mississippi I NBRE - Institutional Development Award (I DeA) from the National Institute of General Medical Sciences of the National Institutes of Health; NSF MS-EPSCoR at Tougaloo College; Department of Pediatrics; Bower Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Mississippi I NBRE, funded by an Institutional Development Award (I DeA) from the National Institute of General Medical Sciences of the National Institutes of Health under Grant No. P20GM103476. BS also acknowledges financial and research support from NSF MS-EPSCoR Grant No. EPS-0903787 at Tougaloo College. This work was also supported by a grant from the Department of Pediatrics and the Bower Foundation (to IA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Mississippi INBRE, funded by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under Grant No. P20GM103476. BS also acknowledges financial and research support from NSF MS-EPSCoR Grant No. EPS-0903787 at Tougaloo College. This work was also supported by a grant from the Department of Pediatrics and the Bower Foundation (to IA).	Akhlaghi M, 2009, J MOL CELL CARDIOL, V46, P309, DOI 10.1016/j.yjmcc.2008.12.003; Al-Malki AL, 2013, TOXICOL IND HEALTH, V29, P202, DOI 10.1177/0748233711430976; Alam J, 2003, CURR PHARM DESIGN, V9, P2499, DOI 10.2174/1381612033453730; Arany I, 2005, KIDNEY INT, V68, P1573, DOI 10.1111/j.1523-1755.2005.00569.x; Arany I, 2004, KIDNEY INT, V65, P1231, DOI 10.1111/j.1523-1755.2004.00500.x; Arany I, 2017, APOPTOSIS, V22, P220, DOI 10.1007/s10495-016-1309-3; Arany I, 2016, MOL MED REP, V14, P2771, DOI 10.3892/mmr.2016.5543; Arany I, 2013, NEPHROL DIAL TRANSPL, V28, P1417, DOI 10.1093/ndt/gfs596; Arany I, 2011, AM J PHYSIOL-RENAL, V301, pF125, DOI 10.1152/ajprenal.00041.2011; Arany I, 2010, AM J PHYSIOL-RENAL, V298, pF1214, DOI 10.1152/ajprenal.00639.2009; Baeza-Loya S, 2014, B MENNINGER CLIN, V78, P243, DOI 10.1521/bumc.2014.78.3.243; Bedogni B, 2003, J BIOL CHEM, V278, P16510, DOI 10.1074/jbc.M301089200; Ben Mansour H, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-32; Benowitz Neal L, 2009, Handb Exp Pharmacol, P29, DOI 10.1007/978-3-540-69248-5_2; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dinkova-Kostova AT, 2008, MOL NUTR FOOD RES, V52, pS128, DOI 10.1002/mnfr.200700195; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Grana R, 2014, CIRCULATION, V129, P1972, DOI 10.1161/CIRCULATIONAHA.114.007667; Gunsteren WV, 2001, MOL DYNAMICS SIMULAT, V55, P856; Heim KE, 2002, J NUTR BIOCHEM, V13, P572, DOI 10.1016/S0955-2863(02)00208-5; Huang XS, 2014, MOL CELL BIOCHEM, V385, P33, DOI 10.1007/s11010-013-1812-6; Ibrahim ZS, 2016, MOL MED REP, V13, P3017, DOI 10.3892/mmr.2016.4922; Jaimes EA, 2007, AM J PHYSIOL-HEART C, V292, pH76, DOI 10.1152/ajpheart.00693.2006; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Ji LL, 2015, FREE RADICAL BIO MED, V85, P12, DOI 10.1016/j.freeradbiomed.2015.03.035; Khosravi I, 2016, J MOL STRUCT, V1119, P373, DOI 10.1016/j.molstruc.2016.04.094; Kim HP, 1999, J BIOL CHEM, V274, P37455, DOI 10.1074/jbc.274.52.37455; Korkmaz A, 2010, J SURG RES, V164, P309, DOI 10.1016/j.jss.2009.03.022; Kris-Etherton PM, 2002, CURR OPIN LIPIDOL, V13, P41, DOI 10.1097/00041433-200202000-00007; Lamson D W, 2000, Altern Med Rev, V5, P196; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lo Presti R, 2007, NUTRITION, V23, P598, DOI 10.1016/j.nut.2007.04.012; Mohammadi F, 2015, SPECTROCHIM ACTA A, V140, P274, DOI 10.1016/j.saa.2014.12.032; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Mulligan AA, 2007, EUR J CLIN NUTR, V61, P248, DOI 10.1038/sj.ejcn.1602509; Orth SR, 2008, CLIN J AM SOC NEPHRO, V3, P226, DOI 10.2215/CJN.03740907; Pahari B, 2012, CHEM PHYS LIPIDS, V165, P488, DOI 10.1016/j.chemphyslip.2011.10.006; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pietta PG, 2000, J NAT PROD, V63, P1035, DOI 10.1021/np9904509; Rice-Evans C, 2001, CURR MED CHEM, V8, P797, DOI 10.2174/0929867013373011; Sahihi M, 2014, COMPUT BIOL MED, V51, P44, DOI 10.1016/j.compbiomed.2014.04.022; Sahihi M, 2014, CHEM PAP, V68, P1601, DOI 10.2478/s11696-014-0598-7; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Schumacher MA, 2000, J BIOL CHEM, V275, P35242, DOI 10.1074/jbc.M007293200; Sengupta B, 2002, BIOCHEM BIOPH RES CO, V299, P400, DOI 10.1016/S0006-291X(02)02667-0; Singh AK, 2013, NEUROMOL MED, V15, P570, DOI 10.1007/s12017-013-8243-0; Snijman PW, 2009, J AGR FOOD CHEM, V57, P6678, DOI 10.1021/jf901417k; Tong KI, 2007, MOL CELL BIOL, V27, P7511, DOI 10.1128/MCB.00753-07; Tsuji PA, 2013, NUTR CANCER, V65, P1014, DOI 10.1080/01635581.2013.809127; Zhou J, 2016, CLIN NUTR, V35, P117, DOI 10.1016/j.clnu.2015.03.012	53	19	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179777	10.1371/journal.pone.0179777	http://dx.doi.org/10.1371/journal.pone.0179777			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640852	Green Published, gold, Green Submitted			2022-12-27	WOS:000404135800063
J	van Hoof, RHM; Hermeling, E; Sluimer, JC; Salzmann, J; Hoeks, APG; Roussel, J; Daemen, MJAP; Struijker-Boudier, H; Wildberger, JE; Heeneman, S; Kooi, ME				van Hoof, Raf H. M.; Hermeling, Evelien; Sluimer, Judith C.; Salzmann, Julie; Hoeks, Arnold P. G.; Roussel, Jerome; Daemen, Mat J. A. P.; Struijker-Boudier, Harry; Wildberger, Joachim E.; Heeneman, Sylvia; Kooi, M. Eline			Heart rate lowering treatment leads to a reduction in vulnerable plaque features in atherosclerotic rabbits	PLOS ONE			English	Article							CONTRAST-ENHANCED MRI; DCE-MRI; NONINVASIVE ASSESSMENT; ARTERIAL STIFFNESS; BRADYCARDIAC AGENT; RATE REACTIVITY; ANIMAL-MODELS; MOUSE MODELS; RISK-FACTOR; PET-CT	Objective To investigate the effect of a heart rate (HR) lowering agent (Ivabradine) on features of atherosclerotic plaque vulnerability with magnetic resonance imaging (MRI), ultrasound imaging, and histology. Approach and results Atherosclerosis was induced in the abdominal aorta of 19 rabbits. Nine rabbits were treated with Ivabradine (17 mg/kg/day) during the entire study period. At week 14, imaging was performed. Plaque size was quantified on contrast-enhanced T1-weighted MR images. Microvascular flow, density, and permeability was studied with dynamic contrast-enhanced MRI. Plaque biomechanics was studied by measuring the aortic distension with ultrasound. After, animals were sacrificed and histology was performed. HR was reduced by 16% (p = 0.026) in Ivabradine-treated animals. No differences in absolute and relative vessel wall beat-to-beat distension were found, but due to the reduction in HR, the frequency of the biomechanical load on the plaque was reduced. Plaque size (MR and histology) was similar between groups. Although microvessel density (histology) was similar between groups, AUC and K-trans, indicative for plaque microvasculature flow, density, and permeability, were decreased by 24% (p = 0.029) and 32% (p = 0.037), respectively. Macrophage content (relative RAM11 positive area) was reduced by 44% (p<0.001) on histology in Ivabradine-treated animals. Conclusions HR lowering treatment with Ivabradine in an atherosclerotic rabbit model is associated with a reduction in vulnerable plaque features. The current study suggests that HR reduction may be beneficial for inducing or maintaining a more stable plaque phenotype.	[van Hoof, Raf H. M.; Hermeling, Evelien; Wildberger, Joachim E.; Kooi, M. Eline] Maastricht Univ, Dept Radiol, Med Ctr, Maastricht, Netherlands; [van Hoof, Raf H. M.; Hermeling, Evelien; Sluimer, Judith C.; Hoeks, Arnold P. G.; Struijker-Boudier, Harry; Wildberger, Joachim E.; Heeneman, Sylvia; Kooi, M. Eline] Maastricht Univ, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands; [Sluimer, Judith C.; Heeneman, Sylvia] Maastricht Univ, Dept Pathol, Med Ctr, Maastricht, Netherlands; [Salzmann, Julie; Roussel, Jerome] Inst Rech Int Servier, Suresnes, France; [Hoeks, Arnold P. G.] Maastricht Univ, Dept Biomed Engn, Maastricht, Netherlands; [Daemen, Mat J. A. P.] Acad Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Struijker-Boudier, Harry] Maastricht Univ, Dept Pharmacol, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Servier; Institut de Recherches Internationales Servier; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University	Kooi, ME (corresponding author), Maastricht Univ, Dept Radiol, Med Ctr, Maastricht, Netherlands.; Kooi, ME (corresponding author), Maastricht Univ, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands.	eline.kooi@mumc.nl	Kooi, M. Eline/D-3848-2016; Sluimer, Judith c/D-5277-2012	Kooi, M. Eline/0000-0001-7562-5724; Sluimer, Judith c/0000-0002-0269-4582; Wildberger, Joachim/0000-0002-4810-6854; Daemen, Mat/0000-0003-1076-199X	project PARISk [01C-202]; Dutch Heart Foundation; Netherlands Organization for Scientific Research [015.008.047]; Stichting de Weijerhorst; Servier	project PARISk; Dutch Heart Foundation(Netherlands Heart Foundation); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Stichting de Weijerhorst; Servier(Servier)	This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project PARISk (grant 01C-202), and supported by the Dutch Heart Foundation. M.E. Kooi is supported by Aspasia Grant 015.008.047 from the Netherlands Organization for Scientific Research. J.E. Wildberger and M.E. Kooi are supported by Stichting de Weijerhorst. This research was supported by a research grant of Servier. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaladejo P, 2003, J VASC RES, V40, P320, DOI 10.1159/000072696; Albrecht M, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0198-3; Bassiouny HS, 2002, J CARDIOVASC RISK, V9, P331, DOI 10.1097/00043798-200212000-00006; BEERE PA, 1984, SCIENCE, V226, P180, DOI 10.1126/science.6484569; BEERE PA, 1992, ARTERIOSCLER THROMB, V12, P1245, DOI 10.1161/01.ATV.12.11.1245; Bois P, 1996, BRIT J PHARMACOL, V118, P1051, DOI 10.1111/j.1476-5381.1996.tb15505.x; Brands PJ, 1997, ULTRASOUND MED BIOL, V23, P911, DOI 10.1016/S0301-5629(97)00021-5; Calcagno C, 2008, ARTERIOSCL THROM VAS, V28, P1311, DOI 10.1161/ATVBAHA.108.166173; Calcagno C, 2015, NMR BIOMED, V28, P1304, DOI 10.1002/nbm.3369; Calcagno C, 2013, EUR J NUCL MED MOL I, V40, P1884, DOI 10.1007/s00259-013-2518-4; Calcagno C, 2010, J MAGN RESON IMAGING, V32, P191, DOI 10.1002/jmri.22225; Chirinos JA, 2012, J CARDIOVASC TRANSL, V5, P243, DOI 10.1007/s12265-012-9359-6; Custodis F, 2008, CIRCULATION, V117, P2377, DOI 10.1161/CIRCULATIONAHA.107.746537; DiFrancesco D, 2004, DRUGS, V64, P1757, DOI 10.2165/00003495-200464160-00003; Dominguez-Rodriguez A, 2011, WORLD J CARDIOL, V3, P101, DOI 10.4330/wjc.v3.i4.101; Epstein FH, 2007, NMR BIOMED, V20, P238, DOI 10.1002/nbm.1152; Fox K, 2007, J AM COLL CARDIOL, V50, P823, DOI 10.1016/j.jacc.2007.04.079; Fox K, 2014, NEW ENGL J MED, V371, P1091, DOI 10.1056/NEJMoa1406430; Gaens ME, 2013, RADIOLOGY, V266, P271, DOI 10.1148/radiol.12120499; GARDINER SM, 1995, BRIT J PHARMACOL, V115, P579, DOI 10.1111/j.1476-5381.1995.tb14971.x; Getz GS, 2012, ARTERIOSCL THROM VAS, V32, P1104, DOI 10.1161/ATVBAHA.111.237693; Grant Edward G, 2003, Ultrasound Q, V19, P190, DOI 10.1097/00013644-200312000-00005; HOEKS APG, 1990, ULTRASOUND MED BIOL, V16, P121, DOI 10.1016/0301-5629(90)90139-4; Jaspers K, 2010, MED PHYS, V37, P5746, DOI 10.1118/1.3484057; KAPLAN JR, 1987, CIRCULATION, V76, P1364, DOI 10.1161/01.CIR.76.6.1364; Kapourchali FR, 2014, WORLD J CLIN CASES, V2, P126, DOI 10.12998/wjcc.v2.i5.126; Kerwin W, 2003, CIRCULATION, V107, P851, DOI 10.1161/01.CIR.0000048145.52309.31; Kerwin WS, 2006, RADIOLOGY, V241, P459, DOI 10.1148/radiol.2412051336; Kwee RM, 2008, NEUROLOGY, V70, P2401, DOI 10.1212/01.wnl.0000314697.76580.cb; Lees-Miller JP, 2015, J MOL CELL CARDIOL, V85, P71, DOI 10.1016/j.yjmcc.2015.05.009; Levy S, 2006, THERAPIE, V61, P115, DOI 10.2515/therapie:2006033; Lobatto ME, 2010, MOL PHARMACEUT, V7, P2020, DOI 10.1021/mp100309y; Lobbes MBI, 2009, RADIOLOGY, V250, P682, DOI 10.1148/radiol.2503080875; MANUCK SB, 1988, AM HEART J, V116, P328, DOI 10.1016/0002-8703(88)90110-X; Manuck SB, 1997, ARTERIOSCL THROM VAS, V17, P1774, DOI 10.1161/01.ATV.17.9.1774; Meinders JM, 2001, ULTRASONIC IMAGING, V23, P199, DOI 10.1177/016173460102300401; Michel JB, 2011, EUR HEART J, V32, P1977, DOI 10.1093/eurheartj/ehr054; Millon A, 2014, VASCULAR, V22, P221, DOI 10.1177/1708538113478758; Moreno PR, 2006, CIRCULATION, V113, P2245, DOI 10.1161/CIRCULATIONAHA.105.578955; Nawarskas JJ, 2015, CARDIOL REV, V23, P201, DOI 10.1097/CRD.0000000000000070; Niccoli G, 2017, INTERNATIONAL JOURNA; Oliphant CS, 2016, AM J CARDIOVASC DRUG, V16, P337, DOI 10.1007/s40256-016-0178-z; Palatini P, 2007, DRUGS, V67, P3, DOI 10.2165/00003495-200767002-00002; Pei X, 2014, JACC-CARDIOVASC IMAG, V7, P738, DOI 10.1016/j.jcmg.2014.01.019; Phinikaridou A, 2010, CIRC-CARDIOVASC IMAG, V3, P323, DOI 10.1161/CIRCIMAGING.109.918524; Sluimer JC, 2008, J AM COLL CARDIOL, V51, P1258, DOI 10.1016/j.jacc.2007.12.025; Sun J, 2016, ARTERIOSCL THROM VAS, V36, P743, DOI 10.1161/ATVBAHA.115.307043; Swedberg K, 2010, LANCET, V376, P875, DOI 10.1016/S0140-6736(10)61198-1; Tardif JC, 2009, BRIT MED BULL, V90, P71, DOI 10.1093/bmb/ldp016; Truijman MTB, 2013, STROKE, V44, P3568, DOI 10.1161/STROKEAHA.113.003140; van Popele NM, 2001, STROKE, V32, P454, DOI 10.1161/01.STR.32.2.454; Versluis A, 2006, J BIOMECH, V39, P339, DOI 10.1016/j.jbiomech.2004.10.041; Virmani R, 2005, ARTERIOSCL THROM VAS, V25, P2054, DOI 10.1161/01.ATV.0000178991.71605.18; Vucic E, 2012, JACC-CARDIOVASC IMAG, V5, P819, DOI 10.1016/j.jcmg.2011.11.025; Vucic E, 2011, JACC-CARDIOVASC IMAG, V4, P1100, DOI 10.1016/j.jcmg.2011.04.020; Wang J, 2014, STROKE, V45, P1842, DOI 10.1161/STROKEAHA.114.005147; Yankeelov TE, 2005, MAGN RESON IMAGING, V23, P519, DOI 10.1016/j.mri.2005.02.013; Zuurbier CJ, 2002, AM J PHYSIOL-HEART C, V282, pH2099, DOI 10.1152/ajpheart.01002.2001	58	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179024	10.1371/journal.pone.0179024	http://dx.doi.org/10.1371/journal.pone.0179024			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640847	Green Submitted, gold, Green Published			2022-12-27	WOS:000404135800015
J	Borgo, F; Riva, A; Benetti, A; Casiraghi, MC; Bertelli, S; Garbossa, S; Anselmetti, S; Scarone, S; Pontiroli, AE; Morace, G; Borghi, E				Borgo, Francesca; Riva, Alessandra; Benetti, Alberto; Casiraghi, Maria Cristina; Bertelli, Sara; Garbossa, Stefania; Anselmetti, Simona; Scarone, Silvio; Pontiroli, Antonio E.; Morace, Giulia; Borghi, Elisa			Microbiota in anorexia nervosa: The triangle between bacterial species, metabolites and psychological tests	PLOS ONE			English	Article							HUMAN GUT MICROBIOTA; EATING-DISORDERS; ANXIETY DISORDERS; INTESTINAL MICROBIOTA; WEIGHT-GAIN; BUTYRATE; ACID; DEPRESSION; OBESITY; SYSTEM	Anorexia nervosa (AN) is a psychiatric disease with devastating physical consequences, with a pathophysiological mechanism still to be elucidated. Metagenomic studies on anorexia nervosa have revealed profound gut microbiome perturbations as a possible environmental factor involved in the disease. In this study we performed a comprehensive analysis integrating data on gut microbiota with clinical, anthropometric and psychological traits to gain new insight in the pathophysiology of AN. Fifteen AN women were compared with fifteen age-, sex- and ethnicity-matched healthy controls. AN diet was characterized by a significant lower energy intake, but macronutrient analysis highlighted a restriction only in fats and carbohydrates consumption. Next generation sequencing showed that AN intestinal microbiota was significantly affected at every taxonomic level, showing a significant increase of Enterobacteriaceae, and of the archeon Methanobrevibactersmithiicompared with healthy controls. On the contrary, the genera Roseburia, Ruminococcus and Clostridium, were depleted, in line with the observed reduction in AN of total short chain fatty acids, butyrate, and propionate. Butyrate concentrations inversely correlated with anxiety levels, whereas propionate directly correlated with insulin levels and with the relative abundance of Roseburia inulinivorans, a known propionate producer. BMI represented the best predictive value for gut dysbiosis and metabolic alterations, showing a negative correlation with Bacteroides uniformis (microbiota), with alanine aminotransferase (liver function), and with psychopathological scores (obsession-compulsion, anxiety, and depression), and a positive correlation with white blood cells count. In conclusion, our findings corroborate the hypothesis that the gut dysbiosis could take part in the AN neurobiology, in particular in sustaining the persistence of alterations that eventually result in relapses after renourishment and psychological therapy, but causality still needs to be proven.	[Borgo, Francesca; Riva, Alessandra; Garbossa, Stefania; Scarone, Silvio; Pontiroli, Antonio E.; Morace, Giulia; Borghi, Elisa] Univ Milan, Dept Hlth Sci, Milan, Italy; [Benetti, Alberto; Bertelli, Sara; Garbossa, Stefania; Anselmetti, Simona; Scarone, Silvio; Pontiroli, Antonio E.] ASST St Paolo & Carlo, Milan, Italy; [Casiraghi, Maria Cristina] Univ Milan, Dept Food Environm & Nutr Sci, Milan, Italy	University of Milan; University of Milan	Borghi, E (corresponding author), Univ Milan, Dept Hlth Sci, Milan, Italy.	elisa.borghi@unimi.it	Riva, Alessandra/AAA-4038-2020; pontiroli, antonio e/AAI-5575-2020; BORGO, FRANCESCA CLAUDIA/AAM-7200-2020; Borghi, Elisa/I-8811-2012; Casiraghi, Maria Cristina/L-3103-2017	BORGO, FRANCESCA CLAUDIA/0000-0001-9685-1069; Borghi, Elisa/0000-0002-1893-0455; Riva, Alessandra/0000-0002-5724-7616; scarone, silvio/0000-0001-7187-3747; Morace, Giulia/0000-0003-1696-1183; Casiraghi, Maria Cristina/0000-0001-9875-8087	Universita degli Studi di Milano	Universita degli Studi di Milano	This study was supported by the Universita degli Studi di Milano. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adan RAH, 2001, EUR NEUROPSYCHOPHARM, V11, P483, DOI 10.1016/S0924-977X(01)00125-0; Alcock J, 2014, BIOESSAYS, V36, P940, DOI 10.1002/bies.201400071; [Anonymous], 2017, BRAIN BEHAV IMMUN; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Arora T, 2011, APPETITE, V56, P511, DOI 10.1016/j.appet.2011.01.016; Bailey MT, 2011, BRAIN BEHAV IMMUN, V25, P397, DOI 10.1016/j.bbi.2010.10.023; Beck AT., 1996, MANUAL BECK DEPRESSI; Belmonte L, 2016, SCI REP-UK, V6, DOI 10.1038/srep35813; Breton J, 2016, INT J EAT DISORDER, V49, P805, DOI 10.1002/eat.22531; BRIGHENTI F, 1991, EUR J CLIN NUTR, V45, P221; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Cryan JF, 2011, NEUROGASTROENT MOTIL, V23, P187, DOI 10.1111/j.1365-2982.2010.01664.x; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Derogatis L.R., 1994, USE PSYCHOL TESTING, P217; DEURENBERG P, 1991, BRIT J NUTR, V65, P105, DOI 10.1079/BJN19910073; DSM-5, 2013, DIAGNOSTIC STAT MANU; Fernandez-Aranda F, 2007, AUST NZ J PSYCHIAT, V41, P24, DOI 10.1080/00048670601057718; Foster JA, 2013, TRENDS NEUROSCI, V36, P305, DOI 10.1016/j.tins.2013.01.005; Frost G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4611; GARNER DM, 1983, INT J EAT DISORDER, V2, P15, DOI 10.1002/1098-108X(198321)2:2<15::AID-EAT2260020203>3.0.CO;2-6; Gkolfakis P, 2015, HEPATOB PANCREAT DIS, V14, P572, DOI 10.1016/S1499-3872(15)60026-1; Godart NT, 2002, INT J EAT DISORDER, V32, P253, DOI 10.1002/eat.10096; Goh KHR, 2015, SINGAP MED J, V56, P488, DOI 10.11622/smedj.2015132; Harrison IF, 2013, PHARMACOL THERAPEUT, V140, P34, DOI 10.1016/j.pharmthera.2013.05.010; Hoek HW, 2006, CURR OPIN PSYCHIATR, V19, P389, DOI 10.1097/01.yco.0000228759.95237.78; Imhann F., 2016, GUT; Jesus P, 2014, CLIN NUTR, V33, P1046, DOI 10.1016/j.clnu.2013.11.006; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Kaplan AS, 2009, PSYCHOL MED, V39, P1037, DOI 10.1017/S003329170800442X; Kaye WH, 2004, AM J PSYCHIAT, V161, P2215, DOI 10.1176/appi.ajp.161.12.2215; Kleiman SC, 2015, PSYCHOSOM MED, V77, P969, DOI 10.1097/PSY.0000000000000247; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Klump KL, 2009, INT J EAT DISORDER, V42, P97, DOI 10.1002/eat.20589; Ktsoyan ZA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00776; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Louis P, 2010, ENVIRON MICROBIOL, V12, P304, DOI 10.1111/j.1462-2920.2009.02066.x; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; MacFabe DF, 2011, BEHAV BRAIN RES, V217, P47, DOI 10.1016/j.bbr.2010.10.005; Mack I, 2016, SCI REP-UK, V6, DOI 10.1038/srep26752; Mehler PS, 2015, J EAT DISORD, V3, DOI 10.1186/s40337-015-0040-8; Mercader JM, 2012, GENE, V497, P181, DOI 10.1016/j.gene.2012.01.057; Million M, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.28; Misra M, 2014, LANCET DIABETES ENDO, V2, P581, DOI 10.1016/S2213-8587(13)70180-3; Montagnese C, 2007, INT J EAT DISORDER, V40, P746, DOI 10.1002/eat.20432; Morita C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145274; Oksanen JF, 2010, VEGAN COMMUNITY ECOL; Pfleiderer A, 2013, EUR J CLIN MICROBIOL, V32, P1471, DOI 10.1007/s10096-013-1900-2; Pingitore A, 2017, DIABETES OBES METAB, V19, P257, DOI 10.1111/dom.12811; Puertollano E, 2014, CURR OPIN CLIN NUTR, V17, P139, DOI 10.1097/MCO.0000000000000025; Rios-Covian D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00185; Rosen E, 2015, INT J EAT DISORDER, P151; Schroeder FA, 2007, BIOL PSYCHIAT, V62, P55, DOI 10.1016/j.biopsych.2006.06.036; Scott KP, 2006, J BACTERIOL, V188, P4340, DOI 10.1128/JB.00137-06; Seiler N, 2007, CRIT REV CL LAB SCI, V44, P365, DOI 10.1080/10408360701250016; Spielberger C., 1983, MAN STATE TRAIT ANXI, P4; Steer RA, 1999, J CLIN PSYCHOL, V55, P117, DOI 10.1002/(SICI)1097-4679(199901)55:1<117::AID-JCLP12>3.0.CO;2-A; Strain GW, 2008, OBESITY, V16, P1953, DOI 10.1038/oby.2008.321; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; SULLIVAN PF, 1995, AM J PSYCHIAT, V152, P1073; Swinbourne JM, 2007, EUR EAT DISORD REV, V15, P253, DOI 10.1002/erv.784; Tamanai-Shacoori Z, 2017, FUTURE MICROBIOL, V12, P157, DOI 10.2217/fmb-2016-0130; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Waldecker M, 2008, NUTRITION, V24, P366, DOI 10.1016/j.nut.2007.12.013; Weaver GA, 1997, J NUTR, V127, P717, DOI 10.1093/jn/127.5.717; Wildes JE, 2017, INT J EAT DISORDER, V50, P389, DOI 10.1002/eat.22651; Winter SE, 2014, GUT MICROBES, V5, P71, DOI 10.4161/gmic.27129	68	112	115	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179739	10.1371/journal.pone.0179739	http://dx.doi.org/10.1371/journal.pone.0179739			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY6UH	28636668	Green Published, gold, Green Submitted			2022-12-27	WOS:000404118300053
J	Gugsa, S; Potter, K; Tweya, H; Phiri, S; Sande, O; Sikwese, P; Chikonda, J; O'Malley, G				Gugsa, Salem; Potter, Katy; Tweya, Hannock; Phiri, Sam; Sande, Odala; Sikwese, Pascal; Chikonda, Janet; O'Malley, Gabrielle			Exploring factors associated with ART adherence and retention in care under Option B plus strategy in Malawi: A qualitative study	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; ADULT HIV PATIENTS; ANTIRETROVIRAL THERAPY; PMTCT PROGRAM; FOLLOW-UP; PREVENTION; BARRIERS; WOMEN; FACILITATORS; INVOLVEMENT	Although several studies have documented challenges related to inadequate adherence to antiretroviral therapy (ART) and high loss to follow-up (LTFU) among Option B+ women, there is limited understanding of why these challenges occur and how to address them. This qualitative study examines women's experiences with ART adherence and retention in care. Between July and October 2015, in-depth interviews were conducted with 39 pregnant and lactating women who initiated ART at Bwaila Hospital in Lilongwe, Malawi. Study participants included 14 in care and 25 out of care women, according to facility records. Data were analyzed using an inductive, open-coding approach to thematic analysis. Ten of the respondents (7 out of care, 3 in-care) had stopped and re-started treatment before the interview date. One of the most important factors influencing adherence and retention was the strength of women's support systems. In contrast to women in-care, most out-of-care women lacked emotional and financial support from male partners, received minimal counseling from providers at initiation, lacked designated guardians to assist with medication refills or clinic appointments, and were highly mobile. Mobility led to difficulties in accessing treatment in new settings. The most common reasons women re-started treatment following interruptions were due to providers' counseling and encouragement and the mother's desire to be healthy. Improved counseling at initiation, active follow-up counseling, women's economic empowerment interventions, promotion of peer counseling schemes and meaningful engagement of male partners can help in addressing the identified barriers and promoting sustained retention of Option B+ women.	[Gugsa, Salem; Tweya, Hannock; Phiri, Sam; Sande, Odala; Sikwese, Pascal] Lighthouse Trust, Lilongwe, Malawi; [Gugsa, Salem; Potter, Katy; O'Malley, Gabrielle] Univ Washington, Dept Global Hlth, Int Training & Educ Ctr Hlth, Seattle, WA 98195 USA; [Tweya, Hannock] Int Union TB & Lung Dis, Paris, France; [Phiri, Sam] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC USA; [Phiri, Sam] Univ Malawi, Coll Med, Sch Publ Hlth & Family Med, Dept Publ Hlth, Lilongwe, Malawi; [Chikonda, Janet] Minist Hlth, Dist Hlth Off, Lilongwe, Malawi	University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Malawi	Gugsa, S (corresponding author), Lighthouse Trust, Lilongwe, Malawi.; Gugsa, S (corresponding author), Univ Washington, Dept Global Hlth, Int Training & Educ Ctr Hlth, Seattle, WA 98195 USA.	salemtg@uw.edu		O&apos;Malley, Gabrielle/0000-0002-7514-8240; Gugsa, Salem/0000-0003-3545-3117	National Institute of Allergy and Infectious Diseases [5U01-A1069924]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases, grant 5U01-A1069924. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluisio A, 2016, J ACQUIR IMMUNE DEFI, V1; Bezabhe WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097353; Bolu OO, 2007, AM J OBSTET GYNECOL, V197, pS83, DOI 10.1016/j.ajog.2007.03.006; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Busza J, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.4.17373; Byamugisha R, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-12; Chimbwandira F, 2013, MMWR-MORBID MORTAL W, V62, P148; Chung MH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000422; Clouse K, 2014, JAIDS-J ACQ IMM DEF, V67, pE12, DOI 10.1097/QAI.0000000000000263; Colombini M, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20766; Dunlap J, 2014, CURR HIV-AIDS REP, V11, P109, DOI 10.1007/s11904-014-0200-5; Ebuy H, 2015, INT J INFECT DIS, V33, P123, DOI 10.1016/j.ijid.2014.12.026; Elwell K, 2016, AIDS CARE, V28, P971, DOI 10.1080/09540121.2016.1153586; Goudge J, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-75; Gourlay A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106325; Gourlay A, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18588; Haas AD, 2016, CLIN INFECT DIS, DOI [10.1093/cid/ciw500, DOI 10.1093/CID/CIW500]; Haas AD, 2016, LANCET HIV, V3, pE175, DOI 10.1016/S2352-3018(16)00008-4; Kalembo FW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066517; Katirayi L, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20919; Kim MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149527; Loccoh E, 2014, WJA, V04, P446; MacLachlan EW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153042; Malawi Ministry of Health, 2016, INT HIV PROGR REP; Mitiku I, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20662; Mshana GH, 2006, AIDS PATIENT CARE ST, V20, P649, DOI 10.1089/apc.2006.20.649; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, pS127, DOI 10.1097/01.qai.0000248349.25630.3d; Nam SL, 2008, SOC SCI MED, V67, P301, DOI 10.1016/j.socscimed.2008.03.042; Napua M, 2016, JAIDS-J ACQ IMM DEF, V72, pS181, DOI 10.1097/QAI.0000000000001061; Patton MQ, 2015, QUALITATIVE RES EVAL, V4th; Rogers AJ, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21224; Roy M, 2016, CURR HIV-AIDS REP, V13, P177, DOI 10.1007/s11904-016-0317-9; Sanjobo N, 2008, SAHARA J-J SOC ASP H, V5, P136, DOI 10.1080/17290376.2008.9724912; Schnack A, 2016, AIDS PATIENT CARE ST, V30, P110, DOI 10.1089/apc.2015.0318; Skovdal M, 2011, INT J HEALTH PLAN M, V26, P296, DOI 10.1002/hpm.1082; Stinson K, 2012, AJAR-AFR J AIDS RES, V11, P65, DOI 10.2989/16085906.2012.671263; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; Tweya H, 2014, TROP MED INT HEALTH, V19, P1360, DOI 10.1111/tmi.12369; Tweya H, 2010, TROP MED INT HEALTH, V15, P82, DOI 10.1111/j.1365-3156.2010.02509.x; UNAIDS, 2016, FAST TRACK AIDS FREE; Wachira J, 2014, INT J QUAL HEALTH C, V26, P190, DOI 10.1093/intqhc/mzu004; Ware NC, 2009, PLOS MED, V6, P39, DOI 10.1371/journal.pmed.1000011; Watt MH, 2009, SOC SCI MED, V68, P1793, DOI 10.1016/j.socscimed.2009.02.037; Zhou A, 2016, SOC SCI MED, V158, P52, DOI 10.1016/j.socscimed.2016.04.013	44	22	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179838	10.1371/journal.pone.0179838	http://dx.doi.org/10.1371/journal.pone.0179838			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY6UH	28636669	Green Submitted, Green Published, gold			2022-12-27	WOS:000404118300058
J	Kondo, K; Morino, K; Nishio, Y; Ishikado, A; Arima, H; Nakao, K; Nakagawa, F; Nikami, F; Sekine, O; Nemoto, K; Suwa, M; Matsumoto, M; Miura, K; Makino, T; Ugi, S; Maegawa, H				Kondo, Keiko; Morino, Katsutaro; Nishio, Yoshihiko; Ishikado, Atsushi; Arima, Hisatomi; Nakao, Keiko; Nakagawa, Fumiyuki; Nikami, Fumio; Sekine, Osamu; Nemoto, Ken-ichi; Suwa, Makoto; Matsumoto, Motonobu; Miura, Katsuyuki; Makino, Taketoshi; Ugi, Satoshi; Maegawa, Hiroshi			Fiber-rich diet with brown rice improves endothelial function in type 2 diabetes mellitus: A randomized controlled trial	PLOS ONE			English	Article							C-REACTIVE PROTEIN; MEDITERRANEAN DIET; RISK; DISEASE; OBESITY; HUMANS; HEALTH; WOMEN; DYSFUNCTION; MANAGEMENT	Background & Aims A fiber-rich diet has a cardioprotective effect, but the mechanism for this remains unclear. We hypothesized that a fiber-rich diet with brown rice improves endothelial function in patients with type 2 diabetes mellitus. Methods Twenty-eight patients with type 2 diabetes mellitus at a single general hospital in Japan were randomly assigned to a brown rice (n = 14) or white rice (n = 14) diet and were followed for 8 weeks. The primary outcome was changes in endothelial function determined from flow debt repayment by reactive hyperemia using strain-gauge plethysmography in the fasting state. Secondary outcomes were changes in HbA(1c), postprandial glucose excursions, and markers of oxidative stress and inflammation. The area under the curve for glucose after ingesting 250 kcal of assigned rice was compared between baseline (TO) and at the end of the intervention (T1) to estimate glucose excursions in each group. Results Improvement in endothelial function, assessed by fasting flow debt repayment (20.4% vs. -5.8%, p = 0.004), was significantly greater in the brown rice diet group than the white rice diet group, although the between-group difference in change of fiber intake was small (5.6 g/day vs. -1.2 g/day, p<0.0001). Changes in total, HDL-, and LDL-cholesterol, and urine 8-isoprostane levels did not differ between the two groups. The high-sensitivity C-reactive protein level tended to improve in the brown rice diet group compared with the white rice diet group (0.01 pg/L vs. -0.04 mu g/L, p = 0.063). The area under the curve for glucose was subtly but consistently lower in the brown rice diet group (TO: 21.4 mmol/L*h vs. 24.0 mmol/L*h, p = 0.043, Ti: 20.4 mmol/L*h vs. 23.3 mmol/L*h, p = 0.046) without changes in HbA(1c) Conclusions Intervention with a fiber-rich diet with brown rice effectively improved endothelial function, without changes in HbA(1c) levels, possibly through reducing glucose excursions.	[Kondo, Keiko; Morino, Katsutaro; Ishikado, Atsushi; Nakao, Keiko; Nakagawa, Fumiyuki; Sekine, Osamu; Nemoto, Ken-ichi; Ugi, Satoshi; Maegawa, Hiroshi] Shiga Univ Med Sci, Dept Med, Otsu, Shiga, Japan; [Kondo, Keiko; Arima, Hisatomi; Miura, Katsuyuki] Shiga Univ Med Sci, Dept Publ Hlth, Otsu, Shiga, Japan; [Nishio, Yoshihiko] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Diabet & Endocrine Med, Kagoshima, Japan; [Ishikado, Atsushi; Nikami, Fumio; Suwa, Makoto; Matsumoto, Motonobu; Makino, Taketoshi] Sunstar Inc, R&D Dept, Takatsuki, Osaka, Japan; [Arima, Hisatomi] Fukuoka Univ, Fac Med, Dept Prevent Med & Publ Hlth, Fukuoka, Japan; [Nakagawa, Fumiyuki] CMIC Pharma Sci Co, Osaka Lab, Osaka, Japan	Shiga University of Medical Science; Shiga University of Medical Science; Kagoshima University; Fukuoka University	Morino, K (corresponding author), Shiga Univ Med Sci, Dept Med, Otsu, Shiga, Japan.	morino@belle.shiga-med.ac.jp	MORINO, KATSUTARO/I-3207-2019	MORINO, KATSUTARO/0000-0003-2420-3817; Kondo, Keiko/0000-0002-9709-4474; Maegawa, Hiroshi/0000-0002-4611-8149	Department of Medicine, Shiga University of Medical Science (SUMS); Sunstar Inc.; Japan Society for the Promotion of Science KAKENHI [25750346]; Japan Foundation for Applied Enzymology	Department of Medicine, Shiga University of Medical Science (SUMS); Sunstar Inc.; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Foundation for Applied Enzymology	This study was funded by the Department of Medicine, Shiga University of Medical Science (SUMS), and Sunstar Inc. This study was also supported, in part, by a Grant-in-Aid from the Japan Society for the Promotion of Science KAKENHI, grant number 25750346 (to K. Kondo), and the Japan Foundation for Applied Enzymology (to K. Kondo). The Department of Medicine at SUMS received research promotion grants (Shougaku Kifukin) from Ono Pharmaceutical, Takeda, Boehringer Ingelheim, Astellas, AstraZeneca, Sunstar, Taisho-Toyama, Daiichi-Sankyo, and MSD. The research topics of these grants were not restricted. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript except for Sunstar. Atsushi Ishikado, Fumio Nikami, Makoto Suwa, Motonobu Matsumoto and Taketoshi Makino are employed by Sunstar Inc. Sunstar Inc. provided support in the form of salaries for authors Al, F. Nikami, MS, MM and TM, and provided brown rice products but did not have any additional role in the data collection and analysis, and decision to publish. Al contributed to the study design, Al, F. Nikami, MS, MM and TM reviewed and edited final version of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Fumiyuki Nakagawa is employed by CMIC Pharma Science Co. CMIC Pharma Science Co. provided support in the form of salary for author F. Nakagawa, but did not have role in the study design, data collection and analysis, and decision to publish. F. Nakagawa reviewed and edited final version of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Ajani UA, 2004, J NUTR, V134, P1181, DOI 10.1093/jn/134.5.1181; Arcaro G, 2002, CIRCULATION, V105, P576, DOI 10.1161/hc0502.103333; Canfora E. E., 2015, NAT REV ENDOCRINOL; CREAGER MA, 1990, J CLIN INVEST, V86, P228, DOI 10.1172/JCI114688; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Evert AB, 2014, DIABETES CARE, V37, pS120, DOI 10.2337/dc14-S120; Gerich JE, 2003, ARCH INTERN MED, V163, P1306, DOI 10.1001/archinte.163.11.1306; Hamilton Sandra J, 2007, Diab Vasc Dis Res, V4, P89; Higashi Y, 2001, AM J CARDIOL, V87, P121, DOI 10.1016/S0002-9149(00)01288-1; Japan Diabetes Society, 2013, TREATM GUID DIAB; King DE, 2007, ARCH INTERN MED, V167, P502, DOI 10.1001/archinte.167.5.502; Kondo K, 2014, NUTR RES, V34, P491, DOI 10.1016/j.nutres.2014.06.001; Kondo K, 2014, METABOLISM, V63, P930, DOI 10.1016/j.metabol.2014.04.005; LINDER L, 1990, CIRCULATION, V81, P1762, DOI 10.1161/01.CIR.81.6.1762; Marangoni F, 2008, NUTR METAB CARDIOVAS, V18, P602, DOI 10.1016/j.numecd.2007.11.003; McGill CR, 2015, NUTRIENTS, V7, P1119, DOI 10.3390/nu7021119; Ministry of Health and Welfare, 2015, ANN REP NAT NUTR SUR; Park Y, 2011, ARCH INTERN MED, V171, P1061, DOI 10.1001/archinternmed.2011.18; Perticone F, 2001, CIRCULATION, V104, P191, DOI 10.1161/01.CIR.104.2.191; Qi L, 2006, DIABETES CARE, V29, P1501, DOI 10.2337/dc06-0221; Rallidis LS, 2009, AM J CLIN NUTR, V90, P263, DOI 10.3945/ajcn.2008.27290; Resouces Council Science and Technology Agency Ministry of Education Culture Sports Science and Technology Japan, 2010, STAND TABL FOOD COMP; Rodriguez-Moran M, 2003, DIABETES CARE, V26, P1147, DOI 10.2337/diacare.26.4.1147; Shimabukuro M, 2014, BRIT J NUTR, V111, P310, DOI 10.1017/S0007114513002432; TAGAWA T, 1994, CIRCULATION, V90, P2285, DOI 10.1161/01.CIR.90.5.2285; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Vita JA, 2011, CIRCULATION, V124, pE906, DOI 10.1161/CIRCULATIONAHA.111.078824; Whitehead A, 2014, AM J CLIN NUTR, V100, P1413, DOI 10.3945/ajcn.114.086108; Wolk A, 1999, JAMA-J AM MED ASSOC, V281, P1998, DOI 10.1001/jama.281.21.1998; Yao BD, 2014, EUR J EPIDEMIOL, V29, P79, DOI 10.1007/s10654-013-9876-x; Yeboah J, 2007, CIRCULATION, V115, P2390, DOI 10.1161/CIRCULATIONAHA.106.678276	31	37	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179869	10.1371/journal.pone.0179869	http://dx.doi.org/10.1371/journal.pone.0179869			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662074	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300061
J	Exposito-Granados, M; Parejo, D; Martinez, JG; Sanchez-Tojar, A; Precioso, M; Molina-Morales, M; Aviles, JM				Exposito-Granados, Monica; Parejo, Deseada; Martinez, Juan Gabriel; Sanchez-Tojar, Alfredo; Precioso, Marta; Molina-Morales, Mercedes; Aviles, Jesus M.			An experimental test of host's life history traits modulation in response to cuckoo parasitism risk	PLOS ONE			English	Article							GREAT SPOTTED CUCKOO; EXPERIMENTAL BROOD PARASITISM; REED WARBLERS; PHENOTYPIC PLASTICITY; RECOGNITION ERRORS; PLANT TOLERANCE; PREDATION RISK; MAGPIE HOSTS; NEST DEFENSE; CLUTCH SIZE	Hosts can counteract parasites through defences based on resistance and/or tolerance. The mechanistic basis of tolerance, which involve defensive mechanisms minimizing parasite damage after a successful parasitic attack, remains poorly explored in the study of cuckoo-host interactions. Here, we experimentally explore the possibility that the risk of great spotted cuckoo Clamator glandarius parasitism may induce tolerance defences in magpie Pica pica hosts through plasticity in life-history traits. We predict that magpies exposed to auditory cues indicating high parasitism risk will more likely exhibit resistance and/or modify their life-history traits to minimize parasitism costs (i.e. tolerance) compared to magpies under low parasitism risk. We found that manipulating the perceived parasitism risk did not affect host resistance (i.e. rejection of parasitic eggs) nor host life-history traits. Unexpectedly, host's egg volume increased over the season in nests exposed to auditory cues of control non-harmful hoopoes Upupa epops. Our results do not provide support for inducible defences (either based on resistance or tolerance) in response to risk of parasitism in magpie hosts. Even so, we encourage studying plastic expression of breeding strategies in response to risk of cuckoo parasitism to achieve a better understanding of the mechanistic basis of tolerance defences.	[Exposito-Granados, Monica; Parejo, Deseada; Aviles, Jesus M.] EEZA CSIC, Dept Funct & Evolutionary Ecol, Almeria, Spain; [Parejo, Deseada] Univ Extremadura, Dept Zool, Badajoz, Spain; [Martinez, Juan Gabriel; Sanchez-Tojar, Alfredo; Precioso, Marta; Molina-Morales, Mercedes] Univ Granada, Dept Zool, Granada, Spain; [Sanchez-Tojar, Alfredo] Max Planck Inst Ornithol, Evolutionary Biol Grp, Seewiesen, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA); Universidad de Extremadura; University of Granada; Max Planck Society	Exposito-Granados, M (corresponding author), EEZA CSIC, Dept Funct & Evolutionary Ecol, Almeria, Spain.	moexposit@eeza.csic.es	Martinez, Juan/GXM-4393-2022; Expósito-Granados, Mónica/K-1863-2019; Parejo, Deseada/L-3953-2014; Avilés, Jesús/K-3332-2014; Sánchez-Tójar, Alfredo/H-3619-2019; Molina-Morales, Mercedes/I-8397-2019; Martínez, Juan Gabriel/L-9471-2014	Expósito-Granados, Mónica/0000-0002-7996-2469; Parejo, Deseada/0000-0002-7368-2378; Avilés, Jesús/0000-0002-1463-8393; Sánchez-Tójar, Alfredo/0000-0002-2886-0649; Martínez, Juan Gabriel/0000-0001-5277-4620; Molina Morales, Mercedes/0000-0001-8669-6624; Precioso, Marta/0000-0002-2030-5966	Spanish Ministry of Education and Science/FEDER [CGL2011-27561/BOS, CGL2014-56769-P]; Government of Extremadura [TA13002]; Spanish Ministry of Economy and Competitiveness [BES-2012-051898]	Spanish Ministry of Education and Science/FEDER(Spanish Government); Government of Extremadura; Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by the Spanish Ministry of Education and Science/FEDER (Projects CGL2011-27561/BOS and CGL2014-56769-P to D. P. and J.M.A.). D.P. was supported by the Government of Extremadura while writing (contract number TA13002). M.E.G. was supported by the Spanish Ministry of Economy and Competitiveness (grant number BES-2012-051898).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MG, 2013, EMU, V113, P187, DOI 10.1071/MU12086; Arias-de-Reyna L, 1998, OX ORN SER, V9, P129; Aviles JM, 2010, J EVOLUTION BIOL, V23, P293, DOI 10.1111/j.1420-9101.2009.01898.x; Aviles JM, 2004, ANIM BEHAV, V67, P951, DOI 10.1016/j.anbehav.2003.08.022; Bartol I, 2002, J AVIAN BIOL, V33, P420, DOI 10.1034/j.1600-048X.2002.02945.x; Birkhead T. R., 1991, MAGPIES ECOLOGY BEHA; Brooker M, 1996, BEHAV ECOL, V7, P395, DOI 10.1093/beheco/7.4.395; Campobello D, 2011, ANIM BEHAV, V82, P885, DOI 10.1016/j.anbehav.2011.07.028; Capek M, 2010, CONDOR, V112, P763, DOI 10.1525/cond.2010.100063; Cresswell W, 2008, IBIS, V150, P3, DOI 10.1111/j.1474-919X.2007.00793.x; Cunningham EJA, 2006, BEHAV ECOL, V17, P126, DOI 10.1093/beheco/arj006; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; Davies NB, 1996, P ROY SOC B-BIOL SCI, V263, P925, DOI 10.1098/rspb.1996.0137; DAVIES NB, 1988, ANIM BEHAV, V36, P262, DOI 10.1016/S0003-3472(88)80269-0; Eggers S, 2006, P ROY SOC B-BIOL SCI, V273, P701, DOI 10.1098/rspb.2005.3373; Emmering QC, 2011, J ANIM ECOL, V80, P1305, DOI 10.1111/j.1365-2656.2011.01869.x; Feeney WE, 2015, AUK, V132, P359, DOI 10.1642/AUK-14-218.1; Fontaine JJ, 2006, ECOL LETT, V9, P428, DOI 10.1111/j.1461-0248.2006.00892.x; Fornoni J, 2011, FUNCT ECOL, V25, P399, DOI 10.1111/j.1365-2435.2010.01805.x; Forsman JT, 2009, OIKOS, V118, P464, DOI 10.1111/j.1600-0706.2008.17000.x; Grim T, 2005, AUK, V122, P530, DOI 10.1642/0004-8038(2005)122[0530:HROBPI]2.0.CO;2; Hauber ME, 2003, EVOL ECOL RES, V5, P559; Hoover JP, 2007, P NATL ACAD SCI USA, V104, P4479, DOI 10.1073/pnas.0609710104; HOYT DF, 1979, AUK, V96, P73; Hua FY, 2014, BEHAV ECOL, V25, P509, DOI 10.1093/beheco/aru017; Kleindorfer S, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-30; Krist M, 2011, BIOL REV, V86, P692, DOI 10.1111/j.1469-185X.2010.00166.x; LaManna JA, 2016, ECOL LETT, V19, P403, DOI 10.1111/ele.12573; Langmore NE, 2003, NATURE, V422, P157, DOI 10.1038/nature01460; Lima SL, 2009, BIOL REV, V84, P485, DOI 10.1111/j.1469-185X.2009.00085.x; Lindholm AK, 2000, BEHAVIOUR, V137, P43, DOI 10.1163/156853900501863; Llimosa F., 1999, GUIA SONORA AVES ESP; LOTEM A, 1995, ANIM BEHAV, V49, P1185, DOI 10.1006/anbe.1995.0152; Martin TE, 2009, ANN NY ACAD SCI, V1168, P201, DOI 10.1111/j.1749-6632.2009.04577.x; Medina I, 2016, BIOL REV, V91, P569, DOI 10.1111/brv.12181; Aviles JM, 2014, BEHAV ECOL SOCIOBIOL, V68, P1287, DOI 10.1007/s00265-014-1739-2; Miller MR, 2006, EVOLUTION, V60, P945, DOI 10.1111/j.0014-3820.2006.tb01173.x; MOKSNES A, 1993, BEHAV ECOL, V4, P120, DOI 10.1093/beheco/4.2.120; Molina-Morales M, 2016, BEHAV ECOL, V27, P1441, DOI 10.1093/beheco/arw066; Molina-Morales M, 2014, EVOLUTION, V68, P3020, DOI 10.1111/evo.12471; Molina-Morales M, 2013, J ANIM ECOL, V82, P389, DOI 10.1111/1365-2656.12022; Molina-Morales M, 2012, ANIM BEHAV, V83, P671, DOI 10.1016/j.anbehav.2011.12.011; Nunez-Farfan J, 2007, ANNU REV ECOL EVOL S, V38, P541, DOI 10.1146/annurev.ecolsys.38.091206.095822; Parejo D, 2012, BEHAV ECOL SOCIOBIOL, V66, P1097, DOI 10.1007/s00265-012-1360-1; Parejo D, 2012, P ROY SOC B-BIOL SCI, V279, P2135, DOI 10.1098/rspb.2011.2601; PAYNE RB, 1977, ANNU REV ECOL SYST, V8, P1, DOI 10.1146/annurev.es.08.110177.000245; Price P. W., 1980, EVOLUTIONARY BIOL PA; Raberg L, 2009, PHILOS T R SOC B, V364, P37, DOI 10.1098/rstb.2008.0184; Rausher MD, 2001, NATURE, V411, P857, DOI 10.1038/35081193; Rohr JR, 2010, FUNCT ECOL, V24, P1110, DOI 10.1111/j.1365-2435.2010.01709.x; Roskaft E, 2002, BEHAVIOUR, V139, P613, DOI 10.1163/15685390260136735; ROTHSTEIN SI, 1990, ANNU REV ECOL SYST, V21, P481, DOI 10.1146/annurev.es.21.110190.002405; Saino N, 2005, J EXP ZOOL PART A, V303A, P998, DOI 10.1002/jez.a.224; Saino N, 2010, BEHAV ECOL SOCIOBIOL, V64, P1813, DOI 10.1007/s00265-010-0993-1; Saino N, 2010, P ROY SOC B-BIOL SCI, V277, P1203, DOI 10.1098/rspb.2009.2012; Sato NJ, 2010, BIOL LETTERS, V6, P67, DOI 10.1098/rsbl.2009.0540; SIMMS EL, 1994, EVOLUTION, V48, P1973, DOI 10.1111/j.1558-5646.1994.tb02227.x; Soler JJ, 2001, ECOL LETT, V4, P470, DOI 10.1046/j.1461-0248.2001.00247.x; SOLER JJ, 1995, BEHAV ECOL SOCIOBIOL, V36, P201, DOI 10.1007/BF00177797; Soler JJ, 2016, ENCICLOPEDIA VIRTUAL; Soler JJ, 2010, P R SOC LOND B; Soler M, 2000, BEHAVIOUR, V137, P213, DOI 10.1163/156853900502033; SOLER M, 1995, EVOLUTION, V49, P770, DOI 10.1111/j.1558-5646.1995.tb02312.x; SOLER M, 1990, NATURE, V343, P748, DOI 10.1038/343748a0; SOLER M, 1990, ORNIS SCAND, V21, P212, DOI 10.2307/3676781; Soler Manuel, 1996, Ardeola, V43, P87; Spottiswoode CN, 2010, P NATL ACAD SCI USA, V107, P8672, DOI 10.1073/pnas.0910486107; Stowe KA, 2000, ANNU REV ECOL SYST, V31, P565, DOI 10.1146/annurev.ecolsys.31.1.565; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Svensson EI, 2010, TRENDS ECOL EVOL, V25, P267, DOI 10.1016/j.tree.2009.12.005; Thorogood R, 2013, EVOLUTION, V67, P3545, DOI 10.1111/evo.12213; Welbergen JA, 2012, BEHAV ECOL, V23, P783, DOI 10.1093/beheco/ars031; Welbergen JA, 2009, CURR BIOL, V19, P235, DOI 10.1016/j.cub.2008.12.041	73	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179206	10.1371/journal.pone.0179206	http://dx.doi.org/10.1371/journal.pone.0179206			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658287	Green Published, Green Submitted, gold			2022-12-27	WOS:000404607900016
J	Tariku, A; Alemu, K; Gizaw, Z; Muchie, KF; Derso, T; Abebe, SM; Yitayal, M; Fekadu, A; Ayele, TA; Alemayehu, GA; Tsegaye, AT; Shimeka, A; Biks, GA				Tariku, Amare; Alemu, Kassahun; Gizaw, Zemichael; Muchie, Kindie Fentahun; Derso, Terefe; Abebe, Solomon Mekonnen; Yitayal, Mezgebu; Fekadu, Abel; Ayele, Tadesse Awoke; Alemayehu, Geta Asrade; Tsegaye, Adino Tesfahun; Shimeka, Alemayehu; Biks, Gashaw Andargie			Mothers' education and ANC visit improved exclusive breastfeeding in Dabat Health and Demographic Surveillance System Site, northwest Ethiopia	PLOS ONE			English	Article							CHILD NUTRITION; RISK; ASSOCIATION; OUTCOMES	Introduction Despite its proven benefit in reducing child mortality and morbidity, the coverage of exclusive breastfeeding (EBF) remains sub-optimal. In Ethiopia, about 52% of infants under six months of age were exclusively breastfed, implying the need for further identification of the barriers to optimal EBF practice. Therefore, this study aimed to investigate EBF and its determinants in the predominantly rural northwest Ethiopia. Methods The study was conducted at the Dabat Health and Demographic Surveillance System (HDSS) site, which is located in Dabat District, northwest Ethiopia. A total of 5,227 mothers with children under five years of age were included for analysis. Multivariable binary logistic regression analysis was employed to identify factors associated with EBF. The Adjusted Odds Ratio (AOR) with a 95% Confidence Interval (CI) was estimated to show the strength of association. A P-value of <0.05 was used to declare statistical significance. Results About 54.5% [95% CI: 51.9, 57.1] of the mothers practiced EBF. Mothers' education [AOR = 2.10; 95% CI: 1.63, 2.71], age (20-35 years) [AOR = 1.39; CI: 1.07, 1.80], urban residence [AOR = 1.28; 95% CI: 1.07, 1.54], at least one ANC visit [AOR = 1.41; 95% CI: 1.23,1.61], initiation of breastfeeding within one hour of birth [AOR = 1.32; 95% CI: 1.15,1.50], richer household [AOR = 1.34; 95% CI: 1.07, 1.65], and withholding prelacteal feeds [AOR = 1.34; 95% CI: 1.17, 1.53] were found important determinants of EBF. Conclusion In this study area, the prevalence of EBF is lower than the national as well as the global recommendation for universal coverage of EBF. Therefore, strengthening the implementation of Infant and Young Child Feeding strategy (IYCF) and maternal health care utilization are essential for stepping up EBF coverage. Moreover, attention should be given to uneducated, rural resident, and adolescent mothers.	[Tariku, Amare; Derso, Terefe; Abebe, Solomon Mekonnen] Univ Gondar, Dept Human Nutr, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia; [Tariku, Amare; Alemu, Kassahun; Muchie, Kindie Fentahun; Abebe, Solomon Mekonnen; Yitayal, Mezgebu; Ayele, Tadesse Awoke; Alemayehu, Geta Asrade; Tsegaye, Adino Tesfahun; Biks, Gashaw Andargie] Univ Gondar, Dabat Res Ctr Hlth & Demog Surveillance Syst, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia; [Alemu, Kassahun; Muchie, Kindie Fentahun; Fekadu, Abel; Ayele, Tadesse Awoke; Tsegaye, Adino Tesfahun; Shimeka, Alemayehu] Univ Gondar, Dept Epidemiol & Biostat, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia; [Gizaw, Zemichael] Univ Gondar, Dept Environm & Occupat Hlth & Safety, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia; [Yitayal, Mezgebu; Alemayehu, Geta Asrade; Biks, Gashaw Andargie] Univ Gondar, Dept Hlth Serv Management & Hlth Econ, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar; University of Gondar; University of Gondar; University of Gondar; University of Gondar	Tariku, A (corresponding author), Univ Gondar, Dept Human Nutr, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia.; Tariku, A (corresponding author), Univ Gondar, Dabat Res Ctr Hlth & Demog Surveillance Syst, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia.	amaretariku15@yahoo.com	Gizaw, Zemichael/CAF-1126-2022; Dadi, Abel Fekadu/AAU-3433-2020; Workneh, Zemichael Gizaw/M-1774-2019	Gizaw, Zemichael/0000-0002-6713-1975; Dadi, Abel Fekadu/0000-0001-9967-7713; Yitayal, Mezgebu/0000-0002-9206-9528	Centers for Disease Control and Prevention (CDC) through Ethiopian Public Health Association (EPHA); EPHA-CDC Cooperative Agreement [NU22GGH001039-04-00]; University of Gondar	Centers for Disease Control and Prevention (CDC) through Ethiopian Public Health Association (EPHA)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); EPHA-CDC Cooperative Agreement; University of Gondar	This work was supported by the Centers for Disease Control and Prevention (CDC) through Ethiopian Public Health Association (EPHA) in accordance with the EPHA-CDC Cooperative Agreement No. NU22GGH001039-04-00 and University of Gondar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agho KE, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-2; Aidam BA, 2005, EUR J CLIN NUTR, V59, P789, DOI 10.1038/sj.ejcn.1602144; Alemayehu T, 2009, ETHIOPIAN J HLTH DEV, V23; Arora S, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.5.e67; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Biks GA, 2015, INT BREASTFEED J, V10, DOI 10.1186/s13006-015-0055-4; Cai XD, 2012, INT BREASTFEED J, V7, DOI 10.1186/1746-4358-7-12; Central Statistical Authority, 2011, ETH DEM HLTH SURV; Central Statistical Authority [Ethiopia] and ORC Macro, 2005, DEM HLTH SUR; Coutsoudis A, 2015, IAEA B; Desai S, 1998, DEMOGRAPHY, V35, P71, DOI 10.2307/3004028; Duijts L, 2010, PEDIATRICS, V126, pE18, DOI 10.1542/peds.2008-3256; Egata G, 2013, INT BREASTFEED J, V8, DOI 10.1186/1746-4358-8-8; Federal Democratic Republic of Ethiopa, HLTH SECT DEV PROGR; Federal Ministry of Health, 2004, FAM HLTH DEP ETH NAT; Ghwass MMEA, 2011, BREASTFEEDING MED, V6; Greiner T, 2014, INT BREASTFEED J, V9, DOI 10.1186/1746-4358-9-18; Hackett KM, 2015, MATERN CHILD NUTR, V11, P173, DOI 10.1111/mcn.12007; Haider R, 2000, LANCET, V356, P1643, DOI 10.1016/S0140-6736(00)03159-7; Himani BK, 2011, NURSING MIDWIFERY RE, V7; Ivarsson A, 2002, AM J CLIN NUTR, V75, P914, DOI 10.1093/ajcn/75.5.914; Jedrychowski W, 2012, EUR J PEDIATR, V171, P151, DOI 10.1007/s00431-011-1507-5; Jessri M, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-77; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Jones JR, 2011, FACTORS ASSOCIATED E; Jorgensen MH, 2001, J PEDIATR GASTR NUTR, V32, P293, DOI 10.1097/00005176-200103000-00011; Khanal V, 2014, NUTRIENTS, V6, P1691, DOI 10.3390/nu6041691; Knip M, 2005, ADV EXP MED BIOL, V569, P142; Kushwaha KP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109181; Lakati A, 2010, E AFRICAN J PUBLIC H, V7; Lamberti LM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S18; Lamberti LM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S15; Legesse M, 2014, INT BREASTFEED J, V9, DOI 10.1186/s13006-014-0025-2; Li RW, 2014, PEDIATRICS, V134, pS13, DOI 10.1542/peds.2014-0646D; Lin SS, 2008, J CLIN NURS, V17, P296, DOI 10.1111/j.1365-2702.2006.01927.x; Mannion CA, 2013, INT BREASTFEED J, V8, DOI 10.1186/1746-4358-8-4; Mgongo M, 2013, INT BREASTFEED J, V8, DOI 10.1186/1746-4358-8-12; Mortensen EL, 2002, JAMA-J AM MED ASSOC, V287, P2365, DOI 10.1001/jama.287.18.2365; Oddy WH, 1999, BMJ-BRIT MED J, V319, P815, DOI 10.1136/bmj.319.7213.815; Parizoto GM, 2009, J PEDIAT-BRAZIL, V85, P201, DOI [10.2223/JPED.1888, 10.1590/S0021-75572009000300004]; PerezEscamilla R, 1996, J NUTR, V126, P2765; Pisacane A, 2005, PEDIATRICS, V116, pE494, DOI 10.1542/peds.2005-0479; Quinn PJ, 2001, J PAEDIATR CHILD H, V37, P465, DOI 10.1046/j.1440-1754.2001.00702.x; Reynolds A, 2001, PEDIATR CLIN N AM, V48, P159, DOI 10.1016/S0031-3955(05)70291-1; Rundall P, 2007, ORG BM; SAARINEN UM, 1995, LANCET, V346, P1065, DOI 10.1016/S0140-6736(95)91742-X; Seid AM, 2013, INT BREASTFEED J, V8, DOI 10.1186/1746-4358-8-14; Seifu W., 2014, J PEDIAT NEONATAL CA, V1; Sonko A, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0098-4; Su L-L, 2007, BMJ; Tan KL, 2011, INT BREASTFEED J, V6, DOI 10.1186/1746-4358-6-2; Tariku A, 2016, INT BREASTFEED J, V11, DOI 10.1186/s13006-016-0074-9; Vieira TO, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-175; Wassie MM, 2015, BMC NUTR, V1, P1, DOI DOI 10.1186/S40795-015-0015-9; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED; Yeneabat T, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-262; Yoon PW, 1996, AM J EPIDEMIOL, V143, P1142, DOI 10.1093/oxfordjournals.aje.a008692	57	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179056	10.1371/journal.pone.0179056	http://dx.doi.org/10.1371/journal.pone.0179056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658257	Green Submitted, Green Published, gold			2022-12-27	WOS:000404607900012
J	Contreras-Aguilar, MD; Escribano, D; Martinez-Subiela, S; Martinez-Miro, S; Rubio, M; Tvarijonaviciute, A; Tecles, F; Ceron, JJ				Contreras-Aguilar, Maria Dolores; Escribano, Damian; Martinez-Subiela, Silvia; Martinez-Miro, Silvia; Rubio, Monica; Tvarijonaviciute, Asta; Tecles, Fernando; Ceron, Jose J.			Influence of the way of reporting alpha-Amylase values in saliva in different naturalistic situations: A pilot study	PLOS ONE			English	Article							STRESS-RESPONSE; METHODOLOGICAL CONSIDERATIONS; ANTIMICROBIAL PROTEINS; VETERINARY STUDENTS; PSYCHOSOCIAL STRESS; EXERCISE; DETERMINANTS; BIOMARKERS; INTENSITY; CORTISOL	The objective of this pilot study was to compare the different ways of measuring salivary alpha-amylase (sAA, enzymatic vs. concentration) and to evaluate the influence that the different ways of reporting the results can have in sAA interpretation. For this purpose, sAA was measured by direct quantification and also by an enzymatic assay in three different naturalistic situations, a physical stressor (situation 1) and two mental stressors of different intensity (situations 2 and 3). The results were expressed in three different ways (without correction, multiplied by flow rate and divided by protein concentration). sAA concentration and activity increased just after situations 1 and 3. When values were multiplied by the flow rate, significant changes after situation 1 were detected only for sAA activity but not for sAA concentration, being these changes of lower significance and magnitude that those observed for sAA activity without any correction. In addition, a significant increase in sAA activity was found at T+15 in situation 2. In situation 3 the significant decrease in sAA at T+15 disappeared. When values were divided by protein concentration, there were no significant changes in situations 1 or 3, but a decrease in situation 2 at T+0 and an increase at T+15. sAA activity and concentration showed a significant correlation in all situations. This pilot study points out that the way of expressing sAA can influence the results obtained in different stress models and also their interpretation. Therefore, how sAA is reported and the factors involved in the different ways of expressing sAA, should be taken into consideration for an objective interpretation of sAA values.	[Contreras-Aguilar, Maria Dolores; Escribano, Damian; Martinez-Subiela, Silvia; Tvarijonaviciute, Asta; Tecles, Fernando; Ceron, Jose J.] Clin Anal Interdisciplinary Lab Interlab UMU, Campus Excellence Mare Nostrum, Murcia, Spain; [Martinez-Miro, Silvia] Vet Sch, Dept Anim Prod, Campus Excellence Mare Nostrum, Murcia, Spain; [Rubio, Monica] Univ CEU Cardenal Herrera, Vet Sch, Dept Med & Anim Surgey, Valencia, Spain; [Escribano, Damian] Univ Autonoma Barcelona, Vet Sci, Dept Anim & Food Sci, Barcelona, Spain	University of Murcia; Universidad CEU Cardenal Herrera; Autonomous University of Barcelona	Tecles, F (corresponding author), Clin Anal Interdisciplinary Lab Interlab UMU, Campus Excellence Mare Nostrum, Murcia, Spain.	ftecles@um.es	Martínez, Silvia/I-3194-2015; Tecles, Fernando/Z-4602-2019; Ceron, Jose J/H-9043-2015; Tortosa, Damian Escribano/AAG-1780-2019; Contreras-Aguilar, María Dolores/AAG-6239-2019; Martinez-Subiela, Silvia/H-5719-2015; Tortosa, Damian Escribano/L-6138-2017; Tvarijonaviciute, Asta/U-4303-2017	Martínez, Silvia/0000-0002-1350-0886; Ceron, Jose J/0000-0002-8654-1793; Tortosa, Damian Escribano/0000-0001-9439-6779; Contreras-Aguilar, María Dolores/0000-0003-2898-0410; Martinez-Subiela, Silvia/0000-0002-1524-1558; Tortosa, Damian Escribano/0000-0001-9439-6779; Tvarijonaviciute, Asta/0000-0002-5323-5001; Tecles, Fernando/0000-0002-7635-533X; RUBIO, MONICA/0000-0002-2689-8862	Seneca Foundation of Murcia Region [19894/GERM/15]; 'FPU' of University of Murcia [R.-605/2016]; 'Juan de la Cierva' of the 'Ministerio de Economia y Competitividad'; 'Juan de la Cierva incorporacion' of the 'Ministerio de Economia y Competitividad' which recipient is Asta Tvarijonaviciute	Seneca Foundation of Murcia Region(Fundacion Seneca); 'FPU' of University of Murcia; 'Juan de la Cierva' of the 'Ministerio de Economia y Competitividad'; 'Juan de la Cierva incorporacion' of the 'Ministerio de Economia y Competitividad' which recipient is Asta Tvarijonaviciute	This work was supported by the Seneca Foundation of Murcia Region (19894/GERM/15, https://www).fseneca.es/node/7667). Predoctoral contract 'FPU' of University of Murcia (R.-605/2016) which recipient is Maria Dolores Contreras-Aguilar; the postdoctoral program 'Juan de la Cierva' of the 'Ministerio de Economia y Competitividad' which recipient is Damian Escribano; and the postdoctoral program 'Juan de la Cierva incorporacion' of the 'Ministerio de Economia y Competitividad' which recipient is Asta Tvarijonaviciute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgrove JE, 2014, SCAND J MED SCI SPOR, V24, P649, DOI 10.1111/sms.12056; Allgrove JE, 2008, J SPORT SCI, V26, P653, DOI 10.1080/02640410701716790; Allgrove JE, 2012, J REHABIL RES DEV, V49, P925, DOI 10.1682/JRRD.2011.06.0105; BARDO JW, 1978, PERCEPT MOTOR SKILL, V46, P308, DOI 10.2466/pms.1978.46.1.308; Beltzer EK, 2010, PHYSIOL BEHAV, V101, P289, DOI 10.1016/j.physbeh.2010.05.016; BORG G, 1985, EUR J APPL PHYSIOL O, V54, P343, DOI 10.1007/BF02337176; Bosch JA, 2011, PSYCHONEUROENDOCRINO, V36, P449, DOI 10.1016/j.psyneuen.2010.12.019; Campbell J, 2012, PSYCHONEUROENDOCRINO, V37, P1111, DOI 10.1016/j.psyneuen.2011.12.010; de Oliveira VN, 2010, INT J SPORTS MED, V31, P377, DOI 10.1055/s-0030-1248332; DeCaro JA, 2008, AM J HUM BIOL, V20, P617, DOI 10.1002/ajhb.20795; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fortes MB, 2011, CELL STRESS CHAPERON, V16, P345, DOI 10.1007/s12192-010-0244-4; Fuentes-Rubio M, 2015, J VET BEHAV, V10, P122, DOI 10.1016/j.jveb.2014.12.008; Gallina S, 2011, CLIN ENDOCRINOL, V75, P747, DOI 10.1111/j.1365-2265.2011.04143.x; Granger DA, 2007, ANN NY ACAD SCI, V1098, P122, DOI 10.1196/annals.1384.008; Hafen M, 2008, J VET MED EDUC, V35, P102, DOI 10.3138/jvme.35.1.102; Hirtz C, 2005, PROTEOMICS, V5, P4597, DOI 10.1002/pmic.200401316; Koibuchi E, 2014, EXP THER MED, V7, P773, DOI 10.3892/etm.2014.1497; MACKINNON LT, 1993, MED SCI SPORT EXER, V25, P678; Mandel AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013352; Mirzaii-Dizgah I, 2011, ORAL DIS, V17, P597, DOI 10.1111/j.1601-0825.2011.01817.x; Nagel C, 2015, REPROD DOMEST ANIM, V50, P866, DOI 10.1111/rda.12600; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Nater UM, 2007, PSYCHONEUROENDOCRINO, V32, P392, DOI 10.1016/j.psyneuen.2007.02.007; Paszynska E, 2016, WORLD J BIOL PSYCHIA, V17, P266, DOI 10.3109/15622975.2016.1163419; Polo A., 2016, REV ANSIEDAD ESTRES, V2, P159; Proctor GB, 2007, AUTON NEUROSCI-BASIC, V133, P3, DOI 10.1016/j.autneu.2006.10.006; Rohleder N, 2006, PSYCHOPHYSIOLOGY, V43, P645, DOI 10.1111/j.1469-8986.2006.00457.x; Rohleder N, 2009, PSYCHONEUROENDOCRINO, V34, P469, DOI 10.1016/j.psyneuen.2008.12.004; STOREY K, 1993, AM J MENT RETARD, V98, P437; Tecles F, 2016, SCAND J CLIN LAB INV, P1; Tecles F, 2014, J VET MED EDUC, V41, P37, DOI 10.3138/jvme.0513-073R1; TOMASI TB, 1982, J CLIN IMMUNOL, V2, P173, DOI 10.1007/BF00915219; van der Heiden C, 1999, CLIN CHIM ACTA, V281, pS5; van Stegeren AH, 2008, INT J PSYCHOPHYSIOL, V69, P33, DOI 10.1016/j.ijpsycho.2008.02.008; Walsh NP, 1999, J SPORT SCI, V17, P129, DOI 10.1080/026404199366226	36	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0180100	10.1371/journal.pone.0180100	http://dx.doi.org/10.1371/journal.pone.0180100			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654668	Green Published, Green Submitted, gold			2022-12-27	WOS:000404541500055
J	Vu, NX; Pruksametanan, N; Srila, W; Yuttavanichakul, W; Teamtisong, K; Teaumroong, N; Boonkerd, N; Tittabutr, P; Yamabhai, M				Nguyen Xuan Vu; Pruksametanan, Natcha; Srila, Witsanu; Yuttavanichakul, Watcharin; Teamtisong, Kamonluck; Teaumroong, Neung; Boonkerd, Nantakorn; Tittabutr, Panlada; Yamabhai, Montarop			Generation of a rabbit single-chain fragment variable (scFv) antibody for specific detection of Bradyrhizobiumsp. DOA9 in both free-living and bacteroid forms	PLOS ONE			English	Article							LEGUMINOSARUM STRAIN 3841; MONOCLONAL-ANTIBODIES; PHAGE DISPLAY; POLYCLONAL ANTISERA; FUSION PROTEINS; ANTIGENS; IDENTIFICATION; SELECTION; LIPOPOLYSACCHARIDES; RHIZOBIA	A simple and reliable method for the detection of specific nitrogen-fixing bacteria in both free-living and bacteroid forms is essential for the development and application of biofertilizer. Traditionally, a polyclonal antibody generated from an immunized rabbit was used for detection. However, the disadvantages of using a polyclonal antibody include limited supply and cross-reactivity to related bacterial strains. This is the first report on the application of phage display technology for the generation of a rabbit recombinant monoclonal antibody for specific detection and monitoring of nitrogen-fixing bacteria in both free-living form and in plant nodules. Bradyrhizobium sp. DOA9, a broad host range soil bacteria, originally isolated from the root nodules of Aeschynomene americana in Thailand was used as a model in this study. A recombinant single-chain fragment variable (scFv) antibody library was constructed from the spleen of a rabbit immunized with DOA9. After three rounds of biopanning, one specific phage-displayed scFv antibody, designated bDOA9rb8, was identified. Specific binding of this antibody was confirmed by phage enzyme-linked immunosorbent assay (phage ELISA). The phage antibody could bind specifically to DOA9 in both free-living cells (pure culture) and bacteroids inside plant nodules. In addition to phage ELISA, specific and robust immunofluorescence staining of both free-living and bacteroid forms could also be observed by confocal-immunofluorescence imaging, without cross-reactivity with other tested bradyrhizobial strains. Moreover, specific binding of free scFv to DOA9 was also demonstrated by ELISA. This recombinant antibody can also be used for the study of the molecular mechanism of plant-microbe interactions in the future.	[Nguyen Xuan Vu; Pruksametanan, Natcha; Srila, Witsanu; Yamabhai, Montarop] Suranaree Univ Technol, Inst Agr Technol, Sch Biotechnol, Mol Biotechnol Lab, Nakhon Ratchasima, Thailand; [Nguyen Xuan Vu; Yuttavanichakul, Watcharin; Teaumroong, Neung; Boonkerd, Nantakorn; Tittabutr, Panlada] Suranaree Univ Technol, Inst Agr Technol, Sch Biotechnol, Biofertilizer & Plant Microbe Interact Res Unit, Nakhon Ratchasima, Thailand; [Teamtisong, Kamonluck] Suranaree Univ Technol, Ctr Sci & Technol Equipment, Nakhon Ratchasima, Thailand; [Nguyen Xuan Vu] Thai Nguyen Univ Agr & Forestry, Fac Biotechnol & Food Technol, Thai Nguyen City, Thai Nguyen Pro, Vietnam	Suranaree University of Technology; Suranaree University of Technology; Suranaree University of Technology; Thai Nguyen University	Yamabhai, M (corresponding author), Suranaree Univ Technol, Inst Agr Technol, Sch Biotechnol, Mol Biotechnol Lab, Nakhon Ratchasima, Thailand.; Tittabutr, P (corresponding author), Suranaree Univ Technol, Inst Agr Technol, Sch Biotechnol, Biofertilizer & Plant Microbe Interact Res Unit, Nakhon Ratchasima, Thailand.	panlada@sut.ac.th; montarop@g.sut.ac.th	Yamabhai, Montarop/AFM-1335-2022; Yamabhai, Montarop/AAX-8731-2021	Srila, Witsanu/0000-0001-9522-5437; Yuttavanichakul, watcharin/0000-0002-3786-0405; Yamabhai, Montarop/0000-0003-2674-2419	Suranaree University of Technology; Office of the Higher Education Commission under the NRU project of Thailand; National Research Council of Thailand; Agricultural Research Development Agency (Public Organization), Thailand [CRP5507010890]; SUT-PhD Scholarship Program for ASEAN	Suranaree University of Technology; Office of the Higher Education Commission under the NRU project of Thailand; National Research Council of Thailand(National Research Council of Thailand (NRCT)); Agricultural Research Development Agency (Public Organization), Thailand; SUT-PhD Scholarship Program for ASEAN	This work was supported by Suranaree University of Technology, the SUT-PhD Scholarship Program for ASEAN, and by the Office of the Higher Education Commission under the NRU project of Thailand. It was also supported by the National Research Council of Thailand and by the Agricultural Research Development Agency (Public Organization), Thailand CRP5507010890. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad ZA, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/980250; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARLSON RW, 1984, J BACTERIOL, V158, P1012, DOI 10.1128/JB.158.3.1012-1017.1984; Ducancel F, 2012, MABS-AUSTIN, V4, P445, DOI 10.4161/mabs.20776; Filpula D, 2007, BIOMOL ENG, V24, P201, DOI 10.1016/j.bioeng.2007.03.004; FUHRMANN J, 1985, APPL ENVIRON MICROB, V49, P1010, DOI 10.1128/AEM.49.4.1010-1013.1985; Griffiths AD, 1998, CURR OPIN BIOTECH, V9, P102, DOI 10.1016/S0958-1669(98)80092-X; HOBEN HJ, 1994, WORLD J MICROB BIOT, V10, P538, DOI 10.1007/BF00367662; Huang JX, 2012, ANTIMICROB AGENTS CH, V56, P4569, DOI 10.1128/AAC.00567-12; Jayaraman V, 1998, BIOCHEM MOL BIOL INT, V44, P777; Ji ZJ, 2017, SYST APPL MICROBIOL, V40, P114, DOI 10.1016/j.syapm.2016.12.003; KANNENBERG EL, 1992, MOL MICROBIOL, V6, P2477, DOI 10.1111/j.1365-2958.1992.tb01424.x; Kay B. K, 1996, PHAGE DISPLAY PEPTID; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kontermann R, 2010, ANTIBODY ENG; Lei L, 2014, PLANT PHYSIOL, V164, P1045, DOI 10.1104/pp.113.232637; Lucas MM, 1996, J BACTERIOL, V178, P2727, DOI 10.1128/jb.178.10.2727-2733.1996; Noisangiam R, 2012, APPL ENVIRON MICROB, V78, P6236, DOI 10.1128/AEM.00897-12; Okazaki S, 2016, ISME J, V10, P64, DOI 10.1038/ismej.2015.103; OLSEN PE, 1989, APPL ENVIRON MICROB, V55, P520, DOI 10.1128/AEM.55.2.520-522.1989; Pansri P, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-6; Payakapong W, 2003, WORLD J MICROB BIOT, V19, P981, DOI 10.1023/B:WIBI.0000007416.10475.d9; Rangnoi K, 2011, MOL BIOTECHNOL, V49, P240, DOI 10.1007/s12033-011-9398-2; Rohrbach P, 2003, BIOTECHNOL GENET ENG, V20, P137, DOI 10.1080/02648725.2003.10648041; Rosander A, 2002, J MICROBIOL METH, V51, P43, DOI 10.1016/S0167-7012(02)00052-0; SCHLOTER M, 1995, BIOTECHNOL ADV, V13, P75, DOI 10.1016/0734-9750(94)00023-6; Schloter M, 1997, APPL ENVIRON MICROB, V63, P2038, DOI 10.1128/AEM.63.5.2038-2046.1997; SCHMIDT EL, 1968, J BACTERIOL, V95, P1987, DOI 10.1128/JB.95.6.1987-1992.1968; Sidhu S. S., 2005, PHAGE DISPLAY BIOTEC, V2nd; Sidhu SS, 2001, TRENDS MICROBIOL, V9, P565, DOI [10.1016/S0966-842X(01)02206-5, DOI 10.1016/S0966-842X(01)02206-5]; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Smothers JF, 2002, SCIENCE, V298, P621, DOI 10.1126/science.298.5593.621; Spadiut O, 2014, TRENDS BIOTECHNOL, V32, P54, DOI 10.1016/j.tibtech.2013.10.002; Teamtisong K, 2014, MICROBES ENVIRON, V29, P370, DOI 10.1264/jsme2.ME14065; Teillaud JL, 2005, EXPERT OPIN BIOL TH, V5, pS15, DOI 10.1517/14712598.5.1.S15; WRIGHT SF, 1986, APPL ENVIRON MICROB, V52, P119, DOI 10.1128/AEM.52.1.119-123.1986	36	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179983	10.1371/journal.pone.0179983	http://dx.doi.org/10.1371/journal.pone.0179983			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654662	Green Published, Green Submitted, gold			2022-12-27	WOS:000404541500045
J	Pettibone, L; Vohland, K; Ziegler, D				Pettibone, Lisa; Vohland, Katrin; Ziegler, David			Understanding the (inter) disciplinary and institutional diversity of citizen science: A survey of current practice in Germany and Austria	PLOS ONE			English	Article							PUBLIC ENGAGEMENT; TOOL	Citizen science has become more popular in recent years, quickly taking on a variety of potentially conflicting characteristics: a way to collect massive data sets at relatively low cost, a way to break science out of the ivory tower and better engage the public, an approach to educate lay people in scientific methods. But the extent of current citizen science practice-the types of actors and scientific disciplines who take part-is still poorly understood. This article builds on recent surveys of citizen science in PLOS One by analyzing citizen science practice in Germany and Austria through the projects on two online platforms. We find evidence supporting previous findings that citizen science is a phenomenon strongest in biodiversity and environmental monitoring research, but at home in a number of scientific fields, such as history and geography. In addition, our survey method yields new insights into citizen science projects initiated by non-scientific actors. We close by discussing additional methodological considerations in attempting to present a cross-disciplinary overview of citizen science.	[Pettibone, Lisa; Vohland, Katrin; Ziegler, David] Museum Nat Kunde Berlin, Publ Engagement Sci, Berlin, Germany; [Pettibone, Lisa] Ludwig Maximilians Univ Munchen, Rachel Carson Ctr Environm & Soc, Munich, Germany	Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of Munich	Pettibone, L (corresponding author), Museum Nat Kunde Berlin, Publ Engagement Sci, Berlin, Germany.; Pettibone, L (corresponding author), Ludwig Maximilians Univ Munchen, Rachel Carson Ctr Environm & Soc, Munich, Germany.	lisa.pettibone@mfn-berlin.de	Vohland, Katrin/AAV-1393-2020	Vohland, Katrin/0000-0002-7214-7015	German Federal Ministry of Education and Research (BMBF); BMBF; German Stifterverband; Rachel Carson Center; Open Access Fund of the Leibniz Association	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); BMBF(Federal Ministry of Education & Research (BMBF)); German Stifterverband; Rachel Carson Center; Open Access Fund of the Leibniz Association	This publication was written as part of the consortium project BurGEr schaffen WISSen - Wissen schafft Burger' (Citizens create knowledge), funded by the German Federal Ministry of Education and Research (BMBF) and the online platform buergerschaffenwissen.de funded by BMBF and the German Stifterverband. A fellowship from the Rachel Carson Center allowed the corresponding author to finalize and submit the manuscript. The publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This publication was written as part of the consortium project 'BurGEr schaffen WISSen-Wissen schafft Burger' (Citizens create knowledge), funded by the German Federal Ministry of Education and Research (BMBF) and the online platform buergerschaffenwissen.de funded by BMBF and the German Stifterverband. A fellowship from the Rachel Carson Center allowed the corresponding author to finalize and submit the manuscript and coordinate revisions.	Association ECS, 2015, 10 PRINC CIT SCI; Beberg AL, 2009, IPDPS 2009; Bonn A., 2016, CITIZEN SCI STRATEGI; Bonney R, 2014, SCIENCE, V343, P1436, DOI 10.1126/science.1251554; Bonney R, 2009, BIOSCIENCE, V59, P977, DOI 10.1525/bio.2009.59.11.9; Bowser A., 2013, NEW VISIONS CITIZEN; CATLINGROVES CL, 2012, INT J ZOOL, V2012, DOI DOI 10.1155/2012/349630; Cooper C, 2015, YALE ENV, V360, P1; Cooper CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106508; Cooper CB, 2012, DEMOCR ED, V20; Crain R, 2014, ANNU REV ENV RESOUR, V39, P641, DOI 10.1146/annurev-environ-030713-154609; Curtis V, 2014, APPL TRANSL GENOM, V3, P90, DOI 10.1016/j.atg.2014.07.001; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; Finke Peter., 2016, B RGER K NSTE WISSEN, P31; Follett R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143687; Franzoni C, 2014, RES POLICY, V43, P1, DOI 10.1016/j.respol.2013.07.005; Gerstberger M, 1993, FAUNA BERLIN BRANDEN; Gottschick J., 2013, EXPEDITION MUNSTERLA; Haklay M, 2015, FUTURES; Heigl F, 2014, HUM COMPUT, V1, P163; Heiss R, 2017, GAIA, V26, P22, DOI 10.14512/gaia.26.1.7; Irwin A., 1995, CITIZEN SCI STUDY PE, DOI DOI 10.4324/9780203202395; Kullenberg C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147152; Kuznetsov S., 2013, INTERACTIONS, V20, P26; Lang DJ, 2012, SUSTAIN SCI, V7, P25, DOI 10.1007/s11625-011-0149-x; Mahr D., 2014, CITIZEN SCI PARTIZIP; Mey W., 2016, MAERK ENTOMOL NACHR, V17, P239; Newman G, 2012, FRONT ECOL ENVIRON, V10, P298, DOI 10.1890/110294; Nov O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090375; Ottinger G, 2010, SCI TECHNOL HUM VAL, V35, P244, DOI 10.1177/0162243909337121; Pei L, 2014, INSIGHTS PERSPECTIVE, P1; Pettibone L, 2015, 5 GEWISS; Pettibone L., 2016, CITIZEN SCI ALL GUID; Pettibone L, 2016, CITIZEN SCI KULTUR G, P57; Pettibone L., 2015, INT POL AN C 8 10 JU; Pettibone L., 2016, 12 GEWISS; Pettibone L, 2016, 8 GEWISS; Purdam K, 2014, CURR SOCIOL, V62, P374, DOI 10.1177/0011392114527997; Raddick MJ, 2009, ASTRO2010 ASTRON AST, V2010, P46; Ranard BL, 2014, J GEN INTERN MED, V29, P187, DOI 10.1007/s11606-013-2536-8; Richter A, 2015, GEWISS DIALOGFORUM B; Scheinberg K., 2016, PRACTICAL INEXACT PR, P1; Shirk JL, 2012, ECOL SOC, V17, DOI 10.5751/ES-04705-170229; Stilgoe J, 2014, PUBLIC UNDERST SCI, V23, P4, DOI 10.1177/0963662513518154; Tweddle JC, 2012, GUIDE CITIZEN SCI DE; Vohland K, 2015, VIRTUELLE BURGERWISS; Weinstein M., 2012, DEMOCRACY ED, V20, DOI 10.013/epic.42529.d001; Wiggins A, 2011, P ANN HAW INT C SYST, DOI 10.1109/HICSS.2011.207; Woolley JP, 2016, BMC MED ETHICS, V17, DOI 10.1186/s12910-016-0117-1; Ziegler D., 2014, FORUM GEOOKOLOGIE, V25, P8; Ziegler D, 2016, WISSNET K EXZ ALL 6	51	28	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0178778	10.1371/journal.pone.0178778	http://dx.doi.org/10.1371/journal.pone.0178778			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654930	Green Submitted, Green Published, gold			2022-12-27	WOS:000404541500003
J	Uematsu, H; Yamashita, K; Kunisawa, S; Fushimi, K; Imanaka, Y				Uematsu, Hironori; Yamashita, Kazuto; Kunisawa, Susumu; Fushimi, Kiyohide; Imanaka, Yuichi			Estimating the disease burden of methicillin-resistant Staphylococcus aureus in Japan: Retrospective database study of Japanese hospitals	PLOS ONE			English	Article							INFECTION; HEALTH; IMPACT; CARE; OUTCOMES; QUALITY; COSTS	Objectives The nationwide impact of antimicrobial-resistant infections on healthcare facilities throughout Japan has yet to be examined. This study aimed to estimate the disease burden of methicillin-resistant Staphylococcus aureus (MRSA) infections in Japanese hospitals. Design Retrospective analysis of inpatients comparing outcomes between subjects with and without MRSA infection. Data source A nationwide administrative claims database. Setting 1133 acute care hospitals throughout Japan. Participants All surgical and non-surgical inpatients who were discharged between April 1, 2014 and March 31, 2015. Main outcome measures Disease burden was assessed using hospitalization costs, length of stay, and in-hospital mortality. Using a unique method of infection identification, we categorized patients into an anti-MRSA drug group and a control group based on anti-MRSA drug utilization. To estimate the burden of MRSA infections, we calculated the differences in outcome measures between these two groups. The estimates were extrapolated to all 1584 acute care hospitals in Japan that have adopted a prospective payment system. Results We categorized 93 838 patients into the anti-MRSA drug group and 2 181 827 patients into the control group. The mean hospitalization costs, length of stay, and in-hospital mortality of the anti-MRSA drug group were US$ 33 548, 75.7 days, and 22.9%, respectively; these values were 3.43, 2.95, and 3.66 times that of the control group, respectively. When extrapolated to the 1584 hospitals, the total incremental burden of MRSA was estimated to be US $ 2 billion (3.41% of total hospitalization costs), 4.34 million days (3.02% of total length of stay), and 14.3 thousand deaths (3.62% of total mortality). Conclusions This study quantified the approximate disease burden of MRSA infections in Japan. These findings can inform policymakers on the burden of antimicrobial-resistant infections and support the application of infection prevention programs.	[Uematsu, Hironori; Yamashita, Kazuto; Kunisawa, Susumu; Imanaka, Yuichi] Kyoto Univ, Grad Sch Med, Dept Healthcare Econ & Qual Management, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Kyoto, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hlth Policy & Informat, Bunkyo Ku, Tokyo, Japan	Kyoto University; Tokyo Medical & Dental University (TMDU)	Imanaka, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Healthcare Econ & Qual Management, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Kyoto, Japan.	imanaka-y@umin.net	KUNISAWA, Susumu/HCH-1094-2022		Ministry of Health, Labour and Welfare of Japan [H27-shinkogyosei-shitei-005, H27-seisaku-shitei-009]; Japan Society for the Promotion of Science [[A]25253033]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Health Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan (H27-shinkogyosei-shitei-005, H27-seisaku-shitei-009; http://www.mhlw.go.jp/), and a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science. ([A]25253033; https://www.jsps.go.jp/index.html) to YI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa N, 2013, J INFECT CHEMOTHER, V19, P447, DOI 10.1007/s10156-012-0501-9; Anderson Gerard F, 2010, Issue Brief (Commonw Fund), V90, P1; [Anonymous], 2015, DISCHARGE SURVEY 201; [Anonymous], 2016, JAP NOS INF SURV 201; [Anonymous], 2014, REV ANTIMICROBIAL RE; Bozic KJ, 2005, J BONE JOINT SURG AM, V87A, P1746, DOI 10.2106/JBJS.D.02937; Centres for Disease Control and Prevention (US), 2013, ANT RES THREATS US; COELLO R, 1993, J HOSP INFECT, V25, P239, DOI 10.1016/0195-6701(93)90110-L; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P1433, DOI 10.1086/375081; Filice GA, 2010, INFECT CONT HOSP EP, V31, P365, DOI 10.1086/651094; Guidos RJ, 2011, CLIN INFECT DIS, V52, pS397, DOI 10.1093/cid/cir153; Hamada H, 2012, HEALTH POLICY, V107, P194, DOI 10.1016/j.healthpol.2012.01.002; Lee J, 2011, J HOSP INFECT, V77, P316, DOI 10.1016/j.jhin.2010.11.013; Mauldin PD, 2010, ANTIMICROB AGENTS CH, V54, P109, DOI 10.1128/AAC.01041-09; Park S, 2013, HEALTH POLICY, V111, P264, DOI 10.1016/j.healthpol.2013.05.015; PPP. OECD, 2016, PURCH POW PART PPP I, DOI 10.1787/1290ee5a-en; Reed SD, 2001, NEUROLOGY, V57, P305, DOI 10.1212/WNL.57.2.305; Roberts RR, 2009, CLIN INFECT DIS, V49, P1175, DOI 10.1086/605630; Sasaki T, 2015, NEUROL MED-CHIR, V55, P267, DOI 10.2176/nmc.ra.2014-0317; Sekimoto M, 2010, VOX SANG, V98, P538, DOI 10.1111/j.1423-0410.2009.01290.x; Shih T, 2014, ANONYMOUS SUCCESS AC, P153; Uematsu H, 2016, RESPIROLOGY; Uematsu H, 2016, AM J INFECT CONTROL; Uematsu H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125284; Uematsu H, 2014, INT J QUAL HEALTH C, V26, P100, DOI 10.1093/intqhc/mzt078; World Health Organization, 2014, ANT RES GLOB REP SUR	26	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179767	10.1371/journal.pone.0179767	http://dx.doi.org/10.1371/journal.pone.0179767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654675	Green Submitted, gold, Green Published			2022-12-27	WOS:000404541500032
J	Yan, H; Ajuwon, KM				Yan, Hui; Ajuwon, Kolapo M.			Butyrate modifies intestinal barrier function in IPEC-J2 cells through a selective upregulation of tight junction proteins and activation of the Akt signaling pathway	PLOS ONE			English	Article							EPITHELIAL-CELLS; PERMEABILITY; EXPRESSION; GUT; LIPOPOLYSACCHARIDE; DISEASE; KINASE; LPS; INFLAMMATION; PERFORMANCE	The intestinal epithelial barrier, composed of epithelial cells, tight junction proteins and intestinal secretions, prevents passage of luminal substances and antigens through the paracellular space. Dysfunction of the intestinal barrier integrity induced by toxins and pathogens is associated with a variety of gastrointestinal disorders and diseases. Although butyrate is known to enhance intestinal health, its role in the protection of intestinal barrier function is poorly characterized. Therefore, we investigated the effect of butyrate on intestinal epithelial integrity and tight junction permeability in a model of LPS-induced inflammation in IPEC-J2 cells. Butyrate dose-dependently reduced LPS impairment of intestinal barrier integrity and tight junction permeability, measured by trans-epithelial electrical resistance (TEER) and paracellular uptake of fluorescein isothiocyanate-dextran (FITC-dextran). Additionally, butyrate increased both mRNA expression and protein abundance of claudins-3 and 4, and influenced intracellular ATP concentration in a dose-dependent manner. Furthermore, butyrate prevented the downregulation of Akt and 4E-BP1 phosphorylation by LPS, indicating that butyrate might enhance tight junction protein abundance through mechanisms that included activation of Akt/mTOR mediated protein synthesis. The regulation of AMPK activity and intracellular ATP level by butyrate indicates that butyrate might regulate energy status of the cell, perhaps by serving as a nutrient substrate for ATP synthesis, to support intestinal epithelial barrier tight junction protein abundance. Our findings suggest that butyrate might protect epithelial cells from LPS-induced impairment of barrier integrity through an increase in the synthesis of tight junction proteins, and perhaps regulation of energy homeostasis.	[Yan, Hui; Ajuwon, Kolapo M.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Ajuwon, KM (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.	kajuwon@purdue.edu			Purdue Research Foundation	Purdue Research Foundation	HY was supported by a fellowship from the Purdue Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Ahdieh M, 2001, AM J PHYSIOL-CELL PH, V281, pC2029, DOI 10.1152/ajpcell.2001.281.6.C2029; Al-Sadi R, 2008, J IMMUNOL, V180, P5653, DOI 10.4049/jimmunol.180.8.5653; Arce C, 2010, COMP IMMUNOL MICROB, V33, P161, DOI 10.1016/j.cimid.2008.08.003; Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373; Ashida H, 2012, NAT CHEM BIOL, V8, P36, DOI 10.1038/nchembio.741; Awad WA, 2012, POULTRY SCI, V91, P2949, DOI 10.3382/ps.2012-02448; Balda MS, 2008, J CELL SCI, V121, P3677, DOI 10.1242/jcs.023887; Brandtzaeg P, 2011, EUR J PHARMACOL, V668, pS16, DOI 10.1016/j.ejphar.2011.07.006; Brosnahan AJ, 2012, VET MICROBIOL, V156, P229, DOI 10.1016/j.vetmic.2011.10.017; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Clayburgh DR, 2004, LAB INVEST, V84, P282, DOI 10.1038/labinvest.3700050; Forster C, 2008, HISTOCHEM CELL BIOL, V130, P55, DOI 10.1007/s00418-008-0424-9; Fusunyan RD, 1998, PEDIATR RES, V43, P84, DOI 10.1203/00006450-199801000-00013; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Guilloteau P, 2010, NUTR RES REV, V23, P366, DOI 10.1017/S0954422410000247; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Guo SH, 2015, J IMMUNOL, V195, P4999, DOI 10.4049/jimmunol.1402598; Guttman JA, 2009, BBA-BIOMEMBRANES, V1788, P832, DOI 10.1016/j.bbamem.2008.10.028; Hall M N, 2008, Transplant Proc, V40, pS5, DOI 10.1016/j.transproceed.2008.10.009; Hammer AM, 2015, ALCOHOL RES-CURR REV, V37, P209; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hu CH, 2012, ANIM FEED SCI TECH, V177, P108, DOI 10.1016/j.anifeedsci.2012.07.028; Mandal M, 2001, GASTROENTEROLOGY, V120, P71, DOI 10.1053/gast.2001.20897; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marette A, 2002, CURR OPIN CLIN NUTR, V5, P377, DOI 10.1097/00075197-200207000-00005; Murugesan GR, 2015, POULTRY SCI, V94, P1298, DOI 10.3382/ps/pev075; Nakanishi N, 2009, MICROBIOL-SGM, V155, P521, DOI 10.1099/mic.0.023499-0; Neunlist M, 2013, NAT REV GASTRO HEPAT, V10, P90, DOI 10.1038/nrgastro.2012.221; Oswald IP, 2006, VET RES, V37, P359, DOI 10.1051/vetres:2006006; Peace RM, 2011, J NUTR, V141, P1312, DOI 10.3945/jn.110.136796; Pearce SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070215; Peng LY, 2007, PEDIATR RES, V61, P37, DOI 10.1203/01.pdr.0000250014.92242.f3; Peng LY, 2009, J NUTR, V139, P1619, DOI 10.3945/jn.109.104638; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piche T, 2009, GUT, V58, P196, DOI 10.1136/gut.2007.140806; Pinton P, 2010, J NUTR, V140, P1956, DOI 10.3945/jn.110.123919; Pinton P, 2009, TOXICOL APPL PHARM, V237, P41, DOI 10.1016/j.taap.2009.03.003; Quinteiro WM, 2010, POULTRY SCI, V89, P1905, DOI 10.3382/ps.2010-00812; Raqib R, 2006, P NATL ACAD SCI USA, V103, P9178, DOI 10.1073/pnas.0602888103; Ruemmele FM, 2003, GUT, V52, P94, DOI 10.1136/gut.52.1.94; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; Schlegel N, 2012, HISTOCHEM CELL BIOL, V138, P627, DOI 10.1007/s00418-012-0983-7; Song ZH, 2015, J ANIM SCI, V93, P1599, DOI 10.2527/jas.2014-8580; Tan B, 2010, AMINO ACIDS, V38, P1227, DOI 10.1007/s00726-009-0334-8; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Vaarala O, 2008, CURR OPIN GASTROEN, V24, P701, DOI 10.1097/MOG.0b013e32830e6d98; Valenzano MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133926; VELLENGA L, 1992, AM J VET RES, V53, P1180; Vergauwen H., 2015, IMPACT FOOD BIOACTIV, P125; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Wang H, 2015, J NUTR, V145, P1156, DOI 10.3945/jn.114.209817; Weber P, 2003, CLIN EXP RHEUMATOL, V21, P657; Yan H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145940; Yan H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059581; Yang FJ, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0372-1; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239	61	172	191	6	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e017958	10.1371/journal.pone.0179586	http://dx.doi.org/10.1371/journal.pone.0179586			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654658	Green Published, Green Submitted, gold			2022-12-27	WOS:000404541500018
J	Zhao, J; Brown, K; Liem, RKH				Zhao, Jian; Brown, Kristy; Liem, Ronald K. H.			Abnormal neurofilament inclusions and segregations in dorsal root ganglia of a Charcot-Marie-Tooth type 2E mouse model	PLOS ONE			English	Article							SLOW AXONAL-TRANSPORT; TRANSGENIC MICE; LIGHT GENE; N98S MUTATION; DISEASE; NEUROPATHY; SUBUNIT; PHENOTYPE; BETA,BETA'-IMINODIPROPIONITRILE; CYTOSKELETON	Charcot-Marie-Tooth (CMT) disease or hereditary motor and sensory neuropathy is the most prevalent inherited peripheral neuropathy and is associated with over 90 causative genes. Mutations in neurofilament light polypeptide gene, NEFL cause CMT2E, an axonal form of CMT that results in abnormal structures and/or functions of peripheral axons in spinal cord motor neurons and dorsal root ganglion neurons. We have previously generated and characterized a knock-in mouse model of CMT2E with the N98S mutation in Nefl that presented with multiple inclusions in spinal cord neurons. In this report, we conduct immunofluorescence studies of cultured dorsal root ganglia (DRG) from Nefl N98S/+ mice, and show that inclusions found in DRG neurites can occur in embryonic stages. Ultrastructural analyses reveal that the inclusions are disordered neurofilaments packed in high density, segregated from other organelles. Immunochemical studies show decreased NFL protein levels in DRG, cerebellum and spinal cord in Nefl N98S/+ mice, and total NFL protein pool is shifted toward the triton-insoluble fraction. Our findings reveal the nature of the inclusions in Nefl N98S/+ mice, provide useful information to understand mechanisms of CMT2E disease, and identify DRG from Nefl N98S/+ mice as a useful cell line model for therapeutic discoveries.	[Zhao, Jian; Brown, Kristy; Liem, Ronald K. H.] Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, 630 W 168th St, New York, NY 10032 USA; [Liem, Ronald K. H.] Columbia Univ Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, 630 W 168th St, New York, NY 10032 USA	Columbia University; Columbia University	Liem, RKH (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, 630 W 168th St, New York, NY 10032 USA.; Liem, RKH (corresponding author), Columbia Univ Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, 630 W 168th St, New York, NY 10032 USA.	rkl2@cumc.columbia.edu			Muscular Dystrophy Association [MDA2550838]	Muscular Dystrophy Association(Muscular Dystrophy Association)	This work was supported by the Muscular Dystrophy Association, Grant # MDA2550838 (https://www.mda.org/) to RKHL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2009, J HUM GENET, V54, P94, DOI 10.1038/jhg.2008.13; Adebola AA, 2015, HUM MOL GENET, V24, P2163, DOI 10.1093/hmg/ddu736; Beaulieu JM, 1999, J CELL BIOL, V147, P531, DOI 10.1083/jcb.147.3.531; Beaulieu JM, 2000, J NEUROSCI, V20, P5321, DOI 10.1523/JNEUROSCI.20-14-05321.2000; Berciano J, 2016, J NEUROL, V263, P361, DOI 10.1007/s00415-015-7985-z; BIZZI A, 1984, J NEUROSCI, V4, P722; Ching GY, 1999, J NEUROSCI, V19, P2974; COTE F, 1993, CELL, V73, P35, DOI 10.1016/0092-8674(93)90158-M; DONAGHY M, 1988, J NEUROCYTOL, V17, P197, DOI 10.1007/BF01674207; EYER J, 1994, NEURON, V12, P389, DOI 10.1016/0896-6273(94)90280-1; Fabrizi GM, 2004, NEUROLOGY, V62, P1429, DOI 10.1212/01.WNL.0000120664.07186.3C; GILBERT MR, 1992, J NEUROSCI, V12, P1763; GRIFFIN JW, 1978, SCIENCE, V202, P633, DOI 10.1126/science.81524; GRIFFIN JW, 1983, J NEUROSCI, V3, P557; Jordanova A, 2003, BRAIN, V126, P590, DOI 10.1093/brain/awg059; Jordanova A, 2003, AM J HUM GENET, V73, P1423, DOI 10.1086/379792; KAPLAN MP, 1991, J NEUROSCI RES, V30, P545, DOI 10.1002/jnr.490300312; LEE MK, 1994, NEURON, V13, P975, DOI 10.1016/0896-6273(94)90263-1; Liem RKH, 1993, CURR OPIN CELL BIOL, V5, P12, DOI 10.1016/S0955-0674(05)80003-1; Marszalek JR, 1996, J CELL BIOL, V135, P711, DOI 10.1083/jcb.135.3.711; Mersiyanova IV, 2000, AM J HUM GENET, V67, P37, DOI 10.1086/302962; MORRIS JR, 1982, J CELL BIOL, V92, P192, DOI 10.1083/jcb.92.1.192; PACHTER JS, 1984, DEV BIOL, V103, P200, DOI 10.1016/0012-1606(84)90021-6; Perez-Olle R, 2004, HUM MOL GENET, V13, P2207, DOI 10.1093/hmg/ddh236; SPENCER PS, 1975, J NEUROL NEUROSUR PS, V38, P771, DOI 10.1136/jnnp.38.8.771; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; VICKERS JC, 1994, J NEUROSCI, V14, P5603; Xue C, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004406; Yoshihara T, 2002, J PERIPHER NERV SYST, V7, P221, DOI 10.1046/j.1529-8027.2002.02028.x; Yum SW, 2009, ANN NEUROL, V66, P759, DOI 10.1002/ana.21728; Zuchner S, 2004, NEUROMUSCULAR DISORD, V14, P147, DOI 10.1016/j.nmd.2003.10.003	31	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0180038	10.1371/journal.pone.0180038	http://dx.doi.org/10.1371/journal.pone.0180038			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654681	Green Submitted, Green Published, gold			2022-12-27	WOS:000404541500049
J	Hlavin, G; Hampson, LV; Koenig, F				Hlavin, Gerald; Hampson, Lisa V.; Koenig, Franz			Many-to-one comparisons after safety selection in multi-arm clinical trials	PLOS ONE			English	Article							MULTIPLICITY ADJUSTMENT METHODS; ADAPTIVE DESIGNS; RARE CANCERS; ASSOCIATION	In phase II platform trials, 'many-to-one' comparisons are performed when K experimental treatments are compared with a common control to identify the most promising treatment(s) to be selected for Phase III trials. However, when sample sizes are limited, such as when the disease of interest is rare, only a single Phase II/III trial addressing both treatment selection and confirmatory efficacy testing may be feasible. In this paper, we suggest a two-step safety selection and testing procedure for such seamless trials. At the end of the study, treatments are first screened on the basis of safety, and those deemed to be sufficiently safe are then taken forwards for efficacy testing against a common control. All safety and efficacy evaluations are therefore performed at the end of the study, when for each patient all safety and efficacy data are available. If confirmatory conclusions are to be drawn from the trial, strict control of the family-wise error rate (FWER) is essential. However, to avoid unnecessary losses in power, no type I error rate should be "wasted" on comparisons which are no longer of interest because treatments have been dropped due to safety concerns. We investigate the impact on power and FWER control of multiplicity adjustments which correct efficacy tests only for the number of safe selected treatments instead of adjusting for all K null hypotheses the trial begins testing. We derive conditions under which strict control of the FWER can be achieved. Procedures using the estimated association between safety and efficacy outcomes are developed for the case when the correlation between endpoints is unknown. The operating characteristics of the proposed procedures are assessed via simulation.	[Hlavin, Gerald; Koenig, Franz] Med Univ Vienna, Sect Med Stat, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria; [Hampson, Lisa V.] AstraZeneca, Adv Analyt Ctr, Stat Innovat, Cambridge, England; [Hampson, Lisa V.] Univ Lancaster, Dept Math & Stat, Lancaster, England	Medical University of Vienna; AstraZeneca; Lancaster University	Koenig, F (corresponding author), Med Univ Vienna, Sect Med Stat, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria.	franz.koenig@meduniwien.ac.at		Konig, Franz/0000-0002-6893-3304	European Union's Seventh Framework Programme [FP7] [602552]; Medical Research Council MRC [MR/M013510/1]; AstraZeneca (AZ); MRC [MR/M013510/1] Funding Source: UKRI; Medical Research Council [MR/M013510/1] Funding Source: researchfish	European Union's Seventh Framework Programme [FP7]; Medical Research Council MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AstraZeneca (AZ)(AstraZeneca); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project [GH, FK] has received funding from the European Union's Seventh Framework Programme [FP7 2007-2013] under grant agreement no. 602552 for research, technological development, and demonstration (IDEAL - Integrated Design and Analysis of small population group trials). This funder provided support in the form of salaries for authors [GH, FK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. LVH is an employee of AstraZeneca and Lancaster University, and her contribution was partly funded by the Medical Research Council MRC (grant MR/M013510/1). AstraZeneca (AZ) provided financial support in the form of salaries for authors [LVH], but AZ and MRC did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The research leading to these results has received funding from the EU Seventh Framework Programme [FP7 2007-2013] under grant agreement no. 602552. We are grateful to the editor and three referees for their helpful comments, which improved the presentation of the article.	Abola MV, 2014, ANN ONCOL, V25, P2284, DOI 10.1093/annonc/mdu444; Alosh M, 2014, STAT MED, V33, P693, DOI 10.1002/sim.5974; Alvarez PA, 2010, CURR DRUG SAF, V5, P97, DOI 10.2174/157488610789869265; Baron G, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-84; Bauer P, 2016, STAT MED, V35, P325, DOI 10.1002/sim.6472; Billingham L, 2016, LANCET ONCOL, V17, pE70, DOI 10.1016/S1470-2045(15)00396-4; Bogaerts J, 2015, EUR J CANCER, V51, P271, DOI 10.1016/j.ejca.2014.10.027; Bretz F., 2010, MULTIPLE COMP USING; Bretz F, 2009, STAT MED, V28, P1181, DOI 10.1002/sim.3538; Dmitrienko A, 2013, STAT MED, V32, P5172, DOI 10.1002/sim.5990; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; ESARY JD, 1967, ANN MATH STAT, V38, P1466, DOI 10.1214/aoms/1177698701; European Medicines Agency, 2016, 000915N0034 H C EMEA; Herberich E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009788; Hochberg Y., 1987, MULTIPLE COMP PROCED; ICH, 1998, TOP E 9 STAT PRINC C; Jaki T, 2016, STAT MED, V35, P522, DOI 10.1002/sim.6760; JENNISON C, 1993, BIOMETRICS, V49, P741, DOI 10.2307/2532195; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Koenig F, 2008, STAT MED, V27, P1612, DOI 10.1002/sim.3048; Konig F, 2006, BIOMETRICAL J, V48, P663, DOI 10.1002/bimj.200510235; Parmar MKB, 2014, LANCET, V384, P283, DOI 10.1016/S0140-6736(14)61122-3; PITT LD, 1982, ANN PROBAB, V10, P496, DOI 10.1214/aop/1176993872; SHAH RR, 2008, PHARM MED, V22, P151; Tong YL., 2012, MULTIVARIATE NORMAL; Wason JMS, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-364; Weinberger MH, 2002, AM J HYPERTENS, V15, P709, DOI 10.1016/S0895-7061(02)02957-6; Weisler RH, 2006, CNS SPECTRUMS, V11, P625, DOI 10.1017/S1092852900013687	28	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0180131	10.1371/journal.pone.0180131	http://dx.doi.org/10.1371/journal.pone.0180131			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651023	Green Submitted, gold, Green Published			2022-12-27	WOS:000404537300041
J	Poleo, ABS; Schjolden, J; Sorensen, J; Nilsson, GE				Poleo, Antonio B. S.; Schjolden, Joachim; Sorensen, Jorgen; Nilsson, Goran E.			The high tolerance to aluminium in crucian carp (Carassius carassius) is associated with its ability to avoid hypoxia	PLOS ONE			English	Article							TROUT SALVELINUS-FONTINALIS; ACID-MINE DRAINAGE; SALMON SALMO-SALAR; LOW PH; RAINBOW-TROUT; AQUEOUS ALUMINUM; MIXING ZONES; BROOK TROUT; PHYSIOLOGICAL DISTURBANCES; SCANNING ELECTRON	It is well known that aluminium is the principle toxicant killing fish in acidified freshwater systems, and it has been shown that crucian carp (Carassius carassius) can survive exposures to aqueous aluminium levels toxic to most other freshwater fish species. The crucian carp has a remarkable ability to survive anoxic conditions, and the aim of the present study was to reveal if the tolerance to aluminium can be associated with the ability to survive prolonged anoxia. Crucian carps were exposed to either acidic Al-rich water (pH 5.8; 960 mu g Al/l), acidic Al-poor water (pH 5.8; 50 mu g Al/l) or untreated control water (pH 6.5; 50 mu g Al/l). Blood, muscle and gill samples were collected from exposed fish, and closed respirometry was performed to measure critical O-2-tension an normoxic O-2-consumption. The results show an increased gill surface area in Al-exposed fish, while the critical O-2-tension did not change. The normoxic O-2-consumption was lower in Al-exposed fish and might be due to a reduced metabolic rate. The results suggest that crucian carp exposed to aluminium do not become hypoxic, since haematocrit, plasma lactate and blood ethanol did not differ from that of control fish after 14 days of exposure. We also observed an initial loss of plasma chloride and sodium, followed by a stabilisation of these ions at a lower level than in control fish. The decrease in plasma ions caused a transient increase in haematocrit and water content in muscle tissue, returning to control levels when the ion concentrations stabilised, suggesting that the water balance was restored. We conclude that the high tolerance to aluminium in crucian carp is associated with its ability to avoid hypoxia as well as an ability to counteract a continuous loss of plasma ions.	[Poleo, Antonio B. S.] Inland Norway Univ Appl Sci, Campus Evenstad, Evenstad, Norway; [Schjolden, Joachim] Norwegian Natl Author Invest & Prosecut Econ & En, Oslo, Norway; [Sorensen, Jorgen] Fresenius Kabi Norge AS, Halden, Norway; [Nilsson, Goran E.] Univ Oslo, Dept Biosci, Oslo, Norway	Inland Norway University of Applied Sciences; University of Oslo	Poleo, ABS (corresponding author), Inland Norway Univ Appl Sci, Campus Evenstad, Evenstad, Norway.	antonio.poleo@inn.no	Nilsson, Göran Erik/Q-6129-2019					BAKER JP, 1982, WATER AIR SOIL POLL, V18, P289, DOI 10.1007/BF02419419; BARNES RB, 1975, CHEM GEOL, V15, P177, DOI 10.1016/0009-2541(75)90018-2; DALZIEL TRK, 1987, ANN SOC ROY ZOOL BEL, V117, P421; DICKSON W, 1978, VERH INT VEREIN THEO, V20, P851; DIETRICH D, 1989, AQUAT TOXICOL, V15, P197, DOI 10.1016/0166-445X(89)90036-2; DRISCOLL CT, 1980, NATURE, V284, P161, DOI 10.1038/284161a0; DRISCOLL CT, 1984, INT J ENVIRON AN CH, V16, P267, DOI 10.1080/03067318408076957; Exley C, 1996, J THEOR BIOL, V179, P25, DOI 10.1006/jtbi.1996.0044; Gensemer RW, 1999, CRIT REV ENV SCI TEC, V29, P315, DOI 10.1080/10643389991259245; Hem J.D., 1967, GEOLOGICAL SURVEY A; Henry TB, 2001, ENVIRON TOXICOL CHEM, V20, P1304, DOI 10.1002/etc.5620200619; Hochachka P. W., 1980, LIVING OXYGEN CLOSED; Howells G., 1994, Environmental Topics, V6, P55; Howells G, 1990, CHEM ECOL, V4, P117, DOI DOI 10.1080/02757549008035972; HUGHES GM, 1979, J ZOOL, V187, P443; LEWIS SV, 1976, MICRON, V7, P205, DOI 10.1016/0047-7206(76)90004-2; LYDERSEN E, 1990, NORD HYDROL, V21, P195; Lydersen E, 1994, J ECOL CHEM, V3, P357; MCDONALD DG, 1988, CAN J FISH AQUAT SCI, V45, P1606, DOI 10.1139/f88-190; Muniz IP, 1980, P INT C ECOLOGICAL I, P84; NEVILLE CM, 1985, CAN J FISH AQUAT SCI, V42, P2004, DOI 10.1139/f85-248; NILSSON GE, 1993, J EXP BIOL, V180, P153; NILSSON GE, 1990, J EXP BIOL, V150, P295; NILSSON GE, 1992, J EXP BIOL, V164, P243; Nilsson GE, 2012, RESP PHYSIOL NEUROBI, V184, P214, DOI 10.1016/j.resp.2012.07.012; OUGHTON DH, 1992, ANALYST, V117, P619, DOI 10.1039/an9921700619; PIIRONEN J, 1986, ANN ZOOL FENN, V23, P335; PLAYLE RC, 1989, CAN J ZOOL, V67, P314, DOI 10.1139/z89-046; Poleo A, 2000, CAN J FISH AQUAT SCI, V57, P1423, DOI 10.1139/cjfas-57-7-1423; Poleo ABS, 2003, J INORG BIOCHEM, V97, P89, DOI 10.1016/S0162-0134(03)00261-7; POLEO ABS, 1994, WATER AIR SOIL POLL, V75, P339, DOI 10.1007/BF00482945; Poleo ABS, 1995, AQUAT SCI, V57, P350, DOI 10.1007/BF00878398; Poleo ABS, 1997, ENVIRON POLLUT, V96, P129, DOI 10.1016/S0269-7491(97)00033-X; POLEO ABS, 1995, AQUAT TOXICOL, V31, P347, DOI 10.1016/0166-445X(94)00083-3; RAJBANSHI VK, 1977, J FISH BIOL, V10, P325, DOI 10.1111/j.1095-8649.1977.tb04066.x; ROSSELAND BO, 1992, ENVIRON POLLUT, V78, P3, DOI 10.1016/0269-7491(92)90003-S; Schjolden J, 2007, SCI TOTAL ENVIRON, V384, P239, DOI 10.1016/j.scitotenv.2007.06.009; Schofield C. L., 1980, POLLUTED RAIN, P341; SMITH TR, 1995, ENVIRON POLLUT, V90, P33, DOI 10.1016/0269-7491(94)00094-T; Sollid J, 2003, J EXP BIOL, V206, P3667, DOI 10.1242/jeb.00594; Sparling DW, 1996, REV ENVIRON CONTAM T, V145, P1; Sprague J.B., 1973, ASTMSTP528 AM SOC TE, P6; STAURNES M, 1984, EXPERIENTIA, V40, P226, DOI 10.1007/BF01963613; TIETGE JE, 1988, CAN J FISH AQUAT SCI, V45, P1643, DOI 10.1139/f88-194; ULTSCH GR, 1979, COMP BIOCHEM PHYS A, V62, P685, DOI 10.1016/0300-9629(79)90125-7; VANWAVERSVELD J, 1989, J EXP BIOL, V142, P325; Waters AS, 2016, MINE WATER ENVIRON, V35, P235, DOI 10.1007/s10230-016-0387-3; Waters AS, 2013, WATER SCI TECHNOL, V67, P1764, DOI 10.2166/wst.2013.051; WEATHERLEY NS, 1991, WATER AIR SOIL POLL, V55, P345; Witters HE, 1996, ENVIRON TOXICOL CHEM, V15, P986, DOI 10.1002/etc.5620150622; WOOD CM, 1987, ANN SOC ROY ZOOL BEL, V117, P399	51	11	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179519	10.1371/journal.pone.0179519	http://dx.doi.org/10.1371/journal.pone.0179519			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644866	Green Published, Green Submitted, gold			2022-12-27	WOS:000404145100021
J	Buehring, GC; Shen, HM; Schwartz, DA; Lawson, JS				Buehring, Gertrude C.; Shen, HuaMin; Schwartz, Daniel A.; Lawson, James S.			Bovine leukemia virus linked to breast cancer in Australian women and identified before breast cancer development	PLOS ONE			English	Article							DNA; PATTERNS; RISK	Bovine leukemia virus (BLV), a common virus of cattle globally, was believed for decades not to infect humans. More recent techniques (in situ PCR and DNA sequencing) enabled detection of BLV in human breast tissue, and determination of its significant association with breast cancer in a US population. Using similar techniques to study 96 Australian women, we report here detection of retrotranscribed BLV DNA in breast tissue of 40/50(80%) of women with breast cancer versus 19/46(41%) of women with no history of breast cancer, indicating an age-adjusted odds ratio and confidence interval of 4.72(1.71-13.05). These results corroborate the findings of the previous study of US women with an even higher odds ratio for the Australian population. For 48 of the subjects, paired breast tissue samples, removed 3-10 years apart in two unrelated procedures, were available. For 23/31 (74%) of these, in which the first specimen was diagnosed as nonmalignant (benign or premalignant) and the second as malignant, BLV was already present in benign breast tissue years 3-10 years before the malignancy was diagnosed. This is consistent with the supposition of a causative temporal relationship between BLV infection and subsequent development of cancer.	[Buehring, Gertrude C.; Shen, HuaMin; Schwartz, Daniel A.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Lawson, James S.] Univ New South Wales, Dept Biotechnol & Biomol Sci, Sydney, NSW, Australia	University of California System; University of California Berkeley; University of New South Wales Sydney	Buehring, GC (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	buehring@berkeley.edu		, Gertrude/0000-0002-8868-7390	University of California, Berkeley; James and Margaret Lawson Research Fund	University of California, Berkeley(University of California System); James and Margaret Lawson Research Fund	This research was supported by a Research Enabling Grant from the University of California, Berkeley and the James and Margaret Lawson Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bray F, 2004, BREAST CANCER RES, V6, P229, DOI 10.1186/bcr932; Buehring GC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134304; Buehring GC, 2014, EMERG INFECT DIS, V20, P772, DOI 10.3201/eid2005.131298; Chartsbin, 2007, CURR WORLDW TOL MILK; Cooper JK, 2007, IN VITRO CELL DEV-AN, V43, P344, DOI 10.1007/s11626-007-9060-2; Dairy Australia, 2012, DAIRY AUSTR; Fitzgibbons PL, 1998, ARCH PATHOL LAB MED, V122, P1053; Gardner SN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-668; Gillet N, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-18; Gillio-Tos A, 2007, PATHOLOGY, V39, P345, DOI 10.1080/00313020701329757; Giovanna M, 2013, OPEN J MED MICROBIOL; Globcan, 2012, EST AG STAND BREAST; GRAVES DC, 1976, CANCER RES, V36, P4152; Jaisamrarn U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079260; McGirr KM, 2006, VIRUS GENES, V32, P229, DOI 10.1007/s11262-005-6907-z; Nuovo GJ, 1996, PCR SITU HYBRIDIZATI, P193; Parkin DM, 2006, BREAST J, V12, pS70, DOI 10.1111/j.1075-122X.2006.00205.x; Robinson LA, 2016, BRIT J CANCER, V115, P497, DOI 10.1038/bjc.2016.213; Ryan D, 2012, FLOCK HERD CASE NOTE; Smit E, 1999, J AM DIET ASSOC, V99, P813, DOI 10.1016/S0002-8223(99)00193-5; StataCorp, 2015, STAT 14 BAS REF MAN; Van Der Maaten M J, 1975, Bibl Haematol, P360; Vedham V, 2015, CANCER MED-US, V4, P1908, DOI 10.1002/cam4.538; ZIEGLER RG, 1993, JNCI-J NATL CANCER I, V85, P1819, DOI 10.1093/jnci/85.22.1819	24	47	50	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179367	10.1371/journal.pone.0179367	http://dx.doi.org/10.1371/journal.pone.0179367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640828	Green Submitted, gold, Green Published			2022-12-27	WOS:000404135800031
J	Nishikawa, E; Oakley, L; Seed, PT; Doyle, P; Oteng-Ntim, E				Nishikawa, Erin; Oakley, Laura; Seed, Paul T.; Doyle, Pat; Oteng-Ntim, Eugene			Maternal BMI and diabetes in pregnancy: Investigating variations between ethnic groups using routine maternity data from London, UK	PLOS ONE			English	Article							BODY-MASS INDEX; RACIAL ORIGIN; OBESITY; INTERRELATIONSHIP; COMPLICATIONS; PREVALENCE; MELLITUS; POINTS; RISK	Objective To investigate the ethnicity-specific association between body mass index (BMI) and diabetes in pregnancy, with a focus on the appropriateness of using BMI cut-offs to identify pregnant women at risk of diabetes. Study design Analysis of routinely-collected data from a maternity unit in London, UK. Data were available on 53 264 women delivering between 2004 and 2012. Logistic regression was used to explore the association between diabetes in pregnancy and BMI among women of different ethnicities, and adjusted probability estimates were used to derive risk equivalent cut-offs. ROC curve analysis was used to assess the performance of BMI as a predictor of diabetes in pregnancy. Results The prevalence of diabetes in pregnancy was 2.3% overall; highest in South and East Asian women (4.6% and 3.7%). In adjusted analysis, BMI category was strongly associated with diabetes in all ethnic groups. Modelled as a continuous variable with a quadratic term, BMI was an acceptable predictor of diabetes according to ROC curve analysis. Applying a BMI cut-off of 30 kg/m(2) would identify just over half of Black women with diabetes in pregnancy, a third of White (32%) and South Asian (35%) women, but only 13% of East Asian women. The 'risk equivalent' (comparable to 30 kg/m(2) in White women) threshold for South Asian and East Asian women was approximately 21 kg/m(2), and 27.5 kg/m(2) for Black women. Conclusions This study suggests that current BMI thresholds are likely to be ineffective for diabetes screening in South and East Asian women, as many cases of diabetes will occur at low BMI levels. Our results suggest that East Asian women appear to face a similarly high risk of diabetes to South Asian women. Current UK guidelines recommend diabetes screening should be offered to all pregnant South Asian women; extending this recommendation to include women of East Asian ethnicity may be appropriate.	[Nishikawa, Erin; Oakley, Laura; Doyle, Pat] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England; [Seed, Paul T.] Kings Coll London, Womens Hlth Acad Ctr, London, England; [Oteng-Ntim, Eugene] Guys & St Thomas NHS Fdn Trust, Dept Womens Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Oakley, L (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England.	laura.oakley@lshtm.ac.uk	Seed, Paul T/C-4435-2008	Seed, Paul T/0000-0001-7904-7933; /0000-0002-4697-4316	Tommy's [1060508]; CLAHRC South London (NIHR)	Tommy's; CLAHRC South London (NIHR)	Paul T Seed is partly funded by Tommy's (Registered charity no. 1060508) and by CLAHRC South London (NIHR).	Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bryant M, 2014, INT J OBESITY, V38, P444, DOI 10.1038/ijo.2013.117; Chiu M, 2011, DIABETES CARE, V34, P1741, DOI 10.2337/dc10-2300; Chong YS, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-345; Chu SY, 2007, DIABETES CARE, V30, P2070, DOI 10.2337/dc06-2559a; Department of Communities and Local Government, 2010, ENGL IND DEPR; Hedderson M, 2012, DIABETES CARE, V35, P1492, DOI 10.2337/dc11-2267; Heslehurst N, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-156; Hsu WC, 2015, DIABETES CARE, V38, P150, DOI 10.2337/dc14-2391; Khalil A, 2013, ULTRASOUND OBST GYN, V41, P278, DOI 10.1002/uog.12313; Kim SY, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110249; Makgoba M, 2012, BJOG-INT J OBSTET GY, V119, P276, DOI 10.1111/j.1471-0528.2011.03156.x; McDonald R, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/297420; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Misra A, 2009, J Assoc Physicians India, V57, P163; Mitanchez D, 2015, WORLD J DIABETES, V6, P734, DOI 10.4239/wjd.v6.i5.734; Mpondo BCT, 2015, J DIABETES METABOLIC, V14, P1; National Collaborating Centre for Women's and Children's Health (UK), 2015, DIAB PREGN MAN DIAB; National Institute for Health and Care Excellence (NICE), 2013, BMI PREV ILL HLTH PR; NHS Digital, 2017, HOSP EP STAT WWW DOC; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Ramos GA, 2005, AM J OBSTET GYNECOL, V193, P1089, DOI 10.1016/j.ajog.2005.06.040; Retnakaran R, 2006, J CLIN ENDOCR METAB, V91, P93, DOI 10.1210/jc.2005-1253; Royal College of Obstetricians and Gynaecologists, 2011, DIAGN TREATM GEST DI; Shah A, 2011, AM J PERINAT, V28, P515, DOI 10.1055/s-0031-1272968	25	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179332	10.1371/journal.pone.0179332	http://dx.doi.org/10.1371/journal.pone.0179332			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640854	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000404135800028
J	Popova, EY; Salzberg, AC; Yang, C; Zhang, SSM; Barnstable, CJ				Popova, Evgenya Y.; Salzberg, Anna C.; Yang, Chen; Zhang, Samuel Shao-Min; Barnstable, Colin J.			Identification and prediction of alternative transcription start sites that generate rod photoreceptor-specific transcripts from ubiquitously expressed genes	PLOS ONE			English	Article							RECEPTOR-BETA; RETINAL DEGENERATION; PROMOTER USAGE; MOUSE RETINA; DIVERSITY; SEQUENCE; ISOFORM; SUBUNIT; BRAIN; CHIP	Transcriptome complexity is substantially increased by the use of multiple transcription start sites for a given gene. By utilizing a rod photoreceptor-specific chromatin signature, and the RefSeq database of established transcription start sites, we have identified essentially all known rod photoreceptor genes as well as a group of novel genes that have a high probability of being expressed in rod photoreceptors. Approximately half of these novel rod genes are transcribed into multiple mRNA and/or protein isoforms through alternative transcriptional start sites (ATSS), only one of which has a rod-specific epigenetic signature and gives rise to a rod transcript. This suggests that, during retina development, some genes use ATSS to regulate cell type and temporal specificity, effectively generating a rod transcript from otherwise ubiquitously expressed genes. Biological confirmation of the relationship between epigenetic signatures and gene expression, as well as comparison of our genome-wide chromatin signature maps with available data sets for retina, namely a ChIP-on-Chip study of Polymerase-II (Pol-II) binding sites, ChIP-Seq studies for NRL- and CRX-binding sites and DHS (University of Washington data, available on UCSC mouse Genome Browser as a part of ENCODE project) fully support our hypothesis and together accurately identify and predict an array of new rod transcripts. The same approach was used to identify a number of TSS that are not currently in RefSeq. Biological conformation of the use of some of these TSS suggests that this method will be valuable for exploring the range of transcriptional complexity in many tissues. Comparison of mouse and human genome-wide data indicates that most of these alternate TSS appear to be present in both species, indicating that our approach can be useful for identification of regulatory regions that might play a role in human retinal disease.	[Popova, Evgenya Y.; Yang, Chen; Zhang, Samuel Shao-Min; Barnstable, Colin J.] Penn State Univ, Coll Med, Dept Neural & Behav Sci, Hershey, PA 16801 USA; [Popova, Evgenya Y.; Zhang, Samuel Shao-Min; Barnstable, Colin J.] Penn State Hershey Eye Ctr, Hershey, PA 17033 USA; [Salzberg, Anna C.] Penn State Univ, Coll Med, Bioinformat Core, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Barnstable, CJ (corresponding author), Penn State Univ, Coll Med, Dept Neural & Behav Sci, Hershey, PA 16801 USA.; Barnstable, CJ (corresponding author), Penn State Hershey Eye Ctr, Hershey, PA 17033 USA.	cbarnstable@psu.edu	Barnstable, Colin/GLU-9219-2022; Barnstable, Colin/ABB-4822-2021	Barnstable, Colin/0000-0002-7011-4068; Popova, Evgenya/0000-0001-6164-262X	Macula Vision Foundation for CJB	Macula Vision Foundation for CJB	Support was provided by Macula Vision Foundation for CJB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre E, 1998, EMBO J, V17, P3867, DOI 10.1093/emboj/17.14.3867; Batut P, 2013, GENOME RES, V23, P169, DOI 10.1101/gr.139618.112; Blackshaw S, 2001, CELL, V107, P579, DOI 10.1016/S0092-8674(01)00574-8; Brooks MJ, 2011, MOL VIS, V17, P3034; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Corbo JC, 2010, GENOME RES, V20, P1512, DOI 10.1101/gr.109405.110; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Dong XJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r53; Dorrell MI, 2004, INVEST OPHTH VIS SCI, V45, P1009, DOI 10.1167/iovs.03-0806; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Farjo R, 2002, VISION RES, V42, P463, DOI 10.1016/S0042-6989(01)00219-X; Farkas MH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-486; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Fu YL, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.605774; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Gamsiz ED, 2012, GENOMICS, V99, P44, DOI 10.1016/j.ygeno.2011.09.003; Geisert EE, 2009, MOL VIS, V15, P1730; Hackam AS, 2004, INVEST OPHTH VIS SCI, V45, P2929, DOI 10.1167/iovs.03-1184; Hao H, 2012, PLOS GENET, V8, P380, DOI 10.1371/journal.pgen.1002649; Hinnebusch AG, 2016, SCIENCE, V352, P1413, DOI 10.1126/science.aad9868; Jones BW, 2016, EXP EYE RES, V150, P149, DOI 10.1016/j.exer.2016.03.018; Kim JW, 2016, CELL REP, V17, P2460, DOI 10.1016/j.celrep.2016.10.074; Link S, 2009, J BIOL CHEM, V284, P30129, DOI 10.1074/jbc.M109.045583; Liu H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2793; Livesey FJ, 2000, CURR BIOL, V10, P301, DOI 10.1016/S0960-9822(00)00379-1; Loeffen J, 1998, BIOCHEM BIOPH RES CO, V247, P751, DOI 10.1006/bbrc.1998.8882; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Matsumoto K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku600; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mo A, 2016, ELIFE, V5, DOI 10.7554/eLife.11613; Mortazavi A, 2013, GENOME RES, V23, P2136, DOI 10.1101/gr.158261.113; Mu XQ, 2001, NUCLEIC ACIDS RES, V29, P4983, DOI 10.1093/nar/29.24.4983; Nair KS, 2002, CURR BIOL, V12, P421, DOI 10.1016/S0960-9822(02)00691-7; Natarajan A, 2012, GENOME RES, V22, P1711, DOI 10.1101/gr.135129.111; Pal S, 2011, GENOME RES, V21, P1260, DOI 10.1101/gr.120535.111; Popova EY, 2016, MOL NEUROBIOL, V53, P4563, DOI 10.1007/s12035-015-9395-8; Popova EY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046867; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Rach EA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001274; Roof DJ, 1997, J CELL BIOL, V138, P575, DOI 10.1083/jcb.138.3.575; Ruzycki PA, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0732-z; Sergouniotis PI, 2011, AM J HUM GENET, V89, P782, DOI 10.1016/j.ajhg.2011.11.004; Shabalina SA, 2014, NUCLEIC ACIDS RES, V42, P7132, DOI 10.1093/nar/gku342; Shafit-Zagardo B, 1998, MOL NEUROBIOL, V16, P149, DOI 10.1007/BF02740642; Sharon D, 2002, P NATL ACAD SCI USA, V99, P315, DOI 10.1073/pnas.012582799; Siegert S, 2012, NAT NEUROSCI, V15, P487, DOI 10.1038/nn.3032; Stohr H, 2002, BBA-GENE STRUCT EXPR, V1579, P18, DOI 10.1016/S0167-4781(02)00499-2; Sun H, 2011, NUCLEIC ACIDS RES, V39, P190, DOI 10.1093/nar/gkq775; Suzuki A, 2015, NUCLEIC ACIDS RES, V43, pD87, DOI 10.1093/nar/gku1080; Tamarkin-Ben-Harush A, 2017, ELIFE, P6, DOI DOI 10.7554/ELIFE.21907270.E10; Tummala P, 2010, MOL VIS, V16, P252; Wang X, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20166941; Watson AJ, 1996, J BIOL CHEM, V271, P28154, DOI 10.1074/jbc.271.45.28154; WATSON AJ, 1994, J BIOL CHEM, V269, P22150; Wilken MS, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/1756-8935-8-8; Wong P, 2011, BLOOD, V118, pE128, DOI 10.1182/blood-2011-03-341404; Yamashita R, 2010, NUCLEIC ACIDS RES, V38, pD98, DOI 10.1093/nar/gkp1017; Yasuda M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-982; Zhang JH, 2000, J NEUROCHEM, V75, P393, DOI 10.1046/j.1471-4159.2000.0750393.x; Zhang SSM, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-48; Zhang SSM, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-40; Zhang XC, 2016, CELL, V166, P1147, DOI 10.1016/j.cell.2016.07.025	63	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179230	10.1371/journal.pone.0179230	http://dx.doi.org/10.1371/journal.pone.0179230			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640837	Green Published, Green Submitted, gold			2022-12-27	WOS:000404135800023
J	Torche, PC; Muller, V; Westerlund, F; Ambjornsson, T				Torche, Paola C.; Muller, Vilhelm; Westerlund, Fredrik; Ambjornsson, Tobias			Noise reduction in single time frame optical DNA maps	PLOS ONE			English	Article							STRUCTURAL VARIATION; HYBRIDIZATION	In optical DNA mapping technologies sequence-specific intensity variations (DNA barcodes) along stretched and stained DNA molecules are produced. These "fingerprints" of the underlying DNA sequence have a resolution of the order one kilobasepairs and the stretching of the DNA molecules are performed by surface adsorption or nano-channel setups. A post-processing challenge for nano-channel based methods, due to local and global random movement of the DNA molecule during imaging, is how to align different time frames in order to produce reproducible time-averaged DNA barcodes. The current solutions to this challenge are computationally rather slow. With high-throughput applications in mind, we here introduce a parameter-free method for filtering a single time frame noisy barcode (snap-shot optical map), measured in a fraction of a second. By using only a single time frame barcode we circumvent the need for post-processing alignment. We demonstrate that our method is successful at providing filtered barcodes which are less noisy and more similar to time averaged barcodes. The method is based on the application of a low-pass filter on a single noisy barcode using the width of the Point Spread Function of the system as a unique, and known, filtering parameter. We find that after applying our method, the Pearson correlation coefficient (a real number in the range from -1 to 1) between the single time-frame barcode and the time average of the aligned kymograph increases significantly, roughly by 0.2 on average. By comparing to a database of more than 3000 theoretical plasmid barcodes we show that the capabilities to identify plasmids is improved by filtering single time-frame barcodes compared to the unfiltered analogues. Since snap-shot experiments and computational time using our method both are less than a second, this study opens up for high throughput optical DNA mapping with improved reproducibility.	[Torche, Paola C.; Ambjornsson, Tobias] Lund Univ, Dept Astron & Theoret Phys, Lund, Sweden; [Muller, Vilhelm; Westerlund, Fredrik] Chalmers Univ Technol, Dept Biol & Biol Engn, Gothenburg, Sweden	Lund University; Chalmers University of Technology	Ambjornsson, T (corresponding author), Lund Univ, Dept Astron & Theoret Phys, Lund, Sweden.	tobias.ambjornsson@thep.lu.se		Muller, Vilhelm/0000-0002-4554-2124; Ambjornsson, Tobias/0000-0002-6439-8842	EU Horizon 2020 program [634890]; EuroNanoMed2 (project NanoDiaBac); Torsten Soderbergs Stiftelse; Swedish Research Council [2014-4305]	EU Horizon 2020 program; EuroNanoMed2 (project NanoDiaBac); Torsten Soderbergs Stiftelse; Swedish Research Council(Swedish Research CouncilEuropean Commission)	FW and TA acknowledge the EU Horizon 2020 program (Grant 634890, BeyondSeq, https://ec.europa.eu/programmes/horizon2020/). FW acknowledges the EuroNanoMed2 (project NanoDiaBac, http://www.euronanomed.net/) and Torsten Soderbergs Stiftelse (http://www.torstensoderbergsstiftelse.se/) for funding. TA acknowledges the Swedish Research Council (grant number 2014-4305, http://www.vr.se/) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Lena Nyberg is acknowledged for assisting with some of the experiments. The plasmids where a kind gift from Assoc. Prof. Linus Sandegren at Uppsala University. FW and TA acknowledges the EU Horizon 2020 program (Grant 634890, BeyondSeq). FW is grateful to the EuroNanoMed2 project NanoDiaBac and Torsten Soderbergs Stiftelse. TA acknowledges the Swedish Research Council (grant number 2014-4305) for funding.	Aitman T, 2005, NATURE; Alvarez L, 1992, SIAM J NUMERICAL ANA; Boulanger J, 2010, IEEE T MED IMAGING, V29, P442, DOI 10.1109/TMI.2009.2033991; Chamala S, 2014, SCIENCE; Chambolle A., 2004, J MATH IMAGING VISIO; Chapleau R, 2015, J CLIN DIAGNOSTIC RE; Chen Q, 2006, MICROBIOL-SGM, V152, P1041, DOI 10.1099/mic.0.28648-0; Conrad D, 2009, NATURE; Dong Y, 2012, NATURE BIOTECHNOLOGY; Easton Jr R.L., 2010, FOURIER METHODS IMAG; Faraji H, 2006, IEEE T IMAGE PROCESS, V15, P2676, DOI 10.1109/TIP.2006.877363; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fiore L, 1996, J NEUROSCIENCE METHO; Grunwald A, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv563; Haider S, 2016, SCI REPORTS; Howe K, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0052-y; Iarko V, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.062701; Jackson SA, 2012, APPL ENVIRON MICROB, V78, P1601, DOI 10.1128/AEM.07464-11; Jo K, 2009, METHODS MOL BIOL, V544, P29, DOI 10.1007/978-1-59745-483-4_3; Kervrann C, 2007, LECT NOTES COMPUT SC, V4485, P520; Kervrann C, 2006, IEEE T IMAGE PROCESS, V15, P2866, DOI 10.1109/TIP.2006.877529; Lacroix J, 2016, SMALL; Lavigne JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034294; Lee C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001390; Lewis NE, 2013, NAT BIOTECHNOL, V31, P759, DOI 10.1038/nbt.2624; Lim A, 2001, GENOME RES; Loudon R., 2000, QUANTUM THEORY LIGHT; Meng X, 1995, NATURE GENETICS; Mrazek P, 2003, INT J COMPUTER VISIO; Muller V, 2016, SCI REPORTS, P6; Muller V, 2016, ACS INFECT DIS; Muller V, 2017, LAB CHIP, V17, P579, DOI 10.1039/c6lc01439a; NAGARAJAN N, 2008, BIOINFORMATICS; Neely RK, 2011, BIOPOLYMERS, V95, P298, DOI 10.1002/bip.21579; Nilsson AN, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku556; Noble C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121905; Nyberg L, 2011, BIOCH BIOPHYSICAL RE; Nyberg L, 2016, NATURE; Okada M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157595; Ostergaard P, 2015, J MICROMECHANICS MIC; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pedersen J, 2013, BIOPHYSICAL J; Phelippeau H, 2008, INT C SIGN PROC; Pitas I, 1992, P IEEE; Pizurica A, 2003, IEEE T MED IMAGING, V22, P323, DOI 10.1109/TMI.2003.809588; Ponomarev VI, 1996, MMET'96 - VITH INTERNATIONAL CONFERENCE ON MATHEMATICAL METHODS IN ELECTROMAGNETIC THEORY, PROCEEDINGS, P211, DOI 10.1109/MMET.1996.565693; Ramirez MS, 2011, ANTIMICROB AGENTS CH, V55, P1520, DOI 10.1128/AAC.01595-10; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reisner W, 2010, P NATL ACAD SCI USA, V107, P13294, DOI 10.1073/pnas.1007081107; Richards B, 1959, P ROYAL SOC LONDON; Schwan WR, 2010, MICROBIOL-SGM, V156, P2124, DOI 10.1099/mic.0.033977-0; SCHWARTZ DC, 1993, SCIENCE, V262, P110, DOI 10.1126/science.8211116; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shearer LA, 2014, G3-GENES GENOM GENET, V4, P1395, DOI 10.1534/g3.114.011197; Shukla SK, 2009, J BACTERIOL, V191, P5717, DOI 10.1128/JB.00325-09; Stallinga S, 2010, OPTICS EXPRESS; Teague B, 2010, P NATL ACAD SCI USA, V107, P10848, DOI 10.1073/pnas.0914638107; Teo ASM, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0106-1; Vranken C, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1406; Weischenfeldt J, 2013, NAT REV GENET, V14, P125, DOI 10.1038/nrg3373; Zhou S, 2009, PLOS GENETICS	61	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179041	10.1371/journal.pone.0179041	http://dx.doi.org/10.1371/journal.pone.0179041			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640821	Green Published, gold, Green Submitted			2022-12-27	WOS:000404135800016
J	Assfalg, R; Alupei, MC; Wagner, M; Koch, S; Gonzalez, OG; Schelling, A; Scharffetter-Kochanek, K; Iben, S				Assfalg, Robin; Alupei, Marius Costel; Wagner, Maximilian; Koch, Sylvia; Gonzalez, Omar Garcia; Schelling, Adrian; Scharffetter-Kochanek, Karin; Iben, Sebastian			Cellular sensitivity to UV-irradiation is mediated by RNA polymerase I transcription	PLOS ONE			English	Article							RIBOSOMAL-PROTEIN L11; COCKAYNE-SYNDROME; DNA-DAMAGE; P53; APOPTOSIS; INHIBITION; ACTIVATION; DISRUPTION; ELONGATION; PATHWAY	The nucleolus has long been considered to be a pure ribosome factory. However, over the last two decades it became clear that the nucleolus is involved in numerous other functions besides ribosome biogenesis. Our experiments indicate that the activity of RNA polymerase I (Pol l) transcription monitors the integrity of the DNA and influences the response to nucleolar stress as well as the rate of survival. Cells with a repressed ribosomal DNA (rDNA) transcription activity showed an increased and prolonged p53 stabilisation after UVC-irradiation. Furthermore, p53 stabilisation after inhibition and especially after UVC-irradiation might be due to abrogation of the HDM2-p53 degradation pathway by ribosomal proteins (RPs). Apoptosis mediated by highly activated p53 is a typical hallmark of Cockayne syndrome cells and transcriptional abnormalities and the following activation of the RP-HDM2-p53 pathway would be a possible explanation.	[Assfalg, Robin; Alupei, Marius Costel; Wagner, Maximilian; Koch, Sylvia; Gonzalez, Omar Garcia; Schelling, Adrian; Scharffetter-Kochanek, Karin; Iben, Sebastian] Univ Ulm, Dept Dermatol & Allerg Dis, Ulm, Germany; [Assfalg, Robin] Helmholtz Ctr Munich, Inst Diabet Res, Neuherberg, Germany	Ulm University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Assfalg, R (corresponding author), Univ Ulm, Dept Dermatol & Allerg Dis, Ulm, Germany.	sebastian.iben@uni-ulm.de	Assfalg, Robin/O-8495-2016	Assfalg, Robin/0000-0003-1277-716X; Scharffetter-Kochanek, Karin/0000-0002-9655-685X	German Research Foundation DFG [KFO 142, IB 83-3/1, 11383 2-2, IB 83 3/3]; DFG	German Research Foundation DFG(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work was funded by grants of the German Research Foundation DFG (KFO 142, IB 83-3/1,11383 2-2, IB 83 3/3) to Dr Sebastian Iben, by the DFG funded CEMMA (cellular and molecular mechanisms in aging) program to Marius Alupei, and Perspektivfoerderung des Landes Baden-Wuertemberg to Dr Sebastian Iben. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assfalg R, 2012, NUCLEIC ACIDS RES, V40, P650, DOI 10.1093/nar/gkr746; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Bradsher J, 2002, MOL CELL, V10, P819, DOI 10.1016/S1097-2765(02)00678-0; Brooks PJ, 2013, DNA REPAIR, V12, P656, DOI 10.1016/j.dnarep.2013.04.018; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; CAVANAUGH AH, 1995, NATURE, V374, P177, DOI 10.1038/374177a0; Drygin D, 2011, CANCER RES, V71, P1418, DOI 10.1158/0008-5472.CAN-10-1728; HADJIOLOVA KV, 1995, EUR J BIOCHEM, V228, P605, DOI 10.1111/j.1432-1033.1995.tb20300.x; Horn HF, 2008, ONCOGENE, V27, P5774, DOI 10.1038/onc.2008.189; Iben S, 2002, CELL, V109, P297, DOI 10.1016/S0092-8674(02)00729-8; Kalita K, 2008, J NEUROCHEM, V105, P2286, DOI 10.1111/j.1471-4159.2008.05316.x; Koch S, 2014, CELL CYCLE, V13, P2029, DOI 10.4161/cc.29018; Laposa RR, 2007, P NATL ACAD SCI USA, V104, P1389, DOI 10.1073/pnas.0610619104; Larsen DH, 2014, NAT CELL BIOL, V16, P792, DOI 10.1038/ncb3007; Laugel V, 2013, MECH AGEING DEV, V134, P161, DOI 10.1016/j.mad.2013.02.006; Lebedev A, 2008, J MOL BIOL, V382, P266, DOI 10.1016/j.jmb.2008.07.018; Ljungman M, 2007, CELL CYCLE, V6, P2252, DOI 10.4161/cc.6.18.4751; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; MARECHAL V, 1994, MOL CELL BIOL, V14, P7414, DOI 10.1128/MCB.14.11.7414; Miyahara H, 2015, NEUROPATHOLOGY, V35, P266, DOI 10.1111/neup.12183; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Parlato R, 2008, J NEUROSCI, V28, P12759, DOI 10.1523/JNEUROSCI.2439-08.2008; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Tremblay M, 2014, NUCLEIC ACIDS RES, V42, P380, DOI 10.1093/nar/gkt871; Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003	26	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179843	10.1371/journal.pone.0179843	http://dx.doi.org/10.1371/journal.pone.0179843			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636660	Green Published, Green Submitted, gold			2022-12-27	WOS:000404118300059
J	dos Santos, BP; Marinho, CRM; Marques, TEBS; Angelo, LKG; Malta, MVD; Duzzioni, M; de Castro, OW; Leite, JP; Barbosa, FT; Gita, DLG				dos Santos, Bruna Priscila; Maciel Marinho, Chiara Rachel; Batista Sales Marques, Thalita Ewellyn; Gomes Angelo, Layanne Kelly; da Silva Malta, Maisa Vieira; Duzzioni, Marcelo; de Castro, Olagide Wagner; Leite, Joao Pereira; Barbosa, Fabiano Timbo; Goes Gita, Daniel Leite			Genetic susceptibility in Juvenile Myoclonic Epilepsy: Systematic review of genetic association studies	PLOS ONE			English	Article							IDIOPATHIC GENERALIZED EPILEPSY; REGULATORY-PROMOTER POLYMORPHISM; GENOME-WIDE ASSOCIATION; CALCIUM-CHANNEL GENE; ALLELIC ASSOCIATION; POPULATION STRATIFICATION; DRUG-RESISTANCE; BRD2 RING3; RECEPTOR; VARIANTS	Background Several genetic association investigations have been performed over the last three decades to identify variants underlying Juvenile Myoclonic Epilepsy (JME). Here, we evaluate the accumulating findings and provide an updated perspective of these studies. Methodology A systematic literature search was conducted using the PubMed, Embase, Scopus, Lilacs, epiGAD, Google Scholar and Sigle up to February 12, 2016. The quality of the included studies was assessed by a score and classified as low and high quality. Beyond outcome measures, information was extracted on the setting for each study, characteristics of population samples and polymorphisms. Results Fifty studies met eligibility criteria and were used for data extraction. With a single exception, all studies used a candidate gene approach, providing data on 229 polymorphisms in or near 55 different genes. Of variants investigating in independent data sets, only rs2029461 SNP in GRM4, rs3743123 in CX36 and rs3918149 in BRD2 showed a significant association with JME in at least two different background populations. The lack of consistent associations might be due to variations in experimental design and/or limitations of the approach. Conclusions Thus, despite intense research evidence established, specific genetic variants in JME susceptibility remain inconclusive. We discussed several issues that may compromise the quality of the results, including methodological bias, endophenotype and potential involvement of epigenetic factors.	[dos Santos, Bruna Priscila; Maciel Marinho, Chiara Rachel; Batista Sales Marques, Thalita Ewellyn; Gomes Angelo, Layanne Kelly; da Silva Malta, Maisa Vieira; Goes Gita, Daniel Leite] Univ Fed Alagoas, Inst Biol Sci & Hlth, Dept Cellular & Mol Biol, Maceio, Alagoas, Brazil; [Duzzioni, Marcelo] Univ Fed Alagoas, Inst Biol Sci & Hlth, Dept Pharmacol, Maceio, Alagoas, Brazil; [de Castro, Olagide Wagner] Univ Fed Alagoas, Inst Biol Sci & Hlth, Dept Physiol, Maceio, Alagoas, Brazil; [Leite, Joao Pereira] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Neurosci & Behav Sci, Div Neurol, Ribeirao Preto, SP, Brazil; [Barbosa, Fabiano Timbo] Univ Fed Alagoas, Sch Med, Maceio, Alagoas, Brazil	Universidade Federal de Alagoas; Universidade Federal de Alagoas; Universidade Federal de Alagoas; Universidade de Sao Paulo; Universidade Federal de Alagoas	Gita, DLG (corresponding author), Univ Fed Alagoas, Inst Biol Sci & Hlth, Dept Cellular & Mol Biol, Maceio, Alagoas, Brazil.	danielgitai@gmail.com	Duzzioni, Marcelo/C-6797-2015; Leite, Joao/B-9070-2012; da Saúde, Programa Ciências/ABF-1705-2020; Barbosa, Fabiano/S-7117-2019; Castro, Olagide/C-6781-2015; Gitai, Daniel LG/A-7982-2019	Leite, Joao/0000-0003-0558-3519; Castro, Olagide/0000-0002-1874-509X; Gitai, Daniel LG/0000-0001-7056-2373; Santos, Bruna/0000-0002-3694-9977	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [484911/2012-0]; Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL); TEBSM; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL)(Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL)); TEBSM; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), grant number: 484911/2012-0, DLG, JPL; Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL), DLG, TEBSM; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), TEBSM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], EPILEPSIA, V30, P389; Bai DS, 2009, EPILEPSIA, V50, P1184, DOI 10.1111/j.1528-1167.2008.01762.x; Balan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089253; Balan S, 2013, PHARMACOGENET GENOM, V23, P605, DOI 10.1097/FPC.0000000000000000; Balan S, 2013, GENE, V526, P449, DOI 10.1016/j.gene.2013.05.067; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Boycott KM, 2013, NAT REV GENET, V14, P681, DOI 10.1038/nrg3555; Buono RJ, 2013, EPILEPSY BEHAV, V28, pS63, DOI 10.1016/j.yebeh.2012.07.006; Camfield CS, 2013, EPILEPSY BEHAV, V28, pS15, DOI 10.1016/j.yebeh.2012.06.024; Campbell H., 2002, Pharmacogenomics Journal, V2, P349; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Cavalleri GL, 2007, LANCET NEUROL, V6, P970, DOI 10.1016/S1474-4422(07)70247-8; Cavalleri GL, 2007, EPILEPSIA, V48, P706, DOI 10.1111/j.1528-1167.2007.00977.x; Chioza B, 2002, EPILEPSY RES, V52, P107, DOI 10.1016/S0920-1211(02)00195-X; Chioza B, 2002, EUR J HUM GENET, V10, P857, DOI 10.1038/sj.ejhg.5200896; Clarke GM, 2011, NAT PROTOC, V6, P121, DOI 10.1038/nprot.2010.182; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Cordoba M, 2012, MOL BIOL REP, V39, P10615, DOI 10.1007/s11033-012-1949-5; Cossette P, 2002, NAT GENET, V31, P184, DOI 10.1038/ng885; de Kovel CGF, 2007, EPILEPSIA, V48, P2191, DOI 10.1111/j.1528-1167.2007.01306.x; Delgado-Escueta AV, 2013, EPILEPSY BEHAV, V28, pS52, DOI 10.1016/j.yebeh.2012.06.033; Delgado-Escueta Antonio V, 2007, Epilepsy Curr, V7, P61, DOI 10.1111/j.1535-7511.2007.00171.x; DELGADOESCUETA AV, 1984, NEUROLOGY, V34, P285, DOI 10.1212/WNL.34.3.285; Dibbens LM, 2004, HUM MOL GENET, V13, P1315, DOI 10.1093/hmg/ddh146; Doshi MA, 2014, PNS MOL ANAL LGI4 GE; DURNER M, 1991, NEUROLOGY, V41, P1651, DOI 10.1212/WNL.41.10.1651; Escayg A, 2000, AM J HUM GENET, V66, P1531, DOI 10.1086/302909; Esmail EH, 2014, ACTA NEUROL BELG; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Genton P, 2013, EPILEPSY BEHAV, V28, pS8, DOI 10.1016/j.yebeh.2012.10.034; Genton P, 2013, EPILEPSY BEHAV, V28, pS2, DOI 10.1016/j.yebeh.2013.01.002; Gitai DLG, 2008, REV ASSOC MED BRAS, V54, P272, DOI 10.1590/S0104-42302008000300023; Gitai LLG, NEUROL INDIA, V60, P585; Greenberg DA, 1996, NEUROLOGY, V47, P750, DOI 10.1212/WNL.47.3.750; Greenberg DA, 2000, AM J HUM GENET, V66, P508, DOI 10.1086/302763; GREENBERG DA, 1988, AM J MED GENET, V31, P185, DOI 10.1002/ajmg.1320310125; Greenberg DA, 2007, CURR NEUROL NEUROSCI, V7, P320, DOI 10.1007/s11910-007-0049-8; Greenberg DA, 2011, EPILEPSIA, V52, P1, DOI 10.1111/j.1528-1167.2010.02734.x; Gu WL, 2005, EPILEPSY RES, V66, P91, DOI 10.1016/j.eplepsyres.2005.07.003; Guipponi M, 1997, AM J MED GENET, V74, P150, DOI 10.1002/(SICI)1096-8628(19970418)74:2<150::AID-AJMG6>3.3.CO;2-H; Guo Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124896; Haug K, 2000, EPILEPSY RES, V39, P127, DOI 10.1016/S0920-1211(99)00116-3; Heinzen EL, 2012, AM J HUM GENET, V91, P293, DOI 10.1016/j.ajhg.2012.06.016; Helbig I, 2013, EPILEPSY BEHAV, V28, pS66, DOI 10.1016/j.yebeh.2012.07.005; Hempelmann A, 2007, EPILEPSY RES, V74, P28, DOI 10.1016/j.eplepsyres.2006.12.001; Hempelmann A, 2006, EPILEPSY RES, V71, P223, DOI 10.1016/j.eplepsyres.2006.06.021; Heron SE, 2007, EPILEPSY RES, V74, P237, DOI 10.1016/j.eplepsyres.2007.03.003; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Izzi C, 2003, AM J MED GENET B, V123B, P59, DOI 10.1002/ajmg.b.20024; Jacobson GM, 2010, BRAIN RES, V1360, P198, DOI 10.1016/j.brainres.2010.09.006; Jiang JM, 2012, NEURAL REGEN RES, V7, P96, DOI 10.3969/j.issn.1673-5374.2012.02.003; Kapoor A, 2008, ANN NEUROL, V64, P158, DOI 10.1002/ana.21428; Kjeldsen MJ, 2005, TWIN RES HUM GENET, V8, P138, DOI 10.1375/twin.8.2.138; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Layouni S, 2010, INT J IMMUNOGENET, V37, P117, DOI 10.1111/j.1744-313X.2010.00900.x; Layouni S, 2010, NEUROL SCI, V31, P53, DOI 10.1007/s10072-009-0190-z; Le Hellard S, 1999, EPILEPSIA, V40, P117; Lenzen KP, 2005, EPILEPSY RES, V65, P53, DOI 10.1016/j.eplepsyres.2005.04.005; Lenzen KP, 2005, EPILEPSY RES, V63, P113, DOI 10.1016/j.eplepsyres.2005.01.002; Born JPL, 2015, ARQ NEURO-PSIQUIAT, V73, P289, DOI 10.1590/0004-282X20150010; Lorenz S, 2006, NEUROSCI LETT, V397, P234, DOI 10.1016/j.neulet.2005.12.030; Lorenz S, 2006, NEUROSCI LETT, V400, P135, DOI 10.1016/j.neulet.2006.02.026; Martinez-Juarez IE, 2006, BRAIN, V129, P1269, DOI 10.1093/brain/awl048; Mas C, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.017954; Medina MT, 2008, NEUROLOGY, V70, P2137, DOI 10.1212/01.wnl.0000313149.73035.99; Mefford HC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000962; MOEN T, 1995, SEIZURE-EUR J EPILEP, V4, P119, DOI 10.1016/S1059-1311(95)80090-5; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Muhle H, 2010, EPILEPSY RES, V89, P319, DOI 10.1016/j.eplepsyres.2010.02.004; Myers CT, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0214-7; Neubauer BA, 2008, NEUROLOGY, V71, P177, DOI 10.1212/01.wnl.0000317090.92185.ec; Ngomba RT, 2008, NEUROPHARMACOLOGY, V54, P344, DOI 10.1016/j.neuropharm.2007.10.004; Pais I, 2003, J NEUROPHYSIOL, V89, P2046, DOI 10.1152/jn.00549.2002; Pal DK, 2008, EPILEPSIA, V49, P386, DOI 10.1111/j.1528-1167.2007.01416.x; Pal DK, 2003, AM J HUM GENET, V73, P261, DOI 10.1086/377006; Panayiotopoulos CP, 2005, EPILEPSIA, V46, P1, DOI 10.1111/j.1528-1167.2005.00330.x; Parihar R, 2014, J GENET, V93, P193, DOI 10.1007/s12041-014-0334-7; Pavlovic M, 2011, SEIZURE-EUR J EPILEP, V20, P520, DOI 10.1016/j.seizure.2011.03.007; Peng QL, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-85; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Fontes LP, 2015, NEUROLOGIA, V30, P111, DOI 10.1016/j.nrl.2014.03.012; Qu J, 2015, J NEUROL SCI, V354, P56, DOI 10.1016/j.jns.2015.04.045; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; Roeder K, 2006, AM J HUM GENET, V78, P243, DOI 10.1086/500026; Rozycka A, 2013, DNA CELL BIOL, V32, P640, DOI 10.1089/dna.2012.1880; Rozycka A, 2009, SEIZURE-EUR J EPILEP, V18, P601, DOI 10.1016/j.seizure.2009.06.007; Sander T, 1999, EPILEPSY RES, V33, P227, DOI 10.1016/S0920-1211(98)00093-X; Sander T, 1999, AM J MED GENET, V88, P305, DOI 10.1002/(SICI)1096-8628(19990820)88:4<305::AID-AJMG5>3.0.CO;2-X; Sander T, 1999, EPILEPSY RES, V36, P61, DOI 10.1016/S0920-1211(99)00024-8; Sander T, 2002, EPILEPSY RES, V49, P173, DOI 10.1016/S0920-1211(02)00025-6; Sander T, 1997, NEUROLOGY, V49, P842, DOI 10.1212/WNL.49.3.842; Santos B, 2014, EPILEPSY BEHAV, V36, P82, DOI 10.1016/j.yebeh.2014.04.024; Sapio MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123180; Sobetzko D, 2001, AM J MED GENET, V105, P534, DOI 10.1002/ajmg.1488; Sohl G, 2000, MOL BRAIN RES, V83, P44, DOI 10.1016/S0169-328X(00)00195-9; Steffens M, 2012, HUM MOL GENET, V21, P5359, DOI 10.1093/hmg/dds373; Steinlein O, 1997, AM J MED GENET, V74, P445, DOI 10.1002/(SICI)1096-8628(19970725)74:4<445::AID-AJMG18>3.0.CO;2-I; Steinlein OK, 2010, N-S ARCH PHARMACOL, V382, P109, DOI 10.1007/s00210-010-0531-8; Stogmann E, 2006, NEUROLOGY, V67, P2029, DOI 10.1212/01.wnl.0000250254.67042.1b; Suzuki T, 2004, NAT GENET, V36, P842, DOI 10.1038/ng1393; Tan NCK, 2004, EPILEPSIA, V45, P1429, DOI 10.1111/j.0013-9580.2004.22904.x; Tang B, 2008, NEUROBIOL DIS, V29, P59, DOI 10.1016/j.nbd.2007.08.006; Thakkinstian A, 2004, J BONE MINER RES, V19, P419, DOI 10.1359/JBMR.0301265; Thomas RH, 2013, EPILEPSY BEHAV, V26, P241, DOI 10.1016/j.yebeh.2012.09.006; Thomsen C, 1998, NEUROPHARMACOLOGY, V37, P1465, DOI 10.1016/S0028-3908(98)00138-5; Tikka Sai Krishna, 2013, J Pediatr Neurosci, V8, P97, DOI 10.4103/1817-1745.117835; Usui N, 2005, EPILEPSIA, V46, P1668, DOI 10.1111/j.1528-1167.2005.00262.x; Velisek L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023656; Vijai J, 2005, J MED GENET, V42, P439, DOI 10.1136/jmg.2004.023812; Wang LMC, 2009, ASN NEURO, V1, DOI 10.1042/AN20090020; WEISSBECKER KA, 1991, AM J MED GENET, V38, P32, DOI 10.1002/ajmg.1320380109; Yacubian EM, 2017, SEIZURE-EUR J EPILEP, V44, P48, DOI 10.1016/j.seizure.2016.09.005; Yang XK, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/041006; Zhang Y, 2014, CNS NEUROSCI THER, V20, P1008, DOI 10.1111/cns.12328; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	115	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179629	10.1371/journal.pone.0179629	http://dx.doi.org/10.1371/journal.pone.0179629			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636645	Green Published, Green Submitted, gold			2022-12-27	WOS:000404118300043
J	Murphy, C; Rettedal, E; Lehouritis, P; Devoy, C; Tangney, M				Murphy, Carola; Rettedal, Elizabeth; Lehouritis, Panos; Devoy, Ciaran; Tangney, Mark			Intratumoural production of TNF alpha by bacteria mediates cancer therapy	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; GENE-THERAPY; IONIZING-RADIATION; DNA DELIVERY; TUMOR-GROWTH; SALMONELLA; TRANSCRIPTION; MELANOMA; VECTOR; SYSTEM	Systemic administration of the highly potent anticancer therapeutic, tumour necrosis factor alpha (TNF alpha) induces high levels of toxicity and is responsible for serious side effects. Consequently, tumour targeting is required in order to confine this toxicity within the locality of the tumour. Bacteria have a natural capacity to grow within tumours and deliver therapeutic molecules in a controlled fashion. The non-pathogenic E. co/istrain MG1655 was investigated as a tumour targeting system in order to produce TNF alpha specifically within murine tumours. In vivo bioluminescence imaging studies and ex vivo immunofluorescence analysis demonstrated rapid targeting dynamics and prolonged survival, replication and spread of this bacterial platform within tumours. An engineered TNF alpha producing construct deployed in mouse models via either intra-tumoural (i.t.) or intravenous (i.v.) administration facilitated robust TNF alpha production, as evidenced by ELISA of tumour extracts. Tumour growth was impeded in three subcutaneous murine tumour models (CT26 colon, RENCA renal, and TRAMP prostate) as evidenced by tumour volume and survival analyses. A pattern of pro inflammatory cytokine induction was observed in tumours of treated mice vs. controls. Mice remained healthy throughout experiments. This study indicates the therapeutic efficacy and safety of TNF alpha expressing bacteria in vivo, highlighting the potential of non-pathogenic bacteria as a platform for restricting the activity of highly potent cancer agents to tumours.	[Murphy, Carola; Rettedal, Elizabeth; Lehouritis, Panos; Devoy, Ciaran; Tangney, Mark] Univ Coll Cork, Cork Canc Res Ctr, Cork, Ireland; [Devoy, Ciaran; Tangney, Mark] Univ Coll Cork, SynBioCtr, Cork, Ireland; [Tangney, Mark] Univ Coll Cork, APC Microbiome Inst, Cork, Ireland	University College Cork; University College Cork; University College Cork	Tangney, M (corresponding author), Univ Coll Cork, Cork Canc Res Ctr, Cork, Ireland.; Tangney, M (corresponding author), Univ Coll Cork, SynBioCtr, Cork, Ireland.; Tangney, M (corresponding author), Univ Coll Cork, APC Microbiome Inst, Cork, Ireland.	m.tangney@ucc.ie		Tangney, Mark/0000-0002-6314-1260; Rettedal, Elizabeth/0000-0001-5586-0508	Irish Cancer Society [PCI12TAN]; European Commission Seventh Framework Program [PIAPGA-2013-612219-VIP]; Breakthrough Cancer Research	Irish Cancer Society; European Commission Seventh Framework Program; Breakthrough Cancer Research	The authors wish to acknowledge support relevant to this manuscript to MT, from the Irish Cancer Society (PCI12TAN), the European Commission Seventh Framework Program (PIAPGA-2013-612219-VIP) and Breakthrough Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agorio C, 2007, J GENE MED, V9, P416, DOI 10.1002/jgm.1023; Ahmad S, 2009, MOL THER, V17, P1101, DOI 10.1038/mt.2009.66; Baban CK, 2012, JOVE-J VIS EXP, DOI 10.3791/4318; Baban Chwanrow K, 2010, Bioeng Bugs, V1, P385, DOI 10.4161/bbug.1.6.13146; Barbe S, 2005, FEMS MICROBIOL LETT, V246, P67, DOI 10.1016/j.femsle.2005.03.037; Byrne WL, 2014, J CONTROL RELEASE, V196, P384, DOI 10.1016/j.jconrel.2014.10.030; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; Chen JX, 2012, CANCER SCI, V103, P325, DOI 10.1111/j.1349-7006.2011.02147.x; Cronin M, 2014, MOL THER, V22, P1188, DOI 10.1038/mt.2014.23; Cronin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030940; Cronin M, 2010, MOL THER, V18, P1397, DOI 10.1038/mt.2010.59; Cummins J, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-11; DATTA R, 1993, P NATL ACAD SCI USA, V90, P2419, DOI 10.1073/pnas.90.6.2419; DATTA R, 1992, P NATL ACAD SCI USA, V89, P10149, DOI 10.1073/pnas.89.21.10149; Din MO, 2016, NATURE, V536, P81, DOI 10.1038/nature18930; Feng KK, 2005, CANCER LETT, V221, P41, DOI 10.1016/j.canlet.2004.09.030; Flores Bueso Y, 2017, TRENDS BIOTECHNOLOGY; Giacalone MJ, 2006, BIOTECHNIQUES, V40, P355, DOI 10.2144/000112112; HALLAHAN DE, 1991, P NATL ACAD SCI USA, V88, P2156, DOI 10.1073/pnas.88.6.2156; Herman JM, 2013, J CLIN ONCOL, V31, P886, DOI 10.1200/JCO.2012.44.7516; Lehouritis P, 2013, J CONTROL RELEASE, V170, P120, DOI 10.1016/j.jconrel.2013.05.005; Loeffler M, 2008, CANCER GENE THER, V15, P787, DOI 10.1038/cgt.2008.48; Loeffler M, 2008, J NATL CANCER I, V100, P1113, DOI 10.1093/jnci/djn205; Loessner H, 2009, MICROBES INFECT, V11, P1097, DOI 10.1016/j.micinf.2009.08.002; Morrissey D, 2010, CURR GENE THER, V10, P3, DOI 10.2174/156652310790945575; Murphy CT, 2010, J LEUKOCYTE BIOL, V88, P1271, DOI 10.1189/jlb.0909627; Nuyts S, 2001, GENE THER, V8, P1197, DOI 10.1038/sj.gt.3301499; O'Brien MER, 2000, BRIT J CANCER, V83, P853, DOI 10.1054/bjoc.2000.1401; Stanton M, 2015, CURR GENE THER, V15, P277, DOI 10.2174/1566523215666150126122712; Tangney M, 2010, DISCOV MED, V10, P195; Theys J, 1999, APPL ENVIRON MICROB, V65, P4295; van Pijkeren JP, 2010, HUM GENE THER, V21, P405, DOI 10.1089/hum.2009.022; Yuan Z, 2013, CANCER GENE THER, V20, P46, DOI 10.1038/cgt.2012.83	33	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180034	10.1371/journal.pone.0180034	http://dx.doi.org/10.1371/journal.pone.0180034			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662099	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300090
J	Kar, R; Nangpal, P; Mathur, S; Singh, S; Tyagi, AK				Kar, Ritika; Nangpal, Prachi; Mathur, Shubhita; Singh, Swati; Tyagi, Anil K.			bioA mutant of Mycobacterium tuberculosis shows severe growth defect and imparts protection against tuberculosis in guinea pigs	PLOS ONE			English	Article							7,8-DIAMINOPELARGONIC ACID AMINOTRANSFERASE; EXPERIMENTAL AIRBORNE TUBERCULOSIS; PULMONARY TUBERCULOSIS; PANTOTHENATE AUXOTROPH; BIOTIN BIOSYNTHESIS; CLINICAL DEVELOPMENT; BCG; VACCINE; MODEL; MICE	Owing to the devastation caused by tuberculosis along with the unsatisfactory performance of the Bacillus Calmette-Guerin (BCG) vaccine, a more efficient vaccine than BCG is required for the global control of tuberculosis. A number of studies have demonstrated an essential role of biotin biosynthesis in the growth and survival of several microorganisms, including mycobacteria, through deletion of the genes involved in de novo biotin biosynthesis. In this study, we demonstrate that a bioA mutant of Mycobacterium tuberculosis (Mtb Delta bioA) is highly attenuated in the guinea pig model of tuberculosis when administered aerogenically as well as intradermally. Immunization with Mtb Delta bioA conferred significant protection in guinea pigs against an aerosol challenge with virulent M. tuberculosis, when compared with the unvaccinated animals. Booster immunization with Mtb Delta bioA offered no advantage over a single immunization. These experiments demonstrate the vaccinogenic potential of the attenuated M. tuberculosis bioA mutant against tuberculosis.	[Kar, Ritika; Nangpal, Prachi; Mathur, Shubhita; Singh, Swati; Tyagi, Anil K.] Univ Delhi, Dept Biochem, South Campus,Benito Juarez Rd, New Delhi, India; [Tyagi, Anil K.] Guru Gobind Singh Indraprastha Univ, New Delhi, India	University of Delhi; GGS Indraprastha University	Tyagi, AK (corresponding author), Univ Delhi, Dept Biochem, South Campus,Benito Juarez Rd, New Delhi, India.; Tyagi, AK (corresponding author), Guru Gobind Singh Indraprastha Univ, New Delhi, India.	aniltyagi@south.du.ac.in		Kar, Ritika/0000-0003-3953-4897	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/01/COE/05/06-II]; Council of Scientific and Industrial Research (CSIR), India; Department of Biotechnology, Government of India; Indian Council of Medical Research (ICMR), India	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Indian Council of Medical Research (ICMR), India(Indian Council of Medical Research (ICMR))	This work was supported by financial grant from Department of Biotechnology, Ministry of Science and Technology, Government of India (Grant Number-BT/01/COE/05/06-II). RK and PN are grateful to Council of Scientific and Industrial Research (CSIR), India, for research fellowships. SM is grateful to Department of Biotechnology, Government of India for research fellowship. SS is grateful to Indian Council of Medical Research (ICMR), India for research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, orpreparation of the manuscript.	Aguilo N, 2016, TUBERCULOSIS, V96, P71, DOI 10.1016/j.tube.2015.10.010; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Arbues A, 2013, VACCINE, V31, P4867, DOI 10.1016/j.vaccine.2013.07.051; ARONSON JD, 1958, ARCH INTERN MED, V101, P881, DOI 10.1001/archinte.1958.00260170037006; Baldwin SL, 1998, INFECT IMMUN, V66, P2951, DOI 10.1128/IAI.66.6.2951-2959.1998; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Basaraba RJ, 2006, VACCINE, V24, P280, DOI 10.1016/j.vaccine.2005.07.103; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Dai R, 2014, CHEMBIOCHEM, V15, P575, DOI 10.1002/cbic.201300748; Dascher CC, 1999, J IMMUNOL, V163, P5478; Dascher CC, 2003, TRENDS IMMUNOL, V24, P412, DOI 10.1016/S1471-4906(03)00179-0; DasGupta SK, 1998, BIOCHEM BIOPH RES CO, V246, P797, DOI 10.1006/bbrc.1998.8724; Dey S, 2010, BIOCHEMISTRY-US, V49, P6746, DOI 10.1021/bi902097j; Dhar N, 2000, FEMS MICROBIOL LETT, V190, P309, DOI 10.1111/j.1574-6968.2000.tb09304.x; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Geldmacher C, 2015, LANCET RESP MED, V3, P906, DOI 10.1016/S2213-2600(15)00474-9; Ginsberg AM, 2016, TUBERCULOSIS, V99, pS16, DOI 10.1016/j.tube.2016.05.013; Gupta UD, 2005, TUBERCULOSIS, V85, P277, DOI 10.1016/j.tube.2005.08.008; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Hinchey J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015857; Jain R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003869; Kamath AT, 2005, VACCINE, V23, P3753, DOI 10.1016/j.vaccine.2005.03.001; Kaushal D, 2002, P NATL ACAD SCI USA, V99, P8330, DOI 10.1073/pnas.102055799; Kaushal D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9533; Keer J, 2000, MICROBIOL-SGM, V146, P2209, DOI 10.1099/00221287-146-9-2209; Klinkenberg LG, 2010, J INFECT DIS, V202, P1397, DOI 10.1086/656524; Koch R, 1891, Br Med J, V1, P125; Lasco TM, 2005, TUBERCULOSIS, V85, P245, DOI 10.1016/j.tube.2005.01.001; Lee S, 2006, INFECT IMMUN, V74, P6491, DOI 10.1128/IAI.00531-06; Mann S, 2005, BIOCHEM SOC T, V33, P802, DOI 10.1042/BST0330802; Mann S, 2009, BIOCHIMIE, V91, P826, DOI 10.1016/j.biochi.2009.03.019; Martin C, 2006, VACCINE, V24, P3408, DOI 10.1016/j.vaccine.2006.03.017; McMurray DN, 2001, TRENDS MOL MED, V7, P135, DOI 10.1016/S1471-4914(00)01901-8; Medina E, 1998, IMMUNOLOGY, V93, P270, DOI 10.1046/j.1365-2567.1998.00419.x; Mehra S, 2012, J INFECT DIS, V205, P1203, DOI 10.1093/infdis/jis102; Moreira AL, 2002, INFECT IMMUN, V70, P2100, DOI 10.1128/IAI.70.4.2100-2107.2002; Ordway D, 2007, J IMMUNOL, V179, P2532, DOI 10.4049/jimmunol.179.4.2532; Padilla-Carlin DJ, 2008, COMPARATIVE MED, V58, P324; Park SW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002264; Pavelka MS, 2003, INFECT IMMUN, V71, P4190, DOI 10.1128/IAI.71.7.4190-4192.2003; Reddy PV, 2013, J INFECT DIS, V208, P1255, DOI 10.1093/infdis/jit250; Reddy PV, 2012, J BACTERIOL, V194, P567, DOI 10.1128/JB.05553-11; Rhoades ER, 1997, TUBERCLE LUNG DIS, V78, P57, DOI 10.1016/S0962-8479(97)90016-2; Rodionov DA, 2002, GENOME RES, V12, P1507, DOI 10.1101/gr.314502; RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Said HM, 2009, J NUTR, V139, P158, DOI 10.3945/jn.108.092023; Salaemae W, 2011, PROTEIN CELL, V2, P691, DOI 10.1007/s13238-011-1100-8; Sambandamurthy VK, 2006, VACCINE, V24, P6309, DOI 10.1016/j.vaccine.2006.05.097; Sambandamurthy VK, 2005, INFECT IMMUN, V73, P1196, DOI 10.1128/IAI.73.2.1196-1203.2005; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; Sampson SL, 2004, INFECT IMMUN, V72, P3031, DOI 10.1128/IAI.72.5.3031-3037.2004; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Schneider G, 2001, FEBS LETT, V495, P7, DOI 10.1016/S0014-5793(01)02325-0; Smith DA, 2001, INFECT IMMUN, V69, P1142, DOI 10.1128/IAI.69.2.1442-1150.2001; SMITH DW, 1977, AM J PATHOL, V89, P273; SMITH DW, 1970, AM REV RESPIR DIS, V102, P937; Spertini F, 2015, LANCET RESP MED, V3, P953, DOI 10.1016/S2213-2600(15)00435-X; STONER GL, 1975, J BIOL CHEM, V250, P4029; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Taylor JL, 2003, INFECT IMMUN, V71, P2192, DOI 10.1128/IAI.71.4.2192-2198.2003; Tsai MC, 2006, CELL MICROBIOL, V8, P218, DOI 10.1111/j.1462-5822.2005.00612.x; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Williams A, 2005, TUBERCULOSIS, V85, P29, DOI 10.1016/j.tube.2004.09.009; Williams A, 2009, TUBERCULOSIS, V89, P389, DOI 10.1016/j.tube.2009.08.004; Yu J, 2011, MICROBES INFECT, V13, P33, DOI 10.1016/j.micinf.2010.08.010; Zhang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071243	68	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179513	10.1371/journal.pone.0179513	http://dx.doi.org/10.1371/journal.pone.0179513			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658275	Green Submitted, Green Published, gold			2022-12-27	WOS:000404607900029
J	Kodaira, S; Li, HK; Konishi, T; Kitamura, H; Kurano, M; Hasegawa, S				Kodaira, Satoshi; Li, Huizi Keiko; Konishi, Teruaki; Kitamura, Hisashi; Kurano, Mieko; Hasegawa, Sumitaka			Validating alpha-particle emission from (211) At-labeled antibodies in single cells for cancer radioimmunotherapy using CR-39 plastic nuclear track detectors	PLOS ONE			English	Article							CHARGED-PARTICLES; DISTRIBUTIONS; COMBINATION; MICROSCOPE; RESOLUTION; DOSIMETRY; SURFACE	Recently, (211) At has received increasing attention as a potential radionuclide for cancer radioimmunotherapy. It is a alpha-particle emitter, which is extremely effective against malignant cells. We demonstrate a method to verify the efficiency of (211) At-labeled trastuzumab antibodies ((211) At-trastuzumab) against HER2 antigens, which has not been determined for radioimmunotherapy. A CR-39 plastic nuclear detector is used for measuring the position and the linear energy transfer (LET) of individual (211) At alpha-particle tracks. The tracks and (211) At-trastuzumab-binding cells were co-visualized by using the geometric information recorded on the CR-39. HER2-positive human gastric cancer cells (NCI-N87), labelled with (211) At-trastuzumab, were dropped on the centre of the CR-39 plate. Microscope images of the cells and the corresponding alpha-tracks acquired by position matching were obtained. In addition, 3.5 cm x 3.5 cm macroscopic images of the whole plate were acquired. The distribution of number of a-particles emitted from single cells suggests that 80% of the (211) At-trastuzumab-binding cells emitted alpha-particles. It also indicates that the alpha-particles may strike the cells several times along their path. The track-averaged LET of the alpha-particles is evaluated to be 131 keV/mu m. These results will enable quantitative evaluation of delivered doses to target cells, and will be useful for the in vitro assessment of (211) At-based radioimmunotherapeutic agents.	[Kodaira, Satoshi; Kitamura, Hisashi; Kurano, Mieko] Natl Inst Quantum & Radiol Sci & Technol, Radiat Measurement Res Team, Natl Inst Radiol Sci, Chiba, Japan; [Li, Huizi Keiko; Hasegawa, Sumitaka] Natl Inst Quantum & Radiol Sci & Technol, Natl Inst Radiol Sci, Radiat & Canc Biol Team, Chiba, Japan; [Li, Huizi Keiko] Chiba Univ, Grad Sch Med & Pharmaceut Sci, Chiba, Japan; [Konishi, Teruaki] Natl Inst Quantum & Radiol Sci & Technol, Regenerat Therapy Res Team, Natl Inst Radiol Sci, Chiba, Japan	National Institutes for Quantum Science & Technology; National Institutes for Quantum Science & Technology; Chiba University; National Institutes for Quantum Science & Technology	Kodaira, S (corresponding author), Natl Inst Quantum & Radiol Sci & Technol, Radiat Measurement Res Team, Natl Inst Radiol Sci, Chiba, Japan.	kodaira.satoshi@qst.go.jp	Konishi, Teruaki/B-9638-2008; Kodaira, Satoshi/J-3399-2019; Kitamura, Hisashi/AAH-5031-2020	Konishi, Teruaki/0000-0002-2485-9659; Kitamura, Hisashi/0000-0002-3449-7364; Kodaira, Satoshi/0000-0003-4216-6984	National Institute of Radiological Sciences	National Institute of Radiological Sciences	This work was supported by the President's grant from National Institute of Radiological Sciences to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya K, 2005, RADIAT MEAS, V40, P283, DOI 10.1016/j.radmeas.2005.01.010; Andersson H, 2009, J NUCL MED, V50, P1153, DOI 10.2967/jnumed.109.062604; Benton ER, 2010, RADIAT MEAS, V45, P957, DOI 10.1016/j.radmeas.2010.05.008; BENTON EV, 1969, NUCL INSTRUM METHODS, V67, P343, DOI 10.1016/0029-554X(69)90471-6; Berger M.J, 1993, PENETRATION PROTON B; Claesson K, 2011, INT J RADIAT BIOL, V87, P372, DOI 10.3109/09553002.2011.538127; DOKE T, 1995, RADIAT MEAS, V24, P75, DOI 10.1016/1350-4487(94)00084-E; Fleischer R.L., 1975, NUCL TRACKS SOLIDS; Green DJ, 2015, BLOOD, V125, P2111, DOI 10.1182/blood-2014-11-612770; HILL A, 2004, RADIAT RES, V162, P667; ICRP, 1975, REP TASK GROUP REF M; ICRU, 1970, 16 ICRU, DOI [10.1093/jicru/os9.1.Report16, DOI 10.1093/JICRU/OS9.1.REPORT16]; ISHIGURE N, 1985, Radioisotopes, V34, P101; Kodaira S, 2007, NUCL INSTRUM METH A, V574, P163, DOI 10.1016/j.nima.2007.01.086; Kodaira S, 2016, NUCL INSTRUM METH B, V383, P129, DOI 10.1016/j.nimb.2016.07.002; Kodaira S, 2013, RADIAT MEAS, V50, P232, DOI 10.1016/j.radmeas.2012.10.001; Konishi T, 2007, J RADIAT RES, V48, P255, DOI 10.1269/jrr.06078; Larson SM, 2015, NAT REV CANCER, V15, P347, DOI 10.1038/nrc3925; Li HK, 2015, CANCER BIOTHER RADIO, V30, P349, DOI 10.1089/cbr.2015.1882; Lindegren S, 2008, J NUCL MED, V49, P1537, DOI 10.2967/jnumed.107.049833; Nagatsu K, 2014, APPL RADIAT ISOTOPES, V94, P363, DOI 10.1016/j.apradiso.2014.09.012; Newman HC, 1997, INT J RADIAT BIOL, V71, P347, DOI 10.1080/095530097143978; Ogura K, 2001, NUCL INSTRUM METH B, V185, P222, DOI 10.1016/S0168-583X(01)00816-3; OGURA K, RAD MEAS, V34, P555; Ota S, 2008, RADIAT MEAS, V43, pS195, DOI 10.1016/j.radmeas.2008.04.058; Ota S, 2011, NUCL INSTRUM METH B, V269, P1382, DOI 10.1016/j.nimb.2011.03.018; Ota S, 2011, ASTROPHYS SPACE SCI, V7, P495; Palm S, 2007, INT J RADIAT ONCOL, V69, P572, DOI 10.1016/j.ijrobp.2007.06.023; RAJU MR, 1991, RADIAT RES, V128, P204, DOI 10.2307/3578139; Robinson MK, 2008, CLIN CANCER RES, V14, P875, DOI 10.1158/1078-0432.CCR-07-1250; Skvarc J, 2001, RADIAT MEAS, V34, P113, DOI 10.1016/S1350-4487(01)00134-2; SOMOGYI G, 1973, NUCL INSTRUM METHODS, V109, P211, DOI 10.1016/0029-554X(73)90265-6; Tanaka H, 2014, J RADIAT RES, V55, P373, DOI 10.1093/jrr/rrt110; Tawara H, 2008, JPN J APPL PHYS, V47, P1726, DOI 10.1143/JJAP.47.1726; Vaidyanathan G, 2011, CURR RADIOPHARM, V4, P283, DOI 10.2174/1874471011104040283; Yasuda N, 2005, RADIAT MEAS, V40, P311, DOI 10.1016/j.radmeas.2005.02.013	36	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0178472	10.1371/journal.pone.0178472	http://dx.doi.org/10.1371/journal.pone.0178472			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658304	Green Submitted, Green Published, gold			2022-12-27	WOS:000404607900005
J	Tembo, C; Burns, S; Kalembo, F				Tembo, Chimwemwe; Burns, Sharyn; Kalembo, Fatch			The association between levels of alcohol consumption and mental health problems and academic performance among young university students	PLOS ONE			English	Article							IDENTIFICATION TEST AUDIT; RANDOMIZED CONTROLLED-TRIAL; USE DISORDERS; PSYCHOLOGICAL DISTRESS; COLLEGE-STUDENTS; DRINKING; PREVALENCE	Purpose Mental health problems and harmful alcohol consumption have been found to be high among young university students compared to the general population in Australia. This research aimed to investigate the association between levels of drinking and mental health problems and academic performance among university students aged 18 to 24 years. Methods This study used a quantitative cross-sectional design using data that were collected in 2014 as part of the Youth Alcohol Project (YAP). Participants were randomly drawn from a cross sectional sample of 6000 undergraduate students. Included in the study were only students who were within the age of 18-24, undergraduate, and internally enrolled at the main campus. A total of 2518 undergraduate students aged 18 to 24 years who were enrolled internally at Curtin University Bentley campus were randomly recruited. Data were collected through an online survey. Students were invited to participate in the study through their student email address. The email invitations coincided with the release of semester results to increase the likelihood of students accessing their emails. A further 628 students were randomly recruited through face to face intercept survey during the campus market days. Data were collected by trained research assistants. Validated instruments were used to collected data on levels of alcohol consumption, mental health, and academic performance. Results A considerable proportion of participants (44%) reported consuming alcohol at hazardous or harmful levels. Multiple logistic regression analysis showed that students who were consuming alcohol at hazardous levels were 1.2 times more likely to report psychological distress than those with lower levels of alcohol consumption (aOR 1.2, 95% CI: 1.1-1.5). In addition, being late for class (aOR 1.7, 95% CI: 1.1-2.4), missing classes (aOR = 2.6, 95% CI: 1.9-2.6), inability to concentrate in class (aOR = 2.6, 95% CI: 1.9-3.4), and inability to complete assignments (aOR = 3.5, 95% CI 2.0-6.0) independently predicted for moderate or hazardous alcohol consumption. Conclusion The study shows that a considerable proportion of undergraduate students at university consume alcohol at hazardous or harmful levels. In addition, high levels of alcohol consumption are associated with poor academic performance and mental health outcomes among students. The results of the study warrant multi-strategy interventions that focus on policy, organisational, educational, environmental and economic strategies that will help to reduce alcohol related harms among university students.	[Tembo, Chimwemwe] St John God Hosp Serv, Lilongwe, Malawi; [Burns, Sharyn] Curtin Univ, Sch Publ Hlth, Perth, WA, Australia; [Kalembo, Fatch] Mzuzu Univ, Fac Hlth Sci, Mzuzu, Malawi	Curtin University	Tembo, C (corresponding author), St John God Hosp Serv, Lilongwe, Malawi.	chimweptembo@yahoo.co.uk	Burns, Sharyn Kay/Q-9944-2018					Australian Bureau of Statistics (ABS), 2013, AUSTR BUREAU STAT CA; BARRY KL, 1993, ALCOHOL ALCOHOLISM, V28, P33; Bell S, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-91; Boden JM, 2011, ADDICTION, V106, P906, DOI 10.1111/j.1360-0443.2010.03351.x; Burns S., 2015, Open Journal of Preventive Medicine, V5, P1, DOI 10.4236/ojpm.2015.51001; Burns S, 2014, YOUTH ALCOHOL PROJEC; Burns S, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1278-2; Cleary M, 2011, NURSE ED TODAY; Colby SM, 2012, J COLL STUDENT DEV, V53, P797, DOI 10.1353/csd.2012.0080; Collins HP, 2010, DRINKING PATTERNS AU, V2001, P2007; Cvetkovski S, 2012, AUST NZ J PSYCHIAT, V46, P457, DOI 10.1177/0004867411435290; Davey J, 2002, YOUTH STUDIES AUSTR, V21, P25; FLEMING MF, 1991, INT J ADDICT, V26, P1173, DOI 10.3109/10826089109062153; Hallett J., 2014, Open Journal of Preventive Medicine, V4, P616; Hallett J, 2013, HEALTH PROMOT J AUST, V24, P170, DOI 10.1071/HE13094; Hallett J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-37; Headspace, 2020, HEADSP NAT YOUTH MEN; Jorm AF, 2011, NOTING LANDMARK ACHI, P808; KESSLER RC, 1979, J HEALTH SOC BEHAV, V20, P259, DOI 10.2307/2136450; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kirsch DJ, 2015, J AM COLL HEALTH, V63, P50, DOI 10.1080/07448481.2014.960423; Kypri K, 2007, ADDICT BEHAV, V32, P2586, DOI 10.1016/j.addbeh.2007.05.013; Kypri K, 2009, ARCH INTERN MED, V169, P1508, DOI 10.1001/archinternmed.2009.249; McGee R, 2004, AUST NZ J PUBL HEAL, V28, P321, DOI 10.1111/j.1467-842X.2004.tb00437.x; McGorry Patrick, 2013, Br J Psychiatry Suppl, V54, ps30, DOI 10.1192/bjp.bp.112.119214; McGorry PD, 2007, MED J AUSTRALIA, V187, pS5; [NDSHS Summerill A Australian Institute of H Welfare National Drug S Australia. Dept. of H Ageing], 2014, NAT DRUG STRAT HOUS; Pennay A, 2011, AUST FAM PHYSICIAN, V40, P584; Pereira G, 2013, PLOS ONE, V8; Reinert DF, 2002, ALCOHOL CLIN EXP RES, V26, P272, DOI 10.1111/j.1530-0277.2002.tb02534.x; Rickwood D., 2011, Youth Studies Australia, V30, P34; Said D, 2013, SOC PSYCH PSYCH EPID, V48, P935, DOI 10.1007/s00127-012-0574-x; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Slade T, 2011, AUST NZ J PSYCHIAT, V45, P308, DOI 10.3109/00048674.2010.543653; Slutske WS, 2005, ARCH GEN PSYCHIAT, V62, P321, DOI 10.1001/archpsyc.62.3.321; Stallman HM, 2008, AUST FAM PHYSICIAN, V37, P673; Stallman HM, 2010, AUST PSYCHOL, V45, P249, DOI 10.1080/00050067.2010.482109; Stallman HM, 2009, AUST PSYCHOL, V44, P122, DOI 10.1080/00050060902733727; Tanner-Smith EE, 2015, J SUBST ABUSE TREAT, V51, P1, DOI 10.1016/j.jsat.2014.09.001; WHO, 2012, CONS HARM POL APPR C	41	50	52	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0178142	10.1371/journal.pone.0178142	http://dx.doi.org/10.1371/journal.pone.0178142			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JT	28658300	Green Submitted, Green Published, gold			2022-12-27	WOS:000404607900004
J	Wang, ZM; Qiu, ZW; Gao, CX; Sun, YJ; Dong, W; Zhang, Y; Chen, RL; Qi, Y; Li, SY; Guo, YJ; Piao, YJ; Li, S; Piao, FY				Wang, Zhemin; Qiu, Zewen; Gao, Chenxue; Sun, Yijie; Dong, Wei; Zhang, Yan; Chen, Ruolin; Qi, Yuan; Li, Shuangyue; Guo, Yanjie; Piao, Yongjun; Li, Sheng; Piao, Fengyuan			2,5-hexanedione downregulates nerve growth factor and induces neuron apoptosis in the spinal cord of rats via inhibition of the PI3K/Akt signaling pathway	PLOS ONE			English	Article							NORMAL-HEXANE; CELL-DEATH; IN-VITRO; BAD; BCL-2; NGF; EXPRESSION; NEUROPATHY; CASPASE-3; SURVIVAL	2,5-hexanedione (2,5-HD) is the main active metabolite of n-hexane and induces apoptosis in nerve tissue, however, the mechanism of which remains unclear. In the present study, neuropathic animal models were successfully constructed in rats by injecting 100, 200 and 400 mg/kg 2,5-HD intraperitoneally for 5 weeks. Rats exposed to 2,5-HD exhibited progressive gait abnormalities and slower motor neural response in a dose-dependent manner. TUNEL analysis and immunofluorescence dual labeling revealed that the spinal cord of the 2,5-HD treated rats underwent significantly more apoptosis in the cells of spinal cord than that of the control group. The neuron apoptosis index in spinal cord was 4.1%, 6.7%, 9.8% respectively in rats exposed to 100, 200 and 400 mg/kg 2,5-HD, compared with 1.1% in the control group (p < 0.05). Biochemical analysis showed that 2,5-HD exposure downregulated NGF expression in the spinal cord of the intoxicated rats; inhibited the phosphorylation of Akt and Bad, two key players in PI3K/Akt pathway downstream of NGF; increased the dimerization of Bad with Bcl-xL in the mitochondrial fraction, followed by the release of cytochrome c and activation of caspase-3 in the spinal cord of rats. In vitro study showed that the NGF expression decreased significantly in VSC4.1 cells dosed with 5.0, 10.0 mM 2,5HD in comparison with the control group. It was also found that NGF supplement repressed the induced apoptosis, and increased p-Akt and p-Bad level in 2,5-HD treated VSC4.1 cells, which could be antagonized by PI3K kinase (the upstream member of Akt) inhibitor LY294002. Taken together, our experimental results indicate that 2,5-HD may induce apoptosis in the spinal cord of rats via downregulating NGF expression and subsequently repressing PI3K/Akt signaling pathway.	[Wang, Zhemin; Gao, Chenxue; Sun, Yijie; Dong, Wei; Zhang, Yan; Qi, Yuan; Li, Shuangyue; Piao, Fengyuan] Dalian Med Univ, Dept Occupat & Environm Hlth, Dalian, Liaoning, Peoples R China; [Qiu, Zewen] Dalian Med Univ, Lab Anim Ctr, Dalian, Liaoning, Peoples R China; [Chen, Ruolin] Heping Ctr Dis Control & Prevent Tianjin, Dept Sexually Transmitted Dis, Tianjin, Peoples R China; [Guo, Yanjie; Li, Sheng] Dalian Med Univ, Dept Biochem, Dalian, Liaoning, Peoples R China; [Piao, Yongjun] Dalian Med Univ, Dept Dermatol, Affiliated Hosp 1, Dalian, Liaoning, Peoples R China; [Wang, Zhemin] Baotou Med Coll, Affiliated Hosp 2, Dept Prevent & Hlth Care, Baotou, Inner Mongolia, Peoples R China	Dalian Medical University; Dalian Medical University; Tianjin Center for Disease Control & Prevention; Dalian Medical University; Dalian Medical University; Baotou Medical College	Piao, FY (corresponding author), Dalian Med Univ, Dept Occupat & Environm Hlth, Dalian, Liaoning, Peoples R China.; Li, S (corresponding author), Dalian Med Univ, Dept Biochem, Dalian, Liaoning, Peoples R China.	lisheng_1996@163.com; piaofengyuan353@163.com			National Natural Science Foundation of China [81273038, 81102160]; Dalian Municipal Science and Technology Plan Project [2013E15SF163]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Dalian Municipal Science and Technology Plan Project	This work was supported by National Natural Science Foundation of China (grant numbers 81273038 and 81102160) and Dalian Municipal Science and Technology Plan Project (grant number 2013E15SF163).	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Angelucci F, 2007, EUR NEUROPSYCHOPHARM, V17, P756, DOI 10.1016/j.euroneuro.2007.03.002; Bergmann A, 2002, DEV CELL, V3, P607, DOI 10.1016/S1534-5807(02)00328-3; Blume-Jensen P, 1998, CURR BIOL, V8, P779, DOI 10.1016/S0960-9822(98)70302-1; Bottger D, 2010, BRAIN RES, V1312, P108, DOI 10.1016/j.brainres.2009.11.062; Chang AP, 1998, MUSCLE NERVE, V21, P964, DOI 10.1002/(SICI)1097-4598(199807)21:7<964::AID-MUS21>3.3.CO;2-I; CHANG YC, 1991, BRIT J IND MED, V48, P12; CHANG YC, 1990, BRIT J IND MED, V47, P485; Chen RL, 2015, IND HEALTH, V53, P222, DOI 10.2486/indhealth.2014-0182; Connor B, 1998, BRAIN RES REV, V27, P1, DOI 10.1016/S0165-0173(98)00004-6; CRAWFORD GD, 1992, J NEUROSCI, V12, P3392; Cui N, 2007, NEUROCHEM RES, V32, P1566, DOI 10.1007/s11064-007-9359-0; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; GILBERT SG, 1982, J TOXICOL ENV HEALTH, V10, P31, DOI 10.1080/15287398209530228; GRAHAM DG, 1995, CRIT REV TOXICOL, V25, P91, DOI 10.3109/10408449509021609; Hou JL, 2011, CURR NEUROVASC RES, V8, P220, DOI 10.2174/156720211796558069; Hsu SY, 1997, MOL ENDOCRINOL, V11, P1858, DOI 10.1210/me.11.12.1858; Huang Chin-Chang, 2008, Acta Neurol Taiwan, V17, P3; Koh PO, 2011, NEUROSCI LETT, V498, P105, DOI 10.1016/j.neulet.2011.05.003; Kristiansen M, 2014, CELL DEATH DIFFER, V21, P1025, DOI 10.1038/cdd.2014.47; Lehning EJ, 2000, TOXICOL APPL PHARM, V165, P127, DOI 10.1006/taap.2000.8937; Li Y, 2013, J BIOMED RES, V27, P43, DOI 10.7555/JBR.27.20120051; Li YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111707; Liu Qiang, 2005, Wei Sheng Yan Jiu, V34, P271; LoPachin RM, 2004, TOXICOL APPL PHARM, V198, P61, DOI 10.1016/j.taap.2004.03.002; LoPachin RM, 2003, TOXICOL APPL PHARM, V193, P29, DOI 10.1016/j.taap.2003.07.005; Namgung U, 2000, J NEUROSCI, V20, P6442, DOI 10.1523/JNEUROSCI.20-17-06442.2000; Ogawa Y, 1996, INT ARCH OCC ENV HEA, V68, P495, DOI 10.1007/s004200050099; OGE AE, 1994, MUSCLE NERVE, V17, P1416, DOI 10.1002/mus.880171211; Schorey JS, 2003, CELL MICROBIOL, V5, P133, DOI 10.1046/j.1462-5822.2003.00263.x; Shimoke K, 2005, NEUROSCI LETT, V389, P124, DOI 10.1016/j.neulet.2005.07.030; SMITH RG, 1994, P NATL ACAD SCI USA, V91, P3393, DOI 10.1073/pnas.91.8.3393; SPENCER PS, 1975, J NEUROL NEUROSUR PS, V38, P771, DOI 10.1136/jnnp.38.8.771; STRANGE P, 1991, NEUROTOXICOL TERATOL, V13, P401, DOI 10.1016/0892-0362(91)90088-E; Sun Y, 2012, ARCH TOXICOL, V86, P205, DOI 10.1007/s00204-011-0745-7; TAKEUCHI Y, 1983, BRIT J IND MED, V40, P199; Torres ME, 2014, ENVIRON TOXICOL PHAR, V38, P807, DOI 10.1016/j.etap.2014.09.008; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Wang QS, 2007, TOXICOLOGY, V231, P58, DOI 10.1016/j.tox.2006.11.071; Wang T, 2010, ACTA PHARMACOL SIN, V31, P765, DOI 10.1038/aps.2010.69; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yin HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076011; Zassler B, 2006, EXP NEUROL, V198, P391, DOI 10.1016/j.expneurol.2005.12.009; Zhang HY, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-130; Zhang WC, 2013, J APPL TOXICOL, V33, P661, DOI 10.1002/jat.2714; Zhang X., 2010, MODERN PRIMARY SECON, V4, P5; Zhang Yanshu, 2007, Wei Sheng Yan Jiu, V36, P263; Zhao L, 2011, BIOMED ENVIRON SCI, V24, P374, DOI 10.3967/0895-3988.2011.04.008; Zilz TR, 2007, TOXICOLOGY, V231, P210, DOI 10.1016/j.tox.2006.12.002	49	11	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179388	10.1371/journal.pone.0179388	http://dx.doi.org/10.1371/journal.pone.0179388			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654704	gold, Green Published, Green Submitted			2022-12-27	WOS:000404541500061
J	Skoog, P; Ohlsson, M; Ferno, M; Ryden, L; Borrebaeck, CAK; Wingren, C				Skoog, Petter; Ohlsson, Mattias; Ferno, Marten; Ryden, Lisa; Borrebaeck, Carl A. K.; Wingren, Christer			Tumor tissue protein signatures reflect histological grade of breast cancer	PLOS ONE			English	Article							RECOMBINANT ANTIBODY MICROARRAYS; NOTTINGHAM MODIFICATION; BIOMARKER DISCOVERY; EXPRESSION; REPRODUCIBILITY; RECEPTOR; DESIGN; PROGRESSION; GENERATION; CARCINOMAS	Histological grade is one of the most commonly used prognostic factors for patients diagnosed with breast cancer. However, conventional grading has proven technically challenging, and up to 60% of the tumors are classified as histological grade 2, which represents a heterogeneous cohort less informative for clinical decision making. In an attempt to study and extend the molecular puzzle of histologically graded breast cancer, we have in this pilot project searched for additional protein biomarkers in a new space of the proteome. To this end, we have for the first time performed protein expression profiling of breast cancer tumor tissue, using recombinant antibody microarrays, targeting mainly immunoregulatory proteins. Thus, we have explored the immune system as a disease-specific sensor (clinical immunoproteomics). Uniquely, the results showed that several biologically relevant proteins reflecting histological grade could be delineated. In more detail, the tentative biomarker panels could be used to i) build a candidate model classifying grade 1 vs. grade 3 tumors, ii) demonstrate the molecular heterogeneity among grade 2 tumors, and iii) potentially re-classify several of the grade 2 tumors to more like grade 1 or grade 3 tumors. This could, in the long-term run, lead to improved prognosis, by which the patients could benefit from improved tailored care.	[Skoog, Petter; Borrebaeck, Carl A. K.; Wingren, Christer] Lund Univ, Dept Immunotechnol, Lund, Sweden; [Ohlsson, Mattias] Lund Univ, Dept Astron & Theoret Phys, Computat Biol & Biol Phys, Lund, Sweden; [Ferno, Marten] Lund Univ, Dept Oncol & Pathol, Clin Sci, Lund, Sweden; [Ryden, Lisa] Lund Univ, Dept Surg, Clin Sci, Lund, Sweden	Lund University; Lund University; Lund University; Lund University	Wingren, C (corresponding author), Lund Univ, Dept Immunotechnol, Lund, Sweden.	christer.wingren@immun.lth.se		Skoog, Per/0000-0003-0934-0063	Strategic Centre for Translational Cancer Research CREATE Health; VINNOVA (Breast Cancer Initiative); Lund University	Strategic Centre for Translational Cancer Research CREATE Health; VINNOVA (Breast Cancer Initiative); Lund University	This work was supported by grants from the Strategic Centre for Translational Cancer Research CREATE Health, VINNOVA (Breast Cancer Initiative), and Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the Strategic Centre for Translational Cancer Research CREATE Health, VINNOVA (Breast Cancer Initiative), and Lund University.	Addona TA, 2009, NAT BIOTECHNOL, V27, P633, DOI 10.1038/nbt.1546; Alo PL, 1996, CANCER, V77, P474, DOI 10.1002/(SICI)1097-0142(19960201)77:3<474::AID-CNCR8>3.0.CO;2-K; Alwarawrah Y, 2016, CELL CHEM BIOL, V23, P678, DOI 10.1016/j.chembiol.2016.04.011; Anestakis D, 2015, INT J MOL SCI, V16, P1691, DOI 10.3390/ijms16011691; Aubele M, 2009, VIRCHOWS ARCH, V455, P117, DOI 10.1007/s00428-009-0809-8; Borrebaeck CA., 2017, NAT REV CANC; Borrebaeck CAK, 2014, METHODS MOL BIOL, V1131, P563, DOI 10.1007/978-1-62703-992-5_36; Borrebaeck CAK, 2009, J PROTEOMICS, V72, P928, DOI 10.1016/j.jprot.2009.01.027; Bouchal P, 2009, J PROTEOME RES, V8, P362, DOI 10.1021/pr800622b; Carlsson A, 2008, EUR J CANCER, V44, P472, DOI 10.1016/j.ejca.2007.11.025; Carlsson A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005033; Carlsson A, 2011, P NATL ACAD SCI USA, V108, P14252, DOI 10.1073/pnas.1103125108; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen L, 2016, CAN RESPIR J, V2016, DOI 10.1155/2016/9092871; Christgen M, 2016, PATHOLOGE, V37, P328, DOI 10.1007/s00292-016-0182-8; Chung JH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000863; Cristianini Nello, 2000, INTRO SUPPORT VECTOR; Delfani P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159138; Dexlin-Mellby L, 2011, PROTEOMICS, V11, P1550, DOI 10.1002/pmic.200900808; Dinarello CA, 2010, CANCER METAST REV, V29, P317, DOI 10.1007/s10555-010-9229-0; Doustjalali SR, 2004, ELECTROPHORESIS, V25, P2392, DOI 10.1002/elps.200305950; Duffy MJ, 2010, CLIN CHIM ACTA, V411, P1869, DOI 10.1016/j.cca.2010.08.039; Ellmark P, 2006, MOL CELL PROTEOMICS, V5, P1638, DOI 10.1074/mcp.M600170-MCP200; Elston C W, 2002, Histopathology, V41, P154; Ferlay J, 2013, CANC INCIDENCE MORTA, DOI DOI 10.1002/IJC.29210; Ferno M, 2000, BREAST CANCER RES TR, V59, P69, DOI 10.1023/A:1006332423620; FRIERSON HF, 1995, AM J CLIN PATHOL, V103, P195; Geiger T, 2012, CANCER RES, V72, P2428, DOI 10.1158/0008-5472.CAN-11-3711; Gholami AM, 2013, CELL REP, V4, P609, DOI 10.1016/j.celrep.2013.07.018; Gromov P, 2014, EXPERT REV PROTEOMIC, V11, P285, DOI 10.1586/14789450.2014.899469; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Ingvarsson J, 2008, PROTEOMICS, V8, P2211, DOI 10.1002/pmic.200701167; Ingvarsson J, 2007, J PROTEOME RES, V6, P3527, DOI 10.1021/pr070204f; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Karakas C, 2016, AM J PATHOL, V186, P1900, DOI 10.1016/j.ajpath.2016.02.024; Kennedy JJ, 2014, NAT METHODS, V11, P149, DOI [10.1038/NMETH.2763, 10.1038/nmeth.2763]; Klintman M, 2010, MODERN PATHOL, V23, P251, DOI 10.1038/modpathol.2009.167; Lewis AM, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-48; Lv M, 2015, ONCOL REP, V33, P1938, DOI 10.3892/or.2015.3780; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mori J, 2016, CANCER SCI, V107, P298, DOI 10.1111/cas.12881; Olsson N, 2013, MOL CELL PROTEOMICS, V12, P3612, DOI 10.1074/mcp.M113.030379; Olsson N, 2012, PROTEIN SCI, V21, P1897, DOI 10.1002/pro.2173; Olsson N, 2012, MOL CELL PROTEOMICS, V11, P342, DOI 10.1074/mcp.M111.016238; Pan W, 2013, IRISH J MED SCI, V182, P719, DOI 10.1007/s11845-013-0931-0; Pefani DE, 2014, NAT CELL BIOL, V16, P962, DOI 10.1038/ncb3035; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Persson J, 2009, TUMOR BIOL, V30, P221, DOI 10.1159/000240634; Polley MYC, 2013, JNCI-J NATL CANCER I, V105, P1897, DOI 10.1093/jnci/djt306; Rahn JJ, 2001, CANCER, V91, P1973, DOI 10.1002/1097-0142(20010601)91:11<1973::AID-CNCR1222>3.0.CO;2-A; ROBBINS P, 1995, HUM PATHOL, V26, P873, DOI 10.1016/0046-8177(95)90010-1; Sall A, 2016, PROTEIN ENG DES SEL, V29, P427, DOI 10.1093/protein/gzw042; Sandstrom A, 2012, PROTEOM CLIN APPL, V6, P486, DOI 10.1002/prca.201200051; Soderlind E, 2000, NAT BIOTECHNOL, V18, P852, DOI 10.1038/78458; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Strande V, 2009, PROTEOM CLIN APPL, V3, P41, DOI 10.1002/prca.200800083; Suman S, 2016, J PROTEOMICS, V148, P183, DOI 10.1016/j.jprot.2016.07.033; Thathiah A, 2004, BIOCHEM J, V382, P363, DOI 10.1042/BJ20040513; Thathiah A, 2003, J BIOL CHEM, V278, P3386, DOI 10.1074/jbc.M208326200; Tjalsma H, 2008, PROTEOM CLIN APPL, V2, P167, DOI 10.1002/prca.200780012; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Varga Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037379; Wingren C, 2008, CURR OPIN BIOTECH, V19, P55, DOI 10.1016/j.copbio.2007.11.010; Wingren C, 2007, PROTEOMICS, V7, P3055, DOI 10.1002/pmic.200700025; Zhang R, 2010, CHINESE MED J-PEKING, V123, P1976, DOI 10.3760/cma.j.issn.0366-6999.2010.15.005	67	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179775	10.1371/journal.pone.0179775	http://dx.doi.org/10.1371/journal.pone.0179775			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650989	gold, Green Published, Green Submitted			2022-12-27	WOS:000404537300021
J	Wang, FM; King, JDM; Rose, T; Kretzschmar, T; Wissuwa, M				Wang, Fanmiao; King, James Douglas Morrison; Rose, Terry; Kretzschmar, Tobias; Wissuwa, Matthias			Can natural variation in grain P concentrations be exploited in rice breeding to lower fertilizer requirements?	PLOS ONE			English	Article							SEED PHYTATE; PHOSPHORUS; EFFICIENCY; REDISTRIBUTION; IMPROVE; YIELD	Agricultural usage of phosphorus (P) is largely driven by the amount of P removed from fields in harvested plant matter as offtake needs to be balanced by P fertilizer application. Reducing P concentration in grains is a way to decrease P offtake and reduce P fertilizer requirements or soil P mining where insufficient P is applied. Our objective was to assesses the genotypic variation for grain P concentration present within the rice gene pool and resolve to what extent it is affected by environment (P supply) or associated with genetic factors. About 2-fold variation in grain P concentrations were detected in two rice diversity panels, however, environmental effects were stronger than genotype effects. Genome wide association studies identified several putative loci associated with grain P concentrations. In most cases this was caused by minor haplotype associations with high grain P concentrations while associations with reduced P concentrations were identified on chromosomes 1, 6, 8, 11 and 12. Only the latter type of locus is of interest in breeding for reduced P concentrations and the most promising locus was at 20.7 Mb on chromosome 8, where a rare haplotype that was absent from all modern varieties studied reduced grain P concentration by 9.3%. This and all other loci were not consistently detected across environments or association panels, confirming that genetic effects were small compared to effects of environment. We conclude that the genetic effects detected were not sufficiently large or consistent to be of utility in plant breeding. Instead breeding efforts may have to rely on small to medium effect mutants already identified and attempt to achieve a more pronounced reduction in grain P concentration through the introgression of these mutants into a single genetic background.	[Wang, Fanmiao; King, James Douglas Morrison; Wissuwa, Matthias] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo, Japan; [Wang, Fanmiao; King, James Douglas Morrison; Wissuwa, Matthias] Japan Int Res Ctr Agr Sci, Crop Livestock & Environm Div, 1-1 Ohwashi, Tsukuba, Ibaraki, Japan; [Wang, Fanmiao; Kretzschmar, Tobias] IRRI, Los Banos, Laguna, Philippines; [Rose, Terry] Southern Cross Univ, Southern Cross Plant Sci, Lismore, NSW, Australia	University of Tokyo; Japan International Research Center for Agricultural Sciences; CGIAR; International Rice Research Institute (IRRI); Southern Cross University	Wissuwa, M (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo, Japan.; Wissuwa, M (corresponding author), Japan Int Res Ctr Agr Sci, Crop Livestock & Environm Div, 1-1 Ohwashi, Tsukuba, Ibaraki, Japan.	wissuwa@affrc.go.jp	kretzschmar, tobias/AAH-3739-2021	Wissuwa, Matthias/0000-0003-3505-9398; kretzschmar, tobias/0000-0002-8227-0746; Rose, Terry/0000-0001-5386-6818	Global Rice Science Partnership (GRISP) New Frontiers Research Project [DRPC2012-46]	Global Rice Science Partnership (GRISP) New Frontiers Research Project	Financial support in the form of Global Rice Science Partnership (GRISP) New Frontiers Research Project (DRPC2012-46) to MW is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blair MW, 2009, CROP SCI, V49, P237, DOI 10.2135/cropsci2008.05.0246; Dobermann A, 1996, NUTR CYCL AGROECOSYS, V46, P111, DOI 10.1007/BF00704311; Fageria NK, 2013, J PLANT NUTR, V36, P1841, DOI 10.1080/01904167.2013.816727; Fairhurst T., 2000, NUTRIENT DISORDERS N, DOI DOI 10.2136/SSSABOOKSER5.4.C12; Heuer S, 2017, PLANT J, V90, P868, DOI 10.1111/tpj.13423; HOCKING PJ, 1994, J PLANT NUTR, V17, P1289, DOI 10.1080/01904169409364807; Jeong K, 2017, PLANT BIOTECHNOL J, V15, P15, DOI 10.1111/pbi.12586; Julia C, 2016, ANN BOT-LONDON, V118, P1151, DOI 10.1093/aob/mcw164; MacDonald GK, 2011, P NATL ACAD SCI USA, V108, P3086, DOI 10.1073/pnas.1010808108; McCouch SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10532; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Pariasca-Tanaka J, 2015, PLANT SOIL, V392, P253, DOI 10.1007/s11104-015-2460-2; Raboy V, 2001, TRENDS PLANT SCI, V6, P458, DOI 10.1016/S1360-1385(01)02104-5; Raboy V, 2014, J HERED, V105, P656, DOI 10.1093/jhered/esu044; Raboy V, 2009, PLANT SCI, V177, P281, DOI 10.1016/j.plantsci.2009.06.012; Rose TJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00444; Rose TJ, 2012, ADV AGRON, V116, P185, DOI 10.1016/B978-0-12-394277-7.00005-1; Rose TJ, 2010, FIELD CROP RES, V119, P154, DOI 10.1016/j.fcr.2010.07.004; Sattari SZ, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/5/054003; Simpson RJ, 2011, PLANT SOIL, V349, P89, DOI 10.1007/s11104-011-0880-1; Spindel JE, 2016, NEW PHYTOL, V212, P814, DOI 10.1111/nph.14174; Van Kauwenbergh SJ, 2010, WORLD PHOSPHATE ROCK, V75, P58; Vandamme E, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01435; Vandamme E, 2016, NUTR CYCL AGROECOSYS, V104, P413, DOI 10.1007/s10705-015-9716-3; Vandamme E, 2016, FIELD CROP RES, V186, P10, DOI 10.1016/j.fcr.2015.11.003; Wang FM, 2016, J EXP BOT, V67, P1221, DOI 10.1093/jxb/erv517; Wissuwa M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124215; Yamaji N, 2017, NATURE, V541, P92, DOI 10.1038/nature20610; Ye YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101776; Zhao HJ, 2016, NEW PHYTOL, V211, P926, DOI 10.1111/nph.13969; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	32	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179484	10.1371/journal.pone.0179484	http://dx.doi.org/10.1371/journal.pone.0179484			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651022	Green Published, Green Submitted, gold			2022-12-27	WOS:000404537300009
J	Mellem, D; Sattler, M; Pagel-Wolff, S; Jaspers, S; Wenck, H; Rubhausen, MA; Fischer, F				Mellem, Daniel; Sattler, Martin; Pagel-Wolff, Sonja; Jaspers, Soeren; Wenck, Horst; Ruebhausen, Michael Alexander; Fischer, Frank			Fragmentation of the mitochondria! network in skin in vivo	PLOS ONE			English	Article							NADH FLUORESCENCE; OXIDATIVE STRESS; DIFFERENTIATION; AUTOPHAGY; CELLS; KERATINOCYTES; HEPATOCYTES; HYPERFUSION; MORPHOLOGY; FISSION	Mitochondria form dynamic networks which adapt to the environmental requirements of the cell. We investigated the aging process of these networks in human skin cells in vivo by multiphoton microscopy. A study on the age-dependency of the mitochondrial network in young and old volunteers revealed that keratinocytes in old skin establish a significantly more fragmented network with smaller and more compact mitochondrial clusters than keratinocytes in young skin. Furthermore, we investigated the mitochondrial network during differentiation processes of keratinocytes within the epidermis of volunteers. We observe a fragmentation similar to the age-dependent study in almost all parameters. These parallels raise questions about the dynamics of biophysical network structures during aging processes.	[Mellem, Daniel; Ruebhausen, Michael Alexander] Univ Hamburg, Ctr Free Electron Laser Sci CFEL, Hamburg, Germany; [Mellem, Daniel; Sattler, Martin; Pagel-Wolff, Sonja; Jaspers, Soeren; Wenck, Horst; Fischer, Frank] Beiersdorf AG, Appl Biophys, Hamburg, Germany	University of Hamburg; Beiersdorf AG	Fischer, F (corresponding author), Beiersdorf AG, Appl Biophys, Hamburg, Germany.	frank.fischer@beiersdorf.com	Fischer, Frank/AFO-7637-2022	Fischer, Frank/0000-0002-7932-7174	Foundation of German Business; DFG [773/6-2]; Germany Economy Foundation	Foundation of German Business; DFG(German Research Foundation (DFG)); Germany Economy Foundation	This work was supported by Foundation of German Business: DM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Beiersdorf AG and DFG by Ru 773/6-2 provided support in the form of salaries for authors DM, MS, SPJ, SJ, HW and FF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. DM acknowledges financial support by the Germany Economy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allombert-Blaise C, 2003, CELL DEATH DIFFER, V10, P850, DOI 10.1038/sj.cdd.4401245; AVIDOR Y, 1962, J BIOL CHEM, V237, P2377; Aymard E, 2011, EXP DERMATOL, V20, P263, DOI 10.1111/j.1600-0625.2010.01157.x; Balu M, 2013, BIOPHYS J, V104, P258, DOI 10.1016/j.bpj.2012.11.3809; Brown GC, 2012, MITOCHONDRION, V12, P1, DOI 10.1016/j.mito.2011.02.001; D'Orazio J, 2013, INT J MOL SCI, V14, P12222, DOI 10.3390/ijms140612222; Figge MT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002576; Fitzpatrick TB, 1975, J MED ESTHETIQUE, V2, P2; Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064; Hamanaka R.B., 2013, CELL LOGIST, V3, DOI [10.4161/cl.25456, DOI 10.4161/CL.25456]; Hamanaka RB, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003638; Jakobs S, 2003, J CELL SCI, V116, P2005, DOI 10.1242/jcs.00423; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; KLAIDMAN LK, 1995, ANAL BIOCHEM, V228, P312, DOI 10.1006/abio.1995.1356; LAKOWICZ JR, 1992, P NATL ACAD SCI USA, V89, P1271, DOI 10.1073/pnas.89.4.1271; Mayevsky A, 2007, AM J PHYSIOL-CELL PH, V292, pC615, DOI 10.1152/ajpcell.00249.2006; Mellem D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146973; Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976; Oberley TD, 2008, J HISTOCHEM CYTOCHEM, V56, P615, DOI 10.1369/jhc.2008.950873; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Prahl S, 2008, BIOFACTORS, V32, P245, DOI 10.1002/biof.5520320129; Puschmann S, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.3.036005; Regmi SG, 2014, AGING-US, V6, P118, DOI 10.18632/aging.100639; Rolland SG, 2013, P NATL ACAD SCI USA, V110, pE2967, DOI 10.1073/pnas.1303872110; Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Singh SB, 2010, NAT CELL BIOL, V12, P1154, DOI 10.1038/ncb2119; Skala MC, 2007, P NATL ACAD SCI USA, V104, P19494, DOI 10.1073/pnas.0708425104; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779; van der Bliek AM, 2013, COLD SPRING HARB PER, V5; Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855	34	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0174469	10.1371/journal.pone.0174469	http://dx.doi.org/10.1371/journal.pone.0174469			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644888	Green Published, gold, Green Submitted			2022-12-27	WOS:000404145100001
J	Aiyegbusi, OL; Kyte, D; Cockwell, P; Marshall, T; Gheorghe, A; Keeley, T; Slade, A; Calvert, M				Aiyegbusi, Olalekan Lee; Kyte, Derek; Cockwell, Paul; Marshall, Tom; Gheorghe, Adrian; Keeley, Thomas; Slade, Anita; Calvert, Melanie			Measurement properties of patient-reported outcome measures (PROMs) used in adult patients with chronic kidney disease: A systematic review	PLOS ONE			English	Review							QUALITY-OF-LIFE; STAGE RENAL-DISEASE; BASIC PSYCHOMETRIC PROPERTIES; GLOMERULAR-FILTRATION-RATE; NOTTINGHAM HEALTH PROFILE; SYMPTOM ASSESSMENT SYSTEM; SHORT FORM QUESTIONNAIRE; CULTURAL-ADAPTATION; METHODOLOGICAL QUALITY; HEMODIALYSIS-PATIENTS	Background Patient-reported outcome measures (PROMs) can provide valuable information which may assist with the care of patients with chronic kidney disease (CKD). However, given the large number of measures available, it is unclear which PROMs are suitable for use in research or clinical practice. To address this we comprehensively evaluated studies that assessed the measurement properties of PROMs in adults with CKD. Methods Four databases were searched; reference list and citation searching of included studies was also conducted. The COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) checklist was used to appraise the methodological quality of the included studies and to inform a best evidence synthesis for each PROM. Results The search strategy retrieved 3,702 titles/abstracts. After 288 duplicates were removed, 3,414 abstracts were screened and 71 full-text articles were retrieved for further review. Of these, 24 full-text articles were excluded as they did not meet the eligibility criteria. Following reference list and citation searching, 19 articles were retrieved bringing the total number of papers included in the final analysis to 66. There was strong evidence supporting internal consistency and moderate evidence supporting construct validity for the Kidney Disease Quality of Life-36 (KDQOL-36) in pre-dialysis patients. In the dialysis population, the KDQOL-Short Form (KDQOL-SF) had strong evidence for internal consistency and structural validity and moderate evidence for test-retest reliability and construct validity while the KDQOL-36 had moderate evidence of internal consistency, test-retest reliability and construct validity. The End Stage Renal Disease-Symptom Checklist Transplantation Module (ESRD-SCLTM) demonstrated strong evidence for internal consistency and moderate evidence for test-retest reliability, structural and construct validity in renal transplant recipients. Conclusions We suggest considering the KDQOL-36 for use in pre-dialysis patients; the KDQOL-SF or KDQOL-36 for dialysis patients and the ESRD-SCLTM for use in transplant recipients. However, further research is required to evaluate the measurement error, structural validity, responsiveness and patient acceptability of PROMs used in CKD.	[Aiyegbusi, Olalekan Lee; Kyte, Derek; Cockwell, Paul; Marshall, Tom; Slade, Anita; Calvert, Melanie] Univ Birmingham, Ctr Patient Reported Outcomes Res, Birmingham, W Midlands, England; [Aiyegbusi, Olalekan Lee; Kyte, Derek; Marshall, Tom; Slade, Anita; Calvert, Melanie] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England; [Cockwell, Paul] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp Birmingham, Dept Renal Med, Birmingham, W Midlands, England; [Gheorghe, Adrian] Oxford Policy Management Ltd, Oxford, England; [Keeley, Thomas] PAREXEL Int, London, England	University of Birmingham; University of Birmingham; University of Birmingham; Parexel International	Kyte, D (corresponding author), Univ Birmingham, Ctr Patient Reported Outcomes Res, Birmingham, W Midlands, England.; Kyte, D (corresponding author), Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England.	d.g.kyte@bham.ac.uk	Slade, Anita/M-3246-2017; Aiyegbusi, Olalekan Lee/AAO-7278-2021; Calvert, Melanie/F-7055-2011	Slade, Anita/0000-0003-2827-7741; Aiyegbusi, Olalekan Lee/0000-0001-9122-8251; Calvert, Melanie/0000-0002-1856-837X; Cockwell, Paul/0000-0003-1975-266X; kyte, Derek/0000-0002-7679-6741	Health Foundation's Improvement Science Programme; Health Foundation's PhD Awards for Improvement Science [7452]; Oxford Policy Management Ltd; PAREXEL International; National Institute for Health Research [PDF-2016-09-009] Funding Source: researchfish	Health Foundation's Improvement Science Programme; Health Foundation's PhD Awards for Improvement Science; Oxford Policy Management Ltd; PAREXEL International; National Institute for Health Research(National Institute for Health Research (NIHR))	This project was funded as part of the Health Foundation's Improvement Science Programme. Website: http://www.health.org.uk/ OLA is the recipient of the Health Foundation's PhD Awards for Improvement Science (Ref: 7452). The Health Foundation is an independent charity committed to bringing about better health and health care for people in the UK. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. AG is employed by Oxford Policy Management Ltd. Oxford Policy Management Ltd provides support in the form of salary for Dr. Gheorghe, but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. TK is employed by PAREXEL International. PAREXEL International provides support in the form of salary for Dr. Keeley, but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. MC receives consultancy fees from Ferring and Astellas Pharma. Ferring and Astellas Pharma did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all the authors are articulated in the 'author contributions' section.	Agarwal R, 2010, NEPHROL DIAL TRANSPL, V25, P160, DOI 10.1093/ndt/gfp426; Aiyasanon Nipa, 2009, Journal of the Medical Association of Thailand, V92, P1159; Aiyegbusi OL, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012014; Almutary H, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0036-2; Almutary H, 2013, J RENAL CARE, V39, P140, DOI 10.1111/j.1755-6686.2013.12022.x; Alvarez-Ude F, 1997, NEFROLOGIA, V17, P486; BADIA X, 1994, SOC SCI MED, V38, P153, DOI 10.1016/0277-9536(94)90310-7; Barotfi S, 2006, J PSYCHOSOM RES, V60, P495, DOI 10.1016/j.jpsychores.2005.09.009; Basch E, 2016, J CLIN ONCOL, V34, P557, DOI 10.1200/JCO.2015.63.0830; Bataclan RP, 2009, NEPHROLOGY, V14, P663, DOI 10.1111/j.1440-1797.2009.01130.x; Beauger D, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-148; Bjordal K, 2004, ANN ONCOL, V15, P279, DOI 10.1093/annonc/mdh939; Black N, 2013, BMJ-BRIT MED J, V346, pf167, DOI [DOI 10.1136/BMJ.F167, 10.1136/bmj.f167]; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boini S, 2007, NEPHROL THER, V3, P372, DOI 10.1016/j.nephro.2007.05.005; BRECKENRIDGE K, 2015, NEPHROL DIAL TRANSPL, DOI DOI 10.1111/J.1440-1797.2010.01389.X; BROSS IDJ, 1958, BIOMETRICS, V14, P18, DOI 10.2307/2527727; Calvert M, 2015, J ROY SOC MED, V108, P299, DOI 10.1177/0141076815579896; Calvert MJ, 2003, J CLIN PHARM THER, V28, P513, DOI 10.1046/j.0269-4727.2003.00521.x; Chao SM, 2016, WESTERN J NURS RES, V38, P1067, DOI 10.1177/0193945916640765; Cheung YB, 2012, J PAIN SYMPTOM MANAG, V44, P923, DOI 10.1016/j.jpainsymman.2011.12.282; Chisholm-Burns MA, 2011, PATIENT PREFER ADHER, V5, P517, DOI 10.2147/PPA.S24261; CHOW SKY, 2014, BMC NEPHROL, V15, P199, DOI DOI 10.1186/14'71-2369-15-199; CHURCHILL DN, 1987, CLIN INVEST MED, V10, P14; Cleemput I, 2004, VALUE HEALTH, V7, P499, DOI 10.1111/j.1524-4733.2004.74013.x; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; Davison SN, 2006, NEPHROL DIAL TRANSPL, V21, P3189, DOI 10.1093/ndt/gfl380; Davison SN, 2006, KIDNEY INT, V69, P1621, DOI 10.1038/sj.ki.5000184; Dehesh T, 2014, INT UROL NEPHROL, V46, P1183, DOI 10.1007/s11255-013-0537-5; Devlin N., 2010, GETTING MOST OUT PRO; Duarte PS, 2005, BRAZ J MED BIOL RES, V38, P261, DOI 10.1590/S0100-879X2005000200015; Elbers RG, 2012, QUAL LIFE RES, V21, P925, DOI 10.1007/s11136-011-0009-2; ElHafeez SA, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-170; FARDINMEHR O, 2012, J ISFAHAN MED SCH, V29, DOI DOI 10.1080/00365590500240253; FERRANS CE, 1985, ADV NURS SCI, V8, P15, DOI 10.1097/00012272-198510000-00005; Feurer ID, 2004, CLIN TRANSPLANT, V18, P39, DOI 10.1111/j.1399-0012.2004.00216.x; Finkelstein FO, 2009, KIDNEY INT, V76, P946, DOI 10.1038/ki.2009.307; Food and Drug Administration, 2009, PAT REP OUTC MEAS US; Franke GH, 1999, NEPHRON, V83, P31, DOI 10.1159/000045470; Gentile S, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-78; Gibbons E, 2010, STRUCTURED REV PATIE; Gilbody SM, 2003, QUAL SAF HEALTH CARE, V12, P149, DOI 10.1136/qhc.12.2.149; Green A, 2014, MANUAL THER, V19, P517, DOI 10.1016/j.math.2014.05.013; Green J, 2001, QUAL LIFE RES, V10, P93, DOI 10.1023/A:1016630825992; Greenhalgh J, 2009, QUAL LIFE RES, V18, P115, DOI 10.1007/s11136-008-9430-6; Hadi Monica, 2010, CAR CAS COM; Halabi JO, 2006, J ADV NURS, V55, P604, DOI 10.1111/j.1365-2648.2006.03952_1.x; HAM CIC, 2011, NEXT NHS REFORMS CAS, DOI DOI 10.1136/BMJ.F167; Hamer RA, 2006, BMJ-BRIT MED J, V332, P563, DOI 10.1136/bmj.332.7541.563; HAYS R, 1995, KIDNEY DIS QUALITY L, DOI DOI 10.1016/J.TRANSPROCEED.2014.02.011; HAYS RD, 1994, QUAL LIFE RES, V3, P329, DOI 10.1007/BF00451725; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Hjollund NHI, 2014, INTERACT J MED RES, V3, P2, DOI 10.2196/ijmr.2885; Honeycutt AA, 2013, J AM SOC NEPHROL, V24, P1478, DOI 10.1681/ASN.2012040392; HUNT SM, 1985, J ROY COLL GEN PRACT, V35, P185; Jablonski Anita, 2007, Nephrol Nurs J, V34, P29; Janssens A, 2016, DEV MED CHILD NEUROL, V58, P437, DOI 10.1111/dmcn.12982; Johnson JA, 1998, PHARMACOECONOMICS, V13, P421, DOI 10.2165/00019053-199813040-00005; Joshi VD, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-36; Kerr M, 2012, NEPHROL DIAL TRANSPL, V27, P73, DOI 10.1093/ndt/gfs269; Kleinman L, 2006, QUAL LIFE RES, V15, P1223, DOI 10.1007/s11136-006-0053-5; Klersy C, 2007, J NEPHROL, V20, P43; Kontodimopoulos N, 2005, QUAL LIFE RES, V14, P1967, DOI 10.1007/s11136-005-3868-6; Kontodimopoulos N, 2007, ARCH HELL MED, V24, P590; Korevaar JC, 2002, QUAL LIFE RES, V11, P437, DOI 10.1023/A:1015631411960; Korkut Y, 2007, ARCH NEUROPSYCHIATR, V44, P14; Kyle DG, 2013, PLOS ONE, V8; LAUPACIS A, 1992, NEPHRON, V60, P302, DOI 10.1159/000186769; LAUPACIS A, 1993, NEPHRON, V64, P226, DOI 10.1159/000187318; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Malindretos P, 2010, AM J NEPHROL, V31, P9, DOI 10.1159/000252926; Marshall S, 2006, J EVAL CLIN PRACT, V12, P559, DOI 10.1111/j.1365-2753.2006.00650.x; Martini C, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0527-2; Mateti UV, 2015, SAUDI J KIDNEY DIS T, V26, P1246, DOI 10.4103/1319-2442.168662; MATHIAS SD, 1994, J GEN INTERN MED, V9, P606, DOI 10.1007/BF02600303; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Merkus MP, 1999, NEPHROL DIAL TRANSPL, V14, P1163, DOI 10.1093/ndt/14.5.1163; MEYER T, 2007, THE NEW ENGLAND JOUR, V13, P1316; Mingardi G, 1999, NEPHROL DIAL TRANSPL, V14, P1503, DOI 10.1093/ndt/14.6.1503; Moher D, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000023.pub3; MOKKINK LB, 2009, COSMIN CHECKLIST MAN, DOI DOI 10.1016/J.INJURY.2010.11.042; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Mokkink LB, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-22; Molsted S, 2005, SCAND J UROL NEPHROL, V39, P498, DOI 10.1080/00365590500240253; Moons P, 2001, J Nurs Meas, V9, P115; Moreira CA, 2009, REV ASSOC MED BRAS, V55, P22, DOI 10.1590/S0104-42302009000100010; Murtagh FEM, 2011, CLIN J AM SOC NEPHRO, V6, P1580, DOI 10.2215/CJN.09021010; Nitsch D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f324; Niu YJ, 2015, INT J CLIN EXP MED, V8, P22570; Onsoz HB, 2013, TURK NEPHROL DIAL TR, V22, P60, DOI 10.5262/tndt.2013.1001.08; Ortega T, 2007, TRANSPLANTATION, V84, P1428, DOI 10.1097/01.tp.0000290231.39240.df; Pakpour AH, 2011, IRAN J KIDNEY DIS, V5, P175; Pakpour AH, 2011, NEPHROLOGY, V16, P106, DOI 10.1111/j.1440-1797.2010.01389.x; Park HJ, 2007, TOHOKU J EXP MED, V211, P321, DOI 10.1620/tjem.211.321; Perneger TV, 2003, J NEPHROL, V16, P252; *PROGRAM NKDE, 2014, NIH PUBLICATION, P14; Rao S, 2000, CLIN THER, V22, P1099, DOI 10.1016/S0149-2918(00)80087-9; Rebollo Pablo, 2003, Health Qual Life Outcomes, V1, P56, DOI 10.1186/1477-7525-1-56; Reeve B, 2013, QUAL LIFE RES, V22, P1889, DOI 10.1007/s11136-012-0344-y; Rhou H, 2014, TRANSPL P, V46, P1295, DOI 10.1016/j.transproceed.2014.02.011; Ricardo AC, 2013, ETHNIC DIS, V23, P202; Scholtes VA, 2011, INJURY, V42, P236, DOI 10.1016/j.injury.2010.11.042; Stavem Knut, 2006, BMC Nephrol, V7, P17, DOI 10.1186/1471-2369-7-17; Suet-Ching WL, 2001, J ADV NURS, V36, P441, DOI 10.1046/j.1365-2648.2001.01992.x; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Tao XJ, 2014, BMC NEPHROL, V15, DOI [10.1186/1471-2369-15-115, 10.1186/1471-2369-15-199]; Terwee CB, 2016, QUAL LIFE RES, V25, P767, DOI 10.1007/s11136-015-1122-4; Terwee C.B., 2011, PROTOCOL SYSTEMATIC; Terwee CB, 2012, QUAL LIFE RES, V21, P651, DOI 10.1007/s11136-011-9960-1; Terwee CB, 2009, J CLIN EPIDEMIOL, V62, P1062, DOI 10.1016/j.jclinepi.2008.10.011; Terwee CB, 2009, QUAL LIFE RES, V18, P1115, DOI 10.1007/s11136-009-9528-5; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Thaweethamcharoen T, 2013, Value Health Reg Issues, V2, P98, DOI 10.1016/j.vhri.2013.02.011; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; [ВАСИЛЬЕВА И.А. VASILIEVA I.A.], 2007, [Нефрология, Nefrologiya], V11, P64; Velikova G, 2004, J CLIN ONCOL, V22, P714, DOI 10.1200/JCO.2004.06.078; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weisbord SD, 2004, J PAIN SYMPTOM MANAG, V27, P226, DOI 10.1016/j.jpainsymman.2003.07.004; Wu AW, 2001, AM J KIDNEY DIS, V37, P11, DOI 10.1053/ajkd.2001.20571; Yang F, 2013, PATIENT, V6, P135, DOI 10.1007/s40271-013-0015-2; Yang SC, 2006, J FORMOS MED ASSOC, V105, P299, DOI 10.1016/S0929-6646(09)60121-2; Yidirim A, 2007, TRANSPLANT P, V39, P51, DOI 10.1016/j.transproceed.2006.10.196; Yu HT, 2003, ARCH INTERN MED, V163, P1417, DOI 10.1001/archinte.163.12.1417; Zengin N, 2014, INT J NURS PRACT, V20, P115, DOI 10.1111/ijn.12130	127	60	61	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179733	10.1371/journal.pone.0179733	http://dx.doi.org/10.1371/journal.pone.0179733			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY6UH	28636678	Green Published, Green Submitted, gold			2022-12-27	WOS:000404118300052
J	Dilley, KA; Voorhies, AA; Luthra, P; Puri, V; Stockwell, TB; Lorenzi, H; Basler, CF; Shabman, RS				Dilley, Kari A.; Voorhies, Alexander A.; Luthra, Priya; Puri, Vinita; Stockwell, Timothy B.; Lorenzi, Hernan; Basler, Christopher F.; Shabman, Reed S.			The Ebola virus VP35 protein binds viral immunostimulatory and host RNAs identified through deep sequencing	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; DEFECTIVE INTERFERING PARTICLES; RIG-I; IMMUNE EVASION; 5'-TRIPHOSPHATE RNA; IRF-3 ACTIVATION; ANTAGONISM; INFECTION; SURVEILLANCE; GENERATION	Ebola virus and Marburg virus are members of the Filovirdae family and causative agents of hemorrhagic fever with high fatality rates in humans. Filovirus virulence is partially attributed to the VP35 protein, a well-characterized inhibitor of the RIG-I-like receptor pathway that triggers the antiviral interferon (IFN) response. Prior work demonstrates the ability of VP35 to block potent RIG-I activators, such as Sendai virus (SeV), and this IFN-antagonist activity is directly correlated with its ability to bind RNA. Several structural studies demonstrate that VP35 binds short synthetic dsRNAs; yet, there are no data that identify viral immunostimulatory RNAs (isRNA) or host RNAs bound to VP35 in cells. Utilizing a SeV infection model, we demonstrate that both viral isRNA and host RNAs are bound to Ebola and Marburg VP35s in cells. By deep sequencing the purified VP35-bound RNA, we identified the SeV copyback defective interfering (DI) RNA, previously identified as a robust RIG-I activator, as the isRNA bound by multiple filovirus VP35 proteins, including the VP35 protein from the West African outbreak strain (Makona EBOV). Moreover, RNAs isolated from a VP35 RNA-binding mutant were not immunostimulatory and did not include the SeV DI RNA. Strikingly, an analysis of host RNAs bound by wild-type, but not mutant, VP35 revealed that select host RNAs are preferentially bound by VP35 in cell culture. Taken together, these data support a model in which VP35 sequesters isRNA in virus-infected cells to avert RIG-I like receptor (RLR) activation.	[Dilley, Kari A.; Puri, Vinita; Stockwell, Timothy B.; Shabman, Reed S.] J Craig Venter Inst, Virol Grp, Rockville, MD 20850 USA; [Voorhies, Alexander A.; Lorenzi, Hernan] J Craig Venter Inst, Infect Dis Grp, Rockville, MD USA; [Luthra, Priya; Basler, Christopher F.] Georgia State Univ, Ctr Microbial Pathogenesis, Atlanta, GA 30303 USA; [Stockwell, Timothy B.] Natl Biodef Anal & Countermeasures Ctr, Ft Detrick, MD USA	J. Craig Venter Institute; J. Craig Venter Institute; University System of Georgia; Georgia State University	Dilley, KA; Shabman, RS (corresponding author), J Craig Venter Inst, Virol Grp, Rockville, MD 20850 USA.	kdilley@jcvi.org; rshabman@jcvi.org		Basler, Christopher/0000-0003-4195-425X; Lorenzi, Hernan/0000-0003-0910-7894; Stockwell, Timothy/0000-0002-3595-4539	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [U19AI110819]; NIH [AI109945]; Department of the Defense, Defense Threat Reduction Agency [HDTRA1-12-1-0051]; JCV [9260]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI110819, U19AI109945] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of the Defense, Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); JCV; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in whole or part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under Award Number U19AI110819.This work was also supported NIH grant AI109945 and Department of the Defense, Defense Threat Reduction Agency grant HDTRA1-12-1-0051 to CFB. RS Sand KD were also supported by JCV Iinternal funding (9260).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anthony SM, 2015, VIRUSES-BASEL, V7, P5172, DOI 10.3390/v7102867; Bai YH, 2016, BRIEF BIOINFORM, V17, P63, DOI 10.1093/bib/bbv026; Basler CF, 2000, P NATL ACAD SCI USA, V97, P12289, DOI 10.1073/pnas.220398297; Basler CF, 2003, J VIROL, V77, P7945, DOI 10.1128/JVI.77.14.7945-7956.2003; Basler CF, 2015, VIROLOGY, V479, P122, DOI 10.1016/j.virol.2015.03.030; Basler CF, 2013, EXPERT REV ANTI-INFE, V11, P475, DOI [10.1586/eri.13.30, 10.1586/ERI.13.30]; Basler CF, 2009, J INTERF CYTOK RES, V29, P511, DOI 10.1089/jir.2009.0076; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Binning JM, 2013, BIOCHEMISTRY-US, V52, P8406, DOI 10.1021/bi400704d; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brown CS, 2014, J MOL BIOL, V426, P2045, DOI 10.1016/j.jmb.2014.01.010; Calain P, 1999, VIROLOGY, V262, P114, DOI 10.1006/viro.1999.9915; Cannas V, 2015, J INFECT DIS, V212, pS277, DOI 10.1093/infdis/jiv214; Cardenas WB, 2006, J VIROL, V80, P5168, DOI 10.1128/JVI.02199-05; Chan YK, 2015, CURR OPIN VIROL, V12, P7, DOI 10.1016/j.coviro.2015.01.004; Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5; Dunham EC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9000; Edwards MR, 2016, CELL REP, V14, P1632, DOI 10.1016/j.celrep.2016.01.049; Ekins Sean, 2014, F1000Res, V3, P277, DOI 10.12688/f1000research.5741.1; Geisbert Thomas W., 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404008300; Ghosh S, 2016, METHODS MOL BIOL, V1374, P339, DOI 10.1007/978-1-4939-3167-5_18; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Hartman AL, 2008, J VIROL, V82, P2699, DOI 10.1128/JVI.02344-07; Hartman AL, 2006, J VIROL, V80, P6430, DOI 10.1128/JVI.00044-06; HOLLAND J, 1982, SCIENCE, V215, P1577, DOI 10.1126/science.7041255; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Johnson RF, 2006, J VIROL, V80, P5135, DOI 10.1128/JVI.01857-05; Kohlway A, 2013, EMBO REP, V14, P772, DOI 10.1038/embor.2013.108; Lassig C, 2015, ELIFE, V4, DOI 10.7554/eLife.10859; Leung DW, 2010, NAT STRUCT MOL BIOL, V17, P165, DOI 10.1038/nsmb.1765; Leung DW, 2009, ACTA CRYSTALLOGR F, V65, P163, DOI 10.1107/S1744309108044187; Lopez CB, 2006, J VIROL, V80, P4538, DOI 10.1128/JVI.80.9.4538-4545.2006; Luthra P, 2013, CELL HOST MICROBE, V14, P74, DOI 10.1016/j.chom.2013.06.010; Martinez-Romero C, 2015, VIRUS RES, V209, P4, DOI 10.1016/j.virusres.2015.05.025; Messaoudi I, 2015, NAT REV MICROBIOL, V13, P663, DOI 10.1038/nrmicro3524; Moser LA, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00039-15; Nakhaei P, 2009, SEMIN IMMUNOL, V21, P215, DOI 10.1016/j.smim.2009.05.001; Patel JR, 2014, CYTOKINE GROWTH F R, V25, P513, DOI 10.1016/j.cytogfr.2014.08.005; Perrault J, 1981, Curr Top Microbiol Immunol, V93, P151; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Prins KC, 2010, J VIROL, V84, P3004, DOI 10.1128/JVI.02459-09; Prins KC, 2009, J VIROL, V83, P3069, DOI 10.1128/JVI.01875-08; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Spiropoulou CF, 2009, VIROLOGY, V392, P11, DOI 10.1016/j.virol.2009.06.032; St Reid P, 2005, VIROLOGY, V341, P179, DOI 10.1016/j.virol.2005.06.044; Sun Y, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005122; Team RC, 2015, LANG ENV STAT COMP; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Valmas C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000721; Xu W, 2014, CELL HOST MICROBE, V16, P187, DOI 10.1016/j.chom.2014.07.008; Xue Q, 2014, BIOPOLYMERS, V101, P849, DOI 10.1002/bip.22463; Yount JS, 2006, J IMMUNOL, V177, P4503, DOI 10.4049/jimmunol.177.7.4503; Zhang HX, 2013, P NATL ACAD SCI USA, V110, P6459, DOI 10.1073/pnas.1304432110	56	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0178717	10.1371/journal.pone.0178717	http://dx.doi.org/10.1371/journal.pone.0178717			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636653	Green Published, gold, Green Submitted			2022-12-27	WOS:000404118300016
J	Mitrega, KA; Spalek, AM; Nozynski, J; Porc, M; Stankiewicz, M; Krzeminski, TF				Mitrega, Katarzyna A.; Spalek, Adrianna M.; Nozynski, Jerzy; Porc, Maurycy; Stankiewicz, Magdalena; Krzeminski, Tadeusz F.			Cardiomyopathy development protection after myocardial infarction in rats: Successful competition for major dihydropyridines' common metabolite against captopril	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING-ENZYME; CARDIOVASCULAR EVENTS; CALCIUM-ANTAGONIST; HEART-FAILURE; TNF-ALPHA; INHIBITION; SIZE; ARRHYTHMIAS; EXPRESSION; REDUCTION	During the last 25 years angiotensin-converting enzyme inhibitors spectacularly conquered the field of cardiovascular diseases therapy. Nevertheless, lack of new studies concerning side effects associated with their chronic administration seems to be rather confusing. In our previous research, we proved that the main furnidipines' metabolite (M-2) possess multiple cardioprotective actions. Currently, we compared effects of post-infarction long-term oral treatment with M-2 and captopril on hemodynamic parameters and ''ischemic cardiomyopathy'' development in rats. Myocardial infarction was evoked by permanent left anterior descending coronary artery occlusion for 35 days. Surviving rats were treated with captopril (2 x 25 mg/kg) or M-2 (4 mg/kg) from 6(th) -35(th) day. At 35(th) day rats' hearts were tested on working heart setup, where following parameters were measured: heart rate, preload pressure, aortic systolic and diastolic pressures, aortic maximum rise and fall, aortic and coronary flow, myocardial oxygen consumption and oximetry in perfusate. Subsequently, heart tissue specimens were assessed during morphological estimation. Captopril caused significant heart rate increase and markedly diminished preload pressure in comparison to M-2. Both drugs evoked essential aortic pressure increase. Aortic flow was significantly decreased after M-2, whereas captopril increased this parameter in comparison to M-2. Both agents caused marked coronary flow increase. Morphologic examination in captopril revealed cardiomyopathic process in 70% of hearts, whereas in M-2 this value reached 30%. Neovascularization of post-infarcted myocardium was visible only after M-2 therapy. Concluding, M-2 presented itself as more attractive agent in long-term post-infarction treatment by preventing cardiomyopathy development, angiogenesis stimulation and preserving cardiac performance.	[Mitrega, Katarzyna A.; Nozynski, Jerzy] Silesian Ctr Heart Dis, Zabrze, Poland; [Spalek, Adrianna M.; Porc, Maurycy; Stankiewicz, Magdalena; Krzeminski, Tadeusz F.] Med Univ Silesia, Chair & Dept Pharmacol, Zabrze, Poland	Silesian Center for Heart Diseases; Medical University Silesia	Spalek, AM (corresponding author), Med Univ Silesia, Chair & Dept Pharmacol, Zabrze, Poland.	adrianna.spalek@gmail.com		Porc, Maurycy Pawel/0000-0001-8914-1173; Stankiewicz, Magdalena/0000-0002-2608-1959; Spalek, Adrianna/0000-0001-9314-6292; Krzeminski, Tadeusz/0000-0003-3663-4518				Bergmeyer H. U., 1983, METHODS ENZYMATIC AN; Bonarjee VVS, 1996, DRUGS, V51, P347, DOI 10.2165/00003495-199651030-00001; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; BUDDEN R, 1980, RAT ELECTROCARDIOGRA; CARLSSON L, 1989, EUR J PHARMACOL, V166, P157, DOI 10.1016/0014-2999(89)90055-1; Cleland JGF, 1997, EUR HEART J, V18, P41; CROME R, 1986, J CARDIOVASC PHARM, V8, P1249, DOI 10.1097/00005344-198611000-00023; CROTTOGINI AJ, 1985, AM HEART J, V110, P753, DOI 10.1016/0002-8703(85)90453-3; Deck CC, 1996, J CARDIOVASC PHARM, V28, P167, DOI 10.1097/00005344-199607000-00024; Dembinska-Kiec A, 1998, ADV EXPT MED BIOL, P163; ELLRODT G, 1980, CIRCULATION, V62, P669, DOI 10.1161/01.CIR.62.4.669; ERTL G, 1983, BASIC RES CARDIOL, V78, P518, DOI 10.1007/BF01906463; ERTL G, 1988, EUR HEART J, V9, P716, DOI 10.1093/eurheartj/9.7.716; ERTL G, 1982, CIRCULATION, V65, P40, DOI 10.1161/01.CIR.65.1.40; FERRARI R, 1994, CARDIOVASC DRUG THER, V8, P565, DOI 10.1007/BF00877225; Fox KM, 2003, LANCET, V362, P782; Fryer RM, 2000, J PHARMACOL EXP THER, V294, P451; Gerol M, 1998, COMP BIOCHEM PHYS C, V120, P397, DOI 10.1016/S0742-8413(98)10064-6; GUENDJEV Z, 1977, ARZNEIMITTELFORSCH, V27-2, P1576; HAMM CW, 1983, CIRC RES, V52, P129; Heba G, 2001, J PHYSIOL PHARMACOL, V52, P39; Heba G, 2001, J VASC RES, V38, P288, DOI 10.1159/000051057; HIRSCH AT, 1991, CIRC RES, V69, P475, DOI 10.1161/01.RES.69.2.475; Jin H, 2001, CIRCULATION, V103, P736; JOHNSTON CI, 1991, CLIN EXP PHARMACOL P, V18, P107, DOI 10.1111/j.1440-1681.1991.tb01417.x; KEMNITZ J, 1987, AM J SURG PATHOL, V11, P503, DOI 10.1097/00000478-198707000-00002; Kleinman L, 1986, HARVARD APPARATUS BI, P25; KREHER P, 1995, J CARDIOVASC PHARM, V25, P75, DOI 10.1097/00005344-199501000-00012; Krzeminski TF, 2008, VASC PHARMACOL, V49, P91, DOI 10.1016/j.vph.2008.06.005; Krzeminski TF, 2006, EUR J PHARMACOL, V549, P91, DOI 10.1016/j.ejphar.2006.08.002; Krzeminski TF, 2011, J CARDIOVASC PHARM, V57, P183, DOI 10.1097/FJC.0b013e318202e2ea; Krzeminski TF, 2005, VASC PHARMACOL, V43, P164, DOI 10.1016/j.vph.2005.06.003; Krzeminski TF, 1995, 9 FREIB FOC BIOM PHA, P128; Langendorff O., 1898, PFLUGERS ARCH, V70, P473; Letelier CS, 2002, US 477 Patent, Patent No. [US 6,482,841B1, 6482841]; Luscher T F, 1993, Drugs, V46 Suppl 2, P121; MARTORANA PA, 1990, EUR J PHARMACOL, V182, P395, DOI 10.1016/0014-2999(90)90301-L; MCDONALD KM, 1990, T ASSOC AM PHYSICIAN, V103, P229; MELIN JA, 1984, CIRCULATION, V69, P131, DOI 10.1161/01.CIR.69.1.131; Mitrega KA, 2013, J CLIN EXP CARDIOLOG, V4, P281; Mitrega KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089477; NEELY JR, 1967, AM J PHYSIOL, V212, P804; OLSEN EGJ, 1986, COR VASA, V28, P241; OLSEN EGJ, 1984, AM J CARDIOL, V53, P654, DOI 10.1016/0002-9149(84)90064-X; Opie LH, 2000, PROG CARDIOVASC DIS, V43, P171, DOI 10.1053/pcad.2000.7010; PFEFFER MA, 1988, NEW ENGL J MED, V319, P80, DOI 10.1056/NEJM198807143190204; PFEFFER MA, 1985, CIRCULATION, V72, P406, DOI 10.1161/01.CIR.72.2.406; Roden DM, 2003, J CARDIOVASC ELECTR, V14, P1389, DOI 10.1046/j.1540-8167.2003.03441.x; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Rouleau JL, 2008, CIRCULATION, V117, P24, DOI 10.1161/CIRCULATIONAHA.106.685073; Russ U, 1996, PFLUG ARCH EUR J PHY, V432, P75, DOI 10.1007/s004240050107; SCHRAMM M, 1983, NATURE, V303, P535, DOI 10.1038/303535a0; SELYE H., 1960, ANGIOLOGY, V11, P398, DOI 10.1177/000331976001100505; Stormont MF, 1930, J PHARMACOL EXP THER, V39, P165; Thandroyen FT, 1981, AM J CARDIOL, V47, P15; Triggle DJ, 2003, CELL MOL NEUROBIOL, V23, P293, DOI 10.1023/A:1023632419813; TUMAS J, 1985, J CARDIOVASC PHARM, V7, P361, DOI 10.1097/00005344-198503000-00023; VANGILST WH, 1986, J CARDIOVASC PHARM, V8, P722; WEATHERALL JAC, 1960, BRIT J PHARM CHEMOTH, V15, P454, DOI 10.1111/j.1476-5381.1960.tb01272.x; WESTLIN W, 1988, CIRCULATION, V77, P30; Wilkens H, 1970, SHOCK BIOCH PHARM CL, P201; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zander B, 1967, MEASUREMENT OXYGEN, P271; Zdrojewski T., 1994, European Heart Journal, V15, P118; ZUGHAIB ME, 1993, BASIC RES CARDIOL, V88, P155; Zwieten PA, 1966, CARDIOVASC DRUG THER, V10, P693	66	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179633	10.1371/journal.pone.0179633	http://dx.doi.org/10.1371/journal.pone.0179633			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636634	Green Submitted, Green Published, gold			2022-12-27	WOS:000404118300045
J	Downing, NS; Cloninger, A; Venkatesh, AK; Hsieh, A; Drye, EE; Coifman, RR; Krumholz, HM				Downing, Nicholas S.; Cloninger, Alexander; Venkatesh, Arjun K.; Hsieh, Angela; Drye, Elizabeth E.; Coifman, Ronald R.; Krumholz, Harlan M.			Describing the performance of US hospitals by applying big data analytics	PLOS ONE			English	Article								Public reporting of measures of hospital performance is an important component of quality improvement efforts in many countries. However, it can be challenging to provide an overall characterization of hospital performance because there are many measures of quality. In the United States, the Centers for Medicare and Medicaid Services reports over 100 measures that describe various domains of hospital quality, such as outcomes, the patient experience and whether established processes of care are followed. Although individual quality measures provide important insight, it is challenging to understand hospital performance as characterized by multiple quality measures. Accordingly, we developed a novel approach for characterizing hospital performance that highlights the similarities and differences between hospitals and identifies common patterns of hospital performance. Specifically, we built a semi-supervised machine learning algorithm and applied it to the publicly-available quality measures for 1,614 U.S. hospitals to graphically and quantitatively characterize hospital performance. In the resulting visualization, the varying density of hospitals demonstrates that there are key clusters of hospitals that share specific performance profiles, while there are other performance profiles that are rare. Several popular hospital rating systems aggregate some of the quality measures included in our study to produce a composite score; however, hospitals that were top-ranked by such systems were scattered across our visualization, indicating that these top-ranked hospitals actually excel in many different ways. Our application of a novel graph analytics method to data describing U.S. hospitals revealed nuanced differences in performance that are obscured in existing hospital rating systems.	[Downing, Nicholas S.; Venkatesh, Arjun K.; Hsieh, Angela; Drye, Elizabeth E.; Krumholz, Harlan M.] Yale New Haven Hlth, Ctr Outcomes Res & Evaluat, New Haven, CT 06519 USA; [Cloninger, Alexander; Coifman, Ronald R.] Yale Univ, Dept Math, New Haven, CT 06520 USA; [Venkatesh, Arjun K.] Yale Sch Med, Dept Emergency Med, New Haven, CT USA; [Drye, Elizabeth E.] Yale Sch Med, Dept Gen Pediat, New Haven, CT USA; [Krumholz, Harlan M.] Yale Sch Med, Sect Cardiovasc Med, Dept Internal Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Sch Med, Dept Internal Med, Robert Wood Johnson Fdn, Clin Scholars Program, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06510 USA; [Downing, Nicholas S.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Hsieh, Angela] Genentech Inc, San Francisco, CA USA	Yale University; Yale University; Yale University; Yale University; Yale University; Robert Wood Johnson Foundation (RWJF); Yale University; Yale University; Harvard University; Brigham & Women's Hospital; Roche Holding; Genentech	Krumholz, HM (corresponding author), Yale New Haven Hlth, Ctr Outcomes Res & Evaluat, New Haven, CT 06519 USA.; Krumholz, HM (corresponding author), Yale Sch Med, Sect Cardiovasc Med, Dept Internal Med, New Haven, CT 06510 USA.; Krumholz, HM (corresponding author), Yale Sch Med, Dept Internal Med, Robert Wood Johnson Fdn, Clin Scholars Program, New Haven, CT 06510 USA.; Krumholz, HM (corresponding author), Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06510 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020	Cloninger, Alexander/0000-0002-1423-9624; Krumholz, Harlan/0000-0003-2046-127X	National Science Foundation [DMS-1402254]	National Science Foundation(National Science Foundation (NSF))	The authors received no specific funding for this work. Angela Hsieh was a full-time employee of the Center for Outcomes Research and Evaluation at Yale University when this work was conducted, and accepte daposition at Genentech as the initial draft of this manuscript was being written. This does not alter our adherence to PLOSONE policies on sharing data and materials. Genentech had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, nor did it provide any form of financial support for any of the investigators, with the exception of the employment of Angela Hsieh outside of the time she spent on this manuscript. Alexander Cloninger was partially supported by the National Science Foundation grant DMS-1402254.	American Hospital Association, ANN SURV DAT 2013; Austin JM, 2015, HEALTH AFFAIR, V34, P423, DOI 10.1377/hlthaff.2014.0201; Cloninger A, BIGEOMETRIC ORG DEEP; Coifman R. R., 2013, YALEUDCSTR1482; Coifman RR, 2011, APPL NUMER HARMON AN, P161, DOI 10.1007/978-0-8176-8095-4_9; Healthgrades, VOIC AM BEST STRAT S; U.S. Census Bureau, TABL DP05 ACS DEM HO; U.S. Census Bureau, TABL S1901 INC PAST; U.S. News and World Report, BEST HOSP 2014 15 OV	9	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179603	10.1371/journal.pone.0179603	http://dx.doi.org/10.1371/journal.pone.0179603			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662045	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300036
J	Hansen, C; Rezzoug, N; Gorce, P; Isableu, B; Venture, G				Hansen, Clint; Rezzoug, Nasser; Gorce, Philippe; Isableu, Brice; Venture, Gentiane			Center of pressure based segment inertial parameters validation	PLOS ONE			English	Article							STATIC MULTIFINGER PREHENSION; INVERSE DYNAMICS SOLUTIONS; TORQUE PRODUCTION; TRUNK; ADJUSTMENTS; MODELS; FORCE; JOINT; IDENTIFICATION; COMPENSATION	By proposing efficient methods for estimating Body Segment Inertial Parameters' (BSIP) estimation and validating them with a force plate, it is possible to improve the inverse dynamic computations that are necessary in multiple research areas. Until today a variety of studies have been conducted to improve BSIP estimation but to our knowledge a real validation has never been completely successful. In this paper, we propose a validation method using both kinematic and kinetic parameters (contact forces) gathered from optical motion capture system and a force plate respectively. To compare BSIPs, we used the measured contact forces (Force plate) as the ground truth, and reconstructed the displacements of the Center of Pressure (COP) using inverse dynamics from two different estimation techniques. Only minor differences were seen when comparing the estimated segment masses. Their influence on the COP computation however is large and the results show very distinguishable patterns of the COP movements. Improving BSIP techniques is crucial and deviation from the estimations can actually result in large errors. This method could be used as a tool to validate BSIP estimation techniques. An advantage of this approach is that it facilitates the comparison between BSIP estimation methods and more specifically it shows the accuracy of those parameters.	[Hansen, Clint] Univ Kiel, Fac Med, Dept Neurol, Kiel, Germany; [Rezzoug, Nasser; Gorce, Philippe] Univ Toulon & Var, HandiBio, Toulon, France; [Isableu, Brice] Aix Marseille Univ, PSYCLE, Aix En Provence, France; [Venture, Gentiane] Tokyo Univ Agr & Technol, GVLab, Tokyo, Japan	University of Kiel; Universite de Toulon; UDICE-French Research Universities; Aix-Marseille Universite; Tokyo University of Agriculture & Technology	Hansen, C (corresponding author), Univ Kiel, Fac Med, Dept Neurol, Kiel, Germany.	C.Hansen@neurologie.uni-kiel.de	Rezzoug, Nasser/I-1430-2019; Hansen, Clint/J-4961-2019; Venture, Gentiane/E-7060-2013	Rezzoug, Nasser/0000-0002-8037-3522; Hansen, Clint/0000-0003-4813-3868; Venture, Gentiane/0000-0001-7767-4765	Japan Society for the Promotion of Science (JSPS/FF1/391) [PE 12509]; Land Schleswig-Holstein within the funding programme Open Access Publikationsfonds	Japan Society for the Promotion of Science (JSPS/FF1/391)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Land Schleswig-Holstein within the funding programme Open Access Publikationsfonds	This study was supported by the Japan Society for the Promotion of Science (JSPS/FF1/391 ID No. PE 12509). We acknowledge financial support by Land Schleswig-Holstein within the funding programme Open Access Publikationsfonds.	[Anonymous], [No title captured]; Atchonouglo E, 2008, PMM-J APPL MATH MEC+, V72, P22, DOI 10.1016/j.jappmathmech.2008.03.007; Ayusawa Ko, 2011, IEEE International Conference on Robotics and Automation, P6282; Bonnet V, 2015, IEEE T NEUR SYS REH, V23, P628, DOI 10.1109/TNSRE.2015.2405087; Chen SC, 2011, GAIT POSTURE, V33, P695, DOI 10.1016/j.gaitpost.2011.03.004; Clement J, 2015, J BIOMECH, V48, P3796, DOI 10.1016/j.jbiomech.2015.09.040; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; Dempster W.T., 1955, SPACE REQUIREMENT SE; Diaz-Rodriguez M, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4032997; Dumas R, 2007, J BIOMECH, V40, P543, DOI 10.1016/j.jbiomech.2006.02.013; Dumas R, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4030363; Hanavan Jr. E.P., 1964, MATH MODEL HUMAN BOD; Hansen C, 2013, COMPUT METHOD BIOMEC, V16, P72, DOI 10.1080/10255842.2013.815964; Hansen C, 2014, J BIOMECH, V47, P1577, DOI 10.1016/j.jbiomech.2014.03.004; Hoang KLH, 2015, J BIOMECH, V48, P3732, DOI 10.1016/j.jbiomech.2015.08.018; Iino Y, 2012, J APPL BIOMECH, V28, P420, DOI 10.1123/jab.28.4.420; KINGMA I, 1995, J BIOMECH, V28, P1137, DOI 10.1016/0021-9290(94)00164-Y; Kodek T, 2006, CLIN BIOMECH, V21, P710, DOI 10.1016/j.clinbiomech.2006.02.006; Ma Y, 2011, APPL ERGON, V42, P297, DOI 10.1016/j.apergo.2010.07.005; McConville JT., 1980, AFAMRLT80119; Muller A, 2015, COMPUT METHOD BIOMEC, V18, P2010, DOI 10.1080/10255842.2015.1069600; Nikolova GS, 2007, J BIOMECH, V40, P3700, DOI 10.1016/j.jbiomech.2007.06.016; Pataky TC, 2003, CLIN BIOMECH, V18, P364, DOI 10.1016/S0268-0033(03)00015-9; Pillet H, 2010, GAIT POSTURE, V31, P147, DOI 10.1016/j.gaitpost.2009.09.014; Plamondon A, 1996, CLIN BIOMECH, V11, P101, DOI 10.1016/0268-0033(95)00043-7; Rao G, 2006, J BIOMECH, V39, P1531, DOI 10.1016/j.jbiomech.2005.04.014; Riemer R, 2008, GAIT POSTURE, V27, P578, DOI 10.1016/j.gaitpost.2007.07.012; Rossi M, 2013, J SPORT SCI MED, V12, P761; Rouhandeh A, 2014, IEEE ENG MED BIO, P4342, DOI 10.1109/EMBC.2014.6944585; Silva MPT, 2004, GAIT POSTURE, V19, P35, DOI 10.1016/S0966-6362(03)00013-4; Sreenivasa M, 2016, J BIOMECH, V49, P1918, DOI 10.1016/j.jbiomech.2016.05.001; Sunaga Y, 2016, APPL ERGON, V55, P173, DOI 10.1016/j.apergo.2016.02.010; Venture G, 2009, NUMERICAL METHOD CHO, P1226; Wicke J, 2008, J BIOMECH, V41, P861, DOI 10.1016/j.jbiomech.2007.10.022; Wicke J, 2009, J BIOMECH, V42, P55, DOI 10.1016/j.jbiomech.2008.10.003; Yamane K, 2010, SPRINGER TRAC ADV RO, V66, P49; Young J, 1983, FAAM8316 FAA CIV AER; Zatsiorsky VM, 2002, BIOL CYBERN, V87, P40, DOI 10.1007/s00422-002-0320-7; Zatsiorsky VM, 2002, BIOL CYBERN, V87, P50, DOI 10.1007/s00422-002-0321-6	39	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180011	10.1371/journal.pone.0180011	http://dx.doi.org/10.1371/journal.pone.0180011			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662090	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300086
J	Mills, AJ; Milewski, AV; Snyman, D; Jordaan, JJ				Mills, Anthony J.; Milewski, Antoni V.; Snyman, Dirk; Jordaan, Jorrie J.			Effects of anabolic and catabolic nutrients on woody plant encroachment after long-term experimental fertilization in a South African savanna	PLOS ONE			English	Article							SHRUB ENCROACHMENT; PHOTOSYSTEM-II; SOIL PHOSPHATE; VEGETATION; BORON; GRASSLAND; NITROGEN; TREES; CARBON; WATER	The causes of the worldwide problem of encroachment of woody plants into grassy vegetation are elusive. The effects of soil nutrients on competition between herbaceous and woody plants in various landscapes are particularly poorly understood. A long-term experiment of 60 plots in a South African savanna, comprising annual applications of ammonium sulphate (146 +/- 1166 kg ha(-1) yr(-1)) and superphosphate (233 +/- 466 kg ha(-1) yr(-1)) over three decades, and subsequent passive protection over another three decades, during which indigenous trees encroached on different plots to extremely variable degrees, provided an opportunity to investigate relationships between soil properties and woody encroachment. All topsoils were analysed for pH, acidity, EC, water-dispersible clay, Na, Mg, K, Ca, P, S, C, N, NH4, NO3, B, Mn, Cu and Zn. Applications of ammonium sulphate (AS), but not superphosphate (SP), greatly constrained tree abundance relative to control plots. Differences between control plots and plots that had received maximal AS application were particularly marked (16.3 +/- 5.7 versus 1.2 +/- 0.8 trees per plot). Soil properties most affected by AS applications included pH (H2O) (control to maximal AS application: 6.4 +/- 0.1 to 5.1 +/- 0.2), pH (KCl) (5.5 +/- 0.2 to 4.0 +/- 0.1), acidity (0.7 +/- 0.1 to 2.6 +/- 0.3 cmol kg(-1)), acid saturation (8 +/- 2 to 40 +/- 5%), Mg (386 +/- 25 to 143 +/- 15 mg kg(-1)), Ca (1022 +/- 180 to 322 +/- 14 mg kg(-1)), Mn (314 +/- 11 to 118 +/- 9 mg kg(-1)), Cu (3.6 +/- 0.3 to 2.3 +/- 0.2 mg kg(-1)) and Zn (6.6 +/- 0.4 to 3.7 +/- 0.4 mg kg(-1)). Magnesium, B, Mn and Cu were identified using principal component analysis, boundary line analysis and Kruskal-Wallis rank sum tests as the nutrients most likely to be affecting tree abundance. The ratio Mn/Cu was most related to tree abundance across the experiment, supporting the hypothesis that competition between herbaceous and woody plants depends on the availability of anabolic relative to catabolic nutrients. These findings, based on more than six decades of experimentation, may have global significance for the theoretical understanding of changes in vegetation structure and thus the practical control of invasive woody plants.	[Mills, Anthony J.] Stellenbosch Univ, Dept Soil Sci, Stellenbosch, South Africa; [Milewski, Antoni V.] Univ Cape Town, Percy FitzPatrick Inst, DST NRF Ctr Excellence, Rondebosch, South Africa; [Snyman, Dirk] C4 EcoSolut, Tokai, Ibaraki, South Africa; [Jordaan, Jorrie J.] Univ Limpopo, Sovenga, South Africa	Stellenbosch University; National Research Foundation - South Africa; University of Cape Town; University of Limpopo	Mills, AJ (corresponding author), Stellenbosch Univ, Dept Soil Sci, Stellenbosch, South Africa.	mills@sun.ac.za	Mills, Anthony J/W-9228-2019; Mills, Anthony/AAY-6268-2021	Mills, Anthony J/0000-0001-5676-2440; 	South African Government's Department of Environmental Affairs; Natural Resources Management Programme; National Research Foundation [FA2005040700027]	South African Government's Department of Environmental Affairs; Natural Resources Management Programme; National Research Foundation	We gratefully acknowledge the South African Government's Department of Environmental Affairs, Natural Resources Management Programme, and the National Research Foundation (grant number FA2005040700027) for funding this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber J, 2003, Q REV BIOPHYS, V36, P71, DOI 10.1017/S0033583502003839; Barker A. V., 2015, Handbook of plant nutrition; BEADLE NCW, 1954, ECOLOGY, V35, P370, DOI 10.2307/1930100; BEADLE NCW, 1966, ECOLOGY, V47, P992, DOI 10.2307/1935647; BEATON J. D., 1968, Technical Bulletin. Sulphur Institute; BELSKY AJ, 1994, ECOLOGY, V75, P922, DOI 10.2307/1939416; BELSKY AJ, 1989, J APPL ECOL, V26, P1005, DOI 10.2307/2403708; Ben-Gal A, 2003, PLANT SOIL, V256, P179, DOI 10.1023/A:1026229612263; BEYERS C P D L, 1971, Agrochemophysica, V3, P49; Bingham FT, 1982, METHODS SOIL ANAL; Blanco-Macías F., 2009, Rev. Chapingo Ser.Hortic, V15, P217; Bond WJ, 2010, BIOL CONSERV, V143, P2395, DOI 10.1016/j.biocon.2009.12.012; Bond WJ, 2010, PLANT SOIL, V334, P47, DOI 10.1007/s11104-010-0440-0; Bond WJ, 2008, ANNU REV ECOL EVOL S, V39, P641, DOI 10.1146/annurev.ecolsys.39.110707.173411; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Bowman D.M, 2000, AUSTR RAINFORESTS IS, DOI DOI 10.1017/CBO9780511583490; Bowman RA, 1998, SOIL SCI, V163, P241, DOI 10.1097/00010694-199803000-00009; Brady NC, 2013, ELEMENTS NATURE PROP; Broadley M, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P191, DOI 10.1016/B978-0-12-384905-2.00007-8; Brown PH, 2002, PLANT BIOLOGY, V4, P205, DOI 10.1055/s-2002-25740; Brzezinski P, 2008, J BIOENERG BIOMEMBR, V40, P521, DOI 10.1007/s10863-008-9181-7; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Camacho-Cristobal JJ, 2008, J INTEGR PLANT BIOL, V50, P1247, DOI 10.1111/j.1744-7909.2008.00742.x; Cole M. M., 1986, The savannas, biogeography and geobotany.; COWLING RM, 1980, VEGETATIO, V43, P191, DOI 10.1007/BF00158749; Cramer MD, 2007, J ECOL, V95, P1123, DOI 10.1111/j.1365-2745.2007.01285.x; da Silva J. J. R. Frausto, 2001, BIOL CHEM ELEMENTS; Division of Chemical Services, 1956, ANAL METHODS; Dodd JR, 2005, SOIL SCI SOC AM J, V69, P1118, DOI 10.2136/sssaj2004.0279; Donaldson C. H., 1984, Journal of the Grassland Society of Southern Africa, V1, P27; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Du Plessis SF, 1964, S AFR J AGR SCI, V8, P1113; Duce RA, 2008, SCIENCE, V320, P893, DOI 10.1126/science.1150369; Eaton T.E., 2015, HDB PLANT NUTR, P427; Eldridge DJ, 2011, ECOL LETT, V14, P709, DOI 10.1111/j.1461-0248.2011.01630.x; Fageria NK, 2010, COMMUN SOIL SCI PLAN, V41, P1565, DOI 10.1080/00103624.2010.485237; Farley RA, 1999, J ECOL, V87, P688, DOI 10.1046/j.1365-2745.1999.00390.x; Fey MV., 2010, SOILS S AFRICA; Fleischer A, 1999, PLANT PHYSIOL, V121, P829, DOI 10.1104/pp.121.3.829; FREDEEN AL, 1989, PLANT PHYSIOL, V89, P225, DOI 10.1104/pp.89.1.225; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Garrison VH, 2003, BIOSCIENCE, V53, P469, DOI 10.1641/0006-3568(2003)053[0469:AAADFD]2.0.CO;2; Gibbens RP, 2005, J ARID ENVIRON, V61, P651, DOI 10.1016/j.jaridenv.2004.10.001; GOODLAND R, 1973, J ECOL, V61, P219, DOI 10.2307/2258929; Goussias C, 2002, PHILOS T R SOC B, V357, P1369, DOI 10.1098/rstb.2002.1134; GRAHAM RD, 1980, Z PFLANZ BODENKUNDE, V143, P161, DOI 10.1002/jpln.19801430205; Grzebisz W., 2015, HDB PLANT NUTR, P199; Gupta U. C., 1979, Journal of Agronomy, V31, P273; HARIDASAN M, 1992, NATURE AND DYNAMICS OF FOREST-SAVANNA BOUNDARIES, P171; Havlin J, 2005, SOIL FERTILITY SOIL; HOPKINS W. G., 2008, INTRO PLANT PHYSL, VFourth; Jiao WT, 2012, ENVIRON POLLUT, V168, P44, DOI 10.1016/j.envpol.2012.03.052; Jordaan JJ, 2010, AFR J RANGE FOR SCI, V27, P105, DOI 10.2989/10220119.2010.502650; KELLMAN M, 1979, J ECOL, V67, P565, DOI 10.2307/2259112; Knapp AK, 2008, GLOBAL CHANGE BIOL, V14, P615, DOI 10.1111/j.1365-2486.2007.01512.x; Kramer U, 2006, MOL BIOL METAL HOMEO, P216; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lane N., 2010, LIFE ASCENDING 10 GR, VReprint; Lane N., 2010, WHY ARE CELLS POWERE; Lee D, 1996, COMMUN SOIL SCI PLAN, V27, P783, DOI 10.1080/00103629609369595; Lloyd J, 2008, TREE PHYSIOL, V28, P451, DOI 10.1093/treephys/28.3.451; LOUW A. J., 1966, S AFRICAN J AGR SCI, V9, P173; Maestre FT, 2009, ECOL LETT, V12, P930, DOI 10.1111/j.1461-0248.2009.01352.x; Marschner H., 2012, MINERAL NUTR HIGHER, P226; MCLEAN EO, 1983, AGRON J, V75, P635, DOI 10.2134/agronj1983.00021962007500040014x; Milewski AV, 2015, S AFR J BOT; Mills AJ, 2004, GEODERMA, V121, P45, DOI 10.1016/j.geoderma.2003.10.004; Mills AJ, 2006, BIOSCIENCE, V56, P579, DOI 10.1641/0006-3568(2006)56[579:AFFETD]2.0.CO;2; Mills AJ, 2016, AUSTRAL ECOL, V41, P927, DOI 10.1111/aec.12385; Mills AJ, 2012, GEODERMA, V189, P124, DOI 10.1016/j.geoderma.2012.05.006; Milne AE, 2006, ANN APPL BIOL, V149, P223, DOI 10.1111/j.1744-7348.2006.00086.x; Mortvedt J. J., 2000, HDB SOIL SCI, pD71; Mucina L., 2006, VEGETATION S AFRICA; Murovhi R. N., 2006, Southern African Forestry Journal, P23; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Noble J.C., 1998, DELICATE NOXIOUS SCR; OCONNOR TG, 1995, OECOLOGIA, V103, P214, DOI 10.1007/BF00329083; Pilbeam DJ., 2015, HDB PLANT NUTR, P305, DOI DOI 10.1201/B18458-11; R Core Team, 2021, R LANGUAGE ENV STAT; Rerkasem B, 2004, FIELD CROP RES, V89, P173, DOI 10.1016/j.fcr.2004.01.022; SANBI (South African National Biodiversity Institute), 2016, VEG MAP S AFR LES SW; Scholes RJ, 2015, NPP GRASSLAND NPP GR; Scholes RJ, 1993, NYLSVLEY STUDY AFRIC; SETA AK, 1996, GEODERMA, V74, P255; Shorrocks VM, 1997, PLANT SOIL, V193, P121, DOI 10.1023/A:1004216126069; Sims JT, 2000, HDB SOIL SCI, pD; Soil Classification Working Group, 1991, MEM AGR NAT RESOUR S, V15, P1; Specht R.L., 1979, P1; SPECHT RL, 1983, ECOL STUD, V43, P41; Sprengel C., 1828, J TECHNISCHE OKONOMI, V2, P423; Sumner M.E., 2000, HDB SOIL SCI; The Non-Affiliated Soil Analysis Work Committee, 1990, HDB STAND SOIL TEST; TRIERWEILER JF, 1969, SOIL SCI SOC AM PRO, V33, P49, DOI 10.2136/sssaj1969.03615995003300010017x; Trotter M, 2014, CROP PASTURE SCI, V65, P817, DOI 10.1071/CP13449; Van Auken OW, 2009, J ENVIRON MANAGE, V90, P2931, DOI 10.1016/j.jenvman.2009.04.023; Van Auken OW, 2000, ANNU REV ECOL SYST, V31, P197, DOI 10.1146/annurev.ecolsys.31.1.197; Van Oudtshoorn FV., 1999, GUIDE GRASSES SO AFR; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; von Liebig J., 1855, RELATIONS CHEM AGR A; Wakeling JL, 2010, PLANT SOIL, V336, P173, DOI 10.1007/s11104-010-0457-4; Walkley A, 1935, J AGR SCI, V25, P598, DOI 10.1017/S0021859600019687; Ward D, 2010, PLANT ECOL, V209, P147, DOI 10.1007/s11258-010-9731-z; WEBB LJ, 1969, J ECOL, V57, P817, DOI 10.2307/2258502; WESTOBY M, 1988, BIOSCIENCE, V38, P549, DOI 10.2307/1310763; WHITTAKER R H, 1975, P385; Wiegand K, 2006, PERSPECT PLANT ECOL, V7, P229, DOI 10.1016/j.ppees.2005.10.001; YEOMANS JC, 1991, COMMUN SOIL SCI PLAN, V22, P843, DOI 10.1080/00103629109368458; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	108	6	6	6	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179848	10.1371/journal.pone.0179848	http://dx.doi.org/10.1371/journal.pone.0179848			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662068	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300058
J	Ruiz-Rodriguez, M; Moller, AP; Mousseau, TA; Soler, JJ				Ruiz-Rodriguez, Magdalena; Moller, Anders P.; Mousseau, Timothy A.; Soler, Juan J.			Capacity of blood plasma is higher in birds breeding in radioactively contaminated areas	PLOS ONE			English	Article							LOW-DOSE RADIATION; BARN SWALLOWS; NATURAL ANTIBODIES; IONIZING-RADIATION; CHERNOBYL; CONSEQUENCES; COMPLEMENT; VIRULENCE; POLLUTION; EXPOSURE	Background Environmental pollution in general, and radioactive contamination in particular, may deeply affect host-parasite relationships and their consequences for the evolution of organisms. The nuclear accident that occurred more than 30 years ago in Chernobyl resulted in significant changes in diversity and richness of microbial communities that could influence characteristics of animal-bacteria interactions, including host immune responses and competitive interference by bacteria. Given the high mortality rate of birds breeding in radioactively contaminated zones, those with stronger defences against infections should experience significant fitness advantages. Methodology/Principal Findings Here we characterized antimicrobial capacity of barn swallows (Hirundo rustica) from different Ukrainian populations (subject to a gradient of ionizing radiation) against 12 bacterial species. We also quantified constitutive innate immunity, which is the non-specific first barrier of protection of hosts against microbial parasites. We found a positive association between specific antimicrobial capacity of individual hosts and radiation levels in breeding habitats even after controlling for other confounding variables such as sex and age. However, no significant relationship was found between immunocompetence (non-specific response) and background radiation. Conclusions/Significance These results suggest that radiation selects for broad antimicrobial spectra of barn swallows, although not for all bacterial strains. We discuss these results in the framework of host-parasite evolution under extreme environmental conditions.	[Ruiz-Rodriguez, Magdalena; Soler, Juan J.] CSIC, Estn Expt Zonas Aridas, Dept Ecol Func & Evolut, La Canada De San Urbano, Almeria, Spain; [Ruiz-Rodriguez, Magdalena; Moller, Anders P.] Univ Paris Saclay, AgroParisTech, Univ Paris Sud, Ecol Syst Evolut,CNRS, Orsay, France; [Mousseau, Timothy A.] Univ South Carolina, Dept Biol Sci, Columbia, SC 29208 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA); AgroParisTech; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of South Carolina System; University of South Carolina Columbia	Ruiz-Rodriguez, M (corresponding author), CSIC, Estn Expt Zonas Aridas, Dept Ecol Func & Evolut, La Canada De San Urbano, Almeria, Spain.; Ruiz-Rodriguez, M (corresponding author), Univ Paris Saclay, AgroParisTech, Univ Paris Sud, Ecol Syst Evolut,CNRS, Orsay, France.	magda@eeza.csic.es	Ruiz-Rodríguez, Magdalena/AAZ-6384-2021; Ruiz-Rodríguez, Magdalena/D-4226-2014; Mousseau, Timothy A/A-1253-2011; Moller, Anders/O-6665-2016; Soler, J. J./H-2363-2011	Ruiz-Rodríguez, Magdalena/0000-0002-4202-5180; Ruiz-Rodríguez, Magdalena/0000-0002-4202-5180; Moller, Anders/0000-0003-3739-4675; Soler, J. J./0000-0003-2990-1489; Mousseau, Timothy/0000-0002-2235-4868	Samuel Freeman Charitable Trust; US Fulbright Program; CNRS (France); American Council of Learned Societies; University of South Carolina College of Arts and Sciences; Spanish Ministerio de Economia y Competitividad European funds (FEDER) [CGL2013-48193-C3-1-P]; program "AndalucoAaTalentHub" (Agencia Andaluzadel Conocimiento, Junta de Andalucia)	Samuel Freeman Charitable Trust; US Fulbright Program; CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); American Council of Learned Societies; University of South Carolina College of Arts and Sciences; Spanish Ministerio de Economia y Competitividad European funds (FEDER); program "AndalucoAaTalentHub" (Agencia Andaluzadel Conocimiento, Junta de Andalucia)(Junta de Andalucia)	M.Ruiz-Rodriguez had a postdoc stipend from the program "AndalucoAaTalentHub" (Agencia Andaluzadel Conocimiento, Junta de Andalucia). Funding was provided in part by the Samuel Freeman Charitable Trust, the US Fulbright Program, the CNRS (France), the American Council of Learned Societies, the University of South Carolina College of Arts and Sciences, and the Spanish Ministerio de Economia y Competitividad European funds (FEDER)) (CGL2013-48193-C3-1-P).	Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Balbontin J, 2015, ECOLOGY, V96, P948, DOI 10.1890/14-1274.1; Benyacoub J, 2014, BENEF MICROBES, V5, P129, DOI 10.3920/BM2013.0014; Bonisoli-Alquati A, 2010, COMP BIOCHEM PHYS C, V151, P271, DOI 10.1016/j.cbpc.2009.11.006; Bonisoli-Alquati A, 2010, COMP BIOCHEM PHYS A, V155, P205, DOI 10.1016/j.cbpa.2009.10.041; Brown SP, 2012, TRENDS MICROBIOL, V20, P336, DOI 10.1016/j.tim.2012.04.005; Camplani A, 1999, P ROY SOC B-BIOL SCI, V266, P1111, DOI 10.1098/rspb.1999.0751; Carroll MC, 1998, CURR OPIN IMMUNOL, V10, P36; Clark NJ, 2014, INT J PARASITOL, V44, P329, DOI 10.1016/j.ijpara.2014.01.004; Copplestone D, 2004, J ENVIRON RADIOACTIV, V74, P31, DOI 10.1016/j.jenvrad.2004.01.020; Czirjak GA, 2010, MICROB ECOL, V60, P373, DOI 10.1007/s00248-010-9716-4; Eeva T, 2005, OECOLOGIA, V145, P629, DOI 10.1007/s00442-005-0145-x; Eeva T, 2013, PARASITOLOGY, V140, P1384, DOI 10.1017/S0031182013000796; Ferreira M, 2016, FOOD REV INT, V32, P377, DOI 10.1080/87559129.2015.1094816; Flannagan RS, 2015, PATHOGENS, V4, P826, DOI 10.3390/pathogens4040826; Galvan I, 2014, FUNCT ECOL, V28, P1387, DOI 10.1111/1365-2435.12283; Gupta R, 2006, APPL MICROBIOL BIOT, V70, P21, DOI 10.1007/s00253-005-0239-8; HAMMOND CW, 1960, P SOC EXP BIOL MED, V104, P261; Hammond CW, 1959, RADIAT RES, V11, P242; Hu QH, 2010, J ENVIRON RADIOACTIV, V101, P426, DOI 10.1016/j.jenvrad.2008.08.004; Jaakohuhta S, 2007, INT J FOOD MICROBIOL, V114, P288, DOI 10.1016/j.ijfoodmicro.2006.09.025; Ksiazek A, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0684; Larsson CM, 2008, J ENVIRON RADIOACTIV, V99, P1364, DOI 10.1016/j.jenvrad.2007.11.019; Martin LB, 2008, PHILOS T R SOC B, V363, P321, DOI 10.1098/rstb.2007.2142; Matson KD, 2005, DEV COMP IMMUNOL, V29, P275, DOI 10.1016/j.dci.2004.07.006; McGarigal K., 2000, MULTIVARIATE STAT WI; Mironenko NV, 2000, ECOTOX ENVIRON SAFE, V45, P177, DOI 10.1006/eesa.1999.1848; Moller AP, 2007, BIOLOGY LETT, V3, P483, DOI 10.1098/rsbl.2007.0226; Moller AP, 2013, BIOL REV, V88, P226, DOI 10.1111/j.1469-185X.2012.00249.x; Moller AP, 2007, FUNCT ECOL, V21, P363, DOI 10.1111/j.1365-2435.2006.01215.x; Moller AP, 2012, OECOLOGIA, V170, P1155, DOI 10.1007/s00442-012-2374-0; Moller AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035223; Moller AP, 2006, TRENDS ECOL EVOL, V21, P200, DOI 10.1016/j.tree.2006.01.008; Moller AP, 2005, J ANIM ECOL, V74, P1102, DOI 10.1111/j.1365-2656.2005.01009.x; Moller AP., 1994, SEXUAL SELECTION BAR; Mollert AP, 2016, TRENDS ECOL EVOL, V31, P281, DOI 10.1016/j.tree.2016.01.005; Morley NJ, 2012, J ENVIRON RADIOACTIV, V106, P81, DOI 10.1016/j.jenvrad.2011.12.019; Mousseau TA, 2014, J HERED, V105, P704, DOI 10.1093/jhered/esu040; Murphy K, 2008, JANEWAYS IMMUNOBIOLO; Ochsenbein AF, 2000, IMMUNOL TODAY, V21, P624, DOI 10.1016/S0167-5699(00)01754-0; Pike N, 2011, METHODS ECOL EVOL, V2, P278, DOI 10.1111/j.2041-210X.2010.00061.x; Porcheron G, 2015, VET MICROBIOL, V179, P2, DOI 10.1016/j.vetmic.2015.03.024; Poulin R, 2011, TRENDS PARASITOL, V27, P355, DOI 10.1016/j.pt.2011.05.003; Quillfeldt P, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-26; Ragon M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021764; Romanovskaya VA, 1998, MICROBIOLOGY+, V67, P226; Rozalski A, 1997, MICROBIOL MOL BIOL R, V61, P65; Ruiz-Gonzalez MX, 2016, SCI REP-UK, V6, DOI 10.1038/srep22969; Ruiz-Rodriguez M, 2016, SCI NAT-HEIDELBERG, V103, DOI 10.1007/s00114-016-1397-5; Saino N, 2003, J EVOLUTION BIOL, V16, P1127, DOI 10.1046/j.1420-9101.2003.00616.x; Simkova A, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0438-6; Skrypnyk A., 2008, P 18 EUR C CLIN MICR; Smith J.T., 2005, CHERNOBYL CATASTROPH; Statsoft Inc, 2005, STATISTICA DAT AN SO; Thompson JN, 1999, AM NAT, V153, pS1, DOI 10.1086/303208; THORNTON BP, 1994, J IMMUNOL, V152, P1727; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Weis JS, 2011, BIOSCIENCE, V61, P375, DOI 10.1525/bio.2011.61.5.6; Weller R, 2009, VET ITAL, V45, P225; Yablokov AV, 2009, ANN NY ACAD SCI, V1181, P237, DOI [10.1111/j.1749-6632.2009.04832.x, 10.1111/j.1749-6632.2009.04830.x]; Yablokov AV, 2009, ANN NY ACAD SCI, V1181, P58, DOI 10.1111/j.1749-6632.2009.04822.x; Yuen GJ, 2014, J MICROBIOL, V52, P200, DOI 10.1007/s12275-014-4011-6; Zhdanova NN, 2000, MYCOL RES, V104, P1421, DOI 10.1017/S0953756200002756	64	1	1	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179209	10.1371/journal.pone.0179209	http://dx.doi.org/10.1371/journal.pone.0179209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662048	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300017
J	Urvanegia, AC; Braga, JCT; Shitara, D; Fregnani, JH; Neves, JI; Pinto, CA; Marghoob, AA; Duprat, JP; Rezze, GG				Urvanegia, Ana Claudia; Tavoloni Braga, Juliana Casagrande; Shitara, Danielle; Fregnani, Jose Humberto; Neves, Jose Ivanildo; Pinto, Clovis Antonio; Marghoob, Ashfaq A.; Duprat, Joao Pedreira; Rezze, Gisele Gargantini			Reflectance confocal microscopy features of BRAF V600E mutated thin melanomas detected by immunohistochemistry	PLOS ONE			English	Article							METASTATIC MELANOMA; DIAGNOSTIC-ACCURACY; MELANOCYTIC NEVI; DERMOSCOPY; PATHWAYS; CELLS	The classification of melanoma into four histological subtypes has been questioned regarding its clinical validity in providing relevant information for treatment for metastatic tumors. Specific genetic alterations are associated with particular clinical and histopathological features, suggesting that these could be helpful in refining existing melanoma classification schemes. We analyzed BRAF V600E mutated melanomas to explore the Reflectance confocal microscopy (RCM) utility as a screening aid in the evaluation of the most appropriate patients for genetic testing. Thus, 32 melanomas were assessed regarding their BRAF V600E mutational status. Experts blinded to dermoscopic images and V600E immunohistochemistry results evaluated RCM images regarding previously described melanoma features. BRAF positive melanomas were related to younger age (p = 0.035), invasive melanomas (p = 0.03) and to the presence of hiporreflective cells (p = 0.02), epidermal nests (p = 0.02), dermal-epidermal junction nests (p = 0.05), edged papillae (p = 0.05), and bright dots (p = 0.05), and to absence of junctional thickening due to isolated cells (p = 0.01) and meshwork (p = 0.02). This study can not characterize other mutations in the BRAF, because the immunohistochemistry is specific to the type V600E. The findings should encourage the genetic evaluation of BRAF mutation. This study highlights the potential of RCM as a supplementary tool in the screening of BRAF-mutated melanomas.	[Urvanegia, Ana Claudia; Tavoloni Braga, Juliana Casagrande; Duprat, Joao Pedreira; Rezze, Gisele Gargantini] AC Camargo Canc Ctr, Cutaneous Oncol Dept, Sao Paulo, Brazil; [Tavoloni Braga, Juliana Casagrande; Shitara, Danielle; Rezze, Gisele Gargantini] Dermaimage Med Associates, Sao Paulo, Brazil; [Fregnani, Jose Humberto] Barretos Canc Hosp, Teaching & Res Inst, Sao Paulo, Brazil; [Neves, Jose Ivanildo; Pinto, Clovis Antonio] AC Camargo Canc Ctr, Anat Pathol Dept, Sao Paulo, Brazil; [Marghoob, Ashfaq A.] Mem Sloan Kettering Skin Canc Ctr, Dermatol Serv, New York, NY USA	A.C.Camargo Cancer Center; Hospital de Cancer de Barretos; A.C.Camargo Cancer Center; Memorial Sloan Kettering Cancer Center	Rezze, GG (corresponding author), AC Camargo Canc Ctr, Cutaneous Oncol Dept, Sao Paulo, Brazil.; Rezze, GG (corresponding author), Dermaimage Med Associates, Sao Paulo, Brazil.	ggrezze@hotmail.com	Fregnani, José H/H-4238-2012; Braga, Juliana/M-2997-2014; Duprat, Joao P/I-4198-2015	Fregnani, José H/0000-0002-5235-6469; Braga, Juliana/0000-0002-1378-6992; Duprat, Joao P/0000-0001-8968-4506; Machado Urvanegia, Ana Claudia/0000-0002-8987-8156	FAPESP (Sao Paulo Research Foundation/Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2012/13090-5]	FAPESP (Sao Paulo Research Foundation/Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was funded by Grants from FAPESP (Sao Paulo Research Foundation/Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) process number 2012/13090-5,URL:http://WWW.fapesp.br/, to JPD	Benati E, 2015, BRIT J DERMATOL, V173, P1232, DOI 10.1111/bjd.14049; Capper D, 2011, ACTA NEUROPATHOL, V122, P11, DOI 10.1007/s00401-011-0841-z; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Flaherty KT, 2011, CLIN CANCER RES, V17, P4922, DOI 10.1158/1078-0432.CCR-10-2612; Gill M, 2005, J AM ACAD DERMATOL, V53, P108, DOI 10.1016/j.jaad.2005.04.013; Giovanni P, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/671283; Langley RGB, 2007, DERMATOLOGY, V215, P365, DOI 10.1159/000109087; Long E, 2015, J EUR ACAD DERMATOL, V29, P2436, DOI 10.1111/jdv.13332; Long GV, 2013, AM J SURG PATHOL, V37, P61, DOI 10.1097/PAS.0b013e31826485c0; Longo C, 2011, J AM ACAD DERMATOL, V65, P604, DOI 10.1016/j.jaad.2010.10.035; Losi A, 2014, BRIT J DERMATOL, V171, P48, DOI 10.1111/bjd.12781; Marchetti MA, 2014, BRIT J DERMATOL, V171, P1060, DOI 10.1111/bjd.13260; Menzies AM, 2012, CLIN CANCER RES, V18, P3242, DOI 10.1158/1078-0432.CCR-12-0052; Pan Zhan-Yan, 2012, J Am Acad Dermatol, V66, pe47, DOI 10.1016/j.jaad.2010.09.722; Pellacani G, 2005, BRIT J DERMATOL, V152, P384, DOI 10.1111/j.1365-2133.2005.06348.x; Pellacani G, 2007, J INVEST DERMATOL, V127, P2759, DOI 10.1038/sj.jid.5700993; Pellacani G, 2014, EXP DERMATOL, V23, P414, DOI 10.1111/exd.12417; Pellacani G, 2012, J AM ACAD DERMATOL, V66, pE109, DOI 10.1016/j.jaad.2011.05.017; Ponti G, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/246751; Pozzobon FC, 2014, BRIT J DERMATOL, V171, P754, DOI 10.1111/bjd.13069; Rezze GG, 2015, ATLAS MICROSCOPIA CO; Ruini C, 2015, MELANOMA RES, V25, P367, DOI 10.1097/CMR.0000000000000147; Shitara D, 2015, BRIT J DERMATOL, V173, P671, DOI 10.1111/bjd.13829; Singh M, 2008, BRIT J DERMATOL, V158, P15, DOI 10.1111/j.1365-2133.2007.08316.x; Braga JCT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081205; Tschandl P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069639; Viros A, 2008, PLOS MED, V5, P941, DOI 10.1371/journal.pmed.0050120; Whiteman DC, 2011, PIGM CELL MELANOMA R, V24, P879, DOI 10.1111/j.1755-148X.2011.00880.x; Whiteman DC, 2003, J NATL CANCER I, V95, P806, DOI 10.1093/jnci/95.11.806; Zalaudek I, 2008, AM J DERMATOPATH, V30, P402, DOI 10.1097/DAD.0b013e3181734e9a; Zalaudek I, 2011, J INVEST DERMATOL, V131, P542, DOI 10.1038/jid.2010.332	31	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179745	10.1371/journal.pone.0179745	http://dx.doi.org/10.1371/journal.pone.0179745			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662062	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300045
J	Zhong, NF; Dai, QF; Liang, RS; Li, XP; Tan, XP; Zhang, XM; Wei, ZC; Wang, FQ; Liu, HZ; Meng, HY				Zhong, Nianfa; Dai, Qiaofeng; Liang, Ruisheng; Li, Xianping; Tan, Xiaopei; Zhang, Xiaomeng; Wei, Zhongchao; Wang, Faqiang; Liu, Hongzhan; Meng, Hongyun			Analogue of electromagnetically induced absorption with double absorption windows in a plasmonic system	PLOS ONE			English	Article							INDUCED TRANSPARENCY	We report the observation of an analog of double electromagnetically induced absorption (EIA) in a plasmonic system consisting of two disk resonators side-coupled to a discrete metal-insulator-metal (MIM) waveguide. The finite-difference time-domain (FDTD) simulation calculations show that two absorption windows are obtained and can be easily tuned by adjusting the parameters of the two resonance cavities. The consistence between the coupled-model theory and FDTD simulation results verify the feasibility of the proposed system. Since the scheme is easy to be fabricated, our proposed configuration may thus be applied to narrow-band filtering, absorptive switching, and absorber applications.	[Zhong, Nianfa; Dai, Qiaofeng; Liang, Ruisheng; Li, Xianping; Tan, Xiaopei; Zhang, Xiaomeng; Wei, Zhongchao; Wang, Faqiang; Liu, Hongzhan; Meng, Hongyun] South China Normal Univ, Sch Informat & Optoelect Sci & Engn, Guangzhou Key Lab Special Fiber Photon Devices, Guangzhou, Guangdong, Peoples R China	South China Normal University	Dai, QF; Wei, ZC (corresponding author), South China Normal Univ, Sch Informat & Optoelect Sci & Engn, Guangzhou Key Lab Special Fiber Photon Devices, Guangzhou, Guangdong, Peoples R China.	daiqf@scnu.edu.cn; wzc@scnu.edu.cn	Wei, Zhongchao/V-7626-2017	Wei, Zhongchao/0000-0003-3586-2180	National Natural Science Foundation of China (NSFC) [61275059, 11374107, 61475049, 11674109]; Natural Science Foundation of Guangdong Province, China [2016A030313851, 2016A030313443]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (NSFC) under Grant Nos. 61275059, 11374107, 61475049, 11674109 and the Natural Science Foundation of Guangdong Province, China under Grant Nos. 2016A030313851, 2016A030313443	Bozhevolnyi SI, 2006, NATURE, V440, P508, DOI 10.1038/nature04594; Cao GT, 2014, OPT LETT, V39, P216, DOI 10.1364/OL.39.000216; Guo J, 2014, APPL OPTICS, V53, P1604, DOI 10.1364/AO.53.001604; Han ZH, 2011, OPT EXPRESS, V19, P3251, DOI 10.1364/OE.19.003251; HAUS HA, 1991, P IEEE, V79, P1505, DOI 10.1109/5.104225; He JN, 2015, OPT EXPRESS, V23, P6083, DOI 10.1364/OE.23.006083; Huang Y, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3647951; Lai G, 2015, OPT EXPRESS, V23, P6554, DOI 10.1364/OE.23.006554; Lezama A, 1999, PHYS REV A, V59, P4732, DOI 10.1103/PhysRevA.59.4732; Li G.-Z., 2015, EVIDENCE BASED COMPL, V2015, P1, DOI DOI 10.1155/2015/720706; Li H-J, 2016, APPL PHYS EXPRESS, V9, DOI DOI 10.7567/APEX.9.012001; Liu DD, 2016, AIP ADV, V6, DOI 10.1063/1.4942937; Lu H, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.053803; Okamoto K, 2016, SCI REP-UK, V6, DOI 10.1038/srep36165; Piao X, 2012, OPT EXPRESS, V20, P18994, DOI 10.1364/OE.20.018994; Rakic AD, 1998, APPL OPTICS, V37, P5271, DOI 10.1364/AO.37.005271; Shi SS, 2015, J APPL PHYS, V118, DOI 10.1063/1.4932668; Taubert R, 2012, NANO LETT, V12, P1367, DOI 10.1021/nl2039748; Wei ZC, 2017, PLASMONICS, V12, P641, DOI 10.1007/s11468-016-0309-z; Yu DM, 2016, APPL PHYS EXPRESS, V9, DOI 10.7567/APEX.9.054301; Yun BF, 2014, OPT EXPRESS, V22, P28662, DOI 10.1364/OE.22.028662; Zhang S, 2008, PHYS REV LETT; Zhang X, 2016, PLASMONICS; Zhang XY, 2015, SCI REP-UK, V5, DOI [10.1038/srep09940, 10.1038/srep09803]	24	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179609	10.1371/journal.pone.0179609	http://dx.doi.org/10.1371/journal.pone.0179609			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662059	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300039
J	Beaujean, O; Locri, F; Aronsson, M; Kvanta, A; Andre, H				Beaujean, Ophelie; Locri, Filippo; Aronsson, Monica; Kvanta, Anders; Andre, Helder			A novel in vivo model of puncture-induced iris neovascularization	PLOS ONE			English	Article							CHOROIDAL NEOVASCULARIZATION; ANGIOGENESIS; RETINOPATHY; MOUSE; CELLS; EYE	Purpose To assess iris neovascularization by uveal puncture of the mouse eye and determine the role of angiogenic factors during iris neovascularization. Methods Uveal punctures were performed on BalbC mouse eyes to induce iris angiogenesis. VEGF-blockage was used as an anti-angiogenic treatment, while normoxia-and hypoxia-conditioned media from retinal pigment epithelium (RPE) cells was used as an angiogenic-inducer in this model. Iris vasculature was determined in vivo by noninvasive methods. Iris blood vessels were stained for platelet endothelial cell adhesion molecule-1 and vascular sprouts were counted as markers of angiogenesis. Expression of angiogenic and inflammatory factors in the puncture-induced model were determined by qPCR and western blot. Results Punctures led to increased neovascularization and sprouting of the iris. qPCR and protein analysis showed an increase of angiogenic factors, particularly in the plasminogen-activating receptor and inflammatory systems. VEGF-blockage partly reduced iris neovascularization, and treatment with hypoxia-conditioned RPE medium led to a statistically significant increase in iris neovascularization. Conclusions This study presents the first evidence of a puncture-induced iris angiogenesis model in the mouse. In a broader context, this novel in vivo model of neovascularization has the potential for noninvasive evaluation of angiogenesis modulating substances.	[Beaujean, Ophelie; Locri, Filippo; Aronsson, Monica; Kvanta, Anders; Andre, Helder] Karolinska Inst, St Erik Eye Hosp, Sect Eye & Vis, Dept Clin Neurosci, Stockholm, Sweden	Karolinska Institutet	Andre, H (corresponding author), Karolinska Inst, St Erik Eye Hosp, Sect Eye & Vis, Dept Clin Neurosci, Stockholm, Sweden.	helder.andre@ki.se	Andre, Helder/AAC-5220-2019	Andre, Helder/0000-0002-2926-2376	Regne Ars Foundation for Research in Eye Diseases; Swedish Eye Foundation; Cronqvist Foundation; Karolinska Institutet; Erasmus Trainee scholarship	Regne Ars Foundation for Research in Eye Diseases; Swedish Eye Foundation; Cronqvist Foundation; Karolinska Institutet(Karolinska Institutet); Erasmus Trainee scholarship	The presented work was supported by grants from the Regne Ars Foundation for Research in Eye Diseases, the Swedish Eye Foundation, the Cronqvist Foundation, and the Karolinska Institutet; Ophelie Beauhean was partly supported by an Erasmus Trainee scholarship.	Adair T.H, 2010, ANGIOGENESIS C SERIE, P1; Andre H, 2015, INVEST OPHTH VIS SCI, V56, P6591, DOI 10.1167/iovs.15-16476; Baldock R, 2015, KAUFMANS ATLAS MOU S; Besharse J., 2010, ENCY EYE; Cammalleri M, 2016, INVEST OPHTH VIS SCI, V57, P2586; Dorrell M, 2007, SURV OPHTHALMOL, V52, pS3, DOI 10.1016/j.survophthal.2006.10.017; Eming SA, 2007, PROG HISTOCHEM CYTO, V42, P115, DOI 10.1016/j.proghi.2007.06.001; Forooghian F, AM J OPHTHALMOL; Forooghian F, 2007, BRIT J OPHTHALMOL, V91, DOI 10.1136/bjo.2007.123125; ISHIBASHI T, 1995, ARCH OPHTHALMOL-CHIC, V113, P227, DOI 10.1001/archopht.1995.01100020111041; Jeong YC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160662; Kleinstreuer NC, 2011, ENVIRON HEALTH PERSP, V119, P1596, DOI 10.1289/ehp.1103412; Kvanta A, 2006, ACTA OPHTHALMOL SCAN, V84, P282, DOI 10.1111/j.1600-0420.2006.00659.x; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Salman AG, 2013, OPHTHALMIC RES, V49, P20, DOI 10.1159/000341734; Scott A, 2010, EYE, V24, P416, DOI 10.1038/eye.2009.306; Speier S, 2008, NAT PROTOC, V3, P1278, DOI 10.1038/nprot.2008.118; Takei A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42546; Tkatchenko TV, 2010, INVEST OPHTH VIS SCI, V51, P21, DOI 10.1167/iovs.08-2767; Tolentino MJ, 1996, ARCH OPHTHALMOL-CHIC, V114, P964, DOI 10.1001/archopht.1996.01100140172010; Uhrin P, 2013, CELL ADHES MIGR, V7, P23, DOI 10.4161/cam.22124; Yang HF, 2015, EXP EYE RES, V140, P106, DOI 10.1016/j.exer.2015.08.025	22	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180235	10.1371/journal.pone.0180235	http://dx.doi.org/10.1371/journal.pone.0180235			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658313	Green Submitted, Green Published, gold			2022-12-27	WOS:000404607900068
J	Helwig, NE; Sohre, NE; Ruprecht, MR; Guy, SJ; Lyford-Pike, S				Helwig, Nathaniel E.; Sohre, Nick E.; Ruprecht, Mark R.; Guy, Stephen J.; Lyford-Pike, Sofia			Dynamic properties of successful smiles	PLOS ONE			English	Article							FACIAL ATTRACTIVENESS; EMOTIONAL EXPRESSION; MODELS; ASYMMETRY; SYMMETRY; FACES; BEAUTY; NERVE	Facial expression of emotion is a foundational aspect of social interaction and nonverbal communication. In this study, we use a computer-animated 3D facial tool to investigate how dynamic properties of a smile are perceived. We created smile animations where we systematically manipulated the smile's angle, extent, dental show, and dynamic symmetry. Then we asked a diverse sample of 802 participants to rate the smiles in terms of their effectiveness, genuineness, pleasantness, and perceived emotional intent. We define a "successful smile" as one that is rated effective, genuine, and pleasant in the colloquial sense of these words. We found that a successful smile can be expressed via a variety of different spatiotemporal trajectories, involving an intricate balance of mouth angle, smile extent, and dental show combined with dynamic symmetry. These findings have broad applications in a variety of areas, such as facial reanimation surgery, rehabilitation, computer graphics, and psychology.	[Helwig, Nathaniel E.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Helwig, Nathaniel E.; Ruprecht, Mark R.] Univ Minnesota, Sch Stat, Minneapolis, MN 55455 USA; [Sohre, Nick E.; Guy, Stephen J.] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA; [Lyford-Pike, Sofia] Univ Minnesota, Dept Otolaryngol Head & Neck Surg, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Helwig, NE (corresponding author), Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA.; Helwig, NE (corresponding author), Univ Minnesota, Sch Stat, Minneapolis, MN 55455 USA.; Guy, SJ (corresponding author), Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA.; Lyford-Pike, S (corresponding author), Univ Minnesota, Dept Otolaryngol Head & Neck Surg, Minneapolis, MN 55455 USA.	helwig@umn.edu; sjguy@cs.umn.edu; lyfor009@umn.edu		Helwig, Nathaniel/0000-0003-2907-1497; Guy, Stephen/0000-0001-8986-5817	University of Minnesota	University of Minnesota(University of Minnesota System)	This work was supported by faculty startup funds from the University of Minnesota (NEH, SJG, SL-P).	Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2021, LANG ENV STAT COMP; Bae YC, 2006, PLAST RECONSTR SURG, V117, P2407, DOI 10.1097/01.prs.0000218798.95027.21; Bhuvaneswaran Mohan, 2010, J Conserv Dent, V13, P225, DOI 10.4103/0972-0707.73387; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohn J. F., 2004, INT J WAVELETS MULTR, V2, P121, DOI [10.1142/S021969130400041X, DOI 10.1142/S021969130400041X]; CRAVEN P, 1979, NUMER MATH, V31, P377, DOI 10.1007/BF01437407; EKMAN P, 1980, J PERS SOC PSYCHOL, V39, P1125, DOI 10.1037/h0077722; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; EKMAN P, 1990, J PERS SOC PSYCHOL, V58, P342, DOI 10.1037/0022-3514.58.2.342; EKMAN P, 1957, J PSYCHOL, V43, P141, DOI 10.1080/00223980.1957.9713059; GRAMMER K, 1994, J COMP PSYCHOL, V108, P233, DOI 10.1037/0735-7036.108.3.233; Gu C, 2005, J COMPUT GRAPH STAT, V14, P485, DOI 10.1198/106186005X47651; Gu C., 2013, SMOOTHING SPLINE ANO; Gu C., 1993, J COMPUTATIONAL GRAP, V2, P97, DOI DOI 10.1080/10618600.1993.10474601; Hadlock T, 2016, JAMA FACIAL PLAST SU, V18, P85, DOI 10.1001/jamafacial.2015.2095; Helwig NE, 2016, STAT COMPUT, V26, P1319, DOI 10.1007/s11222-015-9610-5; Helwig NE, 2015, J COMPUT GRAPH STAT, V24, P715, DOI 10.1080/10618600.2014.926819; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Jowett N, 2015, FACIAL PLAST SURG CL, V23, P313, DOI 10.1016/j.fsc.2015.04.005; Krumhuber E, 2007, EMOTION, V7, P730, DOI 10.1037/1528-3542.7.4.730; Krumhuber E, 2009, J NONVERBAL BEHAV, V33, P1, DOI 10.1007/s10919-008-0056-8; Krumhuber EG, 2013, EMOT REV, V5, P41, DOI 10.1177/1754073912451349; Krumhuber EG, 2012, EMOTION, V12, P351, DOI 10.1037/a0026632; Krumhuber EG, 2009, EMOTION, V9, P807, DOI 10.1037/a0017844; Lee LN, 2013, OTOLARYNG CLIN N AM, V46, P825, DOI 10.1016/j.otc.2013.07.001; Niziol R, 2015, J PLAST RECONSTR AES, V68, P447, DOI 10.1016/j.bjps.2014.12.015; O'Toole AJ, 2002, TRENDS COGN SCI, V6, P261, DOI 10.1016/S1364-6613(02)01908-3; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; Pighin F., 2006, ACM SIGGRAPH 2006 CO, P19; Rhodes G, 1998, PSYCHON B REV, V5, P659, DOI 10.3758/BF03208842; Roesch EB, 2011, J NONVERBAL BEHAV, V35, P1, DOI 10.1007/s10919-010-0095-9; Schmidt KL, 2006, LATERALITY, V11, P540, DOI 10.1080/13576500600832758; Schmidt KL, 2005, MOTOR CONTROL, V9, P270, DOI 10.1123/mcj.9.3.270; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Starmer H, 2015, JAMA FACIAL PLAST SU, V17, P274, DOI 10.1001/jamafacial.2015.0477; Trutoiu LC, 2014, ACM T APPL PERCEPT, V11, DOI 10.1145/2641569; Twerski AJ, 1986, FACIAL NERVE, P788; VanSwearingen JM, 1999, AESTHET PLAST SURG, V23, P416, DOI 10.1007/s002669900312; Wang YD, 1998, J AM STAT ASSOC, V93, P341, DOI 10.2307/2669630; Wang YD, 1998, J ROY STAT SOC B, V60, P159, DOI 10.1111/1467-9868.00115; Wehrle T, 2000, J PERS SOC PSYCHOL, V78, P105, DOI 10.1037/0022-3514.78.1.105; Xu F, 2014, ACM T GRAPHIC, V33, DOI 10.1145/2601097.2601210; Yuencheng Lee, 1995, Computer Graphics Proceedings. SIGGRAPH 95, P55; Zaidel DW, 2007, INT J NEUROSCI, V117, P423, DOI 10.1080/00207450600581928; Zaidel DW, 2010, SYMMETRY-BASEL, V2, P136, DOI 10.3390/sym2010136; ZAIDEL DW, 1995, NEUROPSYCHOLOGIA, V33, P649, DOI 10.1016/0028-3932(94)00135-C; Zhang D, 1998, J AM STAT ASSOC, V93, P710	51	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179708	10.1371/journal.pone.0179708	http://dx.doi.org/10.1371/journal.pone.0179708			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JT	28658294	Green Submitted, Green Published, gold			2022-12-27	WOS:000404607900039
J	Duncan, C; Jamieson, FB; Troudt, J; Izzo, L; Bielefeldt-Ohmann, H; Izzo, A; Mehaffy, C				Duncan, Carla; Jamieson, Frances B.; Troudt, JoLynn; Izzo, Linda; Bielefeldt-Ohmann, Helle; Izzo, Angelo; Mehaffy, Carolina			Whole transcriptomic and proteomic analyses of an isogenic M. tuberculosis clinical strain with a naturally occurring 15 Kb genomic deletion	PLOS ONE			English	Article							ALTERNATE SIGMA-FACTOR; GUINEA-PIG MODEL; MYCOBACTERIUM-TUBERCULOSIS; 2-COMPONENT SYSTEM; MOLYBDOPTERIN BIOSYNTHESIS; STRINGENT RESPONSE; MASS-SPECTROMETRY; HYPOXIC RESPONSE; BEIJING LINEAGE; MUTANT LACKING	Tuberculosis remains one of the most difficult to control infectious diseases in the world. Many different factors contribute to the complexity of this disease. These include the ability of the host to control the infection which may directly relate to nutritional status, presence of co-morbidities and genetic predisposition. Pathogen factors, in particular the ability of different Mycobacterium tuberculosis strains to respond to the harsh environment of the host granuloma, which includes low oxygen and nutrient availability and the presence of damaging radical oxygen and nitrogen species, also play an important role in the success of different strains to cause disease. In this study we evaluated the impact of a naturally occurring 12 gene 15 Kb genomic deletion on the physiology and virulence of M. tuberculosis. The strains denominated ON-A WT (wild type) and ON-A NM (natural mutant) were isolated from a previously reported TB outbreak in an inner city under-housed population in Toronto, Canada. Here we subjected these isogenic strains to transcriptomic (via RNA-seq) and proteomic analyses and identified several gene clusters with differential expression in the natural mutant, including the DosR regulon and the molybdenum cofactor biosynthesis genes, both of which were found in lower abundance in the natural mutant. We also demonstrated lesser virulence of the natural mutant in the guinea pig animal model. Overall, our findings suggest that the ON-A natural mutant is less fit to cause disease, but nevertheless has the potential to cause extended transmission in at-risk populations.	[Duncan, Carla; Jamieson, Frances B.; Mehaffy, Carolina] Publ Hlth Ontario, Toronto, ON, Canada; [Jamieson, Frances B.] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Troudt, JoLynn; Izzo, Linda; Izzo, Angelo; Mehaffy, Carolina] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Bielefeldt-Ohmann, Helle] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia; [Bielefeldt-Ohmann, Helle] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Bielefeldt-Ohmann, Helle] Univ Queensland, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia	University of Toronto; Colorado State University; University of Queensland; University of Queensland; University of Queensland	Mehaffy, C (corresponding author), Publ Hlth Ontario, Toronto, ON, Canada.; Mehaffy, C (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Carolina.Mehaffy@colostate.edu			Lung Association/Ontario Thoracic Society; NIH/NIAID IDIQ [HHSN2722010000091, HHSN27200004]; Task A58, entitled "Testing of mutant mycobacteria in established advanced small animal models"	Lung Association/Ontario Thoracic Society; NIH/NIAID IDIQ; Task A58, entitled "Testing of mutant mycobacteria in established advanced small animal models"	This study was supported by a grant-in-aid from The Lung Association/Ontario Thoracic Society (http://www.on.lung.ca) (CM, FBJ). Guinea Pig infections were supported by NIH/NIAID IDIQ Contract No. HHSN2722010000091 Task Order HHSN27200004, Task A58, entitled "Testing of mutant mycobacteria in established advanced small animal models" (Al). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam HJ, 2010, INT J TUBERC LUNG D, V14, P1350; Atkinson GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023479; Bamrah S, 2013, INT J TUBERC LUNG D, V17, P1414, DOI 10.5588/ijtld.13.0270; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Banuls AL, 2015, J MED MICROBIOL, V64, P1261, DOI 10.1099/jmm.0.000171; Beaucher J, 2002, MOL MICROBIOL, V45, P1527, DOI 10.1046/j.1365-2958.2002.03135.x; Bhattacharya M, 2011, BIOCHEM BIOPH RES CO, V415, P17, DOI 10.1016/j.bbrc.2011.09.143; Bhattacharya M, 2010, BIOCHIMIE, V92, P263, DOI 10.1016/j.biochi.2009.11.009; Bisson GP, 2012, J BACTERIOL, V194, P6441, DOI 10.1128/JB.01013-12; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Bretl DJ, 2012, INFECT IMMUN, V80, P3018, DOI 10.1128/IAI.00520-12; Brites D, 2015, IMMUNOL REV, V264, P6, DOI 10.1111/imr.12264; Brodin P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001100; Chen P, 2000, INFECT IMMUN, V68, P5575, DOI 10.1128/IAI.68.10.5575-5580.2000; Cho HY, 2009, J BIOL CHEM, V284, P13057, DOI 10.1074/jbc.M808905200; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Converse PJ, 2009, INFECT IMMUN, V77, P1230, DOI 10.1128/IAI.01117-08; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Daffe M, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0021-2013; Dasgupta N, 2000, TUBERCLE LUNG DIS, V80, P141, DOI 10.1054/tuld.2000.0240; Domenech P, 2009, MICROBIOL-SGM, V155, P3532, DOI 10.1099/mic.0.029199-0; Drumm JE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000460; Espinosa-Cueto P, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0102-3; Feske ML, 2013, AM J PUBLIC HEALTH, V103, P839, DOI 10.2105/AJPH.2012.300973; Galagan JE, 2013, NATURE, V499, P178, DOI 10.1038/nature12337; Gautam US, 2015, AM J RESP CELL MOL, V52, P708, DOI 10.1165/rcmb.2014-0230OC; Geiman DE, 2004, INFECT IMMUN, V72, P1733, DOI 10.1128/IAI.72.3.1733-1745.2004; Grover A, 2012, TUBERCULOSIS, V92, P105, DOI 10.1016/j.tube.2011.09.003; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hack Catherine Jane, 2004, Briefings in Functional Genomics & Proteomics, V3, P212, DOI 10.1093/bfgp/3.3.212; Haddad MB, 2005, JAMA-J AM MED ASSOC, V293, P2762, DOI 10.1001/jama.293.22.2762; He HJ, 2011, J BACTERIOL, V193, P5105, DOI 10.1128/JB.05562-11; Hershkovitz I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003426; Hu YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020958; Hu YM, 1999, J BACTERIOL, V181, P1380, DOI 10.1128/JB.181.5.1380-1387.1999; Kana BD, 2001, J BACTERIOL, V183, P7076, DOI 10.1128/JB.183.24.7076-7086.2001; Kendall SL, 2004, TUBERCULOSIS, V84, P247, DOI 10.1016/j.tube.2003.12.007; Kettman JR, 2001, BIOMOL ENG, V18, P207, DOI 10.1016/S1389-0344(01)00096-X; Khan K, 2011, EMERG INFECT DIS, V17, P357, DOI 10.3201/eid1703.100833; Kirksey MA, 2011, INFECT IMMUN, V79, P2829, DOI 10.1128/IAI.00097-11; Klinkenberg LG, 2010, J INFECT DIS, V202, P1397, DOI 10.1086/656524; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; MacGurn JA, 2007, INFECT IMMUN, V75, P2668, DOI 10.1128/IAI.01872-06; Malhotra V, 2004, FEMS MICROBIOL LETT, V231, P237, DOI 10.1016/S0378-1097(04)00002-3; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; Mattow J, 2006, PROTEOMICS, V6, P2485, DOI 10.1002/pmic.200500547; Mehaffy C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112928; Lopez PM, 2010, MICROBIOL-SGM, V156, P2112, DOI 10.1099/mic.0.037200-0; Merker M, 2015, NAT GENET, V47, P242, DOI 10.1038/ng.3195; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Organization W. H., 2015, GLOB TUB REP; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Pesavento C, 2009, CURR OPIN MICROBIOL, V12, P170, DOI 10.1016/j.mib.2009.01.007; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Rao Prahlad K, 2009, J Proteomics Bioinform, V2, P19; Reed MB, 2007, J BACTERIOL, V189, P2583, DOI 10.1128/JB.01670-06; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Rustad TR, 2013, NUCLEIC ACIDS RES, V41, P509, DOI 10.1093/nar/gks1019; Saini DK, 2004, MICROBIOL-SGM, V150, P865, DOI 10.1099/mic.0.26218-0; Sala C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-33; Shi TY, 2011, J CELL BIOCHEM, V112, P2721, DOI 10.1002/jcb.23233; Sulzenbacher G, 2006, EMBO J, V25, P1436, DOI 10.1038/sj.emboj.7601048; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; TAKAYAMA K, 1975, J LIPID RES, V16, P308; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; Venugopal A, 2011, CELL HOST MICROBE, V9, P21, DOI 10.1016/j.chom.2010.12.004; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Voss M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028170; Wieczorek AE, 2014, PATHOG DIS, V71, P315, DOI 10.1111/2049-632X.12147; Williams MJ, 2011, J BACTERIOL, V193, P98, DOI 10.1128/JB.00774-10	71	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179996	10.1371/journal.pone.0179996	http://dx.doi.org/10.1371/journal.pone.0179996			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650996	Green Published, Green Submitted, gold			2022-12-27	WOS:000404537300036
J	Malachin, G; Reiten, MR; Salvesen, O; Aanes, H; Kamstra, JH; Skovgaard, K; Heegaard, PMH; Ersdal, C; Espenes, A; Tranulis, MA; Bakkebo, MK				Malachin, Giulia; Reiten, Malin R.; Salvesen, Oyvind; Aanes, Havard; Kamstra, Jorke H.; Skovgaard, Kerstin; Heegaard, Peter M. H.; Ersdal, Cecilie; Espenes, Arild; Tranulis, Michael A.; Bakkebo, Maren K.			Loss of prion protein induces a primed state of type I interferon-responsive genes	PLOS ONE			English	Article							UP-REGULATED GENES; DIFFERENTIAL EXPRESSION; MICE LACKING; PRP; MOUSE; REVEALS; PROFILE	The cellular prion protein (PrPC) has been extensively studied because of its pivotal role in prion diseases; however, its functions remain incompletely understood. A unique line of goats has been identified that carries a nonsense mutation that abolishes synthesis of PrPC. In these animals, the PrP-encoding mRNA is rapidly degraded. Goats without PrPC are valuable in re-addressing loss-of-function phenotypes observed in Prnp knockout mice. As PrPC has been ascribed various roles in immune cells, we analyzed transcriptomic responses to loss of PrPC in peripheral blood mononuclear cells (PBMCs) from normal goat kids (n = 8, PRNP (+/+)) and goat kids without PrPC (n = 8, PRNPTer/Ter) by mRNA sequencing. PBMCs normally express moderate levels of PrPC. The vast majority of genes were similarly expressed in the two groups. However, a curated list of 86 differentially expressed genes delineated the two genotypes. About 70% of these were classified as interferon-responsive genes. In goats without PrPC, the majority of type I interferon-responsive genes were in a primed, modestly upregulated state, with fold changes ranging from 1.4 to 3.7. Among these were ISG15, DDX58 (RIG-1), MX1, MX2, OAS1, OAS2 and DRAM1, all of which have important roles in pathogen defense, cell proliferation, apoptosis, immunomodulation and DNA damage response. Our data suggest that PrPC contributes to the fine-tuning of resting state PBMCs expression level of type I interferon-responsive genes. The molecular mechanism by which this is achieved will be an important topic for further research into PrPC physiology.	[Malachin, Giulia; Reiten, Malin R.; Salvesen, Oyvind; Kamstra, Jorke H.; Ersdal, Cecilie; Espenes, Arild; Tranulis, Michael A.; Bakkebo, Maren K.] Norwegian Univ Life Sci, Fac Vet Med, Oslo, Norway; [Aanes, Havard] Oslo Univ Hosp, Rikshosp, Inst Clin Med, Dept Microbiol,Div Diagnost & Intervent, Oslo, Norway; [Skovgaard, Kerstin; Heegaard, Peter M. H.] Tech Univ Denmark, Natl Vet Inst, Sect Immunol & Vaccinol, Innate Immunol Grp, Lyngby, Denmark	Norwegian University of Life Sciences; University of Oslo; National Hospital Norway; Technical University of Denmark	Tranulis, MA (corresponding author), Norwegian Univ Life Sci, Fac Vet Med, Oslo, Norway.	Michael.Tranulis@nmbu.no	Heegaard, Peter/E-9794-2015	Heegaard, Peter/0000-0003-4506-4932; skovgaard, kerstin/0000-0001-5663-4879; Malachin, Giulia/0000-0003-1888-6850; Kamstra, Jorke/0000-0001-7984-0229; Salvesen, Oyvind/0000-0003-2480-1294	Norwegian Research Council [227386/E40]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	MAT received funding from the Norwegian Research Council, Grant number 227386/E40 (http://www.forskningsradet.no/no/Forsiden/1173185591033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker CA, 2004, J NEUROVIROL, V10, P29, DOI 10.1080/13550280490261761; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Benestad SL, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-87; Benvegnu S, 2011, PHYSIOL GENOMICS, V43, P711, DOI 10.1152/physiolgenomics.00205.2010; Bolker J, 2012, NATURE, V491, P31, DOI 10.1038/491031a; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Carroll JA, 2015, J VIROL, V89, P2388, DOI 10.1128/JVI.02952-14; Chadi S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-448; Crecelius AC, 2008, NEUROREPORT, V19, P1027, DOI 10.1097/WNR.0b013e3283046157; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; Durig J, 2000, BRIT J HAEMATOL, V108, P488, DOI 10.1046/j.1365-2141.2000.01881.x; Herrmann US, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004662; Isaacs JD, 2006, CLIN EXP IMMUNOL, V146, P1, DOI 10.1111/j.1365-2249.2006.03194.x; Isaacs JD, 2008, IMMUNOLOGY, V125, P313, DOI 10.1111/j.1365-2567.2008.02853.x; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Mariante RM, 2012, J BIOL CHEM, V287, P35506, DOI 10.1074/jbc.M112.394924; McLennan NF, 2004, AM J PATHOL, V165, P227, DOI 10.1016/S0002-9440(10)63291-9; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Moore RC, 2001, P NATL ACAD SCI USA, V98, P15288, DOI 10.1073/pnas.251550798; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nuvolone M, 2016, J EXP MED, V213, P313, DOI 10.1084/jem.20151610; Nuvolone M, 2013, J EXP MED, V210, P2539, DOI 10.1084/jem.20131274; Peralta OA, 2012, MOL REPROD DEV, V79, P488, DOI 10.1002/mrd.22057; Porritt RA, 2015, TRENDS IMMUNOL, V36, P150, DOI 10.1016/j.it.2015.02.002; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Ramljak S, 2008, J PROTEOME RES, V7, P2681, DOI 10.1021/pr7007187; Reiten MR, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00044; Richt JA, 2007, NAT BIOTECHNOL, V25, P132, DOI 10.1038/nbt1271; Riemer C, 2000, J VIROL, V74, P10245, DOI 10.1128/JVI.74.21.10245-10248.2000; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rossi D, 2001, EMBO J, V20, P694, DOI 10.1093/emboj/20.4.694; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Sakaguchi S, 1996, NATURE, V380, P528, DOI 10.1038/380528a0; Salvesen O, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0879-5; Salvesen O, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0870-x; Satoh J, 2000, AM J PATHOL, V157, P59, DOI 10.1016/S0002-9440(10)64517-8; Spudich A, 2005, NEUROBIOL DIS, V20, P442, DOI 10.1016/j.nbd.2005.04.002; Steele AD, 2007, PRION, V1, P83, DOI 10.4161/pri.1.2.4346; Stobart MJ, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-5; Tobler I, 1996, NATURE, V380, P639, DOI 10.1038/380639a0; Walz R, 1999, EPILEPSIA, V40, P1679, DOI 10.1111/j.1528-1157.1999.tb01583.x; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831; Yokoyama T, 2001, J BIOL CHEM, V276, P11265, DOI 10.1074/jbc.M008734200; Yu GH, 2009, MOL REPROD DEV, V76, P3, DOI 10.1002/mrd.20960; Zhou RY, 2008, J HERED, V99, P647, DOI 10.1093/jhered/esn073	50	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179881	10.1371/journal.pone.0179881	http://dx.doi.org/10.1371/journal.pone.0179881			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651013	Green Published, gold			2022-12-27	WOS:000404537300027
J	Chen, JS; Zhou, H				Chen, Jinsong; Zhou, Hui			Test designs and modeling under the general nominal diagnosis model framework	PLOS ONE			English	Article							SITUATIONAL JUDGMENT TESTS; ITEM RESPONSE THEORY; COGNITIVE DIAGNOSIS; MULTIPLE-CHOICE; ANSWERS	Most psychological questionnaires face issues of response bias in respondent-reported scales, inadequacy for criterion-reference testing, or difficulty in estimating a large number of latent traits. Situational tests together with the general nominal diagnosis model framework provide a viable alternative to alleviate these concerns. Under this framework, there are different ways to design situationally nominal items, which can offer more flexibility for test development. Any response bias remaining with respondent-reported questionnaires may be addressed with appropriate test designs. The saturated model subsumes different reduced forms that can help inform whether the test is designed as expected. Two simulation studies are presented to demonstrate the effectiveness of the models and designs.	[Chen, Jinsong; Zhou, Hui] Sun Yat Sen Univ, Dept Psychol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Chen, JS (corresponding author), Sun Yat Sen Univ, Dept Psychol, Guangzhou, Guangdong, Peoples R China.	jinsong.chen@live.com		Chen, Jinsong/0000-0002-0157-5469	Open Fund of the National Higher Education Quality Monitoring Data Center (Guangzhou) [M1601]	Open Fund of the National Higher Education Quality Monitoring Data Center (Guangzhou)	This work was supported by the Open Fund of the National Higher Education Quality Monitoring Data Center (Guangzhou). Grant, No. M1601. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	[Anonymous], 2014, PSYCHOMETRICS INTRO; Chen JW, 2017, APPL COMPOS MATER, V24, P1107, DOI [10.1007/s10443-016-9576-2, 10.1007/s42114-017-0009-y]; Chen JS, 2013, APPL PSYCH MEAS, V37, P419, DOI 10.1177/0146621613479818; Chen JS, 2013, J EDUC MEAS, V50, P123, DOI 10.1111/j.1745-3984.2012.00185.x; Chiu CY, 2009, PSYCHOMETRIKA, V74, P633, DOI 10.1007/s11336-009-9125-0; De la Torre J, 2004, PSYCHOMETRIKA, V69, P333, DOI 10.1007/BF02295640; de la Torre J., 2011, ANN M NAT COUNC MEAS; de la Torre J, 2015, PSYCHOMETRIKA; de la Torre J., 2010, INT M PSYCH SOC; de la Torre J, 2011, PSYCHOMETRIKA, V76, P179, DOI 10.1007/s11336-011-9207-7; de la Torre J, 2009, APPL PSYCH MEAS, V33, P163, DOI 10.1177/0146621608320523; la Torre J, 2008, PSYCHOMETRIKA, V73, P595, DOI 10.1007/s11336-008-9063-2; DEELY JJ, 1981, J AM STAT ASSOC, V76, P833, DOI 10.2307/2287578; Doornik J. A., 2003, OBJECT ORIENTED MATR; Garcia PE, 2014, PSICOTHEMA, V26, P372, DOI 10.7334/psicothema2013.322; Fabes RA., 2002, MARRIAGE FAMILY REV, V34, P285, DOI DOI 10.1300/J002V34N03_05; Friedman H. H., 1999, J MARKETING MANAGEME, V9, P114, DOI DOI 10.2307/3151463; Henson RA, 2009, PSYCHOMETRIKA, V74, P191, DOI 10.1007/s11336-008-9089-5; Junker BW, 2001, APPL PSYCH MEAS, V25, P258, DOI 10.1177/01466210122032064; Lehmann E. L., 1998, THEORY POINT ESTIMAT; Lievens F, 2008, PERS REV, V37, P426, DOI 10.1108/00483480810877598; Ma W, 2016, APPL PSYCH MEAS, V40, P200, DOI 10.1177/0146621615621717; McDaniel MA., 2007, APPL MEASUREMENT IND, P235; Mirabile SP, 2015, EUR J DEV PSYCHOL, V12, P459, DOI 10.1080/17405629.2015.1037735; Ozaki K, 2015, APPL PSYCH MEAS, V39, P431, DOI 10.1177/0146621615574693; Rothbart MK, 2001, CHILD DEV, V72, P1394, DOI 10.1111/1467-8624.00355; Schwarz N, 1999, AM PSYCHOL, V54, P93, DOI 10.1037/0003-066X.54.2.93; Sorrel MA, 2016, ORGAN RES METHODS, V19, P506, DOI 10.1177/1094428116630065; TATSUOKA KK, 1983, J EDUC MEAS, V20, P345, DOI 10.1111/j.1745-3984.1983.tb00212.x; Templin J, 2008, COGNITIVE DIAGNOSIS; Templin JL, 2006, PSYCHOL METHODS, V11, P287, DOI 10.1037/1082-989X.11.3.287; von Davier M, 2008, BRIT J MATH STAT PSY, V61, P287, DOI 10.1348/000711007X193957	32	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0180016	10.1371/journal.pone.0180016	http://dx.doi.org/10.1371/journal.pone.0180016			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY7CO	28644865	gold, Green Published, Green Submitted			2022-12-27	WOS:000404145100057
J	Afiune, LAF; Leal-Silva, T; Sinzato, YK; Moraes-Souza, RQ; Soares, TS; Campos, KE; Fujiwara, RT; Herrera, E; Damasceno, DC; Volpato, GT				Freitas Afiune, Luana Alves; Leal-Silva, Thais; Sinzato, Yuri Karen; Moraes-Souza, Rafaianne Queiroz; Soares, Thaigra Sousa; Campos, Kleber Eduardo; Fujiwara, Ricardo Toshio; Herrera, Emilio; Damasceno, Debora Cristina; Volpato, Gustavo Tadeu			Beneficial effects of Hibiscus rosa-sinensis L. flower aqueous extract in pregnant rats with diabetes	PLOS ONE			English	Article							OXIDATIVE STRESS STATUS; ANTIFERTILITY ACTIVITY; BENZENE EXTRACT; LIPID PROFILE; CHOLESTEROL; HDL; SUPPLEMENTATION; ANTIOXIDANT; METABOLISM; MECHANISMS	Purpose The Hibiscus rosa-sinensis flower is widely used in Brazilian traditional medicine for the treatment of diabetes and has shown antifertility activity in female Wistar rats. However, there is no scientific confirmation of its effect on diabetes and pregnancy. The aim of this study was evaluate the effect of aqueous extract of H. rosa-sinensis flowers on maternalfetal outcome in pregnant rats with diabetes. Methods Diabetes was induced by streptozotocin (STZ, 40 mg/kg) in virgin, adult, female Wistar rats. After diabetes induction, the rats were mated. The pregnant rats were distributed into four groups (n minimum = 11 animals/group): non-diabetic, non-diabetic treated, diabetic, and diabetic treated. Oral aqueous extract of Hibiscus rosa-sinensis was administered to rats in the treatment groups during pregnancy. At term pregnancy, maternal reproductive outcomes, fetal parameters, and biochemical parameters were analyzed. Results The non-diabetic treated group showed decreased high density lipoprotein cholesterol, increased atherogenic index (AI) and coronary artery risk index (CRI), and increased preimplantation loss rate compared to the non-diabetic group. Although treatment with H. rosasinensis led to no toxicity, it showed deleterious effects on cardiac and reproductive functions. However, the diabetic treated group showed increased maternal and fetal weights, reduced AI and CRI, and reduced preimplantation loss rate compared to the untreated diabetic group. Conclusion Our results demonstrate beneficial effects of this flower only in pregnant rats with diabetes and their offspring. Although these findings cannot be extrapolated to human clinical use, they show that the indiscriminate intake of H. rosa-sinensis may be harmful to healthy individuals and its use should be completely avoided in pregnancy.	[Freitas Afiune, Luana Alves; Leal-Silva, Thais; Moraes-Souza, Rafaianne Queiroz; Soares, Thaigra Sousa; Campos, Kleber Eduardo; Volpato, Gustavo Tadeu] Fed Univ Mato Grosso UFMT, Inst Biol & Hlth Sci, Lab Syst Physiol & Reprod Toxicol, Barra Do Garcas, Mato Grosso Sta, Brazil; [Sinzato, Yuri Karen; Moraes-Souza, Rafaianne Queiroz; Soares, Thaigra Sousa; Damasceno, Debora Cristina; Volpato, Gustavo Tadeu] Univ Estadual Paulista Unesp, Botucatu Med Sch, Lab Expt Res Gynecol & Obstet, Gynecol Obstet & Mastol Grad Course, Botucatu, SP, Brazil; [Fujiwara, Ricardo Toshio] Fed Univ Minas Gerais UFMG, Inst Biol Sci, Dept Parasitol, Belo Horizonte, MG, Brazil; [Herrera, Emilio] Univ CEU San Pablo, Dept Biochem & Mol Biol, Madrid, Spain	Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso do Sul; Universidade Estadual Paulista; Universidade Federal de Minas Gerais; San Pablo CEU University	Volpato, GT (corresponding author), Fed Univ Mato Grosso UFMT, Inst Biol & Hlth Sci, Lab Syst Physiol & Reprod Toxicol, Barra Do Garcas, Mato Grosso Sta, Brazil.; Volpato, GT (corresponding author), Univ Estadual Paulista Unesp, Botucatu Med Sch, Lab Expt Res Gynecol & Obstet, Gynecol Obstet & Mastol Grad Course, Botucatu, SP, Brazil.	gtvolpato@yahoo.com	Volpato, Gustavo Tadeu/A-5350-2013; Sinzato, Yuri K/E-8626-2019; Herrera-Castillon, Emilio/D-9143-2012; Volpato, Gustavo Tadeu/ABC-4863-2020; Damasceno, Débora C/C-7234-2012; Fujiwara, Ricardo Toshio/J-7579-2012; Afiune, Luana Alves de Freitas/F-1166-2018	Volpato, Gustavo Tadeu/0000-0002-4753-3264; Sinzato, Yuri K/0000-0002-2973-1099; Herrera-Castillon, Emilio/0000-0002-8152-787X; Volpato, Gustavo Tadeu/0000-0002-4753-3264; Damasceno, Débora C/0000-0002-7003-9643; Fujiwara, Ricardo Toshio/0000-0002-4713-575X; Moraes-Souza, Rafaianne/0000-0002-3639-5740; Afiune, Luana Alves de Freitas/0000-0001-7702-2548; Sousa Soares, Thaigra/0000-0003-4402-0241	Conselho Nacional de Desenvolvimento Ciento e Tecnologico	Conselho Nacional de Desenvolvimento Ciento e Tecnologico	Ricardo T. Fujiwara and Debora C. Damasceno received support from Conselho Nacional de Desenvolvimento Ciento e Tecnologico.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Ajiboye TO, 2011, DRUG CHEM TOXICOL, V34, P109, DOI 10.3109/01480545.2010.536767; Anusha Bhaskar, 2011, Annals of Biological Research, V2, P653; Bhaskar A, 2012, INDIAN J PHARMACOL, V44, P694, DOI 10.4103/0253-7613.103252; Boers M, 2003, ANN RHEUM DIS, V62, P842, DOI 10.1136/ard.62.9.842; Consonni M, 2012, BRAZ ARCH BIOL TECHN, V55, P695, DOI 10.1590/S1516-89132012000500008; Da-Costa-Rocha I, 2014, FOOD CHEM, V165, P424, DOI 10.1016/j.foodchem.2014.05.002; Damasceno D. C., 2008, Botanical medicine in clinical practice, P547, DOI 10.1079/9781845934132.0547; Damasceno DC, 2002, ANIM REPROD SCI, V72, P235, DOI 10.1016/S0378-4320(02)00094-5; Damasceno DC, 2008, ANOMALIAS CONGENITAS; Damasceno DC, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-20; Damasceno DC, 2013, REPROD SCI, V20, P730, DOI 10.1177/1933719112461186; Dobiasova M, 2004, CLIN CHEM, V50, P1113, DOI 10.1373/clinchem.2004.033175; Eriksson UJ, 2003, REV ENDOCR METAB DIS, V4, P79, DOI 10.1023/A:1021879504372; Fernandez-Arroyo S, 2011, FOOD RES INT, V44, P1490, DOI 10.1016/j.foodres.2011.03.040; Gauthaman K. K., 2006, BMC Complementary and Alternative Medicine, V6; Guerin M, 2001, ARTERIOSCL THROM VAS, V21, P282, DOI 10.1161/01.ATV.21.2.282; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; JOLLOW DJ, 1974, PHARMACOLOGY, V11, P151, DOI 10.1159/000136485; Kahn CR, 2004, JOSLINS DIABETES MEL; Khalid L, 2014, PAK J PHARM SCI, V27, P1327; KHOLKUTE SD, 1976, PLANTA MED, V29, P321, DOI 10.1055/s-0028-1097671; Knopfholz J, 2014, CHOLESTEROL, V2014, P261; Liu Chiu-Shong, 1999, Acta Paediatrica Sinica, V40, P319; LUCIANI MF, 1994, GENOMICS, V21, P150, DOI 10.1006/geno.1994.1237; Mak Yin Wei, 2013, Journal of King Saud University Science, V25, P275, DOI 10.1016/j.jksus.2012.12.003; MASAKI H, 1995, BIOL PHARM BULL, V18, P162, DOI 10.1248/bpb.18.162; Moqbel FS, 2011, INDIAN J EXP BIOL, V49, P24; MURAKAMI T, 1995, ARTERIOSCL THROM VAS, V15, P1819, DOI 10.1161/01.ATV.15.11.1819; Murthy DRK, 1997, BIOL PHARM BULL, V20, P756, DOI 10.1248/bpb.20.756; Nayak D, 2015, IET NANOBIOTECHNOL, V9, P288, DOI 10.1049/iet-nbt.2014.0047; PAL AK, 1985, CONTRACEPTION, V32, P517, DOI 10.1016/0010-7824(85)90021-6; Pillai SS, 2016, PLANT FOOD HUM NUTR, V71, P42, DOI 10.1007/s11130-015-0521-6; Pinheiro MS, 2017, AN ACAD BRAS CIENC, V89, P263, DOI 10.1590/0001-3765201720160050; Qin Y, 2009, AM J CLIN NUTR, V90, P485, DOI 10.3945/ajcn.2009.27814; Rader DJ, 2007, NAT CLIN PRACT CARD, V4, P102, DOI 10.1038/ncpcardio0768; Ruban P., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P399, DOI 10.1016/S2221-1691(12)60064-1; Sachdewa A, 2003, J ETHNOPHARMACOL, V89, P61, DOI 10.1016/S0378-8741(03)00230-7; Sachdewa Archana, 2001, Indian Journal of Experimental Biology, V39, P284; SALEWSKL E., 1964, ARCH EXP PATHOL PHARMAKOL [NAUNYN SCHMEEDEBERGS], V247, P367; Shewale PB, 2012, INDIAN J PHARMACOL, V44, P454, DOI 10.4103/0253-7613.99303; Shivananda Nayak B, 2007, Int J Low Extrem Wounds, V6, P76; SINGH MP, 1982, PLANTA MED, V44, P171, DOI 10.1055/s-2007-971433; Sinzato Yuri Karen, 2012, Exp Diabetes Res, V2012, P108163, DOI 10.1155/2012/108163; STAPLES RE, 1964, STAIN TECHNOL, V39, P61; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; Vasudeva N, 2008, EVID-BASED COMPL ALT, V5, P91, DOI 10.1093/ecam/nem003; Venkatesh S, 2008, FITOTERAPIA, V79, P79, DOI 10.1016/j.fitote.2007.06.015; Volpato GT, 2008, J ETHNOPHARMACOL, V116, P131, DOI 10.1016/j.jep.2007.11.013; Volpato GT, 2011, J ETHNOPHARMACOL, V138, P691, DOI 10.1016/j.jep.2011.09.044; Volpato GT, 2017, CURR MED CHEM, V24, P404, DOI 10.2174/0929867323666161003122914; Volpato GT, 2015, REPROD SCI, V22, P602, DOI 10.1177/1933719114556485; Wilson JG, 1965, TERATOLOGY PRINCIPLE, P47; Young D, 2000, EFFECTS DRUGS CLIN L; Zhu YN, 2014, J CLIN ENDOCR METAB, V99, P561, DOI 10.1210/jc.2013-2845	55	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179785	10.1371/journal.pone.0179785	http://dx.doi.org/10.1371/journal.pone.0179785			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644857	gold, Green Published, Green Submitted			2022-12-27	WOS:000404145100037
J	Herath, H; Herath, R; Wickremasinghe, R				Herath, Himali; Herath, Rasika; Wickremasinghe, Rajitha			Gestational diabetes mellitus and risk of type 2 diabetes 10 years after the index pregnancy in Sri Lankan women-A community based retrospective cohort study	PLOS ONE			English	Article							FOLLOW-UP	Background Women with a history of gestational diabetes mellitus (GDM) have an increased risk of type 2 diabetes mellitus (T2DM) later in life compared to women with no GDM. This study was aimed to determine the risk of developing T2DM 10 years after GDM in Sri Lankan women. Methods A retrospective cohort study was conducted in the Colombo district, Sri Lanka. 7205 women who delivered a child in 2005 were identified through Public Health Midwives in the field. Women with antenatal records were interviewed and relevant data were extracted from medical records to identify potential participants. One hundred and nineteen women who had GDM and 240 women who did not have GDM were recruited. Current diagnosis of diabetes was based on history, relevant medical records and blood reports within the past 1 year. Results The mean duration of follow up was 10.9 (SD = 0.35) years in the GDM group and 10.8 (SD = 0.31) years in the non-GDM group. The incidence density of diabetes in the GDM group was 56.3 per 1000 person years compared to 5.4 per 1000 person years in non GDM group giving a rate ratio of 10.42 (95% CI: 6.01-19.12). A woman having GDM in the index pregnancy was 10.6 times more likely to develop diabetes within 10 years compared to women with no GDM after controlling for other confounding variables. Delivering a child after 30 years, being treated with insulin during the pregnancy and delivering a baby weighing more than 3.5 Kg were significant predictors of development of T2DM after controlling for family history of diabetes mellitus (DM), GDM in previous pregnancies, parity and gestational age at delivery. Conclusions Women with GDM had a 10-fold higher risk of developing T2DM during a 10-year follow up period as compared to women with no GDM after controlling for other confounding variables.	[Herath, Himali] Med Res Inst, Dept Nutr, Colombo, Sri Lanka; [Herath, Rasika] Univ Kelaniya, Dept Obstet & Gynaecol, Fac Med, Ragama, Sri Lanka; [Wickremasinghe, Rajitha] Univ Kelaniya, Dept Publ Hlth, Fac Med, Ragama, Sri Lanka	Medical Research Institute Sri Lanka (MRI); University Kelaniya; University Kelaniya	Herath, H (corresponding author), Med Res Inst, Dept Nutr, Colombo, Sri Lanka.	himalides@yahoo.com		Herath, Himali/0000-0003-3316-2463; Herath, Rasika/0000-0001-7209-2512	National Research Council SriLanka [15-045]	National Research Council SriLanka	This work was supported by the National Research Council SriLanka (http://www.nrc.gov.lk/) Grant Number 15-045 to RH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; American Diabetes Association, 2016, DIABETES CARE, V39, P536; Baptiste-Roberts K, 2009, AM J MED, V122, P207, DOI 10.1016/j.amjmed.2008.09.034; Barden A, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.15; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Ben-Haroush A, 2004, DIABETIC MED, V21, P103, DOI 10.1046/j.1464-5491.2003.00985.x; Bentley-Lewis R, 2009, LANCET, V373, P1738, DOI 10.1016/S0140-6736(09)60958-2; Cheung NW, 2003, DIABETES CARE, V26, P2005, DOI 10.2337/diacare.26.7.2005; Chyad Al-Noaemi M, 2011, GESTATIONAL DIABETES, P91; Dahanayaka NJ, 2012, CEYLON MED J, V57, P5, DOI 10.4038/cmj.v57i1.4193; Damm P, 2016, DIABETOLOGIA, V59, P1396, DOI 10.1007/s00125-016-3985-5; Eades CE, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0457-8; Family Health Bureau Ministry of Health SL, 2005, ANN REP FAM HLTH 200; Feig DS, 2008, CAN MED ASSOC J, V179, P229, DOI 10.1503/cmaj.080012; Ginige S., 2004, J COLL COMMUNITY PHY, V9, P40, DOI [10.4038/JCCPSL.V9I1.8278, DOI 10.4038/JCCPSL.V9I1.8278]; Gunderson EP, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000490; Hod M, 2015, INT J GYNECOL OBSTET, V131, pS16, DOI 10.1016/j.ijgo.2015.02.010; Internal Medicine Milestone Group. Accreditation Council for graduate medical education (ACGME) and American board of internal medicine (ABIM), 2015, IPC ANN REP 2015, P1; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Krishnaveni GV, 2007, DIABETES RES CLIN PR, V78, P398, DOI 10.1016/j.diabres.2007.06.002; Lee AJ, 2007, DIABETES CARE, V30, P878, DOI 10.2337/dc06-1816; Linne Y, 2002, BJOG-INT J OBSTET GY, V109, P1227; Mahalakshmi Manni Mohanraj, 2014, Indian J Endocrinol Metab, V18, P400, DOI 10.4103/2230-8210.131205; Metzger BE, 2007, DIABETES CARE, V30, pS251, DOI 10.2337/dc07-s225; O'Reilly SL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002092; Oldfield MD, 2007, POSTGRAD MED J, V83, P426, DOI 10.1136/pgmj.2006.056267; Peacock AS, 2014, WOMEN BIRTH, V27, pE7, DOI 10.1016/j.wombi.2014.09.002; Rayanagoudar G, 2016, DIABETOLOGIA, V59, P1403, DOI 10.1007/s00125-016-3927-2; Soma-Pillay P, 2016, CARDIOVASC J AFR, V27, P89, DOI 10.5830/CVJA-2016-021; World Health Organization, 1999, WHONCDNCS992PDF	30	72	77	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179647	10.1371/journal.pone.0179647	http://dx.doi.org/10.1371/journal.pone.0179647			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644881	Green Submitted, Green Published, gold			2022-12-27	WOS:000404145100028
J	Fu, XM; Peng, C; Li, Z; Liu, S; Tan, MM; Song, JL				Fu, Xiaoming; Peng, Chun; Li, Zan; Liu, Shan; Tan, Minmin; Song, Jinlin			The application of multi-baseline digital close-range photogrammetry in three-dimensional imaging and measurement of dental casts	PLOS ONE			English	Article							MODELS	Objective To explore a new technique for reconstructing and measuring three-dimensional (3D) models of orthodontic plaster casts using multi-baseline digital close-range photogrammetry (MBDCRP) with a single-lens reflex camera. Study design Thirty sets of orthodontic plaster casts that do not exhibit severe horizontal overlap (> 2 mm) between any two teeth were recorded by a single-lens reflex camera with 72 pictures taken in different directions. The 3D models of these casts were reconstructed and measured using the open source software MeshLab. These parameters, including mesio-distal crown diameter, arch width, and arch perimeter, were recorded six times on both the 3D digital models and on plaster casts by two examiners. Statistical analysis was carried out using the Bland-Altman method to measure agreement between the novel method and the traditional calliper method by calculating the differences between mean values. Results The average differences between the measurements of the photogrammetric 3D models and the plaster casts were 0.011-0.402mm. The mean differences between measurements obtained by the photogrammetric 3D models and the dental casts were not significant except for the lower arch perimeter (P> 0.05), and all the differences were regarded as clinically acceptable (< 0.5 mm). Conclusions Measurements obtained by MBDCRP are compared well with those obtained from plaster casts, indicating that MBDCRP is an alternate way to store and measure dental plaster casts without severe horizontal overlap between any two teeth.	[Fu, Xiaoming; Liu, Shan; Tan, Minmin; Song, Jinlin] Chongqing Key Lab Oral Dis & Biomed Sci, Chongqing, Peoples R China; [Fu, Xiaoming; Liu, Shan; Tan, Minmin; Song, Jinlin] Chongqing Med Univ, Coll Stomatol, Chongqing, Peoples R China; [Fu, Xiaoming; Liu, Shan; Tan, Minmin; Song, Jinlin] Chongqing Municipal Key Lab Oral Biomed Engn High, Chongqing, Peoples R China; [Peng, Chun] Chongqing Med Univ, Yongchuan Hosp, Chongqing, Peoples R China; [Li, Zan] Chongqing Peoples Hosp, Dept Pathol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Song, JL (corresponding author), Chongqing Key Lab Oral Dis & Biomed Sci, Chongqing, Peoples R China.; Song, JL (corresponding author), Chongqing Med Univ, Coll Stomatol, Chongqing, Peoples R China.; Song, JL (corresponding author), Chongqing Municipal Key Lab Oral Biomed Engn High, Chongqing, Peoples R China.	soongjl@163.com			National Natural Science Foundation of China [81400572]; Medical Research Project of Chongqing [20142051]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Research Project of Chongqing	Funded by National Natural Science Foundation of China (81400572), http://www.nsfc.gov.cn/; Medical Research Project of Chongqing (20142051), http://183.230.146.1:9117/kysystem/. XMF received the fundings, who had roles in study design, preparation of the manuscript.	Asquith J, 2007, EUR J ORTHODONT, V29, P517, DOI 10.1093/ejo/cjm044; Bell A, 2003, J Orthod, V30, P219, DOI 10.1093/ortho/30.3.219; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Correia Gabriele Dória Cabral, 2014, Dental Press J. Orthod., V19, P107, DOI 10.1590/2176-9451.19.4.107-113.oar; Czarnota J, 2016, J OROFAC ORTHOP, V77, P22, DOI 10.1007/s00056-015-0004-2; Fetic DJ, 2012, P 35 INT CONV MIPRO; Gilson SJ, 2011, J NEUROSCI METH, V199, P328, DOI 10.1016/j.jneumeth.2011.05.011; Hayashi K, 2015, AM J ORTHOD DENTOFAC, V147, P373, DOI 10.1016/j.ajodo.2014.11.015; Hirogaki Y, 2001, IEEE T MED IMAGING, V20, P1093, DOI 10.1109/42.959306; Im J, 2014, AM J ORTHOD DENTOFAC, V145, P434, DOI 10.1016/j.ajodo.2013.12.014; Leifert MF, 2009, AM J ORTHOD DENTOFAC, V136, DOI 10.1016/j.ajodo.2008.11.019; Lemos LS, 2015, DENTOMAXILLOFAC RAD, V44, DOI 10.1259/dmfr.20140337; Li LL, 2014, OPT EXPRESS, V22, P27707, DOI 10.1364/OE.22.027707; Li WW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117320; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Lu M, 2014, SENSORS-BASEL, V14, P24156, DOI 10.3390/s141224156; Machen DE, 1991, LEGAL ASPECTS ORTHOD; Okunami TR, 2007, AM J ORTHOD DENTOFAC, V131, P51, DOI 10.1016/j.ajodo.2005.04.042; Persson A, 2006, J PROSTHET DENT, V95, P194, DOI 10.1016/j.prosdent.2006.01.003; Previtali M, 2011, 38 C INT ARCH PHOT R, P103; Radeke J, 2014, J OROFAC ORTHOP, V75, P264, DOI 10.1007/s00056-014-0217-9; Redlich M, 2008, ORTHOD CRANIOFAC RES, V11, P90, DOI 10.1111/j.1601-6343.2007.00417.x; Remondino F, 2006, THESIS; Schenk T, 2005, INTRO PHOTOGRAMMETRY; Sokovic M, 2006, J MATER PROCESS TECH, V175, P398, DOI 10.1016/j.jmatprotec.2005.04.047; Yau HT, 2014, COMPUT BIOL MED, V48, P8, DOI 10.1016/j.compbiomed.2014.02.001; Yazdi B, 2014, ULTRASOUND OBST GYN, V43, P170, DOI 10.1002/uog.12509; Zheng S., 2004, ISPRS 20 C COMM 5 GE, P70	28	14	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0178858	10.1371/journal.pone.0178858	http://dx.doi.org/10.1371/journal.pone.0178858			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640827	Green Published, Green Submitted, gold			2022-12-27	WOS:000404135800012
J	Kieh, MD; Cho, EM; Myles, IA				Kieh, Mark D.; Cho, Elim M.; Myles, Ian A.			Contrasting academic and lay press print coverage of the 2013-2016 Ebola Virus Disease outbreak	PLOS ONE			English	Article							EMERGENCY RISK COMMUNICATION; BLOOD-CONTAINING AEROSOLS; HEMORRHAGIC-FEVER; SOCIAL MEDIA; WEST-AFRICA; TRANSMISSION; MANAGEMENT; EPIDEMIC; VACCINES; LESSONS	Under a traditional paradigm, only those with the expected background knowledge consume academic literature. The lay press, as well as government and non-government agencies, play a complementary role of extracting findings of high interest or importance and translating them for general viewing. The need for accurate reporting and public advising is paramount when attempting to tackle epidemic outbreaks through behavior change. Yet, public trust in media outlets is at a historic low. The Crisis and Emergency Risk Communication (CERC) model for media reporting on public health emergencies was established in 2005 and has subsequently been used to analyze media reporting on outbreaks of influenza and measles as well as smoking habits and medication compliance. However, no media analysis had yet been performed on the 2013-2016 Ebola Virus Disease (EVD) outbreak. This study compared the EVD information relayed by lay press sources with general review articles in the academic literature through a mixed-methods analysis. These findings suggest that comprehensive review articles could not serve as a source to clarify and contextualize the uncertainties around the EVD outbreak, perhaps due to adherence to technical accuracy at the expense of clarity within the context of outbreak conditions. This finding does not imply inferiority of the academic literature, nor does it draw direct causation between confusion in review articles and public misunderstanding. Given the erosion of the barriers siloing academia, combined with the demands of today's fast-paced media environment, contemporary researchers should realize that no study is outside the public forum and to therefore consider shifting the paradigm to take personal responsibility in the process of accurately translating their scientific words into public policy actions to best serve as a source of clarity.	[Kieh, Mark D.; Cho, Elim M.; Myles, Ian A.] NIAID, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Myles, Ian A.] George Washington Sch Publ Hlth, MPH Program, Washington, DC 20052 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); George Washington University	Myles, IA (corresponding author), NIAID, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Myles, IA (corresponding author), George Washington Sch Publ Hlth, MPH Program, Washington, DC 20052 USA.	mylesi@niaid.nih.gov	Myles, Ian/AAE-7623-2019	Myles, Ian/0000-0001-9316-3703				Abdullah S, 2015, EUR REV MED PHARMACO, V19, P2983; Afshordi N, 2017, ARXIV201717030538, P1703; Afshordi N, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.041301; Anderson G, 2015, J MED VIROL, V87, P537, DOI 10.1002/jmv.24130; Baize S, 2015, CURR OPIN VIROL, V10, P70, DOI 10.1016/j.coviro.2015.01.008; Barker J, 2005, J APPL MICROBIOL, V99, P339, DOI 10.1111/j.1365-2672.2005.02610.x; Bastug A, 2015, TURK J MED SCI, V45, P1, DOI 10.3906/sag-1411-37; Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545; Bebell LM, 2015, OBSTET GYNECOL, V125, P1293, DOI 10.1097/AOG.0000000000000853; Beeching NJ, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7348; Bishop BM, 2015, ANN PHARMACOTHER, V49, P196, DOI 10.1177/1060028014561227; Bociaga-Jasik Monika, 2014, Folia Med Cracov, V54, P49; Bogoch II, 2015, LANCET, V385, P29, DOI 10.1016/S0140-6736(14)61828-6; Bousso R, 2002, REV MOD PHYS, V74, P825, DOI 10.1103/RevModPhys.74.825; Burd EM, 2015, J CLIN MICROBIOL, V53, P4, DOI 10.1128/JCM.03115-14; Burnouf T, 2014, TRANSFUS APHER SCI, V51, P120, DOI 10.1016/j.transci.2014.10.003; Butler D, 2013, NATURE, V495, P433, DOI 10.1038/495433a; Camacho A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009346; Cardile Anthony P, 2014, Recent Pat Antiinfect Drug Discov, V9, P97; Carroll SA, 2013, J VIROL, V87, P2608, DOI 10.1128/JVI.03118-12; Casadevall A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004717; Centers for Disease Control and Prevention, 2017, OUTBR CHRON EB VIR D; Chiappelli F, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-014-0362-3; Choi JH, 2013, BIODRUGS, V27, P565, DOI 10.1007/s40259-013-0046-1; Chowell G, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0196-0; Davis J., 2002, OCCASIONAL PAPERS S, V1, P1; De Clercq E, 2015, BIOCHEM PHARMACOL, V93, P1, DOI 10.1016/j.bcp.2014.11.008; de La Vega MA, 2015, VIRAL IMMUNOL, V28, P3, DOI 10.1089/vim.2014.0068; Dhama K, 2015, J INFECT DEV COUNTR, V9, P441, DOI 10.3855/jidc.6197; Durojaiye ET, 2015, AFR J REPROD HEALTH, V19, P18; Eisa-Beygi S, 2015, ANTIVIR RES, V114, P53, DOI 10.1016/j.antiviral.2014.12.005; Elshabrawy HA, 2015, REV MED VIROL, V25, P241, DOI 10.1002/rmv.1841; Eriksson CO, 2015, PEDIATR CRIT CARE ME, V16, P97, DOI 10.1097/PCC.0000000000000358; Falasca L, 2015, CELL DEATH DIFFER, V22, P1250, DOI 10.1038/cdd.2015.67; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Formenty P, 2006, CLIN INFECT DIS, V42, P1521, DOI 10.1086/503836; Fowler RA, 2014, AM J RESP CRIT CARE, V190, P733, DOI 10.1164/rccm.201408-1514CP; Fung ICH, 2016, AM J INFECT CONTROL, V44, P1660, DOI 10.1016/j.ajic.2016.05.011; Funk DJ, 2015, CAN J ANESTH, V62, P80, DOI 10.1007/s12630-014-0257-z; Galas Aleksander, 2014, Folia Med Cracov, V54, P17; Galas Aleksander, 2014, Folia Med Cracov, V54, P27; Galvin Sheila, 2015, J Ir Dent Assoc, V61, P141; Gao JJ, 2014, DRUG DISCOV THER, V8, P229, DOI 10.5582/ddt.2014.01040; Gatherer D, 2014, J GEN VIROL, V95, P1619, DOI 10.1099/vir.0.067199-0; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Glisic S, 2015, EXPERT OPIN DRUG DIS, V10, P1025, DOI 10.1517/17460441.2015.1062872; Gomes Marcelo F C, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.cd818f63d40e24aef769dda7df9e0da5; Goodfellow NA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-909; Gostin LO, 2015, LANCET, V385, P1902, DOI 10.1016/S0140-6736(15)60644-4; Gulland A, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4336; Gumusova S, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0089-x; Gut Wlodzimierz, 2015, Przegl Epidemiol, V69, P15; Hartman AL, 2010, CLIN LAB MED, V30, P161, DOI 10.1016/j.cll.2009.12.001; HEINSOHN P, 1993, AM IND HYG ASSOC J, V54, P446, DOI 10.1080/15298669391354946; Hellman J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005088; Hewlett AL, 2015, CURR OPIN INFECT DIS, V28, P343, DOI 10.1097/QCO.0000000000000176; Heymann DL, 2015, LANCET, V385, P1884, DOI 10.1016/S0140-6736(15)60858-3; Hilton S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1116; Hoenen T, 2015, SCIENCE, V348, P117, DOI 10.1126/science.aaa5646; Jadav Surender Singh, 2015, Infectious Disorders - Drug Targets, V15, P20; Jensen JD, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-S3-S4; Judson S, 2015, VIRUSES-BASEL, V7, P511, DOI 10.3390/v7020511; Katz LM, 2014, TRANSFUSION, V54, P3247, DOI 10.1111/trf.12913; Kekule AS, 2015, VIRUSES-BASEL, V7, P3789, DOI 10.3390/v7072797; Ker K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011386.pub2; Kilgore PE, 2015, PHARMACOTHERAPY, V35, P43, DOI 10.1002/phar.1545; Kite J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162765; Knipe DM, 2015, J VIROL, V89, P7446, DOI 10.1128/JVI.01251-15; Knust B, 2012, J INFECT DIS S2, V2, pS119; Krause PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa8202; Laakso M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-124; Lanini S, 2015, LANCET INFECT DIS, V15, P738, DOI 10.1016/S1473-3099(15)70106-4; Leroy EM, 2011, CLIN MICROBIOL INFEC, V17, P964, DOI 10.1111/j.1469-0691.2011.03535.x; Li HY, 2015, MICROBES INFECT, V17, P109, DOI 10.1016/j.micinf.2014.11.012; Li J, 2016, INT J INFECT DIS, V42, P34, DOI 10.1016/j.ijid.2015.10.021; Lindblad R, 2015, J ALLERGY CLIN IMMUN, V135, P868, DOI 10.1016/j.jaci.2014.12.012; Madariaga MG, 2015, AM J MED, V128, P682, DOI 10.1016/j.amjmed.2015.01.035; Marcinkiewicz Janusz, 2014, Folia Med Cracov, V54, P39; Martines RB, 2015, J PATHOL, V235, P153, DOI 10.1002/path.4456; Marzi A, 2014, EXPERT REV VACCINES, V13, P521, DOI 10.1586/14760584.2014.885841; McCoy CE, 2014, WEST J EMERG MED, V15, P723, DOI 10.5811/westjem.2014.10.24155; McElroy Anita, 2015, Clin Adv Hematol Oncol, V13, P29; Meir L., EBOLA PANIC BOOSTS S; Meyers L, 2015, ANN EMERG MED, V65, P101, DOI 10.1016/j.annemergmed.2014.10.009; MILLER RL, 1995, AM IND HYG ASSOC J, V56, P670, DOI 10.1202/0002-8894(1995)056<0670:COBAGB>2.0.CO;2; Mirazimi A, 2015, J INTERN MED, V278, P227, DOI 10.1111/joim.12386; Mishra B, 2014, INDIAN J MED MICROBI, V32, P364, DOI 10.4103/0255-0857.142230; Missair A, 2015, ANESTH ANALG, V121, P810, DOI 10.1213/ANE.0000000000000573; Mollema L, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3863; Moller-Tank S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004731; Moore LSP, 2014, BRIT J HOSP MED, V75, P515, DOI 10.12968/hmed.2014.75.9.515; Mora-Rillo M, 2015, LANCET RESP MED, V3, P554, DOI 10.1016/S2213-2600(15)00180-0; Mrozek-Budzyn Dorota, 2014, Folia Med Cracov, V54, P33; Murray MJ, 2015, ANESTH ANALG, V121, P798, DOI 10.1213/ANE.0000000000000866; Muyembe-Tamfum JJ, 2012, ONDERSTEPOORT J VET, V79, DOI 10.4102/ojvr.v79i2.451; Oliphant E, 2014, GENET TEST MOL BIOMA, V18, P715, DOI 10.1089/gtmb.2014.1560; Olszanecki Rafal, 2014, Folia Med Cracov, V54, P67; Olupot-Olupot P, 2015, PEDIATR INFECT DIS J, V34, P314, DOI 10.1097/INF.0000000000000638; Osterholm M. T., 2015, MBIO, V6; Osungbade K O, 2014, Afr J Med Med Sci, V43, P87; Parkes-Ratanshi R, 2014, INTENS CARE MED, V40, P1742, DOI 10.1007/s00134-014-3497-z; Patane S, 2014, INT J CARDIOL, V177, P524, DOI 10.1016/j.ijcard.2014.08.114; Pellecchia U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143036; Picazo E, 2015, DRUG DISCOV TODAY, V20, P277, DOI 10.1016/j.drudis.2014.12.010; Reynolds B, 2005, J HEALTH COMMUN, V10, P43, DOI 10.1080/10810730590904571; Reynolds B, 2008, HEALTH PROMOT PRACT, V9, p13S, DOI 10.1177/1524839908325267; Richardson KJ, 2015, ADV EMERG NURS J, V37, P102, DOI 10.1097/TME.0000000000000063; Rid A, 2014, LANCET, V384, P1896, DOI 10.1016/S0140-6736(14)61315-5; Riffkin R., 2015, GALLUP; Roca A, 2015, J ALLERGY CLIN IMMUN, V135, P856, DOI 10.1016/j.jaci.2015.02.015; Rogstad KE, 2015, CURR OPIN INFECT DIS, V28, P83, DOI 10.1097/QCO.0000000000000135; Rougeron V, 2015, J CLIN VIROL, V64, P111, DOI 10.1016/j.jcv.2015.01.014; Sagripanti JL, 2011, ARCH VIROL, V156, P489, DOI 10.1007/s00705-010-0847-1; Schirrmacher V, 2015, INT J MOL MED, V36, P3, DOI 10.3892/ijmm.2015.2213; Sharma N, 2015, DIGEST DIS SCI, V60, P2590, DOI 10.1007/s10620-015-3691-z; Shears P, 2015, J HOSP INFECT, V90, P1, DOI 10.1016/j.jhin.2015.01.002; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007; Silver S, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnu008; Smith MJ, 2015, MONASH BIOETH REV, V33, P130, DOI 10.1007/s40592-015-0038-7; Snow CE, 2016, NATL ACAD COLLECTION; Somerville RCJ, 2011, PHYS TODAY, V64, P48, DOI 10.1063/PT.3.1296; Sordillo PP, 2015, IN VIVO, V29, P1; Starbird K., 2017, EXAMINING ALTERNATIV; Suwantarat N, 2015, CURR OPIN INFECT DIS, V28, P349, DOI 10.1097/QCO.0000000000000183; Swenson DL, 2008, CLIN VACCINE IMMUNOL, V15, P460, DOI 10.1128/CVI.00431-07; Tan DX, 2014, J PINEAL RES, V57, P381, DOI 10.1111/jpi.12186; Tattevin P, 2014, INTENS CARE MED, V40, P1738, DOI 10.1007/s00134-014-3473-7; Timen A, 2015, EUR J PUBLIC HEALTH, V25, P187, DOI 10.1093/eurpub/cku236; Timsit JF, 2015, INTENS CARE MED, V41, P575, DOI 10.1007/s00134-015-3755-8; To KKW, 2015, MICROBES INFECT, V17, P84, DOI 10.1016/j.micinf.2014.11.007; Toner E, 2015, DISASTER MED PUBLIC, V9, P33, DOI 10.1017/dmp.2014.115; Torres Mercedes, 2015, Emerg Med Clin North Am, V33, pe1; Tosh PK, 2014, MAYO CLIN PROC, V89, P1710, DOI 10.1016/j.mayocp.2014.10.010; Towers S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129179; Tully CM, 2015, LANCET INFECT DIS, V15, P356, DOI 10.1016/S1473-3099(14)71071-0; Vos SC, 2016, J HEALTH COMMUN, V21, P301, DOI 10.1080/10810730.2015.1064495; Wadman MC, 2015, ANN EMERG MED, V66, P306, DOI 10.1016/j.annemergmed.2015.04.020; Waters A, 2015, J HOSP MED, V10, P50, DOI 10.1002/jhm.2298; Weingartl HM, 2013, DEV BIOLOGICALS, V135, P211, DOI 10.1159/000178495; Weingartl HM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00811; West T Eoin, 2014, Ann Am Thorac Soc, V11, P1341, DOI 10.1513/AnnalsATS.201410-481PS; WOLLINA U, 1989, ACTA HISTOCHEM, V87, P87, DOI 10.1016/S0065-1281(89)80005-4; Wong G, 2015, EXPERT OPIN INV DRUG, V24, P999, DOI 10.1517/13543784.2015.1052403; Wong G, 2015, CLIN MICROBIOL REV, V28, P593, DOI 10.1128/CMR.00014-15; Wong G, 2014, EXPERT REV CLIN IMMU, V10, P781, DOI 10.1586/1744666X.2014.908705; Wozniak-Kosek A, 2015, ADV EXP MED BIOL, V857, P19, DOI 10.1007/5584_2015_123; Yang Y, 2008, ANN APPL STAT, V2, P1409, DOI 10.1214/08-AOAS193; Ye L, 2015, MICROBES INFECT, V17, P98, DOI 10.1016/j.micinf.2014.12.004; Zawilinska Barbara, 2014, Folia Med Cracov, V54, P57	150	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179356	10.1371/journal.pone.0179356	http://dx.doi.org/10.1371/journal.pone.0179356			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640889	Green Published, gold, Green Submitted			2022-12-27	WOS:000404135800030
J	Kim, SY; Kim, HJ; Park, EK; Joe, J; Sim, S; Choi, HG				Kim, So Young; Kim, Hyung-Jong; Park, Eun-Kyu; Joe, Jiwon; Sim, Songyong; Choi, Hyo Geun			Severe hearing impairment and risk of depression: A national cohort study	PLOS ONE			English	Article							OLDER-ADULTS; COCHLEAR IMPLANTS; HEALTH; ASSOCIATION; DIFFICULTIES; ADOLESCENTS; PREVALENCE; SYMPTOMS; CHILDREN	Objective Hearing impairment is suggested to be associated with depression in the elderly. The present study evaluated the risk of depression after hearing impairment in all age groups matched by age, sex, income, and region of residence. Methods The Korean Health Insurance Review and Assessment Service-National Patient Samples were collected for a period from 2002 to 2013. Hearing impairment was defined as a hearing threshold >= 60 dB in both ears or as >= 80 dB in one ear and >= 40 dB in one ear. Hearing-impaired participants performed a pure tone audiometry test 3 times and an auditory brainstem response threshold test once. The 6,136 hearing-impaired participants were matched 1: 4 with 24,544 controls with no reported hearing impairment for age, sex, income, and region of residence. Depression was investigated based on the International Classification of Disease-10 codes F31 (bipolar affective disorder) through F39 (unspecified mood disorder) by a psychiatrist from 2002 through 2013. The crude (simple) and adjusted (age, sex, income, region of residence, dementia, hypertension, diabetes, and dyslipidemia) hazard ratio (HR) of hearing impairment on depression were analyzed using Cox-proportional hazard model. Results The rate of depression was significantly higher in the severe hearing-impaired group than in the control group (7.9% vs. 5.7%, P < 0.001). Severe hearing impairment increased the risk of depression (adjusted HR = 1.37, 95% confidence interval [CI] = 1.24-1.52, P < 0.001). In a subgroup analysis, young (0-29 years old), middle-aged (30-59 years old), and old (>= 60 years old) severe hearing-impaired groups showed significantly increased risk of depression compared to controls with no reported hearing impairment. In accordance with income level, severe hearing impairment elevated depression in the low and high income groups, but not in the middle income group. Conclusion Severe hearing impairment increased the risk of depression independently of age, sex, region, past medical histories, and income (in low and high income persons but not in middle income persons).	[Kim, So Young] CHA Univ, CHA Bundang Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seongnam, South Korea; [Kim, Hyung-Jong; Park, Eun-Kyu; Joe, Jiwon; Choi, Hyo Geun] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea; [Sim, Songyong] Hallym Univ, Dept Stat, Chunchon, South Korea	Pochon Cha University; Hallym University; Hallym University	Choi, HG (corresponding author), Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea.	pupen@naver.com	Choi, Hyo Geun/K-4461-2019	Choi, Hyo Geun/0000-0003-1655-9549	National Research Foundation (NRF) of Korea [NRF-2015-R1D1A1A01060860, 2016M3A9E8941669]; Hallym University Sacred Heart Hospital [HURF-2016-38]	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Hallym University Sacred Heart Hospital	This work was supported in part by a research grant (NRF-2015-R1D1A1A01060860 and 2016M3A9E8941669) from the National Research Foundation (NRF) of Korea and a research grant funded by Hallym University Sacred Heart Hospital (HURF-2016-38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi JS, 2016, JAMA OTOLARYNGOL, V142, P652, DOI 10.1001/jamaoto.2016.0700; Dawes P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119616; dos Santos FD, 2015, INT ARCH OTORHINOLAR, V19, P229, DOI 10.1055/s-0034-1396792; Emmett SD, 2015, OTOL NEUROTOL, V36, P545, DOI 10.1097/MAO.0000000000000562; Gopinath B, 2009, J AM GERIATR SOC, V57, P1306, DOI 10.1111/j.1532-5415.2009.02317.x; Harada S, 2008, PREV MED, V47, P433, DOI 10.1016/j.ypmed.2008.06.011; Hong JW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000611; Huber M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00953; Jeddi Zahra, 2012, Iran J Otorhinolaryngol, V24, P7; Joo YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131247; Jun HJ, 2015, LARYNGOSCOPE, V125, P690, DOI 10.1002/lary.24913; Li CM, 2014, JAMA OTOLARYNGOL, V140, P293, DOI 10.1001/jamaoto.2014.42; Lin CS, 2016, J LARYNGOL OTOL, V130, P42, DOI 10.1017/S0022215115002960; Mick P, 2016, EAR HEARING, V37, pE194, DOI 10.1097/AUD.0000000000000267; Mick P, 2014, OTOLARYNG HEAD NECK, V150, P378, DOI 10.1177/0194599813518021; Moon IJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001580; Park JW, 2016, ANN OCCUP ENVIRON ME, V28, DOI 10.1186/s40557-016-0140-1; Pronk M, 2013, AM J AUDIOL, V22, P316, DOI 10.1044/1059-0889(2013/12-0069); Schmitt C, 2000, Int Tinnitus J, V6, P41; Stevenson J, 2015, EUR CHILD ADOLES PSY, V24, P477, DOI 10.1007/s00787-015-0697-1; Theunissen SCPM, 2011, INT J PEDIATR OTORHI, V75, P1313, DOI 10.1016/j.ijporl.2011.07.023; Tremblay KL, 2015, EAR HEARING, V36, pE290, DOI 10.1097/AUD.0000000000000195; Tseng CC, 2016, J AFFECT DISORDERS, V197, P94, DOI 10.1016/j.jad.2016.03.020	23	45	45	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179973	10.1371/journal.pone.0179973	http://dx.doi.org/10.1371/journal.pone.0179973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY6ZV	28640916	Green Submitted, gold, Green Published			2022-12-27	WOS:000404135800088
J	Udo, EE; Al-Sweih, N				Udo, Edet E.; Al-Sweih, Noura			Dominance of community-associated methicillin-resistant Staphylococcus aureus clones in a maternity hospital	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; NEONATAL UNIT; SAUDI-ARABIA; CHROMOSOME; EPIDEMIOLOGY; INFECTIONS; DIVERSITY; MRSA; SURVEILLANCE; EMRSA-15	Background Methicillin-resistant Staphylococcus aureus (MRSA) is a major pathogen causing healthcare-and community-acquired infections. The purpose of this study was to characterize MRSA isolated at the Maternity Hospital between 2006 and 2011 for their genetic relatedness. Materials and methods The MRSA isolates were investigated using a combination of antibiogram, Staphylococcal chromosome cassette mec (SCCmec) and spa typing to determine their relatedness to MRSA isolated in other Kuwait hospitals. The isolates were also investigated for the carriage of genes for Pantone valentine Leukocidin (PVL). Results A total of 103 MRSA obtained from 64 neonates, 17 adult patients and 12 healthcare workers. The isolates were resistant to Kanamycin (46.6%), gentamicin (40.8%), trimethoprim (32%), ciprofloxacin (22.3%), fusidic acid (16.5%), tetracycline (19.4%), erythromycin (15.5%), clindamycin (15.5%), streptomycin (11.6%) high-level mupirocin (2.9%) and chloramphenicol (0.9%). Twenty (19.4%) of the isolates were multiresistant. Thirty-one (30.0%) isolates were positive for PVL. Molecular typing revealed the presence of 11 clonal complexes and 23 clones with ST5-V-t002, (N = 22), ST22-IV-t223 (N = 18), ST22-IV-t852 (N = 10), ST80-IV-t044 (N = 7), ST5-V-t688 (N = 5), ST772-V-t657 (N = 5) and ST239-III-t860 (N = 4) constituting 66.9% of the isolates. Other clones were isolated sporadically. The number of MRSA isolates increased from two in 2006 to 22 in 2011 with a peak of 43 in 2008. Conclusion The study revealed a high prevalence of community-associated MRSA Maternity hospital. The MRSA population consisted of known strains, such as ST239-III-t680, ST22-IV-t223/t852 and ST80-IV-t044, that were reported previously in Kuwait and novel strains such as	[Udo, Edet E.; Al-Sweih, Noura] Kuwait Univ, Fac Med, Dept Microbiol, Jabriya, Kuwait	Kuwait University	Udo, EE (corresponding author), Kuwait Univ, Fac Med, Dept Microbiol, Jabriya, Kuwait.	EDET@hsc.edu.kw	Udo, Edet E/H-7367-2016	Udo, Edet E/0000-0002-7269-7949	Kuwait University [MI 01/11]	Kuwait University	This study was funded by Research Sector, Kuwait University, grant MI 01/11.	Abou Shady HM, 2015, BRAZ J INFECT DIS, V19, P68, DOI 10.1016/j.bjid.2014.09.005; Al-Haddad AM, 2001, J MED MICROBIOL, V50, P558, DOI 10.1099/0022-1317-50-6-558; Machuca MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073434; Ali H, 2012, J HOSP INFECT, V80, P293, DOI 10.1016/j.jhin.2011.12.019; Alsubaie S, 2012, PEDIATR INT, V54, P786, DOI 10.1111/j.1442-200X.2012.03673.x; Aqel AA, 2015, J INFECT PUBLIC HEAL, V8, P90, DOI 10.1016/j.jiph.2014.05.007; Biber A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042864; Boswihi SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162744; Bratu S, 2005, EMERG INFECT DIS, V11, P808, DOI 10.3201/eid1106.040885; BSAC, 2010, BSAC METH SUSC TEST; Carey AJ, 2010, J PERINATOL, V30, P135, DOI 10.1038/jp.2009.119; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Chung M, 2004, J CLIN MICROBIOL, V42, P542, DOI 10.1128/JCM.42.2.542-547.2004; Clinical and Laboratory Standard Institute, 2012, M100S22 CLSI; Coombs GW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-215; Creech CB, 2010, AM J INFECT CONTROL, V38, P72, DOI 10.1016/j.ajic.2009.06.015; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Djoudi F, 2013, NEW MICROBIOL, V36, P49; Ellington MJ, 2008, J ANTIMICROB CHEMOTH, V61, P73, DOI 10.1093/jac/dkm422; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Garcia CP, 2014, PEDIATR INFECT DIS J, V33, pE252, DOI 10.1097/INF.0000000000000435; Geraci DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087760; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Higuchi W, 2008, BIOCHEM BIOPH RES CO, V377, P752, DOI 10.1016/j.bbrc.2008.10.009; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Johnson AP, 2001, J ANTIMICROB CHEMOTH, V48, P143, DOI 10.1093/jac/48.1.143; Kamath S, 2010, INDIAN J PEDIATR, V77, P37, DOI 10.1007/s12098-010-0005-5; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Ma XX, 2002, ANTIMICROB AGENTS CH, V46, P1147, DOI 10.1128/AAC.46.4.1147-1152.2002; Maltezou HC, 2006, INT J ANTIMICROB AG, V27, P87, DOI 10.1016/j.ijantimicag.2005.11.004; McAdams RM, 2008, PEDIATR INT, V50, P810, DOI 10.1111/j.1442-200X.2008.02646.x; Monecke S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-146; Nubel U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054898; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Schaumburg F, 2014, CLIN MICROBIOL INFEC, V20, pO390, DOI 10.1111/1469-0691.12417; Schuenck RP, 2009, DIAGN MICR INFEC DIS, V64, P434, DOI 10.1016/j.diagmicrobio.2009.04.007; Seidl K, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0075-3; Senok A, 2016, INT J INFECT DIS, V51, P31, DOI 10.1016/j.ijid.2016.08.016; Smyth DS, 2009, J MED MICROBIOL, V58, P1343, DOI 10.1099/jmm.0.009837-0; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; Takei Y, 2010, BIOCONTROL SCI, V15, P129, DOI 10.4265/bio.15.129; Tokajian ST, 2010, EPIDEMIOL INFECT, V138, P707, DOI 10.1017/S0950268810000440; Udo EE, 2008, MED PRIN PRACT, V17, P71, DOI 10.1159/000109594; Udo E. E., 2016, New Microbes and New Infections, V12, P24, DOI 10.1016/j.nmni.2016.03.008; Udo EE, 2013, MED PRIN PRACT, V22, P535, DOI 10.1159/000350526; Udo EE, 2011, J MED MICROBIOL, V60, P600, DOI 10.1099/jmm.0.028381-0; Udo EE, 2006, CLIN MICROBIOL INFEC, V12, P262, DOI 10.1111/j.1469-0691.2005.01350.x; Williams K, 2014, J HOSP INFECT, V88, P149, DOI 10.1016/j.jhin.2014.06.012; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	51	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179563	10.1371/journal.pone.0179563	http://dx.doi.org/10.1371/journal.pone.0179563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640870	gold, Green Submitted, Green Published			2022-12-27	WOS:000404135800038
J	Yamaguchi, T; Suzuki, A; Hokkirigawa, K				Yamaguchi, Takeshi; Suzuki, Akito; Hokkirigawa, Kazuo			Required coefficient of friction in the anteroposterior and mediolateral direction during turning at different walking speeds	PLOS ONE			English	Article							CENTER-OF-MASS; LEVEL WALKING; KINEMATICS; PATH; STRATEGIES; FALLS; GAIT; STABILITY; INJURIES; SLIP	This study investigated the required coefficient of friction (RCOF) and the tangent of center of mass (COM)-center of pressure (COP) angle in the mediolateral (ML) and anteroposterior (AP) directions during turning at different walking speeds. Sixteen healthy young adults (8 males and 8 females) participated in this study. The participants were instructed to conduct trials of straight walking and 90 degrees step and spin turns to the right at each of three self-selected speeds (slow, normal, and fast). The ML and AP directions during turning gait were defined using the orientation of the pelvis to construct a body-fixed reference frame. The RCOF values and COM-COP angle tangent in the ML direction during turning at weight acceptance phase were higher than those during straight walking, and those values increased with increasing walking speed. The ML component of the RCOF and COM-COP tangent values during weight acceptance for step turns were higher than those for spin turns. The mean centripetal force during turning tended to increase with an increase in walking speed and had a strong positive correlation with the RCOF values in the ML direction (R = 0.97 during the weight acceptance phase; R = 0.95 during the push-off phase). Therefore, turning, particularly step turn, is likely to cause lateral slip at weight acceptance because of the increased centripetal force compared with straight walking. Future work should test at-risk population and compare with the present results.	[Yamaguchi, Takeshi; Suzuki, Akito; Hokkirigawa, Kazuo] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi, Japan; [Yamaguchi, Takeshi] Tohoku Univ, Grad Sch Bioengn, Sendai, Miyagi, Japan	Tohoku University; Tohoku University	Yamaguchi, T (corresponding author), Tohoku Univ, Grad Sch Engn, Sendai, Miyagi, Japan.; Yamaguchi, T (corresponding author), Tohoku Univ, Grad Sch Bioengn, Sendai, Miyagi, Japan.	yamatake@gdl.mech.tohoku.ac.jp	YAMAGUCHI, Takeshi/ABF-8367-2021; Yamaguchi, Takeshi T/D-3550-2017	Yamaguchi, Takeshi T/0000-0002-5063-9924	 [25420080]; Grants-in-Aid for Scientific Research [16K06038] Funding Source: KAKEN	; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant-in-Aid for Scientific Research (C) (25420080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially supported by a Grant-in-Aid for Scientific Research (C) (25420080).	Akram SB, 2010, GAIT POSTURE, V31, P23, DOI 10.1016/j.gaitpost.2009.08.238; Burnfield JM, 2007, J FORENSIC SCI, V52, P1328, DOI 10.1111/j.1556-4029.2007.00549.x; Cham R, 2002, GAIT POSTURE, V15, P159, DOI 10.1016/S0966-6362(01)00150-3; Chang WR, 2013, SAFETY SCI, V58, P49, DOI 10.1016/j.ssci.2013.03.014; Chang WR, 2012, ERGONOMICS, V55, P308, DOI 10.1080/00140139.2011.642008; Chang WR, 2012, SAFETY SCI, V50, P240, DOI 10.1016/j.ssci.2011.08.056; Courtine G, 2003, EUR J NEUROSCI, V18, P177, DOI 10.1046/j.1460-9568.2003.02736.x; Courtney TK, 2001, ERGONOMICS, V44, P1118, DOI 10.1080/00140130110085538; DTI, 1997, 19 ANN REP HOM ACC S; Fino P, 2014, J BIOMECH, V47, P1395, DOI 10.1016/j.jbiomech.2014.01.032; Fino PC, 2015, J BIOMECH, V48, P104, DOI 10.1016/j.jbiomech.2014.10.034; Glaister BC, 2007, J BIOMECH, V40, P3527, DOI 10.1016/j.jbiomech.2007.05.014; Glaister BC, 2007, GAIT POSTURE, V25, P289, DOI 10.1016/j.gaitpost.2006.04.003; HAGEMAN PA, 1986, PHYS THER, V66, P1382, DOI 10.1093/ptj/66.9.1382; Hase K, 1999, J NEUROPHYSIOL, V81, P2914, DOI 10.1152/jn.1999.81.6.2914; Hollands MA, 2001, EXP BRAIN RES, V140, P223, DOI 10.1007/s002210100811; Keall MD, 2015, LANCET, V385, P231, DOI 10.1016/S0140-6736(14)61006-0; Kim S, 2005, SAFETY SCI, V43, P425, DOI 10.1016/j.ssci.2005.08.004; Koepp GA, 2015, ERGONOMICS, V58, P674, DOI 10.1080/00140139.2014.985260; Maki B E, 1999, IEEE Trans Rehabil Eng, V7, P80, DOI 10.1109/86.750556; Maki Brian E., 1999, Physiotherapy Theory and Practice, V15, P69, DOI 10.1080/095939899307784; Menz HB, 2003, AGE AGEING, V32, P137, DOI 10.1093/ageing/32.2.137; Orendurff MS, 2006, GAIT POSTURE, V23, P106, DOI 10.1016/j.gaitpost.2004.12.008; PATLA AE, 1991, J EXP PSYCHOL HUMAN, V17, P603, DOI 10.1037/0096-1523.17.3.603; Redfern M. S., 1984, P 1984 INT C OCC ERG, VI, P573; Rogers MW, 2003, EXERC SPORT SCI REV, V31, P182, DOI 10.1097/00003677-200310000-00005; Sedgman R., 1994, P IN C FAC HLTH SCI; Taylor MJD, 2005, HUM MOVEMENT SCI, V24, P558, DOI 10.1016/j.humov.2005.07.005; Yamaguchi T, 2008, TRIBOL ONLINE, V3, DOI [10.2474/trol.3.59, DOI 10.2474/TROL.3.59]; Yamaguchi T., 2016, BIOTRIBOLOGY, V5, P16, DOI [DOI 10.1016/J.BIOTRI.2015.12.002, 10.1016/j.biotri.2015.12.002]; Yamaguchi T, 2008, IND HEALTH, V46, P23, DOI 10.2486/indhealth.46.23; Yamaguchi T, 2013, GAIT POSTURE, V38, P209, DOI 10.1016/j.gaitpost.2012.11.007; Yamaguchi T, 2012, J BIOMECH, V45, P2624, DOI 10.1016/j.jbiomech.2012.08.006	33	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179817	10.1371/journal.pone.0179817	http://dx.doi.org/10.1371/journal.pone.0179817			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY6ZV	28640853	Green Published, Green Submitted, gold			2022-12-27	WOS:000404135800069
J	Devis-Devis, J; Lizandra, J; Valencia-Peris, A; Perez-Gimeno, E; Garcia-Masso, X; Peiro-Velert, C				Devis-Devis, Jose; Lizandra, Jorge; Valencia-Peris, Alexandra; Perez-Gimeno, Esther; Garcia-Masso, Xavier; Peiro-Velert, Carmen			Longitudinal changes in physical activity, sedentary behavior and body mass index in adolescence: Migrations towards different weight cluster	PLOS ONE			English	Article							SCREEN MEDIA TIME; OBESITY; OVERWEIGHT; ASSOCIATIONS; TELEVISION; CHILDREN; BMI; PREVALENCE; EXERCISE; NUMBER	This study examined longitudinal changes in physical activity, sedentary behavior and body mass index in adolescents, specifically their migrations towards a different weight cluster. A cohort of 755 adolescents participated in a three-year study. A clustering Self-Organized Maps Analysis was performed to visualize changes in subjects' characteristics between the first and second assessment, and how adolescents were grouped. Also a classification tree was used to identify the behavioral characteristics of the groups that changed their weight cluster. Results indicated that boys were more active and less sedentary than girls. Boys were especially keen to technological-based activities while girls preferred social-based activities. A moderate competing effect between sedentary behaviors and physical activities was observed, especially in girls. Overweight and obesity were negatively associated with physical activity, although a small group of overweight/obese adolescents showed a positive relationship with vigorous physical activity. Cluster migrations indicated that 22.66% of adolescents changed their weight cluster to a lower category and none of them moved in the opposite direction. The behavioral characteristics of these adolescents did not support the hypothesis that the change to a lower weight cluster was a consequence of an increase in time devoted to physical activity or a decrease in time spent on sedentary behavior. Physical activity and sedentary behavior does not exert a substantial effect on overweight and obesity. Therefore, there are other ways of changing to a lower-weight status in adolescents apart from those in which physical activity and sedentary behavior are involved.	[Devis-Devis, Jose] Univ Valencia, Dept Educ Fis & Esport, Valencia, Spain; [Lizandra, Jorge; Valencia-Peris, Alexandra; Perez-Gimeno, Esther; Garcia-Masso, Xavier; Peiro-Velert, Carmen] Univ Valencia, Dept Didact Expressio Mus Plast & Corporal, Valencia, Spain	University of Valencia; University of Valencia	Devis-Devis, J (corresponding author), Univ Valencia, Dept Educ Fis & Esport, Valencia, Spain.	jose.devis@uv.es	Lizandra, Jorge/O-6916-2015; Valencia-Peris, Alexandra/ABE-5860-2020; Devis-Devis, Jose/G-8758-2015; García-Massó, Xavier/L-8222-2014; Valencia-Peris, Alexandra/L-2260-2014; Peiró-Velert, Carmen/N-6056-2015	Lizandra, Jorge/0000-0001-5599-133X; Valencia-Peris, Alexandra/0000-0002-2031-9743; Devis-Devis, Jose/0000-0003-4599-3782; Peiró-Velert, Carmen/0000-0003-4794-6541; Garcia-Masso, Xavier/0000-0002-5925-4537	Ministry of Science and Innovation (Spain) [EDU2009-13664]; Generalitat Valenciana (Spain) [ACIF/2013/214]	Ministry of Science and Innovation (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana (Spain)(Center for Forestry Research & Experimentation (CIEF))	This work was partially funded by the Ministry of Science and Innovation (Spain) (EDU2009-13664), as well as the Generalitat Valenciana (Spain) which supported this work by the VALi+d predoctoral contract to JL (ACIF/2013/214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron DJ, 2002, ARCH PEDIAT ADOL MED, V156, P1075, DOI 10.1001/archpedi.156.11.1075; Aires L, 2010, INT J SPORTS MED, V31, P133, DOI 10.1055/s-0029-1243255; Belanger M, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0237-x; Bickham DS, 2013, PEDIATRICS, V131, P935, DOI 10.1542/peds.2012-1197; Biddle SJH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-1; Boreham Colin, 2004, Int J Behav Nutr Phys Act, V1, P14, DOI 10.1186/1479-5868-1-14; Camhi SM, 2011, J SCHOOL HEALTH, V81, P409, DOI 10.1111/j.1746-1561.2011.00609.x; Carrascosa A, 2010, REV ESP ENDOCRINOL P, V2, P59, DOI 10.3266; Cleland V, 2008, INT J OBESITY, V32, P1685, DOI 10.1038/ijo.2008.171; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Collings PJ, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0222-4; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Devis-Devis J, 2009, J ADOLESCENCE, V32, P213, DOI 10.1016/j.adolescence.2008.04.004; Elgar FJ, 2005, PUBLIC HEALTH, V119, P518, DOI 10.1016/j.puhe.2004.10.011; Fang J, 2003, AM J PREV MED, V25, P283, DOI 10.1016/S0749-3797(03)00207-1; Fisher A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018576; Garcia-Continente X, 2014, EUR J PUBLIC HEALTH, V24, P5, DOI 10.1093/eurpub/ckt013; Gebremariam MK, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-104; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hands BP, 2011, J SCI MED SPORT, V14, P397, DOI 10.1016/j.jsams.2011.03.011; Hardy LL, 2007, PREV MED, V45, P71, DOI 10.1016/j.ypmed.2007.03.014; Hills AP, 2011, BRIT J SPORT MED, V45, P866, DOI 10.1136/bjsports-2011-090199; Janssen I, 2005, OBES REV, V6, P123, DOI 10.1111/j.1467-789X.2005.00176.x; Laurson K, 2008, ACTA PAEDIATR, V97, P795, DOI 10.1111/j.1651-2227.2008.00713.x; Lohman T.J., 1988, ANTHROPOMETRIC STAND; Maher C, 2012, ACTA PAEDIATR, V101, P1170, DOI 10.1111/j.1651-2227.2012.02804.x; Mark AE, 2008, J PUBLIC HEALTH-UK, V30, P153, DOI 10.1093/pubmed/fdn022; Mcmurray RG, 2004, MED SCI SPORT EXER, V36, P2135; Melkevik O, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1810-6; Mitchell JA, 2013, OBESITY, V21, P572, DOI 10.1002/oby.20157; Mitchell JA, 2012, MED SCI SPORT EXER, V44, P1081, DOI 10.1249/MSS.0b013e3182446c65; Must A, 2005, INT J OBESITY, V29, pS84, DOI 10.1038/sj.ijo.0803064; Nelson MC, 2006, PEDIATRICS, V118, pE1627, DOI 10.1542/peds.2006-0926; Nelson TF, 2011, CURR SPORT MED REP, V10, P360, DOI 10.1249/JSR.0b013e318237bf74; Olds T, 2011, INT J PEDIATR OBES, V6, P342, DOI 10.3109/17477166.2011.605895; Peiro-Velert C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099478; Rokholm B, 2010, OBES REV, V11, P835, DOI 10.1111/j.1467-789X.2010.00810.x; Rosenberg DE, 2007, J ADOLESCENT HEALTH, V41, P472, DOI 10.1016/j.jadohealth.2007.05.018; SALLIS JF, 1985, AM J EPIDEMIOL, V121, P91, DOI 10.1093/oxfordjournals.aje.a113987; Schoeller DA, 2009, NUTR REV, V67, P249, DOI 10.1111/j.1753-4887.2009.00197.x; Sisson SB, 2011, J PHYS ACT HEALTH, V8, pS188, DOI 10.1123/jpah.8.s2.s188; Sundblad GB, 2008, PAIN, V136, P239, DOI 10.1016/j.pain.2007.06.032; te Velde SJ, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-16; Thompson AM, 2005, MED SCI SPORT EXER, V37, P1902, DOI 10.1249/01.mss.0000176306.11134.23; Timperio A, 2017, HEALTH PLACE, V43, P121, DOI 10.1016/j.healthplace.2016.10.004; Trang NHHD, 2013, AM J PREV MED, V44, P223, DOI 10.1016/j.amepre.2012.10.021; Tremblay MS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-98; Tremblay MS, 2003, INT J OBESITY, V27, P1100, DOI 10.1038/sj.ijo.0802376; Valencia-Peris A, 2016, J PHYS ACT HEALTH, V13, P579, DOI 10.1123/jpah.2015-0407; Vesanto Juha, 1999, P MATLAB DSP C, V99, P35	51	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179502	10.1371/journal.pone.0179502	http://dx.doi.org/10.1371/journal.pone.0179502			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY6UH	28636644	gold, Green Submitted, Green Published			2022-12-27	WOS:000404118300039
J	Elsherif, O; Bannan, C; Keating, S; McKiernan, S; Bergin, C; Norris, S				Elsherif, Omar; Bannan, Ciaran; Keating, Shay; McKiernan, Susan; Bergin, Colm; Norris, Suzanne			Outcomes from a large 10 year hepatitis C treatment programme in people who inject drugs: No effect of recent or former injecting drug use on treatment adherence or therapeutic response	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS INFECTION; ANTIVIRAL TREATMENT; HCV TREATMENT; SOFOSBUVIR; RIBAVIRIN; ABT-450/R-OMBITASVIR; EPIDEMIOLOGY; METAANALYSIS; REINFECTION; DASABUVIR	Background and aims People who inject drugs (PWID) are historically viewed as having "difficult to treat" hepatitis C disease, with perceived inferior treatment adherence and outcomes, and concerns regarding reinfection risk. We evaluated for differences in treatment adherence and response to Peginterferon-alfa-2a/Ribavirin (Peg-IFN alpha/RBV) in a large urban cohort with and without a history of remote or recent injection drug use. Methods Patient data was retrospectively reviewed for 1000 consecutive patients D 608 former (no injecting drug use for 6 months of therapy), 85 recent (injecting drug use within 6 months) PWID, and 307 non-drug users who were treated for chronic hepatitis C with Peg-IFN alpha/RBV. The groups were compared for baseline characteristics, treatment adherence, and outcome. Results There was no significant difference in treatment non-adherence between the groups (8.4% in PWID vs 6.8% in non-PWIDs; RR = 1.23, CI 0.76-1.99). The overall SVR rate in PWID (64.2%) was not different from non-PWIDs (60.9%) [RR = 1.05, 95% CI 0.95-1.17]. There was no significant difference in SVR rates between the groups controlling for genotype (48.4% vs 48.4% for genotype 1; 74.9 vs 73.3% for genotype 3). Former and recent PWID had similar adherence rates. Conclusions PWID have comparable treatment adherence and SVR rates when compared to non-drug users treated with Peg-IFNa/RBV. These data support a public health strategy of HCV treatment and eradication in PWID in the DAA era.	[Elsherif, Omar; McKiernan, Susan; Norris, Suzanne] St James Hosp, Dept Hepatol, Dublin, Ireland; [Bannan, Ciaran; Bergin, Colm] St James Hosp, Dept Genito Urinary Med & Infect Dis, Dublin, Ireland; [Keating, Shay] Drug Treatment Ctr Board, Dublin, Ireland; [McKiernan, Susan; Bergin, Colm; Norris, Suzanne] Trinity Coll Dublin, Sch Med, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	Elsherif, O (corresponding author), St James Hosp, Dept Hepatol, Dublin, Ireland.	elsherio@tcd.ie						Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Alavi M, 2014, LIVER INT, V34, P1198, DOI 10.1111/liv.12370; [Anonymous], 1999, J Hepatol, V30, P956; [Anonymous], 1997, HEPATOLOGY S, V26, p71S; Backmund M, 2001, HEPATOLOGY, V34, P188, DOI 10.1053/jhep.2001.25882; Barua S, 2015, ANN INTERN MED, V163, P215, DOI 10.7326/M15-0406; Cescon A, 2014, AIDS, V28, P121, DOI 10.1097/QAD.0000000000000020; Cornberg M, 2011, LIVER INT, V31, P30, DOI 10.1111/j.1478-3231.2011.02539.x; Dalgard O, 2002, EUR ADDICT RES, V8, P45, DOI 10.1159/000049487; Dimova RB, 2013, CLIN INFECT DIS, V56, P806, DOI 10.1093/cid/cis1007; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Gazdik F, 2009, BRATISL MED J, V110, P77; Goldberg D, 2008, EURO SURVEILL, P13; Grady BP, 2013, CLIN INFECT DIS, V57, pS105, DOI 10.1093/cid/cit301; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Grebely J, 2012, HEPATOLOGY, V55, P1058, DOI 10.1002/hep.24754; Hellard M, 2009, CLIN INFECT DIS, V49, P561, DOI 10.1086/600304; Hellard ME, 2012, MED J AUSTRALIA, V196, P638, DOI 10.5694/mja11.10981; Iversen J, 2013, J VIRAL HEPATITUS, DOI [DOI 10.1111/JVH.12129, 10.1111/jvh.12129]; Martin NK, 2015, J VIRAL HEPATITIS, V22, P399, DOI 10.1111/jvh.12338; Martin NK, 2016, J HEPATOL, V65, P17, DOI 10.1016/j.jhep.2016.02.007; McDonald SA, 2014, J VIRAL HEPATITIS, V21, P366, DOI 10.1111/jvh.12153; Melin P, 2010, EUR J GASTROEN HEPAT, V22, P1050, DOI 10.1097/MEG.0b013e328338d9aa; Monga HK, 2001, CLIN INFECT DIS, V33, P240, DOI 10.1086/321819; Moussalli J, 2010, GASTROENTEROL RES PR, V2010; Myles A, 2011, CAN J GASTROENTEROL, V25, P135, DOI 10.1155/2011/810108; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Robaeys G, 2006, EUR J GASTROEN HEPAT, V18, P159, DOI 10.1097/00042737-200602000-00008; Scottish Executive Health Department (SEND), 2006, HEP C ACT PLAN SCOTL; Simmons B, 2016, CLIN INFECT DIS, V62, P683, DOI 10.1093/cid/civ948; Skipper C, 2003, GUT, V52, P1500, DOI 10.1136/gut.52.10.1500; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Sylvestre DL, 2004, J URBAN HEALTH, V81, P719, DOI 10.1093/jurban/jth153; 2009, HEPATOLOGY, V49, P1335, DOI DOI 10.1002/HEP.22759	36	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0178398	10.1371/journal.pone.0178398	http://dx.doi.org/10.1371/journal.pone.0178398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636638	Green Published, gold, Green Submitted			2022-12-27	WOS:000404118300011
J	Kolosenko, I; Yu, Y; Busker, S; Dyczynski, M; Liu, JP; Haraldsson, M; Apergi, CP; Helleday, T; Tamm, KP; Page, BDG; Grander, D				Kolosenko, Iryna; Yu, Yasmin; Busker, Sander; Dyczynski, Matheus; Liu, Jianping; Haraldsson, Martin; Apergi, Caroline Palm; Helleday, Thomas; Tamm, Katja Pokrovskaja; Page, Brent D. G.; Grander, Dan			Identification of novel small molecules that inhibit STAT3-dependent transcription and function	PLOS ONE			English	Article							STAT3 ACTIVATION; SIGNAL TRANSDUCER; KINASE INHIBITOR; GROWTH-FACTOR; HUMAN BREAST; PHASE-I; INTERLEUKIN-6; PATHWAY; ASSAY; IL-6	Activation of Signal Transducer and Activator of Transcription 3 (STAT3) has been linked to several processes that are critical for oncogenic transformation, cancer progression, cancer cell proliferation, survival, drug resistance and metastasis. Inhibition of STAT3 signaling has shown a striking ability to inhibit cancer cell growth and therefore, STAT3 has become a promising target for anti-cancer drug development. The aim of this study was to identify novel inhibitors of STAT-dependent gene transcription. A cellular reporter-based system for monitoring STAT3 transcriptional activity was developed which was suitable for high-throughput screening (Z' = 0,8). This system was used to screen a library of 28,000 compounds (the ENAMINE Drug-Like Diversity Set). Following counter-screenings and toxicity studies, we identified four hit compounds that were subjected to detailed biological characterization. Of the four hits, KI16 stood out as the most promising compound, inhibiting STAT3 phosphorylation and transcriptional activity in response to IL6 stimulation. In silico docking studies showed that KI16 had favorable interactions with the STAT3 SH2 domain, however, no inhibitory activity could be observed in the STAT3 fluorescence polarization assay. KI16 inhibited cell viability preferentially in STAT3-dependent cell lines. Taken together, using a targeted, cell-based approach, novel inhibitors of STAT-driven transcriptional activity were discovered which are interesting leads to pursue further for the development of anti-cancer therapeutic agents.	[Kolosenko, Iryna; Yu, Yasmin; Busker, Sander; Dyczynski, Matheus; Apergi, Caroline Palm; Tamm, Katja Pokrovskaja; Grander, Dan] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, Stockholm, Sweden; [Liu, Jianping] Karolinska Inst, Div Funct Gen, Dept Med Biochem & Biophys, Karolinska High Throughput Ctr, Stockholm, Sweden; [Haraldsson, Martin] Karolinska Inst, Div Translat Med & Chem Biol, Dept Med Biochem & Biophys, Chem Biol Consortium Sweden, Stockholm, Sweden; [Helleday, Thomas; Page, Brent D. G.] Karolinska Inst, Sci Life Lab, Div Translat Med & Chem Biol, Dept Med Biochem & Biophys, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Kolosenko, I; Grander, D (corresponding author), Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, Stockholm, Sweden.	Iryna.Kolosenko@ki.se; Dan.Grander@ki.se		Dyczynski, Matheus/0000-0002-7650-3574; Helleday, Thomas/0000-0002-7384-092X; Yu, Yasmin/0000-0002-0560-5012; Pokrovskaja Tamm, Katja/0000-0001-6359-1256; Liu, Jianping/0000-0002-7336-3895; Palm Apergi, Caroline/0000-0003-2236-2099	The Swedish Research Council [521-2012-2037]; The Swedish Cancer Foundation [150768]; Radiumhemmet Research Foundation [144063]; Ruthand Rickard Julins Fond [46442]	The Swedish Research Council(Swedish Research Council); The Swedish Cancer Foundation; Radiumhemmet Research Foundation; Ruthand Rickard Julins Fond	Support was provided by The Swedish Research Council; 521-2012-2037 [www.vr.se] (DG) The Swedish Cancer Foundation; 150768 [www.cancerfonden.se] (DG); Radiumhemmet Research Foundation; 144063 [www.rahfo.se] (DG); Ruthand Rickard Julins Fond; 2016 juli 46442, managed by Karolinska Institutet Funds [www.fonder.ki.se] (IK); Robert Lund bergs Memmorial Fund; 2015 lund 45360, managed by Karolinska Institutet Funds [fonder.ki.se] (IK); Jakob Linder's Memorial Foundation, [www. carls onlinder.se] (IK); Swedish Society for Medical Research (SSMF), [www.ssmf.se] (BDGP);The David and Astrid Hagele An Foundation; managed by Karolinska Institutet Funds [fonder.ki.se] (BDGP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AM, 2016, CHEMMEDCHEM, V11, P850, DOI 10.1002/cmdc.201600021; Avalle Lidia, 2012, JAKSTAT, V1, P65, DOI 10.4161/jkst.20045; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Chen KF, 2012, EUR J MED CHEM, V55, P220, DOI 10.1016/j.ejmech.2012.07.023; Chen SH, 2008, CANCER BIOL THER, V7, P1994, DOI 10.4161/cbt.7.12.6967; Cimica V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020188; Coppo P, 2006, BRIT J HAEMATOL, V134, P171, DOI 10.1111/j.1365-2141.2006.06161.x; Debnath B, 2012, J MED CHEM, V55, P6645, DOI 10.1021/jm300207s; Duarte CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029653; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gao D, 2016, BIOORG MED CHEM; Garske AL, 2011, P NATL ACAD SCI USA, V108, P15046, DOI 10.1073/pnas.1111239108; Giri D, 2001, AM J PATHOL, V159, P2159, DOI 10.1016/S0002-9440(10)63067-2; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang M, 2016, BIOORG MED CHEM LETT, V26, P5172, DOI 10.1016/j.bmcl.2016.09.073; Huang R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094226; Huang WL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-309; Khodarev NN, 2004, P NATL ACAD SCI USA, V101, P1714, DOI 10.1073/pnas.0308102100; Kim EJ, 2002, J CELL BIOCHEM, V85, P369, DOI 10.1002/jcb.10142; Kolosenko I, 2014, INT J CANC; Lai PS, 2015, EXPERT OPIN THER PAT, V25, P1397, DOI 10.1517/13543776.2015.1086749; Lee HJ, 2014, CANCER CELL, V26, P207, DOI 10.1016/j.ccr.2014.05.019; Leeman-Neill RJ, 2011, CANCER PREV RES, V4, P230, DOI 10.1158/1940-6207.CAPR-10-0249; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Maldonado V, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-152; McMurray JS, 2006, CHEM BIOL, V13, P1123, DOI 10.1016/j.chembiol.2006.11.001; Noolvi Malleshappa N, 2010, J Basic Clin Pharm, V1, P153; Ogura M, 2015, CANCER SCI, V106, P896, DOI 10.1111/cas.12683; Oh DY, 2015, CANCER RES TREAT, V47, P607, DOI 10.4143/crt.2014.249; Pedranzini L, 2006, CANCER RES, V66, P9714, DOI 10.1158/0008-5472.CAN-05-4280; Quesnelle KM, 2007, J CELL BIOCHEM, V102, P311, DOI 10.1002/jcb.21475; Ramsauer K, 2007, P NATL ACAD SCI USA, V104, P2849, DOI 10.1073/pnas.0610944104; Ren ZY, 2003, BIOORG MED CHEM LETT, V13, P633, DOI 10.1016/S0960-894X(02)01050-8; Sasser AK, 2007, FASEB J, V21, P3763, DOI 10.1096/fj.07-8832com; Schaper F, 2015, CYTOKINE GROWTH F R, V26, P475, DOI 10.1016/j.cytogfr.2015.07.004; Schiavone D, 2011, FEBS LETT, V585, P2455, DOI 10.1016/j.febslet.2011.06.020; Schust J, 2004, ANAL BIOCHEM, V330, P114, DOI 10.1016/j.ab.2004.03.024; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; Wake MS, 2015, FEBS J, V282, P2600, DOI 10.1111/febs.13285; Wang HL, 2000, CARCINOGENESIS, V21, P1313, DOI 10.1093/carcin/21.7.1313; Wang SW, 2014, INT J ONCOL, V44, P1032, DOI 10.3892/ijo.2014.2259; WANG Y, 1994, MOL BIOL CELL, V5, P819, DOI 10.1091/mbc.5.7.819; Wang YX, 2013, P NATL ACAD SCI USA, V110, P16975, DOI 10.1073/pnas.1315862110; Weichselbaum RR, 2008, P NATL ACAD SCI USA, V105, P18490, DOI 10.1073/pnas.0809242105; Yang E, 2003, J BIOL CHEM, V278, P15794, DOI 10.1074/jbc.M213073200; Yang F, 2010, MOL CANCER THER, V9, P953, DOI 10.1158/1535-7163.MCT-09-0947; Yang JB, 2010, P NATL ACAD SCI USA, V107, P21499, DOI 10.1073/pnas.1016147107; Zeng Y, 2015, SCI PROGRAMMING-NETH, V2015, DOI 10.1155/2015/910281; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang L, 2006, MOL CELL BIOCHEM, V288, P179, DOI 10.1007/s11010-006-9137-3; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P9623, DOI 10.1073/pnas.1121606109; Zong CS, 2000, J BIOL CHEM, V275, P15099, DOI 10.1074/jbc.M000089200	54	13	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0178844	10.1371/journal.pone.0178844	http://dx.doi.org/10.1371/journal.pone.0178844			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636670	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000404118300018
J	Bose, U; Kruangkum, T; Wang, TF; Zhao, M; Ventura, T; Mitu, SA; Hodson, MP; Shaw, PN; Sobhon, P; Cummins, SF				Bose, Utpal; Kruangkum, Thanapong; Wang, Tianfang; Zhao, Min; Ventura, Tomer; Mitu, Shahida Akter; Hodson, Mark P.; Shaw, Paul N.; Sobhon, Prasert; Cummins, Scott F.			Biomolecular changes that occur in the antennal gland of the giant freshwater prawn (Machrobrachium rosenbergii)	PLOS ONE			English	Article							CHINESE MITTEN CRAB; JUVENILE-HORMONE; ANDROGENIC GLAND; SPINY LOBSTER; URIC-ACID; IDENTIFICATION; PHEROMONE; SEQUENCE; RELEASE; CRUSTACEANS	In decapod crustaceans, the antennal gland (AnG) is a major primary source of externally secreted biomolecules, and some may act as pheromones that play a major role in aquatic animal communication. In aquatic crustaceans, sex pheromones regulate reproductive behaviours, yet they remain largely unidentified besides the N-acetylglucosamine-1,5-lactone (NAGL) that stimulates male to female attraction. In this study, we used an AnG transcriptome of the female giant freshwater prawn (Macrobrachium rosenbergii) to predict the secretion of 226 proteins, including the most abundantly expressed transcripts encoding the Spaetzle protein, a serine protease inhibitor, and an arthropodial cuticle protein AMP 8.1. A quantitative proteome analysis of the female AnG at intermolt, premolt and postmolt, identified numerous proteins of different abundances, such as the hemocyanin subunit 1 that is most abundant at intermolt. We also show that hemocyanin subunit 1 is present within water surrounding females. Of those metabolites identified, we demonstrate that the NAGL and Nacetylglucosamine (NAG) can bind with high affinity to hemocyanin subunit 1. In summary, this study has revealed components of the female giant freshwater prawn AnG that are released and contribute to further research towards understanding crustacean conspecific signalling.	[Bose, Utpal; Wang, Tianfang; Zhao, Min; Ventura, Tomer; Mitu, Shahida Akter; Cummins, Scott F.] Univ Sunshine Coast, Genet Ecol & Physiol Ctr, Fac Sci Hlth Educ & Engn, Maroochydore, Qld, Australia; [Bose, Utpal; Hodson, Mark P.] Univ Queensland, Metabol Australia, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia; [Kruangkum, Thanapong] Mahidol Univ, Dept Anat, Fac Sci, Bangkok, Thailand; [Kruangkum, Thanapong; Sobhon, Prasert] Mahidol Univ, Ctr Excellence Shrimp Mol Biol & Biotechnol Cente, Fac Sci, Bangkok, Thailand; [Hodson, Mark P.; Shaw, Paul N.] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia; [Sobhon, Prasert] Burapha Univ, Fac Allied Hlth Sci, Chon Buri, Thailand	University of the Sunshine Coast; University of Queensland; Mahidol University; Mahidol University; University of Queensland; Burapha University	Cummins, SF (corresponding author), Univ Sunshine Coast, Genet Ecol & Physiol Ctr, Fac Sci Hlth Educ & Engn, Maroochydore, Qld, Australia.	scummins@usc.edu.au	Wang, Tianfang/GRO-0844-2022; Shaw, Paul/Q-8454-2019; Ventura, T./H-9832-2019; Shaw, Paul N/G-4418-2010; Wang, Tianfang/L-5192-2016; Zhao, Min/J-6588-2019; Bose, Utpal/AAU-5241-2020; Bose, Utpal/A-1785-2019; Wang, Tianfang/AAG-4290-2020; Hodson, Mark/J-7609-2013; Cummins, Scott/I-6420-2016	Wang, Tianfang/0000-0002-4876-7767; Shaw, Paul/0000-0001-7154-592X; Ventura, T./0000-0002-0777-2367; Shaw, Paul N/0000-0001-7154-592X; Wang, Tianfang/0000-0002-4876-7767; Zhao, Min/0000-0001-5498-3434; Bose, Utpal/0000-0003-1156-6504; Bose, Utpal/0000-0003-1156-6504; Wang, Tianfang/0000-0002-4876-7767; Hodson, Mark/0000-0002-5436-1886; Cummins, Scott/0000-0002-1454-2076	Australian Research Council [FT110100990]; Australian Government	Australian Research Council(Australian Research Council); Australian Government(Australian GovernmentCGIAR)	This work was supported by the Australian Research Council (Future Fellowship, FT110100990 to SFC). This research was undertaken with the assistance of resources from the National Computational Infrastructure (NCI), which is supported by the Australian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mohsen I, 2009, THESIS; ATEMA J, 1986, J CHEM ECOL, V12, P2065, DOI 10.1007/BF01041997; Bamber SD, 1997, ESTUAR COAST SHELF S, V44, P195, DOI 10.1006/ecss.1996.0211; BARKER DL, 1979, BRAIN RES, V161, P99, DOI 10.1016/0006-8993(79)90198-7; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Bhavan P. S., 2010, International Journal of Biology, V2, P107; BINNS R, 1969, BIOL BULL, V136, P147, DOI 10.2307/1539809; Bose U, 2016, COMP BIOCHEM PHYS D, V19, P25, DOI 10.1016/j.cbd.2016.05.004; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Case D.A., 2016, AMBER 2016, DOI DOI 10.13140/RG.2.2.27958.70729; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Chandler JC, 2015, SEX DEV, V9, P338, DOI 10.1159/000443943; Coates CJ, 2014, DEV COMP IMMUNOL, V45, P43, DOI 10.1016/j.dci.2014.01.021; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Eriksson L., 2001, MULTI MEGAVARIATE DA; Felgenhauer B.E., 1992, P45; FINGERMAN M, 1994, J CRUSTACEAN BIOL, V14, P413, DOI 10.2307/1548990; Fingerman M, 1997, INVERTEBR REPROD DEV, V31, P47, DOI 10.1080/07924259.1997.9672562; FLOWER DR, 1993, PROTEIN SCI, V2, P753, DOI 10.1002/pro.5560020507; Gao Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144350; Giraud-Billoud M, 2011, COMP BIOCHEM PHYS A, V158, P506, DOI 10.1016/j.cbpa.2010.12.012; Glazer L, 2013, J EXP BIOL, V216, P1898, DOI 10.1242/jeb.080945; Guo YR, 2014, FISHERIES SCI, V80, P621, DOI 10.1007/s12562-014-0738-6; Hardege JD, 2011, CHEMICAL COMMUNICATION IN CRUSTACEANS, P373, DOI 10.1007/978-0-387-77101-4_19; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Homola E, 1997, COMP BIOCHEM PHYS B, V117, P347, DOI 10.1016/S0305-0491(96)00337-9; Huang S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14015; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kamio M, 2005, BIOL BULL-US, V208, P12, DOI 10.2307/3593096; Kamio M, 2014, J EXP BIOL, V217, P1286, DOI 10.1242/jeb.099051; KEEN JN, 1991, EUR J BIOCHEM, V197, P407, DOI 10.1111/j.1432-1033.1991.tb15925.x; Kind T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-105; Kruangkum T, 2015, ANIM REPROD SCI, V161, P129, DOI 10.1016/j.anireprosci.2015.08.015; Lan JF, 2013, DEV COMP IMMUNOL, V41, P608, DOI 10.1016/j.dci.2013.07.004; LAUFER H, 1987, SCIENCE, V235, P202, DOI 10.1126/science.235.4785.202; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Levesque B, 1999, PHARMACOGENETICS, V9, P207; Li X, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059064, 10.1371/journal.pone.0067880, 10.1371/journal.pone.0063227, 10.1371/journal.pone.0080399]; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; MANGUM CP, 1980, AM ZOOL, V20, P19; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Nor Faadila M, 2012, INT FOOD RES J, V20, P751; PETERSON DR, 1974, J EXP ZOOL, V189, P85, DOI 10.1002/jez.1401890108; Pinnow P, 2016, J COMP PHYSIOL B, V186, P161, DOI 10.1007/s00360-015-0943-3; Rittschof D, 2004, PEPTIDES, V25, P1503, DOI 10.1016/j.peptides.2003.10.024; RYAN EP, 1966, SCIENCE, V151, P340, DOI 10.1126/science.151.3708.340; Sangster T, 2006, ANALYST, V131, P1075, DOI 10.1039/b604498k; Sautin YY, 2008, NUCLEOS NUCLEOT NUCL, V27, P608, DOI 10.1080/15257770802138558; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SPENCER M, 1986, J COMP PHYSIOL A, V158, P59, DOI 10.1007/BF00614520; Suwansa-ard S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123848; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tian ZH, 2012, FISHERIES SCI, V78, P67, DOI 10.1007/s12562-011-0426-8; Vasudevan Sugumar, 2013, Journal of Marine Animals and their Ecology, V6, P12; Ventura T, 2015, SCI REP-UK, V5, DOI 10.1038/srep13537; Ventura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055322; Ventura T, 2012, BIOTECHNOL ADV, V30, P1543, DOI 10.1016/j.biotechadv.2012.04.008; Want EJ, 2013, NAT PROTOC, V8, P17, DOI 10.1038/nprot.2012.135; Weihrauch D, 2004, J EXP BIOL, V207, P4491, DOI 10.1242/jeb.01308; Zeeck E, 1998, J CHEM ECOL, V24, P13, DOI 10.1023/A:1022328610423	62	11	11	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0177064	10.1371/journal.pone.0177064	http://dx.doi.org/10.1371/journal.pone.0177064			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662025	Green Published, Green Submitted, gold			2022-12-27	WOS:000404608300002
J	Curran, MM; Sandman, CA; Davis, EP; Glynn, LM; Baram, TZ				Curran, Megan M.; Sandman, Curt A.; Davis, Elysia Poggi; Glynn, Laura M.; Baram, Tallie Z.			Abnormal dendritic maturation of developing cortical neurons exposed to corticotropin releasing hormone (CRH): Insights into effects of prenatal adversity?	PLOS ONE			English	Article							HUMAN-PREGNANCY; ALZHEIMERS-DISEASE; PLACENTAL CLOCK; MESSENGER-RNA; STRESS; EXPRESSION; BRAIN; FETAL; HIPPOCAMPUS; RECEPTORS	Corticotropin releasing hormone (CRH) produced by the hypothalamus initiates the hypothalamic-pituitary-adrenal (HPA) axis, which regulates the body's stress response. CRH levels typically are undetectable in human plasma, but during pregnancy the primate placenta synthesizes and releases large amounts of CRH into both maternal and fetal circulations. Notably, placental CRH synthesis increases in response to maternal stress signals. There is evidence that human fetal exposure to high concentrations of placental CRH is associated with behavioral consequences during infancy and into childhood, however the direct effects on of the peptide on the human brain are unknown. In this study, we used a rodent model to test the plausibility that CRH has direct effects on the developing cortex. Because chronic exposure to CRH reduces dendritic branching in hippocampal neurons, we tested the hypothesis that exposure to CRH would provoke impoverishment of dendritic trees in cortical neurons. This might be reflected in humans as cortical thinning. We grew developing cortical neurons in primary cultures in the presence of graded concentrations of CRH. We then employed Sholl analyses to measure dendritic branching and total dendritic length of treated cells. A seven-day exposure to increasing levels of CRH led to a significant, dose-dependent impoverishment of the branching of pyramidal-like cortical neurons. These results are consistent with the hypothesis that, rather than merely being a marker of prenatal stress, CRH directly decreases dendritic branching. Because dendrites comprise a large portion of cortical volume these findings might underlie reduced cortical thickness and could contribute to the behavioral consequences observed in children exposed to high levels of CRH in utero.	[Curran, Megan M.; Baram, Tallie Z.] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA; [Sandman, Curt A.; Davis, Elysia Poggi] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA; [Davis, Elysia Poggi] Univ Denver, Dept Psychol, Denver, CO 80208 USA; [Glynn, Laura M.] Chapman Univ, Dept Psychol, Orange, CA USA; [Baram, Tallie Z.] Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA; [Baram, Tallie Z.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of Denver; Chapman University System; Chapman University; University of California System; University of California Irvine; University of California System; University of California Irvine	Baram, TZ (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA.; Baram, TZ (corresponding author), Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA.; Baram, TZ (corresponding author), Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA.	tallie@uci.edu	Baram, Tallie Z/AGV-2524-2022	Baram, Tallie Z/0000-0003-0771-8616; Davis, Elysia/0000-0001-6345-9271; Garcia-Curran, Megan/0000-0003-3240-8310	National Institute of Health awards [P50 MH096889]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD51852, HD28413, HD50662, HD065823, HD40967]; National Institute of Neurological Disorders and Stroke [NS41298, T32 NS045540, NS28912]; National Institute of General Medical Sciences [T32GM08620]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065823] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040967, R01HD050662, R01HD051852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073136, P50MH096889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS045540, R01NS028912, R01NS041298] Funding Source: NIH RePORTER	National Institute of Health awards; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by National Institute of Health awards P50 MH096889 (TZB, LMG, EPD). Eunice Kennedy Shriver National Institute of Child Health and Human Development through HD51852 and HD28413 (CAS); HD50662 and HD065823 (EPD); HD40967 (LMG), National Institute of Neurological Disorders and Stroke through NS41298 (CAS) T32 NS045540 (TZB/MMC), NS28912 (TZB). National Institute of General Medical Sciences through T32GM08620 (MMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres AL, 2013, J NEUROSCI, V 33, P16945, DOI 10.1523/JNEUROSCI.1445-13.2013; Avishai-Eliner S, 2002, TRENDS NEUROSCI, V25, P518, DOI 10.1016/S0166-2236(02)02241-5; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; BARAM TZ, 1991, INT J DEV NEUROSCI, V9, P473, DOI 10.1016/0736-5748(91)90033-I; BARAM TZ, 1992, ANN NEUROL, V31, P488, DOI 10.1002/ana.410310505; BARAM TZ, 1995, NEUROREPORT, V6, P277, DOI 10.1097/00001756-199501000-00013; Baram TZ, 1998, TRENDS NEUROSCI, V21, P471, DOI 10.1016/S0166-2236(98)01275-2; BEHAN DP, 1995, NATURE, V378, P284, DOI 10.1038/378284a0; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Brunson KL, 2001, P NATL ACAD SCI USA, V98, P8856, DOI 10.1073/pnas.151224898; Chen JC, 2000, J COMP NEUROL, V420, P305, DOI 10.1002/(SICI)1096-9861(20000508)420:3<305::AID-CNE3>3.0.CO;2-8; Chen YC, 2004, P NATL ACAD SCI USA, V101, P15782, DOI 10.1073/pnas.0403975101; Chen Y, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00013; Class Quetzal A, 2008, Dev Neurosci, V30, P419, DOI 10.1159/000191213; Curran M, PROTOCOL PRIMARY NEU; Davis EP, 2005, DEV NEUROSCI-BASEL, V27, P299, DOI 10.1159/000086709; Deussing J, 2017, CURR MOL PHARMACOL, V10, P1; DORR HG, 1989, J CLIN ENDOCR METAB, V68, P863; FRIM DM, 1988, J CLIN INVEST, V82, P287, DOI 10.1172/JCI113585; Gayle DA, 2004, AM J PHYSIOL-REG I, V286, pR1024, DOI 10.1152/ajpregu.00664.2003; Gitau R, 2004, ARCH DIS CHILD-FETAL, V89, pF29, DOI 10.1136/fn.89.1.F29; GOLAND RS, 1986, J CLIN ENDOCR METAB, V63, P1199, DOI 10.1210/jcem-63-5-1199; GRINO M, 1989, ENDOCRINOLOGY, V124, P60, DOI 10.1210/endo-124-1-60; Gunn BG, 2008, J NEUROSCI, V28, P2903; Herman JP, 2016, COMPR PHYSIOL, V6, P603, DOI 10.1002/cphy.c150015; Howland MA, 2016, PSYCHONEUROENDOCRINO, V67, P10, DOI 10.1016/j.psyneuen.2016.01.023; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; Karteris E, 2001, MOL GENET METAB, V72, P287, DOI 10.1006/mgme.2001.3159; Kastin AJ, 2002, NEUROENDOCRINOLOGY, V75, P367, DOI 10.1159/000059433; KEEGAN CE, 1994, ENDOCRINOLOGY, V134, P2547, DOI 10.1210/en.134.6.2547; Khan S, 2004, BRAIN RES, V1016, P48, DOI 10.1016/j.brainres.2004.04.062; Korosi A, 2008, EUR J PHARMACOL, V583, P204, DOI 10.1016/j.ejphar.2007.11.066; Kostich WA, 2004, J COMP NEUROL, V478, P111, DOI 10.1002/cne.20271; Koutmani Y, 2013, MOL PSYCHIATR, V18, P300, DOI 10.1038/mp.2012.198; Liu XJ, 2016, J NEUROSCI, V36, P4802, DOI 10.1523/JNEUROSCI.3186-15.2016; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; Maras PM, 2012, TRENDS NEUROSCI, V35, P315, DOI 10.1016/j.tins.2012.01.005; MCLEAN M, 1995, NAT MED, V1, P460, DOI 10.1038/nm0595-460; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Noam Y, 2010, J BIOL CHEM, V285, P14724, DOI 10.1074/jbc.M109.070391; Paus T., 2009, HDB ADOLESCENT PSYCH, V1, P95, DOI DOI 10.1002/9780470479193; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Regev L, 2014, FRONT NEUROENDOCRIN, V35, P171, DOI 10.1016/j.yfrne.2013.10.001; Rissman RA, 2012, P NATL ACAD SCI USA, V109, P6277, DOI 10.1073/pnas.1203140109; ROBINSON BG, 1988, P NATL ACAD SCI USA, V85, P5244, DOI 10.1073/pnas.85.14.5244; ROBINSON BG, 1989, MOL CELL ENDOCRINOL, V62, P337, DOI 10.1016/0303-7207(89)90022-1; Roozendaal B, 2002, P NATL ACAD SCI USA, V99, P13908, DOI 10.1073/pnas.212504599; Sandman CA, 1999, ANN NY ACAD SCI, V897, P66, DOI 10.1111/j.1749-6632.1999.tb07879.x; Sandman CA, 2006, PEPTIDES, V27, P1457, DOI 10.1016/j.peptides.2005.10.002; Smith R, 2007, NEW ENGL J MED, V356, P271, DOI 10.1056/NEJMra061360; Smith R, 2007, FRONT BIOSCI, V12, P912, DOI 10.2741/2113; SWANSON LW, 1983, NEUROENDOCRINOLOGY, V36, P165, DOI 10.1159/000123454; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; Van Pett K, 2000, J COMP NEUROL, V428, P191, DOI 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U; Yan XX, 1998, HIPPOCAMPUS, V8, P231, DOI 10.1002/(SICI)1098-1063(1998)8:3<231::AID-HIPO6>3.0.CO;2-M; Zhang C, 2016, ALZHEIMERS DEMENT, V12, P527, DOI 10.1016/j.jalz.2015.09.007	56	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180311	10.1371/journal.pone.0180311	http://dx.doi.org/10.1371/journal.pone.0180311			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658297	Green Published, gold			2022-12-27	WOS:000404607900071
J	Luz, C; Rodrigues, LP; de Meester, A; Cordovil, R				Luz, Carlos; Rodrigues, Luis P.; de Meester, An; Cordovil, Rita			The relationship between motor competence and health-related fitness in children and adolescents	PLOS ONE			English	Article							FUNDAMENTAL MOVEMENT SKILLS; PHYSICAL-ACTIVITY; COORDINATION; PROFICIENCY; CHILDHOOD; YOUTH; ASSOCIATIONS; STRENGTH; OBESITY	Background and aims In the last twenty years, there has been increasing evidence that Motor Competence (MC) is vital for developing an active and healthy lifestyle. This study analyses the associations between motor competence and its components, with health-related fitness (HRF). Methods A random sample of 546 children (278 males, mean = 10.77 years) divided into four age groups (7-8; 9-10; 11-12; 13-14 years old) was evaluated. A quantitative MC instrument (evaluating stability, locomotor and manipulative skills), a maximal multistage 20-m shuttle-run test and the handgrip test, height and BMI were used in the analyses. Pearson correlations and standard regression modelling were performed to explore the associations between variables. Results Moderate to strong significant correlations (0.49 < r < 0.73) were found between MC and HRF, for both sexes, and correlation values were stable across the age groups. The MC model explained 74% of the HRF variance, with the locomotor component being the highest predictor for the entire sample (beta =.302; p < .001). Gender-related differences were found when boys and girls were analysed at each age group. Locomotor MC for girls was the most consistent significant predictor of HRF across all age groups (0.47 < beta < 0.65; all p <=.001). For boys, significant predictors were locomotor and manipulative MC (0.21 <beta< 0.49; all p < .05) in the two younger age groups (7-8 and 9-10 years) and stability (0.50 <beta< 0.54; all p <=.001) for the older two age groups (11-12 and 13-14 years). Conclusion These results support the idea that: (1) the relationship between overall MC and HRF is strong and stable across childhood and early adolescence; (2) when accounting for the different MC components, boys and girls show different relationship patterns with HFR across age.	[Luz, Carlos] Inst Politecn Lisboa, Escola Super Educ Lisboa, Lisbon, Portugal; [Luz, Carlos] Univ Lisbon, Fac Motricidade Humana, Lisbon, Portugal; [Rodrigues, Luis P.] Res Ctr Sports Hlth & Human Dev CIDESD, Vila Real, Portugal; [Rodrigues, Luis P.] Inst Politecn Viana do Castelo, Escola Super Desporto & Lazer Melgaco, Melgaco, Portugal; [de Meester, An] Univ Ghent, Dept Movement & Sports Sci, Ghent, Belgium; [Cordovil, Rita] Univ Lisbon, CIPER, Fac Motricidade Humana, Lisbon, Portugal	Polytechnic Institute of Lisbon; Universidade de Lisboa; Polytechnic Institute of Viana do Castelo; Ghent University; Universidade de Lisboa	Luz, C (corresponding author), Inst Politecn Lisboa, Escola Super Educ Lisboa, Lisbon, Portugal.; Luz, C (corresponding author), Univ Lisbon, Fac Motricidade Humana, Lisbon, Portugal.	carlosmiguelluz@gmail.com	Rodrigues, Luis P./W-1962-2018; da Luz, Carlos miguel nunes/U-3940-2019; Cordovil, Rita/E-7593-2012; De Meester, An/H-5410-2019	Rodrigues, Luis P./0000-0002-6804-3600; Cordovil, Rita/0000-0002-4907-7186; De Meester, An/0000-0003-2270-719X; Luz, Carlos/0000-0002-9126-5375	Foundation for Science and Technology (Portugal) [I&D472 (UID/DTP/00447/2013)]	Foundation for Science and Technology (Portugal)(Portuguese Foundation for Science and Technology)	This research was funded by the Foundation for Science and Technology (Portugal) I&D472 (UID/DTP/00447/2013).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, FITNESSGRAM ACTIVITY; Barnett LM, 2009, J ADOLESCENT HEALTH, V44, P252, DOI 10.1016/j.jadohealth.2008.07.004; Barnett LM, 2008, MED SCI SPORT EXER, V40, P2137, DOI 10.1249/MSS.0b013e31818160d3; Castelli DM, 2007, J TEACH PHYS EDUC, V26, P358, DOI 10.1123/jtpe.26.4.358; Cattuzzo MT, 2016, J SCI MED SPORT, V19, P123, DOI 10.1016/j.jsams.2014.12.004; Cohen DD, 2010, ACTA PAEDIATR, V99, P1065, DOI 10.1111/j.1651-2227.2010.01723.x; D'Hondt E, 2014, OBESITY, V22, P1505, DOI 10.1002/oby.20723; D'hondt E, 2011, INT J PEDIATR OBES, V6, pE556, DOI 10.3109/17477166.2010.500388; De Miguel-Etayo P, 2014, INT J OBESITY, V38, pS57, DOI 10.1038/ijo.2014.136; Erwin HE, 2008, RES Q EXERCISE SPORT, V79, P495, DOI 10.1080/02701367.2008.10599516; Fransen J, 2014, RES DEV DISABIL, V35, P1375, DOI 10.1016/j.ridd.2014.03.011; Gallahue DL., 2012, UNDERSTANDING MOTOR; Gisladottir P, 2014, PEDIATR PHYS THER, V26, P69, DOI 10.1097/PEP.0000000000000006; Haga M, 2008, CHILD CARE HLTH DEV, V34, P329, DOI 10.1111/j.1365-2214.2008.00814.x; Haga M, 2015, PERCEPT MOTOR SKILL, V121, P900, DOI 10.2466/10.PMS.121c24x2; Hands B, 2009, SCAND J MED SCI SPOR, V19, P655, DOI 10.1111/j.1600-0838.2008.00847.x; Hardy LL, 2013, MED SCI SPORT EXER, V45, P1965, DOI 10.1249/MSS.0b013e318295a9fc; Hills AP, 2007, SPORTS MED, V37, P533, DOI 10.2165/00007256-200737060-00006; Holfelder B, 2014, PSYCHOL SPORT EXERC, V15, P382, DOI 10.1016/j.psychsport.2014.03.005; Laukkanen A, 2014, SCAND J MED SCI SPOR, V24, pE102, DOI 10.1111/sms.12116; Lopes L, 2013, HUM MOVEMENT SCI, V32, P9, DOI 10.1016/j.humov.2012.05.005; Lopes L, 2012, AM J HUM BIOL, V24, P746, DOI 10.1002/ajhb.22310; Lopes VP, 2011, SCAND J MED SCI SPOR, V21, P663, DOI 10.1111/j.1600-0838.2009.01027.x; Lopes VP, 2012, J SCI MED SPORT, V15, P38, DOI 10.1016/j.jsams.2011.07.005; Low S, 2009, ANN ACAD MED SINGAP, V38, P57; Lubans DR, 2010, SPORTS MED, V40, P1019, DOI 10.2165/11536850-000000000-00000; Luz C, 2016, J SCI MED SPORT, V19, P568, DOI 10.1016/j.jsams.2015.07.005; Milliken LA, 2008, J STRENGTH COND RES, V22, P1339, DOI 10.1519/JSC.0b013e31817393b1; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Robinson LE, 2015, SPORTS MED, V45, P1273, DOI 10.1007/s40279-015-0351-6; Ross WD, 1991, PHYSL TESTING ELITEA, P223; Stodden D, 2009, RES Q EXERCISE SPORT, V80, P223; Stodden DF, 2008, QUEST, V60, P290, DOI 10.1080/00336297.2008.10483582; Stodden DF, 2014, PEDIATR EXERC SCI, V26, P231, DOI 10.1123/pes.2013-0027; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Vandorpe B, 2011, SCAND J MED SCI SPOR, V21, P378, DOI 10.1111/j.1600-0838.2009.01067.x; Vedul-Kjelsas V, 2012, CHILD CARE HLTH DEV, V38, P394, DOI 10.1111/j.1365-2214.2011.01275.x; Wrotniak BH, 2006, PEDIATRICS, V118, pE1758, DOI 10.1542/peds.2006-0742	38	29	33	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179993	10.1371/journal.pone.0179993	http://dx.doi.org/10.1371/journal.pone.0179993			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JT	28658292	Green Submitted, Green Published, gold			2022-12-27	WOS:000404607900048
J	Hover, SS; Bertke, AS				Hover, Shantal S.; Bertke, Andrea S.			Herpes simplex virus 1 and 2 educational assessment of young adults in rural southwest Virginia	PLOS ONE			English	Article							GENITAL HERPES; SEXUAL HEALTH; KNOWLEDGE; INTERNET; FEMALE	Purpose Herpes simplex virus 2 (HSV-2) causes genital herpes, one of the most common sexually transmitted infections (STIs) in the U.S. HSV-1, commonly associated with cold sores, is increasing as a cause of genital herpes. Abstinence-only sexual health classes, commonly taught in Virginia, generate young adults who are under-educated in sexual health, increasing STI risks. College students in southwest Virginia were surveyed to assess comprehensiveness of high school health education regarding HSV-1 and HSV-2 and to identify students' preferred methods for STI education. Methods To obtain data on knowledge of HSV, comprehensiveness of sexual health education in high school, and preferred learning methods, 237 college students participated in an online questionnaire and 28 students were interviewed using structured interviews. Results Questionnaire and interview data indicated that Family Life Education classes need to include more comprehensive information on prevention, viral transmission, and differences between HSV-1 and HSV-2. The majority of total respondents (both the questionnaire and interview) (65%) reported non-comprehensive high school sexual health education. The majority of interview (79%) and questionnaire (55%) respondents wished they had learned more about herpes and other STIs in high school. Education preferences of both interviewed and surveyed respondents included interactive internet programs or games, more realistic lectures, and learning about STIs later in high school when students reported greater sexual activity. Conclusion Our results indicate that more comprehensive sexual health education is needed and wanted by students in southwest Virginia. More relevant educational programs should be implemented for VA high school students utilizing technology and interactive methods to improve student engagement in sexual health education.	[Hover, Shantal S.; Bertke, Andrea S.] Virginia Polytech Inst & State Univ, Dept Populat Hlth Sci, Blacksburg, VA 24061 USA; [Hover, Shantal S.] Santa Barbara Publ Hlth Dept, Santa Barbara, CA USA	Virginia Polytechnic Institute & State University	Bertke, AS (corresponding author), Virginia Polytech Inst & State Univ, Dept Populat Hlth Sci, Blacksburg, VA 24061 USA.	asbertke@vt.edu		Bertke, Andrea/0000-0002-8941-8010	Virginia Maryland College of Veterinary Medicine (ASB Startup)	Virginia Maryland College of Veterinary Medicine (ASB Startup)	Funding was provided by Virginia Maryland College of Veterinary Medicine (ASB Startup). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern NR, 2006, FAM COMMUNITY HEALTH, V29, P299, DOI 10.1097/00003727-200610000-00008; Aral SO, 2006, SPECIAL ISSUE SEXUAL, pS1; Batalden K, 2007, J PEDIATR ADOL GYNEC, V20, P319, DOI 10.1016/j.jpag.2007.04.004; Bull S, 2009, AIDS BEHAV, V13, P474, DOI 10.1007/s10461-008-9487-9; CDC Fact Sheet, 2013, INC PREV COST SEX TR; Chong A, 2012, EFFECTIVENESS SPILLO; Donovan P., 1998, 4 GUTTM I; Guse K, 2012, J ADOLESCENT HEALTH, V51, P535, DOI 10.1016/j.jadohealth.2012.03.014; Heymann DL, 2008, CONTROL COMMUNICABLE; Kohler PK, 2008, J ADOLESCENT HEALTH, V42, P344, DOI 10.1016/j.jadohealth.2007.08.026; Lewis LM, 1999, INT J STD AIDS, V10, P703, DOI 10.1258/0956462991913376; Lou CH, 2006, J ADOLESCENT HEALTH, V39, P720, DOI 10.1016/j.jadohealth.2006.04.003; Merin A, 2011, J HEALTH PSYCHOL, V16, P80, DOI 10.1177/1359105310367528; MERTZ GJ, 1992, ANN INTERN MED, V116, P197, DOI 10.7326/0003-4819-116-3-197; Murray PR, 2009, MED MICROBIOLOGY, V6th, P361; NARAL, 2014, COMPR SEX ED; Peskin MF, 2015, J ADOLESCENT HEALTH, V56, P515, DOI 10.1016/j.jadohealth.2015.01.001; Rana RK, 2005, SEX TRANSM DIS, V32, P308, DOI 10.1097/01.olq.0000162363.82005.fe; Ratnam S, 2007, CAN J INFECT DIS MED, V18, P233, DOI 10.1155/2007/505364; Royer HR, 2013, J PEDIATR ADOL GYNEC, V26, P109, DOI 10.1016/j.jpag.2012.11.007; Tortolero SR, 2010, J ADOLESCENT HEALTH, V46, P169, DOI 10.1016/j.jadohealth.2009.06.008; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964	22	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179969	10.1371/journal.pone.0179969	http://dx.doi.org/10.1371/journal.pone.0179969			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ2LT	28654651	gold, Green Submitted, Green Published			2022-12-27	WOS:000404541500043
J	Uemura, A; Nakata, M; Goya, S; Fukayama, T; Tanaka, R				Uemura, Akiko; Nakata, Mary; Goya, Seijirow; Fukayama, Toshiharu; Tanaka, Ryou			Effective new membrane for preventing postthoracotomy pleural adhesion by surface water induction technology	PLOS ONE			English	Article							SEPRAFILM(R); RATS	Background After thoracic surgery, adhesions between the pleura can cause substantial complications. This study investigated the effectiveness of a novel membrane utilizing surface water induction technology to prevent adhesions. Methods Eight beagles were divided into an experimental group (five males) and a control group (three females). The experimental group underwent thoracotomy on both the left and right sides of the chest. Both sides received the membrane, and the membrane on one side was glued to the pleura using tissue adhesive. The control group underwent thoracotomy only on the left side. Two weeks postoperatively, all dogs were sacrificed and adhesions were evaluated macroscopically and microscopically. Results Severe adhesion was seen between the parietal and visceral pleura in all control dogs, whereas the experimental group showed minor adhesion in only one dog on one side. Conclusions Our novel anti-adhesive membrane appeared highly effective in preventing postthoracotomy pleural adhesions.	[Uemura, Akiko; Nakata, Mary; Goya, Seijirow; Tanaka, Ryou] Tokyo Univ Agr & Technol, Anim Med Ctr, Fuchu, Tokyo, Japan; [Fukayama, Toshiharu] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan	Tokyo University of Agriculture & Technology; National Cerebral & Cardiovascular Center - Japan	Uemura, A; Tanaka, R (corresponding author), Tokyo Univ Agr & Technol, Anim Med Ctr, Fuchu, Tokyo, Japan.	anco@vet.ne.jp; ryo@vet.ne.jp	uemura, akiko/T-1481-2019; Tanaka, Ryo S/C-8376-2013; Tanaka, Ryou/M-3078-2019	uemura, akiko/0000-0003-2671-5074; Tanaka, Ryo S/0000-0001-9948-6490; Tanaka, Ryou/0000-0001-9948-6490	Japan Science and Technology Agency (National Research and Development Agency)	Japan Science and Technology Agency (National Research and Development Agency)	This research was funded by the Japan Science and Technology Agency (National Research and Development Agency); however, the sponsor played no role in the collection, analysis or interpretation of data; in the writing of the report; or in the decision to submit the article for publication. Therefore, the authors have declared that no competing interests exist.	Barmparas G, 2010, J GASTROINTEST SURG, V14, P1619, DOI 10.1007/s11605-010-1189-8; Buyukkale S, 2015, INT J CLIN EXP MED, V8, P11544; Diamond MP, 2012, GYNECOL SURG, V9, P237, DOI 10.1007/s10397-012-0741-9; Diamond MP, 2012, GYNECOL SURG, V9, P247, DOI 10.1007/s10397-012-0742-8; diZeregal GS, 2001, HUM REPROD UPDATE, V7, P547, DOI 10.1093/humupd/7.6.547; Gataullin N G, 1968, Sov Med, V31, P43; Getman Vladyslav, 2006, Interact Cardiovasc Thorac Surg, V5, P243, DOI 10.1510/icvts.2005.121129; Gonzalez-Quintero Victor Hugo, 2009, Rev Obstet Gynecol, V2, P38; Izumi Y, 2012, EUR SURG RES, V48, P93, DOI 10.1159/000337033; Karacam V, 2011, INT J MED SCI, V8, P380, DOI 10.7150/ijms.8.380; Kim JH, 2015, ANN DERMATOL, V27, P224, DOI 10.5021/ad.2015.27.2.224; Lefort B, 2015, J CARDIOTHORAC SURG, V10, DOI 10.1186/s13019-015-0257-2; Luijendijk RW, 1996, ANN SURG, V223, P242, DOI 10.1097/00000658-199603000-00003; Masuda M, 2015, GEN THORAC CARDIOVAS, V63, P670, DOI 10.1007/s11748-015-0590-3; Noishiki Y, 2010, ARTIF ORGANS, V34, P224, DOI 10.1111/j.1525-1594.2009.00787.x; Oizumi H, 1990, Nihon Kyobu Geka Gakkai Zasshi, V38, P72; SANDEN C, 1959, Munch Med Wochenschr, V101, P1970; Satoh H, 2013, TUBERK TORAK, V61, P357, DOI 10.5578/tt.6268; STANGEL JJ, 1984, J REPROD MED, V29, P143; Sulaiman H, 2001, ANN SURG, V234, P256, DOI 10.1097/00000658-200108000-00016; Takagi K, 2013, J SURG RES, V179, pE13, DOI 10.1016/j.jss.2012.01.056; Yim APC, 1998, ANN THORAC SURG, V65, P328, DOI 10.1016/S0003-4975(97)01341-6	22	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179815	10.1371/journal.pone.0179815	http://dx.doi.org/10.1371/journal.pone.0179815			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654705	Green Published, gold, Green Submitted			2022-12-27	WOS:000404541500033
J	Elsohaby, I; Burns, JB; Riley, CB; Shaw, RA; McClure, JT				Elsohaby, Ibrahim; Burns, Jennifer B.; Riley, Christopher B.; Shaw, R. Anthony; McClure, J. Trenton			Application of laboratory and portable attenuated total reflectance infrared spectroscopic approaches for rapid quantification of alpaca serum immunoglobulin G	PLOS ONE			English	Article							PASSIVE TRANSFER STATUS; NEONATAL LLAMAS; HAND-HELD; IMMUNITY; FAILURE; AUTHENTICATION; SPECTROMETERS; QUANTITATION; DIAGNOSIS; CAMELIDS	The objective of this study was to develop and compare the performance of laboratory grade and portable attenuated total reflectance infrared (ATR-IR) spectroscopic approaches in combination with partial least squares regression (PLSR) for the rapid quantification of alpaca serum IgG concentration, and the identification of low IgG (< 1000 mg/dL), which is consistent with the diagnosis of failure of transfer of passive immunity (FTPI) in neonates. Serum samples (n = 175) collected from privately owned, healthy alpacas were tested by the reference method of radial immunodiffusion (RID) assay, and laboratory grade and portable ATR-IR spectrometers. Various pre-processing strategies were applied to the ATR-IR spectra that were linked to corresponding RID-IgG concentrations, and then randomly split into two sets: calibration (training) and test sets. PLSR was applied to the calibration set and calibration models were developed, and the test set was used to assess the accuracy of the analytical method. For the test set, the Pearson correlation coefficients between the IgG measured by RID and predicted by both laboratory grade and portable ATR-IR spectrometers was 0.91. The average differences between reference serum IgG concentrations and the two IR-based methods were 120.5 mg/dL and 71 mg/dL for the laboratory and portable ATR-IR-based assays, respectively. Adopting an IgG concentration < 1000 mg/dL as the cut-point for FTPI cases, the sensitivity, specificity, and accuracy for identifying serum samples below this cut point by laboratory ATR-IR assay were 86, 100 and 98%, respectively (within the entire data set). Corresponding values for the portable ATR-IR assay were 95, 99 and 99%, respectively. These results suggest that the two different ATR-IR assays performed similarly for rapid qualitative evaluation of alpaca serum IgG and for diagnosis of IgG <1000 mg/dL, the portable ATR-IR spectrometer performed slightly better, and provides more flexibility for potential application in the field.	[Elsohaby, Ibrahim; Burns, Jennifer B.; Riley, Christopher B.; McClure, J. Trenton] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Hlth Management, Charlottetown, PE, Canada; [Elsohaby, Ibrahim] Zagazig Univ, Fac Vet Med, Dept Anim Med, Div Infect Dis, Zagazig, Sharkia Provinc, Egypt; [Riley, Christopher B.] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand; [Shaw, R. Anthony] Natl Res Council Canada, Med Devices Portfolio, Winnipeg, MB, Canada	University of Prince Edward Island; Egyptian Knowledge Bank (EKB); Zagazig University; Massey University; National Research Council Canada	Elsohaby, I (corresponding author), Univ Prince Edward Isl, Atlantic Vet Coll, Dept Hlth Management, Charlottetown, PE, Canada.; Elsohaby, I (corresponding author), Zagazig Univ, Fac Vet Med, Dept Anim Med, Div Infect Dis, Zagazig, Sharkia Provinc, Egypt.	ielsohaby@upei.ca	Elsohaby, Ibrahim/L-4214-2014; Elsohaby, Ibrahim/GQQ-4026-2022	Elsohaby, Ibrahim/0000-0003-2533-988X; Riley, Christopher/0000-0001-8679-7986	Atlantic Canada Opportunities Agency	Atlantic Canada Opportunities Agency	This research was funded by the Atlantic Canada Opportunities Agency.; The authors thank Cynthia Mitchell for her technical assistance. The authors also thank Professor Michael Reichel (University of Adelaide, Australia) and Dr. Nicole Jewett (New Brunswick, Canada) for providing the samples used in this study. Also, we would like to thank the anonymous reviewers for their helpful comments in the preparation of this article. This study was partially supported by the Atlantic Canada Opportunities Agency.	ADAMS R, 1994, VET CLIN N AM-FOOD A, V10, P209, DOI 10.1016/S0749-0720(15)30556-9; ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; Ayvaz H, 2015, FOOD CHEM, V174, P154, DOI 10.1016/j.foodchem.2014.11.001; Barnes R, 2004, J NEAR INFRARED SPEC, V1, P185; BARNES RJ, 1989, APPL SPECTROSC, V43, P772, DOI 10.1366/0003702894202201; BLAND JM, 1995, INT J EPIDEMIOL, V24, pS7, DOI 10.1093/ije/24.Supplement_1.S7; Burns J, 2014, J VET INTERN MED, V28, P639, DOI 10.1111/jvim.12258; Chappuis G, 1998, VACCINE, V16, P1468, DOI 10.1016/S0264-410X(98)00110-8; De Marchi M, 2014, J DAIRY SCI, V97, P1171, DOI 10.3168/jds.2013-6799; DEAN RB, 1951, ANAL CHEM, V23, P636, DOI 10.1021/ac60052a025; Dolente BA, 2007, J VET INTERN MED, V21, P519, DOI 10.1892/0891-6640(2007)21[519:CSINCC]2.0.CO;2; Elsohaby I, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0539-x; Elsohaby I, 2014, VET J, V202, P510, DOI 10.1016/j.tvjl.2014.09.014; Fowler ME, 2010, MEDICINE AND SURGERY OF CAMELIDS, 3RD EDITION, P17; GARMENDIA AE, 1987, AM J VET RES, V48, P1472; Hou S, 2016, CHEMOMETR INTELL LAB, V156, P108, DOI 10.1016/j.chemolab.2016.05.020; HUTCHISON JM, 1995, J VET DIAGN INVEST, V7, P515, DOI 10.1177/104063879500700416; Johnston NA, 1997, J AM VET MED ASSOC, V211, P1165; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; Pinn TL, 2013, J VET DIAGN INVEST, V25, P91, DOI 10.1177/1040638712472182; Rehman Saif, 2003, J Intensive Care Med, V18, P261, DOI 10.1177/0885066603255905; Reid LM, 2006, TRENDS FOOD SCI TECH, V17, P344, DOI 10.1016/j.tifs.2006.01.006; Riley CB, 2007, J VET INTERN MED, V21, P828, DOI 10.1892/0891-6640(2007)21[828:UOFISF]2.0.CO;2; Rodriguez-Saona LE, 2011, ANNU REV FOOD SCI T, V2, P467, DOI 10.1146/annurev-food-022510-133750; RORABACHER DB, 1991, ANAL CHEM, V63, P139, DOI 10.1021/ac00002a010; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Shaw RA, 1998, ANN CLIN BIOCHEM, V35, P624, DOI 10.1177/000456329803500505; Shaw RA, 2000, ENCY ANAL CHEM, P83; Shaw RA M H, 2008, ENCY ANAL CHEM APPL, P83; SMITH B. C., 2011, FUNDAMENTALS FOURIER; Sorak D, 2012, APPL SPECTROSC REV, V47, P83, DOI 10.1080/05704928.2011.625748; Sun DW, 2009, INFRARED SPECTROSCOPY FOR FOOD QUALITY ANALYSIS AND CONTROL, P1; Walker P, 1999, J CAMEL PRACT RES, V6, P255; Wang T, 2015, J FOOD SCI, V80, pC2111, DOI 10.1111/1750-3841.13006; Weaver DM, 2000, AM J VET RES, V61, P738, DOI 10.2460/ajvr.2000.61.738; Weaver DM, 2000, J AM VET MED ASSOC, V216, P559, DOI 10.2460/javma.2000.216.559; Wernery U, 2001, J VET MED B, V48, P561, DOI 10.1046/j.1439-0450.2001.00478.x; Whitehead CE, 2009, VET CLIN N AM-FOOD A, V25, P353, DOI 10.1016/j.cvfa.2009.03.006; Williams PC, 1996, NEAR INFRARED SPECTR, P185; Xu QS, 2001, CHEMOMETR INTELL LAB, V56, P1, DOI 10.1016/S0169-7439(00)00122-2	42	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179644	10.1371/journal.pone.0179644	http://dx.doi.org/10.1371/journal.pone.0179644			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651006	Green Published, gold, Green Submitted			2022-12-27	WOS:000404537300012
J	Izuogu, AO; McNally, KL; Harris, SE; Youseff, BH; Presloid, JB; Burlak, C; Munshi-South, J; Best, SM; Taylor, RT				Izuogu, Adaeze O.; McNally, Kristin L.; Harris, Stephen E.; Youseff, Brian H.; Presloid, John B.; Burlak, Christopher; Munshi-South, Jason; Best, Sonja M.; Taylor, R. Travis			Interferon signaling in Peromyscus leucopus confers a potent and specific restriction to vector-borne flaviviruses	PLOS ONE			English	Article							WHITE-FOOTED MOUSE; HOST IMMUNE-RESPONSES; ENCEPHALITIS-VIRUS; BORRELIA-BURGDORFERI; STIMULATED GENES; INFECTION; HANTAVIRUS; NS5; IDENTIFICATION; DETERMINANTS	Tick-borne flaviviruses (TBFVs), including Powassan virus and tick-borne encephalitis virus cause encephalitis or hemorrhagic fevers in humans with case-fatality rates ranging from 1-30%. Despite severe disease in humans, TBFV infection of natural rodent hosts has little noticeable effect. Currently, the basis for resistance to disease is not known. We hypothesize that the coevolution of flaviviruses with their respective hosts has shaped the evolution of potent antiviral factors that suppress virus replication and protect the host from lethal infection. In the current study, we compared virus infection between reservoir host cells and related susceptible species. Infection of primary fibroblasts from the white-footed mouse (Peromyscus leucopus, a representative host) with a panel of vector-borne flaviviruses showed up to a 10,000-fold reduction in virus titer compared to control Mus musculus cells. Replication of vesicular stomatitis virus was equivalent in P. leucopus and M. musculus cells suggesting that restriction was flavivirus-specific. Step-wise comparison of the virus infection cycle revealed a significant block to viral RNA replication, but not virus entry, in P. leucopus cells. To understand the role of the type I interferon (IFN) response in virus restriction, we knocked down signal transducer and activator of transcription 1 (STAT1) or the type I IFN receptor (IFNAR1) by RNA interference. Loss of IFNAR1 or STAT1 significantly relieved the block in virus replication in P. leucopus cells. The major IFN antagonist encoded by TBFV, nonstructural protein 5, was functional in P. leucopus cells, thus ruling out ineffective viral antagonism of the host IFN response. Collectively, this work demonstrates that the IFN response of P. leucopus imparts a strong and virus-specific barrier to flavivirus replication. Future identification of the IFN-stimulated genes responsible for virus restriction specifically in P. leucopus will yield mechanistic insight into efficient control of virus replication and may inform the development of antiviral therapeutics.	[Izuogu, Adaeze O.; Youseff, Brian H.; Presloid, John B.; Taylor, R. Travis] Univ Toledo, Coll Med & Life Sci, Dept Med Microbiol & Immunol, 2801 W Bancroft St, Toledo, OH 43606 USA; [McNally, Kristin L.; Best, Sonja M.] NIAID, Innate Immun & Pathogenesis Unit, Lab Virol, Rocky Mt Labs,DIR,NIH, Hamilton, MT USA; [Harris, Stephen E.] CUNY, Grad Ctr, New York, NY 10021 USA; [Burlak, Christopher] Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA; [Munshi-South, Jason] Fordham Univ, Louis Calder Ctr, Biol Field Stn, Armonk, NY USA	University System of Ohio; University of Toledo; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); City University of New York (CUNY) System; University of Minnesota System; University of Minnesota Twin Cities; Fordham University	Taylor, RT (corresponding author), Univ Toledo, Coll Med & Life Sci, Dept Med Microbiol & Immunol, 2801 W Bancroft St, Toledo, OH 43606 USA.	travis.taylor@utoledo.edu	Presloid, John B/G-2447-2015	Munshi-South, Jason/0000-0002-8067-4341	Lyme Disease Association, Inc. [N12484701]; National Institutes of Health, National Institutes of Allergy and Infectious Diseases [ZIA-AI001125]; National Institute of General Medical Sciences of the National Institutes of Health [R15GM099055]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM099055] Funding Source: NIH RePORTER	Lyme Disease Association, Inc.; National Institutes of Health, National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was primarily funded by a pilot grant from the Lyme Disease Association, Inc., N12484701 to RTT. This work was supported in part by the Intramural Research Program of the National Institutes of Health, National Institutes of Allergy and Infectious Diseases. ZIA-AI001125 to SMB. Research reported in this publication was also supported by the National Institute of General Medical Sciences of the National Institutes of Health. R15GM099055 to JMS. The content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achazi K, 2011, VECTOR-BORNE ZOONOT; Ang F, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-24; [Anonymous], 2014, INNATE IMMUNITY DENG, V426, P1148; Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007; Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08; Barbour AG, 2016, SEMIN CELL DEV BIOL, P1; Baum E, 2012, MBIO, V3, DOI 10.1128/mBio.00434-12; Bayer N, 1998, J VIROL, V72, P9645, DOI 10.1128/JVI.72.12.9645-9655.1998; Belikov SI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094946; Best SM, 2005, J VIROL, V79, P12828, DOI 10.1128/JVI.79.20.12828-12839.2005; Brien JD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002230; Brinton M, 2003, ADV VIRUS RES, P1; BROWN RN, 1994, J WILDLIFE DIS, V30, P389, DOI 10.7589/0090-3558-30.3.389; D'Agostino PM, 2012, P NATL ACAD SCI USA, V109, P6175, DOI 10.1073/pnas.1203941109; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dorrbecker B, 2010, TRAVEL MED INFECT DI, V8, P213, DOI 10.1016/j.tmaid.2010.05.010; Duggal NK, 2012, NAT REV IMMUNOL, V12, P687, DOI 10.1038/nri3295; Ebel GD, 2010, ANNU REV ENTOMOL, V55, P95, DOI 10.1146/annurev-ento-112408-085446; Egyed L, 2015, INTERVIROLOGY, V58, P369, DOI 10.1159/000443833; El Khoury MY, 2013, EMERG INFECT DIS, V19, P1926, DOI 10.3201/eid1912.130903; Gritsun TS, 2003, ANTIVIR RES, V57, P129, DOI 10.1016/S0166-3542(02)00206-1; Heinz FX, 2015, EUROSURVEILLANCE, V20, P9, DOI 10.2807/1560-7917.es2015.20.13.21077; Hollidge BS, 2011, VIRUSES-BASEL, V3, P629, DOI 10.3390/v3060629; Imhoff M, 2015, TICKS TICK-BORNE DIS, V6, P592, DOI 10.1016/j.ttbdis.2015.05.001; Jaenson TGT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-184; Korenberg EI, 2001, EMERG INFECT DIS, V7, P459, DOI 10.3201/eid0703.017319; Lani R, 2014, TICKS TICK-BORNE DIS, V5, P457, DOI 10.1016/j.ttbdis.2014.04.001; Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09; Lim JK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000321; Luong LT, 2011, VECTOR-BORNE ZOONOT, V11, P1459, DOI 10.1089/vbz.2010.0255; Machida M, 2014, BRAIN BEHAV IMMUN, V35, P125, DOI 10.1016/j.bbi.2013.09.006; Maffioli C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044703; Mandl JN, 2015, CELL, V160, P20, DOI 10.1016/j.cell.2014.12.003; Mansfield KL, 2009, J GEN VIROL, V90, P1781, DOI 10.1099/vir.0.011437-0; Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847; Mitzel DN, 2008, VIROLOGY, V381, P268, DOI 10.1016/j.virol.2008.08.030; Mitzel DN, 2007, VIROLOGY, V365, P410, DOI 10.1016/j.virol.2007.03.057; Mlera L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005346; Munoz-Jordan JL, 2010, VIRUSES-BASEL, V2, P676, DOI 10.3390/v2020676; Munshi-South J, 2016, EVOL APPL, V9, P546, DOI 10.1111/eva.12357; Overby AK, 2010, J VIROL, V84, P8470, DOI 10.1128/JVI.00176-10; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001; Pletnev AG, 2001, VIROLOGY, V282, P288, DOI 10.1006/viro.2001.0846; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Ramsdell CM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-65; Robertson SJ, 2014, J IMMUNOL, V192, P2744, DOI 10.4049/jimmunol.1302110; Robertson SJ, 2009, IMMUNOL RES, V43, P172, DOI 10.1007/s12026-008-8065-6; Ruzek D, 2010, TRAVEL MED INFECT DI, V8, P223, DOI 10.1016/j.tmaid.2010.06.004; Santos RI, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080220; Scherbik SV, 2007, VIROLOGY, V368, P232, DOI 10.1016/j.virol.2007.08.017; Scherbik SV, 2007, J VIROL, V81, P12005, DOI 10.1128/JVI.01359-07; Schoggins JW, 2014, CURR OPIN VIROL, V6, P40, DOI 10.1016/j.coviro.2014.03.006; SCHOGGINS JW, 2011, NATURE; Schountz T, 2014, VIRUSES-BASEL, V6, P1317, DOI 10.3390/v6031317; Schwanz LE, 2011, VECTOR-BORNE ZOONOT, V11, P117, DOI 10.1089/vbz.2009.0215; SONG JW, 1994, LANCET, V344, P1637, DOI 10.1016/S0140-6736(94)90430-8; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; Suss J, 2010, WIEN MED WOCHENSCHR, V160, P94, DOI 10.1007/s10354-010-0756-7; Suss J, 2002, INT J MED MICROBIOL, V291, P34; Suss J, 2008, EUROSURVEILLANCE, V13, P1; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Taylor RT, 2011, CELL HOST MICROBE, V10, P185, DOI 10.1016/j.chom.2011.08.004; Telford SR, 1997, EMERG INFECT DIS, V3, P165, DOI 10.3201/eid0302.970209; WRIGHT SD, 1990, AM J VET RES, V51, P1980; Ye J, 2013, VACCINE, V31, P461, DOI 10.1016/j.vaccine.2012.11.015; Zoldi V, 2014, NFECTIOUS DIS, V47, P178; Zurney J, 2007, J VIROL, V81, P13668, DOI 10.1128/JVI.01172-07	68	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179781	10.1371/journal.pone.0179781	http://dx.doi.org/10.1371/journal.pone.0179781			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650973	gold, Green Submitted, Green Published			2022-12-27	WOS:000404537300022
J	Cheng, J; Huang, J; Yuan, SZ; Zhou, S; Yan, W; Shen, W; Chen, Y; Xia, X; Luo, AY; Zhu, D; Wang, SX				Cheng, Jing; Huang, Jia; Yuan, Suzhen; Zhou, Su; Yan, Wei; Shen, Wei; Chen, Yun; Xia, Xi; Luo, Aiyue; Zhu, Da; Wang, Shixuan			Circular RNA expression profiling of human granulosa cells during maternal aging reveals novel transcripts associated with assisted reproductive technology outcomes	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; HUMAN CUMULUS CELLS; FOLLICULAR-FLUID; GENE-EXPRESSION; OVARIAN RESERVE; CLINICAL-IMPLICATIONS; AGE; OOCYTE; BIOMARKER; WOMEN	Circular RNAs (circRNAs) are a unique class of endogenous RNAs which could be used as potential diagnostic and prognostic biomarkers of many diseases. Our study aimed to investigate circRNA profiles in human granulosa cells (GCs) during maternal aging and to uncover age-related circRNA variations that potentially reflect decreased oocyte competence. CircRNAs in GCs from in vitro fertilization (IVF) patients with young age (YA, <= 30 years) and advanced age (AA, >= 38 years) were profiled by microarray, and validated in 20 paired samples. The correlation between circRNAs expression and clinical characteristics was analyzed in additional 80 samples. Chip-based analysis revealed 46 up-regulated and 11 down-regulated circRNAs in AA samples (fold change > 2.0). Specifically, circRNA_103829, circRNA_103827 and circRNA_104816 were validated to be up regulated, while circRNA_101889 was down-regulated in AA samples. After adjustment for gonadotropin treatment, only circRNA_103827 and circRNA_104816 levels were positively associated with maternal age (partial r = 0.332, P = 0.045; partial r = 0.473, P = 0.003; respectively). Moreover, circRNA_103827 and circRNA_104816 expressions in GCs were negatively correlated with the number of top quality embryos (r = -0.235, P = 0.036; r = -0.221, P = 0.049; respectively). Receiver operating characteristic (ROC) curve analysis indicated that the performance of circRNA_103827 for live birth prediction reached 0.698 [0.570-0.825], with 77.2% sensitivity and 60.9% specificity (P = 0.006), and that of circRNA_104816 was 0.645 [0.507-0.783] (P = 0.043). Bioinformatics analysis revealed that both circRNAs were potentially involved in glucose metabolism, mitotic cell cycle, and ovarian steroidogenesis. Therefore, age-related up-regulation of circRNA_103827 and circRNA_104816 might be potential indicators of compromised follicular micro-environment which could be used to predict IVF prognosis, and improve female infertility management.	[Cheng, Jing; Huang, Jia; Yuan, Suzhen; Zhou, Su; Yan, Wei; Shen, Wei; Luo, Aiyue; Zhu, Da; Wang, Shixuan] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Obstet & Gynecol, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Chen, Yun] Peking Univ, Ultrason Dept, Shenzhen Hosp, Shenzhen, Peoples R China; [Xia, Xi] Peking Univ, Reprod Ctr, Shenzhen Hosp, Shenzhen, Peoples R China	Huazhong University of Science & Technology; Peking University; Peking University	Wang, SX (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Obstet & Gynecol, Tongji Med Coll, Wuhan, Hubei, Peoples R China.	sxwang2012@hotmail.com			National Natural Science Foundation of China [81370469, 81300453, 81502253, 81501227, 81471508]; International Science and Technology Corporation Program of China [2013DFA31400]; Guang Dong Natural Scientific Foundation [2015A030313889, 2014A030313797]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science and Technology Corporation Program of China; Guang Dong Natural Scientific Foundation	This work was financially supported by the National Natural Science Foundation of China (No. 81370469; 81300453; 81502253; 81501227; 81471508), International Science and Technology Corporation Program of China (No. 2013DFA31400) and Guang Dong Natural Scientific Foundation (2015A030313889; 2014A030313797). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini DF, 2003, REPRODUCTION, P49; [American Society for Reproductive Medicine and Society for Assisted Reproductive Technology Centers for Disease Control and Prevention], 2011, 2011 ASS REPR TECHN, P24; Broekmans FJ, 2009, ENDOCR REV, V30, P465, DOI 10.1210/er.2009-0006; Broekmans FJ, 2007, TRENDS ENDOCRIN MET, V18, P58, DOI 10.1016/j.tem.2007.01.004; Broer SL, 2014, HUM REPROD UPDATE, V20, P688, DOI 10.1093/humupd/dmu020; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; Du XF, 2016, REPROD SCI, V23, P1019, DOI 10.1177/1933719115625843; Dumesic DA, 2015, FERTIL STERIL, V103, P303, DOI 10.1016/j.fertnstert.2014.11.015; Ferrero H, 2012, HUM REPROD, V27, P1781, DOI 10.1093/humrep/des096; Fragouli E, 2014, HUM REPROD UPDATE, V20, P1, DOI 10.1093/humupd/dmt044; Fragouli E, 2012, HUM REPROD, V27, P2559, DOI 10.1093/humrep/des170; Gardner DK, 2000, FERTIL STERIL, V73, P1155, DOI 10.1016/S0015-0282(00)00518-5; Gatta V, 2013, FERTIL STERIL, V99, P2000, DOI 10.1016/j.fertnstert.2013.01.150; Grondahl ML, 2009, FERTIL STERIL, V91, P1820, DOI 10.1016/j.fertnstert.2008.02.137; Gruner H, 2016, SCI REP-UK, V6, DOI 10.1038/srep38907; Hamel M, 2008, HUM REPROD, V23, P1118, DOI 10.1093/humrep/den048; Hamel M, 2010, MOL HUM REPROD, V16, P87, DOI 10.1093/molehr/gap079; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hartge P, 2009, NAT GENET, V41, P637, DOI 10.1038/ng0609-637; Huang GL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131225; Iager AE, 2013, FERTIL STERIL, V99, P745, DOI 10.1016/j.fertnstert.2012.10.041; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Kanduri C, 2011, SEMIN CELL DEV BIOL, V22, P343, DOI 10.1016/j.semcdb.2011.02.020; Lasda E, 2014, RNA, V20, P1829, DOI 10.1261/rna.047126.114; Li PF, 2015, CLIN CHIM ACTA, V444, P132, DOI 10.1016/j.cca.2015.02.018; Li Y, 2015, CELL RES, V25, P981, DOI 10.1038/cr.2015.82; Liu Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep22572; Lukiw Walter J., 2013, Frontiers in Genetics, V4, P307, DOI [10.3389/fgene.2013.00307, 10.3389/fgene.2013.00077]; Moreno JM, 2015, FERTIL STERIL, V104, P1037, DOI 10.1016/j.fertnstert.2015.07.001; Martin J. A., 2013, NATL VITAL STA REP, V64, P1; McReynolds S, 2012, FERTIL STERIL, V98, P1574, DOI 10.1016/j.fertnstert.2012.08.012; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; NAVOT D, 1991, LANCET, V337, P1375, DOI 10.1016/0140-6736(91)93060-M; Pacella L, 2012, FERTIL STERIL, V98, P986, DOI 10.1016/j.fertnstert.2012.06.025; Panda AC, 2016, NUCL ACIDS RES; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; Sauer MV, 2015, FERTIL STERIL, V103, P1136, DOI 10.1016/j.fertnstert.2015.03.004; Scalici E, 2016, SCI REP-UK, V6, DOI 10.1038/srep24976; Shang XC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003811; Tab R, 2015, FERTIL STERIL, V103; Tatone C, 2008, HUM REPROD UPDATE, V14, P131, DOI 10.1093/humupd/dmm048; Tatone C, 2013, FERTIL STERIL, V99, P12, DOI 10.1016/j.fertnstert.2012.11.029; Tremellen K, 2014, HUM REPROD, V29, P2606, DOI 10.1093/humrep/deu265; Uyar A, 2013, FERTIL STERIL, V99, P979, DOI 10.1016/j.fertnstert.2013.01.129; Wainer-Katsir K, 2015, FERTIL STERIL, V103, P1117, DOI 10.1016/j.fertnstert.2015.02.008; Yang W, 2016, EUROPEAN HEART J; Yu B, 2015, ONCOTARGET, V6, P3627, DOI 10.18632/oncotarget.2875; Zeng Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep21243; Zhang Y, 2016, METHODS MOL BIOL, V1402, P215, DOI 10.1007/978-1-4939-3378-5_17; Zhang YG, 2016, BJOG INT J OBSTET GY; Zhao ZZ, 2017, SCI REP-UK, V7, DOI 10.1038/srep39918	52	49	55	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0177888	10.1371/Journal.pone.0177888	http://dx.doi.org/10.1371/Journal.pone.0177888			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644873	Green Published, Green Submitted, gold			2022-12-27	WOS:000404145100002
J	Kandel, KP; Neupane, BB; Giri, B				Kandel, Krishna Prasad; Neupane, Bhanu Bhakta; Giri, Basant			Status of chemistry lab safety in Nepal	PLOS ONE			English	Article							CHEMICAL SAFETY	Chemistry labs can become a dangerous environment for students as the lab exercises involve hazardous chemicals, glassware, and equipment. Approximately one hundred thousand students take chemistry laboratory classes annually in Nepal. We conducted a survey on chemical lab safety issues across Nepal. In this paper, we assess the safety policy and equipment, protocols and procedures followed, and waste disposal in chemistry teaching labs. Significant population of the respondents believed that there is no monitoring of the lab safety in their lab (p<0.001). Even though many labs do not allow food and beverages inside lab and have first aid kits, they lack some basic safety equipment. There is no institutional mechanism to dispose lab waste and chemical waste is disposed haphazardly. Majority of the respondents believed that the safety training should be a part of educational training (p = 0.001) and they would benefit from short course and/or workshop on lab safety (p<0.001).	[Kandel, Krishna Prasad] Tribhuvan Univ, Dept Chem, Birendra Multiple Campus, Chitwan, Nepal; [Neupane, Bhanu Bhakta; Giri, Basant] Kathmandu Inst Appl Sci, Ctr Analyt Sci, Kathmandu, Nepal; [Neupane, Bhanu Bhakta] Tribhuvan Univ, Dept Chem, Amrit Campus, Kathmandu, Nepal	Tribhuvan University; Tribhuvan University	Giri, B (corresponding author), Kathmandu Inst Appl Sci, Ctr Analyt Sci, Kathmandu, Nepal.	bgiri@kias.org.np	Neupane, Bhanu/AAN-5876-2020; Giri, Basant/AAR-8848-2020	Giri, Basant/0000-0003-4798-3414	Small Research Grants, Institute of Science and Technology, Tribhuvan University, Kathmandu Nepal; Kathmandu Institute of Applied Sciences, Kathmandu, Nepal; Institute of Science and Technology, Tribhuvan University; Kathmandu Institute of Applied Sciences	Small Research Grants, Institute of Science and Technology, Tribhuvan University, Kathmandu Nepal; Kathmandu Institute of Applied Sciences, Kathmandu, Nepal; Institute of Science and Technology, Tribhuvan University; Kathmandu Institute of Applied Sciences	This work received support from Small Research Grants, Institute of Science and Technology, Tribhuvan University, Kathmandu Nepal. It also received support from a Start up grant from Kathmandu Institute of Applied Sciences, Kathmandu, Nepal.; KPK received small research grant from Institute of Science and Technology, Tribhuvan University. BG received start up grant from the Kathmandu Institute of Applied Sciences for partial support to the work presented in this paper. Mahendra Thapa is acknowledged for his help during the survey. We thank Prakash K. Paudel for his critical feedback on initial draft of the manuscript and Susma Giri for proofreading.	Alaimo PJ, 2010, J CHEM EDUC, V87, P856, DOI 10.1021/ed100207d; Alaimo R.J., 2001, HDB CHEM HLTH SAFETY; [Anonymous], 2016, REPORT HIGHER ED NEP; [Anonymous], 2016, BACH SCI CHEM CURR; [Anonymous], 2010, PROMOTING CHEM LAB S; Bajracharya D., 2006, SCI RES TECHNOLOGY N; Crockett JM, 2011, J CHEM HEALTH SAF, V18, P16, DOI 10.1016/j.jchas.2010.08.001; Dangi MB, 2011, J ENVIRON MANAGE, V92, P240, DOI 10.1016/j.jenvman.2010.09.005; Engida T., 2011, AFRICAN J CHEM ED, P35; Richards-Babb M, 2010, J CHEM HEALTH SAF, V17, P6, DOI 10.1016/j.jchas.2009.05.001; Sedghpour BS, 2013, PROCD SOC BEHV, V90, P57, DOI 10.1016/j.sbspro.2013.07.065; SENKBEIL EG, 1991, J CHEM EDUC, V68, P410, DOI 10.1021/ed068p410; Uy MM, 2011, J CHEM HEALTH SAF, V18, P8, DOI 10.1016/j.jchas.2011.06.002; Young JA, 1991, IMPROVING SAFETY CHE	14	6	6	8	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179104	10.1371/journal.pone.0179104	http://dx.doi.org/10.1371/journal.pone.0179104			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644869	gold, Green Published, Green Submitted			2022-12-27	WOS:000404145100010
J	Yang, GD; Agapow, PM; Yedid, G				Yang, Guan-Dong; Agapow, Paul-Michael; Yedid, Gabriel			The tree balance signature of mass extinction is erased by continued evolution in clades of constrained size with trait-dependent speciation	PLOS ONE			English	Article							PERMIAN-TRIASSIC BOUNDARY; PHYLOGENETIC TREE; MOLECULAR PHYLOGENIES; FOSSIL RECORD; ORGANISMAL DIVERSITY; STATISTICAL-ANALYSIS; ECOLOGICAL LIMITS; NULL MODEL; DIVERSIFICATION; PATTERNS	The kind and duration of phylogenetic topological "signatures" left in the wake of macroevolutionary events remain poorly understood. To this end, we examined a broad range of simulated phylogenies generated using trait-biased, heritable speciation probabilities and mass extinction that could be either random or selective on trait value, but also using background extinction and diversity-dependence to constrain clade sizes. In keeping with prior results, random mass extinction increased imbalance of clades that recovered to pre-extinction size, but was a relatively weak effect. Mass extinction that was selective on trait values tended to produce clades of similar or greater balance compared to random extinction or controls. Allowing evolution to continue past the point of clade-size recovery resulted in erosion and eventual erasure of this signal, with all treatments converging on similar values of imbalance, except for very intense extinction regimes targeted at taxa with high speciation rates. Return to a more balanced state with extended post-extinction evolution was also associated with loss of the previous phylogenetic root in most treatments. These results further demonstrate that while a mass extinction event can produce a recognizable phylogenetic signal, its effects become increasingly obscured the further an evolving clade gets from that event, with any sharp imbalance due to unrelated evolutionary factors.	[Yang, Guan-Dong; Yedid, Gabriel] Nanjing Agr Univ, Dept Zool, Coll Life Sci, Nanjing, Jiangsu, Peoples R China; [Agapow, Paul-Michael] Imperial Coll, Data Sci Inst, William Penney Lab, London, England; [Yang, Guan-Dong] Emory Univ, Dept Biostat & Bioinformat, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Nanjing Agricultural University; Imperial College London; Emory University; Rollins School Public Health	Yedid, G (corresponding author), Nanjing Agr Univ, Dept Zool, Coll Life Sci, Nanjing, Jiangsu, Peoples R China.	gyedid02@gmail.com			Chinese Ministry of Education [KYRC201301]; National Natural Science Foundation of China [680600529]	Chinese Ministry of Education(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by research grants #KYRC201301 from Chinese Ministry of Education (http://www.moe.edu.cn) and #680600529 from National Natural Science Foundation of China (http://www.nsfc.gov.cn) to GY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2002, SYST BIOL, V51, P866, DOI 10.1080/10635150290155845; Aldous DJ, 2001, STAT SCI, V16, P23, DOI 10.1214/ss/998929474; Alroy John, 2009, P301; Barraclough TG, 2003, EVOLUTION, V57, P2166; Beerling DJ, 2001, J GEOL SOC LONDON, V158, P737, DOI 10.1144/jgs.158.5.737; Benton MJ, 2004, NATURE, V432, P97, DOI 10.1038/nature02950; Blum MGB, 2005, MATH BIOSCI, V195, P141, DOI 10.1016/j.mbs.2005.03.003; Blum MGB, 2006, SYST BIOL, V55, P685, DOI 10.1080/10635150600889625; Bortolussi N, 2006, BIOINFORMATICS, V22, P363, DOI 10.1093/bioinformatics/bti798; Carlson SJ, 2008, FOSS STRATA, P167; Chan KMA, 1999, AM NAT, V153, P332, DOI 10.1086/303173; Colless D.H., 1982, SYST ZOOL, V31, P100, DOI DOI 10.2307/2413420; Crisp MD, 2009, EVOLUTION, V63, P2257, DOI 10.1111/j.1558-5646.2009.00728.x; D'Hondt S, 1998, SCIENCE, V282, P276, DOI 10.1126/science.282.5387.276; dos Reis M, 2012, P ROY SOC B-BIOL SCI, V279, P3491, DOI 10.1098/rspb.2012.0683; Duchene D, 2015, MOL ECOL RESOUR, V15, P785, DOI 10.1111/1755-0998.12352; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Erwin D, 2000, NATURE, V404, P129, DOI 10.1038/35004679; Fabre PH, 2009, MOL PHYLOGENET EVOL, V53, P808, DOI 10.1016/j.ympev.2009.08.004; Foote M, 1999, PALEOBIOLOGY, V25, P1, DOI 10.1666/0094-8373(1999)25[1:MDITER]2.0.CO;2; Friedman M, 2011, P R SOC B, V277, P1675; Hagen O, 2015, SYST BIOL, V64, P432, DOI 10.1093/sysbio/syv001; Halliday TJD, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.3026; Harcourt-Brown KG, 2002, SYST BIOL, V51, P908, DOI 10.1080/10635150290155962; Harcourt-Brown KG, 2001, PALEOBIOLOGY, V27, P188, DOI 10.1666/0094-8373(2001)027<0188:TIOPT>2.0.CO;2; Harding E., 1971, ADV APPL PROBAB, V3, P44, DOI DOI 10.2307/1426329; Harmon LJ, 2007, RECONSTRUCTING EVOLU, P149; Heard SB, 1996, EVOLUTION, V50, P2141, DOI 10.1111/j.1558-5646.1996.tb03604.x; HEARD SB, 1992, EVOLUTION, V46, P1818, DOI 10.1111/j.1558-5646.1992.tb01171.x; Heard SB, 2002, SYST BIOL, V51, P889, DOI 10.1080/10635150290155917; Heard SB, 2007, AM NAT, V169, pE107, DOI 10.1086/512690; Heath TA, 2008, SYST BIOL, V57, P160, DOI 10.1080/10635150701884640; Holman EW, 2005, SYSTEMATIC BIOL, V54, P895, DOI 10.1080/10635150500354696; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; KIRKPATRICK M, 1993, EVOLUTION, V47, P1171, DOI [10.2307/2409983, 10.1111/j.1558-5646.1993.tb02144.x]; Lau KV, 2016, P NAT ACAD SCI, V113, P2; Liow LH, 2010, SYST BIOL, V59, P646, DOI 10.1093/sysbio/syq052; Looy CV, 1999, P NATL ACAD SCI USA, V96, P13857, DOI 10.1073/pnas.96.24.13857; LOSOS JB, 1995, AM NAT, V145, P329, DOI 10.1086/285743; McGowan AJ, 2004, PALEOBIOLOGY, V30, P369, DOI 10.1666/0094-8373(2004)030<0369:TEOTPB>2.0.CO;2; McPeek MA, 2008, AM NAT, V172, pE270, DOI 10.1086/593137; MCSHEA DW, 1994, EVOLUTION, V48, P1747, DOI 10.1111/j.1558-5646.1994.tb02211.x; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Mir A, 2013, MATH BIOSCI, V241, P125, DOI 10.1016/j.mbs.2012.10.005; Mooers AO, 1997, Q REV BIOL, V72, P31, DOI 10.1086/419657; Mooers AO, 2004, SYST BIOL, V53, P809, DOI 10.1080/10635150490502595; Paradis E, 2005, EVOLUTION, V59, P1; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; Price TD, 2014, NATURE, V509, P222, DOI 10.1038/nature13272; Purvis A, 2000, BIOESSAYS, V22, P1123, DOI 10.1002/1521-1878(200012)22:12<1123::AID-BIES10>3.0.CO;2-C; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Purvis A, 2002, SYST BIOL, V51, P844, DOI 10.1080/10635150290155809; Purvis Andy, 1996, P153; Purvis A, 2011, PHILOS T R SOC B, V366, P2462, DOI 10.1098/rstb.2011.0025; Quental TB, 2009, EVOLUTION, V63, P3158, DOI 10.1111/j.1558-5646.2009.00794.x; Rabosky DL, 2008, EVOLUTION, V62, P1866, DOI 10.1111/j.1558-5646.2008.00409.x; Rabosky Daniel L., 2006, Evolutionary Bioinformatics Online, V2, P257; Rabosky DL, 2015, AM NAT, V185, P572, DOI 10.1086/680850; Rabosky DL, 2009, AM NAT, V173, P662, DOI 10.1086/597378; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Ricklefs RE, 2007, J EVOLUTION BIOL, V20, P1751, DOI 10.1111/j.1420-9101.2007.01388.x; Ruber L, 2005, EVOLUTION, V59, P1119; Ruta M, 2007, P ROY SOC B-BIOL SCI, V274, P3087, DOI 10.1098/rspb.2007.1250; SACKIN MJ, 1972, SYST ZOOL, V21, P225, DOI 10.2307/2412292; Sahney S, 2008, P ROY SOC B-BIOL SCI, V275, P759, DOI 10.1098/rspb.2007.1370; SAVAGE HM, 1983, BIOL J LINN SOC, V20, P225, DOI 10.1111/j.1095-8312.1983.tb01874.x; Schaal EK, 2016, PALEOBIOLOGY, V42, P127, DOI 10.1017/pab.2015.36; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Sepulveda J, 2009, SCIENCE, V326, P129, DOI 10.1126/science.1176233; SHAO KT, 1990, SYST ZOOL, V39, P266, DOI 10.2307/2992186; SLOWINSKI JB, 1993, AM NAT, V142, P1019, DOI 10.1086/285586; SLOWINSKI JB, 1989, AM NAT, V134, P907, DOI 10.1086/285021; Stam E, 2002, EVOLUTION, V56, P1292; Tarver JE, 2011, SYST BIOL, V60, P700, DOI 10.1093/sysbio/syr018; Twitchett RJ, 2004, GEOLOGY, V32, P805, DOI 10.1130/G20585.1; Wei HY, 2015, EARTH-SCI REV, V149, P108, DOI 10.1016/j.earscirev.2014.10.007; Weir JT, 2006, EVOLUTION, V60, P842; WELLBORN GA, 1994, ECOLOGY, V75, P2104, DOI 10.2307/1941614; Wellborn GA, 2008, MOL ECOL, V17, P2927, DOI 10.1111/j.1365-294X.2008.03805.x; Yedid G, 2001, AM NAT, V157, P465, DOI 10.1086/319928; Yedid G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037233; Yedid G, 2009, AM NAT, V173, pE139, DOI 10.1086/597228; Yin HF, 2007, GLOBAL PLANET CHANGE, V55, P1, DOI 10.1016/j.gloplacha.2006.06.005; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002	85	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179553	10.1371/journal.pone.0179553	http://dx.doi.org/10.1371/journal.pone.0179553			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644846	Green Published, gold, Green Submitted			2022-12-27	WOS:000404145100023
J	Shi, XY; Li, QB; Wang, T; Lackner, KS				Shi, Xiaoyang; Li, Qibin; Wang, Tao; Lackner, Klaus S.			Kinetic analysis of an anion exchange absorbent for CO2 capture from ambient air	PLOS ONE			English	Article							CARBON-DIOXIDE CAPTURE; MOISTURE	This study reports a preparation method of a new moisture swing sorbent for CO2 capture from air. The new sorbent components include ion exchange resin (IER) and polyvinyl chloride (PVC) as a binder. The IER can absorb CO2 when surrounding is dry and release CO2 when surrounding is wet. The manuscript presents the studies of membrane structure, kinetic model of absorption process, performance of desorption process and the diffusivity of water molecules in the CO2 absorbent. It has been proved that the kinetic performance of CO2 absorption/desorption can be improved by using thin binder and hot water treatment. The fast kinetics of P-100-90C absorbent is due to the thin PVC binder, and high diffusion rate of H2O molecules in the sample. The impressive is this new CO2 absorbent has the fastest CO2 absorption rate among all absorbents which have been reported by other up-todate literatures.	[Shi, Xiaoyang] Columbia Univ, Dept Earth & Environm Engn, New York, NY USA; [Li, Qibin] Chongqing Univ, Coll Aerosp Engn, Chongqing, Peoples R China; [Wang, Tao] Zhejiang Univ, State Key Lab Clean Energy Utilizat, Hangzhou, Zhejiang, Peoples R China; [Lackner, Klaus S.] Arizona State Univ, Sch Sustainable Engn & Built Environm, Tempe, AZ 85287 USA	Columbia University; Chongqing University; Zhejiang University; Arizona State University; Arizona State University-Tempe	Wang, T (corresponding author), Zhejiang Univ, State Key Lab Clean Energy Utilizat, Hangzhou, Zhejiang, Peoples R China.; Lackner, KS (corresponding author), Arizona State Univ, Sch Sustainable Engn & Built Environm, Tempe, AZ 85287 USA.	oatgnaw@zju.edu.cn; Klaus.Lackner@asu.edu	li, qibin/O-2013-2019	li, qibin/0000-0001-9365-3788	National Natural Science Foundation of China [51676169]; Office of Naval Research [ONR BAA 14-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Office of Naval Research(Office of Naval Research)	This work was partly supported by the National Natural Science Foundation of China (No. 51676169), and partly supported by a grant from the Office of Naval Research (ONR BAA 14-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi S, 2011, CHEMSUSCHEM, V4, P628, DOI 10.1002/cssc.201000355; Choi S, 2011, ENVIRON SCI TECHNOL, V45, P2420, DOI 10.1021/es102797w; Drese JH, 2009, ADV FUNCT MATER, V19, P3821, DOI 10.1002/adfm.200901461; Ho YS, 2004, SCIENTOMETRICS, V59, P171, DOI 10.1023/B:SCIE.0000013305.99473.cf; Keith DW, 2009, SCIENCE, V325, P1654, DOI 10.1126/science.1175680; Lackner KS, 2009, EUR PHYS J-SPEC TOP, V176, P93, DOI 10.1140/epjst/e2009-01150-3; Lackner KS, 2016, SCIENCE, V354, P714, DOI 10.1126/science.aal2432; Lackner KS, 2012, P NATL ACAD SCI USA, V109, P13156, DOI 10.1073/pnas.1108765109; Lackner KS, 2003, SCIENCE, V300, P1677, DOI 10.1126/science.1079033; Li QB, 2015, INT J MOD PHYS B, V29, DOI 10.1142/S0217979215501854; Lin YC, 2005, CHEM PHYS LETT, V412, P322, DOI 10.1016/j.cplett.2005.07.022; Lu YF, 1997, NATURE, V389, P364, DOI 10.1038/38699; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; Shi X., 2017, ARXIV170200388; Shi X., 2017, ARXIV PREPRINT ARXIV; Shi X., 2016, ANGEW CHEM, V128, P4094, DOI DOI 10.1002/ANGE.201507846; Shi XY, 2016, CHEM-EUR J, V22, P18326, DOI 10.1002/chem.201603701; Shi XY, 2016, ANGEW CHEM INT EDIT, V55, P4026, DOI 10.1002/anie.201507846; Socolow R., 2011, DIRECT AIR CAPTURE C; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Springer George S., 1988, ENV EFFECTS COMPOSIT, V3; Vyas PV, 2001, J MEMBRANE SCI, V187, P39, DOI 10.1016/S0376-7388(00)00613-X; Wang T, 2015, GREENH GASES; Wang T, 2016, PHYS CHEM CHEM PHYS, V18, P13084, DOI 10.1039/c5cp07229h; Wang T, 2013, PHYS CHEM CHEM PHYS, V15, P504, DOI 10.1039/c2cp43124f; Wang T, 2011, ENVIRON SCI TECHNOL, V45, P6670, DOI 10.1021/es201180v; Xiao H, 2017, ARXIV170203036	27	30	34	6	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179828	10.1371/journal.pone.0179828	http://dx.doi.org/10.1371/journal.pone.0179828			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640914	Green Published, Green Submitted, gold			2022-12-27	WOS:000404135800071
J	Yang, XN; Zhang, Q; Chen, ZY; Liu, HX; Li, PW				Yang, Xiaona; Zhang, Qi; Chen, Zhi-Yuan; Liu, Hongxia; Li, Peiwu			Investigation of Pseudomonas fluorescens strain 3JW1 on preventing and reducing aflatoxin contaminations in peanuts	PLOS ONE			English	Article							ATOXIGENIC ASPERGILLUS-FLAVUS; HEPATOCELLULAR-CARCINOMA; BIOLOGICAL-CONTROL; INHIBITS GROWTH; BIOCONTROL; DEGRADATION; MAIZE; SOIL	Pseudomonas fluorescens strain 3JW1, which has a broad-spectrum antimicrobial activity, was studied to investigate whether it affects the amounts of aflatoxin B-1 (AFB(1)) produced by Aspergillus flavus. It was found that the bacterium reduced the amounts of AFB(1) in potato dextrose broth (PDB) and peanut medium by 97.8% and 99.4%, respectively. It also reduced AFB(1) by similar to 183 mu g/kg (55.8%) when applied onto peanut kernels. This strain reduced AFB(1) via three mechanisms. First, it significantly inhibited A. flavus growth; second, our data showed that strain 3JW1 inhibits aflatoxin biosynthesis by A. flavus; and third, P. fluorescens strain 3JW1 is capable of degrading AFB(1) at a rate as high as 88.3% in 96 hours. This is the first report demonstrating that Pseudomonas fluorescens can reduce toxin contamination caused by A. flavus on peanut kernels. Our findings indicate that P. fluorescens strain 3JW1 had multiple effects including reducing A. flavus infection and aflatoxin contamination. And the results also highlight the potential applications of the strain 3JW1 for the biological control of aflatoxin contamination in peanuts and other susceptible crops.	[Yang, Xiaona; Liu, Hongxia] Nanjing Agr Univ, Dept Plant Pathol, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China; [Yang, Xiaona; Liu, Hongxia] Nanjing Agr Univ, Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China; [Zhang, Qi; Li, Peiwu] Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Peoples R China; [Zhang, Qi; Li, Peiwu] Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan, Peoples R China; [Zhang, Qi; Li, Peiwu] Minist Agr, Key Lab Detect Mycotoxins, Wuhan, Peoples R China; [Zhang, Qi; Li, Peiwu] Minist Agr, Lab Risk Assessment Oilseeds Prod Wuhan, Wuhan, Peoples R China; [Chen, Zhi-Yuan] Louisiana State Univ, Ctr Agr, Dept Plant Pathol & Crop Physiol, Baton Rouge, LA 70803 USA	Nanjing Agricultural University; Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs; Louisiana State University System; Louisiana State University	Liu, HX (corresponding author), Nanjing Agr Univ, Dept Plant Pathol, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China.; Liu, HX (corresponding author), Nanjing Agr Univ, Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China.; Li, PW (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Peoples R China.; Li, PW (corresponding author), Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan, Peoples R China.; Li, PW (corresponding author), Minist Agr, Key Lab Detect Mycotoxins, Wuhan, Peoples R China.; Li, PW (corresponding author), Minist Agr, Lab Risk Assessment Oilseeds Prod Wuhan, Wuhan, Peoples R China.	hxliu@njau.edu.cn; peiwuli@oilcrops.cn			Special Fund for Agri-food-scientific Research in the Public Interest [201303088, 201513006]; National Key Project for Agro-product Quality & Safety Risk Assessment, PRC [GJFP2017001]; International Science & Technology Cooperation Program of China [2016YFE0112900]	Special Fund for Agri-food-scientific Research in the Public Interest; National Key Project for Agro-product Quality & Safety Risk Assessment, PRC; International Science & Technology Cooperation Program of China	This work was supported by the Special Fund for Agri-food-scientific Research in the Public Interest (201303088, 201513006), the National Key Project for Agro-product Quality & Safety Risk Assessment, PRC (GJFP2017001) and the International Science & Technology Cooperation Program of China (2016YFE0112900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Special Fund for Agri-food-scientific Research in the Public Interest (201303088, 201513006), the National Key Project for Agro-product Quality & Safety Risk Assessment, PRC (GJFP2017001) and the International Science & Technology Cooperation Program of China (2016YFE0112900).	Atehnkeng J, 2008, FOOD ADDIT CONTAM A, V25, P1264, DOI 10.1080/02652030802112635; Bock CH, 1999, BIOCONTROL SCI TECHN, V9, P529, DOI 10.1080/09583159929497; Chen R, 2014, FOOD CHEM, V146, P284, DOI 10.1016/j.foodchem.2013.09.059; Cho KM, 2009, FOOD CONTROL, V20, P402, DOI 10.1016/j.foodcont.2008.07.010; COTTY PJ, 1990, PLANT DIS, V74, P233, DOI 10.1094/PD-74-0233; Dharmaputra OS, 2003, BIOTROPIA SE ASIAN J, P21; EATON DL, 1994, ANNU REV PHARMACOL, V34, P135, DOI 10.1146/annurev.pa.34.040194.001031; Egmond HPV, 2004, TOXIN REV, V119, P92; Farombi EO, 2006, AFR J BIOTECHNOL, V5, P1; Farzaneh M, 2012, FOOD CONTROL, V23, P100, DOI 10.1016/j.foodcont.2011.06.018; Groopman JD, 2011, CURR CANCER RES, P113, DOI 10.1007/978-1-61737-995-6_6; Hedayati MT, 2007, MICROBIOL-SGM, V153, P1677, DOI 10.1099/mic.0.2007/007641-0; Henry SH, 2002, ADV EXP MED BIOL, V504, P229; Horn BW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146169; Horn BW, 2009, BIOCONTROL SCI TECHN, V19, P249, DOI 10.1080/09583150802696541; Hua SST, 2014, MYCOTOXIN RES, V30, P71, DOI 10.1007/s12550-014-0189-z; Khlangwiset P, 2011, CRIT REV TOXICOL, V41, P740, DOI 10.3109/10408444.2011.575766; Kong Q, 2010, INT J FOOD MICROBIOL, V139, P31, DOI 10.1016/j.ijfoodmicro.2010.01.036; Kumar SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106041; Kumar V, 2008, CROP PROT, V27, P891, DOI 10.1016/j.cropro.2007.12.011; Liang ZhiHong, 2008, Agricultural Sciences in China, V7, P1433, DOI 10.1016/S1671-2927(08)60399-5; Liu Y, 2010, ENVIRON HEALTH PERSP, V118, P818, DOI 10.1289/ehp.0901388; Mishra HN, 2003, CRIT REV FOOD SCI, V43, P245, DOI 10.1080/10408690390826518; Moore GG, 2009, MOL ECOL, V18, P4870, DOI 10.1111/j.1365-294X.2009.04414.x; Nyikal J., 2004, Morbidity and Mortality Weekly Report, V53, P790; Palumbo JD, 2007, J FOOD PROTECT, V70, P1615, DOI 10.4315/0362-028X-70.7.1615; Payne GA, 1998, ANNU REV PHYTOPATHOL, V36, P329, DOI 10.1146/annurev.phyto.36.1.329; Probst C, 2011, PLANT DIS, V95, P212, DOI 10.1094/PDIS-06-10-0438; Reddy KRN, 2010, AFR J BIOTECHNOL, V9, P4247; Samuel MS, 2014, INT BIODETER BIODEGR, V86, P202, DOI 10.1016/j.ibiod.2013.08.026; Sangmanee P, 2014, FOOD CONTROL, V40, P224, DOI 10.1016/j.foodcont.2013.12.005; Sindhu S, 2011, FOOD CHEM TOXICOL, V49, P1188, DOI 10.1016/j.fct.2011.02.014; Wild CP, 2010, CARCINOGENESIS, V31, P71, DOI 10.1093/carcin/bgp264; Wu F, 2010, FOOD ADDIT CONTAM A, V27, P496, DOI 10.1080/19440040903437865; Yang W.T., 2011, THESIS; Yazdanpanah H, 2005, FOOD CHEM TOXICOL, V43, P1135, DOI 10.1016/j.fct.2005.03.004	36	14	17	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0178810	10.1371/journal.pone.0178810	http://dx.doi.org/10.1371/journal.pone.0178810			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640833	Green Submitted, Green Published, gold			2022-12-27	WOS:000404135800010
J	Hoddinott, J; Ahmed, I; Ahmed, A; Roy, S				Hoddinott, John; Ahmed, Ishita; Ahmed, Akhter; Roy, Shalini			Behavior change communication activities improve infant and young child nutrition knowledge and practice of neighboring non-participants in a cluster-randomized trial in rural Bangladesh	PLOS ONE			English	Article							FEEDING PRACTICES; INTERVENTIONS; UNDERNUTRITION; PROGRAM	Objective To examine the impact on infant and young child nutrition knowledge and practice of mothers who were neighbors of mothers participating in a nutrition Behavior Change Communication (BCC) intervention in rural Bangladesh. Methods We analyzed data from 300 mothers whose neighbor participated in a nutrition BCC intervention and 600 mothers whose neighbor participated in an intervention that did not include BCC. We constructed measures capturing mothers' knowledge of infant and young child nutrition (IYCN) and measures of food consumption by children 6-24 m. The effect on these outcomes of exposure to a neighbor receiving a nutrition BCC intervention was estimated using ordinary least squares and probit regressions. The study was registered with Clinical-Trials. gov (Study ID: NCT02237144). Results Having a neighboring mother participate in a nutrition BCC intervention increased non-participant mothers' IYCN knowledge by 0.17 SD (translating to 0.3 more correct answers). They were 14.1 percentage points more likely to feed their 6-24 m children legumes and nuts; 11.6 percentage points more likely to feed these children vitamin A rich fruits and vegetables; and 10.0 percentage points more likely to feed these children eggs. Children of non-participant mothers who had a neighboring mother participate in a nutrition BCC intervention were 13.8 percentage points more likely to meet World Health Organization (WHO) guidelines for minimum diet diversity, 11.9 percentage points more likely to meet WHO guidelines for minimum acceptable diet, and 10.3 percentage points more likely to meet WHO guidelines for minimum meal frequency for children who continue to be breastfed after age 6m. Children aged 0-6m of non-participant mothers who are neighbors of mothers receiving BCC were 7.1 percentage points less likely to have ever consumed water-based liquids. Conclusions Studies of nutrition BCC that do not account for information spillovers to non-participants may underestimate its benefits in terms of IYCN knowledge and practice.	[Hoddinott, John] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Ahmed, Ishita] Univ Maryland, Dept Econ, College Pk, MD 20742 USA; [Ahmed, Akhter] IFPRI, Dhaka, Bangladesh; [Roy, Shalini] IFPRI, Washington, DC USA	Cornell University; University System of Maryland; University of Maryland College Park; CGIAR; International Food Policy Research Institute (IFPRI); CGIAR; International Food Policy Research Institute (IFPRI)	Hoddinott, J (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.	jfh246@cornell.edu		Hoddinott, John/0000-0002-0590-3917	German Ministry for Economic Cooperation and Development; UK's Department for International Development; Swiss Agency for Development and Cooperation (SDC); United Nations Development Programme; United Nations World Food; Department for International Development (DFID) [201448] Funding Source: researchfish	German Ministry for Economic Cooperation and Development; UK's Department for International Development; Swiss Agency for Development and Cooperation (SDC); United Nations Development Programme; United Nations World Food; Department for International Development (DFID)	This study received financial support from the German Ministry for Economic Cooperation and Development, the UK's Department for International Development, the Swiss Agency for Development and Cooperation (SDC), the United Nations Development Programme, the United Nations World Food	Ahmed AU., 2016, OPERATION IMPACTS TR; Ahmed T, 2012, J HEALTH POPUL NUTR, V30, P1; Avula R, 2013, J NUTR, V143, P2029, DOI 10.3945/jn.113.179085; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Berihu GBA, 2014, GLOB J MED RES, V13; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Caulfield Laura E., 1999, Food and Nutrition Bulletin, V20, P183; Dewey KG, 2008, MATERN CHILD NUTR, V4, P24, DOI 10.1111/j.1740-8709.2007.00124.x; Dornemann J, 2013, MATERN CHILD NUTR, V9, P74, DOI 10.1111/j.1740-8709.2012.00428.x; Fabrizio CS, 2014, MATERN CHILD NUTR, V10, P575, DOI 10.1111/mcn.12119; Garrett J., 2001, STATA TECHNICAL B; Huda TMN, 2012, SOC SCI MED, V75, P604, DOI 10.1016/j.socscimed.2011.10.042; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S1; National Institute of Population Research and Training (NIPORT) Mitra and Associates and ICF International, 2016, BANGL DEM HLTH SURV; Nguyen PH, 2013, FASEB J, V27; Qiong W, 2014, BMJ OPEN, V4; Shahrawat R, 2013, INDIAN J PEDIATR, V80, P1041, DOI 10.1007/s12098-012-0894-6; Shi L, 2011, J TROP PEDIATRICS, V57, P91, DOI 10.1093/tropej/fmq053; Vitta BS, 2016, MATERN CHILD NUTR, V12, P77, DOI 10.1111/mcn.12292; WHO, 2008, STRENGTH ACT IMPR FE; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1	24	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179866	10.1371/journal.pone.0179866	http://dx.doi.org/10.1371/journal.pone.0179866			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636674	Green Published, Green Submitted, gold			2022-12-27	WOS:000404118300061
J	Ravenscroft, J; Wazny, K; Davis, JM				Ravenscroft, John; Wazny, Kerri; Davis, John M.			Factors associated with successful transition among children with disabilities in eight European countries	PLOS ONE			English	Article								Introduction This research paper aims to assess factors reported by parents associated with the successful transition of children with complex additional support requirements that have undergone a transition between school environments from 8 European Union member states. Methods Quantitative data were collected from 306 parents within education systems from 8 EU member states (Bulgaria, Cyprus, Greece, Ireland, the Netherlands, Romania, Spain and the UK). The data were derived from an online questionnaire and consisted of 41 questions. Information was collected on: parental involvement in their child's transition, child involvement in transition, child autonomy, school ethos, professionals' involvement in transition and integrated working, such as, joint assessment, cooperation and coordination between agencies. Survey questions that were designed on a Likert-scale were included in the Principal Components Analysis (PCA), additional survey questions, along with the results from the PCA, were used to build a logistic regression model. Results Four principal components were identified accounting for 48.86% of the variability in the data. Principal component 1 (PC1), 'child inclusive ethos,' contains 16.17% of the variation. Principal component 2 (PC2), which represents child autonomy and involvement, is responsible for 8.52% of the total variation. Principal component 3 (PC3) contains questions relating to parental involvement and contributed to 12.26% of the overall variation. Principal component 4 (PC4), which involves transition planning and coordination, contributed to 11.91% of the overall variation. Finally, the principal components were included in a logistic regression to evaluate the relationship between inclusion and a successful transition, as well as whether other factors that may have influenced transition. All four principal components were significantly associated with a successful transition, with PC1 being having the most effect (OR: 4.04, CI: 2.43-7.18, p < 0.0001). Discussion To support a child with complex additional support requirements through transition from special school to mainstream, governments and professionals need to ensure children with additional support requirements and their parents are at the centre of all decisions that affect them. It is important that professionals recognise the educational, psychological, social and cultural contexts of a child with additional support requirements and their families which will provide a holistic approach and remove barriers for learning.	[Ravenscroft, John; Wazny, Kerri; Davis, John M.] Univ Edinburgh, Moray House Sch Educ, Scottish Sensory Ctr, Edinburgh, Midlothian, Scotland; [Wazny, Kerri] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Ctr Global Hlth Res, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Ravenscroft, J (corresponding author), Univ Edinburgh, Moray House Sch Educ, Scottish Sensory Ctr, Edinburgh, Midlothian, Scotland.	john.ravenscroft@ed.ac.uk	Wazny, Kerri/U-3918-2019		Education, Audiovisual and Culture Executive Agency (EACEA) under the Comenius Life Long Learning Programme [517748-LLP-2011-IECOMENIUS-CNW]	Education, Audiovisual and Culture Executive Agency (EACEA) under the Comenius Life Long Learning Programme	This work was supported by the Education, Audiovisual and Culture Executive Agency (EACEA) under the Comenius Life Long Learning Programme, 517748-LLP-2011-IECOMENIUS-CNW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abenavoli RM, 2017, EARLY CHILD RES Q, V38, P33, DOI 10.1016/j.ecresq.2016.09.001; Ainscow M., 2004, INT J INCLUSIVE EDUC, V8, P125, DOI DOI 10.1080/1360311032000158015; Ainscow M., 2003, DEV INCLUSIVE TEACHE, P15; Allan J, 2010, BRIT J SOCIOL EDUC, V31, P603, DOI 10.1080/01425692.2010.500093; [Anonymous], 2000, INT J EDUC RES, DOI DOI 10.1016/S0883-0355(00)00021-5; Bronfenbrenner U, 1979, ECOLOGY HUMAN DEV EX; Brooker L., 2008, SUPPORTING TRANSITIO; Brostrom S., 2003, TRANSITIONS EARLY YE, P52; Carter EW, 2010, RES PRACT PERS SEV D, V35, P63, DOI 10.2511/rpsd.35.3-4.63; Charles M, 2009, CHILD SOC, V23, P364, DOI 10.1111/j.1099-0860.2009.00224.x; Davis JM, 2014, INT J INCLUSIVE EDUC, V18, P515, DOI 10.1080/13603116.2013.802023; Davis J.M, 2011, INTEGRATED CHILDRENS; Davis J.M., 2015, CHILD CARE PRACTICE, V21, P33, DOI [DOI 10.1080/13575279.2014.976543, 10.1080/13575279.2014.976543]; Davis JM, TAKING 1 STEPS IS CH; Davis JM, 2014, FIESTA BEST PRACTICE; Davis JM, 2012, WORKING MULTIPROFESS; Davis JM, 2013, IMPROV SCH, V16, P5, DOI 10.1177/1365480213480260; Dolan P, 2008, CHILD CARE PRACTICE, V14, P83, DOI DOI 10.1080/13575270701733765; Dunlop A-W., 2007, INFORM TRANSITIONS E; Ebersold S., 2011, SYNTHESIS EVIDENCE A; European Union, 2010, EUR DIS STRAT 2010 2; European Union, 2012, CHART FUND RIGHTS EU; Evans J., 2002, EUROPEAN J SPECIAL N, V17, P1, DOI DOI 10.1080/08856250110098980; Fabian H., 2002, TRANSITIONS EARLY YE; FARRELL P, 2001, BRIT J SPECIAL ED, V28, P3, DOI DOI 10.1111/1467-8527.T01-1-00197; Hamalainen TJ, 2007, SOCIAL INNOVATIONS, INSTITUTIONAL CHANGE AND ECONOMIC PERFORMANCE: MAKING SENSE OF STRUCTURAL ADJUSTMENT PROCESSES IN INDUSTRIAL SECTORS, REGIONS AND SOCIETIES, P1; Jindal-Snape D., 2010, ED TRANSITIONS MOVIN; King Gillian, 2003, Physical & Occupational Therapy in Pediatrics, V23, P63, DOI 10.1300/J006v23n01_05; Kinsella W, 2008, INT J INCLUSIVE EDUC, V12, P651, DOI 10.1080/13603110802377698; MacNaughton G., 2005, DOING FOUCAULT EARLY; Munn P., 2000, SCOTTISH AFFAIRS, P116; Murphy NA, 2008, PEDIATRICS, V121, P1057, DOI 10.1542/peds.2008-0566; Piaget J., 1962, PLAY DREAMS IMITATIO; Pianta RC, 2003, SCHOOL PSYCHOL REV, V32, P331; Pianta RC, 1979, TRANSITION KINDERGAR; Pratt S., 2005, CHILDREN SOC, V19, DOI [DOI 10.1002/CHI.830, 10.1002/chi.830]; Priestley M., EUROPEAN SEMESTER 20; Qasim S, 2014, AUST J EDUC DEV PSYC, V14, P167; Riddell S, SPECIAL ED GLOBALISA; Rogoff B., 2003, CULTURAL NATURE HUMA; Schaefer JM, 2016, REM SPEC EDUC, V37, P345, DOI 10.1177/0741932516629220; Shevlin M, 2008, J RES SPEC EDUC NEED, V8, P141, DOI 10.1111/j.1471-3802.2008.00116.x; Shilling V, 2015, CHILD CARE HLTH DEV, V41, P524, DOI 10.1111/cch.12223; Slee R, 2011, FOUND FUTURES EDUC, P1; Smith E, 2014, INT J INCLUSIVE EDUC, V18, P443, DOI 10.1080/13603116.2013.788222; The United Nations, 1989, TREAT SER, V1577, P3; Thompson N., 2006, FAMILY SUPPORT REFLE; Vlachou-Balafouti A, 2000, INCLUSIVE ED POLICY, P27; Welchons LW, 2014, TOP EARLY CHILD SPEC, V35, P52	49	8	8	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179904	10.1371/journal.pone.0179904	http://dx.doi.org/10.1371/journal.pone.0179904			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY6UH	28636649	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000404118300062
J	Masood, M; Reidpath, DD				Masood, Mohd; Reidpath, Daniel D.			Effect of national wealth on BMI: An analysis of 206,266 individuals in 70 low-, middle- and high-income countries	PLOS ONE			English	Article							BODY-MASS-INDEX; MULTILEVEL ANALYSIS; UNITED-STATES; WEIGHT-GAIN; OBESITY; INEQUALITY; HEALTH; ASSOCIATIONS; GENDER; ADULTS	Background This study explores the relationship between BMI and national-wealth and the cross-level interaction effect of national-wealth and individual household-wealth using multilevel analysis. Methods Data from the World Health Survey conducted in 2002-2004, across 70 low-, middle-and high-income countries was used. Participants aged 18 years and over were selected using multistage, stratified cluster sampling. BMI was used as outcome variable. The potential determinants of individual-level BMI were participants' sex, age, marital-status, education, occupation, household-wealth and location(rural/urban) at the individual-level. The country-level factors used were average national income (GNI-PPP) and income inequality (Giniindex). A two-level random-intercepts and fixed-slopes model structure with individuals nested within countries was fitted, treating BMI as a continuous outcome. Results The weighted mean BMI and standard-error of the 206,266 people from 70-countries was 23.90 (4.84). All the low-income countries were below the 25.0 mean BMI level and most of the high-income countries were above. All wealthier quintiles of household-wealth had higher scores in BMI than lowest quintile. Each USD10000 increase in GNI-PPP was associated with a 0.4 unit increase in BMI. The Gini-index was not associated with BMI. All these variables explained 28.1% of country-level, 4.9% of individual-level and 7.7% of total variance in BMI. The cross-level interaction effect between GNI-PPP and household-wealth was significant. BMI increased as the GNI-PPP increased in first four quintiles of householdwealth. However, the BMI of the wealthiest people decreased as the GNI-PPP increased. Conclusion Both individual-level and country-level factors made an independent contribution to the BMI of the people. Household-wealth and national-income had significant interaction effects.	[Masood, Mohd] La Trobe Univ, La Trobe Rural Hlth Sch, Dept Dent & Oral Hlth, Bendigo, Australia; [Masood, Mohd; Reidpath, Daniel D.] Monash Univ, Sch Med & Hlth Sci, Global Publ Hlth, Bandar Sunway, Malaysia	La Trobe University; Monash University; Monash University Sunway	Masood, M (corresponding author), La Trobe Univ, La Trobe Rural Hlth Sch, Dept Dent & Oral Hlth, Bendigo, Australia.; Masood, M (corresponding author), Monash Univ, Sch Med & Hlth Sci, Global Publ Hlth, Bandar Sunway, Malaysia.	m.masood@latrobe.edu.au						Bates Douglas, 2014, J STAT SOFT IN PRESS; Chamieh MCa, 2013, THESIS; Chang VW, 2005, ARCH INTERN MED, V165, P2122, DOI 10.1001/archinte.165.18.2122; Chou SY, 2004, J HEALTH ECON, V23, P565, DOI 10.1016/j.jhealeco.2003.10.003; Cowell F., 2011, MEASURING INEQUALITY, P7; Dean JA, 2012, J URBAN HEALTH, V89, P196, DOI 10.1007/s11524-011-9620-3; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Du SF, 2002, PUBLIC HEALTH NUTR, V5, P169, DOI 10.1079/PHN2001290; Egger G, 2012, ECON HUM BIOL, V10, P147, DOI 10.1016/j.ehb.2012.01.002; Goldthorpe John H., 1987, SOCIAL MOBILITY CLAS; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Islam MK, 2010, HEALTH ECON, V19, P334, DOI 10.1002/hec.1479; James WPT, 2008, INT J OBESITY, V32, pS120, DOI 10.1038/ijo.2008.247; Katan MB, 2009, EUR J CLIN NUTR, V63, P2, DOI 10.1038/sj.ejcn.1602923; Kopelman P, 2007, OBES REV, V8, pVI; Lumley T., 2010, COMPLEX SURVEYS GUID, DOI [10.1002/9780470580066, DOI 10.1002/9780470580066]; Lynch JW, 1998, AM J PUBLIC HEALTH, V88, P1074, DOI 10.2105/AJPH.88.7.1074; Mellor JM, 2003, HEALTH SERV RES, V38, P137, DOI 10.1111/1475-6773.00109; Nandi A, 2014, AM J PUBLIC HEALTH, V104, pE162, DOI 10.2105/AJPH.2013.301392; Neuman M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099327; Ng SW, 2011, OBES REV, V12, P1, DOI 10.1111/j.1467-789X.2010.00750.x; Philipson T. J., 1999, LONG RUN GROWTH OBES; Pickett KE, 2005, J EPIDEMIOL COMMUN H, V59, P670, DOI 10.1136/jech.2004.028795; [R-Team Computing RFfS], 2012, COMP RFFS; Robert SA, 2004, SOC SCI MED, V59, P2421, DOI 10.1016/j.socscimed.2004.03.034; Robinson WS, 2011, INT J EPIDEMIOL, V40, P1134, DOI [10.1093/ije/dyn357, 10.1093/ije/dyr082]; Su DJ, 2012, J BIOSOC SCI, V44, P417, DOI 10.1017/S002193201100071X; Subramanian SV, 2007, J EPIDEMIOL COMMUN H, V61, P802, DOI 10.1136/jech.2006.053801; Subramanian SV, 2004, EPIDEMIOL REV, V26, P78, DOI 10.1093/epirev/mxh003; SUSSER M, 1994, AM J PUBLIC HEALTH, V84, P830, DOI 10.2105/AJPH.84.5.830; Swinburn B, 1999, PREV MED, V29, P563, DOI 10.1006/pmed.1999.0585; Swinburn B, 2004, BMJ-BRIT MED J, V329, P736, DOI 10.1136/bmj.329.7468.736; Swinburn BA, 2004, PUBLIC HEALTH NUTR, V7, P123, DOI 10.1079/PHN2003585; Volland B, 2012, EFFECTS INCOME INEQU; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Wells JCK, 2012, SOC SCI MED, V75, P482, DOI 10.1016/j.socscimed.2012.03.029; Wilkinson R., 2003, Social determinants of health: the solid facts; Wilkinson RG, 2006, SOC SCI MED, V62, P1768, DOI 10.1016/j.socscimed.2005.08.036; World Bank, 2005, WORLD DEV IND; Zhang L, 2012, MULTILEVEL STUDY EFF	40	21	22	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0178928	10.1371/journal.pone.0178928	http://dx.doi.org/10.1371/journal.pone.0178928			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JX	28662041	Green Published, gold, Green Submitted			2022-12-27	WOS:000404608300011
J	Kunzelmann, S; Forstemann, K				Kunzelmann, Stefan; Foerstemann, Klaus			Reversible perturbations of gene regulation after genome editing in Drosophila cells	PLOS ONE			English	Article							ENDO-SIRNAS; RNA PATHWAY; HETEROCHROMATIN	The prokaryotic phage defense CRISPR/cas-system has developed into a versatile toolbox for genome engineering and genetic studies in many organisms. While many efforts were spent on analyzing the consequences of off-target effects, only few studies addressed side-effects that occur due to the targeted manipulation of the genome. Here, we show that the CRISPR/cas9-mediated integration of an epitope tag in combination with a selection cassette can trigger an siRNA-mediated, epigenetic genome surveillance pathway in Drosophila melanogaster cells. After homology-directed insertion of the sequence coding for the epitope tag and the selection marker, a moderate level of siRNAs covering the inserted sequence and extending into the targeted locus was detected. This response affected protein levels less than two-fold and it persisted even after single cell cloning. However, removal of the selection cassette abolished the siRNA generation, demonstrating that this response is reversible. Consistently, marker-free genome engineering did not trigger the same surveillance mechanism. These two observations indicate that the selection cassette we employed induces an aberrant transcriptional arrangement and ultimately sets off the siRNA production. There have been prior concerns about undesirable effects induced by selection markers, but fortunately we were able to show that at least one of the epigenetic changes reverts as the marker gene is excised. Although the effects observed were rather weak (less than twofold de-repression upon ago2 or dcr-2 knock-down), we recommend that when selection markers are used during genome editing, a strategy for their subsequent removal should always be included.	[Kunzelmann, Stefan; Foerstemann, Klaus] Ludwig Maximilians Univ Munchen, Gene Ctr, Dept Biochem, Munich, Germany	University of Munich	Forstemann, K (corresponding author), Ludwig Maximilians Univ Munchen, Gene Ctr, Dept Biochem, Munich, Germany.	foerstemann@lmb.uni-muenchen.de			Sondeforschungsbereich (SFB) of the Deutsche Forschungsgemeinschaft (DFG) [646]	Sondeforschungsbereich (SFB) of the Deutsche Forschungsgemeinschaft (DFG)	The work was supported by the Sondeforschungsbereich (SFB) 646 of the Deutsche Forschungsgemeinschaft (DFG). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber GN, 2011, CURR OPIN IMMUNOL, V23, P10, DOI 10.1016/j.coi.2010.12.015; Bottcher R, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku289; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Elmer K, 2014, METHODS MOL BIOL, V1173, P33, DOI 10.1007/978-1-4939-0931-5_4; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Halic M, 2010, CELL, V140, P504, DOI 10.1016/j.cell.2010.01.019; Hartig JV, 2011, NUCLEIC ACIDS RES, V39, P3836, DOI 10.1093/nar/gkq1324; Hartig JV, 2009, EMBO J, V28, P2932, DOI 10.1038/emboj.2009.220; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kunzelmann S, 2016, G3-GENES GENOM GENET, V6, P1777, DOI 10.1534/g3.116.028241; Levin HL, 2011, NAT REV GENET, V12, P615, DOI 10.1038/nrg3030; Lin CC, 2016, G3 BETHESDA; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Rathinam VAK, 2011, VIROLOGY, V411, P153, DOI 10.1016/j.virol.2011.02.003; Vastenhouw NL, 2003, CURR BIOL, V13, P1311, DOI 10.1016/s0960-9822(03)00539-6; Verdel A, 2005, FEBS LETT, V579, P5872, DOI 10.1016/j.febslet.2005.08.083; Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37	23	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180135	10.1371/journal.pone.0180135	http://dx.doi.org/10.1371/journal.pone.0180135			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658280	Green Published, gold, Green Submitted			2022-12-27	WOS:000404607900064
J	Berntsson, SG; Landtblom, AM; Flensner, G				Berntsson, Shala Ghaderi; Landtblom, Anne-Marie; Flensner, Gullvi			Cerebellar ataxia and intrathecal baclofen therapy: Focus on patients' experiences	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; FRIEDREICH ATAXIA; CLINICAL-FEATURES; CEREBRAL-PALSY; HEALTH; INDIVIDUALS; DISABILITY; DEPRESSION; RESOURCE; DISEASES	Elucidating patients A experiences of living with chronic progressive hereditary ataxia and the symptomatic treatment with intrathecal baclofen (ITB) is the objective of the current study. A multicenter qualitative study with four patients included due to the rare combination of hereditary ataxia and ITB therapy was designed to elucidate participants' experiences through semi-structured interviews. The transcribed text was analyzed according to content analysis guidelines. Overall we identified living in the present/taking one day at a time as the main theme covering the following categories: 1) Uncertainty about the future as a consequence of living with a hereditary disease; The disease; 2) Impact on life as a whole, 3) Influence on personal life in terms of feeling forced to terminate employment, 4) Limiting daily activities, and 5) ITB therapy, advantages, and disadvantages. Uncertainty about the future was the category that affected participants' personal life, employment, and daily activities. The participants' experience of receiving ITB therapy was expressed in terms of improved quality of life due to better body position and movement as well as better sleep and pain relief.	[Berntsson, Shala Ghaderi; Landtblom, Anne-Marie] Uppsala Univ, Univ Hosp, Dept Neurosci, Neurol, Uppsala, Sweden; [Landtblom, Anne-Marie] Univ Linkoping, Med Fac, Dept Clin & Expt Med, Neurol, Linkoping, Sweden; [Flensner, Gullvi] Univ West, Dept Hlth Sci, Trollhattan, Sweden	Uppsala University; Uppsala University Hospital; Linkoping University; University West - Sweden	Berntsson, SG (corresponding author), Uppsala Univ, Univ Hosp, Dept Neurosci, Neurol, Uppsala, Sweden.	shala.berntsson@neuro.uu.se		Landtblom, Anne-Marie/0000-0001-9567-470X				Albright AL, 1996, J CHILD NEUROL, V11, P77, DOI 10.1177/088307389601100202; Ben Smail D, 2005, MOVEMENT DISORD, V20, P758, DOI 10.1002/mds.20405; Berntsson SG, 2013, CASE REP NEUROL, V5, P201, DOI 10.1159/000356823; Blomqvist P, 1997, SCAND J GASTROENTERO, V32, P1134, DOI 10.3109/00365529709002993; BOUTTE MI, 1987, SOC SCI MED, V24, P209, DOI 10.1016/0277-9536(87)90048-7; Carson AJ, 2000, J NEUROL NEUROSUR PS, V68, P202, DOI 10.1136/jnnp.68.2.202; Daker-White G, 2015, HEALTH EXPECT, V18, P177, DOI 10.1111/hex.12016; Daker-White G, 2013, PHYSIOTHERAPY, V99, P335, DOI 10.1016/j.physio.2013.02.001; Daker-White G, 2011, CHRONIC ILLN, V7, P120, DOI 10.1177/1742395310390532; Delatycki MB, 2012, J CHILD NEUROL, V27, P1133, DOI 10.1177/0883073812448230; Dickson S, 2008, INT J LANG COMM DIS, V43, P135, DOI 10.1080/13682820701862228; Dilorenzo TA, 2008, DISABIL REHABIL, V30, P1088, DOI 10.1080/09638280701464256; Egede LE, 2007, GEN HOSP PSYCHIAT, V29, P409, DOI 10.1016/j.genhosppsych.2007.06.002; Flensner G, 2003, INT J NURS STUD, V40, P707, DOI 10.1016/S0020-7489(03)00010-5; Fogel BL, 2007, LANCET NEUROL, V6, P245, DOI 10.1016/S1474-4422(07)70054-6; Fujioka S, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-14; Gauffin H, 2011, EPILEPSY BEHAV, V22, P750, DOI 10.1016/j.yebeh.2011.09.007; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Hayashi A, 2008, NEUROREHABILITATION, V23, P159; Jutel A, 2009, SOCIOL HEALTH ILL, V31, P278, DOI 10.1111/j.1467-9566.2008.01152.x; Koopman W, 1999, J Neurosci Nurs, V31, P17; Krach L E, 2006, Pediatr Rehabil, V9, P210, DOI 10.1080/13638490500138678; Kralik D, 2001, J ADV NURS, V33, P594, DOI 10.1046/j.1365-2648.2001.01704.x; Lebre AS, 2003, CYTOGENET GENOME RES, V100, P154, DOI 10.1159/000072850; Maring J, 2013, PEDIATR PHYS THER, V25, P305, DOI 10.1097/PEP.0b013e31828ed7cb; Mathur SN, 2014, PM&R, V6, P506, DOI 10.1016/j.pmrj.2013.12.005; Mishel M H, 1988, Image J Nurs Sch, V20, P225, DOI 10.1111/j.1547-5069.1988.tb00082.x; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Mozo-Dutton L, 2012, DISABIL REHABIL, V34, P1208, DOI 10.3109/09638288.2011.638032; Natale M, 2016, CLIN NEUROL NEUROSUR, V143, P121, DOI 10.1016/j.clineuro.2016.02.016; Nuttin B, 1999, NEUROMODULATION, V2, P120, DOI 10.1046/j.1525-1403.1999.00120.x; Panourias IG, 2007, ACTA NEUROCHIR SUPPL, V97, P145; Paulson H., 1993, GENEREVIEWS; Ribai P, 2007, ARCH NEUROL-CHICAGO, V64, P558, DOI 10.1001/archneur.64.4.558; Storey E, 2014, SEMIN NEUROL, V34, P280, DOI 10.1055/s-0034-1386766; Strickland K, 2016, J CLIN NURSING	36	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0180054	10.1371/journal.pone.0180054	http://dx.doi.org/10.1371/journal.pone.0180054			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654671	Green Submitted, gold, Green Published			2022-12-27	WOS:000404541500051
J	Savini, L; Candeloro, L; Conte, A; De Massis, F; Giovannini, A				Savini, L.; Candeloro, L.; Conte, A.; De Massis, F.; Giovannini, A.			Development of a forecasting model for brucellosis spreading in the Italian cattle trade network aimed to prioritise the field interventions	PLOS ONE			English	Article							BOVINE BRUCELLOSIS; SIMULATION-MODEL; TRANSMISSION; ENVIRONMENT; EPIDEMIC; RISK	Brucellosis caused by Brucella abortus is an important zoonosis that constitutes a serious hazard to public health. Prevention of human brucellosis depends on the control of the disease in animals. Livestock movement data represent a valuable source of information to understand the pattern of contacts between holdings, which may determine the inter-herds and intra-herd spread of the disease. The manuscript addresses the use of computational epidemic models rooted in the knowledge of cattle trade network to assess the probabilities of brucellosis spread and to design control strategies. Three different spread network-based models were proposed: the DFC (Disease Flow Centrality) model based only on temporal cattle network structure and unrelated to the epidemiological disease parameters; a deterministic SIR (Susceptible-Infectious-Recovered) model; a stochastic SEIR (SusceptibleExposed- Infectious-Recovered) model in which epidemiological and demographic within-farm aspects were also modelled. Containment strategies based on farms centrality in the cattle network were tested and discussed. All three models started from the identification of the entire sub-network originated from an infected farm, up to the fifth order of contacts. Their performances were based on data collected in Sicily in the framework of the national eradication plan of brucellosis in 2009. Results show that the proposed methods improves the efficacy and efficiency of the tracing activities in comparison to the procedure currently adopted by the veterinary services in the brucellosis control, in Italy. An overall assessment shows that the SIR model is the most suitable for the practical needs of the veterinary services, being the one with the highest sensitivity and the shortest computation time.	[Savini, L.; Candeloro, L.; Conte, A.; De Massis, F.; Giovannini, A.] Ist Zooprofilatt Sperimentale Abruzzo & Molise, Natl & OIE Reference Lab Brucellosis, OIE Collaborating Ctr Vet Training Epidemiol Food, Via Campo Boario, Teramo, Italy	IZS Dell'abruzzo E Del Molise Giuseppe Caporale	Savini, L (corresponding author), Ist Zooprofilatt Sperimentale Abruzzo & Molise, Natl & OIE Reference Lab Brucellosis, OIE Collaborating Ctr Vet Training Epidemiol Food, Via Campo Boario, Teramo, Italy.	l.savini@izs.it	Conte, Annamaria/H-5869-2016; De Massis, Fabrizio/ABG-8949-2021; Giovannini, Armando/B-9828-2013; Savini, Lara LS/C-2851-2018; Candeloro, Luca/ABA-6009-2021; De Massis, Fabrizio/P-9099-2016	Conte, Annamaria/0000-0001-6975-2698; De Massis, Fabrizio/0000-0001-9811-699X; Giovannini, Armando/0000-0001-5006-5564; Savini, Lara LS/0000-0001-6175-7793; Candeloro, Luca/0000-0001-8475-3787; De Massis, Fabrizio/0000-0001-9811-699X				Ainseba Bedr'Eddine, 2010, Journal of Biological Dynamics, V4, P2, DOI 10.1080/17513750903171688; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; [Anonymous], 2015, CYTOSCAPE V 3 2 1; Calistri P, 2013, PREV VET MED, V110, P329, DOI 10.1016/j.prevetmed.2012.12.008; Caporale V., 2009, P 10 C OIE REG COMM, P111; De Massis F, 2005, Clin Microbiol Infect, V11, P632, DOI 10.1111/j.1469-0691.2005.01204.x; Aparicio ED, 2013, REV SCI TECH OIE, V32, P53; Dube C, 2011, REV SCI TECH OIE, V30, P425; Dubie T, 2014, GLOBAL RES J PUBLIC, V1; England T, 2004, PREV VET MED, V63, P63, DOI 10.1016/j.prevetmed.2004.01.009; Gabor C, 2015, PACKAGE IGRAPH; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Martinez-Lopez B, 2009, TRANSBOUND EMERG DIS, V56, P109, DOI 10.1111/j.1865-1682.2009.01073.x; Moore C, 2000, PHYS REV E, V61, P5678, DOI 10.1103/PhysRevE.61.5678; Natale F, 2011, PREV VET MED, V98, P111, DOI 10.1016/j.prevetmed.2010.11.013; Natale F, 2009, PREV VET MED, V92, P341, DOI 10.1016/j.prevetmed.2009.08.026; Nicoletti P, 2010, Prilozi, V31, P21; Ortiz-Pelaez A, 2006, PREV VET MED, V76, P40, DOI 10.1016/j.prevetmed.2006.04.007; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Perez-Sancho Marta, 2015, CONTROL ANIMAL BRUCE; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Roy S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001259; Saegerman C, 2010, INFECTIOUS PARASITIC; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Yamamoto T, 2008, PREV VET MED, V86, P57, DOI 10.1016/j.prevetmed.2008.03.004; Zinsstag J, 2005, PREV VET MED, V69, P77, DOI 10.1016/j.prevetmed.2005.01.017	26	11	11	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0177313	10.1371/journal.pone.0177313	http://dx.doi.org/10.1371/journal.pone.0177313			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654703	gold, Green Submitted, Green Published			2022-12-27	WOS:000404541500060
J	Chien, CY; Hung, YJ; Shieh, YS; Hsieh, CH; Lu, CH; Lin, FH; Su, SC; Lee, CH				Chien, Chu-Yen; Hung, Yi-Jen; Shieh, Yi-Shing; Hsieh, Chang-Hsun; Lu, Chieh-Hua; Lin, Fu-Huang; Su, Sheng-Chiang; Lee, Chien-Hsing			A novel potential biomarker for metabolic syndrome in Chinese adults: Circulating protein disulfide isomerase family A, member 4	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; INSULIN-RESISTANCE; APOLIPOPROTEIN-B; HEPATIC STEATOSIS; OBESITY; SECRETION; INFLAMMATION; ADIPONECTIN; CHOLESTEROL; PREVALENCE	Background/Objectives Protein disulfide isomerase (PDI) family members are specific endoplasmic reticulum proteins that are involved in the pathogenesis of numerous diseases including neurodegenerative diseases, cancer and obesity. However, the metabolic effects of PDIA4 remain unclear in humans. The aims of this study were to investigate the associations of serum PDIA4 with the metabolic syndrome (MetS) and its components in Chinese adults. Subjects/Methods A total of 669 adults (399 men and 270 women) were recruited. Serum PDIA4 concentrations and biochemical variables were recorded. Insulin sensitivity and beta-cell function were examined by homeostasis model assessment. MetS was defined based on the modified National Cholesterol Education Program Adult Treatment Panel III criteria for Asia Pacific. Results The participants with MetS had significantly higher serum PDIA4 levels than those without MetS (P<0.001). After adjustments, the individuals with the highest PDIA4 tertile were associated with a higher risk of MetS than those with the lowest tertile (OR = 4.83, 95% CI: 2.71-8.60). The concentration of PDIA4 showed a stepwise increase with the components of MetS (P<0.001 for trend). The individuals with the highest PDIA4 tertile were significantly associated with waist circumference (OR = 2.41, 95% CI 1.34-4.32), blood pressure (OR = 2.71, 95% CI 1.57-4.67), fasting glucose concentration (OR = 3.17, 95% CI 1.80-5.57), and serum triglycerides (OR = 4.12, 95% CI 2.30-7.37) than those with the lowest tertile. At cutoff point of 15.24 ng/ml, the diagnostic sensitivity and specificity of PDIA4 for the metabolic syndrome were 67 and 72%, respectively, in male patients and 60 and 78%, respectively, in female patients. Finally, the result showed that PDIA4 had a significantly higher area under the curve compared with blood pressure to detect MetS using receiver operating characteristic analysis. Conclusions Serum PDIA4 concentrations are closely associated to MetS and its components in Chinese adults.	[Chien, Chu-Yen; Su, Sheng-Chiang; Lee, Chien-Hsing] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Hung, Yi-Jen; Hsieh, Chang-Hsun; Lu, Chieh-Hua; Su, Sheng-Chiang; Lee, Chien-Hsing] Natl Def Med Ctr, Tri Serv Gen Hosp, Div Endocrinol & Metab, Taipei, Taiwan; [Shieh, Yi-Shing] Natl Def Med Ctr, Sch Dent, Taipei, Taiwan; [Shieh, Yi-Shing] Tri Serv Gen Hosp, Dept Oral Diag & Pathol, Taipei, Taiwan; [Lin, Fu-Huang] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center	Lee, CH (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.; Lee, CH (corresponding author), Natl Def Med Ctr, Tri Serv Gen Hosp, Div Endocrinol & Metab, Taipei, Taiwan.	doc10383@gmail.com			National Science Council [MOST 104-2314-B-016-026, MOST 104-2314-B-016-053, MOST 105-2314-B-016-040-MY3, MOST 105-2314-B-016-030-MY2]; National Defense Medical Center [MAB-104-82]; Tri-Service General Hospital, Taiwan [TSGH-C105-005-503, TSGH-C105-005-S04, TSGH-C106-006-S01, TSGH-C106-006-S02, TSGH-C106-007-S01, TSGH-C105-120, TSGH-C105-183, TSGH-C105-184, TSGH-C105-185]	National Science Council(Ministry of Science and Technology, Taiwan); National Defense Medical Center; Tri-Service General Hospital, Taiwan	This work was supported by research grants from the National Science Council (MOST 104-2314-B-016-026, MOST 104-2314-B-016-053, MOST 105-2314-B-016-040-MY3, MOST 105-2314-B-016-030-MY2), National Defense Medical Center (MAB-104-82), and Tri-Service General Hospital (TSGH-C105-005-503, TSGH-C105-005-S04, TSGH-C106-006-S01, TSGH-C106-006-S02, TSGH-C106-007-S01, TSGH-C105-120, TSGH-C105-183, TSGH-C105-184, TSGH-C105-185), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by research grants from the National Science Council (MOST 104-2314-B-016-026, MOST 104-2314-B-016-053, MOST 105-2314-B-016-040-MY3, MOST 105-2314-B-016-030-MY2), National Defense Medical Center (MAB-104-82), and Tri-Service General Hospital (TSGH-C105-005-503, TSGH-C105-005-504, TSGH-C106-006-501, TSGH-C106-006-502, TSGH-C106-007-501, TSGH-C105-120, TSGH-C105-183, TSGH-C105-184, TSGH-C105-185), Taiwan.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Benham AM, 2012, ANTIOXID REDOX SIGN, V16, P781, DOI 10.1089/ars.2011.4439; Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; Davis RA, 1999, BBA-MOL CELL BIOL L, V1440, P1, DOI 10.1016/S1388-1981(99)00083-9; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Galligan JJ, 2012, HUM GENOMICS, V6, DOI 10.1186/1479-7364-6-6; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Grek C, 2014, ENDOPLASMIC RETICULU, V1, P4, DOI 10.2478/ersc-2013-0001; Haffner SM, 2006, AM J CARDIOL, V97, p3A, DOI 10.1016/j.amjcard.2005.11.010; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hong D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124285; Hosoi T, 2010, CLIN SCI, V118, P19, DOI 10.1042/CS20080680; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hummasti S, 2010, CIRC RES, V107, P579, DOI 10.1161/CIRCRESAHA.110.225698; Hung YJ, 2010, DIABETES CARE, V33, P1840, DOI 10.2337/dc09-1073; Jo H, 2013, HEPATOLOGY, V57, P1366, DOI 10.1002/hep.26126; Lee J, 2014, J BIOL CHEM, V289, P1203, DOI 10.1074/jbc.R113.534743; Lembar S., 2013, INDONESIAN J CLIN PA, V20, P25, DOI [10.24293/ijcpml.v20i1.442, DOI 10.24293/IJCPML.V20I1.442]; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Meigs JB, 2007, DIABETES CARE, V30, P1219, DOI 10.2337/dc06-2484; Mojiminiyi OA, 2007, INT J OBESITY, V31, P213, DOI 10.1038/sj.ijo.0803355; Morand JPF, 2005, J BIOL CHEM, V280, P17626, DOI 10.1074/jbc.M413343200; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Okumura M, 2015, FREE RADICAL BIO MED, V83, P314, DOI 10.1016/j.freeradbiomed.2015.02.010; Organization WH, 2000, AS PAC PERS RED OB I; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Panagiotakos DB, 2004, AM HEART J, V147, P106, DOI 10.1016/S0002-8703(03)00442-3; Park HS, 2004, INT J EPIDEMIOL, V33, P328, DOI 10.1093/ije/dyh032; Petremand J, 2012, DIABETES, V61, P1100, DOI 10.2337/db11-1221; Pons V, 2011, HUM MUTAT, V32, P751, DOI 10.1002/humu.21494; Prattes S, 2000, J CELL SCI, V113, P2977; Rutter MK, 2005, DIABETES, V54, P3252, DOI 10.2337/diabetes.54.11.3252; Spee P, 1999, BIOCHEMISTRY-US, V38, P10559, DOI 10.1021/bi990321r; Sun RQ, 2015, BBA-MOL BASIS DIS, V1852, P156, DOI 10.1016/j.bbadis.2014.11.017; Tan AH, 2011, METABOLISM, V60, P1186, DOI 10.1016/j.metabol.2011.01.002; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Wang ZV, 2007, MOL CELL BIOL, V27, P3716, DOI 10.1128/MCB.00931-06; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Wen-Chin Yang L-TC, 2015, PDIA4 PROTEIN TARGET; Xiong XL, 2014, J HEPATOL, V60, P847, DOI 10.1016/j.jhep.2013.12.003; YAO ZM, 1994, BBA-LIPID LIPID MET, V1212, P152, DOI 10.1016/0005-2760(94)90249-6; Zhang JY, 2003, J BIOL CHEM, V278, P7459, DOI 10.1074/jbc.M207976200	49	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179963	10.1371/journal.pone.0179963	http://dx.doi.org/10.1371/journal.pone.0179963			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650993	Green Published, Green Submitted, gold			2022-12-27	WOS:000404537300033
J	Ma, XY; Pham, VT; Mori, H; MacDougald, OA; Shah, YM; Bodary, PF				Ma, Xiaoya; Pham, Vinh T.; Mori, Hiroyuki; MacDougald, Ormond A.; Shah, Yatrik M.; Bodary, Peter F.			Iron elevation and adipose tissue remodeling in the epididymal depot of a mouse model of polygenic obesity	PLOS ONE			English	Article							ESTROGEN SULFOTRANSFERASE; CHRONIC INFLAMMATION; INSULIN-RESISTANCE; OXIDATIVE STRESS; BETA-THALASSEMIA; EXPRESSION; ADIPONECTIN; MACROPHAGES; FERRITIN; MICE	Background Iron dysregulation is a potential contributor to the pathology of obesity-related metabolic complications. KK/HIJ (KK) mice, a polygenic obese mouse model, have elevated serum iron levels. A subset of KK male mice display a bronzing of epididymal adipose tissue (eAT) associated with > 100-fold (p<0.001) higher iron concentration. Methods To further phenotype and characterize the adipose tissue iron overload, 27 male KK mice were evaluated. 14 had bronzing eAT and 13 had normal appearing eAT. Fasting serum and tissues were collected for iron content, qPCR, histology and western blot. Results High iron levels were confirmed in bronzing eAT (High Iron group, HI) versus normal iron level (NI) in normal appearing eAT. Surprisingly, iron levels in subcutaneous and brown adipose depots were not different between the groups (p>0.05). The eAT histology revealed iron retention, macrophage clustering, tissue fibrosis, cell death as well as accumulation of HIF-2 alpha in the high iron eAT. qPCR showed significantly decreased Lep (leptin) and AdipoQ (adiponectin), whereas Tnfa (tumor necrosis factor alpha), and Slc40a1 (ferroportin) were upregulated in HI (p<0.05). Elevated HIF-2 alpha, oxidative stress and local insulin signaling loss was also observed. Significance Our data suggest that deposition of iron in adipose tissue is limited to the epididymal depot in male KK mice. A robust adipose tissue remodeling is concomitant with the high iron concentration, which causes local adipose tissue insulin resistance.	[Ma, Xiaoya; Pham, Vinh T.; Bodary, Peter F.] Univ Michigan, Sch Kinesiol, 1402 Washington Hts, Ann Arbor, MI 48109 USA; [Ma, Xiaoya; Mori, Hiroyuki; MacDougald, Ormond A.; Shah, Yatrik M.] Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [MacDougald, Ormond A.; Shah, Yatrik M.] Univ Michigan, Sch Med, Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Bodary, PF (corresponding author), Univ Michigan, Sch Kinesiol, 1402 Washington Hts, Ann Arbor, MI 48109 USA.	pfbodary@umich.edu		MacDougald, Ormond/0000-0001-6907-7960	University of Michigan; Eunice Kennedy Shriver NICHD/NIH (SCCPIR) [U54-HD28934]; NIH [CA148828, DK095201];  [DK62876];  [DK092759]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028934] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA148828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R56DK062876, R01DK095201, R24DK092759, R01DK062876, P30DK089503] Funding Source: NIH RePORTER	University of Michigan(University of Michigan System); Eunice Kennedy Shriver NICHD/NIH (SCCPIR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Rackham Graduate Research Grant from University of Michigan. The University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core is supported by the Eunice Kennedy Shriver NICHD/NIH (SCCPIR) grant U54-HD28934. YMS work was supported by NIH grants (CA148828 and DK095201). OAM is supported by DK62876 and DK092759. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cighetti G, 2002, EUR J CLIN INVEST, V32, P55, DOI 10.1046/j.1365-2362.2002.0320s1055.x; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Cooksey RC, 2010, AM J PHYSIOL-ENDOC M, V298, pE1236, DOI 10.1152/ajpendo.00022.2010; Corna G, 2010, HAEMATOL-HEMATOL J, V95, P1814, DOI 10.3324/haematol.2010.023879; Dongiovanni P, 2013, AM J PATHOL, V182, P2254, DOI 10.1016/j.ajpath.2013.02.019; Farahani P, 2004, OBES RES, V12, P191, DOI 10.1038/oby.2004.26; Fernandez-Real JM, 2002, DIABETES, V51, P1000, DOI 10.2337/diabetes.51.4.1000; Gotardo EMF, 2013, J NUTR SCI VITAMINOL, V59, P454, DOI 10.3177/jnsv.59.454; Festa M, 2000, J BIOL CHEM, V275, P36708, DOI 10.1074/jbc.M004988200; Forouhi NG, 2007, DIABETOLOGIA, V50, P949, DOI 10.1007/s00125-007-0604-5; Gabrielsen JS, 2012, J CLIN INVEST, V122, P3529, DOI 10.1172/JCI44421; Ganz T, 2012, J INNATE IMMUN, V4, P446, DOI 10.1159/000336423; Green A, 2006, METABOLISM, V55, P1042, DOI 10.1016/j.metabol.2006.03.015; Hazel M, 2004, ENDOCRINOLOGY, V145, P2118, DOI 10.1210/en.2003-0812; Hotamisligil GS, 2003, INT J OBESITY, V27, pS53, DOI 10.1038/sj.ijo.0802502; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Jiang R, 2004, JAMA-J AM MED ASSOC, V291, P711, DOI 10.1001/jama.291.6.711; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Khor VK, 2008, ENDOCRINOLOGY, V149, P5440, DOI 10.1210/en.2008-0271; Khor VK, 2010, AM J PHYSIOL-ENDOC M, V299, pE657, DOI 10.1152/ajpendo.00707.2009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Ma XY, 2013, INT J SPORT NUTR EXE, V23, P513, DOI 10.1123/ijsnem.23.5.513; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; Minamiyama Y, 2010, AM J PHYSIOL-ENDOC M, V298, pE1140, DOI 10.1152/ajpendo.00620.2009; Morris DL, 2011, CURR OPIN CLIN NUTR, V14, P341, DOI 10.1097/MCO.0b013e328347970b; Orr JS, 2014, DIABETES; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Raso GM, 2009, BIOCHEM PHARMACOL, V78, P1001, DOI 10.1016/j.bcp.2009.05.034; Rebouche CJ, 2004, J BIOCHEM BIOPH METH, V58, P239, DOI 10.1016/j.jbbm.2003.11.003; Shah YM, 2009, CELL METAB, V9, P152, DOI 10.1016/j.cmet.2008.12.012; Sinke AP, 2011, PHYSIOL GENOMICS, V43, P265, DOI 10.1152/physiolgenomics.00188.2010; Tajima S, 2012, AM J PHYSIOL-ENDOC M, V302, pE77, DOI 10.1152/ajpendo.00033.2011; TANNER LI, 1987, J BIOL CHEM, V262, P8975; Valenti L, 2007, AM J GASTROENTEROL, V102, P1251, DOI 10.1111/j.1572-0241.2007.01192.x; Walter PB, 2006, BRIT J HAEMATOL, V135, P254, DOI 10.1111/j.1365-2141.2006.06277.x; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xue X, 2013, GASTROENTEROLOGY, V145, P831, DOI 10.1053/j.gastro.2013.07.010; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007	40	22	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179889	10.1371/journal.pone.0179889	http://dx.doi.org/10.1371/journal.pone.0179889			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651003	Green Published, gold, Green Submitted			2022-12-27	WOS:000404537300028
J	Xu, K; Niu, QS; Zhao, HT; Du, YL; Jiang, YS				Xu, Kai; Niu, Qingsheng; Zhao, Huiting; Du, Yali; Jiang, Yusuo			Transcriptomic analysis to uncover genes affecting cold resistance in the Chinese honey bee (Apis cerana cerana)	PLOS ONE			English	Article							SHOCK-PROTEIN GENES; THERMAL ADAPTATION; STRESS; EXPRESSION; TOLERANCE; KINASE; TEMPERATURE; ACCLIMATION; HYMENOPTERA; HARDINESS	The biological activity and geographical distribution of honey bees is strongly temperature-dependent, due to their ectothermic physiology. In China, the endemic Apis cerana cerana exhibits stronger cold hardiness than Western honey bees, making the former species important pollinators of winter-flowering plants. Although studies have examined behavioral and physiological mechanisms underlying cold resistance in bees, data are scarce regarding the exact molecular mechanisms. Here, we investigated gene expression in A. c. cerana under two temperature treatments, using transcriptomic analysis to identify differentially expressed genes (DEGs) and relevant biological processes, respectively. Across the temperature treatments, 501 DEGs were identified. A gene ontology analysis showed that DEGs were enriched in pathways related to sugar and amino acid biosynthesis and metabolism, as well as calcium ion channel activity. Additionally, heat shock proteins, zinc finger proteins, and serine/threonine-protein kinases were differentially expressed between the two treatments. The results of this study provide a general digital expression profile of thermoregulation genes responding to cold hardiness in A. c. cerana. Our data should prove valuable for future research on cold tolerance mechanisms in insects, and may be beneficial in breeding efforts to improve bee hardiness.	[Xu, Kai; Du, Yali; Jiang, Yusuo] Shanxi Agr Univ, Coll Anim Sci & Technol, Taigu, Shanxi, Peoples R China; [Niu, Qingsheng] Apiculture Sci Inst Jilin Prov, Jilin, Jilin, Peoples R China; [Zhao, Huiting] Shanxi Agr Univ, Coll Life Sci, Taigu, Shanxi, Peoples R China	Shanxi Agricultural University; Shanxi Agricultural University	Jiang, YS (corresponding author), Shanxi Agr Univ, Coll Anim Sci & Technol, Taigu, Shanxi, Peoples R China.	jiangys-001@163.com			National Nature Science Foundation of China; foundation is Qingsheng Niu;  [31372382]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); foundation is Qingsheng Niu; 	This work is supported by the National Nature Science Foundation of China. The award number of this foundation is 31372382. The recipient of this foundation is Qingsheng Niu who is the second author of this paper. The funders were undertaken to explore cold tolerance mechanism of honey bee and had an important role in study design, decision to publish, and preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bahar MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073901; Ben Saad R, 2010, PLANT MOL BIOL, V72, P171, DOI 10.1007/s11103-009-9560-4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berkvens N, 2010, J INSECT PHYSIOL, V56, P438, DOI 10.1016/j.jinsphys.2009.11.019; Blumberg H, 1979, BREAST CANC RES TREA, V139, P163; Carrillo MA, 2005, J INSECT PHYSIOL, V51, P759, DOI 10.1016/j.jinsphys.2005.03.006; CHEN CP, 1994, J INSECT PHYSIOL, V40, P661, DOI 10.1016/0022-1910(94)90093-0; CHEN CP, 1993, ECOL ENTOMOL, V18, P184, DOI 10.1111/j.1365-2311.1993.tb01088.x; Chen YJ, 2005, SCI SERICULTURE, V31, P111; Cheng WN, 2016, J INSECT PHYSIOL, V95, P66, DOI 10.1016/j.jinsphys.2016.09.005; Clark MS, 2008, J COMP PHYSIOL B, V178, P917, DOI 10.1007/s00360-008-0286-4; COELHO JR, 1991, ENVIRON ENTOMOL, V20, P1627, DOI 10.1093/ee/20.6.1627; Cohen-Katsenelson K, 2013, J BIOL CHEM, V288, P7294, DOI 10.1074/jbc.M112.422055; Colinet H, 2017, INSECT BIOCHEM MOLEC, V80, P52, DOI 10.1016/j.ibmb.2016.11.007; Dahlhoff EP, 2007, J BIOSCIENCES, V32, P477, DOI 10.1007/s12038-007-0047-7; Dennis AB, 2015, SCI REP-UK, V5, DOI 10.1038/srep13965; Doucet D, 2009, CELL MOL LIFE SCI, V66, P1404, DOI 10.1007/s00018-009-8320-6; Faucher SP, 2008, FEMS MICROBIOL LETT, V281, P160, DOI 10.1111/j.1574-6968.2008.01094.x; Feng YQ, 2015, NATURE, V528, P132, DOI 10.1038/nature16141; Feurtado JA, 2011, PLANT CELL, V23, P1772, DOI 10.1105/tpc.111.085134; Fu L, 2015, ONCOTARGET, V6, P8144, DOI 10.18632/oncotarget.3519; Fu S, 2006, PLANTA, V224, P42, DOI 10.1007/s00425-005-0191-y; Fujikake N, 2005, FEBS LETT, V579, P3842, DOI 10.1016/j.febslet.2005.05.074; Gong HC, 2001, J MEMBRANE BIOL, V184, P35, DOI 10.1007/s00232-001-0072-7; Goto M, 2001, J INSECT PHYSIOL, V47, P157, DOI 10.1016/S0022-1910(00)00099-8; Hanai S, 2004, P NATL ACAD SCI USA, V101, P82, DOI 10.1073/pnas.2237114100; Hazell SP, 2010, J INSECT PHYSIOL, V56, P115, DOI 10.1016/j.jinsphys.2009.08.020; Heinrich B, 1980, PHYS LETT A, V29, P551; HOLDEN CP, 1994, INSECT BIOCHEM MOLEC, V24, P167, DOI 10.1016/0965-1748(94)90083-3; Huang GY, 1990, J ZHEJIANG FOREST CO, P140; Janska A, 2010, PLANT BIOLOGY, V12, P395, DOI 10.1111/j.1438-8677.2009.00299.x; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kang L, 2009, ANNU REV ENTOMOL, V54, P127, DOI 10.1146/annurev.ento.54.110807.090507; King AM, 2015, ANNU REV ENTOMOL, V60, P59, DOI 10.1146/annurev-ento-011613-162107; King CD, 2000, CURR DRUG METAB, V1, P143, DOI 10.2174/1389200003339171; Kostal V, 2012, P NATL ACAD SCI USA, V109, P3270, DOI 10.1073/pnas.1119986109; Lal SV, 2015, CELL STRESS CHAPERON, V20, P545, DOI 10.1007/s12192-014-0563-y; LARSEN KJ, 1994, J INSECT PHYSIOL, V40, P859, DOI 10.1016/0022-1910(94)90019-1; LI ZY, 2006, J BEE, V26, P12; Liberek K, 2008, EMBO J, V27, P328, DOI 10.1038/sj.emboj.7601970; Liu PG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135215; Liu ZH, 2014, GENE, V545, P205, DOI 10.1016/j.gene.2014.05.034; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mahroof R, 2005, COMP BIOCHEM PHYS A, V141, P247, DOI 10.1016/j.cbpb.2005.05.044; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Nation J. L., 2002, INSECT PHYSL BIOCH, DOI DOI 10.1017/CBO9781107415324.004; Owens CD, 1971, TECHNICAL B; Park D, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-1; PATEL J, 1991, J MOL NEUROSCI, V3, P19, DOI 10.1007/BF02896845; Qin W, 2005, INSECT MOL BIOL, V14, P607, DOI 10.1111/j.1365-2583.2005.00589.x; RITTER W, 1982, APIDOLOGIE, V13, P169, DOI 10.1051/apido:19820205; Rudrabhatla P, 2002, PLANT PHYSIOL, V130, P380, DOI 10.1104/pp.005173; Rudrabhatla P, 2006, PLANT MOL BIOL, V60, P293, DOI 10.1007/s11103-005-4109-7; Sivan A, 2017, ACTA TROP, V167, P121, DOI 10.1016/j.actatropica.2016.12.017; Sorensen JG, 2005, J EVOLUTION BIOL, V18, P829, DOI 10.1111/j.1420-9101.2004.00876.x; Stabentheiner A, 1995, J COMP PHYSIOL B, V165, P433, DOI 10.1007/BF00261297; Stetina T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128976; Sun Y, 2016, INSECT SCI, V23, P37, DOI 10.1111/1744-7917.12193; Takeuchi K, 2009, SCIENCE, V323, P1740, DOI 10.1126/science.1165712; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Waagner D, 2013, J EXP BIOL, V216, P1991, DOI 10.1242/jeb.079814; Wang XH, 2010, J INSECT PHYSIOL, V56, P966, DOI 10.1016/j.jinsphys.2010.04.008; Wanke V, 1997, FEBS LETT, V402, P251, DOI 10.1016/S0014-5793(97)00009-4; Yang Guan-Huang, 2005, Acta Entomologica Sinica, V48, P401; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Yu SH, 2016, INSECT SCI, V23, P430, DOI 10.1111/1744-7917.12320; Zhao YX, 2000, J APPL ENTOMOL, V124, P185, DOI 10.1046/j.1439-0418.2000.00463.x	70	17	21	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179922	10.1371/journal.pone.0179922	http://dx.doi.org/10.1371/journal.pone.0179922			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650988	Green Published, gold, Green Submitted			2022-12-27	WOS:000404537300030
J	Cantrell, M; Peers, G				Cantrell, Michael; Peers, Graham			A mutant of Chlamydomonas without LHCSR maintains high rates of photosynthesis, but has reduced cell division rates in sinusoidal light conditions	PLOS ONE			English	Article							CARBON-CONCENTRATING MECHANISM; XANTHOPHYLL-DEFICIENT MUTANT; CYCLIC ELECTRON FLOW; PROTEIN-KINASE STT7; PHOTOSYSTEM-II; CHLOROPHYLL FLUORESCENCE; STATE TRANSITIONS; GREEN-ALGAE; PHOTOOXIDATIVE STRESS; ENERGY-DISSIPATION	The LHCSR protein belongs to the light harvesting complex family of pigment -binding proteins found in oxygenic photoautotrophs. Previous studies have shown that this complex is required for the rapid induction and relaxation of excess light energy dissipation in a wide range of eukaryotic algae and moss. The ability of cells to rapidly regulate light harvesting between this dissipation state and one favoring photochemistry is believed to be important for reducing oxidative stress and maintaining high photosynthetic efficiency in a rapidly changing light environment. We found that a mutant of Chlamydomonas reinhardtii lacking LHCSR, npq41hcsrl, displays minimal photoinhibition of photosystem II and minimal inhibition of short term oxygen evolution when grown in constant excess light compared to a wild type strain. We also investigated the impact of no LHCSR during growth in a sinusoidal light regime, which mimics daily changes in photosynthetically active radiation. The absence of LHCSR correlated with a slight reduction in the quantum efficiency of photosystem II and a stimulation of the maximal rates of photosynthesis compared to wild type. However, there was no reduction in carbon accumulation during the day. Another novel finding was that npq41hcsrl cultures underwent fewer divisions at night, reducing the overall growth rate compared to the wild type. Our results show that the rapid regulation of light harvesting mediated by LHCSR is required for high growth rates, but it is not required for efficient carbon accumulation during the day in a sinusoidal light environment. This finding has direct implications for engineering strategies directed at increasing photosynthetic productivity in mass cultures.	[Cantrell, Michael; Peers, Graham] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA	Colorado State University	Peers, G (corresponding author), Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA.	Graham.Peers@colostate.edu		Peers, Graham/0000-0002-3590-7820	Colorado State University	Colorado State University	This work was supported by funds provided by Colorado State University.	Adams WW, 2013, PHOTOSYNTH RES, V117, P31, DOI 10.1007/s11120-013-9849-7; Allorent G, 2013, PLANT CELL, V25, P545, DOI 10.1105/tpc.112.108274; Alric J, 2010, BBA-BIOENERGETICS, V1797, P44, DOI 10.1016/j.bbabio.2009.07.009; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Bailleul B, 2010, P NATL ACAD SCI USA, V107, P18214, DOI 10.1073/pnas.1007703107; Ballottari M, 2016, J BIOL CHEM, V291, P7334, DOI 10.1074/jbc.M115.704601; Baroli I, 2004, J BIOL CHEM, V279, P6337, DOI 10.1074/jbc.M312919200; Berteotti S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21339; Bisova K, 2014, J EXP BOT, V65, P2585, DOI 10.1093/jxb/ert466; Bonente G, 2012, J BIOL CHEM, V287, P5833, DOI 10.1074/jbc.M111.304279; Bonente G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000577; Brueggeman AJ, 2012, PLANT CELL, V24, P1860, DOI 10.1105/tpc.111.093435; Correa-Galvis V, 2016, J BIOL CHEM, V291, P17478, DOI 10.1074/jbc.M116.737312; CRAIGIE RA, 1982, J CELL SCI, V54, P173; Cross FR, 2015, PLANT J, V82, P370, DOI 10.1111/tpj.12795; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Derks A, 2015, BBA-BIOENERGETICS, V1847, P468, DOI 10.1016/j.bbabio.2015.02.008; Dinc E, 2016, P NATL ACAD SCI USA, V113, P7673, DOI 10.1073/pnas.1605380113; Erickson E, 2015, PLANT J, V82, P449, DOI 10.1111/tpj.12825; Golan T, 2006, PLANT CELL ENVIRON, V29, P879, DOI 10.1111/j.1365-3040.2005.01467.x; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; HORTON P, 1994, PLANT PHYSIOL, V106, P415, DOI 10.1104/pp.106.2.415; Horton P, 2012, PHILOS T R SOC B, V367, P3455, DOI 10.1098/rstb.2012.0069; Houille-Vernes L, 2011, P NATL ACAD SCI USA, V108, P20820, DOI 10.1073/pnas.1110518109; Jallet D, 2016, ALGAL RES, V18, P51, DOI 10.1016/j.algal.2016.05.014; Joliet D, 2016, CHLOROPLASTS CURRENT; Juergens MT, 2016, PLANT PHYSIOL, V171, P2445, DOI 10.1104/pp.16.00761; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Krieger-Liszkay A, 2008, PHOTOSYNTH RES, V98, P551, DOI 10.1007/s11120-008-9349-3; Kropat J, 2011, PLANT J, V66, P770, DOI 10.1111/j.1365-313X.2011.04537.x; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Ledford HK, 2004, MOL GENET GENOMICS, V272, P470, DOI 10.1007/s00438-004-1078-5; Lemeille S, 2009, PLOS BIOL, V7, P664, DOI 10.1371/journal.pbio.1000045; Li ZR, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.140, 10.1038/nplants.2016.140]; Liguori N, 2013, J AM CHEM SOC, V135, P18339, DOI 10.1021/ja4107463; Lucker B, 2013, PHOTOSYNTH RES, V117, P449, DOI 10.1007/s11120-013-9932-0; Lucker BF, 2014, ALGAL RES, V6, P242, DOI 10.1016/j.algal.2013.12.007; Malnoe A, 2014, PLANT CELL, V26, P373, DOI 10.1105/tpc.113.120113; Mathy G, 2010, J PROTEOME RES, V9, P2825, DOI 10.1021/pr900866e; MCDUFF RE, 1982, LIMNOL OCEANOGR, V27, P783, DOI 10.4319/lo.1982.27.4.0783; Murchie EH, 2011, PLANT PHYSIOL, V155, P86, DOI 10.1104/pp.110.168831; Nagy G, 2014, P NATL ACAD SCI USA, V111, P5042, DOI 10.1073/pnas.1322494111; Naumann B, 2007, PROTEOMICS, V7, P3964, DOI 10.1002/pmic.200700407; Nilkens M, 2010, BBA-BIOENERGETICS, V1797, P466, DOI 10.1016/j.bbabio.2010.01.001; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; Niyogi KK, 1997, P NATL ACAD SCI USA, V94, P14162, DOI 10.1073/pnas.94.25.14162; Niyogi KK, 1997, PLANT CELL, V9, P1369, DOI 10.2307/3870388; Niyogi KK, 2013, CURR OPIN PLANT BIOL, V16, P307, DOI 10.1016/j.pbi.2013.03.011; Oxborough K, 1997, PHOTOSYNTH RES, V54, P135, DOI 10.1023/A:1005936823310; Peers G, 2015, US Patent, Patent No. [8,940,508, 8940508]; Peers G, 2014, TRENDS BIOTECHNOL, V32, P551, DOI 10.1016/j.tibtech.2014.09.007; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Perrine Z, 2012, ALGAL RES, V1, P134, DOI 10.1016/j.algal.2012.07.002; PLATT T, 1980, J MAR RES, V38, P687; Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740; Raven J.A, 2013, AQUATIC PHOTOSYNTHES; RAVEN JA, 1989, FUNCT ECOL, V3, P5, DOI 10.2307/2389670; Raven JA, 2011, PHYSIOL PLANTARUM, V142, P87, DOI 10.1111/j.1399-3054.2011.01465.x; Richard C, 2000, PLANT MOL BIOL, V42, P303, DOI 10.1023/A:1006340308077; Ritchie RJ, 2008, PHOTOSYNTH RES, V96, P201, DOI 10.1007/s11120-008-9300-7; Ruban AV, 2015, J EXP BOT, V66, P7, DOI 10.1093/jxb/eru400; Shriwastav A, 2015, J APPL PHYCOL, V27, P211, DOI 10.1007/s10811-014-0302-x; Sun J, 2003, J PLANKTON RES, V25, P1331, DOI 10.1093/plankt/fbg096; Takahashi H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2954; Takahashi S, 2005, BBA-BIOENERGETICS, V1708, P352, DOI 10.1016/j.bbabio.2005.04.003; Tokutsu R, 2013, P NATL ACAD SCI USA, V110, P10016, DOI 10.1073/pnas.1222606110; Triantaphylides C, 2009, TRENDS PLANT SCI, V14, P219, DOI 10.1016/j.tplants.2009.01.008; Truong T. B., 2011, INVESTIGATING ROLES; Tyystjarvi E, 1996, P NATL ACAD SCI USA, V93, P2213, DOI 10.1073/pnas.93.5.2213; Umen JG, 2001, GENE DEV, V15, P1652, DOI 10.1101/gad.892101; Unlu C, 2014, P NATL ACAD SCI USA, V111, P3460, DOI 10.1073/pnas.1319164111; Vandenhecke JMR, 2015, PHOTOSYNTH RES, V124, P275, DOI 10.1007/s11120-015-0137-6; Wehner A, 2006, J BIOL CHEM, V281, P21924, DOI 10.1074/jbc.M602915200; Wobbe L, 2016, TRENDS PLANT SCI, V21, P55, DOI 10.1016/j.tplants.2015.10.004; Wobbe L, 2015, J BIOTECHNOL, V201, P28, DOI 10.1016/j.jbiotec.2014.08.021; Yamano T, 2008, PLANT PHYSIOL, V147, P340, DOI 10.1104/pp.107.114652; Yarnold J, 2016, ALGAL RES, V13, P182, DOI 10.1016/j.algal.2015.11.001; Zhang ZD, 2004, EUKARYOT CELL, V3, P1331, DOI 10.1128/EC.3.5.1331-1348.2004; Zones JM, 2015, PLANT CELL, V27, P2743, DOI 10.1105/tpc.15.00498	83	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179395	10.1371/journal.pone.0179395	http://dx.doi.org/10.1371/journal.pone.0179395			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644828	gold, Green Published, Green Submitted			2022-12-27	WOS:000404145100014
J	Kim, HS; Tian, LJ; Kim, H; Moon, WK				Kim, Hoe Suk; Tian, Lianji; Kim, Hyeonjin; Moon, Woo Kyung			Investigation of discriminant metabolites in tamoxifen-resistant and choline kinase-alpha-downregulated breast cancer cells using H-1-nuclear magnetic resonance spectroscopy	PLOS ONE			English	Article							DRUG-RESISTANCE; GLUTAMINE-METABOLISM; CARCINOMA CELLS; AUTOPHAGY; METABOLOMICS; INHIBITION; PROLIFERATION; MECHANISMS; THERAPY; GLYCINE	Metabolites linked to changes in choline kinase-alpha (CK-alpha) expression and drug resistance, which contribute to survival and autophagy mechanisms, are attractive targets for breast cancer therapies. We previously reported that autophagy played a causative role in driving tamoxifen (TAM) resistance of breast cancer cells (BCCs) and was also promoted by CK-alpha knockdown, resulting in the survival of TAM-resistant BCCs. There is no comparative study yet about the metabolites resulting from BCCs with TAM-resistance and CK-alpha knockdown. Therefore, the aim of this study was to explore the discriminant metabolic biomarkers responsible for TAM resistance as well as CK-alpha expression, which might be linked with autophagy through a protective role. A total of 33 intracellular metabolites, including a range of amino acids, energy metabolism-related molecules and others from cell extracts of the parental cells (MCF-7), TAM-resistant cells (MCF-7/TAM) and CK-alpha knockdown cells (MCF-7/shCK-alpha, MCF-7/TAM/shCK-alpha) were analyzed by proton nuclear magnetic resonance spectroscopy (H-1-NMRS). Principal component analysis (PCA) and partial least square discriminant analysis (PLS-DA) revealed the existence of differences in the intracellular metabolites to separate the 4 groups: MCF-7 cells, MCF-7/TAM cells, MCF-7-shCK-alpha cells, and MCF-7/TAM/shCK-alpha cells. The metabolites with VIP> 1 contributed most to the differentiation of the cell groups, and they included fumarate, UA (unknown A), lactate, myoinositol, glycine, phosphocholine, UE (unknown E), glutamine, formate, and AXP (AMP/ADP/ATP). Our results suggest that these altered metabolites would be promising metabolic biomarkers for a targeted therapeutic strategy in BCCs that exhibit TAM-resistance and aberrant CK-alpha expression, which triggers a survival and drug resistance mechanism.	[Kim, Hoe Suk; Tian, Lianji; Kim, Hyeonjin; Moon, Woo Kyung] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Tian, Lianji; Moon, Woo Kyung] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Kim, H; Moon, WK (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea.; Moon, WK (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea.	hyeonjinkim@snu.ac.kr; moonwk@snu.ac.kr	Kim, Hyeonjin/M-3761-2019		SNUH Research Fund to (HSK) [04-2013-1040, 04-2015-0870]; National Research Foundation of Korea (NRF); Korean government (MEST) [2015R1A2A1A05001860]; rain Korea 21 Plus [BK21Plus]	SNUH Research Fund to (HSK); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); rain Korea 21 Plus	This work was supported by grant no.04-2013-1040 and 04-2015-0870 from the SNUH Research Fund to (HSK), and the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (2015R1A2A1A05001860) to (WKM), and (LT)is awardee of graduate student fellowship funded by rain Korea 21 Plus (BK21Plus). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71; Amelio I, 2014, TRENDS BIOCHEM SCI, V39, P191, DOI 10.1016/j.tibs.2014.02.004; Brisson L, 2016, CANCER CELL, V30, P418, DOI 10.1016/j.ccell.2016.08.005; Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595; Cabot MC, 1997, INT J CANCER, V70, P567, DOI 10.1002/(SICI)1097-0215(19970304)70:5<567::AID-IJC13>3.0.CO;2-A; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Clem BF, 2011, ONCOGENE, V30, P3370, DOI 10.1038/onc.2011.51; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; de Molina AR, 2002, ONCOGENE, V21, P4317, DOI 10.1038/sj.onc.1205556; Eliyahu G, 2007, INT J CANCER, V120, P1721, DOI 10.1002/ijc.22293; Fanciulli M, 2000, CLIN CANCER RES, V6, P1590; Glunde K, 2005, CANCER RES, V65, P11034, DOI 10.1158/0008-5472.CAN-05-1807; Glunde K, 2004, CANCER RES, V64, P4270, DOI 10.1158/0008-5472.CAN-03-3829; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Jia M, 2016, CANCER RES, V76, P5634, DOI 10.1158/0008-5472.CAN-15-2910; Kim HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141110; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Martinez-Outschoorn UE, 2011, CANCER BIOL THER, V12, P924, DOI 10.4161/cbt.12.10.17780; Mitsuhashi S, 2011, AUTOPHAGY, V7, P1559, DOI 10.4161/auto.7.12.17925; Mitsuhashi S, 2011, HUM MOL GENET, V20, P3841, DOI 10.1093/hmg/ddr305; Mori N, 2015, NMR BIOMED, V28, P1697, DOI 10.1002/nbm.3429; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; Nazarewicz RR, 2007, CANCER RES, V67, P1282, DOI 10.1158/0008-5472.CAN-06-3099; NEEMAN M, 1989, CANCER RES, V49, P589; Rahman M, 2015, METABOLITES, V5, P571, DOI 10.3390/metabo5040571; Ramirez de Molina A, 2002, BIOCHEM BIOPH RES CO, V296, P580, DOI 10.1016/S0006-291X(02)00920-8; Ramirez de Molina A, 2004, CANCER RES, V64, P6732, DOI 10.1158/0008-5472.CAN-04-0489; Raykov Z, 2014, INT J CANCER, V134, P2572, DOI 10.1002/ijc.28597; Riggins RB, 2007, CANCER LETT, V256, P1, DOI 10.1016/j.canlet.2007.03.016; Ring A, 2004, ENDOCR-RELAT CANCER, V11, P643, DOI 10.1677/erc.1.00776; Rodriguez-Gonzalez A, 2005, INT J ONCOL, V26, P999; Sanchez-Lopez E, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.453; Serkova NJ, 2007, CURR OPIN MOL THER, V9, P572; Serkova NJ, 2006, EXPERT REV MOL DIAGN, V6, P717, DOI 10.1586/14737159.6.5.717; Shah T, 2010, NMR BIOMED, V23, P633, DOI 10.1002/nbm.1510; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Stewart DA, 2016, J PROTEOME RES, V15, P3225, DOI 10.1021/acs.jproteome.6b00430; Sui X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.350; Sullivan LB, 2016, NAT REV CANCER, V16, P680, DOI 10.1038/nrc.2016.85; Thewes V, 2015, CANCER RES, V75, P720, DOI 10.1158/0008-5472.CAN-14-0652; Thomas C, 2011, NAT MED, V17, P658, DOI 10.1038/nm0611-658; Thorburn A, 2014, MOL PHARMACOL, V85, P830, DOI 10.1124/mol.114.091850; Tian L, 2013, J PROTEOME RES, V12, P3738, DOI 10.1021/pr400315e; van der Vos KE, 2012, AUTOPHAGY, V8, P1862, DOI 10.4161/auto.22152; Viedma-Rodriguez R, 2014, ONCOL REP, V32, P3, DOI 10.3892/or.2014.3190; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Yalcin A, 2010, ONCOGENE, V29, P139, DOI 10.1038/onc.2009.317; Yang M, 2016, NAT REV CANCER, V16, P650, DOI 10.1038/nrc.2016.81; Zarzynska JM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/710345; Zhao Z, 2015, CANCER LETT, V358, P17, DOI 10.1016/j.canlet.2014.11.046	52	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179773	10.1371/journal.pone.0179773	http://dx.doi.org/10.1371/journal.pone.0179773			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644842	Green Published, gold, Green Submitted			2022-12-27	WOS:000404145100036
J	Zhu, YR; Reinach, PS; Zhu, HL; Tan, QF; Zheng, QX; Qu, J; Chen, W				Zhu, Yirui; Reinach, Peter S.; Zhu, Hanlei; Tan, Qiufan; Zheng, Qinxiang; Qu, Jia; Chen, Wei			High-intensity corneal collagen crosslinking with riboflavin and UVA in rat cornea	PLOS ONE			English	Article							IN-VIVO; ENZYMATIC DIGESTION; MOUSE CORNEA; KERATOCONUS; RESISTANCE; IRRADIATION; MICROSCOPY; THICKNESS; KERATITIS; STANDARD	Corneal collagen cross-linking (CXL) halts human corneal ectasias progression by increasing stromal mechanical stiffness. Although some reports describe that this procedure is effective in dealing with some infectious and immunologic corneal thinning diseases, there is a need for more animal models whose corneal thickness more closely resemble those occurring in these patients. To meet this need, we describe here high-intensity protocols that are safe and effective for obtaining CXL in rat corneas. Initially, a range of potentially effective UVA doses were evaluated based on their effectiveness in increasing tissue enzymatic resistance to dissolution. At UVA doses higher than a threshold level of 0.54 J/cm(2), resistance to enzymatic digestion increased relative to that in non-irradiated corneas. Based on the theoretical threshold CXL dose, a CXL regimen was established in which the UVA tissue irradiance was 9 mW/cm(2), which was delivered at doses of either 2.16, 2.7 or 3.24 J/cm(2). Their dose dependent effects were evaluated on ocular surface morphological integrity, keratocyte apoptotic frequency, tissue thickness and endothelial cell layer density. Doses of 2.16 and 2.7 J/cm(2) transiently decreased normal corneal transparency and increased thickness. These effects were fully reversed after 14 days. In contrast, 3.24 J/cm(2) had more irreversible side effects. Three days after treatment, apoptotic frequency in the CXL-2.16 group was lower than that at higher doses. Endothelial cell losses remained evident only in the CXL-3.24 group at 42 days posttreatment. Stromal fiber thickening was evident in all the CXL-treated groups. We determined both the threshold UVA dose using the high-intensity CXL procedure and identified an effective dose range that provides optimal CXL with minimal transient side effects in the rat cornea. These results may help to provide insight into how to improve the CXL outcome in patients afflicted with a severe corneal thinning disease.	[Qu, Jia; Chen, Wei] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; Wenzhou Med Univ, Hosp Eye, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Qu, J; Chen, W (corresponding author), Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China.	13806898805@163.com; chenweimd@hotmail.com	Reinach, Peter/AAI-3582-2021		 [81170820];  [81470605]	; 	This study was funded by the research China (81170820 and 81470605 to Wei Chen).The funders had role in study design, decision to publish and preparation of the manuscript.	Aldahlawi NH, 2016, INVEST OPHTH VIS SCI, V57, P1547, DOI 10.1167/iovs.15-18769; Aldahlawi NH, 2015, J CATARACT REFR SURG, V41, P1989, DOI 10.1016/j.jcrs.2015.10.004; Alio JL, 2013, J OPHTHALMIC INFLAMM, V3, DOI 10.1186/1869-5760-3-47; Angunawela RI, 2009, J CATARACT REFR SURG, V35, P606, DOI 10.1016/j.jcrs.2008.11.050; Bawa G, 2013, BIOMED OPT EXPRESS, V4, P2585, DOI 10.1364/BOE.4.002585; Chen YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep28145; Dhaliwal JS, 2009, CORNEA, V28, P62, DOI 10.1097/ICO.0b013e31818225c3; Ehlers N, 2009, J REFRACT SURG, V25, pS803, DOI 10.3928/1081597X-20090813-08; Gokhale NS, 2010, CORNEA, V29, P117, DOI 10.1097/ICO.0b013e3181a06c31; Hammer A, 2015, INVEST OPHTH VIS SCI, V56, P6581, DOI 10.1167/iovs.15-17426; Hovakimyan M, 2011, CORNEA, V30, P196, DOI 10.1097/ICO.0b013e3181e16d93; Iseli HP, 2008, CORNEA, V27, P590, DOI 10.1097/ICO.0b013e318169d698; JAKUS MA, 1954, AM J OPHTHALMOL, V38, P40, DOI 10.1016/0002-9394(54)90008-2; Kanellopoulos AJ, 2016, CORNEA, V35, P557, DOI 10.1097/ICO.0000000000000758; Kanellopoulos AJ, 2015, BRIT J OPHTHALMOL, V99, P870, DOI 10.1136/bjophthalmol-2014-306411; Kling S, 2017, TRANSL VIS SCI TECHN, V6, DOI 10.1167/tvst.6.1.7; Koller T, 2009, J CATARACT REFR SURG, V35, P1358, DOI 10.1016/j.jcrs.2009.03.035; Kolozsvari BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076333; Lian Y, 2013, INVEST OPHTH VIS SCI, V54, P691, DOI 10.1167/iovs.12-10263; Mazzotta C, 2015, OCUL SURF, V13, P298, DOI 10.1016/j.jtos.2015.04.007; Messmer EM, 2013, CORNEA, V32, P111, DOI 10.1097/ICO.0b013e31824d701b; Rama P, 2009, J CATARACT REFR SURG, V35, P788, DOI 10.1016/j.jcrs.2008.09.035; Schumacher S, 2011, INVEST OPHTH VIS SCI, V52, P9048, DOI 10.1167/iovs.11-7818; Schwartzkopff J, 2010, MOL VIS, V16, P2368; Spadea L, 2010, J REFRACT SURG, V26, P375, DOI 10.3928/1081597X-20100114-03; Spoerl E, 1998, EXP EYE RES, V66, P97, DOI 10.1006/exer.1997.0410; Spoerl E, 2004, CURR EYE RES, V29, P35, DOI 10.1080/02713680490513182; Spoerl E, 2007, CORNEA, V26, P385, DOI 10.1097/ICO.0b013e3180334f78; Spoerl Eberhard, 2011, Open Ophthalmol J, V5, P14, DOI 10.2174/1874364101105010014; TRESELER PA, 1986, TRANSPLANTATION, V41, P248, DOI 10.1097/00007890-198602000-00022; Wang F, 2008, OPHTHALMOLOGICA, V222, P369, DOI 10.1159/000151247; Wang JH, 2009, EYE CONTACT LENS, V35, P44, DOI 10.1097/ICL.0b013e31819579f2; Wollensak G, 2004, CORNEA, V23, P503, DOI 10.1097/01.ico.0000105827.85025.7f; Wollensak G, 2003, J CATARACT REFR SURG, V29, P1786, DOI 10.1016/S0886-3350(03)00343-2; Wollensak G, 2003, J CATARACT REFR SURG, V29, P1780, DOI 10.1016/S0886-3350(03)00407-3; Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1; Zhang HM, 2013, EXP EYE RES, V115, P255, DOI 10.1016/j.exer.2013.07.025	37	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179580	10.1371/journal.pone.0179580	http://dx.doi.org/10.1371/journal.pone.0179580			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644862	Green Published, Green Submitted, gold			2022-12-27	WOS:000404145100024
J	Alhusban, A; Kozak, A; Pillai, B; Ahmed, H; Sayed, MA; Johnson, MH; Ishrat, T; Ergul, A; Fagan, SC				Alhusban, Ahmed; Kozak, Anna; Pillai, Bindu; Ahmed, Heba; Sayed, Mohammed A.; Johnson, Maribeth H.; Ishrat, Tauheed; Ergul, Adviye; Fagan, Susan C.			Mechanisms of acute neurovascular protection with AT1 blockade after stroke: Effect of prestroke hypertension	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; NITRIC-OXIDE SYNTHASE; FOCAL CEREBRAL-ISCHEMIA; AT(1) RECEPTOR BLOCKADE; NEUROTROPHIC FACTOR; BRAIN ISCHEMIA; VASCULAR PROTECTION; OXIDATIVE STRESS; DIABETIC STROKE; UP-REGULATION	Stroke is a leading cause of adult disability worldwide. Improving stroke outcome requires an orchestrated interplay that involves up regulation of pro-survival pathways and a concomitant suppression of pro-apoptotic mediators. In this investigation, we assessed the involvement of eNOS in the AT1 blocker-mediated protective and pro-recovery effects in animals with hypertension. We also evaluated the effect of acute eNOS inhibition in hypertensive animals. To achieve these goals, spontaneously hypertensive rats (SHR) were implanted with blood pressure transmitters, and randomized to receive either an eNOS inhibitor (L-NIO) or saline one hour before cerebral ischemia induction. After 3 hours of ischemia, animals were further randomized to receive either candesartan or saline at the time of reperfusion and sacrificed either 24 hours or 7 days later. Candesartan induced an early protective effect that was independent of eNOS inhibition (50% improvement in motor function). However, the protective effect of candesartan was associated with about five fold up regulation of BDNF expression and about three fold reduction in ER stress markers, in an eNOS dependent manner. The early benefit of a single dose of candesartan, present at 24 hours after stroke, was diminished at 7 days, perhaps due to a failure to induce an angiogenic response in these hypertensive animals. In conclusion, our findings demonstrate an early prorecovery effect of candesartan at both functional and molecular levels. Candesartan induced prorecovery signaling was mediated through eNOS. This effect was not maintained at 7 days after experimental ischemia.	[Alhusban, Ahmed; Kozak, Anna; Pillai, Bindu; Ahmed, Heba; Sayed, Mohammed A.; Ishrat, Tauheed; Ergul, Adviye] Univ Georgia, Program Clin & Expt Therapeut, Charlie Norwood VA Med Ctr, Augusta, GA USA; [Alhusban, Ahmed; Kozak, Anna; Pillai, Bindu; Ahmed, Heba; Sayed, Mohammed A.; Ishrat, Tauheed; Ergul, Adviye] Univ Georgia, Coll Pharm, Augusta, GA USA; [Alhusban, Ahmed] Jordan Univ Sci & Technol, Coll Pharm, Irbid, Jordan; [Johnson, Maribeth H.; Fagan, Susan C.] Augusta Univ, Dept Biostat, Med Coll Georgia, Augusta, GA 30912 USA; [Ergul, Adviye] Augusta Univ, Dept Physiol, Med Coll Georgia, Augusta, GA USA; [Fagan, Susan C.] Augusta Univ, Dept Neurol, Med Coll Georgia, Augusta, GA 30912 USA	University System of Georgia; University of Georgia; US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Georgia; University of Georgia; Jordan University of Science & Technology; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Fagan, SC (corresponding author), Augusta Univ, Dept Biostat, Med Coll Georgia, Augusta, GA 30912 USA.; Fagan, SC (corresponding author), Augusta Univ, Dept Neurol, Med Coll Georgia, Augusta, GA 30912 USA.	sfagan@uga.edu	Alhusban, Ahmed/AEO-4211-2022	Sayed, Mohammed/0000-0001-5362-9839; Alhusban, Ahmed/0000-0003-1105-0620	NINDS [NS063965, NS054688]; VA Merit Review [BX000891, BX000347]; American Heart Association Established Investigator Award [0740002N]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083559, R01NS063965, R03NS054688] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000891, I01BX000347] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); VA Merit Review(US Department of Veterans Affairs); American Heart Association Established Investigator Award(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	Funded by NINDS grants NS063965 (SCF), NS054688 (AE), VA Merit Review: BX000891 (SCF) and BX000347 (AE) and American Heart Association Established Investigator Award 0740002N (AE).; Support: NINDS grants NS063965 (SCF) and NS054688 (AE), VA Merit Review BX000891 (SCF) and BX000347 (AE).	Abdelsaid M, 2015, DIABETES, V64, P1804, DOI 10.2337/db14-1423; Abdelsaid MA, 2012, J CELL SCI, V125, P4751, DOI 10.1242/jcs.103481; Alhusban Ahmed, 2016, Exp Transl Stroke Med, V8, P4, DOI 10.1186/s13231-016-0018-x; Alhusban A, 2015, J HYPERTENS, V33, P170, DOI 10.1097/HJH.0000000000000364; Alhusban A, 2013, J PHARMACOL EXP THER, V344, P348, DOI 10.1124/jpet.112.197483; Brdon J, 2007, J HYPERTENS, V25, P187, DOI 10.1097/01.hjh.0000254376.80864.d3; Caporali A, 2009, PHYSIOL REV, V89, P279, DOI 10.1152/physrev.00007.2008; Chen G, 2007, J NEUROSCI RES, V85, P1674, DOI 10.1002/jnr.21292; Chen JL, 2005, J NEUROSCI, V25, P2366, DOI 10.1523/JNEUROSCI.5071-04.2005; COMELLI MC, 1993, NEUROSCIENCE, V55, P473, DOI 10.1016/0306-4522(93)90517-J; Dai WJ, 1999, STROKE, V30, P2391, DOI 10.1161/01.STR.30.11.2391; de la Torre JC, 2005, J CEREBR BLOOD F MET, V25, P663, DOI 10.1038/sj.jcbfm.9600057; Dromparis P, 2013, CIRCULATION, V127, P115, DOI 10.1161/CIRCULATIONAHA.112.133413; Elgebaly MM, 2010, J CEREBR BLOOD F MET, V30, P1928, DOI 10.1038/jcbfm.2010.120; Engelhorn T, 2004, J CEREBR BLOOD F MET, V24, P467, DOI 10.1097/00004647-200404000-00012; Ergul A, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-33; Ergul A, 2012, STROKE, V43, P2270, DOI 10.1161/STROKEAHA.111.642710; Fagan SC, 2006, J HYPERTENS, V24, P535, DOI 10.1097/01.hjh.0000209990.41304.43; Fouda AY, 2017, MOL NEUROBIOL, V54, P661, DOI 10.1007/s12035-015-9675-3; Guan WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024551; Guo SZ, 2008, P NATL ACAD SCI USA, V105, P7582, DOI 10.1073/pnas.0801105105; Hamai M, 2006, NEUROPHARMACOLOGY, V51, P822, DOI 10.1016/j.neuropharm.2006.05.029; Hennigan A, 2007, BIOCHEM SOC T, V35, P424, DOI 10.1042/BST0350424; Ito T, 2002, STROKE, V33, P2297, DOI 10.1161/01.STR.0000027274.03779.F3; Iwai M, 2004, CIRCULATION, V110, P843, DOI 10.1161/01.CIR.0000138848.58269.80; Iwai M, 2008, HYPERTENS RES, V31, P161, DOI 10.1291/hypres.31.161; Jiang MH, 2002, BRAIN RES, V946, P139, DOI 10.1016/S0006-8993(02)02870-6; Kilic E, 2010, J CEREBR BLOOD F MET, V30, P969, DOI 10.1038/jcbfm.2009.268; Kishi T, 2012, J CARDIOL, V60, P489, DOI 10.1016/j.jjcc.2012.08.004; Klingbeil AU, 2003, AM J HYPERTENS, V16, P123, DOI 10.1016/S0895-7061(02)03154-0; Koh Phil-Ok, 2012, Lab Anim Res, V28, P273, DOI 10.5625/lar.2012.28.4.273; Kozak A, 2009, STROKE, V40, P1870, DOI 10.1161/STROKEAHA.108.537225; Kozak W, 2008, J PHARMACOL EXP THER, V326, P773, DOI 10.1124/jpet.108.139618; Krikov M, 2008, J HYPERTENS, V26, P544, DOI 10.1097/HJH.0b013e3282f2dac9; Liu ZW, 2011, STROKE, V42, P740, DOI 10.1161/STROKEAHA.110.607226; Lou M, 2004, J CEREBR BLOOD F MET, V24, P536, DOI 10.1097/00004647-200405000-00008; Lu Q, 2011, NITRIC OXIDE-BIOL CH, V24, P132, DOI 10.1016/j.niox.2011.01.007; Madri JA, 2009, J PHYSIOL PHARMACOL, V60, P95; Mecca AP, 2009, EXP PHYSIOL, V94, P937, DOI 10.1113/expphysiol.2009.047936; Prakash R, 2012, DIABETES, V61, P1533, DOI 10.2337/db11-1528; Qiu B, 2013, BIOCHEM BIOPH RES CO, V436, P655, DOI 10.1016/j.bbrc.2013.05.142; Roussel BD, 2013, LANCET NEUROL, V12, P105, DOI 10.1016/S1474-4422(12)70238-7; Schmerbach K, 2008, BRAIN RES, V1208, P225, DOI 10.1016/j.brainres.2008.02.032; Schulz E, 2011, HYPERTENS RES, V34, P665, DOI 10.1038/hr.2011.39; Shi QD, 2009, NEUROSCI LETT, V465, P220, DOI 10.1016/j.neulet.2009.08.049; Sierra C, 2011, CURR HYPERTENS REP, V13, P200, DOI 10.1007/s11906-011-0195-x; Srinivasan K, 2012, LIFE SCI, V90, P154, DOI 10.1016/j.lfs.2011.10.017; Sun YJ, 2005, J CEREBR BLOOD F MET, V25, P485, DOI 10.1038/sj.jcbfm.9600049; Yamakawa H, 2003, J CEREBR BLOOD F MET, V23, P371, DOI 10.1097/01.WCB.0000047369.05600.03; Young CN, 2012, J CLIN INVEST, V122, P3960, DOI 10.1172/JCI64583; Zhou J, 2006, STROKE, V37, P1271, DOI 10.1161/01.STR.0000217404.64352.d7	51	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0178867	10.1371/journal.pone.0178867	http://dx.doi.org/10.1371/journal.pone.0178867			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640888	Green Published, Green Submitted, gold			2022-12-27	WOS:000404135800013
J	Maas, F; Arends, S; Wink, FR; Bos, R; Bootsma, H; Brouwer, E; Spoorenberg, A				Maas, Fiona; Arends, Suzanne; Wink, Freke R.; Bos, Reinhard; Bootsma, Hendrika; Brouwer, Elisabeth; Spoorenberg, Anneke			Ankylosing spondylitis patients at risk of poor radiographic outcome show diminishing spinal radiographic progression during long-term treatment with TNF-a inhibitors	PLOS ONE			English	Article							BODY-MASS INDEX; AXIAL SPONDYLOARTHRITIS; DISEASE-ACTIVITY; DAMAGE; SYNDESMOPHYTES; PREDICTORS; SMOKING; SMOKERS; OBESITY; COHORT	Objective To investigate the influence of patient characteristics on the course of spinal radiographic progression in a large prospective longitudinal cohort study of ankylosing spondylitis (AS) patients treated long-term with TNF-a inhibitors. Methods Consecutive patients from the Groningen Leeuwarden AS (GLAS) cohort starting TNF-a inhibitors with spinal radiographs at least available at baseline and 6 years of follow-up were included. Radiographs were scored using mSASSS by two independent readers. Generalized estimating equations (GEE) were used to explore the associations between baseline characteristics and spinal radiographic progression. The course of radiographic progression in patients with and without risk factors for poor radiographic outcome was investigated using different time models (linear and non-linear). Single linear imputation was used in case of missing radiographic data at the intermediate (2 or 4 years) follow-up visits. Results 80 AS patients were included with mean baseline mSASSS 8.7 +/- 13.3. Baseline syndesmophytes, male gender, older age, longer symptom duration, smoking, and higher BMI were significantly associated with more radiographic damage over time. GEE analysis in patients with these risk factors revealed that radiographic progression followed a non-linear course with mean mSASSS progression rates reducing from max. 2.8 units over 0-2 years to min. 0.9 units over 4-6 years. The GEE model revealed a linear course with overall very low progression (<= 1 mSASSS units/2yrs) in patients without risk factors. Complete case analysis in 53 patients showed similar results. Conclusion AS patients at risk of poor radiographic outcome showed the highest but diminishing spinal radiographic progression during long-term treatment with TNF-a inhibitors.	[Maas, Fiona; Arends, Suzanne; Bootsma, Hendrika; Brouwer, Elisabeth; Spoorenberg, Anneke] Univ Groningen, Univ Med Ctr Groningen, Rheumatol & Clin Immunol, Groningen, Netherlands; [Arends, Suzanne; Wink, Freke R.; Bos, Reinhard; Spoorenberg, Anneke] Med Ctr Leeuwarden, Rheumatol, Leeuwarden, Netherlands	University of Groningen; Medical Center Leeuwarden	Maas, F (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Rheumatol & Clin Immunol, Groningen, Netherlands.	f.maas@umcg.nl	Brouwer, Elisabeth/AAL-9029-2020; Brouwer, Elisabeth/A-3198-2015; Bos, Reinhard/AAS-1726-2020; Arends, Suzanne/M-5436-2015	Brouwer, Elisabeth/0000-0002-5652-4423; Brouwer, Elisabeth/0000-0002-5652-4423; Arends, Suzanne/0000-0002-4422-7640; Bos, Reinhard/0000-0003-1094-5596	Pfizer	Pfizer(Pfizer)	The GLAS cohort was supported by an unrestricted grant from Pfizer. Pfizer had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraliakos X, 2007, ANN RHEUM DIS, V66, P910, DOI 10.1136/ard.2006.066415; Baraliakos X, 2009, J RHEUMATOL, V36, P997, DOI 10.3899/jrheum.080871; Braun J, 2006, ANN RHEUM DIS, V65, P316, DOI 10.1136/ard.2005.040758; Chung HY, 2012, ANN RHEUM DIS, V71, P809, DOI 10.1136/annrheumdis-2011-200180; Durcan L, 2012, J RHEUMATOL, V39, P2310, DOI 10.3899/jrheum.120595; Glintborg B, 2016, RHEUMATOLOGY, V55, P659, DOI 10.1093/rheumatology/kev392; Gremese E, 2014, RHEUMATOLOGY, V53, P875, DOI 10.1093/rheumatology/ket433; Haroon N, 2013, ARTHRITIS RHEUM-US, V65, P2645, DOI 10.1002/art.38070; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Jacques P, 2014, ANN RHEUM DIS, V73, P437, DOI 10.1136/annrheumdis-2013-203643; Jeong H, 2015, JOINT BONE SPINE, V82, P473, DOI 10.1016/j.jbspin.2014.11.009; Kaan U, 2005, RHEUMATOL INT, V25, P357, DOI 10.1007/s00296-004-0451-3; Kroon F, 2012, ANN RHEUM DIS, V71, P1623, DOI 10.1136/annrheumdis-2012-201370; Maas F, 2016, ARTHRITIS CARE RES; Maas F, 2016, J RHEUMATOL, V43, P383, DOI 10.3899/jrheum.150648; Maas F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122693; Ottaviani S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3841; Poddubnyy D, 2016, ANN RHEUM DIS; Poddubnyy D, 2012, CURR OPIN RHEUMATOL, V24, P363, DOI 10.1097/BOR.0b013e328352b7bd; Poddubnyy D, 2012, ARTHRITIS RHEUM-US, V64, P1388, DOI 10.1002/art.33465; Poddubnyy D, 2011, ANN RHEUM DIS, V70, P1369, DOI 10.1136/ard.2010.145995; Ramiro S, 2015, ANN RHEUM DIS, V74, P52, DOI 10.1136/annrheumdis-2013-204055; Ramiro S, 2014, ANN RHEUM DIS, V73, P1455, DOI 10.1136/annrheumdis-2014-205178; Spoorenberg A, 2004, J RHEUMATOL, V31, P125; US Department of Health and Human Services, HLTH CONS SMOK 50 YE; van Tubergen A, 2012, ANN RHEUM DIS, V71, P518, DOI 10.1136/annrheumdis-2011-200411; Wanders AJB, 2004, ARTHRITIS RHEUM-US, V50, P2622, DOI 10.1002/art.20446	27	26	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0177231	10.1371/journal.pone.0177231	http://dx.doi.org/10.1371/journal.pone.0177231			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640818	Green Published, Green Submitted, gold			2022-12-27	WOS:000404135800003
